PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Denyer, S; Bhimani, AD; Papastefan, S; Kheirkhah, P; Aguilar, T; Zakrzewski, J; Rosinski, CL; Patel, AS; Patel, S; Zakrzewski, V; Seksenyan, A; Prins, GS; Mehta, AI				Denyer, Steven; Bhimani, Abhiraj D.; Papastefan, Steven; Kheirkhah, Pouyan; Aguilar, Tania; Zakrzewski, Jack; Rosinski, Clayton L.; Patel, Akash S.; Patel, Saavan; Zakrzewski, Victoria; Seksenyan, Akop; Prins, Gail S.; Mehta, Ankit I.			Magnetic kyphoplasty: A novel drug delivery system for the spinal column	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; NANOPARTICLES; POLYMERS; THERAPY; DESIGN	Vertebral compression fractures (VCFs) caused by metastatic malignancies or osteoporosis are devastating injuries with debilitating outcomes for patients. Minimally invasive kyphoplasty is a common procedure used for symptomatic amelioration. However, it fails in treating the underlying etiologies of VCFs. Use of systemic therapy is limited due to low perfusion to the spinal column and systemic toxicity. Localized delivery of drugs to the vertebral column can provide a promising alternative approach. A porcine kyphoplasty model was developed to study the magnetically guided drug delivery of systemically injected magnetic nanoparticles (MNPs). Jamshidi cannulated pedicle needles were placed into the thoracic vertebra and, following inflatable bone tamp expansion, magnetic bone cement was injected to the vertebral body. Histological analysis was performed after intravenous injection of MNPs. Qualitative analysis of harvested tissues revealed successful placement of magnetic cement into the vertebral body. Further quantitative analysis of histological sections of several vertebral bodies demonstrated enhanced accumulation of MNPs to regions that had magnetic cement injected during kyphoplasty compared to those that did not. By modifying the kyphoplasty bone cement to include magnets, thereby providing a guidance stimulus and a localizer, we were successfully able to guide intravenously injected magnetic nanoparticles to the thoracic vertebra. These results demonstrate an in-vivo proof of concept of a novel drug delivery strategy that has the potential to treat the underlying causes of VCFs, in addition to providing symptomatic support.	[Denyer, Steven; Bhimani, Abhiraj D.; Papastefan, Steven; Kheirkhah, Pouyan; Aguilar, Tania; Zakrzewski, Jack; Rosinski, Clayton L.; Patel, Akash S.; Patel, Saavan; Zakrzewski, Victoria; Seksenyan, Akop; Mehta, Ankit I.] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA; [Seksenyan, Akop] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA; [Prins, Gail S.] Univ Illinois, Dept Urol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rosalind Franklin University Medical & Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, AI (corresponding author), Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.	ankitm@uic.edu	Mehta, Ankit/AAL-3851-2020	Papastefan, Steven/0000-0002-6576-1631; Zakrzewski, Jack/0000-0002-9824-8148; Denyer, Steven/0000-0001-5631-8788	University of Illinois at Chicago Department of Neurosurgery; NATIONAL CANCER INSTITUTE [R01CA172220] Funding Source: NIH RePORTER	University of Illinois at Chicago Department of Neurosurgery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by University of Illinois at Chicago Department of Neurosurgery.	Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110904; Dayyani N, 2015, EUR J MED CHEM, V98, P190, DOI 10.1016/j.ejmech.2015.05.028; Gholibegloo E, 2018, J PHOTOCH PHOTOBIO B, V181, P14, DOI 10.1016/j.jphotobiol.2018.02.004; Huang YP, 2017, MAT SCI ENG C-MATER, V70, P763, DOI 10.1016/j.msec.2016.09.052; Katonis P, 2013, CLIN MED INSIGHTS-ON, V7, P199, DOI 10.4137/CMO.S10099; Kudr J, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7090243; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; Lueshen E, 2014, NANOMEDICINE-UK, V9, P1155, DOI [10.2217/NNM.13.69, 10.2217/nnm.13.69]; Malekzadeh AM, 2017, J COLLOID INTERF SCI, V490, P64, DOI 10.1016/j.jcis.2016.11.014; Mathis JM, 2001, AM J NEURORADIOL, V22, P373; Mir M, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2249-8; Prasad Mandava, 2016, J Clin Exp Dent, V8, pe164, DOI 10.4317/jced.52352; Rezaei SJT, 2018, APPL ORGANOMET CHEM, V32, DOI 10.1002/aoc.4303; Sadr SH, 2018, J DRUG DELIV SCI TEC, V45, P240, DOI 10.1016/j.jddst.2018.03.019; Sadr SH, 2018, J BIOMAT SCI-POLYM E, V29, P277, DOI 10.1080/09205063.2017.1414482; Stadelmann VA, 2008, EUR CELLS MATER, V16, P10, DOI 10.22203/eCM.v016a02; Tarasi R, 2016, J MAGN MAGN MATER, V417, P451, DOI 10.1016/j.jmmm.2016.05.080; Venugopal I, 2017, NANOMEDICINE-UK, V12, P865, DOI 10.2217/nnm-2016-0418; Watts N B, 2001, Neurosurg Focus, V10, pE12; Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031; Yamashita S, 2018, BIOMATERIALS, V154, P74, DOI 10.1016/j.biomaterials.2017.10.053	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201402	10.1371/journal.pone.0201402	http://dx.doi.org/10.1371/journal.pone.0201402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052650	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600041
J	Eavarone, DA; Al-Alem, L; Lugovskoy, A; Prendergast, JM; Nazer, RI; Stein, JN; Dransfield, DT; Behrens, J; Rueda, BR				Eavarone, David A.; Al-Alem, Linah; Lugovskoy, Alexey; Prendergast, Jillian M.; Nazer, Rawan I.; Stein, Jenna N.; Dransfield, Daniel T.; Behrens, Jeff; Rueda, Bo R.			Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma	PLOS ONE			English	Article							POTENT ANTITUMOR-ACTIVITY; METASTATIC BREAST-CANCER; DRUG CONJUGATE; PRECLINICAL DEVELOPMENT; KLH VACCINE; GLYCOSYLATION; PHARMACOKINETICS; SPECIFICITY; EXPRESSION; PREVENTION	The expression of Sialyl-Tn (STn) in tumors is associated with metastatic disease, poor prognosis, and reduced overall survival. STn is expressed on ovarian cancer biomarkers including CA-125 (MUC16) and MUC1, and elevated serum levels of STn in ovarian cancer patients correlate with lower five-year survival rates. In the current study, we humanized novel anti-STn antibodies and demonstrated the retention of nanomolar (nM) target affinity while maintaining STn antigen selectivity. STn antibodies conjugated to Monomethyl Auristatin E (MMAE-ADCs) demonstrated in vitro cytotoxicity specific to STn-expressing ovarian cancer cell lines and tumor growth inhibition in vivo with both ovarian cancer cell line- and patient-derived xenograft models. We further validated the clinical potential of these STn-ADCs through tissue cross-reactivity and cynomolgus monkey toxicity studies. No membrane staining for STn was present in any organs of human or cynomolgus monkey origin, and the toxicity profile was favorable and only revealed MMAE-class associated events with none being attributed to the targeting of STn. The up-regulation of STn in ovarian carcinoma in combination with high affinity and STn-specific selectivity of the mAbs presented herein warrant further investigation for anti-STn antibody-drug conjugates in the clinical setting.	[Eavarone, David A.; Prendergast, Jillian M.; Nazer, Rawan I.; Stein, Jenna N.; Dransfield, Daniel T.; Behrens, Jeff] Siamab Therapeut Inc, Newton, MA 02458 USA; [Al-Alem, Linah; Rueda, Bo R.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Al-Alem, Linah; Rueda, Bo R.] Harvard Med Sch, Boston, MA USA; [Lugovskoy, Alexey] Morph Therapeut, Waltham, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Eavarone, DA (corresponding author), Siamab Therapeut Inc, Newton, MA 02458 USA.	david@siamab.com		Prendergast, Jillian/0000-0001-7965-4143	SBIR [HHSN261201600042C]; Advanced Medical Research Foundation; Siamab Therapeutics, Inc.	SBIR; Advanced Medical Research Foundation; Siamab Therapeutics, Inc.	This work was supported by SBIR Contract #HHSN261201600042C: DAE, JMP, RIN, DTD; Advanced Medical Research Foundation: BRR, LA. Siamab Therapeutics, Inc. provided support in the form of salaries or compensation for authors [DAE, AL, JMP, RIN, JNS, DTD, JB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akita K, 2012, INT J GYNECOL CANCER, V22, P531, DOI 10.1097/IGC.0b013e3182473292; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Challita-Eid PM, 2016, CANCER RES, V76, P3003, DOI 10.1158/0008-5472.CAN-15-1313; Chen KW, 2013, J PROTEOME RES, V12, P1408, DOI 10.1021/pr3010474; Christon M.A., 2013, P 15 INT TOP M NUCL, P1, DOI [10.1002/pmic.201300387.This, DOI 10.1002/PMIC.201300387.THIS]; CO MS, 1991, NATURE, V351, P501, DOI 10.1038/351501a0; Cont NT, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.584; Cotton S, 2017, MOL ONCOL, V11, P895, DOI 10.1002/1878-0261.12035; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Fang LY, 2006, J MED CHEM, V49, P6290, DOI 10.1021/jm060647f; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Groeneweg JW, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0095-1; Hauselmann I, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00028; Hege KM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0222-9; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Holmberg LA, 2001, EXPERT OPIN BIOL TH, V1, P881, DOI 10.1517/14712598.1.5.881; Ibrahim NK, 2013, J CANCER, V4, P577, DOI 10.7150/jca.7028; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Julien S, 2012, BIOMOLECULES, V2, P435, DOI 10.3390/biom2040435; Kailemia MJ, 2016, ANAL BIOANAL CHEM AN, DOI [10.1007/s00216-016-9880, DOI 10.1007/S00216-016-9880-]; KASHMIRI SVS, 1995, HYBRIDOMA, V14, P461, DOI 10.1089/hyb.1995.14.461; KOBAYASHI H, 1991, J CLIN ONCOL, V9, P983, DOI 10.1200/JCO.1991.9.6.983; KOBAYASHI H, 1992, J CLIN ONCOL, V10, P95, DOI 10.1200/JCO.1992.10.1.95; Kolbl AC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00219; Lambert JM, 2017, ADV THER, V34, P1015, DOI 10.1007/s12325-017-0519-6; Leal M, 2015, BIOCONJUGATE CHEM, V26, P2223, DOI 10.1021/acs.bioconjchem.5b00205; Lin KD, 2015, CLIN CANCER RES, V21, P5139, DOI 10.1158/1078-0432.CCR-14-3383; Liu JF, 2016, ANN ONCOL, V27, P2124, DOI 10.1093/annonc/mdw401; Ma DS, 2006, CLIN CANCER RES, V12, P2591, DOI 10.1158/1078-0432.CCR-05-2107; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Miles David, 2003, Clin Breast Cancer, V3 Suppl 4, pS134, DOI 10.3816/CBC.2003.s.002; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; MILES DW, 1994, BRIT J CANCER, V70, P1272, DOI 10.1038/bjc.1994.486; Moore KN, 2018, FUTURE ONCOL, V14, P1669, DOI 10.2217/fon-2017-0646; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Nezhat FR, 2015, AM J OBSTET GYNECOL, V213, P262, DOI 10.1016/j.ajog.2015.03.044; Ohyama C, 2008, INT J CLIN ONCOL, V13, P308, DOI 10.1007/s10147-008-0809-8; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Prendergast JM, 2017, MABS-AUSTIN, V9, P615, DOI 10.1080/19420862.2017.1290752; Qi RG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02390-7; Scales SJ, 2014, MOL CANCER THER, V13, P2630, DOI 10.1158/1535-7163.MCT-14-0487-T; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Yu X, 2016, TUMOR BIOL, V37, P12213, DOI 10.1007/s13277-016-5086-y; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048	52	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201314	10.1371/journal.pone.0201314	http://dx.doi.org/10.1371/journal.pone.0201314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052649	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600038
J	Kodidela, S; Ranjit, S; Sinha, N; McArthur, C; Kumar, A; Kumar, S				Kodidela, Sunitha; Ranjit, Sabina; Sinha, Namita; McArthur, Carole; Kumar, Anil; Kumar, Santosh			Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; VIRUS TYPE-1 REPLICATION; ANTIRETROVIRAL THERAPY; OXIDATIVE STRESS; EXTRACELLULAR VESICLES; INFLAMMATORY CYTOKINES; ETHANOL-CONSUMPTION; IMMUNE ACTIVATION; LIVER-DISEASE; MURINE AIDS	Cytokines and chemokines circulate in plasma and may be transferred to distant sites, via exosomes. HIV infection is associated with dysregulation of cytokines and chemokines, which subsequently contribute to the pathogenesis of HIV. Alcohol and tobacco exposure, which are prevalent in HIV-infected individuals, may induce changes in the expression of cytokines and chemokines. Therefore, our aim in this study was to quantify plasma exosomal cytokines and chemokines that we expect to exacerbate toxicity or disease progression in HIV-positive drug abusers. We measured the levels of cytokines and chemokines in the plasma and plasma exosomes of 39 patients comprising six groups: HIV-negative and HIV-positive non drug abusers, HIV-negative and HIV-positive alcohol users, and HIV-negative and HIV positive tobacco smokers. We measured six cytokines (TNF-alpha, IL-1 beta, IL-8, IL-6, IL1-ra, IL-10) and two chemokines (MCP-1 and RANTES). All were present in exosomes of healthy subjects, but their levels varied between different study groups. HIV-positive alcohol drinkers had higher levels of plasma IL-8 compared to those of HIV-positive non-drinkers. The IL-1ra level was significantly higher in exosomes of non-HIV-infected alcohol drinkers compared to those of HIV-positive alcohol drinkers. Interestingly, the IL-10 level was higher in exosomes compared with their respective plasma levels in all study groups except HIVpositive non-alcohol drinkers. IL-10 was completely packaged in exosomes of HIV-positive smokers. HIV-positive smokers had significantly higher levels of plasma IL-8 compared with HIV-positive non-smokers and significantly higher exosomal IL-6 levels compared with HIV-negative subjects. HIV-positive smokers had significantly increased plasma levels of IL-1ra compared to HIV-positive non-smokers. The MCP-1 levels in the plasma of HIV-positive smokers was significantly higher than in either HIV-positive non-drug abusers or HIV-negative smokers. Overall, the findings suggest that plasma cytokines and chemokines are packaged in exosomes at varying degrees in different study groups. Exosomal cytokines and chemokines are likely to have a significant biological role at distant sites including cells in the brain.	[Kodidela, Sunitha; Ranjit, Sabina; Sinha, Namita; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN 38163 USA; [McArthur, Carole] Univ Missouri Kansas City, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO USA; [Kumar, Anil] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO USA	University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN 38163 USA.	ksantosh@uthsc.edu	, sunitha/J-4231-2019; ranjit, sabina/ABE-5008-2021; Boothapati, Anil Kumar/HHS-1813-2022; Kodidela, Sunitha/AAB-2816-2019; KUMAR, ANIL/ACD-8340-2022	Kumar, Santosh/0000-0001-7846-5674	National Institute on Alcohol Abuse and Alcoholism [AA022063]; National Institute on Drug Abuse [DA042374]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Alcohol Abuse and Alcoholism, AA022063, Dr. Santosh Kumar; National Institute on Drug Abuse, DA042374, Dr. Santosh Kumar.	Ande A, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0071-x; Ande A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122402; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Arimilli S, 2017, INFLAMMATION, V40, P1622, DOI 10.1007/s10753-017-0602-9; Bagasra O, 1996, J INFECT DIS, V173, P550, DOI 10.1093/infdis/173.3.550; BAGASRA O, 1989, ALCOHOL CLIN EXP RES, V13, P636, DOI 10.1111/j.1530-0277.1989.tb00396.x; BAGASRA O, 1993, J INFECT DIS, V167, P789, DOI 10.1093/infdis/167.4.789; Bagby GJ, 2003, ALCOHOL CLIN EXP RES, V27, P495, DOI 10.1097/01.ALC.0000057947.57330.BE; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; BREEN EC, 1990, J IMMUNOL, V144, P480; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Chander G, 2008, HIV MED, V9, P196, DOI 10.1111/j.1468-1293.2008.00545.x; Chen CC, 2016, CELL MOL BIOENG, V9, P509, DOI 10.1007/s12195-016-0458-3; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen JI, 2011, J DIGEST DIS, V12, P3, DOI 10.1111/j.1751-2980.2010.00468.x; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; CSCHB, 2017, ALC DRUG US HIV RISK; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Dong R, 2016, INT J CHRONIC OBSTR, V11, P31, DOI 10.2147/COPD.S96412; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; EMILIE D, 1994, INT J IMMUNOPHARMACO, V16, P391, DOI 10.1016/0192-0561(94)90026-4; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fuster D, 2014, AIDS, V28, P1059, DOI 10.1097/QAD.0000000000000184; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Haque S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16301-9; Hodge-Bell KC, 2007, INHAL TOXICOL, V19, P361, DOI 10.1080/08958370601144076; Iho S, 2003, J LEUKOCYTE BIOL, V74, P942, DOI 10.1189/jlb.1202626; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Johnson K, 2013, J IMMUNOL, V190; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kawaratani H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/495156; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kekwaletswe CT, 2014, AIDS CARE, V26, pS78, DOI 10.1080/09540121.2014.906558; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Konadu KA, 2015, J INFECT DIS, V211, P1712, DOI 10.1093/infdis/jiu676; Kumar S, 2015, J DRUG METAB TOXICOL, P1, DOI [10.4172/2157-7609.1000e124, DOI 10.4172/2157-7609.1000E124]; Kumar S, 2017, BIOCHEM BIOPH RES CO, V491, P675, DOI 10.1016/j.bbrc.2017.07.145; Kumar S, 2015, EXPERT OPIN DRUG MET, V11, P343, DOI 10.1517/17425255.2015.996546; Kumar S, 2012, EXPERT OPIN DRUG MET, V8, P1363, DOI 10.1517/17425255.2012.714366; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Li JJ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-017-1038-8; Lin Jin, 2015, ScientificWorldJournal, V2015, P657086, DOI 10.1155/2015/657086; Louis H, 2003, ACTA GASTRO-ENT BELG, V66, P7; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810; Marshall MM, 2009, AIDS EDUC PREV, V21, P28, DOI 10.1521/aeap.2009.21.3_supp.28; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; McMaster SK, 2008, BRIT J PHARMACOL, V153, P536, DOI 10.1038/sj.bjp.0707595; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; Momen-Heravi F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0623-9; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Morojele NK, 2014, AIDS BEHAV, V18, P519, DOI 10.1007/s10461-013-0583-0; Nakamura M, 2014, BIOMARKERS, V19, P368, DOI 10.3109/1354750X.2014.915342; Parsons JT, 2008, HEALTH PSYCHOL, V27, P628, DOI 10.1037/a0012664; Persidsky Y, 2011, BRAIN BEHAV IMMUN, V25, pS61, DOI 10.1016/j.bbi.2011.03.001; Potula R, 2006, AM J PATHOL, V168, P1335, DOI 10.2353/ajpath.2006.051181; Promadej-Lanier N, 2010, JAIDS-J ACQ IMM DEF, V53, P574, DOI 10.1097/QAI.0b013e3181d3521f; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Saha B, 2016, J BIOL CHEM, V291, P149, DOI 10.1074/jbc.M115.694133; Samanta S, 2018, ACTA PHARMACOL SIN, V39, P501, DOI 10.1038/aps.2017.162; Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Sarko DK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00082; Sereti I, 2016, CURR OPIN HIV AIDS, V11, P129, DOI 10.1097/COH.0000000000000244; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Silverstein PS, 2014, CURR HIV RES, V12, P282, DOI 10.2174/1570162X12666140721122956; Singh SP, 2000, TOXICOL APPL PHARM, V164, P65, DOI 10.1006/taap.2000.8897; Teow SY, 2016, ADV VIROL, V2016, DOI 10.1155/2016/9852494; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wang JY, 1997, ALCOHOL, V14, P155, DOI 10.1016/S0741-8329(97)83138-2; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; WANG YJ, 1994, ALCOHOL CLIN EXP RES, V18, P976, DOI 10.1111/j.1530-0277.1994.tb00069.x; Wood MJA, 2011, THER DELIV, V2, P1095, DOI 10.4155/TDE.11.83; Wu KR, 2017, BBA-REV CANCER, V1868, P538, DOI 10.1016/j.bbcan.2017.10.001	78	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201144	10.1371/journal.pone.0201144	http://dx.doi.org/10.1371/journal.pone.0201144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052665	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600025
J	Menon, PS; Said, FA; Mei, GS; Berhanuddin, DD; Umar, AA; Shaari, S; Majlis, BY				Menon, P. Susthitha; Said, Fairus Atida; Mei, Gan Siew; Berhanuddin, Dilla Duryha; Umar, Akrajas Ali; Shaari, Sahbudin; Majlis, Burhanuddin Yeop			Urea and creatinine detection on nano-laminated gold thin film using Kretschmann-based surface plasmon resonance biosensor	PLOS ONE			English	Article							ENHANCED RAMAN-SCATTERING; SPR-BASED SENSOR; FABRICATION; AMMONIA	This work investigates the surface plasmon resonance (SPR) response of 50-nm thick nano-laminated gold film using Kretschmann-based biosensing for detection of urea and creatinine in solution of various concentrations (non-enzymatic samples). Comparison was made with the presence of urease and creatininase enzymes in the urea and creatinine solutions (enzymatic samples), respectively. Angular interrogation technique was applied using optical wavelengths of 670 nm and 785 nm. The biosensor detects the presence of urea and creatinine at concentrations ranging from 50-800 mM for urea samples and 10-200 mM for creatinine samples. The purpose of studying the enzymatic sample was mainly to enhance the sensitivity of the sensor towards urea and creatinine in the samples. Upon exposure to 670 nm optical wavelength, the sensitivity of 1.4 degrees/M was detected in non-enzymatic urea samples and 4 degrees/M in non-enzymatic creatinine samples. On the other hand, sensor sensitivity as high as 16.2 degrees/M in urea-urease samples and 10 degrees/M in creatinine-creatininase samples was detected. The enhanced sensitivity possibly attributed to the increase in refractive index of analyte sensing layer due to urea-urease and creatinine-creatininase coupling activity. This work has successfully proved the design and demonstrated a proof-of-concept experiment using a low-cost and easy fabrication of Kretschmann based nano-laminated gold film SPR biosensor for detection of urea and creatinine using urease and creatininase enzymes.	[Menon, P. Susthitha; Said, Fairus Atida; Mei, Gan Siew; Berhanuddin, Dilla Duryha; Umar, Akrajas Ali; Shaari, Sahbudin; Majlis, Burhanuddin Yeop] Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Ukm Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Menon, PS (corresponding author), Univ Kebangsaan Malaysia, Inst Microengn & Nanoelect, Ukm Bangi, Selangor, Malaysia.	susi@ukm.edu.my	Umar, Akrajas Ali/B-4780-2010; Umar, Akrajas Ali/K-3921-2016; bin Ahmad, Ibrahim/AAL-9554-2021; Menon, P Susthitha/H-6080-2011; Menon, P Susthitha/AAK-5229-2020	Umar, Akrajas Ali/0000-0001-8299-4827; Umar, Akrajas Ali/0000-0001-8299-4827; Menon, P Susthitha/0000-0003-4693-7934; Menon, P Susthitha/0000-0003-4693-7934	UNIVERSITI KEBANGSAAN MALAYSIA [DIP-2016-022, GUP-2016-062]; Higher Institution Centre of Excellence (HiCOE) grant from Malaysian Ministry of Higher Education [AKU-95]; Malaysian Ministry of Higher Education (KPT); Universiti Kebangsaan Malaysia (UKM) [DIP-2016-022, GUP-2016-062, AKU-95]; Institute of Microengineering and Nanoelectronics (IMEN); National University of Malaysia (UKM); KPT; Public Services Department (JPA) Malaysia	UNIVERSITI KEBANGSAAN MALAYSIA; Higher Institution Centre of Excellence (HiCOE) grant from Malaysian Ministry of Higher Education; Malaysian Ministry of Higher Education (KPT); Universiti Kebangsaan Malaysia (UKM); Institute of Microengineering and Nanoelectronics (IMEN); National University of Malaysia (UKM); KPT; Public Services Department (JPA) Malaysia	This work was supported by Grants DIP-2016-022 (Dana Impak Perdana, National Impact Grant), GUP-2016-062 (Grant Universiti Penyelidikan, Research University Grant) provided by UNIVERSITI KEBANGSAAN MALAYSIA (http://research.ukm.my/muat-turun/) AND Higher Institution Centre of Excellence (HiCOE) AKU-95 grant from Malaysian Ministry of Higher Education (https://www.mohe.gov.my/en/download/awam/borang-1/hicoe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Malaysian Ministry of Higher Education (KPT) and Universiti Kebangsaan Malaysia (UKM) using the Higher Institution Centre of Excellence (HiCOE) Grant of AKU-95, National Impact Grant DIP-2016-022 and Research University Grant GUP-2016-062. The authors would like to thank the Institute of Microengineering and Nanoelectronics (IMEN), National University of Malaysia (UKM), KPT and Public Services Department (JPA) Malaysia for the support.	Abdullah NA, 2017, ADV NAT SCI-NANOSCI, V8, P4; Ashley J, 2017, BIOSENS BIOELECTRON, V88, P109, DOI 10.1016/j.bios.2016.07.101; Bakar NA, 2017, INT J BIOMEDICAL NAN, V3, P335; Bhardwaj SK, 2018, THIN SOLID FILMS, V645, P10, DOI 10.1016/j.tsf.2017.10.021; Bhatia P, 2012, SENSOR ACTUAT B-CHEM, V161, P434, DOI 10.1016/j.snb.2011.10.056; Gomez-Grana S, 2015, CHEM MATER, V27, P8310, DOI 10.1021/acs.chemmater.5b03620; Jamil NA, 2017, PROCEEDINGS OF THE 2017 IEEE REGIONAL SYMPOSIUM ON MICRO AND NANOELECTRONICS (RSM), P112, DOI 10.1109/RSM.2017.8069122; Karim MN, 2018, BIOSENS BIOELECTRON, V110, P8, DOI 10.1016/j.bios.2018.03.025; Kumar G, 2006, J PHYS D APPL PHYS, V39, P4436, DOI 10.1088/0022-3727/39/20/021; Lee C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11644; Leordean C, 2012, SPECTROSC LETT, V45, P550, DOI 10.1080/00387010.2011.649439; Liu CS, 2006, J APPL PHYS, V100, DOI 10.1063/1.2213151; Mahadeva SK, 2013, IEEE SENS J, V13, P2223, DOI 10.1109/JSEN.2013.2250497; Meyer SA, 2012, J PHYS CHEM A, V116, P1000, DOI 10.1021/jp2107507; Mishra SK, 2014, SENSOR ACTUAT B-CHEM, V199, P190, DOI 10.1016/j.snb.2014.03.109; Mishra YK, 2013, PLASMONICS, V8, P811, DOI 10.1007/s11468-013-9477-2; Moon J, 2005, KEY ENG MATER, V277-279, P383, DOI 10.4028/www.scientific.net/KEM.277-279.383; Nooke A, 2010, SENSOR ACTUAT B-CHEM, V149, P194, DOI 10.1016/j.snb.2010.05.061; Pernites R, 2011, BIOSENS BIOELECTRON, V26, P2766, DOI 10.1016/j.bios.2010.10.027; Polavarapu L, 2016, J AM CHEM SOC, V138, P11453, DOI 10.1021/jacs.6b06706; Polinder-Bos HA, 2017, KIDNEY INT REP, V2, P676, DOI 10.1016/j.ekir.2017.02.021; Prabhash PG, 2017, SENSOR ACTUAT B-CHEM, V240, P580, DOI 10.1016/j.snb.2016.08.159; Premanode B, 2007, SENSOR ACTUAT B-CHEM, V120, P732, DOI 10.1016/j.snb.2006.03.051; Raveendran J, 2017, SENSOR ACTUAT B-CHEM, V243, P589, DOI 10.1016/j.snb.2016.11.158; Reddy KK, 2013, SENSOR ACTUAT B-CHEM, V183, P356, DOI 10.1016/j.snb.2013.04.015; Rodal-Cedeira S, 2016, CHEM MATER, V28, P9169, DOI 10.1021/acs.chemmater.6b04941; Said FA, 2017, IET NANOBIOTECHNOL, V11, P981, DOI 10.1049/iet-nbt.2017.0051; Saini A, 2015, PLASMONICS, V10, P617, DOI 10.1007/s11468-014-9847-4; Tran TQN, 2017, SENSOR ACTUAT B-CHEM, V243, P78, DOI 10.1016/j.snb.2016.11.126; Vala M, 2010, SENSOR ACTUAT B-CHEM, V148, P544, DOI 10.1016/j.snb.2010.05.067; Verma R, 2014, ANALYST, V139, P1449, DOI 10.1039/c3an01983g; Wu CM, 2005, SENSOR ACTUAT B-CHEM, V110, P231, DOI 10.1016/j.snb.2005.01.047; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001	33	33	34	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201228	10.1371/journal.pone.0201228	http://dx.doi.org/10.1371/journal.pone.0201228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052647	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600030
J	Messchaert, M; Dona, M; Broekman, S; Peters, TA; Corral-Serrano, JC; Slijkerman, RWN; van Wijk, E; Collin, RWJ				Messchaert, Muriel; Dona, Margo; Broekman, Sanne; Peters, Theo A.; Corral-Serrano, Julio C.; Slijkerman, Ralph W. N.; van Wijk, Erwin; Collin, Rob W. J.			Eyes shut homolog is important for the maintenance of photoreceptor morphology and visual function in zebrafish	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; MULLER CELLS; EYS; ORTHOLOG; DAMAGE	Mutations in eyes shut homolog (EYS), a gene predominantly expressed in the photoreceptor cells of the retina, are among the most frequent causes of autosomal recessive (ar) retinitis pigmentosa (RP), a progressive retinal disorder. Due to the absence of EYS in several rodent species and its retina-specific expression, still little is known about the exact function of EYS and the pathogenic mechanism underlying EYS-associated RP. We characterized eys in zebrafish, by RT-PCR analysis on zebrafish eye-derived RNA, which led to the identification of a 8,715 nucleotide coding sequence that is divided over 46 exons. The transcript is predicted to encode a 2,905-aa protein that contains 39 EGF-like domains and five laminin A G-like domains, which overall shows 33% identity with human EYS. To study the function of EYS, we generated a stable eys(rmc101/rmc101) mutant zebrafish model using CRISPR/Cas9 technology. The introduced lesion is predicted to result in premature termination of protein synthesis and lead to loss of Eys function. Immunohistochemistry on retinal sections revealed that Eys localizes at the region of the connecting cilium and that both rhodopsin and cone transducin are mislocalized in the absence of Eys. Electroretinogram recordings showed diminished b-wave amplitudes in eys(rmc101/rmc101) zebrafish (5 dpf) compared to age- and strain-matched wild-type larvae. In addition, decreased locomotor activity in response to light stimuli was observed in eys mutant larvae. Altogether, our study shows that absence of Eys leads to a disorganized retinal architecture and causes visual dysfunction in zebrafish.	[Messchaert, Muriel; Corral-Serrano, Julio C.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Messchaert, Muriel; Peters, Theo A.; van Wijk, Erwin; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Dona, Margo; Broekman, Sanne; Peters, Theo A.; Slijkerman, Ralph W. N.; van Wijk, Erwin] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Nijmegen, Netherlands; [Dona, Margo; Corral-Serrano, Julio C.; Slijkerman, Ralph W. N.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.; Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	rob.collin@radboudumc.nl	Dona, Margo/B-3167-2016; van Wijk, Erwin/J-8913-2014; Peters, T.A./L-4571-2015	van Wijk, Erwin/0000-0002-5702-3460; Peters, T.A./0000-0001-8443-5500; Corral Serrano, Julio Cesar/0000-0002-4277-4931	Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Oogfonds Nederland; Stichting Macula Degeneratie Fonds; Stichting Retina Nederland Fonds [UitZicht 2015-31]; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Stichting voor Ooglijders; Stichting Dowilvo; Foundation Fighting Blindness USA [PPA-0517-0717-RAD]	Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Oogfonds Nederland; Stichting Macula Degeneratie Fonds; Stichting Retina Nederland Fonds; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Stichting voor Ooglijders; Stichting Dowilvo; Foundation Fighting Blindness USA	This work was supported by the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Stichting Blinden-Penning, Landelijke Stichting voor Blinden en Slechtzienden, Stichting Oogfonds Nederland, Stichting Macula Degeneratie Fonds and Stichting Retina Nederland Fonds that contributed through UitZicht 2015-31, together with the Rotterdamse Stichting Blindenbelangen, Stichting Blindenhulp, Stichting tot Verbetering van het Lot der Blinden, Stichting voor Ooglijders and Stichting Dowilvo (to RWJC), and by the Foundation Fighting Blindness USA (PPA-0517-0717-RAD) to EvW and RWJC.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chen A, 2002, GLIA, V38, P115, DOI 10.1002/glia.10061; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Easter SS, 1996, DEV BIOL, V180, P646; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fleisch Valerie C, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4973; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Ganzen L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061185; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hosono K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031036; Huber-Reggi Sabina P, 2013, Methods Mol Biol, V935, P139, DOI 10.1007/978-1-62703-080-9_10; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Lu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46098; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morris AC, 2005, PHYSIOL BEHAV, V86, P306, DOI 10.1016/j.physbeh.2005.08.020; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; Sifuentes CJ, 2016, INVEST OPHTH VIS SCI, V57, P5148, DOI 10.1167/iovs.16-19973; Sirisi S, 2014, HUM MOL GENET, V23, P5069, DOI 10.1093/hmg/ddu231; Slijkerman RWN, 2015, PROG RETIN EYE RES, V48, P137, DOI 10.1016/j.preteyeres.2015.04.004; Tucker BA, 2013, ELIFE, V2, DOI 10.7554/eLife.00824; Wan J, 2016, CURR OPIN GENET DEV, V40, P41, DOI 10.1016/j.gde.2016.05.009; Yu M, 2016, BIOL OPEN, V5, P1662, DOI 10.1242/bio.021584; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047	29	26	28	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200789	10.1371/journal.pone.0200789	http://dx.doi.org/10.1371/journal.pone.0200789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052645	gold, Green Published, Green Submitted			2022-12-27	WOS:000440006600015
J	Panda, S; Begley, C; Daly, D				Panda, Sunita; Begley, Cecily; Daly, Deirdre			Clinicians' views of factors influencing decision-making for caesarean section: A systematic review and metasynthesis of qualitative, quantitative and mixed methods studies	PLOS ONE			English	Review							OBSTETRICIANS PERSONAL PREFERENCE; MATERNAL REQUEST; VAGINAL BIRTH; DELIVERY RATES; ATTITUDES; WOMENS; MODE; KNOWLEDGE; LEVEL	Background Caesarean section rates are increasing worldwide and are a growing concern with limited explanation of the factors that influence the rising trend. Understanding obstetricians' and midwives' views can give insight to the problem. This systematic review aimed to offer insight and understanding, through aggregation, summary, synthesis and interpretation of findings from studies that report obstetricians' and midwives' views on the factors that influence the decision to perform caesarean section. Methods The electronic databases of PubMed (1958-2016), CINAHL (1988-2016), Maternity and Infant Care (1971-2016), PsycINFO (1980-2016) and Web of Science (1991-2016) were searched in September 2016. All quantitative, qualitative and mixed methods studies, published in English, whose aim was to explore obstetricians' and/or midwives' views of factors influencing decision-making for caesarean section were included. Papers were independently reviewed by two authors for selection by title, abstract and full text. Thomas et al's 12 assessment criteria checklist (2003) was used to assess methodological quality of the included studies. Result The review included 34 studies: 19 quantitative, 14 qualitative, and one using mixed methods, involving 7785 obstetricians and 1197 midwives from 20 countries. Three main themes, each with several subthemes, emerged. Theme 1: "clinicians' personal beliefs"-('Professional philosophies'; 'beliefs in relation to women's request for CS'; 'ambiguous versus clear clinical reasons'); Theme 2: "health care systems"-('litigation'; 'resources'; 'private versus public/insurance/payments'; 'guidelines and management policy'). Theme 3: "clinicians' characteristics" ('personal convenience'; 'clinicians' demographics'; 'confidence and skills'). Conclusion This systematic review and metasynthesis identified clinicians' personal beliefs as a major factor that influenced the decision to perform caesarean section, further contributed by the influence of factors related to the health care system and clinicians' characteristics. Obstetricians and midwives are directly involved in the decision to perform a caesarean section, hence their perspectives are vital in understanding various factors that have influence on decision-making for caesarean section. These results can help clinicians identify and acknowledge their role as crucial members in the decision-making process for caesarean section within their organisation, and to develop intervention studies to reduce caesarean section rates in future.	[Panda, Sunita; Begley, Cecily; Daly, Deirdre] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland; [Begley, Cecily] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	Trinity College Dublin; University of Gothenburg	Panda, S (corresponding author), Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland.	spanda@tcd.ie		Daly, Deirdre/0000-0003-3045-9894				AlDakhil LO, 2016, J FORENSIC LEG MED, V40, P8, DOI 10.1016/j.jflm.2016.02.001; Appleton B, 2000, AUST NZ J OBSTET GYN, V40, P195, DOI 10.1111/j.1479-828X.2000.tb01146.x; Arikan DC, 2011, ARCH GYNECOL OBSTET, V284, P543, DOI 10.1007/s00404-010-1682-z; Bagheri A, 2013, WOMEN BIRTH, V26, pE45, DOI 10.1016/j.wombi.2012.09.004; Bailit JL, 2007, J REPROD MED, P52; Bergholt T, 2004, ACTA OBSTET GYN SCAN, V83, P262, DOI 10.1111/j.0001-6349.2004.0312.x; Betran AP, 2016, PLOS ONE, P11; Bettes BA, 2007, OBSTET GYNECOL, V109, P57, DOI 10.1097/01.AOG.0000249608.11864.b6; Brick A, 2016, BMC HEALTH SERV RES, V16, P1, DOI [DOI 10.1186/S12913-015-1254-9, 10.1186/s12913-015-1254-9]; Brick A, 2011, ECON SOC REV, V42, P383; Bryant J, 2007, SOC SCI MED, V65, P1192, DOI 10.1016/j.socscimed.2007.05.025; Burke N, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.017; Chaillet N, 2007, B WORLD HEALTH ORGAN, V85, P791, DOI 10.2471/BLT.06.039289; CHALMERS BE, 1992, S AFR MED J, V82, P161; Chigbu CO, 2010, J OBSTET GYNAECOL, V30, P813, DOI 10.3109/01443615.2010.489165; Coleman VH, 2005, J REPROD MED, V50, P261; Coleman-Cowger VH, 2010, J REPROD MED, V55, P25; Colomar M, 2014, MATERN CHILD HLTH J, V18, P2382, DOI 10.1007/s10995-014-1478-z; Cotzias CS, 2001, EUR J OBSTET GYN R B, V97, P15, DOI 10.1016/S0301-2115(00)00360-2; Cox KJ, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-72; Danishevski K, 2008, INT J QUAL HEALTH C, V20, P88, DOI 10.1093/intqhc/mzm070; Degani N, 2015, Ont Health Technol Assess Ser, V15, P1; Doret M, 2010, J MATERN-FETAL NEO M, V23, P1487, DOI 10.3109/14767051003678176; Edmonds JK, 2013, JOGNN-J OBST GYN NEO, V42, P3, DOI 10.1111/j.1552-6909.2012.01422.x; Faas-Fehervary P, 2005, EUR J OBSTET GYN R B, V122, P162, DOI 10.1016/j.ejogrb.2005.01.016; Foureur M, 2017, WOMEN BIRTH, V30, P3, DOI 10.1016/j.wombi.2016.05.011; Fuglenes D, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.021; Gibbons L, 2010, GLOBAL NUMBERS COSTS; Huang K, 2013, MIDWIFERY, V29, P911, DOI 10.1016/j.midw.2012.11.003; Josefsson A, 2011, MATERN CHILD HLTH J, V15, P555, DOI 10.1007/s10995-010-0630-7; Kabakian-Khasholian T, 2007, HEALTH POLICY, V83, P37, DOI 10.1016/j.healthpol.2006.11.006; Kamal P, 2005, BJOG-INT J OBSTET GY, V112, P1054, DOI 10.1111/j.1471-0528.2005.00647.x; Karlstrom Annika, 2009, Women Birth, V22, P57, DOI 10.1016/j.wombi.2008.12.002; Kawakita T, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.023; Kenton K, 2005, AM J OBSTET GYNECOL, V192, P1872, DOI 10.1016/j.ajog.2005.01.046; Koigi-Kamau R, 2005, East Afr Med J, V82, P631; Kwee A, 2004, EUR J OBSTET GYN R B, V113, P186, DOI 10.1016/j.ejogrb.2003.09.017; Litorp H, 2015, SOC SCI MED, V143, P232, DOI 10.1016/j.socscimed.2015.09.003; Litorp H, 2015, MIDWIFERY, V31, P713, DOI 10.1016/j.midw.2015.03.008; Lucas PJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-4; Lutomski JE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-13; Marshall JL, 2015, MIDWIFERY, V31, P332, DOI 10.1016/j.midw.2014.10.005; Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x; Mazzoni A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0824-0; Monari F, 2008, BIRTH-ISS PERINAT C, V35, P129, DOI 10.1111/j.1523-536X.2008.00226.x; Mylonas I, 2015, DTSCH ARZTEBL INT, V112, P489, DOI 10.3238/arztebl.2015.0489; Renes L, 2017, J MATERN-FETAL NEO M, P1; Sareh S, 2013, J OBSTET GYN INDIA, V63, P301, DOI 10.1007/s13224-013-0401-7; Schantz C, 2016, REPROD HEALTH MATTER, V24, P111, DOI 10.1016/j.rhm.2016.11.009; Thomas J., 2003, CHILDREN HLTH EATING; Turner MJ, 2011, INT J GYNECOL OBSTET, V113, P175, DOI 10.1016/j.ijgo.2011.01.012; Vogel J, 2015, LANCET GLOB HEALTH, V3, pe270; Weaver JJ, 2007, BIRTH-ISS PERINAT C, V34, P32, DOI 10.1111/j.1523-536X.2006.00144.x; Yazdizadeh B, 2011, BMC HLTH SERVICES RE; Zhao YJ, 2017, PAEDIATR PERINAT EP, V31, P251, DOI 10.1111/ppe.12363	55	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200941	10.1371/journal.pone.0200941	http://dx.doi.org/10.1371/journal.pone.0200941			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052666	Green Submitted, gold, Green Published			2022-12-27	WOS:000440006600019
J	Petrelli, F; Lazzari, C; Ardito, R; Borgonovo, K; Bulotta, A; Conti, B; Cabiddu, M; Capitanio, JF; Brighenti, M; Ghilardi, M; Gianni, L; Barni, S; Gregorc, V				Petrelli, Fausto; Lazzari, Chiara; Ardito, Raffaele; Borgonovo, Karen; Bulotta, Alessandra; Conti, Barbara; Cabiddu, Mary; Capitanio, Jody Filippo; Brighenti, Matteo; Ghilardi, Mara; Gianni, Luca; Barni, Sandro; Gregorc, Vanesa			Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies	PLOS ONE			English	Review							CELL LUNG-CANCER; OPEN-LABEL; PHASE 1/2; CRIZOTINIB; CERITINIB; ALECTINIB; CHEMOTHERAPY; EML4-ALK; SAFETY; TRIAL	Background Patients with anaplastic lymphoma kinase rearranged (ALK+) non-small cell lung cancer (NSCLC) have a higher risk of developing brain metastases (BMs) than patients with other NSCLC sub-types. ALK inhibitors have activity in BMs due to ALK+ NSCLC. We performed a systematic review of the literature with the aim of assessing the efficacy of ALK inhibitors on BMs. Material and methods A systematic search of the literature was performed using the databases Pubmed, EMBASE, Web of Science, The Cochrane Library, and SCOPUS. Relevant publications reporting activity of ALK inhibitors in NSCLC BMs were retrieved. Data were pooled using the number of events/number of evaluable patients according to fixed or random effect models. Intracranial tumour response was assessed through overall response rate (ORR), disease control rate (DCR: ORR + stable disease rate), median progression-free survival (PFS), and overall survival (OS). The primary endpoint was intracranial overall response rate (IC ORR). Results A total of 1,016 patients with BMs from 21 studies were analysed. In patients receiving ALK inhibitors in the first line setting, the pooled IC ORR was 39.17% (95% CI 13.1-65.2%), while the pooled IC ORR observed in further lines was 44.2% (95% CI 33.3-55.1%). Intracranial disease control rate (IC DCR) was 70.3% and 78.2% in naive and pre-treated patients, respectively. Patients who had not received brain radiation attained an IC ORR of 49.0%. Conclusions Based on these data, ALK inhibitors are effective in both naive and pre-treated patients with similar IC ORR and IC DCR, irrespective of the line of therapy.	[Petrelli, Fausto; Borgonovo, Karen; Cabiddu, Mary; Ghilardi, Mara; Barni, Sandro] ASST Bergamo Ovest, Oncol Unit, Oncol Dept, Treviglio, BG, Italy; [Lazzari, Chiara; Bulotta, Alessandra; Gianni, Luca; Gregorc, Vanesa] IRCCS San Raffaele, Oncol Unit, Dept Oncol, Div Expt Med, Milan, Italy; [Ardito, Raffaele] IRCCS, CROB, Oncol Unit, Via Padre Pio 1, Rionero In Vulture, PZ, Italy; [Conti, Barbara] ASST Bergamo Ovest, Surg Oncol Unit, Surg Dept, Treviglio, BG, Italy; [Capitanio, Jody Filippo] IRCCS, San Raffaele Sci Inst, Neurosurg Unit, Dept Neurosurg, Milan, Italy; [Capitanio, Jody Filippo] IRCCS, San Raffaele Sci Inst, Gamma Knife Unit, Milan, Italy; [Brighenti, Matteo] ASST Osped Cremona, Oncol Unit, Oncol Dept, Viale Concordia 1, Cremona, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS CROB; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Petrelli, F (corresponding author), ASST Bergamo Ovest, Oncol Unit, Oncol Dept, Treviglio, BG, Italy.	faupe@libero.it		GREGORC, Vanesa/0000-0001-7168-9704				Bendaly E, 2017, ADV THER, V34, P1145, DOI 10.1007/s12325-017-0527-6; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Costa DB, 2015, J CLIN ONCOL, V33, P1881, DOI 10.1200/JCO.2014.59.0539; Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Crino L, 2016, J CLIN ONCOL, V34, P2866, DOI 10.1200/JCO.2015.65.5936; Davis KL, 2017, INT J RADIAT ONCOL, V98, P239, DOI 10.1016/j.ijrobp.2017.01.169; Doherty MK, 2017, RADIOTHER ONCOL, V123, P195, DOI [10.1016/J.radonc.2017.03.007, 10.1016/j.radonc.2017.03.007]; Gadgeel SM, 2016, J CLIN ONCOL, V34, P4079, DOI 10.1200/JCO.2016.68.4639; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gainor JF, 2015, J THORAC ONCOL, V10, P232, DOI 10.1097/JTO.0000000000000455; Gettinger SN, 2016, LANCET ONCOL, V17, P1683, DOI 10.1016/S1470-2045(16)30392-8; Hida T, 2017, LANCET, V390, P29, DOI 10.1016/S0140-6736(17)30565-2; Hong XC, 2017, ONCOTARGET, V8, P41631, DOI 10.18632/oncotarget.15892; Johung KL, 2016, J CLIN ONCOL, V34, P123, DOI 10.1200/JCO.2015.62.0138; Kim DW, 2016, LANCET ONCOL, V17, P452, DOI 10.1016/S1470-2045(15)00614-2; Kort A, 2015, PHARMACOL RES, V102, P200, DOI 10.1016/j.phrs.2015.09.003; Lei YY, 2015, J THORAC DIS, V7, P1181, DOI 10.3978/j.issn.2072-1439.2015.06.04; Metro G, 2016, J NEURO-ONCOL, V129, P355, DOI 10.1007/s11060-016-2184-z; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peters S, 2017, N ENGL J MED; Rangachari D, 2015, LUNG CANCER, V88, P108, DOI 10.1016/j.lungcan.2015.01.020; Shaw AT, 2017, LANCET ONCOL, V18, P874, DOI 10.1016/S1470-2045(17)30339-X; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2016, J CLIN ONCOL, V34, P2858, DOI 10.1200/JCO.2015.63.5888; Soria J. C., 2017, LANCET; Tamura T, 2017, J CLIN ONCOL, V35, P1515, DOI 10.1200/JCO.2016.70.5749; Xing PY, 2016, ONCOTARGET, V7, P84666, DOI 10.18632/oncotarget.13179; Yang JCH, 2017, J CLIN ONCOL, V35, P1288, DOI 10.1200/JCO.2016.70.3223; Yoshida T, 2016, LUNG CANCER, V97, P43, DOI 10.1016/j.lungcan.2016.04.006; Zhang S, 2016, CLIN CANCER RES, V22, P5527, DOI 10.1158/1078-0432.CCR-16-0569	31	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201425	10.1371/journal.pone.0201425	http://dx.doi.org/10.1371/journal.pone.0201425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052658	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600045
J	Chen, HH; Chao, WC; Liao, TL; Lin, CH; Chen, DY				Chen, Hsin-Hua; Chao, Wen-Cheng; Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Der-Yuan			Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; SYSTEMIC INFLAMMATION; CYTOKINE PRODUCTION; JAPANESE PATIENTS; ARTHRITIS; ASSOCIATION; HLA; PROGRESSION; KOREANS; CELLS	Objective To estimate the relative risk of autoimmune rheumatic diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogrens syndrome (SS), dermatomyositis (DM) and polymyositis (PM), among patients with palindromic rheumatism (PR) compared with non-PR individuals. Methods The study utilized 2003-2013 claims data from the Taiwanese National Health Insurance Research Database. We identified 4,421 cases of PR from 2007 to 2012 and randomly chose 44,210 non-PR individuals who matched (1:10) for age, sex and the year of index date without prior history of RA, SLE, SSc, SS, DM, or PM. After adjusting for age, sex, and the Charlson comorbidity index, we calculated the hazard ratios (HRs) with 95% confidence intervals (CIs) using the Cox proportional hazard model to quantify the risk of RA, SLE, SS, DM and PM in PR patients compared with that in matched non-PR individuals. Results Among the 4,421 patients with PR, 569 (12.87%) developed RA, 269 (6.08%) developed SS, 113 (2.56%) developed SLE, 5 (0.11%) developed SSc, 8 (0.18%) developed PM, and 1 (0.02%) developed DM. After adjusting for potential confounders, the patients with PR had an increased risk of RA (HR, 118.76; 95% CI, 89.81-157.04), SS (HR, 59.57; 95% CI, 43.87-80.88), SLE (HR, 51.56; 95% CI, 32.96-80.66) PM (HR, 57.38; 95% CI, 6.90-476.83), and SSc (HR, 13.42; 95% CI, 3.79-47.55) but not of DM (HR, 3.44; 95% CI, 0.34-34.59). Conclusion Patients with PR had an increased risk of developing RA, SS, SLE, PM, and SSc.	[Chen, Hsin-Hua; Chao, Wen-Cheng; Liao, Tsai-Ling; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Hsin-Hua; Liao, Tsai-Ling; Chen, Der-Yuan] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua; Liao, Tsai-Ling; Chen, Der-Yuan] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital	Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, DY (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, DY (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, DY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan.	epid@vghtc.gov.tw; dychen@vghtc.gov.tw						Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Ceelen JJM, 2014, CURR OPIN SUPPORT PA, V8, P339, DOI 10.1097/SPC.0000000000000088; Chen HH, 2010, J MED ULTRASOUND, V18, P17; Chen HH, 2009, J ULTRAS MED, V28, P1193, DOI 10.7863/jum.2009.28.9.1193; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Duncan BB, 2006, DIABETES TECHNOL THE, V8, P7, DOI 10.1089/dia.2006.8.7; Emad Y, 2014, CLIN RHEUMATOL, V33, P791, DOI 10.1007/s10067-014-2569-3; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Furuya T, 1998, J RHEUMATOL, V25, P1109; Furuya T, 2004, J RHEUMATOL, V31, P1768; Gardner AW, 2014, ANGIOLOGY, V65, P683, DOI 10.1177/0003319713501376; Gonzalez-Lopez L, 1999, J RHEUMATOL, V26, P540; Grabulosa CC, 2018, EXP CELL RES, V365, P157, DOI 10.1016/j.yexcr.2018.02.022; GUERNE PA, 1992, AM J MED, V93, P451, DOI 10.1016/0002-9343(92)90177-D; HANNONEN P, 1987, SCAND J RHEUMATOL, V16, P413, DOI 10.3109/03009748709165412; Haydari Aghigh, 2017, Acta Med Iran, V55, P597; Hench PR, 1944, ARCH INTERN MED, V73, P28; Huang RL, 2015, J AUTOIMMUN, V57, P53, DOI 10.1016/j.jaut.2014.11.006; Kang SH, 2001, J RHEUMATOL, V28, P1577; Kim SK, 2006, ANN RHEUM DIS, V65, P1539, DOI 10.1136/ard.2006.052928; Koskinen E, 2009, J RHEUMATOL, V36, P1873, DOI 10.3899/jrheum.090025; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Maksymowych WP, 2002, J RHEUMATOL, V29, P2319; MATTINGLY S, 1966, ANN RHEUM DIS, V25, P307, DOI 10.1136/ard.25.4.307; McColl BW, 2007, BIOCHEM SOC T, V35, P1163, DOI 10.1042/BST0351163; Morimoto S, 2000, Mod Rheumatol, V10, P235, DOI 10.3109/s101650070009; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Peila R, 2006, ACTA NEUROL SCAND, V114, P102, DOI 10.1111/j.1600-0404.2006.00693.x; Pitsavos Christos, 2007, Rev Diabet Stud, V4, P98, DOI 10.1900/RDS.2007.4.98; Powell A, 2008, J RHEUMATOL, V35, P992; Azambuja MIR, 2010, LANCET INFECT DIS, V10, P142, DOI 10.1016/S1473-3099(10)70029-3; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008; ROWLEY MJ, 1968, LANCET, V2, P24; Russell AS, 2006, J RHEUMATOL, V33, P1240; Sanmarti R, 2004, BEST PRACT RES CL RH, V18, P647, DOI 10.1016/j.berh.2004.05.005; SKAER TL, 1992, CLIN THER, V14, P496; WAJED MA, 1977, ANN RHEUM DIS, V36, P56, DOI 10.1136/ard.36.1.56; WILLIAMS MH, 1971, ANN RHEUM DIS, V30, P375, DOI 10.1136/ard.30.4.375; YOUSSEF W, 1991, J RHEUMATOL, V18, P35	43	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201340	10.1371/journal.pone.0201340	http://dx.doi.org/10.1371/journal.pone.0201340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048527	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400079
J	Gustavsson, J; Bonander, C; Nilson, F				Gustavsson, Johanna; Bonander, Carl; Nilson, Finn			A quasi-experimental evaluation of compliant flooring in a residential care setting	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; OLDER-PEOPLE; FRACTURE RATES; IMPACT ATTENUATION; INJURY PREVENTION; RISK-FACTORS; FALL; FACILITIES; COVERINGS; PROGRAMS	Background Fall injuries affect the lives of older people to a substantial degree. This quasi-experimental observational study investigates the potential fall injury reducing effect of a compliant flooring in a residential care setting. Methods The allocation of the compliant flooring was non-random. Data on fall-events and individual characteristics were collected in a residential care unit during a period of 68 months. The primary outcome was the fall injury rate per fall, and a logistic regression analysis was used to test for the effect of complaint flooring. Falls per 1000 bed days was the secondary outcome, used to measure the difference in fall risk on compliant flooring versus regular flooring. Results The event dataset is an unbalanced panel with repeated observations on 114 individuals, with 70% women. The mean age was 84.9 years of age, the average Body Mass Index (BMI) was 24.7, and there was a mean of 6.57 (SD: 15.28) falls per individual. The unadjusted effect estimate showed a non-significant relative risk injury reduction of 29% per fall (RR 0.71 [95% CI: 0.46-1.09]) compared to regular flooring. Re-estimating, excluding identified outliers, showed an injury risk reduction of 63% (RR 0.37 [95% CI: 0.25-0.54]). Falls per 1000 bed days showed that individuals living in apartments with compliant flooring had a fall rate of 5.3 per 1000 bed days compared to a fall rate of 8.4 per 1000 bed days among individuals living in regular apartments. This corresponds to an incidence rate ratio (IRR) of 0.63 (95% exact Poisson CI: 0.50-0.80). Conclusion The results of this non-randomized study indicate that compliant flooring has the potential to reduce the risk of fall injury without increasing the fall risk among older people in a Swedish residential care setting.	[Gustavsson, Johanna; Bonander, Carl; Nilson, Finn] Karlstad Univ, Fac Hlth Sci & Technol, Ctr Publ Safety, Karlstad, Sweden	Karlstad University	Gustavsson, J (corresponding author), Karlstad Univ, Fac Hlth Sci & Technol, Ctr Publ Safety, Karlstad, Sweden.	Johanna.gustavsson@kau.se	Nilson, Finn/H-2383-2017	Nilson, Finn/0000-0002-6928-0683; Bonander, Carl/0000-0002-1189-9950; Gustavsson, Johanna/0000-0003-4840-6424	Karlstad Municipality, Lansforsakringar [P1/13]; Swedish Civil Contingencies Agency [2013-4176]	Karlstad Municipality, Lansforsakringar; Swedish Civil Contingencies Agency	This project was funded by Karlstad Municipality, Lansforsakringar (grant number P1/13) and the Swedish Civil Contingencies Agency (grant number 2013-4176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PATIENTREGISTRET; Picorelli AMA, 2014, J PHYSIOTHER, V60, P151, DOI 10.1016/j.jphys.2014.06.012; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Bhan S, 2013, J APPL BIOMECH, V29, P731, DOI 10.1123/jab.29.6.731; Buchele G, 2014, J AM MED DIR ASSOC, V15, P559, DOI 10.1016/j.jamda.2014.03.015; Bunn F, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-4; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Casalena JA, 1998, J BIOMECH ENG-T ASME, V120, P527, DOI 10.1115/1.2798023; Chen JS, 2008, J AM GERIATR SOC, V56, P2020, DOI 10.1111/j.1532-5415.2008.01954.x; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gustavsson J, 2017, J HOUS ELDER, V31, P367, DOI 10.1080/02763893.2017.1335670; Gustavsson J, 2015, INJURY PREV, V21, P320, DOI 10.1136/injuryprev-2014-041468; Hanger HC, 2017, J AM MED DIR ASSOC, V18, P588, DOI 10.1016/j.jamda.2017.01.012; HAYES WC, 1993, CALCIFIED TISSUE INT, V52, P192, DOI 10.1007/BF00298717; Jensen J, 2002, ANN INTERN MED, V136, P733, DOI 10.7326/0003-4819-136-10-200205210-00008; Knoefel F, 2013, J AM MED DIR ASSOC, V14, P303, DOI 10.1016/j.jamda.2012.12.077; Knol MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021248; Lachance CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171652; Laing AC, 2006, J ORTHOP RES, V24, P1405, DOI 10.1002/jor.20172; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; MAKI BE, 1990, APPL ERGON, V21, P107, DOI 10.1016/0003-6870(90)90132-H; Rapp K, 2012, AGE AGEING, V41, P653, DOI 10.1093/ageing/afs044; Robertson L, 2007, INJURY EPIDEMIOLOGY; Robinovitch SN, 2012, STUDY RECORD DETAIL; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Ryen L, 2016, EUR J PUBLIC HEALTH, V26, P407, DOI 10.1093/eurpub/ckv197; Schwenk M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-50; Sherrington C, 2017, BRIT J SPORT MED, V51, P1749, DOI 10.1136/bjsports-2016-096547; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; Tukey JW, 1977, EXPLORATORY DATA ANA; Vlaeyen E, 2015, J AM GERIATR SOC, V63, P211, DOI 10.1111/jgs.13254; Warren CJ, 2013, CLIN REHABIL, V27, P258, DOI 10.1177/0269215512455530; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Wright AD, 2014, GAIT POSTURE, V40, P160, DOI 10.1016/j.gaitpost.2014.03.015	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201290	10.1371/journal.pone.0201290	http://dx.doi.org/10.1371/journal.pone.0201290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048517	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400069
J	Tian, XM; Wang, ZY; Zhang, Q; Ci, HC; Wang, PS; Yu, L; Jia, GX				Tian, Xiaoming; Wang, Zhenyu; Zhang, Qing; Ci, Huacong; Wang, Pengshan; Yu, Lu; Jia, Guixia			Genome-wide transcriptome analysis of the salt stress tolerance mechanism in Rosa chinensis	PLOS ONE			English	Article							PROLINE ACCUMULATION; GENE-EXPRESSION; COLD STRESS; SALINITY; ANNOTATION; RESPONSES; DROUGHT; WATER; PHOTOSYNTHESIS; BIOSYNTHESIS	Plants regulate responses to salt stress using biological pathways, such as signal perception and transduction, photosynthesis, and energy metabolism. Little is known about the genetics of salt tolerance in Rosa chinensis. Tineke and Hiogi are salt-tolerant and salt-sensitive varieties of R. chinensis, respectively, and are good choices for studying salt-tolerance genes. We studied leaf and root tissues from 1-year-old Hiogi and Tineke plants simultaneously grown under the same conditions. A 0.4%-mmol/L salt ion mixture was added to the basic growth medium. Illumina sequencing was used to identify differentially expressed transcripts. GO and KEGG pathway enrichment analyses were performed to identify differentially expressed genes. We identified many differentially expressed genes associated with salt tolerance. The abscisic acid-dependent signaling pathway was the main pathway that mediated the salt stress response in R. chinensis. Two pathways ( plant hormone signal transduction and glutathione metabolism) were also active in salt stress responses in R. chinensis. The difference in salt tolerance in the cultivars was due to different gene sensitivity to salt in these two pathways. Roots also play a role in salt stress response. The effects of salt stress in the roots are eventually manifested in the leaves, causing changes in processes such as photosynthesis, which eventually result in leaf wilting. In Tineke, Snrk2, ABF, HSP, GSTs, and GSH1 showed high activity during salt stress, indicating that these genes are markers of salt tolerance.	[Tian, Xiaoming; Jia, Guixia] Beijing Forestry Univ, Beijing, Peoples R China; [Wang, Zhenyu; Zhang, Qing; Ci, Huacong; Wang, Pengshan; Yu, Lu] Tianjin TEDA Salina Ecolandscape Res Ctr, Tianjin, Peoples R China	Beijing Forestry University	Jia, GX (corresponding author), Beijing Forestry Univ, Beijing, Peoples R China.	1270050018@qq.com			industrial platform construction of coastal saline ecological afforestation in Beijing-Tianjin-Hebei region [15YDLJSF00050]	industrial platform construction of coastal saline ecological afforestation in Beijing-Tianjin-Hebei region	This work was supported by industrial platform construction of coastal saline ecological afforestation in Beijing-Tianjin-Hebei region, 15YDLJSF00050 (http://www.tstc.gov.cn/zhengwugongkai/ztzl/kjgzhy/2016/dxfy/kjtd/201602/t20160205_87310.html) to XT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harrasi I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191492; Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Bittsanszky A, STRESS CAPACITY ZN P; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chutipaijit S, 2010, PHILIPP AGRIC SCI, V93, P165; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Ding W., 2016, P 11 INT C ECOLOGICA, P1; Ergun E, 2004, ANAL BIOANAL CHEM, V379, P803, DOI 10.1007/s00216-004-2637-7; Fu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39865; Fu JJ, 2016, J PHOTOCH PHOTOBIO B, V163, P30, DOI 10.1016/j.jphotobiol.2016.08.008; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hatano-Iwasaki A, 2012, PLANT CELL PHYSIOL, V53, P1195, DOI 10.1093/pcp/pcs075; Hoque MA, 2007, J PLANT PHYSIOL, V164, P1457, DOI 10.1016/j.jplph.2006.10.004; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Josine TL, 2012, BREEDING EXPRESSION; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WJ, 2017, INT J AGRIC BIOL, V19, P1201, DOI [10.17957/IJAB/15.0422, 10.17957/ijab/15.0422]; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Mattison CP, 2017, J AGR FOOD CHEM; Nianiou-Obeidat I, 2017, PLANT CELL REP, V36, P791, DOI 10.1007/s00299-017-2139-7; Pan Xiaodong, 2002, PRODUCTION TECHNOLOG; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Parida A, 2010, GLUTATHIONE S TRANSF; Santos CV, 2004, SCI HORTIC-AMSTERDAM, V103, P93, DOI 10.1016/j.scienta.2004.04.009; Schellingen K, 2015, ENVIRON EXP BOT, V117, P1, DOI 10.1016/j.envexpbot.2015.04.005; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Skaggs TH, 2006, AGR WATER MANAGE, V86, P140, DOI 10.1016/j.agwat.2006.06.005; Teh CY, 2015, PLANT GROWTH REGUL, V75, P771, DOI 10.1007/s10725-014-9980-2; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Wachter A, 2005, PLANT J, V41, P15, DOI 10.1111/j.1365-313X.2004.02269.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XS, 2009, AGR SCI CHINA, V8, P431, DOI 10.1016/S1671-2927(08)60229-1; Wu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171451; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiuzhen Zh, 2006, ROSA CHINENSIS; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4484-5; Yaish MW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3633-6; Yang GY, 2016, PLANT CELL REP, V35, P681, DOI 10.1007/s00299-015-1912-8; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang ZH, 2012, AFRICAN J AGR RES, V7; Zhang Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01231; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	50	19	24	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200938	10.1371/journal.pone.0200938	http://dx.doi.org/10.1371/journal.pone.0200938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048505	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400034
J	Walder, A; Muller, M; Dahdal, S; Sidler, D; Devetzis, V; Leichtle, AB; Fiedler, MG; Popp, AW; Lippuner, K; Vogt, B; Uehlinger, D; Huynh-Do, U; Arampatzis, S				Walder, Anna; Muller, Martin; Dahdal, Suzan; Sidler, Daniel; Devetzis, Vasilios; Leichtle, Alexander B.; Fiedler, Martin G.; Popp, Albrecht W.; Lippuner, Kurt; Vogt, Bruno; Uehlinger, Dominik; Huynh-Do, Uyen; Arampatzis, Spyridon			The effect of a previous created distal arteriovenous-fistula on radial bone DXA measurements in prevalent renal transplant recipients	PLOS ONE			English	Article							POSITION DEVELOPMENT CONFERENCE; ABDOMINAL AORTIC-ANEURYSM; CHRONIC KIDNEY-DISEASE; MINERAL DENSITY; FRACTURE RISK; HEMODIALYSIS-PATIENTS; CKD; CALCANEUS; TURNOVER; PLAYERS	Background Accelerated bone loss occurs rapidly following renal transplantation due to intensive immunosuppression and persistent hyperparathyroidism. In renal transplant recipients (RTRs) due to the hyperparathyroidism the non-dominant forearm is often utilized as a peripheral measurement site for dual-energy x-ray absorptiometry (DXA) measurements. The forearm is also the site of previous created distal arteriovenous fistulas (AVF). Although AVF remain patent long after successful transplantation, there are no data available concerning their impact on radial bone DXA measurements. Methods In this cross-sectional study we performed DXA in 40 RTRs with preexisting distal AVF (RTRs-AVF) to assess areal bone mineral density (aBMD) differences between both forearms (three areas) and compared our findings to patients with chronic kidney disease (CKD, n = 40), pre-emptive RTRs (RTRs-pre, n = 15) and healthy volunteers (n = 20). In addition, we assessed relevant demographic, biochemical and clinical aspects. Results We found a marked radial asymmetry between the forearms in RTRs with preexisting AVF. The radial aBMD at the distal AVF forearm was lower compared to the contralateral forearm, resulting in significant differences for all three areas analyzed: the Rad-1/3: median (interquartile range) in g/cm(2), Rad-1/3: 0.760 (0.641 +/- 0.804) vs. 0.742 (0.642, 0.794), p = 0.016; ultradistal radius, Rad-UD: 0.433 (0.392 +/- 0.507) vs. 0.420 (0.356, 0.475), p = 0.004; and total radius, Rad-total: 0.603 (0.518, 0.655) vs. 0.599 (0.504, 0.642), p = 0.001). No such asymmetries were observed in any other groups. Lower aBMD in AVF forearm subregions resulted in misclassification of osteoporosis. Conclusions In renal transplant recipients, a previously created distal fistula may exert a negative impact on the radial bone leading to significant site-to-site aBMD differences, which can result in diagnostic misclassifications.	[Walder, Anna; Dahdal, Suzan; Sidler, Daniel; Devetzis, Vasilios; Vogt, Bruno; Uehlinger, Dominik; Huynh-Do, Uyen; Arampatzis, Spyridon] Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland; [Walder, Anna; Muller, Martin; Dahdal, Suzan; Sidler, Daniel; Devetzis, Vasilios; Leichtle, Alexander B.; Fiedler, Martin G.; Popp, Albrecht W.; Lippuner, Kurt; Vogt, Bruno; Uehlinger, Dominik; Huynh-Do, Uyen; Arampatzis, Spyridon] Univ Bern, Bern, Switzerland; [Muller, Martin] Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland; [Leichtle, Alexander B.; Fiedler, Martin G.] Bern Univ Hosp, Inselspital, Ctr Lab Med, Bern, Switzerland; [Popp, Albrecht W.; Lippuner, Kurt] Bern Univ Hosp, Inselspital, Dept Osteoporosis, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Arampatzis, S (corresponding author), Bern Univ Hosp, Inselspital, Dept Hypertens & Nephrol, Bern, Switzerland.; Arampatzis, S (corresponding author), Univ Bern, Bern, Switzerland.	Spiros.arampatzis@insel.ch	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Vogt, Bruno/AAS-2876-2020; Sidler, Daniel/G-2447-2019	Fiedler, Georg Martin/0000-0001-5689-4574; Vogt, Bruno/0000-0002-1548-6387; Arampatzis, Spyridon/0000-0002-6959-0411; Popp, Albrecht/0000-0002-5954-7495	AMGEN	AMGEN(Amgen)	This PIs of this Study (SA, UH) received an independent medical education grant by AMGEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaberi S, 2008, AM J TRANSPLANT, V8, P2647, DOI 10.1111/j.1600-6143.2008.02423.x; [Anonymous], CLIN J AM SOC NEPHRO, V4, P1494, DOI [10.2215/CJN.01470209, DOI 10.2215/CJN.01470209]; [Anonymous], SEMINARS NEPHROLOGY, V33, P191, DOI [10.1016/j.semnephrol.2012.12.019, DOI 10.1016/J.SEMNEPHROL.2012.12.019]; Aydogan M, 2008, SPINE J, V8, P394, DOI 10.1016/j.spinee.2006.12.001; Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014; Barbour KE, 2010, J BONE MINER RES, V25, P1017, DOI 10.1002/jbmr.6; Cruz DN, 2001, TRANSPLANTATION, V72, P83, DOI 10.1097/00007890-200107150-00017; Diekerhof CH, 2002, SPINE, V27, P382; Ducher G, 2011, J BONE MINER RES, V26, P1321, DOI 10.1002/jbmr.323; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Iyer SP, 2014, J AM SOC NEPHROL, V25, P1331, DOI 10.1681/ASN.2013080851; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P1191, DOI 10.1007/s00198-011-1781-0; Jamal SA, 2006, J BONE MINER RES, V21, P543, DOI 10.1359/JBMR.060105; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; Karacan I, 2004, J BONE MINER METAB, V22, P44, DOI 10.1007/s00774-003-0447-1; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Mancini F, 2014, J ORTHOP TRAUMATOL, V15, P291, DOI 10.1007/s10195-014-0308-9; Mikuls TR, 2003, TRANSPLANTATION, V75, P49, DOI 10.1097/00007890-200301150-00009; Min JY, 2007, J CLIN DENSITOM, V10, P184, DOI 10.1016/j.jocd.2006.12.004; Muxi A, 2009, CLIN J AM SOC NEPHRO, V4, P1494, DOI 10.2215/CJN.01470209; Muyshondt I, 2003, NEPHROL DIAL TRANSPL, V18, P2185, DOI 10.1093/ndt/gfg331; Naylor KL, 2013, TRANSPLANTATION, V95, P1461, DOI 10.1097/TP.0b013e31828eead8; Nikkel LE, 2009, TRANSPLANTATION, V87, P1846, DOI 10.1097/TP.0b013e3181a6bbda; Nishiyama KK, 2015, J BONE MINER RES, V30, P456, DOI 10.1002/jbmr.2358; Rajapakse CS, 2012, RADIOLOGY, V262, P912, DOI 10.1148/radiol.11111044; Schousboe JT, 2013, J CLIN DENSITOM, V16, P455, DOI 10.1016/j.jocd.2013.08.004; Sergi G, 2009, J ENDOCRINOL INVEST, V32, P298, DOI 10.1007/BF03345715; Shen JI, 2012, AM J KIDNEY DIS, V60, P473, DOI 10.1053/j.ajkd.2012.03.017; Shepherd JA, 2015, J CLIN DENSITOM, V18, P274, DOI 10.1016/j.jocd.2015.06.013; Shin A, 2004, OSTEOPOROSIS INT, V15, P639, DOI 10.1007/s00198-004-1587-4; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Tasbas BA, 2003, J RECONSTR MICROSURG, V19, P395; Uhlig K, 2010, AM J KIDNEY DIS, V55, P773, DOI 10.1053/j.ajkd.2010.02.340; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200708	10.1371/journal.pone.0200708	http://dx.doi.org/10.1371/journal.pone.0200708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048464	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400013
J	Saiz, A; Salazar, A; Bernard, J				Saiz, Albert; Salazar, Arianna; Bernard, James			Crowdsourcing architectural beauty: Online photo frequency predicts building aesthetic ratings	PLOS ONE			English	Article								The aesthetic quality of the built environment is of paramount importance to the quality of life of an increasingly urbanizing population. However, a lack of data has hindered the development of comprehensive measures of perceived architectural beauty. In this paper, we demonstrate that the local frequency of geotagged photos posted by internet users in two photo-sharing websites strongly predict the beauty ratings of buildings. We conduct an independent beauty survey with respondents rating proprietary stock photos of 1,000 buildings across the United States. Buildings with higher ratings were found more likely to be geotagged with user-uploaded photos in both Google Maps and Flickr. This correlation also holds for the beauty rankings of raters who seldom upload materials to the internet. Objective architectural characteristics that predict higher average beauty ratings of buildings also positively covary with their internet photo frequency. These results validate the use of localized user-generated image uploads in photo-sharing sites to measure the aesthetic appeal of the urban environment in the study of architecture, real estate, urbanism, planning, and environmental psychology.	[Saiz, Albert; Salazar, Arianna] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA; [Bernard, James] Brown Univ, Dept Econ, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Brown University	Salazar, A (corresponding author), MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA.	ariana@mit.edu	Saiz, Albert/AAZ-2321-2021	Salazar Miranda, Arianna/0000-0003-4093-9250				Ahlfeldt G.M., 2013, URBANITY; Antoniou V., 2010, GEOMATICA, V64, P99, DOI DOI 10.HTTP://DX.D0I.0RG/10.5623/GE0MAT-2010-0009; Brown G, 2017, T GIS, V21, P39, DOI 10.1111/tgis.12207; Cela-Conde CJ, 2013, P NATL ACAD SCI USA, V110, P10454, DOI 10.1073/pnas.1302855110; Dubey A, 2016, LECT NOTES COMPUT SC, V9905, P196, DOI 10.1007/978-3-319-46448-0_12; Dunkel A, 2015, LANDSCAPE URBAN PLAN, V142, P173, DOI 10.1016/j.landurbplan.2015.02.022; Feick R, 2015, COMPUT ENVIRON URBAN, V53, P96, DOI 10.1016/j.compenvurbsys.2013.11.006; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Isham EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071698; Kennedy L. S., 2008, P 17 INT C WORLD WID, P297, DOI [10.1145/1367497.1367539, DOI 10.1145/1367497.1367539]; Krieger MH, 2010, J URBAN TECHNOL, V17, P21, DOI 10.1080/10630732.2010.515087; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lynch K., 1960, IMAGEN CITY; Martin PR, 2011, IAAP HDB APPL PSYCHO, DOI [10.1002/9781444395150, DOI 10.1002/9781444395150]; Milgram S, 1977, PSYCHOL MAPS PARIS; Nadal M, 2008, SPATIAL VISION, V21, P379, DOI 10.1163/156856808784532653; NASAR JL, 1990, J AM PLANN ASSOC, V56, P41, DOI 10.1080/01944369008975742; Newman O., 1973, DEFENSIBLE SPACE CRI; Nov O, 2010, J AM SOC INF SCI TEC, V61, P555, DOI 10.1002/asi.21278; Paldino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165753; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Saiz A, 2013, J EUR ECON ASSOC, V11, P137, DOI 10.1111/j.1542-4774.2012.01110.x; Seresinhe CI, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170170; Seresinhe CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep16899; Seresinhe CI, 2017, ENV PLANNING B URBAN; Silveira S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00528; Varian H, 2012, PREDICTING PRESENT G	28	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0194369	10.1371/journal.pone.0194369	http://dx.doi.org/10.1371/journal.pone.0194369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044772	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500002
J	Wehrens, EJ; Wong, KA; Gupta, A; Khan, A; Benedict, CA; Zuniga, EI				Wehrens, Ellen J.; Wong, Kurt A.; Gupta, Ankan; Khan, Ayesha; Benedict, Chris A.; Zuniga, Elina I.			IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPLETION; IMMUNE-RESPONSES; CUTTING EDGE; INFECTION; RECEPTOR; WSX-1; EXPRESSION; IL-10; INTERLEUKIN-27	The role of IL-27 in antiviral immunity is still incompletely understood, especially in the context of chronic viruses that induce a unique environment in their infected host. Cytomegalovirus (CMV) establishes a persistent, tissue localized infection followed by lifelong latency. CMV infects the majority of people and although asymptomatic in healthy individuals, can cause serious disease or death in those with naive or compromised immune systems. Therefore, there is an urgent need to develop a protective CMV vaccine for people at-risk and identifying key regulators of the protective immune response towards CMV will be crucial. Here we studied mouse CMV (MCMV) in IL-27 receptor deficient animals (IL27ra(-/-)) to assess the role of IL-27 in regulating CMV immunity. We found that IL-27 enhanced the number of antiviral CD4 T cells upon infection. However, in contrast to a well-established role for CD4 T cells in controlling persistent replication and a positive effect of IL-27 on their numbers, IL-27 promoted MCMV persistence in the salivary gland. This coincided with IL-27 mediated induction of IL-10 production in CD4 T cells. Moreover, IL-27 reduced expression of the transcription factor T-bet and restricted a cytotoxic phenotype in antiviral CD4 T cells. This is a highly intriguing result given the profound cytotoxic phenotype of CMV-specific CD4 T cells seen in humans and we established that dendritic cell derived IL-27 was responsible for this effect. Together, these data show that IL-27 regulates the number and effector functions of MCMV-specific CD4 T cells and could be targeted to enhance control of persistent/latent infection.	[Wehrens, Ellen J.; Wong, Kurt A.; Khan, Ayesha; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gupta, Ankan; Benedict, Chris A.] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA	University of California System; University of California San Diego; La Jolla Institute for Immunology	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eizuniga@ucsd.edu			National Institutes of Health (NIH) [AI113923, AI081923, AI101423]; Dutch Society for Scientific Research (NWO); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113923, R01AI081923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Society for Scientific Research (NWO); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institutes of Health (NIH) (https://www.nih.gov/) grant AI113923 and AI081923 (to E.I.Z.), and AI101423 (to C.B.). E.J.W. was supported by a Dutch Society for Scientific Research (NWO) (https://www.nwo.nl/en) Rubicon postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chemin K, 2018, EUR J IMMUNOL, V48, P655, DOI 10.1002/eji.201747296; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Cheroutre H, 2013, SEMIN IMMUNOL, V25, P273, DOI 10.1016/j.smim.2013.10.022; Clement M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006050; Crompton L, 2008, BLOOD, V111, P2053, DOI 10.1182/blood-2007-04-079863; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; de Aquino MTP, 2014, J IMMUNOL, V193, P285, DOI 10.4049/jimmunol.1400058; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gamadia LE, 2004, HUM IMMUNOL, V65, P486, DOI 10.1016/j.humimm.2004.02.020; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Harker JA, 2018, J VIROL, V92, DOI 10.1128/JVI.02196-17; Harker JA, 2013, IMMUNITY, V39, P548, DOI 10.1016/j.immuni.2013.08.010; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; JONJIC S, 1990, J VIROL, V64, P5457; JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199; Juno JA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00019; Kim G, 2013, J IMMUNOL, V190, P1510, DOI 10.4049/jimmunol.1201017; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee HM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004635; Lewis GM, 2016, J CLIN INVEST, V126, P3799, DOI 10.1172/JCI87041; Liu FDM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004110; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; LUCIN P, 1992, J VIROL, V66, P1977, DOI 10.1128/JVI.66.4.1977-1984.1992; Mandaric S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002846; Marshall NB, 2017, J IMMUNOL, V198, P1142, DOI 10.4049/jimmunol.1601297; Muallem G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006173; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muraro E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00197; Pachnio A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005832; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pyle CJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006640; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takeda A, 2005, INT IMMUNOL, V17, P889, DOI 10.1093/intimm/dxh268; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Verma S, 2016, J VIROL, V90, P650, DOI 10.1128/JVI.02123-15; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villegas-Mendez A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003293; Walton SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002214; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Zhang S, 2013, HEPATOLOGY, V57, P1620, DOI 10.1002/hep.26166; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	73	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201249	10.1371/journal.pone.0201249	http://dx.doi.org/10.1371/journal.pone.0201249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044874	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500095
J	Richins, RD; Rodriguez-Uribe, L; Lowe, K; Ferral, R; O'Connell, MA				Richins, Richard D.; Rodriguez-Uribe, Laura; Lowe, Kiah; Ferral, Rebekah; O'Connell, Mary A.			Accumulation of bioactive metabolites in cultivated medical Cannabis	PLOS ONE			English	Article							ACID-SYNTHASE; SATIVA L.; CHEMOTAXONOMIC ANALYSIS; CHEMICAL PHENOTYPE; GENES; PLANT; IDENTIFICATION; TRICHOMES; CYCLASE; FRUIT	There has been an increased use of medical Cannabis in the United States of America as more states legalize its use. Complete chemical analyses of this material can vary considerably between producers and is often not fully provided to consumers. As phytochemists in a state with legal medical Cannabis we sought to characterize the accumulation of phytochemicals in material grown by licensed commercial producers. We report the development of a simple extraction and analysis method, amenable to use by commercial laboratories for the detection and quantification of both cannabinoids and terpenoids. Through analysis of developing flowers on plants, we can identify sources of variability of floral metabolites due to flower maturity and position on the plant. The terpenoid composition varied by accession and was used to cluster cannabis strains into specific types. Inclusion of terpenoids with cannabinoids in the analysis of medical cannabis should be encouraged, as both of these classes of compounds could play a role in the beneficial medical effects of different cannabis strains.	[Richins, Richard D.; Rodriguez-Uribe, Laura; Lowe, Kiah; Ferral, Rebekah; O'Connell, Mary A.] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Richins, Richard D.] Rio Grande Analyt, Las Cruces, NM USA	New Mexico State University	O'Connell, MA (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	moconnel@nmsu.edu		O'Connell, Mary/0000-0003-4430-6733	Agricultural Experiment Station at New Mexico State University	Agricultural Experiment Station at New Mexico State University	MOC, LRU, and RDR received support from the Agricultural Experiment Station at New Mexico State University. This funder provided support in the form of salaries for authors MOC, LRU, KL, RF, RDR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Rio Grande Analytics, a commercial licensed medical marijuana testing laboratory provided access to research space licensed for analysis of the plant material in this report. All material costs and salaries of staff working on this project were paid through the Agricultural Experiment Station at New Mexico State University. RDR is an owner of Rio Grande Analytics, in addition to his full-time position at NMSU, however, Rio Grande Analytics did not provide salary support or have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Carvalho A, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox037; Chandra S, 2010, PLANTA MED, V76, P743, DOI 10.1055/s-0029-1240628; Curry J, 1999, PLANT SCI, V148, P47, DOI 10.1016/S0168-9452(99)00118-1; de Meijer EPM, 2003, GENETICS, V163, P335; Fischedick JT, 2017, CANNABIS CANNABINOID, V2, P34, DOI 10.1089/can.2016.0040; Fischedick JT, 2010, PHYTOCHEMISTRY, V71, P2058, DOI 10.1016/j.phytochem.2010.10.001; Friedman D, 2015, NEW ENGL J MED, V373, P1048, DOI 10.1056/NEJMra1407304; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00463, 10.3389/fpls.2016.00019]; Happyana N, 2016, PLANTA MED, V82, P1217, DOI 10.1055/s-0042-108058; Happyana N, 2013, PHYTOCHEMISTRY, V87, P51, DOI 10.1016/j.phytochem.2012.11.001; Hillig KW, 2004, BIOCHEM SYST ECOL, V32, P875, DOI 10.1016/j.bse.2004.04.004; Hillig KW, 2004, AM J BOT, V91, P966, DOI 10.3732/ajb.91.6.966; Ibrahim EA, 2018, PLANTA MED, V84, P250, DOI 10.1055/s-0043-124088; Jin D, 2017, J ANAL BIOANALYTICAL, V08; Keyhaninejad N, 2014, PLANT SCI, V215, P59, DOI 10.1016/j.plantsci.2013.10.013; Marks MD, 2009, J EXP BOT, V60, P3715, DOI 10.1093/jxb/erp210; Martin C, 2012, LAVENDER CULTIVAR TR; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Medina-Holguin AL, 2008, PHYTOCHEMISTRY, V69, P919, DOI 10.1016/j.phytochem.2007.11.006; Mudge EM, 2017, ANAL BIOANAL CHEM, V409, P3153, DOI 10.1007/s00216-017-0256-3; National Academies of Sciences. Engineering and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice, 2017, HLTH EFF CANN CANN C; Onofri C, 2015, PHYTOCHEMISTRY, V116, P57, DOI 10.1016/j.phytochem.2015.03.006; Pacifico D, 2008, EUPHYTICA, V160, P231, DOI 10.1007/s10681-007-9543-y; Page J.E., 2015, Patent No. [2015/196275 A1, 2015196275]; Page J.E., 2012, US patent, Patent No. [US20120144523A1, 20120144523]; Potter DJ, 2014, DRUG TEST ANAL, V6, P31, DOI 10.1002/dta.1531; Rodriguez-Uribe L, 2014, HORTSCIENCE, V49, P1370, DOI 10.21273/HORTSCI.49.11.1370; Rodriguez-Uribe L, 2012, J EXP BOT, V63, P517, DOI 10.1093/jxb/err302; Russo E., 2007, CHEM BIODIVER; Russo E., 2011, BRIT J PHARM, V163; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; SMALL E, 1973, LLOYDIA, V36, P144; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; Thomas B, 2016, ANAL CHEM CANNABIS, P1; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Weiblen GD, 2015, NEW PHYTOL, V208, P1241, DOI 10.1111/nph.13562; Welling MT, 2016, EUPHYTICA, V208, P463, DOI 10.1007/s10681-015-1585-y; Yang XM, 2016, FEBS J, V283, P1088, DOI 10.1111/febs.13654	43	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201119	10.1371/journal.pone.0201119	http://dx.doi.org/10.1371/journal.pone.0201119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036388	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200029
J	Tangsuwansri, C; Saeliw, T; Thongkorn, S; Chonchaiya, W; Suphapeetiporn, K; Mutirangura, A; Tencomnao, T; Hu, VW; Sarachana, T				Tangsuwansri, Chayanin; Saeliw, Thanit; Thongkorn, Surangrat; Chonchaiya, Weerasak; Suphapeetiporn, Kanya; Mutirangura, Apiwat; Tencomnao, Tewin; Hu, Valerie Wailin; Sarachana, Tewarit			Investigation of epigenetic regulatory networks associated with autism spectrum disorder (ASD) by integrated global LINE-1 methylation and gene expression profiling analyses	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; DNA METHYLATION; L1 RETROTRANSPOSITION; ALU METHYLATION; ELEMENTS; CHILDREN; PATTERNS; REVEAL; TRANSCRIPTOME; DISRUPTION	Background The exact cause and mechanisms underlying the pathobiology of autism spectrum disorder (ASD) remain unclear. Dysregulation of long interspersed element-1 (LINE-1) has been reported in the brains of ASD-like mutant mice and ASD brain tissues. However, the role and methylation of LINE-1 in individuals with ASD remain unclear. In this study, we aimed to investigate whether LINE-1 insertion is associated with differentially expressed genes (DEGs) and to assess LINE-1 methylation in ASD. Methods To identify DEGs associated with LINE-1 in ASD, we reanalyzed previously published transcriptome profiles and overlapped them with the list of LINE-1-containing genes from the TranspoGene database. An Ingenuity Pathway Analysis (IPA) of DEGs associated with LINE-1 insertion was conducted. DNA methylation of LINE-1 was assessed via combined bisulfite restriction analysis (COBRA) of lymphoblastoid cell lines from ASD individuals and unaffected individuals, and the methylation levels were correlated with the expression levels of LINE-1 and two LINE-1-inserted DEGs, Clorf27 and ARMC8. Results We found that LINE-1 insertion was significantly associated with DEGs in ASD. The IPA showed that LINE-1-inserted DEGs were associated with ASD-related mechanisms, including sex hormone receptor signaling and axon guidance signaling. Moreover, we observed that the LINE-1 methylation level was significantly reduced in lymphoblastoid cell lines from ASD individuals with severe language impairment and was inversely correlated with the transcript level. The methylation level of LINE-1 was also correlated with the expression of the LINE-1-inserted DEG Clorf27but not ARMC8. Conclusions In ASD individuals with severe language impairment, LINE-1 methylation was reduced and correlated with the expression levels of LINE-1 and the LINE-1-inserted DEG Clorf27. Our findings highlight the association of LINE-1 with DEGs in ASD blood samples and warrant further investigation. The molecular mechanisms of LINE-1 and the effects of its methylation in ASD pathobiology deserve further study.	[Tangsuwansri, Chayanin; Saeliw, Thanit; Thongkorn, Surangrat] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, MSc Program Clin Biochem & Mol Med, Bangkok, Thailand; [Chonchaiya, Weerasak] Chulalongkorn Univ, Fac Med, Div Growth & Dev, Dept Pediat, Bangkok, Thailand; [Chonchaiya, Weerasak] Chulalongkorn Univ, Fac Med, Dept Pediat, Maximizing Thai Childrens Dev Potential Res Unit, Bangkok, Thailand; [Chonchaiya, Weerasak] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Suphapeetiporn, Kanya] Chulalongkorn Univ, Fac Med, Ctr Excellence Med Genet, Dept Pediat, Bangkok, Thailand; [Suphapeetiporn, Kanya] Thai Red Cross Soc, Excellence Ctr Med Genet, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Dept Anat, Bangkok, Thailand; [Tencomnao, Tewin; Sarachana, Tewarit] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand; [Hu, Valerie Wailin] George Washington Univ, Dept Biochem & Mol Med, Sch Med & Hlth Sci, Washington, DC 20037 USA	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; George Washington University	Sarachana, T (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand.	tewarit.sa@chula.ac.th	Chonchaiya, Weerasak/AAJ-8062-2020	Chonchaiya, Weerasak/0000-0002-0223-9969; Tencomnao, Tewin/0000-0003-4177-2165	Office of the Higher Education Commission [MRG6080118]; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project" [RGN_2557_007_01_37]; Faculty of Allied Health Sciences Research Fund [AHS-CU 58003]; 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR1125601058M 53-4, GCUGR1125601055M 53-1, GCUGR1125601056M 53-2]; Research Assistant Scholarship, Chulalongkorn University; Graduate School, Chulalongkorn University; NIEHS [R21 ES023061]; Thailand Research Fund [MRG6080118, DPG5980005, BRG5980001]; National Institute of Mental Health [1U24MH081810]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	Office of the Higher Education Commission; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project"; Faculty of Allied Health Sciences Research Fund; 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Research Assistant Scholarship, Chulalongkorn University; Graduate School, Chulalongkorn University(Chulalongkorn University); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Thailand Research Fund(Thailand Research Fund (TRF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CT, TSae, and ST are graduate students in the M.Sc. Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University. This work is part of CT's thesis research to be presented in partial fulfillment of the requirements for the M.Sc. degree. This research is supported by the Research Grant for New Scholar by The Thailand Research Fund and Office of the Higher Education Commission (MRG6080118), the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project" (RGN_2557_007_01_37), and the Faculty of Allied Health Sciences Research Fund (AHS-CU 58003) to TS. CT, TSae, and ST were financially supported by The 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CT-GCUGR1125601058M 53-4; TSae-GCUGR1125601055M 53-1; ST-GCUGR1125601056M 53-2). CT received the Research Assistant Scholarship, Chulalongkorn University, while TSae and ST received additional financial support from "The Scholarship from the Graduate School, Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". VWH is supported by NIEHS grant R21 ES023061. AM is supported by the Thailand Research Fund (DPG5980005). KS is supported by the Thailand Research Fund (BRG5980001).; CT, TSae, and ST are graduate students in the M.Sc. Program in Clinical Biochemistry and Molecular Medicine, Faculty of Allied Health Sciences, Chulalongkorn University. This work is part of CT's thesis research to be presented in partial fulfillment of the requirements for the M.Sc. degree. This research is supported by the Research Grant for New Scholar by The Thailand Research Fund and Office of the Higher Education Commission (MRG6080118), the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project" (RGN_2557_007_01_37), and the Faculty of Allied Health Sciences Research Fund (AHS-CU 58003) to TS. CT, TSae, and ST were financially supported by The 90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund: CT-GCUGR1125601058M 53-4; TSae-GCUGR1125601055M 53-1; ST-GCUGR11256 01056M 53-2). CT received the Research Assistant Scholarship, Chulalongkorn University, while TSae and ST received additional financial support from "The Scholarship from the Graduate School, Chulalongkorn University to commemorate the 72nd anniversary of His Majesty King Bhumibala Aduladeja". VWH is supported by NIEHS grant R21 ES023061. AM is supported by the Thailand Research Fund (DPG5980005). KS is supported by the Thailand Research Fund (BRG5980001). We wish to thank Dr. Charoenchai Puttipanyalears for teaching CT and TSae to conduct the COBRA and also thank Ms.Kannika Saina, Ms.Nungruthai Suntronwong, Mr.Perawatt Akaraamornthum, and Ms.Surangkhanan Khamthong for their assistance in LCL culture and RNA isolation. We also gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). The AGRE Consortium: Dan Geschwind, M.D., Ph.D., UCLA, Los Angeles, CA; Maja Bucan, Ph.D., University of Pennsylvania, Philadelphia, PA; W.Ted Brown, M.D., Ph.D., F.A.C.M.G., N.Y.S. Institute for Basic Research in Developmental Disabilities, Long Island, NY; Rita M. Cantor, Ph.D., UCLA School of Medicine, Los Angeles, CA; John N. Constantino, M.D., Washington University School of Medicine, St. Louis, MO; T. Conrad Gilliam, Ph.D., University of Chicago, Chicago, IL; Martha Herbert, M.D., Ph.D., Harvard Medical School, Boston, MA; Clara Lajonchere, Ph.D, Cure Autism Now, Los Angeles, CA; David H. Ledbetter, Ph.D., Emory University, Atlanta, GA; Christa Lese-Martin, Ph.D., Emory University, Atlanta, GA; Janet Miller, J.D., Ph.D., Cure Autism Now, Los Angeles, CA; Stanley F. Nelson, M.D., UCLA School of Medicine, Los Angeles, CA; Gerard D. Schellenberg, Ph.D., University of Washington, Seattle, WA; Carol A. Samango-Sprouse, Ed.D., George Washington University, Washington, D.C.; Sarah Spence, M.D., Ph.D., UCLA, Los Angeles, CA; Matthew State, M.D., Ph.D., Yale University, New Haven, CT. Rudolph E. Tanzi, Ph.D., Massachusetts General Hospital, Boston, MA.	Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Altun H, 2017, PSYCHIAT RES, V257, P67, DOI 10.1016/j.psychres.2017.06.008; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Bodo C, 2006, FRONT NEUROENDOCRIN, V27, P217, DOI 10.1016/j.yfrne.2006.02.004; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bruchhage Muriel M K, 2018, Handb Clin Neurol, V155, P61, DOI 10.1016/B978-0-444-64189-2.00004-4; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Christensen DL, 2016, J DEV BEHAV PEDIATR, V37, P1, DOI 10.1097/DBP.0000000000000235; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crider A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-46; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Ansary A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-265; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Fadini CC, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00347, 10.3389/fnhum.2015.00347]; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hu V. W., 2013, N AM J MED SCI BOSTO, V6; Hu VW, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-7; Hu VW, 2012, DIS MARKERS, V33, P277, DOI [10.1155/2012/835728, 10.3233/DMA-2012-0916]; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kanherkar RR, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00049; Kitkumthorn N, 2012, ASIAN PAC J CANCER P, V13, P4469, DOI 10.7314/APJCP.2012.13.9.4469; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Kwan V, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9176-3; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehman CW, 2005, GENOMICS, V85, P386, DOI 10.1016/j.ygeno.2004.11.009; Lertkhachonsuk R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421747; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Macia A, 2017, GENOME RES, V27, P335, DOI 10.1101/gr.206805.116; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; Mueller Stefan O., 2001, Current Opinion in Pharmacology, V1, P613, DOI 10.1016/S1471-4892(01)00105-9; Mukaetova-Ladinska EB, 2004, NEUROPATH APPL NEURO, V30, P615, DOI 10.1111/j.1365-2990.2004.00574.x; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nardone S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.70; Newkirk SJ, 2017, P NATL ACAD SCI USA, V114, pE5635, DOI 10.1073/pnas.1701069114; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pramparo T, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156108; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saeliw T, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0213-9; Sarachana T., 2013, MOL AUTISM, V4; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Schaefer GB, 2008, GENET MED, V10, P4, DOI 10.1097/GIM.0b013e31815efdd7; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Senthong A, 2014, INT J GYNECOL CANCER, V24, P36, DOI 10.1097/IGC.0000000000000021; Shpyleva S., 2017, MOL NEUROBIOL; Sirivanichsuntorn P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-10; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Suda S, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-14; Sukapan P, 2014, J HUM GENET, V59, P178, DOI 10.1038/jhg.2013.140; Talebizadeh Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067569; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Tonacci A, 2017, CHILD NEUROPSYCHOL, V23, P1, DOI 10.1080/09297049.2015.1081678; Tordjman S, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00001; Tremblay A, 2000, MOL CELL BIOL, V20, P54, DOI 10.1128/MCB.20.1.54-60.2000; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Wangsri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045292; Wanichnopparat W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-205; Wong CCY, 2014, MOL PSYCHIATR, V19, P495, DOI 10.1038/mp.2013.41; Xie CY, 2014, TUMOR BIOL, V35, P8903, DOI 10.1007/s13277-014-2162-z; Yeung KS, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0182-4	90	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201071	10.1371/journal.pone.0201071	http://dx.doi.org/10.1371/journal.pone.0201071			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036398	gold, Green Published, Green Submitted			2022-12-27	WOS:000439429200026
J	Casana-Granell, S; Lacomba-Trejo, L; Valero-Moreno, S; Prado-Gasco, V; Montoya-Castilla, I; Perez-Marin, M				Casana-Granell, Sara; Lacomba-Trejo, Laura; Valero-Moreno, Selene; Prado-Gasco, Vicente; Montoya-Castilla, Inmaculada; Perez-Marin, Marian			A brief version of the Pediatric Inventory for Parents (PIP) in Spanish population: Stress of main family carers of chronic paediatric patients	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; PSYCHOLOGICAL-RESEARCH; CHRONIC ILLNESS; CHILDREN; METAANALYSIS; SYMPTOMS; HEALTH; CAREGIVERS; CHILDHOOD; DISEASE	A chronic illness in childhood has a negative impact on the paediatric patient and on family functioning. Psychological stress in parents influences the level of adjustment to the illness of their children. The Pediatric Inventory for Parents (PIP) was designed to measure stress in parents whose child has a chronic illness or requires prolonged medical monitoring. The main objective of this study is to provide a brief version of the Spanish translation of the PIP, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ((X) over bar = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ((X) over bar = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus type I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217). After performing several EFAs (Exploratory Factor Analyses) and CFAs (Confirmatory Factorial Analyses), it was decided that 30 items need to be removed. Reliability and validity results suggest that the new 12-item version possesses appropriate psychometric properties. Cronbach's alpha value ranging between alpha = .42 and alpha = .81 and fit values obtained indicate a good fit: chi(2)/df (88.393/48) = 1.84 (alpha < .01); S-B chi(2)(df) = 88.393 (48); CFI = .95; IFI = .95; RMSEA = .05 (.033 - .074) for the frequency scales and chi(2)/df (72.002/48) = 1.5 (alpha < .01); S-B chi(2)(df) = 72.002 (48); CFI = .97; IFI = .97; RMSEA = .04 (.011 - .063) for the difficulty scales. The PIP also showed predictive ability in regards to anxiety and depression, a positive relationship between the instrument's own scales and a negative relationship with the caregiver's age. Finally, depending on the paediatric patient's diagnosis, differences in stress levels were found.	[Casana-Granell, Sara; Lacomba-Trejo, Laura; Valero-Moreno, Selene; Prado-Gasco, Vicente; Montoya-Castilla, Inmaculada; Perez-Marin, Marian] Univ Valencia, Fac Psychol, Dept Personal Assessment & Psychol Treatments, Valencia, Spain	University of Valencia	Perez-Marin, M (corresponding author), Univ Valencia, Fac Psychol, Dept Personal Assessment & Psychol Treatments, Valencia, Spain.	marian.perez@uv.es	PRADO-GASCO, VICENTE/K-7276-2014; Perez-Marin, Marian/G-9394-2011; Montoya-Castilla, Inmaculada/G-8963-2011; Lacomba-Trejo, Laura/ABG-8585-2020; Valero-Moreno, Selene/Y-8905-2019	PRADO-GASCO, VICENTE/0000-0002-2108-2186; Perez-Marin, Marian/0000-0003-3532-8818; Montoya-Castilla, Inmaculada/0000-0003-2536-2019; Lacomba-Trejo, Laura/0000-0002-1990-9711; Valero-Moreno, Selene/0000-0002-5228-2738	Instituto de Investigacion Sanitaria La Fe [20_DMPT1_MORENO_2014]; Asociacion Espanola de Piscologia Clinica y Psicopatologia (EAPCP) [1/2013]; Federacion Espanola de Asociaciones de Terapia Familiar (FEAP) [FEATF 1/2017]; Asociacion Espanola de Psicologia Clinica y Psicopatologia (EAPCP) [1/2017 AEPCP]	Instituto de Investigacion Sanitaria La Fe; Asociacion Espanola de Piscologia Clinica y Psicopatologia (EAPCP); Federacion Espanola de Asociaciones de Terapia Familiar (FEAP); Asociacion Espanola de Psicologia Clinica y Psicopatologia (EAPCP)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders were: Program VLC-BIOMED 2014 from Instituto de Investigacion Sanitaria La Fe (Proyect Ref: 20_DMPT1_MORENO_2014), http://www.vlc-biomed.es/index.php/ayudas; Asociacion Espanola de Piscologia Clinica y Psicopatologia (EAPCP) (Proyect Ref: 1/2013), http://www.aepcp.net/; Federacion Espanola de Asociaciones de Terapia Familiar (FEAP) (Proyect Ref: FEATF 1/2017), https://www.featf.org/; Asociacion Espanola de Psicologia Clinica y Psicopatologia (EAPCP) (Proyect Ref: 1/2017 AEPCP), http://www.aepcp.net/.	Alcantara Moreno G, 2008, REV U INVESTIGACION, V9, P93; Arriola MJ, 2015, ACTA PEDIAT ESPANOLA, V73, P165; Barakat LP, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-60; Bentler P. M., 2004, EQS 6 STRUCTURAL EQU; Browne MW, 1993, ALTERNATIVE WAYS ASS; Byrne B., 2009, STRUCTURAL EQUATION, V2nd ed.; Carmassi C, 2018, NEUROPSYCH DIS TREAT, V14, P1371, DOI 10.2147/NDT.S158249; Carmines E.G., 1981, SOCIAL MEASUREMENT, DOI DOI 10.1207/S15327965PLI0404_1; Caro T, 1992, B PSICOLOGIA, P43; Cassanello P, 2018, AN PEDIATR, V89, P230, DOI 10.1016/j.anpedi.2017.12.003; Cohen LL, 2010, J PEDIATR PSYCHOL, V35, P748, DOI 10.1093/jpepsy/jsp103; Compas BE, 2012, ANNU REV CLIN PSYCHO, V8, P455, DOI 10.1146/annurev-clinpsy-032511-143108; Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI 10.1093/jpepsy/jst049; Craig F, 2016, PSYCHIAT RES, V242, P121, DOI 10.1016/j.psychres.2016.05.016; Davis JD, 2007, J NEUROPSYCH CLIN N, V19, P43, DOI 10.1176/appi.neuropsych.19.1.43; Del Rincon C, 2007, INT J CLIN HLTH PSYC, V7, P435; Dos Santos D. F., 2009, THESIS; Easter G, 2015, J PEDIATR PSYCHOL, V40, P623, DOI 10.1093/jpepsy/jsv012; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Ferrer C, 2012, ESTRATEGIA ABORDAJE; Garcia Merino A, 2013, CURSO ACTUALIZACION, P25765; Plumed ABG, 2013, PSICOTHEMA, V25, P252, DOI 10.7334/psicothema2012.201; Helgeson VS, 2012, J PEDIATR PSYCHOL, V37, P467, DOI 10.1093/jpepsy/jsr110; Howard E., 2009, THESIS; Hung CC, 2016, NURS EDUC TODAY, V40, P72, DOI 10.1016/j.nedt.2016.02.016; Iobst EA, 2009, J PEDIATR PSYCHOL, V34, P817, DOI 10.1093/jpepsy/jsn140; Iversen AS, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1487758; Jimenez EG, 2000, ANALISIS FACTORIAL; Ferrando PJ, 2010, PAPEL PSICOL, V31, P18; Johnson L. M., 2013, THESIS; Kearney JA, 2015, PEDIATR BLOOD CANCER, V62, pS632, DOI 10.1002/pbc.25761; Kountz-Edwards S, 2017, CHRONIC ILLN, V13, P262, DOI 10.1177/1742395317690034; Lacasa Maseri A., 2012, Rev Pediatr Aten Primaria, V14, P217, DOI 10.4321/s1139-76322012000400006; Law EF, 2014, J PEDIATR PSYCHOL, V39, P866, DOI 10.1093/jpepsy/jsu032; Lazarus RS., 1984, STRESS APPRAISAL COP; Lewis A.B., 2005, FAMILIES SYSTEMS HLT, V23, P56, DOI [10.1037/1091-7527.23.1.56, DOI 10.1037/1091-7527.23.1.56]; Lloret-Segura S, 2014, AN PSICOL-SPAIN, V30, P1151, DOI 10.6018/analesps.30.3.199361; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Monaghan M, 2015, J PEDIATR PSYCHOL, V40, P878, DOI 10.1093/jpepsy/jsv041; Montero Pardo X, 2015, PSICOONCOLOGIA POZUE, V12, P67, DOI [10.5209/rev_PSIC.2015.v12.n1.48905, DOI 10.5209/REV_PSIC.2015.V12.N1.48905]; Morris A, 2012, J PEDIATR PSYCHOL, V37, P1076, DOI 10.1093/jpepsy/jss091; Nieuwesteeg AM, 2016, EUR J PEDIATR, V175, P329, DOI 10.1007/s00431-015-2631-4; Ohleyer Vanessa, 2007, J Child Health Care, V11, P132, DOI 10.1177/1367493507076065; Pate T, 2019, J HEALTH PSYCHOL, V24, P209, DOI 10.1177/1359105316650931; Pierpont EI, 2016, AM J MED GENET A, V170, P1974, DOI 10.1002/ajmg.a.37725; Pombo M, 2011, PROTOC DIAGN TER PED, V1, P236; Power TG, 2004, PARENT-SCI PRACT, V4, P271, DOI 10.1207/s15327922par0404_1; Preston A, 2005, CLIN PEDIATR, V44, P327, DOI 10.1177/000992280504400407; Quitmann JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153953; */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Seino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032913; Senger BA, 2016, APPL NURS RES, V29, P195, DOI 10.1016/j.apnr.2015.03.010; Sicouri G, 2017, BEHAV RES THER, V89, P14, DOI 10.1016/j.brat.2016.11.004; Silverman AH, 2015, J PEDIATR PSYCHOL, V40, P814, DOI 10.1093/jpepsy/jsv028; Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155; Torres-Ortuno A, 2014, HAEMOPHILIA, V20, P756, DOI 10.1111/hae.12471; Vila N., 2000, QUADERNS TREBALL, V104; Vrijmoet-Wiersma CMJ, 2009, CARDIOL YOUNG, V19, P608, DOI 10.1017/S1047951109991831; Vrijmoet-Wiersma CMJ, 2010, PSYCHO-ONCOLOGY, V19, P368, DOI 10.1002/pon.1571; Wagner JL, 2010, EPILEPSY BEHAV, V18, P280, DOI 10.1016/j.yebeh.2010.04.019; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zelikovsky N, 2007, J CLIN PSYCHOL MED S, V14, P320, DOI 10.1007/s10880-007-9084-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	9	9	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201390	10.1371/journal.pone.0201390	http://dx.doi.org/10.1371/journal.pone.0201390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048532	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400085
J	Da Pozzo, E; Giacomelli, C; Cavallini, C; Martini, C				Da Pozzo, Eleonora; Giacomelli, Chiara; Cavallini, Chiara; Martini, Claudia			Cytokine secretion responsiveness of lymphomonocytes following cortisol cell exposure: Sex differences	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; TNF-ALPHA; ANTIINFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; DOSAGE COMPENSATION; GENDER-DIFFERENCE; GENE-EXPRESSION; IMMUNE-SYSTEM; STRESS; AGE	The stress hormone cortisol has been recognized as a coordinator of immune response. However, its different ability to modulate the release of inflammatory mediators in males and females has not been clarified yet. Indeed, the dissection of cortisol specific actions may be difficult due to the complex hormonal and physio-pathological individual status. Herein, the release of inflammatory mediators following increasing cortisol concentrations was investigated in an in vitro model of primary human male and female lymphomonocytes. The use of a defined cellular model to assess sex differences in inflammatory cytokine secretion could be useful to exclude the effects of divergent and fluctuating sex hormone levels occurring in vivo. Herein, the cells were challenged with cortisol concentrations resembling the plasma levels achieving in physiological and stressful conditions. The production of cytokines and other molecules involved in inflammatory process was determined. In basal conditions, male cells presented higher levels of some pro-inflammatory molecules (NF-kB and IDO-1 mRNAs, IL-6 and kynurenine) than female cells. Following cortisol exposure, the levels of the pro-inflammatory cytokines, IL-6 and IL-8, were increased in male cells. Conversely, in female cells IL-6 release was unchanged and IL-8 levels were decreased. Anti-inflammatory cytokines, IL-4 and IL-10, did not change in male cells and increased in female cells. Interestingly, kynurenine levels were higher in female cells than in male cells following cortisol stimulus. These results highlighted that cortisol differently affects male and female lymphomonocytes, shifting the cytokine release in favour of a pro-inflammatory pattern in male cells and an anti-inflammatory secretion profile in female cells, opening the way to study the influences of other stressful factors involved in the neurohumoral changes occurring in the response to stress conditions.	[Da Pozzo, Eleonora; Giacomelli, Chiara; Cavallini, Chiara; Martini, Claudia] Univ Pisa, Dept Pharm, Pisa, Italy	University of Pisa	Da Pozzo, E; Martini, C (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	eleonora.dapozzo@unipi.it; claudia.martini@unipi.it	Giacomelli, Chiara/K-4954-2016; Da Pozzo, Eleonora/AAW-8186-2020; Martini, Claudia/AAC-4089-2019; Cavallini, Chiara/ABC-9438-2020	Giacomelli, Chiara/0000-0002-6244-602X; Da Pozzo, Eleonora/0000-0003-4762-8949; Martini, Claudia/0000-0001-9379-3027; Cavallini, Chiara/0000-0002-3456-5152	Seventh FRAMEWORK PROGRAMME, 'Science in Society', Project title: Transforming Institutions by gendering contents and gaining equality in research (TRIGGER), GA [611034]	Seventh FRAMEWORK PROGRAMME, 'Science in Society', Project title: Transforming Institutions by gendering contents and gaining equality in research (TRIGGER), GA	Funding for this study was provided by the Seventh FRAMEWORK PROGRAMME, 'Science in Society', Project title: Transforming Institutions by gendering contents and gaining equality in research (TRIGGER), GA. No 611034. The FP7 EU commission had no role in the design of the study and collection, analysis, or interpretation of data, nor in writing the manuscript.	Agarwal SK, 1998, J INTERF CYTOK RES, V18, P1059, DOI 10.1089/jir.1998.18.1059; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Andersen MH, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv154; Aoyama M, 2009, SHOCK, V32, P401, DOI 10.1097/SHK.0b013e31819c358a; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; ARNOLD R, 1995, IMMUNOLOGY, V85, P364; Balestri F, 2013, J ENVIRON MANAGE, V117, P76, DOI 10.1016/j.jenvman.2012.12.030; Bauer I, 2006, ANAESTHESIST, V55, P515, DOI 10.1007/s00101-006-0983-x; Beck KD, 2003, INTEGR PHYS BEH SCI, V38, P179, DOI 10.1007/BF02688852; Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Casimir GJA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-28; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Choi Joungbum, 2014, Immune Netw, V14, P289, DOI 10.4110/in.2014.14.6.289; Daniele S, 2015, CELL SIGNAL, V27, P1609, DOI 10.1016/j.cellsig.2015.04.006; DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V; Dementyeva EV, 2009, BIOESSAYS, V31, P21, DOI 10.1002/bies.080149; Elsenmenger SJ, 2004, CELL IMMUNOL, V230, P17, DOI 10.1016/j.cellimm.2004.08.002; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; Feuerecker M, 2013, CLIN EXP IMMUNOL, V172, P290, DOI 10.1111/cei.12049; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Guilbault C, 2002, IMMUNOLOGY, V107, P297, DOI 10.1046/j.1365-2567.2002.01508.x; Hermes GL, 2006, AM J PHYSIOL-REG I, V290, pR273, DOI 10.1152/ajpregu.00368.2005; Hol JW, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0102-2; Holden C, 2005, SCIENCE, V308, P1574, DOI 10.1126/science.308.5728.1574; Howard RR, 1996, CYTOMETRY, V26, P231, DOI 10.1002/(SICI)1097-0320(19960915)26:3<231::AID-CYTO9>3.3.CO;2-3; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Jankord R, 2007, ENDOCRINOLOGY, V148, P3758, DOI 10.1210/en.2006-1650; Jansky L, 2003, PHYSIOL RES, V52, P593; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Katial RK, 1998, CLIN DIAGN LAB IMMUN, V5, P78, DOI 10.1128/CDLI.5.1.78-81.1998; Kinser PA, 2014, BRAIN BEHAV, V4, P665, DOI 10.1002/brb3.249; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lestage J, 2002, BRAIN BEHAV IMMUN, V16, P596, DOI 10.1016/S0889-1591(02)00014-4; Lovallo WR, 2015, NEUROPSYCHOPHARMACOL, V40, P2546, DOI 10.1038/npp.2015.101; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundberg U, 2005, PSYCHONEUROENDOCRINO, V30, P1017, DOI 10.1016/j.psyneuen.2005.03.014; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Moxley G, 2004, J RHEUMATOL, V31, P686; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Pallotta MT, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00497; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Porreca E, 1999, ATHEROSCLEROSIS, V146, P345, DOI 10.1016/S0021-9150(99)00160-4; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P622, DOI 10.1016/j.bbi.2008.11.004; Prothero KE, 2009, CHROMOSOME RES, V17, P637, DOI 10.1007/s10577-009-9063-9; Queen AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152289; READE MC, 2009, CRIT CARE MED, V37, P1809, DOI DOI 10.1097/CCM.0B013E3181A1A12B; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Spolarics Z, 2007, SHOCK, V27, P597, DOI 10.1097/SHK.0b013e31802e40bd; TOLLERUD DJ, 1989, J CLIN IMMUNOL, V9, P214, DOI 10.1007/BF00916817; Turck J, 2005, MED MICROBIOL IMMUN, V194, P47, DOI 10.1007/s00430-003-0210-1; Tyagi P, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-23; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; WILDER RL, 1995, ANNU REV IMMUNOL, V13, P307; Wolf JM, 2009, BRAIN BEHAV IMMUN, V23, P742, DOI 10.1016/j.bbi.2008.09.009; Xiang LB, 2013, INT IMMUNOPHARMACOL, V17, P556, DOI 10.1016/j.intimp.2013.07.019	72	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200924	10.1371/journal.pone.0200924	http://dx.doi.org/10.1371/journal.pone.0200924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048487	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400031
J	Holmes, G; Zhang, LN; Rivera, J; Murphy, R; Assouline, C; Sullivan, L; Oppeneer, T; Jabs, EW				Holmes, Greg; Zhang, Lening; Rivera, Joshua; Murphy, Ryan; Assouline, Claudia; Sullivan, Lorraine; Oppeneer, Todd; Jabs, Ethylin Wang			C-type natriuretic peptide analog treatment of craniosynostosis in a Crouzon syndrome mouse model	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SKELETAL DYSPLASIAS; FACTOR RECEPTOR-2; ACHONDROPLASIA; MUTATIONS; EXPRESSION; GENE; CNP; ORGANOGENESIS; OSSIFICATION	Activating mutations of fibroblast growth factor receptors (FGFRs) are a major cause of skeletal dysplasias, and thus they are potential targets for pharmaceutical intervention. BMN 111, a C-type natriuretic peptide analog, inhibits FGFR signaling at the level of the RAF1 kinase through natriuretic peptide receptor 2 (NPR2) and has been shown to lengthen the long bones and improve skull morphology in the Fgfr3(Y367C/+) thanatophoric dysplasia mouse model. Here we report the effects of BMN 111 in treating craniosynostosis and aberrant skull morphology in the Fgfr2c(C342Y/+) Crouzon syndrome mouse model. We first demonstrated that NPR2 is expressed in the murine coronal suture and spheno-occipital synchondrosis in the newborn period. We then gave Fgfr2c(C342Y/+) and Fgfr2c(+/+) (WT) mice once-daily injections of either vehicle or reported therapeutic levels of BMN 111 between post-natal days 3 and 31. Changes in skeletal morphology, including suture patency, skull dimensions, and long bone length, were assessed by micro-computed tomography. Although BMN 111 treatment significantly increased long bone growth in both WT and mutant mice, skull dimensions and suture patency generally were not significantly affected. A small but significant increase in the relative length of the anterior cranial base was observed. Our results indicate that the differential effects of BMN 111 in treating various skeletal dysplasias may depend on the process of bone formation targeted (endochondral or intramembranous), the specific FGFR mutated, and/or the specific signaling pathway changes due to a given mutation.	[Holmes, Greg; Rivera, Joshua; Assouline, Claudia; Jabs, Ethylin Wang] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhang, Lening; Murphy, Ryan; Sullivan, Lorraine; Oppeneer, Todd] BioMarin Pharmaceut, Novato, CA USA	Icahn School of Medicine at Mount Sinai; BioMarin Pharmaceutical Inc.	Holmes, G (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	gregory.holmes@mssm.edu		Holmes, Greg/0000-0003-0717-6722	BioMarin Pharmaceutical, Inc.; National Institute of Health (NIH) National Institute of Dental and Craniofacial Research [R01 DE022988]; NIH National Institute of Child Health and Human Development [P01 HD078233]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022988] Funding Source: NIH RePORTER	BioMarin Pharmaceutical, Inc.; National Institute of Health (NIH) National Institute of Dental and Craniofacial Research; NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc., provided support in the form of partial salaries (GH, EWJ), reagents, equipment, and facilities, and had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of the authors employed by BioMarin Pharmaceutical included imaging methodology, data curation, visualization, and analysis, which were performed by LZ and RM, who along with LS and TO reviewed and edited the manuscript. Their specific roles are articulated in the Author Contributions section. Additional funding was supplied by National Institute of Health (NIH) National Institute of Dental and Craniofacial Research (https://www.nidcr.nih.gov/) R01 DE022988 (to EWJ) and NIH National Institute of Child Health and Human Development (https://www.nichd.nih.gov/) P01 HD078233 (to EWJ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Di Rocco F, 2014, HUM MOL GENET, V23, P2914, DOI 10.1093/hmg/ddu004; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Goodrich JT, 2005, CHILD NERV SYST, V21, P871, DOI 10.1007/s00381-004-1113-1; Helman SN, 2014, ORAL MAXILLOFAC SURG, V18, P373, DOI 10.1007/s10006-014-0467-0; Heuze Yann, 2014, Curr Genet Med Rep, V2, P135; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Legeai-Mallet L, 2016, ENDOCR DEV, V30, P98, DOI 10.1159/000439334; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Martinez-Abadias N, 2013, DEV DYNAM, V242, P80, DOI 10.1002/dvdy.23903; Nakao K, 2013, J DENT RES, V92, P58, DOI 10.1177/0022034512466413; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Pannier S, 2009, BBA-MOL BASIS DIS, V1792, P140, DOI 10.1016/j.bbadis.2008.11.010; Perlyn CA, 2006, NEUROSURGERY, V59, P210, DOI 10.1227/01.NEU.0000224323.53866.1E; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; PETERS KG, 1992, DEVELOPMENT, V114, P233; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; Rijken BFM, 2013, PLAST RECONSTR SURG, V132, p993E, DOI 10.1097/PRS.0b013e3182a8077e; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Vora SR, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00417; Wang SR, 2015, HUM MUTAT, V36, P474, DOI 10.1002/humu.22773; Wendt DJ, 2015, J PHARMACOL EXP THER, V353, P132, DOI 10.1124/jpet.114.218560; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 2010, ENDOCR J, V57, P659, DOI 10.1507/endocrj.K10E-164; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201492	10.1371/journal.pone.0201492	http://dx.doi.org/10.1371/journal.pone.0201492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048539	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400095
J	Link, KG; Stobb, MT; Di Paola, J; Neeves, KB; Fogelson, AL; Sindi, SS; Leiderman, K				Link, Kathryn G.; Stobb, Michael T.; Di Paola, Jorge; Neeves, Keith B.; Fogelson, Aaron L.; Sindi, Suzanne S.; Leiderman, Karin			A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow	PLOS ONE			English	Article							SURFACE-MEDIATED CONTROL; FACTOR PATHWAY INHIBITOR; BLOOD-COAGULATION; THROMBIN GENERATION; ANTITHROMBIN-III; ACTIVATED PLATELETS; BINDING-SITE; FACTOR-IXA; FACTOR-XI; UNCERTAINTY	The hemostatic response involves blood coagulation and platelet aggregation to stop blood loss from an injured blood vessel. The complexity of these processes make it difficult to intuit the overall hemostatic response without quantitative methods. Mathematical models aim to address this challenge but are often accompanied by numerous parameters choices and thus need to be analyzed for sensitivity to such choices. Here we use local and global sensitivity analyses to study a model of coagulation and platelet deposition under flow. To relate with clinical assays, we measured the sensitivity of three specific thrombin metrics: lag time, maximum relative rate of generation, and final concentration after 20 minutes. In addition, we varied parameters of three different classes: plasma protein levels, kinetic rate constants, and platelet characteristics. In terms of an overall ranking of the model's sensitivities, we found that the local and global methods provided similar information. Our local analysis, in agreement with previous findings, shows that varying parameters within 50-150% of baseline values, in a one-at-a-time (OAT) fashion, always leads to significant thrombin generation in 20 minutes. Our global analysis gave a different and novel result highlighting groups of parameters, still varying within the normal 50-150%, that produced little or no thrombin in 20 minutes. Variations in either plasma levels or platelet characteristics, using either OAT or simultaneous variations, always led to strong thrombin production and overall, relatively low output variance. Simultaneous variation in kinetics rate constants or in a subset of all three parameter classes led to the highest overall output variance, incorporating instances with little to no thrombin production. The global analysis revealed multiple parameter interactions in the lag time and final concentration leading to relatively high variance; high variance was also observed in the thrombin generation rate, but parameters attributed to that variance acted independently and additively.	[Fogelson, Aaron L.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Link, Kathryn G.; Fogelson, Aaron L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Stobb, Michael T.; Sindi, Suzanne S.] Univ Calif Merced, Dept Appl Math, Merced, CA USA; [Leiderman, Karin] Colorado Sch Mines, Dept Appl Math & Stat, Golden, CO 80401 USA; [Di Paola, Jorge; Neeves, Keith B.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Neeves, Keith B.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Merced; Colorado School of Mines; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Mines	Leiderman, K (corresponding author), Colorado Sch Mines, Dept Appl Math & Stat, Golden, CO 80401 USA.	kleiderman@mines.edu	Neeves, Keith/J-9494-2019	Neeves, Keith/0000-0001-7546-4588; Sindi, Suzanne/0000-0003-2742-4332; Di Paola, Jorge/0000-0002-1461-2871; Link, Kathryn/0000-0002-2148-9883	National Institutes of Health [R01 HL120728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120728, R01HL126864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (www.nih.gov) grant R01 HL120728 to JDP, KBN, ALF, and K. Leiderman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AHMAD SS, 1989, J BIOL CHEM, V264, P3244; Anand M, 2008, J THEOR BIOL, V253, P725, DOI 10.1016/j.jtbi.2008.04.015; Anand M., 2003, J THEOR MED, V5, P183, DOI [10.1080/10273660412331317415, DOI 10.1080/10273660412331317415]; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Archer GEB, 1997, J STAT COMPUT SIM, V58, P99, DOI 10.1080/00949659708811825; Ataullakhanov FI, 2002, INT J BIFURCAT CHAOS, V12, P1969, DOI 10.1142/S0218127402005637; BAGLIA FA, 1995, J BIOL CHEM, V270, P6734, DOI 10.1074/jbc.270.12.6734; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bungay SD, 2003, MATH MED BIOL, V20, P105, DOI 10.1093/imammb20.1.105; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Edgington E., 2007, STAT SERIES TXB MONO, VFourth; Elizondo P, 2016, BIOPHYS J, V111, P2722, DOI 10.1016/j.bpj.2016.10.030; Flamm MH, 2012, BLOOD, V120, P190, DOI 10.1182/blood-2011-10-388140; Fogelson AL, 2012, BIOPHYS J, V102, P10, DOI 10.1016/j.bpj.2011.10.048; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; Govindarajan V, 2018, BIOPHYS J, V114, P978, DOI 10.1016/j.bpj.2017.12.034; Govindarajan V, 2016, BIOPHYS J, V110, P1869, DOI 10.1016/j.bpj.2016.03.010; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; JANSEN MJW, 1994, PREDICTABILITY AND NONLINEAR MODELLING IN NATURAL SCIENCES AND ECONOMICS, P334; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Leiderman K, 2016, ARTERIOSCL THROM VAS, V36, P2334, DOI 10.1161/ATVBAHA.116.308186; Leiderman K, 2013, B MATH BIOL, V75, P1255, DOI 10.1007/s11538-012-9784-3; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; London FS, 2004, J BIOL CHEM, V279, P19854, DOI 10.1074/jbc.M310624200; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; MANN KG, 1992, SEMIN HEMATOL, V29, P213; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Miller TN, 2007, BIOCHEMISTRY-US, V46, P14450, DOI 10.1021/bi701310x; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Naidu PP, 2014, MATH MODEL NAT PHENO, V9, P17, DOI 10.1051/mmnp/20149603; NESHEIM ME, 1988, J BIOL CHEM, V263, P16467; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sobol I M, 1990, MATH MODEL COMPUT EX, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Susree M, 2017, SADHANA-ACAD P ENG S, V42, P291, DOI 10.1007/s12046-017-0602-3; Susree M, 2018, ACTA BIOTHEOR, P1; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; WALSH PN, 1994, HEMOSTASIS THROMBOSI, P629; Wilkinson FH, 2001, J BIOL CHEM; Xu ZL, 2010, BIOPHYS J, V98, P1723, DOI 10.1016/j.bpj.2009.12.4331; Zarnitsina VI, 2001, CHAOS, V11, P57, DOI 10.1063/1.1345728	56	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200917	10.1371/journal.pone.0200917	http://dx.doi.org/10.1371/journal.pone.0200917			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048479	Green Submitted, gold, Green Published			2022-12-27	WOS:000439952400030
J	Soutome, S; Hayashida, S; Funahara, M; Sakamoto, Y; Kojima, Y; Yanamoto, S; Umeda, M				Soutome, Sakiko; Hayashida, Saki; Funahara, Madoka; Sakamoto, Yuki; Kojima, Yuka; Yanamoto, Souichi; Umeda, Masahiro			Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?	PLOS ONE			English	Article							TREATMENT OUTCOMES; ZOLEDRONIC ACID; SINGLE-CENTER; MANAGEMENT; PREVENTION; DIAGNOSIS; TRIALS; COHORT; BRONJ	Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who have received high-dose bisphosphonate (BP) or denosumab (Dmab) have not yet been established. Tooth extraction after starting medication has been believed to be a major risk factor for MRONJ, and therefore this procedure tends to be avoided. This study investigated the risk factors for MRONJ, with a special reference to the correlation between tooth extraction and development of MRONJ. One hundred and thirty-five cancer patients who were administrated high-dose BP or Dmab were enrolled in the study. Demographic factors, general condition, treatment factors, and dental findings were examined retrospectively using medical records and panoramic X-ray findings. The cumulative occurrence rate of MRONJ was calculated using the Kaplan-Meier method, and the correlation between these variables and development of MRONJ was analyzed by univariate and multivariate Cox regression analysis. MRONJ developed in 18 of 135 patients. The 1-, 2-, and 3-year cumulative occurrence rates were 8.6%, 21.5%, and 29.2%, respectively. The duration of medication before first visit to the dental unit and the presence of a tooth with clinical symptoms were significantly correlated with the development of MRONJ. The rate of MRONJ occurrence in patients who had teeth with clinical symptoms, but who did not undergo tooth extraction, became higher 2 years later than that in patients who underwent extraction of teeth with symptoms, although not significant. Early dental examination and effective preventative care to avoid infection/inflammation are important for preventing MRONJ.	[Soutome, Sakiko] Nagasaki Univ Hosp, Perioperat Oral Management Ctr, Nagasaki, Japan; [Hayashida, Saki; Funahara, Madoka; Sakamoto, Yuki; Yanamoto, Souichi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan; [Kojima, Yuka] Kansai Med Univ, Dept Dent & Oral Surg, Osaka, Japan	Nagasaki University; Nagasaki University; Kansai Medical University	Hayashida, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan.	sakihaya@nagasaki-u.ac.jp	Yanamoto, Souichi/X-2576-2019	Yanamoto, Souichi/0000-0003-2372-8347				Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Fedele S, 2010, AM J MED, V123, P1060, DOI 10.1016/j.amjmed.2010.04.033; Fliefel R, 2015, INT J ORAL MAX SURG, V44, P568, DOI 10.1016/j.ijom.2015.01.026; Graziani F, 2012, J ORAL MAXIL SURG, V70, P2501, DOI 10.1016/j.joms.2012.05.019; Hayashida S, 2017, J BONE MINER RES, V32, P2022, DOI 10.1002/jbmr.3191; Jacobsen C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13605; Kajizono M, 2015, BIOL PHARM BULL, V38, P1850, DOI 10.1248/bpb.b15-00385; Khan A, 2016, OSTEOPOROSIS INT, V27, P853, DOI 10.1007/s00198-015-3335-3; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kim HY, 2017, J ORAL MAXIL SURG, V75, P1404, DOI 10.1016/j.joms.2016.12.014; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Lazarovici TS, 2009, J ORAL MAXIL SURG, V67, P850, DOI 10.1016/j.joms.2008.11.015; Lerman MA, 2013, ORAL ONCOL, V49, P977, DOI 10.1016/j.oraloncology.2013.05.012; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Mozzati M, 2012, ORAL ONCOL, V48, P817, DOI 10.1016/j.oraloncology.2012.03.009; Mucke T, 2011, J CANCER RES CLIN, V137, P907, DOI 10.1007/s00432-010-0953-1; Nisi M, 2016, BRIT J ORAL MAX SURG, V54, P930, DOI 10.1016/j.bjoms.2016.06.015; Otto S, 2015, J CRANIO MAXILL SURG, V43, P847, DOI 10.1016/j.jcms.2015.03.039; Ruggiero SL, 2015, J ORAL MAXIL SURG, V73, pS94, DOI 10.1016/j.joms.2015.09.024; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Rupel K, 2014, ORAL ONCOL, V50, P1049, DOI 10.1016/j.oraloncology.2014.08.016; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Schubert M, 2012, ORAL ONCOL, V48, P349, DOI 10.1016/j.oraloncology.2011.11.004; Scoletta M, 2013, J ORAL MAXIL SURG, V71, P994, DOI 10.1016/j.joms.2013.01.006; Vahtsevanos K, 2009, J CLIN ONCOL, V27, P5356, DOI 10.1200/JCO.2009.21.9584; Vescovi P, 2012, J ORAL PATHOL MED, V41, P214, DOI 10.1111/j.1600-0714.2011.01091.x; Yamazaki T, 2012, INT J ORAL MAX SURG, V41, P1397, DOI 10.1016/j.ijom.2012.06.020; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7	30	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201343	10.1371/journal.pone.0201343	http://dx.doi.org/10.1371/journal.pone.0201343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048523	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400081
J	Tivane, A; Daniels, R; Nguenha, N; Machalele, L; Nacoto, A; Pale, M; Mateonane, E; Mavale, S; Chilundo, J; Muteto, D; Salencia, J; Albati, F; Gudo, E; Mussa, T; McCauley, J				Tivane, Almiro; Daniels, Rodney; Nguenha, Neuza; Machalele, Loira; Nacoto, Afonso; Pale, Mirela; Mateonane, Edirsse; Mavale, Sandra; Chilundo, Josina; Muteto, Delcio; Salencia, Judite; Albati, Felix; Gudo, Eduardo; Mussa, Tufaria; McCauley, John			Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season	PLOS ONE			English	Article							HEMAGGLUTININ; NEURAMINIDASE; ADAPTATION; H1N1	Background Due to the high rate of antigenic variation of influenza virus, seasonal characterization of the virus is crucial to assess and monitor the emergence of new pathogenic variants and hence formulate effective control measures. However, no study has yet been conducted in Mozambique to assess genetic, antigenic and antiviral susceptibility profile of influenza virus. Methods A subset of samples (n = 20) from influenza positive children detected in two hospitals in Maputo city during 2015 season as part of the implementation of influenza surveillance system, were selected. The following assays were performed on these samples: antigenic characterization by hemagglutination inhibition assay, genetic characterization by Sanger sequencing of hemagglutinin (HA) and neuraminidase (NA) and susceptibility to oseltamivir and zanamivir (NA inhibitors) by enzymatic assay. Results The A(H1N1) pdm09 subtype viruses remained closely related antigenically and genetically to the 2016 vaccine virus A/California/7/2009 and other widely distributed viruses belonging to genetic group 6B. The majority of influenza A(H3N2) viruses studied were antigenically similar to the 2016-2017 vaccine virus, A/Hong Kong/4801/2014, and their HA and NA gene sequences fell into genetic subclade 3C.2a being closely related to viruses circulating in southern Africa. The influenza B viruses were antigenically similar to the 2016 season vaccine virus and HA sequences of all three fell into the B/Yamagata-lineage, clade 3, but contained NA genes of the B/Victoria-lineage. All tested viruses were sensitive to oseltamivir and zanamivir. Conclusion Overall, all Mozambican influenza A and B viruses were most closely related to Southern African viruses and all were sensitive to oseltamivir and zanamivir. These findings suggest the existence of an ecological niche of influenza viruses within the region and hence highlighting the need for joint epidemiologic and virologic surveillance to monitor the evolution of influenza viruses.	[Tivane, Almiro; Nguenha, Neuza; Machalele, Loira; Nacoto, Afonso; Pale, Mirela; Mateonane, Edirsse; Muteto, Delcio; Salencia, Judite; Albati, Felix; Gudo, Eduardo; Mussa, Tufaria] Minist Hlth, Inst Nacl Saude, Dept Technol Platforms, Maputo, Mozambique; [Daniels, Rodney; McCauley, John] Worldwide Influenza Ctr, Francis Crick Inst, London, England; [Mavale, Sandra; Chilundo, Josina] Maputo Cent Hosp, Dept Pediat, Maputo, Mozambique; [Mussa, Tufaria] Eduardo Mondlane Univ, Fac Med, Dept Microbiol, Maputo, Mozambique	Francis Crick Institute; Eduardo Mondlane University	Tivane, A (corresponding author), Minist Hlth, Inst Nacl Saude, Dept Technol Platforms, Maputo, Mozambique.	artivane@gmail.com		Tivane, Almiro/0000-0002-8308-4136; Mussa, Tufaria/0000-0002-9635-3585	Francis Crick Institute - Cancer Research UK [FC001030]; Francis Crick Institute - Medical Research Council [FC001030]; Francis Crick Institute - Wellcome Trust [FC001030]; Centre for Disease Control and Prevention [U51IP000825]; World Health Organization (WHO)	Francis Crick Institute - Cancer Research UK; Francis Crick Institute - Medical Research Council; Francis Crick Institute - Wellcome Trust; Centre for Disease Control and Prevention; World Health Organization (WHO)(World Health Organization)	The work done at the Crick Worldwide Influenza Centre, a WHO Collaborating Centre for Reference and Research on Influenza, was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001030), the Medical Research Council (FC001030) and the Wellcome Trust (FC001030). The influenza surveillance in Mozambique is supported by the Centre for Disease Control and Prevention (Grant # U51IP000825) and by the World Health Organization (WHO). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P545; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P121; [Anonymous], 2017, WEEKLY EPIDEMIOLOGIC, V92, P117; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Christman MC, 2011, INFECT GENET EVOL, V11, P803, DOI 10.1016/j.meegid.2011.02.021; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Fazekas de St Groth, 1969, Bull World Health Organ, V41, P651; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Lin YP, 2017, INFLUENZA OTHER RESP, V11, P263, DOI 10.1111/irv.12447; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McCauley J, 2016, REPORT PREPARED WHO; McCauley JW, 2015, REPOR PREPARED WHO A; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P197, DOI 10.1016/B978-0-12-803109-4.00023-4; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1985, VIROLOGY, V143, P166, DOI 10.1016/0042-6822(85)90105-9; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Seleka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177655; Shaw ML, 2013, FIELDS VIROLOGY, P1151; Skowronski DM, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.3.30112; Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023; Stohr Klaus, 2012, Methods Mol Biol, V865, P147, DOI 10.1007/978-1-61779-621-0_9; Tivane A, 2014, INT J INFECT DIS, V21, P275, DOI 10.1016/j.ijid.2014.03.991; Tivane AR, 2014, INFLUENZA SURVEILLAN, P2579; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WHO, 2015, INFL TRANSM ZON; WHO, 2017, GLOB INFL SURV RESP; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2014, INF PREV CONTR EP PA	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201248	10.1371/journal.pone.0201248	http://dx.doi.org/10.1371/journal.pone.0201248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048502	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400065
J	Zamora-Martinez, FJ; Espana-Boquera, S; Castro-Bleda, MJ; Palacios-Corella, A				Zamora-Martinez, Francisco J.; Espana-Boquera, Salvador; Castro-Bleda, Maria Jose; Palacios-Corella, Adrian			Fallback Variable History NNLMs: Efficient NNLMs by precomputation and stochastic training	PLOS ONE			English	Article							LANGUAGE MODEL	This paper presents a new method to reduce the computational cost when using Neural Networks as Language Models, during recognition, in some particular scenarios. It is based on a Neural Network that considers input contexts of different length in order to ease the use of a fallback mechanism together with the precomputation of softmax normalization constants for these inputs. The proposed approach is empirically validated, showing their capability to emulate lower order N-grams with a single Neural Network. A machine translation task shows that the proposed model constitutes a good solution to the normalization cost of the output softmax layer of Neural Networks, for some practical cases, without a significant impact in performance while improving the system speed.	[Zamora-Martinez, Francisco J.] Veridas SL, R&D Dept, Pol Ind Talluntxe 2, Tajonar 31192, Spain; [Espana-Boquera, Salvador; Castro-Bleda, Maria Jose; Palacios-Corella, Adrian] Univ Politecn Valencia, Valencia, Spain	Universitat Politecnica de Valencia	Castro-Bleda, MJ (corresponding author), Univ Politecn Valencia, Valencia, Spain.	mcastro@dsic.upv.es	Castro-Bleda, M. J./H-2372-2011	Castro-Bleda, MariaJose/0000-0003-1001-8258	Spanish MINECO; FEDER [TIN2017-85854-C4-2-R]	Spanish MINECO(Spanish Government); FEDER(European Commission)	This work was partially supported by the Spanish MINECO and FEDER founds under project TIN2017-85854-C4-2-R (to MJCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisoy E.S., 2012, NAACL HLT 2012 WORKS, P20; Arisoy E, 2013, INT CONF ACOUST SPEE, P8242, DOI 10.1109/ICASSP.2013.6639272; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bengio Y, 2008, IEEE T NEURAL NETWOR, V19, P713, DOI 10.1109/TNN.2007.912312; Callison-Burch Chris, 2008, P 3 WORKSH STAT MACH; Callison-Burch Chris, 2010, P JOINT 5 WORKSH STA, P17; Chen W, 2015, STRATEGIES TRAINING; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Devlin J, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1370; Goodman JT, 2001, MSRTR200172; Graves A., 2006, P 23 INT C MACH LEAR; Graves A, 2014, PR MACH LEARN RES, V32, P1764; Hinton G., 2015, DISTILLING KNOWLEDGE; Jozefowicz Rafal, 2016, EXPLORING LIMITS LAN; KATZ SM, 1987, IEEE T ACOUST SPEECH, V35, P400, DOI 10.1109/TASSP.1987.1165125; Koehn P., 2007, P 45 ANN M ACL INT P, P177, DOI DOI 10.3115/1557769.1557821; Koehn P, 2003, P 2003 C N AM CHAPT, V1, P48, DOI DOI 10.3115/1073445.1073462; Le HS, 2011, INT CONF ACOUST SPEE, P5524; Martin S, 1999, P 6 EUR C SPEECH COM, V5, P1939; Mikolov T., 2013, PREPRINT; Mikolov T, 2013, P 2013 C N AM CHAPT, DOI DOI 10.3109/10826089109058901; Mnih A., 2012, FAST SIMPLE ALGORITH; NEY H, 1994, COMPUT SPEECH LANG, V8, P1, DOI 10.1006/csla.1994.1001; Och F. J., 2003, Computational Linguistics, V29, P19, DOI 10.1162/089120103321337421; Och FJ, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P160; Palacios-Corella A., 2015, THESIS; Paul Baltescu, 2014, Prague Bulletin of Mathematical Linguistics, P81, DOI 10.2478/pralin-2014-0016; Rastogi P, 2015, SUBLINEAR PARTITION; Rosenfeld R, 1996, COMPUT SPEECH LANG, V10, P187, DOI 10.1006/csla.1996.0011; Schwenk H, 2007, COMPUT SPEECH LANG, V21, P492, DOI 10.1016/j.csl.2006.09.003; Schwenk Holger, 2008, P INT JOINT C NAT LA, P661; Schwenk Holger, 2006, P COLINGACL 2006 MAI, P723; Shi YZ, 2014, IEEE SIGNAL PROC LET, V21, P377, DOI 10.1109/LSP.2014.2303136; Shrivastava Anshumali, 2014, NEURIPS; Siu MH, 2000, IEEE T SPEECH AUDI P, V8, P63, DOI 10.1109/89.817454; Stolcke A., 2002, P INT C SPOK LANG PR, V2, P901; Vijayanarasimhan S, 2014, DEEP NETWORKS LARGE; Wang R., 2013, P 2013 C EMP METH NA, P845; Xuedong Huang, 1993, Computer Speech and Language, V7, P137, DOI 10.1006/csla.1993.1007; Zamora-Martinez F, 2014, PATTERN RECOGN, V47, P1642, DOI 10.1016/j.patcog.2013.10.020; Zamora-Martinez F, 2009, LECT NOTES COMPUT SC, V5517, P33, DOI 10.1007/978-3-642-02478-8_5; Zamora-Martinez FJ, 2012, THESIS; Zamora-Martinez F, 2018, INT J NEURAL SYST, V28, DOI 10.1142/S0129065718500077	45	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200884	10.1371/journal.pone.0200884	http://dx.doi.org/10.1371/journal.pone.0200884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048480	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400027
J	Byrou, S; Makrigiorgos, GM; Christofides, A; Kallikas, I; Papasavva, T; Kleanthous, M				Byrou, Stefania; Makrigiorgos, G. Mike; Christofides, Agathoklis; Kallikas, Ioannis; Papasavva, Thessalia; Kleanthous, Marina			Fast Temperature-Gradient COLD PCR for the enrichment of the paternally inherited SNPs in cell free fetal DNA; an application to non-invasive prenatal diagnosis of beta-thalassaemia	PLOS ONE			English	Article							MATERNAL PLASMA; CLINICAL-APPLICATION; MONOGENIC DISEASES; RHD STATUS; MUTATIONS; AMNIOCENTESIS; SENSITIVITY; CANCER	Objective To develop a sensitive, specific, simple, cost-effective and reproducible platform for the non-invasive prenatal detection of paternally inherited alleles for beta-thalassaemia. The development of such an assay is of major significance in order to replace currently-applied invasive methods containing inherent fetal loss risks. Methods We present a fast Temperature-Gradient Co-amplification at Lower Denaturation Temperature Polymerase Chain Reaction (fast TG COLD PCR) methodology for the detection of the paternally-inherited fetal alleles in maternal plasma. Two single-nucleotide polymorphisms (SNPs), rs7480526 (G/T) and rs968857 (G/A) that are located on the beta-globin gene cluster and exhibit a high degree of heterozygosity in the Cypriot population were selected for evaluation. Seventeen maternal plasma samples from pregnancies at risk for beta-thalassemia were analysed for the selected SNPs using the novel fast TG COLD PCR assay. Results Using fast TG COLD PCR, the paternally inherited allele in cell free fetal DNA was correctly determined for all the 17 maternal plasma samples tested, showing full agreement with the Chorionic Villus Sampling (CVS) analysis. Conclusions Our findings are encouraging and demonstrate the efficiency and sensitivity of fast TG COLD PCR in detecting the minor paternally-inherited fetal alleles in maternal plasma for the development of a NIPD assay for beta-thalassaemia.	[Byrou, Stefania; Papasavva, Thessalia; Kleanthous, Marina] Cyprus Inst Neurol & Genet, Mol Genet Thalassaemia Dept, Nicosia, Cyprus; [Byrou, Stefania; Papasavva, Thessalia; Kleanthous, Marina] Cyprus Sch Mol Med, Nicosia, Cyprus; [Makrigiorgos, G. Mike] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Med Phys & Biophys, Boston, MA USA; [Christofides, Agathoklis] Archbishop Makarios III Hosp, Med Ctr, Fetal Med Dept, Nicosia, Cyprus; [Kallikas, Ioannis] Ultrasound & Fetal Med Ctr, Nicosia, Cyprus	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Papasavva, T (corresponding author), Cyprus Inst Neurol & Genet, Mol Genet Thalassaemia Dept, Nicosia, Cyprus.; Papasavva, T (corresponding author), Cyprus Sch Mol Med, Nicosia, Cyprus.	thesalia@cing.ac.cy	Makrigiorgos, Mike/AFC-4575-2022	Papasavva, Thessalia/0000-0001-9279-4810	TELETHON GRANT [2015/4]; Molecular Genetics Thalassaemia Department of the Cyprus Institute of Neurology and Genetics; NATIONAL CANCER INSTITUTE [R33CA217652] Funding Source: NIH RePORTER	TELETHON GRANT(Fondazione Telethon); Molecular Genetics Thalassaemia Department of the Cyprus Institute of Neurology and Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by TELETHON GRANT with grant number 2015/4 to TP and by the Molecular Genetics Thalassaemia Department of the Cyprus Institute of Neurology and Genetics. There was no additional external funding received	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bombard AT, 2011, PRENATAL DIAG, V31, P802, DOI 10.1002/pd.2770; Carotenuto P, 2012, INT J ONCOL, V40, P378, DOI 10.3892/ijo.2011.1221; Castellanos-Rizaldos E, 2012, CLIN CHEM, V58, P1130, DOI 10.1373/clinchem.2012.183095; Castellanos-Rizaldos E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051362; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Galbiati S, 2016, J MED GENET, V53, P481, DOI 10.1136/jmedgenet-2015-103229; Galbiati S, 2012, EXPERT OPIN BIOL TH, V12, pS181, DOI 10.1517/14712598.2012.677428; Galbiati S, 2011, CLIN CHEM, V57, P136, DOI 10.1373/clinchem.2010.155671; Fernandez-Martinez FJ, 2012, GENET MED, V14, P101, DOI 10.1038/gim.2011.8; Jenkins LA, 2018, PRENATAL DIAG, V38, P44, DOI 10.1002/pd.5197; Kountouris P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26371; Kyrri AR, 2013, HEMOGLOBIN, V37, P435, DOI 10.3109/03630269.2013.801851; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Li J, 2009, HUM MUTAT, V30, P1583, DOI 10.1002/humu.21112; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; LO YMD, 1989, LANCET, V2, P1363; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Milbury CA, 2012, CLIN CHEM, V58, P580, DOI 10.1373/clinchem.2011.176198; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; New MI, 2014, J CLIN ENDOCR METAB, V99, pE1022, DOI 10.1210/jc.2014-1118; Orhant L, 2016, PRENATAL DIAG, V36, P397, DOI 10.1002/pd.4790; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Papasavva Thessalia, 2016, BMC Res Notes, V9, P198, DOI 10.1186/s13104-016-2002-x; Papasavva T, 2013, EUR J HUM GENET, V21, P1403, DOI 10.1038/ejhg.2013.47; Papasavva TE, 2013, ANN HUM GENET, V77, P115, DOI 10.1111/ahg.12004; Parks M, 2017, EUR J HUM GENET, V25, P416, DOI 10.1038/ejhg.2016.195; Parks M, 2016, PRENATAL DIAG, V36, P312, DOI 10.1002/pd.4781; Qi GJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005126; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Song C, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw650; Song C, 2011, DIAGN MOL PATHOL, V20, P81, DOI 10.1097/PDM.0b013e3181fde92f; Vermeulen C, 2017, AM J HUM GENET, V101, P326, DOI 10.1016/j.ajhg.2017.07.012; Weatherall DJ, 2004, NAT REV GENET, V5, P625, DOI 10.1038/nrg1406; Xiong L, 2015, PRENATAL DIAG, V35, P258, DOI 10.1002/pd.4536; Zhou QY, 2014, PRENATAL DIAG, V34, P1061, DOI 10.1002/pd.4428	43	6	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200348	10.1371/journal.pone.0200348	http://dx.doi.org/10.1371/journal.pone.0200348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044883	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500046
J	Keeley, BW; Keeley, ATH; Houlahan, P				Keeley, Brian W.; Keeley, Annika T. H.; Houlahan, Padraig			Ridge number in bat ears is related to both guild membership and ear length	PLOS ONE			English	Article							ECHOLOCATION CALLS; SPECIALIZATIONS; SENSITIVITY; CHIROPTERA; MORPHOLOGY; PENGUINS; SOUNDS; NARROW; SONAR; PREY	The ears of many mammals have a set of uniformly spaced horizontal ridges that form groove arrays. Contact of coherent waves (e.g. acoustic waves) with a series of slits or grooves causes diffraction, which produces constructive and destructive interference patterns. Increases in signal strength will occur but will depend on the frequencies involved, the groove number and their separations. Diffraction effects can happen for a wide range of frequencies and wavelengths, but no array can diffract wavelengths greater than twice the groove separation, and it is for those wavelengths comparable in size with the groove separation that the effects are greatest. For example, when ridges in bat ears are 1 mm apart, the strongest influence will occur for a 1 mm wavelength which corresponds to a frequency of 343 kHz. If bats could use these wavelengths, it would help them to resolve objects or surface textures of about 0.5 mm. Given how critical acoustics are for bat function, we asked whether bats may be taking advantage of diffraction effects generated by the grooves. We hypothesize that groove number varies with bat foraging strategy. Examining 120 species, we found that groove number is related to both guild and ear length. Bats in guilds that glean prey items from foliage or ground have on average more grooves than bats in other guilds. Harmonics generated by echolocation calls are the most likely source for the wavelengths that would correspond to the groove separations. We apply the physical principles of wave reflection, diffraction, and superposition to support the hypothesis that acoustic responses generated from grooves may be useful to bats. We offer an explanation why some bat species do not have grooves. We also discuss the presence of groove arrays in non-echolocating Chiropterans, and five additional mammalian orders.	[Keeley, Brian W.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Keeley, Annika T. H.] Univ Calif Berkeley, Dept Environm Sci Policy & Planning, Berkeley, CA 94720 USA; [Houlahan, Padraig] Embry Riddle Aeronaut Univ, Dept Phys, Prescott, AZ USA; [Houlahan, Padraig] Coconino Community Coll, Flagstaff, AZ USA	Northern Arizona University; University of California System; University of California Berkeley; Embry-Riddle Aeronautical University	Keeley, BW (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	bkeeley62@yahoo.com						Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Bohn KM, 2004, J COMP PHYSIOL A, V190, P185, DOI 10.1007/s00359-003-0485-0; BRUNS V, 1989, J MORPHOL, V199, P103, DOI 10.1002/jmor.1051990109; Burnham KP, 2002, MODEL SELECTION MULT, P66; DALLAND JI, 1965, J AUD RES, V5, P95; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Falcao F, 2015, BIOACOUSTICS, V24, P175, DOI 10.1080/09524622.2015.1017840; Falk JJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0520; FAURE PA, 1993, J EXP BIOL, V178, P173; FAURE PA, 1992, ANIM BEHAV, V44, P31, DOI 10.1016/S0003-3472(05)80751-1; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2013, ANIM BEHAV, V85, P869, DOI 10.1016/j.anbehav.2013.02.024; Firbas W, 1972, MONATSSCHR OHR LARYN, V106, P156; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goerlitz HR, 2008, J EXP BIOL, V211, P2799, DOI 10.1242/jeb.019596; Griffin D.R., 1958, LISTENING DARK ACOUS; Hallam J, 2004, P 8 INT C SIM AD BEH; Halliday D., 2013, FUNDAMENTALS PHYS; Hickey M. B. C., 2000, Mammalian Species, P1; Hill J., 1984, BATS NATURAL HIST; Ho YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062938; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; Jennings NV, 2004, ACTA CHIROPTEROL, V6, P75, DOI 10.3161/001.006.0106; Jones G, 2003, J EXP BIOL, V206, P4209, DOI 10.1242/jeb.00678; Kingston T, 1999, J ZOOL, V249, P359, DOI 10.1017/S0952836999009917; Konstantinov A, 1971, ZH VYSSHEI NERVNOI D; Kuc R, 2009, J ACOUST SOC AM, V125, P3454, DOI 10.1121/1.3097500; LONG GR, 1975, J COMP PHYSIOL, V100, P211, DOI 10.1007/BF00614531; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Muller R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108701; OBRIST MK, 1993, J EXP BIOL, V180, P119; Parsons S, 2000, J EXP BIOL, V203, P2641; R Core Team, R PROJECT STAT COMPU; ROBISSON P, 1992, AUK, V109, P654; Schmieder DA, 2010, BIOL LETTERS, V6, P604, DOI 10.1098/rsbl.2010.0114; Schneider H., 1961, Zoologische Jahrbuecher (Anatomie), V79, P93; Schoner MG, 2015, CURR BIOL, V25, P1911, DOI 10.1016/j.cub.2015.05.054; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Simon R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00064; Sowell WA, 1983, AFITGEPPH83D13; Wang XB, 2009, J ACOUST SOC AM, V126, P3311, DOI 10.1121/1.3257210	41	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200255	10.1371/journal.pone.0200255	http://dx.doi.org/10.1371/journal.pone.0200255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044815	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500035
J	Verra, WC; van Hilten, JA; Honohan, A; van Zwet, EW; van der Bom, JG; Nelissen, RGHH				Verra, Wiebe C.; van Hilten, Joost A.; Honohan, Aine; van Zwet, Erik W.; van der Bom, Johanna G.; Nelissen, Rob G. H. H.		FIRST-Res Grp	The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial	PLOS ONE			English	Article							PATIENT BLOOD MANAGEMENT; TRANEXAMIC ACID; ARTHROPLASTY; METAANALYSIS; HIP; RELIABILITY; SPRAY	Background Total knee replacement (TKR) is increasingly performed in short term hospital stay, making same day mobilization an important issue is after surgery. This implies little joint effusion by reducing intra-articular blood loss, which will enhance knee range of motion. The application of a topical fibrin sealant on the intraoperative bare bone and synovial tissue may contribute to better early full mobilization and thus improved functional outcomes. Since ambulation with a fully extended knee is less strenuous, we hypothesized that patients who received fibrin sealant would demonstrate improved early knee extension after six weeks compared to patients who received standard care. Methods A multicenter randomized controlled trial in a consecutive series of osteoarthritis patients scheduled for TKR surgery. Participants were randomized to receive fibrin sealant or not before closing the knee joint capsule. Primary outcome was change in knee extension angle (degrees) at short term (2 weeks) follow-up (cExt). Secondary outcomes were 6-week extension angle, knee flexion angle, hemoglobin loss, blood transfusion rates, complication rates, the Knee Society Score, and the KOOS and EQ5D questionnaires. Results When data on primary outcome became available from 250 patients, an interim analysis was performed by an independent Data Safety Monitoring Board for safety and effectivity assessment. This analysis showed that sufficient patients were included to detect a cExt of 10 degrees between both groups. Inclusion was stopped however, all in the meantime included patients were treated according to their randomization. A total of 466 were available for analysis. Both groups were comparable in terms of baseline characteristics. The estimated mean cExt difference was 0.2 degrees (95%CI -0.5 to 0.9). No differences in secondary outcomes were found. Conclusions No beneficial effects or side effects were found of a topically applied fibrin sealant during TKR surgery. These results discourage the clinical use of a fibrin sealant in TKR.	[Verra, Wiebe C.; Nelissen, Rob G. H. H.] Leiden Univ, Dept Orthoped Surg, Med Ctr, Leiden, Netherlands; [Verra, Wiebe C.; van Hilten, Joost A.; Honohan, Aine; van der Bom, Johanna G.] Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands; [Honohan, Aine; van der Bom, Johanna G.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Dept Stat & Bioinformat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verra, WC (corresponding author), Leiden Univ, Dept Orthoped Surg, Med Ctr, Leiden, Netherlands.; Verra, WC (corresponding author), Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands.	w.c.verra@lumc.nl	Nelissen, Rob/AAD-8134-2020	Nelissen, Rob/0000-0003-1228-4162	Sanquin Blood Supply [PPOC-10-016]	Sanquin Blood Supply	Sanquin Blood Supply funded the FIRST-study (PPOC-10-016).	Aggarwal AK, 2014, INT ORTHOP, V38, P387, DOI 10.1007/s00264-013-2136-6; Brosseau L, 2001, ARCH PHYS MED REHAB, V82, P396, DOI 10.1053/apmr.2001.19250; Chen ZY, 2014, KNEE SURG SPORT TR A, V22, P3181, DOI 10.1007/s00167-013-2814-3; de Groot IB, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-16; Hazelaar S, 2012, TRANSFUSION, V52, P517, DOI 10.1111/j.1537-2995.2011.03315.x; Heyse TJ, 2014, CLIN ORTHOP RELAT R, V472, P272, DOI 10.1007/s11999-013-3036-1; Kluba T, 2012, ARCH ORTHOP TRAUM SU, V132, P1147, DOI 10.1007/s00402-012-1519-2; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Levy O, 1999, J BONE JOINT SURG AM, V81A, P1580, DOI 10.2106/00004623-199911000-00010; Liu J, 2014, INT J SURG, V12, P95, DOI 10.1016/j.ijsu.2013.11.011; McConnell JS, 2012, KNEE, V19, P295, DOI 10.1016/j.knee.2011.06.004; Molloy DO, 2007, J BONE JOINT SURG BR, V89B, P306, DOI 10.1302/0301-620X.89B3.17565; Notarnicola A, 2012, BLOOD COAGUL FIBRIN, V23, P278, DOI 10.1097/MBC.0b013e3283518846; Panteli M, 2013, KNEE, V20, P300, DOI 10.1016/j.knee.2013.05.014; Sabatini L, 2012, J ORTHOP TRAUMATOL, V13, P145, DOI 10.1007/s10195-012-0198-7; Skovgaard C, 2013, ACTA ORTHOP, V84, P153, DOI 10.3109/17453674.2013.769082; So-Osman C, 2014, ANESTHESIOLOGY, V120, P839, DOI 10.1097/ALN.0000000000000134; So-Osman C, 2014, ANESTHESIOLOGY, V120, P852, DOI 10.1097/ALN.0000000000000135; Tai TW, 2011, KNEE SURG SPORT TR A, V19, P1121, DOI 10.1007/s00167-010-1342-7; Thoms RJ, 2009, J AM ACAD ORTHOP SUR, V17, P727; VANAGT HME, 1994, SOC SCI MED, V39, P1537, DOI 10.1016/0277-9536(94)90005-1; Wang GJ, 2001, J BONE JOINT SURG AM, V83A, P1503, DOI 10.2106/00004623-200110000-00007; Wang HS, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-36	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200804	10.1371/journal.pone.0200804	http://dx.doi.org/10.1371/journal.pone.0200804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044846	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500067
J	D'Amario, B; Ziveri, P; Grelaud, M; Oviedo, A				D'Amario, Barbara; Ziveri, Patrizia; Grelaud, Michael; Oviedo, Angela			Emiliania huxleyi coccolith calcite mass modulation by morphological changes and ecology in the Mediterranean Sea	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CARBONATE CHEMISTRY; SOUTHERN-OCEAN; ENVIRONMENTAL CONTROLS; EXPORT PRODUCTION; CALCIFICATION; MORPHOTYPES; PRYMNESIOPHYCEAE; GULF; RECOGNITION	To understand the response of marine calcifying organisms under high CO2 scenarios, it is critical to study their calcification patterns in the natural environment. This paper focuses on a major calcifying phytoplankton group, the coccolithophores, through the analysis of water samples collected along a W-E Mediterranean transect during two research cruises, in April 2011 (Meteor cruise M84/3) and May 2013 (MedSeA cruise 2013). The Mediterranean Sea is a marginal sea characterized by large biogeochemical gradients. Currently, it is undergoing both warming and ocean acidification, processes which are rapidly modifying species distribution and calcification. The species Emiliania huxleyi largely dominates the total coccolithophore production in present day oceans and marine basins, including the Mediterranean Sea. A series of morphometric measurements were performed on the coccoliths of this species to estimate their mass, length and calculate a calcification index (proxy for the size-normalized calcification degree). The most abundant morphotype of E. huxleyi in the Mediterranean Sea is Type A. Coccoliths of this morphotype were additionally analyzed based on scanning electron microscopy images: four calcification varieties were quantified, according to the relationship between slit length-tube width, and the state of the central area (open or closed). The average E. huxleyi coccolith mass along the Mediterranean oceanographic transect depended strongly on both the average coccolith length and calcification index. The variability in average coccolith length and calcification index across samples reflected oscillations in the relative abundance of the calcification varieties. We also demonstrated that the distribution of the calcification varieties followed the main environmental gradients (carbonate chemistry, salinity, temperature, nutrient concentrations). Hence, shifts in the distribution of the calcification varieties and of the average E. huxleyi coccolith mass are to be expected in the Mediterranean Sea under climate change. These physiological and ecological responses will modulate the net coccolithophore calcification and, ultimately, the regional carbonate export to the seafloor.	[D'Amario, Barbara; Ziveri, Patrizia; Grelaud, Michael; Oviedo, Angela] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra, Spain; [Ziveri, Patrizia] ICREA, Barcelona, Spain	Autonomous University of Barcelona; ICREA	D'Amario, B; Ziveri, P (corresponding author), Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra, Spain.; Ziveri, P (corresponding author), ICREA, Barcelona, Spain.	3damario@gmail.com; Patrizia.Ziveri@uab.cat	Ziveri, Patrizia/I-3856-2015	Ziveri, Patrizia/0000-0002-5576-0301; Oviedo Sabogal, Angela/0000-0003-1945-8882; Grelaud, Michael/0000-0001-8649-9743; D'Amario, Barbara/0000-0001-5608-5283	EU [265103]; CALMED project [CTM2016-79547-R]; Generalitat de Catalunya [MERS] [2014 SGR- 1356]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [FI-DGR scholarship]; MinECo [MDM2015-0552]	EU(European Commission); CALMED project; Generalitat de Catalunya [MERS]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [FI-DGR scholarship]; MinECo(Spanish Government)	This work was supported by the EU-FP7 "Mediterranean Sea Acidification in a changing climate" project (MedSeA) [grant number 265103], the CALMED project [CTM2016-79547-R], the Generalitat de Catalunya [MERS, 2014 SGR- 1356] and the Agencia de Gestio d'Ajuts Universitaris i de Recerca [FI-DGR scholarship to B.D.]. This work is contributing to the ICTA "Unit of Excellence" [MinECo, MDM2015-0552]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober J, 1994, STUD BOT, V13, P61; [Anonymous], 2013, CLIMATE CHANGE 2013; Beaufort L, 2008, BIOGEOSCIENCES, V5, P1101, DOI 10.5194/bg-5-1101-2008; Beaufort L, 2004, MAR MICROPALEONTOL, V51, P57, DOI 10.1016/j.marmicro.2003.09.003; Beaufort L, 2005, MICROPALEONTOLOGY, V51, P289, DOI 10.2113/gsmicropal.51.4.289; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaufort L, 2001, MAR MICROPALEONTOL, V43, P27, DOI 10.1016/S0377-8398(01)00020-2; Bendif E, 2014, J PHYCOL, V50, P140, DOI 10.1111/jpy.12147; Berger C, 2014, BIOGEOSCIENCES, V11, P929, DOI 10.5194/bg-11-929-2014; Blanco-Ameijeiras S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157697; Bonomo S, 2016, PALAEOGEOGR PALAEOCL, V459, P15, DOI 10.1016/j.palaeo.2016.06.037; Broecker W, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001731; Cook SS, 2011, J PHYCOL, V47, P615, DOI 10.1111/j.1529-8817.2011.00992.x; Cros L, 2002, SCI MAR, V66, P5; Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; D'Amario B, 2017, J PLANKTON RES, V39, P781, DOI 10.1093/plankt/fbx044; Dimiza MD, 2008, MICROPALEONTOLOGY, V54, P159; Dimiza MD, 2008, HELL J GEOSCI, V45, P55; Dollfus D, 1999, NEURAL NETWORKS, V12, P553, DOI 10.1016/S0893-6080(99)00011-8; Fielding SR, 2009, LIMNOL OCEANOGR, V54, P1475, DOI 10.4319/lo.2009.54.5.1475; Flores JA, 1997, MAR MICROPALEONTOL, V29, P351, DOI 10.1016/S0377-8398(96)00029-1; Green JC, 1998, PHYCOLOGIA, V37, P121, DOI 10.2216/i0031-8884-37-2-121.1; Hagino K, 2005, MAR MICROPALEONTOL, V55, P19, DOI 10.1016/j.marmicro.2005.02.002; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; Hainbucher D., 2013, OCEAN SCI DISCUSS, V10, P2399, DOI [10.5194/osd-10-2399-2013, DOI 10.5194/0SD-10-2399-2013]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henderiks J, 2012, MAR ECOL PROG SER, V448, P51, DOI 10.3354/meps09535; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Horigome MT, 2014, BIOGEOSCIENCES, V11, P2295, DOI 10.5194/bg-11-2295-2014; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Incarbona A, 2010, CLIM PAST, V6, P795, DOI 10.5194/cp-6-795-2010; Incarbona A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001581; Jin P, 2016, MAR POLLUT BULL, V103, P101, DOI 10.1016/j.marpolbul.2015.12.039; Karatsolis BT, 2017, CONT SHELF RES, V149, P138, DOI 10.1016/j.csr.2016.12.005; Kershaw S, 2013, OCEANOGRAPHY EARTH S; KNAPPERTSBUSCH M, 1993, MAR MICROPALEONTOL, V21, P219, DOI 10.1016/0377-8398(93)90016-Q; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; MCINTYRE A, 1967, DEEP-SEA RES, V14, P561, DOI 10.1016/0011-7471(67)90065-4; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; Meier KJS, 2014, BIOGEOSCIENCES, V11, P2857, DOI 10.5194/bg-11-2857-2014; Meyer J, 2015, BIOGEOSCIENCES, V12, P1671, DOI 10.5194/bg-12-1671-2015; Milner S, 2016, LIMNOL OCEANOGR, V61, P1322, DOI 10.1002/lno.10292; Muller MN, 2017, ISME J, V11, P1777, DOI 10.1038/ismej.2017.53; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oviedo A, 2015, OCEAN SCI, V11, P13, DOI 10.5194/os-11-13-2015; Oviedo AM, 2014, J EXP MAR BIOL ECOL, V459, P105, DOI 10.1016/j.jembe.2014.04.021; Paasche E, 1996, PHYCOLOGIA, V35, P394, DOI 10.2216/i0031-8884-35-5-394.1; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Poulton AJ, 2011, MAR ECOL PROG SER, V443, P1, DOI 10.3354/meps09445; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; RIAUXGOBIN C, 1995, MAR GEOL, V123, P239, DOI 10.1016/0025-3227(94)00126-6; Rickaby REM, 2016, DEEP-SEA RES PT II, V127, P28, DOI 10.1016/j.dsr2.2016.02.010; Rosas-Navarro A, 2016, BIOGEOSCIENCES, V13, P2913, DOI 10.5194/bg-13-2913-2016; Saruwatari K, 2016, BIOGEOSCIENCES, V13, P2743, DOI 10.5194/bg-13-2743-2016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder DC, 2005, J PHYCOL, V41, P874, DOI 10.1111/j.1529-8817.2005.04188.x; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Tanhua T, 2013, EARTH SYST SCI DATA, V5, P289, DOI 10.5194/essd-5-289-2013; Triantaphyllou M, 2010, GEOBIOS-LYON, V43, P99, DOI 10.1016/j.geobios.2009.09.002; VANBLEIJSWIJK J, 1991, J PHYCOL, V27, P566; von Dassow P, 2015, ISME J, V9, P1365, DOI 10.1038/ismej.2014.221; Winter A., 1994, COCCOLITHOPHORES; Young JR, 2014, BIOGEOSCIENCES, V11, P4771, DOI 10.5194/bg-11-4771-2014; Young J.R., 2003, J NANNOPLANKT RES, V125; Young Jeremy R., 2002, Journal of Nannoplankton Research, V24, P27; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Zhang Y, 2018, BIOGEOSCIENCES DISCU, DOI [10.5194/bg-2018-47, DOI 10.5194/BG-2018-47]; ZIVERI P, 1995, MAR MICROPALEONTOL, V24, P335, DOI 10.1016/0377-8398(94)00017-H; Ziveri P, 2000, DEEP-SEA RES PT II, V47, P2073, DOI 10.1016/S0967-0645(00)00017-5; Ziveri P, 2000, DEEP-SEA RES PT II, V47, P1853, DOI 10.1016/S0967-0645(00)00009-6	77	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201161	10.1371/journal.pone.0201161	http://dx.doi.org/10.1371/journal.pone.0201161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040853	Green Submitted, gold, Green Published			2022-12-27	WOS:000439749200029
J	Ferdosi, S; Ho, TH; Castle, EP; Stanton, ML; Borges, CR				Ferdosi, Shadi; Ho, Thai H.; Castle, Erik P.; Stanton, Melissa L.; Borges, Chad R.			Behavior of blood plasma glycan features in bladder cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; O-GLYCANS; PANCREATIC-CANCER; N-GLYCOSYLATION; SERUM; BIOMARKERS; GLYCOME; MICROVESICLES; CARCINOMA; DIAGNOSIS	Despite systemic therapy and cystectomy, bladder cancer is characterized by a high recurrence rate. Serum glycomics represents a promising source of prognostic markers for monitoring patients. Our approach, which we refer to as "glycan node analysis", constitutes the first example of molecularly "bottom-up" glycomics. It is based on a global glycan methylation analysis procedure that is applied to whole blood plasma/serum. The approach detects and quantifies partially methylated alditol acetates arising from unique glycan features such as alpha 2-6 sialylation, beta 1-4 branching, and core fucosylation that have been pooled together from across all intact glycans within a sample into a single GC-MS chromatographic peak. We applied this method to 122 plasma samples from former and current bladder cancer patients (n = 72 former cancer patients with currently no evidence of disease (NED); n = 38 non-muscle invasive bladder cancer (NMIBC) patients; and n = 12 muscle invasive bladder cancer (MIBC) patients) along with plasma from 30 certifiably healthy living kidney donors. Markers for alpha 2-6 sialylation, beta 1-4 branching, beta 1-6 branching, and outer-arm fucosylation were able to separate current and former (NED) cases from certifiably healthy controls (ROC curve c-statistics similar to 0.80); but NED, NMIBC, and MIBC were not distinguished from one another. Based on the unexpectedly high levels of these glycan nodes in the NED patients, we hypothesized that recurrence of this disease could be predicted by some of the elevated glycan features. Indeed, alpha 2-6 sialylation and beta 1-6 branching were able to predict recurrence from the NED state using a Cox proportional hazards regression model adjusted for age, gender, and time from cancer. The levels of these two glycan features were correlated to C-reactive protein concentration, an inflammation marker and known prognostic indicator for bladder cancer, further strengthening the link between inflammation and abnormal plasma protein glycosylation.	[Ferdosi, Shadi; Borges, Chad R.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Ferdosi, Shadi; Borges, Chad R.] Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA; [Ho, Thai H.] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA; [Castle, Erik P.] Mayo Clin, Dept Urol, Phoenix, AZ USA; [Stanton, Melissa L.] Mayo Clin, Dept Lab Med & Pathol, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Borges, CR (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Borges, CR (corresponding author), Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA.	chad.borges@asu.edu		Ho, Thai/0000-0003-0023-2939; Borges, Chad/0000-0002-8122-3438	Flinn Foundation [1977]; National Cancer Institute of the National Institutes of Health [R33 CA191110]; NATIONAL CANCER INSTITUTE [R33CA191110] Funding Source: NIH RePORTER	Flinn Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Flinn Foundation (https://www.flinn.org) (Grant No. 1977 to CB) and the National Cancer Institute of the National Institutes of Health (https://www.cancer.gov) under Award Number R33 CA191110 (to CB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Flinn Foundation or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ansar W, 2013, IMMUNOL RES, V56, P131, DOI 10.1007/s12026-013-8384-0; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Azevedo R, 2017, ONCOTARGET, V8, P91734, DOI 10.18632/oncotarget.19433; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Baker ES, 2012, GENOME MED, V4, DOI 10.1186/gm364; Borges CR, 2013, ANAL CHEM, V85, P2927, DOI 10.1021/ac3035579; Cagnoni AJ, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00109; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Eggers H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0705-6; Ferdosi S, 2018, J PROTEOME RES, V17, P543, DOI 10.1021/acs.jproteome.7b00672; Fontana S, 2013, PROTEOMICS, V13, P1581, DOI 10.1002/pmic.201200398; Goodison S, 2013, MOL DIAGN THER, V17, P71, DOI 10.1007/s40291-013-0023-x; GRYSKA K, 1995, ADV EXP MED BIOL, V376, P239; Hafeez S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-104; Hamfjord J, 2015, J PROTEOME RES, V14, P5144, DOI 10.1021/acs.jproteome.5b00395; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hegele A, 2010, ANTICANCER RES, V30, P5195; Ho TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132831; Hu YM, 2017, ANALYST, V142, P2748, DOI 10.1039/c7an00396j; Hulsmeier AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33927; Jansen BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23296; Kehinde EO, 2011, SCAND J UROL NEPHROL, V45, P113, DOI 10.3109/00365599.2010.533694; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; Mbeutcha A, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.05.013; Mendez-Huergo SP, 2017, CURR OPIN IMMUNOL, V45, P8, DOI 10.1016/j.coi.2016.12.003; Mitra AP, 2012, SEMIN ONCOL, V39, P524, DOI 10.1053/j.seminoncol.2012.08.008; Miyahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074861; Nagata M, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/8205836; Narisada M, 2008, BIOCHEM BIOPH RES CO, V377, P792, DOI 10.1016/j.bbrc.2008.10.061; Oikawa M, 2018, EUR UROL FOCUS, V4, P405, DOI 10.1016/j.euf.2016.11.004; Okamoto T, 2013, MOL MED REP, V7, P359, DOI 10.3892/mmr.2012.1189; Rabinovich GA, 2016, J MOL BIOL, V428, P3266, DOI 10.1016/j.jmb.2016.03.021; Ries LAG, 2007, NATL CANC I, V07-6215, P7; Roberts AA, 2003, MODERN PATHOL, V16, P543, DOI 10.1097/01.MP.0000071840.84469.06; Roy S, 2013, INT BRAZ J UROL, V39, P631, DOI 10.1590/S1677-5538.IBJU.2013.05.04; Saldova R, 2008, DIS MARKERS, V25, P219, DOI 10.1155/2008/601583; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; Scheffer AR, 2014, WORLD J UROL, V32, P353, DOI 10.1007/s00345-012-1010-2; Sethi MK, 2016, ACCOUNTS CHEM RES, V49, P2099, DOI 10.1021/acs.accounts.6b00193; Shrotriya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143080; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Suzuki Y, 2012, INT J ONCOL, V40, P1831, DOI 10.3892/ijo.2012.1411; Tanaka T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122632; Tsuboi S, 2015, SUGAR CHAINS DECODIN, P177; Tsuboi S, 2013, TRENDS GLYCOSCI GLYC, V25, P117, DOI 10.4052/tigg.25.117; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; Vasseur JA, 2012, GLYCOBIOLOGY, V22, P1684, DOI 10.1093/glycob/cws108; Wang DZ, 2015, CARCINOGENESIS, V36, P1085, DOI 10.1093/carcin/bgv123; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Yun SJ, 2012, INT J ONCOL, V41, P1871, DOI 10.3892/ijo.2012.1622; Zaare S, 2016, JOVE-J VIS EXP, DOI 10.3791/53961; Zhou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12733	58	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201208	10.1371/journal.pone.0201208	http://dx.doi.org/10.1371/journal.pone.0201208			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040854	gold, Green Submitted, Green Published			2022-12-27	WOS:000439749200031
J	Heidarian, R; Fotouhifar, KB; Debets, AJM; Aanen, DK				Heidarian, Reza; Fotouhifar, Khalil-Berdi; Debets, Alfons J. M.; Aanen, Duur K.			Phylogeny of Paecilomyces, the causal agent of pistachio and some other trees dieback disease in Iran	PLOS ONE			English	Article							POLYPHASIC TAXONOMY; PCR; IDENTIFICATION; BYSSOCHLAMYS; DNA	One of the most important fungal agents of pistachio dieback disease belongs to the ascomycete genus Paecilomyces that has been identified as P. variotii. In 2012-2014, 700 plant samples from pistachio trees and 27 other plant species with dieback symptoms were collected from 10 provinces of Iran. Of the 567 pistachio samples, 277 Paecilomyces strains were obtained and from the 133 samples of other plants (except pistachio and including Pistacia mutica, Punica granatum, Prunus amygdalus, Caesalpinia gilliesii, Nerium oleander, Tamarix aphylla, Tamarix hispida and Haloxylon sp.), 23 fungal isolates were recovered and five isolates were obtained from the air of infected pistachio orchards. Based on morphology, all 305 isolates were identified as P. variotii. Physiological studies revealed that 299 isolates belong to P. formosus. Three isolates were assigned to P. variotii, while three isolates could not be assigned to any of the known species. Of the 305 isolates, 62 were selected for phylogenetic analysis based on DNA variation (ITS, beta-tubulin and calmodulin). This analysis showed that all of our isolates form a clade with P. formosus. P. formosus consists of the three former species P. formosa, P. lecythidis and P. maximus. This study shows that our isolates form a strongly supported clade with strains of P. lecythidis. So, the causal agent of dieback disease of pistachio and other examined trees is P. formosus which is closely related to the former species P. lecythidis and has some differences with the former species P. formosa and P. maximus. Based on phylogenetic studies P. formosus thus seems to be a species complex that could be divided into three separate species.	[Heidarian, Reza; Fotouhifar, Khalil-Berdi] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Plant Protect, Karaj, Iran; [Debets, Alfons J. M.; Aanen, Duur K.] Wageningen Univ, Hlth Food & Living Environm Fac, Plant Sci Dept, Lab Genet, Wageningen, Netherlands; [Heidarian, Reza] Agr Jahad Rafsanjan, Rafsanjan, Iran	University of Tehran; Wageningen University & Research	Fotouhifar, KB (corresponding author), Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Plant Protect, Karaj, Iran.	fotowhi@ut.ac.ir	Fotouhifar, Khalil-Berdi/ABH-1857-2021	Fotouhifar, Khalil-Berdi/0000-0002-4790-6171				Alizadeh A., 2000, J AGR SCI TECH-IRAN, V1, P53; AMINAEI M.M, 1989, P 9 IR PLANT PROT C, P82; [Anonymous], EVOLUTION; Bainer G, 1907, B SOC MYCOL FR, V23, P26; BROWN AGNES H. S., 1957, TRANS BRIT MYCOL SOC, V40, P17; Ershad D., 2009, FUNGI IRAN; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frisvad JC, 2004, STUD MYCOL, P1; Ghelichi M., 2012, International Journal of Nuts and Related Sciences (IJNRS), V3, P23; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Heidarian A, 1998, P 13 IR PLANT PROT C, P220; Heidarian R, 2012, ACTA HORTIC, V963, P101; Heidarian R, 2015, P 2 IR MYC C KAR, P206; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2006, ADV EXP MED BIOL, V571, P211, DOI 10.1007/0-387-28391-9_14; Houbraken J, 2010, J CLIN MICROBIOL, V48, P2754, DOI 10.1128/JCM.00764-10; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Luangsa-Ard JJ, 2004, MYCOLOGIA, V96, P773, DOI 10.2307/3762111; Mohammadi A, 2006, DIS DRIED FRUIT TREE; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson R., 1974, STUDIES MYCOLOGY CBS, V6, DOI DOI 10.1016/S0007-1536(75)80098-2; Samson RA, 2009, PERSOONIA, V22, P14, DOI 10.3767/003158509X418925; Tazick Z, 2012, P 20 IR PLANT PROT C, P417; White T.J., 1990, PCR PROTOCOLS GUIDE, P315	25	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200794	10.1371/journal.pone.0200794	http://dx.doi.org/10.1371/journal.pone.0200794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040828	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200010
J	Yang, YM; Lee, JJ; Jeong, E; Kim, SY; Han, MA; Choi, EJ				Yang, Young-Mo; Lee, Jae-Joon; Jeong, Eun; Kim, Sun Young; Han, Mi Ah; Choi, Eun Joo			A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea	PLOS ONE			English	Article							HEALTH-CARE; PHARMACISTS; INFORMATION; KNOWLEDGE; BEHAVIOR; TRENDS; MEDIA; DTCA	Direct-to-consumer advertising (DTCA) of prescription drugs can be both beneficial and harmful to healthcare consumers. Therefore, DTCA for prescription drugs is a topic that should be considered crucially, at this point, when the interests of patients as well as pharmaceutical companies in DTCA of prescription drugs are growing in South Korea. The goals of this study were to investigate Korean college students' perceptions and attitudes about DTCA of prescription drugs through a survey as well as to analyze data according to their college majors in order to identify differences in their perceptions and attitudes about prescription drug DTCAs as future health care professionals and consumers, respectively. A descriptive, cross-sectional survey was conducted between September and November 2015. Participants were recruited from Chosun University in Gwangju, South Korea. Ethical approval for this study was obtained from the Chosun University Institutional Review Board. Of 1,040 questionnaires initially distributed, 774 were collected, and 742 were included in the analysis. The results of this study indicated that most students who had participated in the survey did not have sufficient knowledge of DTCA for prescription drugs. Approximately, 17% reported being cognizant of DTCA for prescription drugs. More healthcare students (24.6%) knew this term than non-healthcare students did (6.3%). In this study, most of the students were likely to feel that healthcare professionals (e.g., doctors and pharmacists) had the responsibility of delivering information about prescription drugs to patients, and that all prescription drugs DTCA, if it were permitted, had to be pre-approved by the Korean government. The results of this study indicated that DTCA for prescription drugs had to be permitted under the condition of pre-approval of the DTCA contents by the Korean government, and prescription drugs should not be advertised through the Internet. It is recommended that the Korean government cautiously examine whether DTCA of prescription drugs should be permitted, after considering the current marketing strategies of pharmaceutical companies on the Internet and the effects of online electronic-DTCA on Korean consumers.	[Yang, Young-Mo; Choi, Eun Joo] Chosun Univ, Coll Pharm, Dept Pharm, Gwangju, South Korea; [Lee, Jae-Joon; Jeong, Eun] Chosun Univ, Dept Food & Nutr, Gwangju, South Korea; [Kim, Sun Young] Chosun Univ, Dept Biol Educ, Gwangju, South Korea; [Han, Mi Ah] Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea	Chosun University; Chosun University; Chosun University; Chosun University	Choi, EJ (corresponding author), Chosun Univ, Coll Pharm, Dept Pharm, Gwangju, South Korea.	ejchoi@chosun.ac.kr	Kim, Sun/GSN-4867-2022		National Research Foundation of Korea (NRF) - Korea government [2016R1C1B1015938]; National Research Foundation of Korea (NRF) - Korean government [2016R1C1B1015938]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2016R1C1B1015938). -Grant recipient: EJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (2016R1C1B1015938).	Abel GA, 2009, J CLIN ONCOL, V27, P4182, DOI 10.1200/JCO.2008.20.6599; Alperstein Neil M, 2014, Health Mark Q, V31, P231, DOI 10.1080/07359683.2014.936291; Chaar Betty, 2010, Int J Pharm Pract, V18, P43; Dens N, 2008, HEALTH COMMUN, V23, P45, DOI 10.1080/10410230701805190; Deshpande A, 2004, J HEALTH COMMUN, V9, P499, DOI 10.1080/10810730490523197; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Gibson S, 2014, LAWS, V3, P410, DOI [10.3390/laws3030410], DOI 10.3390/LAWS3030410]; Gilbody S, 2005, QUAL SAF HEALTH CARE, V14, P246, DOI 10.1136/qshc.2004.012781; Harrington AR, 2013, RES SOC ADMIN PHARM, V9, P458, DOI 10.1016/j.sapharm.2012.07.005; Herzenstein M, 2005, MARKET LETT, V15, P201, DOI 10.1007/s11002-005-0458-x; Humphreys G, 2009, B WORLD HEALTH ORGAN, V87, P576, DOI 10.2471/BLT.09.040809; Kannan S, 2015, Int J Risk Saf Med, V27, P77, DOI 10.3233/JRS-150644; Kim BK, 2005, DIRECT TO CONSUMER P, P20; Kim HJ, 2008, HEALTH AFFAIR, V27, pW260, DOI 10.1377/hlthaff.27.4.w260; 오지운, 2015, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V25, P42; Liang BA, 2011, JAMA-J AM MED ASSOC, V305, P824, DOI 10.1001/jama.2011.203; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Mackey TK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0885-1; Main K.J., 2004, INT J ADVERT, V23, P119, DOI [10.1080/02650487.2004.11072875, DOI 10.1080/02650487.2004.11072875], DOI 10.1080/02650487.2004.11072875]; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; Murray E, 2004, J AM BOARD FAM PRACT, V17, P6, DOI 10.3122/jabfm.17.1.6; Naik RK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710586; Peyrot M, 1998, MARK HEALTH SERV, V18, P26; Singh T, 2005, J CONSUM MARK, V22, P369, DOI 10.1108/07363760510631101; Spake Deborah F, 2014, Health Mark Q, V31, P31, DOI 10.1080/07359683.2013.847344; Suh HS, 2011, HEALTH POLICY, V101, P260, DOI 10.1016/j.healthpol.2011.05.005; Tyrawski J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4357; Viale PH, 2004, ONCOL NURS FORUM, V31, P777, DOI 10.1188/04.ONF.777-783; Williams PA, 2016, PATIENT EDUC COUNS, V99, P583, DOI 10.1016/j.pec.2015.10.019; Wu MH, 2016, CONTRACEPTION, V93, P398, DOI 10.1016/j.contraception.2016.01.010	31	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201108	10.1371/journal.pone.0201108	http://dx.doi.org/10.1371/journal.pone.0201108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040833	Green Submitted, Green Published, gold			2022-12-27	WOS:000439749200026
J	Vangoitsenhoven, R; van der Ende, M; Corbeels, K; Cunha, JPMCM; Lannoo, M; Bedossa, P; van der Merwe, S; Mertens, A; Gesquiere, I; Meulemans, A; Matthys, C; Mathieu, C; Overbergh, L; Van der Schueren, B				Vangoitsenhoven, Roman; van der Ende, Miranda; Corbeels, Katrien; Cunha, Joao Paulo Monteiro Carvalho Mori; Lannoo, Matthias; Bedossa, Pierre; van der Merwe, Schalk; Mertens, Ann; Gesquiere, Ina; Meulemans, Ann; Matthys, Christophe; Mathieu, Chantal; Overbergh, Lut; Van der Schueren, Bart			At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice	PLOS ONE			English	Article							FAT	Background Achieving weight loss is the cornerstone of the treatment of the metabolic consequences of obesity, in particular of glucose intolerance. Objective To determine whether improvement in glucose control depends on dietary macronutrient composition of the diet at identical weight loss. Materials and methods Twenty-two weeks old diet-induced obese C57BU6 mice lost weight through caloric restriction on normal chow (R-NC) or high fat diet (R-HF). Control mice were fed normal chow (LEAN) or high fat diet (OBESE) ad libitum. Body weight and composition were assessed after 8 weeks of dietary intervention. Glucose homeostasis was evaluated by intraperitoneal glucose tolerance tests (IPGTT). Epididymal white adipose (eWAT) and hepatic tissues were analyzed by immunohistochemistry and RT-qPCR. Results By 30 weeks of age, the body weight of the mice on R-NC (31.6 +/- 1.7g, mean +/- SEM) and RHF (32.3 +/- 0.9g) was similar to LEAN mice (31.9 +/- 1.4g), while OBESE mice weighed 51.7 +/- 2.4g. Glucose tolerance in R-NC was better than in LEAN mice (69% AUC IPGTT, P 0.0168) whereas R-HF mice remained significantly less glucose tolerant (125% AUC IPGTT, P 0.0279 vs LEAN), despite identical weight loss. The eWAT pads and adipocyte size were similar in LEAN and R-NC mice, while the eWAT pad size of R-HF was 180% of R-NC (P < 0.0001) and the average adipocyte size of R-HF mice was 134% of R-NC fed mice (P 0.0285). No LEAN or R-NC mice had hepatic steatosis, in contrast to 28.6% of R-HF mice. Compared to OBESE mice, inflammatory markers were lower in eWAT and liver tissue of R-NC, but not in R-HF mice. Measures of visceral adiposity correlated well with glucose tolerance parameters. Conclusions In mice, caloric restriction on a normal chow diet improved glucose tolerance significantly more when identical weight loss was achieved on a high fat diet.	[Vangoitsenhoven, Roman; van der Ende, Miranda; Corbeels, Katrien; Cunha, Joao Paulo Monteiro Carvalho Mori; Mertens, Ann; Gesquiere, Ina; Meulemans, Ann; Matthys, Christophe; Mathieu, Chantal; Overbergh, Lut; Van der Schueren, Bart] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [Vangoitsenhoven, Roman; Mertens, Ann; Meulemans, Ann; Matthys, Christophe; Mathieu, Chantal; Van der Schueren, Bart] Univ Hosp Leuven, Dept Endocrinol, Leuven, Belgium; [Lannoo, Matthias] Univ Hosp Leuven, Dept Abdominal Surg, Leuven, Belgium; [Bedossa, Pierre] Univ Paris Diderot, Dept Anat Pathol, INSERM U773, Paris, France; [van der Merwe, Schalk] Katholieke Univ Leuven, Lab Hepatol, Leuven, Belgium; [van der Merwe, Schalk] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; KU Leuven; KU Leuven; University Hospital Leuven	Vangoitsenhoven, R (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium.; Vangoitsenhoven, R (corresponding author), Univ Hosp Leuven, Dept Endocrinol, Leuven, Belgium.	Roman.vangoitsenhoven@kuleuven.be	da Cunha, João Paulo Monteiro Carvalho Mori/M-3310-2017; Matthys, Christophe/I-4203-2016; lannoo, matthias/AAB-1706-2020; Overbergh, Lut/AAC-3515-2020; Corbeels, Katrien/AAH-1232-2020; mathieu, chantal/ABD-5505-2021; Vangoitsenhoven, Roman/B-3196-2018	da Cunha, João Paulo Monteiro Carvalho Mori/0000-0002-0749-6534; Matthys, Christophe/0000-0003-1770-6862; Corbeels, Katrien/0000-0001-9494-1650; mathieu, chantal/0000-0002-4055-5233; Vangoitsenhoven, Roman/0000-0003-3523-669X; Van der Merwe, Schalk/0000-0002-9891-2686; van der Ende, Miranda/0000-0001-9864-0505; Mertens, Ann/0000-0002-1649-4311; Van der Schueren, Bart/0000-0003-4754-784X; Meulemans, Ann/0000-0003-3938-2408; Lannoo, matthias/0000-0001-7815-1157	Flemish Research Foundation [G.0857.13]; clinical fellowship	Flemish Research Foundation(FWO); clinical fellowship	This work was supported by the Flemish Research Foundation (www.fwo.be): G.0857.13 and clinical fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Bray GA, 2012, INT J OBESITY, V36, P448, DOI 10.1038/ijo.2011.173; Brehm BJ, 2008, NAT CLIN PRACT ENDOC, V4, P140, DOI 10.1038/ncpendmet0730; Daniel S, 2013, CURR OPIN ENDOCRINOL, V20, P377, DOI 10.1097/01.med.0000433067.01671.f5; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044; Dubois V, 2016, ENDOCRINOLOGY, V157, P648, DOI 10.1210/en.2015-1713; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Goss AM, 2013, OBESITY, V21, P1133, DOI 10.1002/oby.20191; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hall KD, 2015, CELL METAB, V22, P427, DOI 10.1016/j.cmet.2015.07.021; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kosinski C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050517; Matsui Y, 2010, BIOL PHARM BULL, V33, P963, DOI 10.1248/bpb.33.963; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schwingshackl L, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0455-1; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Wei P, 2004, DIABETOLOGIA, V47, P1541, DOI 10.1007/s00125-004-1489-1; Williamson DA, 2010, J BEHAV MED, V33, P305, DOI 10.1007/s10865-010-9253-0	28	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200779	10.1371/journal.pone.0200779	http://dx.doi.org/10.1371/journal.pone.0200779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036374	Green Published, Green Submitted, gold			2022-12-27	WOS:000439429200016
J	Cardoso-dos-Santos, AC; Boquett, J; de Oliveira, MZ; Callegari-Jacques, SM; Barbian, MH; Sanseverino, MTV; Matte, U; Schuler-Faccini, L				Cardoso-dos-Santos, Augusto Cesar; Boquett, Juliano; de Oliveira, Marcelo Zagonel; Callegari-Jacques, Sidia Maria; Barbian, Marcia Helena; Vieira Sanseverino, Maria Teresa; Matte, Ursula; Schuler-Faccini, Lavinia			Twin Peaks: A spatial and temporal study of twinning rates in Brazil	PLOS ONE			English	Article							REPRODUCTIVE TECHNOLOGIES; DEVELOPED-COUNTRIES; SAO-PAULO; CARE; AGE; PREGNANCIES; POPULATION; FERTILITY; HEALTH; TRENDS	Twin births are an important public health issue due to health complications for both mother and children. While it is known that contemporary factors have drastically changed the epidemiology of twins in certain developed countries, in Brazil, relevant data are still scarce. Thus, we carried out a population-based study of live births in spatial and temporal dimensions using data from Brazil's Live Birth Information System, which covers the entire country. Over 41 million births registered between 2001 and 2014 were classified as singleton, twin or multiple. Twinning rates (TR) averaged 9.41 per 1,000 for the study period and a first-order autoregressive model of time-series analysis revealed a global upward trend over time; however, there were important regional differences. In fact, a Cluster and Outlier Analysis (Anselin Local Moran's I) was performed and identified clusters of high TR in an area stretching from the south of Brazil's Northeast Region to the South Region (Global Moran Index = 0.062, P< 0.001). Spearman's correlation coefficient and a Wilcoxon matched pairs test revealed a positive association between Human Development Index (HDI) and TRs in different scenarios, suggesting that the HDI might be an important indicator of childbearing age and assisted reproduction techniques in Brazil. Furthermore, there was a sharp increase of 26.42% in TR in women aged 45 and over during study period. The upward temporal trend in TRs is in line with recent observations from other countries, while the spatial analysis has revealed two very different realities within the same country. Our approach to TR using HDI as a proxy for underlying socioeconomic changes can be applied to other developing countries with regional inequalities resembling those found in Brazil.	[Cardoso-dos-Santos, Augusto Cesar; Boquett, Juliano; Vieira Sanseverino, Maria Teresa; Matte, Ursula; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Biosci, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil; [de Oliveira, Marcelo Zagonel; Vieira Sanseverino, Maria Teresa; Matte, Ursula; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Biosci, INAGEMP Inst Nacl Genet Med, Porto Alegre, RS, Brazil; [Callegari-Jacques, Sidia Maria; Barbian, Marcia Helena] Univ Fed Rio Grande do Sul, Dept Stat, Inst Math & Stat, Porto Alegre, RS, Brazil; [Vieira Sanseverino, Maria Teresa; Matte, Ursula; Schuler-Faccini, Lavinia] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Biosci, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Biosci, INAGEMP Inst Nacl Genet Med, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (corresponding author), Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil.	lavinia.faccini@ufrgs.br	Cardoso-dos-Santos, Augusto Cesar/AAH-9840-2019; Callegari-Jacques, Sidia M/H-1774-2016; SCHULER-FACCINI, LAVINIA/C-8309-2013; Da Silveira Matte umatte, Ursula/U-3912-2019; Boquett, Juliano André/F-6893-2018	Cardoso-dos-Santos, Augusto Cesar/0000-0002-1499-9105; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; Boquett, Juliano André/0000-0002-6437-789X; Zagonel de Oliveira, Marcelo/0000-0003-4006-4052	National Institute of Population Medical Genetics (INAGEMP) [CNPq 465549/2014-4]	National Institute of Population Medical Genetics (INAGEMP)	This study was supported by the National Institute of Population Medical Genetics (INAGEMP; CNPq 465549/2014-4 to LSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001; [Anonymous], 2017, BANC DAD SIST UN SAU; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anvisa, 2014, 7 ANV; Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Bahamondes L, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-87; Brazilian Institute of Geography and Statistics, 2000, CENS DEM 2000 CAR PO; Brazilian Institute of Geography and Statistics, 2014, PERF MUN BRAS 2013; Brazilian Institute of Geography and Statistics, 2013, ATL CENS DEM 2010; Brazilian Institute of Geography and Statistics, 2015, MALH DIG MUN; Bulmer MG, 1970, BIOL TWINNING MAN, V1, P1; Colletto GMDD, 2003, GENET MOL BIOL, V26, P245, DOI 10.1590/S1415-47572003000300005; Corrêa Marilena C. D. V, 2015, Physis, V25, P753, DOI 10.1590/S0103-73312015000300005; Corsello G, 2010, J MATERN-FETAL NEO M, V23, P59, DOI 10.3109/14767058.2010.508218; D'Addato AV, 2007, J BIOSOC SCI, V39, P147, DOI 10.1017/S0021932006001337; Dawson AL, 2016, J EPIDEMIOL COMMUN H, V70, P1114, DOI 10.1136/jech-2015-206302; de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113; Delbaere I, 2008, HUM REPROD, V23, P2145, DOI 10.1093/humrep/den134; Duccini dal Colletto G M, 2001, Sao Paulo Med J, V119, P216; ESRI, 2017, ARCGIS PRO; Fellman J, 2006, HUM BIOL, V78, P253, DOI 10.1353/hub.2006.0044; Fellman J, 2016, TWIN RES HUM GENET, V19, P359, DOI 10.1017/thg.2016.49; Frost M, 1990, TELEVISION SERIES SE; Geraldo Cesar Fernando, 2008, Rev. Bras. Saude Mater. Infant., V8, P411, DOI 10.1590/S1519-38292008000400006; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Jauniaux E, 2013, REPROD BIOMED ONLINE, V26, P107, DOI 10.1016/j.rbmo.2012.11.008; Laskov I, 2013, J MATERN-FETAL NEO M, V26, P669, DOI 10.3109/14767058.2012.746298; Leridon H, 2004, HUM REPROD, V19, P1548, DOI 10.1093/humrep/deh304; Madalozzo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040756; Makuch MY, 2011, HUM REPROD, V26, P2054, DOI 10.1093/humrep/der158; Makuch Y, 2012, FACTS VIEWS VIS OBGY, V4, P221; Malamitsi-Puchner A, 2019, J MATERN-FETAL NEO M, V32, P455, DOI 10.1080/14767058.2017.1382469; Ombelet W, 2009, INT J GYNECOL OBSTET, V106, P168, DOI 10.1016/j.ijgo.2009.03.033; Otta E, 2016, TWIN RES HUM GENET, V19, P679, DOI 10.1017/thg.2016.75; Tejada CAO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171888; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pison G, 2015, POPUL DEV REV, V41, P629, DOI 10.1111/j.1728-4457.2015.00088.x; R Core Team, 2021, R PROJECT STAT COMPU; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; Sobek A, 2016, BIOMED PAP, V160, P358, DOI 10.5507/bp.2016.016; Tagliani-Ribeiro A, 2012, HUM REPROD, V27, P2866, DOI 10.1093/humrep/des217; Tavares R, 2016, J BRAS REPROD ASSIST, V20, P112, DOI 10.5935/1518-0557.20160026; United Nations Development Programme, 2013, IN DES HUM MUN BRAS; Vaughan DA, 2016, J ASSIST REPROD GEN, V33, P19, DOI 10.1007/s10815-015-0616-x; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200885	10.1371/journal.pone.0200885	http://dx.doi.org/10.1371/journal.pone.0200885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028857	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900020
J	Corder, KM; Cortes, MA; Bartley, AF; Lear, SA; Lubin, FD; Dobrunz, LE				Corder, Katelynn M.; Cortes, Mariana A.; Bartley, Aundrea F.; Lear, Samantha A.; Lubin, Farah D.; Dobrunz, Lynn E.			Prefrontal cortex-dependent innate behaviors are altered by selective knockdown of Gad1 in neuropeptide Y interneurons	PLOS ONE			English	Article							SPECIES-TYPICAL BEHAVIORS; ANXIETY-LIKE BEHAVIOR; ELEVATED PLUS-MAZE; GABA NEUROTRANSMISSION; MAJOR DEPRESSION; MATERNAL-CARE; ANIMAL-MODELS; MOUSE MODEL; DISORDERS; INHIBITION	GABAergic dysfunction has been implicated in a variety of neurological and psychiatric disorders, including anxiety disorders. Anxiety disorders are the most common type of psychiatric disorder during adolescence. There is a deficiency of GABAergic transmission in anxiety, and enhancement of GABA transmission through pharmacological means reduces anxiety behaviors. GAD67-the enzyme responsible for GABA production-has been linked to anxiety disorders. One class of GABAergic interneurons, Neuropeptide Y (NPY) expressing cells, is abundantly found in brain regions associated with anxiety and fear learning, including prefrontal cortex, hippocampus and amygdala. Additionally, NPY itself has been shown to have anxiolytic effects, and loss of NPY+ interneurons enhances anxiety behaviors. A previous study showed that knockdown of Gad1 from NPY+ cells led to reduced anxiety behaviors in adult mice. However, the role of GABA release from NPY+ interneurons in adolescent anxiety is unclear. Here we used a transgenic mouse that reduces GAD67 in NPY+ cells (NPYGAD1-TG) through Gad1 knockdown and tested for effects on behavior in adolescent mice. Adolescent NPYGAD1-TG mice showed enhanced anxiety-like behavior and sex-dependent changes in locomotor activity. We also found enhancement in two other innate behavioral tasks, nesting construction and social dominance. In contrast, fear learning was unchanged. Because we saw changes in behavioral tasks dependent upon prefrontal cortex and hippocampus, we investigated the extent of GAD67 knockdown in these regions. Immunohistochemistry revealed a 40% decrease in GAD67 in NPY+ cells in prefrontal cortex, indicating a significant but incomplete knockdown of GAD67. In contrast, there was no decrease in GAD67 in NPY+ cells in hippocampus. Consistent with this, there was no change in inhibitory synaptic transmission in hippocampus. Our results show the behavioral impact of cell-specific interneuron dysfunction and suggest that GABA release by NPY+ cells is important for regulating innate prefrontal cortex-dependent behavior in adolescents.	[Corder, Katelynn M.; Cortes, Mariana A.; Bartley, Aundrea F.; Lubin, Farah D.; Dobrunz, Lynn E.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Lear, Samantha A.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dobrunz, LE (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dobrunz@uab.edu		Dobrunz, Lynn E./0000-0002-3317-554X; Corder, Katelynn/0000-0001-8086-5925	National Institutes of Health [1R01MH108342]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant 1R01MH108342 to L.E.D. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Arrant AE, 2016, GENES BRAIN BEHAV, V15, P588, DOI 10.1111/gbb.12300; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Bartley AF, 2015, J NEUROSCI, V35, P15276, DOI 10.1523/JNEUROSCI.1834-15.2015; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Behlke LM, 2016, NEUROPSYCHOPHARMACOL, V41, P2492, DOI 10.1038/npp.2016.49; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; BLANCHARD RJ, 1990, NEUROSCI BIOBEHAV R, V14, P463, DOI 10.1016/S0149-7634(05)80069-7; Blue ME, 1999, EXP NEUROL, V156, P345, DOI 10.1006/exnr.1999.7030; Botta P, 2015, NAT NEUROSCI, V18, P1493, DOI 10.1038/nn.4102; Britton JC, 2013, AM J PSYCHIAT, V170, P1195, DOI 10.1176/appi.ajp.2013.12050651; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Chan T, 2011, J NEUROSCI, V31, P4991, DOI 10.1523/JNEUROSCI.5216-10.2011; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Cipriani A, 2016, LANCET, V388, P881, DOI 10.1016/S0140-6736(16)30385-3; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Corvino V, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00433, 10.3389/fncel.2015.00433]; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; DAWSON GR, 1995, PSYCHOPHARMACOLOGY, V118, P316, DOI 10.1007/BF02245961; Deacon RMJ, 2003, BEHAV BRAIN RES, V139, P139, DOI 10.1016/S0166-4328(02)00225-5; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Demuyser T, 2016, PHYSIOL BEHAV, V156, P199, DOI 10.1016/j.physbeh.2015.12.018; Doremus-Fitzwater TL, 2009, PHYSIOL BEHAV, V97, P484, DOI 10.1016/j.physbeh.2009.03.025; Eaton K, 2007, CURR TOP MED CHEM, V7, P1645, DOI 10.2174/156802607782341037; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fatemi SH, 2013, TRANSL PSYCHIAT, V3, DOI [10.1038/tp.2013.64, 10.1038/tp.2013.46]; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Fatemi SH, 2011, ANAT REC, V294, P1635, DOI 10.1002/ar.21299; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; Garbett KA, 2010, MOL PSYCHIATR, V15, P987, DOI 10.1038/mp.2010.1; Garnefski N, 2002, J ADOLESCENCE, V25, P603, DOI 10.1006/jado.2002.0507; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Hollis F, 2015, P NATL ACAD SCI USA, V112, P15486, DOI 10.1073/pnas.1512653112; Isokawa M, 2005, J PHYSIOL-LONDON, V567, P1001, DOI 10.1113/jphysiol.2005.094219; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kalkman HO, 2003, J NEURAL TRANSM, V110, P803, DOI 10.1007/s00702-003-0826-8; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Karl T, 2008, EUR J NEUROSCI, V28, P173, DOI 10.1111/j.1460-9568.2008.06306.x; Kavushansky Alexandra, 2009, Stress, V12, P412, DOI 10.1080/10253890802556081; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kilb W, 2012, NEUROSCIENTIST, V18, P613, DOI 10.1177/1073858411422114; Kim SS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-6; KOLB B, 1985, BEHAV NEUROSCI, V99, P691, DOI 10.1037/0735-7044.99.4.691; Landgraf R, 1999, J NEUROENDOCRINOL, V11, P405; Li Q, 2017, J NEUROSCI, V37, P23, DOI 10.1523/JNEUROSCI.2599-16.2016; Li X, 2015, NEUROPHARMACOLOGY, V97, P357, DOI 10.1016/j.neuropharm.2015.05.001; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Mason GF, 2001, BRAIN RES, V914, P81, DOI 10.1016/S0006-8993(01)02778-0; MCCARTHY MM, 1995, J COMP NEUROL, V360, P685, DOI 10.1002/cne.903600412; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; MILNER TA, 1992, HIPPOCAMPUS, V2, P107, DOI 10.1002/hipo.450020204; Mitra S, 2017, PHYSIOL BEHAV, V168, P103, DOI 10.1016/j.physbeh.2016.11.002; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Murphy DD, 1998, J NEUROSCI, V18, P2550; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Reichmann F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28182; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Reis FMCV, 2014, PSYCHONEUROENDOCRINO, V49, P130, DOI 10.1016/j.psyneuen.2014.06.019; Rock ML, 2014, J AM ASSOC LAB ANIM, V53, P24; Schmidt MJ, 2014, MOL PSYCHIATR, V19, P580, DOI 10.1038/mp.2013.167; Schmidt MJ, 2015, NEUROPSYCHOPHARMACOL, V40, P190, DOI 10.1038/npp.2014.95; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Serova LI, 2013, NEUROSCIENCE, V236, P298, DOI 10.1016/j.neuroscience.2013.01.040; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Shoji H, 2014, JOVE-J VIS EXP, DOI 10.3791/50871; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smialowska M, 2007, NEUROPSYCHOPHARMACOL, V32, P1242, DOI 10.1038/sj.npp.1301258; Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Velosa JF, 2000, CHILD ADOL PSYCH CL, V9, P119; Vlainic J, 2009, NEUROPHARMACOLOGY, V56, P1124, DOI 10.1016/j.neuropharm.2009.03.010; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weiss SM, 1998, NEUROSCI BIOBEHAV R, V23, P265, DOI 10.1016/S0149-7634(98)00027-X; Wu HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180638; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726	95	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200809	10.1371/journal.pone.0200809	http://dx.doi.org/10.1371/journal.pone.0200809			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024942	Green Submitted, gold, Green Published			2022-12-27	WOS:000439120000055
J	Wu, YW; Ke, YZ; Wen, J; Guo, PC; Ran, F; Wang, MM; Liu, MM; Li, PF; Li, JN; Du, H				Wu, Yunwen; Ke, Yunzhuo; Wen, Jing; Guo, Pengcheng; Ran, Feng; Wang, Mangmang; Liu, Mingming; Li, Pengfeng; Li, Jiana; Du, Hai			Evolution and expression analyses of the MADS-box gene family in Brassica napus	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; PHYSCOMITRELLA-PATENS; TRANSCRIPTION FACTORS; HOMEOTIC GENES; DOMAIN PROTEIN; SEED PLANTS; ARABIDOPSIS; DNA; ANGIOSPERMS; HOMOLOGS	MADS-box transcription factors are important for plant growth and development, and hundreds of MADS-box genes have been functionally characterized in plants. However, less is known about the functions of these genes in the economically important allopolyploid oil crop, Brassica napus. We identified 307 potential MADS-box genes (BnMADSs) in the B. napus genome and categorized them into type I (M-alpha, M-beta, and M-gamma) and type II (MADS DNA-binding domain, intervening domain, keratin-like domain, and C-terminal domain [MIKC](c) and MIKC*) based on phylogeny, protein motif structure, and exon-intron organization. We identified one conserved intron pattern in the MADS-box domain and seven conserved intron patterns in the K-box domain of the MIKCc genes that were previously ignored and may be associated with function. Chromosome distribution and synteny analysis revealed that hybridization between Brassica rapa and Brassica oleracea, segmental duplication, and homologous exchange (HE) in B. napus were the main BnMADSs expansion mechanisms. Promoter cis-element analyses indicated that BnMADSs may respond to various stressors (drought, heat, hormones) and light. Expression analyses showed that homologous genes in a given subfamily or sister pair are highly conserved, indicating widespread functional conservation and redundancy. Analyses of BnMADSs provide a basis for understanding their functional roles in plant development.	[Wu, Yunwen; Ke, Yunzhuo; Wen, Jing; Guo, Pengcheng; Ran, Feng; Wang, Mangmang; Liu, Mingming; Li, Pengfeng; Li, Jiana; Du, Hai] Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China; [Wu, Yunwen; Ke, Yunzhuo; Wen, Jing; Guo, Pengcheng; Ran, Feng; Wang, Mangmang; Liu, Mingming; Li, Pengfeng; Li, Jiana; Du, Hai] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China	Li, JN; Du, H (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China.; Li, JN; Du, H (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.	ljn1950@swu.edu.cn; haidu81@aliyun.com	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Du, Hai/AHD-1445-2022	Du, Hai/0000-0003-4274-5724	"111" Project of China [B12006]; National Natural Science Foundation of China [31671727, 31471528]; National Basic Research Program of China (973 Program) [2015CB150201]	"111" Project of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the "111" Project of China (B12006), National Natural Science Foundation of China (31671727 and 31471528), the National Basic Research Program of China (973 Program; 2015CB150201).	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Angenent GC, 1996, TRENDS PLANT SCI, V1, P228; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11037; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Fernandez DE, 2014, PLANT PHYSIOL, V165, P1591, DOI 10.1104/pp.114.242990; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Gramzow L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00214; Gu Q, 1998, DEVELOPMENT, V125, P1509; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; HAYES TE, 1988, GENE DEV, V2, P1713, DOI 10.1101/gad.2.12b.1713; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; Jaradat Masrur R, 2014, GM Crops Food, V5, P302, DOI 10.4161/21645698.2014.947827; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Khan MR, 2013, MOL BIOTECHNOL, V54, P25, DOI 10.1007/s12033-012-9540-9; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Krogan NT, 2000, NEW PHYTOL, V147, P505, DOI 10.1046/j.1469-8137.2000.00728.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Munster T, 1997, P NATL ACAD SCI USA, V94, P2415, DOI 10.1073/pnas.94.6.2415; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nilsson L, 2007, PLANTA, V225, P589, DOI 10.1007/s00425-006-0374-1; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Rani V, 2007, J BIOSCIENCES, V32, P1325, DOI 10.1007/s12038-007-0142-9; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; TANDRE K, 1995, PLANT MOL BIOL, V27, P69, DOI 10.1007/BF00019179; Thangavel G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00510; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, NATURE, V404, P711, DOI 10.1038/35008171; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/BF02337521; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Wei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084781; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; Yan J, 2014, MOL GENET GENOMICS, V289, P25, DOI 10.1007/s00438-013-0786-0; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yu LH, 2017, MOL PLANT, V10, P834, DOI 10.1016/j.molp.2017.04.004; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang ZB, 2012, J PLANT PHYSIOL, V169, P797, DOI 10.1016/j.jplph.2011.12.020	64	14	18	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200762	10.1371/journal.pone.0200762	http://dx.doi.org/10.1371/journal.pone.0200762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024950	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000047
J	Gutierrez, JP; Garcia-Saiso, S; Aracena, BM				Gutierrez, Juan Pablo; Garcia-Saiso, Sebastian; Aracena, Belkis M.			Mexico's household health expenditure on diabetes and hypertension: What is the additional financial burden?	PLOS ONE			English	Article							GLOBAL BURDEN; CARE; TRENDS; IMPACT	Objective This study aimed to estimate the magnitude of the association between overall household health expenditures & the presence of members with a chronic disease in the household. Research design & methods This was a cross-sectional analysis of a probabilistic household survey, which gathered data on previously diagnosed type 2 diabetes mellitus and hypertension as well as health expenditure in Mexico. From an analytic sample of 44,000 households, we identified those having at least one member with diabetes or hypertension and determined their health expenditure. Using matching procedures, we compared these data with those of households lacking such individuals. Results We found that 24% of the households had at least one member who had been diagnosed with diabetes, hypertension, or both. Households with such members reported health expenditures that were 25%-34% (P <0.01) higher than households without such individuals. Such differences were more pronounced among households at lower socioeconomic levels and among those with no or limited health insurance. Conclusions In addition to their impact on individual health, chronic ailments exert financial pressure on households. The additional health-care expenditure for households owing to such diseases leaves them financially exposed-especially households with lower income levels.	[Gutierrez, Juan Pablo; Aracena, Belkis M.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Garcia-Saiso, Sebastian] Directorate Qual & Hlth Educ, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Garcia-Saiso, S (corresponding author), Directorate Qual & Hlth Educ, Mexico City, DF, Mexico.	sebastian.garcia@salud.gob.mx	Gutierrez, Juan Pablo/A-4253-2010	Gutierrez, Juan Pablo/0000-0002-0557-5562; Aracena-Genao, Belkis/0000-0001-5454-9531; Garcia-Saiso, Sebastian/0000-0003-4455-3080				Arredondo A, 2007, DIABETOLOGIA, V50, P2408, DOI 10.1007/s00125-007-0828-4; Arredondo A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0136-z; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Avila-Burgos L, 2013, SALUD PUBLICA MEXICO, V55, pS91; Bautista-Arredondo S, 2014, SALUD PUBLICA MEXICO, V56, P18; Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295; Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110; Cordova Villalobos J A, 2008, SALUD PUBLICA MEXICO, V50, P419; FID, 2012, ATL DIAB FED INT DIA; Figueroa-Lara A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145177; Garcia-Saiso S, 2015, BIBLIOTECA MEXICANA; Goryakin Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0107-1; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Heckman J, 1998, ECONOMETRICA, V66, P1017, DOI 10.2307/2999630; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lozano R., 2014, CARGA ENFERMEDAD MEX; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; OECD, 2016, OECD REV HLTH SYST M, DOI [10.1787/9789264230491-en, DOI 10.1787/9789264230491-EN]; Gutierrez JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-186; Gutierrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS341, DOI 10.21149/spm.v55s2.5133; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Ravallion M, 2001, WORLD BANK ECON REV, V15, P115, DOI 10.1093/wber/15.1.115; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Saito E, 2014, B WORLD HEALTH ORGAN, V92, P760, DOI 10.2471/BLT.13.126615; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wirtz VJ, 2012, VALUE HEALTH, V15, P593, DOI 10.1016/j.jval.2012.01.006	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201333	10.1371/journal.pone.0201333	http://dx.doi.org/10.1371/journal.pone.0201333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052668	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600039
J	Yang, L; Kong, XY; Yang, SL; Dong, XX; Yang, JF; Gou, X; Zhang, H				Yang, Lin; Kong, Xiaoyan; Yang, Shuli; Dong, Xinxing; Yang, Jianfa; Gou, Xiao; Zhang, Hao			Haplotype diversity in mitochondrial DNA reveals the multiple origins of Tibetan horse	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ANCIENT DNA; DOMESTICATION; EXPANSION; SEQUENCES; SPREAD	The Tibetan horse is a species endemic to the Tibetan plateau, with considerable economic value in the region. However, we currently have little genetic evidence to verify whether the breed originated in Tibet or if it entered the area via an ancient migratory route. In the present study, we analyzed the hypervariable segment I sequences of mitochondrial DNA (mtDNA) in 2,050 horses, including 290 individuals from five Tibetan populations and 1,760 from other areas across Asia. Network analysis revealed multiple maternal lineages in the Tibetan horse. Component analysis of sub-lineage F3 indicated that it decreased in frequency from east to west, a trend reflected both southward and northward from Inner Mongolia. Analysis of population genetics showed that the Deqen horse of eastern Tibet was more closely related to the Ningqiang horse of northern China than to other Tibetan horses or the Yunnan horse. These results indicated that the Tibetan horse migrated first from Central Asia to Mongolia, moved south to eastern Tibet (near Deqen), then finally westward to other regions of Tibet. We also identified a novel lineage K that mainly comprises Tibetan and Yunnan horses, suggesting autochthonous domesticated origin for some Tibetan horse breeds from local wild horses. In conclusion, our study demonstrated that modern Tibetan horse breeds originated from the introgression of local wild horses with exotic domesticated populations outside China.	[Yang, Lin; Zhang, Hao] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China; [Kong, Xiaoyan; Yang, Shuli; Dong, Xinxing; Yang, Jianfa; Gou, Xiao] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University	Zhang, H (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China.; Gou, X (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China.	gouxiaosa@163.com; zhanghao827@163.com			National Natural Science Foundation of China [31560617]; Yunnan Applied Basic Projects [2014FD020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Applied Basic Projects	This work was supported by the National Natural Science Foundation of China [31560617] and Yunnan Applied Basic Projects [2014FD020].	Cai DW, 2009, J ARCHAEOL SCI, V36, P835, DOI 10.1016/j.jas.2008.11.006; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Du D, 2011, ASIAN J ANIM VET ADV, V6, P564, DOI 10.3923/ajava.2011.564.571; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Guangxin E, 2017, MITOCHONDRIAL DNA A, V28, P579, DOI 10.3109/24701394.2016.1143469; Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-73; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Lei CZ, 2009, ANIM GENET, V40, P933, DOI 10.1111/j.1365-2052.2009.01950.x; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Ren ZJ, 2017, J GENET, V96, P119, DOI 10.1007/s12041-017-0753-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wang T, 2012, 50 YEARS HORSE STUDI; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215; Yang YZ, 2017, ANIM SCI J, V88, P19, DOI 10.1111/asj.12583; Zhang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172945; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; Zhao YX, 2017, MOL BIOL EVOL, V34, P2380, DOI 10.1093/molbev/msx181	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201564	10.1371/journal.pone.0201564	http://dx.doi.org/10.1371/journal.pone.0201564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052677	gold, Green Published, Green Submitted			2022-12-27	WOS:000440006600049
J	Deschodt-Arsac, V; Lalanne, R; Spiluttini, B; Bertin, C; Arsac, LM				Deschodt-Arsac, Veronique; Lalanne, Romain; Spiluttini, Beatrice; Bertin, Claire; Arsac, Laurent M.			Effects of heart rate variability biofeedback training in athletes exposed to stress of university examinations	PLOS ONE			English	Article							NEUROVISCERAL INTEGRATION; CONNECTIVITY; RESONANCE; DYNAMICS; ANXIETY; MODEL	Introduction Heart rate variability biofeedback (HRV-BFB) training, a method whereby one controls an unusually low breathing rate to reach cardiac coherence, has been shown to reduce anxiety and improve cardiac autonomic markers in diseased people, but much less is known about HRV-BFB benefits in healthy people. Here we investigated potential benefits in young competitors experiencing stress during university examinations as well as persistence of benefits after HRV-BFB training cessation. Methods A group of sports students (n = 12) practiced 5-min HRV-BFB training twice a day for 5-weeks using URGOfeel (R) (URGOTECH) and was compared to a control group (n = 6). University examinations occurred immediately after HRV-BFB training (Exam1), then 12-weeks later (Exam2). Anxiety markers and cardiac autonomic markers were assessed at baseline, Exam1 and Exam2. Principal Component Analyses (PCA) that combined all these markers were computed at Exam1 and Exam2 to emphasize covariations. Results At Exam 1, immediately after HRV-BFB training cessation, the experimental group demonstrated greater autonomic markers but similar states of anxiety when compared to the Control group. Twelve weeks later at Exam2, autonomic markers were greater and anxiety scores were lesser among the experimental group. PCA highlighted covariations only within cardiac autonomic markers at Exam1. Rather, variations in cardiac markers were associated with anxiety markers at Exam2. Conclusion Short sessions of HRV-BFB training for a brief period of 5 weeks bring substantial benefits to autonomic markers and anxiety levels in young competitors. Here beneficial effects persisted for 12 weeks. Dissociated profiles of anxiety and cardiac autonomic adaptations shed new light on the role of the amygdala in heart-brain interactions after cardiac coherence training.	[Deschodt-Arsac, Veronique; Lalanne, Romain; Arsac, Laurent M.] Univ Bordeaux, CNRS, Lab IMS, UMR 5218, Talence, France; [Deschodt-Arsac, Veronique; Lalanne, Romain; Arsac, Laurent M.] Univ Bordeaux, Fac STAPS, Pessac, France; [Spiluttini, Beatrice; Bertin, Claire] URGOTECH, 15 Ave Iena, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Deschodt-Arsac, V (corresponding author), Univ Bordeaux, CNRS, Lab IMS, UMR 5218, Talence, France.; Deschodt-Arsac, V (corresponding author), Univ Bordeaux, Fac STAPS, Pessac, France.	veronique.arsac@u-bordeaux.fr		Deschodt-Arsac, Veronique/0000-0002-9244-9862				Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Camm AJ, 1996, EUR HEART J, V17, P354; Chen S, 2016, J HUM HYPERTENS, V30, P105, DOI 10.1038/jhh.2015.27; Del Pozo JM, 2004, AM HEART J, V147, pG1, DOI 10.1016/j.ahj.2003.08.013; Dimitriev DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146131; Francis DP, 2002, J PHYSIOL-LONDON, V542, P619, DOI 10.1113/jphysiol.2001.013389; Gevirtz R., 2013, BIOFEEDBACK, V41, P110, DOI [10.5298/1081-5937-41.3.01, DOI 10.5298/1081-5937-41.3.01]; Gianaros PJ, 2015, CURR DIR PSYCHOL SCI, V24, P313, DOI 10.1177/0963721415581476; Gross MJ, 2016, APPL PSYCHOPHYS BIOF, V41, P263, DOI 10.1007/s10484-015-9330-9; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kim DK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00414; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lehrer PM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00756; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; McCraty Rollin, 2014, Front Psychol, V5, P1090, DOI 10.3389/fpsyg.2014.01090; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Paul Maman, 2012, Asian J Sports Med, V3, P29; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Pyne JM, 2016, BIOL PSYCHOL, V121, P91, DOI 10.1016/j.biopsycho.2016.10.008; Sakaki M, 2016, NEUROIMAGE, V139, P44, DOI 10.1016/j.neuroimage.2016.05.076; Schmidt F, 1998, VALIDITY UTILITY SEL, V24, P262; Shaw L., 2011, DISS ABSTR INT B, P4496; Skinner N, 2002, J PERS SOC PSYCHOL, V83, P678, DOI 10.1037//0022-3514.83.3.678; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Strack B. W., 2003, DISS ABSTR INT B, V64, P1540; Tada Y, 2017, J NUTR SCI VITAMINOL, V63, P249, DOI 10.3177/jnsv.63.249; Thayer JF, 2002, IEEE ENG MED BIOL, V21, P24, DOI 10.1109/MEMB.2002.1032635; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thome J, 2017, HUM BRAIN MAPP, V38, P27, DOI 10.1002/hbm.23340; Tomasino D., 2006, STRESS HLTH DIS, P342, DOI 10.1002/; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Yazar S, 2016, MED PRIN PRACT, V25, P374, DOI 10.1159/000444322; Young H, 2015, SCI REP-UK, V5, DOI 10.1038/srep16619	38	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201388	10.1371/journal.pone.0201388	http://dx.doi.org/10.1371/journal.pone.0201388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048519	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400084
J	Souza, TKF; Nucci, MP; Mamani, JB; da Silva, HR; Fantacini, DMC; de Souza, LEB; Picanco-Castro, V; Covas, DT; Vidoto, EL; Tannus, A; Gamarra, LF				Felix Souza, Taylla Klei; Nucci, Mariana Penteado; Mamani, Javier Bustamante; da Silva, Helio Rodrigues; Carvalho Fantacini, Daianne Maciely; Botelho de Souza, Lucas Eduardo; Picanco-Castro, Virginia; Covas, Dimas Tadeu; Vidoto, Edson Luis; Tannus, Alberto; Gamarra, Lionel Fernel			Image and motor behavior for monitoring tumor growth in C6 glioma model	PLOS ONE			English	Article							NEUROLOGICAL DEFICITS; PROGRESSION; DYSFUNCTION	The primary objective of this study is to monitor tumor growth by using image techniques and behavioral testing through general and specific motor activities (spontaneous movements and gait). Our sample includes male Wistar rats, 2 months old and weighing 250-300 g, that is categorized into three groups: control, sham, and experimental. The experimental group was anesthetized; the C6 cells with luciferase expression that were suspended in a culture medium were implanted into the right frontoparietal cortex of the rats. The sham group received implant only with culture medium without cells. Images and behavioral tests were evaluated at base time and at 7, 14, 21, and 28 days after induced tumor growth analysis. The tumor volume measured by magnetic resonance imaging (MRI) and quantitative bioluminescence imaging (BLI) signal showed a correlation coefficient of r = 0.96. The MRI showed that the mean tumor volume increased by approximately 10, 26, and 49 times according to a comparison of tumor volume on the seventh day with 14, 21, and 28 days, respectively. The quantification of the BLI signal was (4.12 +/- 2.01) x 10(8), (8.33 +/- 3.12) x 10(8), (28.43 +/- 6.32) x 10(8), and (63.02 +/- 10.53) x 10(8) photons/s at the seventh, fourteenth, twenty-first, and twenty-eighth day, respectively. After 14 days of tumor induction, both behavioral tests showed significant differences between tumor and sham or control groups. Our study showed a high correlation between MRI and BLI for tumor growth monitoring with complement aspects analysis in tumor volume. In addition, functional behavioral analysis displayed sensitivity to monitor tumor growth, as well as to detect early significant changes between groups, primarily in the tumor group. The results of gait analysis were more sensitive than general motor analysis.	[Felix Souza, Taylla Klei; Mamani, Javier Bustamante; da Silva, Helio Rodrigues; Gamarra, Lionel Fernel] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil; [Nucci, Mariana Penteado] Univ Sao Paulo, Fac Med, LIM44, Sao Paulo, SP, Brazil; [Carvalho Fantacini, Daianne Maciely; Botelho de Souza, Lucas Eduardo; Picanco-Castro, Virginia; Covas, Dimas Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Vidoto, Edson Luis; Tannus, Alberto] Univ Sao Paulo, Inst Fis Sao Carlos, CIERMag, Sao Paulo, Brazil; [Gamarra, Lionel Fernel] Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Gamarra, LF (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.; Gamarra, LF (corresponding author), Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil.	lgamarra@einstein.br	GAMARRA, LIONEL/AAF-7201-2020; Fantacini, Daianne Maciely C/N-9703-2018; Castro, Virginia P/H-2904-2015; Nucci, Mariana/AAC-4990-2020; Gamarra, Lionel fernel/AAA-9638-2020; Mamani, Javier B/D-3924-2013; Picanco-Castro, Virginia/AAC-7242-2019; Covas, Dimas T/C-5431-2013; Nucci, Mariana/AAM-6841-2021; Covas, Dimas/AAL-8499-2021	Fantacini, Daianne Maciely C/0000-0003-2694-0132; Castro, Virginia P/0000-0001-8474-4610; Gamarra, Lionel fernel/0000-0002-3910-0047; Picanco-Castro, Virginia/0000-0001-8474-4610; Covas, Dimas T/0000-0002-7364-2595; Nucci, Mariana/0000-0002-1502-9215; BUSTAMANTE MAMANI, JAVIER/0000-0001-5038-0070	National Council for Scientific and Technological Development [CNPq-400856/2016-6, CNPq-465259/2014-6]; Sao Paulo State Research Support Foundation [FAPESP:2016/21470-3, FAPESP: 2014/50983-3]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Support Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the National Council for Scientific and Technological Development (CNPq-400856/2016-6 to LFG and CNPq-465259/2014-6), Sao Paulo State Research Support Foundation (FAPESP:2016/21470-3 to LFG and FAPESP: 2014/50983-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Brain Tumor Association, 2017, BRAIN TUM STAT; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chien YC, 2014, ONCOL REP, V32, P691, DOI 10.3892/or.2014.3256; da Silva AC, 2012, EINSTEIN-SAO PAULO, V10, P11, DOI 10.1590/S1679-45082012000100004; De Oliveira PA, 2017, BRAIN RES, V1663, P78, DOI 10.1016/j.brainres.2017.03.002; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Fantacini DMC, 1674, RECOMBINANT GLYCOPRO, P63, DOI [10.1007/978-1-4939-7312-5, DOI 10.1007/978-1-4939-7312-5]; Gao SX, 2016, J CRANIOFAC SURG, V27, pE623, DOI 10.1097/SCS.0000000000002957; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hua Y, 2005, ACTA NEUROCHIR SUPPL, V95, P403; Huhndorf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168174; IBM Corp, 2015, REL 2015 IBM SPSS ST; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Jallo GI, 2006, CHILD NERV SYST, V22, P1519, DOI 10.1007/s00381-006-0174-8; Jost SC, 2009, MOL IMAGING, V8, P245, DOI 10.2310/7290.2009.00023; Karthigeyan M, 2017, WORLD NEUROSURG, V100, DOI 10.1016/j.wneu.2017.01.043; Kauppinen RA, 2011, CANCER BIOL THER, V12, P665, DOI 10.4161/cbt.12.8.18137; King GD, 2008, MOL THER, V16, P682, DOI 10.1038/mt.2008.18; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Kushner DS, 2015, NEURO-ONCOL PRACT, V2, P185, DOI 10.1093/nop/npv019; Liu Q, 2008, J NEUROSURG, V109, P849, DOI 10.3171/JNS/2008/109/11/0849; MOKRY J, 1995, PHYSIOL RES, V44, P143; Mollard S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36173; Noell S, 2015, CLIN NEUROL NEUROSUR, V136, P41, DOI 10.1016/j.clineuro.2015.05.021; Ostrom QT, 2013, NEOUROONCOLOGY, V12, P28, DOI DOI 10.1093/NEUONC/NOT151; Papoti D, 2010, CONCEPT MAGN RESON B, V37B, P193, DOI 10.1002/cmr.b.20168; Rasband WS, 2012, ASCL; Roth J, 2008, ACTA NEUROCHIR, V150, P41, DOI 10.1007/s00701-007-1454-0; Samano AK, 2010, TRANSGENIC RES, V19, P829, DOI 10.1007/s11248-010-9361-1; Sciacero Piera, 2014, Tumori, V100, pe74, DOI 10.1700/1578.17236; Silvani A, 2011, NEUROL SCI, V32, pS207, DOI 10.1007/s10072-011-0788-9; Skeie BS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/139674; Stojkovic S, 2016, MOLECULES, V21, DOI 10.3390/molecules21070843; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Swartz AM, 2014, IMMUNOTHERAPY-UK, V6, P679, DOI [10.2217/IMT.14.21, 10.2217/imt.14.21]; Vannini E, 2017, ONCOTARGET, V8, P23539, DOI 10.18632/oncotarget.15328; Yang HY, 2007, BEHAV BRAIN RES, V182, P42, DOI 10.1016/j.bbr.2007.05.013; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhou HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006087	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201453	10.1371/journal.pone.0201453	http://dx.doi.org/10.1371/journal.pone.0201453			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048545	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400090
J	Shoji, M; Minato, H; Ogaki, S; Seki, M; Suzuki, Y; Kume, S; Kuzuhara, T				Shoji, Masaki; Minato, Hiroki; Ogaki, Soichiro; Seki, Masahide; Suzuki, Yutaka; Kume, Shoen; Kuzuhara, Takashi			Different murine-derived feeder cells alter the definitive endoderm differentiation of human induced pluripotent stem cells	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; SELF-RENEWAL; HUMAN ESCS; HUMAN FIBROBLASTS; NANOG EXPRESSION; GROWTH-FACTOR; MOUSE; GENE; KLF4; GENERATION	The crosstalk between cells is important for differentiation of cells. Murine-derived feeder cells, SNL76/7 feeder cells (SNLs) or mouse primary embryonic fibroblast feeder cells (MEFs) are widely used for culturing undifferentiated human induced pluripotent stem cells (hiPSCs). It is still unclear whether different culture conditions affect the induction efficiency of definitive endoderm (DE) differentiation from hiPSCs. Here we show that the efficiency of DE differentiation from hiPSCs cultured on MEFs was higher than that of hiPSCs cultured on SNLs. The qPCR, immunofluorescent and flow cytometry analyses revealed that the expression levels of mRNA and/or proteins of the DE marker genes, SOX17, FOXA2 and CXCR4, in DE cells differentiated from hiPSCs cultured on MEFs were significantly higher than those cultured on SNLs. Comprehensive RNA sequencing and molecular network analyses showed the alteration of the gene expression and the signal transduction of hiPSCs cultured on SNLs and MEFs. Interestingly, the expression of non-coding hXIST exon 4 was up-regulated in hiPSCs cultured on MEFs, in comparison to that in hiPSCs cultured on SNLs. By qPCR analysis, the mRNA expression of undifferentiated stem cell markers KLF4, KLF5, OCT3/4, SOX2, NANOG, UTF1, and GRB7 were lower, while that of hXIST exon 4, LEFTY1, and LEFTY2 was higher in hiPSCs cultured on MEFs than in those cultured on SNLs. Taken together, our finding indicated that differences in murine-feeder cells used for maintenance of the undifferentiated state alter the expression of pluripotency-related genes in hiPSCs by the signaling pathways and affect DE differentiation from hiPSCs, suggesting that the feeder cells can potentiate hiPSCs for DE differentiation.	[Shoji, Masaki; Minato, Hiroki; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima, Japan; [Ogaki, Soichiro; Kume, Shoen] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan; [Seki, Masahide; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan	Tokushima Bunri University; Tokyo Institute of Technology; University of Tokyo	Shoji, M; Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima, Japan.	masaki-shoji@ph.bunri-u.ac.jp; kuzuhara@ph.bunri-u.ac.jp		Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [25460574, 26860083]; Tokushima Bunri University Grant for Educational Reform, and Collaborative Research Grants [TBU2013-2-1, TBU2015-2-2, TBU2016-2-3]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University Grant for Educational Reform, and Collaborative Research Grants	This work was supported by Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research (C) 25460574 (to TK), Grants-in-Aid for Young Scientists (B) 26860083 (to MS), the Tokushima Bunri University Grant for Educational Reform, and Collaborative Research Grants TBU2013-2-1, TBU2015-2-2, and TBU2016-2-3 (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Aksoy I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4719; Bergstrom R, 2011, METHODS MOL BIOL, V767, P125, DOI 10.1007/978-1-61779-201-4_9; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Caparros ML, 2002, CYTOGENET GENOME RES, V99, P99, DOI 10.1159/000071580; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Ghaedi Mahboobe, 2015, Curr Transplant Rep, V2, P81; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanawa M, 2017, STEM CELL REV REP, V13, P542, DOI 10.1007/s12015-016-9709-x; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Kim DK, 2014, STEM CELLS DEV, V23, P457, DOI 10.1089/scd.2013.0220; Kime C, 2016, P NATL ACAD SCI USA, V113, P12478, DOI 10.1073/pnas.1608564113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyazaki T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41165; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Ogaki S, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0120-2; Ogaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17297; Ojala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048659; Onishi K, 2015, DEVELOPMENT, V142, P2230, DOI 10.1242/dev.117598; Oulad-Abdelghani M, 1998, INT J DEV BIOL, V42, P23; Ozawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16479; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Shoji M, 2016, BIOCHEM BIOPH RES CO, V470, P798, DOI 10.1016/j.bbrc.2016.01.092; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama K, 2014, P NATL ACAD SCI USA, V111, P16772, DOI 10.1073/pnas.1413481111; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Toyoda T, 2015, STEM CELL RES, V14, P185, DOI 10.1016/j.scr.2015.01.007; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wade SL, 2015, STEM CELLS, V33, P2925, DOI 10.1002/stem.2084; Wang JL, 2016, P NATL ACAD SCI USA, V113, pE2029, DOI 10.1073/pnas.1520113113; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wills AE, 2015, DEV CELL, V32, P345, DOI 10.1016/j.devcel.2014.11.034; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	61	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201239	10.1371/journal.pone.0201239	http://dx.doi.org/10.1371/journal.pone.0201239			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048506	Green Submitted, gold, Green Published			2022-12-27	WOS:000439952400064
J	Al, WA; Jung, HY; Yun, ID; Jang, Y; Park, HB; Chang, HJ				Al, Walid Abdullah; Jung, Ho Yub; Yun, Il Dong; Jang, Yeonggul; Park, Hyung-Bok; Chang, Hyuk-Jae			Automatic aortic valve landmark localization in coronary CT angiography using colonial walk	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CARDIAC CT; ARM CT; TRANSCATHETER; IMPLANTATION; SEGMENTATION; STENOSIS; REPLACEMENT; FORESTS	The minimally invasive transcatheter aortic valve implantation (TAVI) is the most prevalent method to treat aortic valve stenosis. For pre-operative surgical planning, contrast-enhanced coronary CT angiography (CCTA) is used as the imaging technique to acquire 3D measurements of the valve. Accurate localization of the eight aortic valve landmarks in CT images plays a vital role in the TAVI workflow because a small error risks blocking the coronary circulation. In order to examine the valve and mark the landmarks, physicians prefer a view parallel to the hinge plane, instead of using the conventional axial, coronal or sagittal view. However, customizing the view is a difficult and time-consuming task because of unclear aorta pose and different artifacts of CCTA. Therefore, automatic localization of landmarks can serve as a useful guide to the physicians customizing the viewpoint. In this paper, we present an automatic method to localize the aortic valve landmarks using colonial walk, a regression tree-based machine-learning algorithm. For efficient learning from the training set, we propose a two-phase optimized search space learning model in which a representative point inside the valvular area is first learned from the whole CT volume. All eight landmarks are then learned from a smaller area around that point. Experiment with preprocedural CCTA images of TAVI undergoing patients showed that our method is robust under high stenotic variation and notably efficient, as it requires only 12 milliseconds to localize all eight landmarks, as tested on a 3.60 GHz single-core CPU.	[Al, Walid Abdullah; Yun, Il Dong] Hankuk Univ Foreign Studies, Div Comp & Elect Syst Engn, Yongin, South Korea; [Jung, Ho Yub] Chosun Univ, Dept Comp Engn, Gwangju, South Korea; [Jang, Yeonggul] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul, South Korea; [Park, Hyung-Bok] Yonsei Univ Hlth Syst, Yonsei Cedars Sinai Integrat Cardiovasc Imaging R, Seoul, South Korea; [Park, Hyung-Bok] Seonam Univ, Myongji Hosp, Div Cardiol, Cardiovasc Ctr,Coll Med, Goyang, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea	Hankuk University Foreign Studies; Chosun University; Yonsei University; Yonsei University; Yonsei University Health System; Myongji Hospital; Seonam University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, HY (corresponding author), Chosun Univ, Dept Comp Engn, Gwangju, South Korea.	hoyub@chosun.ac.kr		Chang, Hyuk-Jae/0000-0002-6139-7545; Jung, Ho Yub/0000-0002-2906-9170	Institute for Information and communications Technology Promotion(IITP) - Korea government(MSIP) [R0101-15-0171]; MIST (Ministry of Science & ICT), Korea, under the National Program for Excellence in SW [2017-0-00137]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, Technology, Hankuk University of fForeign Studies Research Fund of 2018 [2017R1A2B4004503, 2014M3C7A1046050]	Institute for Information and communications Technology Promotion(IITP) - Korea government(MSIP); MIST (Ministry of Science & ICT), Korea, under the National Program for Excellence in SW; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, Technology, Hankuk University of fForeign Studies Research Fund of 2018	The data collection, study design, analysis, and decision publish are supported by Institute for Information and communications Technology Promotion(IITP) grant funded by the Korea government(MSIP) (No.R0101-15-0171, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Following grants supported in preparation of the manuscript. This research was supported by MIST (Ministry of Science & ICT), Korea, under the National Program for Excellence in SW supervised by the IITP (Institute for Information & Communications Technology Promotion) (2017-0-00137). Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, Technology (No. 2017R1A2B4004503 and 2014M3C7A1046050), Hankuk University of Foreign Studies Research Fund of 2018.	Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Billings FT, 2009, ANESTH ANALG, V108, P1453, DOI 10.1213/ane.0b013e31819b07ce; Coeytaux RR, 2010, ANN INTERN MED, V153, P314, DOI 10.7326/0003-4819-153-5-201009070-00267; Collobert R, 2001, J MACH LEARN RES, V1, P143, DOI 10.1162/15324430152733142; Criminisi A, 2013, MED IMAGE ANAL, V17, P1293, DOI 10.1016/j.media.2013.01.001; Davidson I, 2006, LECT NOTES ARTIF INT, V4213, P478; Elattar M, 2015, INT J CARDIOVAS IMAG, P1; Gao YZ, 2014, LECT NOTES COMPUT SC, V8679, P165, DOI 10.1007/978-3-319-10581-9_21; Gessat M, SPIE MED IMAGING; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; GRUEN AW, 2003, GEN PROCRUSTES ANAL; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hennemuth A, 2005, INT CONGR SER, V1281, P317, DOI 10.1016/j.ics.2005.03.318; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Ionasec RI, 2010, IEEE T MED IMAGING, V29, P1636, DOI 10.1109/TMI.2010.2048756; Ionasec RI, 2008, LECT NOTES COMPUT SC, V5241, P686, DOI 10.1007/978-3-540-85988-8_82; Jung HY, 2015, PROC CVPR IEEE, P2467, DOI 10.1109/CVPR.2015.7298861; Jung HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138328; Karar ME, 2009, IEEE ENG MED BIO, P3645, DOI 10.1109/IEMBS.2009.5332516; Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lepetit V, IEEE COMP SOC C COMP, V2; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Mack MJ, 2010, TEX HEART I J, V37, P658; Nguyen MH, 2009, IEEE I CONF COMP VIS, P1925, DOI 10.1109/ICCV.2009.5459426; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Okuyama K, 2013, CATHETER CARDIO INTE, V82, pE754, DOI 10.1002/ccd.25059; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Raykar VC, 2007, SCALABLE MACH LEARNI; Ross A., 2004, PROCRUSTES ANAL; Russakovsky O, 2012, LECT NOTES COMPUT SC, V7573, P1, DOI 10.1007/978-3-642-33709-3_1; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Schoenhagen P, 2011, CARDIOVASC DIAGN THE, V1, P44, DOI 10.3978/j.issn.2223-3652.2011.08.01; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Steinberg D, 2009, CH CRC DATA MIN KNOW, P179, DOI 10.1201/9781420089653.ch10; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Syed N.A., 1999, P 5 ACM SIGKDD INT C, P317, DOI [10.1145/312129.312267, DOI 10.1145/312129.312267]; Tek H, 2008, INSIGHT J; Vahanian A, 2008, EUR J CARDIO-THORAC, V34, P1, DOI 10.1016/j.ejcts.2008.04.039; Wachter I., 2010, MED IMAGE COMPUT COM, P526, DOI DOI 10.1007/978-3-642-15705-9_; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zheng YF, 2012, IEEE T MED IMAGING, V31, P2307, DOI 10.1109/TMI.2012.2216541; Zheng YF, 2010, LECT NOTES COMPUT SC, V6361, P476	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200317	10.1371/journal.pone.0200317	http://dx.doi.org/10.1371/journal.pone.0200317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044802	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500041
J	Kucharski, AJ; Wenham, C; Brownlee, P; Racon, L; Widmer, N; Eames, KTD; Conlan, AJK				Kucharski, Adam J.; Wenham, Clare; Brownlee, Polly; Racon, Lucie; Widmer, Natasha; Eames, Ken T. D.; Conlan, Andrew J. K.			Structure and consistency of self-reported social contact networks in British secondary schools	PLOS ONE			English	Article							SPREAD; INFECTIONS; DYNAMICS; MEASLES; ADULTS	Self-reported social mixing patterns are commonly used in mathematical models of infectious diseases. It is particularly important to quantify patterns for school-age children given their disproportionate role in transmission, but it remains unclear how the structure of such social interactions changes over time. By integrating data collection into a public engagement programme, we examined self-reported contact networks in year 7 groups in four UK secondary schools. We collected data from 460 unique participants across four rounds of data collection conducted between January and June 2015, with 7,315 identifiable contacts reported in total. Although individual-level contacts varied over the study period, we were able to obtain out-of-sample accuracies of more than 90% and F-scores of 0.49-0.84 when predicting the presence or absence of social contacts between specific individuals across rounds of data collection. Network properties such as clustering and number of communities were broadly consistent within schools between survey rounds, but varied significantly between schools. Networks were assortative according to gender, and to a lesser extent school class, with the estimated clustering coefficient larger among males in all surveyed co-educational schools. Our results demonstrate that it is feasible to collect longitudinal self-reported social contact data from school children and that key properties of these data are consistent between rounds of data collection.	[Kucharski, Adam J.; Wenham, Clare; Eames, Ken T. D.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Wenham, Clare] London Sch Econ, Dept Hlth Policy, London, England; [Brownlee, Polly] Highgate Sch, London, England; [Racon, Lucie] St Bonaventures Sch, London, England; [Widmer, Natasha] St Pauls Catholic Coll, Burgess Hill, England; [Conlan, Andrew J. K.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science; University of Cambridge	Kucharski, AJ (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.	adam.kucharski@lshtm.ac.uk	Conlan, Andrew/Q-3861-2019	Conlan, Andrew/0000-0002-2593-6353	Wellcome Trust People Award [105107/Z/14/Z]; Sir Henry Dale Fellowship - Wellcome Trust [206250/Z/17/Z]; Sir Henry Dale Fellowship - Royal Society [206250/Z/17/Z]; Medical Research Council [MR/K021524/1]; MRC [MR/K021524/1] Funding Source: UKRI	Wellcome Trust People Award(Wellcome Trust); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by a Wellcome Trust People Award (105107/Z/14/Z, wellcome.ac.uk). AJK was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant Number 206250/Z/17/Z, wellcome.ac.uk) and the Medical Research Council (MR/K021524/1, mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Cairns R, 1998, New Dir Child Dev, P25; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; COIE JD, 1982, DEV PSYCHOL, V18, P557, DOI 10.1037/0012-1649.18.4.557; Conlan AJK, 2011, P ROY SOC B-BIOL SCI, V278, P1467, DOI 10.1098/rspb.2010.1807; Danon L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1037; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209; GOODMAN GS, 1986, LAW HUMAN BEHAV, V10, P317, DOI 10.1007/BF01047344; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; House T, 2011, P ROY SOC B-BIOL SCI, V278, P2753, DOI 10.1098/rspb.2010.2688; Huijsdens X, 2009, EMERG INFECT DIS, V15, P136, DOI 10.3201/eid1501.081269; Kucharski AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128070; Kucharski AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004206; Li S, 2009, AM J EPIDEMIOL, V170, P257, DOI 10.1093/aje/kwp116; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; van Hoek AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076180; Waterman AH, 2001, APPL COGNITIVE PSYCH, V15, P521, DOI 10.1002/acp.741	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200090	10.1371/journal.pone.0200090	http://dx.doi.org/10.1371/journal.pone.0200090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044816	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000439942500028
J	Lee, CY; Chen, HC; Lin, HW; Huang, JY; Lin, TL; Yang, CH; Yeh, CB; Lin, HY; Yang, SF				Lee, Chia-Yi; Chen, Hung-Chi; Lin, Hui-Wen; Huang, Jing-Yang; Lin, Teng-Li; Yang, Chia-Hsuan; Yeh, Chao-Bin; Lin, Hung-Yu; Yang, Shun-Fa			Increased risk of keratopathy after psoriasis: A nationwide population-based study	PLOS ONE			English	Article							DRY EYE; DISEASES; CORNEA	Background To evaluate whether the presence of psoriasis increases the risk of keratopathy incidence by using Taiwan's National Health Insurance Research Database (NHIRD). Methodology/Principal findings This retrospective cohort study used data from the NHIRD for the 2009 to 2012 period. A total of 3,648 patients diagnosed with psoriasis were enrolled in the study group while another 14,592 individuals were selected as the control group. The study group was propensity score-matched with a group of controls who had not received a diagnosis of psoriasis. Multivariate Cox regression analysis was performed to estimate the adjusted hazard ratio (aHR) of keratopathy. For the events of keratopathy, 71 patients in the study group and 208 patients in the control group developed keratopathy with a attributable risk of 23.43 per 100,000 person-months (incidence rate ratio = 1.40; P = 0.01) which correlated to the elevated cumulative probability (P = 0.03). The multivariate analysis revealed that the risk of keratopathy was higher in patients who had psoriasis (aHR = 1.31, P = 0.04). In addition, age older than 60 years (aHR = 2.10, P<0.01) and dry eye disease (aHR = 2.79, P<0.01) would also increase the risk of developing keratopathy. Conclusions Psoriasis was associated with an increased risk of keratopathy in patients without preexisting prominent corneal disease. Moreover, the risk of incident keratopathy increases with exposure to psoriasis.	[Lee, Chia-Yi; Lin, Hung-Yu] Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chen, Hung-Chi] Chang Gung Univ, Dept Med, Coll Med, Taoyuan, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan; [Lin, Hui-Wen] Asia Univ, Dept Optometry, Taichung, Taiwan; [Lin, Hui-Wen; Yang, Shun-Fa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Jing-Yang] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Teng-Li] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Yang, Chia-Hsuan] Taipei Med Univ Hosp, Dept Med, Taipei, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Lin, Hung-Yu; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Hung-Yu] Chung Shan Med Univ, Dept Optometry, Taichung, Taiwan; [Lin, Hung-Yu] Yuanpei Univ Med Technol, Dept Optometry, Hsinchu, Taiwan; [Lin, Hung-Yu] Chung Chou Univ Sci & Technol, Coll Hlth, Changhua, Taiwan	Show Chwan Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Lin, HY (corresponding author), Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan.; Yang, SF (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, HY; Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lin, HY (corresponding author), Chung Shan Med Univ, Dept Optometry, Taichung, Taiwan.; Lin, HY (corresponding author), Yuanpei Univ Med Technol, Dept Optometry, Hsinchu, Taiwan.; Lin, HY (corresponding author), Chung Chou Univ Sci & Technol, Coll Hlth, Changhua, Taiwan.	anthonyhungyulin@hotmail.com; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Chen, Hung-Chi/0000-0002-1117-7878	Chung Shan Medical University Hospital [CSH-2018-E-001-Y2]	Chung Shan Medical University Hospital	This study was supported by a grant (CSH-2018-E-001-Y2 to Dr. Shun-Fa Yang) from Chung Shan Medical University Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Celik U, 2015, EYE CONTACT LENS, V41, P127, DOI 10.1097/ICL.0000000000000086; Chen JJ, 2014, J AM ACAD DERMATOL, V70, P569, DOI 10.1016/j.jaad.2013.10.036; Chi CC, 2017, JAMA OPHTHALMOL, V135, P415, DOI 10.1001/jamaophthalmol.2017.0569; Cohen EJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P979; Cosens W B, 1936, Br J Ophthalmol, V20, P315, DOI 10.1136/bjo.20.5.315; Gipson IK, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12840; Gonzalez-Andrades M, 2017, EYE CONTACT LENS, V43, pE1, DOI 10.1097/ICL.0000000000000178; Guidera AC, 2001, OPHTHALMOLOGY, V108, P936, DOI 10.1016/S0161-6420(00)00538-8; Guttman-Yassky E, 2018, EXP DERMATOL, V27, P409, DOI 10.1111/exd.13336; Henrich CF, 2014, CORNEA, V33, P819, DOI 10.1097/ICO.0000000000000173; Her Y, 2013, JPN J OPHTHALMOL, V57, P341, DOI 10.1007/s10384-012-0226-4; Itani S, 2016, INT J DERMATOL, V55, P390, DOI 10.1111/ijd.12811; Kilic B, 2013, INT J DERMATOL, V52, P554, DOI 10.1111/j.1365-4632.2011.05424.x; Kim WB, 2017, CAN FAM PHYSICIAN, V63, P278; Ljubimov AV, 2017, VISION RES, V139, P138, DOI 10.1016/j.visres.2017.03.002; Papadavid E, 2017, SLEEP BREATH, V21, P949, DOI 10.1007/s11325-017-1507-4; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Reddy VS, 2015, EYE, V29, P1585, DOI 10.1038/eye.2015.177; Rehal B, 2011, J AM ACAD DERMATOL, V65, P1202, DOI 10.1016/j.jaad.2010.10.032; Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557; Sadrai Z, 2012, INVEST OPHTH VIS SCI, V53, P3584, DOI 10.1167/iovs.11-9110; Sarac G, 2016, NORTH CLIN ISTANB, V3, P79, DOI 10.14744/nci.2016.16023; Takeshita J, 2017, J AM ACAD DERMATOL, V76, P377, DOI 10.1016/j.jaad.2016.07.064; Valim V, 2015, CLIN REV ALLERG IMMU, V49, P288, DOI 10.1007/s12016-014-8438-7; Villani E, 2007, INVEST OPHTH VIS SCI, V48, P2017, DOI 10.1167/iovs.06-1129	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201285	10.1371/journal.pone.0201285	http://dx.doi.org/10.1371/journal.pone.0201285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044880	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500100
J	Poulsen, JY; Miller, MJ; Sado, T; Hanel, R; Tsukamoto, K; Miya, M				Poulsen, Jan Y.; Miller, Michael J.; Sado, Tetsuya; Hanel, Reinhold; Tsukamoto, Katsumi; Miya, Masaki			Resolving deep-sea pelagic saccopharyngiform eel mysteries: Identification of Neocyema and Monognathidae leptocephali and establishment of a new fish family "Neocyematidae" based on larvae, adults and mitogenomic gene orders	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; NORTH PACIFIC; OCEAN PISCES; GULPER EEL; TELEOSTEI; SEQUENCE; ORIGIN; REARRANGEMENTS; BIODIVERSITY; ORGANIZATION	Deep-sea midwater "saccopharyngiform" eels of the families Cyematidae, Monognathidae, Eurypharyngidae and Saccopharyngidae (order Anguilliformes) are extraordinary fishes having major skeletal reductions and modifications compared to the general anguilliform body structure. Little is known about most aspects of the systematics, phylogeny, and ecology of these families, and few of the approximately 30 species described from adult specimens have been matched with their leptotocephalus larvae. Based on mitogenomic sequence data from rare new specimens, we show that the long-speculated-about larval form referred to as "Leptocephalus holt'', which was thought to possibly be the larva of the rare orange-colored eels of Neocyema (5 known specimens; speculated to belong to the Cyematidae) are actually the larvae of the one-jaw eels of the family Monognathidae. One of the 5 types of L. holti larvae that were collected in the Pacific is genetically matched with Monognathus jesperseni, but multiple species exist based on larval sequence data and the morphology of adult specimens. A rare leptocephalus from the Sargasso Sea, with unique morphological characteristics including many small orange spots on the gut, was found to be the larva of Neocyema, which is presently only known from the Atlantic Ocean. We demonstrate that Neocyema constitutes a separate family being most closely related to Eury-pharyngidae and Saccopharyngidae based on mitogenomic DNA sequences and unique mitochondrial gene orders.	[Poulsen, Jan Y.] Greenland Inst Nat Resources, Dept Fish & Shellfish, Kivioq, Nuuk, Greenland; [Poulsen, Jan Y.] Australian Museum, Fish Sect, Sydney, NSW, Australia; [Miller, Michael J.; Tsukamoto, Katsumi] Nihon Univ, Dept Marine Sci & Resources, Fujisawa, Kanagawa, Japan; [Sado, Tetsuya] Nat Hist Museum & Inst, Chuo Ku, Aoba Cho, Chiba, Japan; [Hanel, Reinhold; Miya, Masaki] Thunen Inst Fisheries Ecol, Hamburg, Germany	Greenland Institute of Natural Resources; Australian Museum; Nihon University; Johann Heinrich von Thunen Institute	Poulsen, JY (corresponding author), Greenland Inst Nat Resources, Dept Fish & Shellfish, Kivioq, Nuuk, Greenland.; Poulsen, JY (corresponding author), Australian Museum, Fish Sect, Sydney, NSW, Australia.	JaPo@natur.gl	Miya, Masaki/O-2664-2019; Hanel, Reinhold/AAO-4887-2021	Miya, Masaki/0000-0002-9791-9886; Poulsen, Jan Yde/0000-0003-2137-0759	JST CREST Grant, Japan [JPMJCR13A2]; Canon Foundation; JSPS KAKENHI Grant [JP 26291083]	JST CREST Grant, Japan; Canon Foundation(Canon Foundation); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST CREST Grant Number JPMJCR13A2, Japan, Canon Foundation and JSPS KAKENHI Grant Number JP 26291083. All awarded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anibaldi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166137; [Anonymous], 1989, FISHES W N ATLANTIC; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BERTELSEN E, 1987, Steenstrupia, V13, P141; Bertelsen E, 1989, FISHES W N ATLANTIC, V1, P636; Bertin L, 1936, CR HEBD ACAD SCI, V203, P1540; Bertin L., 1938, DANA REPORT, V15, P1; Bohlke E. B., 1989, FISHES W N ATLANTI 9, V1, P1; Bohlke EB, 1989, SEARS FDN MARINE RES, V9, P657; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Bu┬hlke, 1989, FISHES W N ATLANTIC, V1, P9; Castle P.H.J., 1975, Dana Reports, VNo. 85, P1; Castle P.H.J., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P62; CASTLE PHJ, 1977, ARCH FISCHEREIWISS, V28, P69; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; de Vera Alejandro, 2014, Vieraea, V42, P179; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DeVaney SC, 2016, INTEGR COMP BIOL, V56, P524, DOI 10.1093/icb/icw032; DeVaney SC, 2009, NORTHEAST NAT, V16, P409, DOI 10.1656/045.016.n308; Drazen JC, 2017, ANNU REV MAR SCI, V9, P337, DOI 10.1146/annurev-marine-010816-060543; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FORTUNO J M, 1986, Miscellania Zoologica (Barcelona), V10, P223; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hanel R, 2014, NATURWISSENSCHAFTEN, V101, P1041, DOI 10.1007/s00114-014-1243-6; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2003, MOL BIOL EVOL, V20, P1917, DOI 10.1093/molbev/msg206; Inoue Jun G., 2001, Japanese Journal of Ichthyology, V48, P75; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; Johnson GD, 2012, P R SOC B, V279, DOI [10.1098/rspb.2011, DOI 10.1098/RSPB.2011]; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kuck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036593; Kumazawa Y, 1998, GENETICS, V150, P313; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Ma T, 2007, FISHERIES SCI, V73, P989, DOI 10.1111/j.1444-2906.2007.01427.x; Miller MJ, 2015, PROG OCEANOGR, V137, P84, DOI 10.1016/j.pocean.2015.05.026; Miller MJ, 2013, MAR BIODIVERS, V43, P493, DOI 10.1007/s12526-013-0170-7; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Miller MJ, 2006, DEEP-SEA RES PT I, V53, P776, DOI 10.1016/j.dsr.2006.01.008; MILLER MJ, 1994, J MAR RES, V52, P743, DOI 10.1357/0022240943076948; Miller MJ, 2004, INTRO LEPTOCEPHALI B, P1; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Mochioka N., 2014, ATLAS EARLY STAGE FI, Vsecond, P2; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NIELSEN J G, 1985, Steenstrupia, V11, P157; NIELSEN JG, 1989, ACTA ZOOL-STOCKHOLM, V70, P187, DOI 10.1111/j.1463-6395.1989.tb01069.x; Nielsen JG, 1996, ICHTHYOL RES, V43, P113, DOI 10.1007/BF02348233; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Orton G. L., 1963, Copeia, V1963, P6, DOI 10.2307/1441268; Poulsen JY, 2018, MAR BIODIVERS, V48, P1009, DOI 10.1007/s12526-017-0762-8; Poulsen JY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-111; Poulsen JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159762; Poulsen Jan Yde, 2015, Marine Biodiversity Records, V8, pe53, DOI 10.1017/S175526721500024X; RAJU SN, 1974, FISH B-NOAA, V72, P547; Rambaut A., 2014, TRACER V1 6 1; Randall DJ., 1997, DEEP SEA FISHES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santini F, 2013, MOL PHYLOGENET EVOL, V69, P884, DOI 10.1016/j.ympev.2013.06.016; Satoh TP, 2006, MOL PHYLOGENET EVOL, V40, P129, DOI 10.1016/j.ympev.2006.02.014; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmidt, 1909, MEDDELELSER KOMMISSI, V3, P1; Smith David G., 1996, Breviora, V503, P1; Smith David G., 1989, P973; Smith DG, 1989, MEMOIR SEARS FDN MAR, V1, P630; Smith DG, 1989, FISHES W N ATLANTIC, V9, P948; SMITH DG, 1989, FISHES W N ATLANIC, V9, P1; Smith DG, 424 NOAA TECH NMFS, P1; Smith KF, 2002, GLOBAL ECOL BIOGEOGR, V11, P313, DOI 10.1046/j.1466-822X.2002.00286.x; SMITH KL, 1992, DEEP-SEA RES, V39, P659, DOI 10.1016/0198-0149(92)90094-A; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Tawa A, 2013, B MAR SCI, V89, P461, DOI 10.5343/bms.2012.1010; TCHERNAVIN V. V., 1947, JOUR LINNEAN SOC [LONDON] ZOOL, V41, P287; Tighe KA, 2000, ICHTHYOL RES, V47, P39, DOI 10.1007/BF02674311; VANUTRECHT WL, 1987, COPEIA, P517, DOI 10.2307/1445799; Wang CH, 2003, ZOOL SCR, V32, P231, DOI 10.1046/j.1463-6409.2003.00114.x; Wouthuyzen S, 2005, B MAR SCI, V77, P209	84	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199982	10.1371/journal.pone.0199982	http://dx.doi.org/10.1371/journal.pone.0199982			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044814	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500026
J	Bergeron, J; Doiron, D; Marcon, Y; Ferretti, V; Fortier, I				Bergeron, Julie; Doiron, Dany; Marcon, Yannick; Ferretti, Vincent; Fortier, Isabel			Fostering population-based cohort data discovery: The Maelstrom Research cataloguing toolkit	PLOS ONE			English	Article							RESOURCE; PROJECT	Background The lack of accessible and structured documentation creates major barriers for investigators interested in understanding, properly interpreting and analyzing cohort data and biological samples. Providing the scientific community with open information is essential to optimize usage of these resources. A cataloguing toolkit is proposed by Maelstrom Research to answer these needs and support the creation of comprehensive and user-friendly study- and network-specific web-based metadata catalogues. Methods Development of the Maelstrom Research cataloguing toolkit was initiated in 2004. It was supported by the exploration of existing catalogues and standards, and guided by input from partner initiatives having used or pilot tested incremental versions of the toolkit. Results The cataloguing toolkit is built upon two main components: a metadata model and a suite of open-source software applications. The model sets out specific fields to describe study profiles; characteristics of the subpopulations of participants; timing and design of data collection events; and datasets/variables collected at each data collection event. It also includes the possibility to annotate variables with different classification schemes. When combined, the model and software support implementation of study and variable catalogues and provide a powerful search engine to facilitate data discovery. Conclusions The Maelstrom Research cataloguing toolkit already serves several national and international initiatives and the suite of software is available to new initiatives through the Maelstrom Research website. With the support of new and existing partners, we hope to ensure regular improvements of the toolkit.	[Bergeron, Julie; Doiron, Dany; Marcon, Yannick; Fortier, Isabel] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Doiron, Dany] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Doiron, Dany] Univ Basel, Basel, Switzerland; [Ferretti, Vincent] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada	McGill University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universite de Montreal	Fortier, I (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada.	isabel.fortier2@mcgill.ca		Marcon, Yannick/0000-0003-0138-2023; Bergeron, Julie/0000-0003-4772-4332; Fortier, Isabel/0000-0001-8207-3059	European Union's Seventh Framework Program [261433, 602068, 313010]; Province of Quebec's' Ministere de l'Economie, de la Science et de I'Innovation'; National Institute on Aging [P01AG043362]; Canadian Partnership Against Cancer; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Ontario Institute for Cancer Research; Genome Canada; Genome Quebec; Epigeny	European Union's Seventh Framework Program; Province of Quebec's' Ministere de l'Economie, de la Science et de I'Innovation'; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Canadian Partnership Against Cancer; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Institute for Cancer Research; Genome Canada(Genome Canada); Genome Quebec; Epigeny	This work is supported European Union's Seventh Framework Program (https://ec.europa.eu/research/fp7/index_en.cfm), 261433, 602068, 313010, IF; Province of Quebec's' Ministere de l'Economie, de la Science et de I'Innovation' (https://www.economie.gouv.qc.ca/accueil/?no_cach=el), IF; National Institute on Aging (https://www.nia.nih.gov/), P01AG043362, IF; Canadian Partnership Against Cancer (https://www.partnershipagainstcancer.ca/fr/), IF; Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), IF; Canadian Foundation for Innovation (https://www.innovation.ca/), IF; Ontario Institute for Cancer Research (https://oicr.on.ca/), IF; Genome Canada (https://www.genomecanada.ca/fr), IF; Genome Quebec (http://www.genomequebec.com/), IF; Epigeny (http://www.epigeny.io/), YM. The funders provided support in the form of salaries for authors [IF, JB, DD, YM, VF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], CHPT CROSS COH HARM; Beenackers MA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5031-7; Centre for Longitudinal Studies D, CLS HOM 1958 NAT CHI; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Crosas Merce, 2011, D-Lib Magazine, V17, DOI 10.1045/january2011-crosas; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Doiron D, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-12; Dummer TJB, 2018, CAN MED ASSOC J, V190, pE710, DOI 10.1503/cmaj.170292; Fortier I, 2017, INT J EPIDEMIOL, V46, P103, DOI 10.1093/ije/dyw075; Goldowitz D, 2011, SEMIN PEDIATR NEUROL, V18, P2, DOI 10.1016/j.spen.2011.02.007; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Harvey C, 2008, CANCER RES, V68; Kaplan BJ, 2014, MATERN CHILD NUTR, V10, P44, DOI 10.1111/j.1740-8709.2012.00433.x; Khan Amir Maroof, 2013, Indian J Community Med, V38, P56, DOI 10.4103/0970-0218.106630; Kirkland SA, 2015, CAN J AGING, V34, P366, DOI 10.1017/S071498081500029X; Knoppers BM, 2008, EUR J HUM GENET, V16, P664, DOI 10.1038/ejhg.2008.55; Larsen PS, 2013, PAEDIATR PERINAT EP, V27, P393, DOI 10.1111/ppe.12060; Mayrhofer MT, 2016, BUNDESGESUNDHEITSBLA, V59, P379, DOI 10.1007/s00103-015-2301-8; MIDUS D Midlife in the United States, NAT LONG STUD HLTH W; Minicuci N, 2016, INT J EPIDEMIOL, V45, P1403, DOI 10.1093/ije/dyw181; Nesstar, PUBL DAT WEB; ONTOFORCE, EV DAT SCI; Pang C, 2016, BIOINFORMATICS, V32, P2176, DOI 10.1093/bioinformatics/btw155; Radler Barry T, 2014, Open Health Data, V2; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Roger VL, 2015, AM J EPIDEMIOL, V181, P363, DOI 10.1093/aje/kwv011; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Vardigan M., 2008, INT J DIGITAL CURATI, V3, P107, DOI DOI 10.2218/IJDC.V3I1.45; Wellcome Trust, 2017, ENH DISC PUBL HLTH E; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Zins M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-479	31	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200926	10.1371/journal.pone.0200926	http://dx.doi.org/10.1371/journal.pone.0200926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040866	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000439749200018
J	Fleps, I; Vuille, M; Melnyk, A; Ferguson, SJ; Guy, P; Helgason, B; Cripton, PA				Fleps, Ingmar; Vuille, Muriel; Melnyk, Angela; Ferguson, Stephen J.; Guy, Pierre; Helgason, Benedikt; Cripton, Peter A.			A novel sideways fall simulator to study hip fractures ex vivo	PLOS ONE			English	Article							QUALITY-OF-LIFE; PROXIMAL FEMORAL STRENGTH; TROCHANTERIC SOFT-TISSUES; FINITE-ELEMENT-ANALYSIS; BONE-MINERAL DENSITY; FEMUR STRENGTH; ELDERLY-MEN; PREDICTION; WOMEN; RISK	Falls to the side are the leading cause of hip fractures in the elderly. The load that a person experiences during a fall cannot be measured with volunteers for ethical reasons. To evaluate injurious loads, while considering relevant energy input and body posture for a sideways fall, a subject-specific cadaveric impact experiment was developed. Full cadaveric femurpelvis constructs (N = 2) were embedded in surrogate soft tissue material and attached to metallic surrogate lower limbs. The specimens were then subjected to an inverted pendulum motion, simulating a fall to the side with an impact to the greater trochanter. The load at the ground and the deformation of the pelvis were evaluated using a 6-axis force transducer and two high-speed cameras. Post-test, a trauma surgeon (PG) evaluated specimen injuries. Peak ground contact forces were 7132 N and 5641 N for the fractured and non-fractured specimen, respectively. We observed a cervical fracture of the femur in one specimen and no injuries in a second specimen, showing that the developed protocol can be used to differentiate between specimens at high and low fracture risk.	[Fleps, Ingmar; Vuille, Muriel; Ferguson, Stephen J.; Helgason, Benedikt] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Melnyk, Angela; Cripton, Peter A.] Univ British Columbia, Dept Mech Engn & Orthopaed, Orthopaed & Injury Biomech Grp, Vancouver, BC, Canada; [Melnyk, Angela; Cripton, Peter A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada; [Guy, Pierre] Univ British Columbia, Dept Orthopaed, Div Orthopaed Trauma, Vancouver, BC, Canada; [Helgason, Benedikt] Reykjav Univ, Sch Sci & Engn, Reykjavik, Iceland	ETH Zurich; University of British Columbia; University of British Columbia; University of British Columbia; Reykjavik University	Fleps, I (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	Ingmar.fleps@hest.ethz.ch	Fleps, Ingmar/GRK-5653-2022; Cripton, Peter Alec/AAC-8268-2020; Ferguson, Stephen J./A-4118-2012; Helgason, Benedikt/A-4386-2012	Fleps, Ingmar/0000-0002-6254-8878; Cripton, Peter Alec/0000-0002-5067-0833; Ferguson, Stephen J./0000-0003-0650-5889; Helgason, Benedikt/0000-0001-8324-2651	ETH-Foundation [ETH1514-1]; internal funds at the University of British Columbia; ANSYS, Inc.; BETA CAE Systems International AG	ETH-Foundation; internal funds at the University of British Columbia; ANSYS, Inc.(Ansys, Inc.); BETA CAE Systems International AG	This research was supported by the ETH-Foundation grant nr. ETH1514-1 (BH) and internal funds at the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gavin Vale and Xiaoheng Zhang for their help with manufacturing parts for the experimental setup, Jonah Killam for his help with the ballistic gel characterisation, Enrique Oliveira Chami for his help with specimen dissections and mould prototype manufacturing, and Canada Diagnostics, Vancouver for their help with CT scanning specimens. We also acknowledge the support of ANSYS, Inc. and BETA CAE Systems International AG who provided software on a university research license.	Abdel-Aziz YI, 2015, PHOTOGRAMM ENG REM S, V81, P103, DOI 10.14358/PERS.81.2.103; Amin S, 2011, J BONE MINER RES, V26, P1593, DOI 10.1002/jbmr.347; [Anonymous], 2014, INT BIOMECH; Ariza O, 2015, J BIOMECH, V48, P224, DOI 10.1016/j.jbiomech.2014.11.042; Beason DP, 2003, J BIOMECH, V36, P219, DOI 10.1016/S0021-9290(02)00330-5; Bessho M, 2009, BONE, V45, P226, DOI 10.1016/j.bone.2009.04.241; Black DM, 2008, J BONE MINER RES, V23, P1326, DOI 10.1359/JBMR.080316; Boonen S, 2004, OSTEOPOROSIS INT, V15, P87, DOI 10.1007/s00198-003-1515-z; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Cesari D, 1982, SAE TECHNICAL PAPER; Cody DD, 1999, J BIOMECH, V32, P1013, DOI 10.1016/S0021-9290(99)00099-8; Comley K, 2009, IUTAM BOOKSER, V12, P27, DOI 10.1007/978-1-4020-9404-0_4; Cooper C, 1997, AM J MED, V103, pS12, DOI [10.1016/S0002-9343(97)90022-X, DOI 10.1016/S0002-9343(97)90022-X]; COURTNEY AC, 1994, CALCIFIED TISSUE INT, V55, P53, DOI 10.1007/BF00310169; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Derler S, 2005, MED ENG PHYS, V27, P475, DOI 10.1016/j.medengphy.2005.02.001; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Eckstein F, 2004, J BONE MINER RES, V19, P379, DOI 10.1359/JBMR.0301247; Ekstrom W, 2009, J ORTHOP TRAUMA, V23, P39, DOI 10.1097/BOT.0b013e318191f5e4; Etheridge BS, 2005, ANN BIOMED ENG, V33, P248, DOI 10.1007/s10439-005-8984-5; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; Gilchrist S, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025390; Grassi LVSRMJJIH, 2017, BIOMECHANICS MODELIN; Guillemot H, 1998, P 16 INT TECHN C ENH; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Hayes WC, 1995, T ASME J BIOMECHANIC, V117; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Keyak JH, 2013, BONE, V57, P18, DOI 10.1016/j.bone.2013.07.028; Keyak JH, 2011, BONE, V48, P1239, DOI 10.1016/j.bone.2011.03.682; Keyak JH, 1998, J BIOMECH, V31, P125, DOI 10.1016/S0021-9290(97)00123-1; Kopperdahl DL, 2014, J BONE MINER RES, V29, P570, DOI 10.1002/jbmr.2069; Lafleur B., 2016, FACTORS INFLUENCING; Laing AC, 2010, J BIOMECH, V43, P1898, DOI 10.1016/j.jbiomech.2010.03.025; Lang TF, 2012, BONE, V50, P743, DOI 10.1016/j.bone.2011.12.001; Luo Y, 2016, OSTEOPOROSIS INT, V27, P423, DOI 10.1007/s00198-015-3316-6; Luo Y., 2014, J BIOMEDICAL SCI ENG, V07, P405, DOI DOI 10.4236/jbise.2014.77043; Magaziner J, 2003, AM J EPIDEMIOL, V157, P1023, DOI 10.1093/aje/kwg081; Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; Nachreiner NM, 2007, J WOMENS HEALTH, V16, P1437, DOI 10.1089/jwh.2006.0245; Nasiri M, 2016, BONE, V90, P90, DOI 10.1016/j.bone.2016.06.006; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Payne T, 2014, PROCEDIA ENGINEER, V72, P533, DOI 10.1016/j.proeng.2014.06.092; Qasim M, 2016, OSTEOPOROSIS INT, V27, P2815, DOI 10.1007/s00198-016-3597-4; REIKERAS O, 1983, ACTA ORTHOP SCAND, V54, P18, DOI 10.3109/17453678308992864; Robinovitch SN, 2009, OSTEOPOROSIS INT, V20, P1977, DOI 10.1007/s00198-009-1045-4; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Robinovitch SN, 1995, J ORTHOPAED RES, V13, P956, DOI 10.1002/jor.1100130621; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Sarvi MN, 2015, CLIN BIOMECH, V30, P881, DOI 10.1016/j.clinbiomech.2015.05.013; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; Van Ee CA, 2000, J BIOMECH ENG-T ASME, V122, P9, DOI 10.1115/1.429621; vandenKroonenberg AJ, 1996, J BIOMECH, V29, P807, DOI 10.1016/0021-9290(95)00134-4; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568	60	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201096	10.1371/journal.pone.0201096	http://dx.doi.org/10.1371/journal.pone.0201096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040858	Green Published, gold			2022-12-27	WOS:000439749200025
J	Granato, PA; Hansen, G; Herding, E; Chaudhuri, S; Tang, SW; Garg, SK; Rowell, CR; Sickler, JJ				Granato, Paul A.; Hansen, Glen; Herding, Emily; Chaudhuri, Sheena; Tang, Shaowu; Garg, Sachin K.; Rowell, Catherine R.; Sickler, Joanna Jackson			Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection	PLOS ONE			English	Article							XPERT C. DIFFICILE; BD MAX CDIFF; COMMERCIAL MOLECULAR ASSAYS; ENZYME-IMMUNOASSAY; ABBOTT M2000; DIAGNOSIS; GUIDELINES; CULTURE	Clostridium difficile infection (CDI) is a high burden and significant cause of healthcare-acquired infectious diarrhea in the United States (US). Timely and accurate diagnosis of CDI enables the rapid initiation of antibiotic therapy and infection control policies to minimize disease transmission. Polymerase chain reaction (PCR) assays have become a preferred modality for diagnosing CDI in the US. The cobas Liat Cdiff PCR test is a novel assay that can be performed on-demand for hospital-based testing with a rapid 20-minute turnaround time from specimen collection to result reporting. We compared the clinical performance of the cobas Liat Cdiff test to the previously introduced Xpert C. difficile/Epi test; both tests are FDA-cleared PCR assays that detect the toxin B (tcdB) gene of C. difficile. Prospectively collected and remnant stool specimens from 310 patients with suspected CDI were obtained for analysis. The cobas Liat Cdiff and Xpert PCR tests showed an overall percent agreement of 97.4% (302/310; 95% CI: 95.0-98.9). Low bacterial burdens of toxigenic C. difficile, indicated by significantly delayed PCR cycle threshold (Ct) values, explained most of the discordance. Positive and negative percent agreement of the cobas Liat Cdiff test compared to the Xpert PCR test were 94.5% (52/55) and 98.0% (250/255), respectively. The clinical performance of the cobas Liat Cdiff test, combined with its simplicity of use and rapid result reporting, provides a reliable option for clinical laboratory use.	[Granato, Paul A.] Lab Alliance Cent New York, Dept Clin Microbiol, Syracuse, NY 13203 USA; [Hansen, Glen] Hennepin Cty Med Ctr, Dept Microbiol & Mol Diagnost, Minneapolis, MN 55415 USA; [Herding, Emily] Hennepin Cty Med Ctr, Dept Microbiol & Mol Biol, Minneapolis, MN 55415 USA; [Chaudhuri, Sheena; Tang, Shaowu; Garg, Sachin K.; Sickler, Joanna Jackson] Roche Mol Diagnost, Med & Sci Affairs, Pleasanton, CA USA; [Rowell, Catherine R.] Lab Alliance Cent New York, Dept Lab Device Trials, Syracuse, NY USA	Hennepin County Medical Center; Hennepin County Medical Center; Roche Holding	Granato, PA (corresponding author), Lab Alliance Cent New York, Dept Clin Microbiol, Syracuse, NY 13203 USA.	granatop@upstate.edu			Roche Molecular Systems, Inc.; F. Hoffman-La Roche Grant	Roche Molecular Systems, Inc.; F. Hoffman-La Roche Grant	Roche Molecular Systems, Inc. provided support in the form of salaries for selected authors [SC, ST, SKG, and JJS]. An F. Hoffman-La Roche Grant was awarded to Paul A Granato and Glen Hansen. Roche Molecular Systems, Inc. did not play a role in data collection, but played a supporting role in the study design, data analysis, decision to publish, and preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Berrington A, 2007, J HOSP INFECT, V65, P280, DOI 10.1016/j.jhin.2006.12.011; Butler M., 2016, EARLY DIAGNOSIS PREV; Chapin KC, 2011, J MOL DIAGN, V13, P395, DOI 10.1016/j.jmoldx.2011.03.004; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dalpke AH, 2013, J CLIN MICROBIOL, V51, P1906, DOI 10.1128/JCM.00344-13; Dionne LL, 2013, J CLIN MICROBIOL, V51, P3624, DOI 10.1128/JCM.01444-13; Garg SK, 2017, EUR J MICROBIOL IMMU, V7, P310, DOI 10.1556/1886.2017.00034; Gilbreath JJ, 2014, DIAGN MICR INFEC DIS, V80, P13, DOI 10.1016/j.diagmicrobio.2014.06.001; Le Guern R, 2013, EXPERT REV MOL DIAGN, V13, P681, DOI 10.1586/14737159.2013.829705; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Magill SS, 2014, NEW ENGL J MED, V370, P2542, DOI 10.1056/NEJMc1405194; Paitan Y, 2017, CLIN MICROBIOL INFEC, V23, P567, DOI 10.1016/j.cmi.2017.02.016; Peterson LR, 2017, J CLIN MICROBIOL, V55, P3426, DOI 10.1128/JCM.01135-17; Senchyna F, 2017, J CLIN MICROBIOL, V55, P2651, DOI [10.1128/JCM.00563-17, 10.1128/jcm.00563-17]; Seo JY, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22135; Shin BM, 2016, ANN LAB MED, V36, P131, DOI 10.3343/alm.2016.36.2.131; Shin S, 2012, ANN LAB MED, V32, P355, DOI 10.3343/alm.2012.32.5.355; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Tenover FC, 2010, J CLIN MICROBIOL, V48, P3719, DOI 10.1128/JCM.00427-10; Viala C, 2012, J MICROBIOL METH, V90, P83, DOI 10.1016/j.mimet.2012.04.017; Yoo J, 2015, DIAGN MICR INFEC DIS, V83, P7, DOI 10.1016/j.diagmicrobio.2015.05.005	23	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200498	10.1371/journal.pone.0200498	http://dx.doi.org/10.1371/journal.pone.0200498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040852	Green Submitted, Green Published, gold			2022-12-27	WOS:000439749200005
J	Guo, ZY; Zhou, D; Liu, PY; He, ZY; Lv, C				Guo, Ziyue; Zhou, Dong; Liu, Pengyan; He, Zhiyi; Lv, Chuan			A quantitative assessment method for the space design of products based on ergonomics and virtual simulation	PLOS ONE			English	Article							SWEPT VOLUMES; MUSCULOSKELETAL SYMPTOMS; GEOMETRIC REPRESENTATION; ENVIRONMENT; OBJECTS	Work spaces for assembly or maintenance operations are considered in the design stage of products. Maintenance space is a key factor in determining how well a product can be maintained. If the work space is sufficiently considered in the design stage, it will benefit both the user and the maintainer. From a maintenance perspective, this paper proposes a quantitative method to evaluate the maintenance space by virtual simulation and consideration of ergonomics. In this method, maintenance operations are concisely classified into three types. Based on the virtual simulation of the maintenance process and maintainer data, the swept volume of a hand is built using envelope theory. The operation range of the maintainer is derived by establishing a mathematical model for the upper limb. Combining the swept volume and operation range, the maintenance space can be quantitatively evaluated. A concise validation demonstrates that the proposed method is effective for evaluating the maintenance space to improve the space design. The proposed method could be applied to the space design of a complex product.	[Guo, Ziyue; Zhou, Dong; Liu, Pengyan; Lv, Chuan] State Key Lab Virtual Real Technol & Syst, Beijing, Peoples R China; [Guo, Ziyue; Zhou, Dong; Liu, Pengyan; He, Zhiyi; Lv, Chuan] Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China; [Zhou, Dong; He, Zhiyi; Lv, Chuan] State Key Def Sci & Technol Lab Reliabil & Enviro, Beijing, Peoples R China	Beihang University	Guo, ZY (corresponding author), State Key Lab Virtual Real Technol & Syst, Beijing, Peoples R China.; Guo, ZY (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China.	samsamsoo@163.com	Lv, Chuan/AAI-7076-2020					Abate AF, 2009, J VISUAL LANG COMPUT, V20, P318, DOI 10.1016/j.jvlc.2009.07.003; Abshire KJ, 1998, REL MAIN S 1998 P AN; [Anonymous], 2011, THESIS; [Anonymous], 2003, TOOL PROD, V69, P20; [Anonymous], 2001, MECH ENG, V123, P76; Baoxiang R, 2016, ERGONOMICS IND DESIG; Birolini A., 2017, RELIABILITY ENG THEO, V8; Blackmore D, 1999, COMPUT AIDED DESIGN, V31, P215, DOI 10.1016/S0010-4485(99)00017-2; BLACKMORE D, 1994, COMPUT AIDED DESIGN, V26, P315, DOI 10.1016/0010-4485(94)90077-9; BLACKMORE D, 1992, INT J ROBOT RES, V11, P516, DOI 10.1177/027836499201100602; Corvaglia D, 2004, P 1 INT WORKSH WEB3D; Cruz-Neira C., 1993, P 20 ANN C COMP GRAP; Cutler LD, 1997, P 1957 S INT 3D GRAP; Ganter M, 1993, ALGEBRAIC METHODS IM; Glor PJ, 1993, REL MAIN S 1993 P AN; Jayaram S, 1999, IEEE COMPUT GRAPH, V19, P44, DOI 10.1109/38.799739; Kilroy N, 2000, BRIT J BIOMED SCI, V57, P199; Lane K, 1998, DTIC DOCUMENT; Lanzerotti M. Y., 2016, PRODUCTION PLANNING, P1; LEU MC, 1986, J ENG IND-T ASME, V108, P113, DOI 10.1115/1.3187045; Li JR, 2003, COMPUT IND, V52, P109, DOI 10.1016/S0166-3615(03)00103-9; Lv C, 2012, DESIGN ANAL VERIFICA, P300; Macchiarella MD, 2004, DIGITAL AVIONICS SYS; MARTIN RR, 1990, COMPUT AIDED DESIGN, V22, P223, DOI 10.1016/0010-4485(90)90051-D; Massaccesi M, 2003, APPL ERGON, V34, P303, DOI 10.1016/S0003-6870(03)00052-8; Peng GL, 2010, ASSEMBLY AUTOM, V30, P333, DOI 10.1108/01445151011075799; Pourmahabadian M., 2006, Pakistan Journal of Medical Sciences, V22, P379; Saraviapinilla MH, 2015, APPL ERGONOMICS; Sebok A., 2006, Transactions of the American Nuclear Society, V94, P16; Shuval K, 2005, INT J IND ERGONOM, V35, P569, DOI 10.1016/j.ergon.2005.01.004; von Dziegielewski A, 2015, IEEE T AUTOM SCI ENG, V12, P183, DOI 10.1109/TASE.2013.2290193; Vora J, 2002, APPL ERGON, V33, P559, DOI 10.1016/S0003-6870(02)00039-X; Wang W, 2010, COMP SUPP COOP WORK; Wang W. P., 1986, IEEE Computer Graphics and Applications, V6, P8, DOI 10.1109/MCG.1986.276586; WELD JD, 1990, INT J ROBOT RES, V9, P105, DOI 10.1177/027836499000900507; Yu HQ, 2011, ASSEMBLY AUTOM, V31, P53, DOI 10.1108/01445151111104173; Zhou D, 2014, ASSEMBLY AUTOM, V34, P192, DOI 10.1108/AA-04-2013-044	37	4	4	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200880	10.1371/journal.pone.0200880	http://dx.doi.org/10.1371/journal.pone.0200880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036397	gold, Green Published, Green Submitted			2022-12-27	WOS:000439429200020
J	Hillebrand, AC; Pizzolato, LS; Neto, BS; Branchini, G; Brum, IS				Hillebrand, Ana Caroline; Pizzolato, Lolita Schneider; Neto, Brasil Silva; Branchini, Gisele; Brum, Ilma Simoni			Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer	PLOS ONE			English	Article							SPLICE VARIANT; FULL-LENGTH; PROGRESSION; GROWTH; DEGRADATION; RESISTANCE; AR-V7	The role of molecular changes in the androgen receptor (AR) as AR variants (AR-Vs) is not clear in the pathophysiology of benign prostatic hyperplasia (BPH) and hormone-naive PCa. The aim of the current work was to identify the presence of AR isoforms in benign tissue and primary PCa, and to evaluate the possible association with tumor aggressiveness and biochemical recurrence in primary PCa. The mRNA levels of full length AR (AR-FL) and AR-Vs (AR-V1, AR-V4 and AR-V7) were measured using RT-qPCR. The protein expression of AR-FL (AR-CTD and AR-NTD) and AR-V7 were evaluated by the H-Score in immunohistochemistry (IHC). All investigated mRNA targets were expressed both in BPH and PCa. AR-FL mRNA levels were similar in both groups. AR-V4 mRNA expression showed higher levels in BPH, and AR-V1 and AR-V7 mRNA expression were higher in PCa. The AR-V7 protein showed a similar H-Score in both groups, while AR-CTD and AR-NTD were higher in nuclei of epithelial cells from BPH. These results support the assumption that these constitutively active isoforms of AR are involved in the pathophysiology of primary PCa and BPH. The role of AR-Vs and their possible modulation by steroid tissue levels in distinct types of prostate tumors needs to be elucidated to help guide the best clinical management of these diseases.	[Hillebrand, Ana Caroline; Pizzolato, Lolita Schneider; Branchini, Gisele; Brum, Ilma Simoni] Univ Fed Rio Grande do Sul, Dept Physiol, Lab Endocrine & Mol Biol, Porto Alegre, RS, Brazil; [Neto, Brasil Silva] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Urol, Porto Alegre, RS, Brazil; [Branchini, Gisele] Univ Fed Ciencias Saude Porto Alegre, Dept Basic Sci Hlth, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Brum, IS (corresponding author), Univ Fed Rio Grande do Sul, Dept Physiol, Lab Endocrine & Mol Biol, Porto Alegre, RS, Brazil.	ilma@ufrgs.br	Branchini, Gisele/N-1930-2017; Hillebrand, Ana Caroline/J-7050-2014	Branchini, Gisele/0000-0003-2524-8603; Schneider Pizzolato, Lolita/0000-0002-7546-5131; Hillebrand, Ana Caroline/0000-0003-0496-4424	Brazilian Funding Agency FIPE - HCPA [14-0397]; Brazilian Funding Agency CNPq [477148/2013-1]; Brazilian Funding Agency CAPES; Brazilian Funding Agency FAPERGS	Brazilian Funding Agency FIPE - HCPA; Brazilian Funding Agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Funding Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Funding Agency FAPERGS(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Brazilian Funding Agencies FIPE - HCPA (Grant number 14-0397); CNPq (Grant number 477148/2013-1); CAPES; and FAPERGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Amirghofran Z, 2004, PATHOL ONCOL RES, V10, P37, DOI 10.1007/BF02893407; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; INCA, 2017, ESTIMATE 2018 CANCER; Krajewska M, 1996, AM J PATHOL, V148, P1567; Kruslin B, 2015, BOSNIAN J BASIC MED, V15, P1, DOI 10.17305/bjbms.2015.449; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; MIYAMOTO KK, 1993, J UROLOGY, V149, P1015, DOI 10.1016/S0022-5347(17)36284-5; Nacusi Lucas P, 2009, Expert Rev Endocrinol Metab, V4, P417, DOI 10.1586/eem.09.34; Qu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07654; Scher HI, 2017, EUR UROL, V71, P874, DOI 10.1016/j.eururo.2016.11.024; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Welti J, 2016, EUR UROL, V70, P599, DOI 10.1016/j.eururo.2016.03.049; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhan Y, 2017, MOL CANCER RES, V15, P59, DOI 10.1158/1541-7786.MCR-16-0236; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970; Zhao HJ, 2012, J UROLOGY, V188, P2158, DOI 10.1016/j.juro.2012.08.014	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200613	10.1371/journal.pone.0200613	http://dx.doi.org/10.1371/journal.pone.0200613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028845	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900009
J	Kanazawa, I; Sugimoto, T				Kanazawa, Ippei; Sugimoto, Toshitsugu			Prehypertension increases the risk of atherosclerosis in drug-naive Japanese patients with type 2 diabetes mellitus	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MULTIFACTORIAL INTERVENTION; ARTERIAL STIFFNESS; MEDIA THICKNESS; BLOOD-PRESSURE; GLUCOSE; STROKE; POPULATION; MORTALITY; OUTCOMES	Purpose Hypertension is a risk factor of atherosclerotic diseases. However, the importance of prehypertension in Japanese patients with type 2 diabetes mellitus (T2DM) is controversial. The aim of this study was to examine association between prehypertension, hypertension and atherosclerosis in T2DM. Methods We recruited 179 Japanese patients with T2DM, who never took any medication for diabetes, hypertension, dyslipidemia, or atherosclerosis. Intima-media thickness (IMT) of common carotid artery was evaluated by high-resolution B-mode ultrasonography. Results Multiple regression analysis adjusted for age, duration of diabetes, body mass index, HbA1c, fasting C-peptide, triglyceride, HDL-cholesterol, LDL-cholesterol, and estimated glomerular filtration rate showed that systolic blood pressure (SBP), but not diastolic BP, was significantly and positively associated with maximum IMT (IMT-max), mean IMT, and plaque score (beta = 0.28, p<0.001; beta = 0.26, p = 0.047; and beta = 0.25, p = 0.006, respectively). ROC analysis showed that the cut-off value of SBP to detect atherosclerosis (IMT-max 1.8mm, the mean of IMT-max of this subjects) was 133.5 (p = 0.008), while DBP was not useful to detect it (p = 0.433). Then, participants were categorized as normotension (SBP <119 mmHg), prehypertension (SBP 120-139 mmHg), and hypertension (>140 mmHg). Multiple logistic regression analysis adjusted for the variables described above plus gender and smoking showed that prehypertension and hypertension were significantly associated with the increased risk of atherosclerosis [prehypertension; odds ratio (OR) 3.45, 95% confidence interval (CI) 1.11-10.76, p = 0.033, and hypertension; OR 7.29, 95%CI 1.99-26.78, p = 0.003]. Conclusion These findings suggest that prehypertension categorized by SBP is an important risk factor of atherosclerosis independently of conventional risk factors in patients with T2DM.	[Kanazawa, Ippei; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Shimane, Japan	Shimane University	Kanazawa, I (corresponding author), Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Shimane, Japan.	ippei.k@med.shimane-u.ac.jp	Kanazawa, Ippei/F-8609-2010					Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Eastwood SV, 2015, HYPERTENSION, V66, P481, DOI 10.1161/HYPERTENSIONAHA.115.05672; Fujishima M, 1979, DIABETES S3, V45, pS14; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gde P, 2016, DIABETOLOGIA, V59, P2298, DOI 10.1007/s00125-016-4065-6; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; IMAI E, 2008, NIPPON NAIKA GAKKAI, V97, P921, DOI DOI 10.2169/NAIKA.97.921; Kanazawa I, 2011, CLIN ENDOCRINOL, V74, P467, DOI 10.1111/j.1365-2265.2010.03946.x; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Li J, 2016, J DIABETES, V8, P824, DOI 10.1111/1753-0407.12361; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Onat A, 2008, AM J HYPERTENS, V21, P890, DOI 10.1038/ajh.2008.212; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ravikumar R, 2002, AM J CARDIOL, V90, P702, DOI 10.1016/S0002-9149(02)02593-6; Roddgers A, 1996, BMJ-BRIT MED J, V313, P147; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; Tan JR, 2010, J DIABETES, V2, P56, DOI 10.1111/j.1753-0407.2009.00062.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ueki K, 2017, LANCET DIABETES ENDO, V5, P951, DOI 10.1016/S2213-8587(17)30327-3; UK Prospective Diabetes Study Group, 1999, BMJ-BRIT MED J, V317, P703; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201055	10.1371/journal.pone.0201055	http://dx.doi.org/10.1371/journal.pone.0201055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028862	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900037
J	Tsvetkova, M; Wagner, C; Mao, A				Tsvetkova, Milena; Wagner, Claudia; Mao, Andrew			The emergence of inequality in social groups: Network structure and institutions affect the distribution of earnings in cooperation games	PLOS ONE			English	Article							PROMOTE COOPERATION; HUMANS; PUNISHMENT; REPUTATION; WEALTH; RECIPROCITY; SOCIETIES; DILEMMA; PLAY	From small communities to entire nations and society at large, inequality in wealth, social status, and power is one of the most pervasive and tenacious features of the social world. What causes inequality to emerge and persist? In this study, we investigate how the structure and rules of our interactions can increase inequality in social groups. Specifically, we look into the effects of four structural conditions-network structure, network fluidity, reputation tracking, and punishment institutions-on the distribution of earnings in network cooperation games. We analyze 33 experiments comprising 96 experimental conditions altogether. We find that there is more inequality in clustered networks compared to random networks, in fixed networks compared to randomly rewired and strategically updated networks, and in groups with punishment institutions compared to groups without. Secondary analyses suggest that the reasons inequality emerges under these conditions may have to do with the fact that fixed networks allow exploitation of the poor by the wealthy and clustered networks foster segregation between the poor and the wealthy, while the burden of costly punishment falls onto the poor, leaving them poorer. Surprisingly, we do not find evidence that inequality is affected by reputation in a systematic way but this could be because reputation needs to play out in a particular network environment in order to have an effect. Overall, our findings suggest possible strategies and interventions to decrease inequality and mitigate its negative impact, particularly in the context of mid- and large-sized organizations and online communities.	[Tsvetkova, Milena] London Sch Econ & Polit Sci, Dept Methodol, London, England; [Wagner, Claudia] GESIS Leibniz Inst Social Sci, Cologne, Germany; [Mao, Andrew] Aarhus Univ, Dept Management, Aarhus, Denmark; [Mao, Andrew] CTRL Labs, New York, NY USA	University of London; London School Economics & Political Science; Leibniz Institut fur Sozialwissenschaften (GESIS); Aarhus University	Tsvetkova, M (corresponding author), London Sch Econ & Polit Sci, Dept Methodol, London, England.	m.tsvetkova@lse.ac.uk	Tsvetkova, Milena/AAE-9386-2021	Tsvetkova, Milena/0000-0002-3552-108X	Volkswagen Foundation [92 173]	Volkswagen Foundation(Volkswagen)	This research was made possible through the generous support of the Volkswagen Foundation (https://www.volkswagenstiftung.de/) under Grant Ref. 92 173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1978, AM SOCIOL REV, V43, P865, DOI 10.2307/2094626; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bloom M, 1999, ACAD MANAGE J, V42, P25, DOI 10.2307/256872; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Borenstein, 2009, INTRO METAANALYSIS; Breen R, 2005, ANNU REV SOCIOL, V31, P223, DOI 10.1146/annurev.soc.31.041304.122232; Casari M, 2009, J ECON BEHAV ORGAN, V71, P273, DOI 10.1016/j.jebo.2009.03.022; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Chiang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128777; Cook K, 2003, HDB SOCIAL PSYCHOL, P53; Credit Suisse, 2016, GLOBAL WEALTH DATABO; Cuesta JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07843; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; DiMaggio P, 2012, ANNU REV SOCIOL, V38, P93, DOI 10.1146/annurev.soc.012809.102545; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Epstein J.M., 1996, GROWING ARTIFICIAL S; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Frey V, 2016, SCI REP-UK, V6, DOI 10.1038/srep38304; Gachter S, 2017, J PUBLIC ECON, V150, P1, DOI 10.1016/j.jpubeco.2017.03.002; Gould RV, 2002, AM J SOCIOL, V107, P1143, DOI 10.1086/341744; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Kamei K, 2017, ECON J, V127, P1069, DOI 10.1111/ecoj.12320; KERCKHOFF AC, 1995, ANNU REV SOCIOL, V21, P323; Kirchkamp O, 2007, GAME ECON BEHAV, V58, P269, DOI 10.1016/j.geb.2006.04.002; Kohler TA, 2017, NATURE, V551, P619, DOI 10.1038/nature24646; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Milanovic B., 2016, GLOBAL INEQUALITY; Mulder MB, 2009, SCIENCE, V326, P682, DOI 10.1126/science.1178336; Mullainathan S., 2013, SCARCITY WHY HAVING; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nishi A, 2015, SOCIOL SCI, V2, P544, DOI 10.15195/v2.a26; Nishi A, 2015, NATURE, V526, P426, DOI 10.1038/nature15392; O'Gorman R, 2009, P ROY SOC B-BIOL SCI, V276, P323, DOI 10.1098/rspb.2008.1082; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Payne B. K., 2017, BROKEN LADDER INEQUA; Piketty T., 2014, CAPITAL SIGLO 21; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Ridgeway Cecilia L., 2006, CONT SOCIAL PSYCHOL, P301; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Scheffer M, 2017, P NATL ACAD SCI USA, V114, P13154, DOI 10.1073/pnas.1706412114; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Starmans C, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0082; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tilly C, 1998, DURABLE INEQUALITY; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; van de Rijt A, 2014, P NATL ACAD SCI USA, V111, P6934, DOI 10.1073/pnas.1316836111; Wang J, 2012, P NATL ACAD SCI USA, V109, P14363, DOI 10.1073/pnas.1120867109; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	53	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200965	10.1371/journal.pone.0200965	http://dx.doi.org/10.1371/journal.pone.0200965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028884	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000439396900028
J	Lacey, RE; McMunn, A; Webb, E				Lacey, Rebecca E.; McMunn, Anne; Webb, Elizabeth			Informal caregiving and markers of adiposity in the UK Household Longitudinal Study	PLOS ONE			English	Article							GENDER-DIFFERENCES; PHYSICAL HEALTH; METAANALYSIS; CARE; STRESS; CONSEQUENCES; MORTALITY; SPOUSES; SUPPORT; BURDEN	Objectives The aim was to investigate associations between caregiving and adiposity using a representative UK longitudinal study. We also investigated whether associations differed by age, gender and caregiving characteristics. Methods Data on 9,421 participants aged 16+ from three waves (2009-2012) of the UK Household Longitudinal Study were used. Body mass index, waist circumference and percentage body fat were assessed. Caregiving and caregiving characteristics (hours per week, number of people cared for, co-resident caregiving and combining working and caregiving) was available from the prior wave. Gender-stratified associations between caregiving/caregiving characteristics with adiposity were tested. Covariates included caregiver's health, socioeconomic position, parenthood and partnerships. Results Caregiving was associated with higher adiposity for women but not men. Younger women caregivers had particularly higher levels of adiposity. Men combining part-time paid work with caregiving had higher levels of adiposity than men working full-time and not caregiving. Women aged 16-44 or 65+ had particularly high levels of adiposity when combining full-time work and caregiving, compared to full-time work alone. Conclusion The health of caregivers should be a public health priority, particularly for younger women and those combining paid work with caregiving responsibilities.	[Lacey, Rebecca E.; McMunn, Anne; Webb, Elizabeth] UCL, Res Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Lacey, RE (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	rebecca.lacey@ucl.ac.uk		Lacey, Rebecca/0000-0002-3510-0795; McMunn, Anne/0000-0003-3237-9345	UK's Economic and Social Research Council [ES/N012054/1]; Economic and Social Research Council; ESRC [ES/N012054/1, ES/R008930/1, ES/N012054/2] Funding Source: UKRI	UK's Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the UK's Economic and Social Research Council (grant number: ES/N012054/1, PI: Elizabeth Webb). The Economic and Social Research Council funded the UK Household Longitudinal Study. The funders had no role in the study design of this specific study, analysis, decision to publish, or preparation of the manuscript.	ALLEN SM, 1994, J GERONTOL, V49, pS187, DOI 10.1093/geronj/49.4.S187; Arber S., 2007, HEALTH SOC CARE COMM, V3, P19, DOI DOI 10.1111/j.1365-2524.1995.tb00003.x; Bauer JM, 2015, J POPUL AGEING, V8, P113, DOI 10.1007/s12062-015-9116-0; CarersTrust, 2017, KEY FACTS CAR PEOPL; Carr E, 2018, J GERONTOL B-PSYCHOL, V73, P1253, DOI 10.1093/geronb/gbw156; Davis JMD, 2001, PSYCHOL MED, V31, P1475, DOI 10.1017/S003329170105398z; Feinberg L., 2012, FACT SHEET 271; Glaser K, 2005, HEALTH SOC CARE COMM, V13, P470, DOI 10.1111/j.1365-2524.2005.00574.x; Hajek A, 2017, PUBLIC HEALTH, V151, P81, DOI 10.1016/j.puhe.2017.06.022; Hajek A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4786-6; Hassink WHJ, 2011, SOC SCI MED, V73, P1508, DOI 10.1016/j.socscimed.2011.08.027; Hounsell C, 2015, CARE GIVING US AARP; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kim Y, 2005, PSYCHOSOMATICS, V46, P123, DOI 10.1176/appi.psy.46.2.123; KRAMER BJ, 1995, GERONTOLOGIST, V35, P340, DOI 10.1093/geront/35.3.340; Lacey RE, 2017, INT J OBESITY, V41, P332, DOI 10.1038/ijo.2016.197; Legg L, 2013, J EPIDEMIOL COMMUN H, V67, P95, DOI 10.1136/jech-2012-201652; LGA, 2016, AD SOC CAR FUND STAT; Lynn P., 2009, SAMPLE DESIGN UNDERS; McFall S, 2014, GUIDE NURSE HLTH ASS; O'Reilly D, 2008, SOC SCI MED, V67, P1282, DOI 10.1016/j.socscimed.2008.06.025; ONS, 2016, MORT 2014 BAS NAT PO; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Raschick M, 2004, FAM RELAT, V53, P317, DOI 10.1111/j.0022-2445.2004.0008.x; Roepke SK, 2009, INT J GERIATR PSYCH, V24, P1453, DOI 10.1002/gps.2286; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Vitaliano PP, 1996, PSYCHOL AGING, V11, P155, DOI 10.1037/0882-7974.11.1.155; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Vlachantoni A, 2016, SSM-POPUL HLTH, V2, P495, DOI 10.1016/j.ssmph.2016.05.009; Vlachantoni A, 2013, MATURITAS, V74, P114, DOI 10.1016/j.maturitas.2012.10.013; Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241; World Health Organization (WHO), 2017, BOD MASS IND BMI; Yee JL, 2000, GERONTOLOGIST, V40, P147, DOI 10.1093/geront/40.2.147	36	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200777	10.1371/journal.pone.0200777	http://dx.doi.org/10.1371/journal.pone.0200777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024946	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000052
J	Amparo, ACB; Jayme, SI; Roces, MCR; Quizon, MCL; Mercado, MLL; Dela Cruz, MPZ; Licuan, DA; Villalon, EES; Baquilod, MS; Hernandez, LM; Taylor, LH; Nel, LH				Amparo, Anna Charinna B.; Jayme, Sarah I.; Roces, Maria Concepcion R.; Quizon, Maria Consorcia L.; Mercado, Maria Luisa L.; Dela Cruz, Maria Pinky Z.; Licuan, Dianne A.; Villalon, Ernesto E. S., III; Baquilod, Mario S.; Hernandez, Leda M.; Taylor, Louise H.; Nel, Louis H.			The evaluation of Animal Bite Treatment Centers in the Philippines from a patient perspective	PLOS ONE			English	Article							RABIES; ATTITUDES; KNOWLEDGE	Background The Philippines has built an extensive decentralised network of Animal Bite Treatment Centers (ABTCs) to help bite victims receive timely rabies post-exposure prophylaxis (PEP) at little cost. This study surveyed patients in the community and at ABTCs of three provinces to assess animal bite/scratch incidence, health-seeking behaviour and PEP-related out-of pocket expenses (OOPE). Methodology and principal findings During community surveys in 90 barangays (neighbourhoods), 53% of households reported at least one animal bite/scratch injury over the past 3 years, similar across urban and rural barangays. Overall bite/scratch incidences in 2016 +/- 17 were 67.3, 41.9 and 48.8 per 1,000 population per year for Nueva Vizcaya, Palawan and Tarlac respectively. Incidences were around 50% higher amongst those under 15 years of age, compared to-those older than 15. Household awareness of the nearest ABTCs was generally over 80%, but only 44.9% sought proper medical treatment and traditional remedies were still frequently used. The proportion of patients seeking PEP was not related to the distance or travel time to the nearest ABTC. For those that did not seek medical treatment, most cited a lack of awareness or insufficient funds and almost a third visited a traditional healer. No deaths from bite/scratch injuries were reported. A cohort of 1,105 patients were interviewed at six ABTCs in early 2017. OOPE varied across the ABTCs, from 5.53 USD to 37.83 USD per patient, primarily dependent on the need to pay for immunization if government supplies had run out. Overall, 78% of patients completed the recommended course, and the main reason for non-completion was a lack of time, followed by insufficient funds. Dog observation data revealed that 85% of patients were not truly exposed to rabies, and education in bite prevention might reduce provoked bites and demand for PEP. An accompanying paper details the ABTC network from the health provider's perspective.	[Amparo, Anna Charinna B.; Jayme, Sarah I.; Mercado, Maria Luisa L.; Dela Cruz, Maria Pinky Z.; Licuan, Dianne A.] Global Alliance Rabies Control, Sta Rosa City, Philippines; [Roces, Maria Concepcion R.; Quizon, Maria Consorcia L.] South Asia Field Epidemiol & Technol Network SAFE, Quezon City, Philippines; [Villalon, Ernesto E. S., III; Baquilod, Mario S.; Hernandez, Leda M.] Dis Prevent & Control Bur, Dept Hlth, Manila, Philippines; [Taylor, Louise H.; Nel, Louis H.] Global Alliance Rabies Control, Manhattan, KS USA; [Nel, Louis H.] Univ Pretoria, Pretoria, South Africa	Philippine Department Health; University of Pretoria	Amparo, ACB (corresponding author), Global Alliance Rabies Control, Sta Rosa City, Philippines.	chari.amparo@rabiesalliance.org	Nel, Louis H/F-1001-2012	Nel, Louis H/0000-0001-8963-0153; Amparo, Anna Charinna/0000-0002-9358-3983; Roces, Maria Concepcion/0000-0003-3047-9529	GlaxoSmithKline Biologicals SA (Belgium)	GlaxoSmithKline Biologicals SA (Belgium)(GlaxoSmithKline)	The Global Alliance for Rabies Control received funds from GlaxoSmithKline Biologicals SA (Belgium) to undertake the study. ACBA, SIJ, MLLM, MPZDC, DAL were funded by the study, while MCR, MCLQ, and LHT received partial funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparo AC, EVALUATION OPERATING; Deray R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189596; Dimaano EM, 2011, INT J INFECT DIS, V15, pE495, DOI 10.1016/j.ijid.2011.03.023; Elio-Villa LP, EPIDEMIOLOGICAL STUD; Fenelon N, 2017, EPIDEMIOL INFECT, V145, P1624, DOI 10.1017/S0950268816003125; Frey J, 2013, TROP MED INT HEALTH, V18, P1555, DOI 10.1111/tmi.12202; GAVI, 2013, RAB VACC INV STRAT B; Hampson K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000982; Moran David, 2015, BMC Res Notes, V8, P955, DOI 10.1186/s13104-014-0955-1; Mucheru GM, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.255.4745; OIE, 2016, GLOB STRAT FRAM EL D; Philippine Statistics Authority, 2017, PHIL STAND GEOGR COD; Philippines Department of Health Philippines Department of Agriculture, 2011, ADM ORD DOH 2011 200; Sharma S, 2016, ANN MED HEALTH SCI R, V6, P115, DOI 10.4103/2141-9248.181836; Shi JF, 2010, VACCINE, V28, P2573, DOI [10.1016/j.vaccine.2010.01.051, 10.1016/j.vaccine.2010.08.082]; Valenzuela LM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00054	16	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200873	10.1371/journal.pone.0200873	http://dx.doi.org/10.1371/journal.pone.0200873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048466	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400024
J	Daniels, B; Girosi, F; Tervonen, H; Kiely, BE; Lord, SJ; Houssami, N; Pearson, SA				Daniels, Benjamin; Girosi, Federico; Tervonen, Hanna; Kiely, Belinda E.; Lord, Sarah J.; Houssami, Nehmat; Pearson, Sallie-Anne			Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)	PLOS ONE			English	Article							TRASTUZUMAB PLUS TAXANE; PHASE-III; SURVIVAL ANALYSIS; PROGRESSION; LAPATINIB; WOMEN; CHEMOTHERAPY; PERTUZUMAB; EMTANSINE; THERAPY	Background Targeted cancer therapy is often complex, involving multiple agents and chemotherapeutic partners. In Australia, prescribing restrictions are put in place to reflect existing evidence of cost-effectiveness of these medicines. As therapeutic options continue to expand, these restrictions may not be perceived to align with best practice and it is not known if their use in the real-world clinic adheres to these restrictions. We examined the treatment of women receiving trastuzumab for HER2-positive metastatic breast cancer (HER2+MBC) to determine the extent to which treatment adhered to national prescribing restrictions. Patients and methods Our population-based, retrospective cohort study used dispensing records for every Australian woman initiating publicly-subsidised trastuzumab for HER2+MBC between 2001-2013, followed through 2016. We used group-based trajectory models (GBTMs) to cluster patients, first on their patterns of trastuzumab exposure, and then on their patterns of lapatinib and chemotherapy exposure. We described the characteristics of patients within each cluster, and examined their treatments and combinations of treatments to determine restriction adherence. Results Of 5,052 patients initiating trastuzumab, 1,795 (36%) received at least one non-adherent HER2-targeted treatment. The most common non-adherent treatments were trastuzumab combinations involving vinorelbine (24% of non-adherent treatments); capecitabine (24%); and anthracyclines (10%). Non-adherent lapatinib use was observed in 4% of patients. GBTM identified three trastuzumab exposure clusters, each containing three further subclusters. The largest proportions of non-adherent treatments were in sub-clusters with longer trastuzumab exposure and more non-taxane chemotherapy. Patients in these sub-clusters were younger than those in sub-clusters with less non-adherent treatment. Conclusions Our study highlights that, even during the relatively simpler treatment era of our study period, a substantial amount of treatment did not adhere to prescribing restrictions. As more trials are conducted exploring pertuzumab and T-DM1 in combination with different chemotherapies and other HER2-targeted therapies, the regulation and funding of HER2-targeted treatment will become more challenging.	[Daniels, Benjamin; Tervonen, Hanna; Pearson, Sallie-Anne] UNSW, Ctr Big Data Res Hlth, Med Policy Res Unit, Sydney, NSW, Australia; [Girosi, Federico] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia; [Girosi, Federico] Capital Markets CRC, Sydney, NSW, Australia; [Kiely, Belinda E.; Lord, Sarah J.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Lord, Sarah J.] Univ Sydney, Sch Med, Univ Notre Dame Australia, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Houssami, Nehmat] Univ Sydney, Sydney Sch Publ Hlth, Sydney Med Sch, Sydney, NSW, Australia	University of New South Wales Sydney; Western Sydney University; University of Sydney; University of Notre Dame Australia; University of Sydney; University of Sydney	Daniels, B (corresponding author), UNSW, Ctr Big Data Res Hlth, Med Policy Res Unit, Sydney, NSW, Australia.	b.daniels@unsw.edu.au	Houssami, Nehmat/ABC-1103-2020; Lord, Sally/GZM-7796-2022; Tervonen (nee Uosukainen), Hanna/B-9833-2015	Houssami, Nehmat/0000-0002-3641-952X; Lord, Sally/0000-0003-2763-5949; Girosi, Federico/0000-0003-3937-2285; Daniels, Benjamin/0000-0001-8617-6055; Tervonen (nee Uosukainen), Hanna/0000-0002-1211-9709	Cancer Australia Priority Driven Collaborative Support Scheme [1050648]; NHMRC Centre of Research Excellence in Medicines and Ageing (CREMA) [1060407]; NHMRC [1094325]; Sydney Catalyst Translational Cancer Research Centre; CREMA; National Breast Cancer Foundation (Australia) Breast Cancer Research Leadership Fellowship	Cancer Australia Priority Driven Collaborative Support Scheme; NHMRC Centre of Research Excellence in Medicines and Ageing (CREMA)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sydney Catalyst Translational Cancer Research Centre; CREMA; National Breast Cancer Foundation (Australia) Breast Cancer Research Leadership Fellowship	This work was supported by a Cancer Australia Priority Driven Collaborative Support Scheme (ID: 1050648) and the NHMRC Centre of Research Excellence in Medicines and Ageing (CREMA; ID: 1060407). BD is supported by an NHMRC Postgraduate Research Scholarship (ID: 1094325), the Sydney Catalyst Translational Cancer Research Centre (no grant number), and a CREMA PhD scholarship top-up (no grant number). NH receives funding through a National Breast Cancer Foundation (Australia) Breast Cancer Research Leadership Fellowship (no grant number). FG is affiliated with the Capital Markets Cooperative Research Centre, Ltd. The listed funders provided support in the form of salary for NH and FG; and postgraduate research support for BD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of NH, FG, and BD are articulated in the 'author contributions' section.	[Anonymous], R LANG ENV STAT COMP; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Bostock M, 2018, SUNBURSTR HTMLWIDGE; Burstein HJ, 2007, CANCER-AM CANCER SOC, V110, P965, DOI 10.1002/cncr.22885; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Cardoso F, 2017, ANN ONCOL; Chen T, 2011, CANCER TREAT REV, V37, P312, DOI 10.1016/j.ctrv.2010.09.001; Daniels B, 2018, BREAST, V38, P7, DOI 10.1016/j.breast.2017.11.007; Daniels B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014439; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Gradishar WJ, 2012, NEW ENGL J MED, V366, P176, DOI 10.1056/NEJMe1113641; Haviland AM, 2011, SOCIOL METHOD RES, V40, P367, DOI 10.1177/0049124111400041; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Joshi V, 2017, ASIA-PAC J CLIN ONCO, V13, pE246, DOI 10.1111/ajco.12602; Masoud V, 2017, WORLD J CLIN ONCOL, V8, P120, DOI 10.5306/wjco.v8.i2.120; Mellish Leigh, 2015, BMC Res Notes, V8, P634, DOI 10.1186/s13104-015-1616-8; Nagin DS, STAT METHODS MED RES; Pearson SA, 2007, J CLIN ONCOL, V25, P3688, DOI 10.1200/JCO.2007.11.2516; Perez EA, 2017, J CLIN ONCOL, V35, P141, DOI 10.1200/JCO.2016.67.4887; Pharmaceutical Benefits Advisory Committee, 2014, PUBL SUMM DOC NOV 20; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Santoro A, 2010, ANN ONCOL, V21, P2131, DOI 10.1093/annonc/mdq410; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; von Minckwitz G, 2011, EUR J CANCER, V47, P2273, DOI 10.1016/j.ejca.2011.06.021; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	28	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0198152	10.1371/journal.pone.0198152	http://dx.doi.org/10.1371/journal.pone.0198152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048453	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400002
J	Garon, M; Lavallee, MM; Estay, EV; Beauchamp, MH				Garon, Mathieu; Maxime Lavallee, Marie; Vera Estay, Evelyn; Beauchamp, Miriam H.			Visual encoding of social cues predicts sociomoral reasoning	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MORAL DEVELOPMENT; EMPATHY; DESIRABILITY; COGNITION; AGGRESSION; JUDGMENT; VALIDITY; BEHAVIOR; EYE	As the first step of social information processing, visual encoding underlies the interpretation of social cues. Faces, in particular, convey a large amount of affective information, which can be subsequently used in the planning and production of adaptive social behaviors. Sociomoral reasoning is a specific social skill that is associated with engagement in appropriate social behaviors when faced with dilemmas. Previous studies using eye tracking suggest that visual encoding may play an important role in decision-making when individuals are faced with extreme moral dilemmas, but it is not known if this is generalizable to everyday situations. The main objective of this study was to assess the contribution of visual encoding to everyday sociomoral reasoning using eye tracking and ecological visual dilemmas. Participants completed the SocioMoral Reasoning Aptitude Level (SoMoral) task while their eye movements and pupil dilation were recorded. While visual encoding was not a predictor of sociomoral decision-making, sociomoral maturity was predicted by fixation count. Thus, in an ecological context, visual encoding of social cues appears to be associated with sociomoral maturity: the production of a justification is associated with volitional encoding strategies. Implications with regards to the dual-process theory of sociomoral reasoning and social information processing are discussed.	[Garon, Mathieu; Maxime Lavallee, Marie; Vera Estay, Evelyn; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Vera Estay, Evelyn] Pontificia Univ Catolica Chile, Ctr Desarrollo Tecnol Inclus, Escuela Psicol, Macul, Chile; [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Pontificia Universidad Catolica de Chile; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Beauchamp, MH (corresponding author), St Justine Hosp Res Ctr, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca		Garon, Mathieu/0000-0003-1143-8668	National Science and Engineering Research Council of Canada [386527]; National Science and Engineering Research Council of Canada graduate scholarship	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council of Canada graduate scholarship	This study was made possible through a National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) grant (#386527) awarded to M.H.B. and through a National Science and Engineering Research Council of Canada graduate scholarship for doctoral studies awarded to M.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2017, CURR DIR PSYCHOL SCI, V26, P282, DOI 10.1177/0963721417694656; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Arsenio WF, 2010, J ABNORM CHILD PSYCH, V38, P627, DOI 10.1007/s10802-010-9408-z; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barger B, 2013, J MORAL EDUC, V42, P443, DOI 10.1080/03057240.2013.809517; BASINGER KS, 1987, PSYCHOL REP, V61, P139, DOI 10.2466/pr0.1987.61.1.139; Bauman CW, 2014, SOC PERSONAL PSYCHOL, V8, P536, DOI 10.1111/spc3.12131; Bauminger N, 2005, J LEARN DISABIL-US, V38, P45, DOI 10.1177/00222194050380010401; Beauchamp M, 2012, ADM CODING MANUAL SO; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Birmingham E., 2012, COGNITIVE NEUROSCIEN, P251, DOI DOI 10.1093/ACPROF:OSO/9780195315455.003.0010; Blair R.J.R., 2008, INT J DEV SCI, V2, P303, DOI DOI 10.3233/DEV-2008-2308; Blake BF, 2006, PERS INDIV DIFFER, V40, P1625, DOI 10.1016/j.paid.2005.12.007; BLOOM L, 1959, J Genet Psychol, V95, P3; Bruers S, 2014, PHILOSOPHIA, V42, P251, DOI 10.1007/s11406-013-9507-5; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; CHRISTOPHER FS, 1993, J MARRIAGE FAM, V55, P469, DOI 10.2307/352816; Cottone J, 2007, J SCI STUD RELIG, V46, P37, DOI 10.1111/j.1468-5906.2007.00339.x; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crispo M, 2017, TROLLEYOLOGIE UTILIT; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Davis M. H, 1980, MULTIDIMENSIONAL APP; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Edmonds D., 2013, WOULD YOU KILL FAT M; Ehmke C., 2007, IDENTIFYING WEB USAB, P119, DOI [10.5555/1531294.1531311, DOI 10.5555/1531294.1531311]; Einhauser W, 2010, FRONTIERS HUMAN NEUR, V4; ELM DR, 1994, J BUS ETHICS, V13, P341, DOI 10.1007/BF00871762; FeldmanHall O, 2012, COGNITION, V123, P434, DOI 10.1016/j.cognition.2012.02.001; Fiedler S, 2015, CURR OPIN PSYCHOL, V6, P139, DOI 10.1016/j.copsyc.2015.08.008; Francis KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164374; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Gibbs J.C, 2013, MORAL DEV REALITY TH; GIBBS JC, 1982, CHILD DEV, V53, P895, DOI 10.2307/1129126; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060418; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Greenwood JD, 2011, J THEOR SOC BEHAV, V41, P333, DOI 10.1111/j.1468-5914.2011.00472.x; Gu J, 2013, J EXP PSYCHOL GEN, V142, P307, DOI 10.1037/a0029549; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2008, SOCIAL INTUITIONISTS; Holmqvist K, COMMON PREDICTORS AC; Horsley TA, 2010, J ABNORM CHILD PSYCH, V38, P587, DOI 10.1007/s10802-009-9361-x; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Kahneman D, 2005, RES PER NEUROSCI, P91, DOI 10.1007/3-540-29803-7_8; Kastner Rebecca M, 2010, CHRESTOMATHY ANN REV, V9, P114; KOHLBERG L, 1973, GERONTOLOGIST, V13, P497, DOI 10.1093/geront/13.4.497; Kohlberg L, 1981, PHILOS MORAL DEV MOR, V1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langdon PE, 2011, AJIDD-AM J INTELLECT, V116, P438, DOI 10.1352/1944-7558-116.6.438; Latif DA, 2000, J BUS ETHICS, V25, P255, DOI 10.1023/A:1006049605298; Lawson C, 2010, WORLD POLIT, V62, P561, DOI 10.1017/S0043887110000195; LEE M, 1988, J ABNORM CHILD PSYCH, V16, P127, DOI 10.1007/BF00913589; Li JL, 2013, AGGRESS VIOLENT BEH, V18, P357, DOI 10.1016/j.avb.2013.01.001; Loas G, 1995, LENCEPHALE REV PSYCH; Maestripieri D., 2017, BEHAV BRAIN SCI, V40; Malti T, 2013, CHILD DEV, V84, P397, DOI 10.1111/j.1467-8624.2012.01851.x; McCoy M, 2016, ENCY EVOLUTIONARY PS, P1; Narvaez D, 2001, J MORAL EDUC, V30, P43, DOI 10.1080/03057240120033802; Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561; Olsen A., 2012, TOBII VT FIXATION FI; Parnamets P, 2008, THESIS; Parnamets P, 2015, P NATL ACAD SCI USA, V112, P4170, DOI 10.1073/pnas.1415250112; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; Patil I, 2014, SOC NEUROSCI-UK, V9, P94, DOI 10.1080/17470919.2013.870091; Piaget J., 1932, JUGEMENT MORAL CHEZ; Porter S, 2010, PSYCHOL CRIME LAW, V16, P477, DOI 10.1080/10683160902926141; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rest J., 1986, ADV RES THEOR; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Saunders L.F., 2009, 2 MINDS DUAL PROCESS, P335, DOI DOI 10.1093/ACPROF:OSO/9780199230167.001.0001; Schonfeld AM, 2005, J STUD ALCOHOL, V66, P545, DOI 10.15288/jsa.2005.66.545; Skulmowski A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00426; Sneddon A, 2007, PHILOS PSYCHOL, V20, P731, DOI 10.1080/09515080701694110; Spraggins EF, 1987, EMPATHY CLIN DIETITI; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Teper R, 2015, PERS SOC PSYCHOL B, V41, P887, DOI 10.1177/0146167215583848; Teper R, 2011, PSYCHOL SCI, V22, P553, DOI 10.1177/0956797611402513; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Vera-Estay E, 2015, J MORAL EDUC, V44, P17, DOI 10.1080/03057240.2014.986077; Vera-Estay E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00227; Wechsler D, 1999, MANUAL WECHSLER ABBR; Witteman, 2009, FDN TRACING INTUITIO, P32; Zarinpoush F, 2000, J MORAL EDUC, V29, P397, DOI 10.1080/713679391	92	4	5	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201099	10.1371/journal.pone.0201099	http://dx.doi.org/10.1371/journal.pone.0201099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044875	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500079
J	Yang, X; Yu, XZ; Wei, YZ				Yang, Xi; Yu, Xianzhong; Wei, Yanzhang			Lentiviral delivery of novel fusion protein IL12/FasTI for cancer immune/gene therapy	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATORY ELEMENT; EXPRESSION; APOPTOSIS; VECTORS; CELLS; GENE	Many of the cytokine-based cancer immunotherapies are hindered by the devastating side effects of systemic delivery of the cytokines. To address this problem, we previously described a novel approach to locally achieve high doses of interleukin-12 (IL-12) in tumors and demonstrated that bi-functional fusion protein mIL-12/FasTI expressed by stable clones of TC-1 cells efficiently suppressed tumor proliferation by activating natural killer (NK) cells and other cytolytic killer cells and sending apoptotic signals into tumor cells. In the present study, we employed a lentiviral vector-based gene delivery system to deliver this fusion construct directly into tumor cells. We show that lentiviral vector efficiently delivers the fusion constructs into Hela cells in vitro as assayed by RT-PCR and immunohistochemistry (IHC). We also confirm that fusion protein mIL-12/FasTI delivered by the viral vector significantly enhanced killer cell activation, increased caspase-3 activity and decreased tumor growth in vitro. This study offers a further step for fusion protein cancer therapy for cancer patients.	[Yang, Xi; Yu, Xianzhong; Wei, Yanzhang] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	Wei, YZ (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ywei@clemson.edu		Yang, Xi/0000-0002-0908-8884				Dias S, 1998, INT J CANCER, V78, P361, DOI 10.1002/(SICI)1097-0215(19981029)78:3<361::AID-IJC17>3.0.CO;2-9; Lamboley C, 2002, J HEPATOL, V36, P385, DOI 10.1016/S0168-8278(01)00284-7; Lavrik IN, CELL DEATH DIFFER; Ngai SC, 2012, GENE, V498, P231, DOI 10.1016/j.gene.2012.01.071; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rubin B, 2008, CANC IMMUN, V8; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sotiriadou NN, 2005, CELL IMMUNOL, V234, P67, DOI 10.1016/j.cellimm.2005.05.002; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Yang X, 2016, INT J ONCOL, V48, P2381, DOI 10.3892/ijo.2016.3475; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	14	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201100	10.1371/journal.pone.0201100	http://dx.doi.org/10.1371/journal.pone.0201100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044833	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500080
J	Armstrong, E; Iriarte, A; Nicolini, P; De Los Santos, J; Ithurralde, J; Bielli, A; Bianchi, G; Penagaricano, F				Armstrong, Eileen; Iriarte, Andres; Nicolini, Paula; De Los Santos, Jorge; Ithurralde, Javier; Bielli, Alejandro; Bianchi, Gianni; Penagaricano, Francisco			Comparison of transcriptomic landscapes of different lamb muscles using RNA-Seq	PLOS ONE			English	Article							EXPRESSION ANALYSIS; SKELETAL-MUSCLE; PROTEIN; QUALITY; CELLS; IDENTIFICATION; ISOFORM; KINASE; FAMILY; GENES	Transcriptome deep sequencing is a powerful tool for exploring the genetic architecture of complex traits. Gene expression patterns may explain a high degree of the observed phenotypic differences in histochemical and metabolic parameters related to meat quality among different muscles. In this study, we sequenced by RNA-Seq the whole transcriptome of nine lamb muscles: Semimembranosus (SM), Semitendinosus (ST), Cranial gluteobiceps, Gluteus medius (GM), Rectus femoris, Supraspinatus (SS), Longissimus lumborum (LL), Adductor and Psoas major. Significant gene expression differences were detected between almost all pairwise comparisons, being more pronounced between SS and ST, SM and LL, and ST and GM. These differences can be explained in terms of ATPase and glycolytic activities, muscle fiber typing and oxidative score, clustering muscles as fast glycolytic, intermediate or slow oxidative. ST showed up-regulation of gene pathways related to carbohydrate metabolism, energy generation and protein turnover as expected from a fast white muscle. SS showed myosin isoforms typical of slow muscles and high expression of genes related to calcium homeostasis and vascularization. SM, LL and GM showed in general intermediate gene expression patterns. Several novel transcripts were detected, mostly related to muscle contraction and structure, oxidative metabolism, lipid metabolism and protein phosphorylation. Expression profiles were consistent with previous histochemical and metabolic characterization of these muscles. Up-regulation of ion transport genes may account for significant differences in water holding capacity. High expression of genes related to cell adhesion, cytoskeleton organization, extracellular matrix components and protein phosphorylation may be related to meat yellowness and lower tenderness scores. Differential expression of genes related to glycolytic activity and lactic acid generation among fast, intermediate and slow muscles may explain the detected final meat pH differences. These results reveal new candidate genes associated with lamb meat quality, and give a deeper insight into the genetic architecture of these complex traits.	[Armstrong, Eileen] Univ Republica, Fac Vet, Dept Genet & Mejora Anim, Montevideo, Uruguay; [Iriarte, Andres] Univ Republica, Fac Med, Inst Higiene, Dept Desarrollo Biotecnol, Montevideo, Uruguay; [Nicolini, Paula] Univ Republ, Ctr Univ Tacuarembo, Polo Desarrollo Univ Inst Super Carne, Tacuarembo, Uruguay; [De Los Santos, Jorge] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Ithurralde, Javier; Bielli, Alejandro] Univ Republica, Fac Vet, Dept Morfol & Desarrollo, Montevideo, Uruguay; [Penagaricano, Francisco] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Penagaricano, Francisco] Univ Florida, Genet Inst, Gainesville, FL USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Wisconsin System; University of Wisconsin Madison; Universidad de la Republica, Uruguay; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Armstrong, E (corresponding author), Univ Republica, Fac Vet, Dept Genet & Mejora Anim, Montevideo, Uruguay.	eileen.armstrong@gmail.com	Peñagaricano, Francisco/C-8083-2015	Peñagaricano, Francisco/0000-0001-6661-3991; Iriarte, Andres/0000-0002-5862-0152; Armstrong, Eileen/0000-0002-1769-1368	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay) [I+D 679]	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay)	Funding source: Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay). ID of the project: I+D 679 (year 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; BRIAND M, 1981, EUR J APPL PHYSIOL, V46, P347, DOI 10.1007/BF00422122; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen CC, 2011, CLIN IMMUNOL, V140, P268, DOI 10.1016/j.clim.2011.04.007; Chen LJ, 2016, J SCI FOOD AGR, V96, P1474, DOI 10.1002/jsfa.7244; CORNFORTH DP, 1980, MEAT SCI, V4, P103, DOI 10.1016/0309-1740(80)90036-4; Coumailleau P, 2009, INT J DEV BIOL, V53, P149, DOI 10.1387/ijdb.082659pc; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Damon M, 2013, MEAT SCI, V95, P744, DOI 10.1016/j.meatsci.2013.01.016; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Hnia K, 2015, CELL TISSUE RES, V360, P591, DOI 10.1007/s00441-014-2016-4; Hocquette JF, 2012, MEAT SCI, V92, P197, DOI 10.1016/j.meatsci.2012.04.007; Hsieh CM, 1996, J BIOL CHEM, V271, P17354, DOI 10.1074/jbc.271.29.17354; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huff-Lonergan E, 2005, MEAT SCI, V71, P194, DOI 10.1016/j.meatsci.2005.04.022; Ithurralde J, 2018, ANIM PROD SCI, V58, P1358, DOI 10.1071/AN16013; Ithurralde J, 2015, SMALL RUMINANT RES, V125, P88, DOI 10.1016/j.smallrumres.2015.02.006; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knight MI, 2014, MEAT SCI, V96, P1025, DOI 10.1016/j.meatsci.2013.07.008; Kotaka M, 2000, J CELL BIOCHEM, V78, P558, DOI 10.1002/1097-4644(20000915)78:4<558::AID-JCB5>3.0.CO;2-I; Krick S, 2001, AM J PHYSIOL-CELL PH, V280, pC970, DOI 10.1152/ajpcell.2001.280.4.C970; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Lei R, 2015, GENE, V557, P82, DOI 10.1016/j.gene.2014.12.013; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Penagaricano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072302; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Raz V, 2018, FASEB J, V32, P1579, DOI 10.1096/fj.201700861R; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez EJ, 2011, MOL CELL BIOCHEM, V353, P195, DOI 10.1007/s11010-011-0787-4; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sevane N, 2014, MOL BIOL REP, V41, P4721, DOI 10.1007/s11033-014-3343-y; Sun LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33586; Tao YX, 2003, J NEUROSCI, V23, P6703; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troxler H, 1999, ANAL BIOCHEM, V268, P64, DOI 10.1006/abio.1998.3015; Tschirhart-Hoelscher TE, 2006, MEAT SCI, V73, P48, DOI 10.1016/j.meatsci.2005.10.015; Vorachek WR, 2013, INT J MOL SCI, V14, P11484, DOI 10.3390/ijms140611484; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117327	65	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200732	10.1371/journal.pone.0200732	http://dx.doi.org/10.1371/journal.pone.0200732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040835	Green Published, Green Submitted, gold			2022-12-27	WOS:000439749200009
J	Lu, W; Gu, JY; Zhang, YY; Gong, DJ; Zhu, YM; Sun, Y				Lu, Wei; Gu, Jian-yu; Zhang, Yao-yao; Gong, Dan-jun; Zhu, Yi-ming; Sun, Ying			Tolerance induced by Porphyromonas gingivalis may occur independently of TLR2 and TLR4	PLOS ONE			English	Article							ENDOTOXIN TOLERANCE; PERIODONTAL HEALTH; SIGNALING PATHWAY; CELLS; LIPOPOLYSACCHARIDE; MACROPHAGES; INDUCTION; ASSOCIATION; EXPRESSION; COMPONENTS	Objective Periodontitis is a microbe-induced chronic inflammatory disease. Previous exposure of the host to bacteria or their virulence factors leads to refractory responses to further stimuli, which is called tolerance. Porphyromonas gingivalis (P. gingivalis) is one of the most important pathogenic microorganisms associated with periodontitis, and is a potent inducer of pro-and anti-inflammatory cytokines. The aim of this study was to explore the roles and possible mechanisms of tolerance induced by P. gingivalis. Methods THP-1-derived macrophages were pretreated with 1x10(8) colony-forming units/ml P. gingivalis ATCC 33277 or 21 clinical isolates from moderate to severe chronic periodontitis patients (24 h), washed (2 h) and treated with P. gingivalis ATCC 33277 or the same clinical isolates again (24 h). Levels of pro-inflammatory cytokines TNF-alpha and IL-1 beta and anti-inflammatory cytokine IL-10 in supernatants were detected by ELISA. Moreover, to identify the possible mechanisms for the changes in cytokine secretion, Toll-like receptor 2 (TLR2) and TLR4 protein expressions were explored in these cells by flow cytometry. Results After repeated challenge with P. gingivalis ATCC 33277 or clinical isolates, production of TNF-a and IL-1 beta in macrophages was decreased significantly compared with that following a single stimulation (p<0.05), while only comparable levels of IL-10 were detected in P. gingivalis ATCC 33277 or clinical isolate-tolerized cells (p>0.05). In addition, there was interstrain variability in the ability to induce IL-1 beta and IL-10 production after repeated P. gingivalis stimulation. However, no significant changes in TLR2 or TLR4 were detected in macrophages that were repeatedly treated with P. gingivalis ATCC 33277 or clinical isolates compared with those stimulated with P. gingivalis only once (p>0.05). Conclusions Repeated P. gingivalis stimulation triggered tolerance, which might contribute to limiting periodontal inflammation. However, tolerance induced by P. gingivalis might develop independently of TLR2 and TLR4 and be related to molecules in signaling pathways downstream of TLR2 and TLR4.	[Lu, Wei; Gu, Jian-yu; Zhang, Yao-yao; Gong, Dan-jun; Zhu, Yi-ming; Sun, Ying] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Lu, Wei; Gu, Jian-yu; Zhang, Yao-yao; Gong, Dan-jun; Zhu, Yi-ming; Sun, Ying] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China; [Gong, Dan-jun] Suzhou Hosp, Dept Stomatol, Suzhou, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, Y (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Sun, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China.	ebolasun@njmu.edu.cn	Zhang, Yaoyao/GWD-0693-2022	Sun, Ying/0000-0003-3996-9946	National Natural Science Foundation of China [81771075]; Natural Science Foundation of Jiangsu Province [BK20161565]; Science and Technology Development Fund of Nanjing Medical University [2016NJMU052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science and Technology Development Fund of Nanjing Medical University	Grant 81771075 (http://www.nsfc.gov.cn/) from National Natural Science Foundation of China and Grant BK20161565 (http://kxjst.jiangsu.gov.cn/) from Natural Science Foundation of Jiangsu Province were received by YS. Grant 2016NJMU052 (http://www.njmu.edu.cn/) from Science and Technology Development Fund of Nanjing Medical University was received by WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhogail S, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2677-x; Baek KJ, 2015, VIRULENCE, V6, P274, DOI 10.1080/21505594.2014.1000764; Cecil JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151967; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Eick S, 2006, ORAL MICROBIOL IMMUN, V21, P231, DOI 10.1111/j.1399-302X.2006.00282.x; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Fontaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100909; Gamboa Fredy, 2014, Acta odontol. latinoam., V27, P137, DOI 10.1590/S1852-48342014000300007; Goncalves PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085066; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Gunther J, 2017, INNATE IMMUN-LONDON, V23, P155, DOI 10.1177/1753425916681076; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Herrmann JM, 2015, PERIODONTOL 2000, V69, P111, DOI 10.1111/prd.12088; Holcombe SJ, 2016, VET IMMUNOL IMMUNOP, V173, P10, DOI 10.1016/j.vetimm.2016.03.016; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; How KY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00053; Ji S, 2015, J PERIODONTAL RES, V50, P570, DOI 10.1111/jre.12248; Kim HJ, 2018, J PERIODONTAL IMPLAN, V48, P60, DOI 10.5051/jpis.2018.48.1.60; Kristoffersen AK, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.29124; [李云鹏 Li Yunpeng], 2012, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V32, P64; Madianos PN, 1997, J PERIODONTAL RES, V32, P120; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Moreno S, 2015, COLOMB MEDICA, V46, P122; Murphy MB, 2015, J LEUKOCYTE BIOL, V98, P963, DOI 10.1189/jlb.2VMA0515-229RR; Palaska I, 2016, J BIOL REG HOMEOS AG, V30, P655; Rafiei Mohammad, 2017, Med J Islam Repub Iran, V31, P62, DOI 10.18869/mjiri.31.62; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Savidge TC, 2006, PEDIATR RES, V59, P89, DOI 10.1203/01.pdr.0000195101.74184.e3; Siqueira JF, 2004, J ENDODONT, V30, P638, DOI 10.1097/01.DON.0000125875.88377.85; Stobernack T, 2016, J PROTEOME RES, V15, P4532, DOI 10.1021/acs.jproteome.6b00634; Su H, 2015, EUR REV MED PHARMACO, V19, P2482; Sun Y, 2014, INFLAMMATION, V37, P268, DOI 10.1007/s10753-013-9737-5; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039224; VANWINKELHOFF AJ, 1993, ORAL MICROBIOL IMMUN, V8, P259; Wu X, 2015, ARCH ORAL BIOL, V60, P463, DOI 10.1016/j.archoralbio.2014.10.005; Xiong YB, 2013, J LEUKOCYTE BIOL, V94, P291, DOI 10.1189/jlb.0812401; Yasaki-Inagaki Y, 2006, FEMS IMMUNOL MED MIC, V47, P287, DOI 10.1111/j.1574-695X.2006.00091.x; Zaric SS, 2011, J BIOL CHEM, V286, P29492, DOI 10.1074/jbc.M111.252791; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2006, INFECT IMMUN, V74, P1204, DOI 10.1128/IAI.74.2.1204-1214.2006; Zhu MF, 2010, INFLAMM RES, V59, P855, DOI 10.1007/s00011-010-0197-1	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200946	10.1371/journal.pone.0200946	http://dx.doi.org/10.1371/journal.pone.0200946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040860	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200019
J	Saevarsson, E; Svansdottir, E; Arngrimsson, S; Sveinsson, T; Johannsson, E				Saevarsson, Elvar; Svansdottir, Erla; Arngrimsson, Sigurbjorn; Sveinsson, Thorarinn; Johannsson, Erlingur			Different cardiorespiratory fitness expressions based on the maximal cycle ergometer test show no effect on the relation of cardiorespiratory fitness to the academic achievement of nine-year-olds	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AEROBIC FITNESS; SOCIOECONOMIC-STATUS; BODY-COMPOSITION; PERFORMANCE; CHILDREN; HEALTH; EXERCISE; MOTOR; ASSOCIATIONS	The relationship between cardiorespiratory fitness and academic achievement has been inconclusive. The results may depend on how cardiorespiratory fitness is expressed. The aim of this study is to explore the impact of different cardiorespiratory fitness expression methods, measured by the maximal cycle ergometer test, on the relationship between cardiorespiratory fitness and academic achievement. A cross-sectional study consisting of 303 Icelandic 4th grade students (163 girls) was conducted. Cardiorespiratory fitness was assessed using a graded maximal cycle ergometer test and scores of standardized tests in Icelandic and math obtained from the Icelandic National Examination Institute. Cardiorespiratory fitness was measured as absolute power output in watts in a maximal progressive cycle ergometer test. To adjust for different body sizes, the power output was scaled to body weight, body height, body surface area, and allometrically expressed body weight. In addition, linear regression scaling was also used to adjust for different body sizes. No significant relationship was found between any of the cardiorespiratory fitness expressions and academic achievement, using both univariate and multivariate linear regression analyses. The use of different methods to express cardiorespiratory fitness does not significantly affect the association with the academic achievement of fourth grade students.	[Saevarsson, Elvar; Svansdottir, Erla; Arngrimsson, Sigurbjorn; Johannsson, Erlingur] Univ Iceland, Sch Educ, Reykjavik, Iceland; [Sveinsson, Thorarinn] Univ Iceland, Res Ctr Movements Sci, Reykjavik, Iceland; [Johannsson, Erlingur] Western Norway Univ Appl Sci, Dept Sport & Phys Act, Bergen, Norway	University of Iceland; University of Iceland; Western Norway University of Applied Sciences	Johannsson, E (corresponding author), Univ Iceland, Sch Educ, Reykjavik, Iceland.; Johannsson, E (corresponding author), Western Norway Univ Appl Sci, Dept Sport & Phys Act, Bergen, Norway.	erljo@hi.is	Sveinsson, Thorarinn/F-7554-2010	Sveinsson, Thorarinn/0000-0001-8989-5514; Svansdottir, Erla/0000-0001-6783-3195	Icelandic Centre for Research (RANNIS)	Icelandic Centre for Research (RANNIS)	The Icelandic Centre for Research (RANNIS) funded this study, along with the Ministry of Education, Science and Culture, and The Icelandic Primary Health Care Research Fund. The authors have no conflicts of interest.	ARMSTRONG N, 1995, ANN HUM BIOL, V22, P427, DOI 10.1080/03014469500004102; Armstrong N, 2011, BRIT J SPORT MED, V45, P849, DOI 10.1136/bjsports-2011-090200; Armstrong N, 2011, MED SPORT SCI, V56, P59, DOI 10.1159/000320633; Bass RW, 2013, ACTA PAEDIATR, V102, P832, DOI 10.1111/apa.12278; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Coe DP, 2013, J SCHOOL HEALTH, V83, P500, DOI 10.1111/josh.12058; Dencker M, 2012, J SCI MED SPORT, V15, pS161; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Dwyer T, 2001, PEDIATR EXERC SCI, V13, P225, DOI 10.1123/pes.13.3.225; Haapala EA, 2014, MED SCI SPORT EXER, V46, P1016, DOI 10.1249/MSS.0000000000000186; Haapala EA, 2013, J HUM KINET, V36, P55, DOI 10.2478/hukin-2013-0006; HANSEN HS, 1989, EUR J APPL PHYSIOL, V58, P618, DOI 10.1007/BF00418508; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P361, DOI 10.5717/jenb.2014.18.4.361; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; Kantomaaa MT, 2013, P NATL ACAD SCI USA, V110, P1917, DOI 10.1073/pnas.1214574110; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; KRAMER RA, 1995, AM J PUBLIC HEALTH, V85, P312, DOI 10.2105/AJPH.85.3.312; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Magnusson KT, 2012, HEALTH EDUC RES, V27, P484, DOI 10.1093/her/cys049; McMurray RG, 2011, ANN HUM BIOL, V38, P647, DOI 10.3109/03014460.2011.598561; Moore SA, 2015, MED SCI SPORT EXER, V47, P1755, DOI 10.1249/MSS.0000000000000588; Rauner RR, 2013, J PEDIATR-US, V163, P344, DOI 10.1016/j.jpeds.2013.01.006; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Rowland TW, 2005, CHILDRENSS EXERCISE; Saevarsson ES, 2016, ANN HUM BIOL, V43, P229, DOI 10.3109/03014460.2015.1042522; Sardinha LB, 2016, MED SCI SPORT EXER, V48, P839, DOI 10.1249/MSS.0000000000000830; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Skulason S, 2008, SKYRSLA SAMRAEMD PRO; Skulason S, 2004, SKYRSLA SAMRAEMD PRO; Sveinsson T, 2009, EUR J SPORT SCI, V9, P141, DOI 10.1080/17461390802638149; Tomkinson G.R., 2008, PAEDIAT EXERCISE SCI, P109, DOI [10.1093/med/9780199232482.003.0009, DOI 10.1093/MED/9780199232482.003.0009]; TOTH MJ, 1993, J APPL PHYSIOL, V75, P2288, DOI 10.1152/jappl.1993.75.5.2288; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Welk GJ, 2010, RES Q EXERCISE SPORT, V81, pS6, DOI 10.1080/02701367.2010.10599689; Welsman JR, 2000, PEDIATR EXERC SCI, V12, P112, DOI 10.1123/pes.12.2.112	38	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200643	10.1371/journal.pone.0200643	http://dx.doi.org/10.1371/journal.pone.0200643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036375	gold, Green Published, Green Submitted			2022-12-27	WOS:000439429200013
J	Paolini, KE; Strickland, BK; Tegt, JL; VerCauteren, KC; Street, GM				Paolini, Kelsey E.; Strickland, Bronson K.; Tegt, Jessica L.; VerCauteren, Kurt C.; Street, Garrett M.			Seasonal variation in preference dictates space use in an invasive generalist	PLOS ONE			English	Article							BOAR SUS-SCROFA; WILD BOAR; FUNCTIONAL-RESPONSES; RESOURCE SELECTION; HABITAT SELECTION; PLANT PHENOLOGY; HOME-RANGE; REGRESSION; DIET; MISSISSIPPI	Background The spatiotemporal distribution of resources is a critical component of realized animal distributions. In agricultural landscapes, space use by generalist consumers is influenced by ephemeral resource availability that may produce behavioral differences across agricultural seasons, resulting in economic and production consequences and increased human-wildlife conflict. Our objective was to assess changes in habitat selection across seasons in an invasive generalist omnivore (feral pigs, Sus scrofa). Hypothesizing that pig space use is primarily driven by forage availability, we predicted strong selection for the most nutritionally beneficial crops and resource types as agricultural seasons progressed. We deployed GPS collars on 13 adult feral pigs in the Mississippi Alluvial Valley to study resource selection in a fragmented agricultural landscape. We estimated resource selection using mixed-effect logistic regression to assess variation in selection across planting, growing, harvest, and fallow seasons. Results We found that feral pigs varied resource selection across seasons, particularly for corn (Zea mais). We also detected seasonal dependencies in proportional coverage on the net probability of selection of a land unit (e.g., selection was generally strongest for locations composed of both agricultural and natural habitat), resulting in marked variation in predicted space use among agricultural seasons. Conclusions These findings indicate behavioral changes in selection across agricultural seasons are driven by complex interactions between the availabilities of temporally dynamic resources and temporally static natural cover. Temporal variations in resource selection trends indicate seasonal responses to crop phenology which suggests a season-specific habitat functional response.	[Paolini, Kelsey E.; Strickland, Bronson K.; Tegt, Jessica L.; Street, Garrett M.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Starkville, MS 39759 USA; [VerCauteren, Kurt C.] USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA	Mississippi State University; United States Department of Agriculture (USDA)	Paolini, KE (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Starkville, MS 39759 USA.	kpaolini619@yahoo.com		Paolini, Kelsey/0000-0002-4947-2020	Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service National Wildlife Research Center [14-7428-1089CA]; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service/Wildlife Services	Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service National Wildlife Research Center; National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service/Wildlife Services	This work was supported by Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services, and the National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service National Wildlife Research Center 14-7428-1089CA. Funding was received by GMS, BKS, JLT, and KCV.r We thank C.D. Gibson and D.H. Foster for their capturing and collaring efforts in the field. We also thank those who reviewed on earlier drafts. This work was supported by Mississippi Agriculture and Forest Experiment Station, Mississippi State University Extension Services, and the National Feral Swine Damage Management Program of the United States Department of Agriculture Animal Plant Health Inspection Service/Wildlife Services.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; [Anonymous], 2016, USDA NATL AGR STAT S; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1076, DOI 10.2307/3802560; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Doorenbos J, 1979, IRRIG AGR DEV; Dupke C, 2017, ECOGRAPHY, V40, P1014, DOI 10.1111/ecog.02152; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; EASTLAND WG, 1989, J MAMMAL, V70, P824, DOI 10.2307/1381720; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A, 2007, DATA ANALYSIS USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Hanway J, 1966, SPECIAL REPORT, V38; Herrero J, 2006, EUR J WILDLIFE RES, V52, P245, DOI 10.1007/s10344-006-0045-3; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Keiter DA, 2016, WILDLIFE SOC B, V40, P384, DOI 10.1002/wsb.649; Keuling O, 2009, MAMM BIOL, V74, P145, DOI 10.1016/j.mambio.2008.05.007; Keuling O, 2008, EUR J WILDLIFE RES, V54, P403, DOI 10.1007/s10344-007-0157-4; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Manley SW, 2005, WILDLIFE SOC B, V33, P981, DOI 10.2193/0091-7648(2005)33[981:AIOWMI]2.0.CO;2; Manly B., 2002, RESOURCE SELECTION A, DOI [10.2307/5247, DOI 10.2307/5247]; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; Maul JD, 2000, AGR ECOSYST ENVIRON, V81, P171, DOI 10.1016/S0167-8809(00)00157-2; Mayer JJ, 2009, WILD PIGS BIOL DAMAG, DOI [10.1016/B978-0-08-024821-9.50009-3, DOI 10.1016/B978-0-08-024821-9.50009]; McClure ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133771; MEENTS JK, 1983, ECOLOGY, V64, P1022, DOI 10.2307/1937809; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mississippi Department of Wildlife Fisheries and Parks, 2017, WILD HOG REG MISS; Monteith KL, 2015, OECOLOGIA, V178, P1137, DOI 10.1007/s00442-015-3296-4; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Mungall EC, 2001, ECOLOGY MANAGEMENT L, p736 ; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Plard F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001828; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; R Development Core Team, 2009, R LANG ENV STAT COMP; Reinecke K.J., 1989, P203; RICE SM, 1993, J WILDLIFE MANAGE, V57, P92, DOI 10.2307/3809005; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Seward N. W., 2004, Sheep & Goat Research Journal, V19, P34; SINGER FJ, 1981, J WILDLIFE MANAGE, V45, P343, DOI 10.2307/3807917; Snow NP, 2017, J APPL ECOL, V54, P2022, DOI 10.1111/1365-2664.12866; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stanturf JA, 2001, RESTOR ECOL, V9, P189, DOI 10.1046/j.1526-100x.2001.009002189.x; Street GM, 2016, LANDSCAPE ECOL, V31, P1939, DOI 10.1007/s10980-016-0372-z; Tanger SM, 2015, J NATL ASS CTY AGR A, V8, P357; Tobajas J, 2016, EUR J WILDLIFE RES, V62, P85, DOI 10.1007/s10344-015-0976-7; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; U. S. Geological Survey, 2016, NAT HYDR DAT NHD; van Beest FM, 2010, J ANIM ECOL, V79, P910, DOI 10.1111/j.1365-2656.2010.01701.x; Xu JG, 2010, J AGR FOOD CHEM, V58, P5751, DOI 10.1021/jf100364k; Zuur Alain F., 2009, P1	67	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0199078	10.1371/journal.pone.0199078	http://dx.doi.org/10.1371/journal.pone.0199078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028855	gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900002
J	Cui, K; Wang, B; Zhang, NF; Tu, Y; Ma, T; Diao, QY				Cui, Kai; Wang, Bo; Zhang, Naifeng; Tu, Yan; Ma, Tao; Diao, Qiyu			iTRAQ-based quantitative proteomic analysis of alterations in the intestine of Hu sheep under weaning stress	PLOS ONE			English	Article							EARLY-WEANED PIGLETS; BARRIER FUNCTION; IMMUNE-SYSTEM; FEED-INTAKE; PERFORMANCE; EXPRESSION; SEPARATION; WELFARE	When Lambs are weaned off ewe's milk, metabolic, structural, and functional changes often occur in the small intestine. Because information on the effects of weaning stress on the proteome of the intestine is limited, an animal model was established with eight pairs of twin lambs divided into artificially reared and ewe-reared groups, which was followed by proteome analysis using iTRAQ technology. Changes occurred in the morphology of the intestine and 5,338 proteins in three biological replicates with less than a 1.2% false discovery rate were identified and quantified. Among them, a subset of 389 proteins were screened as significantly up- (143) and down-regulated (246) in artificially reared compared with ewe-reared. According to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, the differentially expressed proteins that were strongly downregulated were enriched in immune system processes, biological adhesion, and metabolic processes. The up-regulated proteins were enriched in gene expression, cellular biosynthetic processes, ribosome and RNA binding in response to weaning stress. A series of proteins associated with intestine morphology and immune function were identified, and levels of the mRNAs encoding these proteins were analyzed by real-time quantitative reverse transcription PCR. The results of this study increased our understanding of the response of lambs weaned off ewe's milk and helped to determine the mechanisms underlying weaning stress.	[Cui, Kai; Wang, Bo; Zhang, Naifeng; Tu, Yan; Ma, Tao; Diao, Qiyu] Chinese Acad Agr Sci, Feed Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS	Diao, QY (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Beijing, Peoples R China.	diaoqiyu@caas.cn	Ma, Tao/AAD-5514-2020; zhang, naifeng/P-8386-2014	Ma, Tao/0000-0003-4821-836X; zhang, naifeng/0000-0001-6272-7553	National Technology Program for the Meat Sheep Industry of China; Fundamental Research Funds for Central Non-profit Scientific Institution [1610382016012]	National Technology Program for the Meat Sheep Industry of China; Fundamental Research Funds for Central Non-profit Scientific Institution	The National Technology Program for the Meat Sheep Industry of China and Fundamental Research Funds for Central Non-profit Scientific Institution (1610382016012) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, P NATI ACAD SCI US, V101, P12781, DOI [10.1073/pnas.0404890101, DOI 10.1073/PNAS.0404890101]; Aw TY, 2005, TOXICOL APPL PHARM, V204, P320, DOI 10.1016/j.taap.2004.11.016; Awad WA, 2013, RES VET SCI, V95, P249, DOI 10.1016/j.rvsc.2013.02.009; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bomba L, 2014, FUNCT INTEGR GENOMIC, V14, P657, DOI 10.1007/s10142-014-0396-x; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Carroll MC, 2008, VACCINE, V26, pI28, DOI 10.1016/j.vaccine.2008.11.022; Eckersall PD, 2012, J PROTEOMICS, V75, P4187, DOI 10.1016/j.jprot.2012.05.014; Flower FC, 2001, APPL ANIM BEHAV SCI, V70, P275, DOI 10.1016/S0168-1591(00)00164-7; Gu XH, 2002, ARCH ANIM NUTR, V56, P275, DOI 10.1080/00039420214345; Hu PF, 2014, GENET MOL RES, V13, P9019, DOI 10.4238/2014.October.31.16; Johnsen JF, 2015, J DAIRY SCI, V98, P4800, DOI 10.3168/jds.2014-9128; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Meier R, 2003, CURR OPIN CLIN NUTR, V6, P563, DOI 10.1097/00075197-200309000-00010; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Napolitano F, 2008, APPL ANIM BEHAV SCI, V110, P58, DOI 10.1016/j.applanim.2007.03.020; Orgeur P, 1999, REPROD NUTR DEV, V39, P231, DOI 10.1051/rnd:19990208; Pascual-Alonso M, 2015, J APPL ANIM WELF SCI, V18, P42, DOI 10.1080/10888705.2014.941107; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; Ricklin Oikonomopoulou Katerina, 2011, INTERACTIONS COAGU L, P151, DOI [10.1007/s00281-011-0280-x, DOI 10.1007/S00281-011-0280-X]; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Spreeuwenberg MAM, 2001, J NUTR, V131, P1520, DOI 10.1093/jn/131.5.1520; Stokes CR, 2004, ANIM RES, V53, P325, DOI 10.1051/animres:2004020; Tao X, 2015, ARCH ANIM NUTR, V69, P201, DOI 10.1080/1745039X.2015.1034828; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Vente-Spreeuwenberg MAM, 2004, LIVEST PROD SCI, V86, P169, DOI 10.1016/S0301-6226(03)00166-0; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Yue GH, 1996, ANIM REPROD SCI, V44, P223, DOI 10.1016/0378-4320(96)01562-X	32	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200680	10.1371/journal.pone.0200680	http://dx.doi.org/10.1371/journal.pone.0200680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024939	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000041
J	Dobson, KL; Smith, ZH; Bellamy, TC				Dobson, Katharine L.; Smith, Zoe H.; Bellamy, Tomas C.			Distribution of vesicle pools in cerebellar parallel fibre terminals after depression of ectopic transmission	PLOS ONE			English	Article							BERGMANN GLIAL-CELLS; LONG-TERM DEPRESSION; CURRENTS; RELEASE; STIMULATION; GLUTAMATE; NEURON	At parallel fibre terminals in the cerebellar cortex, glutamate released outside of the active zone can activate AMPA receptors on juxtaposed Bergmann glial cell processes. This process is termed "ectopic" release, and allows for directed transmission to astroglial cells that is functionally independent of synaptic transmission to postsynaptic Purkinje neurons. The location of ectopic sites in presynaptic terminals is uncertain. Functional evidence suggests that stimulation of parallel fibres at 1 Hz exhausts ectopic transmission due to a failure to rapidly recycle vesicles to the ectopic pool, and so would predict a loss of vesicles in the near vicinity of extrasynaptic glial processes. In this study we used this stimulation protocol to investigate whether the distribution of vesicles within the presynaptic terminal is altered after suppression of ectopic release. Stimulation at 1 Hz had only a minor impact on the distribution of vesicles in presynaptic terminals when analysed with electron microscopy. Vesicle number and terminal size were unaffected by 1 Hz stimulation, but the relative abundance of vesicles in close proximity to the active zone was marginally reduced. In contrast, the fraction of vesicles facing glial membranes was unchanged after suppression of ectopic transmission. 1 Hz stimulation also resulted in a small but statistically-significant increase in the distance between glial membrane and presynaptic terminal, suggesting withdrawal of glial membranes from synapses is detectable in ultrastructural anatomy within minutes. These results raise doubts about the location of ectopic release sites, but indicate that neuron-glial association varies on a dynamic time scale.	[Dobson, Katharine L.; Smith, Zoe H.; Bellamy, Tomas C.] Univ Nottingham, Sch Life Sci, Med Sch, Nottingham, England; [Dobson, Katharine L.] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Midlothian, Scotland	University of Nottingham; University of Edinburgh	Dobson, KL (corresponding author), Univ Nottingham, Sch Life Sci, Med Sch, Nottingham, England.; Dobson, KL (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Midlothian, Scotland.	katharine.dobson@ed.ac.uk	Dobson, Katharine/AAG-8618-2020	Dobson, Katharine/0000-0003-4117-8684	Biotechnology and Biological Sciences Research Council [BB/J015660/1]; National Centre for the Replacement Refinement & Reduction of Animals in Research [NC/N003071/1]; BBSRC [BB/J015660/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement Refinement & Reduction of Animals in Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council, grant number BB/J015660/1 (http://www.bbsrc.ac.uk/), and by the National Centre for the Replacement Refinement & Reduction of Animals in Research, grant number NC/N003071/1 (https://www.nc3rs.org.uk/), both to TCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan S, 2011, GLIA, V59, P82, DOI 10.1002/glia.21078; Balakrishnan S, 2009, GLIA, V57, P393, DOI 10.1002/glia.20768; Bell JJL, 2010, NEURON GLIA BIOL, V6, P193, DOI 10.1017/S1740925X10000165; Bellamy TC, 2006, EUR J NEUROSCI, V23, P581, DOI 10.1111/j.1460-9568.2005.04588.x; Bellamy TC, 2005, GLIA, V52, P325, DOI 10.1002/glia.20248; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Dobson KL, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/602356; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Jung JH, 2016, P NATL ACAD SCI USA, V113, pE1098, DOI 10.1073/pnas.1523054113; Leenders AGM, 2002, NEUROSCIENCE, V109, P195, DOI 10.1016/S0306-4522(01)00450-X; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Marra V, 2014, NAT PROTOC, V9, P1337, DOI 10.1038/nprot.2014.088; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matsui K, 2006, CURR OPIN NEUROBIOL, V16, P305, DOI 10.1016/j.conb.2006.04.001; Nowak LG, 1996, J NEUROSCI METH, V67, P237, DOI 10.1016/0165-0270(96)00065-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; SMITH JE, 1980, J EXP BIOL, V89, P19	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200937	10.1371/journal.pone.0200937	http://dx.doi.org/10.1371/journal.pone.0200937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024947	gold, Green Submitted, Green Published			2022-12-27	WOS:000439120000070
J	Meyvisch, P; Kambili, C; Andries, K; Lounis, N; Theeuwes, M; Dannemann, B; Vandebosch, A; Van der Elst, W; Molenberghs, G; Alonso, A				Meyvisch, Paul; Kambili, Chrispin; Andries, Koen; Lounis, Nacer; Theeuwes, Myriam; Dannemann, Brian; Vandebosch, An; Van der Elst, Wim; Molenberghs, Geert; Alonso, Ariel			Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial	PLOS ONE			English	Article							CAUSAL INFERENCE; BEDAQUILINE; VALIDATION; BIOMARKERS; CRITERIA	The emergence of multidrug resistant-tuberculosis (MDR-TB), defined as Mycobacterium tuberculosis strains with in vitro resistance to at least isoniazid and rifampicin, has necessitated evaluation and validation of appropriate surrogate endpoints for treatment response in drug trials for MDR-TB. The trial that has demonstrated efficacy of bedaquiline, a diarylquinoline that inhibits mycobacterial ATP synthase, possesses the requisite features to conduct this evaluation. Approval of bedaquiline for use in MDR-TB was based primarily on the results of the controlled C208 Stage II study (ClinicalTrials.gov number, NCT00449644) including 160 patients randomized 1:1 to receive bedaquiline or placebo for 24 weeks when added to an 18-24-month preferred five-drug background regimen. Since randomization in C208 Stage II was preserved until study end, the trial results allow for the investigation of the complex relationship between sustained durable outcome with either Week 8 or Week 24 culture conversion as putative surrogate endpoints. The relationship between Week 120 outcome with Week 8 or Week 24 culture conversion was investigated using a descriptive analysis and with a recently developed statistical methodology for surrogate endpoint evaluation using methods of causal inference. The results demonstrate that sputum culture conversion at 24 weeks is more reliable than sputum culture conversion at 8 weeks when assessing the outcome of adding one new drug to a MDR-TB regimen.	[Meyvisch, Paul; Andries, Koen; Lounis, Nacer; Theeuwes, Myriam; Vandebosch, An; Van der Elst, Wim; Alonso, Ariel] Janssen Pharmaceut, Beerse, Belgium; [Meyvisch, Paul; Molenberghs, Geert] Univ Hasselt, I BioStat, Diepenbeek, Belgium; [Kambili, Chrispin] Johnson & Johnson Global Serv, Raritan, NJ USA; [Dannemann, Brian] Janssen Res & Dev, Titusville, NJ USA; [Molenberghs, Geert] Katholieke Univ Leuven, I BioStat, Leuven, Belgium; [Theeuwes, Myriam] DURECT Corp, Cupertino, CA USA	Johnson & Johnson; Janssen Pharmaceuticals; Hasselt University; Johnson & Johnson; Janssen Pharmaceuticals; KU Leuven	Meyvisch, P (corresponding author), Janssen Pharmaceut, Beerse, Belgium.; Meyvisch, P (corresponding author), Univ Hasselt, I BioStat, Diepenbeek, Belgium.	paul.meyvisch@hotmail.com	Alonso, Ariel/ABB-3765-2021; Van der Elst, Wim/AAE-4459-2020		Janssen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Janssen funded the C208 Stage II trial and was involved in its design and conduct and in the collection and analysis of the data. All the authors who worked for Janssen at the time of the analysis and manuscript preparation (Paul Meyvisch, Chrispin Kambili, Koen Andries, Myriam Theeuwes, Brian Dannemann, An Vandebosch, Wim Van der Elst) played a role in the decision to publish and preparation of the manuscript.	Alonso A, 2017, STAT MED, V36, P1083, DOI 10.1002/sim.7197; Alonso A, 2016, BIOMETRICS, V72, P669, DOI 10.1111/biom.12483; Alonso Ariel, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P255, DOI 10.1586/14737167.8.3.255; [Anonymous], 1981, Tubercle, V62, P95; Buyse M, 1998, BIOMETRICS, V54, P1014, DOI 10.2307/2533853; Buyse M, 2000, Biostatistics, V1, P49, DOI 10.1093/biostatistics/1.1.49; Conradie F, 2017, 2017 C RETR OPP INF; Davies GR, 2010, TUBERCULOSIS, V90, P171, DOI 10.1016/j.tube.2010.03.007; Dawson R, 2017, 2017 C RETR OPP INF; Diacon AH, 2017, AM J RESP CRIT CARE, V196, P1612, DOI [10.1164/rccm.201704-0796le, 10.1164/rccm.201704-0796LE]; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; EAST AFRICAN /BRITISH MEDICAL RESEARCH COUNCIL STUDY, 1976, American Review of Respiratory Disease, V114, P471; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; Lassere MN, 2007, J RHEUMATOL, V34, P607; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Phillips PPJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0565-y; Phillips PPJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063840; Pym AS, 2016, EUR RESPIR J, V47, P564, DOI 10.1183/13993003.00724-2015; Svensson EM, 2017, J ANTIMICROB CHEMOTH, V72, P3398, DOI 10.1093/jac/dkx317; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Wallis RS, 2015, CLIN INFECT DIS, V61, pS160, DOI 10.1093/cid/civ612; Robert S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125403; Wallis RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071116; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; World Health Organization, 2016, RAP DIAGN TEST SHORT; World Health Organization, WHOHTMTB2009420, V4th	31	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200539	10.1371/journal.pone.0200539	http://dx.doi.org/10.1371/journal.pone.0200539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024924	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000028
J	Frolund, M; Wikstron, A; Lidbrink, P; Abu Al-Soud, W; Larsen, N; Harder, CB; Sorensen, SJ; Jensen, JS; Ahrens, P				Frolund, Maria; Wikstron, Arne; Lidbrink, Peter; Abu Al-Soud, Waleed; Larsen, Niels; Harder, Christoffer Bugge; Sorensen, Soren Johannes; Jensen, Jorgen Skov; Ahrens, Peter			The bacterial microbiota in first-void urine from men with and without idiopathic urethritis	PLOS ONE			English	Article							REAL-TIME PCR; CHLAMYDIA-TRACHOMATIS INFECTION; NONGONOCOCCAL URETHRITIS; MYCOPLASMA-GENITALIUM; NEISSERIA-GONORRHOEAE; VAGINOSIS; DNA; ASSOCIATION; CULTURE; PREVALENCE	Background Non-gonococcal urethritis (NGU) is a common syndrome in men. NGU may have several causes, but many cases are caused by sexually transmitted infections that may also cause complications in their female partners. Chlamydia trachomatis and Mycoplasma genitalium are the most common causes of NGU, but in up to 35% of the cases, none of the known viral or bacterial causes are found. Traditionally, pathogens have been detected using various culture techniques that may not identify all species present in the urethra. To address this, we used culture-independent methods for analysis of the male urethral microbiota. Methods This case-control study analysed first void urine samples, collected at STD clinics in Stockholm, Sweden from men with idiopathic urethritis (IU), i.e. negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, Trichomonas vaginalis, adenovirus, and herpes simplex virus type 1 and -2 together with samples from men without urethritis. Forty-six controls and 39 idiopathic urethritis patients were analysed. Results The microbiota was highly diverse: None of the 302 operational taxonomic units (OTUs) found in negative controls and IU patients were found in all of the samples or even in all of the samples in one group. More than 50% of the OTUs were only found in one or two of the total of 85 samples. Still the most dominant 1/6 of the genera constituted 79% of the sequences. Hierarchical clustering in a heatmap showed no specific clustering of patients or controls. A number of IU patient samples were dominated by a single genus previously related to urethritis (Gardnerella, Haemophilus, Ureaplasma). Conclusion The male urethra contain a very diverse composition of bacteria, even in healthy controls. NGU may be caused by a number of different bacteria but more studies including a higher number of samples are needed for elucidation of the role of each species.	[Frolund, Maria; Harder, Christoffer Bugge; Jensen, Jorgen Skov; Ahrens, Peter] Statens Serum Inst, Res Unit Reprod Tract Microbiol, Dept Bacteriol Parasitol & Mycol, Copenhagen, Denmark; [Wikstron, Arne; Lidbrink, Peter] Karolinska Univ Hosp, Dept Dermatovenereol, Stockholm, Sweden; [Wikstron, Arne; Lidbrink, Peter] Karolinska Inst, Inst Med, Stockholm, Sweden; [Abu Al-Soud, Waleed; Sorensen, Soren Johannes] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Larsen, Niels] Danish Genome Inst, Aarhus, Denmark; [Abu Al-Soud, Waleed] Jouf Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Al Quryyat, Saudi Arabia; [Harder, Christoffer Bugge] Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA	Statens Serum Institut; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Copenhagen; Aarhus University; Al Jouf University; Texas Tech University System; Texas Tech University	Ahrens, P (corresponding author), Statens Serum Inst, Res Unit Reprod Tract Microbiol, Dept Bacteriol Parasitol & Mycol, Copenhagen, Denmark.	pae@ssi.dk	Sørensen, Søren J/J-5015-2014; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/AAH-3477-2021	Sørensen, Søren J/0000-0001-6227-9906; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Ahrens, Peter/0000-0003-3776-7929; Jensen, Jorgen Skov/0000-0002-7464-7435	Kongelig hofbundtmager Aage Bangs fond [9622-3011]; Wallevik Foundation [1234]	Kongelig hofbundtmager Aage Bangs fond; Wallevik Foundation	This work was supported by Kongelig hofbundtmager Aage Bangs fond, Grant 9622-3011 (URL: https://aagebangsfond.dk/) and The Wallevik Foundation, Grant: 1234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azariah S, 2000, INT J STD AIDS, V11, P548, DOI 10.1258/0956462001916308; Babics A, 2015, MED MALADIES INFECT, V45, P423, DOI 10.1016/j.medmal.2015.09.007; Bachmann LH, 2015, CLIN INFECT DIS, V61, pS763, DOI 10.1093/cid/civ755; Barbee LA, 2016, SEX TRANSM INFECT, V92, P155, DOI 10.1136/sextrans-2015-052214; Barth WF, 1999, AM FAM PHYSICIAN, V60, P499; Benjamini Y, 1995, J ROYAL STAT SOC B, V289, P300; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Chen LS, 2015, EPIDEMIOL INFECT, V143, P3327, DOI 10.1017/S0950268815000461; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cox C, 2016, INT J STD AIDS, V27, P861, DOI 10.1177/0956462415597620; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; Deguchi T, 1996, EUR J CLIN MICROBIOL, V15, P169, DOI 10.1007/BF01591493; Deguchi T, 2015, INT J STD AIDS, V26, P1035, DOI 10.1177/0956462414565796; Deza G, 2016, SEX TRANSM INFECT, V92, P29, DOI 10.1136/sextrans-2015-052135; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Frolund M, 2016, ACTA DERM-VENEREOL, V96, P689, DOI 10.2340/00015555-2314; Frolund M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102743; Gaydos CA, 2013, SEX TRANSM INFECT, V89, P504, DOI 10.1136/sextrans-2012-050946; Gerard HC, 2001, ARTHRITIS RHEUM-US, V44, P1689, DOI 10.1002/1529-0131(200107)44:7<1689::AID-ART293>3.0.CO;2-K; Hjelmevoll SO, 2006, J MOL DIAGN, V8, P574, DOI 10.2353/jmoldx.2006.060024; Iser P, 2005, SEX TRANSM INFECT, V81, P163, DOI 10.1136/sti.2004.010751; Ito S, 2012, INT J UROL, V19, P234, DOI 10.1111/j.1442-2042.2011.02917.x; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8; Keane FEA, 1997, GENITOURIN MED, V73, P373; KENGNE P, 1994, CELL MOL BIOL, V40, P819; KIVIAT NB, 1990, AM J SURG PATHOL, V14, P167, DOI 10.1097/00000478-199002000-00008; KIVIAT NB, 1986, AM J OBSTET GYNECOL, V154, P865, DOI 10.1016/0002-9378(86)90473-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Manhart LE, 2013, SEX TRANSM DIS, V40, P944, DOI 10.1097/OLQ.0000000000000054; McDonald JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157046; Moi H, 2017, SEX TRANSM DIS, V44, P189, DOI 10.1097/OLQ.0000000000000565; Mortensen C, 2013, LIVER INT, V33, P1309, DOI 10.1111/liv.12205; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Oksanen J., 2018, PACKAGE VEGAN; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Paavonen J, 1999, HUM REPROD UPDATE, V5, P433, DOI 10.1093/humupd/5.5.433; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Price TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16; Priest D, 2017, SEX TRANSM INFECT, V93, P478, DOI 10.1136/sextrans-2016-052950; Riemersma WA, 2003, J CLIN MICROBIOL, V41, P1977, DOI 10.1128/JCM.41.5.1977-1986.2003; Rietmeijer CA, 2012, SEX TRANSM DIS, V39, P18, DOI 10.1097/OLQ.0b013e3182354da3; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Shimada Y, 2014, INT J STD AIDS, V25, P294, DOI 10.1177/0956462413504556; Shoskes DA, 2016, UROLOGY, V92, P26, DOI 10.1016/j.urology.2016.02.043; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Svenstrup HF, 2005, J CLIN MICROBIOL, V43, P3121, DOI 10.1128/JCM.43.7.3121-3128.2005; Tabrizi SN, 2007, SEX HEALTH, V4, P41, DOI 10.1071/SH06054; Tamarelle J, 2019, CLIN MICROBIOL INFEC, V25, P35, DOI 10.1016/j.cmi.2018.04.019; Thomas-White K, 2016, CURR BLADDER DYSFUNC, V11, P18, DOI 10.1007/s11884-016-0345-8; Warnes GR, 2015, GPLOTS VARIOUS R PRO; Westh H, 2008, SEX TRANSM INFECT, V84, P546, DOI 10.1136/sti.2008.031906; Wetmore CM, 2011, SEX TRANSM DIS, V38, P180, DOI 10.1097/OLQ.0b013e3182040de9; Whiteside SA, 2015, NAT REV UROL, V12, P81, DOI 10.1038/nrurol.2014.361; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; You CL, 2016, MICROB PATHOGENESIS, V95, P95, DOI 10.1016/j.micpath.2016.02.022; Yu Y, 2005, WATER SCI TECHNOL, V52, P85, DOI 10.2166/wst.2005.0502	65	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201380	10.1371/journal.pone.0201380	http://dx.doi.org/10.1371/journal.pone.0201380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052651	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600040
J	O'Neill, L; Park, SH; Rosinia, F				O'Neill, Liam; Park, Sae-Hwan; Rosinia, Frank			The role of the built environment and private rooms for reducing central line-associated bloodstream infections	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; PATIENT SAFETY INDICATORS; QUALITY IMPROVEMENT; FACILITY DESIGN; SINGLE ROOMS; ACQUISITION; PREVENTION; PERFORMANCE; OCCUPANCY; HOSPITALS	Private hospital rooms are believed to offer some protective effect against hospital-acquired infections, including central line-associated bloodstream infections. Yet a recent meta-analysis found the evidence-base to be lacking from a policy perspective. We sought to determine whether private rooms were associated with a lower risk of central-line infections. We examined the discharge records of more than one million inpatients from 335 Texas hospitals to determine patients that stayed in private rooms. Patients who stayed in bay rooms had 64 percent more central line infections than patients who stayed in private rooms. Even after adjusting for relevant covariates, patients assigned to bay rooms had a 21 percent greater relative risk of a central line infection (p = 0.005), compared with patients assigned to private rooms. At the hospital level, a 10% increase in private rooms was associated with an 8.6% decrease in central line infections (p<0.001), regardless of individual patients' room assignment. This study demonstrates and validates the use of private rooms as a structural measure and independent predictor of hospital quality.	[O'Neill, Liam; Park, Sae-Hwan] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA; [Rosinia, Frank] John Peter Smith Hosp, Dept Anesthesiol, Ft Worth, TX 76104 USA; [Rosinia, Frank] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	O'Neill, L (corresponding author), Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA.	liam.oneill@unthsc.edu		ONeill, Liam/0000-0003-1599-7774				[Anonymous], 2012, PSI 07 CENTRAL VENOU; Bartley J, 2010, CRIT CARE MED, V38, pS388, DOI 10.1097/CCM.0b013e3181e6d0c1; Bracco D, 2007, INTENS CARE MED, V33, P836, DOI 10.1007/s00134-007-0559-5; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Centers for Disease Control and Prevention (CDC), 2016, HEALTHC ASS INF HAI; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; Chaudhury H, 2006, APPL NURS RES, V19, P118, DOI 10.1016/j.apnr.2005.06.002; Datta R, 2011, ARCH INTERN MED, V171, P491, DOI 10.1001/archinternmed.2011.64; Detsky ME, 2008, JAMA-J AM MED ASSOC, V300, P954, DOI 10.1001/jama.300.8.954; Dettenkofer M, 2004, INFECT CONT HOSP EP, V25, P21, DOI 10.1086/502286; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Donabedian A., 1980, EXPLORATIONS QUALITY, P3; Edwards JN, 2011, ELIMINATING CENTRAL; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellison J, 2014, CAN J INFECT DIS MED, V25, P265, DOI 10.1155/2014/685402; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; Gallagher B, 2005, READMISSIONS SELECTE; Goldman DP, 2010, NEW ENGL J MED, V363, P2185, DOI 10.1056/NEJMp1009501; Hall KK, 2013, HERD-HEALTH ENV RES, V7, P13, DOI 10.1177/193758671300701S03; HCUP CCS. Healthcare Cost and Utilization Project (HCUP), 2017, CLIN CLASS SOFTW CCS; Hearld LR, 2008, MED CARE RES REV, V65, P259, DOI 10.1177/1077558707309613; Hendrich AL, 2004, AM J CRIT CARE, V13, P35, DOI 10.4037/ajcc2004.13.1.35; Lenfestey NF, 2013, HERD-HEALTH ENV RES, V7, P31, DOI 10.1177/193758671300701S05; Levin PD, 2011, CRIT CARE, V15, DOI 10.1186/cc10446; Liang SY, 2011, ANN EMERG MED, V58, P450; Marsteller JA, 2014, AM J INFECT CONTROL, V42, pS209, DOI 10.1016/j.ajic.2014.06.001; Moehring RW, 2013, INFECT CONT HOSP EP, V34, P238, DOI 10.1086/669527; National Conference of State Legislatures, 2017, CON CERT NEED STAT L; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P628, DOI 10.1377/hlthaff.2011.0047; Rivard PE, 2006, HEALTH SERV RES, V41, P1633, DOI 10.1111/j.1475-6773.2006.00569.x; Romano PS, 2003, HEALTH AFFAIR, V22, P154, DOI 10.1377/hlthaff.22.2.154; Rosen AK, 2012, MED CARE, V50, P74, DOI 10.1097/MLR.0b013e3182293edf; Stone PW, 2007, MED CARE, V45, P571, DOI 10.1097/MLR.0b013e3180383667; Studnicki J, 2013, AM J MED QUAL, V28, P525, DOI 10.1177/1062860613480826; Teltsch DY, 2011, ARCH INTERN MED, V171, P32, DOI 10.1001/archinternmed.2010.469; Texas Department of State Health Services center for health statistics Austin Texas, 2020, TEX INP PUBL US DAT; van de Glind I, 2007, HEALTH POLICY, V84, P153, DOI 10.1016/j.healthpol.2007.06.002; van Mourik MSM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008424; Weiner BJ, 2006, MED CARE RES REV, V63, P29, DOI 10.1177/1077558705283122; Winters BD, 2016, MED CARE, V55, P1105, DOI 10.1097/MLR.0000000000000550; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763; Zuberi D., 2013, CLEANING HOSP OUTS I	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201002	10.1371/journal.pone.0201002	http://dx.doi.org/10.1371/journal.pone.0201002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052672	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600021
J	Sala-Puigdollers, A; Figueras-Roca, M; Hereu, M; Hernandez, T; Morato, M; Adan, A; Zarranz-Ventura, J				Sala-Puigdollers, Anna; Figueras-Roca, Marc; Hereu, Mireia; Hernandez, Teresa; Morato, Montse; Adan, Alfredo; Zarranz-Ventura, Javier			Repeatability and reproducibility of retinal and choroidal thickness measurements in Diabetic Macular Edema using Swept-source Optical Coherence Tomography	PLOS ONE			English	Article							TIME-DOMAIN; RETINOPATHY; CONVERSION; METRICS; EYES	Purpose To evaluate the repeatability and reproducibility of retinal and choroidal thickness measured with Swept source Optical Coherence Tomography (SS-OCT) in eyes with Diabetic Macular Edema (DME). Methods 42 DME eyes were imaged using SS-OCT standard Macular scanning protocols. Retinal and choroidal thickness were measured in the Total macular circle (TMC) and foveal central subfield (FCS) using device-integrated specific software. The coefficient of repeatability (CR) and intraclass correlation coefficient (ICC) were determined as a measure of repeatability and relative reliability within graders. Reproducibility was assessed using Bland-Altman plots and 95% limits of agreement (LoA) were determined as a measure of interobserver variability. Results Intragrader CR of retinal and choroidal thickness were 8.37 and 12.20 microns for TMC and 22.24 and 32.40 microns for FCS, and intergrader 95% LoA were 7.37 +/- 8.69 and -27.2 +/- 27.71 microns for TMC and -34.21 +/- 41.93 and -30.46 +/- 24.84 for FCS, respectively. Retinal and choroidal thickness showed very good intraobserver reliability for both TMC and FCS (ICC 0.99, LoA 0.98 +/- 0.99 in all cases). Intraobserver and interobserver variability for retinal and choroidal thickness was not significantly different for TMC (p = 0.98 and p = 0.90, p = 0.98 and p = 0.91) or FCS (p = 0.97 and p = 0.85, p = 0.78 and p = 0.73), respectively. Conclusions Retinal and choroidal thickness in DME eyes can be quantified with good reliability, repeatability and reproducibility using new OCT devices that incorporate swept source technology. The technical advantages of this technology may provide new insights in the understanding of the choroidal changes related with DME.	[Sala-Puigdollers, Anna; Figueras-Roca, Marc; Hereu, Mireia; Hernandez, Teresa; Morato, Montse; Adan, Alfredo; Zarranz-Ventura, Javier] Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain; [Sala-Puigdollers, Anna; Figueras-Roca, Marc; Adan, Alfredo; Zarranz-Ventura, Javier] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Sala-Puigdollers, Anna] Ctr Med Teknon, Inst Macula, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sala-Puigdollers, A (corresponding author), Hosp Clin Barcelona, Inst Clin Oftalmol ICOF, Barcelona, Spain.; Sala-Puigdollers, A (corresponding author), August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.; Sala-Puigdollers, A (corresponding author), Ctr Med Teknon, Inst Macula, Barcelona, Spain.	ansala@clinic.cat	Figueras-Roca, Marc/G-9095-2017; Zarranz-Ventura, Javier/AAB-5390-2021	Figueras-Roca, Marc/0000-0002-0548-0539; Zarranz-Ventura, Javier/0000-0003-2338-8143; Hereu, Mireia/0000-0002-7179-2514; Sala-Puigdollers, Anna/0000-0001-5792-6937				Abadia B I, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0191977, DOI 10.1371/JOURNAL.PONE.0191977]; Abadia B, 2019, RETINA-J RET VIT DIS, V39, P786, DOI 10.1097/IAE.0000000000002022; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bressler SB, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.1.5; Bressler SB, 2014, JAMA OPHTHALMOL, V132, P1113, DOI 10.1001/jamaophthalmol.2014.1698; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Fiore T, 2013, CURR EYE RES, V38, P674, DOI 10.3109/02713683.2013.781191; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Hodzic-Hadzibegovic D, 2015, ACTA OPHTHALMOL, V93, P74, DOI 10.1111/aos.12494; Hua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083494; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Melancia D, 2016, GRAEF ARCH CLIN EXP, V254, P1453, DOI 10.1007/s00417-016-3360-8; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2893, DOI 10.1167/iovs.12-11085; Stanga PE, 2014, AM J OPHTHALMOL, V157, P397, DOI 10.1016/j.ajo.2013.10.008; Vujosevic S, 2012, RETINA-J RET VIT DIS, V32, P1781, DOI 10.1097/IAE.0b013e31825db73d; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836	20	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200819	10.1371/journal.pone.0200819	http://dx.doi.org/10.1371/journal.pone.0200819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048478	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400022
J	Sarwar, A; Brader, G; Corretto, E; Aleti, G; Ullah, MA; Sessitsch, A; Hafeez, FY				Sarwar, Ambrin; Brader, Gunter; Corretto, Erika; Aleti, Gajender; Ullah, Muhammad Abaid; Sessitsch, Angela; Hafeez, Fauzia Yusuf			Qualitative analysis of biosurfactants from Bacillus species exhibiting antifungal activity (vol 13, e0198107, 2018)	PLOS ONE			English	Correction													Aleti, Gajender/AAZ-1506-2021; Ullah, Muhammad Abaid/AAP-2014-2021; Corretto, Erika/V-5796-2019; Sessitsch, Angela/AAW-3191-2020	Ullah, Muhammad Abaid/0000-0002-9366-1523; Corretto, Erika/0000-0002-7767-5191; Sessitsch, Angela/0000-0003-0137-930X; Aleti, Gajender/0000-0002-1867-9758				Sarwar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198107	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201624	10.1371/journal.pone.0201624	http://dx.doi.org/10.1371/journal.pone.0201624			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048549	Green Published, gold			2022-12-27	WOS:000439952400098
J	Ominde, M; Sande, J; Ooko, M; Bottomley, C; Benamore, R; Park, K; Ignas, J; Maitland, K; Bwanaali, T; Gleeson, F; Scott, A				Ominde, M.; Sande, J.; Ooko, M.; Bottomley, C.; Benamore, R.; Park, K.; Ignas, J.; Maitland, K.; Bwanaali, T.; Gleeson, F.; Scott, A.			Reliability and validity of the World Health Organization reading standards for paediatric chest radiographs used in the field in an impact study of Pneumococcal Conjugate Vaccine in Kilifi, Kenya	PLOS ONE			English	Article							PLACEBO-CONTROLLED-TRIAL; DOUBLE-BLIND; PNEUMONIA; EFFICACY; CHILDREN; DIAGNOSIS; DISEASE; SAFETY; PERCH	Background Radiologically-confirmed pneumonia (RCP) is a specific end-point used in trials of Pneumococcal Conjugate Vaccine (PCV) to estimate vaccine efficacy. However, chest radiograph (CXR) interpretation varies within and between readers. We measured the repeatability and reliability of paediatric CXR interpretation using percent agreement and Cohen's Kappa and the validity of field readings against expert review in a study of the impact of PCV on pneumonia. Methods CXRs were obtained from 2716 children admitted between 2006 and 2014 to Kilifi County Hospital, Kilifi, Kenya, with clinically-defined severe or very-severe pneumonia. Five clinicians and radiologists attended a three-day training course on CXR interpretation using a WHO standard. All CXRs were read once by two local primary readers. Discordant readings and 13% of concordant readings were arbitrated by a panel of three expert radiologists. To assess repeatability, a 5% median random sample was presented twice. Sensitivity and specificity of the primary readers' interpretations was estimated against the 'gold-standard' of the arbitrators' results. Results Of 2716 CXRs, 2 were uninterpretable and 159 were evaluated twice. The percent agreement and Kappa for RCP were 89% and 0.68 and ranged between 84-97% and 0.19-0.68, respectively, for all pathological findings. Intra-observer repeatability was inter observer reliability. Sensitivities of the primary readers to detect RCP were 69% and 73%; specificities were 96% and 95%. Conclusion Intra- and inter-observer agreements on interpretations of radiologically-confirmed pneumonia are fair to good. Reasonable sensitivity and high specificity make radiologically-confirmed pneumonia, determined in the field, a suitable measure of relative vaccine effectiveness.	[Ominde, M.; Ooko, M.; Ignas, J.; Maitland, K.; Bwanaali, T.; Scott, A.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Ominde, M.; Sande, J.] Aga Khan Univ Hosp, Nairobi, Kenya; [Bottomley, C.; Bwanaali, T.; Scott, A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Benamore, R.; Park, K.; Gleeson, F.] Oxford Univ Hosp Fdn NHS Trust, Oxford, England; [Maitland, K.] Imperial Coll, London, England; [Gleeson, F.; Scott, A.] Univ Oxford, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; Oxford University Hospitals NHS Foundation Trust; Imperial College London; University of Oxford	Ominde, M (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.; Ominde, M (corresponding author), Aga Khan Univ Hosp, Nairobi, Kenya.	mikasilaba@gmail.com		Maitland, Kathryn/0000-0002-0007-0645; Ominde, Micah/0000-0002-9512-6401; Bottomley, Christian/0000-0002-5241-8412; Gleeson, Fergus/0000-0002-5121-3917	GAVI, The Vaccine Alliance; Wellcome Trust [098532]	GAVI, The Vaccine Alliance; Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by GAVI, The Vaccine Alliance; http://www.gavi.org/. AS is supported by a fellowship from The Wellcome Trust (098532).; We thank the participants and their parents/guardians for accepting to take part in this study. This paper is published with the permission of the Director, Kenya Medical Research Institute. AS was supported by a fellowship from the Wellcome Trust (098532)	Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; Allisy-Roberts P., 2008, FARRS PHYS MEDICAL I, P1, DOI [10.1016/B978-0-7020-2844-1.50005-3, DOI 10.1016/B978-0-7020-2844-1.50005-3]; Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082; Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Gwet K, KAPPA STAT IS NOT SA; Gwet K, INTER RATER RELIABIL; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Nagaoki Kenji, 1997, Nippon Acta Radiologica, V57, P258; Norweck JT, 2013, J DIGIT IMAGING, V26, P38, DOI 10.1007/s10278-012-9522-2; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Silaba MO, 2017, IMPACT 10 VALENT PNE; WHO Pneumonia Vaccine Trial Investigators' Group, 2001, STAND INT CHEST RAD; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200715	10.1371/journal.pone.0200715	http://dx.doi.org/10.1371/journal.pone.0200715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044834	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000439942500064
J	Motoyama, H; Tamori, A; Kubo, S; Uchida-Kobayashi, S; Takemura, S; Tanaka, S; Ohfuji, S; Teranishi, Y; Kozuka, R; Kawamura, E; Hagihara, A; Morikawa, H; Enomoto, M; Murakami, Y; Kawada, N				Motoyama, Hiroyuki; Tamori, Akihiro; Kubo, Shoji; Uchida-Kobayashi, Sawako; Takemura, Shigekazu; Tanaka, Shogo; Ohfuji, Satoko; Teranishi, Yuga; Kozuka, Ritsuzo; Kawamura, Etsushi; Hagihara, Atsushi; Morikawa, Hiroyasu; Enomoto, Masaru; Murakami, Yoshiki; Kawada, Norifumi			Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication (vol 13, e0194163, 2018)	PLOS ONE			English	Correction													Ohfuji, Satoko/AHB-4998-2022; kawada, norifumi/AAS-1367-2020		Japan Society for the Promotion of Science grant (JSPS KAKENHI) [JP15K09019, JP17H04124]	Japan Society for the Promotion of Science grant (JSPS KAKENHI)	This study was supported in part by the Japan Society for the Promotion of Science grant (JSPS KAKENHI Grant No. JP15K09019, A.T., and JP17H04124, S.O.). Web site; http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Motoyama H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194163	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201423	10.1371/journal.pone.0201423	http://dx.doi.org/10.1371/journal.pone.0201423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040864	gold, Green Submitted, Green Published			2022-12-27	WOS:000439749200038
J	Zhang, W; Chen, KR; Zhang, XQ; Guo, CH; Chen, YS; Liu, XH				Zhang, Wei; Chen, Keren; Zhang, Xueqing; Guo, Chunhe; Chen, Yaosheng; Liu, Xiaohong			An integrated analysis of membrane remodeling during porcine reproductive and respiratory syndrome virus replication and assembly	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CORONAVIRUS REPLICATION; ULTRASTRUCTURAL CHARACTERIZATION; 3-DIMENSIONAL ARCHITECTURE; ARTERIVIRUS REPLICASE; SARS-CORONAVIRUS; RNA REPLICATION; LIFE-CYCLE; COMPLEX; PROTEIN	Background Recently, three-dimensional (3D) imaging techniques have been used to detect viral invasion and the appearance of specialized structures established in virus-infected cells. These methods have had a positive impact in the field of virology and helped to further our knowledge of how viruses invade cells. Nearly all positive-strand RNA viruses propagate their viral genomes in part through intracellular membranes. Porcine reproductive and respiratory syndrome virus (PRRSV), an Arterivirus, accumulates viral RNA that forms replication complexes (RCs) in infected cells. In this study, using immunofluorescence and electron microscopy (EM), we dissected PRRSV-induced membrane structures in infected cells and determined the correlations between PRRSV particles and vesicles stimulated by PRRSV to understand the structural and dynamic aspects of PRRSV infection. Methods We identified the appropriate time point by determining the 50% tissue culture infectious dose (TCID50) and using qRT-PCR and Western blotting. The co-localization of viruses and organelles was determined by immunofluorescence and immune-electron microscopy (IEM). The ultrastructure of cells infected by PRRSV was observed using EM and electron tomography (ET). Results In our study, we found that PRRSV dsRNA was located at the endoplasmic reticulum (ER) and autophagosomes; in addition, the N protein was located at the mitochondria, ER and autophagosomes. Vesicles induced by PRRSV appeared at 16 hours post-infection (h.p.i.) and increased in size with time during the infection period. In addition, our findings demonstrated that the virus vesicles originated from the ER, and these two organelle structures connected with each other to form a reticulovesicular network (RVN) that provided a site for virus replication and assembly. Conclusion Our results revealed that membrane vesicles induced by PRRSV were derived from the ER. The vesicles may provide a location for PRRSV replication and assembly.	[Zhang, Wei; Chen, Keren; Zhang, Xueqing; Guo, Chunhe; Chen, Yaosheng; Liu, Xiaohong] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei; Chen, Keren; Zhang, Xueqing; Guo, Chunhe; Chen, Yaosheng; Liu, Xiaohong] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, XH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Liu, XH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	xhliu@163.net	Guo, Chunhe/ABB-3754-2021	Guo, Chunhe/0000-0002-7859-1985; Wei, Zhang/0000-0002-8378-1142	Natural Science Foundation of Guangdong Province [2014A030312011]; National Natural Science Foundation of China [31601917]; Guangdong Sailing Program [2014YT02H042]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Sailing Program	This work was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the National Natural Science Foundation of China (31601917) and the Guangdong Sailing Program (2014YT02H042) (YC).	Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11; Blanchard E, 2015, CELL MICROBIOL, V17, P45, DOI 10.1111/cmi.12372; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; Dea S, 1995, Adv Exp Med Biol, V380, P95; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li SF, 2016, ONCOTARGET, V7, P56002, DOI 10.18632/oncotarget.10817; Maier HJ, 2013, MBIO, V4, DOI 10.1128/mBio.00801-13; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Metwally S, 2010, TRANSBOUND EMERG DIS, V57, P315, DOI 10.1111/j.1865-1682.2010.01152.x; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Misinzo G, ADV EXPT MED BIOL, P449; Molenkamp R, 2000, J GEN VIROL, V81, P2491, DOI 10.1099/0022-1317-81-10-2491; Oudshoorn D, 2016, MBIO, V7, DOI 10.1128/mBio.01991-16; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Peng L, 2010, STRUCTURE, V18, P47, DOI 10.1016/j.str.2009.10.017; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Spilman MS, 2009, J GEN VIROL, V90, P527, DOI 10.1099/vir.0.007674-0; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Suarez C, 2015, CELL MICROBIOL, V17, P1683, DOI 10.1111/cmi.12468; Ulasli M, 2010, CELL MICROBIOL, V12, P844, DOI 10.1111/j.1462-5822.2010.01437.x; Urakova N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169913; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; World Organization for Animal Health (OIE), 2001, WORLD AN HLTH 2000 1; Yoo D, 2003, J VIROL, V77, P12173, DOI 10.1128/JVI.77.22.12173-12183.2003; Zhang QF, 2004, J MED VIROL, V73, P332, DOI 10.1002/jmv.20095; Zhao HJ, 2014, THERIOGENOLOGY, V82, P790, DOI 10.1016/j.theriogenology.2014.06.003; Zhu HL, 2014, INT J MED MICROBIOL, V304, P577, DOI 10.1016/j.ijmm.2014.03.002	41	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200919	10.1371/journal.pone.0200919	http://dx.doi.org/10.1371/journal.pone.0200919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040832	gold, Green Submitted, Green Published			2022-12-27	WOS:000439749200016
J	Kim, B; Kim, J; Jo, YH; Lee, JH; Hwang, JE; Park, MJ; Lee, S				Kim, Byunghyun; Kim, Joonghee; Jo, You Hwan; Lee, Jae Hyuk; Hwang, Ji Eun; Park, Min Ji; Lee, Sihyung			Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; HOSPITALIZED-PATIENTS; ADULTS; MANAGEMENT; GUIDELINES; SEVERITY; DIAGNOSIS; THERAPY; BINAX	Background The pneumococcal urinary antigen test (UAT) has been known to improve sensitivity and specificity for the diagnosis of pneumococcal pneumonia. Associations of UAT results with prognosis in community acquired pneumonia (CAP) are not known. We hypothesized that positive UAT is associated with a good prognosis, and incorporation of UAT into CRB65 would improve its prognostic performance. Methods In this registry-based retrospective study, we analyzed CAP patients over a 10-year period beginning in April 2008. Patients who had UAT results were included in multivariable extended Cox-regression analyses to determine the association between UAT positivity and 30-day mortality. UAT results were incorporated for patients with a CRB65 score of 1 by subtracting 1 from the scoring system if the test was positive. The performance of the modified scoring systems was assessed with area under the receiver operating characteristic (AUROC) curves. Results Among 5145 CAP patients, total 2280 patients had UAT results and were included in analyses. A positive UAT result was associated with a good prognosis after a week of hospitalization (aHR, 0.14; p = 0.007). After modification of CRB65 using UAT results, positive and negative predictive values for 30-day mortality were increased from 7.7 to 8.3 (p<0.001) and 98.9 to 99.1 (p = 0.010). The AUROC increased from 0.73 to 0.75 (p<0.001). Conclusions Positive results on UAT could be considered as a good prognostic factor in CAP. UAT could be used as a useful tool in deciding whether to refer patients to the hospital, especially in moderate CAP with a CRB score of 1.	[Kim, Byunghyun; Kim, Joonghee; Jo, You Hwan; Lee, Jae Hyuk; Hwang, Ji Eun; Park, Min Ji; Lee, Sihyung] Seoul Natl Univ, Bundang Hosp, Dept Emergency Med, Gyeonggi Do, South Korea	Seoul National University (SNU)	Kim, J (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Emergency Med, Gyeonggi Do, South Korea.	joonghee79@gmail.com	Lee, Jae Hyuk/W-5616-2018; Kim, Joonghee/C-9811-2014	Lee, Jae Hyuk/0000-0003-2429-4085; Kim, Joonghee/0000-0001-5080-7097				Abe R, 2010, CRIT CARE, V14, DOI 10.1186/cc8898; Alexandraki I, 2010, CRIT CARE, V14, DOI 10.1186/cc9013; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arancibia F, 2002, ARCH INTERN MED, V162, P1849, DOI 10.1001/archinte.162.16.1849; Arens C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1233-5; Dwyer R, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000038; Eccles S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6722; Falguera M, 2010, THORAX, V65, P101, DOI 10.1136/thx.2009.118588; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Guchev IA, 2005, CLIN INFECT DIS, V40, P1608, DOI 10.1086/429919; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Heo JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177342; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Molinos L, 2015, ANN AM THORAC SOC, V12, P1482, DOI 10.1513/AnnalsATS.201505-304OC; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Shindo Y, 2008, RESPIROLOGY, V13, P731, DOI 10.1111/j.1440-1843.2008.01329.x; Smith MD, 2003, J CLIN MICROBIOL, V41, P2810, DOI 10.1128/JCM.41.7.2810-2813.2003; Sorde R, 2011, ARCH INTERN MED, V171, P166, DOI 10.1001/archinternmed.2010.347; Stralin K, 2005, CLIN INFECT DIS, V41, P1209, DOI 10.1086/444566; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; West Devin M, 2016, ERJ Open Res, V2, DOI 10.1183/23120541.00011-2016; Zalacain R, 2014, RESPIROLOGY, V19, P936, DOI 10.1111/resp.12341	25	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200620	10.1371/journal.pone.0200620	http://dx.doi.org/10.1371/journal.pone.0200620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028834	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900010
J	Tai, YH; Chang, WK; Wu, HL; Chan, MY; Chen, HH; Chang, KY				Tai, Ying-Hsuan; Chang, Wen-Kuei; Wu, Hsiang-Ling; Chan, Min-Ya; Chen, Hsiu-Hsi; Chang, Kuang-Yi			The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study	PLOS ONE			English	Article							PERIOPERATIVE BLOOD-TRANSFUSIONS; LONG-TERM OUTCOMES; MU-OPIOID RECEPTOR; COLON-CANCER; CLINICAL-OUTCOMES; CELL TRANSFUSIONS; LIVER METASTASES; SURGERY; RECURRENCE; SURVIVAL	Retrospective clinical studies showed perioperative epidural analgesia (EA) was associated with better postoperative oncologic outcomes in patients with specific types of non-metastatic cancers. This study aimed to investigate the effects of EA on cancer prognosis after surgical intervention for stage IV colorectal cancer. In this retrospective study, patients with stage IV colorectal cancer undergoing primary tumor resection and metastasectomy between January 2005 and December 2014 were classified into two groups based on their use of perioperative EA or not and evaluated through August 2016. Primary and secondary endpoints were postoperative progression-free survival (PFS) and overall survival (OS), respectively. A total of 999 patients were included and 165 (16.5%) of them received EA. The median follow-up interval was 17.5 months and no significant difference in PFS or OS was noted between the EA and non-EA groups in the univariate analysis. Multivariable Cox proportional hazards model identified four independent risk factors both for disease progression and mortality, including American Society of Anesthesiologists (ASA) physical status >= 3, higher pretreatment carcinoembryonic antigen (CEA), multiple distant metastases, and pathologic lymphovascular invasion. After adjustment for the selected risk factors, the effects of EA on PFS and OS remained non-significant (hazard ratio: 1.06, 95% CI: 0.87 to 1.29, for PFS and 0.90, 95% CI: 0.68 to 1.20 for OS). Similar findings were demonstrated by propensity score analysis. Our results did not support the association between perioperative epidural analgesia and better progression-free or overall survival in patients following stage IV colorectal cancer surgery.	[Tai, Ying-Hsuan; Chang, Wen-Kuei; Wu, Hsiang-Ling; Chan, Min-Ya; Chang, Kuang-Yi] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tai, Ying-Hsuan] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Tai, Ying-Hsuan; Chang, Wen-Kuei; Wu, Hsiang-Ling; Chang, Kuang-Yi] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Tai, Ying-Hsuan] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Wu, Hsiang-Ling] Taipei Vet Gen Hosp, Dept Surg, Yuli Branch, Hualien, Taiwan; [Chan, Min-Ya] Natl Taiwan Normal Univ, Dept Technol Applicat & Human Resource Dev, Taipei, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Div Biostat, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Veterans General Hospital; National Taiwan Normal University; National Taiwan University	Chang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.; Chang, KY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	kychang@vghtpe.gov.tw	tai, yh/GRR-4574-2022	Chen, Hsiu-Hsi/0000-0002-5799-6705	Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C [V104C-096]; Ministry of Science and Technology, Taipei, Taiwan, R.O.C [MOST 104-2314-B-075-015]; Anesthesiology Research and Development Foundation, Taipei, Taiwan [ARDF10501]	Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C(Taipei Veterans General Hospital); Ministry of Science and Technology, Taipei, Taiwan, R.O.C; Anesthesiology Research and Development Foundation, Taipei, Taiwan	This study was supported by the grants from Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C (V104C-096; https://www.vghtpe.gov.tw), Ministry of Science and Technology, Taipei, Taiwan, R.O.C (MOST 104-2314-B-075-015; https://www.most.gov.tw) and Anesthesiology Research and Development Foundation, Taipei, Taiwan (ARDF10501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Aggarwal C, 2013, ANN ONCOL, V24, P420, DOI 10.1093/annonc/mds336; Amato A, 2006, COCHRANE DB SYST REV, DOI 10.1002/1465158.CD005033.pub2; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Buggy DJ, 1999, BMJ-BRIT MED J, V319, P530, DOI 10.1136/bmj.319.7209.530; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Edge SB, 2010, AJCC CANC STAGING MA; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hallet J, 2015, ANN SURG ONCOL, V22, P4038, DOI 10.1245/s10434-015-4477-4; Hiller JG, 2018, NAT REV CLIN ONCOL, V15, P205, DOI 10.1038/nrclinonc.2017.194; Hogan J, 2015, DIS COLON RECTUM, V58, P547, DOI 10.1097/DCR.0000000000000361; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Kawaraguchi Y, 2011, ANESTHESIOLOGY, V115, P499, DOI 10.1097/ALN.0b013e3182276d42; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lennon FE, 2012, ANESTHESIOLOGY, V116, P940, DOI 10.1097/ALN.0b013e31824b9512; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Nitsche U, 2013, ANN SURG, V258, P775, DOI 10.1097/SLA.0b013e3182a69f7e; Nylund G, 2008, DIGEST DIS SCI, V53, P461, DOI 10.1007/s10620-007-9897-y; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Singleton PA, 2015, CANCER-AM CANCER SOC, V121, P2681, DOI 10.1002/cncr.29460; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Sun YX, 2015, REGION ANESTH PAIN M, V40, P589, DOI 10.1097/AAP.0000000000000273; Thirunavukarasu P, 2015, JAMA SURG, V150, P747, DOI 10.1001/jamasurg.2015.0871; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Van Osdol AD, 2015, AM J SURG, V210, P990, DOI 10.1016/j.amjsurg.2015.06.026; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5; Wada H, 2007, ANESTHESIOLOGY, V106, P499, DOI 10.1097/00000542-200703000-00014; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zimmitti G, 2016, ANN SURG ONCOL, V23, P1003, DOI 10.1245/s10434-015-4933-1; Zylla D, 2013, CANCER-AM CANCER SOC, V119, P4103, DOI 10.1002/cncr.28345	40	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200893	10.1371/journal.pone.0200893	http://dx.doi.org/10.1371/journal.pone.0200893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028851	Green Published, gold			2022-12-27	WOS:000439396900023
J	Kim, DH; Lee, DI; Ahn, J; Lee, KN; Roh, SY; Shim, J; Choi, JI; Kim, YH				Kim, Dong-Hyeok; Lee, Dae-In; Ahn, Jinhee; Lee, Kwang-No; Roh, Seung-Young; Shim, Jaemin; Choi, Jong-Il; Kim, Young-Hoon			Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; THROMBOEMBOLIC EVENTS; ORAL ANTICOAGULATION; THERAPY; MULTICENTER; DEATH; TRIAL	The interruption of oral anticoagulation therapy (OAC) after CA of atrial fibrillation (AF) is controversial. The purpose of this study was to evaluate the relationship between successful long-term outcomes of catheter resection and SR maintenance and ischemic stroke risk in Korea. We studied 1,548 consecutive patients who were followed up for more than 2 years after CA of AF. We investigated the incidence of ischemic stroke during long-term follow-up. Compared to the AF recurrence group (n = 619), the sinus rhythm (SR) maintenance group (n = 929) had more paroxysmal AF (74.6% versus 44.4%, p<0.001), smaller LA size (39.9 +/- 5.7mm versus 42.3 +/- 6.0mm, p<0.001), and younger age (54.2 +/- 10.9 years versus 56.4 +/- 10.6 years, p<0.001). However, CHA(2)DS(2)-VASc scores were not significantly different between the two groups (0.9 vs. 1.1, p = 0.053). The overall incidence of ischemic stroke during the mean follow-up period of 54 months after CA was 0.6%, and was significantly lower in the SR group than the AF recurrence group (0.3% vs. 1.1%, log-rank test p<0.001). However, in sub-analysis in the SR group, the rate of ischemic stroke was significantly increasing in patients with a CHA(2)DS(2)-VASc score >= 4 compared to those with a CHA(2)DS(2)-VASc score < 4 (4.3% vs. 0.2%, log-rank test p<0.001). In conclusion, this long-term followup data in patients with AF who underwent successful CA showed that SR maintenance was correlated with a lower rate of ischemic stroke in Korea. However, it was only observed in patients with CHA(2)DS(2)-VASc score <= 3.	[Kim, Dong-Hyeok; Lee, Kwang-No; Shim, Jaemin; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Lee, Dae-In] Chungbuk Natl Univ Hosp, Div Cardiol, Cheongju, South Korea; [Ahn, Jinhee] Pusan Natl Univ Hosp, Div Cardiol, Busan, South Korea; [Roh, Seung-Young] Dongguk Univ, Coll Med, Div Cardiol, Goyang, South Korea; [Roh, Seung-Young] Dongguk Univ, Med Ctr, Goyang, South Korea	Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Chungbuk National University Hospital; Pusan National University; Pusan National University Hospital; Dongguk University; Dongguk University	Kim, YH (corresponding author), Korea Univ, Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea.	yhkmd@unitel.co.kr	Kim, Dong-Hyeok/N-7559-2018; Kim, Young-Hoon/AAO-5792-2021	Kim, Dong-Hyeok/0000-0002-6339-8496; Choi, Jong-Il/0000-0001-6617-508X; Kim, Young-Hoon/0000-0002-4254-647X				Bunch TJ, 2011, J CARDIOVASC ELECTR, V22, P839, DOI 10.1111/j.1540-8167.2011.02035.x; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Friberg L, 2016, EUR HEART J, V37, P2478, DOI 10.1093/eurheartj/ehw087; Hakalahti A, 2015, EUROPACE, V17, P370, DOI 10.1093/europace/euu376; Hindricks G, 2005, CIRCULATION, V112, P307, DOI 10.1161/CIRCULATIONAHA.104.518837; Holmqvist F, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001901; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Jons C, 2009, EUROPACE, V11, P917, DOI 10.1093/europace/eup122; Karasoy D, 2015, EUR HEART J, V36, P307, DOI 10.1093/eurheartj/ehu421; Kochhauser S, 2017, J CARDIOVASC ELECTR, V28, P273, DOI 10.1111/jce.13138; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Lickfett L, 2006, J CARDIOVASC ELECTR, V17, P1, DOI 10.1111/j.1540-8167.2005.00279.x; Nademanee K, 2008, J AM COLL CARDIOL, V51, P843, DOI 10.1016/j.jacc.2007.10.044; Oral H, 2006, CIRCULATION, V114, P759, DOI 10.1161/CIRCULATIONAHA.106.641225; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Potpara TS, 2015, EUROPACE, V17, P986, DOI 10.1093/europace/euv132; Saad EB, 2011, CIRC-ARRHYTHMIA ELEC, V4, P615, DOI 10.1161/CIRCEP.111.963231; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Themistoclakis S, 2010, J AM COLL CARDIOL, V55, P735, DOI 10.1016/j.jacc.2009.11.039; Verma A, 2013, JAMA INTERN MED, V173, P149, DOI 10.1001/jamainternmed.2013.1561; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093	21	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201061	10.1371/journal.pone.0201061	http://dx.doi.org/10.1371/journal.pone.0201061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024976	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000085
J	Holt, R; Upadhyay, J; Smith, P; Allison, C; Baron-Cohen, S; Chakrabarti, B				Holt, Rosemary; Upadhyay, Jessica; Smith, Paula; Allison, Carrie; Baron-Cohen, Simon; Chakrabarti, Bhismadev			The Cambridge Sympathy Test: Self-reported sympathy and distress in autism	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; SPECTRUM DISORDERS; SEX-DIFFERENCES; EMPATHY; BEHAVIOR; ADULTS; BRAIN; PSYCHOPATHY; QUOTIENT	Background Difficulties with aspects of social interaction, including empathy, comprise a core symptom of autism spectrum conditions (autism). Sympathy is a specific form of empathy and involves both cognitive and affective empathy. Data are presented from a new task of self-reported sympathy and personal distress. Methods Participants with autism (93 males; 161 females) and controls (40 males, 93 females) took part in an online survey via the Autism Research Centre or Cambridge Psychology websites. Participants completed a task where they were asked to rate photographic images that were either of distressing, neutral or happy scenes, according to the amount of sympathy they had for the individual in the photo and the degree of personal distress they felt. All participants also completed the Empathy Quotient (EQ). Results Significant differences were found between the autism and control groups for both self-reported sympathy and personal distress, with participants with autism giving lower ratings than controls. Control females scored significantly higher than control males in both sympathy and distress. Sympathy and distress ratings in the autism group did not differ significantly by sex. EQ showed positive correlations with sympathy and distress scores. Conclusions Using a new measure of self-reported sympathy, we found that both males and females with autism gave lower ratings of sympathy when viewing people in distressing scenarios, compared to controls.	[Holt, Rosemary; Smith, Paula; Allison, Carrie; Baron-Cohen, Simon; Chakrabarti, Bhismadev] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Upadhyay, Jessica] Exeter Univ, Sch Med, Exeter, Devon, England; [Chakrabarti, Bhismadev] Univ Reading, Ctr Autism, Sch Psychol & Clin Language Sci, Reading, Berks, England	University of Cambridge; University of Exeter; University of Reading	Holt, R (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	rh465@medschl.cam.ac.uk		Baron-Cohen, Simon/0000-0001-9217-2544	Innovative Medicines Initiative Joint Undertaking from the European Union's Seventh Framework Programme (FP7/2007-2013) [115300]; Autism Research Trust; MRC; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; EFPIA; MRC [G0600977] Funding Source: UKRI	Innovative Medicines Initiative Joint Undertaking from the European Union's Seventh Framework Programme (FP7/2007-2013); Autism Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; EFPIA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115300, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The authors were also supported by Autism Research Trust, the MRC and the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust.	Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2013, EMPATHY DEFICITS AUT; Baron-Cohen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136521; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Batson CD., 1991, ALTRUISM QUESTION SO; Beadle JN, 2015, J GERONTOL B-PSYCHOL, V70, P213, DOI 10.1093/geronb/gbt091; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bird G, 2014, NEUROSCI BIOBEHAV R, V47, P520, DOI 10.1016/j.neubiorev.2014.09.021; Blair RJR, 2008, Q J EXP PSYCHOL, V61, P157, DOI 10.1080/17470210701508855; Blair RJR, 1999, PERS INDIV DIFFER, V26, P477, DOI 10.1016/S0191-8869(98)00154-8; Bolte S, 2011, AUTISM, V15, P497, DOI 10.1177/1362361310391116; Chakrabarti B, 2006, PROG BRAIN RES, V156, P403, DOI 10.1016/S0079-6123(06)56022-4; Channon S, 2010, J AUTISM DEV DISORD, V40, P1219, DOI 10.1007/s10803-010-0980-4; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; Eisenberg Nancy, 2009, EMPATHIC RESPONDING; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Jameel L, 2015, J AUTISM DEV DISORD, V45, P2311, DOI 10.1007/s10803-015-2393-x; Jones AP, 2010, J CHILD PSYCHOL PSYC, V51, P1188, DOI 10.1111/j.1469-7610.2010.02280.x; Koopmann-Holm B, 2014, J PERS SOC PSYCHOL, V107, P1092, DOI 10.1037/a0037684; Lai MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047198; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lockwood PL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00760; Lombardo MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35333; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; Rueda PF-B, 2015, ASPERGER SYNDROME EU, V12; Ruzich E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141229; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/2040-2392-6-2, 10.1186/s13229-015-0038-8]; Schwenck C, 2012, J CHILD PSYCHOL PSYC, V53, P651, DOI 10.1111/j.1469-7610.2011.02499.x; Sims TB, 2012, PSYCHOPHYSIOLOGY, V49, P998, DOI 10.1111/j.1469-8986.2012.01377.x; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sonnby-Borgstrom M, 2003, SCAND J PSYCHOL, V44, P141, DOI 10.1111/1467-9450.00332; Stein E., 1989, PROBLEM EMPATHY; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Toussaint L, 2005, J SOC PSYCHOL, V145, P673, DOI 10.3200/SOCP.145.6.673-686; Trimmer E, 2016, AUTISM, DOI [10.1177/1362361316648520, DOI 10.1177/1362361316648520PMID:27246093]; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10	48	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0198273	10.1371/journal.pone.0198273	http://dx.doi.org/10.1371/journal.pone.0198273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052646	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000440006600002
J	Yang, WK; Hsu, AD; Kang, CK; Lai, IP; Liao, PS; Lee, TH				Yang, Wen-Kai; Hsu, An-Di; Kang, Chao-Kai; Lai, Ivan Pochou; Liao, Pei-Shao; Lee, Tsung-Han			Intestinal FXYD12 and sodium-potassium ATPase: A comparative study on two euryhaline medakas in response to salinity changes	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; NA+/K+-ATPASE; ORYZIAS-LATIPES; FRESH-WATER; K+-ATPASE; OSMOREGULATORY ACCLIMATION; BRACKISH-WATER; ION REGULATION; GILL; SEAWATER	FXYD proteins are the regulators of sodium-potassium ATPase (Na+/K+-ATPase, NKA). In teleosts, NKA is a primary driving force for the operation of many ion transport systems in the osmoregulatory organs (e.g. intestines). Hence, the purpose of this study was to determine the expression of FXYD proteins and NKA alpha-subunit in the intestines of two closely related medakas (Oryzias dancena and O. latipes), which came from different salinity habitats and have diverse osmoregulatory capabilities, to illustrate the association between NKA and FXYD proteins of two medaka species in response to salinity changes. The results showed that the fxyd12 mRNA was the most predominant in the intestines of both medakas. The association of FXYD12 and NKA in the intestines of the two medaka species was demonstrated via double immunofluorescent staining and co-immunoprecipitation. Upon salinity challenge, the localization of FXYD12 and NKA was similar in the intestines of the two medaka species. However, the expression profiles of intestinal FXYD12 and NKA (mRNA and protein levels), as well as NKA activity differed between the medakas. These results showed that FXYD12 may play a role in modulating NKA activity in the intestines of the two medakas following salinity changes in the maintenance of internal homeostasis. These findings contributed to knowledge of the expression and potential role of vertebrate FXYD12, the regulators of NKA, upon salinity challenge.	[Yang, Wen-Kai; Hsu, An-Di; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Yang, Wen-Kai; Lee, Tsung-Han] Natl Chung Hsing Univ, iEGG, Taichung, Taiwan; [Yang, Wen-Kai; Lee, Tsung-Han] Natl Chung Hsing Univ, Anim Biotechnol Ctr, Taichung, Taiwan; [Yang, Wen-Kai] Hungkuang Univ, Bachelor Degree Program Anim Healthcare, Taichung, Taiwan; [Kang, Chao-Kai] Natl Cheng Kung Univ, Tainan Hydraul Lab, Tainan, Taiwan; [Lai, Ivan Pochou; Liao, Pei-Shao] Natl Taichung First Senior High Sch, Taichung, Taiwan; [Lai, Ivan Pochou; Liao, Pei-Shao] Natl Taiwan Univ, Coll Med, Sch Med, Taipei, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Hungkuang University; National Cheng Kung University; National Taiwan University	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.; Lee, TH (corresponding author), Natl Chung Hsing Univ, iEGG, Taichung, Taiwan.; Lee, TH (corresponding author), Natl Chung Hsing Univ, Anim Biotechnol Ctr, Taichung, Taiwan.	thlee@email.nchu.edu.tw		Lee, Tsung-Han/0000-0002-3542-4335; Yang, Wen-Kai/0000-0001-8095-2420; Liao, Pei-Shao/0000-0002-7182-6913; Lai, Ivan/0000-0001-8349-7056	Animal Biotechnology Center from The Feature Area Research Center Program by the Ministry of Education (MOE) in Taiwan [107S0023F]; iEGG; Ministry of Science and Technology, Taiwan [MOST 106-2313-B-005-038-MY3, MOST 105-2811-B-005-006]	Animal Biotechnology Center from The Feature Area Research Center Program by the Ministry of Education (MOE) in Taiwan; iEGG; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was in part financially supported by the iEGG and Animal Biotechnology Center from The Feature Area Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (107S0023F). This study was also in part financially supported by a grant to THL from the Ministry of Science and Technology, Taiwan (MOST 106-2313-B-005-038-MY3). WKY was supported by a postdoctoral fellowship of Ministry of Science and Technology, Taiwan (MOST 105-2811-B-005-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2011, J COMP PHYSIOL B, V181, P1045, DOI 10.1007/s00360-011-0592-0; Bagherie-Lachidan M, 2008, AM J PHYSIOL-REG I, V294, pR1638, DOI 10.1152/ajpregu.00039.2008; Bollinger RJ, 2016, J COMP PHYSIOL B, V186, P485, DOI 10.1007/s00360-016-0972-6; Chang CH, 2016, COMP BIOCHEM PHYS A, V194, P19, DOI 10.1016/j.cbpa.2016.01.013; Chew SF, 2010, J COMP PHYSIOL B, V180, P511, DOI 10.1007/s00360-009-0436-3; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; Hiroi J, 2012, RESP PHYSIOL NEUROBI, V184, P257, DOI 10.1016/j.resp.2012.07.019; Hu P, 2014, COMP BIOCHEM PHYS B, V174, P15, DOI 10.1016/j.cbpb.2014.05.002; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Juo JJ, 2016, ZOOL SCI, V33, P414, DOI 10.2108/zs150157; Kang CK, 2008, COMP BIOCHEM PHYS A, V151, P566, DOI 10.1016/j.cbpa.2008.07.020; Li ZQ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00066; Liang FF, 2017, J COMP PHYSIOL B, V187, P973, DOI 10.1007/s00360-017-1059-8; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Madsen SS, 2015, BIOL BULL-US, V229, P70, DOI 10.1086/BBLv229n1p70; Madsen SS, 2014, J EXP BIOL, V217, P3108, DOI 10.1242/jeb.105098; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Oguz AR, 2015, MAR FRESHW BEHAV PHY, V48, P135, DOI 10.1080/10236244.2015.1004838; Peh WYX, 2009, MAR BIOL, V156, P1751, DOI 10.1007/s00227-009-1210-5; Roberts TR, 1998, ICHTHYOL RES, V45, P213, DOI 10.1007/BF02673919; Saito K, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00129; Sardella BA, 2008, COMP BIOCHEM PHYS C, V148, P430, DOI 10.1016/j.cbpc.2008.05.006; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Sundell KS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1311; Sundell KS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00388; Sundh H, 2014, J FISH BIOL, V85, P1227, DOI 10.1111/jfb.12531; Takei Y, 2014, AM J PHYSIOL-REG I, V307, pR778, DOI 10.1152/ajpregu.00104.2014; Tang CH, 2012, COMP BIOCHEM PHYS A, V163, P302, DOI 10.1016/j.cbpa.2012.07.017; Teranishi K, 2010, J HISTOCHEM CYTOCHEM, V58, P707, DOI 10.1369/jhc.2010.955492; Tipsmark CK, 2010, AM J PHYSIOL-REG I, V299, pR1212, DOI 10.1152/ajpregu.00015.2010; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1367, DOI 10.1152/ajpregu.00454.2007; Tomy S, 2009, GEN COMP ENDOCR, V161, P123, DOI 10.1016/j.ygcen.2008.12.003; Wang PJ, 2008, J EXP BIOL, V211, P3750, DOI 10.1242/jeb.018440; Wang PJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00576; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wong MKS, 2016, ZOOL LETT, V2, DOI 10.1186/s40851-016-0050-7; Yang WK, 2016, COMP BIOCHEM PHYS B, V202, P23, DOI 10.1016/j.cbpb.2016.07.008; Yang Wen-Kai, 2016, Int J Biol Sci, V12, P730, DOI 10.7150/ijbs.15066; Yang WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055470, 10.1371/journal.pone.0076447]; Yang WK, 2011, J COMP PHYSIOL B, V181, P953, DOI 10.1007/s00360-011-0568-0; Yang WK, 2009, J EXP MAR BIOL ECOL, V375, P41, DOI 10.1016/j.jembe.2009.05.004	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201252	10.1371/journal.pone.0201252	http://dx.doi.org/10.1371/journal.pone.0201252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052675	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600033
J	Gibson, AD; Mazeri, S; Lohr, F; Mayer, D; Bailey, JLB; Wallace, RM; Handel, IG; Shervell, K; Bronsvoort, BMD; Mellanby, RJ; Gamble, L				Gibson, Andrew D.; Mazeri, Stella; Lohr, Frederic; Mayer, Dagmar; Bailey, Jordana L. Burdon; Wallace, Ryan M.; Handel, Ian G.; Shervell, Kate; Bronsvoort, Barend M. deC.; Mellanby, Richard J.; Gamble, Luke			One million dog vaccinations recorded on mHealth innovation used to direct teams in numerous rabies control campaigns	PLOS ONE			English	Article							RURAL AFRICA; ELIMINATION; HEALTH; IMPACT	Background Canine transmitted rabies kills an estimated 59,000 people annually, despite proven methods for elimination through mass dog vaccination. Challenges in directing and monitoring numerous remote vaccination teams across large geographic areas remain a significant barrier to the up-scaling of focal vaccination programmes to sub-national and national level. Smartphone technology (mHealth) is increasingly being used to enhance the coordination and efficiency of public health initiatives in developing countries, however examples of successful scaling beyond pilot implementation are rare. This study describes a smartphone app and website platform, "Mission Rabies App", used to co-ordinate rabies control activities at project sites in four continents to vaccinate over one million dogs. Methods Mission Rabies App made it possible to not only gather relevant campaign data from the field, but also to direct vaccination teams systematically in near real-time. The display of user-allocated boundaries on Google maps within data collection forms enabled a project manager to define each team's region of work, assess their output and assign subsequent areas to progressively vaccinate across a geographic area. This ability to monitor work and react to a rapidly changing situation has the potential to improve efficiency and coverage achieved, compared to regular project management structures, as well as enhancing capacity for data review and analysis from remote areas. The ability to plot the location of every vaccine administered facilitated engagement with stakeholders through transparent reporting, and has the potential to motivate politicians to support such activities. Results Since the system launched in September 2014, over 1.5 million data entries have been made to record dog vaccinations, rabies education classes and field surveys in 16 countries. Use of the system has increased year-on-year with adoption for mass dog vaccination campaigns at the India state level in Goa and national level in Haiti. Conclusions Innovative approaches to rapidly scale mass dog vaccination programmes in a sustained and systematic fashion are urgently needed to achieve the WHO, OIE and FAO goal to eliminate canine-transmitted human deaths by 2030. The Mission Rabies App is an mHealth innovation which greatly reduces the logistical and managerial barriers to implementing large scale rabies control activities. Free access to the platform aims to support pilot campaigns to better structure and report on proof-of-concept initiatives, clearly presenting outcomes and opportunities for expansion. The functionalities of the Mission Rabies App may also be beneficial to other infectious disease interventions.	[Gibson, Andrew D.; Mazeri, Stella; Lohr, Frederic; Bailey, Jordana L. Burdon; Shervell, Kate; Gamble, Luke] Mission Rabies, Cranborne, Dorset, England; [Gibson, Andrew D.; Mazeri, Stella; Handel, Ian G.; Bronsvoort, Barend M. deC.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Roslin Inst, Roslin, Midlothian, Scotland; [Gibson, Andrew D.; Mazeri, Stella; Handel, Ian G.; Bronsvoort, Barend M. deC.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies,Div Genet & Genom, Roslin, Midlothian, Scotland; [Mayer, Dagmar; Gamble, Luke] Worldwide Vet Serv, Cranborne, Dorset, England; [Wallace, Ryan M.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA; [Mellanby, Richard J.] Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies,Div Vet Clin Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Centers for Disease Control & Prevention - USA; University of Edinburgh	Gamble, L (corresponding author), Mission Rabies, Cranborne, Dorset, England.; Gamble, L (corresponding author), Worldwide Vet Serv, Cranborne, Dorset, England.; Mellanby, RJ (corresponding author), Univ Edinburgh, Hosp Small Anim, Easter Bush Vet Ctr, Royal Dick Sch Vet Studies,Div Vet Clin Studies, Roslin, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk; Luke@missionrabies.com	Mazeri, Stella/AAH-7611-2020; Gamble, Luke/F-2746-2018	Mazeri, Stella/0000-0002-4591-8267; Mellanby, Richard John/0000-0002-3467-7007; Lohr, Frederic/0000-0002-7158-3122; Gamble, Luke/0000-0003-3095-5935; Gibson, Andrew/0000-0002-4641-2583	Dogs Trust; Wellcome Trust Intermediate Clinical Fellowship; BBSRC through the Institute Strategic Programme funding [BB/J004235/1, BB/P013740/1]	Dogs Trust; Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); BBSRC through the Institute Strategic Programme funding(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Mission Rabies vaccination and education campaign were funded by a grant from Dogs Trust. MSD Animal Health donated all Nobivac Rabies vaccine used in the campaigns. RJM was supported by a Wellcome Trust Intermediate Clinical Fellowship. BB and RM were supported by BBSRC through the Institute Strategic Programme funding (BB/J004235/1 and BB/P013740/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Ali M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-86; Aviles W, 2008, AM J TROP MED HYG, V78, P311, DOI 10.4269/ajtmh.2008.78.311; Bailey JLB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006293; Bernabe-Ortiz A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-11; Bourhy H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000839; Chigona, 2018, INT J PRIV HEAL INF, V6, P49, DOI [10.4018/IJPHIM.2018010104, DOI 10.4018/IJPHIM.2018010104]; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Cleaveland S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1880; Cleaveland S, 2014, VET REC, V175, P188, DOI 10.1136/vr.g4996; Ferguson EA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18232; Gibson AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004824; Gibson AD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1320-2; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; International Telecommunication Union (ITU), 2017, ITC FACTS 2017 FIG; Jibat T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003447; Kaare M, 2009, VACCINE, V27, P152, DOI 10.1016/j.vaccine.2008.09.054; Kim SS, 2017, VACCINE, V35, P1373, DOI 10.1016/j.vaccine.2017.01.058; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Mazeri S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006159; Mtema Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002002; Mwabukusi M, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.737; Schneider MC, 2007, CAD SAUDE PUBLICA, V23, P2049, DOI 10.1590/S0102-311X2007000900013; Stanton Michelle, 2016, JMIR Public Health Surveill, V2, pe2, DOI 10.2196/publichealth.5064; Susan Paul N.S., 2018, INT J COMMUNITY MED, V5, P81, DOI [10.18203/2394-6040.ijcmph20175514, DOI 10.18203/2394-6040.IJCMPH20175514]; Teng JE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003050; Thriemer Kamala, 2012, BMC Res Notes, V5, P113, DOI 10.1186/1756-0500-5-113; Tohma K, 2016, INFECT GENET EVOL, V38, P22, DOI 10.1016/j.meegid.2015.12.001; Wallace RM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00009; Welburn SC, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00032; Welburn SC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005000; Widyastuti MDW, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0061-1	35	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200942	10.1371/journal.pone.0200942	http://dx.doi.org/10.1371/journal.pone.0200942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048469	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400035
J	Petersen, MT; da Silveira, ID; Tatila-Ferreira, A; David, MR; Chouin-Carneiro, T; Van den Wouwer, L; Maes, L; Maciel-De-Freitas, R				Petersen, Martha Thieme; da Silveira, Isabella Dias; Tatila-Ferreira, Aline; David, Mariana Rocha; Chouin-Carneiro, Thais; Van den Wouwer, Liesbeth; Maes, Louis; Maciel-de-Freitas, Rafael			The impact of the age of first blood meal and Zika virus infection on Aedes aegypti egg production and longevity	PLOS ONE			English	Article							RIO-DE-JANEIRO; DAILY SURVIVAL RATES; CONTAINER PRODUCTIVITY; BODY-SIZE; DIPTERA; DISPERSAL; FECUNDITY; TRANSMISSION; MOSQUITOS; PARASITE	The impact of senescence and pathogen infection on Aedes aegypti life-history traits remains poorly understood. This laboratory study focused on the impact of Zika virus (ZIKV) infection and the age of first blood intake on blood meal and clutch sizes, and more importantly on the egg production ratio per mu L of blood. Three groups of ZIKV-infected and uninfected Ae. aegypti females that received their first blood meal at 7 (young feeders), 14 (mature feeders) and 21 days old (old feeders) were monitored daily for survival and received a blood meal free of ZIKV once a week. The number of eggs laid per female were registered 3-4 days after blood feeding. Infection by ZIKV and age of feeding produced a strong negative impact on survival and oviposition success (e.g. likelihood of laying at least one egg per gonotrophic cycle). Interestingly, clutch size presented a dramatic reduction on uninfected mosquitoes, but raised from 36.5 in clutch1 to 55.1 eggs in clutch 3. Blood meal size remained stable in uninfected females, while a slight increase was observed for the infected counterparts. In uninfected Ae. aegypti, egg production was strongly affected by the age of feeding with younger females laying three times more eggs than when older. On the other hand, ZIKV-infected mosquitoes had a constant but low egg production. Overall, mosquito senescence and ZIKV infection had an impact on mosquito egg production by causing a sharp decrease in the number of eggs along the clutches for uninfected mosquitoes and a slight increase for infected mosquitoes. Despite some study limitations, our results contribute to a better understanding of the effects of mosquito aging and pathogen infection on the vectorial capacity of Ae. aegypti.	[Petersen, Martha Thieme; da Silveira, Isabella Dias; Tatila-Ferreira, Aline; David, Mariana Rocha; Chouin-Carneiro, Thais; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoa, Rio De Janeiro, RJ, Brazil; [Chouin-Carneiro, Thais] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, RJ, Brazil; [Van den Wouwer, Liesbeth; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Maciel-De-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoa, Rio De Janeiro, RJ, Brazil.	freitas@ioc.fiocruz.br	Maciel-de-Freitas, Rafael/J-1997-2012; Maes, Louis JRM/A-2384-2017	Maes, Louis JRM/0000-0002-2324-9509; Maciel-de-Freitas, Rafael/0000-0002-2198-6492; Rocha David, Mariana/0000-0003-1241-3585	MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit [E14/2016 (440929/2016-4)]; Faperj [Faperj]	MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit; Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Brazilian Research Councils MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit E14/2016 (440929/2016-4) and Faperj E18/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; BRIEGEL H, 1980, EXPERIENTIA, V36, P1428, DOI 10.1007/BF01960142; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Chahad-Ehlers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052559; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; DYE C, 1986, Parasitology Today, V2, P203; Edman John D., 1992, Journal of Medical Entomology, V29, P1035, DOI 10.1093/jmedent/29.6.1035; Faria NR, 2016, PLOS CURR, V8; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320; Harbach R.E., 1980, TAXONOMISTS GLOSSARY, P1; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610; Lucio PS, 2013, J VECTOR ECOL, V38, P20, DOI 10.1111/j.1948-7134.2013.12005.x; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252; McCann S, 2009, J VECTOR ECOL, V34, P174, DOI [10.1111/j.1948-7134.2009.00024.x, 10.3376/038.034.0202]; Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933; Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200766	10.1371/journal.pone.0200766	http://dx.doi.org/10.1371/journal.pone.0200766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048481	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400018
J	Spillane, NT; Zamudio, S; Alvarez-Perez, J; Andrews, T; Nyirenda, T; Alvarez, M; Al-Khan, A				Spillane, Nicole T.; Zamudio, Stacy; Alvarez-Perez, Jesus; Andrews, Tracy; Nyirenda, Themba; Alvarez, Manuel; Al-Khan, Abdulla			Increased incidence of respiratory distress syndrome in neonates of mothers with abnormally invasive placentation	PLOS ONE			English	Article							PRETERM INFANTS; OUTCOMES; MORBIDITY; ACCRETA; RISK; PREVIA; BIRTH; WOMEN; BORN	Background The incidence of abnormally invasive placentation (AIP) is increasing. Most of these pregnancies are delivered preterm. We sought to characterize neonatal outcomes in AIP pregnancies. Methods In this retrospective case-control study (2006-2015), AIP neonates (n = 108) were matched to two controls each for gestational age, antenatal glucocorticoid exposure, sex, plurity, and delivery mode. Medical records were reviewed for neonatal and maternal characteristics/outcomes. Univariate and multivariate Poisson regressions were performed to determine relative risk ratios (RR). Results There were no mortalities. All neonatal outcomes were similar except for respiratory distress syndrome (RDS), which affected 37% of AIP neonates (versus 21% of controls). AIP neonates required respiratory support (64.8% vs. 51.9%) and continuous positive airway pressure (53.7% vs. 42.1%) for a longer duration. Univariate regression yielded elevated RRs for RDS for AIP (RR 1.78, 95% CI 1.24-2.54), placenta previa (RR = 1.94, 95% CI 1.36-2.76), and placenta previa with bleeding (RR 2.29, 95% CI 1.36-3.86). One episode of bleeding had a RR of 2.43 (95% CI 1.57-3.76), 2 or more episodes had a RR of 2.95 (95% CI 1.96-4.44), and bleeding/abruption as the delivery indication had a RR of 2.57 (95% CI 1.82-3.64). A multivariate regression stratifying for AIP and evaluating the combined and individual associations of AIP, bleeding, placenta previa, and GA, resulted in elevated RRs for placenta previa alone (RR 2.16, 95% CI 1.15-4.06) and placenta previa and bleeding (RR 1.69, 95% CI 1.001-2.85). Conclusions The increased incidence of RDS at later gestational ages in AIP is driven by placenta previa. AIP neonates required respiratory support for a longer duration than age-matched controls. Providers should be prepared to counsel expectant parents and care for affected neonates.	[Spillane, Nicole T.] Hackensack Univ, Med Ctr, Dept Pediat, Div Neonatol, Hackensack, NJ 07601 USA; [Spillane, Nicole T.; Alvarez-Perez, Jesus; Alvarez, Manuel; Al-Khan, Abdulla] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA; [Zamudio, Stacy; Alvarez-Perez, Jesus; Alvarez, Manuel; Al-Khan, Abdulla] Hackensack Univ, Med Ctr, Ctr Abnormal Placentat, Dept Obstet & Gynecol,Div Maternal Fetal Med & Su, Hackensack, NJ USA; [Andrews, Tracy; Nyirenda, Themba] Hackensack Univ, Med Ctr, Dept Res, Off Res Adm, Hackensack, NJ USA	Hackensack University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hackensack University Medical Center; Hackensack University Medical Center	Spillane, NT (corresponding author), Hackensack Univ, Med Ctr, Dept Pediat, Div Neonatol, Hackensack, NJ 07601 USA.; Spillane, NT (corresponding author), Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA.	Nicole.Spillane@HackensackMeridian.org		Spillane, Nicole/0000-0002-9689-0743	National Institute of Health [U01 HD 087209]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Health, U01 HD 087209. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khan A, 2014, REPROD SCI, V21, P761, DOI 10.1177/1933719113512528; Alkozei A, 2014, J MATERN-FETAL NEO M, V27, P1738, DOI 10.3109/14767058.2014.942626; Altman M, 2013, PAEDIATR PERINAT EP, V27, P172, DOI 10.1111/ppe.12035; American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2016, Obstet Gynecol, V128, pe187, DOI 10.1097/AOG.0000000000001715; [Anonymous], 2017, Obstet Gynecol, V130, P493, DOI 10.1097/AOG.0000000000002231; [Anonymous], 2013, Obstet Gynecol, V121, P908, DOI 10.1097/01.AOG.0000428648.75548.00; [Anonymous], 2014, MAN OP 2, P1; Balayla J, 2013, J PERINAT MED, V41, P141, DOI 10.1515/jpm-2012-0219; Bekku S, 2000, J Matern Fetal Med, V9, P110; Belfort MA, 2011, SEMIN PERINATOL, V35, P252, DOI 10.1053/j.semperi.2011.05.002; Collins SL, 2015, OBSTET GYNECOL, V126, P645, DOI 10.1097/AOG.0000000000000962; Crane JMG, 1999, OBSTET GYNECOL, V93, P541, DOI 10.1016/S0029-7844(98)00480-3; Downes KL, 2017, AM J EPIDEMIOL, V186, P1319, DOI 10.1093/aje/kwx202; Eshkoli T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.037; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Gielchinsky Y, 2004, OBSTET GYNECOL, V104, P527, DOI 10.1097/01.AOG.0000136084.92846.95; Gouyon JB, 2008, PAEDIATR PERINAT EP, V22, P22, DOI 10.1111/j.1365-3016.2007.00875.x; Gregoire MC, 1998, PEDIATRICS, V101, P856, DOI 10.1542/peds.101.5.856; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hnat MD, 2005, AM J OBSTET GYNECOL, V193, P164, DOI 10.1016/j.ajog.2004.10.625; Holditch-Davis D, 2015, INFANT BEHAV DEV, V41, P154, DOI 10.1016/j.infbeh.2015.10.004; Hsu Y, 1998, CLIN NEONATOLOGY, V5, P1; Kassem GA, 2013, INT J WOMENS HEALTH, V5, P803, DOI 10.2147/IJWH.S53865; Koivisto M, 2005, J PEDIATR-US, V147, P486, DOI 10.1016/j.jpeds.2005.04.036; Lin CH, 2001, EARLY HUM DEV, V60, P215, DOI 10.1016/S0378-3782(00)00121-3; Martin R.J, 2020, FANAROFF MARTINS NEO, P1218; MCSHANE PM, 1985, OBSTET GYNECOL, V65, P176; Mehrabadi A, 2015, OBSTET GYNECOL, V125, P814, DOI 10.1097/AOG.0000000000000722; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Robinson BK, 2010, OBSTET GYNECOL, V116, P835, DOI 10.1097/AOG.0b013e3181f3588d; Schneiderman M, 2013, J MATERN-FETAL NEO M, V26, P1121, DOI 10.3109/14767058.2013.770465; SECKL JR, 2004, EUR J ENDOCRINOL S3, V151; SPINILLO A, 1994, AM J PERINAT, V11, P85, DOI 10.1055/s-2007-994562; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stroustrup A, 2012, J PEDIATR-US, V160, P38, DOI 10.1016/j.jpeds.2011.06.027; Stutchfield PR, 2016, NEW ENGL J MED, V375, P485, DOI 10.1056/NEJMc1605902; Warshak CR, 2010, OBSTET GYNECOL, V115, P65, DOI 10.1097/AOG.0b013e3181c4f12a; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074	38	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201266	10.1371/journal.pone.0201266	http://dx.doi.org/10.1371/journal.pone.0201266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048504	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400068
J	Baboolal, N; Davis, G; Stewart, R; Ramesar, J; McRae, A				Baboolal, Nelleen; Davis, Gershwin; Stewart, Robert; Ramesar, Jolie; McRae, Amanda			Comparisons between different elements of reported burden and common mental disorder in caregivers of ethnically diverse people with dementia in Trinidad	PLOS ONE			English	Article							HEALTH; INTERVENTIONS; PREVALENCE; RISK	Objective Culture plays a significant role in determining family responsibilities and possibly influences the caregiver burden associated with providing care for a relative with dementia. This study was carried out to determine the elements of caregiver burden in Trinidadians regarding which interventions will provide the most benefit. Methods Seventy-five caregivers of patients diagnosed with dementia participated in this investigation. Demographic data were recorded for each caregiver and patient. Caregiver burden was assessed using the Zarit Burden Interview (ZBI), and the General Health Questionnaire (GHQ) was used as a measure of psychiatric morbidity. Statistical analyses were performed using Stata and SPSS software. Associations between individual ZBI items and GHQ-28 scores in caregivers were analyzed in logistic regression models; the above-median GHQ-28 scores were used a binary dependent variable, and individual ZBI item scores were entered as 5-point ordinal independent variables. Results The caregiver sample was composed of 61 females and 14 males. Caregiver burden was significantly associated with the participant being male; there was heterogeneity by ethnic group, and a higher burden on female caregivers was detected at borderline levels of significance. Upon examining the associations between different ZBI items and the above-median GHQ-28 scores in caregivers, the strongest associations were found with domains reflecting the caregiver's health having suffered, the caregiver not having sufficient time for him/herself, the caregiver's social life suffering, and the caregiver admitting to feeling stressed due to caregiving and meeting other responsibilities. Conclusions In this sample, with a majority of female caregivers, the factors of the person with dementia being male and belonging to a minority ethnic group were associated with a greater degree of caregiver burden. The information obtained through the association of individual ZBI items and above-median GHQ-28 scores is a helpful guide for profiling Trinidadian caregiver burden.	[Baboolal, Nelleen] Univ West Indies, Fac Med Sci, Dept Clin Med Sci, St Augustine Campus, St Augustine, Trinidad Tobago; [Davis, Gershwin] Univ West Indies, Fac Med Sci, Dept Paraclin Sci, St Augustine Campus, St Augustine, Trinidad Tobago; [Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Stewart, Robert] South London & Maudsley NHS Fdn Trust, London, England; [Ramesar, Jolie] Univ Florida, Dept Pediat Hematol Oncol, Gainesville, FL USA; [McRae, Amanda] Univ West Indies, Dept Preclin Sci, Fac Med Sci, St Augustine Campus, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine; University West Indies Mona Jamaica; University West Indies Saint Augustine; University of London; King's College London; South London & Maudsley NHS Trust; State University System of Florida; University of Florida; University West Indies Mona Jamaica; University West Indies Saint Augustine	Baboolal, N (corresponding author), Univ West Indies, Fac Med Sci, Dept Clin Med Sci, St Augustine Campus, St Augustine, Trinidad Tobago.	Nelleen.Baboolal@sta.uwi.edu	Stewart, Robert/B-1667-2010	Stewart, Robert/0000-0002-4435-6397	University of the West Indies CRP [26600-467135, CRP.3.MAR08.23]; National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London; Faculty of Medical Sciences, The University of the West Indies, St. Augustine [CRP.3.MAR08.23]; MRC [MC_PC_17214] Funding Source: UKRI	University of the West Indies CRP; National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London; Faculty of Medical Sciences, The University of the West Indies, St. Augustine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the University of the West Indies CRP # 26600-467135 (CRP.3.MAR08.23, Caregiver Burden of Persons Caring for Patients with Dementia) (NB); and the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their thanks to the Faculty of Medical Sciences, The University of the West Indies, St. Augustine who supported the study with a grant (CRP.3.MAR08.23, Caregiver Burden of Persons Caring for Patients with Dementia). The National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. We thank the caregivers who consented to participate in the study at the memory clinic at the Eric Williams Medical Sciences Complex and those who were part of the caregiver support group of the Alzheimer's association of Trinidad and Tobago.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; American Psychiatric Association, 2000, TEXT REV DSM 4 TR; [Anonymous], 2004, CRIT PERSPECT; [Anonymous], 2015, WORLD ALZHEIMER REPO; [Anonymous], 2012, AGEING 21 CENTURY CE; Baboolal Nelleen, 2014, Dement. neuropsychol., V8, P330, DOI 10.1590/S1980-57642014DN84000005; Bowers K, 2012, WOMEN ALZHEIMERS DIS; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; CSO, 2011, TRIN TOB 2011 DEM RE; Davis G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018288; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Erol R., 2015, WOMEN DEMENTIA GLOBA; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gitlin LN, 2012, AM J PSYCHIAT, V169, P894, DOI 10.1176/appi.ajp.2012.12060774; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Goldberg D, 1978, MANUAL GEN HLTH QUES; Haley WE, 2004, AGING MENT HEALTH, V8, P316, DOI 10.1080/13607860410001728998; Janevic MR, 2001, GERONTOLOGIST, V41, P334, DOI 10.1093/geront/41.3.334; Messinger-Rapport B. J., 2006, ANN LONG TERM CARE, V14, P34; Ministry of Health Government of Trinidad and Tobago, PAN STEPS CHRON NON; Napoles AM, 2010, AM J ALZHEIMERS DIS, V25, P389, DOI 10.1177/1533317510370957; Norton MC, 2010, J AM GERIATR SOC, V58, P895, DOI 10.1111/j.1532-5415.2010.02806.x; Petros G, 2011, GLOBAL AGING, V7, P31; Pinquart M, 2005, GERONTOLOGIST, V45, P90, DOI 10.1093/geront/45.1.90; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M., 2013, WORLD ALZHEIMER REPO; Prince M, 2012, INT J GERIATR PSYCH, V27, P670, DOI 10.1002/gps.2727; Prince MJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000176; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Shaji K S, 2009, Indian J Psychiatry, V51, P45, DOI 10.4103/0019-5545.44905; Shriver M., 2010, WOMANS NATION TAKES; Sink KM, 2004, J AM GERIATR SOC, V52, P1277, DOI 10.1111/j.1532-5415.2004.52356.x; Skuse David, 2010, Int Psychiatry, V7, P29; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Willmott SA, 2004, SOC PSYCH PSYCH EPID, V39, P613, DOI 10.1007/s00127-004-0801-1; Zarit S.H., 1985, HIDDEN VICTIMS ALZHE; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201165	10.1371/journal.pone.0201165	http://dx.doi.org/10.1371/journal.pone.0201165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044879	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500086
J	Shell-Duncan, B; Moreau, A; Wander, K; Smith, S				Shell-Duncan, Bettina; Moreau, Amadou; Wander, Katherine; Smith, Sarah			The role of older women in contesting norms associated with female genital mutilation/cutting in Senegambia: A factorial focus group analysis	PLOS ONE			English	Article							ATTITUDES; DYNAMICS	Social norms theory has become prominent framework for understanding the perpetuation of female genital mutilation/cutting (FGM/C), and has influenced the design of interventions aimed at stopping the practice. Theoretical advances draw attention to the fact that FGM/C is often upheld by multiple interconnected norms that may vary and shift over time, offering a potential resource for social transformation. Analyzing focus group data from Senegambian women, the questions we explore are: What are the constellation of norms associated with FGM/C? When are existing practices and norms being contested, and how does this reflect prevailing structures of power and authority? Our research identifies four overarching themes: 1) pressure to conform with FGM/C arising from sanctions such as ostracization, and moral norms linked to the embodiment of virtue; 2) upholding tradition as a means of venerating ancestors; 3) upholding social hierarchy by displaying respect for elders; and 4) shifting beliefs about the healthful vs. harmful nature of FGM/C. While strong value is placed on upholding tradition, there is also an appreciation that elements of tradition must be revised to meet fluctuating realities, including the novel threat of HIV infection. Moreover, older women are uniquely positioned to realize the dual goal of honoring tradition while negotiating change. Rather than resisting change, we find that some older women express an openness to reassessing norms and practices as they seek solutions to maintaining the physical well-being, moral integrity and cultural identity of girls in their families. Moreover, given the authority of older women over younger women, they also have power to negotiate change. By recognizing older women as potential change leaders, and drawing on variability and fluidity in social norms, it may be increasingly possible to design interventions that will shape possibilities for action and accelerate abandonment of FGM/C without undermining the cultural value of tradition.	[Shell-Duncan, Bettina] Univ Washington, Seattle, WA 98195 USA; [Moreau, Amadou; Smith, Sarah] Global Res & Advocacy Grp, Dakar, Senegal; [Wander, Katherine] SUNY Binghamton, Binghamton, NY USA	University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Shell-Duncan, B (corresponding author), Univ Washington, Seattle, WA 98195 USA.	bsd@uw.edu	Wander, Katherine/AAL-1551-2020	Wander, Katherine/0000-0002-4913-5075	Department for International Development project, "Evidence to End FGM/C: Research to Help Girls and Women Thrive"; National Science Foundation: Directorate for Social, Behavioral and Economic Sciences [0313503]; UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development, and Research Training in Human Reproduction; Eunice Kennedy Shriver National Institute of Health and Human Development award [5R24HD042828]	Department for International Development project, "Evidence to End FGM/C: Research to Help Girls and Women Thrive"; National Science Foundation: Directorate for Social, Behavioral and Economic Sciences; UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development, and Research Training in Human Reproduction; Eunice Kennedy Shriver National Institute of Health and Human Development award	This research was funded by Department for International Development project, "Evidence to End FGM/C: Research to Help Girls and Women Thrive," coordinated by Population Council; National Science Foundation: Directorate for Social, Behavioral and Economic Sciences (grant number 0313503); and UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development, and Research Training in Human Reproduction. Computing support and grant administration through the Center for the Study of Demography and Ecology was supported by the Eunice Kennedy Shriver National Institute of Health and Human Development award number 5R24HD042828.	Abdelshahid A, 2015, J COMMUNITY APPL SOC, V25, P49, DOI 10.1002/casp.2195; AHMADU Fuambai, 2005, THESIS; An-Na'im Abdullah A., 2002, CULTURAL TRANSFORMAT, P13; [Anonymous], 2011, RES METHODS ANTHR; Aubel J, 2004, SOC SCI MED, V59, P945, DOI 10.1016/j.socscimed.2003.11.044; Aubel J, 2012, MATERN CHILD NUTR, V8, P19, DOI 10.1111/j.1740-8709.2011.00333.x; Burke NJ, 2009, HEALTH EDUC BEHAV, V36, p55S, DOI 10.1177/1090198109335338; Campo S, 2004, COMMUN MONOGR, V71, P448, DOI 10.1080/0363452042000307498; Cowan J.K., 2001, CULTURE RIGHTS ANTHR, P1; Creswell J. W., 2007, QUALITATIVE INQUIRY; Daffeh J, 1999, LISTENING VOICE PEOP; Diop N., 2006, ENQUETE DEMOGRAPHIQU; Gruenbaum E, 2005, CULT HEALTH SEX, V7, P429, DOI 10.1080/13691050500262953; Hernlund Y., 2000, FEMALE CIRCUMCISION, P235; Hernlund Ylva, 2003, THESIS U WASHINGTON; Knodel J, 1993, SUCCESSFUL FOCUS GRO, P35, DOI DOI 10.4135/9781483349008; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Mackie G., 2000, FEMALE CIRCUMCISION, P253; Mackie G., 2015, WHAT ARE SOCIAL NORM; Mackie G., 2009, SPECIAL SERIES SOCIA; Merry Sally Engle, 2001, CULTURE RIGHTS ANTHR, P31, DOI DOI 10.1017/CBO9780511804687; Merry Sally Engle, 2006, HUMAN RIGHTS GENDER; Miles M., 2013, QUALITATIVE DATA ANA; Nyamu-Musembi C, 2002, CULTURAL TRANSFORMAT, P126; O'Neill S., 2013, THESIS; Rah JH, 2004, J NUTR EDUC BEHAV, V36, P238, DOI 10.1016/S1499-4046(06)60386-2; Richards L., 2007, README 1 USERS GUIDE; Scholly K, 2005, J AM COLL HEALTH, V53, P159, DOI 10.3200/JACH.53.4.159-166; Shell-Duncan B., 2007, AFR TODAY, V53, P42, DOI [10.2979/AFT.2007.53.4.42, DOI 10.2979/AFT.2007.53.4.42]; Shell-Duncan B., 2016, STATE OF THE ART SYN; Shell-Duncan B, 2010, CONTINGENCY CHANGE P; Shell-Duncan B, 2011, SOC SCI MED, V73, P1275, DOI 10.1016/j.socscimed.2011.07.022; Skramstad H., 1990, FLUID MEANINGS FEMAL; Sylla MHS, 1990, EXCISION AU SENEGAL; UNAIDS, 2008, UNAIDS0825EJC151OE; UNICEF, 2013, FEM GEN MUT CUTT STA; Vogt S, 2016, NATURE, V538, P506, DOI 10.1038/nature20100	37	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199217	10.1371/journal.pone.0199217	http://dx.doi.org/10.1371/journal.pone.0199217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044770	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500010
J	Mortazavi, F; Nadian-Ghomsheh, A				Mortazavi, Fatemeh; Nadian-Ghomsheh, Ali			Stability of Kinect for range of motion analysis in static stretching exercises	PLOS ONE			English	Article							REHABILITATION; RELIABILITY; VALIDITY; TIME	Physical rehabilitation aims people with physical impairments to enhance and restore their functional ability. The Microsoft Kinect v1 and v2 technologies apply depth information and machine vision techniques to generate 3D coordinates of a set of anatomical landmarks on the human body regarded as Kinect joints. Trigonometry relationship between Kinect joints can be used to extract body Range of Motion ( ROM). The purpose of this study was to evaluate stability of Kinect for ROM measurement during static stretching exercises. According to the literature, the stability of Kinect in static exercises has been reported to a limited extent. 13 healthy men participated in this study and performed 5 exercises in 2 different distances from the cameras. Exercises were recorded by Kinect v1 and Kinect v2, concurrently. The stability of Kinect was also evaluated for 5 ROMs including: elbow flexion, shoulder abduction, wrist pronation, wrist flexion, and wrist ulnar deviation. Maximum and average joint displacement errors were used for stability analysis. Results showed that Kinect v2 is more stable compared to Kinect v1. Kinect v2 joints showed displacement error of more than 15 mm for wrist. For the other joints, Kinect showed an average displacement error of less than 10 mm.	[Mortazavi, Fatemeh; Nadian-Ghomsheh, Ali] Shahid Beheshti Univ, Cyber Space Res Inst, GC, Tehran, Iran	Shahid Beheshti University	Nadian-Ghomsheh, A (corresponding author), Shahid Beheshti Univ, Cyber Space Res Inst, GC, Tehran, Iran.	a_nadian@sbu.ac.ir		Nadian-Ghomsheh, Ali/0000-0002-2215-409X				BANDY WD, 1994, PHYS THER, V74, P845, DOI 10.1093/ptj/74.9.845; Bonnechere B, 2014, GAIT POSTURE, V39, P593, DOI 10.1016/j.gaitpost.2013.09.018; Chang YJ, 2013, RES DEV DISABIL, V34, P3654, DOI 10.1016/j.ridd.2013.08.021; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Fern'ndez-Baena, 2012, 4 INT C INT NETW COL, DOI 10.1109/iNCoS.2012.66; GAJDOSIK RL, 1987, PHYS THER, V67, P1867, DOI 10.1093/ptj/67.12.1867; Huang QX, 2016, ISIJ INT, V56, P288, DOI 10.2355/isijinternational.ISIJINT-2015-324; Kitsunezaki N, 2013, MED MEAS APPL P MEME; Kolar P, 2014, CLIN REHABILITATION; Lange B, 2011, ENG MED BIOL SOC EMB; Lee SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129398; Mousavi Hondori Hossein, 2014, J Med Eng, V2014, P846514, DOI 10.1155/2014/846514; Otte K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166532; Page P, 2012, INT J SPORTS PHYS TH, V7, P109; Pastor I, 2012, ENG MED BIOL SOC EMB; Reither LR, 2018, DISABIL REHABIL-ASSI, V13, P54, DOI 10.1080/17483107.2016.1278473; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Suma E. A, FLEXIBLE ACTION ARTI; Wade E, 2011, TOP STROKE REHABIL, V18, P685, DOI 10.1310/tsr1806-685; Wang Q, 2015, INT C HEALTHC INF IC; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Yang L, 2015, IEEE SENS J, V15, P4275, DOI 10.1109/JSEN.2015.2416651; Zulkarnain RF, 2017, J SHOULDER ELB SURG, V26, P895, DOI 10.1016/j.jse.2016.10.026	24	12	12	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200992	10.1371/journal.pone.0200992	http://dx.doi.org/10.1371/journal.pone.0200992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040848	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200021
J	Crucitti, T; Hardy, L; van de Wijgert, J; Agaba, S; Buyze, J; Kestelyn, E; Delvaux, T; Mwambarangwe, L; De Baetselier, I; Jespers, V				Crucitti, Tania; Hardy, Liselotte; van de Wijgert, Janneke; Agaba, Stephen; Buyze, Jozefien; Kestelyn, Evelyne; Delvaux, Therese; Mwambarangwe, Lambert; De Baetselier, Irith; Jespers, Vicky		Ring Plus Study Grp	Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women	PLOS ONE			English	Article							HORMONAL CONTRACEPTION; AFRICAN WOMEN; GRAM STAIN; ASSOCIATION; ACQUISITION; HIV; COMMUNITIES; PREVENTION; MICROBIOTA; ACYCLOVIR	Background Hormonal contraception has been associated with a reduced risk of vaginal dysbiosis, which in turn has been associated with reduced prevalence of sexually transmitted infections (STIs), including HIV. Vaginal rings are used or developed as delivery systems for contraceptive hormones and antimicrobial drugs for STI and HIV prevention or treatment. We hypothesized that a contraceptive vaginal ring (CVR) containing oestrogen enhances a lactobacilli-dominated vaginal microbial community despite biomass accumulation on the CVR's surface. Methods We enrolled 120 women for 12 weeks in an open-label NuvaRing((R)) study at Rinda Ubuzima, Kigali, Rwanda. Vaginal and ring microbiota were assessed at baseline and each ring removal visit by Gram stain Nugent scoring (vaginal only), quantitative PCR for Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae, and fluorescent in situ hybridization to visualize cell-adherent bacteria. Ring biomass was measured by crystal violet staining. Results Bacterial vaginosis (BV) prevalence was 48% at baseline. The mean Nugent score decreased significantly with ring use. The presence and mean log(10) concentrations of Lactobacillus species in vaginal secretions increased significantly whereas those of G. vaginalis and presence of A. vaginae decreased significantly. Biomass accumulated on the CVRs with a species composition mirroring the vaginal microbiota. This ring biomass composition and optical density after crystal violet staining did not change significantly over time. Conclusion NuvaRing((R)) promoted lactobacilli-dominated vaginal microbial communities in a population with high baseline BV prevalence despite the fact that biomass accumulated on the rings.	[Crucitti, Tania; Hardy, Liselotte; Buyze, Jozefien; Delvaux, Therese; De Baetselier, Irith; Jespers, Vicky] Inst Trop Med, Antwerp, Belgium; [van de Wijgert, Janneke; Kestelyn, Evelyne] Univ Liverpool, Liverpool, Merseyside, England; [Agaba, Stephen; Kestelyn, Evelyne; Mwambarangwe, Lambert] Rinda Ubuzima, Kigali, Rwanda	Institute of Tropical Medicine (ITM); University of Liverpool	Crucitti, T (corresponding author), Inst Trop Med, Antwerp, Belgium.	tcrucitti@itg.be	Crucitti, Tania/AAB-9967-2019; Kestelyn, Evelyne/AAD-6052-2019; Crucitti, Tania/AAH-1902-2021; Hardy, Liselotte/AAF-3515-2019; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Kestelyn, Evelyne/0000-0002-5728-0918; Crucitti, Tania/0000-0002-2235-6038; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy' [SP.2011.41304.043]; Institute of Tropical Medicine in Antwerp; University of Liverpool	European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy'; Institute of Tropical Medicine in Antwerp; University of Liverpool	This study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy' (grant code SP.2011.41304.043 to Tania Crucitti), with contributions from the Institute of Tropical Medicine in Antwerp and the University of Liverpool. The results and opinions expressed in this manuscript are those of the authors and not necessarily those of EDCTP, the Institute of Tropical Medicine in Antwerp, or the University of Liverpool, and these institutions are not responsible for any future use of the information contained in this manuscript. EDCTP did not have a role in the study design, data collection, analysis, and interpretation, report-writing, and the decision to submit the paper for publication. NuvaRings for use in the study were bought on the European market; Organon and Merck were not involved in any way in this trial.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Boonstra HD, 2015, GUTTMACHER POLICY RE, V18, P62; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Buve A, 2014, AIDS, V28, P2333, DOI 10.1097/QAD.0000000000000432; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Crucitti T, 2017, RES MICROBIOL, V168, P773, DOI 10.1016/j.resmic.2017.07.004; Danielsson D, 2011, ANN NY ACAD SCI, V1230, P48, DOI 10.1111/j.1749-6632.2011.06041.x; De Seta F, 2012, CONTRACEPTION, V86, P526, DOI 10.1016/j.contraception.2012.02.012; Donders GGG, 2017, RES MICROBIOL, V168, P845, DOI 10.1016/j.resmic.2017.04.004; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205; Gunawardana M, 2011, J MED MICROBIOL, V60, P828, DOI 10.1099/jmm.0.028225-0; Hardy L, 2017, RES MICROBIOL, V168, P865, DOI 10.1016/j.resmic.2017.02.001; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178324; Huang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134460; Jespers V, 2016, RES MICROBIOL, V167, P133, DOI 10.1016/j.resmic.2015.10.006; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Jiang X., 2015, PLOS ONE, V10; Keller MJ, 2012, J ANTIMICROB CHEMOTH, V67, P2005, DOI 10.1093/jac/dks151; King Caroline C, 2011, Infect Dis Obstet Gynecol, V2011, P319460, DOI 10.1155/2011/319460; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lokken EM, 2017, AM J EPIDEMIOL, V186, P194, DOI 10.1093/aje/kwx043; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Miller L, 2005, CONTRACEPTION, V71, P65, DOI 10.1016/j.contraception.2004.07.015; Mirmonsef P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153553; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Pal Z, 2005, J MED MICROBIOL, V54, P1199, DOI 10.1099/jmm.0.46197-0; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pruthi V, 2003, Indian J Med Microbiol, V21, P161; Rabe L, 2014, AIDS RES HUM RETROV, V30, pA290, DOI 10.1089/aid.2014.5657.abstract; Rathod SD, 2011, SEX TRANSM DIS, V38, P882, DOI 10.1097/OLQ.0b013e31821f91a1; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Romano J, 2013, ANTIVIR RES, V100, pS32, DOI 10.1016/j.antiviral.2013.09.016; Schurmans C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1680-y; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Tachedjian G, 2017, RES MICROBIOL, V168, P782, DOI 10.1016/j.resmic.2017.04.001; Ursell LK, 2014, ANTIVIR RES, V102, P87, DOI 10.1016/j.antiviral.2013.12.004; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van de Wijgert JHHM, 2017, RES MICROBIOL, V168, P859, DOI 10.1016/j.resmic.2017.02.003; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Vaneechoutte M, 2017, RES MICROBIOL, V168, P811, DOI 10.1016/j.resmic.2017.08.001; Vaneechoutte M, 2017, RES MICROBIOL, V168, P826, DOI 10.1016/j.resmic.2017.09.003; Veeh RH, 2003, J INFECT DIS, V188, P519, DOI 10.1086/377001; Veres S, 2004, OBSTET GYNECOL, V104, P555, DOI 10.1097/01.AOG.0000136082.59644.13; Vodstrcil LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073055; Wolcott R, 2013, CLIN MICROBIOL INFEC, V19, P107, DOI 10.1111/j.1469-0691.2012.04001.x	53	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201003	10.1371/journal.pone.0201003	http://dx.doi.org/10.1371/journal.pone.0201003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036385	gold, Green Published, Green Submitted			2022-12-27	WOS:000439429200023
J	Fang, H; Cui, YB; Wang, Z; Wang, S				Fang, Hao; Cui, Yibin; Wang, Zhuang; Wang, Se			Toxicological assessment of multi-walled carbon nanotubes combined with nonylphenol in male mice	PLOS ONE			English	Article							OXIDATIVE STRESS; SINGLE-WALL; BISPHENOL-A; DNA-DAMAGE; PULMONARY TOXICITY; GRAPHITIC CARBON; MEAT FLAVOR; CELL-CYCLE; IN-VITRO; KAPPA-B	Carbon nanotubes have attracted increasing attention attributable to their widespread application. To evaluate the joint toxicity of multi-walled carbon nanotubes (MWCNTs) and nonylphenol (NP), we investigated the toxicological effects of NP, pristine MWCNTs, and MWCNTs combined with NP in male mice. After exposing male mice by gavage for 5 days, intracellular superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activity, as well as malondialdehyde (MDA) and glutathione (GSH) levels in tissues were determined to evaluate in vivo oxidative stress. In addition, genotoxicity was assessed by examining DNA damage in mouse liver and sperm via the comet assay, and transmission electron microscopy (TEM) was used for direct visual observations of mitochondrial damage in the liver. Results from the oxidative damage and DNA damage experiments indicate that after adsorbing NP, MWCNTs at a high dose induce oxidative lesions in the liver and cause DNA damage in mouse sperm; these data offer new insights regarding the toxicological assessment of MWCNTs.	[Fang, Hao; Wang, Zhuang; Wang, Se] Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Atmospher Environm & Equip, Sch Environm Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Cui, Yibin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University of Information Science & Technology	Cui, YB (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	cyb@nies.org	Wang, Zhuang/M-1964-2016	Wang, Zhuang/0000-0001-7032-4500	Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology [2014r020]; Natural Science Foundation of Jiangsu Province [BK20170948]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [17KJB610007]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015C222]; National Natural Science Foundation of China, China [31572623]	Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC))	This project was supported by Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology (2014r020 to HF), The Natural Science Foundation of Jiangsu Province (BK20170948 to HF), The Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJB610007 to HF), Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015C222 to HF) and National Natural Science Foundation of China (31572623 to YC), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by Startup Foundation for Introducing Talent (2014r020) of Nanjing University of Information Science and Technology, The Natural Science Foundation of Jiangsu Province (BK20170948), The Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJB610007), Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015C222) and National Natural Science Foundation of China (31572623), China.	Aly HAA, 2012, TOXICOL APPL PHARM, V261, P134, DOI 10.1016/j.taap.2012.02.015; Aydogan M, 2008, TOXICOLOGY, V249, P35, DOI 10.1016/j.tox.2008.04.002; Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]; Brown DM, 2007, CARBON, V45, P1743, DOI 10.1016/j.carbon.2007.05.011; Chitra KC, 2002, ARCH TOXICOL, V76, P545, DOI 10.1007/s00204-002-0372-4; Clark KA, 2012, J TOXICOL ENV HEAL A, V75, P25, DOI 10.1080/15287394.2011.589105; Colerangle JB, 1996, ENDOCRINE, V4, P115, DOI 10.1007/BF02782756; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; DAVID NA, 1972, ANNU REV PHARMACOLOG, V12, P353, DOI 10.1146/annurev.pa.12.040172.002033; Deng X, 2007, CARBON, V45, P1419, DOI 10.1016/j.carbon.2007.03.035; El-Dakdoky MH, 2007, B ENVIRON CONTAM TOX, V79, P188, DOI 10.1007/s00128-007-9158-y; Ghosh M, 2011, J HAZARD MATER, V197, P327, DOI 10.1016/j.jhazmat.2011.09.090; Gong Y, 2006, REPROD TOXICOL, V22, P623, DOI 10.1016/j.reprotox.2006.04.019; Gundersen JL, 2001, J CHROMATOGR A, V914, P161, DOI 10.1016/S0021-9673(00)01235-8; Horiuchi K, 2005, ARCH HISTOL CYTOL, V68, P51, DOI 10.1679/aohc.68.51; Hu CW, 2013, ENVIRON SCI-PROC IMP, V15, P2125, DOI 10.1039/c3em00376k; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kisin ER, 2007, J TOXICOL ENV HEAL A, V70, P2071, DOI 10.1080/15287390701601251; Kudo C, 2004, J NEUROCHEM, V88, P1416, DOI 10.1046/j.1471-4159.2003.02270.x; Kyselova Vendula, 2003, Reprod Biol Endocrinol, V1, P30, DOI 10.1186/1477-7827-1-30; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Lee PC, 1998, ENDOCRINE, V9, P105, DOI 10.1385/ENDO:9:1:105; Lee S, 2009, ENVIRON TOXICOL PHAR, V27, P90, DOI 10.1016/j.etap.2008.08.009; Li XN, 2014, J COLLOID INTERF SCI, V415, P159, DOI 10.1016/j.jcis.2013.10.021; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Li ZY, 2013, ENVIRON MONIT ASSESS, V185, P5221, DOI 10.1007/s10661-012-2938-9; Liang GY, 2010, J TOXICOL ENV HEAL A, V73, P463, DOI 10.1080/15287390903523378; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Matsumoto M, 2012, J TOXICOL SCI, V37, P463; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Negishi T, 2004, ENVIRON HEALTH PERSP, V112, P1159, DOI 10.1289/ehp.6961; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P5480, DOI 10.1021/es8001184; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; RAMARATHNAM N, 1993, J AGR FOOD CHEM, V41, P939, DOI 10.1021/jf00030a020; RAMARATHNAM N, 1993, J AGR FOOD CHEM, V41, P933, DOI 10.1021/jf00030a019; Reddy ARN, 2011, REGUL TOXICOL PHARM, V59, P251, DOI 10.1016/j.yrtph.2010.10.007; Roy D, 1998, FRONT BIOSCI-LANDMRK, V3, P913; Sanchis J, 2016, ENVIRON SCI TECHNOL, V50, P961, DOI 10.1021/acs.est.5b03966; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/713853956; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; SUN Y, 1988, CLIN CHEM, V34, P497; Vazquez-Duhalt R., 2005, APPL ECOL ENV RES, V4, P1; Wang JX, 2006, BIOCHEM PHARMACOL, V71, P872, DOI 10.1016/j.bcp.2005.12.001; Wang WW, 2014, INT J MOL SCI, V15, P15981, DOI 10.3390/ijms150915981; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Watanabe H, 2004, J MOL ENDOCRINOL, V33, P243, DOI 10.1677/jme.0.0330243; Xu C, 2016, ONCOTARGET, V7, P39270, DOI 10.18632/oncotarget.9689; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Yang K, 2009, ENVIRON POLLUT, V157, P1095, DOI 10.1016/j.envpol.2008.11.007; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137	61	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200238	10.1371/journal.pone.0200238	http://dx.doi.org/10.1371/journal.pone.0200238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028835	Green Submitted, gold, Green Published			2022-12-27	WOS:000439396900005
J	Mastrangelo, T; Kovaleski, A; Botteon, V; Scopel, W; Costa, MDZ				Mastrangelo, Thiago; Kovaleski, Adalecio; Botteon, Victor; Scopel, Wanessa; Zamboni Costa, Maria de Lourdes			Optimization of the sterilizing doses and overflooding ratios for the South American fruit fly	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; INSECT TECHNIQUE; TEPHRITIDAE; POPULATIONS; FEMALES; COMPLEX; INDUCTION; MALES; FLIES	The Sterile Insect Technique (SIT) is an autocidal control method that relies on inundative releases of sterilized mass-reared insects. This technology has been used in several area-wide programmes for the suppression/eradication of fruit fly populations. Choosing the optimum sterilizing dose and the sterile release density is an essential step of the SIT. Considering unsolved issues related to the application of this technique against Anastrepha fraterculus (Wiedemann), this study aimed to define accurately the central target dose for both sexes of this species and to verify the induction of sterility in fertile flies at different sterile:fertile ratios. The results from the regression analyses proved that the sterilization process for the A. fraterculus Brazilian-1 morphotype (the most common in southern Brazil and Argentina) could consist of irradiating pupae 72 h before adult emergence at 40 Gy, with no detrimental effects to standard quality control parameters. The ovarian development in irradiated females was characterized, demonstrating that doses equal to or higher than 25 Gy cause complete and irreversible ovarian atrophy. The laboratory and field cage tests showed that the sterility induction increased with the proportion of sterile flies, and a sterile:fertile ratio of 50:1 should be appropriate in SIT field trials. The sterile females apparently did not distract the sterile males, despite of the slightly higher reductions in pupal yield for all ratios in their absence. The data generated in this study have a great practical value and will help decision-makers in planning field trials to evaluate the efficacy of the SIT against A. fraterculus populations.	[Mastrangelo, Thiago; Botteon, Victor; Zamboni Costa, Maria de Lourdes] Univ Sao Paulo, CENA, Sao Paulo, Brazil; [Kovaleski, Adalecio] Empresa Brasileira Pesquisa Agr EMBRAPA, Estacao Expt Fruticultura Clima Temperado, Vacaria, RS, Brazil; [Scopel, Wanessa] Univ Sao Paulo, ESALQ, Sao Paulo, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Mastrangelo, T (corresponding author), Univ Sao Paulo, CENA, Sao Paulo, Brazil.	piaui@cena.usp.br	Mastrangelo, Thiago/N-3569-2019	Mastrangelo, Thiago/0000-0003-1882-9565; Botteon, Victor Wilson/0000-0002-2660-3796	FAPESP [2016/24510-6]; CNPq [401369/2016-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The experiments of this study were supported by FAPESP (grant number 2016/24510-6) and CNPq (grant number 401369/2016-1) for Prof. Thiago Mastrangelo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abraham S, 2013, B ENTOMOL RES, V103, P310, DOI 10.1017/S0007485312000727; Abraham S, 2011, ENTOMOL EXP APPL, V141, P15, DOI 10.1111/j.1570-7458.2011.01160.x; Alba MG, 2016, 9 M TEPHR WORK W HEM; Allinghi A, 2007, FLA ENTOMOL, V90, P27, DOI 10.1653/0015-4040(2007)90[27:CACOAL]2.0.CO;2; Allinghi A, 2007, FLA ENTOMOL, V90, P96, DOI 10.1653/0015-4040(2007)90[96:IOSIAF]2.0.CO;2; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bartolucci AF, 2006, P 7 INT S FRUIT FLIE; Bron Ilana U., 2006, Braz. J. Plant Physiol., V18, P389, DOI 10.1590/S1677-04202006000300005; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; Cendra PG, 2007, FLA ENTOMOL, V90, P147, DOI 10.1653/0015-4040(2007)90[147:COLBAL]2.0.CO;2; Costa MLZ, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew071; Devescovi F, 2014, ENTOMOL EXP APPL, V152, P238, DOI 10.1111/eea.12219; Dias VS, 2016, BIOL J LINN SOC, V117, P725, DOI 10.1111/bij.12712; Dyck V.A., 2006, STERILE INSECT TECHN; Flores S, 2017, ENTOMOL EXP APPL, V164, P284, DOI 10.1111/eea.12580; Flores S, 2014, J ECON ENTOMOL, V107, P1502, DOI 10.1603/EC13398; Cendra PG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.17501; Gonzalez J, 1971, REV PERUANA ENTOMOLO, V14, P77; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hernandez-Ortiz V, 2015, ZOOKEYS, P95, DOI 10.3897/zookeys.540.6027; [IAEA USDA FAO], 2014, PROD QUAL CONTR STER; *IAEA, 2004, DOS SYST SIT STAND O; Knipling E.F., 1979, USDA SEA AGR HDB, V512, P659; Kovaleski A., 2007, P581, DOI 10.1007/978-1-4020-6059-5_54; Liendo MC, 2013, B ENTOMOL RES, V103, P1, DOI 10.1017/S0007485312000442; Machota JR, 2010, TECNICA CRIACAO ANAS; Mastrangelo T, 2010, J ECON ENTOMOL, V103, P85, DOI 10.1603/EC09139; Mehta K, 2011, RADIAT PHYS CHEM, V80, P107, DOI 10.1016/j.radphyschem.2010.08.011; Walder JMM, 2014, SCI AGR, V71, P281, DOI 10.1590/0103-9016-2013-233; Meza JS, 2016, 9 M TEPHR WORK W HEM; Orozco D, 2013, J APPL ENTOMOL, V137, P321, DOI 10.1111/j.1439-0418.2012.01748.x; Orozco-Davila D, 2017, ENTOMOL EXP APPL, V164, P176, DOI 10.1111/eea.12581; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; RHODE RH, 1971, J ECON ENTOMOL, V64, P708, DOI 10.1093/jee/64.3.708; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Rull J, 2013, ENTOMOL EXP APPL, V148, P213, DOI 10.1111/eea.12094; SAS Institute Inc, 2013, SAS SOFTW VERS 9 4; Segura DF, 2013, J APPL ENTOMOL, V137, P19, DOI 10.1111/j.1439-0418.2010.01534.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shelly T, 2016, ANN ENTOMOL SOC AM, V109, P1, DOI 10.1093/aesa/sav101; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; STEINER LF, 1969, J ECON ENTOMOL, V62, P4, DOI 10.1093/jee/62.1.4; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; Vera MT, 2002, FLA ENTOMOL, V85, P156, DOI 10.1653/0015-4040(2002)085[0156:FAFRFI]2.0.CO;2; Villasenor A., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P361	48	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201026	10.1371/journal.pone.0201026	http://dx.doi.org/10.1371/journal.pone.0201026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028883	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900032
J	Quah, SW; Majid, HA; Al-Sadat, N; Yahya, A; Sue, TT; Jalaludin, MY				Quah, Shiao Wei; Majid, Hazreen Abdul; Al-Sadat, Nabilla; Yahya, Abqariyah; Sue, Tin Tin; Jalaludin, Muhammad Yazid			Risk factors of vitamin D deficiency among 15-year-old adolescents participating in the Malaysian Health and Adolescents Longitudinal Research Team Study (MyHeARTs)	PLOS ONE			English	Article							25-HYDROXYVITAMIN D-3; SUN PROTECTION; CHILDREN; SCHOOLCHILDREN; EPIDEMIOLOGY; DETERMINANTS; CHILDHOOD; NUTRITION; ETHNICITY; ADULTHOOD	Background This study is to determine the prevalence and risk factors of vitamin D deficiency (vitamin D <= 50 nmol/L) among 15-year-old Malaysian adolescents. By identifying potential risk factors, prevention strategies and interventions can be carried out to improve the vitamin D status in adolescents. Methods and findings Stratified random sampling design was used to select adolescents from 15 urban and rural secondary schools in Selangor, Perak and Kuala Lumpur, Malaysia. Data collection was carried out from 1st April 2014 to 30th June 2014. Information regarding socio-demographic characteristics, sun exposure and sun protective behaviours, clinical data and environmental factors were collected. Blood for total vitamin D was sampled. Descriptive and multivariate logistic regressions were performed. Total 1061 participants were analyzed (62% were female; mean age 15.1 +/- 0.4 years). The prevalence of vitamin D deficiency was 33%. Mean vitamin D was lower in female (53 +/- 15 nmol), obese (body fat percentage (>= 25%(m); >33.8%(f)) (56 +/- 16 nmol/L), Malays (58 +/- 18 nmol/L) and Indians (58 +/- 15 nmol/L). In multivariate analysis, female (OR = 5.5; 95% CI: 3.4-7.5), Malay (OR = 3.2; 95% CI: 1.3-8.0), Indian (OR = 4.3; 95% CI: 1.6-12.0) and those always wearing long sleeve (OR = 2.4; 95% CI: 1.1-5.4) were more likely to have vitamin D deficiency. For female participants, ethnicity {Malays (OR = 6.7; 95% CI: 2.0-18.5), Indian (OR = 4.5; 95% CI: 1.8-19.3)} was an important risk factors. Cloud cover, school residence, skin pigmentation, sun-exposure and sun-protective behaviours were not significant risk factors. The limitation of this study was recall bias as it relied on self-reported on the sun exposure and protective behaviours. The diet factors were not included in this analysis. Conclusions The prevalence of Vitamin D deficiency among Malaysian adolescents was considerable. Gender, ethnicity and clothing style were important risk factors.	[Quah, Shiao Wei; Jalaludin, Muhammad Yazid] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Majid, Hazreen Abdul; Al-Sadat, Nabilla; Sue, Tin Tin] Univ Malaya, Fac Med, Ctr Populat Hlth CePH, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Yahya, Abqariyah] Univ Malaya, Fac Med, Dept Social & Prevent Med, JCUM, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Jalaludin, MY (corresponding author), Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia.	yazidj@ummc.edu.my	Yahya, Abqariyah/B-5638-2017; Jalaludin, Muhammad Yazid/B-9172-2010; Abdul Majid, Hazreen/B-8619-2010	Yahya, Abqariyah/0000-0001-9158-415X; Jalaludin, Muhammad Yazid/0000-0003-4513-8444; Su, Tin Tin/0000-0003-0387-6406; Abdul Majid, Hazreen/0000-0002-2718-8424	University of Malaya [RP022-14HTM]	University of Malaya(Universiti Malaya)	The study was funded by the grant from University of Malaya Research Program: RP022-14HTM to HAM. The funders had no role in study design, collection, analysis and interpretation of data, writing of the manuscript, or decision to submit for publication.	Abdullah NF, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090551; Al-Sadat N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010689; Alshahrani FM, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23351; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; [Anonymous], UV RES GUID SUNSCR; Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cashman KD, 2007, POSTGRAD MED J, V83, P230, DOI 10.1136/pgmj.2006.052787; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Chew A, 2013, NUTR REV, V71, P189, DOI 10.1111/nure.12015; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Foo LH, 2009, OSTEOPOROSIS INT, V20, P417, DOI 10.1007/s00198-008-0667-2; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Grober U, 2014, DERMATOENDOCRINOL, V4, P158; Harinarayan CV, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23873; Hazreen MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S6; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Holick MF, 2012, J PARENTERAL ENTERAL, V36; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Huh SY, 2008, REV ENDOCR METAB DIS, V9, P161, DOI 10.1007/s11154-007-9072-y; Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x; Jayaratne N, 2012, PREV MED, V55, P146, DOI 10.1016/j.ypmed.2012.05.011; Juonala M, 2015, J CLIN ENDOCR METAB, V100, P1469, DOI 10.1210/jc.2014-3944; Karaguzel G, 2014, J PEDIATR GASTR NUTR, V58, P654, DOI 10.1097/MPG.0000000000000274; KHOR GL, 2011, BMC PUBLIC HEALTH, V11, DOI DOI 10.1186/1471-2458-11-1; Kouda K, 2013, NUTRITION, V29, P1204, DOI 10.1016/j.nut.2013.03.010; Linos E, 2012, CANCER CAUSE CONTROL, V23, P133, DOI 10.1007/s10552-011-9862-0; Majid HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30544; Majid HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155447; MARTINEAU AR, 2017, BMJ OPEN, V356, DOI DOI 10.1136/BMJ.I6583; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McDonnell SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180483; McKenzie RL, 2009, PHOTOCHEM PHOTOBIOL, V85, P88, DOI 10.1111/j.1751-1097.2008.00400.x; Moy FM, 2011, J PHOTOCH PHOTOBIO B, V104, P444, DOI 10.1016/j.jphotobiol.2011.05.002; Narchi H, 2015, PAEDIATR INT CHILD H, V35, P36, DOI 10.1179/2046905514Y.0000000144; Nessvi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1173, DOI 10.1111/j.1751-1097.2011.00956.x; O'Neill V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067663; Parisi AV, 2007, ENV HLTH, V7, P1; Pike JW, 2016, VITAM HORM, V100, P44, DOI [10.1016/bs.vh.2015, DOI 10.1016/BS.VH.2015]; Pludowski P, 2017, J STEROID BIOCHEM, P125, DOI [10.1016/j.asbmb.2017.01.021, DOI 10.1016/J.ASBMB.2017.01.021]; Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092; Poomthavorn P, 2012, INT J OBESITY, V36, P491, DOI 10.1038/ijo.2011.260; Puri S, 2008, BRIT J NUTR, V99, P876, DOI 10.1017/S0007114507831758; Rahmadhani R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178695; Rajakumar K, 2008, OBESITY, V16, P90, DOI 10.1038/oby.2007.23; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Sim PY, 2014, BIOMED RES INT, V4, P1; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski AT, 2015, SCI REPORT; Soesanti F., 2013, INT J PEDIAT ENDO S1, V2013, pP167, 1687, DOI [10.1186/1687-9856-2013-S1-P167, DOI 10.1186/1687-9856-2013-S1-P167]; Sullivan SS, 2003, NUTR RES, V23, P631, DOI 10.1016/S0271-5317(03)00018-6; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; Villamor E, 2011, AM J CLIN NUTR, V94, P1020, DOI 10.3945/ajcn.111.018168; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wu FT, 2018, ANN MED, V50, P74, DOI 10.1080/07853890.2017.1399446; Zmuda JM, 2000, EPIDEMIOL REV, V22, P203, DOI 10.1093/oxfordjournals.epirev.a018033	63	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200736	10.1371/journal.pone.0200736	http://dx.doi.org/10.1371/journal.pone.0200736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024934	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000046
J	Shipton, C; Blinkhorn, J; Breeze, PS; Cuthbertson, P; Drake, N; Groucutt, HS; Jennings, RP; Parton, A; Scerri, EML; Alsharekh, A; Petraglia, MD				Shipton, Ceri; Blinkhorn, James; Breeze, Paul S.; Cuthbertson, Patrick; Drake, Nick; Groucutt, Huw S.; Jennings, Richard P.; Parton, Ash; Scerri, Eleanor M. L.; Alsharekh, Abdullah; Petraglia, Michael D.			Acheulean technology and landscape use at Dawadmi, central Arabia	PLOS ONE			English	Article							STONE TOOL PRODUCTION; VARIABILITY SELECTION; PENINSULA; PLEISTOCENE; DISPERSALS; EUROPE; BIFACE; PERSPECTIVE; ADAPTATIONS; TRANSITION	Despite occupying a central geographic position, investigations of hominin populations in the Arabian Peninsula during the Lower Palaeolithic period are rare. The colonization of Eurasia below 55 degrees latitude indicates the success of the genus Homo in the Early and Middle Pleistocene, but the extent to which these hominins were capable of innovative and novel behavioural adaptations to engage with mid-latitude environments is unclear. Here we describe new field investigations at the Saffaqah locality (206-76) near Dawadmi, in central Arabia that aim to establish how hominins adapted to this region. The site is located in the interior of Arabia over 500 km from both the Red Sea and the Gulf, and at the headwaters of two major extinct river systems that were likely used by Acheulean hominins to cross the Peninsula. Saffaqah is one of the largest Acheulean sites in Arabia with nearly a million artefacts estimated to occur on the surface, and it is also the first to yield stratified deposits containing abundant artefacts. It is situated in the unusual setting of a dense and well-preserved landscape of Acheulean localities, with sites and isolated artefacts occurring regularly for tens of kilometres in every direction. We describe both previous and recent excavations at Saffaqah and its large lithic assemblage. We analyse thousands of artefacts from excavated and surface contexts, including giant andesite cores and flakes, smaller cores and retouched artefacts, as well as handaxes and cleavers. Technological assessment of stratified lithics and those from systematic survey, enable the reconstruction of stone tool life histories. The Acheulean hominins at Dawadmi were strong and skilful, with their adaptation evidently successful for some time. However, these biface-makers were also technologically conservative, and used least-effort strategies of resource procurement and tool transport. Ultimately, central Arabia was depopulated, likely in the face of environmental deterioration in the form of increasing aridity.	[Shipton, Ceri] Australian Natl Univ, Ctr Excellence Australian Biodivers & Heritage, Canberra, ACT, Australia; [Shipton, Ceri] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Blinkhorn, James] Royal Holloway Univ London, Dept Geog, London, England; [Blinkhorn, James; Groucutt, Huw S.; Scerri, Eleanor M. L.; Petraglia, Michael D.] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Breeze, Paul S.; Drake, Nick] Kings Coll London, Dept Geog, London, England; [Cuthbertson, Patrick; Groucutt, Huw S.; Scerri, Eleanor M. L.] Univ Oxford, Sch Archaeol, Oxford, England; [Jennings, Richard P.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Parton, Ash] Oxford Brookes Univ, Dept Social Sci, Oxford, England; [Parton, Ash] Univ Oxford, Mansfield Coll, Oxford, England; [Alsharekh, Abdullah] King Saud Univ, Dept Archaeol, Riyadh, Saudi Arabia	Australian National University; University of Cambridge; University of London; Royal Holloway University London; University of London; King's College London; University of Oxford; Liverpool John Moores University; Oxford Brookes University; University of Oxford; King Saud University	Shipton, C (corresponding author), Australian Natl Univ, Ctr Excellence Australian Biodivers & Heritage, Canberra, ACT, Australia.; Shipton, C (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England.	ceri.shipton@anu.edu.au	Alsharekh, Abdullah M/AAH-3718-2019; CABAH, ARC/T-6419-2019; Groucutt, Huw/GNM-5500-2022; Petraglia, Michael/ABA-9748-2021; Scerri, Eleanor/AHC-6769-2022	Scerri, Eleanor/0000-0002-7468-9977; Petraglia, Michael/0000-0003-2522-5727; Blinkhorn, James/0000-0002-9399-5515	Saudi Commission for Tourism and National Heritage; H2020 European Research Council Advanced Grant [295719]; Max Planck Society; SCTH	Saudi Commission for Tourism and National Heritage; H2020 European Research Council Advanced Grant; Max Planck Society(Max Planck Society); SCTH	This study was funded by the Saudi Commission for Tourism and National Heritage: https://scth.gov.sa/en/Pages/default.aspx; by a H2020 European Research Council Advanced Grant (295719) awarded to MDP: http://www.palaeodeserts.com/; and by the Max Planck Society: https://www.shh.mpg.de/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank HRH Prince Sultan bin Salman, President of the Saudi Commission for Tourism and National Heritage (SCTH) and Professor Ali I Al-Ghabban, Vice President, for permission to carry out this study. We are grateful for the support of the SCTH, in particular the staff who were with us in the field: Abdul-Aziz al-Omari, Sultan Al-Fageri, Khalid Al-Mura, and Abdul Rahman. We thank Laine Clark-Balzan, Oshan Wedage, Tom White, and Chris Stimpson for their assistance in the field. We thank Mary Ann Mullen for the consent to publish Fig 4 containing an image of her relative Norman Whalen. We thank Ian R. Cartwright (Institute of Archaeology, University of Oxford) for the lithic photographs shown in Figs 20 and 21. We thank Javier Baena and an anonymous reviewer for constructive feedback on a draft of this manuscript.	Preysler JB, 2018, QUATERNARY SCI REV, V190, P123, DOI 10.1016/j.quascirev.2018.04.015; del Cueto SB, 2016, QUATERN INT, V411, P329, DOI 10.1016/j.quaint.2016.01.041; Beshkani A, 2017, ARAB ARCHAEOL EPIGR, V28, P125, DOI 10.1111/aae.12101; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Breeze PS, 2015, QUATERN INT, V382, P98, DOI 10.1016/j.quaint.2015.01.022; Bridgland DR, 2015, J QUATERNARY SCI, V30, P623, DOI 10.1002/jqs.2805; Brooks AS, 2018, SCIENCE, V360, P90, DOI 10.1126/science.aao2646; Clarkson C, 2011, J ARCHAEOL SCI, V38, P1062, DOI 10.1016/j.jas.2010.12.001; Claud E, 2015, J ARCHAEOL SCI, V62, P105, DOI 10.1016/j.jas.2015.05.013; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; de la Torre I, 2018, GEOARCHAEOLOGY, V33, P218, DOI 10.1002/gea.21629; de la Torre I, 2014, J HUM EVOL, V76, P1, DOI 10.1016/j.jhevol.2014.06.008; DELFOUR J., 1982, SAUDI ARABIAN DEPUTY, V60, P36; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Foulds FWF, 2017, ANTIQUITY, V91, P1421, DOI 10.15184/aqy.2017.153; GALLART F, 1993, CATENA, V20, P529, DOI 10.1016/0341-8162(93)90015-H; Gallotti R, 2014, QUATERN INT, V343, P17, DOI 10.1016/j.quaint.2014.04.039; Gingerich JA, 2016, QUATERN INT, V466, P269; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 2006, AXE AGE ACHEULIAN TO, P111; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Groucutt HS, 2017, ARCHAEOL RES ASIA, V9, P44, DOI 10.1016/j.ara.2017.01.003; Groucutt HS, 2016, J FIELD ARCHAEOL, V41, P131, DOI 10.1080/00934690.2016.1156928; Groucutt HS, 2015, QUATERN INT, V382, P215, DOI 10.1016/j.quaint.2014.12.001; Groucutt HS, 2013, QUATERN INT, V300, P1, DOI 10.1016/j.quaint.2013.03.043; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Grove M, 2011, J HUM EVOL, V61, P306, DOI 10.1016/j.jhevol.2011.04.005; Hardaker T., 2011, NEW APPROACHES STUDY; Herzlinger G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188337; Hopkinson T, 2007, ANTIQUITY, V81, P294, DOI 10.1017/S0003598X00095181; Isaac G., 1972, CALIBRATION HOMINOID, P381; Isaac G.L., 1977, OLORGESAILIE ARCHEOL; Jennings RP, 2015, QUATERN INT, V382, P58, DOI 10.1016/j.quaint.2015.01.028; KELLY RL, 1988, AM ANTIQUITY, V53, P717, DOI 10.2307/281115; Key A, 2017, J ARCHAEOL SCI-REP, V12, P43, DOI 10.1016/j.jasrep.2017.01.023; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Movius H.L., 1948, T AM PHILOS SOC, V38, P329; Petraglia MD, 2005, GEOL SOC SPEC PUBL, V247, P305, DOI 10.1144/GSL.SP.2005.247.01.18; Petraglia MD, 2003, J WORLD PREHIST, V17, P141, DOI 10.1023/A:1025849206519; Petraglia MD, 2009, VERTEBR PALEOBIOL PA, P103, DOI 10.1007/978-90-481-2719-1_8; Pope M, 2005, HOMINID INDIVIDUAL C, P81; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Potts R, 2015, J HUM EVOL, V87, P5, DOI 10.1016/j.jhevol.2015.06.014; Proborukmi MS, 2018, PALAEOGEOGR PALAEOCL, V489, P166, DOI 10.1016/j.palaeo.2017.10.007; Rose Jeffrey I., 2018, 1 PEOPLES OMAN PALAE; Ruxton GD, 2011, J HUM EVOL, V61, P169, DOI 10.1016/j.jhevol.2011.02.012; Sampson CG., 2001, VERY REMOTE PERIOD I, P28; Scerri EML, 2015, QUATERN INT, V382, P200, DOI 10.1016/j.quaint.2014.09.036; Sharon G., 2010, PALEOANTHROPOLOGY, V2010, P79, DOI DOI 10.4207/PA.2010.ART35; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; Sharon G, 2010, QUATERN INT, V223, P226, DOI 10.1016/j.quaint.2009.11.023; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shipton C, 2016, CAMB ARCHAEOL J, V26, P599, DOI 10.1017/S095977431600041X; Shipton C, 2015, J ARCHAEOL SCI-REP, V2, P169, DOI 10.1016/j.jasrep.2015.01.013; Shipton C, 2013, J HUM EVOL, V65, P93, DOI 10.1016/j.jhevol.2013.03.007; Shipton C, 2018, AFRICAN ARCHAEOLOGIC; Shipton C., 2013, B MUJ; Shipton Ceri, 2014, Paleoanthropology, P446; Shipton C, 2011, AFR ARCHAEOL REV, V28, P141, DOI 10.1007/s10437-011-9089-1; Shipton C, 2010, VERTEBR PALEOBIOL PA, P49, DOI 10.1007/978-90-481-9094-2_5; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; WENBANSMITH FF, 1989, J ARCHAEOL SCI, V16, P17, DOI 10.1016/0305-4403(89)90053-8; Wendorf F., 1980, PREHISTORY E SAHARA; Whalen N., 1984, ATLAL, V8, P9; Whalen N.M., 1988, ATLAL, V11, P77; WHALEN NM, 1983, ATLAL, V7, P9; WHEELER PE, 1992, J HUM EVOL, V23, P379, DOI 10.1016/0047-2484(92)90086-O; Williams EM, 2014, J HUM EVOL, V72, P52, DOI 10.1016/j.jhevol.2014.03.004; ZARINS J, 1980, ATLAL, V4, P9	72	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200497	10.1371/journal.pone.0200497	http://dx.doi.org/10.1371/journal.pone.0200497			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052630	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000440006600008
J	Barretto, KT; Swanson, CM; Nguyen, CL; Annis, DS; Esnault, SJ; Mosher, DF; Johansson, MW				Barretto, Karina T.; Swanson, Calvin M.; Nguyen, Christopher L.; Annis, Douglas S.; Esnault, Stephane J.; Mosher, Deane F.; Johansson, Mats W.			Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IL-5 RECEPTOR-ALPHA; IL-5-STIMULATED EOSINOPHILS; AIRWAY EOSINOPHILS; NEWT EOSINOPHILS; GM-CSF; ASTHMA; ACTIVATION; EXPRESSION; ROLES	Periostin, which is induced by interleukin (IL)-13, is an extracellular matrix (ECM) protein that supports alpha(M)beta(2) integrin-mediated adhesion and migration of IL-5-stimulated eosinophils. Transforming growth factor (TGF)-beta-induced protein (TGFBI) is a widely expressed periostin paralog known to support monocyte adhesion. Our objective was to compare eosinophil adhesion and migration on TGFBI and periostin in the presence of IL-5-family cytokines. Eosinophil adhesion after 1 h and random motility over 20 h in the presence of various concentrations of IL-5, IL-3, or granulocyte macrophage-colony stimulating factor (GM-CSF) were quantified in wells coated with various concentrations of TGFBI or periostin. Results were compared to video microscopy of eosinophils. Cytokine-stimulated eosinophils adhered equivalently well to TGFBI or periostin in a coating concentration-dependent manner. Adhesion was blocked by anti-alpha(M)beta(2) and stimulated at the lowest concentration by GMCSF. In the motility assay, periostin was more potent than TGFBI, the coating-concentration effect was bimodal, and IL-3 was the most potent cytokine. Video microscopy revealed that under the optimal coating condition of 5 mu g/ml periostin, most eosinophils migrated persistently and were polarized and acorn-shaped with a ruffling forward edge and granules gathered together, in front of the nucleus. On 10 mu g/ml periostin or TGFBI, more eosinophils adopted a flattened pancake morphology with dispersed granules and nuclear lobes, and slower migration. Conversion between acorn and pancake morphologies were observed. We conclude that TGFBI or periostin supports two modes of migration by IL-5 family cytokine-activated eosinophils. The rapid mode is favored by intermediate protein coatings and the slower by higher coating concentrations. We speculate that eosinophils move by haptotaxis up a gradient of adhesive ECM protein and then slow down to surveil the tissue.	[Barretto, Karina T.; Swanson, Calvin M.; Nguyen, Christopher L.; Annis, Douglas S.; Mosher, Deane F.; Johansson, Mats W.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Esnault, Stephane J.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Johansson, MW (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	mwjohansson@wisc.edu	Esnault, Stephane/AAJ-4511-2020; Esnault, Stephane/AAO-4712-2020	Esnault, Stephane/0000-0001-7238-8671; Johansson, Mats/0000-0001-5699-978X	National Institutes of Health [P01 HL088594, R01 AI125390, UL1 RR025011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Program Project grant P01 HL088594 (NN Jarjour and DFM), research grant R01 AI125390 (DFM), and Clinical and Translational Science Award grant UL1 RR025011 (MK Drezner) from the National Institutes of Health (https://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfeld SK, 2016, AM J PATHOL, V186, P777, DOI 10.1016/j.ajpath.2015.11.024; Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Annis DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135374; Barthel SR, 2008, J LEUKOCYTE BIOL, V83, P1, DOI 10.1189/jlb.0607344; Barthel SR, 2006, AM J RESP CELL MOL, V35, P378, DOI 10.1165/rcmb.2006-0027OC; Billings PC, 2000, AM J RESP CELL MOL, V22, P352, DOI 10.1165/ajrcmb.22.3.3732; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Doran E, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00139; Esnault S, 2017, CLIN EXP ALLERGY, V47, P488, DOI 10.1111/cea.12876; Esnault S, 2018, J PROTEOME RES, V17, P2102, DOI 10.1021/acs.jproteome.8b00057; Esnault S, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00150; Esnault S, 2016, CRIT REV IMMUNOL, V36, P429, DOI 10.1615/CritRevImmunol.2017020172; Esnault S, 2015, J IMMUNOL, V195, P2529, DOI 10.4049/jimmunol.1500871; Esnault S, 2014, CLIN IMMUNOL, V150, P90, DOI 10.1016/j.clim.2013.11.009; GILBERT SH, 1994, J CELL BIOL, V127, P489, DOI 10.1083/jcb.127.2.489; Gregory B, 2003, J IMMUNOL, V170, P5359, DOI 10.4049/jimmunol.170.11.5359; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Han ST, 2014, AM J RESP CELL MOL, V50, P654, DOI 10.1165/rcmb.2013-0181OC; Hind LE, 2016, DEV CELL, V38, P161, DOI 10.1016/j.devcel.2016.06.031; Izuhara K, 2017, CELL MOL LIFE SCI, V74, P4293, DOI 10.1007/s00018-017-2648-0; Izuhara K, 2016, AM J RESP CRIT CARE, V193, P949, DOI 10.1164/rccm.201510-2032PP; Johansson MW, 2017, CLIN EXP ALLERGY, V47, P1263, DOI 10.1111/cea.12934; Johansson MW, 2014, CLIN EXP ALLERGY, V44, P482, DOI 10.1111/cea.12292; Johansson MW, 2008, J IMMUNOL, V180, P7622, DOI 10.4049/jimmunol.180.11.7622; Johansson MW, 2016, J ALLERGY CLIN IMMUN, V137, P1904, DOI 10.1016/j.jaci.2015.12.1346; Johansson Mats W, 2013, Front Pharmacol, V4, P33, DOI 10.3389/fphar.2013.00033; Johansson MW, 2013, AM J RESP CELL MOL, V48, P503, DOI 10.1165/rcmb.2012-0150OC; Kim HJ, 2008, INT J BIOCHEM CELL B, V40, P991, DOI 10.1016/j.biocel.2007.11.001; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; Liu AY, 2014, MATRIX BIOL, V37, P150, DOI 10.1016/j.matbio.2014.04.007; Liu LY, 2002, J IMMUNOL, V169, P6459, DOI 10.4049/jimmunol.169.11.6459; Lukassen MV, 2016, BIOCHEMISTRY-US, V55, P5610, DOI 10.1021/acs.biochem.6b00694; McBrien CN, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00093; Morra L, 2012, LUNG CANCER, V76, P183, DOI 10.1016/j.lungcan.2011.10.013; Mosher DF, 2015, CRIT REV BIOCHEM MOL, V50, P427, DOI 10.3109/10409238.2015.1069791; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Nakamura Y, 2015, ALLERGOL INT, V64, P209, DOI 10.1016/j.alit.2015.01.001; Nance T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092111; Nhu QM, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00128; Noguchi T, 2016, J ALLERGY CLIN IMMUN, V138, P1449, DOI 10.1016/j.jaci.2016.05.020; Schwanekamp JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181945; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Venge P, 2010, CLIN RESPIR J, V4, P15, DOI 10.1111/j.1752-699X.2010.00192.x; Viloria Katrina, 2016, BioMolecular Concepts, V7, P117, DOI 10.1515/bmc-2016-0004; Wang M, 2015, J ALLERGY CLIN IMMUN, V136, P1700, DOI 10.1016/j.jaci.2015.09.005; Wilkerson EM, 2016, J PROTEOME RES, V15, P1524, DOI 10.1021/acs.jproteome.6b00006; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yoshimura-Uchiyama C, 2003, BIOCHEM BIOPH RES CO, V309, P26, DOI 10.1016/S0006-291X(03)01526-2	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201320	10.1371/journal.pone.0201320	http://dx.doi.org/10.1371/journal.pone.0201320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048528	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400076
J	Calamnius, L; Lundin, M; Fjalling, A; Konigson, S				Calamnius, Linda; Lundin, Mikael; Fjalling, Arne; Konigson, Sara			Pontoon trap for salmon and trout equipped with a seal exclusion device catches larger salmons	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; BALTIC SEA; FISHERIES; MITIGATION; PREDATION; NET; MANAGEMENT; CONFLICT; QUALITY; BYCATCH	The growing seal populations of the Baltic have led to more frequent interactions with coastal fisheries. The motivation for seals to interact with fishing gear is high. It provides high densities of fish. A successful means of mitigating the conflict is the pontoon trap. Seal visits here have been frequent. Seals have access to most parts of the trap system including the middle chamber, which is an overhead environment. Concerns have been raised about seals possible entanglement in this specific part of the trap. As a means of keeping seals from entering the middle chamber, two different Seal Exclusion Devices (SEDs) were tested. A diamond mesh SED and a square mesh SED, which was rotated 45 degrees. The aim was to compare the functionality of the different SEDs with respect to seal deterrent abilities and catch composition. The hypothesis tested were (i) that seals would not be able to enter the middle chamber, (ii) that the catch would increase and (iii) that the SED would deter larger fish from swimming into the middle chamber. Catch data and underwater film were collected. Larger salmons were caught in traps equipped with SEDs. The SEDs did not affect the number of caught fish or the total catch per soak day.	[Calamnius, Linda] Univ Gavle, Fac Hlth & Occupat Studies, Dept Biol, Gavle, Sweden; [Calamnius, Linda; Fjalling, Arne] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Freshwater Res, Stangholmsvagen 2, Stockholm, Sweden; [Lundin, Mikael] Harmangers Machine & Marine, Stocka, Sweden; [Lundin, Mikael] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Skogsmarksgrand 9, Umea, Sweden; [Konigson, Sara] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Lysekil, Sweden	University of Gavle; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Calamnius, L (corresponding author), Univ Gavle, Fac Hlth & Occupat Studies, Dept Biol, Gavle, Sweden.; Calamnius, L (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Freshwater Res, Stangholmsvagen 2, Stockholm, Sweden.	linda.calamnius@hig.se			Operational Program for Fisheries in Sweden 2007 - 2013, Swedish Board of Agriculture; European Union, European Fisheries Fund Investing in sustainable fisheries [18-7965/11]; Harmangers Machine and Marine; The Wildlife Damage Centre, through the Swedish Agency for Marine and Water Management; County Administrative Board of Gavleborg [2342-15]; University of Gavle; Sven-Gunnar Lunneryd of Program Seals Fisheries	Operational Program for Fisheries in Sweden 2007 - 2013, Swedish Board of Agriculture; European Union, European Fisheries Fund Investing in sustainable fisheries; Harmangers Machine and Marine; The Wildlife Damage Centre, through the Swedish Agency for Marine and Water Management; County Administrative Board of Gavleborg; University of Gavle; Sven-Gunnar Lunneryd of Program Seals Fisheries	This research was supported in full by the Operational Program for Fisheries in Sweden 2007 - 2013, Swedish Board of Agriculture and was co-financed by the European Union, European Fisheries Fund Investing in sustainable fisheries, Dnr 18-7965/11, Harmangers Machine and Marine, The Wildlife Damage Centre, through the Swedish Agency for Marine and Water Management and the County Administrative Board of Gavleborg, Dnr 2342-15, LC, University of Gavle, and Sven-Gunnar Lunneryd of Program Seals & Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlin B-M, 2016, STOCKHOLM, P116; Bruckmeier K., 2013, HUMAN WILDLIFE CONFL, P15; Bruckmeier K, 2008, MAR POLICY, V32, P201, DOI 10.1016/j.marpol.2007.09.005; Butler JRA, 2011, MAR POLICY, V35, P317, DOI 10.1016/j.marpol.2010.10.011; Enivronmental Systems Research Institute (ESRI), 2017, ARCGIS DESKT; Fjalling A, 2005, ICES J MAR SCI, V62, P1630, DOI 10.1016/j.icesjms.2005.02.015; Fjalling Arne, 2007, NAMMCO Scientific Publications, V6, P215; Forrest KW, 2009, N AM J FISH MANAGE, V29, P885, DOI 10.1577/M08-083.1; Gearin PJ, 1988, 8830 NWAFC; Gotz T, 2010, J EXP BIOL, V213, P1536, DOI 10.1242/jeb.035535; Gordon J, 2002, POTENTIAL IMPACTS AC; Graham IM, 2011, ANIM CONSERV, V14, P604, DOI 10.1111/j.1469-1795.2011.00513.x; Hamer DJ, 2006, BIOL CONSERV, V130, P517, DOI 10.1016/j.biocon.2006.01.014; Harding KC, 1999, AMBIO, V28, P619; HELCOM, 2010, BALTIC SEA ENV P B, P116; Hemmingsson M, 2008, FISH RES, V93, P357, DOI 10.1016/j.fishres.2008.06.013; Hooper J, 2005, CCAMLR SCI, V12, P195; Hume F., 2002, Papers and Proceedings of the Royal Society of Tasmania, V136, P1; Jamieson GS, 2001, SALMON FARM PINNIPED; Jokikokko E, 2014, FISHERIES MANAG ECOL, V21, P250, DOI 10.1111/fme.12068; Jounela P, 2006, ICES J MAR SCI, V63, P936, DOI 10.1016/j.icesjms.2006.02.005; Konigson S., 2007, NAMMCO Scientific Publications, V6, P203; Konigson S, 2015, FISH RES, V167, P114, DOI 10.1016/j.fishres.2015.01.013; Konigson S, 2013, FISH RES, V148, P117, DOI 10.1016/j.fishres.2013.07.014; Lehtonen E, 2004, ICES J MAR SCI, V61, P1195, DOI 10.1016/j.icesjms.2004.06.012; Lehtonen E, 2010, FISH RES, V102, P214, DOI 10.1016/j.fishres.2009.10.007; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; LOWE TE, 1993, J FOOD SCI, V58, P770, DOI 10.1111/j.1365-2621.1993.tb09355.x; Lundin M, 2012, FISH RES, V127, P83, DOI 10.1016/j.fishres.2012.05.009; Lundin M, 2011, FISH RES, V108, P81, DOI 10.1016/j.fishres.2010.12.001; Lunneryd SG, 2003, ICES J MAR SCI, V60, P1194, DOI 10.1016/S1054-3139(03)00145-0; Lyle JM, 2016, CAN J FISH AQUAT SCI, V73, P436, DOI 10.1139/cjfas-2015-0273; Marine and Marine Industries Council, 2002, SEAL FISH INT MAN ST; Mate B.R., 1986, ACOUSTICAL DETERRENT, P23; Nelson ML, 2006, CAN J FISH AQUAT SCI, V63, P1710, DOI 10.1139/F06-067; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Prado J, 1990, FISHERMANS WORKBOOK, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Reeves R. R., 2002, NATL AUDUBON SOC GUI; Sepulveda M, 2005, AQUAC RES, V36, P1062, DOI 10.1111/j.1365-2109.2005.01320.x; Stansbury AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1595; Stewardson C, 2007, NATL ASSESSMENT HUMA; Stewardson C, 2003, SPEC SESSFEAG M RED; Suuronen P, 2006, FISH RES, V79, P129, DOI 10.1016/j.fishres.2006.02.014; Suuronen P, 2012, FISH RES, V119, P135, DOI 10.1016/j.fishres.2011.12.009; Swedish Agency for Marine and Water Management, 2014, SALP TILLV UTBR SAMT; Tilzey R., 2006, SEAL FISHERY INTERAC; Vanhatalo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113836; Varjopuro R., 2006, MAST, V5, P61; Varjopuro R, 2011, MAR POLICY, V35, P450, DOI 10.1016/j.marpol.2010.10.023; Westerberg H, 2007, RECONCILING FISHERIE, VI, P587; Wursig B, 2002, RESPONSIBLE MARINE AQUACULTURE, P45, DOI 10.1079/9780851996042.0045; Yurk H, 2000, T AM FISH SOC, V129, P1360, DOI 10.1577/1548-8659(2000)129<1360:EATRPB>2.0.CO;2	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201164	10.1371/journal.pone.0201164	http://dx.doi.org/10.1371/journal.pone.0201164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048493	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400056
J	Fathi, Z; Mousavi, SAJ; Roudi, R; Ghazi, F				Fathi, Zahra; Mousavi, Seyed Ali Javad; Roudi, Raheleh; Ghazi, Farideh			Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients	PLOS ONE			English	Article							JOINT-CONSENSUS-RECOMMENDATION; POLYMERASE-CHAIN-REACTION; SEQUENCE VARIANTS; P53; CARCINOMA; EGFR; ADENOCARCINOMA; ASSOCIATION; EXPRESSION; BRAF	Purpose Lung cancer is the deadliest known cancer in the world, with the highest number of mutations in proto-oncogenes and tumor suppressor genes. Therefore, this study was conducted to determine the status of hotspot regions in DDR2 and KRAS genes for the first time, as well as in TP53 gene, in lung cancer patients within the Iranian population. Experimental design The mutations in exon 2 of KRAS, exon 18 of DDR2, and exons 5-6 of TP53 genes were screened in lung cancer samples, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) using PCR and sequencing techniques. Results Analysis of the KRAS gene showed only a G12C variation in one large cell carcinoma (LCC) patient, whereas variants were not found in adenocarcinoma (ADC) and squamous cell carcinoma (SCC) cases. The Q808H variation in the DDR2 gene was detected in one SCC sample, while no variant was seen in the ADC and LCC subtypes. Variations in the TP53 gene were seen in all NSCLC subtypes, including six ADC (13.63%), seven SCC (15.9%) and two LCC (4.54%). Forty-eight variants were found in the TP53 gene. Of these, 15 variants were found in coding regions V147A, V157F, Q167Q, D186G, H193R, T211T, F212L and P222P, 33 variants in intronic regions rs1625895 (HGVS: c.672+62A>G), rs766856111 (HGVS: c.672+6G>A) and two new variants (c.560-12A>G and c.672+86T>C). Conclusions In conclusion, KRAS, DDR2, and TP53 variants were detected in 2%, 2.17% and 79.54% of all cases, respectively. The frequency of DDR2 mutation is nearly close to other studies, while KRAS and TP53 mutation frequencies are lower and higher than other populations, respectively. Three new putative pathogenic variants, for the first time, have been detected	[Fathi, Zahra; Ghazi, Farideh] Iran Univ Med Sci, Dept Med Genet & Mol Biol, Fac Med, Tehran, Iran; [Mousavi, Seyed Ali Javad] Iran Univ Med Sci, Minimally Invas Surg Res Ctr, Tehran, Iran; [Roudi, Raheleh] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Ghazi, F (corresponding author), Iran Univ Med Sci, Dept Med Genet & Mol Biol, Fac Med, Tehran, Iran.; Roudi, R (corresponding author), Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran.	Raheleroudi@gmail.com; Ghazi.f@iums.ac.ir	Roudi, Raheleh/J-2587-2018; mousavi, seyyed amin ayatollahi/Q-8504-2016	Roudi, Raheleh/0000-0001-5023-4743; mousavi, seyyed amin ayatollahi/0000-0002-5367-483X	Iran University of Medical Sciences [95-02-30-27795]	Iran University of Medical Sciences	This study was supported by a grant from Iran University of Medical Sciences (Grant #95-02-30-27795). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Andriani F, 2004, INT J CANCER, V108, P91, DOI 10.1002/ijc.11510; Ashktorab H, 2017, ONCOTARGET, V8, P7852, DOI 10.18632/oncotarget.13977; Bandoh N, 2002, CANCER, V94, P1968, DOI 10.1002/cncr.10388; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Baugh EH, 2018, CELL DEATH DIFFER, V25, P154, DOI 10.1038/cdd.2017.180; Chalela R, 2017, J THORAC DIS, V9, P2142, DOI 10.21037/jtd.2017.06.20; Chatziandreou I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133859; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; deAnta JM, 1997, ONCOGENE, V15, P2951, DOI 10.1038/sj.onc.1201475; Deben C, 2016, CRIT REV ONCOL HEMAT, V99, P63, DOI 10.1016/j.critrevonc.2015.11.019; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Ellard S, 2016, PRACTICE GUIDELINES; Fathi Z, 2018, J HUM GENET, V63, P783, DOI 10.1038/s10038-018-0450-y; Gobbini E, 2017, LUNG CANCER, V111, P30, DOI 10.1016/j.lungcan.2017.06.009; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Huang CL, 1998, INT J ONCOL, V12, P553; Jafari H, 2013, BIOIMPACTS, V3, P135, DOI 10.5681/bi.2013.018; Karami-Matin Behzad, 2016, Asian Pac J Cancer Prev, V17, P2131; Kenmotsu H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-786; Kim HJ, 2012, LUNG CANCER, V75, P321, DOI 10.1016/j.lungcan.2011.08.005; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lee HJ, 2013, KOREAN J PATHOL, V47, P52, DOI 10.4132/KoreanJPathol.2013.47.1.52; Lee MS, 2017, CANCER RES TREAT, V49, P1065, DOI 10.4143/crt.2016.347; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Lim SM, 2018, CANCER TREAT REV, V65, P1, DOI 10.1016/j.ctrv.2018.02.006; Liu DG, 2002, CANCER, V94, P2239, DOI 10.1002/cncr.10450; Liu X, 2014, CLIN ONCOL-UK, V26, P18, DOI 10.1016/j.clon.2013.09.003; Luthra R, 2015, CANCERS, V7, P2023, DOI 10.3390/cancers7040874; Ma XL, 2016, J THORAC ONCOL, V11, P850, DOI 10.1016/j.jtho.2016.02.002; Mardis ER, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0540-7; Martorell PM, 2017, CLIN LUNG CANCER, V18, pE395, DOI 10.1016/j.cllc.2017.04.006; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Matsumoto S, 2014, NEW NATIONWIDE GENOM; Miao LY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-369; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mitsudomi T, 2000, CLIN CANCER RES, V6, P4055; Mohammadi A, 2008, AM J BIOCH BIOTECHNO, V4, P1, DOI DOI 10.3844/AJBBSP.2008.1.6; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nadal E, 2014, J THORAC ONCOL, V9, P1513, DOI 10.1097/JTO.0000000000000305; Nicos M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0176-4; Pitini V, 2013, LUNG CANCER, V82, P171, DOI 10.1016/j.lungcan.2013.07.004; Poghosyan H, 2013, LUNG CANCER, V81, P11, DOI 10.1016/j.lungcan.2013.03.013; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richters A, 2014, J MED CHEM, V57, P4252, DOI 10.1021/jm500167q; Ricordel C, 2018, CLIN LUNG CANCER, V19, P163, DOI 10.1016/j.cllc.2017.10.006; Roudi R, 2015, CANCER INVEST, V33, P294, DOI 10.3109/07357907.2015.1034869; Roudi R, 2014, CANCER BIOMARK, V14, P457, DOI 10.3233/CBM-140424; Roviello G, 2018, CLIN EXP MED, V18, P15, DOI 10.1007/s10238-017-0460-7; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Terai H, 2015, ACS CHEM BIOL, V10, P2687, DOI 10.1021/acschembio.5b00655; Timar J, 2014, CURR OPIN ONCOL, V26, P138, DOI 10.1097/CCO.0000000000000051; Tsang H, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00214; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Viktorsson K, 2005, BIOCHEM BIOPH RES CO, V331, P868, DOI 10.1016/j.bbrc.2005.03.192; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Warth A, 2016, ONCOTARGET; Yang IS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2011-y; Yashima H, 2014, MOL CLIN ONCOL, V2, P714, DOI 10.3892/mco.2014.302; Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10; Zhu JW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011300.pub2	65	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200633	10.1371/journal.pone.0200633	http://dx.doi.org/10.1371/journal.pone.0200633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048458	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400011
J	Guo, J; Liu, C; Wang, W; Liu, Y; He, HW; Chen, C; Xiang, R; Luo, YP				Guo, Jian; Liu, Chen; Wang, Wei; Liu, Yan; He, Huiwen; Chen, Chong; Xiang, Rong; Luo, Yunping			Identification of serum miR-1915-3p and miR455-3p as biomarkers for breast cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; METASTASIS; ONCOGENE; GENOMICS; PATHWAY; CHINA	Breast cancer is one of the most malignant diseases in women worldwide. Serum microRNAs (miRNAs), with the characteristics of high sensitivity and specificity, have recently attracted more attentions to serve as potential biomarkers for tumor diseases. In this study, 194 breast cancer patients' serum samples were collected before surgery and enrolled into different groups based on their diagnostic information. To search for breast cancer diagnostic biomarkers, serum miRNAs were screened by microarray in pooled samples of healthy volunteers and breast cancer patients in different clinical stages. The miRNAs were further verified in each individual patient's serum samples in diagnostic and predictive sets. The serum level of miR-1915-3p was upregulated and miR-455-3p was downregulated significantly in breast cancer patients compared with healthy volunteers. Furthermore, the patients with infiltrating carcinoma or lymph node metastasis had a higher serum level of miR-1915-3p and lower serum level of miR-455-3p than patients with the carcinoma in situ or patients without lymph node metastasis. ROC analysis suggested that miR-1915-3p and miR-455-3p had the potential as a promising serum diagnostic and predictive biomarkers of breast cancer. miR-1915-3p was over-expressed in certain human breast cancer cells. Functional experiments in vitro showed that miR-1915-3p enhanced cell proliferative and migrational abilities. Overexpression of miR-1915-3p repressed target gene DUSP3 and activated ERK1/2. Collectively, this study provided a new insight that miR-1915-3p might play a role in the development of breast cancer and that serum miR-1915-3p and miR-4553p could serve as diagnostic and predictive biomarkers for breast cancer.	[Guo, Jian; Wang, Wei; Liu, Yan; He, Huiwen; Chen, Chong; Luo, Yunping] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Immunol,Inst Basic Med Sci, Beijing, Peoples R China; [Guo, Jian; Wang, Wei; Liu, Yan; He, Huiwen; Chen, Chong; Luo, Yunping] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Collaborat Innovat Ctr Biotherapy,Inst Basic Med, Beijing, Peoples R China; [Liu, Chen] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China; [Xiang, Rong] Nankai Univ, Coll Med, Collaborat Innovat Ctr Biotherapy, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chongqing Medical University; Nankai University	Luo, YP (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Immunol,Inst Basic Med Sci, Beijing, Peoples R China.; Luo, YP (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Collaborat Innovat Ctr Biotherapy,Inst Basic Med, Beijing, Peoples R China.	ypluo@ibms.pumc.edu.cn			National Natural Science Foundation of China [81472654, 81672914]; National Basic Research Program of China [2013CB967202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 81472654), http://www.nsfc.gov.cn/; the National Natural Science Foundation of China (No.81672914), http://www.nsfc.gov.cn/; the National Basic Research Program of China (No. 2013CB967202), http://program.most.gov.cn/.	Ali HEA, 2017, CLIN RES HEPATOL GAS, V41, pE51, DOI 10.1016/j.clinre.2017.06.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hua YQ, 2017, CANCER BIOMARK, V20, P95, DOI 10.3233/CBM-170231; Inamura K, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020012; Jia WH, 2015, MOL CLIN ONCOL, V3, P851, DOI 10.3892/mco.2015.560; Liu SN, 2017, CANCER BIOMARK, V20, P547, DOI 10.3233/CBM-170351; Markopoulos GS, 2017, CELL ONCOL, V40, P303, DOI 10.1007/s13402-017-0341-9; Matsuzaki J, 2017, INT J CLIN ONCOL, V22, P413, DOI 10.1007/s10147-017-1104-3; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Peng QL, 2017, ONCOTARGET, V8, P44893, DOI 10.18632/oncotarget.16488; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shi GL, 2017, CLIN LAB, V133; Takahashi RU, 2017, CLIN CHEM LAB MED, V55, P648, DOI 10.1515/cclm-2016-0708; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang W, 2015, J ZHEJIANG UNIV-SC B, V16, P18, DOI 10.1631/jzus.B1400184; Weng YX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0531-x; Zhu MX, 2017, ONCOTARGET, V8, P17081, DOI 10.18632/oncotarget.15059	30	39	42	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200716	10.1371/journal.pone.0200716	http://dx.doi.org/10.1371/journal.pone.0200716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048472	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400015
J	Laviola, M; Priori, R; D'Angelo, MG; Aliverti, A				Laviola, Marianna; Priori, Rita; D'Angelo, Maria Grazia; Aliverti, Andrea			Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients	PLOS ONE			English	Article							RESPIRATORY-FUNCTION ASSESSMENT; MUSCLE STRENGTH; 3-DIMENSIONAL RECONSTRUCTION; NEUROMUSCULAR DISORDERS; NORMAL VALUES; LUNG-VOLUMES; ULTRASOUND; CHILDREN; DISEASE; ADULTS	Introduction In Duchenne muscular dystrophy (DMD) the assessment of diaphragmatic function is crucial because respiratory muscle weakness can cause respiratory failure. We aimed to noninvasively assess diaphragmatic function in DMD by measuring diaphragmatic thickness by ultrasonography, under the hypothesis that the progressive decrease of lung function is related to alterations of diaphragmatic thickness. Methods Forty-four DMD patients and thirteen healthy controls were enrolled and subdivided into three age groups. Diaphragmatic thickness was measured during quiet breathing, inspiratory capacity, maximal inspiratory pressure and expiratory pressure maneuvers. Results In DMD, absolute values of diaphragmatic thickness were significantly lower than in controls in the majority of the manoeuvers and diaphragmatic thickness significantly decreased with age at end-expiration, remaining constant at end-inspiration and during maximal inspiratory pressure maneuvers. Comparing to controls, absolute values of diaphragmatic thickness and diaphragmatic thickness variations were significantly lower ( p<0.001), with the exception of quiet breathing and maximal expiratory pressure maneuvers in the youngest DMD. During maximal inspiratory pressure maneuver, variation of diaphragmatic thickness was not significantly different in the all groups, nevertheless maximal inspiratory pressure decreases with age. Conclusions The diaphragm is prone to pseudo-hypertrophy in the youngest DMD, and to progressive atrophy in middle-age and oldest DMD. Diaphragm impairment could be expressed as a dissociation between muscle drive and muscle developed force. Ultrasonography could be used as a noninvasive method to assess progressive diaphragmatic weakness.	[Laviola, Marianna; Priori, Rita; Aliverti, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [D'Angelo, Maria Grazia] Sci Inst IRCCS Eugenio Medea, Dept Neurorehabil, Bosisio Parini, Italy	Polytechnic University of Milan; IRCCS Eugenio Medea	Aliverti, A (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy.	andrea.aliverti@polimi.it	Andrea, Aliverti/A-3901-2015; Laviola, Marianna/M-5254-2019; D'Angelo, Maria Grazia/K-4685-2016	Andrea, Aliverti/0000-0002-2950-0231; Laviola, Marianna/0000-0001-6279-6137; D'Angelo, Maria Grazia/0000-0003-1241-4350	Fondo DMD "Amici di Emanuele" Onlus	Fondo DMD "Amici di Emanuele" Onlus	This work was supported by Fondo DMD "Amici di Emanuele" Onlus.	Baldwin CE, 2011, RESPIROLOGY, V16, P1136, DOI 10.1111/j.1440-1843.2011.02005.x; Beck J, 2006, NEUROMUSCULAR DISORD, V16, P161, DOI 10.1016/j.nmd.2006.01.003; Boon AJ, 2013, MUSCLE NERVE, V47, P884, DOI 10.1002/mus.23702; Boussuges A, 2009, CHEST, V135, P391, DOI 10.1378/chest.08-1541; Brown PI, 2013, EUR J APPL PHYSIOL, V113, P2849, DOI 10.1007/s00421-013-2726-4; Burns DP, 2017, J PHYSIOL-LONDON, V595, P6653, DOI 10.1113/JP274792; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Day JM, 2013, MANUAL THER, V18, P588, DOI 10.1016/j.math.2013.07.003; DeBruin PF, 1997, THORAX, V52, P472, DOI 10.1136/thx.52.5.472; Dube B-P, 2017, THORAX; Fromageot C, 2001, ARCH PHYS MED REHAB, V82, P123, DOI 10.1053/apmr.2001.18053; Gaeta M, 2015, NEUROMUSCULAR DISORD, V25, P852, DOI 10.1016/j.nmd.2015.09.003; GAUTHIER AP, 1994, J APPL PHYSIOL, V76, P495, DOI 10.1152/jappl.1994.76.2.495; Gottesman E, 1997, AM J RESP CRIT CARE, V155, P1570, DOI 10.1164/ajrccm.155.5.9154859; Kang SW, 2006, YONSEI MED J, V47, P184, DOI 10.3349/ymj.2006.47.2.184; Lee EP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183560; Li QL, 2013, ULTRASOUND MED BIOL, V39, P2194, DOI 10.1016/j.ultrasmedbio.2013.06.009; Lo Mauro A, 2010, EUR RESPIR J, V35, P1118, DOI 10.1183/09031936.00037209; LoMauro A, 2015, THER CLIN RISK MANAG, V11, P1475, DOI 10.2147/TCRM.S55889; LoMauro A, 2014, PEDIATR PULM, V49, P357, DOI 10.1002/ppul.22836; Matamis D, 2013, INTENS CARE MED, V39, P801, DOI 10.1007/s00134-013-2823-1; Mayer OH, 2017, ADV PULMONARY CARE D, V13, P7; Mead AF, 2014, J APPL PHYSIOL, V116, P807, DOI 10.1152/japplphysiol.00833.2013; Mellies U, 2005, CURR OPIN NEUROL, V18, P543, DOI 10.1097/01.wco.0000180662.03544.5f; NEWSOMDAVIS J, 1980, BRIT MED BULL, V36, P135, DOI 10.1093/oxfordjournals.bmb.a071628; Nicot F, 2006, AM J RESP CRIT CARE, V174, P67, DOI 10.1164/rccm.200512-1841OC; Pettiaux N, 1997, J APPL PHYSIOL, V82, P998, DOI 10.1152/jappl.1997.82.3.998; Romei M, 2012, RESP MED, V106, P276, DOI 10.1016/j.rmed.2011.10.010; Takahashi Y, 2013, J LOW FREQ NOISE V A, V32, P1; Taniguchi N MJ, 1991, J MED ULTRASON, V18, P93; Terzi N, 2008, EUR RESPIR J, V31, P93, DOI 10.1183/09031936.00094707; Testa A, 2011, ULTRASOUND MED BIOL, V37, P44, DOI 10.1016/j.ultrasmedbio.2010.10.004; Thibaud JL, 2017, NEUROMUSCULAR DISORD, V27, P315, DOI 10.1016/j.nmd.2017.02.003; UEKI J, 1995, THORAX, V50, P1157, DOI 10.1136/thx.50.11.1157; WAIT JL, 1989, J APPL PHYSIOL, V67, P1560, DOI 10.1152/jappl.1989.67.4.1560; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535	37	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200582	10.1371/journal.pone.0200582	http://dx.doi.org/10.1371/journal.pone.0200582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048455	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400009
J	Ofori, PA; Mizuno, A; Suzuki, M; Martinoia, E; Reuscher, S; Aoki, K; Shibata, D; Otagaki, S; Matsumoto, S; Shiratake, K				Ofori, Peter Amoako; Mizuno, Ayaka; Suzuki, Mami; Martinoia, Enrico; Reuscher, Stefan; Aoki, Koh; Shibata, Daisuke; Otagaki, Shungo; Matsumoto, Shogo; Shiratake, Katsuhiro			Genome-wide analysis of ATP binding cassette (ABC) transporters in tomato	PLOS ONE			English	Article							CADMIUM TOLERANCE; PROVIDES INSIGHTS; PROTEIN; PLANT; ACID; RESISTANCE; SUBFAMILY; GENE; COMATOSE; OVEREXPRESSION	ATP binding cassette (ABC) transporters are proteins that actively mediate the transport of a wide range of molecules, such as organic acids, metal ions, phytohormones and secondary metabolites. Therefore, ABC transporters must play indispensable roles in growth and development of tomato, including fruit development. Most ABC transporters have transmembrane domains (TMDs) and belong to the ABC protein family, which includes not only ABC transporters but also soluble ABC proteins lacking TMDs. In this study, we performed a genome-wide identification and expression analysis of genes encoding ABC proteins in tomato (Solanum lycopersicum), which is a valuable horticultural crop and a model plant for studying fleshy fruits. In the tomato genome, a total of 154 genes putatively encoding ABC transporters, including 9 ABCAs, 29 ABCBs, 26 ABCCs, 2 ABCDs, 2 ABCEs, 6 ABCFs, 70 ABCGs and 10 ABCIs, were identified. Gene expression data from the eFP Browser and reverse transcription-semi-quantitative PCR analysis revealed their tissue-specific and development-specific expression profiles. This work suggests physiological roles of ABC transporters in tomato and provides fundamental information for future studies of ABC transporters not only in tomato but also in other Solanaceae species.	[Ofori, Peter Amoako; Mizuno, Ayaka; Suzuki, Mami; Reuscher, Stefan; Otagaki, Shungo; Matsumoto, Shogo; Shiratake, Katsuhiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Martinoia, Enrico] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland; [Aoki, Koh] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan; [Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Japan	Nagoya University; University of Zurich; Osaka Metropolitan University; Kazusa DNA Research Institute	Shiratake, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.	shira@agr.nagoya-u.ac.jp	Martinoia, Enrico/AAH-8712-2021	SHIRATAKE, Katsuhiro/0000-0002-2608-7912	Programme for Promotion of Basic and Applied Researchers for Innovations from Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries (MAFF); Cross-ministerial Strategic Innovation Promotion Program (SIP) from the Cabinet Office; Japan Society for the Promotion of Science (JSPS)	Programme for Promotion of Basic and Applied Researchers for Innovations from Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries (MAFF); Cross-ministerial Strategic Innovation Promotion Program (SIP) from the Cabinet Office; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported partially by the Programme for Promotion of Basic and Applied Researchers for Innovations from Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (BRAIN), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries (MAFF), the Cross-ministerial Strategic Innovation Promotion Program (SIP) from the Cabinet Office, and the Grant-in-Aids for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS).	Andolfo G, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0323-2; Banasiak J, PLANT ABC TRANSPORTE, V22; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Bienert MD, 2014, SIGNAL COMMUN PLANTS, P137, DOI 10.1007/978-3-319-06511-3_8; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Borghi L, 2015, BIOCHEM SOC T, V43, P924, DOI 10.1042/BST20150106; Braz ASK, 2004, J MOL EVOL, V59, P20, DOI 10.1007/s00239-004-2600-4; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Bussell JD, 2014, PLANT PHYSIOL, V164, P48, DOI 10.1104/pp.113.229807; Cakir B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078860; Cerino Badone F, 2010, PLANTA, V231, P1189, DOI 10.1007/s00425-010-1123-z; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; Chen PJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02150; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; D'Agostino N, 2007, NUCLEIC ACIDS RES, V35, pD901, DOI 10.1093/nar/gkl921; Dave A, 2011, PLANT CELL, V23, P583, DOI 10.1105/tpc.110.081489; Davies TGE, 1997, GENE, V199, P195, DOI 10.1016/S0378-1119(97)00367-3; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Fernandez-Pozo N, 2017, BIOINFORMATICS, V33, P2397, DOI 10.1093/bioinformatics/btx190; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; Gaillard S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-22; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2017, PLANT CELL PHYSIOL, V58, P1601, DOI 10.1093/pcp/pcx104; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Hanikenne M, 2005, PLANT CELL ENVIRON, V28, P863, DOI 10.1111/j.1365-3040.2005.01335.x; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kato T, 2009, PLANT BIOTECHNOL-NAR, V26, P409, DOI 10.5511/plantbiotechnology.26.409; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kudo T, 2017, PLANT CELL PHYSL, V58, P1, DOI [10.1093/pcp/pcw227, DOI 10.1093/PCP/PCW227]; Kuromori T, 2016, PLANT SCI, V251, P75, DOI 10.1016/j.plantsci.2016.02.019; Kuromori T, 2011, J PLANT PHYSIOL, V168, P2001, DOI 10.1016/j.jplph.2011.05.014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen PB, 2007, PLANTA, V225, P1447, DOI 10.1007/s00425-006-0452-4; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lefevre F, 2015, BIOCHEM SOC T, V43, P931, DOI 10.1042/BST20150108; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Meissner R, 1997, PLANT J, V12, P1465, DOI 10.1046/j.1365-313x.1997.12061465.x; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Nie ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116857; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Remy E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00201; Reuscher S, 2014, PLANT CELL PHYSIOL, V55, P1123, DOI 10.1093/pcp/pcu052; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Russell L, 2000, DEVELOPMENT, V127, P3759; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Sarmiento C, 2006, PLANT MOL BIOL, V61, P153, DOI 10.1007/s11103-005-0001-8; Sasaki T, 2002, PLANT CELL PHYSIOL, V43, P177, DOI 10.1093/pcp/pcf025; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Shitan N, 2003, P NATL ACAD SCI USA, V100, P751, DOI 10.1073/pnas.0134257100; Sugiyama A, 2006, DNA RES, V13, P205, DOI 10.1093/dnares/dsl013; Tagashira Yusuke, 2015, Plants-Basel, V4, P196, DOI 10.3390/plants4020196; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI 10.1199/tab.0153; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; van den Brule S, 2002, PLANT J, V30, P649, DOI 10.1046/j.1365-313X.2002.01321.x; Vasiliou Vasilis, 2008, Hum Genomics, V3, P1; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wanke D, 2010, PLANT BIOLOGY, V12, P15, DOI 10.1111/j.1438-8677.2010.00380.x; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Wu GS, 2010, PLANT J, V62, P179, DOI 10.1111/j.1365-313X.2010.04137.x; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yano K, 2007, PLANT BIOTECHNOL-NAR, V24, P17, DOI 10.5511/plantbiotechnology.24.17; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Zhu YQ, 2003, PLANT PHYSIOL, V133, P580, DOI 10.1104/pp.103.027052; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	97	42	46	12	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200854	10.1371/journal.pone.0200854	http://dx.doi.org/10.1371/journal.pone.0200854			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048467	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400023
J	Duivenvoorden, HM; Spurling, A; O'Toole, SA; Parker, BS				Duivenvoorden, Hendrika M.; Spurling, Alex; O'Toole, Sandra A.; Parker, Belinda S.			Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; MYOSIN HEAVY-CHAIN; BREAST-CANCER; DUCTAL CARCINOMA; IN-SITU; MOLECULAR CHARACTERIZATION; TUMOR MICROENVIRONMENT; GLAND DEVELOPMENT; DEFICIENT MICE; CELLS	Mammographic screening has led to increased detection of breast cancer at a pre-invasive state, hence modelling the earliest stages of breast cancer invasion is important in defining candidate biomarkers to predict risk of relapse. Discrimination of pre-invasive from invasive lesions is critically important for such studies. Myoepithelial cells are the barrier between epithelial cells and the surrounding stroma in the breast ductal system. A number of myoepithelial immunohistochemistry markers have been identified and validated in human tissue for use by pathologists as diagnostic tools to distinguish in situ carcinoma from invasive breast cancer. However, robust myoepithelial markers for mouse mammary tissue have been largely under-utilised. Here, we investigated the utility of the myoepithelial markers smooth muscle actin (SMA), smooth muscle myosin heavy chain (SMMHC), cytokeratin-14 (CK14) and p63 to discriminate mammary intraepithelial neoplasia (MIN) from invasive disease in the C57BL/6J MMTV-PyMT transgenic model of mammary carcinoma. We identified that SMMHC and CK14 are retained in early in situ neoplasia and are appropriate markers for distinguishing MIN from invasive disease in this model. Additionally, the proliferation marker Ki67 is a superior marker for differentiating between normal and hyperplastic ducts, prior to the development of MIN. Based on this, we developed a scoring matrix for discriminating normal, hyperplasia, MIN and invasive lesions in this spontaneous mammary tumorigenesis model. This study demonstrates heterogeneous expression of myoepithelial proteins throughout tumour development, and highlights the need to characterise the most appropriate markers in other models of early breast cancer to allow accurate classification of disease state.	[Duivenvoorden, Hendrika M.; Spurling, Alex; Parker, Belinda S.] La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia; [O'Toole, Sandra A.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [O'Toole, Sandra A.] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [O'Toole, Sandra A.] Australian Clin Labs, Bella Vista, NSW, Australia	University of Sydney; Garvan Institute of Medical Research	Parker, BS (corresponding author), La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia.; O'Toole, SA (corresponding author), Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia.; O'Toole, SA (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW, Australia.; O'Toole, SA (corresponding author), Australian Clin Labs, Bella Vista, NSW, Australia.	s.otoole@garvan.org.au; Belinda.Parker@latrobe.edu.au		Parker, Belinda/0000-0002-8333-1926	National Health and Medical Research Council (NHMRC) [BSP 1047748, 1127754]; Victorian Cancer Agency; National Breast Cancer Foundation [PRAC-16-006]; Cancer Council Victoria; Sydney Breast Cancer Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; National Breast Cancer Foundation; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Sydney Breast Cancer Foundation	This work was supported by grant funding from the National Health and Medical Research Council (NHMRC) (BSP 1047748 and 1127754) to BSP; fellowship support to BSP from Victorian Cancer Agency, SAOT from National Breast Cancer Foundation (Practitioner Fellowship PRAC-16-006) and HMD from Cancer Council Victoria. Support from the Sydney Breast Cancer Foundation is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Clinical Labs provided support in the form of salaries for author SAOT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Cardiff RD, 2000, J MAMMARY GLAND BIOL, V5, P421, DOI 10.1023/A:1009534129331; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; DEANE HW, 1956, J APPL PHYSIOL, V9, P495, DOI 10.1152/jappl.1956.9.3.495; Downs-Holmes Catherine, 2011, Nurse Pract, V36, P20, DOI 10.1097/01.NPR.0000407602.29522.d7; Duivenvoorden HM, 2017, J PATHOL, V243, P496, DOI 10.1002/path.4990; Gudjonsson T, 2002, J CELL SCI, V115, P39; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hilson JB, 2009, AM J SURG PATHOL, V33, P227, DOI 10.1097/PAS.0b013e318180431d; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Kalof AN, 2004, J CLIN PATHOL, V57, P625, DOI 10.1136/jcp.2003.013227; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maglione JE, 2001, CANCER RES, V61, P8298; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; Medina D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004523; Mirtti T, 2003, PROSTATE, V54, P290, DOI 10.1002/pros.10196; Polyak K, 2005, J MAMMARY GLAND BIOL, V10, P231, DOI 10.1007/s10911-005-9584-6; Polyak Kornelia, 2010, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgq019; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Rautela J, 2015, CANCER IMMUNOL RES, V3, P1207, DOI 10.1158/2326-6066.CIR-15-0065; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Sameni M, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0847-0; Schurigt U, 2008, BIOL CHEM, V389, P1067, DOI 10.1515/BC.2008.115; Shousha S, 2016, J CLIN PATHOL, V69, P702, DOI 10.1136/jclinpath-2015-203408; TREISMAN R, 1981, NATURE, V292, P595, DOI 10.1038/292595a0; Van Cleef A, 2014, FACTS VIEWS VIS OBGY, V6, P210; Werling RW, 2003, AM J SURG PATHOL, V27, P82, DOI 10.1097/00000478-200301000-00009; World Health Organization, 2012, WHO CLASSIFICATION T	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201370	10.1371/journal.pone.0201370	http://dx.doi.org/10.1371/journal.pone.0201370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044853	gold, Green Published			2022-12-27	WOS:000439942500102
J	Dunn, VK; Gleason, E				Dunn, Vernon K.; Gleason, Evanna			Inhibition of endocytosis suppresses the nitric oxide-dependent release of Cl- in retinal amacrine cells	PLOS ONE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; SYNTHASE-IMMUNOREACTIVE NEURONS; CLATHRIN TERMINAL DOMAIN; GUINEA-PIG RETINA; CALCIUM-CHANNELS; CYSTIC-FIBROSIS; TRANSMITTER RELEASE; ACTIN CYTOSKELETON; DYNAMIN INHIBITORS; GTPASE ACTIVITY	Our lab has previously shown that nitric oxide (NO) can alter the synaptic response properties of amacrine cells by releasing Cl- from internal acidic compartments. This alteration in the Cl- gradient brings about a positive shift in the reversal potential of the GABA-gated current, which can convert inhibitory synapses into excitatory synapses. Recently, we have shown that the cystic fibrosis transmembrane regulator (CFTR) Cl- channel is involved in the Cl- release. Here, we test the hypothesis that (acidic) synaptic vesicles are a source of NO-releasable Cl- in chick retinal amacrine cells. If SVs are a source of Cl-, then depleting synaptic vesicles should decrease the nitric oxide-dependent shift in the reversal potential of the GABA-gated current. The efficacy of four inhibitors of dynamin (dynasore, Dyngo 4a, Dynole 34-2, and MiTMAB) were evaluated. In order to deplete synaptic vesicles, voltagesteps were used to activate V-gated Ca2+ channels and stimulate the synaptic vesicle cycle either under control conditions or after treatment with the dynamin inhibitors. Voltage-ramps were used to measure the NO-dependent shift in the reversal potential of the GABA-gated currents under both conditions. Our results reveal that activating the synaptic vesicle cycle in the presence of dynasore or Dyngo 4a blocked the NO-dependent shift in EGABA. However, we also discovered that some dynamin inhibitors reduced Ca2+ signaling and L-type Ca2+ currents. Conversely, dynasore also increased neurotransmitter release at autaptic sites. To further resolve the mechanism underlying the inhibition of the NO-dependent shift in the reversal potential for the GABA-gated currents, we also tested the effects of the clathrin assembly inhibitor Pitstop 2 and found that this compound also inhibited the shift. These data provide evidence that dynamin inhibitors have multiple effects on amacrine cell synaptic transmission. These data also suggest that inhibition of endocytosis disrupts the ability of NO to elicit Cl- release from internal stores which may in part be due to depletion of synaptic vesicles.	[Dunn, Vernon K.; Gleason, Evanna] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Gleason, E (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	egleaso@lsu.edu			National Science Foundation, Division of Integrative Organismal Systems [IOS 1256782]; NIH [R25 Gm069743]; NSF [HRD-1141152]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069743] Funding Source: NIH RePORTER	National Science Foundation, Division of Integrative Organismal Systems(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Science Foundation, Division of Integrative Organismal Systems, IOS 1256782 to EG; https://www.nsf.gov/div/index.jsp?div=IOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was partially supported by NIH under award number R25 Gm069743 and NSF award number HRD-1141152 to Vernon K. Dunn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Cantiello HF, 1996, EXP PHYSIOL, V81, P505, DOI 10.1113/expphysiol.1996.sp003953; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao LX, 2001, VISUAL NEUROSCI, V18, P949, DOI 10.1017/S0952523801186128; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Castellani S, 2017, HISTOL HISTOPATHOL, V32, P445, DOI 10.14670/HH-11-842; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; COBCROFT M, 1989, NEUROSCI LETT, V103, P1, DOI 10.1016/0304-3940(89)90475-8; Cook T, 1996, J NEUROCHEM, V67, P927; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Edwards BS, 2016, ENDOCRINOLOGY, V157, P831, DOI 10.1210/en.2015-1575; El-Salem K, 2010, J CLIN NEUROPHYSIOL, V27, P216, DOI 10.1097/01.WNP.0b013e3181e0a9f9; Eldred WD, 2005, VISION RES, V45, P3469, DOI 10.1016/j.visres.2005.07.033; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Garthwaite J, 2016, J PHYSIOL-LONDON, V594, P9, DOI 10.1113/JP270297; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; GLEASON E, 1994, NEURON, V13, P1109, DOI 10.1016/0896-6273(94)90049-3; GLEASON E, 1989, J COMP NEUROL, V287, P213, DOI 10.1002/cne.902870205; GLEASON E, 1993, J NEUROSCI, V13, P2359, DOI 10.1523/JNEUROSCI.13-06-02359.1993; Habermann CJ, 2003, J NEUROSCI, V23, P6904; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hill TA, 2004, BIOORG MED CHEM LETT, V14, P3275, DOI 10.1016/j.bmcl.2004.03.096; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoffpauir B, 2006, J NEUROPHYSIOL, V95, P2866, DOI 10.1152/jn.01317.2005; Hofmann ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174915; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Kim IB, 2000, MICROSC RES TECHNIQ, V50, P112, DOI 10.1002/1097-0029(20000715)50:2<112::AID-JEMT3>3.0.CO;2-S; KOISTINAHO J, 1993, NEUROSCIENCE, V57, P587, DOI 10.1016/0306-4522(93)90008-4; Krishnan V, 2017, J NEUROPHYSIOL; Krishnan V, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00213; Lemmon SK, 2012, TRAFFIC, V13, P511, DOI 10.1111/j.1600-0854.2011.01321.x; Linares-Clemente P, 2015, J PHYSIOL-LONDON, V593, P2867, DOI 10.1113/JP270112; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maddox JW, 2018, J NEUROPHYSIOL, V119, P262, DOI 10.1152/jn.00500.2017; Maddox JW, 2017, J NEUROPHYSIOL, V117, P1185, DOI 10.1152/jn.00803.2016; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Nguyen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036913; Oh SJ, 1999, CELL TISSUE RES, V297, P397, DOI 10.1007/s004410051367; ORIORDAN JI, 1995, IRISH J MED SCI, V164, P207, DOI 10.1007/BF02967830; OSBORNE NN, 1993, BRAIN RES, V610, P194, DOI 10.1016/0006-8993(93)91400-M; PEREZ MTR, 1995, EXP BRAIN RES, V104, P207; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rios H, 2000, DEV BRAIN RES, V120, P17, DOI 10.1016/S0165-3806(99)00166-2; SANDELL JH, 1985, J COMP NEUROL, V238, P466, DOI 10.1002/cne.902380410; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tekmen M, 2010, J NEUROPHYSIOL, V104, P1849, DOI 10.1152/jn.00031.2010; Tooker RE, 2015, J COMP NEUROL, V523, P2082, DOI 10.1002/cne.23780; Trippett TM, 2001, CANCER RES, V61, P1941; VACCARO TM, 1991, CELL TISSUE RES, V265, P371, DOI 10.1007/BF00398085; VANEY DI, 1988, BRAIN RES, V474, P380, DOI 10.1016/0006-8993(88)90455-6; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Vigh J, 2004, VISUAL NEUROSCI, V21, P129, DOI 10.1017/S095252380404204X; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang GY, 2003, J NEUROPHYSIOL, V90, P1304, DOI 10.1152/jn.00243.2003; WASSLE H, 1987, J COMP NEUROL, V265, P391, DOI 10.1002/cne.902650308; Willox AK, 2012, TRAFFIC, V13, P70, DOI 10.1111/j.1600-0854.2011.01289.x; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219	76	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201184	10.1371/journal.pone.0201184	http://dx.doi.org/10.1371/journal.pone.0201184			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044876	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500089
J	Eto, S; Goto, M; Soga, M; Kaneko, Y; Uehara, Y; Mizuta, H; Era, T				Eto, Shinya; Goto, Mizuki; Soga, Minami; Kaneko, Yumi; Uehara, Yusuke; Mizuta, Hiroshi; Era, Takumi			Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials	PLOS ONE			English	Article							PRESSURE ULCER; T-CELLS; MSC; PLURIPOTENCY; MECHANISMS	Mesenchymal stem cells (MSCs) isolated from adult human tissues are capable of proliferating in vitro and maintaining their multipotency, making them attractive cell sources for regenerative medicine. However, the availability and capability of self-renewal under current preparation regimes are limited. Induced pluripotent stem cells (iPSCs) now offer an alternative, similar cell source to MSCs. Herein, we established new methods for differentiating hiPSCs into MSCs via mesoderm-like and neuroepithelium-like cells. Both derived MSC populations exhibited self-renewal and multipotency, as well as therapeutic potential in mouse models of skin wounds, pressure ulcers, and osteoarthritis. Interestingly, the therapeutic effects differ between the two types of MSCs in the disease models, suggesting that the therapeutic effect depends on the cell origin. Our results provide valuable basic insights for the clinical application of such cells.	[Eto, Shinya; Goto, Mizuki; Soga, Minami; Kaneko, Yumi; Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto, Japan; [Goto, Mizuki] Oita Univ, Dept Dermatol, Fac Med, Yufu, Japan; [Uehara, Yusuke; Mizuta, Hiroshi] Kumamoto Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kumamoto, Japan	Kumamoto University; Oita University; Kumamoto University	Goto, M; Era, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto, Japan.; Goto, M (corresponding author), Oita Univ, Dept Dermatol, Fac Med, Yufu, Japan.	gotomizu@oita-u.ac.jp; tera@kumamoto-u.ac.jp			Japan Society for the Promotion Science (JSPS) [S2803]; Ministry of Health, Labor, and Welfare of Japan; Japan Agency for Medical Research and Development (A-MED); Core Research for Evolutional Science and Technology (CREST); KAKENHI [25505002, 18K06264]; Japan Science and Technology Agency (JST)	Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (A-MED)(Japan Agency for Medical Research and Development (AMED)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This study was supported, in part, by grants from Japan Society for the Promotion Science (JSPS, URLs: http://www.jsps.go.jp/english/) program on Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (Grant Number S2803), the Ministry of Health, Labor, and Welfare of Japan (URLs: http://www.mhlw.go.jp/english/), the Japan Agency for Medical Research and Development (A-MED, URLs: https://www.amed.go.jp/en/), Core Research for Evolutional Science and Technology (CREST, URLs: https://www.jst.go.jp/kisoken/crest/en/), Grant-in-Aid for Scientific Research (KAKENHI C, 25505002 and 18K06264, URLs: https://www.jsps.go.jp/english/e-grants/) and the Japan Science and Technology Agency (JST, URLs: https://www.jst.go.jp/EN/). T.E. received all of above grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Basiouny Hend Shafik, 2013, International Journal of Stem Cells, V6, P12; Bomsta BD, 2006, OSTEOARTHR CARTILAGE, V14, P477, DOI 10.1016/j.joca.2005.11.011; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bortolotti F, 2015, STEM CELL REP, V4, P332, DOI 10.1016/j.stemcr.2015.01.001; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Christiansen BA, 2015, OSTEOARTHR CARTILAGE, V23, P1627, DOI 10.1016/j.joca.2015.05.009; D'Antonio M, 2017, STEM CELL REP, V8, P1101, DOI 10.1016/j.stemcr.2017.03.011; de Rham C, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/518135; Fukuta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112291; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Hurley MM, 2016, J CELL BIOCHEM, V117, P721, DOI 10.1002/jcb.25357; Hynes K, 2012, PERIODONTOL 2000, V59, P203, DOI 10.1111/j.1600-0757.2012.00443.x; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kasuya A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04173; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Li JF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/470418; Li YY, 2014, BIO-MED MATER ENG, V24, pS47, DOI 10.3233/BME-140973; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mishra Pravin J, 2012, World J Stem Cells, V4, P35; Miwa H, 2018, DEVELOPMENT, V29, P145; Miwa H, 2014, METHODS MOL BIOL; Murphy WJ, 2012, CELL STEM CELL, V10, P485, DOI 10.1016/j.stem.2012.04.013; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pripuzova NS, 2015, STEM CELL RES, V14, P323, DOI 10.1016/j.scr.2015.01.009; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z; Resnick IB, 2013, AM J BLOOD RES, V3, P225; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Sheyn D, 2016, STEM CELL TRANSL MED, V5, P1447, DOI 10.5966/sctm.2015-0311; Soga M, 2014, STEM CELLS, V33, P1057; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; van Essen TH, 2015, PROG RETIN EYE RES, V46, P84, DOI 10.1016/j.preteyeres.2015.01.001; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wysocki A B, 1996, J Wound Ostomy Continence Nurs, V23, P283, DOI 10.1016/S1071-5754(96)90047-9; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Yang JJ, 2013, ANAT REC, V296, P1161, DOI 10.1002/ar.22676; Zhang JY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0417-0	51	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200790	10.1371/journal.pone.0200790	http://dx.doi.org/10.1371/journal.pone.0200790			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044827	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500066
J	Faoro, C; Wilkinson-White, L; Kwan, AH; Ataide, SF				Faoro, Camilla; Wilkinson-White, Lorna; Kwan, Ann H.; Ataide, Sandro F.			Discovery of fragments that target key interactions in the signal recognition particle (SRP) as potential leads for a new class of antibiotics	PLOS ONE			English	Article							GTPASE ACTIVATION; TRANSLATING RIBOSOME; CRYSTAL-STRUCTURE; RECEPTOR FTSY; DRUG DESIGN; PROTEIN; COMPLEX; NMR; RNA; BINDING	Given the increasing incidence of antibiotic resistance, antibiotics that employ new strategies are urgently needed. Bacterial survival is dependent on proper function of the signal recognition particle (SRP) and its receptor (FtsY). A unique set of interactions in FtsY:SRP-RNA represents a promising candidate for new antibiotic development as no antibiotic targets this complex and these interactions are functionally replaced by protein:protein interactions in eukaryotes. We used a Fragment Based Drug Design (FBDD) approach to search for new compounds that can bind FtsY, and have identified three lead fragments. In vitro and in vivo analyses have shown that despite a high micromolar binding affinity, one fragment has some antimicrobial properties. X-ray structures of E. coli FtsY:fragments reveal the fragments bind in the targeted RNA interaction site. Our results show that FBDD is a suitable approach for targeting FtsY:SRP-RNA for antibiotic development and opens the possibility of targeting protein:RNA interactions in general.	[Faoro, Camilla; Kwan, Ann H.; Ataide, Sandro F.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Wilkinson-White, Lorna] Univ Sydney, Sydney Analyt Core Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney	Kwan, AH; Ataide, SF (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	ann.kwan@sydney.edu.au; sandro.ataide@sydney.edu.au		Faoro, Camilla/0000-0002-6872-668X; F Ataide, Sandro/0000-0003-1807-5708; Kwan, Ann/0000-0002-1506-2226	ANSTO NDF [5132]; ARC LIEF [LE160100047]; University of Sydney; Faculties of Science and Medicine and School of Life and Environmental Sciences	ANSTO NDF; ARC LIEF(Australian Research Council); University of Sydney(University of Sydney); Faculties of Science and Medicine and School of Life and Environmental Sciences	This work was supported by internal University funding to SFA and AK, ANSTO NDF grant 5132 to SFA and AK as well as ARC LIEF grant LE160100047 to AK. We are grateful for financial contributions from the University of Sydney, including from the Faculties of Science and Medicine and School of Life and Environmental Sciences for support of the NMR and X-ray crystallography facilities that were used in this work. https://sydney.edu.au/; http://www.ansto. gov.au/; http://www.arc.gov.au/.	Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Baker M, 2013, NAT REV DRUG DISCOV, V12, P5, DOI 10.1038/nrd3926; Bange G, 2007, CURR BIOL, V17, pR980, DOI 10.1016/j.cub.2007.09.041; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; BROWN JD, 1994, EMBO J, V13, P4390, DOI 10.1002/j.1460-2075.1994.tb06759.x; Chavanieu A, 2016, EXPERT OPIN DRUG DIS, V11, P489, DOI 10.1517/17460441.2016.1160888; Costa EA, 2018, SCIENCE, V359, P689, DOI 10.1126/science.aar3607; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b; Doak BC, 2016, PHARMACOL THERAPEUT, V167, P28, DOI 10.1016/j.pharmthera.2016.07.003; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Huber S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175842; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Kalverda AP, 2014, MOL MEMBR BIOL, V31, P131, DOI 10.3109/09687688.2014.911980; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Retra K, 2010, ANAL BIOCHEM, V407, P58, DOI 10.1016/j.ab.2010.06.021; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; Sauer-Eriksson AE, 2003, CURR OPIN STRUC BIOL, V13, P64, DOI 10.1016/S0959-440X(02)00010-6; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Voigts-Hoffmann F, 2013, MOL CELL, V52, P643, DOI 10.1016/j.molcel.2013.10.005; Wild K, 2002, CURR OPIN STRUC BIOL, V12, P72, DOI 10.1016/S0959-440X(02)00292-0; Zhang DW, 2012, J BIOL CHEM, V287, P7652, DOI 10.1074/jbc.M111.325001	30	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200387	10.1371/journal.pone.0200387	http://dx.doi.org/10.1371/journal.pone.0200387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044812	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500050
J	Yu, WB; Wang, H; Liu, ML; Grabovskaya-Borodina, AE; Li, DZ				Yu, Wen-Bin; Wang, Hong; Liu, Min-Lu; Grabovskaya-Borodina, Alisa E.; Li, De-Zhu			Phylogenetic approaches resolve taxonomical confusion in Pedicularis (Orobanchaceae): Reinstatement of Pedicularis delavayi and discovering a new species Pedicularis milliana	PLOS ONE			English	Article							BAYESIAN POSTERIOR PROBABILITIES; HENGDUAN MOUNTAINS; SEED PRODUCTION; COROLLA TUBES; EVOLUTION; BOOTSTRAP; POLLINATION; ALGORITHM; SOFTWARE; BARCODE	Morphological identification of Pedicularis depends on floral characters. However, some important characters may be lost during the process of pressing the specimen. Pedicularis delavayi was described from northwestern Yunnan, and widely adopted as a variety of P. siphonantha. Unfortunately, the name "P. siphonantha var. delavayi incorrectly referred to P. milliana (a new species described in this study) or P. tenuituba in some herbarium specimens and publications. Moreover, phylogenetic relationships among P. delavayi, P. siphonantha and its allies (P. milliana and P. tenuituba) were not fully resolved. In this study, we sampled 76 individuals representing 56 taxa. Of them, 10 taxa were from P. siphonantha lineage, and 11 individuals of P. delavayi represented 9 populations. These species were named as P. siphonantha group on the basis of morphological similarity. Nuclear ribosomal internal transcribed spacer (nrITS) and four chloroplast genes/regions were used for phylogenetic analyses. Phylogenetic analyses showed that the P. siphonantha group was polyphyletic: P. delavayi was sister to P. obliquigaleata in Glade A; and the remaining species of P. siphonantha group were monophyletic in Glade B, named as P. siphonantha lineage. In the P. siphonantha lineage, P. milliana, P. siphonantha, and P. tenuituba were well supported as monophyletic, and P. dolichosiphon was sister to P. leptosiphon. Morphologically, P. de/avayidiffers from species of the P. siphonantha lineage in having a long petiole (similar to 50 mm) and pedicel (similar to 40 mm), a ridged corolla tube, and a folded lower-lip of the corolla. Therefore, both morphological characters and phylogenetic evidence strongly supported to reinstate P. delavayi as an independent species and describe P. milliana as new species. In addition, P. neolatituba was proposed to reduce as a new synonymy of P. delavayi.	[Yu, Wen-Bin] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China; [Yu, Wen-Bin] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Yezin, Nay Pyi Taw, Myanmar; [Wang, Hong; Liu, Min-Lu; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Wang, Hong; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Grabovskaya-Borodina, Alisa E.] Komarov Bot Inst, Prof Popov Str, St Petersburg, Russia	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Yu, WB (corresponding author), Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China.; Yu, WB (corresponding author), Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Yezin, Nay Pyi Taw, Myanmar.; Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.; Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.	yuwenbin@xtbg.ac.cn; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011; Yu, Wen-Bin/H-8339-2014	Li, De-Zhu/0000-0002-4990-724X; Yu, Wen-Bin/0000-0002-7643-2112	National Natural Science Foundation of China [31470323, 31200185]; National Key Basic Research Program of China [2014CB954100]; Major International Joint Research Project of National Natural Science Foundation of China [31320103919]; West Light Foundation of the Chinese Academy of Sciences [Y2227111W1]; Visiting Scholar Fellowship of Chinese Academy of Sciences; Komarov Botanical Institute of the Russian Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Major International Joint Research Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Visiting Scholar Fellowship of Chinese Academy of Sciences; Komarov Botanical Institute of the Russian Academy of Sciences	This study is supported by grants from the National Natural Science Foundation of China (grants 31470323, and 31200185), the National Key Basic Research Program of China (2014CB954100), the Major International Joint Research Project of National Natural Science Foundation of China (31320103919), the West Light Foundation of the Chinese Academy of Sciences (Y2227111W1), Visiting Scholar Fellowship of Chinese Academy of Sciences, and the research project of the Komarov Botanical Institute of the Russian Academy of Sciences: "Collections of vascular plants in BIN RAS (history, conservation, study and replenishment).	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Bonati G., 1921, NOTES ROY BOT GARD, V13, P103; Bonati G, 1904, RECORDS BOT SURVEY I, V4, P323; Bonati G., 1910, B SOC BOT FRANCE, V57, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Don D, 1825, PRODROMUS FLORAE NEP; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Gelman A, 1992, INFERENCE ITERATIVE, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guan KY, 1998, HIGHLAND FLOWERS YUN; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handel-Mazzetti HRE, 1923, AKAD WISSENSCHAFTEN, V60, P114; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hong W, 2005, ANN MO BOT GARD, V92, P127; Huang SQ, 2007, INT J PLANT SCI, V168, P325, DOI 10.1086/510209; Huang SQ, 2016, J INTEGR PLANT BIOL, V58, P698, DOI 10.1111/jipb.12460; Husain T, 2010, GENUS PEDICULARIS L; Jie C, 2004, CARYOLOGIA, V57, P337, DOI 10.1080/00087114.2004.10589817; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kolaczkowski B, 2007, MOL BIOL EVOL, V24, P2108, DOI 10.1093/molbev/msm141; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li H-L, 1948, P ACAD NAT SCI PHILA, V100, P205; LI HL, 1951, EVOLUTION, V5, P158, DOI 10.1111/j.1558-5646.1951.tb02771.x; LI HUI-LIN, 1949, PROC ACAD NAT SCI PHILADELPHIA, V101, P1; Li R, 2016, ORYX, V50, P204, DOI 10.1017/S0030605316000016; Limpricht W, 1924, REPERT SPEC NOV REGN, V20, P161, DOI DOI 10.1002/FEDR.19240200612; Liu ML, 2015, PHYTOTAXA, V217, P53, DOI 10.11646/phytotaxa.217.1.4; Liu Min-Lu, 2013, Plant Diversity and Resources, V35, P707, DOI 10.7677/ynzwyj201313168; MACIOR L W, 1991, Plant Species Biology, V6, P75, DOI 10.1111/j.1442-1984.1991.tb00212.x; Macior Lazarus Walter, 2001, Plant Species Biology, V16, P83, DOI 10.1046/j.1442-1984.2001.00048.x; Macior Lazarus Walter, 1997, Plant Species Biology, V12, P1, DOI 10.1111/j.1442-1984.1997.tb00150.x; Maximowicz CJ., 1888, B ACAD SCI ST PETERS, V32, P477; McNeil D, 2012, REGNUM VEGETABILE; Mill RR, 2001, FLORA BHUTAN, V2, P1156; Pennell Francis W, 1943, ACAD NAT SCI PHILADELPHIA MONOGR, V5, P1; Pennell FW, 1935, SCROPHULARIACEAE E T; Prain D., 1890, ANN ROYAL BOT GARDEN, V3, P1; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; Robart BW, 2015, SYST BOT, V40, P229, DOI 10.1600/036364415X686549; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tkach N, 2014, MOL PHYLOGENET EVOL, V76, P75, DOI 10.1016/j.ympev.2014.03.004; Tsoong P-C., 1955, ACTA PHYTOTAX SINICA, V4, P71; Tsoong P-C, 1956, ACTA PHYTOTAX SINICA, V5, P205; Tsoong P-C., 1961, ACTA BOT SIN, V9, P230; Tsoong P-C., 1963, FLORA REIPUBLICAE PO, V68, P1; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wang H., 2006, FLORA YUNNANICA, V16, P468; Wang W-T, 1994, VASCULAR PLANTS HE 2; [郁文彬 Wenbin Yu], 2008, [植物学通报, Chinese Bulletin of Botany], V25, P392; Xu B, 2013, SEED PLANTS ALPINE S; Yamazaki T, 1988, BULLETIN, V31, P91; Yang CF, 2005, BOT J LINN SOC, V147, P83, DOI 10.1111/j.1095-8339.2005.00363.x; Yang CF, 2002, PLANT SYST EVOL, V236, P89, DOI 10.1007/s00606-002-0223-z; Yang CF, 2015, BOT J LINN SOC, V179, P526, DOI 10.1111/boj.12331; Yang FS, 2007, PLANT SYST EVOL, V264, P251, DOI 10.1007/s00606-006-0510-1; Yang H-B, 1998, FLORA CHINA, V16, P97; Yu WB, 2008, NOVON, V18, P125, DOI 10.3417/2006032; Yu WB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0547-9; Yu WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074828; Yu WB, 2013, J SYST EVOL, V51, P435, DOI 10.1111/jse.12018; Yu WB, 2012, J SYST EVOL, V50, P218, DOI 10.1111/j.1759-6831.2012.00180.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x	66	1	2	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200372	10.1371/journal.pone.0200372	http://dx.doi.org/10.1371/journal.pone.0200372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044806	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500048
J	Calao, M; Wilson, JL; Spelman, L; Billot, L; Rubel, D; Watts, AD; Jemec, GBE				Calao, Miriam; Wilson, Jodie L.; Spelman, Lynda; Billot, Laurent; Rubel, Diana; Watts, Alan D.; Jemec, Gregor B. E.			Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study	PLOS ONE			English	Article							OF-LIFE IMPAIRMENT; QUALITY INDEX DLQI; DISEASE SEVERITY; DIAGNOSIS; EPIDEMIOLOGY	Background Hidradenitis Suppurativa (HS) is a painful, chronic inflammatory skin disease. Global estimates of prevalence vary between 0.03% and 4% of the population. Our main aim was to determine HS prevalence in the Australian adult population focussing on the demographics, management pathways and diagnosis rate of individuals living with HS. Methods In this population-based cross-sectional study, 17,050 individuals representative of the Australian adult population were asked through face-to-face household interviews to answer a previously validated HS screening questionnaire with high diagnostic power. Individuals who screened positive were asked additional questions, including previous diagnosis of HS and number/type of physicians consulted regarding their condition. Results 11,433 Australian residents answered the HS questionnaire, 88 screening positive for HS (0.77%; 95% CI 0.62-0.95). Considering the previously reported sensitivity (0.97) and positive predictive value (0.85) of the screening questionnaire, HS prevalence was estimated to be 0.67% (95% CI 0.53%-0.84%). 6 of 88 suspected HS individuals reported a pre-existing HS diagnosis (6.8%; 95% CI 3.2%-14.1%). 25.6% of the undiagnosed individuals suspected of having HS had not seen any clinicians regarding their boils; the remaining ones had consulted General Practitioners (96.7%), and clinicians from different specialties. Comparisons of individuals who screened positive for HS versus those who screened negative demonstrated statistically significant differences in gender (p = 0.0046), age (p<0.0001), BMI (p = 0.0307), smoking status (p<0.0001), employment status (p<0.0001) and income (p = 0.0321). Conclusions The prevalence of HS in Australia was estimated to be 0.67% (95% CI 0.53%-0.84%). The diagnosis rate amongst the suspected HS cases was low, which appeared to be due to a combination of patients not seeking help and decentralization of care. Individuals suspected of having HS were more likely to be females, young, obese, smokers, unemployed or at home duties and having lower annual personal income in comparison with individuals not suspected of having HS.	[Calao, Miriam; Wilson, Jodie L.; Watts, Alan D.] Abbvie Pty Ltd, Mascot, NSW, Australia; [Spelman, Lynda] Verac Clin Res, Woolloongabba, Qld, Australia; Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Billot, Laurent] George Inst Global Hlth, Sydney, NSW, Australia; [Rubel, Diana] Woden Dermatol, Canberra, ACT, Australia; [Jemec, Gregor B. E.] Univ Copenhagen, Roskilde Hosp, Hlth Sci Fac, Dept Dermatol, Roskilde, Denmark	AbbVie; University of Sydney; George Institute for Global Health; University of Sydney; University of Copenhagen	Calao, M (corresponding author), Abbvie Pty Ltd, Mascot, NSW, Australia.	miriam.calao@abbvie.com		Billot, Laurent/0000-0002-4975-9793; Jemec, Gregor/0000-0002-0712-2540	AbbVie Pty Ltd.	AbbVie Pty Ltd.	AbbVie Pty Ltd funded the research for these studies and participated in the studies design; studies research; analysis and interpretation of data; and writing, reviewing and approving of this publication.	Alavi A, 2015, AM J CLIN DERMATOL, V16, P61, DOI 10.1007/s40257-014-0105-5; ANDERSON M J Jr, 1958, Dis Colon Rectum, V1, P23, DOI 10.1007/BF02616510; Bettoli V, 2016, J EUR ACAD DERMATOL, V30, P1965, DOI 10.1111/jdv.13687; Canoui-Poitrine F, 2009, J AM ACAD DERMATOL, V61, P51, DOI 10.1016/j.jaad.2009.02.013; Collier F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2121; Deckers IE, 2016, J AM ACAD DERMATOL, V75, P755, DOI 10.1016/j.jaad.2016.04.067; Delany E, 2018, J EUR ACAD DERMATOL, V32, P467, DOI 10.1111/jdv.14686; Esmann S, 2010, BRIT J DERMATOL, V163, P102, DOI 10.1111/j.1365-2133.2010.09773.x; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Horvath B, 2015, J AM ACAD DERMATOL, V73, pS47, DOI 10.1016/j.jaad.2015.07.046; Ingram JR, 2018, BRIT J DERMATOL, V178, P917, DOI 10.1111/bjd.16101; Ingram JR, 2016, BRIT J DERMATOL, V175, P263, DOI 10.1111/bjd.14475; Jansen T, 2001, J EUR ACAD DERMATOL, V15, P532, DOI 10.1046/j.1468-3083.2001.00303.x; Jemec G B, 1998, Ugeskr Laeger, V160, P847; Jemec GB, 2006, HIDRADENITIS SUPPURA; JEMEC GBE, 1988, BRIT J DERMATOL, V119, P345, DOI 10.1111/j.1365-2133.1988.tb03227.x; Jemec GBE, 2015, J AM ACAD DERMATOL, V73, pS4, DOI 10.1016/j.jaad.2015.07.052; Jemec GBE, 2015, J AM ACAD DERMATOL, V73, pS3, DOI 10.1016/j.jaad.2015.08.060; Katoulis AC, 2017, SKIN APPENDAGE DISOR, V3, P197, DOI 10.1159/000475822; Kohorst JJ, 2015, J AM ACAD DERMATOL, V73, pS27, DOI 10.1016/j.jaad.2015.07.055; Mattei PL, 2014, J EUR ACAD DERMATOL, V28, P333, DOI 10.1111/jdv.12106; Matusiak L, 2009, J AM ACAD DERMATOL, V61, P362, DOI 10.1016/j.jaad.2009.03.043; McMillan K, 2014, AM J EPIDEMIOL, V179, P1477, DOI 10.1093/aje/kwu078; Miller LM, 2016, DERMATOL CLIN, V34, P7, DOI 10.1016/j.det.2015.08.002; PALETTA C, 1987, CLIN PLAST SURG, V14, P383; Poli F, 2006, CLIN PRESENTATION HI, P11; Research RM, 2016, WE COLL PROC SINGL S; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Riis PT, 2017, BRIT J DERMATOL, V176, P1083, DOI 10.1111/bjd.14922; Saunte DM, 2015, BRIT J DERMATOL, V173, P1546, DOI 10.1111/bjd.14038; Saunte DML, 2017, JAMA-J AM MED ASSOC, V318, P2019, DOI 10.1001/jama.2017.16691; Schrader AMR, 2014, J AM ACAD DERMATOL, V71, P460, DOI 10.1016/j.jaad.2014.04.001; van der Zee HH, 2015, J AM ACAD DERMATOL, V73, pS23, DOI 10.1016/j.jaad.2015.07.047; van der Zee HH, 2012, EXP DERMATOL, V21, P735, DOI 10.1111/j.1600-0625.2012.01552.x; Vazquez BG, 2013, J INVEST DERMATOL, V133, P97, DOI 10.1038/jid.2012.255; Vinding GR, 2014, BRIT J DERMATOL, V170, P884, DOI 10.1111/bjd.12787; von der Werth JM, 2000, J EUR ACAD DERMATOL, V14, P389, DOI 10.1046/j.1468-3083.2000.00087.x; Wolkenstein P, 2007, J AM ACAD DERMATOL, V56, P621, DOI 10.1016/j.jaad.2006.08.061; Zouboulis CC, 2017, BRIT J DERMATOL, V177, P1401, DOI 10.1111/bjd.15748; Zouboulis CC, 2015, J EUR ACAD DERMATOL, V29, P619, DOI 10.1111/jdv.12966	40	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200683	10.1371/journal.pone.0200683	http://dx.doi.org/10.1371/journal.pone.0200683			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040827	Green Submitted, Green Published, gold			2022-12-27	WOS:000439749200008
J	Williams, RA; Machin, LL				Williams, Richard A.; Machin, Laura L.			Rethinking gamete donor care: A satisfaction survey of egg and sperm donors in the UK	PLOS ONE			English	Article							OOCYTE DONATION; EMBRYO DONORS; FOLLOW-UP; MOTIVATION; ATTITUDES; GENDER; WOMEN	Objective Despite poor clinic communication and staff treatment being reported by donors, high rates of overall satisfaction are still reported in surveys. This study will evaluate the importance of communication and interaction between donors and fertility clinic staff in gamete donor care. Methods We report on 120 egg and sperm donors' responses to a UK-wide online satisfaction survey. The survey focused on donors' interactions with fertility clinic staff pre-, during, and post-donation. Basic cross-tabulation was performed on the data using online survey software. Textual data was read and extracts identified, which illustrated and expanded on the findings from the numerical data. Diagrammatic modeling was also utilised to analyse the textual data, with particular focus to relationships between the donors and clinic staff, the main activities within the gamete donation process, and how these activities may affect donor satisfaction with the gamete donation process. Results Donors expressed concern for the infertile couple and the resulting child; conveyed frustration at not receiving information on the expenses they could claim; felt lost in the system regarding the ease of making clinic appointments, and once made they were routinely not seen on time for these appointments. Donors also negatively commented on aftercare, the location and condition of the donation room, and information on contraception. In addition, Ovarian Hyperstimulation Syndrome was frequently reported, with these egg donors believing that clinic staff were not concerned with their physical or emotional well-being, but were instead disproportionately focused on extracting the eggs. Conclusions The multifaceted notion of donors highlights the complexity inherent to the gamete donation process, which comprises various aspects of uncertainty in the donation system, and ambiguity in the donation process. Categorising donors as Altruist, Customer, and Patient, conveys the particular importance of staff communication and treatment in donor care. These categories are not mutually exclusive however, in that an individual donor may experience more than one of these perspectives during the course of their gamete donation journey. Finally, there were a number of exemplar cases, where donors reported high satisfaction throughout, and these correlated with them being given a single point of contact at the clinic. Subject to resource constraints, we suggest that this practice should be implemented throughout clinics in the UK, so that donors have access to dedicated clinic staff who not only support them emotionally and physically throughout the gamete donation process, but also ensure that communication is open, clear, timely, and consistent.	[Williams, Richard A.] Univ Lancaster, Management Sch, Dept Management Sci, Lancaster, England; [Williams, Richard A.] Univ Lancaster, Data Sci Inst, Lancaster, England; [Machin, Laura L.] Univ Lancaster, Fac Hlth & Med, Med Sch, Lancaster, England	Lancaster University; Lancaster University; Lancaster University	Machin, LL (corresponding author), Univ Lancaster, Fac Hlth & Med, Med Sch, Lancaster, England.	l.machin@lancaster.ac.uk	Williams, Richard A/I-7883-2014; Williams, Richard/AAI-9331-2020	Williams, Richard A/0000-0001-6333-9448; Williams, Richard/0000-0001-6333-9448; Machin, Laura/0000-0002-6717-959X	National Gamete Donation Trust	National Gamete Donation Trust	The authors received funding from the National Gamete Donation Trust. Members of the Trust designed the questionnaire that was used for data collection, but have had no role in data analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their gratitude to the National Gamete Donation Trust who funded this study, and Kriss Fearon. Members of the Trust designed the questionnaire to collect the data used in this paper. However, the views expressed in this paper are the authors' own, and the Trust played no role in the data analysis or the writing of this paper.	Allan H, 2001, Nurs Inq, V8, P51, DOI 10.1046/j.1440-1800.2001.00090.x; Allan Helen T, 2005, Nurs Inq, V12, P175, DOI 10.1111/j.1440-1800.2005.00275.x; Allan HT, 2002, J ADV NURS, V38, P86, DOI 10.1046/j.1365-2648.2002.02149.x; Almeling R, 2006, NEW GENET SOC, V25, P143, DOI 10.1080/14636770600855184; Applegarth LD, 2006, INFERTILITY COUNSELING: A COMPREHENSIVE HANDBOOK FOR CLINICIANS, 2ND EDITION, P339; Arlow J, 2009, UML2 UN PROC PRACT O; Attride-Stirling J., 2001, QUAL RES, V1, P385, DOI [DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; AVIS M, 1995, J ADV NURS, V22, P316, DOI 10.1046/j.1365-2648.1995.22020316.x; BOOCH G, 1998, UNIFIED MODELING LAN; Braverman Andrea M., 2001, American Journal of Bioethics, V1, P16, DOI 10.1162/152651601317139234; Brett Sanora, 2008, Hum Fertil (Camb), V11, P101, DOI 10.1080/14647270801953109; Byrd Louise M, 2002, Hum Fertil (Camb), V5, P175, DOI 10.1080/1464727022000199082; Checkland P., 1999, RETHINKING MANAGEMEN; Crawshaw M, 2012, HUM FERTIL, V15, P82, DOI 10.3109/14647273.2012.687123; Fielding D, 1998, J COMMUNITY APPL SOC, V8, P273, DOI 10.1002/(SICI)1099-1298(199807/08)8:4<273::AID-CASP496>3.0.CO;2-Q; Fowler M., 2004, UML DISTILLED BRIEF, Vthird; Hamilton M, 2010, HUM FERTIL, V13, P257, DOI 10.3109/14647273.2010.518658; Human Fertilisation and Embryology Authority, FERT REG LAUNCH STRA; Jordan CB, 2004, J PSYCHOSOM OBST GYN, V25, P145, DOI 10.1080/1674820400002261; Kenney NJ, 2010, FERTIL STERIL, V93, P455, DOI 10.1016/j.fertnstert.2008.09.081; Klock SC, 1998, J WOMENS HEALTH, V7, P229, DOI 10.1089/jwh.1998.7.229; Klock SC, 2003, FERTIL STERIL, V79, P1312, DOI 10.1016/S0015-0282(03)00348-0; Machin LL, 2017, J INTERPROF CARE, V31, P342, DOI 10.1080/13561820.2016.1253546; Meerabeau L, 1998, J ADV NURS, V27, P721, DOI 10.1046/j.1365-2648.1998.00613.x; National Gamete Donation Trust, 2014, EGG SPERM DON UK 201; Object Management Group, UN MOD LANG SUP SPEC; Ockhuijsen HDL, 2012, J ADV NURS, V68, P1156, DOI 10.1111/j.1365-2648.2011.05829.x; Payne D, 2007, J ADV NURS, V60, P645, DOI 10.1111/j.1365-2648.2007.04451.x; Procter M., 2002, RES SOCIAL LIFE, P105; Purewal S, 2009, HUM REPROD UPDATE, V15, P499, DOI 10.1093/humupd/dmp018; Rapport F, 2003, J ADV NURS, V43, P28, DOI 10.1046/j.1365-2648.2003.02670.x; Redshaw M, 2008, BIRTH-ISS PERINAT C, V35, P73, DOI 10.1111/j.1523-536X.2007.00215.x; Royal College of Obstetricians and Gynaecologists, 2016, OV HYP SYNDR 2016; Seale C, 1998, RES SOC CULTURE, P146; Svanberg AS, 2013, ACTA OBSTET GYN SCAN, V92, P1049, DOI 10.1111/aogs.12156; Svanberg AS, 2012, ACTA OBSTET GYN SCAN, V91, P944, DOI 10.1111/j.1600-0412.2012.01430.x; Tomlinson MJ, 2010, HUM FERTIL, V13, P159, DOI 10.3109/14647273.2010.512654; Verdin H., 2018, OV HYP SYNDR 2016, P867; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5; Williams RA, 2017, P IEEE 2017 C EV COM, P249; Williams RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160834; Zhang L, 2016, BIOSYSTEMS, V139, P29, DOI 10.1016/j.biosystems.2015.12.006	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199971	10.1371/journal.pone.0199971	http://dx.doi.org/10.1371/journal.pone.0199971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036373	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000439429200009
J	Almeida, BD; Green, AJ; Sebastian-Gonzalez, E; dos Anjos, L				Almeida, Bia de Arruda; Green, Andy J.; Sebastian-Gonzalez, Esther; dos Anjos, Luiz			Comparing species richness, functional diversity and functional composition of waterbird communities along environmental gradients in the neotropics	PLOS ONE			English	Article							TRAIT COMBINATIONS; ECOSYSTEM SERVICES; PARANA RIVER; RESPONSES; SELECTION; SIMILARITY; REGRESSION; WATERFOWL; FRAMEWORK; VARIABLES	Waterbirds have a major functional role in wetlands, and understanding how functional traits of waterbirds depend on environmental characteristics can facilitate management of ecosystems and their services. We investigate how the waterbird community in a Neotropical river-floodplain system responds to environmental gradients, identifying how they affect waterbird species richness, functional diversity (measured as functional dispersion) and functional composition (specific functional traits). We sampled 22 lakes in the Upper Parana floodplain system in southern Brazil, and modelled avian functional diversity and species richness as a function of environmental variables. Then we used a unified RLQ and fourth-corner analysis to evaluate environment-trait relationships. Waterbird species richness and functional diversity varied according to different environmental variables. Lake area and diversity of aquatic vegetation were associated with avian species richness, while relative abundance of grass and emergent macrophytes and mean and variation of depth were related to functional diversity. Furthermore, changes in functional diversity seemed to be mainly driven by presence of species that depend on perches for foraging (e.g. kingfishers, cormorants, and kites), whose presence was mainly associated with deep water and emergent macrophytes. Nevertheless, changes in functional diversity and functional composition did not depend on exactly the same set of environmental variables, suggesting that trait combinations (e.g. below surface feeders who feed on fish), not only specific traits, are important drivers of the variation in functional diversity between lakes. Given the observed differences in responses of species richness and functional diversity, both these diversity metrics should be used as complementary tools in ecosystem management. Furthermore, our results show that functional diversity and composition are partially coupled, suggesting that although functional diversity is influenced by the environmental filtering of particular traits, it also reflects other ecological mechanisms (e.g. competitive interactions among species).	[Almeida, Bia de Arruda] Univ Estadual Maringa, Programa Posgrad & Ecol Ambientes Aquat Continent, Maringa, Parana, Brazil; [Green, Andy J.] EBD CSIC, Dept Wetland Ecol, Donana Biol Stn, Seville, Spain; [Sebastian-Gonzalez, Esther] Univ Miguel Hernandez, Dept Biol Aplicada, Alicante, Spain; [dos Anjos, Luiz] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Biol Anim & Vegetal, Londrina, Parana, Brazil	Universidade Estadual de Maringa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Miguel Hernandez de Elche; Universidade Estadual de Londrina	Almeida, BD (corresponding author), Univ Estadual Maringa, Programa Posgrad & Ecol Ambientes Aquat Continent, Maringa, Parana, Brazil.	bialmeida182@hotmail.com	dos Anjos, Luiz/F-9501-2012; Sebastián-González, Esther/J-7883-2012; Green, Andy J/A-5189-2008; Almeida, Bia/M-7569-2019	dos Anjos, Luiz/0000-0002-8680-2375; Sebastián-González, Esther/0000-0001-7229-1845; Green, Andy J/0000-0002-1268-4951; Almeida, Bia/0000-0001-9738-0270	Proex program of the Coordination for the Improvement of Higher Education Personnel (CAPES-Brazil); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) [PDSE/88881.133362/2016-01]; Ministerio de Economia, Industria y Competitividad of Spain [IJCI-2015-24947]	Proex program of the Coordination for the Improvement of Higher Education Personnel (CAPES-Brazil); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio de Economia, Industria y Competitividad of Spain(Spanish Government)	Field work has been funded by the Proex program of the Coordination for the Improvement of Higher Education Personnel (CAPES-Brazil). B. A. A. received grant PDSE/88881.133362/2016-01 from the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). E. S. received a fellowship IJCI-2015-24947 from the Ministerio de Economia, Industria y Competitividad of Spain.	Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Almeida BD, 2017, AUSTRAL ECOL, V42, P84, DOI 10.1111/aec.12403; Barton K., 2020, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Bidwell MT, 2014, OIKOS, V123, P1499, DOI 10.1111/oik.00821; Bodelier PLE, 2006, OECOLOGIA, V149, P233, DOI 10.1007/s00442-006-0445-9; Boersma KS, 2016, ECOLOGY, V97, P583, DOI 10.1890/15-0688; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Carboni M, 2013, J VEG SCI, V24, P932, DOI 10.1111/jvs.12095; Collazo JA, 2002, WATERBIRDS, V25, P13; del Hoyo J., 1992, P1; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Ding ZF, 2013, J ANIM ECOL, V82, P781, DOI 10.1111/1365-2656.12046; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dray S, 2014, ECOLOGY, V95, P14, DOI 10.1890/13-0196.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dwyer JM, 2017, J VEG SCI, V28, P672, DOI 10.1111/jvs.12567; Dwyer JM, 2017, ECOL LETT, V20, P872, DOI 10.1111/ele.12781; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gagic V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2620; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Green Andy J., 2016, P147; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hahn S, 2007, FRESHWATER BIOL, V52, P2421, DOI 10.1111/j.1365-2427.2007.01838.x; Henry DAW, 2017, LANDSCAPE ECOL, V32, P265, DOI 10.1007/s10980-016-0449-8; Hidasi-Neto J, 2012, ANIM CONSERV, V15, P407, DOI 10.1111/j.1469-1795.2012.00528.x; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; HINCH SG, 1993, CAN J FISH AQUAT SCI, V50, P1870, DOI 10.1139/f93-209; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Junk WJ, 2014, AQUAT CONSERV, V24, P5, DOI 10.1002/aqc.2386; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Legendre P., 1998, NUMERICAL ECOLOGY; Lorenzon RE, 2016, AUSTRAL ECOL, V41, P829, DOI 10.1111/aec.12375; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; McKinstry MC, 2002, ECOL ENG, V18, P293, DOI 10.1016/S0925-8574(01)00088-X; Mendez V, 2012, DIVERS DISTRIB, V18, P356, DOI 10.1111/j.1472-4642.2011.00868.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 1999, TAXON, V48, P331, DOI 10.2307/1224438; POWER ME, 1989, ENVIRON BIOL FISH, V26, P285, DOI 10.1007/BF00002465; POYSA H, 1983, OIKOS, V40, P295, DOI 10.2307/3544594; R Development Core Team, 2009, R LANG ENV STAT COMP; Remsen Jr J.V., 2014, CLASSIFICATION BIRD; Rodriguez-Perez H, 2006, OIKOS, V112, P525, DOI 10.1111/j.0030-1299.2006.14307.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Sebastian-Gonzalez E, 2014, RESTOR ECOL, V22, P311, DOI 10.1111/rec.12078; Sebastian-Gonzalez E, 2013, BIRD CONSERV INT, V23, P344, DOI 10.1017/S0959270912000305; Sebastian-Gonzalez E, 2010, EUR J WILDLIFE RES, V56, P11, DOI 10.1007/s10344-009-0288-x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Seymour CL, 2015, ECOSYSTEMS, V18, P971, DOI 10.1007/s10021-015-9875-8; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wetlands International, 2012, WATERBIRD POPULATION, VFifth; Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	66	21	23	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200959	10.1371/journal.pone.0200959	http://dx.doi.org/10.1371/journal.pone.0200959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028866	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900027
J	Binderup, HG; Madsen, JS; Heegaard, NHH; Houlind, K; Andersen, RF; Brasen, CL				Binderup, Helle Glud; Madsen, Jonna Skov; Heegaard, Niels Henrik Helweg; Houlind, Kim; Andersen, Rikke Fredslund; Brasen, Claus Lohman			Quantification of microRNA levels in plasma - Impact of preanalytical and analytical conditions	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CIRCULATING MICRORNAS; ABSOLUTE QUANTIFICATION; CANCER-PATIENTS; EXPRESSION; CHALLENGES; SIGNATURE; BIOMARKER; MIRNAS	Numerous studies have reported a potential role for circulating microRNAs as biomarkers in a wide variety of diseases. However, there is a critical reproducibility challenge some of which might be due to differences in preanalytical and/or analytical factors. Thus, in the current study we systematically investigated the impact of selected preanalytical and analytical variables on the measured microRNA levels in plasma. Similar levels of microRNA were found in platelet-poor plasma obtained by dual compared to prolonged single centrifugation. In contrast, poor correlation was observed between measurements in standard plasma compared to platelet-poor plasma. The correlation between quantitative real-time PCR and droplet digital PCR was found to be good, contrary to TaqMan Low Density Array and single TaqMan assays where no correlation could be demonstrated. Dependent on the specific microRNA measured and the normalization strategy used, the intra- and inter-assay variation of quantitative real-time PCR were found to be 4.2-6.8% and 10.5-31.4%, respectively. Using droplet digital PCR the intra-assay variation was 4.4-20.1%, and the inter-assay variation 5.7-26.7%. Plasma preparation and microRNA purification were found to account for 39-73% of the total intra-assay variation, dependent on the microRNA measured and the normalization strategy used. In conclusion, our study highlighted the importance of reporting comprehensive methodological information when publishing, allowing others to perform validation studies where preanalytical and analytical variables as causes for divergent results can be minimized. Furthermore, if microRNAs are to become routinely used diagnostic or prognostic biomarkers, the differences in plasma microRNA levels between health and diseased subjects must exceed the high preanalytical and analytical variability.	[Binderup, Helle Glud; Madsen, Jonna Skov; Andersen, Rikke Fredslund; Brasen, Claus Lohman] Lillebaelt Hosp, Biochem & Immunol, Kolding, Denmark; [Binderup, Helle Glud; Madsen, Jonna Skov; Andersen, Rikke Fredslund; Brasen, Claus Lohman] Lillebaelt Hosp, Biochem & Immunol, Vejle, Denmark; [Binderup, Helle Glud; Madsen, Jonna Skov; Houlind, Kim; Brasen, Claus Lohman] Univ Southern Denmark, Dept Reg Hlth Res, Kolding, Denmark; [Heegaard, Niels Henrik Helweg] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen, Denmark; [Heegaard, Niels Henrik Helweg] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Houlind, Kim] Lillebaelt Hosp, Dept Vasc Surg, Kolding, Denmark	University of Southern Denmark; Statens Serum Institut; University of Southern Denmark; Odense University Hospital	Binderup, HG (corresponding author), Lillebaelt Hosp, Biochem & Immunol, Kolding, Denmark.; Binderup, HG (corresponding author), Lillebaelt Hosp, Biochem & Immunol, Vejle, Denmark.; Binderup, HG (corresponding author), Univ Southern Denmark, Dept Reg Hlth Res, Kolding, Denmark.	helle.glud.binderup@rsyd.dk	Madsen, Jonna Skov/AAF-7054-2019; Brasen, Claus/ABG-9421-2021; Andersen, Rikke/GRS-3064-2022	Madsen, Jonna Skov/0000-0001-6668-4714; Houlind, Kim/0000-0002-1600-4415; Binderup, Helle Glud/0000-0001-6698-9948; Andersen, Rikke Fredslund/0000-0002-5894-7745	Overlaege Jorgen Werner Schous og hustru Else Marie Schou, fodt Wonges fond [85832]; Faculty of Health Sciences, University of Southern Denmark	Overlaege Jorgen Werner Schous og hustru Else Marie Schou, fodt Wonges fond; Faculty of Health Sciences, University of Southern Denmark	This work was supported by Overlaege Jorgen Werner Schous og hustru Else Marie Schou, fodt Wonges fond, J.nr. 85832, no URL exists; PhD Scholarship, Faculty of Health Sciences, University of Southern Denmark, www.sdu.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qatati A, 2017, INT J CANCER, V141, P1231, DOI 10.1002/ijc.30815; Bandyopadhyay S, 2014, PLOS ONE; Binderup Helle Glud, 2016, Biochem Biophys Rep, V7, P195, DOI 10.1016/j.bbrep.2016.06.005; Binderup HG, 2016, CLIN BIOCHEM, V49, P1167, DOI 10.1016/j.clinbiochem.2016.04.017; Brunet-Vega A, 2015, ANAL BIOCHEM, V488, P28, DOI 10.1016/j.ab.2015.07.018; Campomenosi P, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0292-7; Cheng HH, 2013, PLOS ONE; Darvasi O, 2019, PATHOL ONCOL RES, V25, P169, DOI 10.1007/s12253-017-0330-3; Ferracin M, 2015, ONCOTARGET, V6, P14545, DOI 10.18632/oncotarget.3859; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gao XJ, 2016, ONCOTARGET, V7, P59664, DOI 10.18632/oncotarget.11198; Guttin Audrey, 2016, Microrna, V5, P201; Heegaard NHH, 2015, EXPERIENTIA SUPPL, V106, P171, DOI 10.1007/978-3-0348-0955-9_8; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Jiang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05026; Jorge KTOS, 2017, J CLIN MICROBIOL, V55, P1516, DOI 10.1128/JCM.02408-16; Liang HW, 2014, WIRES RNA, V5, P285, DOI 10.1002/wrna.1208; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Poel D, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.288; Sayed ASM, 2015, CLINICS, V70, P257, DOI 10.6061/clinics/2015(04)07; Scrutinio D, 2017, J HEART LUNG TRANSPL, V36, P616, DOI 10.1016/j.healun.2017.02.008; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Sourvinou IS, 2013, J MOL DIAGN, V15, P827, DOI 10.1016/j.jmoldx.2013.07.005; Sueta A, 2017, ONCOTARGET, V8, P69934, DOI 10.18632/oncotarget.19482; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Vigneron N, 2016, MOL ONCOL, V10, P981, DOI 10.1016/j.molonc.2016.03.005; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Yan SY, 2016, ACTA DIABETOL, V53, P693, DOI 10.1007/s00592-016-0837-1; Zheng XH, 2013, CHIN J CANCER, V32, P667, DOI 10.5732/cjc.012.10271	32	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201069	10.1371/journal.pone.0201069	http://dx.doi.org/10.1371/journal.pone.0201069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024941	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000088
J	Maraci, O; Ozkan, H; Bilgin, R				Maraci, Oncu; Ozkan, Hakan; Bilgin, Rasit			Phylogeny and genetic structure in the genus Secale	PLOS ONE			English	Article							CEREALE L.; POPULATION-STRUCTURE; MOLECULAR DIVERSITY; EVOLUTIONARY TRENDS; DNA-SEQUENCES; RYE; SOFTWARE; ORIGIN; PLANT; POLYMORPHISM	Secale L. is a small but important genus that includes cultivated rye. Although genetic diversity of cultivated rye is high, patterns of genetic diversity in the whole genus, and potential factors affecting the distribution of genetic diversity remain elusive. The population structure and distribution of genetic variation within Secale, and its correlation with taxonomic delimitation, cultivation status or spatial distribution in relation to geography and climate zones were analyzed in this study. A collection of 726 individual plants derived from 139 different accessions representing Secale cereale, S. vavilovii, S. strictum, and S. sylvestre were investigated using SSR analysis and sequence diversity analysis of a nuclear EST region. Our results indicated that perennial S. strictum subspecies are genetically divergent from annual forms of the genus. Existence of two distinct clusters within the annual taxa was observed, one corresponding to samples from Asia, and a second to those outside of Asia. No clear genetic structure was observed between different annual species/subspecies, indicating introgression between these taxa. The analysis of cultivated rye revealed that landrace populations from the Middle East have the highest genetic diversity, supporting the idea of the area being the center of origin for cultivated rye. Considering high adaptive potential of those populations, Middle Eastern landraces should be regarded as genetic resources reservoirs for new niches and future breeding programs.	[Maraci, Oncu] Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany; [Maraci, Oncu] Bielefeld Univ, Evolutionary Biol, Bielefeld, Germany; [Maraci, Oncu; Bilgin, Rasit] Bogazici Univ, Inst Environm Sci, Istanbul, Turkey; [Ozkan, Hakan] Univ Cukurova, Fac Agr, Dept Field Crops, Adana, Turkey	University of Bielefeld; University of Bielefeld; Bogazici University; Cukurova University	Maraci, O (corresponding author), Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany.; Maraci, O (corresponding author), Bielefeld Univ, Evolutionary Biol, Bielefeld, Germany.; Maraci, O (corresponding author), Bogazici Univ, Inst Environm Sci, Istanbul, Turkey.	oncu.maraci@uni-bielefeld.de	Bilgin, Rasit/A-3129-2016; ÖZKAN, Hakan/C-8510-2011	ÖZKAN, Hakan/0000-0003-3530-2626; Maraci, Oncu/0000-0001-8837-7766	Bogazici University in Istanbul [09S101, 1903]; German Research Foundation (DFG) [11Y00P2]; Bielefeld University; German Research Foundation (DFG)	Bogazici University in Istanbul(Bogazici University); German Research Foundation (DFG)(German Research Foundation (DFG)); Bielefeld University; German Research Foundation (DFG)(German Research Foundation (DFG))	Research Fund of Bogazici University in Istanbul to RB, Grant No: 09S101, 1903 and 11Y00P2 German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge to OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Dr. Emrah Coraman and Pahar Patlar for their support during the data analysis and production of figures. Seed materials were kindly provided by National Small Grains Collection of United States Department of Agriculture and Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany. We acknowledge the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge. We wish to express our sincere gratitude to the reviewers, for extremely valuable suggestions and comments.	Achrem M, 2014, TURK J BOT, V38, P213, DOI 10.3906/bot-1207-26; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Broda Zbigniew, 2016, Acta Agrobotanica, V69, P1652, DOI 10.5586/aa.1652; Burger JC, 2006, MOL ECOL, V15, P2527, DOI 10.1111/j.1365-294X.2006.02938.x; Ceccarelli S, 2009, J AGRIC ENVIRON INT, V103, P131; Chikmawati T, 2012, GENET RESOUR CROP EV, V59, P1743, DOI 10.1007/s10722-012-9796-8; Chikmawati T, 2005, GENOME, V48, P792, DOI 10.1139/g05-043; Chikmawati T., 2003, PHYLOGENETIC RELATIO; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Cuadrado A, 1997, GENOME, V40, P309, DOI 10.1139/g97-043; Cuadrado A, 2002, J HERED, V93, P339, DOI 10.1093/jhered/93.5.339; Cuevas HE, 2013, GENET RESOUR CROP EV, V60, P1817, DOI 10.1007/s10722-013-9956-5; De Bustos A, 2002, PLANT SYST EVOL, V235, P147, DOI 10.1007/s00606-002-0215-z; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falconer DS, 1996, INTROD TO QUANT GENE, V4, P43, DOI [10.1016/j.bbabio.2008.04.029, DOI 10.1016/J.BBABIO.2008.04.029]; Frederiksen S, 1997, NORD J BOT, V17, P185, DOI 10.1111/j.1756-1051.1997.tb00309.x; Frederiksen S, 1998, NORD J BOT, V18, P399, DOI 10.1111/j.1756-1051.1998.tb01517.x; Gailite Agnese, 2013, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V67, P264, DOI 10.2478/prolas-2013-0046; Goudet J., 2013, J HERED, V104, P586, DOI DOI 10.1093/JHERED/EST020; Grabowski R, 2011, VEG HIST ARCHAEOBOT, V20, P479, DOI 10.1007/s00334-011-0283-5; Gutierrez Juan, 2009, J HERED, V6, P718; Hagenblad J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0710-y; Hammer K, 2003, NATURWISSENSCHAFTEN, V90, P241, DOI 10.1007/s00114-003-0433-4; HAMMER K, 1990, BIOL ZBL, V109, P45; Hammer K., 1987, Kulturpflanze, V35, P135; Harris SA, 1999, SYST ASSOC SPEC VOL, V57, P211; Hawtin G, 1996, EUPHYTICA, V92, P255, DOI 10.1007/BF00022853; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jenabi T, 2011, GENET RESOUR CROP EV, V58, P497, DOI 10.1007/s10722-010-9593-1; JONES JDG, 1982, CHROMOSOMA, V86, P595, DOI 10.1007/BF00285606; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Khlestkina EK, 2004, THEOR APPL GENET, V109, P725, DOI 10.1007/s00122-004-1659-z; KHUSH G. S., 1963, Zeitschrift fur Pflanzenzuchtung, V50, P34; KHUSH GS, 1961, AM J BOT, V48, P723, DOI 10.2307/2439062; KHUSH GS, 1962, EVOLUTION, V16, P484, DOI 10.2307/2406180; KHUSH GURDEV S., 1963, ECON BOT, V17, P60, DOI 10.1007/BF02985354; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; LANTERI S, 2006, ROLE BIOTECHNOLOGY E, P55; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu KJ, 2003, GENETICS, V165, P2117; Matos M, 2001, HEREDITAS, V134, P229, DOI 10.1111/j.1601-5223.2001.00229.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Persson K, 2000, HEREDITAS, V132, P7, DOI 10.1111/j.1601-5223.2000.00007.x; Persson K, 2002, HEREDITAS, V136, P29, DOI 10.1034/j.1601-5223.2002.1360105.x; Pritchard JK, 2000, GENETICS, V155, P945; RAMIREZ L, 1986, GENETICA, V69, P209, DOI 10.1007/BF00133523; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Ren TH, 2011, GENOME, V54, P316, DOI [10.1139/G10-121, 10.1139/g10-121]; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saal B, 1999, GENOME, V42, P964, DOI 10.1139/gen-42-5-964; Santarnecchi E, 2017, BRAIN TOPOGR, V30, P502, DOI 10.1007/s10548-017-0565-z; Santos E, 2016, J GENET, V95, P273, DOI 10.1007/s12041-016-0632-3; Schlegel R, 2006, GEN RESOUR CHROM ENG, V2, P365; Schlegel R.H., 2013, RYE GENETICS BREEDIN; SENCER HA, 1980, BIOL J LINN SOC, V13, P299, DOI 10.1111/j.1095-8312.1980.tb00089.x; Shang HY, 2006, GENET MOL BIOL, V29, P685, DOI 10.1590/S1415-47572006000400018; Skuza L, 2007, ACTA BIOL CRACOV BOT, V49, P77; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STUTZ HC, 1972, AM J BOT, V59, P59, DOI 10.2307/2441230; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang SX, 2003, THEOR APPL GENET, V106, P990, DOI 10.1007/s00122-002-1127-6; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Targonska M, 2016, PLANT MOL BIOL REP, V34, P37, DOI 10.1007/s11105-015-0896-4; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Vavilov N. I, 1917, BULL APP BOT, V10, P561; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; VENCES FJ, 1987, PLANT BREEDING, V98, P281, DOI 10.1111/j.1439-0523.1987.tb01131.x; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237; Zhukovsky PM, 1933, LA TURGUIE AGRACOLE; ZOHARY D., 1971, Plant life of south-west Asia., P235; Zohary D, 2000, DOMESTICATION PLANTS, V531, P206; Zohary D, 1996, ORIGINS SPREAD AGR P, P142	80	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200825	10.1371/journal.pone.0200825	http://dx.doi.org/10.1371/journal.pone.0200825			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024916	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000056
J	Setyowibowo, H; Purba, FD; Hunfeld, JAM; Iskandarsyah, A; Sadarjoen, SS; Passchier, J; Sijbrandij, M				Setyowibowo, Hari; Purba, Fredrick Dermawan; Hunfeld, Joke A. M.; Iskandarsyah, Aulia; Sadarjoen, Sawitri S.; Passchier, Jan; Sijbrandij, Marit			Quality of life and health status of Indonesian women with breast cancer symptoms before the definitive diagnosis: A comparison with Indonesian women in general	PLOS ONE			English	Article							POPULATION; IMPACT; DEPRESSION; PERCEPTION; SURVIVORS; EQ-5D-5L	Objectives Breast cancer (BC) is prevalent in low and middle-income countries (LMICs) where the majority of cases are diagnosed in late stages. The aims of this study were: (1) to assess quality of life (QOL) and health status of Indonesian women with BC symptoms before definitive diagnosis; (2) to compare QOL and health status between women with BC symptoms before definitive diagnosis and Indonesian women in general; (3) to evaluate the association between demographic variables (age, residence, social economic status and education level) and QOL within the Indonesian women with BC symptoms before definitive diagnosis. Methods We used WHOQOL-BREF to measure QOL and EQ-5D-5L for health status. Multivariate analysis of covariance (MANCOVA) was used to compare QOL and health status between women with BC symptoms and women from the general Indonesian population in order to control for confounders. Regression analyses were used for testing the association between the demographic variables, QOL, and health status. Results In comparison with the data from the women from the general population (n = 471), the women with BC symptoms (n = 132) reported lower QOL, especially in physical and psychological domains. They also reported more problems in all dimensions of health status. Higher education and monthly income were positively associated with QOL and health status among the women with BC symptoms. Conclusion Before receiving a definitive diagnosis, women who visit hospitals with symptoms of BC, report a lower QOL and health status than women in general. Our results suggest that healthcare providers should provide targeted strategies for women with BC symptoms to improve their QOL.	[Setyowibowo, Hari; Passchier, Jan; Sijbrandij, Marit] Vrije Univ Amsterdam, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands; [Setyowibowo, Hari] Univ Padjadjaran, Dept Educ Psychol, Fac Psychol, Jatinangor, Indonesia; [Purba, Fredrick Dermawan; Hunfeld, Joke A. M.] Erasmus MC Univ Med Ctr, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Purba, Fredrick Dermawan] Univ Padjadjaran, Dept Dev Psychol, Fac Psychol, Jatinangor, Indonesia; [Iskandarsyah, Aulia; Sadarjoen, Sawitri S.] Univ Padjadjaran, Dept Clin Psychol, Fac Psychol, Jatinangor, Indonesia	Vrije Universiteit Amsterdam; Universitas Padjadjaran; Erasmus University Rotterdam; Erasmus MC; Universitas Padjadjaran; Universitas Padjadjaran	Setyowibowo, H (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands.; Setyowibowo, H (corresponding author), Univ Padjadjaran, Dept Educ Psychol, Fac Psychol, Jatinangor, Indonesia.	h.setyowibowo@vu.nl	Setyowibowo, Hari/AAD-5295-2021; Purba, Fredrick/AAV-7775-2020; Sijbrandij, Marit/N-6131-2018; Iskandarsyah, Aulia/GRJ-7939-2022	Purba, Fredrick/0000-0002-7336-3043; Sijbrandij, Marit/0000-0001-5430-9810; Setyowibowo, Hari/0000-0001-5091-3180; Iskandarsyah, Aulia/0000-0002-9526-6922	KWF Kankerbestrijding (the Dutch Cancer Society) [VU 2012-5572]; EuroQol Group (EQ) [2013240]	KWF Kankerbestrijding (the Dutch Cancer Society); EuroQol Group (EQ)	This study was financed by the KWF Kankerbestrijding (the Dutch Cancer Society: number VU 2012-5572 to JP) and the EuroQol Group (EQ Project number: 2013240 to JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadzadeh AS, 2018, CANCER NURS, V41, P484, DOI 10.1097/NCC.0000000000000552; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colombo R, 2018, CUREUS J MED SCIENCE, V10, DOI 10.7759/cureus.2272; Cruz LN, 2011, QUAL LIFE RES, V20, P1123, DOI 10.1007/s11136-011-9845-3; Fang SY, 2018, PSYCHO-ONCOLOGY, V27, P236, DOI 10.1002/pon.4499; Fang SY, 2015, SUPPORT CARE CANCER, V23, P2551, DOI 10.1007/s00520-015-2612-1; Ferlay J, 2012, GLOBOCAN 2012 EST CA; Gangane Nitin, 2017, Asian Pac J Cancer Prev, V18, P3325, DOI 10.22034/APJCP.2017.18.12.3325; Garcia-Gordillo MA, 2016, QUAL LIFE RES, V25, P1313, DOI 10.1007/s11136-015-1164-7; Hawley ST, 2017, BREAST CANCER RES TR, V161, P557, DOI 10.1007/s10549-016-4082-7; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Homaee Shandiz Fatemeh, 2017, Asian Pac J Cancer Prev, V18, P2089; Iskandarsyah A, 2014, HEALTH PSYCHOL, V33, P214, DOI 10.1037/a0031060; Iskandarsyah A, 2013, SUPPORT CARE CANCER, V21, P2999, DOI 10.1007/s00520-013-1877-5; Jones SMW, 2015, J CANCER SURVIV, V9, P620, DOI 10.1007/s11764-015-0438-y; Karlsen RV, 2016, ACTA ONCOL, V55, P720, DOI 10.3109/0284186X.2015.1127415; Keim-Malpass J, 2016, PSYCHO-ONCOLOGY, V25, P873, DOI 10.1002/pon.3951; Kim SY, 2018, GEN HOSP PSYCHIAT, V50, P33, DOI 10.1016/j.genhosppsych.2017.09.009; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Lin CY, 2019, J FORMOS MED ASSOC, V118, P215, DOI 10.1016/j.jfma.2018.03.018; Luo N, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0361-y; Matalqah LM, 2011, J PUBLIC HEALTH-HEID, V19, P475, DOI 10.1007/s10389-011-0406-6; McCaffrey N, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0537-0; Ng CG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172975; Purba FD, 2017, PHARMACOECONOMICS, V35, P1153, DOI 10.1007/s40273-017-0538-9; Rabin EG, 2008, EUR J ONCOL NURS, V12, P53, DOI 10.1016/j.ejon.2007.06.003; Setiawan Didik, 2018, Value Health Reg Issues, V15, P63, DOI 10.1016/j.vhri.2017.07.010; Sharma Neelam, 2017, J Midlife Health, V8, P75, DOI 10.4103/jmh.JMH_15_17; Shin WK, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0706-9; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Snyder CF, 2013, QUAL LIFE RES, V22, P2685, DOI 10.1007/s11136-013-0387-8; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Xia P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-37; Yan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153714	35	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200966	10.1371/journal.pone.0200966	http://dx.doi.org/10.1371/journal.pone.0200966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024978	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000074
J	Banon, JA; Fiorentino, R; Gabriele, A				Banon, Jose Aleman; Fiorentino, Robert; Gabriele, Alison			Using event-related potentials to track morphosyntactic development in second language learners: The processing of number and gender agreement in Spanish	PLOS ONE			English	Article							BRAIN POTENTIALS; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; LANGUAGE COMPREHENSION; GRAMMATICAL GENDER; NONNATIVE SPANISH; ERP EVIDENCE; L2; ACQUISITION; PROFICIENCY	We used event-related potentials to investigate morphosyntactic development in 78 adult English-speaking learners of Spanish as a second language (L2) across the proficiency spectrum. We examined how development is modulated by the similarity between the native language (L1) and the L2, by comparing number (a feature present in English) and gender agreement (novel feature). We also investigated how development is impacted by structural distance, manipulating the distance between the agreeing elements by probing both within-phrase (fruta muy jugosa"fruit(-FEM-SG) very juicy(-FEM-SG)") and across-phrase agreement (fresa es acida "strawberry(-FEM-SG) is tart(-FEM-SG)"). Regression analyses revealed that the learners' overall proficiency, as measured by a standardized test, predicted their accuracy with the target properties in the grammaticality judgment task (GJT), but did not predict P600 magnitude to the violations. However, a relationship emerged between immersion in Spanish-speaking countries and P600 magnitude for gender. Our results also revealed a correlation between accuracy in the GJT and P600 magnitude, suggesting that behavioral sensitivity to the target property predicts neurophysiological sensitivity. Subsequent group analyses revealed that the highest-proficiency learners showed equally robust P600 effects for number and gender. This group also elicited more positive waveforms for within- than across-phrase agreement overall, similar to the native controls. The lowest-proficiency learners showed a P600 for number overall, but no effects for gender. Unlike the highest-proficiency learners, they also showed no sensitivity to structural distance, suggesting that sensitivity to such linguistic factors develops over time. Overall, these results suggest an important role for proficiency in morphosyntactic development, although differences emerged between behavioral and electrophysiological measures. While L2 proficiency predicted behavioral sensitivity to agreement, development with respect to the neurocognitive mechanisms recruited in processing only emerged when comparing the two extremes of the proficiency spectrum. Importantly, while both L1-L2 similarity and hierarchical structure impact development, they do not constrain it.	[Banon, Jose Aleman] Stockholm Univ, Dept Swedish & Multilingualism, Ctr Res Bilingualism, Stockholm, Sweden; [Fiorentino, Robert] Univ Kansas, Dept Linguist, Neurolinguist & Language Proc Lab, Lawrence, KS 66045 USA; [Gabriele, Alison] Univ Kansas, Dept Linguist, Language Acquisit Lab 2, Lawrence, KS 66045 USA	Stockholm University; University of Kansas; University of Kansas	Banon, JA (corresponding author), Stockholm Univ, Dept Swedish & Multilingualism, Ctr Res Bilingualism, Stockholm, Sweden.	jose.aleman.banon@biling.su.se	Aleman Banon, Jose/H-6787-2015	Aleman Banon, Jose/0000-0003-4210-3174	National Science Foundation [BCS-0951900]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (BCS-0951900) to AG and RF.	Aleman Banon J, 2016, LANG COGN NEUROSCI; Banon JA, 2017, J EXP PSYCHOL LEARN, V43, P1509, DOI 10.1037/xlm0000394; Aleman Banon J, 2014, SECOND LANG RES, V30, P275, DOI 10.1177/0267658313515671; Banon JA, 2012, BRAIN RES, V1456, P49, DOI 10.1016/j.brainres.2012.03.057; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Bowden HW, 2013, NEUROPSYCHOLOGIA, V51, P2492, DOI 10.1016/j.neuropsychologia.2013.09.004; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Caffarra S, 2015, NEUROSCI BIOBEHAV R, V51, P31, DOI 10.1016/j.neubiorev.2015.01.010; Carrasco-Ortiz H, 2017, INT J PSYCHOPHYSIOL, V117, P91, DOI 10.1016/j.ijpsycho.2017.04.008; Clahsen H, 2006, APPL PSYCHOLINGUIST, V27, P107, DOI 10.1017/S0142716406060206; Clahsen H, 2010, LANG LEARN, V60, P21, DOI 10.1111/j.1467-9922.2009.00550.x; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; DeKeyser R. M., 1997, STUD SECOND LANG ACQ, V19, P195, DOI DOI 10.1017/S0272263197002040; Diaz B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00133; Drury J, 2007, J COGNITIVE NEUROS S, V249, DOI DOI 10.1016/J.NEUBIOREV.2015.01.010; Dussias PE, 2013, STUD SECOND LANG ACQ, V35, P353, DOI 10.1017/S0272263112000915; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Foote R, 2011, APPL PSYCHOLINGUIST, V32, P187, DOI 10.1017/S0142716410000342; Foucart A, 2012, J MEM LANG, V66, P226, DOI 10.1016/j.jml.2011.07.007; Franceschina F., 2005, FOSSILIZED 2 LANGUAG; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gabriele A, 2013, LINGUIST APPROACH BI, V3, P213, DOI 10.1075/lab.3.2.04gab; Dowens MG, 2010, J COGNITIVE NEUROSCI, V22, P1870, DOI 10.1162/jocn.2009.21304; Gillon-Dowens M, 2010, NEUROPSYCHOLOGIA, V22, P1870, DOI DOI 10.1016/J.NEUR0PSYCH0L0GIA.2011.02.034; Gruter T, 2012, SECOND LANG RES, V28, P191, DOI 10.1177/0267658312437990; Hagoort P, 1999, J PSYCHOLINGUIST RES, V28, P715, DOI 10.1023/A:1023277213129; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; HARRIS JW, 1991, LINGUIST INQ, V22, P27; Hawkins R., 1997, SECOND LANG RES, V13, P187; Hopp H, 2010, LINGUA, V120, P901, DOI 10.1016/j.lingua.2009.06.004; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2016, BILING-LANG COGN, V19, P1, DOI 10.1017/S1366728914000844; Keating GD, 2009, LANG LEARN, V59, P503, DOI 10.1111/j.1467-9922.2009.00516.x; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Liszka S., 2003, LEXICON SYNTAX INTER, V30, P21, DOI DOI 10.1075/LALD.30.03HAW; LONG MH, 1990, TESOL QUART, V24, P649, DOI 10.2307/3587113; Mancini S, 2011, BRAIN RES, V1410, P64, DOI 10.1016/j.brainres.2011.06.055; Marinis T, 2005, STUD SECOND LANG ACQ, V27, P53, DOI 10.1017/S0272263105050035; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; McCarthy C, 2008, SECOND LANG RES, V24, P459, DOI 10.1177/0267658308095737; McLaughlin J, 2010, LANG LEARN, V60, P123, DOI 10.1111/j.1467-9922.2010.00604.x; Molinaro N, 2015, CORTEX, V66, P156, DOI 10.1016/j.cortex.2014.06.009; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Molinaro N, 2011, J MEM LANG, V64, P211, DOI 10.1016/j.jml.2010.12.002; Montrul S, 2008, LANG LEARN, V58, P503, DOI 10.1111/j.1467-9922.2008.00449.x; Morgan-Short K, 2010, LANG LEARN, V60, P154, DOI 10.1111/j.1467-9922.2009.00554.x; Nevins A, 2007, BRAIN RES, V1164, P81, DOI 10.1016/j.brainres.2007.05.058; Nicol JL, 1997, J MEM LANG, V36, P569, DOI 10.1006/jmla.1996.2497; O'Grady W., 2005, SYNTACTIC CARPENTRY; O'Grady W, 2015, LANG LEARN, V65, P6, DOI 10.1111/lang.12091; O'Rourke PL, 2011, BRAIN RES, V1392, P62, DOI 10.1016/j.brainres.2011.03.071; Ojima S, 2005, J COGNITIVE NEUROSCI, V17, P1212, DOI 10.1162/0898929055002436; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Osterhout L, 2006, LANG LEARN, V56, P199, DOI 10.1111/j.1467-9922.2006.00361.x; Pakulak E, 2010, J COGNITIVE NEUROSCI, V22, P2728, DOI 10.1162/jocn.2009.21393; Pearlmutter NJ, 1999, J MEM LANG, V41, P427, DOI 10.1006/jmla.1999.2653; Pienemann M, 2005, STUD BILINGUAL, V30, P1; Pienemann M, 2015, LANG LEARN, V65, P123, DOI 10.1111/lang.12095; Pienemann Manfred., 1998, LANGUAGE PROCESSING; Prego BL, 2014, LINGUIST APPROACH BI, V4, P192, DOI 10.1075/lab.4.2.03lop; Rossi E, 2014, NEUROPSYCHOLOGIA, V62, P11, DOI 10.1016/j.neuropsychologia.2014.07.002; Rossi S, 2005, NEUROSCI LETT, V384, P228, DOI 10.1016/j.neulet.2005.04.077; Rossi S, 2006, J COGNITIVE NEUROSCI, V18, P2030, DOI 10.1162/jocn.2006.18.12.2030; Sagarra N, 2010, LINGUA, V120, P2022, DOI 10.1016/j.lingua.2010.02.004; SAPORTA S, 1965, LANGUAGE, V41, P218, DOI 10.2307/411875; Schwartz B.D., 1994, LANG ACQUIS, P317, DOI 10.1075/lald.8.14sch; Schwartz B.D., 1996, SECOND LANG RES, V12, P40, DOI [10.1177/026765839601200103, DOI 10.1177/026765839601200103]; Steinhauer K, 2009, SECOND LANG RES, V25, P13, DOI 10.1177/0267658308098995; Tagliaferri B., 2005, PARADIGM VERSION 1; Tanner D, 2014, BILING-LANG COGN, V17, P277, DOI 10.1017/S1366728913000370; Tanner D, 2014, NEUROPSYCHOLOGIA, V56, P289, DOI 10.1016/j.neuropsychologia.2014.02.002; Tanner D, 2013, BILING-LANG COGN, V16, P367, DOI 10.1017/S1366728912000302; Teschner R, 1984, HISPANIC LINGUISTICS, V1, P115; Tokowicz N, 2005, STUD SECOND LANG ACQ, V27, P173, DOI 10.1017/S0272263105050102; Tsimpli IM, 2007, SECOND LANG RES, V23, P215, DOI 10.1177/0267658307076546; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman M. T., 2013, ROUTLEDGE ENCY 2 LAN, P160; Ullman M.T., 2001, BILING-LANG COGN, V4, P105, DOI [10.1017/S1366728901000220, DOI 10.1017/S1366728901000220]; Vainikka A., 1996, SECOND LANG RES, V12, P7, DOI DOI 10.1177/026765839601200102; Vainikka A., 1994, LANG ACQUIS, P265; VanPatten B., 2012, ROUTLEDGE HDB 2 LANG, P268; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; White EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052318; White L, 2004, APPL PSYCHOLINGUIST, V25, P105, DOI 10.1017/S0142716404001067; White L, 2007, THEORIES 2 LANGUAGE, P37; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE	98	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200791	10.1371/journal.pone.0200791	http://dx.doi.org/10.1371/journal.pone.0200791			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052686	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600016
J	Lazaro, A; Larrinaga, AR				Lazaro, Amparo; Larrinaga, Asier R.			A multi-level test of the seed number/size trade-off in two Scandinavian communities	PLOS ONE			English	Article							POLLEN LIMITATION; PLANT REPRODUCTION; SIZE VARIATION; POLLINATOR VISITATION; SELECTIVE PRESSURES; RESOURCE-ALLOCATION; SPATIAL VARIATION; MASS; FRUIT; EVOLUTION	Seed size is a fundamental life-history trait for plants. A seed number/size trade-off is assumed because the resources invested in reproduction are limited; however, such a trade-off is not always observed. This could be a consequence of the method used for testing it, where the null hypothesis is dictated by common statistical practice, rather than being based on any underlying theory. Alternatively, there might be some population- and species-dependent variables that affect resource availability and, in turn, influence the presence and intensity of this trade-off. Using data on 42 herbs from two communities (lowland and alpine) from Southern Norway, we tested the validity of the classical linear model vs. two previously proposed models, based on resource competition, when assessing the existence of this trade-off at different levels. We also evaluated whether some species- (fruit aggregation, ovules/flower) and population-dependent (pollen limitation) variables could affect this trade-off. Classical linear modelling outperformed the other proposed functional models. Significant seed number/size relationships were negative in single-fruited species, whereas they were positive in species with infructescences of one-seeded fruits. Concordantly, fruit organization was the most influencing variable for the intra-specific trade-off in the lowland community. In the alpine community, species suffering higher pollen limitation showed more strongly negative slopes between seed size and seed number at the fruit/infructescence level. Across species, seed size and number were negatively related, although the relationship was significant in only one of the communities. No evidence of trade-off was found at the plant level. Linear models provide a flexible framework that allows coping with the variability in the seed number/size relationship. The emergence of the intra-specific relationship between seed number and size depends on species- and population-dependent variables, related to resource allocation and the pollination environment.	[Lazaro, Amparo] UIB, CSIC, Mediterranean Inst Adv Studies, Global Change Res Grp, C Miquel Marques 21, Esporles, Balearic Island, Spain; [Larrinaga, Asier R.] eNeBaDa, Rua Penas 57, Santiago De Compostela, A Coruna, Spain; [Larrinaga, Asier R.] CSIC, Mis Biol Galicia, Carballeira 8, Salcedo, Pontevedra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG)	Lazaro, A (corresponding author), UIB, CSIC, Mediterranean Inst Adv Studies, Global Change Res Grp, C Miquel Marques 21, Esporles, Balearic Island, Spain.	amparo.lazaro@imedea.uib-csic.es	Larrinaga, Asier/B-3826-2013; Lázaro, Amparo/ABG-4657-2020	Larrinaga, Asier/0000-0001-6813-8784; 	Research Council of Norway [170532/V40]; Regional Government of the Balearic Islands; European Social Fund 2014-2020; Ramon y Cajal contract - Spanish Ministry of Competitiveness; Spanish National Research Council (JAEDoc program); Spanish National Research Council (European Social Fund)	Research Council of Norway(Research Council of Norway); Regional Government of the Balearic Islands; European Social Fund 2014-2020(European Social Fund (ESF)); Ramon y Cajal contract - Spanish Ministry of Competitiveness; Spanish National Research Council (JAEDoc program); Spanish National Research Council (European Social Fund)	This study was supported by the project 170532/V40 financed by the Research Council of Norway. During the writing of this manuscript AL was supported by a postdoctoral contract co-funded by the Regional Government of the Balearic Islands and the European Social Fund 2014-2020, and by a Ramon y Cajal contract financed by the Spanish Ministry of Competitiveness, and ARL was supported by the Spanish National Research Council (JAEDoc program, co-funded by the European Social Fund).	AGREN J, 1989, J ECOL, V77, P1080, DOI 10.2307/2260824; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2009, MULTIPLICITY UNITY; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; BAKER K, 1994, NEW PHYTOL, V128, P563, DOI 10.1111/j.1469-8137.1994.tb03002.x; Ben-Hur E, 2012, ECOL LETT, V15, P1276, DOI 10.1111/j.1461-0248.2012.01850.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; CASPER BB, 1993, CURR SCI INDIA, V65, P210; CAVERS PB, 1984, AM NAT, V124, P324, DOI 10.1086/284276; Chatterjee S., 1998, SENSITIVITY ANAL LIN; Chen H, 2009, NEW PHYTOL, V183, P1212, DOI 10.1111/j.1469-8137.2009.02878.x; Delph LF, 1997, ECOLOGY, V78, P1632, DOI 10.1890/0012-9658(1997)078[1632:HEFAPP]2.0.CO;2; Eriksson O, 1999, ACTA OECOL, V20, P61, DOI 10.1016/S1146-609X(99)80016-2; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GERITZ SAH, 1995, AM NAT, V146, P685, DOI 10.1086/285820; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Gnan S, 2014, GENETICS, V198, P1751, DOI 10.1534/genetics.114.170746; Greenway CA, 2007, AM J BOT, V94, P840, DOI 10.3732/ajb.94.5.840; Gundel PE, 2012, BASIC APPL ECOL, V13, P32, DOI 10.1016/j.baae.2011.10.008; Guo H, 2010, J ECOL, V98, P1232, DOI 10.1111/j.1365-2745.2010.01688.x; Halpern SL, 2005, AM J BOT, V92, P205, DOI 10.3732/ajb.92.2.205; Hegland SJ, 2008, OIKOS, V117, P883, DOI [10.1111/j.0030-1299.2008.16561.x, 10.1111/j.2008.0030-1299.16561.x]; Huang QQ, 2017, AM NAT, V190, P430, DOI 10.1086/692543; Jakobsson A, 2003, EVOL ECOL, V17, P233, DOI 10.1023/A:1025526903281; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Koenig WD, 2009, AM NAT, V173, P682, DOI 10.1086/597605; Kosinski I, 2010, PLANT BIOLOGY, V12, P206, DOI 10.1111/j.1438-8677.2009.00199.x; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Lazaro A, 2015, OIKOS, V124, P174, DOI 10.1111/oik.01525; Lazaro A, 2009, EVOL ECOL, V23, P847, DOI 10.1007/s10682-008-9275-z; Lehtila K, 2005, ACTA OECOL, V28, P207, DOI 10.1016/j.actao.2005.04.004; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Lescourret F, 2003, ECOSCIENCE, V10, P334, DOI 10.1080/11956860.2003.11682782; Liu F, 2013, J PLANT ECOL, V6, P499, DOI 10.1093/jpe/rtt021; Martinez I, 2007, EVOL ECOL, V21, P517, DOI 10.1007/s10682-006-9132-x; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MCGINLEY MA, 1989, CAN J BOT, V67, P1298, DOI 10.1139/b89-172; Mendez M, 1997, INT J PLANT SCI, V158, P298, DOI 10.1086/297441; Mossberg B., 2012, GYLDENDALS STORE NOR; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rees M, 1997, OIKOS, V78, P116, DOI 10.2307/3545807; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Sakai A, 2006, AM J BOT, V93, P988, DOI 10.3732/ajb.93.7.988; SALLABANKS R, 1992, OECOLOGIA, V91, P296, DOI 10.1007/BF00317800; Brancalion PHS, 2014, SCI AGR, V71, P226, DOI 10.1590/S0103-90162014000300007; SCHOEN DJ, 1990, AM NAT, V135, P841, DOI 10.1086/285077; SHIPLEY B, 1992, AM NAT, V139, P467, DOI 10.1086/285339; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Sober V, 2013, PLANT ECOL, V214, P883, DOI 10.1007/s11258-013-0216-8; Stocklin J, 1999, FOLIA GEOBOT, V34, P7, DOI 10.1007/BF02803073; Tremayne MA, 2000, NEW PHYTOL, V148, P127, DOI 10.1046/j.1469-8137.2000.00738.x; Van Molken T, 2005, AM J BOT, V92, P432, DOI 10.3732/ajb.92.3.432; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wesselingh RA, 2007, NEW PHYTOL, V174, P26, DOI 10.1111/j.1469-8137.2007.01997.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114	67	9	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201175	10.1371/journal.pone.0201175	http://dx.doi.org/10.1371/journal.pone.0201175			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052656	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600026
J	Amado-Azevedo, J; de Menezes, RX; Amerongen, GPV; van Hinsbergh, VWM; Hordijk, PL				Amado-Azevedo, Joana; de Menezes, Renee X.; Amerongen, Geerten P. van Nieuw; van Hinsbergh, Victor W. M.; Hordijk, Peter L.			A functional siRNA screen identifies RhoGTPase-associated genes involved in thrombin-induced endothelial permeability	PLOS ONE			English	Article							ATYPICAL RHO-GTPASES; NUCLEOTIDE EXCHANGE FACTOR; BARRIER DYSFUNCTION; VASCULAR-PERMEABILITY; CELL PERMEABILITY; SEMAPHORIN 5A; P115 RHOGEF; PROTEIN; RAC; ACTIVATION	Thrombin and other inflammatory mediators may induce vascular permeability through the disruption of adherens junctions between adjacent endothelial cells. If uncontrolled, hyper-permeability leads to an impaired barrier, fluid leakage and edema, which can contribute to multi-organ failure and death. RhoGTPases control cytoskeletal dynamics, adhesion and migration and are known regulators of endothelial integrity. Knowledge of the precise role of each RhoGTPase, and their associated regulatory and effector genes, in endothelial integrity is incomplete. Using a combination of a RNAi screen with electrical impedance measurements, we quantified the effect of individually silencing 270 Rho-associated genes on the barrier function of thrombin-activated, primary endothelial cells. Known and novel RhoGT-Pase-associated regulators that modulate the response to thrombin were identified (RTKN, TIAM2, MLC1, ARPC1B, SEPT2, SLC9A3R1, RACGAP1, RAPGEF2, RHOD, PREX1, ARHGEF7, PLXNB2, ARHGAP45, SRGAP2, ARHGEF5). In conclusion, with this siRNA screen, we confirmed the roles of known regulators of endothelial integrity but also identified new, potential key players in thrombin-induced endothelial signaling.	[Amado-Azevedo, Joana; Amerongen, Geerten P. van Nieuw; van Hinsbergh, Victor W. M.; Hordijk, Peter L.] Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Physiol, Amsterdam, Netherlands; [de Menezes, Renee X.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Hordijk, PL (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Physiol, Amsterdam, Netherlands.	p.hordijk@vumc.nl	Menezes, Renee/L-2182-2019	Hordijk, Peter/0000-0002-3348-078X	Dutch Heart Foundation (Nederlands hartstichting) [2011T072]	Dutch Heart Foundation (Nederlands hartstichting)	This work was supported by the Dutch Heart Foundation (Nederlands hartstichting) grant number 2011T072 to Geerten P. van Nieuw Amerongen.	Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; Amado-Azevedo J, 2018, VASC PHARMACOL, V101, P38, DOI 10.1016/j.vph.2017.11.007; Amado-Azevedo J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10392-0; Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Amsellem V, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-12; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Aspenstrom Pontus, 2020, Small GTPases, V11, P248, DOI 10.1080/21541248.2017.1391365; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Blom M, 2017, EXP CELL RES, V352, P255, DOI 10.1016/j.yexcr.2017.02.013; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Breslin JW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003336; Buul JDV, 2014, CONTROLING SWITCHES, P1; Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Das S, 2015, P NATL ACAD SCI USA, V112, pE267, DOI 10.1073/pnas.1409667112; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Durkin CH, 2017, DEV CELL, V41, P315, DOI 10.1016/j.devcel.2017.04.010; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flynt AS, 2010, CELL CYCLE, V9, P235, DOI 10.4161/cc.9.2.10434; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Fritz Rafael Dominik, 2016, F1000Res, V5, DOI 10.12688/f1000research.7370.1; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gottesbuhren U, 2013, BIOL OPEN, V2, P210, DOI 10.1242/bio.20123574; Hall A, 2008, CURR OPIN CELL BIOL, V20, P117, DOI 10.1016/j.ceb.2008.02.006; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Li XH, 2010, J BIOL CHEM, V285, P32436, DOI 10.1074/jbc.M110.120451; McColl B, 2016, J CELL SCI, V129, P4046, DOI 10.1242/jcs.192211; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Minshall RD, 2010, MICROVASC RES, V80, P240, DOI 10.1016/j.mvr.2010.04.007; Naikawadi RP, 2012, CIRC RES, V111, P1517, DOI 10.1161/CIRCRESAHA.112.273078; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Pronk Manon C A, 2019, Small GTPases, V10, P466, DOI 10.1080/21541248.2017.1339767; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; R Core Team, 2019, R LANG ENV STAT COMP; Reinhard NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25502; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Roney KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024795; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Song GJ, 2012, J MOL CELL CARDIOL, V53, P809, DOI 10.1016/j.yjmcc.2012.08.022; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wylie T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185899; Xie XZ, 2005, CELL SIGNAL, V17, P461, DOI 10.1016/j.cellsig.2004.09.012	72	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201231	10.1371/journal.pone.0201231	http://dx.doi.org/10.1371/journal.pone.0201231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048510	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400063
J	Ayele, BGK; Gebregzabher, TG; Hailu, TT; Assefa, BA				Ayele, Brhane G. Kidan; Gebregzabher, Tesfay Gebrehiwot; Hailu, Tesfay Tekle; Assefa, Belete Abera			Determinants of teenage pregnancy in Degua Tembien District, Tigray, Northern Ethiopia: A community-based case-control study	PLOS ONE			English	Article							ADOLESCENT	Background Approximately 16 million teenagers aged 15-19 years and 2 million teenagers under the age of 15 years give birth annually, with 95% of these births occurring in developing countries. Ethiopia has one of the highest teenage fertility rates in Sub-Saharan Africa; however determinants of teenage pregnancy are not well studied. Therefore, this study aimed to identify determinants of teenage pregnancy among female teenagers in Degua Tembien district, Tigray, Northern Ethiopia, in 2015. Methods A community-based case-control study was conducted in Degua' Tembien district from February 01, 2015 to March 15, 2015 with a randomly selected total sample size of 414 females (with a ratio of 1:2 case to control, 138 and 276 respectively). Data were entered in to Epi-Info and analyzed using SPSS software. Multivariable logistic regression was used to assess predictors of the outcome variable; variables with a p-value <0.25 in bivariable analysis were included in the model. Statistically significance was considered at a p-value <= 0.05 in both bivariable and multivariable logistic regression analyses. Result The mean ages (plus or minus standard deviation (+/- SD)) of cases and controls were 18.47 (0.72) and 17.09 (1.2) years, respectively. After adjustment for other variables, predictors of teenage pregnancy included: lower monthly income below similar to$25 and similar to$25-50 (adjusted odds ratio (AOR) = 23.96; 95% confidence interval (95%CI) 4.89-117.29 and AOR = 4.91; 95%CI 1.64-14.66, respectively); aged 18-19 years (AOR = 16.75; 95%Cl 6.45-43.47); being married (AOR = 15.91; 95%CI 7.43-34.04); not communicating with parents on reproductive health issues (AOR = 6.52; 95%CI 3.12-13.64) and having a history of maternal teenage pregnancy (AOR = 4.14; 95%CI 1.84-9.33). Conclusion The factors associated with teenage pregnancy in our study were lower family monthly income, being married, being in the 18-19 year age group, not communicating with parents on reproductive health issues and having a maternal history of teenage pregnancy. Programs that encourage parent-teenage communication of reproductive health issues, starting from early adolescence, in order to build skills to prevent pregnancy in the late teenage years, are very important. In addition, multi-pronged activities across sectors that encourage delayed marriage and improve health service utilizations for girls are essential.	[Ayele, Brhane G. Kidan; Assefa, Belete Abera] Tigray Hlth Res Inst, Publ Hlth Dept, Publ Hlth Emergency Management Directorate, Mekelle, Ethiopia; [Gebregzabher, Tesfay Gebrehiwot; Hailu, Tesfay Tekle] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia	Mekelle University	Ayele, BGK (corresponding author), Tigray Hlth Res Inst, Publ Hlth Dept, Publ Hlth Emergency Management Directorate, Mekelle, Ethiopia.	brhane3127@gmail.com		Ayele, Brhane/0000-0003-4749-4629	Mekelle University; Degua Tembien district Health Office	Mekelle University; Degua Tembien district Health Office	The author(s) received funding support for this work from Mekelle University and Degua Tembien district Health Office. However the manuscripts contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alemayehu T, 2010, ETHIOP J HEALTH DEV, V24, P30; Ayalew M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-77; Beguy D, 2013, J BIOSOC SCI, V45, P721, DOI 10.1017/S0021932013000199; Dulitha F, 2013, J HLTH SCI, V7; East Patricia L., 2013, NIH PUBLIC ACCESS PM; Emily J., 2007, GUTTMACHER I, V39; Gideon R., 2013, AM J SOCIOL RES, V3, P30, DOI DOI 10.5923/J.SOCIOLOGY.20130302.03; Goicolea I, 2009, PAN AM J PUBLIC HLTH; Grossman JM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010107; Hyde A, 2009, PARENTS APPROACHES E; Isa AI., 2012, OPEN J OBSTET GYNECO, V2, P239, DOI [DOI 10.4236/OJOG.2012.23049, 10.4236/ojog.2012.23049]; Jones N., 2014, EARLY MARRIAGE ED CO; Mangiaterra V, 2008, MAKE PREGNANCY SAFER; Manu AA, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0003-1; Mchunu G, 2012, AFR HEALTH SCI, V12, P426; Mekonnen WA., 2013, DIFFERENTIALS EARLY; Omar K, 2010, INT J GYNECOL OBSTET, V111, P220, DOI 10.1016/j.ijgo.2010.06.023; ONER S, 2012, ASIAN PAC J REPROD, V1, P135, DOI DOI 10.1016/S2305-0500(13)60064-0; Perezieto P, 2013, SOCIAL JUSTICE ADOLE; Peter N., 2008, FACTORS ASS ADOLESCE; Raghav R, 2013, INDIAN MED GAZETTE; Rutgers and the Government of Ethiopia, 2017, FACT SHEET DEV HIGH; Santos MI, 2011, FAMILY PRACTICE INT; Sofia L, 2014, PAN AM J PUBLIC HLTH; Tigray Regional Health Bureau (TRHB), 2013, TIGR REG HLTH BUR AN; Unicef Fact Sheet, 2008, YOUNG E PEOPL FAM PL; United Nations Population Fund (UNFPA), 2012, STAT REP AD YOUNG PE; Vincent G, 2016, S SUDAN MED J, V9; Vundule C, 2001, AFRICA J, V91; Wall-Wieler E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0911-2; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-6; *WHO, 2004, AD PREGN; Woodward LJ, 2001, NEW ZEAL MED J, V114, P301; World Health Organization, 2012, EARL MARR AD YOUNG P; World Health Organization (WHO), 2008, MAK PREGN SAF; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4	36	30	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200898	10.1371/journal.pone.0200898	http://dx.doi.org/10.1371/journal.pone.0200898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044850	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500069
J	Azuma, T; Sato, Y; Ohno, T; Azuma, M; Kume, H				Azuma, Takeshi; Sato, Yujiro; Ohno, Tetsukuni; Azuma, Miyuki; Kume, Haruki			Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; SUPPRESSOR-CELLS; GASTRIC-CANCER; LUNG-CANCER; EXPRESSION; SURVIVAL; MELANOMA	Background B7-H4 is a member of the B7 family of immune-regulatory ligands and is considered to be a negative regulator of the immune response. We investigated the clinical significance of serum soluble B7-H4 in patients with non-metastatic clear cell renal cell carcinoma. Methods We analyzed 108 patients in whom non-metastatic clear cell renal cancer was diagnosed at Tokyo Metropolitan Tama Medical Center between 2008 and 2013. We measured the serum soluble B7-H4 level using the Enzyme-Linked ImmunoSorbent Assay (ELISA) and evaluated the association between the peripheral blood neutrophil count and sB7-H4 as well as the utility of soluble B7-H4 as a prognostic biomarker for clear cell renal cancer. The Cox proportional hazards regression model was used to assess the PFS and OS with the soluble B7-H4 level. Results We detected high levels of soluble B7-H4 in the sera of 56% of patients with non-metastatic clear cell renal cell carcinoma versus only 10% of healthy donors. Elevated soluble B7-H4 levels were associated with changes in an elevated peripheral blood neutrophil count. The increase of soluble B7-H4 also was significantly associated with poor PFS and OS. Multivariate analysis showed that the elevation of the soluble B7-H4 level was an independent prognostic factor for PFS and OS. Conclusions Our data suggest that the association between serum soluble B7-H4 and peripheral blood neutrophil count, as well as the evaluation of serum soluble B7-H4 expression is a useful tool for predicting the prognosis of patients with non-metastatic clear cell renal cell carcinoma.	[Azuma, Takeshi; Sato, Yujiro] Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan; [Azuma, Takeshi; Ohno, Tetsukuni; Azuma, Miyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Tokyo, Japan; [Azuma, Takeshi; Kume, Haruki] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Azuma, T (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Urol, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Tokyo, Japan.; Azuma, T (corresponding author), Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo, Japan.	tazuma-tky@umin.ac.jp	Azuma, Miyuki/AAT-8928-2021	Azuma, Miyuki/0000-0002-3529-4585; Azuma, Takeshi/0000-0002-4921-2122	JSPS KAKENHI [16K11037, 17K11169]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI, Grant Number 16K11037 to Y. Sato and JSPS KAKENHI, Grant Number 17K11169 to T. Azuma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadallah NS, 2008, PANCREAS, V36, P200, DOI 10.1097/MPA.0b013e318150e4e0; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P337, DOI 10.1016/j.clgc.2013.04.003; Azuma T, 2012, CLIN GENITOURIN CANC, V10, P180, DOI 10.1016/j.clgc.2012.03.006; Azuma T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000166; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Dong H, 2016, BIOMARKERS, V21, P129, DOI 10.3109/1354750X.2015.1118544; Dong Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/156432; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Ilie M, 2012, CANCER-AM CANCER SOC, V118, P1726, DOI 10.1002/cncr.26456; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Jiang JT, 2010, CANCER IMMUNOL IMMUN, V59, P1707, DOI 10.1007/s00262-010-0900-7; Ko JS, 2009, CURR ONCOL REP, V11, P87, DOI 10.1007/s11912-009-0014-6; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Leung J, 2013, J IMMUNOL, V190, P6651, DOI 10.4049/jimmunol.1201242; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Mugler KC, 2007, APPL IMMUNOHISTO M M, V15, P363, DOI 10.1097/01.pai.0000213159.79557.71; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Ohki S, 2012, ONCOL REP, V28, P453, DOI 10.3892/or.2012.1812; Shi HB, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-188; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang C, 2015, J SURG RES, V197, P301, DOI 10.1016/j.jss.2015.04.034; Zhu GF, 2009, BLOOD, V113, P1759, DOI 10.1182/blood-2008-01-133223	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e199719	10.1371/journal.pone.0199719	http://dx.doi.org/10.1371/journal.pone.0199719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044793	gold, Green Published			2022-12-27	WOS:000439942500017
J	Romano, MR; Ilardi, G; Ferrara, M; Cennamo, G; Allegrini, D; Pafundi, PC; Costagliola, C; Staibano, S; Cennamo, G				Romano, Mario R.; Ilardi, Gennaro; Ferrara, Mariantonia; Cennamo, Gilda; Allegrini, Davide; Pafundi, Pia Clara; Costagliola, Ciro; Staibano, Stefania; Cennamo, Giovanni			Intraretinal changes in idiopathic versus diabetic epiretinal membranes after macular peeling (vol 13, e0197065, 2018)	PLOS ONE			English	Correction													Pafundi, Pia Clara/AAC-3991-2021; Ferrara, Mariantonia/AEC-7557-2022; Ilardi, Gennaro/AAC-3589-2022	Pafundi, Pia Clara/0000-0002-0310-3529; Ferrara, Mariantonia/0000-0002-1191-4989; Ilardi, Gennaro/0000-0002-9354-4087				Romano MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197065	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201503	10.1371/journal.pone.0201503	http://dx.doi.org/10.1371/journal.pone.0201503			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044861	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500105
J	Civita, P; Menicagli, M; Scopelliti, C; Lessi, F; Millanta, F; Borsacchi, S; Parisi, F; Freer, G; Pistellon, M; Mazzanti, CM; Poli, A				Civita, Prospero; Menicagli, Michele; Scopelliti, Claudia; Lessi, Francesca; Millanta, Francesca; Borsacchi, Sara; Parisi, Francesca; Freer, Giulia; Pistellon, Mauro; Mazzanti, Chiara Maria; Poli, Alessandro			Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions	PLOS ONE			English	Article							HUMAN BREAST-CANCER; GENE-SEQUENCES; PARTICLES; CLASSIFICATION; IDENTIFICATION; RETROVIRUSES; CELLS	Mouse mammary tumour virus-like (MMTV-like) is suspected to be involved in human breast cancer and it has been hypothesized that companion animals might have a role in viral transmission. The aim of our study was to investigate the presence of MMTV-like nucleotide sequences and viral protein in a larger number of feline (FMCs) and canine mammary carcinomas (CMCs) by nested PCR and immunohistochemistry. Results showed that the presence of MMTV-like env sequence in FMCs was 7% (6/86), while all the CMCs and canine dysplastic lesions scored negative. All PCR-positive FMCs scored positive for the MMTV p14 signal peptide of the envelope precursor protein of the virus. In contrast, all PCR-negative FMCs and canine mammary lesions were also negative for immunohistochemistry analysis. Canine and feline normal mammary gland tissues scored negative for both PCR and MMTV-p14 protein. Multiple nucleotide alignment of MMTV-like env gene sequences isolated from cat showed 97% and 99% similarity with HMTV and MMTV, respectively, while the others two presented some polimorphisms. Particularly the sequences of one of these two tumors showed a polymorphism (c. 7575 A> G), that causes a previously unreported amino acid substitution (Thr > Ala). In conclusion, the results of our study showed the presence of MMTV-like sequences and viral protein in some FMCs. Further studies are needed to understand whether this virus does play a role in the development of FMCs, if MMTV-like is an exogenous virus as these data suggest and, in such a case, how and from whom this virus was acquired.	[Civita, Prospero; Menicagli, Michele; Scopelliti, Claudia; Lessi, Francesca; Mazzanti, Chiara Maria] Fdn Pisana Sci, Pisa, Italy; [Millanta, Francesca; Borsacchi, Sara; Parisi, Francesca; Poli, Alessandro] Univ Pisa, Dipartimento Sci Vet, Pisa, Italy; [Freer, Giulia; Pistellon, Mauro] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy	University of Pisa; University of Pisa	Poli, A (corresponding author), Univ Pisa, Dipartimento Sci Vet, Pisa, Italy.	alessandro.poli@unipi.it	Civita, Prospero/AAU-6170-2020; Lessi, Francesca/AAE-6812-2022; Parisi, Francesca/AEI-3375-2022; Mazzanti, Chiara/AAX-6539-2021	Lessi, Francesca/0000-0002-3346-4296; Parisi, Francesca/0000-0001-5635-9360; Civita, Prospero/0000-0002-8313-1094	Universita di Pisa [599999_2017_Neoplasie_Mammarie]	Universita di Pisa	This work was supported by Universita di Pisa grant no. 599999_2017_Neoplasie_Mammarie to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSUMIDAIE AM, 1988, LANCET, V1, P5; Bittner JJ, 1936, SCIENCE, V84, P162, DOI 10.1126/science.84.2172.162; Coffin John M., 1996, P763; Etkind P, 2000, CLIN CANCER RES, V6, P1273; Feldman D, 2012, MOL CANCER RES, V10, P1077, DOI 10.1158/1541-7786.MCR-11-0581; Goedert JJ, 2006, BRIT J CANCER, V94, P548, DOI 10.1038/sj.bjc.6602977; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; HOWARD DK, 1980, INT J CANCER, V25, P647, DOI 10.1002/ijc.2910250515; Hsu WL, 2010, J CLIN MICROBIOL, V48, P4354, DOI 10.1128/JCM.01157-10; Lawson JS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00141; Mazzanti CM, 2015, ONCOTARGET, V6, P18355, DOI 10.18632/oncotarget.4567; Mazzanti CM, 2011, AM J PATHOL, V179, P2083, DOI 10.1016/j.ajpath.2011.06.046; Melana SM, 2007, CANCER RES, V67, P8960, DOI 10.1158/0008-5472.CAN-06-3892; Melana SM, 2010, J VIROL METHODS, V163, P157, DOI 10.1016/j.jviromet.2009.09.015; Misdorp W., 1999, HISTOLOGIC CLASSIFIC, V7; MOORE DH, 1969, TEX REP BIOL MED, V27, P1027; Nandi S., 1973, ADV CANCER RES, V17, P353; Riester M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000777; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar NH, 1980, ROLE VIRUSES HUMAN C, P207; SCHLOM J, 1971, SCIENCE, V174, P840, DOI 10.1126/science.174.4011.840; SCHOCHETMAN G, 1979, VIROLOGY, V97, P342, DOI 10.1016/0042-6822(79)90345-3; Song N, 2013, J GEN VIROL, V94, P1587, DOI 10.1099/vir.0.051862-0; Stewart AFR, 2002, ARCH VIROL, V147, P577, DOI 10.1007/s007050200007; Stewart THM, 2000, BRIT J CANCER, V82, P446, DOI 10.1054/bjoc.1999.0941; Szabo S, 2005, MICROSC RES TECHNIQ, V68, P209, DOI 10.1002/jemt.20233; WANG Y, 1995, CANCER RES, V55, P5173; Wang Y, 2001, INT J ONCOL, V18, P1041; Wang Y, 2001, ARCH VIROL, V146, P171, DOI 10.1007/s007050170201; YANAGAWA SI, 1993, J VIROL, V67, P112, DOI 10.1128/JVI.67.1.112-118.1993; Zammarchi F, 2006, J PATHOL, V209, P436, DOI 10.1002/path.1997; Zappulli V, 2015, VET PATHOL, V52, P46, DOI 10.1177/0300985814528221	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200839	10.1371/journal.pone.0200839	http://dx.doi.org/10.1371/journal.pone.0200839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040851	gold, Green Published, Green Submitted			2022-12-27	WOS:000439749200013
J	Hilton, J; Stober, C; Mazzarello, S; Vandermeer, L; Fergusson, D; Hutton, B; Clemons, M				Hilton, John; Stober, Carol; Mazzarello, Sasha; Vandermeer, Lisa; Fergusson, Dean; Hutton, Brian; Clemons, Mark			Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)	PLOS ONE			English	Article							SURVIVAL; OUTCOMES	Introduction Despite the importance of chemotherapy in the treatment of early stage triple negative breast cancer (TNBC), no one optimal regimen has been identified. We conducted a pilot trial comparing outcomes for the three most commonly used chemotherapy regimens to assess the feasibility of conducting a larger definitive trial. Methods Using integrated consent, newly diagnosed TNBC patients were randomised to one of three standard regimens: dose-dense doxorubicin-cyclophosphamide then paclitaxel, doxorubicin-cyclophosphamide then weekly paclitaxel or 5-FU-epirubicin-cyclophosphamide then docetaxel. Feasibility endpoints included; physician engagement, accrual rates, physician compliance and patient satisfaction with the integrated consent model. Our anticipated pilot trial sample size was 35 randomised patients in one year. Results Between August 30th , 2016 and January 31st 2017, 2 patients met eligibility and were randomised. A survey of 10 participating oncologists was performed to identify potential strategies to enhance accrual. Most investigators (9/10) believed that the best regimen for TNBC was unknown, and 4/10 felt this was a pressing clinical question. Physicians' responses suggested that poor accrual was due to: a lack of interest in some study arms as oncologists already had a preferred regimen (4/10) and concerns about trial demands in busy clinics (3/ 10). The pilot feasibility endpoints were not met and the study was closed. Conclusions Despite initial interest in the trial question and multiple investigators agreeing to approach patients, this trial failed to meet feasibility endpoints. The reasons for poor accrual were multiple and require further evaluation if this important patient-centred question is to be answered.	[Hilton, John; Clemons, Mark] Ottawa Hosp, Dept Med, Div Med Oncol, Ottawa, ON, Canada; [Hilton, John; Stober, Carol; Mazzarello, Sasha; Vandermeer, Lisa; Clemons, Mark] Univ Ottawa, Ottawa, ON, Canada; [Hilton, John; Stober, Carol; Mazzarello, Sasha; Vandermeer, Lisa; Clemons, Mark] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Fergusson, Dean; Hutton, Brian] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Fergusson, Dean; Hutton, Brian] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [Fergusson, Dean; Hutton, Brian] Univ Ottawa, Sch Epidemiol, Ottawa, ON, Canada; [Hutton, Brian; Clemons, Mark] Univ Ottawa, Dept Publ Hlth & Preventat Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Hilton, J (corresponding author), Ottawa Hosp, Dept Med, Div Med Oncol, Ottawa, ON, Canada.; Hilton, J (corresponding author), Univ Ottawa, Ottawa, ON, Canada.; Hilton, J (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	jfhilton@toh.ca		Clemons, Mark/0000-0002-0738-2713; Fergusson, Dean/0000-0002-3389-2485	Rethinking Clinical Trials Program, based at the Ottawa Hospital Research Centre; REaCT program	Rethinking Clinical Trials Program, based at the Ottawa Hospital Research Centre; REaCT program	Funding for this project was provided through The Rethinking Clinical Trials Program, based at the Ottawa Hospital Research Centre. The purpose of this program is to perform pragmatic clinical trials. Funding is through core institutional funds. SM and CS received salary support through the REaCT program.	Amir E, 2010, NAT REV CLIN ONCOL, V7, P79, DOI 10.1038/nrclinonc.2009.231; Arnaout A, 2016, CURR ONCOL, V23, pE276, DOI 10.3747/co.23.2394; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Clinical Trials.gov, 2017, 1504 OTT CLINICALTRI; Dent RA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3484; Fernandes R, 2016, SUPPORT CARE CANCER, V24, P3633, DOI 10.1007/s00520-016-3256-5; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hilton J, 2016, J ONCOL PRACT; Jacobs C, 2017, SUPPORTIVE CARE CANC; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Khalaf D, 2014, ONCOL LETT, V7, P866, DOI 10.3892/ol.2014.1782; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Trivers KF, 2009, CANCER CAUSE CONTROL, V20, P1071, DOI 10.1007/s10552-009-9331-1; Villarreal-Garza C, 2014, BREAST CANCER RES TR, V146, P567, DOI 10.1007/s10549-014-3033-4; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	16	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0199297	10.1371/journal.pone.0199297	http://dx.doi.org/10.1371/journal.pone.0199297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040817	Green Published, Green Submitted, gold			2022-12-27	WOS:000439749200002
J	Roy, SK; Meng, QH; Sadowitz, BD; Kollisch-Singule, M; Yepuri, N; Satalin, J; Gatto, LA; Nieman, GF; Cooney, RN; Clark, D				Roy, Shreyas K.; Meng, Qinghe; Sadowitz, Benjamin D.; Kollisch-Singule, Michaels; Yepuri, Natesh; Satalin, Joshua; Gatto, Louis A.; Nieman, Gary F.; Cooney, Robert N.; Clark, David			Enteral administration of bacteria fermented formula in newborn piglets: A high fidelity model for necrotizing enterocolitis (NEC)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL MUCOSAL INJURY; BIRTH-WEIGHT INFANTS; ESCHERICHIA-COLI; IN-VITRO; PATHOGENESIS; NUTRITION; RATS; EPIDEMIOLOGY; MILK	Objective To develop an animal model which replicates neonatal NEC and characterizes the importance of bacterial fermentation of formula and short chain fatty acids (SCFAs) in its pathogenesis. Background NEC is a severe form of intestinal inflammation in preterm neonates and current models do not reproduce the human condition. Methods Three groups of newborn piglets: Formula alone (FO), Bacteria alone (E.coli: BO) and E. coli-fermented formula (FF) were anesthetized, instrumented and underwent post-pyloric injection of formula, bacteria or fermented-formula. SCFA levels were measured by gas chromatography-mass spectrometry. At 6 h bowel appearance was assessed, histologic and molecular analysis of intestine were performed. Gut inflammation (p65 NF-kappa B, TLR4, TNF-alpha, IL-1 beta), apoptosis (cleaved caspase-3, BAX, apoptosis) and tight junction proteins (claudin-2, occludin) were measured. Results SCFAs were increased in FF. Small bowel from FF piglet's demonstrated inflammation, coagulative necrosis and pneumatosis resembling human NEC. Histologic gut injury (injury score, mast cell activation) were increased by Bacteria, but more severe in FF piglets. Intestinal expression of p65 NF-kappa B, NF-kappa B activation, TNF-alpha and IL-1 beta were increased in BO and markedly increased in the FF group (P<0.05 vs. FO). Intestine from Bacteria piglets demonstrated increased apoptotic index, pro-apoptotic protein expression and decreased tight junction proteins. These changes were more severe in FF piglets. Conclusions Our piglet model demonstrates the findings of NEC in human neonates: systemic acidosis, intestinal inflammation, pneumatosis and portal venous gas. Bacteria alone can initiate intestinal inflammation, injury and apoptosis, but bacterial fermentation of formula generates SCFAs which contribute to the pathogenesis of NEC.	[Roy, Shreyas K.; Meng, Qinghe; Sadowitz, Benjamin D.; Kollisch-Singule, Michaels; Yepuri, Natesh; Satalin, Joshua; Nieman, Gary F.; Cooney, Robert N.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Gatto, Louis A.] SUNY Coll Cortland, Dept Biol, Cortland, NY 13045 USA; [Clark, David] Albany Med Ctr, Dept Pediat, Albany, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; SUNY Cortland; Albany Medical College	Cooney, RN (corresponding author), SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA.	cooneyr@upstate.edu	Nieman, Gary/ABA-9469-2020	Cooney, Robert/0000-0002-8901-3638; Satalin, Joshua/0000-0002-7582-2493	Upstate Medical University HSC Foundation account	Upstate Medical University HSC Foundation account	This project was supported by the Upstate Medical University HSC Foundation account. Voluntary donations were accepted into this fund. Donors waived rights to determine how and to which projects the funds were allocated. Donations were accepted under the condition that ownership of intellectual property rights were waived and donor approval not required for publication. These funds were not provided for goods or services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bizzarro MJ, 2014, J PEDIATR-US, V164, P61, DOI 10.1016/j.jpeds.2013.09.020; Boccia D, 2001, EUR J PEDIATR, V160, P385, DOI 10.1007/s004310100749; CARBONARO CA, 1988, MICROB PATHOGENESIS, V5, P427, DOI 10.1016/0882-4010(88)90004-6; Carlisle EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018084; CLARK DA, 1988, AM J PATHOL, V130, P537; Clark David A, 2014, Pathophysiology, V21, P29, DOI 10.1016/j.pathophys.2013.11.006; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; CUSHING AH, 1983, PEDIATRICS, V71, P626; DILORENZO M, 1995, J PEDIATR SURG, V30, P1138, DOI 10.1016/0022-3468(95)90006-3; Feng JX, 2006, J PEDIATR SURG, V41, P144, DOI 10.1016/j.jpedsurg.2005.10.018; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Hunter Catherine J, 2014, Pathophysiology, V21, P55, DOI 10.1016/j.pathophys.2013.11.010; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; KLIEGMAN RM, 1993, PEDIATR RES, V34, P701, DOI 10.1203/00006450-199312000-00001; KLIEGMAN RM, 1982, J PEDIATR-US, V100, P440, DOI 10.1016/S0022-3476(82)80456-3; KOSLOSKE AM, 1980, J PEDIATR SURG, V15, P558, DOI 10.1016/S0022-3468(80)80773-1; Lambert DK, 2007, J PERINATOL, V27, P437, DOI 10.1038/sj.jp.7211738; Lin J, 2005, J PEDIATR GASTR NUTR, V41, P607, DOI 10.1097/01.mpg.0000179659.09210.ff; Lin J, 2004, MED HYPOTHESES, V62, P291, DOI 10.1016/S0306-9877(03)00333-5; Lin J, 2002, J PEDIATR GASTR NUTR, V35, P545, DOI 10.1097/00005176-200210000-00016; Lu Peng, 2014, Pathophysiology, V21, P81, DOI 10.1016/j.pathophys.2013.11.007; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; MILLER MJS, 1991, SCAND J GASTROENTERO, V26, P379, DOI 10.3109/00365529108996498; Moore SA, 2016, J PEDIATR SURG, V51, P1907, DOI 10.1016/j.jpedsurg.2016.09.011; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Nafday SM, 2005, PEDIATR RES, V57, P201, DOI 10.1203/01.PDR.0000150721.83224.89; Neu J, 2015, CURR OPIN CLIN NUTR, V18, P285, DOI 10.1097/MCO.0000000000000169; Neu J, 2012, JPEN-PARENTER ENTER, V36, p30S, DOI 10.1177/0148607111422068; NEWPORT MJ, 1984, PEDIATR RES, V18, P658, DOI 10.1203/00006450-198407000-00019; NOWICKI P, 1990, J PEDIATR-US, V117, pS14, DOI 10.1016/S0022-3476(05)81125-4; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Penn AH, 2012, PEDIATR RES, V72, P560, DOI 10.1038/pr.2012.125; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; Sachdev AH, 2013, THER ADV CHRONIC DIS, V4, P223, DOI 10.1177/2040622313496126; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; SANTULLI TV, 1975, PEDIATRICS, V55, P376; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Shea-Donohue Terez, 2010, Curr Gastroenterol Rep, V12, P349, DOI 10.1007/s11894-010-0132-1; Sodhi C, 2008, DIS MODEL MECH, V1, P94, DOI 10.1242/dmm.000315; Sonntag J, 1998, J PEDIATR SURG, V33, P481, DOI 10.1016/S0022-3468(98)90092-6; SPEER ME, 1976, J PEDIATR-US, V89, P91, DOI 10.1016/S0022-3476(76)80939-0; STOLL BJ, 1980, J PEDIATR-US, V96, P447; Tatum PM, 2010, J PEDIATR SURG, V45, P1246, DOI 10.1016/j.jpedsurg.2010.02.093; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; VanderKolk WE, 1996, J PEDIATR SURG, V31, P1063, DOI 10.1016/S0022-3468(96)90088-3; Waligora-Dupriet AJ, 2009, ANAEROBE, V15, P138, DOI 10.1016/j.anaerobe.2009.02.001; Young Christopher M, 2011, J Pediatr, V158, pe25, DOI 10.1016/j.jpeds.2010.11.009	54	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201172	10.1371/journal.pone.0201172	http://dx.doi.org/10.1371/journal.pone.0201172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036384	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200032
J	Claxton, DP; Gouaux, E				Claxton, Derek P.; Gouaux, Eric			Expression and purification of a functional heteromeric GABA(A) receptor for structural studies	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; GATED ION-CHANNEL; GREEN FLUORESCENT PROTEIN; X-RAY STRUCTURES; MAMMALIAN-CELL LINES; HAMSTER OVARY CELLS; MEMBRANE-PROTEINS; A RECEPTORS; BENZODIAZEPINE BINDING; SUBUNIT ARRANGEMENT	The GABA-gated chloride channels of the Cys-loop receptor family, known as GABA(A) receptors, function as the primary gatekeepers of fast inhibitory neurotransmission in the central nervous system. Formed by the pentameric arrangement of five identical or homologous subunits, GABA(A) receptor subtypes are defined by the subunit composition that shape ion channel properties. An understanding of the structural basis of distinct receptor properties has been hindered by the absence of high resolution structural information for heteromeric assemblies. Robust heterologous expression and purification protocols of high expressing receptor constructs are vital for structural studies. Here, we describe a unique approach to screen for well-behaving and functional GABA(A) receptor subunit assemblies by using the Xenopus oocyte as an expression host in combination with fluorescence detection size exclusion chromatography (FSEC). To detect receptor expression, GFP fusions were introduced into the alpha 1 subunit isoform. In contrast to expression of alpha 1 alone, co-expression with the beta subunit promoted formation of monodisperse assemblies. Mutagenesis experiments suggest that the alpha and beta subunits can tolerate large truncations in the non-conserved M3/M4 cytoplasmic loop without compromising oligomeric assembly or GABA-gated channel activity, although removal of N-linked glycosylation sites is negatively correlated with expression level. Additionally, we report methods to improve GABA(A) receptor expression in mammalian cell culture that employ recombinant baculovirus transduction. From these methods we have identified a well-behaving minimal functional construct for the alpha 1/beta 1 GABA(A) receptor subtype that can be purified in milligram quantities while retaining high affinity agonist binding activity.	[Claxton, Derek P.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; [Claxton, Derek P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Vanderbilt University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Claxton, Derek P/0000-0002-1374-7176	NIH grant from the National Institute of General Medical Sciences [R01-GM100400]; NRSA from the National Institute of General Medical Sciences [F32-GM100584]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100400, F32GM100584] Funding Source: NIH RePORTER	NIH grant from the National Institute of General Medical Sciences; NRSA from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant from the National Institute of General Medical Sciences (R01-GM100400) to E.G., who is also an Investigator with the Howard Hughes Medical Institute, and by an NRSA postdoctoral fellowship from the National Institute of General Medical Sciences (F32-GM100584) to D.P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Anderson KN, 2009, J CLIN SLEEP MED, V5, P235; Andrell J, 2013, MOL MEMBR BIOL, V30, P52, DOI 10.3109/09687688.2012.703703; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Ashikawa Y, 2011, PROTEIN SCI, V20, P1720, DOI 10.1002/pro.707; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; BIRNIR B, 1992, P ROY SOC B-BIOL SCI, V250, P307, DOI 10.1098/rspb.1992.0163; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Campagna-Slater V, 2007, J MOL GRAPH MODEL, V25, P721, DOI 10.1016/j.jmgm.2006.06.001; CARTER DB, 1992, BIO-TECHNOL, V10, P679, DOI 10.1038/nbt0692-679; CASALOTTI SO, 1986, J BIOL CHEM, V261, P5013; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connor JX, 1998, J BIOL CHEM, V273, P28906, DOI 10.1074/jbc.273.44.28906; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dibbens LM, 2009, NEUROSCI LETT, V453, P162, DOI 10.1016/j.neulet.2009.02.038; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Ferris MM, 2011, J VIROL METHODS, V171, P111, DOI 10.1016/j.jviromet.2010.10.010; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Hsu CS, 2004, BIOTECHNOL BIOENG, V88, P42, DOI 10.1002/bit.20213; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Luckow Verne A., 1993, Current Opinion in Biotechnology, V4, P564, DOI 10.1016/0958-1669(93)90078-B; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mitte K, 2005, J CLIN PSYCHOPHARM, V25, P141, DOI 10.1097/01.jcp.0000155821.74832.f9; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PALERMO DP, 1991, J BIOTECHNOL, V19, P35, DOI 10.1016/0168-1656(91)90073-5; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PREGENZER JF, 1993, MOL PHARMACOL, V43, P801; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; Puthenkalam R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00044; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reeves PJ, 1999, BIOCHEM SOC T, V27, P950, DOI 10.1042/bst0270950; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; SMART TG, 1990, BRIT J PHARMACOL, V99, P643, DOI 10.1111/j.1476-5381.1990.tb12984.x; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; Smart TG, 2012, COLD SPRING HARB PER, V4; Tan KR, 2011, TRENDS NEUROSCI; Tierney ML, 1996, J MEMBRANE BIOL, V154, P11, DOI 10.1007/s002329900128; Tretter V, 1997, J NEUROSCI, V17, P2728; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vijayan RSK, 2012, J CHEM INF MODEL, V52, P2958, DOI [10.1021/ci300189a, 10.1021/ci3001092]; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Wilkins MR, 1999, METH MOL B, V112, P531; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Xie HB, 2013, BIOPHYS CHEM, V180, P1, DOI 10.1016/j.bpc.2013.05.004; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782	89	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201210	10.1371/journal.pone.0201210	http://dx.doi.org/10.1371/journal.pone.0201210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028870	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900046
J	Gonzalez-Redin, J; Polhill, JG; Dawson, TP; Hill, R; Gordon, IJ				Gonzalez-Redin, Julen; Polhill, J. Gareth; Dawson, Terence P.; Hill, Rosemary; Gordon, Iain J.			It's not the 'what', but the 'how': Exploring the role of debt in natural resource (un) sustainability	PLOS ONE			English	Article							GROWTH; PROTOCOL	A debt-based economy cannot survive without economic growth. However, if private debt consistently grows faster than GDP, the consequences are financial crises and the current unprecedented level of global debt. This policy dilemma is aggravated by the lack of analyses factoring the impact of debt-growth cycles on the environment. What is really the relationship between debt and natural resource sustainability, and what is the role of debt in decoupling economic growth from natural resource availability? Here we present a conceptual Agent-Based Model (ABM) that integrates an environmental system into an ABM representation of Steve Keen's debt-based economic models. Our model explores the extent to which debt-driven processes, within debt-based economies, enhance the decoupling between economic growth and the availability of natural resources. Interestingly, environmental and economic collapse in our model are not caused by debt growth, or the debt-based nature of the economic system itself (i.e. the 'what'), but rather, these are due to the inappropriate use of debt by private actors (i.e. the 'how'). Firms inappropriately use bank credits for speculative goals-rather than production-oriented ones-and for exponentially increasing rates of technological development. This context creates temporal mismatches between natural resource growth and firms' resource extraction rates, as well as between economic growth and the capacity of the government to effectively implement natural resource conservation policies. This paper discusses the extent to which economic growth and the availability of natural resources can be re-coupled through a more sustainable use of debt, for instance by shifting mainstream banking forces to partially support environmental conservation as well as economic growth.	[Gonzalez-Redin, Julen; Polhill, J. Gareth; Gordon, Iain J.] JHI, Informat & Computat Sci, Aberdeen, Scotland; [Gonzalez-Redin, Julen; Dawson, Terence P.] UoD, Sch Social Sci, Geog & Environm Sci, Dundee, Scotland; [Dawson, Terence P.] KCL, Dept Geog, London, England; [Hill, Rosemary] JCU, Div Trop Environm & Soc, CSIRO Land & Water, Cairns, Qld, Australia; [Hill, Rosemary; Gordon, Iain J.] JCU, Trop Environm & Soc, Townsville, Qld, Australia; [Gordon, Iain J.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	James Hutton Institute; University of London; King's College London; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Gonzalez-Redin, J (corresponding author), JHI, Informat & Computat Sci, Aberdeen, Scotland.; Gonzalez-Redin, J (corresponding author), UoD, Sch Social Sci, Geog & Environm Sci, Dundee, Scotland.	Julen.Gonzalez@hutton.ac.uk	Dawson, Terence Peter/E-4724-2011; Polhill, Gary/S-5400-2016; Hill, Rosemary/A-6954-2011; Gordon, Iain/S-8076-2019	Dawson, Terence Peter/0000-0002-4314-1378; Polhill, Gary/0000-0002-8596-0590; Hill, Rosemary/0000-0002-7426-3132; Gordon, Iain/0000-0001-9704-0946; Gonzalez-Redin, Julen/0000-0002-5542-0323				Abrahamson D., 2007, P COMP SUPP COLL LEA, V8, P46, DOI [DOI 10.3115/1599600.1599607, 10.3115/1599600.1599607]; [Anonymous], 2010, SUSTAINABILITY-BASEL, DOI DOI 10.3390/SU2061784; Antoniades A, 2017, ASSESSING IMPACT DEB; Axelrod R, 2001, HARNESSING COMPLEXIT; Balbi Stefano, 2010, International Journal of Agent Technologies & Systems, V2, P17, DOI 10.4018/jats.2010100103; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brown DG, 2006, ECOL SOC, V11; Brown JH, 2011, BIOSCIENCE, V61, P19, DOI 10.1525/bio.2011.61.1.7; Bruun C, 2009, MANAGING FINANCIAL I, P25; Clark J, 2016, DOES OIL SPECULATION; COX CC, 1976, J POLIT ECON, V84, P1215, DOI 10.1086/260509; Daly H.E, 2010, SOLUTIONS, V1, P37; DALY HE, 1991, LAND ECON, V67, P255, DOI 10.2307/3146415; Daly H, 2011, ECOL ECON, V72, P5, DOI 10.1016/j.ecolecon.2011.10.006; Dawson TP, 2010, BIODIVERS CONSERV, V19, P2843, DOI 10.1007/s10531-010-9892-z; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Desha C., 2010, CENTS SUSTAINABILITY, DOI [10.4324/9781849776370, DOI 10.4324/9781849776370]; Diamond J., 2011, COLLAPSE SOC CHOOSE, V4th ed; Effken JA, 2012, CIN-COMPUT INFORM NU, V30, P620, DOI 10.1097/NXN.0b013e318261f1bb; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Epstein JM, 2002, P NATL ACAD SCI USA, V99, P7243, DOI 10.1073/pnas.092080199; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Ferber J., 1999, MULTIAGENT SYSTEMS I, P509; Filatova T, 2013, ENVIRON MODELL SOFTW, V45, P1, DOI 10.1016/j.envsoft.2013.03.017; Fischer J, 2015, CURR OPIN ENV SUST, V14, P144, DOI 10.1016/j.cosust.2015.06.002; Galaz V., 2017, COMPLEXITY GOVERNANC, V3, P12, DOI [10.20377/cgn-55, DOI 10.20377/CGN-55]; Gilbert N., 2005, SIMULATION SOCIAL SC; Giraud G, 2016, AIEE EN S; Global Footprint Network, 2018, GLOSS BIOL CAP BIOC; Godley W., 2007, MONETARY EC; Gorton G, 2006, FINANC ANAL J, V62, P47, DOI 10.2469/faj.v62.n2.4083; Graziani A., 1990, EC SOC, V24, P7; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hein E, 2014, CAMB J ECON, V36, P325; Holling CS., 1998, LINKING SOCIAL ECOLO, P342; Huber J., 2000, CREATION NEW MONEY M; Jackson T., 2009, PROSPERITY GROWTH EC, DOI 10.4324/9781315677453; Jackson T, 2015, ECOLOGICAL EC, V121, P206; Jevons WS, 1985, THE QUESTION OF COAL; KEEN S, 1995, J POST KEYNESIAN EC, V17, P607, DOI 10.1080/01603477.1995.11490053; KEEN S, 2010, EC OPEN ACCESS OPEN, V0004; Keen S, 2011, P WOOLL FIN MARK DYS; Keen S, 2010, STRAIGHT TALK S KEEN; Keen S, 2009, AUST ECON REV, V42, P347, DOI 10.1111/j.1467-8462.2009.00560.x; Korotayev A.V., 2010, STRUCT DYN, V4, P3, DOI [10.5070/SD941003306, DOI 10.5070/SD941003306]; Koslowski P, 1995, ETHICAL DIMENSION FI; Lafforgue G, 2008, RESOUR ENERGY ECON, V30, P540, DOI 10.1016/j.reseneeco.2008.07.001; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Lebel L, 2006, ECOL SOC, V11; Lipsey R.G., 1998, GEN PURPOSE TECHNOLO; Martinez-Alier J, 2010, ECOL ECON, V69, P1741, DOI 10.1016/j.ecolecon.2010.04.017; Mauser W, 2013, CURR OPIN ENV SUST, V5, P420, DOI 10.1016/j.cosust.2013.07.001; Meadows D., 2004, LIMITS GROWTH 30 YEA; Modis T, 2002, TECHNOL FORECAST SOC, V69, P377, DOI 10.1016/S0040-1625(01)00172-X; Moss S, 2009, COMPLEX SYSTEMS FINA, P22; Murillo-Zamorano LR, 2003, U YORK DISCUSSION PA, V2003; Nordhaus WD, 2007, J ECON LIT, V45, P686, DOI 10.1257/jel.45.3.686; North M.J., 2007, MANAGING BUSINESS CO; OECD, 2000, SCI TECHN INN NEW EC; Organization for Economic Co-operation and Development (OECD), 2011, OECD M COUNC MIN LEV; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; PBC, 2016, MON POL REP VAR ISS; PCI-Permanent Subcommittee on investigations, 2006, ROL MARK SPEC RIS OI; PERSKY J, 1995, J ECON PERSPECT, V9, P221, DOI 10.1257/jep.9.2.221; Politopoulos I, 2007, REV ANAL AGENT BASED; Redman CL, 2004, ECOSYSTEMS, V7, P161, DOI 10.1007/s10021-003-0215-z; Ripple WJ, 2017, BIOSCIENCE, V67, P1026, DOI 10.1093/biosci/bix125; Ritter FE., 2011, HUMAN IN THE LOOP SI, P97, DOI [10.1007/978-0-85729-883-6_5, DOI 10.1007/978-0-85729-883-6_5, 10.1007/978-0-85729-883, DOI 10.1007/978-0-85729-883]; Schulze J, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3423; Stern Nicholas, 2006, STERN REV EC CLIMATE; Stiglitz DJ, 2009, ANN PUBLIC COOP ECON, V80, P345, DOI 10.1111/j.1467-8292.2009.00389.x; ten Broeke G, 2016, JASSS-J ARTIF SOC S, V19, DOI 10.18564/jasss.2857; Tesfatsion L., 2006, AGENT BASED COMPUTAT; UNCTAD, 2011, PRIC FORM FIN COMM M; Victor PA, 2007, ECOL ECON, V61, P492, DOI 10.1016/j.ecolecon.2006.03.022; Wilensky U, 1999, NETLOGO	81	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201141	10.1371/journal.pone.0201141	http://dx.doi.org/10.1371/journal.pone.0201141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028881	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900040
J	Pavan, TBS; da Silva, JW; Martins, LC; Costa, SCB; de Almeida, EA				Sabaini Pavan, Tycha Bianca; da Silva, Jamiro Wanderley; Martins, Luiz Claudio; Botelho Costa, Sandra Cecilia; de Almeida, Eros Antonio			Hepatic changes by benznidazole in a specific treatment for Chagas disease	PLOS ONE			English	Article							RANDOMIZED-TRIAL	Chagas disease (Cd) is the third most common parasitic disease that causes damage to human health. Even a century after its description by Carlos Chagas and advances in its control, it remains a neglected disease. To eradicate the parasite or reduce the parasitic load, specific treatment for Trypanosoma cruzi(T. cruzi) is advisable; benznidazole (BNZ) is the drug that is currently prescribed. The purpose of this study is to report the adverse events (AE) due to the use of BNZ as a specific treatment for Cd, with a particular focus on hepatic changes. This was an observational, cross-sectional cohort study that included patients who were treated with BNZ. The medical records of patients who joined the Grupo de Estudo em doenca de Chagas [Chagas Disease Study Group]/UNICAMP/Brazil and were treated with BNZ were reviewed for epidemiological, clinical, laboratory and AE parameters for the drug. The 204 patients who were assessed had an average age of 40.6 years +/- 13.5 years, and 104 of them were women (50.98%). Fourteen (6.86%) individuals were in the acute phase of Cd, and 190 (93.13%) were in its chronic phase. AEs occurred in 85 patients (41.66%), 35 (41.17%) of whom had AEs related to the liver, characterized by an elevation of AST liver enzymes, ALT, alkaline phosphatase and gamma-glutamyltransferase (yGT). Other AEs that were observed included the following: 48 cases of cutaneous changes (56.47%), 8 cases of epigastric pain (9.41 %), 7 cases of blood alteration (8.23%), and 3 cases of peripheral neuropathy (3.52%). Treatment was interrupted in 32 patients (37.64%) due to AD. Adverse events related to the liver secondary to the use of BNZ for Cd-specific treatment were frequent in this study and were characterized by an elevation of liver enzymes. Therefore, it is suggested that these enzymes be monitored during treatment with benznidazole.	[Sabaini Pavan, Tycha Bianca; da Silva, Jamiro Wanderley; Martins, Luiz Claudio; Botelho Costa, Sandra Cecilia; de Almeida, Eros Antonio] Univ Estadual Campinas, Grp Estudo Doenca Chagas GEDoCh, Unicamp, Dept Med Clin,Fac Med Sci, Campinas, SP, Brazil; [Sabaini Pavan, Tycha Bianca] Univ Estadual Campinas, Fac Med Sci, Unicamp, Dept Med Clin, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Pavan, TBS (corresponding author), Univ Estadual Campinas, Grp Estudo Doenca Chagas GEDoCh, Unicamp, Dept Med Clin,Fac Med Sci, Campinas, SP, Brazil.; Pavan, TBS (corresponding author), Univ Estadual Campinas, Fac Med Sci, Unicamp, Dept Med Clin, Campinas, SP, Brazil.	tychabianca@gmail.com.br	Martins, Luiz/ABH-4473-2022	Pavan, Tycha Bianca Sabaini/0000-0001-5276-2099				Amato-Neto V, 2001, REV SOC BRASILEIRA M, P419; Andrade J.P., 2011, Arq. Bras. Cardiol., V97, P01, DOI 10.1590/S0066-782X2011001600001; Antunes AF, 2016, ARQ BRAS CARDIOL, V107, P184, DOI 10.5935/abc.20160115; Benziger CP, 2015, WKLY EPIDEMOL REC, P33; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Caldas I.S., 2008, THESIS U FEDERAL OUR; Camargo ME, 1984, REV INST MED TROP SP, P192, DOI [10.1590/S0036-46651984000400003, DOI 10.1590/S0036-46651984000400003]; Cancado JR, 2002, REV INST MED TROP, P29; Chagas Carlos, 1911, C REAL PER ASS MED C; Davanco MG, 2015, BIOMED CHROMATOGR, V29, P1008, DOI 10.1002/bmc.3386; Dias JCP, 2015, EPIDEMOLOGIA CLIN CO, P21; Dooley J. S., 2002, SHERLOCKS DIS LIVER, P20; Marson ME, 2015, EUR J DRUG METAB PH, V40, P209, DOI 10.1007/s13318-014-0195-8; Ferreira HO, 1976, REV INST MED TROP, V18, P357, DOI [10.1590/S0066-782X1998000100012, DOI 10.1590/S0066-782X1998000100012]; Fonseca F.A.H., 2005, ARQ BRAS CARDIOL, V85, P9, DOI DOI 10.1590/S0066-782X2005002400003; Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Gonzalez-Tome M, 2013, ENFERM INFEC MICR CL, V31, P535, DOI [10.1016/j.eimc.2012.09.010, DOI 10.1016/J.EIMC.2012.09.010]; Macedo VO, 1997, CLIN TERAPEUTICA DOE, V486, pI, DOI [10.7476/9788575412435, DOI 10.7476/9788575412435]; Menezes C, 2011, DRUG DEVELOP RES, V72, P471, DOI 10.1002/ddr.20454; Molina I, 2015, ANTIMICROB AGENTS CH; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Novaes RD, 2015, PARASITOL RES, V114, P2873, DOI 10.1007/s00436-015-4488-x; Coronel MVP, 2017, REV SOC BRAS MED TRO, V50, P145, DOI 10.1590/0037-8682-0071-2016; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Perin L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02410-16; Dias JCP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000500002, 10.5123/s1679-49742016000500002]; Porras AI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003697; Sanchez Ariel German, 2016, Rev Fac Cien Med Univ Nac Cordoba, V73, P176; Vallejo A, 2016, ACTA TROP, V164, P117, DOI 10.1016/j.actatropica.2016.09.010	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200707	10.1371/journal.pone.0200707	http://dx.doi.org/10.1371/journal.pone.0200707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028842	gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900013
J	Verma, SK; Albrecht, AK; Siebecke, V; Klock, G; Kolesnikova, TA; Springer, S				Verma, Sujit Kumar; Albrecht, Anja Karin; Siebecke, Verena; Kloeck, Gerd; Kolesnikova, Tatiana A.; Springer, Sebastian			Comparative validation of a microcapsule-based immunoassay for the detection of proteins and nucleic acids	PLOS ONE			English	Article							CROSS-LINKING; SERUM BETA-2-MICROGLOBULIN; CARBONATE MICROPARTICLES; WEAK POLYELECTROLYTES; PROGNOSTIC-FACTOR; FLOW-CYTOMETRY; ASSAY; MICROSPHERES; BIOMARKERS; LYMPHOMAS	To detect and study diseases, research and clinical laboratories must quantify specific biomarkers in the plasma and urine of patients with precision, sensitivity, and cost-effectiveness. Newly developed techniques, such as particle-based immunoassays, must be validated in these terms against standard methods such as enzyme-linked immunosorbent assays (ELISAs). Here, we compare the performance of assays that use hollow polyelectrolyte microcapsules with assays based on solid plastic beads, and with standard microplate immunoassays. The polyelectrolyte microcapsules detect the disease biomarker beta-2 microglobulin with a fifty-fold increase in sensitivity than polystyrene (PS) beads. For sequence-specific nucleic acid detection, the oligonucleotide-coated microcapsules exhibit a two-fold lower increase in sensitivity over PS beads. The microcapsules also detect the presence of a monoclonal antibody in hybridoma supernatant at a fifty-six-fold increase in sensitivity compared to a microplate assay. Overall, polyelectrolyte microcapsule-based assays are more sensitive for the detection of protein and nucleic acid analytes than PS beads and microplate assays, and they are viable alternatives as a platform for the rapid quantitative detection of analytes at very low concentrations.	[Verma, Sujit Kumar; Kolesnikova, Tatiana A.; Springer, Sebastian] Jacobs Univ, Dept Life Sci & Chem, Bremen, Germany; [Albrecht, Anja Karin; Siebecke, Verena; Kloeck, Gerd] City Univ Appl Sci, Bremen, Germany	Jacobs University; Bremen University of Applied Sciences	Springer, S (corresponding author), Jacobs Univ, Dept Life Sci & Chem, Bremen, Germany.	s.springer@jacobs-university.de	Springer, Sebastian/AAJ-7036-2021; Kloeck, Gerd/AAF-9690-2020	Springer, Sebastian/0000-0002-5527-6149; 	German Ministry for Education and Research (BMBF) [031A153A-B]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors gratefully acknowledge the financial support of the German Ministry for Education and Research (BMBF; Kooperationsprojekt 031A153A-B 'Prozessuberwachung in vivo und in vitro mit Polyelektrolyt-Nanokapseln').	Antipov AA, 2003, COLLOID SURFACE A, V224, P175, DOI 10.1016/S0927-7757(03)00195-X; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Brott DA, 2015, DRUG DES DEV THER, V9, P3191, DOI 10.2147/DDDT.S78792; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; De Geest BG, 2008, AM CHEM SOC POLYM PR, V49, P1074, DOI DOI 10.1039/B808262F; de la Escosura-Muniz A, 2015, BIOSENS BIOELECTRON, V67, P162, DOI 10.1016/j.bios.2014.07.086; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Du JM, 2009, J MOL RECOGNIT, V22, P465, DOI 10.1002/jmr.964; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; Fiseha T, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/1501785; Fraga M, 2014, ANAL CHIM ACTA, V850, P57, DOI 10.1016/j.aca.2014.08.030; Germain M, 2006, ADV MATER, V18, P2868, DOI 10.1002/adma.200600860; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; HAGBERG H, 1983, CANCER, V51, P2220, DOI 10.1002/1097-0142(19830615)51:12<2220::AID-CNCR2820511212>3.0.CO;2-A; Hahn YK, 2009, BIOSENS BIOELECTRON, V24, P1870, DOI 10.1016/j.bios.2008.09.016; JOHNSON PWM, 1993, BRIT J CANCER, V67, P792, DOI 10.1038/bjc.1993.144; Johnston APR, 2006, CURR OPIN COLLOID IN, V11, P203, DOI 10.1016/j.cocis.2006.05.001; Kojima T, 2016, J BIOSCI BIOENG, V121, P147, DOI 10.1016/j.jbiosc.2015.06.003; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Manaskova SH, 2013, J IMMUNOL METHODS, V397, P18, DOI 10.1016/j.jim.2013.07.016; Mauser T, 2004, MACROMOL RAPID COMM, V25, P1781, DOI 10.1002/marc.200400331; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; NORFOLK DR, 1987, J CLIN PATHOL, V40, P657, DOI 10.1136/jcp.40.6.657; Qureshi A, 2012, SENSOR ACTUAT B-CHEM, V171, P62, DOI 10.1016/j.snb.2012.05.077; Rodriguez LP, 2014, ANAL BIOCHEM, V447, P58, DOI 10.1016/j.ab.2013.10.035; Saini SK, 2013, MOL IMMUNOL, V54, P386, DOI 10.1016/j.molimm.2013.01.004; Schuetz P, 2003, ADV FUNCT MATER, V13, P929, DOI 10.1002/adfm.200304483; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Sukhorukov GB, 2004, J MATER CHEM, V14, P2073, DOI 10.1039/b402617a; Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q; Sukhorukov GB, 2007, TRENDS BIOTECHNOL, V25, P93, DOI 10.1016/j.tibtech.2006.12.007; Sun M, 2010, STEROIDS, V75, P1089, DOI 10.1016/j.steroids.2010.07.005; Tekin HC, 2013, LAB CHIP, V13, P4711, DOI 10.1039/c3lc50477h; Tong WJ, 2005, POLYM ADVAN TECHNOL, V16, P827, DOI 10.1002/pat.659; Verma SK, 2016, ADV FUNCT MATER, V26, P6015, DOI 10.1002/adfm.201601328; Wood BA, 2011, CLIN VACCINE IMMUNOL, V18, P387, DOI 10.1128/CVI.00289-10; Yoo C, 2014, BLOOD RES, V49, P148, DOI 10.5045/br.2014.49.3.148	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201009	10.1371/journal.pone.0201009	http://dx.doi.org/10.1371/journal.pone.0201009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028867	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900030
J	Sabapathy, K; Hensen, B; Varsaneux, O; Floyd, S; Fidler, S; Hayes, R				Sabapathy, Kalpana; Hensen, Bernadette; Varsaneux, Olivia; Floyd, Sian; Fidler, Sarah; Hayes, Richard			The cascade of care following community-based detection of HIV in sub-Saharan Africa - A systematic review with 90-90-90 targets in sight	PLOS ONE			English	Review							ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; LINKAGE; INITIATION; PROGRAM; MODELS; ADULTS	Introduction We aimed to establish how effective community-based HIV testing services (HTS), including home and community location based (non-health facility) HIV testing services (HB-/CLB-HTS), are in improving care in sub-Saharan Africa (SSA), with a view to achieving the 90-90-90 targets. Methods We conducted a systematic review of published literature from 2007-17 which reported on the proportion of individuals who link-to-care and/or initiate ART after detection with HIV through community-based testing. A meta-analysis was deemed inappropriate due to heterogeneity in reporting. Results and discussion Twenty-five care cascades from 6 SSA countries were examined in the final review - 15 HB-HTS, 8 CLB-HTS, 2 combined HB-/CLB-HTS. Proportions linked-to-care over 1-12 months ranged from 14-96% for HB-HTS and 10-79% for CLB-HTS, with most studies reporting outcomes over short periods (3 months). Fewer studies reported ART-related outcomes following community-based testing and most of these studies included <50 HIV-positive individuals. Proportions initiating ART ranged from 23-93%. One study reported retention on ART (76% 6 months after initiation). Viral suppression 3-12 months following ART initiation was 77-85% in three studies which reported this. There was variability in definitions of outcomes, numerators/denominators and observation periods. Outcomes varied between studies even for similar time-points since HTS. The methodological inconsistencies hamper comparisons. Previously diagnosed individuals appear more likely to link-to-care than those who reported being newly-diagnosed. It appears that individuals diagnosed in the community need time before they are ready to link-to-care/initiate ART. Point-of-care (POC) CD4-counts at the time of HTS did not achieve higher proportions linking-to-care or initiating ART. Similarly, follow-up visits to HIV-positive individuals did not appear to enhance linkage to care overall. Conclusion This systematic review summarises the available data on linkage to care/ART initiation following community-based detection of HIV, to help researchers and policy makers evaluate findings. The available evidence suggests that different approaches to community-based HTS including HB-HTS and CLB-HTS, are equally effective in achieving linkage to care and ART initiation among those detected. Engagement and support for newly diagnosed individuals may be key to achieving all three UNAIDS 90-90-90 targets. We also recommend that standardised measures of reporting of steps on the cascade of care are needed, to measure progress against targets and compare across settings.	[Sabapathy, Kalpana; Hensen, Bernadette; Varsaneux, Olivia; Floyd, Sian; Hayes, Richard] London Sch Hyg & Trop Med, London, England; [Fidler, Sarah] Imperial Coll London, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Sabapathy, K (corresponding author), London Sch Hyg & Trop Med, London, England.	kalpana.sabapathy@lshtm.ac.uk		Hayes, Richard/0000-0002-1729-9892; Fidler, Sarah/0000-0003-1676-7583; varsaneux, olivia/0000-0003-3249-0721; Hensen, Bernadette/0000-0001-6719-6720	HPTN 071/PopART trial; National Institute of Allergy and Infectious Diseases (NIAID) [UM1-AI068619, UM1-AI068617, UM1-AI068613]; U.S. President's Emergency Plan for AIDS Relief (PEPFAR); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation; NIAID; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, UM1AI068613, UM1AI068619] Funding Source: NIH RePORTER	HPTN 071/PopART trial; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KS, SF(1), SF(2) and RH are supported by funding from the HPTN 071/PopART trial. OV and BH received no specific funding for their contribution to this work. HPTN 071 is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617, and UM1-AI068613, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Additional funding is provided by the International Initiative for Impact Evaluation (3ie) with support from the Bill & Melinda Gates Foundation, as well as by NIAID, the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), all part of NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIMH, NIDA, PEPFAR, 3ie, or the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2016, LANCET HIV, V3, pE212, DOI 10.1016/S2352-3018(16)00020-5; Barnabas RV, 2014, LANCET HIV, V1, pE68, DOI 10.1016/S2352-3018(14)70024-4; Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Cohen M, 2015, 8 INT AIDS SOC C HIV; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Iwuji C, 2016, 21 INT AIDS C DURB; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Koenig SP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002357; Kranzer K, 2012, HIV MED, V13, P132, DOI 10.1111/j.1468-1293.2011.00947.x; Labhardt ND, 2018, JAMA-J AM MED ASSOC, V319, P1103, DOI 10.1001/jama.2018.1818; Labhardt ND, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001768; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MacKellar DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150086; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; Maman D, 2016, TROP MED INT HEALTH, V21, P1442, DOI 10.1111/tmi.12772; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Rosen Sydney, 2016, PLoS Med, V13, pe1002050, DOI 10.1371/journal.pmed.1002050; Ruzagira E, 2017, TROP MED INT HEALTH, V22, P807, DOI 10.1111/tmi.12888; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tumwebaze H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051620; UNAIDS, 2016, 90 90 90 RIGHT TRACK; UNAIDS, 2014, UND FAST TRACK ACC A; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; van Zyl MA, 2015, AIDS CARE, V27, P921, DOI 10.1080/09540121.2015.1015483; Velen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155688; Vojnov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155256; WHO, 2015, CONSOLIDATED GUIDELI	41	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200737	10.1371/journal.pone.0200737	http://dx.doi.org/10.1371/journal.pone.0200737			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052637	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000440006600013
J	Lee, K; Kwon, H; Lee, B; Lee, G; Lee, JH; Park, YR; Shin, SY				Lee, Kyunghee; Kwon, Hyeyon; Lee, Byungtae; Lee, Guna; Lee, Jae Ho; Park, Yu Rang; Shin, Soo-Yong			Effect of self-monitoring on long-term patient engagement with mobile health applications	PLOS ONE			English	Article							SMARTPHONE APPLICATION; RECORDS; CARE; ACCEPTANCE; MEDICATION	Despite the growing adoption of the mobile health (mHealth) applications (apps), few studies address concerns with low retention rates. This study aimed to investigate how the usage patterns of mHealth app functions affect user retention. We collected individual usage logs for 1,439 users of single tethered personal health record app, which spanned an 18-months period from August 2011 to January 2013. The user logs contained timestamps whenever an individual uses each function, which enables us to identify the usage patterns based on the intensity of using a particular function in the app. We then estimated how these patterns were related to 1) the app usage over time (using the random effect model) and 2) the probability of stopping the use of the application (using the Cox proportional hazard model). The analyses suggested that the users utilize the app most at the time of the adoption and gradually reduce their usage over time. The average duration of use after starting the app was 25.62 weeks (SD: 18.41). The degree of the usage reduction, however, decreases as the self-monitoring function is more frequently used (coefficient = 0.002, P = 0.013); none of the other functions has this effect. Moreover, engaging with the self-monitoring function frequently (coefficient = -0.18, P = 0.003) and regularly (coefficient = 0.10, P = 0.001) significantly also reduces the probability of abandoning the application. Specifically, the estimated survival rate indicates that, after 40 weeks since the adoption, the probability of the regular users of self-monitoring to stay in use was about 80% while that of non-user was about 60%. This study provides the empirical evidence that sustained use of mHealth app is closely linked to the regular usage on self-monitoring function. The implications can be extended to the education of users and physicians to produce better outcomes as well as application development for effective user interfaces.	[Lee, Kyunghee] Wayne State Univ, Mike Ilitch Sch Business, Detroit, MI USA; [Kwon, Hyeyon; Lee, Jae Ho] Asan Med Ctr, Dept Biomed Informat, Seoul, South Korea; [Lee, Byungtae] KAIST Coll Business, Seoul, South Korea; [Lee, Guna] Ewha Womans Univ, Coll Hlth Sci, Div Nursing Sci, Seoul, South Korea; [Lee, Jae Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea; [Park, Yu Rang] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea; [Shin, Soo-Yong] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea	Wayne State University; University of Ulsan; Asan Medical Center; Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU)	Park, YR (corresponding author), Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea.; Shin, SY (corresponding author), Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea.	yurangpark@yuhs.ac; sy.shin@skku.edu	Lee, Byungtae/C-1585-2011; Lee, Kyunghee/E-5364-2018	Lee, Kyunghee/0000-0002-2192-3328; Park, Yu Rang/0000-0002-4210-2094	Institute for Information & communications Technology Promotion (IITP) project, Korea government (MSIT) [2017M3A9B6061832]; MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program [IITP-2017-01629]; Kyung Hee University [KHU-20161377]	Institute for Information & communications Technology Promotion (IITP) project, Korea government (MSIT)(Korean Government); MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program; Kyung Hee University	This work was supported by a grant from the Institute for Information & communications Technology Promotion (IITP) project, Korea government (MSIT) (No. 2017M3A9B6061832) (YRP); and by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2017-01629) supervised by the IITP (Institute for Information & communications Technology Promotion), by a grant from Kyung Hee University in 2016 (KHU-20161377) (SYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1997, DECISION SCI, V28, P557, DOI 10.1111/j.1540-5915.1997.tb01322.x; Alsos OA, 2012, INT J MED INFORM, V81, P12, DOI 10.1016/j.ijmedinf.2011.09.004; Ancker JS, 2011, J GEN INTERN MED, V26, P1117, DOI 10.1007/s11606-011-1749-y; Andersen ES, 2001, J EVOL ECON, V11, P143, DOI 10.1007/PL00003852; Archer N, 2011, J AM MED INFORM ASSN, V18, P515, DOI 10.1136/amiajnl-2011-000105; Asan Medical Center, KRH DES AG; Bourgeois FT, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.984; Byrnes N., 2014, MIT TECHNOLOGY REV; Carroll Jennifer K, 2017, J Med Internet Res, V19, pe125, DOI 10.2196/jmir.5604; Cho J, 2016, INT J MED INFORM, V87, P75, DOI 10.1016/j.ijmedinf.2015.12.016; Chrischilles EA, 2014, J AM MED INFORM ASSN, V21, P679, DOI 10.1136/amiajnl-2013-002284; Greenhalgh Trisha, 2010, BMJ, V341, pc5814, DOI 10.1136/bmj.c5814; Hamine Saee, 2015, J Med Internet Res, V17, pe52, DOI 10.2196/jmir.3951; Juarascio AS, 2015, INT J MED INFORM, V84, P808, DOI 10.1016/j.ijmedinf.2015.06.004; Kauffman RJ, 2012, INFORM TECHNOL MANAG, V13, P115, DOI 10.1007/s10799-011-0106-5; Kharrazi H, 2012, INT J MED INFORM, V81, P579, DOI 10.1016/j.ijmedinf.2012.04.007; Laing BY, 2014, ANN INTERN MED, V161, pS5, DOI 10.7326/M13-3005; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Nazi KM, 2010, J AM MED INFORM ASSN, V17, P203, DOI 10.1136/jamia.2009.000240; Pagliari C, 2007, BMJ-BRIT MED J, V335, P330, DOI 10.1136/bmj.39279.482963.AD; Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Ramanathan N, 2013, INT J MED INFORM, V82, pE38, DOI 10.1016/j.ijmedinf.2012.05.009; Serrano KJ, 2017, TRANSL BEHAV MED, V7, DOI 10.1007/s13142-017-0508-y; Seto E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1909; Stevens Victor J, 2008, J Med Internet Res, V10, pe1, DOI 10.2196/jmir.931; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025; Tobacman JK, 2004, PATIENT EDUC COUNS, V54, P27, DOI 10.1016/s0738-3991(03)00184-8; Ueckert F, 2003, INT J MED INFORM, V70, P99, DOI 10.1016/S1386-5056(03)00052-2; Vervloet M, 2012, INT J MED INFORM, V81, P594, DOI 10.1016/j.ijmedinf.2012.05.005; World Health Organization mHealth, 2011, GLOBAL OBSERVATORY E, V3, P1; Wu JH, 2007, INT J MED INFORM, V76, P66, DOI 10.1016/j.ijmedinf.2006.06.006	33	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201166	10.1371/journal.pone.0201166	http://dx.doi.org/10.1371/journal.pone.0201166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048546	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400057
J	Tricco, AC; Rios, P; Zarin, W; Cardoso, R; Diaz, S; Nincic, V; Mascarenhas, A; Jassemi, S; Straus, SE				Tricco, Andrea C.; Rios, Patricia; Zarin, Wasifa; Cardoso, Roberta; Diaz, Sanober; Nincic, Vera; Mascarenhas, Alekhya; Jassemi, Sabrina; Straus, Sharon E.			Prevention and management of unprofessional behaviour among adults in the workplace: A scoping review	PLOS ONE			English	Review							EDUCATIONAL WORKSHOP; FAMILY PHYSICIANS; MEDICAL-EDUCATION; SEXUAL-HARASSMENT; FACULTY MEMBERS; PROFESSIONALISM; INTERVENTION; STUDENTS; OUTCOMES; VIOLENCE	Background Unprofessional behaviour is a challenge in academic medicine. Given that faculty are role models for trainees, it is critical to identify strategies to manage these behaviours. A scoping review was conducted to identify interventions to prevent and manage unprofessional behaviour in any workplace or professional setting. Methods A search of 14 electronic databases was conducted in March 2016, reference lists of relevant systematic reviews were scanned, and grey literature was searched to identify relevant studies. Experimental and quasi-experimental studies that reported on interventions to prevent or manage unprofessional behaviours were included. Studies that reported impact on any outcome were eligible. Two reviewers independently screened articles and completed data abstraction. Qualitative analysis of the definitions of unprofessional behaviour was conducted. Data were charted to describe the study, participant, intervention and outcome characteristics. Results 12,482 citations were retrieved; 23 studies with 11,025 participants were included. The studies were 12 uncontrolled before and after studies, 6 controlled before and after studies, 2 cluster-randomised controlled trials (RCTs), 1 RCT, 1 non-randomised controlled trial and 1 quasi-RCT. Four constructs were identified in the definitions of unprofessional behaviour: verbal and/or non-verbal acts, repeated acts, power imbalance, and unwelcome behaviour. Interventions most commonly targeted individuals (22 studies, 95.7%) rather than organisations (4 studies, 17.4%). Most studies (21 studies, 91.3%) focused on increasing awareness. The most frequently targeted behaviour change was sexual harassment (4 of 7 studies). Discussion Several interventions appear promising in addressing unprofessional behaviour. Most of the studies included single component, in-person education sessions targeting individuals and increasing awareness of unprofessional behaviour. Fewer studies targeted the institutional culture or addressed behaviour change.	[Tricco, Andrea C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Tricco, Andrea C.; Rios, Patricia; Zarin, Wasifa; Cardoso, Roberta; Diaz, Sanober; Nincic, Vera; Mascarenhas, Alekhya; Jassemi, Sabrina; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada; [Straus, Sharon E.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Straus, SE (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada.; Straus, SE (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	sharon.straus@utoronto.ca	Tricco, Andrea/B-9920-2011	Tricco, Andrea/0000-0002-4114-8971	Tier 1 Canada Research Chair in Knowledge Translation; Mary Trimmer Chair in Geriatric Medicine (University of Toronto Department of Medicine); Tier 2 Canada Research Chair in Knowledge Synthesis; Department of Medicine, University of Toronto	Tier 1 Canada Research Chair in Knowledge Translation; Mary Trimmer Chair in Geriatric Medicine (University of Toronto Department of Medicine); Tier 2 Canada Research Chair in Knowledge Synthesis; Department of Medicine, University of Toronto(University of Toronto)	SES is funded by a Tier 1 Canada Research Chair in Knowledge Translation and the Mary Trimmer Chair in Geriatric Medicine (University of Toronto Department of Medicine); ACT is funded by a Tier 2 Canada Research Chair in Knowledge Synthesis. This project was funded by the Department of Medicine, University of Toronto to SES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.003; Anderson C, 2006, J PROF NURS, V22, P289, DOI 10.1016/j.profnurs.2006.07.007; [Anonymous], 2011, J Contin Educ Nurs, V42, P402, DOI 10.3928/00220124-20110823-17; [Anonymous], 2014, KNOWL TRANSL PROGR S; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Askew DA, 2012, AUST HEALTH REV, V36, P197, DOI 10.1071/AH11048; BARAK A, 1994, J COUNS DEV, V72, P595, DOI 10.1002/j.1556-6676.1994.tb01688.x; Bazelon E., 2016, NY TIMES; Bernabeo EC, 2013, ADV HEALTH SCI EDUC, V18, P463, DOI 10.1007/s10459-012-9384-x; Bingham SG., 2001, J APPL BEHAV SCI, V37, P125, DOI [10.1177/0021886301372001, DOI 10.1177/0021886301372001]; Boyle T., 2017, TORONTO STAR; Bryden P, 2010, ACAD MED, V85, P1025, DOI 10.1097/ACM.0b013e3181ce64ae; Canadian Agency for Drugs and Technologies in Health (CADTH), 2015, GREY MATT PRACT TOOL; Ceravolo DJ, 2012, J NURS MANAGE, V20, P599, DOI 10.1111/j.1365-2834.2012.01402.x; Chipps EM, 2012, J NURSES PROF DEV, V28, P94, DOI 10.1097/NND.0b013e31825514bb; Cote L, 2014, ACAD MED, V89, P934, DOI 10.1097/ACM.0000000000000246; Coverdill JE, 2016, ACAD MED, V91, pS31, DOI 10.1097/ACM.0000000000001358; Dahlby MA, 2014, J CONTIN EDUC NURS, V45, P344, DOI 10.3928/00220124-20140724-15; Dompierre J, 2008, EUR REV APPL PSYCHOL, V58, P275, DOI 10.1016/j.erap.2008.09.010; Dorsey JK, 2014, ACAD MED, V89, P1032, DOI 10.1097/ACM.0000000000000275; Embree JL, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/207306; Farley SS, 2014, CULTURE CRUELTY WHY; Farnan JM, 2013, J HOSP MED, V8, P386, DOI 10.1002/jhm.2056; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Frank E, 2006, BMJ-BRIT MED J, V333, P682, DOI 10.1136/bmj.38924.722037.7C; Frisbie SH, 2002, DISS ABSTR INT B, V62, P4837; Gale C, 2006, NZ MED J, V119, P1237; Ginsburg S, 2012, ACAD MED, V87, P1685, DOI 10.1097/ACM.0b013e3182736dfc; Ginsburg S, 2011, MED EDUC, V45, P362, DOI 10.1111/j.1365-2923.2010.03903.x; Goldberg CB, 2007, PSYCHOL WOMEN QUART, V31, P62, DOI 10.1111/j.1471-6402.2007.00331.x; Goldstein EA, 2006, ACAD MED, V81, P871, DOI 10.1097/01.ACM.0000238199.37217.68; Grudniewicz A, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0347-5; Heponiemi T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-19; Hodges Brian David, 2011, Med Teach, V33, P354, DOI 10.3109/0142159X.2011.577300; Hoel H., 2006, DESTRUCTIVE INTERPER; Hultman CS, 2012, J SURG RES, V177, P217, DOI 10.1016/j.jss.2012.06.019; Joanna Briggs Institute, 2015, J BRIGGS I REV MAN 2; Johnson SL, 2009, INT NURS REV, V56, P34, DOI 10.1111/j.1466-7657.2008.00679.x; Kastner M, 2016, J CLIN EPIDEMIOL, V73, P43, DOI 10.1016/j.jclinepi.2015.11.022; Keashly L, 2009, COMMUN SER, P339; Kennedy M., WORKPLACE BULLYING E; Lansbury L., 2014, DEV MEASUREMENT IMPL; Leisy HB, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0639-8; Leiter MP, 2011, J APPL PSYCHOL, V96, P1258, DOI 10.1037/a0024442; Leon-Perez JM, 2012, WORKPLACE BULLYING S, P230; Magin PJ, 2005, MED J AUSTRALIA, V183, P352, DOI 10.5694/j.1326-5377.2005.tb07082.x; Mallette Claire, 2011, Nurs Leadersh (Tor Ont), V24, P44; Manca D, 2008, CAN FAM PHYSICIAN, V54, P1434; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Meloni M, 2011, AUST HEALTH REV, V35, P92, DOI 10.1071/AH10896; Miedema B, 2012, ANN FAM MED, V10, P111, DOI 10.1370/afm.1341; Miedema B, 2010, CAN FAM PHYSICIAN, V56, pE101; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nielsen MB, 2012, WORK STRESS, V26, P309, DOI 10.1080/02678373.2012.734709; Osatuke K, 2009, J APPL BEHAV SCI, V45, P384, DOI 10.1177/0021886309335067; Park J, 2010, ACAD MED, V85, P134, DOI 10.1097/ACM.0b013e3181c47b25; Pate Judy, 2010, Employee Relations, V32, P171, DOI 10.1108/01425451011010113; PHILLIPS SP, 1993, NEW ENGL J MED, V329, P1936, DOI 10.1056/NEJM199312233292607; QSR International Pty Ltd, 2018, NVIVO; Quaintance JL, 2010, ACAD MED, V85, P118, DOI 10.1097/ACM.0b013e3181c42acd; Rouse LP, 2016, J WOMENS HEALTH, V25, P882, DOI 10.1089/jwh.2015.5577; Sanderson L., 2014, DISS ABSTR INT B, V74; Stagg SJ, 2011, J CONTIN EDUC NURS, V42, P395, DOI 10.3928/00220124-20110823-22; Stone PW, 2002, APPL NURS RES, V15, P197, DOI 10.1053/apnr.2002.34181; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P1, DOI 10.1002/9781118413555; Sun NZ, 2016, ACAD MED, V91, P401, DOI 10.1097/ACM.0000000000000949; Timm A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005140; Tricco AC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0116-4; Young ME, 2014, ADV HEALTH SCI EDUC, V19, P99, DOI 10.1007/s10459-013-9466-4; Zahid M A, 1999, Eur J Emerg Med, V6, P305	71	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201187	10.1371/journal.pone.0201187	http://dx.doi.org/10.1371/journal.pone.0201187			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048512	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400059
J	Fernandez-Rhodes, L; Malinowski, JR; Wang, YJ; Tao, R; Pankratz, N; Jeff, JM; Yoneyama, S; Carty, CL; Setiawan, VW; Le Marchand, L; Haiman, C; Corbett, S; Demerath, E; Heiss, G; Gross, M; Buzkova, P; Crawford, DC; Hunt, SC; Rao, DC; Schwander, K; Chakravarti, A; Gottesman, O; Abul-Husn, NS; Bottinger, EP; Loos, RJF; Raffel, LJ; Yao, J; Guo, XQ; Bielinski, SJ; Rotter, JI; Vaidya, D; Chen, YDI; Castaneda, SF; Daviglus, M; Kaplan, R; Talavera, GA; Ryckman, KK; Peters, U; Ambite, JL; Buyske, S; Hindorff, L; Kooperberg, C; Matise, T; Franceschini, N; North, KE				Fernandez-Rhodes, Lindsay; Malinowski, Jennifer R.; Wang, Yujie; Tao, Ran; Pankratz, Nathan; Jeff, Janina M.; Yoneyama, Sachiko; Carty, Cara L.; Setiawan, V. Wendy; Le Marchand, Loic; Haiman, Christopher; Corbett, Steven; Demerath, Ellen; Heiss, Gerardo; Gross, Myron; Buzkova, Petra; Crawford, Dana C.; Hunt, Steven C.; Rao, D. C.; Schwander, Karen; Chakravarti, Aravinda; Gottesman, Omri; Abul-Husn, Noura S.; Bottinger, Erwin P.; Loos, Ruth J. F.; Raffel, Leslie J.; Yao, Jie; Guo, Xiuqing; Bielinski, Suzette J.; Rotter, Jerome I.; Vaidya, Dhananjay; Chen, Yii-Der Ida; Castaneda, Sheila F.; Daviglus, Martha; Kaplan, Robert; Talavera, Gregory A.; Ryckman, Kelli K.; Peters, Ulrike; Ambite, Jose Luis; Buyske, Steven; Hindorff, Lucia; Kooperberg, Charles; Matise, Tara; Franceschini, Nora; North, Kari E.			The genetic underpinnings of variation in ages at menarche and natural menopause among women from the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) Study: A trans-ethnic meta-analysis	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; WIDE ASSOCIATION; GENOMEWIDE ASSOCIATION; ADOLESCENT GIRLS; COMPLEX TRAITS; DNA-REPAIR; BODY-MASS; LOCI; VARIANTS; HEALTH	Current knowledge of the genetic architecture of key reproductive events across the female life course is largely based on association studies of European descent women. The relevance of known loci for age at menarche (AAM) and age at natural menopause (ANM) in diverse populations remains unclear. We investigated 32 AAM and 14 ANM previously-identified loci and sought to identify novel loci in a trans-ethnic array-wide study of 196,483 SNPs on the MetaboChip (Illumina, Inc.). A total of 45,364 women of diverse ancestries (African, Hispanic/Latina, Asian American and American Indian/Alaskan Native) in the Population Architecture using Genomics and Epidemiology (PAGE) Study were included in cross-sectional analyses of AAM and ANM. Within each study we conducted a linear regression of SNP associations with self-reported or medical record-derived AAM or ANM (in years), adjusting for birth year, population stratification, and center/region, as appropriate, and meta-analyzed results across studies using multiple meta-analytic techniques. For both AAM and ANM, we observed more directionally consistent associations with the previously reported risk alleles than expected by chance (p-values(binomial)<= 0.01). Eight densely genotyped reproductive loci generalized significantly to at least one non-European population. We identified one trans-ethnic array-wide SNP association with AAM and two significant associations with ANM, which have not been described previously. Additionally, we observed evidence of independent secondary signals at three of six AAM trans-ethnic loci. Our findings support the transferability of reproductive trait loci discovered in European women to women of other race/ethnicities and indicate the presence of additional transethnic associations both at both novel and established loci. These findings suggest the benefit of including diverse populations in future studies of the genetic architecture of female growth and development.	[Fernandez-Rhodes, Lindsay; Wang, Yujie; Yoneyama, Sachiko; Heiss, Gerardo; Franceschini, Nora; North, Kari E.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Fernandez-Rhodes, Lindsay] Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC USA; [Malinowski, Jennifer R.] Write InSciTe LLC, Hebron, CT USA; [Tao, Ran] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Pankratz, Nathan; Gross, Myron] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Jeff, Janina M.] Illumina Inc, Genotyping Arrays Div, San Diego, CA USA; [Carty, Cara L.; Peters, Ulrike; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Setiawan, V. Wendy; Haiman, Christopher] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI USA; [Corbett, Steven] Kansas Hlth Inst, Topeka, KS USA; [Demerath, Ellen] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Buzkova, Petra] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Crawford, Dana C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Inst Computat Biol, Cleveland, OH 44106 USA; [Hunt, Steven C.] Weill Cornell Med Coll Qatar, Dept Genet Med, Doha, Qatar; [Rao, D. C.; Schwander, Karen] Washington Univ, Div Biostat, St Louis, MO USA; [Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Gottesman, Omri] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA; [Abul-Husn, Noura S.; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Raffel, Leslie J.] Univ Calif Irvine, Div Genet & Genom Med, Irvine, CA USA; [Yao, Jie; Guo, Xiuqing; Rotter, Jerome I.; Chen, Yii-Der Ida] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Yao, Jie; Guo, Xiuqing; Rotter, Jerome I.; Chen, Yii-Der Ida] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Bielinski, Suzette J.] Mayo Clin, Coll Med, Rochester, MN USA; [Vaidya, Dhananjay] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Castaneda, Sheila F.; Talavera, Gregory A.] San Diego State Univ, Grad Sch Publ Hlth, South Bay Latino Res Ctr, San Diego, CA 92182 USA; [Daviglus, Martha] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Kaplan, Robert] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Ryckman, Kelli K.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Ambite, Jose Luis] Univ Southern Calif, Inst Informat Sci, Marina Del Rey, CA USA; [Buyske, Steven] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Hindorff, Lucia] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; Illumina; Fred Hutchinson Cancer Center; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; Case Western Reserve University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Washington University (WUSTL); Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Mayo Clinic; Johns Hopkins University; California State University System; San Diego State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yeshiva University; Albert Einstein College of Medicine; University of Iowa; University of Iowa; University of Southern California; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Fernandez-Rhodes, L (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA.; Fernandez-Rhodes, L (corresponding author), Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC USA.	fernandez-rhodes@unc.edu	Loos, Ruth J F/Q-2862-2016; Castaneda, Sheila F./AAK-3025-2020; Loos, Ruth/GON-5877-2022; Crawford, Dana/O-5578-2019; Rotter, Jerome/AAY-6598-2021; Castaneda, Sheila/I-4132-2014; Bielinski, Suzette/A-2238-2009	Loos, Ruth J F/0000-0002-8532-5087; Crawford, Dana/0000-0002-6437-6248; Abul-Husn, Noura/0000-0002-5179-1944; Deloukas, Panos/0000-0001-9251-070X; Castaneda, Sheila/0000-0002-1975-0544; Fernandez-Rhodes, Lindsay/0000-0001-6985-423X; Demerath, Ellen/0000-0002-4585-4064; Malinowski, Jennifer/0000-0001-7500-2199; Ambite, Jose Luis/0000-0003-0087-080X; Buyske, Steven/0000-0001-8539-5416; Bielinski, Suzette/0000-0002-2905-5430; Ryckman, Kelli/0000-0002-9496-4147	Cardiovascular Disease Epidemiology Training Grant from the National Heart, Lung, and Blood Institute [T32HL007055]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [T32-HD007168]; Carolina Population Center [P2C-HD050924]; American Heart Association Go Red for Women Strategically Focused Research Network Grant [16SFRN27940007]; AHA [13GRNT16490017]; National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; NHGRI PAGE program [U01HG004803, U01HG004798, U01HG004802, U01HG004790]; Vanderbilt CTSA grant from NCATS/NIH [UL1 TR000445]; NHGRI [HG004802, HG007397]; NHGRI PAGE program (NHGRI ARRA supplement); National Cancer Institute [CA164973, R37CA54281, R01 CA 063464, P01CA33619, U01CA136792, U01CA98758]; National Heart, Lung, and Blood Institute; NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694, HL055673]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C]; National Heart, Lung, and Blood Institute (NHLBI) [HL055673, HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C, N01-HC65233, HL086694, N01-HC65234, N01-HC65235, N01-HC65236, N01-HC65237]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005]; Andrea and Charles Bronfman Philanthropies; National Heart, Lung, and Blood Institute (NHLBI); MESA Family [R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071258, R01HL071259]; National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences [UL1TR001881]; United States Environmental Protection Agency [RD831697]; Write InSciTe; Illumina Inc.;  [R01-DK089256];  [2R01HD057194];  [U01HG007416];  [R01DK101855];  [UL1RR025005];  [1R01DK101855-01];  [HHSN268201500003I];  [N01 - HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [UL1-TR-000040];  [UL1-TR-001079];  [UL1-TR-001420];  [UL1-TR-001881];  [DK063491];  [R01HL98077];  [N02-HL-64278];  [HL071205];  [P50 ES015915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, R01HD057194, P2CHD050924] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA071789, U01CA136792, R01CA063464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420, UL1TR000445, UL1TR000040, UL1TR001881, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR033176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071205, R01HL071251, R01HL087641, R01HL086694, T32HL007055, R01HL071258, R01HL071051, R01HL071250, R01HL071259] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004790, U01HG007376, U01HG004801, U01HG004803, U01HG007416, U01HG004798, U01HG004802, U01HG007417, U01HG007419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101855, R01DK089256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES015915] Funding Source: NIH RePORTER	Cardiovascular Disease Epidemiology Training Grant from the National Heart, Lung, and Blood Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Carolina Population Center; American Heart Association Go Red for Women Strategically Focused Research Network Grant(American Heart Association); AHA(American Heart Association); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI PAGE program; Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI PAGE program (NHGRI ARRA supplement); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Andrea and Charles Bronfman Philanthropies; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MESA Family; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); United States Environmental Protection Agency(United States Environmental Protection Agency); Write InSciTe; Illumina Inc.; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	LFR was supported by the Cardiovascular Disease Epidemiology Training Grant from the National Heart, Lung, and Blood Institute (T32HL007055), from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32-HD007168), and the Carolina Population Center (P2C-HD050924). SFC was supported by the American Heart Association Go Red for Women Strategically Focused Research Network Grant 16SFRN27940007. KEN was supported by R01-DK089256; 2R01HD057194; U01HG007416; R01DK101855, and AHA grant 13GRNT16490017. The Population Architecture Using Genomics and Epidemiology (PAGE) program was funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center), and their respective NHGRI ARRA supplements. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The complete list of PAGE members can be found at PAGE website (http://www.pagestudy.org). The data and materials included in this report result from a collaboration between the following studies: The "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" was funded through the NHGRI PAGE program (U01HG004798 and its NHGRI ARRA supplement). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which was supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. The Vanderbilt University Center for Human Genetics Research, Computational Genomics Core provided computational and/or analytical support for this work. The Multiethnic Cohort study (MEC) characterization of epidemiological architecture was funded through NHGRI (HG004802, and HG007397) and the NHGRI PAGE program (U01HG004802 and its NHGRI ARRA supplement). The MEC study was funded through the National Cancer Institute (CA164973, R37CA54281, R01 CA 063464, P01CA33619, U01CA136792, and U01CA98758). Funding support for the "Epidemiology of putative genetic variants: The Women's Health Initiative" study was provided through the NHGRI PAGE program (U01HG004790 and its NHGRI ARRA supplement). The WHI program was funded by the National Heart, Lung, and Blood Institute; NIH; and U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. Funding support for the Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) program was provided through the NHGRI PAGE program (U01HG004803 and its NHGRI ARRA supplement). The following studies contributed to this manuscript and were funded by the following agencies: The Atherosclerosis Risk in Communities Study (ARIC) was carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.; The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute (NHLBI), the Intramural Research Program of the National Institute on Aging (NIA), and an intra agency agreement between NIA and NHLBI (AG0005). The Hispanic Community Health Study/Study of Latinos (SOL) was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). Additional support was provided by 1R01DK101855-01 and 13GRNT16490017. The following Institutes/Centers/Offices contributed to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The Mount Sinai BioMe Biobank was supported by The Andrea and Charles Bronfman Philanthropies. The Hypertension Genetic Epidemiology Network (HyperGEN) study was supported by National Heart, Lung, and Blood Institute contracts HL086694 and HL055673. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01 - HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. MetaboChip genotyping data was supported in part by grants and contracts R01HL98077, N02-HL-64278, HL071205, UL1TR001881, DK063491, RD831697, and P50 ES015915. Additional support was provided by MESA Family, which is funded by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071258, R01HL071259, by the National Center for Research Resources, Grant UL1RR033176, and the National Center for Advancing Translational Sciences, Grant UL1TR001881. Although the research described in this manuscript has been funded in part by the United States Environmental Protection Agency through RD831697 to the University of Washington, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. Assistance with phenotype harmonization, SNP selection and annotation, data cleaning, data management, integration and dissemination, and general study coordination was provided by the PAGE Coordinating Center (U01HG004801-01 and its NHGRI ARRA supplement). The National Institutes of Mental Health also contributed support for the Coordinating Center. Contributions made by JRM to this manuscript were performed while as a graduate student at Vanderbilt University. Write InSciTe, LLC, did not play a role in the study design and data analysis of this work.; Write InSciTe provided support to JRM in the form of salary at the time of manuscript preparation and revision, but did not play any other role in the study design, data collection and analysis, decisions to publish or about the specific content of the manuscript. Analytic contributions made by JMJ to this manuscript were performed as a Postdoctoral Research Fellow at the Icahn School of Medicine at Mount Sinai. Illumina Inc. provided support in the form of salary for JMJ at the time of manuscript revisions, but Illumina did not play a role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. NHGRI collaborators (LH) assisted in the study design, analysis, and preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AT, 2014, INT J GYNECOL CANCER, V24, P384, DOI 10.1097/IGC.0000000000000075; Barban N, 2016, NAT GENET; Bodicoat DH, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3613; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Buttke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Canoy D, 2015, CIRCULATION, V131, P237, DOI 10.1161/CIRCULATIONAHA.114.010070; Carty CL, 2013, HUM REPROD, V28, P1695, DOI 10.1093/humrep/det071; Chen CTL, 2014, HUM MOL GENET, V23, P3327, DOI 10.1093/hmg/ddu041; Chen CT, 2011, HUM MOL GENET; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Cousminer DL, 2014, HUM MOL GENET, V23, P4452, DOI 10.1093/hmg/ddu150; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9842; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Day FR, 2017, NAT GENET, DOI 10.1530/ey.15.7.5; Demerath EW, 2013, HUM MOL GENET, V22, P3329, DOI 10.1093/hmg/ddt181; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fernandez-Rhodes L, 2017, HUM GENET; Fernandez-Rhodes L, 2013, AM J EPIDEMIOL, V178, P451, DOI 10.1093/aje/kws473; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; HE C, 2009, NAT GENET; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Henderson KD, 2008, AM J EPIDEMIOL, V167, P1287, DOI 10.1093/aje/kwn046; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Jenkins BWC, 2011, INT J ENV RES PUB HE, V8, P2491, DOI 10.3390/ijerph8062491; Kallen AN, 2011, CURR OPIN OBSTET GYN, V23, P258, DOI 10.1097/GCO.0b013e3283488a21; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Lin DY, 2014, AM J HUM GENET, V95, P675, DOI 10.1016/j.ajhg.2014.11.005; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Liu L, 2017, CAN J CARDIOL, V33, P443, DOI 10.1016/j.cjca.2016.10.029; Liu YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000420; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Malinowski J, 2014, BIOCOMPUT-PAC SYM, P376; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McDowell MA, 2007, J ADOLESCENT HEALTH, V40, P227, DOI 10.1016/j.jadohealth.2006.10.002; McGuinn LA, 2015, ENVIRON RES, V136, P381, DOI 10.1016/j.envres.2014.10.037; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nichols HB, 2006, AM J EPIDEMIOL, V164, P1003, DOI 10.1093/aje/kwj282; Ong KK, 2009, NAT GENET; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Perry JR, 2009, NAT GENET; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyun JA, 2014, MENOPAUSE, V21, P522, DOI 10.1097/GME.0b013e3182a433f7; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Shi JJ, 2016, AGE, V38, P513, DOI 10.1007/s11357-016-9939-5; Spencer KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055258; Steiner M, 2003, J AFFECT DISORDERS, V74, P67, DOI 10.1016/S0165-0327(02)00432-9; STOLK L, 2009, NAT GENET; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Tanikawa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063821; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang W, 2006, INT J OBESITY, V30, P1595, DOI 10.1038/sj.ijo.0803322; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zakharov S, 2015, EUR J HUM GENET, V23, P238, DOI 10.1038/ejhg.2014.78	64	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200486	10.1371/journal.pone.0200486	http://dx.doi.org/10.1371/journal.pone.0200486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044860	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500056
J	Tamayo, JCG; Olivella, M; Rios, S; Hoogstraat, M; Gonzalez, A; Mayol, E; Deupi, X; Campillo, M; Cordomi, A				Gomez Tamayo, Jose Carlos; Olivella, Mireia; Rios, Santiago; Hoogstraat, Marlous; Gonzalez, Angel; Mayol, Eduardo; Deupi, Xavier; Campillo, Mercedes; Cordomi, Arnau			GPCR-SAS: A web application for statistical analyses on G protein-coupled receptors sequences	PLOS ONE			English	Article							INFORMATION-SYSTEM; CRYSTAL-STRUCTURE; MOLECULAR SWITCHES; ALIGNMENT; FAMILY	G protein-coupled receptors (GPCRs) are one of the largest protein families in mammals. They mediate signal transduction across cell membranes and are important targets for the pharmaceutical industry. The G Protein-Coupled Receptors-Sequence Analysis and Statistics (GPCR-SAS) web application provides a set of tools to perform comparative analysis of sequence positions between receptors, based on a curated structural-informed multiple sequence alignment. The analysis tools include: (i) percentage of occurrence of an amino acid or motif and entropy at a position or range of positions, (ii) covariance of two positions, (iii) correlation between two amino acids in two positions (or two sequence motifs in two ranges of positions), and (iv) snake-plot representation for a specific receptor or for the consensus sequence of a group of selected receptors. The analysis of conservation of residues and motifs across transmembrane (TM) segments may guide the design of more selective ligands or help to rationalize activation mechanisms, among others. As an example, here we analyze the amino acids of the "transmission switch", that initiates receptor activation following ligand binding. The tool is freely accessible at http://lmc.uab.cat/gpcrsas/.	[Gomez Tamayo, Jose Carlos; Rios, Santiago; Gonzalez, Angel; Mayol, Eduardo; Campillo, Mercedes; Cordomi, Arnau] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Barcelona, Spain; [Olivella, Mireia] Univ Vic, Grp Rec Bioinformat & Estadist Med, Barcelona, Spain; [Hoogstraat, Marlous] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [Deupi, Xavier] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Deupi, Xavier] Paul Scherrer Inst, Condensed Matter Theory Grp, Villigen, Switzerland; [Gomez Tamayo, Jose Carlos] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Netherlands Cancer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Pompeu Fabra University	Cordomi, A (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Barcelona, Spain.	arnau.cordomi@uab.cat	Gonzalez, Angel/B-2492-2010; Rios, Santiago/GLU-4258-2022; Hoogstraat, Marlous/ABD-2968-2021; Deupi, Xavier/B-2424-2009; Gonzalez, Angel/AAU-5927-2020	Gonzalez, Angel/0000-0002-2284-8307; Rios, Santiago/0000-0003-2492-9247; Deupi, Xavier/0000-0003-4572-9316; Gonzalez, Angel/0000-0002-2284-8307; Hoogstraat, Marlous/0000-0002-4916-1177; Mayol, Eduardo/0000-0003-3120-8667	Spanish Ministerio de Economia y Competitividad; European Regional Development Fund [SAF2015-74627-JIN]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission)	This study was supported by the Spanish Ministerio de Economia y Competitividad and European Regional Development Fund (SAF2015-74627-JIN) (AC).	ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becu JM, 2013, METHOD ENZYMOL, V520, P49, DOI 10.1016/B978-0-12-391861-1.00003-4; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cvicek V, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004805; Davies MN, 2007, BIOINFORMATICS, V23, P3113, DOI 10.1093/bioinformatics/btm506; Deupi X, 2012, BIOCHEM SOC T, V40, P383, DOI 10.1042/BST20120001; Deville J, 2009, J MOL EVOL, V68, P475, DOI 10.1007/s00239-009-9214-9; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; George L, 2012, CURR PHARM DESIGN, V18, P175, DOI 10.2174/138161212799040529; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pele J, 2014, PROTEINS, V82, P2141, DOI 10.1002/prot.24570; Perez-Benito L, 2017, STRUCTURE, V25, P1153, DOI 10.1016/j.str.2017.05.021; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Spyridaki K, 2014, J BIOL CHEM, V289, P18966, DOI 10.1074/jbc.M113.544460; Sun Y, 2007, MOL BIOSYST, V3, P849, DOI 10.1039/b706343a; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199843	10.1371/journal.pone.0199843	http://dx.doi.org/10.1371/journal.pone.0199843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044824	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500020
J	He, JX; Yan, C; Holyoak, M; Wan, XR; Ren, GY; Hou, YF; Xie, Y; Zhang, ZB				He, Jinxing; Yan, Chuan; Holyoak, Marcel; Wan, Xinru; Ren, Guoyu; Hou, Yangfang; Xie, Yan; Zhang, Zhibin			Quantifying the effects of climate and anthropogenic change on regional species loss in China	PLOS ONE			English	Article							BIODIVERSITY LOSS; EXTINCTION RATES; GLOBAL CHANGE; HABITAT LOSS; BIRD; COMMUNITIES; IMPACTS; FRAGMENTATION; PRODUCTIVITY; ENVIRONMENT	Human-induced environmental and climate change are widely blamed for causing rapid global biodiversity loss, but direct estimation of the proportion of biodiversity lost at local or regional scales are still infrequent. This prevents us from quantifying the main and interactive effects of anthropogenic environmental and climate change on species loss. Here, we demonstrate that the estimated proportion of species loss of 252 key protected vertebrate species at a county level of China during the past half century was 27.2% for all taxa, 47.7% for mammals, 28.8% for amphibians and reptiles and 19.8% for birds. Both human population increase and species richness showed significant positive correlations with species loss of all taxa combined, mammals, birds, and amphibians and reptiles. Temperature increase was positively correlated with all-taxa and bird species loss. Precipitation increase was negatively correlated with species loss of birds. Human population change and species richness showed more significant interactions with the other correlates of species loss. High species richness regions had higher species loss under the drivers of human environmental and climate change than low-richness regions. Consequently, ongoing human environmental and climate changes are expected to perpetuate more negative effects on the survival of key vertebrate species, particularly in high-biodiversity regions.	[He, Jinxing; Yan, Chuan; Wan, Xinru; Xie, Yan; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [He, Jinxing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Holyoak, Marcel] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Ren, Guoyu] China Univ Geosci, Sch Environm Studies, Dept Atmospher Sci, Wuhan, Hubei, Peoples R China; [Ren, Guoyu] China Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Hou, Yangfang] Fudan Univ, Ctr Hist Geog Studies, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis; China University of Geosciences; China Meteorological Administration; Fudan University	Zhang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	zhangzb@ioz.ac.cn	Holyoak, Marcel/C-3475-2009; Ren, Guoyu/J-9953-2012; Yan, Chuan/ACA-0195-2022; xinru, wan/GPS-9515-2022	Holyoak, Marcel/0000-0001-9727-3627; Ren, Guoyu/0000-0002-9351-4179; xinru, wan/0000-0002-8189-2033; wan, xinru/0000-0002-1580-9692	National Key R&D Program of China [2017YFA0603300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB31000000]; scientific program of Biological Consequences of Global Change (BCGC) of International Society of Zoological Sciences (ISZS); International Union of Biological Sciences (IUBS); 13th Five-year Informatization Plan of Chinese Academy of Sciences [XXH13506]	National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); scientific program of Biological Consequences of Global Change (BCGC) of International Society of Zoological Sciences (ISZS); International Union of Biological Sciences (IUBS); 13th Five-year Informatization Plan of Chinese Academy of Sciences	Research was supported by National Key R&D Program of China (2017YFA0603300), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB31000000), the scientific program of Biological Consequences of Global Change (BCGC) of International Society of Zoological Sciences (ISZS) and International Union of Biological Sciences (IUBS), and the 13th Five-year Informatization Plan of Chinese Academy of Sciences (XXH13506).	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Boucher-Lalonde V, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2695; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buchmann CM, 2013, ECOL INFORM, V14, P90, DOI 10.1016/j.ecoinf.2012.11.015; Cagnolo L, 2009, CONSERV BIOL, V23, P1167, DOI 10.1111/j.1523-1739.2009.01214.x; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; China NGCo, CART NAT BAS GEOGR I; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Ducatez S, 2017, CONSERV LETT, V10, P186, DOI 10.1111/conl.12258; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Gu Lei, 2015, Biodiversity Science, V23, P583; He FL, 2013, ECOLOGY, V94, P1905, DOI 10.1890/12-1795.1; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Holyoak M, 2016, INTEGR ZOOL, V11, P40, DOI 10.1111/1749-4877.12167; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Keinath DA, 2017, GLOBAL ECOL BIOGEOGR, V26, P115, DOI 10.1111/geb.12509; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKee J, 2013, HUM ECOL, V41, P773, DOI 10.1007/s10745-013-9586-8; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2001, ANIM CONSERV, V4, P45, DOI 10.1017/S1367943001001056; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sciences TBCoCAo, 2015, CAT LIF CHIN 2015 AN; SFA, 2009, INV RES KEY TERR WIL; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245; Wu Qian-qian, 2017, Shengtaixue Zazhi, V36, P2605, DOI 10.13292/j.1000-4890.201709.012; Wu RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103783; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yan C, 2016, GLOBAL ECOL BIOGEOGR, V25, P455, DOI 10.1111/geb.12428; Zhang Lvbing, 2014, Biodiversity Science, V22, P696, DOI 10.3724/SP.J.1003.2014.14225	55	12	12	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199735	10.1371/journal.pone.0199735	http://dx.doi.org/10.1371/journal.pone.0199735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044787	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500018
J	Hosokawa, R; Katsura, T				Hosokawa, Rikuya; Katsura, Toshiki			Association between mobile technology use and child adjustment in early elementary school age	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE SDQ; YOUNG-CHILDREN; COMPUTER USE; PRESCHOOL-CHILDREN; MEDIA VIOLENCE; SOCIOECONOMIC-STATUS; AGGRESSIVE-BEHAVIOR; SLEEP PROBLEMS; CHRONIC STRESS; MENTAL-HEALTH	The time that children spend using digital devices is increasing rapidly with the development of new portable and instantly accessible technology, such as smartphones and digital tablets. Although prior studies have examined the effects of traditional media on children's development, there is limited evidence on the impact of mobile device use. The current study aimed to clarify the link between mobile device use and child adjustment. The sample included 1,642 children aged 6 in first grade at elementary schools in Japan. Parents completed a self-report questionnaire regarding their children's use of mobile devices and emotional/behavioral adjustment. We performed inverse probability of treatment weighted (IPTW) logistic regression to compute odds ratios (OR) for emotional/behavioral problems according to mobile device use. The values for IPTW analysis were computed based on variables assessing sociodemographics and child characteristics. Among the participants, 230 (14.0%) were regular users (60 minutes or more on a typical day) and 1,412 (86.0%) non-regular users (under 60 minutes on a typical day). Relative to non-regular use, regular use of mobile devices was significantly linked to conduct problems (IPTW-OR: 1.77, 95% CI: [1.03-3.04], p < .05) and hyperactivity/inattention (IPTW-OR: 1.82, 95% CI: [1.15-2.87], p < .01). Based on these results, routine and frequent use of mobile devices appear to be associated with behavioral problems in childhood.	[Hosokawa, Rikuya] Nagoya City Univ, Sch Nursing, Nagoya, Aichi, Japan; [Hosokawa, Rikuya; Katsura, Toshiki] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Nagoya City University; Kyoto University	Hosokawa, R (corresponding author), Nagoya City Univ, Sch Nursing, Nagoya, Aichi, Japan.; Hosokawa, R (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	rikuya@med.nagoya-cu.ac.jp	Hernández, Susana Franco/B-7943-2019	Hernández, Susana Franco/0000-0002-3872-8035; Hosokawa, Rikuya/0000-0003-4239-8494	JSPS KAKENHI Grant [26893224]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26893224 and JSPS KAKENHI Grant Number 16K20858. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhusen V, 2005, DEV PSYCHOL, V41, P99, DOI 10.1037/0012-1649.41.1.99; Amichai-Hamburger Y, 2003, COMPUT HUM BEHAV, V19, P71, DOI 10.1016/S0747-5632(02)00014-6; Anderson C.A., 2007, VIOLENT VIDEO GAME E, DOI DOI 10.1111/j.1469-8986.2009.00925.x; Anderson CA, 2003, PSYCHOL SCI, P81, DOI 10.1111/j.1529-1006.2003.pspi_1433.x; Anderson D., 2011, NEW DIGITAL AM FAMIL; [Anonymous], 1997, WHAT MONEY CANT BUY; Boe T, 2012, J PSYCHOSOM RES, V73, P430, DOI 10.1016/j.jpsychores.2012.09.008; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bremer J, 2005, CHILD ADOL PSYCH CL, V14, P405, DOI 10.1016/j.chc.2005.02.003; Bushman BJ, 2009, PSYCHOL SCI, V20, P273, DOI 10.1111/j.1467-9280.2009.02287.x; CAMPBELL SB, 1994, J ABNORM CHILD PSYCH, V22, P147, DOI 10.1007/BF02167897; Certain LK, 2002, PEDIATRICS, V109, P634, DOI 10.1542/peds.109.4.634; COIE JD, 1988, CHILD DEV, V59, P815, DOI 10.1111/j.1467-8624.1988.tb03237.x; Cole PM, 2003, DEV PSYCHOPATHOL, V15, P1, DOI 10.1017/S0954579403000014; COLWELL J, 1995, J COMMUNITY APPL SOC, V5, P195, DOI 10.1002/casp.2450050308; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Conger RD, 2002, J MARRIAGE FAM, V64, P361, DOI 10.1111/j.1741-3737.2002.00361.x; de Jong E, 2013, INT J OBESITY, V37, P47, DOI 10.1038/ijo.2011.244; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; Dietz TL, 1998, SEX ROLES, V38, P425, DOI 10.1023/A:1018709905920; Dworetzky JP, 1996, INTRO CHILD DEV; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; El-Sheikh M, 2013, HEALTH PSYCHOL, V32, P849, DOI 10.1037/a0030413; Evans GW, 2013, CHILD DEV PERSPECT, V7, P43, DOI 10.1111/cdep.12013; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Ferguson CJ, 2014, J YOUTH ADOLESCENCE, V43, P127, DOI 10.1007/s10964-013-9986-5; Fiorini M, 2010, ECON EDUC REV, V29, P55, DOI 10.1016/j.econedurev.2009.06.006; Ginsburg KR, 2007, PEDIATRICS, V119, P182, DOI 10.1542/peds.2006-2697; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Grant KE, 2003, PSYCHOL BULL, V129, P447, DOI 10.1037/0033-2909.129.3.447; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Griffiths M., 1997, ED CHILD PSYCHOL, V14, P25; Guralnick MJ, 1999, MENT RETARD DEV D R, V5, P21; Hart B, 2000, TOP EARLY CHILD SPEC, V20, P28, DOI 10.1177/027112140002000105; Higuchi S, 2005, J SLEEP RES, V14, P267, DOI 10.1111/j.1365-2869.2005.00463.x; Hosokawa R, 2017, CHILD ADOL PSYCH MEN, V11, DOI 10.1186/s13034-017-0206-z; HUESMANN LR, 1983, J PERS SOC PSYCHOL, V44, P899, DOI 10.1037/0022-3514.44.5.899; Huston AC, 1999, DEV PSYCHOL, V35, P912, DOI 10.1037/0012-1649.35.4.912; Jackson L. A., 2008, CHANGING PORTRAYAL A, P377; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kubota T, 2002, NEUROSCI RES, V42, P115, DOI 10.1016/S0168-0102(01)00310-8; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Li XM, 2006, MERRILL PALMER QUART, V52, P239, DOI 10.1353/mpq.2006.0010; Linver MR, 2002, DEV PSYCHOL, V38, P719, DOI 10.1037//0012-1649.38.5.719; Manganello JA, 2009, ARCH PEDIAT ADOL MED, V163, P1037, DOI 10.1001/archpediatrics.2009.193; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; McClelland MM, 2003, EARLY CHILD RES Q, V18, P206, DOI 10.1016/S0885-2006(03)00026-7; Milan S, 2007, J FAM PSYCHOL, V21, P20, DOI 10.1037/0893-3200.21.1.20; Miller GE, 2013, CHILD DEV PERSPECT, V7, P67, DOI 10.1111/cdep.12021; National Institute for Educational Policy Research, 2014, ZENK GAK GAK JYOK CY; NICHOLS LM, 1992, J EDUC COMPUT RES, V8, P407, DOI 10.2190/6UNE-05L9-KCRH-D1NQ; Nielsen Company, 2009, TEL INT MOB US US A2; Phillips CA, 1995, J ADOLESCENCE, V18, P687, DOI 10.1006/jado.1995.1049; Plowman L, 2010, CHILD SOC, V24, P63, DOI 10.1111/j.1099-0860.2008.00180.x; Radesky JS, 2016, JAMA PEDIATR, V170, P397, DOI 10.1001/jamapediatrics.2015.4260; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Rikkers W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3058-1; Roberts D. F., 1999, KIDS MEDIA NEW MILLE; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROCHELEAU B, 1995, J EDUC COMPUT RES, V12, P1, DOI 10.2190/MHUR-4FC9-B187-T8H4; Schmidt ME, 2008, CHILD DEV, V79, P1137, DOI 10.1111/j.1467-8624.2008.01180.x; Schmidt ME, 2009, PEDIATRICS, V123, pe370, DOI 10.1542/peds.2008-3221; Shimpi PM, 2007, J CHILD LANG, V34, P845, DOI 10.1017/S0305000907008112; Strasburger VC, 2013, PEDIATRICS, V132, P958, DOI 10.1542/peds.2013-2656; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563; Stright AD, 2008, CHILD DEV, V79, P186, DOI 10.1111/j.1467-8624.2007.01119.x; Subrahmanyam K, 2000, FUTURE CHILD, V10, P123, DOI 10.2307/1602692; Thompson AL, 2013, PEDIATRICS, V131, pE390, DOI 10.1542/peds.2012-1224; Tomopoulos S, 2007, AMBUL PEDIATR, V7, P18, DOI 10.1016/j.ambp.2006.10.005; Valkenburg PM, 2013, J COMMUN, V63, P221, DOI 10.1111/jcom.12024; Van Cauter E, 1999, ANN NY ACAD SCI, V896, P254, DOI 10.1111/j.1749-6632.1999.tb08120.x; Vandewater EA, 2006, PEDIATRICS, V117, pE181, DOI 10.1542/peds.2005-0812; Vandewater EA, 2007, PEDIATRICS, V119, pE1006, DOI 10.1542/peds.2006-1804; Vandewater EA, 2009, AM BEHAV SCI, V52, P1152, DOI 10.1177/0002764209331539; Watson AC, 1999, DEV PSYCHOL, V35, P386, DOI 10.1037/0012-1649.35.2.386; Ybarra ML, 2008, PEDIATRICS, V122, P929, DOI 10.1542/peds.2007-3377; Zillmann D, 1997, PERS INDIV DIFFER, V22, P613, DOI 10.1016/S0191-8869(96)00245-0; Zimmerman FJ, 2005, ARCH PEDIAT ADOL MED, V159, P619, DOI 10.1001/archpedi.159.7.619	81	37	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199959	10.1371/journal.pone.0199959	http://dx.doi.org/10.1371/journal.pone.0199959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044819	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500025
J	Pan, P; Jin, WF; Li, XH; Chen, Y; Jiang, JH; Wan, HT; Yu, DJ				Pan, Ping; Jin, Weifeng; Li, Xiaohong; Chen, Yi; Jiang, Jiahui; Wan, Haitong; Yu, Daojun			Optimization of multiplex quantitative polymerase chain reaction based on response surface methodology and an artificial neural network-genetic algorithm approach	PLOS ONE			English	Article							MINIMUM INFORMATION; EXPERIMENTAL-DESIGN; PCR; EXTRACTION; QUANTIFICATION; AMPLIFICATION; DIAGNOSIS; MODELS; VIRUS; RSM	Multiplex quantitative polymerase chain reaction (qPCR) has found an increasing range of applications. The construction of a reliable and dynamic mathematical model for multiplex qPCR that analyzes the effects of interactions between variables is therefore especially important. This work aimed to analyze the effects of interactions between variables through response surface method (RSM) for uni- and multiplex qPCR, and further optimize the parameters by constructing two mathematical models via RSM and back-propagation neural network-genetic algorithm (BPNN-GA) respectively. The statistical analysis showed that Mg2+ was the most important factor for both uni- and multiplex qPCR. Dynamic models of uni- and multiplex qPCR could be constructed using both RSM and BPNN-GA methods. But RSM was better than BPNN-GA on prediction performance in terms of the mean absolute error (MAE), the mean square error (MSE) and the Coefficient of Determination (R-2). Ultimately, optimal parameters of uni- and multiplex qPCR were determined by RSM.	[Pan, Ping; Chen, Yi; Jiang, Jiahui; Yu, Daojun] Zhejiang Chinese Med Univ, Hangzhou Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Jin, Weifeng; Li, Xiaohong] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Chen, Yi] Zhejiang Hosp, Hangzhou, Zhejiang, Peoples R China; [Wan, Haitong] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yu, Daojun] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Clin Lab, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang University	Yu, DJ (corresponding author), Zhejiang Chinese Med Univ, Hangzhou Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China.; Yu, DJ (corresponding author), Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Clin Lab, Sch Med, Hangzhou, Zhejiang, Peoples R China.	yudaojun98@163.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; wan, hai/GSM-9077-2022; jin, weifeng/C-7360-2017		Natural Science Foundation of Zhejiang Province [LY17H190001]; Health and Family Planning Commission of Zhejiang Province [2015ZDA025]; Health and Family Planning Commission of Hangzhou Manicipality [2018ZD001]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Health and Family Planning Commission of Zhejiang Province; Health and Family Planning Commission of Hangzhou Manicipality	This work was supported by Natural Science Foundation of Zhejiang Province (LY17H190001) grant to DJY, http://www.zjnsf.gov.cn/, Health and Family Planning Commission of Zhejiang Province (2015ZDA025) grant to DJY, http://www.zjwjw.gov.cn/, and Health and Family Planning Commission of Hangzhou Manicipality grant (2018ZD001) to DJY, http://wsjsw.hangzhou.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01526; Ayer T, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/832509; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buzaev Igor Vyacheslavovich, 2016, Chronic Dis Transl Med, V2, P166, DOI 10.1016/j.cdtm.2016.09.007; Chavali S, 2005, BIOINFORMATICS, V21, P3918, DOI 10.1093/bioinformatics/bti633; Chen Y, 2016, J MED MICROBIOL, V65, P590, DOI 10.1099/jmm.0.000266; Coelho S F., 2016, BIOCH ENG J, V109, P305; Denipitiya DTH, 2016, BIOLOGICALS, V44, P497, DOI 10.1016/j.biologicals.2016.09.004; Dil EA, 2016, ULTRASON SONOCHEM, V33, P129, DOI 10.1016/j.ultsonch.2016.04.031; Dubljanin E, 2014, BRIT J DERMATOL, V171, P1593, DOI 10.1111/bjd.13168; Ebrahimzadeh H, 2012, TALANTA, V97, P211, DOI 10.1016/j.talanta.2012.04.019; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Giordano PC, 2010, BIORESOURCE TECHNOL, V101, P7537, DOI 10.1016/j.biortech.2010.05.001; Hallenbeck PC, 2015, BIORESOURCE TECHNOL, V184, P161, DOI 10.1016/j.biortech.2014.09.022; Hamouda Hamed I, 2015, Biotechnol Res Int, V2015, P905792, DOI 10.1155/2015/905792; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Hwang SH, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1296-5; Jartti T, 2013, PAEDIATR RESPIR REV, V14, P38, DOI 10.1016/j.prrv.2012.04.002; Johnson G, 2014, METHODS MOL BIOL, V1160, P5, DOI 10.1007/978-1-4939-0733-5_2; Kim JY, 2014, J SCI FOOD AGR, V94, P2807, DOI 10.1002/jsfa.6699; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Li Y, 2010, APPL BIOCHEM BIOTECH, V160, P269, DOI 10.1007/s12010-009-8581-4; Li YQ, 2015, EUR J PHARM BIOPHARM, V94, P170, DOI 10.1016/j.ejpb.2015.04.028; Lim CW, 2015, BIOTECHNOL PROGR, V31, P35, DOI 10.1002/btpr.2009; Mohamed MS, 2013, SCI WORLD J, DOI 10.1155/2013/948940; Noda AA, 2013, ADV CLIN EXP MED, V22, P639; Pan HY, 2017, J SEP SCI, V40, P2062, DOI 10.1002/jssc.201601259; Qu WB, 2009, BIOINFORMATICS, V25, P276, DOI 10.1093/bioinformatics/btn614; Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Sarve A, 2015, ULTRASON SONOCHEM, V26, P218, DOI 10.1016/j.ultsonch.2015.01.013; Schoske R, 2003, ANAL BIOANAL CHEM, V375, P333, DOI 10.1007/s00216-002-1683-2; Shanmugaprakash M, 2013, BIORESOURCE TECHNOL, V148, P550, DOI 10.1016/j.biortech.2013.08.149; Taylor MJ, 2012, J IMMUNOL METHODS, V382, P220, DOI 10.1016/j.jim.2012.06.004; Vremera T., 2011, ARCH MICROBIOL IMMUN, V70, P69; Wadle S, 2016, Biomol Detect Quantif, V7, P1, DOI 10.1016/j.bdq.2015.12.002	37	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200962	10.1371/journal.pone.0200962	http://dx.doi.org/10.1371/journal.pone.0200962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044832	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500073
J	Sairanen, E; Lappalainen, P; Hiltunen, A				Sairanen, Essi; Lappalainen, Paivi; Hiltunen, Arto			Psychological inflexibility explains distress in parents whose children have chronic conditions	PLOS ONE			English	Article							COMMITMENT THERAPY; MINDFULNESS QUESTIONNAIRE; CONSTRUCT-VALIDITY; ACCEPTANCE; BURNOUT; STRESS; FLEXIBILITY; DEPRESSION; ANXIETY; DISABILITIES	Experiential avoidance, cognitive defusion, and mindfulness have all been associated with psychological disorders and well-being. This study investigates whether they predict psychological distress, i.e., symptoms of burnout, depression, stress and anxiety, in parents of children with chronic conditions. We hypothesized that these factors would exhibit a large degree of common variance, and that when compared to mindfulness and defusion, experiential avoidance on its own would predict a larger proportion of unique variance. 75 parents of children with chronic conditions having burnout symptoms who participated in an intervention study completed measures of burnout, stress, anxiety, depression, experiential avoidance, cognitive defusion, and mindfulness at the beginning of the intervention study (baseline). We ran several regression analyses to assess the predictive ability of these different constructs. Experiential avoidance on its own accounted for 28-48% of the variance in different psychological symptoms. Cognitive defusion and mindfulness did not make a significant contribution to explaining burnout, stress and anxiety, but cognitive defusion contributed to explaining depression. The results confirmed our hypothesis, supporting research on the importance of psychological flexibility as a central factor in understanding the occurrence of psychological distress.	[Sairanen, Essi; Hiltunen, Arto] Karlstad Univ, Dept Social & Psychol Studies, Karlstad, Sweden; [Lappalainen, Paivi] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	Karlstad University; University of Jyvaskyla	Sairanen, E (corresponding author), Karlstad Univ, Dept Social & Psychol Studies, Karlstad, Sweden.	essi.sairanen@kau.se		Hiltunen, Arto/0000-0001-7453-5399	County Council Varmland, Sweden	County Council Varmland, Sweden	The research was funded by County Council Varmland, Sweden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; Alfonsson S, 2017, J PSYCHIATR MENT HLT, V24, P154, DOI 10.1111/jpm.12363; Anclair M, 2009, J PEDIATR ONCOL NURS, V26, P68, DOI 10.1177/1043454208323912; APPELS A, 1991, BEHAV MED, V17, P53, DOI 10.1080/08964289.1991.9935158; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Boman KK, 2004, J PEDIATR-US, V145, P373, DOI 10.1016/j.jpeds.2004.05.043; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Burke K, 2015, CHILD PSYCHIAT HUM D, V46, P548, DOI 10.1007/s10578-014-0495-x; Burke K, 2014, FAM SYST HEALTH, V32, P122, DOI 10.1037/fsh0000012; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chong YY, 2017, J CHILD FAM STUD, V26, P2610, DOI 10.1007/s10826-017-0757-x; Evans T, 2012, INFANT BEHAV DEV, V35, P1, DOI 10.1016/j.infbeh.2011.10.002; Forman EM, 2007, BEHAV RES THER, V45, P2372, DOI 10.1016/j.brat.2007.04.004; Gifford EV, 2004, BEHAV THER, V35, P689, DOI 10.1016/S0005-7894(04)80015-7; Gillanders DT, 2014, BEHAV THER, V45, P83, DOI 10.1016/j.beth.2013.09.001; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Hastings RP, 2004, J CHILD PSYCHOL PSYC, V45, P1338, DOI 10.1111/j.1469-7610.2004.00357.x; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Kashdan TB, 2006, BEHAV RES THER, V44, P1301, DOI 10.1016/j.brat.2005.10.003; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Lilja Josefine L., 2011, Cognitive Behaviour Therapy, V40, P291, DOI 10.1080/16506073.2011.580367; Lindstrom C, 2010, ACTA PAEDIATR, V99, P427, DOI 10.1111/j.1651-2227.2009.01586.x; Lloyd T, 2008, J INTELL DISABIL RES, V52, P37, DOI 10.1111/j.1365-2788.2007.00974.x; Lundgren T, 2008, J BEHAV MED, V31, P225, DOI 10.1007/s10865-008-9151-x; Lundgren T, 2017, COGN BEHAV THERAPY, V46, P315, DOI 10.1080/16506073.2016.1250228; Lundgren-Nilsson A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; MELAMED S, 1992, BEHAV MED, V18, P53, DOI 10.1080/08964289.1992.9935172; Sairanen E., 2017, PUBLIC HEALTH NUTR, P1; Sairanen E, 2015, BEHAV MODIF; Shirom A., 2006, INT J STRESS MANAGE, V13, P176, DOI [10.1037/1072-5245.13.2.176, DOI 10.1037/1072-5245.13.2.176]; Singer GHS, 2007, MENT RETARD DEV D R, V13, P357, DOI 10.1002/mrdd.20175; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Wallace D., 2016, CLIN PRACT PEDIAT PS, V4, P405, DOI [10.1037/cpp0000160, DOI 10.1037/CPP0000160]; Wallace DP, 2015, J PAIN, V16, P235, DOI 10.1016/j.jpain.2014.11.013; Weiss JA, 2012, AUTISM, V16, P261, DOI 10.1177/1362361311422708; Whalen CK, 2011, J FAM PSYCHOL, V25, P402, DOI 10.1037/a0023473; Whittingham K, 2013, CHILD CARE HLTH DEV, V39, P366, DOI 10.1111/j.1365-2214.2012.01396.x	42	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201155	10.1371/journal.pone.0201155	http://dx.doi.org/10.1371/journal.pone.0201155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044852	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500085
J	Kalman, RS; Stawarz, A; Nunes, D; Zhang, D; Dela Cruz, MA; Mohanty, A; Subramanian, H; Backman, V; Roy, HK				Kalman, Richard S.; Stawarz, Andrew; Nunes, David; Zhang, Di; Dela Cruz, Mart A.; Mohanty, Arpan; Subramanian, Hariharan; Backman, Vadim; Roy, Hemant K.			Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study (vol 13, e0197427, 2018)	PLOS ONE			English	Correction													Backman, Vadim/B-6689-2009; Roy, Hemant/AAC-9096-2020	Mohanty, Arpan/0000-0002-8408-8075	NATIONAL CANCER INSTITUTE [R33CA225323, R01CA165309] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA165309, R33 CA225323] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Kalman R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197427	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201500	10.1371/journal.pone.0201500	http://dx.doi.org/10.1371/journal.pone.0201500			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040862	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200039
J	Pospisilova, P; Grange, PA; Grillova, L; Mikalova, L; Martinet, P; Janier, M; Vermersch, A; Benhaddou, N; Del Giudice, P; Alcaraz, I; Truchetet, F; Dupin, N; Smajs, D				Pospisilova, Petra; Grange, Philippe Alain; Grillova, Linda; Mikalova, Lenka; Martinet, Pervenche; Janier, Michel; Vermersch, Annie; Benhaddou, Nadjet; Del Giudice, Pascal; Alcaraz, Isabelle; Truchetet, Francois; Dupin, Nicolas; Smajs, David			Multi-locus sequence typing of Treponema pallidum subsp pallidum present in clinical samples from France: Infecting treponemes are genetically diverse and belong to 18 allelic profiles	PLOS ONE			English	Article							SYPHILIS-CAUSING STRAINS; MACROLIDE RESISTANCE; IDENTIFIED GENOTYPES; GENE; PREVALENCE; MUTATIONS; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; SPIROCHETE	Treponema pallidum subsp. pallidum, the causative agent of sexually transmitted syphilis, detected in clinical samples from France, was subjected to molecular typing using the recently developed Multilocus Sequence Typing system. The samples (n = 133) used in this study were collected from 2010-2016 from patients with diagnosed primary or secondary syphilis attending outpatient centers or hospitals in several locations in France. Altogether, 18 different allelic profiles were found among the fully typed samples (n = 112). There were five allelic variants identified for TP0136, 12 for TP0548, and eight for TP0705. Out of the identified alleles, one, seven, and three novel alleles were identified in TP0136, TP0548, and TP0705, respectively. Partial allelic profiles were obtained from 6 samples. The majority of samples (n = 110) belonged to the SS14-like cluster of TPA isolates while 7 clustered with Nichols-like isolates. Patients infected with Nichols-like samples were more often older (p = 0.041) and more often diagnosed with secondary syphilis (p = 0.033) compared to patients infected with SS14-like samples. In addition, macrolide resistance caused by the A2058G mutation was found to be associated with allelic profile 1.3.1 or with strains belonging to the 1.3.1 lineage (p<0.001). The genetic diversity among TPA strains infecting the European population was surprisingly high, which suggests that additional studies are needed to reveal the full genetic diversity of TPA pathogens infecting humans.	[Pospisilova, Petra; Grillova, Linda; Mikalova, Lenka; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Grange, Philippe Alain; Benhaddou, Nadjet; Dupin, Nicolas] Univ Sorbonne Paris Descartes, Fac Med, Inst Cochin Equipe Batteux U1016, Lab Dermatol,CNR Syphilis, Paris, France; [Martinet, Pervenche] Serv Prevent Sante Conseil Dept Bouches Rhone, Marseille, France; [Janier, Michel] Hop St Louis, AP HP, Ctr MST, Paris, France; [Vermersch, Annie] Hop Jean Bernard, Serv Dermatol, Valenciennes, France; [Benhaddou, Nadjet] Grp Hosp Paris Ctr Cochin, Serv Bacteriol, Hotel Dieu Broca, Paris, France; [Del Giudice, Pascal] Ctr Hosp Inter Reg, Serv Dermatol Infectiol, Frejus, France; [Alcaraz, Isabelle] Hop Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Truchetet, Francois] Hop Belair, Serv Dermatol, Metz, France; [Dupin, Nicolas] Hop Cochin, AP HP, Serv Dermatol Venereol, Pavillon Tarnier, Paris, France	Masaryk University Brno; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.munu.cz	Grillova, Linda/AAA-8557-2020; Mikalová, Lenka/AAM-1068-2020; Grange, Philippe/W-3442-2017	Grillova, Linda/0000-0003-2371-3161; Pastekova, Lenka/0000-0003-4266-9952; Grange, Philippe/0000-0001-8151-748X	Grant Agency of the Czech Republic [GA17-25455S]; Ministry of Health of the Czech Republic [17-31333A]; Agence Nationale de Sante Publique (ANSP); Faculty of Medicine, Masaryk University	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Agence Nationale de Sante Publique (ANSP)(French National Research Agency (ANR)); Faculty of Medicine, Masaryk University	This work was supported by the Grant Agency of the Czech Republic (GA17-25455S) and by the Ministry of Health of the Czech Republic (17-31333A) to DS, by the Agence Nationale de Sante Publique (ANSP) to ND, NB and PAG and by funds from the Faculty of Medicine, Masaryk University to junior researcher PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.245; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Dai T, 2012, J CLIN MICROBIOL, V50, P3674, DOI 10.1128/JCM.01195-12; Flasarova M., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P105; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Florindo C, 2008, J CLIN MICROBIOL, V46, P3802, DOI 10.1128/JCM.00128-08; Vaulet LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172905; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Giacani L, 2018, SEX TRANSM DIS, V45, P237, DOI 10.1097/OLQ.0000000000000741; Grange PA, 2012, J CLIN MICROBIOL, V50, P546, DOI 10.1128/JCM.00702-11; Grange PA, 2016, SEX TRANSM DIS, V43, P517, DOI 10.1097/OLQ.0000000000000474; Grange PA, 2013, SEX TRANSM DIS, V40, P641, DOI 10.1097/OLQ.0000000000000006; Grillova A L, PLOS ONE; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Katz Kenneth A, 2010, Sex Transm Dis, V37, P660, DOI 10.1097/OLQ.0b013e3181e1a77a; Khairullin R, 2016, APMIS, V124, P595, DOI 10.1111/apm.12541; Knauf S, 2016, EBIOMEDICINE, V11, P85, DOI 10.1016/j.ebiom.2016.07.033; Li Z, 2017, APMIS, V125, P937, DOI 10.1111/apm.12724; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; Mikalova L, 2017, SEX TRANSM DIS, V44, P376, DOI 10.1097/OLQ.0000000000000600; Mikalova L, 2014, SEX TRANSM DIS, V41, P552, DOI 10.1097/OLQ.0000000000000165; Mikalova L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-178; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Mitja O, 2018, LANCET, V391, P1599, DOI 10.1016/S0140-6736(18)30204-6; Molini BJ, 2016, SEX TRANSM DIS, V43, P579, DOI 10.1097/OLQ.0000000000000486; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Noda AA, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.02.006; Oliver S, 2016, SEX TRANSM DIS, V43, P524, DOI 10.1097/OLQ.0000000000000478; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73; Peng RR, 2012, SEX TRANSM DIS, V39, P42, DOI 10.1097/OLQ.0b013e318232697d; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Pillay A, 2002, J CLIN MICROBIOL, V40, P256, DOI 10.1128/JCM.40.1.256-258.2002; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Prevention CfDCa, 1997, MMWR-MORBID MORTAL W, P1; Radolf JD, 2018, CURR TOP MICROBIOL, V415, P1, DOI 10.1007/82_2017_44; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Read P, 2016, J CLIN MICROBIOL, V54, P2172, DOI 10.1128/JCM.00959-16; Salado-Rasmussen K, 2015, DAN MED J, V62; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Smajs D., 2016, FORUM IMMUN DIS THER, V7, P181, DOI DOI 10.1615/F0RUMIMMUNDISTHER.2017020184; Smajs D, 2018, INFECT GENET EVOL, V61, P92, DOI 10.1016/j.meegid.2018.03.015; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; Strouhal M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005894; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tipple C, 2011, SEX TRANSM INFECT, V87, pA69, DOI 10.1136/sextrans-2011-050109.104; Tipple C, 2015, CURR OPIN INFECT DIS, V28, P53, DOI 10.1097/QCO.0000000000000124; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Woznicova V, 2007, J CLIN MICROBIOL, V45, P659, DOI 10.1128/JCM.02209-06; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Xiao YJ, 2016, SEX TRANSM DIS, V43, P310, DOI 10.1097/OLQ.0000000000000445; Zhang RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175477; Zhu BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159787; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838	61	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201068	10.1371/journal.pone.0201068	http://dx.doi.org/10.1371/journal.pone.0201068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024965	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000087
J	Nishio, M; Sugiyama, O; Yakami, M; Ueno, S; Kubo, T; Kuroda, T; Togashi, K				Nishio, Mizuho; Sugiyama, Osamu; Yakami, Masahiro; Ueno, Syoko; Kubo, Takeshi; Kuroda, Tomohiro; Togashi, Kaori			Computer-aided diagnosis of lung nodule classification between benign nodule, primary lung cancer, and metastatic lung cancer at different image size using deep convolutional neural network with transfer learning	PLOS ONE			English	Article							LOW-DOSE CT	We developed a computer-aided diagnosis (CADx) method for classification between benign nodule, primary lung cancer, and metastatic lung cancer and evaluated the following: (i) the usefulness of the deep convolutional neural network (DCNN) for CADx of the ternary classification, compared with a conventional method (hand-crafted imaging feature plus machine learning), (ii) the effectiveness of transfer learning, and (iii) the effect of image size as the DCNN input. Among 1240 patients of previously-built database, computed tomography images and clinical information of 1236 patients were included. For the conventional method, CADx was performed by using rotation-invariant uniform-pattern local binary pattern on three orthogonal planes with a support vector machine. For the DCNN method, CADx was evaluated using the VGG-16 convolutional neural network with and without transfer learning, and hyperparameter optimization of the DCNN method was performed by random search. The best averaged validation accuracies of CADx were 55.9%, 68.0%, and 62.4% for the conventional method, the DCNN method with transfer learning, and the DCNN method without transfer learning, respectively. For image size of 56, 112, and 224, the best averaged validation accuracy for the DCNN with transfer learning were 60.7%, 64.7%, and 68.0%, respectively. DCNN was better than the conventional method for CADx, and the accuracy of DCNN improved when using transfer learning. Also, we found that larger image sizes as inputs to DCNN improved the accuracy of lung nodule classification.	[Nishio, Mizuho; Yakami, Masahiro; Kubo, Takeshi; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Nishio, Mizuho; Sugiyama, Osamu; Yakami, Masahiro] Kyoto Univ Hosp, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Japan; [Ueno, Syoko] Kyoto Univ, Grad Sch Informat, Dept Social Informat, Yoshidahonmachi, Kyoto, Japan; [Kuroda, Tomohiro] Kyoto Univ Hosp, Div Med Informat Technol & Adm Planning, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Nishio, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Japan.	nmizuho@kuhp.kyoto-u.ac.jp	Kuroda, Tomohiro/F-7041-2010; Nishio, Mizuho/ACC-0897-2022	Kuroda, Tomohiro/0000-0003-1472-7203; 	JSPS KAKENHI [JP16K19883]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (grant number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Anirudhi R, 2015, PROC SPIE, V9785, DOI 10.1117/12.2214876; Antony J, 2016, INT C PATT RECOG, P1195, DOI 10.1109/ICPR.2016.7899799; AOYAMA G, 2016, MED IMAGING TECHNOL, V34, P267; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Ciompi F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46479; de Carvalho AS, 2017, J DIGIT IMAGING, V30, P812, DOI 10.1007/s10278-017-9973-6; El-Baz A, 2013, INT J BIOMED IMAGING, V2013, DOI [10.1155/2013/517632, 10.1155/2013/942353]; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Hua KL, 2015, ONCOTARGETS THER, V8, P2015, DOI 10.2147/OTT.S80733; Hussein S, 2017, TUMORNET LUNG NODULE; Kawagishi M, 2017, INT J COMPUT ASS RAD, V12, P767, DOI 10.1007/s11548-017-1554-0; Kim E, 2016, PROC SPIE, V9789, DOI 10.1117/12.2216468; Liang MZ, 2016, RADIOLOGY, V281, P279, DOI 10.1148/radiol.2016150063; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu SF, 2017, PROC SPIE, V10134, DOI 10.1117/12.2277121; Lung CT., SCREENING REPORTING; Narayanan BN, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.1.014504; Nibali A, 2017, INT J COMPUT ASS RAD, V12, P1799, DOI 10.1007/s11548-017-1605-6; Nishio M, 2017, ACAD RADIOL, V24, P328, DOI 10.1016/j.acra.2016.11.007; Nomura Y, 2017, ACAD RADIOL, V24, P124, DOI 10.1016/j.acra.2016.09.023; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Roth HR, 2016, IEEE T MED IMAGING, V35, P1170, DOI 10.1109/TMI.2015.2482920; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Suzuki K, 2017, IMAGE BASED COMPUTER, P9, DOI [10.1007/978-981-10-2945-5_2, DOI 10.1007/978-981-10-2945-5_2]; Teramoto A, 2016, MED PHYS, V43, P2821, DOI 10.1118/1.4948498; Zhao GY, 2007, IEEE T PATTERN ANAL, V29, P915, DOI 10.1109/TPAMI.2007.1110	36	77	81	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200721	10.1371/journal.pone.0200721	http://dx.doi.org/10.1371/journal.pone.0200721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052644	gold, Green Submitted, Green Published			2022-12-27	WOS:000440006600012
J	Francois, P; Lecoanet, A; Caporossi, A; Dols, AM; Seigneurin, A; Boussat, B				Francois, Patrice; Lecoanet, Andre; Caporossi, Alban; Dols, Anne-Marie; Seigneurin, Arnaud; Boussat, Bastien			Experience feedback committees: A way of implementing a root cause analysis practice in hospital medical departments	PLOS ONE			English	Article							IMPROVE PATIENT SAFETY; MORTALITY CONFERENCES; ADVERSE EVENTS; MORBIDITY; MANAGEMENT; PROGRAM; HEALTH; INITIATIVES; INVESTIGATE; TEAMSTEPPS	Background The experience feedback committee (EFC) is a tool designed to involve medical teams in patient safety management, through root cause analysis (RCA) within the team. Objectives To investigate the functioning of EFCs in the departments of a large university-affiliated hospital in France and to consider its potential contribution to the management of patient safety. Methods Cross-sectional, observational study, based on an analysis of the documents produced by the EFCs for 1 year. Data were collected independently by two investigators in meeting minutes, adverse event reports and event analysis reports. Results The study included all 20 EFCs operating in the hospital's medical departments. During the study year, committees held 164 meetings, reviewed 1707 adverse events, conducted 91 event analyses and decided on 206 corrective actions. The median number of corrective actions adopted by each EFC was five actions (range, 0-62). A root cause analysis (RCA) was present in 76% of the analysis reports, and these analyses were complete in only 23% of the reports. There was also a lack of planning corrective actions: an implementation deadline was only defined in 26% of the actions. Conclusions Healthcare professionals adhered to the system-based approach to patient safety, but we observed difficulties in holding regular meetings and deviations from the theoretical framework. These findings confirm the difficulties of practicing RCA in the healthcare setting. Nevertheless, EFCs can be vectors of safety culture and teamwork.	[Francois, Patrice; Lecoanet, Andre; Caporossi, Alban; Dols, Anne-Marie; Seigneurin, Arnaud; Boussat, Bastien] Grenoble Alpes Univ Hosp, Dept Publ Hlth, Grenoble, France; [Francois, Patrice; Seigneurin, Arnaud; Boussat, Bastien] Grenoble Alpes Univ, CNRS, UMR 5525, Lab TIMC, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Francois, P (corresponding author), Grenoble Alpes Univ Hosp, Dept Publ Hlth, Grenoble, France.; Francois, P (corresponding author), Grenoble Alpes Univ, CNRS, UMR 5525, Lab TIMC, Grenoble, France.	pfrancois@chu-grenoble.fr	Seigneurin, Arnaud/M-6099-2014; Boussat, Bastien/D-8132-2018	Boussat, Bastien/0000-0003-0725-9122; Francois, Patrice/0000-0003-1633-7612	French Ministry of Health [PREPS 12-026-0001 2012]	French Ministry of Health	This work was supported by the French Ministry of Health [PREPS 12-026-0001 2012 to PF]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 2013, INT J QUAL HEALTH C, V25, P141, DOI 10.1093/intqhc/mzs081; Baines R, 2015, BMJ QUAL SAF, V24, P561, DOI 10.1136/bmjqs-2014-003702; Bates DW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1775; Boussat B, 2021, J PATIENT SAF, V17, pE1194, DOI 10.1097/PTS.0000000000000456; Boussat B, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0062-2; Bowie P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-50; Braithwaite J, 2006, QUAL SAF HEALTH CARE, V15, P393, DOI 10.1136/qshc.2005.017525; Caporossi A, 2014, J PHARM CARE HLTH SY, pS1, DOI [10.4172/JPCHS.S1-010, DOI 10.4172/JPCHS.S1-010]; Clancy CM, 2007, AM J MED QUAL, V22, P214, DOI 10.1177/1062860607300616; Debouck F, 2012, CANCER RADIOTHER, V16, P201, DOI 10.1016/j.canrad.2011.12.002; Francois P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1279-8; Hettinger A Zachary, 2013, J Healthc Risk Manag, V33, P11, DOI 10.1002/jhrm.21122; Kellogg KM, 2017, BMJ QUAL SAF, V26, P381, DOI 10.1136/bmjqs-2016-005991; Lecoanet A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1431-5; Lecoanet A, 2014, EMERG MED J, V31, P894, DOI 10.1136/emermed-2013-202767; Nicolini D, 2011, SOC SCI MED, V73, P217, DOI 10.1016/j.socscimed.2011.05.010; Peerally MF, 2017, BMJ QUAL SAF, V26, P417, DOI 10.1136/bmjqs-2016-005511; Pelieu I, 2013, INTENS CARE MED, V39, P1214, DOI 10.1007/s00134-013-2923-y; Percarpio KB, 2008, JT COMM J QUAL PATIE, V34, P391, DOI 10.1016/S1553-7250(08)34049-5; Percarpio KB, 2013, JT COMM J QUAL PATIE, V39, P32, DOI 10.1016/S1553-7250(13)39006-0; Pitts SI, 2017, JT COMM J QUAL PATIE, V43, P591, DOI 10.1016/j.jcjq.2017.06.006; Pronovost PJ, 2006, JT COMM J QUAL PATIE, V32, P119, DOI 10.1016/S1553-7250(06)32017-X; Sherman H, 2009, INT J QUAL HEALTH C, V21, P2, DOI 10.1093/intqhc/mzn054; Stavropoulou C, 2015, MILBANK Q, V93, P826, DOI 10.1111/1468-0009.12166; Szekendi MK, 2010, JT COMM J QUAL PATIE, V36, P3, DOI 10.1016/S1553-7250(10)36001-6; Szostek JH, 2010, AM J MED, V123, P663, DOI 10.1016/j.amjmed.2010.03.010; Tignanelli CJ, 2017, J SURG RES, V214, P124, DOI 10.1016/j.jss.2017.02.065; Vincent C, 2000, BRIT MED J, V320, P777, DOI 10.1136/bmj.320.7237.777; Wallace LM, 2009, QUAL SAF HEALTH CARE, V18, P288, DOI 10.1136/qshc.2008.027896; Weaver SJ, 2013, ANN INTERN MED, V158, P369, DOI 10.7326/0003-4819-158-5-201303051-00002; Weld LR, 2016, AM J MED QUAL, V31, P408, DOI 10.1177/1062860615583671; Wu AW, 2008, JAMA-J AM MED ASSOC, V299, P685, DOI 10.1001/jama.299.6.685	32	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201067	10.1371/journal.pone.0201067	http://dx.doi.org/10.1371/journal.pone.0201067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048491	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400046
J	Ideno, Y; Hayashi, K; Nakajima-Shimada, J; Onizuka, Y; Kishi, M; Ueno, T; Uchiyama, S				Ideno, Yuki; Hayashi, Kunihiko; Nakajima-Shimada, Junko; Onizuka, Yoko; Kishi, Mikiko; Ueno, Tomomi; Uchiyama, Shigeto			Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey	PLOS ONE			English	Article							SOY ISOFLAVONES; HABITUAL DIET; METABOLISM; EXCRETION	Equol is one of the most active soy isoflavones. When the association between soy food intake in daily life and health outcomes is examined in epidemiological studies, it is important to define the equol-producing status of each individual. However, few studies have assessed equol-producing status without a soy challenge test. To determine a robust cutoff criterion for equol producer classification in observational studies, we conducted a urinary isoflavone concentration survey in daily life among women. Furthermore, we examined the association between eating habits regarding soy foods and equol-producing status. A total of 4,412 participants were included in the analyses. Urinary isoflavones were analyzed using a high-performance liquid chromatography method. We examined the distribution of the log(10) equol/daidzein ratios, finding a mixture of two normal distributions, corresponding to equol producer and non-producer subpopulations. Applying a finite mixture model, we estimated the means, standard deviations, and mixing proportions of these two distributions. The estimation was carried out using the SAS NLIN procedure. The optimal cutoff point for the log(10) equol/daidzein ratio in the study population was determined to be -1.42, according to the estimated parameters of the mixture distribution. Based on this criterion, 1,830 (41.5%) of the participants were identified as equol producers. Compared with non-consumers of soy foods, consumers of soy foods had significantly higher odds of being equol producers. Using log(10)-transformed equol/daidzein ratios >= -1.42 to define equol producers among Japanese women is reasonable and suitable for determining equol-producing status in epidemiological studies. We found that soy food eating habits were associated with equol-producing status. Further investigation is required to evaluate associations between equol-producing status in daily life and health outcomes. The results of this study suggest the best cutoff point to use in the definition of equol-producing status in daily life.	[Ideno, Yuki] Gunma Univ, Initiat Adv Res, Maebashi, Gunma, Japan; [Hayashi, Kunihiko; Nakajima-Shimada, Junko; Onizuka, Yoko] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan; [Kishi, Mikiko] Gunma Univ, Ctr Med Educ, Maebashi, Gunma, Japan; [Ueno, Tomomi; Uchiyama, Shigeto] Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan	Gunma University; Gunma University; Gunma University; Otsuka Pharmaceutical	Hayashi, K (corresponding author), Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan.	khayashi@gunma-u.ac.jp		Hayashi, Kunihiko/0000-0003-4648-3936	JSPS by the Ministry of Education, Culture, Sports, Science and Technology [16K09049]; Otsuka Pharmaceutical Co., Ltd	JSPS by the Ministry of Education, Culture, Sports, Science and Technology; Otsuka Pharmaceutical Co., Ltd(Otsuka Pharmaceutical)	This work was partly supported by JSPS KAKENHI (grant number 16K09049) to YI by the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Otsuka Pharmaceutical Co., Ltd provided support in the form of salaries for authors TU and SU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; Arai Y, 2000, J Epidemiol, V10, P127; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; AXELSON M, 1982, BIOCHEM J, V201, P353, DOI 10.1042/bj2010353; Cassidy A, 2005, NURS STAND, V19, P54, DOI DOI 10.7748/NS2005.03.19.29.44; Cassidy Aedin, 2005, Nurs Stand, V19, P44; Du JX, 2004, STAT MED, V23, P2049, DOI 10.1002/sim.1797; Franke AA, 2012, J NUTR BIOCHEM, V23, P573, DOI 10.1016/j.jnutbio.2011.03.002; Ko TF, 2010, J FOOD SCI, V75, pH306, DOI 10.1111/j.1750-3841.2010.01860.x; Kobayashi A, 2015, KITAKANTO MED J, V65, P29; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Lampe JW, 1998, P SOC EXP BIOL MED, V217, P335; Liu BH, 2010, J EPIDEMIOL, V20, P377, DOI 10.2188/jea.JE20090185; Liu WY, 2013, ENVIRON HEALTH PREV, V18, P394, DOI 10.1007/s12199-013-0338-6; Messina M, 2002, J NUTR, V132, p547S, DOI 10.1093/jn/132.3.547S; Nagata C, 2008, NUTR CANCER, V60, P49, DOI 10.1080/01635580701525885; Newton KM, 2015, MENOPAUSE, V22, P489, DOI [10.1097/gme.0000000000000363, 10.1097/GME.0000000000000363]; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2003, J NUTR, V133, P1027, DOI 10.1093/jn/133.4.1027; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; YAN L, 2004, INT J CANC PREV, V1, P281; Yoshikata R, 2017, MENOPAUSE, V24, P216, DOI 10.1097/GME.0000000000000743	24	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201318	10.1371/journal.pone.0201318	http://dx.doi.org/10.1371/journal.pone.0201318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048499	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400074
J	Kao, PC; Pierro, MA; Booras, K				Kao, Pei-Chun; Pierro, Michaela A.; Booras, Konstantina			Effects of motor fatigue on walking stability and variability during concurrent cognitive challenges	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; POSITION SENSE; MUSCLE FATIGUE; DESTABILIZING ENVIRONMENTS; MUSCULAR FATIGUE; POSTURAL CONTROL; GAIT; ATTENTION; INTERFERENCE; HUMANS	Cognitive-motor interference, a negative influence on the performance of one or both tasks, is manifested when simultaneously performing a cognitive and a motor task. Motor fatigue reduces the ability of generating a required force level. However, little is known about the effects of motor fatigue on the cognitive-motor dual-tasking performance, an important capability during our daily lives. This study investigated how motor fatigue affects dual-task walking performance. Eighteen healthy younger adults walked on a treadmill under three different conditions: walking only, walking while receiving the Paced Auditory Serial Addition Test (PASAT) or a modified Stroop test before and after a lower-extremity fatiguing exercise. We computed dynamic margins of stability (MOS), step and joint kinematic variability, and short-term local divergence exponent (LDE) of the trunk motion. We found that subjects had similar values of short-term LDE during all conditions, indicating that local stability was not affected by the motor fatigue or dual-task conditions. Compared to the baseline, subjects had significantly greater mean MOS after the fatiguing exercise by walking with greater step length and width while having significantly greater gait variability. In contrast, subjects walked with similar mean MOS but significantly less gait variability during the dual-task conditions, indicating that subjects used different adaptive strategies when walking with motor fatigue and during dual-task conditions. There were no significant differences in the number of errors for the two cognitive tests before and after the fatiguing exercise. The current findings demonstrate that motor fatigue does not affect cognitive but motor performance in younger adults.	[Kao, Pei-Chun; Booras, Konstantina] Univ Massachusetts Lowell, Dept Phys Therapy, Lowell, MA 01854 USA; [Pierro, Michaela A.] Univ Massachusetts Lowell, Biomed Engn & Biotechnol Program, Lowell, MA USA	University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell	Kao, PC (corresponding author), Univ Massachusetts Lowell, Dept Phys Therapy, Lowell, MA 01854 USA.	PeiChun_Kao@uml.edu		Kao, Pei-Chun/0000-0001-8603-3898				Abd-Elfattah HM, 2015, J ADV RES, V6, P351, DOI 10.1016/j.jare.2015.01.011; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Arvin M, 2015, GAIT POSTURE, V42, P545, DOI 10.1016/j.gaitpost.2015.08.011; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Barbieri FA, 2013, J BACK MUSCULOSKELET, V26, P125, DOI 10.3233/BMR-130371; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-12; Ellis RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141694; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Gates DH, 2011, EXP BRAIN RES, V209, P525, DOI 10.1007/s00221-011-2580-8; Gates DH, 2010, J BIOMECH, V43, P913, DOI 10.1016/j.jbiomech.2009.11.001; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Kao PC, 2015, GAIT POSTURE, V41, P947, DOI 10.1016/j.gaitpost.2015.03.347; Knudson D, 2009, SPORT BIOMECH, V8, P96, DOI 10.1080/14763140802629966; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; Lorist MM, 2002, J PHYSIOL-LONDON, V545, P313, DOI 10.1113/jphysiol.2002.027938; Milanese C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192046; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Ribeiro F, 2007, EUR J APPL PHYSIOL, V99, P379, DOI 10.1007/s00421-006-0357-8; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Torres R, 2010, INT J SPORTS MED, V31, P410, DOI 10.1055/s-0030-1248285; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; WILKIE DA, 1990, J AM VET MED ASSOC, V196, P1831; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201433	10.1371/journal.pone.0201433	http://dx.doi.org/10.1371/journal.pone.0201433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048551	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400089
J	Riddell, A; van Dalen-Oskam, K				Riddell, Allen; van Dalen-Oskam, Karina			Readers and their roles: Evidence from readers of contemporary fiction in the Netherlands	PLOS ONE			English	Article							CROSS-VALIDATION; SOCIOLOGY	Reading serves many ends. Some readers report that works of fiction provide an imaginative escape from the rigors of life, others report reading in order to be intellectually challenged. While various characterizations of readers' engagement with prose fiction have been proposed, few have been checked using representative samples of readers. Our research reports on reader self-descriptions observed in a representative sample of 501 adults in the Netherlands. Reader self-descriptions exhibit regularities, with certain self-descriptions predicting others. Contrary to existing theories which posit two types of readers characterized by non-overlapping concerns (identifying readers and distanced readers), we find that while some readers attend to plot structure or read in order to be intellectually challenged, reader self-descriptions overlap more than received theories predict. We hypothesize that some readers have cultivated more reading techniques than others, with educated or experienced readers tending to report deriving additional experiences from reading.	[Riddell, Allen] Indiana Univ, Sch Informat Comp & Engn, Bloomington, IN 47405 USA; [van Dalen-Oskam, Karina] Huygens Inst Hist Netherlands, Dept Literary Studies, Amsterdam, Netherlands; [van Dalen-Oskam, Karina] Univ Amsterdam, Dept Modern Dutch Literature, Amsterdam, Netherlands	Indiana University System; Indiana University Bloomington; Royal Netherlands Academy of Arts & Sciences; Huygens Institute for the History of the Netherlands (KNAW); University of Amsterdam	Riddell, A (corresponding author), Indiana Univ, Sch Informat Comp & Engn, Bloomington, IN 47405 USA.	riddella@indiana.edu			Computational Humanities Programme of the Royal Netherlands Academy of Arts and Sciences (KNAW)	Computational Humanities Programme of the Royal Netherlands Academy of Arts and Sciences (KNAW)	The collection of the data used in this paper was funded by the Computational Humanities Programme of the Royal Netherlands Academy of Arts and Sciences (KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafumi J, 2005, POLIT ANAL, V13, P171, DOI 10.1093/pan/mpi010; Clinton J, 2004, AM POLIT SCI REV, V98, P355, DOI 10.1017/S0003055404001194; Davis JA, 2003, ICPSR VERSION; Felski Rita, 2008, CLARK LECT YOUTUBE; Furr DC, 2017, EDSTAN STAN MODELS I; Hennion A, 2007, CULT SOCIOL-LONDON, V1, P97, DOI 10.1177/1749975507073923; Kraaykamp G, 1999, POETICS, V26, P203, DOI 10.1016/S0304-422X(99)00002-9; Liu C., 2004, APPL BAYESIAN MODELI; Martin A. A., 2002, POLIT ANAL, V10, P134, DOI [DOI 10.1093/PAN/10.2.134, 10.1093/pan/10.2.134]; Nell V., 1988, LOST BOOK PSYCHOL RE; Radway Janice, 1991, READING ROMANCE WOME; Rasch G., 1980, PROBABILISTIC MODELS; Schwarz O, 2013, CULT SOCIOL-LONDON, V7, P415, DOI 10.1177/1749975513480957; Stan Development Team, 2017, STAN C LIB PROB SAMP; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; von Heydebrand R, 1996, EINFU E HRUNG WERTUN; von Heydebrand R, 2008, LINGUIST APPROACH LI, V4, P223; Watanabe S, 2010, J MACH LEARN RES, V11, P3571	18	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201157	10.1371/journal.pone.0201157	http://dx.doi.org/10.1371/journal.pone.0201157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048508	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400054
J	Ho, KT; Wang, X; Chen, L				Ho, Kiti; Wang, Xia; Chen, Lei			Reasons for parental withdrawal of care in a pediatric intensive care unit in China	PLOS ONE			English	Article							ACCESS	Background The past decade saw the establishment of pediatric intensive care units (PICU) across China. This occurred in the context of increasing private shares of medical costs. Payment schemes have not kept pace with the increased availability and demand. As a result a substantial number of parents, in the face of financial constraints, choose to withdraw the medical care of children even when recovery is expected. Objective We set out to describe the experience of one PICU in Changsha, an industrialized city near the center of the country with a population of 7.3 million. Results During the two-year period 883 patients were admitted to the PICU. One hundred one (11%) patients died during their hospital stay. Of these 69 (68%) died after parents elected to withdraw care. A large proportion (33 out of 69 48%) cited economic factors as a reason behind the decision. Compared with the non-withdrawal group the cases had lower disease severity at admission and on the day of death. On the day of death 34% in the withdrawal group had lower disease severity than at admission, showing clinical improvement. The mean hospital charge for the ICU stay was RMB35,000 (similar to$5600). Conclusion A substantial proportion of patients in a Chinese urban PICU died after parents chose to withdraw their care in the face of financial hardship, even while some were showing clinical improvement. The society has an obligation, and, likely, an economic incentive, to share this burden.	[Ho, Kiti; Chen, Lei] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Wang, Xia] Cent S Univ, Xiangya Sch Med, Dept Pediat, Changsha, Hunan, Peoples R China	Yale University; Central South University	Chen, L (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	Lei.chen@yale.edu						Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Li Z, 2012, BMC PUBLIC HLTH S1, V12, P59; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ren XX., 2006, APPL CLIN PEDIAT, V21, P382; Wang HL, 2007, JAMA-J AM MED ASSOC, V298, P1928, DOI 10.1001/jama.298.16.1928; Wang XF, 2012, PEDIATR CARDIOL, V33, P677, DOI 10.1007/s00246-012-0177-z; Yip W, 2014, LANCET, V384, P805, DOI 10.1016/S0140-6736(14)61120-X; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	8	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e199419	10.1371/journal.pone.0199419	http://dx.doi.org/10.1371/journal.pone.0199419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044777	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500012
J	Ptaszynska, AA; Gancarz, M; Hurd, PJ; Borsuk, G; Wiacek, D; Nawrocka, A; Strachecka, A; Zaluski, D; Paleolog, J				Ptaszynska, Aneta A.; Gancarz, Marek; Hurd, Paul J.; Borsuk, Grzegorz; Wiacek, Dariusz; Nawrocka, Agnieszka; Strachecka, Aneta; Zaluski, Daniel; Paleolog, Jerzy			Changes in the bioelement content of summer and winter western honeybees (Apis mellifera) induced by Nosema ceranae infection	PLOS ONE			English	Article							ENERGETIC STRESS; BEE; SUPPLEMENTATION; GLANDS; GROWTH; BORON; ACID; LEAD	Proper bioelement content is crucial for the health and wellness of all organisms, including honeybees. However, the situation is more complicated in these important pollinators due to the fact that they change their physiology during winter in order to survive the relatively harsh climatic conditions. Additionally, honeybees are susceptible to many diseases such as nosemosis, which during winter can depopulate an entire colony. Here we show that summer bees have a markedly higher content of important bioelements such as: Al, Cu, P, V, (physiologically essential); Ca, K, Mg, (electrolytic); Cr, Se, Zn, (enzymatic); As, Hg, (toxic). In contrast, a markedly higher content of: Fe (physiologically essential); Mn, Ni, (enzymatic); Cd (exclusively toxic) were present in winter bees. Importantly, N. ceranae infection resulted in an increased honeybee bioelement content of: S, Sr (physiologically essential) and Pb (exclusively toxic), whereas the Nosema-free worker-bees had higher amounts of B and Si (physiologically essential). We propose that the shortages of Fe, Mn, Ni, and Na observed in Nosema-infected bees, could be the reason for the higher mortality of Nosema-infected bees throughout overwintering. In addition, a shortage of bioelements such as B and Si may be a reason for accelerated aging in foragers that is observed following N. ceranae infection. Therefore, in winter, bioelement content was more strongly affected by N. ceranae infection than during summer. We found a strong correlation between the bioelement content of bees and seasons (summer or winter) and also with Nosema infection. We conclude that the balance of bioelements in the honeybee is altered by both seasonal affects and by Nosema infection.	[Ptaszynska, Aneta A.] Marie Curie Sklodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Bot & Mycol, Lublin, Poland; [Gancarz, Marek; Wiacek, Dariusz; Nawrocka, Agnieszka] Polish Acad Sci, Inst Agrophys, Lublin, Poland; [Hurd, Paul J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Borsuk, Grzegorz; Strachecka, Aneta] Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Inst Biol Basis Anim Prod, Lab Environm Biol & Apidol, Lublin, Poland; [Zaluski, Daniel] Nicolaus Copernicus Univ, Dept Pharmacognosy, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Paleolog, Jerzy] Life Sci Univ Lublin, Dept Zool Ecol & Wildlife Management, Lublin, Poland	Maria Curie-Sklodowska University; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; University of London; Queen Mary University London; University of Life Sciences in Lublin; Nicolaus Copernicus University	Ptaszynska, AA (corresponding author), Marie Curie Sklodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Bot & Mycol, Lublin, Poland.	aneta.ptaszynska@poczta.umcs.lublin.pl	Ptaszynska, Aneta/AAG-7172-2021; Gancarz, Marek/AAF-5498-2019; Paleolog, Jerzy/U-5290-2018; Borsuk, Grzegorz/AAD-3268-2021; Gancarz, Marek/W-3118-2019	Ptaszynska, Aneta/0000-0001-6413-6028; Gancarz, Marek/0000-0003-4719-2954; Paleolog, Jerzy/0000-0002-4447-4318; Borsuk, Grzegorz/0000-0002-8407-3383; Gancarz, Marek/0000-0003-4719-2954; Hurd, Paul/0000-0003-1112-9347; Wiacek, Dariusz/0000-0001-9043-6163; Strachecka, Aneta/0000-0003-1313-9880; Nawrocka, Agnieszka/0000-0001-8618-2092	Vice-rector for Research and International Relations of UMCS (Lublin, Poland); BBSRC [BB/L023164/1]	Vice-rector for Research and International Relations of UMCS (Lublin, Poland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Individual Research Grant of the Vice-rector for Research and International Relations of UMCS (Lublin, Poland) granted to AAP. Work in the Hurd lab is funded by the BBSRC (BB/L023164/1) granted to PJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alina M., 2012, International Food Research Journal, V19, P135; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Black J., 2006, USITC PUBL; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; Bonoan RE, 2018, J INSECT PHYSIOL, V107, P23, DOI 10.1016/j.jinsphys.2018.02.002; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Charbonneau LR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22626; Cohen AC, 2004, INSECT DIETS SCI TEC; Copley TR, 2012, J APPL MICROBIOL, V112, P15, DOI 10.1111/j.1365-2672.2011.05192.x; De Groot AP, 1953, PHYSL COMP ECOLOGIA, V3, P197; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Dzugan M, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6474-0; Eiri DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126330; Filipiak M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183236; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Ghanati F, 2005, PLANT SOIL, V276, P133, DOI 10.1007/s11104-005-3697-y; Ghosh S, 2016, J ASIA-PAC ENTOMOL, V19, P487, DOI 10.1016/j.aspen.2016.03.008; Golubkina NA, 2016, ECOL INDIC, V66, P452, DOI 10.1016/j.ecolind.2016.01.042; Hamdan K., 2010, Bee World, V87, P52, DOI 10.1080/0005772X.2010.11417360; Hunt CD, 2003, J TRACE ELEM EXP MED, V16, P291, DOI 10.1002/jtra.10041; Jack CJ, 2016, J INSECT PHYSIOL, V87, P12, DOI 10.1016/j.jinsphys.2016.01.004; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Jugdaohsingh Ravin, 2015, Bone Rep, V1, P9; Kowalczyk-Pecka D, 2017, ENVIRON POLLUT, V222, P138, DOI 10.1016/j.envpol.2016.12.068; Kowalczyk-Pecka D, 2017, ECOTOX ENVIRON SAFE, V138, P223, DOI 10.1016/j.ecoenv.2016.12.033; Kurze C, 2016, PARASITOL RES, V115, P2381, DOI 10.1007/s00436-016-4988-3; Lamson Davis W, 2002, Altern Med Rev, V7, P218; Li YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121884; Markert B., 2015, CHEM EVOLUTION BIOLO, DOI [10.1007/978-3-319-14355-2_2, DOI 10.1007/978-3-319-14355-2_2]; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meana A, 2010, J APICULT RES, V49, P212, DOI 10.3896/IBRA.1.49.2.12; Michels HT, 2006, ASTM STAND NEWS, V34, P28; Milanino R, 1989, COPPER ZINC INFLAMMA; Mulholland Grace E., 2012, Insects, V3, P1143, DOI 10.3390/insects3041143; Nation J. L, 1971, J Apic Res, V10, P35; Naug D, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0731; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP, DOI [10.17226/13039, DOI 10.17226/13039]; Patrick Lyn, 2002, Altern Med Rev, V7, P456; Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004; Ptaszynska AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164477; Ptaszynska AA, 2012, MED WETER, V68, P618; Ritter W., 2006, 4 FAO AGR FOOD ENG; Safaee S, 2014, PERIOD BIOL, V116, P259; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schwartz K, 1959, ARCH BIOCH BIOPHYS; Skalny AV, 2011, J TRACE ELEM MED BIO, V25, pS3, DOI 10.1016/j.jtemb.2010.10.005; Skalny AV, 2014, PHARM NUTR FUNDAMENT, DOI [10.5772/57368, DOI 10.5772/57368]; Smart MD, 2012, J INVERTEBR PATHOL, V109, P148, DOI 10.1016/j.jip.2011.09.009; Tacon AGJ, 1987, GCPRLA075ITA FAO FIL; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Underwood EA, 1977, TRACE ELEMENTS HUMAN; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Wainwright M, 1997, MYCOL RES, V101, P933, DOI 10.1017/S0953756297003560; WANG DI, 1971, J INVERTEBR PATHOL, V17, P308, DOI 10.1016/0022-2011(71)90002-4; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; Williams LR, 1990, 901448 IRGIWP; WOODS WG, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3431956; Zhai HB, 2000, CONTACT DERMATITIS, V42, P98, DOI 10.1034/j.1600-0536.2000.042002098.x; Zhelyazkova I, 2012, BULG J AGRIC SCI, V18, P435; Zhou XT, 2018, ENVIRON SCI TECHNOL, V52, P991, DOI 10.1021/acs.est.7b04084	66	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200410	10.1371/journal.pone.0200410	http://dx.doi.org/10.1371/journal.pone.0200410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044811	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500051
J	Tang, M; Shen, JF; Li, P; Zhou, LN; Zeng, P; Cui, XX; Chen, MB; Tian, Y				Tang, Min; Shen, Jiao-Feng; Li, Ping; Zhou, Li-Na; Zeng, Ping; Cui, Xi-Xi; Chen, Min-Bin; Tian, Ye			Prognostic significance of CIP2A expression in solid tumors: A meta-analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PHOSPHATASE 2A CIP2A; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; ONCOGENIC NEXUS; PP2A; OVEREXPRESSION; ONCOPROTEIN; RESISTANCE; INHIBITOR	CIP2A, cancerous inhibitor of protein phosphatase 2A, was initially recognized as an oncoprotein. Recently several studies revealed that CIP2A could function as a prognosis bio-marker, however, the result remained not comprehensive, partly due to small number of patients included individually. Here we carried out a meta-analysis of published studies to assess the prognostic significance of CIP2A in solid tumors. All eligible studies were identified through searching PubMed, Embase and Web of Science database. In this meta-analysis, 22 studies involving 4,579 participants were included, and we verified that CIP2A over-expression was significantly related with poor overall survival (pooled HR = 1.844, 95% CI = 1.528-2.225, P<0.001) and short disease free survival (pooled HR = 1.808, 95% CI = 1.591-2.055, P<0.001) in solid tumors. Additionally, subgroup analysis suggested that the trend of a poor overall survival with an increased CIP2A expression was present in East-Asian and European patients, as well as in lung cancer and colorectal cancer. To sum up, CIP2A over-expression was associated with poor survival in human solid tumors and might be a predictive factor of poor prognosis.	[Tang, Min; Li, Ping; Zhou, Li-Na; Tian, Ye] Soochow Univ, Inst Radiotherapy & Oncol, Dept Radiotherapy & Oncol, Affiliated Hosp 2, Suzhou, Jiangsu, Peoples R China; [Tang, Min; Li, Ping; Zhou, Li-Na; Zeng, Ping; Cui, Xi-Xi; Chen, Min-Bin] Jiangsu Univ, Dept Radiotherapy & Oncol, Kunshan Peoples Hosp 1, Kunshan, Jiangsu, Peoples R China; [Shen, Jiao-Feng] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Jiangsu University; Soochow University - China	Tian, Y (corresponding author), Soochow Univ, Inst Radiotherapy & Oncol, Dept Radiotherapy & Oncol, Affiliated Hosp 2, Suzhou, Jiangsu, Peoples R China.	dryetian@126.com	Zhou, Li/GSE-4531-2022		National Natural Science Foundation [81472786, 81773192]; Natural Science Foundation of Jiangsu Province [BK20171248]; Jiangsu Province Youth Medical Talents Project [QNRC2016527]; Foundation of tumor clinical and basic research team [KYC005]; Suzhou City Health Science and Technology Project [LCZX201619]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province Youth Medical Talents Project; Foundation of tumor clinical and basic research team; Suzhou City Health Science and Technology Project	National Natural Science Foundation 81472786 and 81773192, Natural Science Foundation of Jiangsu Province BK20171248, Jiangsu Province Youth Medical Talents Project, QNRC2016527, the Foundation of tumor clinical and basic research team KYC005, and Suzhou City Health Science and Technology Project LCZX201619 to MBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockelman C, 2011, BRIT J CANCER, V105, P989, DOI 10.1038/bjc.2011.346; Bockelman C, 2011, BRIT J CANCER, V104, P1890, DOI 10.1038/bjc.2011.167; Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]; Chao TT, 2016, APMIS, V124, P1031, DOI 10.1111/apm.12602; Chen JN, 2016, EUR J MED CHEM, V107, P12, DOI 10.1016/j.ejmech.2015.10.045; Chen KF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1300-3; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Cristobal I, 2017, ONCOGENE, V36, P3357, DOI 10.1038/onc.2016.474; Cristobal I, 2016, MOL CELL BIOL, V36, P1734, DOI 10.1128/MCB.00130-16; De P, 2015, AM J CANCER RES, V5, P2872; De P, 2014, ONCOTARGET, V5, P4581, DOI 10.18632/oncotarget.2127; Dey N, 2015, AM J CANCER RES, V5, P1; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Florenes VA, 2015, CANCER MED-US, V4, P903, DOI 10.1002/cam4.425; He H, 2012, DIAGN MOL PATHOL, V21, P143, DOI 10.1097/PDM.0b013e318249fd8b; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Huang PZ, 2012, BIOMARKERS, V17, P422, DOI 10.3109/1354750X.2012.680608; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2016, INT J CANCER, V138, P525, DOI 10.1002/ijc.29431; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-111; Liu Z, 2014, ACS MED CHEM LETT, V5, P113, DOI 10.1021/ml400341k; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Peng B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1899-0; Rantanen T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0684-7; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Routila J, 2016, J ORAL PATHOL MED, V45, P329, DOI 10.1111/jop.12372; Ruvolo PP, 2016, BBA CLIN, V6, P87, DOI 10.1016/j.bbacli.2016.08.002; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439; Tang QZ, 2015, ONCOL REP, V34, P2515, DOI 10.3892/or.2015.4217; Teng HW, 2012, J GASTROINTEST SURG, V16, P1037, DOI 10.1007/s11605-012-1828-3; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Wang L, 2013, TUMOR BIOL, V34, P2309, DOI 10.1007/s13277-013-0775-2; Wiegering A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075292; Xu P, 2013, HEPATO-GASTROENTEROL, V60, P669, DOI 10.5754/hge11139; Xu P, 2012, MED ONCOL, V29, P1643, DOI 10.1007/s12032-011-0053-3; Xue YJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0406-6; Yu GZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0524-9	47	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199675	10.1371/journal.pone.0199675	http://dx.doi.org/10.1371/journal.pone.0199675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044786	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500016
J	Desoubeaux, G; Chauvin, D; Piqueras, MD; Bronson, E; Bhattacharya, SK; Sirpenski, G; Bailly, E; Cray, C				Desoubeaux, Guillaume; Chauvin, David; Piqueras, Maria del Carmen; Bronson, Ellen; Bhattacharya, Sanjoy K.; Sirpenski, Gayle; Bailly, Eric; Cray, Carolyn			Translational proteomic study to address host protein changes during aspergillosis	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; SIGNALING PATHWAY; FUNGAL-INFECTIONS; MASS-SPECTROMETRY; RISK-FACTORS; DIAGNOSIS; ELECTROPHORESIS; FUMIGATUS; DISEASE; CELLS	Aspergillosis is a fungal disease due to Aspergillus molds that can affect both humans and animals. As routine diagnosis remains difficult, improvement of basic knowledge with respect to its pathophysiology is critical to search for new biomarkers of infection and new therapeutic targets. Large-scale proteomics allows assessment of protein changes during various disease processes. In the present study, mass spectrometry iTRAQ (R) (isobaric tags for relative and absolute quantitation) protocol was used for direct identification and relative quantitation of host proteins in diseased fluids and tissues collected from an experimental rat model challenged with Aspergillus, as well as in blood obtained from naturally-infected penguins. In all, mass spectrometry analysis revealed that proteome during aspergillosis was mostly represented by proteins that usually express role in metabolic processes and biological process regulation. Ten and 17 proteins were significantly >= 4.0-fold over-represented in blood of Aspergillus-diseased rats and penguins, respectively, while five and 39 were negatively >= 4.0-fold depleted within the same samples. In rat lungs, 33 proteins were identified with positive or negative relative changes versus controls and were quite different from those identified in the blood. Except for some zinc finger proteins, kinases, and histone transferases, and while three pathways were common (Wnt, cadherin and FGF), great inter-species variabilities were observed regarding the identity of the differentially-represented proteins. Thus, this finding confirmed how difficult it is to define a unique biomarker of infection. iTRAQ (R) protocol appears as a convenient proteomic tool that is greatly suited to ex vivo exploratory studies and should be considered as preliminary step before validation of new diagnostic markers and new therapeutic targets in humans.	[Desoubeaux, Guillaume; Cray, Carolyn] Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Div Comparat Pathol, Miami, FL 33136 USA; [Desoubeaux, Guillaume; Bailly, Eric] CHU Tours, Parasitol, Mycol, Med Trop, Tours, France; [Desoubeaux, Guillaume; Chauvin, David] Univ Tours, CEPR INSERM U1100, Equipe 3, Fac Med, Tours, France; [Piqueras, Maria del Carmen; Bhattacharya, Sanjoy K.] Univ Miami, Miller Sch Med, Mass Spectrometry Core Facil, Miami, FL 33136 USA; [Bronson, Ellen] Maryland Zoo Baltimore, Baltimore, MD USA; [Sirpenski, Gayle] Mystic Aquarium, Mystic, CT USA; [Desoubeaux, Guillaume] Hop Bretonneau, Serv Parasitol Mycol Med Trop, Tours, France	University of Miami; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Miami; CHU Tours	Desoubeaux, G (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Div Comparat Pathol, Miami, FL 33136 USA.; Desoubeaux, G (corresponding author), CHU Tours, Parasitol, Mycol, Med Trop, Tours, France.; Desoubeaux, G (corresponding author), Univ Tours, CEPR INSERM U1100, Equipe 3, Fac Med, Tours, France.; Desoubeaux, G (corresponding author), Hop Bretonneau, Serv Parasitol Mycol Med Trop, Tours, France.	guillaume.desoubeaux@univ-tours.fr	DESOUBEAUX, Guillaume/J-5026-2015	DESOUBEAUX, Guillaume/0000-0001-7945-9890	NIH center grant [P30-EY14801]; African penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program	NIH center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); African penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program	This work was supported by internal laboratory funding and partly by NIH center grant P30-EY14801.; The authors are very grateful to Dr. Sophie Guyetant (CHU de Tours, France) for her precious assistance with the ethics and customs regulations, and to Parastou Moshiri for her technical help with beta-D-glucan measurement, and to Emilie Dalloneau for the rat protocol. We also thank the African penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program for supporting this study, as well as all institutions that enrolled their patients: California Academy of Sciences (San Francisco, CA, U.S.A.), Minnesota Zoo (Apple Valley, MN, U.S.A.), Busch Gardens (Tampa, FL, U.S.A.), Maryland Zoo (Baltimore, MA, U.S.A.), Tulsa Zoo, (Tulsa, OK, U.S.A.), Fort Wayne Children's Zoo (Fort Wayne, IN, U.S.A.), Georgia Aquarium (Atlanta, GA, U.S.A.), Mystic Aquarium (Mystic, CT, U.S.A.), and Cincinnati Zoo and Botanical Garden (Cincinnati, OH, U.S.A.).	Arendrup MC, 2012, BONE MARROW TRANSPL, V47, P1030, DOI 10.1038/bmt.2011.246; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Bonnet S, 2017, CURR RES TRANSL MED, V65, P77, DOI 10.1016/j.retram.2017.05.003; Bourassa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125934; Brasier AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143165; Bruser L, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029140; Chandenier J, 2009, MYCOSES, V52, P239, DOI 10.1111/j.1439-0507.2009.01695.x; COULOT P, 1994, INFECT IMMUN, V62, P2169, DOI 10.1128/IAI.62.6.2169-2177.1994; Cray C, 2011, J AVIAN MED SURG, V25, P102, DOI 10.1647/2010-019.1; Cray C, 2009, AVIAN DIS, V53, P491, DOI 10.1637/8673-030209-Reg.1; Cray C, 2009, J AVIAN MED SURG, V23, P125, DOI 10.1647/2007-041.1; Cray C, 2009, J ZOO WILDLIFE MED, V40, P64, DOI 10.1638/2007-0138.1; Csokai J, 2009, VET PARASITOL, V163, P18, DOI 10.1016/j.vetpar.2009.03.057; da Silva RP, 2015, J ZOO WILDLIFE MED, V46, P667, DOI 10.1638/2013-0092.1; Day MJ, 2009, MED MYCOL, V47, pS315, DOI 10.1080/13693780802056038; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Desoubeaux G, 2014, MED MALADIES INFECT, V44, P89, DOI 10.1016/j.medmal.2013.11.006; Desoubeaux G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177961; Desoubeaux G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00841; Desoubeaux G, 2014, INT J MED MICROBIOL, V304, P327, DOI 10.1016/j.ijmm.2013.11.015; Desoubeaux Guillaume, 2012, Methods Mol Biol, V845, P511, DOI 10.1007/978-1-61779-539-8_36; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Heldt S, 2017, CURR FUNGAL INFECT R, V11, P45, DOI 10.1007/s12281-017-0275-8; Hennigan Stephanie, 2008, Ther Clin Risk Manag, V4, P767; Jolink H, 2017, J INFECTION, V74, P81, DOI 10.1016/j.jinf.2016.10.010; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Komiya Yuko, 2008, Organogenesis, V4, P68; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Kuncewitch M, 2015, J TRAUMA ACUTE CARE, V78, P793, DOI 10.1097/TA.0000000000000566; Li GK, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017254; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Melloul E, 2014, COMP IMMUNOL MICROB, V37, P271, DOI 10.1016/j.cimid.2014.07.005; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moghaddam A, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0111-x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Oliva A, 2015, J CLIN MICROBIOL, V53, P248, DOI 10.1128/JCM.02690-14; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Patterson KC, 2014, CHEST, V146, P1358, DOI 10.1378/chest.14-0917; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schreml J, 2017, CURR PHARM DESIGN, V23, P1562, DOI 10.2174/1381612823666170125160108; Schweppe RE, 2003, ACCOUNTS CHEM RES, V36, P453, DOI 10.1021/ar020143l; Seyedmousavi S, 2015, MED MYCOL, V53, P765, DOI 10.1093/mmy/myv067; Speth C, 2004, MYCOSES, V47, P93, DOI 10.1111/j.1439-0507.2004.00979.x; Sulahian A, 2003, NEW ENGL J MED, V349, P2366, DOI 10.1056/NEJM200312113492424; Tang XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15119; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200; Winther Malene, 2014, Adv Neurobiol, V8, P315; Zhong X, 2017, AM J TRANSL RES, V9, P2920	57	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200843	10.1371/journal.pone.0200843	http://dx.doi.org/10.1371/journal.pone.0200843			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040865	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200014
J	Hollenbach, M; Kloting, N; Sommerer, I; Lorenz, J; Heindl, M; Kern, M; Mossner, J; Bluher, M; Hoffmeister, A				Hollenbach, Marcus; Kloeting, Nora; Sommerer, Ines; Lorenz, Jana; Heindl, Mario; Kern, Matthias; Moessner, Joachim; Blueher, Matthias; Hoffmeister, Albrecht			p8 deficiency leads to elevated pancreatic beta cell mass but does not contribute to insulin resistance in mice fed with high-fat diet	PLOS ONE			English	Article							NUCLEAR-PROTEIN P8; GLUCOSE-INTOLERANCE; IN-VIVO; EXPRESSION; SENSITIVITY; GENE; METABOLISM; APOPTOSIS; CLONING; RAT	Background p8 was initially described as being overexpressed in acute pancreatitis and encoding a ubiquitous stress protein. Analysis of insulin sensitivity and glucose tolerance in p8-knockout and haplodeficient mice revealed counterintuitive results. Thus, we determined glycemic control of p8 in mice fed with standard (SD) and high-fat diet (HFD). Methods p8(-/-) and wild type (p8(+/+)) mice were used for analysis of glucagon (immunohistochemistry), insulin levels (ELISA) and beta cell mass. Hyperinsulinemic-euglycemic glucose clamp technique, i.p. glucose tolerance test (ipGTT), i.p. insulin tolerance test (ipITT) and metabolic chamber analysis were performed in SD (4% fat) and HFD (55% fat) groups. Results p8(-/-) mice showed no differences in glucagon or insulin content but higher insulin secretion from pancreatic islets upon glucose stimulation. p8 deficiency resulted in elevated beta cell mass but was not associated with increased insulin resistance in ipGTT or ipITT. Glucose clamp tests also revealed no evidence of association of p8 deficiency with insulin resistance. Metabolic chamber analysis showed equal energy expenditure in p8(-/-) mice and wild type animals. Conclusion p8 depletion may contribute to glucose metabolism via stress-induced insulin production and elevated beta cell mass. Nevertheless, p8 knockout showed no impact on insulin resistance in SD and HFD-fed mice.	[Hollenbach, Marcus; Sommerer, Ines; Lorenz, Jana; Heindl, Mario; Moessner, Joachim; Hoffmeister, Albrecht] Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Med Neurol & Dermatol, Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Kern, Matthias] Univ Leipzig, German Diabet Ctr Leipzig, Leipzig, Germany; [Blueher, Matthias] Univ Leipzig, Dept Med Neurol & Dermatol, Div Endocrinol & Nephrol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Hollenbach, M (corresponding author), Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Med Neurol & Dermatol, Leipzig, Germany.	marcus.hollenbach@medizin.uni-leipzig.de	Hollenbach, Marcus/ABF-7452-2021		Deutsche Forschungsgemeinschaft [SFB 1052, SFB1052:B1, SFB1052:B4]; Federal Ministry of Education and Research (BMBF) [FKZ: 01EO1501, DZD82DZD00601]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work received support from "Deutsche Forschungsgemeinschaft", Grant SFB 1052, SFB1052:B1 and :B4, www.dfg.de; "Federal Ministry of Education and Research (BMBF)", www.bmbf.de, Grants FKZ: 01EO1501 and DZD82DZD00601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barbosa-Sampaio HC, 2015, BBA-MOL BASIS DIS, V1852, P962, DOI 10.1016/j.bbadis.2015.01.013; Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Beguinot Francesco, 2012, Methods Mol Biol, V933, P219, DOI 10.1007/978-1-62703-068-7_14; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler AE, 2016, J CLIN ENDOCR METAB, V101, P523, DOI 10.1210/jc.2015-3566; Chintinne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043959; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Hoffmeister A, 2002, J BIOL CHEM, V277, P22314, DOI 10.1074/jbc.M201657200; Jia Q, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.29; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Kallwellis K, 2006, HORM METAB RES, V38, P570, DOI 10.1055/s-2006-950503; Kern M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038744; Li J, 2017, J NEURO-ONCOL, V132, P15, DOI 10.1007/s11060-016-2337-0; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Malicet Cedric, 2003, Mol Cancer, V2, P37, DOI 10.1186/1476-4598-2-37; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Mu Yanchao, 2018, Autophagy, V14, P654, DOI 10.1080/15548627.2017.1338556; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005; Path G, 2004, DIABETES, V53, pS82, DOI 10.2337/diabetes.53.2007.S82; PEREZ VJ, 1980, PHYSIOL BEHAV, V24, P1185, DOI 10.1016/0031-9384(80)90070-0; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Pommier RM, 2012, BIOCHEM J, V445, P285, DOI 10.1042/BJ20120368; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Tiraby C, 2007, DIABETOLOGIA, V50, P2190, DOI 10.1007/s00125-007-0765-2; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222; Weis S, 2015, ARCH BIOCHEM BIOPHYS, V565, P89, DOI 10.1016/j.abb.2014.11.007; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Zeng Chensi, 2017, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V33, P1240	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201159	10.1371/journal.pone.0201159	http://dx.doi.org/10.1371/journal.pone.0201159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040846	Green Published, Green Submitted, gold			2022-12-27	WOS:000439749200028
J	Koster, K; Largen, A; Foster, JT; Drees, KP; Qian, LS; Desmond, EP; Wan, XH; Hou, SB; Douglas, JT				Koster, Kent; Largen, Angela; Foster, Jeffrey T.; Drees, Kevin P.; Qian, Lishi; Desmond, Edward P.; Wan, Xuehua; Hou, Shaobin; Douglas, James T.			Whole genome SNP analysis suggests unique virulence factor differences of the Beijing and Manila families of Mycobacterium tuberculosis found in Hawaii	PLOS ONE			English	Article							SIGMA-FACTOR SIGG; PROTEIN-KINASE G; UNITED-STATES; COMPLEX; REACTIVATION; GENOTYPE; SURVIVAL; STRAINS; OPERON; MUTANT	While tuberculosis (TB) remains a global disease, the WHO estimates that 62% of the incident TB cases in 2016 occurred in the WHO South-East Asia and Western Pacific regions. TB in the Pacific is composed predominantly of two genetic families of Mycobacterium tuberculosis (Mtb): Beijing and Manila. The Manila family is historically under-studied relative to the families that comprise the majority of TB in Europe and North America (e.g. lineage 4), and it remains unclear why this lineage has persisted in Filipino populations despite the predominance of more globally successful Mtb lineages in most of the world. The Beijing family is of particular interest as it is increasingly associated with drug resistance throughout the world. Both of these lineages are important to the State of Hawaii, where they comprise over two-thirds of TB cases. Here, we performed whole genome sequencing on 82 Beijing family, Manila family, and outgroup clinical Mtb isolates from Hawaii to identify lineage-specific SNPs (SNPs found in all isolates from their respective families, and exclusively in those families) in established virulence factor genes. Six non-silent lineage-specific virulence factor SNPs were found in the Beijing family, including mutations in alternative sigma factor sigG and polyketide synthases pks5 and pks7. The Manila family displayed more than eleven non-silent lineage-specific and characteristic virulence factor mutations, including in genes coding for MCE-family protein Mce1B, two mutations in fatty-acid-AMP ligase FadD26, and virulence-regulating transcriptional regulator VirS. This study further identified an ancient Glade that shared some virulence factor mutations with the Manila family, and investigated the relationship of those and other "Manila-like" spoligotypes to the Manila family with this SNP dataset. This work identified a set of virulence genes that are worth pursuing to determine potential differences in transmission or virulence displayed by these two Mtb families.	[Koster, Kent; Qian, Lishi; Douglas, James T.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Largen, Angela] Hawaii State Dept Hlth, Honolulu, HI USA; [Foster, Jeffrey T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA; [Drees, Kevin P.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Desmond, Edward P.] Calif Dept Publ Hlth, Richmond, CA USA; [Wan, Xuehua; Hou, Shaobin] Adv Studies Genom Prote & Bioinformat, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa; Northern Arizona University; University System Of New Hampshire; University of New Hampshire; California Department of Public Health	Douglas, JT (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	jtd379@gmail.com	Wan, Xuehua/AAE-4237-2022	Wan, Xuehua/0000-0002-6367-848X; Foster, Jeffrey/0000-0001-8235-8564	University of Hawaii Office of the Vice Chancellor for Research	University of Hawaii Office of the Vice Chancellor for Research	This study was funded in part by the University of Hawaii Office of the Vice Chancellor for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, GLOB TUB REP 2017; Bamrah S, 2014, ASIA-PAC J PUBLIC HE, V26, P77, DOI 10.1177/1010539512469249; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chambers HF, 1995, ANTIMICROB AGENTS CH, V39, DOI [10.1038/nm0914-976, DOI 10.1038/NM0914-976]; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Frink S, 2011, J CLIN MICROBIOL, V49, P1951, DOI 10.1128/JCM.01338-10; Gagneux S, 2018, NAT REV MICROBIOL, V16, P202, DOI 10.1038/nrmicro.2018.8; Gaudion A, 2013, TUBERCULOSIS, V93, P482, DOI 10.1016/j.tube.2013.05.005; Gopinath V, 2015, MOL CELL PROTEOMICS, V14, P2160, DOI 10.1074/mcp.M115.051151; Infante E, 2005, CLIN EXP IMMUNOL, V141, P21, DOI 10.1111/j.1365-2249.2005.02832.x; Kaufmann SHE, 2017, INT J INFECT DIS, V56, P263, DOI 10.1016/j.ijid.2016.10.018; Keener AB, 2014, NAT MED, V20, P976, DOI 10.1038/nm0914-976; Khan MZ, 2017, J BIOL CHEM, V292, P16093, DOI 10.1074/jbc.M117.797563; Koster K, 2015, 11 GEN M AM SOC MICR; Koster K, 2012, 12 GEN M AM SOC MICR; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2008, J BACTERIOL, V190, P1128, DOI 10.1128/JB.00511-07; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Liu QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.14; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Muttucumaru DGN, 2011, TUBERCULOSIS, V91, P111, DOI 10.1016/j.tube.2010.11.010; Qian L, 2001, 10 GEN M AM SOC MICR; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Rousseau C, 2003, MICROBIOL-SGM, V149, P1837, DOI 10.1099/mic.0.26278-0; Sahl JW, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000074; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Schmit KM, 2017, MMWR-MORBID MORTAL W, V66, P289, DOI 10.15585/mmwr.mm6611a2; Schurch AC, 2011, INFECT GENET EVOL, V11, P587, DOI 10.1016/j.meegid.2011.01.009; Sharma A, 2017, LANCET INFECT DIS, pS1473; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Singh R, 2005, TUBERCULOSIS, V85, P325, DOI 10.1016/j.tube.2005.08.015; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Team RC., 2022, LANG ENV STAT COMP; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wan XH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175330; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198; Zhou Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174197	52	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201146	10.1371/journal.pone.0201146	http://dx.doi.org/10.1371/journal.pone.0201146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036392	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200030
J	Lou, H; Wang, LM; Duan, DB; Yang, C; Mammadov, M				Lou, Hua; Wang, Limin; Duan, Dingbo; Yang, Cheng; Mammadov, Musa			RDE: A novel approach to improve the classification performance and expressivity of KDB	PLOS ONE			English	Article								Bayesian network classifiers (BNCs) have demonstrated competitive classification performance in a variety of real-world applications. A highly scalable BNC with high expressivity is extremely desirable. This paper proposes Redundant Dependence Elimination (RDE) for improving the classification performance and expressivity of k-dependence Bayesian classifier (KDB). To demonstrate the unique characteristics of each case, RDE identifies redundant conditional dependencies and then substitute/remove them. The learned personalized k-dependence Bayesian Classifier (PKDB) can achieve high-confidence conditional probabilities, and graphically interpret the dependency relationships between attributes. Two thyroid cancer datasets and four other cancer datasets from the UCI machine learning repository are selected for our experimental study. The experimental results prove the effectiveness of the proposed algorithm in terms of zero-one loss, bias, variance and AUC.	[Lou, Hua; Duan, Dingbo; Yang, Cheng] Changzhou Coll Informat Technol, Changzhou, Peoples R China; [Wang, Limin] Jilin Univ, Coll Comp Sci & Technol, Changchun, Jilin, Peoples R China; [Mammadov, Musa] Federat Univ, Fac Sci & Technol, Ballarat, Vic, Australia	Changzhou College of Information Technology; Jilin University; Federation University Australia	Lou, H (corresponding author), Changzhou Coll Informat Technol, Changzhou, Peoples R China.	ccit-louhua@139.com		Mammadov, Musa/0000-0002-2600-3379				Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Blanco R, 2005, J BIOMED INFORM, V38, P376, DOI 10.1016/j.jbi.2005.05.004; Bouckaert RR, 2006, LECT NOTES COMPUT SC, V4304, P243; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen SL, 2017, IEEE T KNOWL DATA EN, V29, P172, DOI 10.1109/TKDE.2016.2608881; Chen SL, 2013, J MACH LEARN RES, P1; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; CHURCH KW, 1990, 27TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P76; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fayyad UM, MULTIINTERVAL DISCRE; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Jiang LX, 2012, KNOWL-BASED SYST, V26, P239, DOI 10.1016/j.knosys.2011.08.010; Kittler J., 1986, HDB PATTERN RECOGNIT; Kohavi R., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P275; Louzada F, 2012, EXPERT SYST APPL, V39, P11583, DOI 10.1016/j.eswa.2012.04.024; Murphy PM., 1995, UCI REPOSITORY MACHI; Park SH, 2014, MACH LEARN, V96, P295, DOI 10.1007/s10994-013-5430-z; Pearl J., 1988, PROBABILISTIC REASON; Sahami M., 1996, P 2 INT C KNOWL DISC, P335; Shannon C.E., 1949, MATH THEORY COMMUNIC; Taheri S, 2015, OPTIM LETT, V9, P931, DOI 10.1007/s11590-014-0803-1; Wang LM, 2015, ENTROPY-SWITZ, V17, P4134, DOI 10.3390/e17064134; Wu J, 2014, J INTELL INF SYST, V42, P671, DOI 10.1007/s10844-013-0279-y; Zheng F., 2006, P 23 INT C MACH LEAR, P1113, DOI DOI 10.1007/S10994-011-5263-6; Zheng F, 2011, MACH LEARN, V87, P1947	26	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199822	10.1371/journal.pone.0199822	http://dx.doi.org/10.1371/journal.pone.0199822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036402	Green Published, Green Submitted, gold			2022-12-27	WOS:000439429200007
J	Johnson, WL; Ramachandran, A; Torres, NJ; Nicholson, AC; Whitney, AM; Bell, M; Villarma, A; Humrighouse, BW; Sheth, M; Dowd, SE; McQuiston, JR; Gustafson, JE				Johnson, William L.; Ramachandran, Akhilesh; Torres, Nathaniel J.; Nicholson, Ainsley C.; Whitney, Anne M.; Bell, Melissa; Villarma, Aaron; Humrighouse, Ben W.; Sheth, Mili; Dowd, Scot E.; McQuiston, John R.; Gustafson, John E.			The draft genomes of Elizabethkingia anophelis of equine origin are genetically similar to three isolates from human clinical specimens	PLOS ONE			English	Article							CHRYSEOBACTERIUM-MENINGOSEPTICUM OUTBREAK; MULTIPLE-ANTIBIOTIC-RESISTANCE; INFECTIOUS-DISEASES SOCIETY; HEALTH-SYSTEM PHARMACISTS; MULTIDRUG EFFLUX PUMP; FLAVOBACTERIUM-MENINGOSEPTICUM; BETA-LACTAMASE; STAPHYLOCOCCUS-AUREUS; GYRA GENE; CONSENSUS RECOMMENDATIONS	We report the isolation and characterization of two Elizabethkingia anophelis strains (OSUVM-1 and OSUVM-2) isolated from sources associated with horses in Oklahoma. Both strains appeared susceptible to fluoroquinolones and demonstrated high MICs to all cell wall active antimicrobials including vancomycin, along with aminoglycosides, fusidic acid, chloramphenicol, and tetracycline. Typical of the Elizabethkingia, both draft genomes contained multiple copies of beta-lactamase genes as well as genes predicted to function in antimicrobial efflux. Phylogenetic analysis of the draft genomes revealed that OSUVM-1 and OSUVM-2 differ by only 6 SNPs and are in a Glade with 3 strains of Elizabethkingia anophelis that were responsible for human infections. These findings therefore raise the possibility that Elizabethkingia might have the potential to move between humans and animals in a manner similar to known zoonotic pathogens.	[Johnson, William L.; Torres, Nathaniel J.; Gustafson, John E.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Ramachandran, Akhilesh] Oklahoma State Univ, Ctr Vet Hlth Sci, Oklahoma Anim Dis Diagnost Lab, Stillwater, OK 74078 USA; [Nicholson, Ainsley C.; Whitney, Anne M.; Bell, Melissa; Villarma, Aaron; Humrighouse, Ben W.; McQuiston, John R.] Ctr Dis Control & Prevent, Special Bacteriol Reference Lab, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Sheth, Mili] Ctr Dis Control & Prevent, Div Sci Resources, Atlanta, GA USA; [Dowd, Scot E.] Mol Res DNA Lab, Shallowater, TX USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Gustafson, JE (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.; Ramachandran, A (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Oklahoma Anim Dis Diagnost Lab, Stillwater, OK 74078 USA.	rakhile@okstate.edu; john.gustafson@okstate.edu		Johnson, William/0000-0003-2616-2553	Oklahoma Agricultural Experiment Station; Advanced Molecular Detection (AMD) initiative	Oklahoma Agricultural Experiment Station; Advanced Molecular Detection (AMD) initiative	WLJ, NJT and JEG acknowledge support from the Oklahoma Agricultural Experiment Station (http://oaes.okstate.edu/). CDC research was supported by the Advanced Molecular Detection (AMD) initiative (https://www.cdc.gov/amd/index.html). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER RC, 1978, ANTIMICROB AGENTS CH, V14, P483, DOI 10.1128/AAC.14.3.483; Agarwal S, 2017, J CLIN DIAGN RES, V11, pDC4, DOI 10.7860/JCDR/2017/24023.9317; ALTMANN G, 1971, J MED MICROBIOL, V4, P296, DOI 10.1099/00222615-4-2-296; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BAQUERO F, 1990, EUR UROL, V17, P3; BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507; Bordelo J, 2016, CAN VET J, V57, P994; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Cambau E, 1993, Drugs, V45 Suppl 3, P15; Centers for Disease Control and Prevention, 2016, RECENT OUTBREAKS; Ceyhan M, 2008, AM J INFECT CONTROL, V36, P453, DOI 10.1016/j.ajic.2007.09.008; Chang JC, 1997, ANTIMICROB AGENTS CH, V41, P1301, DOI 10.1128/AAC.41.6.1301; Chung Y. J., 2001, CURRENT OPINION DRUG, V4, P237; Damborg P, 2004, J CLIN MICROBIOL, V42, P1363, DOI 10.1128/JCM.42.3.1363-1364.2004; de Carvalho Filho E. B., 2017, New Microbes and New Infections, V20, P27, DOI 10.1016/j.nmni.2017.09.002; Di Pentima MC, 1998, CLIN INFECT DIS, V26, P1169, DOI 10.1086/520309; Dias M, 2010, Indian J Nephrol, V20, P203, DOI 10.4103/0971-4065.73460; Doijad S, 2016, INT J SYST EVOL MICR, V66, P4555, DOI 10.1099/ijsem.0.001390; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Dziuban EJ, 2018, CLIN INFECT DIS, V67, P144, DOI 10.1093/cid/cix1052; FASS RJ, 1980, REV INFECT DIS, V2, P841; Finch NA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01293-17, 10.1128/aac.01293-17]; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Frank T, 2013, LANCET, V381, P1876, DOI 10.1016/S0140-6736(13)60318-9; Fraser SL, 1997, ANTIMICROB AGENTS CH, V41, P2738, DOI 10.1128/AAC.41.12.2738; Garay JAR, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00084-16; Gonzalez LJ, 2012, ANTIMICROB AGENTS CH, V56, P1686, DOI 10.1128/AAC.05835-11; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Guardabassi L, 2004, VET MICROBIOL, V98, P23, DOI 10.1016/j.vetmic.2003.09.021; GUMP DW, 1981, REV INFECT DIS, V3, pS289; Gungor S, 2003, INFECT CONT HOSP EP, V24, P613, DOI 10.1086/502261; Gupta P, 2017, WORLD J CLIN CASES, V5, P187, DOI 10.12998/wjcc.v5.i5.187; HAZUKA BT, 1977, J CLIN MICROBIOL, V6, P450; Hu RX, 2017, EMERG INFECT DIS, V23, P2055, DOI 10.3201/eid2312.170942; Jacobs A, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-16; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Jean SS, 2014, J HOSP INFECT, V86, P244, DOI 10.1016/j.jhin.2014.01.009; Jean SS, 2017, INT J ANTIMICROB AG, V50, P507, DOI 10.1016/j.ijantimicag.2017.06.021; Jiang HY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02073; Kampfer P, 2015, INT J SYST EVOL MICR, V65, P2187, DOI 10.1099/ijs.0.000236; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kenna DTD, 2018, DIAGN MICR INFEC DIS, V90, P109, DOI 10.1016/j.diagmicrobio.2017.10.014; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; KING EO, 1959, AM J CLIN PATHOL, V31, P241; Kukutla P, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01030-13; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lau SKP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26045; Lee D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01181-15; LEWIN CS, 1990, J MED MICROBIOL, V31, P153, DOI 10.1099/00222615-31-3-153; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14841-8; Lin PY, 2004, J CLIN MICROBIOL, V42, P3353, DOI 10.1128/JCM.42.7.3353-3355.2004; Lin XH, 2012, INT J ANTIMICROB AG, V40, P186, DOI 10.1016/j.ijantimicag.2012.03.020; Lothuvachai T, 2006, AM J KIDNEY DIS, V48, pE49, DOI 10.1053/j.ajkd.2006.07.010; Lozano C, 2011, CLIN MICROBIOL INFEC, V17, P923, DOI 10.1111/j.1469-0691.2010.03437.x; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Matsumoto T, 2012, ANTIMICROB AGENTS CH, V56, P588, DOI 10.1128/AAC.05165-11; Matyi SA, 2013, J DAIRY SCI, V96, P3535, DOI 10.3168/jds.2013-6590; Mee PT, 2017, EMERG INFECT DIS, V23, P1409, DOI 10.3201/eid2308.161565; Mine T, 1999, ANTIMICROB AGENTS CH, V43, P415, DOI 10.1128/AAC.43.2.415; Mirza HC, 2018, MICROB DRUG RESIST, V24, P816, DOI 10.1089/mdr.2017.0206; Montrucchio G, 2018, INFECTION, V46, P123, DOI 10.1007/s15010-017-1055-7; Moore LSP, 2016, EMERG INFECT DIS, V22, P9, DOI 10.3201/eid2201.150139; Moran-Barrio J, 2016, ANTIMICROB AGENTS CH, V60, P6013, DOI 10.1128/AAC.01067-16; Navon L, 2016, MMWR-MORBID MORTAL W, V65, P1380, DOI 10.15585/mmwr.mm6548a6; Neuner EA, 2012, J ANTIMICROB CHEMOTH, V67, P1558, DOI 10.1093/jac/dks053; Nicholson AC, 2018, ANTON LEEUW INT J G, V111, P55, DOI 10.1007/s10482-017-0926-3; Nicholson AC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00045-16; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Opota O, 2017, INT J ANTIMICROB AG, V49, P93, DOI 10.1016/j.ijantimicag.2016.09.031; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pei D, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01359-17, 10.1128/genomea.01359-17]; Perrin A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15483; PLOTKIN SA, 1966, J AMER MED ASSOC, V198, P662, DOI 10.1001/jama.198.6.662; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Pumbwe L, 2002, FEMS MICROBIOL LETT, V206, P185, DOI 10.1111/j.1574-6968.2002.tb11007.x; Rossolini GM, 1999, ANTIMICROB AGENTS CH, V43, P2193, DOI 10.1128/AAC.43.9.2193; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; RUIZ J, 1995, J ANTIMICROB CHEMOTH, V36, P737, DOI 10.1093/jac/36.4.737; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2009, PHARMACOTHERAPY, V29, P1275, DOI 10.1592/phco.29.11.1275; SADER HS, 1995, CLIN INFECT DIS, V21, P997, DOI 10.1093/clinids/21.4.997; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schindler BD, 2015, ANTIMICROB AGENTS CH, V59, P747, DOI 10.1128/AAC.04678-14; Schmitz FJ, 2002, EUR J CLIN MICROBIOL, V21, P647, DOI 10.1007/s10096-002-0788-z; Sebastiampillai BS, 2018, TROP DOCT, V48, P62, DOI 10.1177/0049475517717135; SMITH JT, 1986, J ANTIMICROB CHEMOTH, V18, P21, DOI 10.1093/jac/18.Supplement_D.21; Soman Rajeev, 2016, J Assoc Physicians India, V64, P98; Tai IC, 2017, J HOSP INFECT, V96, P168, DOI 10.1016/j.jhin.2016.11.018; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tekerekoglu MS, 2003, MICROBIOLOGICA, V26, P57; Teo J, 2014, GENOME BIOL EVOL, V6, P1158, DOI 10.1093/gbe/evu094; Teo J, 2013, LANCET, V382, P855, DOI 10.1016/S0140-6736(13)61858-9; TIZER KB, 1995, PEDIATR INFECT DIS J, V14, P916; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Tseng MH, 2009, CLIN KIDNEY J, V2, P433, DOI 10.1093/ndtplus/sfp080; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; WOLFSON JS, 1989, REV INFECT DIS, V11, pS960; YOSHIDA H, 1988, MOL GEN GENET, V211, P1, DOI 10.1007/BF00338386; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA T, 1994, ANTIMICROB AGENTS CH, V38, P1466, DOI 10.1128/AAC.38.7.1466	109	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200731	10.1371/journal.pone.0200731	http://dx.doi.org/10.1371/journal.pone.0200731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024943	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000044
J	Xu, YM; Zhang, K; Miao, JL; Zhao, P; Lv, MH; Li, J; Fu, XH; Luo, X; Zhu, P				Xu, Yingming; Zhang, Kui; Miao, Jinlin; Zhao, Peng; Lv, Minghua; Li, Jia; Fu, Xianghui; Luo, Xing; Zhu, Ping			The spinal NR2BR/ERK2 pathway as a target for the central sensitization of collagen-induced arthritis pain	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; NEUROPATHIC PAIN; DORSAL-HORN; RECEPTORS; TRAMADOL; HYPERSENSITIVITY; PHOSPHORYLATION; HYPERALGESIA; INFLAMMATION; CONTRIBUTES	Objective Pain management is a huge challenge in the treatment of rheumatoid arthritis (RA), and central sensitization is reportedly involved in the development of pain. The current study was undertaken to explore the possible role of N-methyl-D-aspartate receptors (NMDARs) in the spinal mechanism of central sensitization in RA using a collagen-induced arthritis (CIA) model. Methods Mechanical hypersensitivity was assessed in C57BL/6 mice, before and after the induction of CIA via administration of chick type II collagen. Analgesic drugs, receptor antagonist, and kinase inhibitor were administrated intrathecally in the spinal cord. Protein expression and phosphorylation changes were detected via immunoblotting. Results CIA mice developed significant mechanical hypersensitivity, and spinal administration of the NMDAR antagonist D-2-amino-5-phosphonovaleric acid (D-APV) effectively attenuated peripheral pain hypersensitivity. There was specific enhancement of synaptic NR2B-containing NMDAR (NR2BR) expression in the spinal dorsal horns of the mice. Both the increased total protein expression of NR2B subunit and the enhanced total phosphorylation level of NR2B subunit at 1472 tyrosine promoted the synaptic expression of NMDAR in the mice. Intrathecal injection of tramadol suppressed synaptic NMDAR expression mainly by changing the synaptic phosphorylation state of NR2B subunit at Tyr1472. Extracellular signal-regulated protein kinases 2 (ERK2) activity synchronized with the synaptic expression of NR2BR, which was downregulated by the action of tramadol. Conclusion Specific enhancement of NR2BR in the spinal dorsal horn may be vital for central sensitization in the CIA model of RA. The NR2BR/ERK2 pathway may be a promising target for pain management in RA patients.	[Xu, Yingming; Zhang, Kui; Miao, Jinlin; Zhao, Peng; Lv, Minghua; Li, Jia; Fu, Xianghui; Luo, Xing; Zhu, Ping] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian, Shaanxi, Peoples R China; [Zhao, Peng] Hanzhong 3201 Hosp, Dept Hematol & Rheumatol, Hanzhong, Peoples R China	Air Force Military Medical University	Zhu, P (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian, Shaanxi, Peoples R China.	zhuping@fmmu.edu.cn		Zhu, Ping/0000-0002-8391-4945	National Basic Research Program of China [2015CB553704]; National Natural Science Foundation of China [81701640]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China (NO. 2015CB553704) and the National Natural Science Foundation of China (no. 81701640).	Alter BJ, 2010, J NEUROSCI, V30, P11537, DOI 10.1523/JNEUROSCI.6103-09.2010; Bameri B, 2018, INT J TOXICOL, V37, P164, DOI 10.1177/1091581817753607; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Hama A, 2003, EUR J PHARMACOL, V459, P49, DOI 10.1016/S0014-2999(02)02828-5; Hara K, 2005, ANESTH ANALG, V100, P1400, DOI 10.1213/01.ANE.0000150961.24747.98; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Inglis JJ, 2007, ARTHRITIS RHEUM-US, V56, P4015, DOI 10.1002/art.23063; Jesse CR, 2010, PHARMACOLOGY, V85, P36, DOI 10.1159/000265551; Konig C, 2014, ARTHRITIS RHEUMATOL, V66, P599, DOI 10.1002/art.38271; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Li C, 2012, J ANESTH, V26, P230, DOI 10.1007/s00540-011-1267-4; Li S, 2011, J NEUROSCI RES, V89, P1869, DOI 10.1002/jnr.22719; Li YL, 2018, EUR J PHARMACOL, V818, P167, DOI 10.1016/j.ejphar.2017.10.041; Liu HP, 2017, J PHYSIOL SCI, V67, P197, DOI 10.1007/s12576-016-0456-1; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Luo JG, 2014, ARTHRITIS RHEUMATOL, V66, P896, DOI 10.1002/art.38328; Mannelli LD, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/905360; Nieto FR, 2015, ARTHRITIS RHEUMATOL, V67, P1668, DOI 10.1002/art.39082; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sarantis K, 2015, J NEUROCHEM, V135, P714, DOI 10.1111/jnc.13291; ten Klooster PM, 2007, ANN RHEUM DIS, V66, P1485, DOI 10.1136/ard.2007.069765; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vazquez E, 2012, ARTHRITIS RHEUM-US, V64, P2233, DOI 10.1002/art.34384; Walsh DA, 2014, NAT REV RHEUMATOL, V10, P581, DOI 10.1038/nrrheum.2014.64; Wang D, 2016, ONCOTARGET, V7, P85564, DOI 10.18632/oncotarget.9447; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Xu YM, 2015, EUR J PAIN, V19, P1298, DOI 10.1002/ejp.660; Yamasaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125147; Yanarates O, 2010, ANESTHESIOLOGY, V112, P696, DOI 10.1097/ALN.0b013e3181cd7920; Yang HB, 2011, J NEUROCHEM, V116, P93, DOI 10.1111/j.1471-4159.2010.07088.x; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Yang X, 2009, PAIN, V144, P162, DOI 10.1016/j.pain.2009.04.005	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201021	10.1371/journal.pone.0201021	http://dx.doi.org/10.1371/journal.pone.0201021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024967	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000077
J	Oliveras, A; Baro, A; Montesinos, L; Badosa, E; Montesinos, E; Feliu, L; Planas, M				Oliveras, Angel; Baro, Aina; Montesinos, Laura; Badosa, Esther; Montesinos, Emilio; Feliu, Lidia; Planas, Marta			Antimicrobial activity of linear lipopeptides derived from BP100 towards plant pathogens	PLOS ONE			English	Article							CATIONIC LIPOPEPTIDES; CYCLIC LIPOPEPTIDES; PEPTIDES; ANTIFUNGAL; ANTIBACTERIAL; CONJUGATION; BACTERIAL; BACILLUS; FUNGAL; UNDECAPEPTIDES	A collection of 36 lipopeptides were designed from the cecropin A-melittin hybrid peptide BP100 (H-Lys-Lys-Leu-Phe-Lys-Lys-Ile-Leu-Lys-Tyr-Leu-NH2) previously described with activity against phytopathogenic bacteria. These lipopeptides were synthesized on solid-phase and screened for their antimicrobial activity, toxicity and proteolytic stability. They incorporated a butanoyl, a hexanoyl or a lauroyl group at the N-terminus or at the side chain of a lysine residue placed at each position of the sequence. Their antimicrobial activity and hemolysis depended on the fatty acid length and its position. In particular, lipopeptides containing a butanoyl or a hexanoyl chain exhibited the best biological activity profile. In addition, we observed that the incorporation of the acyl group did not induce the overexpression of defense-related genes in tomato. Best lipopeptides were BP370, BP378, BP381, BP387 and BP389, which were highly active against all the pathogens tested (minimum inhibitory concentration of 0.8 to 12.5 mu M), low hemolytic, low phytotoxic and significantly stable to protease degradation. This family of lipopeptides might be promising functional peptides useful for plant protection.	[Oliveras, Angel; Feliu, Lidia; Planas, Marta] Univ Girona, LIPPSO, Dept Chem, Campus Montilivi, Girona, Spain; [Baro, Aina; Montesinos, Laura; Badosa, Esther; Montesinos, Emilio] Univ Girona, Inst Food & Agr Technol CIDSAV XaRTA, Lab Plant Pathol, Campus Montilivi, Girona, Spain	Universitat de Girona; Universitat de Girona	Feliu, L; Planas, M (corresponding author), Univ Girona, LIPPSO, Dept Chem, Campus Montilivi, Girona, Spain.	lidia.feliu@udg.edu; marta.planas@udg.edu	Planas, Marta/E-4145-2015; Feliu, Lidia/H-8285-2015; Romañó, Esther Badosa/H-3342-2015; MONTESINOS, EMILIO/H-5246-2015	Planas, Marta/0000-0003-4988-4970; Feliu, Lidia/0000-0001-9792-6106; Romañó, Esther Badosa/0000-0001-7776-8286; MONTESINOS, EMILIO/0000-0003-4455-8332	Ministerio de Economia y Competitividad [AGL2012-39880-C02-02, AGL2015-69876-C2-2-R]; University of Girona [MPCUDG2016/038]	Ministerio de Economia y Competitividad(Spanish Government); University of Girona	The work was supported by the following: Ministerio de Economia y Competitividad (ES); AGL2012-39880-C02-02; LM, EB, EM, LF, MP; Ministerio de Economia y Competitividad (ES); AGL2015-69876-C2-2-R; AO, LM, EB, EM, LF, MP; University of Girona (ES); MPCUDG2016/038; AO, LF, MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Badosa E, 2017, J PLANT PATHOL, V99, P65, DOI 10.4454/jpp.v99i0.3915; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Badosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085515; Badosa E, 2009, APPL ENVIRON MICROB, V75, P5563, DOI 10.1128/AEM.00711-09; Bektas Y, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00804; Bionda N, 2016, EUR J MED CHEM, V108, P354, DOI 10.1016/j.ejmech.2015.11.032; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Brotman Y, 2009, APPL ENVIRON MICROB, V75, P5373, DOI 10.1128/AEM.00724-09; Camo C, 2017, MOLECULES, V22, DOI 10.3390/molecules22111817; Chu-Kung AF, 2004, BIOCONJUGATE CHEM, V15, P530, DOI 10.1021/bc0341573; Cochrane SA, 2016, MED RES REV, V36, P4, DOI 10.1002/med.21321; Dalboge LS, 2015, J PEPT SCI, V21, P85, DOI 10.1002/psc.2727; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Goodwin D, 2012, CURR MED CHEM, V19, P4451, DOI 10.2174/092986712803251548; Guell I, 2017, BIOPOLYMERS, V108, DOI 10.1002/bip.23012; Guryanov I, 2016, J PEPT SCI, V22, P471, DOI 10.1002/psc.2890; HAZEL W J, 1980, Plant Disease, V64, P178; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohan S, 2013, CHEM BIOL DRUG DES, V82, P557, DOI 10.1111/cbdd.12182; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Malmsten M, 2016, CURR TOP MED CHEM, V16, P16, DOI 10.2174/1568026615666150703121518; Mandal SM, 2013, BIOTECHNOL ADV, V31, P338, DOI 10.1016/j.biotechadv.2013.01.004; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Meena KR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/473050; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Montesinos E, 2012, ACS SYM SER, V1095, P235; Ng-Choi I, 2014, PROTEIN PEPTIDE LETT, V21, P357, DOI 10.2174/09298665113206660103; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Patel S, 2015, WORLD J MICROB BIOT, V31, P1177, DOI 10.1007/s11274-015-1880-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Rajasekaran K., 2012, ACS S SERIES; Schmidtchen A, 2014, ADV COLLOID INTERFAC, V205, P265, DOI 10.1016/j.cis.2013.06.009; Shai Y, 2006, CURR PROTEIN PEPT SC, V7, P479, DOI 10.2174/138920306779025620; Slootweg JC, 2013, BIOORG MED CHEM LETT, V23, P3749, DOI 10.1016/j.bmcl.2013.05.002; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Strieker M, 2009, CHEMBIOCHEM, V10, P607, DOI 10.1002/cbic.200800546; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; Thennarasu S, 2005, BBA-BIOMEMBRANES, V1711, P49, DOI 10.1016/j.bbamem.2005.02.010; Humpola MV, 2017, J PEPT SCI, V23, P45, DOI 10.1002/psc.2958; Vidaver AK, 2002, CLIN INFECT DIS, V34, pS107, DOI 10.1086/340247; Vila S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151639	53	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201571	10.1371/journal.pone.0201571	http://dx.doi.org/10.1371/journal.pone.0201571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052685	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600050
J	Urkup, C; Bozkaya, B; Salman, FS				Urkup, Cagan; Bozkaya, Burcin; Salman, F. Sibel			Customer mobility signatures and financial indicators as predictors in product recommendation	PLOS ONE			English	Article								The rapid growth of mobile payment and geo-aware systems as well as the resulting emergence of Big Data present opportunities to explore individual consuming patterns across space and time. Here we analyze a one-year transaction dataset of a leading commercial bank to understand to what extent customer mobility behavior and financial indicators can predict the use of a target product, namely the Individual Consumer Loan product. After data preprocessing, we generate 13 datasets covering different time intervals and feature groups, and test combinations of 3 feature selection methods and 10 classification algorithms to determine, for each dataset, the best feature selection method and the most influential features, and the best classification algorithm. We observe the importance of spatio-temporal mobility features and financial features, in addition to demography, in predicting the use of this exemplary product with high accuracy (AUC = 0.942). Finally, we analyze the classification results and report on most interesting customer characteristics and product usage implications. Our findings can be used to potentially increase the success rates of product recommendation systems.	[Urkup, Cagan; Salman, F. Sibel] Koc Univ, Dept Ind Engn, Istanbul, Turkey; [Bozkaya, Burcin] Sabanci Univ, Sch Management, Istanbul, Turkey	Koc University; Sabanci University	Salman, FS (corresponding author), Koc Univ, Dept Ind Engn, Istanbul, Turkey.	ssalman@ku.edu.tr	Bozkaya, Burcin/AAY-8995-2020; Salman, Fatma Sibel/I-4548-2012	Bozkaya, Burcin/0000-0002-3685-4791; Salman, Fatma Sibel/0000-0001-6833-2552				Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Choi SH, 2006, EXPERT SYST APPL, V31, P607, DOI 10.1016/j.eswa.2005.09.074; Edwards C, 2010, NEW ELECTRON, V43, P19; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Liu DR, 2005, INFORM MANAGE-AMSTER, V42, P387, DOI 10.1016/j.im.2004.01.008; Martin-Fernandez JA, 2003, MATH GEOL, V35, P253, DOI 10.1023/A:1023866030544; Moro E., 2012, SCI REPORTS, V3, P1645; Noulas A, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P144, DOI 10.1109/SocialCom-PASSAT.2012.70; Park YJ, 2009, EXPERT SYST APPL, V36, P1932, DOI 10.1016/j.eswa.2007.12.034; Riyaz PA, 2016, PROC TECH, V24, P1393, DOI 10.1016/j.protcy.2016.05.159; Rodrigues F, 2016, PROCEDIA COMPUT SCI, V100, P136, DOI 10.1016/j.procs.2016.09.133; Sanchez-Moreno D, 2016, EXPERT SYST APPL, V66, P234, DOI 10.1016/j.eswa.2016.09.019; Shlens J., 2005, TUTORIAL PRINCIPAL C; Singh VK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136628; Sobolevsky S, 2014, IEEE INT CONGR BIG, P136, DOI 10.1109/BigData.Congress.2014.28; Sola J, 1997, IEEE T NUCL SCI, V44, P1464, DOI 10.1109/23.589532; TUIK, 2017, ADRESE DAYALI NUFUS; Wang CM, 2009, EXPERT SYST APPL, V36, P5900, DOI 10.1016/j.eswa.2008.07.026	22	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201197	10.1371/journal.pone.0201197	http://dx.doi.org/10.1371/journal.pone.0201197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052681	gold, Green Published			2022-12-27	WOS:000440006600028
J	Chabanon, A; Seferian, AM; Daron, A; Pereon, Y; Cances, C; Vuillerot, C; De Waele, L; Cuisset, JM; Laugel, V; Schara, U; Gidaro, T; Gilabert, S; Hogrel, JY; Baudin, PY; Carlier, P; Fournier, E; Lowes, LP; Hellbach, N; Seabrook, T; Toledano, E; Annoussamy, M; Servais, L				Chabanon, Aurelie; Seferian, Andreea Mihaela; Daron, Aurore; Pereon, Yann; Cances, Claude; Vuillerot, Carole; De Waele, Liesbeth; Cuisset, Jean-Marie; Laugel, Vincent; Schara, Ulrike; Gidaro, Teresa; Gilabert, Stephanie; Hogrel, Jean-Yves; Baudin, Pierre-Yves; Carlier, Pierre; Fournier, Emmanuel; Lowes, Linda Pax; Hellbach, Nicole; Seabrook, Timothy; Toledano, Elie; Annoussamy, Melanie; Servais, Laurent		NatHis-SMA Study Grp	Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study	PLOS ONE			English	Article							NASAL INSPIRATORY PRESSURE; MOTOR FUNCTION MEASURE; 6-MINUTE WALK TEST; OUTCOME MEASURES; NEUROMUSCULAR DISEASES; HEALTHY-SUBJECTS; MUSCLE STRENGTH; CLINICAL-TRIALS; CHILDREN; VALUES	Spinal muscular atrophy (SMA) is a monogenic disorder caused by loss of function mutations in the survival motor neuron 1 gene, which results in a broad range of disease severity, from neonatal to adult onset. There is currently a concerted effort to define the natural history of the disease and develop outcome measures that accurately capture its complexity. As several therapeutic strategies are currently under investigation and both the FDA and EMA have recently approved the first medical treatment for SMA, there is a critical need to identify the right association of responsive outcome measures and biomarkers for individual patient follow-up. As an approved treatment becomes available, untreated patients will soon become rare, further intensifying the need for a rapid, prospective and longitudinal study of the natural history of SMA Type 2 and 3. Here we present the baseline assessments of 81 patients aged 2 to 30 years of which 19 are non-sitter SMA Type 2, 34 are sitter SMA Type 2, 9 non-ambulant SMA Type 3 and 19 ambulant SMA Type 3. Collecting these data at nine sites in France, Germany and Belgium established the feasibility of gathering consistent data from numerous and demanding assessments in a multicenter SMA study. Most assessments discriminated between the four groups well. This included the Motor Function Measure (MFM), pulmonary function testing, strength, electroneuromyography, muscle imaging and workspace volume. Additionally, all of the assessments showed good correlation with the MFM score. As the untreated patient population decreases, having reliable and valid multi-site data will be imperative for recruitment in clinical trials. The pending two-year study results will evaluate the sensitivity of the studied outcomes and biomarkers to disease progression.	[Chabanon, Aurelie; Seferian, Andreea Mihaela; Gidaro, Teresa; Gilabert, Stephanie; Hogrel, Jean-Yves; Carlier, Pierre; Fournier, Emmanuel; Annoussamy, Melanie; Servais, Laurent] GH Pitie Salpetriere, Inst Myol, Paris, France; [Daron, Aurore; Servais, Laurent] CHU Liege, Ctr Reference Malad Neuromusculaires, Liege, Belgium; [Pereon, Yann] Hop Hotel Dieu, Ctr Reference Malad Neuromusculaires Atlantique O, Nantes, France; [Cances, Claude] Hop Enfants, Ctr Reference Malad Neuromusculaires, Toulouse, France; [Cances, Claude] Hop Enfants, Unite Neurol Pediat, Toulouse, France; [Vuillerot, Carole] CHU Lyon, Hop Mere Enfant, Serv Reeduc Pediat Infantile LEscale, Lyon, France; [De Waele, Liesbeth] Univ Hosp Leuven, Dept Pediat Neurol, Leuven, Belgium; [De Waele, Liesbeth] KU Leuven Kulak Kortijk, Dept Dev & Regenerat, Kortrijk, Belgium; [Cuisset, Jean-Marie] Hop Roger Salengro, Ctr Reference Malad Neuromusculaires, Lille, France; [Cuisset, Jean-Marie] Hop Roger Salengro, Serv Neuropediat, Lille, France; [Laugel, Vincent] CHU Strasbourg Hautepierre, INSERM, CIC 1434, Neuropediat, Strasbourg, France; [Schara, Ulrike] Univ Essen Gesamthsch, Paediat Neurol & Neuromuscular Ctr, Essen, Germany; [Baudin, Pierre-Yves] CRIS, Tournai, Belgium; [Lowes, Linda Pax] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA; [Hellbach, Nicole; Seabrook, Timothy] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Basel, Switzerland; [Toledano, Elie] Inst Roche, Paris, France; [Servais, Laurent] CHU Liege, Serv Pediat, Liege, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Liege; Nantes Universite; CHU de Nantes; CHU de Toulouse; CHU de Toulouse; CHU Lyon; KU Leuven; University Hospital Leuven; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Duisburg Essen; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Roche Holding; University of Liege	Servais, L (corresponding author), GH Pitie Salpetriere, Inst Myol, Paris, France.; Servais, L (corresponding author), CHU Liege, Ctr Reference Malad Neuromusculaires, Liege, Belgium.; Servais, L (corresponding author), CHU Liege, Serv Pediat, Liege, Belgium.	l.servais@institut-myologie.org	Servais, Laurent/AAL-7384-2020; Lowes, Linda Pax/C-9471-2009	laugel, vincent/0000-0002-5782-6538; Servais, Laurent/0000-0001-9270-4061; Hogrel, Jean-Yves/0000-0003-0045-7505; Chabanon, Aurelie/0000-0001-8740-6924; Toledano, Elie/0000-0002-7190-0052	Institut Roche; Association Institut de Myologie	Institut Roche; Association Institut de Myologie	The NatHis-SMA study is co-funded by Institut Roche and Association Institut de Myologie. Both funders played a role in the study design, data analysis, decision to publish and preparation of the manuscript. Among the authors, Nicole Hellbach, Timothy Seabrook and Elie Toledano are employees of the F. Hoffmann-La Roche group, whereas Pierre-Yves Baudin is employee of Consultants for Research in Imaging and Spectroscopy (CRIS). We confirm these authors contributions reflects the respective roles they had in the study.	Azzabou N, 2015, J MAGN RESON IMAGING, V41, P645, DOI 10.1002/jmri.24613; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Bertini E, 2017, LANCET NEUROL; Bianchi C, 2008, AM J PHYS MED REHAB, V87, P461, DOI 10.1097/PHM.0b013e318174e4c7; Bonati U, 2017, ANN CLIN TRANSL NEUR, V4, P292, DOI 10.1002/acn3.406; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; Carlier PG, 2014, NEUROMUSCULAR DISORD, V24, P390, DOI 10.1016/j.nmd.2014.02.009; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; de Lattre C, 2013, ARCH PHYS MED REHAB, V94, P2218, DOI 10.1016/j.apmr.2013.04.001; Dunaway S, 2016, J PEDIATR REHAB MED, V9, P35, DOI 10.3233/PRM-160360; Farrar MA, 2013, J PEDIATR-US, V162, P155, DOI 10.1016/j.jpeds.2012.05.067; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Fujak Albert, 2005, Ortop Traumatol Rehabil, V7, P175; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hogrel JY, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0612-4; Iannaccone ST, 2003, ARCH NEUROL-CHICAGO, V60, P1130, DOI 10.1001/archneur.60.8.1130; Kang PB, 2014, MUSCLE NERVE, V49, P636, DOI 10.1002/mus.23967; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Khirani S, 2013, EUR J PAEDIATR NEURO, V17, P552, DOI 10.1016/j.ejpn.2013.04.004; Kobayashi DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060113; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Le Moing AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156696; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Lowes LP, 2015, MUSCLE NERVE, V52, P356, DOI 10.1002/mus.24557; Mazzone E, 2014, NEUROMUSCULAR DISORD, V24, P347, DOI 10.1016/j.nmd.2014.01.003; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P126, DOI 10.1016/j.nmd.2015.10.006; Merlini L, 2004, MUSCLE NERVE, V29, P548, DOI 10.1002/mus.20018; Montes J, 2010, NEUROLOGY, V74, P833, DOI 10.1212/WNL.0b013e3181d3e308; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Neve V, 2013, EUR RESPIR J, V42, P671, DOI 10.1183/09031936.00127712; Pereira AC, 2016, ARCH DIS CHILD, V101, P147, DOI 10.1136/archdischild-2014-307396; Ramsey D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172346; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Russman BS, 1996, NEUROLOGY, V47, P973, DOI 10.1212/WNL.47.4.973; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Stefanutti D, 1999, AM J RESP CRIT CARE, V159, P107; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; Vuillerot C, 2013, ARCH PHYS MED REHAB, V94, P1555, DOI 10.1016/j.apmr.2013.01.014; Wadman RI, 2012, NEUROLOGY, V79, P2050, DOI 10.1212/WNL.0b013e3182749eca; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; WILSON SH, 1984, THORAX, V39, P535, DOI 10.1136/thx.39.7.535; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Yonekawa T, 2013, BRAIN DEV-JPN, V35, P165, DOI 10.1016/j.braindev.2012.03.009; Young SD, 2016, MUSCLE NERVE, V54, P836, DOI 10.1002/mus.25120; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	60	81	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201004	10.1371/journal.pone.0201004	http://dx.doi.org/10.1371/journal.pone.0201004			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048507	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400038
J	Shafran, R; Wroe, A; Nagra, S; Pissaridou, E; Coughtrey, A				Shafran, Roz; Wroe, Abigail; Nagra, Sasha; Pissaridou, Eleni; Coughtrey, Anna			Cognitive behaviour treatment of co-occurring depression and generalised anxiety in routine clinical practice	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRANSDIAGNOSTIC TREATMENT; SYMPTOM CHANGE; THERAPY; DISORDERS; SEVERITY; ADULTS; METAANALYSIS; COMORBIDITY; IMPAIRMENT	Background Anxiety and depression are closely associated. However, they are typically treated separately and there is a dearth of information on tackling them together. Aims The study's purpose was to establish how best to treat co-occurring anxiety and depression in a routine clinical service D specifically, to compare cognitive behaviour therapy (CBT) focusing only on depression (CBT-D) to a broader CBT focusing on both depression and anxiety (CBT-DA). Method Case notes of 69 patients with equally severe clinical levels of depression and anxiety seen in a routine clinical service were randomly selected to review from a pool of 990 patients. The mean age was 44.61 years (SD = 12.97). 65% of the sample were female and 88% reported their ethnicity white. The content of electronic records reporting techniques used and scores on a measure of depression (The Patient Health Questionnaire) and anxiety (The Generalized Anxiety Disorder Assessment) were reviewed to categorise therapy as CBT-D or CBT-DA. Results Results indicated significant overall improvement with CBT; 70% and 77% of the sample met criteria for reliable improvement on The Patient Health Questionnaire and The Generalized Anxiety Disorder Assessment respectively. Fewer patients who received CBT-DA met The Generalized Anxiety Disorder Assessment recovery criteria at the end of treatment than those who received CBT-D. Mean post treatment PHQ-9 and GAD-7 scores remained above threshold for those receiving CBT_DA but not those receiving CBT-D. There was no evidence suggesting CBT-DA was superior to CBT-D. Conclusions In patients with equally severe clinical levels of depression and anxiety, a broader treatment addressing both anxiety and depression does not appear to be associated with improved outcomes compared to treatment focused on depression.	[Shafran, Roz; Pissaridou, Eleni; Coughtrey, Anna] UCL, Great Ormond St Inst Child Hlth, Fac Populat Hlth Sci, Populat Policy & Practice, London, England; [Wroe, Abigail; Nagra, Sasha] Berkshire Healthcare NHS Fdn Trust, Reading, Berks, England	University of London; University College London	Shafran, R (corresponding author), UCL, Great Ormond St Inst Child Hlth, Fac Populat Hlth Sci, Populat Policy & Practice, London, England.	r.shafran@ucl.ac.uk		Shafran, Roz/0000-0003-2729-4961	British Association for Behavioural and Cognitive Psychotherapies	British Association for Behavioural and Cognitive Psychotherapies	This study was funded by the British Association for Behavioural and Cognitive Psychotherapies to RS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2021, LANG ENV STAT COMP; Barlow DH, 2014, CLIN PSYCHOL SCI, V2, P344, DOI 10.1177/2167702613505532; Beck AT, 1987, COGNITIVE THERAPY DE; Beck J.S., 2011, COGNITIVE BEHAV THER, V(2nd); Bomyea J, 2015, PSYCHIAT RES, V229, P133, DOI 10.1016/j.psychres.2015.07.056; Brugha T, 2009, ADULT PSYCHIAT MORBI; Craske MG, 2007, BEHAV RES THER, V45, P1095, DOI 10.1016/j.brat.2006.09.006; Craske MG, 2012, DEPRESS ANXIETY, V29, P749, DOI 10.1002/da.21992; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dugas M., 2007, COGNITIVE BEHAV TREA; Dugas MJ, 2010, BEHAV THER, V41, P46, DOI 10.1016/j.beth.2008.12.004; Farchione TJ, 2012, BEHAV THER, V43, P666, DOI 10.1016/j.beth.2012.01.001; Gibbons CJ, 2008, BEHAV THER, V39, P117, DOI 10.1016/j.beth.2007.05.006; Gyani A, 2014, BEHAV THER, V45, P199, DOI 10.1016/j.beth.2013.10.004; Gyani A, 2013, BEHAV RES THER, V51, P597, DOI 10.1016/j.brat.2013.06.004; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; National Institute for Health and Care Excellence, 2009, DEPR TREATM MAN DEPR; National Institute for Health and Care Excellence, 2011, CLIN GUID; Newby JM, 2015, CLIN PSYCHOL REV, V40, P91, DOI 10.1016/j.cpr.2015.06.002; Pinheiro J, 2009, R PACKAGE VERSION, V3, P96; Roth AD, 2008, BEHAV COGN PSYCHOTH, V36, P129, DOI 10.1017/S1352465808004141; SCOGIN F, 1990, PROF PSYCHOL-RES PR, V21, P42, DOI 10.1037/0735-7028.21.1.42; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stewart RE, 2012, PROF PSYCHOL-RES PR, V43, P100, DOI 10.1037/a0025694; Strunk DR, 2010, J CONSULT CLIN PSYCH, V78, P429, DOI 10.1037/a0019631; Titov N, 2015, J ANXIETY DISORD, V35, P88, DOI 10.1016/j.janxdis.2015.08.002; Waller G, 2009, BEHAV RES THER, V47, P119, DOI 10.1016/j.brat.2008.10.018	36	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201226	10.1371/journal.pone.0201226	http://dx.doi.org/10.1371/journal.pone.0201226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048513	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400062
J	Wang, ZC; Sha, QY; Fang, SR; Zhang, K; Zhang, SL				Wang, Zhenchuan; Sha, Qiuying; Fang, Shurong; Zhang, Kui; Zhang, Shuanglin			Testing an optimally weighted combination of common and/or rare variants with multiple traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; DETECTING ASSOCIATION; CORRELATED TRAITS; CONTINUOUS PHENOTYPES; QUANTITATIVE TRAITS; JOINT ANALYSIS; BREAST-CANCER; SEQUENCE DATA; SUSCEPTIBILITY	Recently, joint analysis of multiple traits has become popular because it can increase statistical power to identify genetic variants associated with complex diseases. In addition, there is increasing evidence indicating that pleiotropy is a widespread phenomenon in complex diseases. Currently, most of existing methods test the association between multiple traits and a single genetic variant. However, these methods by analyzing one variant at a time may not be ideal for rare variant association studies because of the allelic heterogeneity as well as the extreme rarity of rare variants. In this article, we developed a statistical method by testing an optimally weighted combination of variants with multiple traits (TOWmuT) to test the association between multiple traits and a weighted combination of variants (rare and/or common) in a genomic region. TOWmuT is robust to the directions of effects of causal variants and is applicable to different types of traits. Using extensive simulation studies, we compared the performance of TOWmuT with the following five existing methods: gene association with multiple traits (GAMuT), multiple sequence kernel association test (MSKAT), adaptive weighting reverse regression (AWRR), single-TOW, and MANOVA. Our results showed that, in all of the simulation scenarios, TOWmuT has correct type I error rates and is consistently more powerful than the other five tests. We also illustrated the usefulness of TOWmuT by analyzing a whole-genome genotyping data from a lung function study.	[Wang, Zhenchuan; Sha, Qiuying; Zhang, Kui; Zhang, Shuanglin] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Fang, Shurong] John Carroll Univ, Dept Math & Comp Sci, University Hts, OH USA	Michigan Technological University; John Carroll University	Zhang, SL (corresponding author), Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA.	shuzhang@mtu.edu		WANG, ZHENCHUAN/0000-0002-6247-2156	National Human Genome Research Institute of the National Institutes of Health [R15HG008209]; NIH from the National Institute of General Medical Sciences [R01 GM031575]; NIH [R01 MH059490, U01HL089856, U01HL089897]; COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089897, U01HL089856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH from the National Institute of General Medical Sciences(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R15HG008209 to QS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Genetic Analysis workshops are supported by NIH grant R01 GM031575 from the National Institute of General Medical Sciences. Preparation of the Genetic Analysis Workshop 17 Simulated Exome Data Set was supported in part by NIH R01 MH059490 and used sequencing data from the 1000 Genomes Project (www.1000genomes.org). This research used data generated by the COPDGene study, which was supported by NIH grants U01HL089856 and U01HL089897. The COPDGene project is also supported by the COPD Foundation through contributions made by an Industry Advisory Board comprised of Pfizer, AstraZeneca, Boehringer Ingelheim, Novartis, and Sunovion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AM, 2007, GENET EPIDEMIOL, V31, P659, DOI 10.1002/gepi.20185; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Broadaway KA, 2016, AM J HUM GENET, V98, P525, DOI 10.1016/j.ajhg.2016.01.017; Capanu M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00176; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Chu JH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-78; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Fang SR, 2013, ANN HUM GENET, V77, P524, DOI 10.1111/ahg.12038; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Figarska SM, 2014, PHYSIOL GENOMICS, V46, P411, DOI 10.1152/physiolgenomics.00178.2013; Greco B, 2016, EUR J HUM GENET, V24, P767, DOI 10.1038/ejhg.2015.194; Gur RE, 2007, AM J PSYCHIAT, V164, P813, DOI 10.1176/appi.ajp.164.5.813; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34323; Lin WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21824; Lutz SM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0299-4; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nazir SA, 2009, DRUG AGING, V26, P813, DOI 10.2165/11316760-000000000-00000; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sha QY, 2014, GENET EPIDEMIOL, V38, P494, DOI 10.1002/gepi.21834; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Sun JP, 2016, EUR J HUM GENET, V24, P1344, DOI 10.1038/ejhg.2016.8; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang YF, 2015, GENET EPIDEMIOL, V39, P259, DOI 10.1002/gepi.21895; Wang ZC, 2016, ANN HUM GENET, V80, P162, DOI 10.1111/ahg.12149; Wang ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150975; Wu BL, 2016, GENET EPIDEMIOL, V40, P91, DOI 10.1002/gepi.21945; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yang XL, 2017, GENET EPIDEMIOL, V41, P233, DOI 10.1002/gepi.22034; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; Zhang YW, 2014, NEUROIMAGE, V96, P309, DOI 10.1016/j.neuroimage.2014.03.061; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]; Zhu HH, 2015, HUM HERED, V80, P144, DOI 10.1159/000446239; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	64	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201186	10.1371/journal.pone.0201186	http://dx.doi.org/10.1371/journal.pone.0201186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048520	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400058
J	Dale, R; Guo, BB				Dale, Renee; Guo, BeiBei			Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statistics	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; UNITED-STATES; ART ADHERENCE; DEEP SOUTH; INFECTION; ACCESS; AIDS; CARE; TRANSMISSION; PREVENTION	Current estimates of the HIV epidemic indicate a decrease in the incidence of the disease in the undiagnosed subpopulation over the past 10 years. However, a lack of access to care has not been considered when modeling the population. Populations at high risk for contracting HIV are twice as likely to lack access to reliable medical care. In this paper, we consider three contributors to the HIV population dynamics: at-risk population exhaustion, lack of access to care, and usage of anti-retroviral therapy (ART) by diagnosed individuals. An extant problem in the mathematical study of this system is deriving parameter estimates due to a portion of the population being unobserved. We approach this problem by looking at the proportional change in the infected subpopulations. We obtain conservative estimates for the proportional change of the infected subpopulations using hierarchical Bayesian statistics. The estimated proportional change is used to derive epidemic parameter estimates for a system of stochastic differential equations (SDEs). Model fit is quantified to determine the best parametric explanation for the observed dynamics in the infected subpopulations. Parameter estimates derived using these methods produce simulations that closely follow the dynamics observed in the data, as well as values that are generally in agreement with prior understanding of transmission and diagnosis rates. Simulations suggest that the undiagnosed population may be larger than currently estimated without significantly affecting the population dynamics.	[Dale, Renee; Guo, BeiBei] Louisiana State Univ, Dept Expt Stat, Baton Rouge, LA 70803 USA; [Dale, Renee] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Dale, R (corresponding author), Louisiana State Univ, Dept Expt Stat, Baton Rouge, LA 70803 USA.; Dale, R (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	rdale1@lsu.edu	Dale, Renee/AAG-8754-2021	Dale, Renee/0000-0002-1674-1247	National Institute of Health [R01 AI12125903]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was partially funded by National Institute of Health (nih.gov) R01 AI12125903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amico KR, 2009, AIDS BEHAV, V13, P66, DOI 10.1007/s10461-007-9311-y; [Anonymous], R LANG ENV STAT COMP; [Anonymous], R2016B MATLAB MATHWO; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2002, J GEN INTERN MED, V17, P812, DOI 10.1046/j.1525-1497.2002.20812.x; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Centers for Disease Control and Prevention, 2014, 17 HIV CTR DIS CONTR; Centers for Disease Control and Prevention, 2016, 4 CDCP; Chen Y., 2017, J SENSORS, V2017, P1, DOI DOI 10.1155/2017/1591504; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Davey DJ, 2017, JAIDS-J ACQ IMM DEF, V74, pE97, DOI [10.1097/QAI.0000000000001233, 10.1097/qai.0000000000001233]; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Arroyo MJH, 2013, PATIENT PREFER ADHER, V7, P729, DOI 10.2147/PPA.S47519; Kinsler JJ, 2007, AIDS PATIENT CARE ST, V21, P584, DOI 10.1089/apc.2006.0202; Lanoy E, 2007, ANTIVIR THER, V12, P89; MacDowell M., 2013, NATL VIEW RURAL HLTH, P16; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Michigan Department of Health and Human Services, 2015, ANN HIV SURV REP; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pinkerton SD, 2012, AIDS BEHAV, V16, P791, DOI 10.1007/s10461-011-0042-8; Rasmussen DA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003570; Reif S, 2006, AM J PUBLIC HEALTH, V96, P970, DOI 10.2105/AJPH.2005.063149; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Sayles JN, 2009, J GEN INTERN MED, V24, P1101, DOI 10.1007/s11606-009-1068-8; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Schoen C, 2008, HEALTH AFFAIR, V27, pW298, DOI 10.1377/hlthaff.27.4.w298; Sherman S.G., 2008, SO STATES MANIFESTO; Simoni JM, 2012, JAIDS-J ACQ IMM DEF, V60, P466, DOI 10.1097/QAI.0b013e31825db0bd; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Stein JA, 2000, AIDS CARE, V12, P343, DOI 10.1080/09540120050043007; Swihart B, 2017, rmutil: Utilities for Nonlinear Regression and Repeated Measurements Models; Valdiserri R. O., 2013, MEASURING WHAT MATTE; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568	39	2	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200126	10.1371/journal.pone.0200126	http://dx.doi.org/10.1371/journal.pone.0200126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044818	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500029
J	Espinoza-Romo, BA; Sainz-Hernandez, JC; Ley-Quinonez, CP; Hart, CE; Leal-Moreno, R; Aguirre, AA; Zavala-Norzagaray, AA				Espinoza-Romo, B. A.; Sainz-Hernandez, J. C.; Ley-Quinonez, C. P.; Hart, C. E.; Leal-Moreno, R.; Aguirre, A. A.; Zavala-Norzagaray, A. A.			Blood biochemistry of olive ridley (Lepidochelys olivacea) sea turtles foraging in northern Sinaloa, Mexico	PLOS ONE			English	Article							BAJA-CALIFORNIA-SUR; CHELONIA-MYDAS; GREEN TURTLES; CARETTA-CARETTA; BODY CONDITION; REFERENCE INTERVALS; PLASMA CHEMISTRY; HEALTH INDEXES; PACIFIC COAST; JUVENILE	Blood parameters provide an excellent tool to evaluate the health status of wildlife. However, there are few studies about health parameters of sea turtles in Mexico. For olive ridley turtles (Lepidochelys olivacea), no information was available to establish the health baseline for the species. The objective of this study was to establish reference blood biochemistry values for olive ridley turtles in the northern Sinaloa foraging area. Between 2013 and 2015, 82 olive ridley turtles were captured. Body condition index (BCI) presented a mean of 1.46 +/- 0.14 (1.17-2.02) that categorized the population with excellent body condition; in addition, 99% of the turtles captured had a good physical appearance. Blood was collected for biochemistry analysis from 60 turtles. Significantly higher values of total protein, albumin, A/G ratio (albumin/globulin) and PCV (packed cell volume or hematocrit) were observed in adult when compared to subadult turtles. On the other hand, no significant differences were found when females and males were compared. Based on the BCI, physical assessment, and blood parameters, and compared to other sea turtle species, olive ridley turtles in northern Sinaloa were considered in excellent health. To the best of our knowledge, this is the first study to establish normal blood biochemistry values of foraging olive ridley turtles in northern Sinaloa.	[Espinoza-Romo, B. A.; Sainz-Hernandez, J. C.; Ley-Quinonez, C. P.; Leal-Moreno, R.; Zavala-Norzagaray, A. A.] Inst Politecn Nacl, CIIDIR SINALOA, Guasave, Sinaloa, Mexico; [Espinoza-Romo, B. A.; Ley-Quinonez, C. P.; Hart, C. E.; Leal-Moreno, R.; Zavala-Norzagaray, A. A.] Grp Tortuguero Californias AC, La Paz, Bcs, Mexico; [Ley-Quinonez, C. P.; Hart, C. E.; Leal-Moreno, R.; Zavala-Norzagaray, A. A.] Invest Capacitac & Soluc Ambientas & Sociales AC, Tepic, Nayarit, Mexico; [Aguirre, A. A.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	Instituto Politecnico Nacional - Mexico; George Mason University	Zavala-Norzagaray, AA (corresponding author), Inst Politecn Nacl, CIIDIR SINALOA, Guasave, Sinaloa, Mexico.; Zavala-Norzagaray, AA (corresponding author), Grp Tortuguero Californias AC, La Paz, Bcs, Mexico.; Zavala-Norzagaray, AA (corresponding author), Invest Capacitac & Soluc Ambientas & Sociales AC, Tepic, Nayarit, Mexico.	anorzaga@ipn.mx	Zavala-Norzagaray, Alan/ABA-3734-2020; Hart, Catherine E./AAD-5944-2022; Ley-Quiñónez, Cesar P./AAV-6746-2020	Hart, Catherine E./0000-0002-0833-2523; Ley-Quiñónez, Cesar P./0000-0003-1043-7276	IPN-CIIDIR SINALOA; GRUPO TORTUGUERO DE LAS CALIFORNIAS; Department of Environmental Science and Policy, George Mason University; Instituto Politecnico Nacional [SIP 20141052]	IPN-CIIDIR SINALOA; GRUPO TORTUGUERO DE LAS CALIFORNIAS; Department of Environmental Science and Policy, George Mason University; Instituto Politecnico Nacional	This work was supported by IPN-CIIDIR SINALOA, GRUPO TORTUGUERO DE LAS CALIFORNIAS and Department of Environmental Science and Policy, George Mason University. Grant number SIP 20141052, Instituto Politecnico Nacional http://www.ipn.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois A, 2014, LEPIDOCHELYS OLIVACE; Aguilar-Gonzalez ME, 2009, EVALUACION IMPACTO A; Aguirre AA, 1999, J AQUAT ANIM HEALTH, V11, P283, DOI 10.1577/1548-8667(1999)011&lt;0283:POFIOR&gt;2.0.CO;2; AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Anderson E, 2010, SOCIAL MEDIA MARKETING: GAME THEORY AND THE EMERGENCE OF COLLABORATION, P1, DOI 10.1007/978-3-642-13299-5_1; Anderson ET, 2013, J ZOO WILDLIFE MED, V44, P62, DOI 10.1638/1042-7260-44.1.62; Anderson Eric T., 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/890829; Barrios-Garrido H, 2015, 35 ANN S SEA TURTL B; Bjorndal KA, 2000, TECNICAS INVESTIGACI, V4, P13; BOLTEN A., 2000, PUBL, V4, P126; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; BOLTEN AB, 1992, AM J VET RES, V53, P2224; Brenes-Chaves L, 2013, REV MAR COST, V5, P16; Camacho M, 2013, MAR ENVIRON RES, V92, P15, DOI 10.1016/j.marenvres.2013.08.002; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Santos MRD, 2015, DIS AQUAT ORGAN, V115, P193, DOI 10.3354/dao02883; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Delgado C, 2011, J WILDLIFE DIS, V47, P523, DOI 10.7589/0090-3558-47.3.523; Ehsanpour M., 2015, Comparative Clinical Pathology, V24, P561, DOI 10.1007/s00580-014-1945-3; Fazio Esterina, 2012, Comparative Clinical Pathology, V21, P105, DOI 10.1007/s00580-010-1070-x; Flint M, 2010, VET J, V185, P299, DOI 10.1016/j.tvjl.2009.06.011; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Fong ChiaLing, 2010, Journal of Veterinary Medicine and Animal Health, V2, P008; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Goldberg DW, 2011, CIENC RURAL, V41, P143, DOI 10.1590/S0103-84782011000100023; Graciano-Obeso A., 2013, CARACTERIZACION AMBI; Gregory LF, 2001, GEN COMP ENDOCR, V124, P66, DOI 10.1006/gcen.2001.7683; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M, 2003, CRC MAR BIOL SER, P135; Hofer H, 2012, NEW DIRECTIONS CONSE, P82; IDEXX, 2014, IDEXX VETTEST CHEM A; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jessop TS, 2004, MAR ECOL PROG SER, V276, P281, DOI 10.3354/meps276281; Kakizoe Y, 2007, J ZOO WILDLIFE MED, V38, P77, DOI 10.1638/05-096.1; Labrada-Martagon V, 2010, CHELONIAN CONSERV BI, V9, P162, DOI 10.2744/CCB-0806.1; Labrada-Martagon V, 2010, CHELONIAN CONSERV BI, V9, P173, DOI 10.2744/CCB-0807.1; Limpus C. J., 1985, STUDY LOGGERHEAD TUR; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Marquez M. R., 1996, TORTUGAS MARINAS NUE; Najera-Hillman E, 2012, REV MEX BIODIVERS, V83, P1171, DOI 10.7550/rmb.27444; Norton T., 2015, BODY CONDITION SCORI; Nunez L, 2007, PATOLOGIA CLIN VET; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Munoz-Perez JP, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox028; Ley-Quinonez CP, 2017, ENVIRON SCI POLLUT R, V24, P9530, DOI 10.1007/s11356-017-8556-x; Perrault JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031841; Price ER, 2016, BIOL REV; Prieto-Torres DA, 2013, S AM J HERPETOL, V8, P147, DOI 10.2994/SAJH-D-13-00010.1; Ramos M, 2007, 27 ANN S SEA TURTL B; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Santoro M, 2007, VET REC, V161, P818; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Seminoff JA, 2003, J MAR BIOL ASSOC UK, V83, P1355, DOI 10.1017/S0025315403008816; Seminoff Jeffrey A., 2010, P135; Sibaja-cordero J.A., 2008, REV BIOL TROP, V56, P49; Snoddy JE, 2009, J WILDLIFE MANAGE, V73, P1394, DOI 10.2193/2008-472; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Swimmer JY, 2000, J WILDLIFE DIS, V36, P102, DOI 10.7589/0090-3558-36.1.102; Sykes John M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P481, DOI 10.1016/j.cvex.2008.03.005; Thomson JA, 2009, COPEIA, P251, DOI 10.1643/CE-07-227; Voigt GL., 2011, HEMATOLOGY TECHNIQUE; Whiting Scott D., 2007, Comparative Clinical Pathology, V16, P109, DOI 10.1007/s00580-006-0646-y; Wibbels T, 2000, PUBLICACION GRUPO ES, V4, P160; Zavala-Norzagaray AA, 2014, B ENVIRON CONTAM TOX, V93, P536, DOI 10.1007/s00128-014-1320-8; Zavala-Norzagaray AA., 2014, MED CONSERVACION MET	68	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199825	10.1371/journal.pone.0199825	http://dx.doi.org/10.1371/journal.pone.0199825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044783	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500019
J	Kefale, B; Tadesse, Y; Alebachew, M; Engidawork, E				Kefale, Belayneh; Tadesse, Yewondwossen; Alebachew, Minyahil; Engidawork, Ephrem			Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; DRUG-THERAPY; MEDICATION; IMPACT; PREVALENCE; CARE; CKD; INTERVENTIONS	Introduction Chronic kidney disease (CKD) has a complicated interrelationship with other diseases and major risk factor for cardiovascular disease. Therapeutic management for CKD patients is complicated due to co-morbidities and dominant risk factors of CKD. Non-adherence to treatment is an increasing problem for patients with CKD and it has not been extensively studied in patients with CKD. Hence, the present study was carried out to assess the management practice, medication adherence and factors affecting medication adherence in CKD patients at Tikur Anbessa Specialized Hospital (TASH). Methods A hospital-based cross-sectional study was conducted at the nephrology clinic of TASH. A total of 256 patients were recruited through systematic random sampling. Data were collected from medical records and interviewing patients. The degree of adherence was determined using eight-item Morisky Medication Adherence Scale. The data were entered into Epi Info 7.2.2.2 and analyzed using SPSS version 20.0 statistical software. Descriptive statistics such as frequency, percent, mean and standard deviation were used to summarize patients' baseline characteristics. Univariable and multivariable binary logistic regression were used to investigate the potential predictors of medication non-adherence. Results About 55% patients with hypertension only were treated with non-angiotensin converting enzyme inhibition based regimens; 57.3% of diabetes mellitus with hypertension treated with combination of insulin and ACEI based regimens. About three-fourth of patients with anemia and osteodystrophy complications were treated with iron preparations and calcium based phosphate binder. Only 61.3% of the study population were adherent to their treatment regimens. Forgetfulness (79.8%) was the major reason for medication non-adherence. Patients who had an average and high monthly income were 4.14 (AOR = 4.14, 95% CI: 1.45-11.84, p = 0.008) and 6.17 times (AOR = 6.17, 95% CI: 1.02-37.46, p = 0.048) more likely to adhere as compared to those who had very low income. Patients who were prescribed with >= 5 drugs were 0.46 times (AOR = 0.54, 95% CI: 0.27-1.10, p = 0.049) less likely to adhere compared to their counterpart. Patients who were students, drivers, teachers working in private school were about 7.46 times (AOR = 7.46, 95% CI: 1.49-37.26, p = 0.014) more likely to adhere compared with patients who were farmers. Conclusion Insulin and ACEIs based regimens were the most frequently used regimens in the treatment of diabetes mellitus and hypertension co-morbidities. Very low income, increased number of prescribed medications and being a farmer were the predictors of medication non-adherence.	[Kefale, Belayneh] Ambo Univ, Dept Pharm, Coll Med & Hlth Sci, Ambo, Ethiopia; [Tadesse, Yewondwossen] Addis Ababa Univ, Sch Med, Dept Internal Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Alebachew, Minyahil; Engidawork, Ephrem] Addis Ababa Univ, Sch Pharm, Dept Pharmacol & Clin Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia	Ambo University; Addis Ababa University; Addis Ababa University	Kefale, B (corresponding author), Ambo Univ, Dept Pharm, Coll Med & Hlth Sci, Ambo, Ethiopia.	Belayneh.kefale@yahoo.com	Kefale, Belayneh/AAK-7367-2020; Woldu, Minyahil/ABD-9452-2020; Engidawork, Ephrem/K-7551-2019	Woldu, Minyahil/0000-0002-3163-0326; Engidawork, Ephrem/0000-0002-9931-6421	Addis Ababa University	Addis Ababa University	This work was supported by Addis Ababa University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Rajiv, 2012, J Am Soc Hypertens, V6, P299, DOI 10.1016/j.jash.2012.07.004; Ahlawat R, 2016, J PHARMA CARE HLTH S, V3, P2376, DOI DOI 10.4172/2376-0419.1000152; Ahmed AK, 2010, NEPHROL DIAL TRANSPL, V25, P3977, DOI 10.1093/ndt/gfp511; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Awuah KT, 2013, KIDNEY INT SUPPL, V3, P227, DOI 10.1038/kisup.2013.20; Bilo H, 2015, NEPHROL DIAL TRANSPL, V30, P1, DOI 10.1093/ndt/gfv100; Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207; Burnier M, 2015, NEPHROL DIAL TRANSPL, V30, P39, DOI 10.1093/ndt/gfu015; Chiu YW, 2009, CLIN J AM SOC NEPHRO, V4, P1089, DOI 10.2215/CJN.00290109; Covic A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-153; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; Dasari P, 2014, INT J PHARM PHARM SC, V6, P363; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Arenas MD, 2010, J NEPHROL, V23, P525; Drenth-van Maanen AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128237; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Fiseha T, 2014, AJHR, V2, P216, DOI [10.11648/j.ajhr.20140204.28, DOI 10.11648/J.AJHR.20140204.28, 10.11648/j. ajhr.20140204.28]; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Garcia GG, 2011, ACTA NEPHROLOGICA, V25, P155; Ghimire S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0583-9; Ghimire S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144119; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Hsu KL, 2015, AM J KIDNEY DIS, V66, P621, DOI 10.1053/j.ajkd.2015.03.026; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Johnson CA, 2004, AM FAM PHYSICIAN, V70, P823; Johnson DW, 2013, NEPHROLOGY, V18, P340, DOI 10.1111/nep.12052; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Koro CE, 2009, CLIN THER, V31, P2608, DOI 10.1016/j.clinthera.2009.10.020; Kugler C, 2011, J NEPHROL, V24, P366, DOI 10.5301/JN.2010.5823; Lessan Pezeshki M, 2009, INT J NEPHROL UROL, V1, P129; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lindberg M, 2008, PHARM WORLD SCI, V30, P571, DOI 10.1007/s11096-008-9212-9; Liu BC, 2008, CLIN CHIM ACTA, V387, P128, DOI 10.1016/j.cca.2007.09.020; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Magacho EJC, 2011, BRAZ J MED BIOL RES, V44, P258, DOI 10.1590/S0100-879X2011007500013; Malluche HH, 2008, CLIN J AM SOC NEPHRO, V3, pS157, DOI 10.2215/CJN.02500607; Manley HJ, 2004, NEPHROL DIAL TRANSPL, V19, P1842, DOI 10.1093/ndt/gfh280; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mason NA, 2011, CURR OPIN NEPHROL HY, V20, P492, DOI 10.1097/MNH.0b013e328349c261; Mathew S, 2007, J AM SOC NEPHROL, V18, P122, DOI 10.1681/ASN.2006050490; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Miller PD., 2014, BONEKEY REPORTS, V3, P1; Molnar MZ, 2014, J AM COLL CARDIOL, V63, P650, DOI 10.1016/j.jacc.2013.10.050; Muntner P, 2010, AM J KIDNEY DIS, V56, P447, DOI 10.1053/j.ajkd.2010.02.348; Nazar CMJ, 2014, J RENAL INJ PREV, V3, P61, DOI 10.12861/jrip.2014.20; Neri L, 2011, AM J NEPHROL, V34, P71, DOI 10.1159/000328391; Okpechi IG, 2017, SEMIN NEPHROL, V37, P260, DOI 10.1016/j.semnephrol.2017.02.006; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Padhi S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2258; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Raymond Colette B, 2011, CANNT J, V21, P47; Rifkin DE, 2010, AM J KIDNEY DIS, V56, P439, DOI 10.1053/j.ajkd.2010.04.021; Rivera JA, 2012, AM FAM PHYSICIAN, V86, P749; Roy L, 2013, KIDNEY INT, V84, P570, DOI 10.1038/ki.2013.103; Salini A, 2013, IJRPC, V3, P2231; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schieppati A, 2003, KIDNEY INT, V63, P1948, DOI 10.1046/j.1523-1755.2003.00926.x; Schmid H, 2009, EUR J MED RES, V14, P185, DOI 10.1186/2047-783X-14-5-185; Singh AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-114; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Sontakke S, 2015, INDIAN J PHARMACOL, V47, P668, DOI 10.4103/0253-7613.169597; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tomson C, 2011, MEDICINE, V39, P407, DOI DOI 10.1016/J.MPMED.2011.04.006; Toto RD, 2005, SEMIN NEPHROL, V25, P435, DOI 10.1016/j.semnephrol.2005.05.016; Tuso Philip J, 2009, Perm J, V13, P51; Vassalotti JA, 2016, AM J MED, V129, P153, DOI 10.1016/j.amjmed.2015.08.025; Victoria A., 2015, AM J NURS SCI, V4, P60, DOI [10.11648/j.ajns.s.2015040201.21, DOI 10.11648/j.ajns.s.2015040201.21]	73	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200415	10.1371/journal.pone.0200415	http://dx.doi.org/10.1371/journal.pone.0200415			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044830	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500053
J	Tamioso, PR; Rucinque, DS; Miele, M; Boissy, A; Molento, CFM				Tamioso, Priscilla Regina; Rucinque, Daniel Santiago; Miele, Mara; Boissy, Alain; Molento, Carla Forte Maiolino			Perception of animal sentience by Brazilian and French citizens: The case of sheep welfare and sentience	PLOS ONE			English	Article							SPECIES PREFERENCES; GENDER-DIFFERENCES; NATIONAL-SURVEY; ATTITUDES; STUDENTS; MIND; INDICATORS; CHILDREN; BELIEFS; FACULTY	The study compared the perception of ordinary citizens from Curitiba, Brazil (OB) and Clermont-Ferrand, France (OF), as well as OB, Brazilian veterinarians (VB), biologists (BB) and animal scientists (AB), concerning animal welfare and sentience. An online survey containing 18 open-ended, multiple choices and Likert scale questions was conducted from November 2014 to May 2016. The survey covered questions on demographics, perception of animal welfare, sheep welfare, sentience and animals' emotional capacities. In total, 1103 respondents participated in the survey (388 OB, 350 OF, 248 VB, 92 BB and 25 AB); data were compared using non-parametric tests. Brazilian citizens (46.9%) believed more than OF (3.7%) that welfare is not considered for farm animals and OB attributed higher scores of suffering to sheep during management procedures (median 4, severe suffering) than OF (3, moderate suffering). Additionally, OB gave higher scores of emotions to animals (5) than OF (4). In general, OB and BB had similar perceptions; OB and BB differed from VB and AB who were similar to each other. Citizens (46.9%) and BB (29.3%) believed more than VB (18.5%) and AB (12.0%) that welfare is not considered for farm animals; OB and BB also attributed higher scores of suffering to sheep during management procedures than VB and AB. Women and older respondents showed higher perception of animal welfare issues. There was no clear correlation between perception of animal welfare or sentience and education. Overall, ordinary citizens differed on their perceptions of welfare and sentience in livestock and specifically in sheep, and sheep suffering during management procedures. Ordinary citizens from Curitiba showed higher perception of animal welfare issues as compared to respondents from Clermont-Ferrand and to veterinarians and animal scientists. Ensuring a better consideration of welfare at farm level and in educational programs seems warranted according to the results of this study.	[Tamioso, Priscilla Regina; Rucinque, Daniel Santiago; Molento, Carla Forte Maiolino] Fed Univ Parana UFPR, Dept Anim Sci, Anim Welf Lab LABEA, Curitiba, Parana, Brazil; [Miele, Mara] Cardiff Univ, Cardiff Sch Geog & Planning, Cardiff, S Glam, Wales; [Boissy, Alain] INRA, Herbivores Inst UMR1213, St Genes Champanelle, France	Universidade Federal do Parana; Cardiff University; INRAE	Tamioso, PR (corresponding author), Fed Univ Parana UFPR, Dept Anim Sci, Anim Welf Lab LABEA, Curitiba, Parana, Brazil.	priscillatamioso@gmail.com	Miele, Mara/AAH-9160-2019; Rucinque, Daniel Santiago/HGD-3834-2022	Rucinque, Daniel Santiago/0000-0003-0522-5746; Tamioso, Priscilla Regina/0000-0003-3141-9720	Coordination for the Improvement of Higher Education (Capes) Programa Ciencias Forenses [25/2014]; Science Without Borders (CSF-CNPq) [206931/2014-0]	Coordination for the Improvement of Higher Education (Capes) Programa Ciencias Forenses; Science Without Borders (CSF-CNPq)	The authors acknowledge the Coordination for the Improvement of Higher Education (Capes) Programa Ciencias Forenses no 25/2014-ProA-forenses to CFMM and Science Without Borders (CSF-CNPq) processo 206931/2014-0 to CFMM and PRT, for funding and supporting the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bjerke T, 1998, ANTHROZOOS, V11, P227, DOI 10.2752/089279398787000544; Boissy A, 2005, GENET SEL EVOL, V37, P381, DOI 10.1051/gse:2005007; Borges TD, 2013, ARQ BRAS MED VET ZOO, V65, P29, DOI 10.1590/S0102-09352013000100005; Borgi M, 2015, ANTHROZOOS, V28, P45, DOI 10.2752/089279315X14129350721939; Broom Donald M., 1998, P69; Davis SL, 1998, J ANIM SCI, V76, P2072; Edwards DS, 1999, VET REC, V144, P603, DOI 10.1136/vr.144.22.603; Eldridge JJ, 1996, ETHICS BEHAV, V6, P239, DOI 10.1207/s15327019eb0603_5; Evans A, 2008, WELFARE QUALITY REPO; Farm Animal Welfare Council, 2009, 5 FREED; FURNHAM A, 1993, PERS INDIV DIFFER, V15, P1, DOI 10.1016/0191-8869(93)90036-3; Goddard P, 2006, SMALL RUMINANT RES, V62, P215, DOI 10.1016/j.smallrumres.2005.08.016; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Heleski CR, 2005, JAVMA-J AM VET MED A, V226, P1538, DOI 10.2460/javma.2005.226.1538; Heleski CR, 2004, J ANIM SCI, V82, P2806; Herzog H. A., 1997, ANTHROPOMORPHISM ANE, P237; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Holloway KS, 2004, DEV PSYCHOBIOL, V44, P58, DOI 10.1002/dev.10151; Kellert S.R., 1996, VALUE LIFE BIOL DIVE; Kellert S. R., 1980, PHASE 3 KNOWLEDGE AF; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Kielland C, 2009, VET REC, V165, P254, DOI 10.1136/vr.165.9.254; Kilic I, 2013, ASIAN AUSTRAL J ANIM, V26, P1329, DOI 10.5713/ajas.2013.13124; Knight S, 2004, ANTHROZOOS, V17, P43, DOI 10.2752/089279304786991945; Lawrence AB, 2008, WELFARE SHEEP, P343; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Martens P, 2016, ANTHROZOOS, V29, P73, DOI 10.1080/08927936.2015.1075299; McCarthy Susan, 1995, ELEPHANTS WEEP EMOTI; Mellor DJ, 2000, NEW ZEAL VET J, V48, P33, DOI 10.1080/00480169.2000.36156; Miele M., 2016, GEOHUMANITIES, V2, P58, DOI [10.1080/2373566X.2016.1167617, DOI 10.1080/2373566X.2016.1167617]; Miele M, 2010, ETHICS POLICY ENV, V13, P171, DOI 10.1080/13668791003778842; Molento CFM, 2009, REV SCI TECH OIE, V28, P617, DOI 10.20506/rst.28.2.1899; Morris P, 2012, SOC ANIM, V20, P211, DOI 10.1163/15685306-12341234; Nakajima S, 2002, ANTHROZOOS, V15, P194, DOI 10.2752/089279302786992504; Orgeur P, 1998, APPL ANIM BEHAV SCI, V58, P87, DOI 10.1016/S0168-1591(97)00140-8; Paul ES, 2000, VET REC, V146, P269, DOI 10.1136/vr.146.10.269; Phillips CJC, 2005, J BIOL EDUC, V40, P17, DOI 10.1080/00219266.2005.9656004; Prokop P., 2008, EURASIA J MATH SCI T, V4, P87, DOI [https://doi.org/10.12973/ejmste/75309, DOI 10.12973/EJMSTE/75309, 10.12973/ejmste/75309]; RASMUSSEN JL, 1993, J COMP PSYCHOL, V107, P283, DOI 10.1037/0735-7036.107.3.283; Remonato BM, REV EC SOCIOL RURAL; Sanger ME, 2011, APPL ANIM BEHAV SCI, V131, P94, DOI 10.1016/j.applanim.2011.02.001; Schaeffer R.L., 1990, ELEMENTARY SURVEY SA, V4th; Schnettler B, 2008, CHIL J AGR RES, V68, P80, DOI 10.4067/S0718-58392008000100008; Signal TD, 2006, SOC ANIM, V14, P147, DOI 10.1163/156853006776778743; Souza APO, 2015, ANIM WELFARE, V24, P45, DOI 10.7120/09627286.24.1.045; Tamioso PR, 2017, J VET BEHAV, V19, P27, DOI 10.1016/j.jveb.2017.01.004; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; Toma L, 2012, APPETITE, V58, P597, DOI 10.1016/j.appet.2011.11.015; Tuyttens FAM, 2015, POULTRY SCI, V94, P1758, DOI 10.3382/ps/pev167; Vanhonacker F, 2008, LIVEST SCI, V116, P126, DOI 10.1016/j.livsci.2007.09.017; Veissier I, 2008, APPL ANIM BEHAV SCI, V113, P279, DOI 10.1016/j.applanim.2008.01.008; Velde HT, 2002, J AGR ENVIRON ETHIC, V15, P203; Wemelsfelder F, 2000, APPL ANIM BEHAV SCI, V67, P193, DOI 10.1016/S0168-1591(99)00093-3	55	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200425	10.1371/journal.pone.0200425	http://dx.doi.org/10.1371/journal.pone.0200425			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044857	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000439942500054
J	Kowalik, A; Siolek, M; Kopczynski, J; Krawiec, K; Kalisz, J; Zieba, S; Kozak-Klonowska, B; Wypiorkiewicz, E; Furmanczyk, J; Nowak-Ozimek, E; Chlopek, M; Macek, P; Smok-Kalwat, J; Gozdz, S				Kowalik, Artur; Siolek, Monika; Kopczynski, Janusz; Krawiec, Kamila; Kalisz, Joanna; Zieba, Sebastian; Kozak-Klonowska, Beata; Wypiorkiewicz, Elzbieta; Furmanczyk, Jowita; Nowak-Ozimek, Ewelina; Chlopek, Matgorzata; Macek, Pawel; Smok-Kalwat, Jolanta; Gozdz, Stanislaw			BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study	PLOS ONE			English	Article							OVARIAN-CANCER FAMILIES; BREAST-CANCER; GERMLINE MUTATIONS; VARIANTS; CARRIERS; POLAND; ASSOCIATION; PATHOLOGY; RISKS; GENE	Hereditary mutations in BRCA1/2 genes increase the risk of breast cancer by 60-80% and ovarian cancer by about 20-40% in female carriers. Detection of inherited mutations in asymptomatic carriers allows for the implementation of appropriate preventive measures. BRCA1/2 genotyping is also important for poly(adenosine diphosphate)-ribose polymerase (PARP) inhibitor administration. This work addresses the need for next-generation sequencing (NGS) technology for the detection of BRCA1/2 mutations in Poland where until recently mostly founder mutations have been tested, and whether BRCA diagnostics should be extended beyond the panel of founder mutations in this population. The study comprises 2931 patients who were referred for genetic counseling and tested for founder and recurrent mutations in BRCA1 (5382insC (c.5266dupC; p.Gln1756Profs), c.5370C>T (c.5251C>T; p.R1751*), 300T>G (c.181T>G; p.Cys61Gly), 185delAG (c.68_69delAG; p.Glu23Valfs), and 4153delA (c.4035delA; p.Glu1346Lysfs)) by high-resolution melting/Sanger sequencing. A total of 103 (3.5%) mutations were detected, including 53 (51%) in healthy subjects and 50 (49%) in cancer patients. Then, based on more stringent clinical and pedigree criteria, sequencing of all BRCA1/2 exons was performed in 454 (16%) patients without founder mutations by NGS, which detected 58 mutations (12.8%), 40 (8.8%) of which were pathogenic. In 14 (3.1%) subjects, variants of uncertain significance (VUS) were detected, and in four (0.9%) subjects, the detected mutations were benign. In total, 161 mutations were detected using our two-step algorithm (founder test and NGS), of which 64% were founder mutations, 25% were NGS-detected pathogenic mutations, 9% were VUS, and 2% were benign. In addition, 38 mutations not yet reported in the Polish population were detected. In total, founder mutations accounted for only 64% of all detected mutations, and the remaining mutations (36%) were dispersed across the BRCA1/2 gene sequences. Thus, in Poland, testing for constitutional mutations in BRCA1/2 should be carried out in two stages, where NGS is performed in qualifying subjects if founder mutations are not identified.	[Kowalik, Artur; Krawiec, Kamila; Kalisz, Joanna; Zieba, Sebastian; Wypiorkiewicz, Elzbieta; Furmanczyk, Jowita; Nowak-Ozimek, Ewelina; Chlopek, Matgorzata] Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland; [Siolek, Monika; Kozak-Klonowska, Beata] Holycross Canc Ctr, Genet Clin, Kielce, Poland; [Kopczynski, Janusz] Holycross Canc Ctr, Dept Surg Pathol, Kielce, Poland; [Macek, Pawel] Holycross Canc Ctr, Dept Canc Epidemiol & Canc Control, Kielce, Poland; [Smok-Kalwat, Jolanta; Gozdz, Stanislaw] Holycross Canc Ctr, Oncol Clin, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland	Jan Kochanowski University	Kowalik, A (corresponding author), Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland.	arturko@onkol.kielce.pl	Kowalik, Artur/AAB-5690-2020; Zięba, Sebastian/AAB-7487-2020; Kowalik, Artur/K-2111-2017; Gozdz, Stanislaw/D-3300-2013	Kowalik, Artur/0000-0002-3718-999X; Kowalik, Artur/0000-0002-3718-999X; Gozdz, Stanislaw/0000-0001-6902-3807; Macek, Pawel/0000-0001-9755-7507	Holycross Cancer Centre	Holycross Cancer Centre	The study was supported by the Holycross Cancer Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Biswas K, 2011, BLOOD, V118, P2430, DOI 10.1182/blood-2010-12-324541; Claes K, 2004, BRIT J CANCER, V90, P1244, DOI 10.1038/sj.bjc.6601656; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Eccles DM, 2015, ANN ONCOL, V26, P2057, DOI 10.1093/annonc/mdv278; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Feliubadalo L, 2013, EUR J HUM GENET, V21, P864, DOI 10.1038/ejhg.2012.270; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Gorski B, 2004, INT J CANCER, V110, P683, DOI 10.1002/ijc.20162; Gronwald J, 2006, J MED GENET, V43, P424, DOI 10.1136/jmg.2005.036921; Grzybowska E, 2002, ACTA BIOCHIM POL, V49, P351; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kluska A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0092-2; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Kwiatkowska E, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<73::AID-HUMU12>3.3.CO;2-F; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lubinski J, 2006, BREAST CANCER RES TR, V99, P71, DOI 10.1007/s10549-006-9182-3; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meeks HD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv315; Moghadasi S, 2018, J MED GENET, V55, P15, DOI 10.1136/jmedgenet-2017-104560; Neveling K, 2017, CLIN CHEM, V63, P503, DOI 10.1373/clinchem.2016.263897; Perkowska M, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9139; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Ratajska M, 2008, ONCOL REP, V19, P263; Ratajska M, 2015, J APPL GENET, V56, P193, DOI 10.1007/s13353-014-0254-5; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Rhiem K, 2007, CANCER GENET CYTOGEN, V176, P76, DOI 10.1016/j.cancergencyto.2007.03.006; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Surowy HM, 2014, BREAST CANCER RES TR, V145, P451, DOI 10.1007/s10549-014-2943-5; Suthers GK, 2007, ANZ J SURG, V77, P314, DOI 10.1111/j.1445-2197.2007.04050.x; Szwiec M, 2015, CLIN GENET, V87, P288, DOI 10.1111/cge.12360; Tonin PN, 2007, FAM CANCER, V6, P491, DOI 10.1007/s10689-007-9152-x; van Der Looij M, 2000, Hum Mutat, V15, P480, DOI 10.1002/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G; Wojcik P, 2016, HERED CANCER CLIN PR, V14, DOI 10.1186/s13053-016-0046-5; Wong-Brown MW, 2015, BREAST CANCER RES TR, V150, P71, DOI 10.1007/s10549-015-3293-7	37	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201086	10.1371/journal.pone.0201086	http://dx.doi.org/10.1371/journal.pone.0201086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040829	gold, Green Published, Green Submitted			2022-12-27	WOS:000439749200023
J	Watson, MC; Skea, ZC				Watson, Margaret C.; Skea, Zoe C.			Jugglers and tightrope walkers: The challenge of delivering quality community pharmacy services	PLOS ONE			English	Article							GENERAL PRACTICES; INDICATORS; CARE	Introduction This is the first exploration of service providers' attitudes and beliefs of quality and quality improvement in the community pharmacy setting in the UK. Materials and methods A series of interviews and focus groups was conducted with stakeholders from the pharmacy profession in the UK. Interviews were semi-structured and conducted face-to-face or by telephone. Focus groups were conducted with naturally-occurring groups i.e. at pharmacy conferences. Interviews and focus groups were audio-recorded, transcribed and analysed systematically using an interpretive approach. Results Forty-two individuals participated across four focus groups and four interviews. A maximum variation sample was achieved in terms of pharmacist and pharmacy characteristics. Participants were generally positive about the need for quality and quality improvement and provided multifaceted and interlinked interpretations of quality and acknowledged its dynamic nature "quality moves forward". The challenge of standardising practice whilst providing person-centred care emerged: "you don't want to lose the personal touch, but you can't have people having a variable experience and one day it's fantastic and the next day it isn't". A variety of quality measurement methods were identified including direct observation (by internal and external agents) and feedback (mystery shoppers, colleagues, regulatory inspectors, service users), suggesting that standardisation was also needed in terms of future quality measurement. There was a tendency to report negative events as triggers for improvement. Future initiatives could adopt more positive approaches including positive deviants "There's nothing more powerful than people who've come up with something really good sharing it with their other colleagues". Discussion The results are being used to develop and evaluate future quality improvement initiatives in this sector. These are likely to be targeted at organisational, team and individual levels.	[Watson, Margaret C.] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England; [Skea, Zoe C.] Univ Aberdeen, Hlth Serv Res Unit, Foresterhill Campus, Aberdeen, Scotland	University of Bath; University of Aberdeen	Watson, MC (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England.	m.c.watson@bath.ac.uk		, Margaret/0000-0002-8198-9273	Prof M Watson's Improvement Science - Health Foundation	Prof M Watson's Improvement Science - Health Foundation	This research was funded by Prof M Watson's Improvement Science Fellowship awarded by the Health Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkaravichien W, 2016, INT J CLIN PHARM-NET, V38, P899, DOI 10.1007/s11096-016-0307-4; Baxter R, 2016, BMJ QUAL SAF, V25, P190, DOI 10.1136/bmjqs-2015-004386; Bowie P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006667; Bowling A., 2002, RES METHODS HLTH INV, V2nd; Braun V., 2022, THEMATIC ANAL PRACTI; Department of Health, 2016, COMM PHARM 2016 17 F; Durand AC, 2011, AM J EMERG MED, V29, P333, DOI 10.1016/j.ajem.2010.01.003; Fielding S, 2015, FAM PRACT, V32, P165, DOI 10.1093/fampra/cmv003; Grey E, 2016, INT J PHARM PRACT, V24, P311, DOI 10.1111/ijpp.12253; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Halsall D, 2012, RES SOC ADMIN PHARM, V8, P360, DOI 10.1016/j.sapharm.2011.09.001; Health Foundation, 2013, QUAL IMPR MAD SIMPL; Inch J, 2017, INT J PHARM PRACT, V25, P253, DOI 10.1111/ijpp.12305; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Lawton R, 2014, BMJ QUAL SAF, V23, P880, DOI 10.1136/bmjqs-2014-003115; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; NHS England, 2013, URG EM CAR REV PHAS; Pearl J., 2013, WHICH, P26; Richer M., 2010, BR J HEALTHC MANAG, V16, P164, DOI [10.12968/bjhc.2010.16.4.47399, DOI 10.12968/BJHC.2010.16.4.47399]; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Shiyanbola OO, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006086; Teichert M, 2016, INT J CLIN PHARM-NET, V38, P870, DOI 10.1007/s11096-016-0301-x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trap B., 2010, Southern Med Review, V3, P4; Watson MC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006261; Watson MC, 2006, QUAL SAF HEALTH CARE, V15, P53, DOI 10.1136/qshc.2005.014720; Watson MC, 2002, FAM PRACT, V19, P529, DOI 10.1093/fampra/19.5.529	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200610	10.1371/journal.pone.0200610	http://dx.doi.org/10.1371/journal.pone.0200610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036368	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000439429200011
J	Whinton, AK; Thompson, KMA; Power, GA; Burr, JF				Whinton, Alanna K.; Thompson, Kyle M. A.; Power, Geoffrey A.; Burr, Jamie F.			Testing a novel isokinetic dynamometer constructed using a 1080 Quantum	PLOS ONE			English	Article							KNEE EXTENSION; RELIABILITY; BIODEX; REPRODUCIBILITY; STRENGTH; FLEXION; TORQUE	This study sought to assess the reliability and comparability of two custom-built isokinetic dynamometers (Model A and Model B) with the gold-standard (Humac Norm). The two custom-built dynamometers consisted of commercially available leg extension machines attached to a robotically controlled resistance device (1080 Quantum), able to measure power, force and velocity outputs. Twenty subjects (14m/6f, 26 +/- 4.8yr, 176 +/- 7cm, 74.4 +/- 12.4kg) performed concentric leg extensions on the custom-built dynamometers and the Humac Norm. Fifteen maximal leg extensions were performed with each leg at 180 degrees s(-1), or the linear equivalent (similar to 0.5m s(-1)). Peak power (W), mean power (W), and fatigue indexes (%) achieved on all three devices were compared. Both custom-built dynamometers revealed high reliability for peak and mean power on repeated tests (ICC>0.88). Coefficient of variation (CV) and standard error of measurement (SEM) were small when comparing power outputs obtained using Model A and the Humac Norm (<(x)overbar> CV = 9.0%, <(x)overbar> SEM = 49W; peak CV = 8.4%, peak SEM = 49W). Whereas, Model B had greater variance (<(x)overbar> CV = 13.3%<(x)overbar> SEM = 120W; peak CV = 14.7%, peak SEM = 146W). The custom-built dynamometers are capable of highly reliable measures, but absolute power outputs varied depending on the leg extension model. Consistent use of a single model offers reliable results for tracking muscular performance overtime or testing an intervention.	[Whinton, Alanna K.; Thompson, Kyle M. A.; Burr, Jamie F.] Univ Guelph, Dept Human Hlth & Nutr Sci, Human Performance & Hlth Res Lab, Guelph, ON, Canada; [Power, Geoffrey A.] Univ Guelph, Dept Human Hlth & Nutr Sci, Neuromech Performance Res Lab, Guelph, ON, Canada	University of Guelph; University of Guelph	Burr, JF (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Human Performance & Hlth Res Lab, Guelph, ON, Canada.	burrj@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada [03974]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The laboratory was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant Number: 03974).	Algotsson M., 2016, DIGITALA VETENSKAPLI; Bardis C, 2004, ISOKINET EXERC SCI, V12, P91, DOI 10.3233/IES-2004-0155; Bayramoglu M, 2001, AM J PHYS MED REHAB, V80, P650, DOI 10.1097/00002060-200109000-00004; Bergkvist C, 2015, ACCURACY REPEATABILI; Coetzee FF, 1992, SA J RES SPORT, V15, P1; Dalton B, 2015, AGE DORDR, V37, P1; Alvares JBDR, 2015, PHYS THER SPORT, V16, P59, DOI 10.1016/j.ptsp.2014.04.004; Dirnberger J, 2012, ISOKINET EXERC SCI, V20, P31, DOI 10.3233/IES-2012-0437; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; El Mhandi L, 2013, AM J PHYS MED REHAB, V92, P163, DOI 10.1097/PHM.0b013e31826ed94c; Folland J, 2008, J SPORT SCI, V26, P163, DOI 10.1080/02640410701370663; Gleeson NP, 1996, SPORTS MED, V21, P18, DOI 10.2165/00007256-199621010-00003; GROSS M T, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P329; Habets Bas, 2018, BMC Res Notes, V11, P15, DOI 10.1186/s13104-018-3128-9; Hallgren F., 2015, VALIDATION FORCE GEN; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Li RCT, 1996, BRIT J SPORT MED, V30, P156, DOI 10.1136/bjsm.30.2.156; Lund H, 2005, CLIN PHYSIOL FUNCT I, V25, P75, DOI 10.1111/j.1475-097X.2004.00593.x; Magalhaes J, 2004, J SPORT MED PHYS FIT, V44, P119; McBride J., 2015, ESSENTIALS STRENGTH, P60; MOLCZYK L, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P37; Papadopoulos K, 2016, INT J PHYS THER REHA, V2, P1; Santos AN, 2013, BRAZ J PHYS THER, V17, P112, DOI 10.1590/S1413-35552012005000074; Sole G, 2007, ARCH PHYS MED REHAB, V88, P626, DOI 10.1016/j.apmr.2007.02.006; STOKES M, 1985, Physiotherapy Practice, V1, P71; THOMPSON M C, 1989, Journal of Orthopaedic and Sports Physical Therapy, V11, P108	26	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201179	10.1371/journal.pone.0201179	http://dx.doi.org/10.1371/journal.pone.0201179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028864	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900042
J	Matsuo, M; Katahata, A; Satoh, S; Matsuzaki, M; Nomura, M; Ishida, K; Inagaki, Y; Obokata, J				Matsuo, Mitsuhiro; Katahata, Atsushi; Satoh, Soichirou; Matsuzaki, Motomichi; Nomura, Mami; Ishida, Ken-ichiro; Inagaki, Yuji; Obokata, Junichi			Characterization of spliced leader trans-splicing in a photosynthetic rhizarian amoeba, Paulinella micropora, and its possible role in functional gene transfer	PLOS ONE			English	Article							CHROMATOPHORE GENOME SEQUENCE; MESSENGER-RNA; TRYPANOSOMA-BRUCEI; C-ELEGANS; TRANSCRIPTION; EVOLUTION; SM; IDENTIFICATION; EUKARYOTES; METAZOA	Paulinella micropora is a rhizarian thecate amoeba, belonging to a photosynthetic Paulinella species group that has a unique organelle termed chromatophore, whose cyanobacterial origin is distinct from that of plant and algal chloroplasts. Because acquisition of the chromatophore was quite a recent event compared with that of the chloroplast ancestor, the Paulinella species are thought to be model organisms for studying the early process of primary endosymbiosis. To obtain insight into how endosymbiotically transferred genes acquire expression competence in the host nucleus, here we analyzed the 5' end sequences of the mRNAs of P. micropora MYN1 strain with the aid of a cap-trapper cDNA library. As a result, we found that mRNAs of 27 genes, including endosymbiotically transferred genes, possessed the common 5' end sequence of 28-33 bases that were posttranscriptionally added by spliced leader (SL) trans-splicing. We also found two subtypes of SL RNA genes encoded by the P. micropora MYN1 genome. Differing from the other SL trans-splicing organisms that usually possess poly(A)-less SL RNAs, this amoeba has polyadenylated SL RNAs. In this study, we characterize the SL trans-splicing of this unique organism and discuss the putative merits of SL trans-splicing in functional gene transfer and genome evolution.	[Matsuo, Mitsuhiro; Katahata, Atsushi; Satoh, Soichirou; Obokata, Junichi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Matsuzaki, Motomichi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan; [Nomura, Mami; Ishida, Ken-ichiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan	Kyoto Prefectural University; University of Tokyo; University of Tsukuba; University of Tsukuba	Obokata, J (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan.	Obokata@kpu.ac.jp	Matsuzaki, Motomichi/D-4043-2016	Matsuzaki, Motomichi/0000-0001-5811-798X; Obokata, Junichi/0000-0002-2973-0109; Inagaki, Yuji/0000-0003-0101-8483; Satoh, Soichirou/0000-0002-7622-1868	Japan Society for the Promotion of Sciences [15K14554, 16K14788]; Ministry of Education, Culture, Sports, Science and Technology of Japan [3308]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Sciences (http://www.jsps.go.jp) Grants 15K14554 (to J.O.), 16K14788 (to M.M.); Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp) Grant-in-Aid for Scientific Research on Innovative Areas 3308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Bitar Maina, 2013, Frontiers in Genetics, V4, P199, DOI 10.3389/fgene.2013.00199; BRUZIK JP, 1992, NATURE, V360, P692, DOI 10.1038/360692a0; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Cheng GF, 2006, J BIOL CHEM, V281, P733, DOI 10.1074/jbc.M506963200; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Davis RE, 1996, PARASITOL TODAY, V12, P33, DOI 10.1016/0169-4758(96)80643-0; Delaye L, 2016, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.e68a099364bb1a1e129a17b4e06b0c6b; Denker JA, 1996, RNA, V2, P746; Derelle R, 2010, RNA, V16, P696, DOI 10.1261/rna.1975210; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Ferguson KC, 1996, GENE DEV, V10, P1543, DOI 10.1101/gad.10.12.1543; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Gibson W, 2000, MOL BIOCHEM PARASIT, V107, P269, DOI 10.1016/S0166-6851(00)00193-6; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Glockner G, 2014, CURR BIOL, V24, P11, DOI 10.1016/j.cub.2013.11.027; HANNON GJ, 1992, SCIENCE, V258, P1775, DOI 10.1126/science.1465612; HANNON GJ, 1990, EMBO J, V9, P1915, DOI 10.1002/j.1460-2075.1990.tb08318.x; HANNON GJ, 1991, J BIOL CHEM, V266, P22792; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lall S, 2004, J BIOL CHEM, V279, P45573, DOI 10.1074/jbc.M407475200; Lamontagne J, 1999, J BIOL CHEM, V274, P6602, DOI 10.1074/jbc.274.10.6602; Lasda E. L., 2011, RNA, V2, P417, DOI [DOI 10.1002/WRNA.71, 10.1002/wrna.71]; Lhee D, 2017, PROTIST, V168, P155, DOI 10.1016/j.protis.2017.01.003; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; Maroney PA, 1996, RNA, V2, P735; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; NILSEN TW, 1989, MOL CELL BIOL, V9, P3543, DOI 10.1128/MCB.9.8.3543; Nomura M, 2014, J EUKARYOT MICROBIOL, V61, P317, DOI 10.1111/jeu.12102; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Nowack ECM, 2016, P NATL ACAD SCI USA, V113, P12214, DOI 10.1073/pnas.1608016113; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; PELLE R, 1993, MOL BIOCHEM PARASIT, V59, P277, DOI 10.1016/0166-6851(93)90225-M; Pouchkina-Stantcheva NN, 2005, MOL BIOL EVOL, V22, P1482, DOI 10.1093/molbev/msi139; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; Schwelm A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11153; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Song B, 2017, GENOME BIOL EVOL, V9, P2037, DOI 10.1093/gbe/evx144; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stangegaard M, 2006, BIOTECHNIQUES, V40, P649, DOI 10.2144/000112153; Stover NA, 2001, P NATL ACAD SCI USA, V98, P5693, DOI 10.1073/pnas.101049998; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; THOMAS JD, 1988, CELL, V54, P533, DOI 10.1016/0092-8674(88)90075-X; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x; Vandenberghe AE, 2001, GENE DEV, V15, P294, DOI 10.1101/gad.865401; Wang PP, 2006, EMBO J, V25, P4513, DOI 10.1038/sj.emboj.7601328; Yang FF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17411; Yoon HS, 2006, CURR BIOL, V16, pR670, DOI 10.1016/j.cub.2006.08.018; Zeiner GM, 2003, J BIOL CHEM, V278, P38269, DOI 10.1074/jbc.M304295200; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019933; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200961	10.1371/journal.pone.0200961	http://dx.doi.org/10.1371/journal.pone.0200961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024971	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000073
J	Andenaes, K; Lunde, IG; Mohammadzadeh, N; Dahl, CP; Aronsen, JM; Strand, ME; Palmero, S; Sjaastad, I; Christensen, G; Engebretsen, KVT; Tonnessen, T				Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Dahl, Christen P.; Aronsen, Jan Magnus; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis			The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; COLLAGEN CROSS-LINKING; MYOCARDIAL FIBROSIS; LYSYL OXIDASE; IMMUNE CELL; LUMICAN; HYPERTROPHY; EXPRESSION; SYNDECAN-4; FIBRILLOGENESIS	Pressure overload of the heart leads to cardiac remodeling that may progress into heart failure, a common, morbid and mortal condition. Increased mechanistic insight into remodeling is instrumental for development of novel heart failure treatment. Cardiac remodeling comprises cardiomyocyte hypertrophic growth, extracellular matrix alterations including fibrosis, and inflammation. Fibromodulin is a small leucine-rich proteoglycan that regulates collagen fibrillogenesis. Fibromodulin is expressed in the cardiac extracellular matrix, however its role in the heart remains largely unknown. We investigated fibromodulin levels in myocardial biopsies from heart failure patients and mice, subjected fibromodulin knock-out (FMOD-KO) mice to pressure overload by aortic banding, and overexpressed fibromodulin in cultured cardiomyocytes and cardiac fibroblasts using adenovirus. Fibromodulin was 3-10-fold upregulated in hearts of heart failure patients and mice. Both cardiomyocytes and cardiac fibroblasts expressed fibromodulin, and its expression was increased by pro-inflammatory stimuli. Without stress, FMOD-KO mice showed no cardiac phenotype. Upon aortic banding, left ventricles of FMOD-KO mice developed mildly exacerbated hypertrophic remodeling compared to wild-type mice, with increased cardiomyocyte size and altered infiltration of leukocytes. There were no differences in mortality, left ventricle dilatation, dysfunction or expression of heart failure markers. Although collagen amount and cross-linking were comparable in FMOD-KO and wild-type, overexpression of fibromodulin in cardiac fibroblasts in vitro decreased their migratory capacity and expression of fibrosis-associated molecules, i.e. the collagen-cross linking enzyme lysyl oxidase, transglutaminase 2 and periostin. In conclusion, despite a robust fibromodulin upregulation in clinical and experimental heart failure, FMOD-KO mice showed a relatively mild hypertrophic phenotype. In cultured cardiac fibroblasts, fibromodulin has anti-fibrotic effects.	[Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Aronsen, Jan Magnus; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway; [Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Aronsen, Jan Magnus; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Univ Oslo, Oslo, Norway; [Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Dahl, Christen P.; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Andenaes, Kine; Lunde, Ida G.; Mohammadzadeh, Naiyereh; Dahl, Christen P.; Strand, Mari E.; Palmero, Sheryl; Sjaastad, Ivar; Christensen, Geir; Engebretsen, Kristin V. T.; Tonnessen, Theis] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Lunde, Ida G.] Oslo Univ Hosp, Ctr Mol Med Norway, Oslo, Norway; [Dahl, Christen P.] Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Dahl, Christen P.] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Engebretsen, Kristin V. T.] Vestre Viken Hosp, Dept Surg, Drammen, Norway; [Tonnessen, Theis] Oslo Univ Hosp, Dept Cardiothorac Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Tonnessen, T (corresponding author), Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway.; Tonnessen, T (corresponding author), Univ Oslo, Oslo, Norway.; Tonnessen, T (corresponding author), Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway.; Tonnessen, T (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.; Tonnessen, T (corresponding author), Oslo Univ Hosp, Dept Cardiothorac Surg, Oslo, Norway.	theis.tonnessen@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018; Lunde, Ida Gjervold/ABN-5567-2022	Lunde, Ida Gjervold/0000-0001-9502-6841	South-Eastern Regional Health Authority; Research Council of Norway; Norwegian Health Association; Kristian Gerhard Jebsen Foundation; Anders Jahre's Fund for the Promotion of Science; Olav Raagholt and Gerd Meidel Raagholt's Fund for Science; Rakel and Otto Kristian Bruun's Fund; Family Blix Fund; Inger Haldorsens Fund, Norway; Simon Fougner Hartmanns Family Fund, Denmark	South-Eastern Regional Health Authority; Research Council of Norway(Research Council of Norway); Norwegian Health Association; Kristian Gerhard Jebsen Foundation; Anders Jahre's Fund for the Promotion of Science; Olav Raagholt and Gerd Meidel Raagholt's Fund for Science; Rakel and Otto Kristian Bruun's Fund; Family Blix Fund; Inger Haldorsens Fund, Norway; Simon Fougner Hartmanns Family Fund, Denmark	This study was investigator initiated and performed, and the manuscript was written independently of the sponsors. This work was supported with unrestricted grants from the South-Eastern Regional Health Authority, the Research Council of Norway, the Norwegian Health Association, the Kristian Gerhard Jebsen Foundation, Anders Jahre's Fund for the Promotion of Science, the Olav Raagholt and Gerd Meidel Raagholt's Fund for Science, the Rakel and Otto Kristian Bruun's Fund, the Family Blix Fund, the Inger Haldorsens Fund, Norway, and the Simon Fougner Hartmanns Family Fund, Denmark. TT received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2017, CIRCULATION, V136; Bjornstad JL, 2011, EUR HEART J, V32, P236, DOI 10.1093/eurheartj/ehq166; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Christensen G, 2018, MATRIX BIOL; Dupuis LE, 2015, J MOL CELL CARDIOL, V84, P70, DOI 10.1016/j.yjmcc.2015.04.007; Engebretsen KVT, 2013, FEBS J, V280, P2382, DOI 10.1111/febs.12235; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Finsen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028302; Frantz S, 2018, EUR J HEART FAIL, V20, P445, DOI 10.1002/ejhf.1138; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Frieler RA, 2015, CIRCULATION, V131, P1019, DOI 10.1161/CIRCULATIONAHA.114.008788; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; Gyongyosi M, 2017, EUR J HEART FAIL, V19, P177, DOI 10.1002/ejhf.696; Herum KM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050053; Herum KM, 2015, CARDIOVASC RES, V106, P217, DOI 10.1093/cvr/cvv002; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jiang WL, 2018, J CELL MOL MED, V22, P2510, DOI 10.1111/jcmm.13516; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Karamanos NK, 2017, FEBS J, V284, P7, DOI 10.1111/febs.13945; Li L, 2018, MATRIX BIOL; Liu RJ, 2016, J MOL CELL CARDIOL, V101, P44, DOI 10.1016/j.yjmcc.2016.08.018; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lunde IG, 2016, CELL TISSUE RES, V365, P539, DOI 10.1007/s00441-016-2454-2; Malgija B, 2018, COMPUT BIOL CHEM, V73, P85, DOI 10.1016/j.compbiolchem.2018.01.011; Melleby AO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165079; Metra M, 2017, LANCET, V390, P1981, DOI 10.1016/S0140-6736(17)31071-1; Mormone E, 2012, GASTROENTEROLOGY, V142, P612, DOI 10.1053/j.gastro.2011.11.029; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ohmura H, 2012, HYPERTENS RES, V35, P1063, DOI 10.1038/hr.2012.92; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; Rydell-Tomaen K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06383; Schaefer L, 2011, J AM SOC NEPHROL, V22, P1200, DOI 10.1681/ASN.2010050570; Schirone L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3920195; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Strand ME, 2015, J MOL CELL CARDIOL, V88, P133, DOI 10.1016/j.yjmcc.2015.10.003; Strand ME, 2013, FEBS J, V280, P2228, DOI 10.1111/febs.12161; Suthahar Navin, 2017, Curr Heart Fail Rep, V14, P235, DOI 10.1007/s11897-017-0343-y; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Waehre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018668; Yu LL, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9874109; Zheng Z, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.50; Zheng Z, 2016, AM J PATHOL, V186, P2824, DOI 10.1016/j.ajpath.2016.07.023; Zheng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096011, 10.1371/journal.pone.0090817]; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	56	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201422	10.1371/journal.pone.0201422	http://dx.doi.org/10.1371/journal.pone.0201422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052659	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600044
J	Li, H; Zeitelhofer, M; Nilsson, I; Liu, XC; Allan, L; Gloria, B; Perani, A; Murone, C; Catimel, B; Neville, AM; Scott, FE; Scott, AM; Eriksson, U				Li, Hong; Zeitelhofer, Manuel; Nilsson, Ingrid; Liu, Xicong; Allan, Laura; Gloria, Benjamin; Perani, Angelo; Murone, Carmel; Catimel, Bruno; Neville, A. Munro; Scott, Fiona E.; Scott, Andrew M.; Eriksson, Ulf			Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFR alpha signalling in vivo	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR-CC; PLASMINOGEN ACTIVATOR; LOBULAR CARCINOMA; ISCHEMIC-STROKE; BREAST-CANCER; CELLS; RECEPTOR; TUMORS; IDENTIFICATION	PDGF-CC is a member of the platelet-derived growth factor (PDGF) family that stimulates PDGFR alpha phosphorylation and thereby activates intracellular signalling events essential for development but also in cancer, fibrosis and neuropathologies involving blood-brain barrier (BBB) disruption. In order to elucidate the biological and pathological role(s) of PDGF-CC signalling, we have generated high affinity neutralizing monoclonal antibodies (mAbs) recognizing human PDGF-CC. We determined the complementarity determining regions (CDRs) of the selected clones, and mapped the binding epitope for clone 6B3. Using the monoclonal 6B3, we determined the expression pattern for PDGF-CC in different human primary tumours and control tissues, and explored its ability to neutralize PDGF-CC-induced phosphorylation of PDGFR alpha. In addition, we showed that PDGF-CC induced disruption of the blood-retinal barrier (BRB) was significantly reduced upon intraperitoneal administration of a chimeric anti-PDGF-CC antibody. In summary, we report on high affinity monoclonal antibodies against PDGF-CC that have therapeutic efficacy in vivo.	[Li, Hong; Zeitelhofer, Manuel; Nilsson, Ingrid; Liu, Xicong; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Allan, Laura; Gloria, Benjamin; Perani, Angelo; Murone, Carmel; Catimel, Bruno; Scott, Fiona E.; Scott, Andrew M.] Ludwig Inst Canc Res, Melbourne Austin Branch, Melbourne, Vic, Australia; [Allan, Laura; Gloria, Benjamin; Murone, Carmel; Scott, Fiona E.; Scott, Andrew M.] La Trobe Univ, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia; [Allan, Laura; Gloria, Benjamin; Murone, Carmel; Scott, Fiona E.; Scott, Andrew M.] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia; [Neville, A. Munro] Ludwig Inst Canc Res, New York, NY USA	Karolinska Institutet; Ludwig Institute for Cancer Research; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; Ludwig Institute for Cancer Research	Li, H; Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Hong.li@ki.se; ulf.pe.erikssson@ki.se	Scott, Fiona E/K-8106-2013	CATIMEL, Bruno/0000-0002-4350-6875; Scott, Andrew/0000-0002-6656-295X; Zeitelhofer, Manuel/0000-0002-4324-2355	Swedish Heart and Lung Foundation [20110451, 20120077]; Swedish Research Council [2011-03861]; Swedish Cancer Foundation [CAN 2011/792, CAN 2014/630]; Karolinska Institutet; Australian National Health and Medical Research Council (NHMRC) Development Grants [1038334, 1075898]; Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship; Victorian Government, Australia	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Karolinska Institutet(Karolinska Institutet); Australian National Health and Medical Research Council (NHMRC) Development Grants(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government, Australia	This study was supported by the Swedish Heart and Lung Foundation (20110451 and 20120077, U.E.), the Swedish Research Council (2011-03861, U.E.), the Swedish Cancer Foundation (CAN 2011/792 and CAN 2014/630, U.E.), and the Karolinska Institutet. This work was supported in part by the Australian National Health and Medical Research Council (NHMRC) Development Grants 1038334 and 1075898 and Practitioner Fellowship to A.M.S. and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [HL, MZ, IN, XL, LA, BG, AP, CM, BC, AMN, FES, AMS and UE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Adzemovic MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056586; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Andrae J, 2002, BIOCHEM BIOPH RES CO, V296, P604, DOI 10.1016/S0006-291X(02)00917-8; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Dijkmans J, 2002, INT J BIOCHEM CELL B, V34, P414, DOI 10.1016/S1357-2725(01)00124-8; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Ehnman M, 2014, EXPERT OPIN INV DRUG, V23, P211, DOI 10.1517/13543784.2014.847086; Eitner F, 2002, NORMAL DISEASED RAT; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; Fredriksson L, 2005, J BIOL CHEM, V280, P26856, DOI 10.1074/jbc.M503388200; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fredriksson L, 2015, ANN CLIN TRANSL NEUR, V2, P722, DOI 10.1002/acn3.209; Grun K, 2005, EUR HEART J, V26, P728, DOI 10.1093/eurheartj/ehi168; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang YJ, 2014, CANCER RES, V74, P1011, DOI 10.1158/0008-5472.CAN-13-1072; Jiao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088191; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P639, DOI 10.1073/pnas.232686499; Lei H, 2008, INVEST OPHTH VIS SCI, V49, P42, DOI 10.1167/iovs.07-0776; Lewandowski SA, 2016, PHARMACOL THERAPEUT, V167, P108, DOI 10.1016/j.pharmthera.2016.07.016; Lewandowski SA, 2016, ACTA NEUROPATHOL, V131, P453, DOI 10.1007/s00401-015-1520-2; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Li XR, 2010, ONCOTARGET, V1, P309, DOI 10.18632/oncotarget.141; Lokker NA, 2002, CANCER RES, V62, P3729; Luo NA, 2014, INT J MOL SCI, V15, P20306, DOI 10.3390/ijms151120306; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Manzat-Saplacan RM, 2015, J BUON, V20, P1193; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Roswall P, 2018, NAT MED, V24, P463, DOI 10.1038/nm.4494; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; SILVERSTEIN MJ, 1994, CANCER-AM CANCER SOC, V73, P1673, DOI 10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Toikkanen S, 1997, BRIT J CANCER, V76, P1234, DOI 10.1038/bjc.1997.540; Wahlgren N, 2017, J INTERN MED, V281, P273, DOI 10.1111/joim.12576; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Zhan Y, 2015, J NEUROSCI RES, V93, P94, DOI 10.1002/jnr.23475; Zhang WS, 2013, J COMPUT AID MOL DES, V27, P539, DOI 10.1007/s10822-013-9661-7; Zhuo Y, 2004, AM J PHYSIOL-LUNG C, V286, pL182, DOI 10.1152/ajplung.00083.2003; Zwerner JP, 2001, ONCOGENE, V20, P626, DOI 10.1038/sj.onc.1204133; Zwerner JP, 2002, DOMINANT NEGATIVE PD	54	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201089	10.1371/journal.pone.0201089	http://dx.doi.org/10.1371/journal.pone.0201089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052660	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600023
J	Machablishvili, A; Chakhunashvili, G; Zakhashvili, K; Karseladze, I; Tarkhan-Mouravi, O; Gavashelidze, M; Jashiashvili, T; Sabadze, L; Imnadze, P; Daniels, RS; Ermetal, B; McCauley, JW				Machablishvili, Ann; Chakhunashvili, Giorgi; Zakhashvili, Khatuna; Karseladze, Irakli; Tarkhan-Mouravi, Olgha; Gavashelidze, Mari; Jashiashvili, Tamar; Sabadze, Lela; Imnadze, Paata; Daniels, Rodney S.; Ermetal, Burcu; McCauley, John W.			Overview of three influenza seasons in Georgia, 2014-2017	PLOS ONE			English	Article							VIRUSES; HEMAGGLUTININ; SURVEILLANCE; AFRICA	Background Influenza epidemiological and virologic data from Georgia are limited. We aimed to present Influenza Like Illness (ILI) and Severe Acute Respiratory Infection (SARI) surveillance data and characterize influenza viruses circulating in the country over three influenza seasons. Methods We analyzed sentinel site ILI and SARI data for the 2014-2017 seasons in Georgia. Patients' samples were screened by real-time RT-PCR and influenza viruses isolated were characterized antigenically by haemagglutination inhibition assay and genetically by sequencing of HA and NA genes. Results 32% (397/1248) of ILI and 29% (581/1997) of SARI patients tested were positive for influenza viruses. In 2014-2015 the median week of influenza detection was week 7/2015 with B/Yamagata lineage viruses dominating (79%); in 2015-2016-week 5/2016 was the median with A/H1N1pdm09 viruses prevailing (83%); and in 2016-2017 a bimodal distribution of influenza activity was observed-the first wave was caused by A/H3N2 (55%) with median week 51/2016 and the second by B/Victoria lineage viruses (45%) with median week 9/2017. For ILI, influenza virus detection was highest in children aged 5-14 years while for SARI patients most were aged >15 years and 27 (4.6%) of 581 SARI cases died during the three seasons. Persons aged 30-64 years had the highest risk of fatal outcome, notably those infected with A/H1N1pdm09 (OR 11.41, CI 3.94-33.04, p<0.001). A/H1N1pdm09 viruses analyzed by gene sequencing fell into genetic groups 6B and 6B.1; N H3N2 viruses belonged to genetic subclades 3C.3b, 3C.3a, 3C.2a and 3C.2a1; B/Yamagata lineage viruses were of Glade 3 and B/Victoria lineage viruses fell in clade1A. Conclusion In Georgia influenza virus activity occurred mainly from December through March in all seasons, with varying peak weeks and predominating viruses. Around one third of ILI/SARI cases were associated with influenza caused by antigenically and genetically distinct influenza viruses over the course of the three seasons.	[Machablishvili, Ann; Chakhunashvili, Giorgi; Zakhashvili, Khatuna; Karseladze, Irakli; Tarkhan-Mouravi, Olgha; Gavashelidze, Mari; Jashiashvili, Tamar; Sabadze, Lela; Imnadze, Paata] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Machablishvili, Ann; Imnadze, Paata] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia; [Daniels, Rodney S.; Ermetal, Burcu; McCauley, John W.] Francis Crick Inst, WHO Collaborating Ctr Reference & Res Influenza, Worldwide Influenza Ctr, London, England	National Center for Disease Control & Public Health - Georgia; Ivane Javakhishvili Tbilisi State University; Francis Crick Institute	Machablishvili, A (corresponding author), Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia.; Machablishvili, A (corresponding author), Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia.	a.machablishvili@ncdc.ge		Machablishvili, Ann/0000-0003-4779-9801	CDC, Atlanta, USA; Cancer Research UK [FC001030]; Medical Research Council [FC001030]; Wellcome Trust [FC001030]	CDC, Atlanta, USA; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	CDC, Atlanta, USA, provided financial support of influenza surveillance in Georgia. The work performed at the Worldwide Influenza Centre (WHO CC, London), the Francis Crick Institute was supported by core funding from Cancer Research UK (FC001030), the Medical Research Council (FC001030) and the Wellcome Trust (FC001030).; The authors wish to thank: (i) CDC, Atlanta, USA for financial support of influenza surveillance in Georgia; (ii) WRAIR, USA for providing sequencing primers; (iii) all sentinel clinic staff for sample and data collection; (iv) all WIC staff involved in virus characterization studies.	Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Altas AB, 2016, MIKROBIYOL BUL, V50, P401, DOI 10.5578/mb.27775; [Anonymous], 2015, FLU NEWS EUROPE; [Anonymous], 2016, FLU NEWS EUROPE; [Anonymous], 2017, FLU NEWS EUROPE; Bonmarin I, 2015, EUROSURVEILLANCE, V20, P30066, DOI DOI 10.2807/1560-7917.ES.2015.20.46.30066; Butsashvili Maia, 2012, Influenza Res Treat, V2012, P480763, DOI 10.1155/2012/480763; CDC, 2016, SEL VIR SEAS INFL VA; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Emukule GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180890; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Kandeel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161301; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Korsun N, 2017, INFECT GENET EVOL, V49, P241, DOI 10.1016/j.meegid.2017.01.027; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Machablishvili A, 2017, Georgian Med News, P71; McMorrow ML, 2015, J INFECT DIS, V212, P853, DOI 10.1093/infdis/jiv100; Meerhoff TJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0722-x; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Milne GJ, 2016, INFLUENZA OTHER RESP, V10, P324, DOI 10.1111/irv.12367; Moasser E, 2017, ARCH VIROL, V162, P1975, DOI 10.1007/s00705-017-3323-3; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Puig-Barbera J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3378-1; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Vestergaard LS, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.14.30506, 10.2807/1560-7917.es.2017.22.14.30506]; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, GLOB EP SURV STAND I; World Health Organization, 2015, REV 2014 2015 INFL S, P90; World Health Organization, 2016, INFL FACT SHEET; World Health Organization, CDC PROT REAL TIM RT; Worldwide Influenza Centre London, 2017, FEBR 2017 INT REP WH; Worldwide Influenza Centre London, 2017, SEPT 2016 INT REP WH; Wu P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01021-x; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279	37	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201207	10.1371/journal.pone.0201207	http://dx.doi.org/10.1371/journal.pone.0201207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052663	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600029
J	Vijayaraghavan, M; Benmarnhia, T; Pierce, JP; White, MM; Kempster, J; Shi, YY; Trinidad, DR; Messer, K				Vijayaraghavan, Maya; Benmarnhia, Tarik; Pierce, John P.; White, Martha M.; Kempster, Jennie; Shi, Yuyan; Trinidad, Dennis R.; Messer, Karen			Income disparities in smoking cessation and the diffusion of smoke-free homes among US smokers: Results from two longitudinal surveys	PLOS ONE			English	Article							UNITED-STATES; CIGARETTE-SMOKING; POPULATION; BEHAVIOR; ADULTS	Background Lower rates of successful quitting among low-income populations in the United States may be from slower dissemination of smoke-free homes, a predictor of cessation. Objectives To explore the role of smoke-free homes in cessation behavior across income levels. Participants Current smokers who were >= 18 years and who participated in the longitudinal 2002-2003 (n = 2801) or 2010-2011 (n = 2723) Tobacco Use Supplements to the Current Population Survey. Measurements We categorized income as multiples of the federal poverty level (FPL) (<300% FPL versus >= 300% FPL). We examined the association of smoke-free homes with 1+day quit attempts and 30+days abstinence at 1-year follow-up. We then conducted a mediation analysis to examine the extent that smoke-free homes contributed to income disparities in 30+days abstinence. Results Between the two surveys, heavy smoking (>= 1 pack/day) declined by 17%, and smoking prevalence declined by 15% among those with higher-incomes (>300%FPL). Although similar in 2002, the prevalence of smoke-free homes was 33% lower among individuals living <300% FPL than those living >= 300% FPL. Although the quit attempt rate was similar, the 30 +days abstinence rate was higher in the 2010-11 cohort than in 2002-3 cohort (20.6% versus 15.5%, p<0.008). Whereas smoking >= 1 pack/ day was associated with lower odds of 30 +days abstinence (Adjusted odds ratio [AOR] 0.7; 95% CI 0.5-0.9), having a higher income (AOR 1.9, 95% CI 1.4-2.6) and a smoke-free home (AOR 1.6, 95% CI 1.2-2.1) were associated with greater odds of 30+day abstinence. Differential changes in smoke-free homes across income groups between the two surveys contributed to 36% (95% CI 35.7-36.3) of the observed income disparity in 30+days abstinence. Conclusions Increasing the diffusion of smoke-free homes among low-income populations may attenuate at least a third of the income disparities in smoking cessation, highlighting the need for interventions to increase adoption of smoke-free homes among low-income households.	[Vijayaraghavan, Maya] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA; [Benmarnhia, Tarik; Pierce, John P.; White, Martha M.; Shi, Yuyan; Trinidad, Dennis R.; Messer, Karen] Univ Calif San Diego, Moores Canc Ctr, Div Populat Sci, La Jolla, CA 92093 USA; [Benmarnhia, Tarik; Pierce, John P.; Kempster, Jennie; Shi, Yuyan; Trinidad, Dennis R.; Messer, Karen] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Benmarnhia, Tarik] Scripps Inst Oceanog, Climate Atmospher Sci & Phys Oceanog, La Jolla, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Vijayaraghavan, M (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA.	maya.vijayaraghavan@ucsf.edu		Pierce, John/0000-0002-0075-7471	Tobacco Related Disease Research Program (TRDRP) [24ST-0050, 23RT-0016, 25IP-0015]	Tobacco Related Disease Research Program (TRDRP)(University of California System)	This study was funded by the Tobacco Related Disease Research Program (TRDRP): 24ST-0050 (JP), 23RT-0016 (KM), 23RT-0016 (DT), and 25IP-0015 (MV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb S, 2017, MMWR-MORBID MORTAL W, V65, P1457, DOI 10.15585/mmwr.mm6552a1; Bader P, 2011, INT J ENV RES PUB HE, V8, P4118, DOI 10.3390/ijerph8114118; Barbeau EM, 2005, PREV MED, V40, P16, DOI 10.1016/j.ypmed.2004.04.056; Campaing for Tobacco-free Kids, 2017, CAMP TOB FREE KIDS S, V2017; Center for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; Cheng KW, 2011, AM J PREV MED, V41, P566, DOI 10.1016/j.amepre.2011.08.014; Gilpin EA, 1997, J NATL CANCER I, V89, P572, DOI 10.1093/jnci/89.8.572; GILPIN EA, 1994, AM J PUBLIC HEALTH, V84, P1576, DOI 10.2105/AJPH.84.10.1576; Hill S, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2013-051110; Hyland A, 2009, NICOTINE TOB RES, V11, P614, DOI 10.1093/ntr/ntp022; International Agency for Research on Cancer, 2009, IARC HDB CANC PREV T, V13; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Judkins D. R., 1990, J OFF STAT, V6, P223, DOI DOI 10.1016/J.AMJMED.2017.09.025.(ADVANCE; Messer K, 2008, AM J PREV MED, V35, P210, DOI 10.1016/j.amepre.2008.05.023; Mills AL, 2011, AM J PREV MED, V41, P559, DOI 10.1016/j.amepre.2011.08.016; Mills AL, 2009, NICOTINE TOB RES, V11, P1131, DOI 10.1093/ntr/ntp122; Odutayo A, 2017, JAMA CARDIOL, V2, P782, DOI 10.1001/jamacardio.2017.1658; Orzechowski, 2016, TAX BURDEN TOBACCO, V51; Passey ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010260; Perlman SE, 2016, NICOTINE TOB RES, V18, P2065, DOI 10.1093/ntr/ntw135; Pierce JP, 2012, ANNU REV PUBL HEALTH, V33, P341, DOI 10.1146/annurev-publhealth-031811-124624; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P61, DOI 10.1001/jama.261.1.61; Pizacani BA, 2003, PREV MED, V36, P99, DOI 10.1006/pmed.2002.1123; Pizacani B, 2011, PREV CHRONIC DIS, V8; Ross H, 2011, ADDICTION, V106, P609, DOI 10.1111/j.1360-0443.2010.03192.x; Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; U.S. Census Bureau Center for Labor Statistics, 2002, 63RV US CENS BUR CTR; US Department of Commerce Census Bureau, 2007, NAT CANC I CTR DIS C; US Department of Commerce Census Bureau, 2017, POV THRESH; US Department of Housing and Urban Development, SMOK FREE PUBL HOUS; VanderWeele TJ, 2013, EPIDEMIOLOGY, V24, P224, DOI 10.1097/EDE.0b013e318281a64e; Vijayaraghavan M, 2014, ADDICT BEHAV, V39, P1452, DOI 10.1016/j.addbeh.2014.05.029; Vijayaraghavan M, 2013, AM J PUBLIC HEALTH, V103, P2276, DOI 10.2105/AJPH.2013.301300; Wan W, WASH POST; Zhu SH, 2012, TOB CONTROL, V21, P110, DOI 10.1136/tobaccocontrol-2011-050371	37	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201467	10.1371/journal.pone.0201467	http://dx.doi.org/10.1371/journal.pone.0201467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052671	Green Published, gold			2022-12-27	WOS:000440006600046
J	Yuille, S; Reichardt, N; Panda, S; Dunbar, H; Mulder, IE				Yuille, Samantha; Reichardt, Nicole; Panda, Suchita; Dunbar, Hayley; Mulder, Imke E.			Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; EPIGENETIC MODIFICATIONS; THERAPEUTIC TARGETS; MICROBIOTA; HOMEOSTASIS; ACTIVATION; DISORDERS; COLITIS; CANCER; CELLS	Overexpression of histone deacetylase (HDAC) isoforms has been implicated in a variety of disease pathologies, from cancer and colitis to cardiovascular disease and neurodegeneration, thus HDAC inhibitors have a long history as therapeutic targets. The gut microbiota can influence HDAC activity via microbial-derived metabolites. While HDAC inhibition (HDI) by gut commensals has long been attributed to the short chain fatty acid (SCFA) butyrate, the potent metabolic reservoir provided by the gut microbiota and its role in host physiology warrants further investigation in a variety of diseases. Cell-free supernatants (CFS) of 79 phylogenetically diverse gut commensals isolated from healthy human donors were screened for their SCFA profile and their total HDAC inhibitory properties. The three most potent HDAC inhibiting strains were further evaluated and subjected to additional analysis of specific class I and class II HDAC inhibition. All three HDAC inhibitors are butyrate producing strains, and one of these also produced substantial levels of valeric acid and hexanoic acid. Valeric acid was identified as a potential contributor to the HDAC inhibitory effects. This bacterial strain, Megasphaera massiliensis MRx0029, was added to a model microbial consortium to assess its metabolic activity in interaction with a complex community. M. massiliensis MRx0029 successfully established in the consortium and enhanced the total and specific HDAC inhibitory function by increasing the capacity of the community to produce butyrate and valeric acid. We here show that single bacterial strains from the human gut microbiota have potential as novel HDI therapeutics for disease areas involving host epigenetic aberrations.	[Yuille, Samantha; Reichardt, Nicole; Panda, Suchita; Dunbar, Hayley; Mulder, Imke E.] 4DPharma Res Ltd, Aberdeen, Scotland		Mulder, IE (corresponding author), 4DPharma Res Ltd, Aberdeen, Scotland.	imke.mulder@4dpharmaplc.com		, Imke/0000-0001-6468-4550	4D Pharma Research Ltd.	4D Pharma Research Ltd.	This work was funded by 4D Pharma Research Ltd. The funder provided support in the form of salaries for authors SY, NR, HD, SP, IEM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Bieliauskas AV, 2008, CHEM SOC REV, V37, P1402, DOI 10.1039/b703830p; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bultman SJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500902; Bultman SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/carcin/bgt392; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Felice C, 2015, ALIMENT PHARM THER, V41, P26, DOI 10.1111/apt.13008; Fellows R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02651-5; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Giloteaux L, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0171-4; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Glauben R, 2011, MOL MED, V17, P426, DOI 10.2119/molmed.2011.00069; Gonneaud A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0043-2; Gulden E, 2015, CLIN IMMUNOL, V159, P143, DOI 10.1016/j.clim.2015.05.013; Hegazi RAF, 2003, INFLAMM BOWEL DIS, V9, P230, DOI 10.1097/00054725-200307000-00003; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jacqueline C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11644-9; Johnsen LG, 2017, J CHROMATOGR A, V1503, P57, DOI 10.1016/j.chroma.2017.04.052; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Meng S, 1999, SURGERY, V126, P293, DOI 10.1067/msy.1999.98927; Minato T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187307; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sivaprakasam S, 2017, HLTH NUTRIENTS, V9; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Strati F, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0242-1; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tang Y, 2017, J AM HEART ASS, V6; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Wang CC, 2012, PROG NEURO-PSYCHOPH, V37, P111, DOI 10.1016/j.pnpbp.2012.01.017; Wang C, 2011, J NAT PROD, V74, P2031, DOI 10.1021/np200324x; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wilson AJ, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-12; Yoon Somy, 2016, Chonnam Med J, V52, P1, DOI 10.4068/cmj.2016.52.1.1; Zhang HL, 2012, J HEPATOL, V57, P803, DOI 10.1016/j.jhep.2012.06.011	46	92	95	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201073	10.1371/journal.pone.0201073	http://dx.doi.org/10.1371/journal.pone.0201073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052654	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600022
J	Kim, SK				Kim, Stuart K.			Identification of 613 new loci associated with heel bone mineral density and a polygenic risk score for bone mineral density, osteoporosis and fracture	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE ULTRASOUND; VERTEBRAL FRACTURES; OLDER WOMEN; HERITABILITY; METAANALYSIS; HIP; MEN; DEFORMITIES; PREDICTION	Low bone mineral density (BMD) leads to osteoporosis, and is a risk factor for bone fractures, including stress fractures. Using data from UK Biobank, a genome-wide association study identified 1,362 independent SNPs that clustered into 899 loci of which 613 are new. These data were used to train a genetic algorithm using 22,886 SNPs as predictors and showing a correlation with heel bone mineral density of 0.415. Combining this genetic algorithm with height, weight, age and sex resulted in a correlation with heel bone mineral density of 0.496. Individuals with low scores (2.2% of total) showed a change in BMD of - 1.16 Tscore units, an increase in risk for osteoporosis of 17.4 fold and an increase in risk for fracture of 1.87 fold. Genetic predictors could assist in the identification of individuals at risk for osteoporosis or fractures.	[Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu		kim, stuart/0000-0001-8887-5095	National Institutes of Aging, R01 grant [5R01 AG02594110]; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	National Institutes of Aging, R01 grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Aging, R01 grant number 5R01 AG02594110 to SKK. https://www.nia.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arden NK, 1996, J BONE MINER RES, V11, P530; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BURGER H, 1994, BRIT MED J, V309, P991, DOI 10.1136/bmj.309.6960.991; Bycroft CF, 2017, GENOME WIDE GENETIC; Cauley JA, 2007, JAMA-J AM MED ASSOC, V298, P2761, DOI 10.1001/jama.298.23.2761; Compston J, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0324-5; Donaldson MG, 2009, J BONE MINER RES, V24, P1793, DOI 10.1359/jbmr.090511; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fredericson Michael, 2006, Top Magn Reson Imaging, V17, P309; Gluer CC, 2004, J BONE MINER RES, V19, P782, DOI 10.1359/JBMR.040304; Goolsby MA, 2017, SPORTS HEALTH, V9, P108, DOI 10.1177/1941738116677732; Hillier TA, 2011, J BONE MINER RES, V26, P1774, DOI 10.1002/jbmr.372; Howard GM, 1998, J BONE MINER RES, V13, P1318, DOI 10.1359/jbmr.1998.13.8.1318; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hunter DJ, 2001, OSTEOPOROSIS INT, V12, P406, DOI 10.1007/s001980170110; Jones BH, 1999, SPORTS MED, V27, P111, DOI 10.2165/00007256-199927020-00004; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Karasik D, 2002, OSTEOPOROSIS INT, V13, P796, DOI 10.1007/s001980200110; Kemp JP, 2017, NAT GENET; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lello L, BIORXIV; Liu CT, 2012, J BONE MINER RES, V27, P954, DOI 10.1002/jbmr.1537; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; McClung Michael R, 2005, Curr Osteoporos Rep, V3, P57, DOI 10.1007/s11914-005-0005-y; Moayyeri A, 2014, HUM MOL GENET, V23, P3054, DOI 10.1093/hmg/ddt675; Mullin BH, 2017, HUM MOL GENET, V26, P2791, DOI 10.1093/hmg/ddx174; Nattiv A, 2000, J Sci Med Sport, V3, P268, DOI 10.1016/S1440-2440(00)80036-5; Paterson R, 2017, EXPERT REV ANTICANC, V17, P991, DOI 10.1080/14737140.2017.1374175; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watts Nelson B, 2010, Endocr Pract, V16 Suppl 3, P1; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	44	80	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200785	10.1371/journal.pone.0200785	http://dx.doi.org/10.1371/journal.pone.0200785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048462	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400020
J	Wauters, J; Wilson, KS; Bouts, T; Valentine, I; Vanderschueren, K; Ververs, C; Howie, AF; Rae, MT; Van Soom, A; Li, RG; Li, DS; Zhang, HM; Vanhaecke, L				Wauters, Jella; Wilson, Kirsten S.; Bouts, Tim; Valentine, Iain; Vanderschueren, Koen; Ververs, Cyrillus; Howie, A. Forbes; Rae, Mick T.; Van Soom, Ann; Li, Rengui; Li, Desheng; Zhang, Hemin; Vanhaecke, Lynn			Urinary specific gravity as an alternative for the normalisation of endocrine metabolite concentrations in giant panda (Ailuropoda melanoleuca) reproductive monitoring	PLOS ONE			English	Article							PLASMA-CONCENTRATIONS; SERUM CERULOPLASMIN; PHYSICAL-ACTIVITY; HORMONE; CREATININE; PREGNANCY; PGFM; REFRACTOMETERS; PROGESTERONE; RELAXIN	Reproductive monitoring for captive breeding in giant pandas is based on behavioural observation and non-invasive hormone analysis. In urine, interpretation of results requires normalisation due to an animal's changing hydration. Correction of urinary concentrations based on creatinine is the gold standard. In this study, a largely unexplored, easy-to-perform normalisation technique, based on urinary specific gravity (USpG), was examined and compared to creatinine. To this extent, six cycles from two female pandas (SB741(1) and SB569 (5)) were monitored through urine analysis for oestrogen, progesterone, ceruloplasmin and 13,14-dihydro-15-keto-PGF2a (PGFM). The Pearson's correlation between creatinine and USpG was high (r = 0.805-0.894; p < 0.01), indicative for a similar performance of both normalisation methods. However, generally lower values were observed during pro-oestrus and primary (progesterone) rise. This could be associated with huge shifts in appetite, monitored by faecal output (kg) with an averaged > 50% decrease during oestrus and > 50% increase during primary progesterone rise. In parallel, respectively highest and lowest creatinine and USpG levels, were measured, with creatinine obviously more affected as a result of linkage with muscle tissue metabolism affected by reproductive hormones. As a consequence, metabolite levels were significantly different between both corrected datasets with significantly higher oestrogen peak levels during oestrus ranging from 2.13-86.93 and 31.61-306.45 ng/mL (USpG correction) versus 2.33-31.20 and 36.36-249.05 ng/mL Cr (creatinine correction) for SB569 and SB741 respectively, and significant lower progesterone levels during primary progesterone rise ranging from 0.35-3.21 and 0.85-6.80 ng/mL (USpG correction) versus 0.52-10.31 and 2.10-272.74 ng/mL Cr (creatinine correction) for SB569 and SB741 respectively. Consequently, USpG correction rendered unbiased profiles, less subject to variation and metabolic artefacts and therefore allowed a more straightforward identification of peak oestrogen and onset of secondary progesterone rise, being potentially advantageous for future studies unravelling key giant panda reproductive events, including (delayed) implantation. The alternative application of USpG as a normalisation factor was further supported by its easy application and environmental and technical robustness.	[Wauters, Jella; Vanhaecke, Lynn] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Chem Anal Lab, Merelbeke, Belgium; [Wauters, Jella; Bouts, Tim; Vanderschueren, Koen] Pairi Daiza Pairi Daiza Fdn, Brugelette, Belgium; [Wilson, Kirsten S.; Howie, A. Forbes] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Valentine, Iain] Edinburgh Zoo, Royal Zool Soc Scotland, Edinburgh, Midlothian, Scotland; [Ververs, Cyrillus; Van Soom, Ann] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, Merelbeke, Belgium; [Rae, Mick T.] Edinburgh Napier Univ, Sch Appl Sci, Sighthill Campus, Edinburgh, Midlothian, Scotland; [Li, Rengui; Li, Desheng; Zhang, Hemin] CCRCGP, Dujiangyan, Sichuan, Peoples R China	Ghent University; University of Edinburgh; Ghent University; Edinburgh Napier University	Wauters, J (corresponding author), Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Chem Anal Lab, Merelbeke, Belgium.; Wauters, J (corresponding author), Pairi Daiza Pairi Daiza Fdn, Brugelette, Belgium.	Jella.wauters@ugent.be	Vanhaecke, Lynn/N-1061-2017	Vanhaecke, Lynn/0000-0003-0400-2188; Wauters, Jella/0000-0002-7046-1764; Ververs, Cyriel/0000-0002-6994-7687	Pairi Daiza Foundation	Pairi Daiza Foundation	This study was partly funded by the Pairi Daiza Foundation (http://www.pairidaiza-foundation.org/fr). The funders had no role in the study design, data collection and analysis or preparation of the manuscript.	Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Bergfelt DR, 2014, THERIOGENOLOGY, V82, P1187, DOI 10.1016/j.theriogenology.2014.07.030; Bowen RS, 2011, SPORTS MED, V41, P73, DOI 10.2165/11536860-000000000-00000; Chadha V, 2001, PEDIATR NEPHROL, V16, P374, DOI 10.1007/s004670000551; COLLINS WP, 1979, ACTA ENDOCRINOL-COP, V90, P336, DOI 10.1530/acta.0.0900336; Dehnhard M, 2012, THERIOGENOLOGY, V77, P1088, DOI 10.1016/j.theriogenology.2011.10.011; DESHMUKH VK, 1985, PHARMACOL RES COMMUN, V17, P633, DOI 10.1016/0031-6989(85)90070-0; Drosdoff D, 2005, AM J PHYS, V73, P973, DOI 10.1119/1.2000974; FULLER NJ, 1988, CLIN CHIM ACTA, V175, P199, DOI 10.1016/0009-8981(88)90096-4; George JW, 2001, VET CLIN PATH, V30, P201, DOI 10.1111/j.1939-165X.2001.tb00432.x; Handler J, 2004, THERIOGENOLOGY, V61, P1573, DOI 10.1016/j.theriogenology.2003.09.005; Kersey DC, 2016, THERIOGENOLOGY, V85, P671, DOI 10.1016/j.theriogenology.2015.10.005; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; Kumar A, 2013, VET WORLD, V6, P59, DOI 10.5455/vetworld.2013.59-63; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Lovendahl P, 2010, J DAIRY SCI, V93, P249, DOI 10.3168/jds.2008-1721; Luz MR, 2006, THERIOGENOLOGY, V66, P1436, DOI 10.1016/j.theriogenology.2006.01.036; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Muscat JE, 2011, BIOMARKERS, V16, P206, DOI 10.3109/1354750X.2010.538084; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Rao P, 2015, INT J PHARM MED RES, V3, P57; Rishniw M, 2015, J FELINE MED SURG, V17, P329, DOI 10.1177/1098612X14541263; Roberts B, 2014, 3 ANN INT SOC WILDL; Roberts BM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195599; Samra Manpreet, 2012, Perm J, V16, P51; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Shrestha HK, 2011, BIOL REPROD, V85, P482, DOI 10.1095/biolreprod.111.092130; Spady TJ, 2007, MAMMAL REV, V37, P21, DOI 10.1111/j.1365-2907.2007.00096.x; Spierto FW, 1997, CLIN CHIM ACTA, V264, P227, DOI 10.1016/S0009-8981(97)00080-6; Steinetz BG, 2005, ANN NY ACAD SCI, V1041, P367, DOI 10.1196/annals.1282.057; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Swaisgood R., 2016, IUCN RED LIST THREAT; Tvedten HW, 2015, NEW ZEAL VET J, V63, P254, DOI 10.1080/00480169.2014.1002553; Wauters J, 2017, ANN C 2017 COMM BREE; Willis EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021159; Wyness Sara P, 2016, Pract Lab Med, V5, P65, DOI 10.1016/j.plabm.2016.06.001	38	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201420	10.1371/journal.pone.0201420	http://dx.doi.org/10.1371/journal.pone.0201420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048530	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400088
J	Fisher, CB; Fried, AL; Puri, LI; Macapagal, K; Mustanski, B				Fisher, Celia B.; Fried, Adam L.; Puri, Leah Ibrahim; Macapagal, Kathryn; Mustanski, Brian			"Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men	PLOS ONE			English	Article							PREVENTIVE MISCONCEPTION; HEALTH-CARE; PREEXPOSURE PROPHYLAXIS; HIV; BARRIERS; GAY; TRANSGENDER; EXPERIENCES; DISPARITIES; CONSENT	Background Adolescent men who have sex with men (AMSM) account for disproportionately high numbers of new HIV diagnoses. Non-adherence to daily use limiting the effectiveness of oral PrEP (Truvada) has led to current trials with adult MSM testing Cabotegravir, a long-term injectable medication. Once comparative studies with young adult MSM have established relative safety and efficacy of these medications, there will be a need for such comparative trials involving adolescents. Trends in state laws and IRB protocol review indicate that many of these studies will permit youth to provide independent consent for participation. Understanding the motivations of AMSM to participate in HIV biomedical prevention studies is important to ensure their agreement is voluntary without misunderstanding and undue influence. This study examined AMSM attitudes toward participation in oral/injectable PrEP RCTs to inform protections of youth's rights and welfare in future studies. Methods We administered to 198 ethnically diverse U.S. AMSM, 14-17 years, a web-based survey including demographic and sexual health questions, description of a year-long oral versus injectable PrEP RCT and 26 Likert-type and one open-ended item assessing motivations for and against participation including: perceived benefits and risks of PrEP; free HIV/STI testing and counseling; confidentiality concerns; random assignment; and benefit to others. Results Sixty-two percent indicated they were likely to participate in the study. The majority endorsed daily HIV protection, free HIV/STI testing, sexual health counseling, not having to rely on partner's condom use, and altruism as reasons to participate. Reasons against participation included medication side effects, concern taking the pill daily and clinic visits would reveal their sexual orientation and behaviors to parents. Over half erroneously assumed they would be assigned to the condition best for them and 39% indicated free access to services would lead them to participate even if they did not want to. Multiple regression indicated these factors accounted for 55% of the variance in participation choice. Nether age or ethnicity yielded significance. Conclusions Results suggest future biomedical HIV prevention research will need to develop procedures to address AMSM's confidentiality concerns, enhance youth's understanding of random assignment, the continued importance of medication adherence and partner condom use during trial participation, and availability of alternative sexual health services to avoid the potentially undue influence of access to free sexual health services.	[Fisher, Celia B.; Puri, Leah Ibrahim] Fordham Univ, Ctr Eth Educ, New York, NY 10023 USA; [Fried, Adam L.] Midwestern Univ, Clin Psychol Dept, Glendale, AZ USA; [Macapagal, Kathryn; Mustanski, Brian] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Fordham University; Midwestern University; Northwestern University; Feinberg School of Medicine	Fisher, CB (corresponding author), Fordham Univ, Ctr Eth Educ, New York, NY 10023 USA.	fisher@fordham.edu		Fisher, Celia/0000-0002-3849-7281	NIMHD [R01MD009561]; National Institute on Minority Health and Health Disparities [R01MD009561] Funding Source: NIH RePORTER	NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The research was funded by NIMHD #R01MD009561 to Celia B. Fisher and Brian Mustanski. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USFaD, 2012, FDA APPR 1 DRUG RED; Bauermeister JA, 2012, FIELD METHOD, V24, P272, DOI 10.1177/1525822X12443097; CDC, 2019, HIV GAY BIS MEN; Chin LJ, 2016, J EMPIRICAL RES HUMA, V11; Cohen S., 2015, J INT AIDS SOC S3, V18; Coker TR, 2010, ANNU REV PUBL HEALTH, V31, P457, DOI 10.1146/annurev.publhealth.012809.103636; Corneli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125458; D'Amico E, 2012, J GLBT FAM STUD, V8, P215, DOI 10.1080/1550428X.2012.677232; Dellar RC, 2014, AIDS BEHAV, V18, P1746, DOI 10.1007/s10461-014-0771-6; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; Emanuel E, 2004, JAMA-J AM MED ASSOC, V283, P2701; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2005, AM J BIOETHICS, V5, P9, DOI 10.1080/15265160500244959; Fisher CB, 2017, AIDS EDUC PREV, V29, P205, DOI 10.1521/aeap.2017.29.3.205; Fisher CB, 2016, J EMPIR RES HUM RES, V11, P3, DOI 10.1177/1556264616633963; Fisher CB, 2014, HASTINGS CENT REP, V44, pS28, DOI 10.1002/hast.367; Gilbert AL, 2015, J ADOLESCENT HEALTH, V57, P113, DOI 10.1016/j.jadohealth.2015.03.017; Gilead Sciences, 2018, US FOOD DRUG ADM APP; Grady Christine, 2016, AJOB Empir Bioeth, V7, P1; Grant RW, 2004, J MED PHILOS, V29, P717, DOI 10.1080/03605310490883046; Health NIo, 2015, NIH SUPP CLIN TRAILS; Heerman William J, 2016, IRB, V38, P8; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Herrick AL, 2011, J ADOLESCENT HEALTH, V48, P306, DOI 10.1016/j.jadohealth.2010.07.008; Hill B. J., 2012, J HEALTH CARE L PORV, V15, P37; HIV Prevention Trials Network, 2017, LONG ACT INJ CAB PRE; Hoffman LF, 2016, J ADOLESCENT HEALTH, V58, P576, DOI 10.1016/j.jadohealth.2016.01.007; Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Institute of Medicine Committee on Lesbian, 2011, BIS TRANSG HLTH ISS; Jackson CL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3467-1; Kann L, 2016, MORBIDITY MORTALITY, V65, P1, DOI DOI 10.15585/MMWR.SS6509A1; Kim Scott Y H, 2013, IRB, V35, P1; King NMP, 2000, J LAW MED ETHICS, V28, P332, DOI 10.1111/j.1748-720X.2000.tb00685.x; Kokolo MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022497; Konstan JA, 2005, J COMPUT-MEDIAT COMM, V10; Levy ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183521; Lidz CW, 2002, MED CARE, V40, P55, DOI 10.1097/01.MLR.0000023956.25813.18; Macapagal K, 2016, LGBT HEALTH, V3, P434, DOI 10.1089/lgbt.2015.0124; Macapagal K, 2016, ARCH SEX BEHAV, V45, P1513, DOI 10.1007/s10508-016-0698-2; Machado DM, 2017, ADOLESC HEALTH MED T, V8, P137, DOI 10.2147/AHMT.S112757; Meyers K, 2018, AIDS BEHAV, V22, P1209, DOI 10.1007/s10461-017-1871-x; Milhausen RR, 2013, CAN J HUM SEX, V22, P142, DOI DOI 10.3138/CJHS.2316; Miller Victoria A, 2016, IRB, V38, P1; Montgomery MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157742; Mustanski B, 2017, PERSPECT SEX REPRO H, V49, P111, DOI 10.1363/psrh.12027; Mustanski B, 2016, AM J PREV MED, V51, P249, DOI 10.1016/j.amepre.2016.02.026; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Napper LE, 2012, AIDS BEHAV, V16, P1075, DOI 10.1007/s10461-011-0003-2; NYS, 2016, GOV CUOM ANN PROP IN; Ott MA, 2013, J MED ETHICS, V39, P765, DOI 10.1136/medethics-2012-100821; Pace C, 2003, CRIT CARE MED, V31, pS121, DOI 10.1097/01.CCM.0000054907.33928.48; Pettifor A, 2015, J INT AIDS SOC, V18, P8, DOI 10.7448/IAS.18.2.19434; Philbin MM, 2014, AIDS BEHAV, V18, P1501, DOI 10.1007/s10461-013-0650-6; Phillips G, 2015, J ADOLESCENT HEALTH, V57, P407, DOI 10.1016/j.jadohealth.2015.06.014; Services DoHH, 2017, FED REGISTER, V83, P7149; Simon AE, 2007, AM J PREV MED, V32, P370, DOI 10.1016/j.amepre.2007.01.007; Smalley KB, 2016, HEALTH PSYCHOL, V35, P103, DOI 10.1037/hea0000231; Strutz KL, 2015, AM J PREV MED, V48, P76, DOI 10.1016/j.amepre.2014.07.038; Uusitalo S, 2017, AM J BIOETHICS, V17, P44, DOI 10.1080/15265161.2017.1388882; Vasgird D R, 2000, J Public Health Manag Pract, V6, P37; Wertheimer A, 2008, J MED ETHICS, V34, P389, DOI 10.1136/jme.2007.021857; Woodsong C, 2012, AIDS BEHAV, V16, P785, DOI 10.1007/s10461-011-0027-7	63	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200560	10.1371/journal.pone.0200560	http://dx.doi.org/10.1371/journal.pone.0200560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044845	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500060
J	Flanagan, J; Bissot, T; Hours, MA; Moreno, B; German, AJ				Flanagan, John; Bissot, Thomas; Hours, Marie-Anne; Moreno, Bernabe; German, Alexander J.			An international multi-centre cohort study of weight loss in overweight cats: Differences in outcome in different geographical locations	PLOS ONE			English	Article							BODY-COMPOSITION; CALORIC RESTRICTION; ENERGY RESTRICTION; CROSS-VALIDATION; DIETARY-PROTEIN; OBESE DOGS; OWNED CATS; EXPENDITURE; PREVALENCE; BOOTSTRAP	Introduction Feline obesity is a worldwide concern which has recently been formally classified as a disease by the veterinary community. Management involves invoking controlled weight loss by feeding a purpose-formulated food in restricted quantities and altering physical activity. Most weight loss studies conducted in cats have been undertaken in research cat colonies from single geographic locations. The aim of this multi-centre cohort study was to determine the efficacy of a short-term dietary weight loss intervention in overweight pet cats across a range of geographical locations globally. Materials and methods A 3-month (median 13 weeks, inter-quartile range [IQR] 12-15 weeks) weight loss programme was conducted at 188 veterinary practices in 22 countries, and involving 730 cats, 413 of which completed the programme and had complete data available. All were fed commercially available dry or wet weight loss diets, and median energy intake was 53 kcal/kg BW0.711/day. The Royal Canin Ethics Committee approved the study, and owners gave informed consent. Owners completed behavioural questionnaires assessing begging, physical activity and quality of life (QOL). Linear mixed models were used to assess the respective influence of time, age, and initial body condition score (BCS) on weight loss and behavioural observations. Results At baseline, median age was 72 months (range 12-200 months) and median BCS was 8 (range 7-9). In all, 402/413 cats (97%) lost weight (mean 10.6 +/- 6.3%) during the programme at a rate of 0.8 +/- 0.50%/week. Based upon owner questionnaires, activity and QOL improved (both P<0.001), while begging behaviour decreased (P<0.001) during weight loss. The main factor influencing percentage weight loss was geographical location (P<0.001), with cats in North America losing less weight (median 7.2%, IQR: 4.4-10.4%) than those in both Europe (10.7%, 6-8-15.4%) and South America (10.0%, 6.2-15.4%). Differences in weight loss were also observed amongst countries (P<0.001), with cats in Argentina, Germany, and Italy losing more weight than cats in the USA, and cats in Germany also losing more weight than cats in Portugal. Discussion/conclusion Most of the overweight cats enrolled in this international multi-centre study successfully lost weight. The reason for the differences in percentage weight loss amongst geographical locations requires further study.	[Flanagan, John; Bissot, Thomas; Hours, Marie-Anne; Moreno, Bernabe] Royal Canin Res Ctr, Aimargues, France; [German, Alexander J.] Univ Liverpool, Inst Ageing & Chron Dis, Neston, Cheshire, England; [German, Alexander J.] Univ Liverpool, Inst Vet Sci, Neston, Cheshire, England; [Bissot, Thomas] Leiber GmbH, Hafenstr, Bramsche, Germany; [Moreno, Bernabe] IDEXX Europe BV, Scorpius, Lr Hoofddorp, Netherlands	University of Liverpool; University of Liverpool	German, AJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Neston, Cheshire, England.; German, AJ (corresponding author), Univ Liverpool, Inst Vet Sci, Neston, Cheshire, England.	ajgerman@liverpool.ac.uk			Royal Canin	Royal Canin	The funder, Royal Canin, provided support in the form of salaries for authors (JF, MAH, BM) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, whilst AJG is an employee of the University of Liverpool, his academic position is financially supported by the funder. The specific roles of these authors are articulated in the 'author contributions section.	Banfield, OB DOGS CATS STAT PE; Bissot T, 2010, J FELINE MED SURG, V12, P104, DOI 10.1016/j.jfms.2009.07.003; Bomberg E, 2017, J COMP PATHOL, V156, P310, DOI 10.1016/j.jcpa.2017.03.007; Butterwick RF, 1996, VET REC, V138, P354, DOI 10.1136/vr.138.15.354; Cameron KM, 2011, J ANIM PHYSIOL AN N, V95, P399, DOI 10.1111/j.1439-0396.2010.01107.x; Cave NJ, 2012, PREV VET MED, V107, P121, DOI 10.1016/j.prevetmed.2012.05.006; Center SA, 2000, J VET INTERN MED, V14, P598, DOI 10.1892/0891-6640(2000)014&lt;0598:TCAMEO&gt;2.3.CO;2; Center SA, 2012, AM J VET RES, V73, P1002, DOI 10.2460/ajvr.73.7.1002; Christmann U, 2016, J FELINE MED SURG, V18, P947, DOI 10.1177/1098612X15599823; Day MJ, 2017, J COMP PATHOL, V156, P293, DOI 10.1016/j.jcpa.2017.03.009; Deagle G, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.36; des Courtis X, 2015, J ANIM PHYSIOL AN N, V99, P474, DOI 10.1111/jpn.12239; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Flanagan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184199; Floerchinger AM, 2015, JAVMA-J AM VET MED A, V247, P365, DOI 10.2460/javma.247.4.365; Garcia-Guasch L, 2015, J FELINE MED SURG, V17, P494, DOI 10.1177/1098612X14548786; German AJ, 2015, J VET INTERN MED, V29, P1547, DOI 10.1111/jvim.13629; German AJ, 2012, VET J, V192, P428, DOI 10.1016/j.tvjl.2011.09.015; German AJ, 2011, J ANIM PHYSIOL AN N, V95, P368, DOI 10.1111/j.1439-0396.2010.01063.x; German AJ, 2009, RES VET SCI, V87, P249, DOI 10.1016/j.rvsc.2009.02.007; German AJ, 2008, J FELINE MED SURG, V10, P452, DOI 10.1016/j.jfms.2008.02.004; German AJ, 2007, J VET INTERN MED, V21, P1174, DOI 10.1892/06-280.1; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0238-z; German AJ, 2010, VET J, V183, P294, DOI 10.1016/j.tvjl.2008.12.004; GONG G, 1986, J AM STAT ASSOC, V81, P108, DOI 10.2307/2287975; Hoenig M, 2006, COMPENDIUM CONT E S4, V28, P71; Hours MA, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0899-x; Judge GeorgeG., 1985, THEORY PRACTICE ECON, V2nd ed.; Laflamme D, 1997, FELINE PRACT, V25, P13; Laflamme DP, 2006, VET CLIN N AM-SMALL, V36, P1283, DOI 10.1016/j.cvsm.2006.08.005; Levine ED, 2016, J VET BEHAV, V11, P37, DOI 10.1016/j.jveb.2015.11.004; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Marshall WG, 2010, VET RES COMMUN, V34, P241, DOI 10.1007/s11259-010-9348-7; Michel KE, 2005, J FELINE MED SURG, V7, P349, DOI 10.1016/j.jfms.2005.05.003; Robertson ID, 1999, PREV VET MED, V40, P75, DOI 10.1016/S0167-5877(99)00024-0; Rowe E, 2015, PREV VET MED, V121, P273, DOI 10.1016/j.prevetmed.2015.07.011; Russell K, 2000, J SMALL ANIM PRACT, V41, P12, DOI 10.1111/j.1748-5827.2000.tb03129.x; SCARLETT JM, 1994, INT J OBESITY, V18, pS22; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Szabo J, 2000, AM J VET RES, V61, P559, DOI 10.2460/ajvr.2000.61.559; Tvarijonaviciute A, 2012, DOMEST ANIM ENDOCRIN, V42, P129, DOI 10.1016/j.domaniend.2011.10.003; Vasconcellos RS, 2009, J NUTR, V139, P855, DOI 10.3945/jn.108.103085; Villaverde C, 2008, J NUTR, V138, P856, DOI 10.1093/jn/138.5.856; Vitger AD, 2016, JAVMA-J AM VET MED A, V248, P174, DOI 10.2460/javma.248.2.174; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Yaissle JE, 2004, JAVMA-J AM VET MED A, V224, P1932, DOI 10.2460/javma.2004.224.1932	47	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200414	10.1371/journal.pone.0200414	http://dx.doi.org/10.1371/journal.pone.0200414			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044843	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500052
J	Huda, N; Hosen, MI; Yasmin, T; Sarkar, PK; Hasan, AKMM; Nabi, AHMN				Huda, Nafiul; Hosen, Md. Ismail; Yasmin, Tahirah; Sarkar, Pankaj Kumar; Hasan, A. K. M. Mahbub; Nabi, A. H. M. Nurun			Genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LINEAGE; ACCELERATOR HYPOTHESIS; SUSCEPTIBILITY LOCI; POLYMORPHISM; VARIANTS; MELLITUS; OBESITY; MASS	Type 2 diabetes mellitus is a multifactorial metabolic disorder caused by environmental factors and has a strong association with hereditary issues. These hereditary issues result in an imbalance in CD4(+)T cells and a decreased level of naive CD4(+)T cells, which may be critical in the pathogenesis of type 2 diabetes. Transcription factors GATA3 and STAT4 mediate the cytokine-induced development of naive T cells into Th1 or Th2 types. In the present study, genetic analyses of GATA3 SNP rs3824662 and STAT4 SNP rs10181656 were performed to investigate the association of allelic and genotypic variations with the risk of T2D in the Bangladeshi population. A total of 297 unrelated Bangladeshi patients with type 2 diabetes and 247 healthy individuals were included in the study. The allelic and genotypic frequencies of rs10181656 located in the STAT4 gene were not found to be associated with risk of type 2 diabetes. The GATA3 rs3824662 T allele and mutant TT genotype had a significant association with the risk of T2D [OR: 1.52 (1.15-2.02), X-2 = 8.66, p = 0.003 and OR: 2.98 (1.36-6.55), X-2 = 7.98, p = 0.04, respectively]. Thus, the present study postulates that the genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population.	[Huda, Nafiul; Hosen, Md. Ismail; Yasmin, Tahirah; Hasan, A. K. M. Mahbub; Nabi, A. H. M. Nurun] Univ Dhaka, Dept Biochem & Mol Biol, Lab Populat Genet, Dhaka, Bangladesh; [Sarkar, Pankaj Kumar] Dinajpur Diabet O Swasthoseba Hosp, Dinajpur, Bangladesh	University of Dhaka	Nabi, AHMN (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Lab Populat Genet, Dhaka, Bangladesh.	nabi@du.ac.bd	Nabi, Ambreen/AED-3676-2022	Nabi, Ambreen/0000-0003-1899-363X; Yasmin, Tahirah/0000-0002-8143-2993; Nabi, AHM Nurun/0000-0002-0504-6556	World Academy of Sciences [15-167 RG/BIO/AS_G - FR3240287016]	World Academy of Sciences	This research work was partly supported by the research grant from The World Academy of Sciences, (Ref No. 15-167 RG/BIO/AS_G - FR3240287016) awarded to A.H.M. Nurun Nabi. Mr Nafiul Huda received a studentship from The World Academy of Sciences.	Afruza Rownock, 2014, J Genomics, V2, P45, DOI 10.7150/jgen.5193; Akther J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6973057; Ali A, 2007, HUM MOL GENET, V16, P265, DOI 10.1093/hmg/ddl454; [Anonymous], NON COMM DIS FACTSH; Bodhini D, 2007, INT J OBESITY, V31, P97, DOI 10.1038/sj.ijo.0803356; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Cunnion KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170500; Desai M, 2007, DIABETOLOGIA, V50, P68, DOI 10.1007/s00125-006-0513-z; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dobrian AD, 2015, J ENDOCRINOL, V227, P13, DOI 10.1530/JOE-15-0098; Dobrian AD, 2013, DIABETES, V62, P4109, DOI 10.2337/db12-1275; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; HITMAN GA, 1991, J MED GENET, V28, P97, DOI 10.1136/jmg.28.2.97; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hou QQ, 2017, ONCOTARGET, V8, P36040, DOI 10.18632/oncotarget.16424; Hypponen E, 2000, DIABETES CARE, V23, P1755, DOI 10.2337/diacare.23.12.1755; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kelley JM, 2010, ANN RHEUM DIS, V69, P778, DOI 10.1136/ard.2009.113183; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Kofteridis D, 2009, GENET TEST MOL BIOMA, V13, P281, DOI 10.1089/gtmb.2008.0128; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Mosaad YM, 2017, LEUKEMIA LYMPHOMA, V58, P689, DOI 10.1080/10428194.2016.1204656; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Nekoua MP, 2016, AFR HEALTH SCI, V16, P712, DOI 10.4314/ahs.v16i3.11; Perez-Andreu V, 2015, BLOOD, V125, P680, DOI 10.1182/blood-2014-09-595744; Pietropaolo M, 2000, DIABETES, V49, P32, DOI 10.2337/diabetes.49.1.32; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Sasaki Y, 2004, HUM GENET, V115, P177, DOI 10.1007/s00439-004-1146-2; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stoffers DA, 2004, HORM METAB RES, V36, P811, DOI 10.1055/s-2004-826168; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walsh KM, 2013, BLOOD, V122, P3385, DOI 10.1182/blood-2013-08-524124; Wang L, 2015, J BIOL CHEM, V290, P19458, DOI 10.1074/jbc.M115.641332; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069; Yi J, 2015, INT J CLIN EXP MED, V8, P3566; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5	56	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0198507	10.1371/journal.pone.0198507	http://dx.doi.org/10.1371/journal.pone.0198507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044774	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500006
J	Jin, S; Kang, M; Cho, H				Jin, Seokha; Kang, MungSoo; Cho, HyungJoon			Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note	PLOS ONE			English	Article							BRAIN-BARRIER BREAKDOWN; ULTRASHORT ECHO TIME; VASCULAR-PERMEABILITY; AGENT EXTRAVASATION; DCE-MRI; VOLUME; PARAMETERS; ISCHEMIA; STROKE; SIZE	In this study, we quantified perfusion deficits using dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) with an extravasating contrast agent (CA). We also investigated the efficacy of leakage compensation from CA pre-load in brains from post-ischemic rat models without significant dynamic contrast-enhanced MRI (DCE-MRI)-derived vessel wall permeability. DSC measurements were obtained using fast (0.3 s) echo-planar imaging in both normal rats and rats with transient middle carotid artery occlusion (MCAO) (1-h MCAO, 24-h reperfusion) after successive administrations of gadoterate meglumine (Dotarem) and intravascular superparamagnetic iron oxide nanoparticles (SPION). The relative cerebral blood volume (CBV) and cerebral blood flow (CBF) values acquired using Dotarem were significantly underestimated (similar to 20%) when compared to those acquired using SPION in ipsilesional post-ischemic brain regions. A slight overestimation of relative mean transit time was observed. Areas with underestimated CBV and CBF values from the corresponding error maps encompassed the area of infarcted tissue (apparent diffusion coefficient < 500 mu m(2)/s) and mostly coincided with the area wherein conspicuous longitudinal relaxation time differences were observed pre- vs. post-injection of Dotarem. The DSC measurements with significant pre-load (0.3 mmol.kg(-1)) of Dotarem displayed minimal perfusion deficits when compared to those determined using the reference intravascular SPION.	[Jin, Seokha; Kang, MungSoo; Cho, HyungJoon] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST)	Cho, H (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea.	hjcho@unist.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C0713]; Ulsan National Institute of Science and Technology (UNIST) [1.180063.01]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Ulsan National Institute of Science and Technology (UNIST)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0713 to SJ). This work was also supported by the 2018 Research Fund (grant number: 1.180063.01 to HC) of the Ulsan National Institute of Science and Technology (UNIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0713). This work was also supported by the 2018 Research Fund (grant number: 1.180063.01) of the Ulsan National Institute of Science and Technology (UNIST)	Bauman G, 2015, MAGN RESON MED, V73, P555, DOI 10.1002/mrm.25158; Boxerman JL, 2012, AM J NEURORADIOL, V33, P1081, DOI 10.3174/ajnr.A2934; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Dosa E, 2011, NEURO-ONCOLOGY, V13, P251, DOI 10.1093/neuonc/noq172; GARCIA JH, 1984, STROKE, V15, P5, DOI 10.1161/01.STR.15.1.5; GILL R, 1995, J CEREBR BLOOD F MET, V15, P1, DOI 10.1038/jcbfm.1995.1; Han SH, 2015, NEUROIMAGE, V112, P382, DOI 10.1016/j.neuroimage.2015.03.042; Heisen M, 2010, MAGN RESON MED, V63, P811, DOI 10.1002/mrm.22171; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; HOSSMANN KA, 1991, CEREBROVASC DIS, V1, P2, DOI 10.1159/000108875; Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570; Keston P, 2003, CLIN RADIOL, V58, P505, DOI 10.1016/S0009-9260(03)00130-2; Lee D, 2017, J MAGN RESON, V274, P57, DOI 10.1016/j.jmr.2016.11.004; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Nahirney PC, 2016, J CEREBR BLOOD F MET, V36, P413, DOI 10.1177/0271678X15608396; Quarles CC, 2005, MAGN RESON MED, V53, P1307, DOI 10.1002/mrm.20497; Reeson P, 2015, J NEUROSCI, V35, P5128, DOI 10.1523/JNEUROSCI.2810-14.2015; Roberts C, 2006, J MAGN RESON IMAGING, V23, P554, DOI 10.1002/jmri.20529; Shen Qiang, 2016, Brain Circ, V2, P20; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Simonsen CZ, 1999, JMRI-J MAGN RESON IM, V9, P342, DOI 10.1002/(SICI)1522-2586(199902)9:2<342::AID-JMRI29>3.3.CO;2-2; Tanaka Y, 2011, J CEREBR BLOOD F MET, V31, P1403, DOI 10.1038/jcbfm.2010.228; Uematsu H, 2006, EUR RADIOL, V16, P180, DOI 10.1007/s00330-005-2807-9; Vonken EJPA, 2000, MAGNET RESON MED, V43, P820, DOI 10.1002/1522-2594(200006)43:6<820::AID-MRM7>3.0.CO;2-F; ZIERLER KL, 1962, CIRC RES, V10, P393, DOI 10.1161/01.RES.10.3.393	27	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201076	10.1371/journal.pone.0201076	http://dx.doi.org/10.1371/journal.pone.0201076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044884	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500078
J	Weiss, G; Smith, DK; Newman, S; Wiener, J; Kitlas, A; Hoover, KW				Weiss, Gretchen; Smith, Dawn K.; Newman, Sarah; Wiener, Jeffrey; Kitlas, Alyssa; Hoover, Karen W.			PrEP implementation by local health departments in US cities and counties: Findings from a 2015 assessment of local health departments	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; INFECTION	Objective The United States Public Health Service released clinical practice guidelines for daily oral preexposure prophylaxis (PrEP) in May 2014. Local health departments (LHDs) are expected to play a critical role in PrEP implementation. We surveyed LHDs to assess awareness of and interest in supporting PrEP implementation, what roles they were taking, or believed they should take, in supporting PrEP, and what resources would be required to do so. Methods LHDs were surveyed in 2015 to assess their engagement in PrEP implementation (n = 500). The study employed a cross-sectional survey design with a randomly selected stratified sample. Results Among responding LHDs (n = 284), 109 (29%, weighted proportion) reported engagement in PrEP implementation. LHDs serving large jurisdictions (population 500,000+) and located in the West were more likely to be engaged in PrEP implementation. Making referrals for PrEP (74%) and conducting education and outreach to community members (51%) were the activities most frequently reported by LHDs engaged in PrEP implementation; 45% anticipated expanding their level of engagement. Among LHDs not engaged in PrEP implementation, 13% expected to become engaged over the next four years, 46% were undecided, and 41% reported it was unlikely. Information about PrEP for health care providers and information about PrEP for health department staff were the most frequently reported resource needs for LHDs engaged and not engaged in PrEP implementation, respectively. Conclusions PrEP implementation by LHDs was limited in 2015, three years after Food and Drug Administration approval and one year after the U.S. Public Health Service issued clinical practice guidelines. PrEP is a recently available intervention that is requiring LHDs to adjust existing HIV prevention efforts and service delivery models. Additional resources and implementation research is needed to effectively support PrEP scale-up by LHDs. Efforts must also be undertaken to increase PrEP awareness, knowledge, and implementation capacity among LHDs.	[Weiss, Gretchen; Newman, Sarah; Kitlas, Alyssa] Natl Assoc Cty & City Hlth Officials, Washington, DC 20005 USA; [Smith, Dawn K.; Wiener, Jeffrey; Hoover, Karen W.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Weiss, G (corresponding author), Natl Assoc Cty & City Hlth Officials, Washington, DC 20005 USA.	gweiss@naccho.org			Centers for Disease Control and Prevention [5U38OT000172-02-REVISED]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this research was provided by the Centers for Disease Control and Prevention (https://www.cdc.gov/) via Award Number 5U38OT000172-02-REVISED. The efforts of GW, SN, and AK were supported by the Centers for Disease Control and Prevention via Award Number 5U38OT000172-02-REVISED. The funder participated in study design, data analysis, decision to publish, and preparation of the manuscript.	Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Black AIDS Institute, 2015, WE KNOW BETT WE DO B; Bush S, 2015, IAPAC TREATMENT PREV; Centers for Disease Control and Prevention, 2017, PROJ PRID; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2017, AB THRIV; Centers for Disease Control and Prevention, 2018, FUND OPP ANN FOA PS1; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Crowley JS, 2015, AIDS EDUC PREV, V27, P84, DOI 10.1521/aeap.2015.27.1.84; District of Columbia Department of Health, 2016, MAYOR MUR BOWS 90 90; Green KR, 2015, SOC SOCIAL WORK RES; Hamel L., 2014, HIV AIDS LIVES GAY B; Kern County Public Health Services Department, 2017, COMMUNITY HLTH ASSES; King County, 2017, KING COUNT 1 NAT ACH; Krakower DS, 2016, CLIN INFECT DIS, V62, P99, DOI 10.1093/cid/civ736; Kuo I, 2016, DRUG ALCOHOL DEPEN, V164, P8, DOI 10.1016/j.drugalcdep.2016.02.044; Laufer FN, 2015, MMWR-MORBID MORTAL W, V64, P1296, DOI 10.15585/mmwr.mm6446a5; National Association of County City Health Officials, 2013, 2013 NAT PROF LOC HL; Smith DK, 2016, AIDS EDUC PREV, V28, P426, DOI 10.1521/aeap.2016.28.5.426; Smith DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156592; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; White House Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U	22	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200338	10.1371/journal.pone.0200338	http://dx.doi.org/10.1371/journal.pone.0200338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044820	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500043
J	Vasconcelos, R; Razgour, O; Tarroso, P; Fasola, M; Carranza, S; Alves, PC				Vasconcelos, Raquel; Razgour, Orly; Tarroso, Pedro; Fasola, Mauro; Carranza, Salvador; Alves, Paulo Cello			Combining molecular and landscape tools for targeting evolutionary processes in reserve design: An approach for islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HEMIDACTYLUS GECKOS; SOCOTRA ARCHIPELAGO; PROTECTED AREAS; CONSERVATION; DIVERSIFICATION; DIVERSITY; PATTERNS; GENETICS; POPULATIONS	The importance of targeting ecological and evolutionary processes in reserve design has been widely acknowledged in the literature but rarely implemented on islands. Using Socotran reptiles as models, we aim to relate richness of widespread and restricted-range species directly with landscape variables and to compare the impact of setting conservation targets for lineages versus species. Socotra Island is a UNESCO Natural World Heritage Site, containing high levels of endemism in relation to its area, especially of reptiles, the vertebrates with the most comprehensive available genetic data. We predicted the occurrences of reptile species using distribution models and used a novel approach to interpolate maps of spatial phylogenetic patterns. Patterns of intra and interspecifc diversity and differences between spatial outputs of lineage and species richness were related to eco-geographic variables. We evaluated differences in target achievement for each conservation unit within protected areas (PAs) under the current Zoning Plan (ZP) using gap and reserve design analyses. Although intraspecific richness was strongly correlated with interspecific richness, differences in their spatial distribution reached similar to 30% in some areas. Differences were more pronounced for wide-ranging than restricted-range taxa. Gap analysis indicates that most conservation units are under-represented in sanctuaries and that intra and interspecific richness were significantly higher outside PAs. This work will guide local-scale conservation planning as the ZP is due to be re-evaluated. This is one of the few studies on islands using genetic data from an entire class of vertebrates to incorporate lineage diversity in reserve design. This study provides an alternative methodological framework for supporting the use of landscape and genetic tools in reserve design, circumventing the use of phylogenetic distances and deterministic spatial interpolation of lineage diversity that can be widely applied to other systems.	[Vasconcelos, Raquel; Tarroso, Pedro; Alves, Paulo Cello] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBIO Lab Associado, CIBIO, Campus Agr Vairao, Vairao, Portugal; [Vasconcelos, Raquel; Tarroso, Pedro; Carranza, Salvador] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [Razgour, Orly] Univ Southampton, Biol Sci, Life Sci Bldg, Southampton, Hants, England; [Fasola, Mauro] Univ Pavia, Dipartimento Sci Terra & Ambiente, Pavia, Italy; [Alves, Paulo Cello] Univ Porto, Fac Ciencias, Dept Biol, Porto, Portugal	Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Southampton; University of Pavia; Universidade do Porto	Vasconcelos, R (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBIO Lab Associado, CIBIO, Campus Agr Vairao, Vairao, Portugal.; Vasconcelos, R (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain.	raquel.vasconcelos@cibio.up.pt	Razgour, Orly/X-3478-2019; Razgour, Orly/B-9646-2011; Tarroso, Pedro/I-3023-2012; Vasconcelos, Raquel/H-5524-2012; Carranza, Salvador/A-2126-2012; ALVES, Paulo Célio/B-5448-2009	Razgour, Orly/0000-0003-3186-0313; Razgour, Orly/0000-0003-3186-0313; Tarroso, Pedro/0000-0002-2694-1170; Vasconcelos, Raquel/0000-0002-4717-9429; Carranza, Salvador/0000-0002-5378-3008; ALVES, Paulo Célio/0000-0003-4797-0939	Fundacao para a Ciencia e Tecnologia - European Social Fund [SFRH/BPD/79913/2011, SFRH/BPD/93473/2013]; Human Potential Operational Program, POPH/FSE; Ministerio de Economia y Competitividad; FEDER [CGL2012-36970, CGL2015-70390-P]; Mohamed bin Zayed Species Conservation Fund [13055714, 1425991]; Natural Environment Research Council (NERC) Independent Research Fellowship [NE/M018660/1]; NERC [NE/M018660/2, NE/M018660/1] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia - European Social Fund; Human Potential Operational Program, POPH/FSE; Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); Mohamed bin Zayed Species Conservation Fund; Natural Environment Research Council (NERC) Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Fundacao para a Ciencia e Tecnologia (SFRH/BPD/79913/2011 fellowships to R.V. and SFRH/BPD/93473/2013 to P.T.), financed by The European Social Fund and the Human Potential Operational Program, POPH/FSE; Ministerio de Economia y Competitividad co-funded by FEDER (CGL2012-36970, CGL2015-70390-P); The Mohamed bin Zayed Species Conservation Fund (projects no 13055714, 1425991); and Natural Environment Research Council (NERC) Independent Research Fellowship (NE/M018660/1 to O.R.). Besides financial support, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, TECTONOPHYSICS, V637, P251, DOI 10.1016/j.tecto.2014.10.014; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Autin J, 2013, TECTONOPHYSICS, V607, P51, DOI 10.1016/j.tecto.2013.05.041; Badiane A, 2014, ZOOTAXA, V3835, P33, DOI 10.11646/zootaxa.3835.1.2; Bennett JR, 2014, BIOL CONSERV, V174, P47, DOI 10.1016/j.biocon.2014.03.013; Beydoun ZR, 1970, Q J GEOL SOC LOND, V125, P413, DOI DOI 10.1144/GSJGS.125.1.0413; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Chen YH, 2017, DIVERS DISTRIB, V23, P146, DOI 10.1111/ddi.12508; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; D'Amen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P93, DOI 10.1111/j.1466-8238.2012.00774.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Sanctis M, 2013, APPL VEG SCI, V16, P148, DOI 10.1111/j.1654-109X.2012.01212.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Porta J, 2017, J BIOGEOGR, V44, P1694, DOI 10.1111/jbi.12929; Garcia-Porta J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23729; Garcia-Porta J, 2016, MOL PHYLOGENET EVOL, V98, P288, DOI 10.1016/j.ympev.2016.02.007; Gillman LN, 2014, J BIOGEOGR, V41, P39, DOI 10.1111/jbi.12173; Gomez-Diaz E, 2012, MOL ECOL, V21, P4074, DOI 10.1111/j.1365-294X.2012.05672.x; Gray CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12306; Hammill E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11042; Hertz PE, 2013, EVOLUTION, V67, P2101, DOI 10.1111/evo.12072; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Laikre L, 2010, CONSERV GENET, V11, P349, DOI 10.1007/s10592-009-0037-4; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Malatesta L, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073527; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin N, 2017, ZOOL ANZ, V267, P69, DOI 10.1016/j.jcz.2017.01.005; Miraldo A, 2016, SCIENCE, V353, P1532, DOI 10.1126/science.aaf4381; Moilanen A., 2014, SPATIAL CONSERVATION, P288; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Myers N, 2003, BIOSCIENCE, V53, P916; Oliveira U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08707-2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pollock LJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0007; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porter R.F., 2016, Sandgrouse, V38, P169; Qu YH, 2014, MOL ECOL, V23, P705, DOI 10.1111/mec.12619; R-Core-Team, 2015, LANG ENV STAT COMP; Razgour O, 2013, ECOL LETT, V16, P1258, DOI 10.1111/ele.12158; Razgour O, 2011, OECOLOGIA, V167, P493, DOI 10.1007/s00442-011-1995-z; Razzetti E, 2011, ZOOTAXA, P1; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rijsdijk KF, 2014, J BIOGEOGR, V41, P1242, DOI 10.1111/jbi.12336; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Russo D, 2016, HYSTRIX, V27, P212, DOI DOI 10.4404/HYSTRIX-27.2-11788; Scholte P, 2011, ORYX, V45, P401, DOI 10.1017/S0030605310001535; Scoble J, 2010, DIVERS DISTRIB, V16, P343, DOI 10.1111/j.1472-4642.2010.00658.x; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Smid J, 2017, ORG DIVERS EVOL, V17, P267, DOI 10.1007/s13127-016-0293-3; Steinbauer MJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P1097, DOI 10.1111/geb.12469; Tarroso P, 2015, MOL ECOL RESOUR, V15, P349, DOI 10.1111/1755-0998.12312; Taylor C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169629; Thomassen HA, 2011, EVOL APPL, V4, P397, DOI 10.1111/j.1752-4571.2010.00172.x; Thomassen HA, 2010, MOL ECOL, V19, P3532, DOI 10.1111/j.1365-294X.2010.04737.x; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Vasconcelos R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149985; Vasconcelos R, 2014, ZOOTAXA, V3835, P501, DOI 10.11646/zootaxa.3835.4.4; Vasconcelos R, 2012, BIOL CONSERV, V153, P276, DOI 10.1016/j.biocon.2012.04.020; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wilson A, 2009, CONSERV GENET, V10, P419, DOI 10.1007/s10592-008-9612-3; Zhang YB, 2016, J NAT CONSERV, V31, P43, DOI 10.1016/j.jnc.2016.03.003	72	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200830	10.1371/journal.pone.0200830	http://dx.doi.org/10.1371/journal.pone.0200830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040840	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000439749200011
J	Karuppagounder, V; Bajpai, A; Meng, S; Arumugam, S; Sreedhar, R; Giridharan, VV; Guha, A; Bhimaraj, A; Youker, KA; Palaniyandi, SS; Karmouty-Quintana, H; Kamal, F; Spiller, KL; Watanabe, K; Thandavarayan, RA				Karuppagounder, Vengadeshprabhu; Bajpai, Anamika; Meng, Shu; Arumugam, Somasundaram; Sreedhar, Remya; Giridharan, Vijayasree V.; Guha, Ashrith; Bhimaraj, Arvind; Youker, Keith A.; Palaniyandi, Suresh S.; Karmouty-Quintana, Harry; Kamal, Fadia; Spiller, Kara L.; Watanabe, Kenichi; Thandavarayan, Rajarajan A.			Small molecule disruption of G protein beta gamma subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats	PLOS ONE			English	Article							DAUNORUBICIN-INDUCED NEPHROTOXICITY; COUPLED-RECEPTOR KINASES; HEART-FAILURE; ATOPIC-DERMATITIS; CARDIOVASCULAR-DISEASE; INFLAMMATION; HMGB1; MICE; POLARIZATION; PROGRESSION	The purpose of this study was to determine whether blocking of G protein beta gamma (G beta gamma) signaling halts heart failure (HF) progression by macrophage phenotype manipulation. Cardiac G beta gamma signaling plays a crucial role in HF pathogenesis. Previous data suggested that inhibiting G beta gamma signaling reprograms T helper cell 1 (Th1) and Th2 cytokines, suggesting that G beta gamma might be a useful drug target for treating HF. We investigated the efficacy of a small molecule G beta gamma inhibitor, gallein, in a clinically relevant, experimental autoimmune myocarditis (EAM) model of HF as well as in human macrophage phenotypes in vitro. In the myocardium of HF patients, we observed that G protein coupled receptor kinase (GRK)2 levels were down-regulated compared with healthy controls. In rat EAM, treatment with gallein effectively improved survival and cardiac function, suppressed cardiac remodeling, and further attenuated myocardial protein expression of GRK2 as well as high mobility group box (HMGB)1 and its cascade signaling proteins. Furthermore, gallein effectively inhibited M1 polarization and promoted M2 polarization in vivo in the EAM heart and in vitro in human monocyte-derived macrophages. Taken together, these data suggest that the small molecule G beta gamma inhibitor, gallein, could be an important pharmacologic therapy for HF as it can switch the phenotypic reprogramming from M1 to M2 phenotype in a rat model of EAM heart and in human macrophages.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Sreedhar, Remya; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata, Japan; [Karuppagounder, Vengadeshprabhu; Kamal, Fadia] Penn State Coll Med, Dept Orthopaed & Rehabil, Hershey, PA USA; [Bajpai, Anamika; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA; [Meng, Shu; Karmouty-Quintana, Harry] Univ Texas Houston, Dept Biochem & Mol Biol, Houston Med Sch, Houston, TX USA; [Giridharan, Vijayasree V.] McGovern Med Sch, Translat Psychiat Program, Dept Psychiat & Behav Sci, Houston, TX USA; [Guha, Ashrith; Bhimaraj, Arvind; Youker, Keith A.; Thandavarayan, Rajarajan A.] Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Palaniyandi, Suresh S.] Henry Ford Hlth Syst, Div Hypertens & Vasc Res, Detroit, MI USA	Niigata University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Drexel University; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Henry Ford Health System; Henry Ford Hospital	Watanabe, K (corresponding author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata, Japan.; Thandavarayan, RA (corresponding author), Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA.	wataken@med.niigata-u.ac.jp; atrajarajan@gmail.com	Arumugam, S./AAT-7570-2020; Vayalanellore Giridharan, Vijayasree/ABD-6290-2020; bajpai, Anamika/AAZ-4943-2021; Kamal, Fadia/AAP-1798-2021; Karmouty-Quintana, Harry/ABC-9144-2020; Karuppagounder, Vengadeshprabhu/AAC-6623-2019	Vayalanellore Giridharan, Vijayasree/0000-0003-3069-7139; Karmouty-Quintana, Harry/0000-0003-4753-9823; KARUPPA GOUNDER, VENGADESHPRABHU/0000-0003-1511-7810; Bajpai, Anamika/0000-0002-6943-3758; Youker, Keith/0000-0003-2535-7973; Arumugam, Somasundaram/0000-0002-2096-2552				Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Dorn GW, 2009, J MOL MED, V87, P455, DOI 10.1007/s00109-009-0450-7; Gao SS, 2015, J MOL CELL CARDIOL, V85, P131, DOI 10.1016/j.yjmcc.2015.04.025; Gounder VK, 2014, INT IMMUNOPHARMACOL, V18, P282, DOI 10.1016/j.intimp.2013.11.018; Hao QQ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/270930; Hynes Thomas R, 2015, J Mol Signal, V10, P1, DOI 10.5334/1750-2187-10-1; Kamal FA, 2014, J AM COLL CARDIOL, V63, P2549, DOI 10.1016/j.jacc.2014.02.587; Karuppagounder V, 2016, EXP DERMATOL, V25, P404, DOI 10.1111/exd.12962; Karuppagounder V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152922; Karuppagounder V, 2015, INT IMMUNOPHARMACOL, V28, P154, DOI 10.1016/j.intimp.2015.05.050; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lurier EB, 2017, IMMUNOBIOLOGY, V222, P847, DOI 10.1016/j.imbio.2017.02.006; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Mrro S, 2011, BIOL PHARM BULL, V34, P974, DOI 10.1248/bpb.34.974; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Reinkober J, 2012, GENE THER, V19, P686, DOI 10.1038/gt.2012.9; Schumacher-Bass Sarah M, 2012, Drug Discov Today Ther Strateg, V9, pe155; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Sreedhar R, 2016, BIOFACTORS, V42, P368, DOI 10.1002/biof.1280; Su ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21884; Su ZL, 2014, J CELL MOL MED, V18, P1740, DOI 10.1111/jcmm.12324; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Travers JG, 2016, CIRC RES, V118, P1049, DOI 10.1161/CIRCRESAHA.116.308542; Watanabe K, 2002, J NUCL MED, V43, P531; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173; Zhao XN, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017348	33	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200697	10.1371/journal.pone.0200697	http://dx.doi.org/10.1371/journal.pone.0200697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024944	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000042
J	Monzani, L; Zurriaga, R; Lopez, GVE				Monzani, Lucas; Zurriaga, Rosario; Espi Lopez, Gemma Victoria			Anxiety and the severity of Tension-Type Headache mediate the relation between headache presenteeism and workers' productivity	PLOS ONE			English	Article							OF-FIT INDEXES; MUSCULOSKELETAL DISORDERS; MANUAL THERAPY; HEALTH; ABSENTEEISM; IMPACT; PERFORMANCE; PREVALENCE; RECOMMENDATIONS; RELIABILITY	The primary objective of this study was to explore the mechanisms and conditions whereby Tension-Type Headache (TTH) presenteeism relates to health-related loss of productivity as a result of both reduced physical and mental health. To this end, Structural Equation Modeling (SEM) was used to conduct a secondary data analysis of a randomized clinical trial involving 78 Tension-type Headache (TTH) patients. The results showed that TTH presenteeism did not directly relate to health-related loss of productivity, either due to physical, or mental health problems. However, through anxiety-state, TTH presenteeism decreased patients' productivity, as consequence of reduced physical and mental health. Moreover, by increasing the severity of the Tension-Type Headache, TTH presenteeism indirectly decreased patients' productivity as consequence of reduced physical health (but not mental health). Finally, our results show that such indirect effects only occur when the cause of TTH is non-mechanical (e.g., hormonal causes, etc.). Our work provides an integrative model that can inform organizational behaviorists and health professionals (e.g., physiotherapists). Implications for organizational health are discussed.	[Monzani, Lucas] Western Univ, Ivey Business Sch, London, ON, Canada; [Monzani, Lucas; Zurriaga, Rosario] Univ Valencia, Univ Res Inst Human Resources Psychol Org Dev & Q, Valencia, Spain; [Espi Lopez, Gemma Victoria] Univ Valencia, Dept Physiotherapy, Valencia, Spain	Western University (University of Western Ontario); University of Valencia; University of Valencia	Monzani, L (corresponding author), Western Univ, Ivey Business Sch, London, ON, Canada.; Monzani, L (corresponding author), Univ Valencia, Univ Res Inst Human Resources Psychol Org Dev & Q, Valencia, Spain.	lmonzani@ivey.uwo.ca	Monzani, Lucas/H-3083-2019; PEIRO, JOSE M./B-3388-2011; Llorens, Rosario Zurriaga/G-8645-2011; Espi Lopez, Gemma V./J-9002-2017	Monzani, Lucas/0000-0002-3375-068X; PEIRO, JOSE M./0000-0001-5293-0355; Llorens, Rosario Zurriaga/0000-0002-3096-8122; Espi Lopez, Gemma V./0000-0003-0042-8034				[Anonymous], 1959, AUTOGENIC TRAINING P; Arendt-Nielsen L, 2016, CLIN J PAIN, V32, P711, DOI 10.1097/AJP.0000000000000318; Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; Baskin SM, 2006, HEADACHE, V46, pS76, DOI 10.1111/j.1526-4610.2006.00559.x; Bergstrom G, 2009, J OCCUP ENVIRON MED, V51, P629, DOI [10.1097/JOM.0b913e3181a8281b, 10.1097/JOM.0b013e3181a8281b]; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bhattacharya A, 2014, INT J IND ERGONOM, V44, P448, DOI 10.1016/j.ergon.2014.01.008; Brouwer WBF, 1999, HEALTH POLICY, V48, P13, DOI 10.1016/S0168-8510(99)00028-7; Byron K, 2011, PERS SOC PSYCHOL B, V37, P269, DOI 10.1177/0146167210392788; CAMACHO LM, 1995, J PERS SOC PSYCHOL, V68, P1071, DOI 10.1037/0022-3514.68.6.1071; Campo M, 2012, J OCCUP ENVIRON MED, V54, P64, DOI 10.1097/JOM.0b013e31823c768a; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chilton MA, 2005, J MANAGE INFORM SYST, V22, P193, DOI 10.1080/07421222.2005.11045849; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Espi Lopez GV., 2010, REVISI N SISTEM TICA, V32, P33; Espi-lopez G V., 2016, EUR J PHYS REHABIL M; Espi-Lopez G V., 2010, MED BALEAR, V25, P23; Fernandez-De-las-Penas C, 2017, EXPERT REV NEUROTHER, V17, P933, DOI 10.1080/14737175.2017.1359088; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Fumal A, 2008, LANCET NEUROL, V7, P70, DOI 10.1016/S1474-4422(07)70325-3; Gosselin E, 2013, J OCCUP HEALTH PSYCH, V18, P75, DOI 10.1037/a0030932; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Hansen CD, 2008, SOC SCI MED, V67, P956, DOI 10.1016/j.socscimed.2008.05.022; Hemp P., 2004, HARVARD BUSINESS REV; Howard KJ, 2009, J OCCUP ENVIRON MED, V51, P724, DOI 10.1097/JOM.0b013e3181a297b5; Iacobucci D, 2012, J CONSUM PSYCHOL, V22, P603, DOI 10.1016/j.jcps.2012.03.010; Johns G, 2011, J OCCUP HEALTH PSYCH, V16, P483, DOI 10.1037/a0025153; Johns G, 2010, J ORGAN BEHAV, V31, P519, DOI 10.1002/job.630; Kalaydjian A, 2007, NEUROLOGY, V68, P1417, DOI 10.1212/01.wnl.0000268250.10171.b3; Koopman C, 2002, J OCCUP ENVIRON MED, V44, P14, DOI 10.1097/00043764-200201000-00004; Lardon A, 2017, CEPHALALGIA, V37, P64, DOI 10.1177/0333102416636096; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P243, DOI 10.1007/s10654-004-6519-2; Manzoni Gian Camillo, 2010, Handb Clin Neurol, V97, P3, DOI 10.1016/S0072-9752(10)97001-2; Mongini F, 2006, J PSYCHOSOM RES, V61, P447, DOI 10.1016/j.jpsychores.2006.03.005; Monzani L, 2016, COMPLEMENT THER MED, V25, P86, DOI 10.1016/j.ctim.2016.01.008; Monzani L, 2015, EUR J WORK ORGAN PSY, V24, P444, DOI 10.1080/1359432X.2014.911173; Moshagen M, 2014, METHODOLOGY-EUR, V10, P60, DOI 10.1027/1614-2241/a000068; Muthen L. K., 2011, MPLUS USERS GUIDE; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pop PHM, 2002, EUR J NEUROL, V9, P171, DOI 10.1046/j.1468-1331.2002.00355.x; Qu P, 2018, PAIN PRACT, V18, P8, DOI 10.1111/papr.12574; Raykov T, 2002, STRUCT EQU MODELING, V9, P195, DOI 10.1207/S15328007SEM0902_3; Rigotti T., 2014, F2199 FED I OCC SAF; Roe RA, 2011, PSYCHOL BEHAV ASPECT, P239; Rosen L. D., 1990, ANXIETY RES, V3, P175, DOI DOI 10.1080/08917779008248751; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Seipp B., 1991, ANXIETY RES, V4, P27, DOI [10.1080/08917779108248762, DOI 10.1080/08917779108248762]; Shockley KM, 2012, HUM PERFORM, V25, P377, DOI 10.1080/08959285.2012.721832; Smith L, 2009, CEPHALALGIA, V29, P250, DOI 10.1111/j.1468-2982.2008.01714.x; Spielberger CD, 1970, SELF EVALUATION QUES; Thomas F., 2015, MPLUS CODE MEDIATION; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Espi-Lopez GV, 2016, INT J OSTEOPATH MED, V22, P11, DOI 10.1016/j.ijosm.2016.05.003; Wada K, 2013, IND HEALTH, V51, P482, DOI 10.2486/indhealth.2013-0016; Waldie KE, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-60; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	60	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201189	10.1371/journal.pone.0201189	http://dx.doi.org/10.1371/journal.pone.0201189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024973	Green Published, gold			2022-12-27	WOS:000439120000096
J	Nizynski, B; Nieznanska, H; Dec, R; Boyko, S; Dzwolak, W; Nieznanski, K				Nizynski, Bartosz; Nieznanska, Hanna; Dec, Robert; Boyko, Solomiia; Dzwolak, Wojciech; Nieznanski, Krzysztof			Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; A-BETA OLIGOMERS; FRONTOTEMPORAL DEMENTIA; CONFORMATIONAL CONVERSION; ALZHEIMERS-DISEASE; REPEAT DOMAIN; AGGREGATION; PROPAGATION; PRINCIPLES; MUTATIONS	Amyloid aggregates of Tau protein have been implicated in etiology of many neurodegenerative disorders including Alzheimer's disease (AD). When amyloid growth is induced by seeding with preformed fibrils assembled from the same protein, structural characteristics of the seed are usually imprinted in daughter generations of fibrils. This so-called conformational memory effect may be compromised when the seeding involves proteins with nonidentical sequences leading to the emergence of distinct structural variants of fibrils (amyloid `strains). Here, we investigate cross-seeding of full-length human Tau (FL Tau) with fibrils assembled from K18 and K18 Delta K280 fragments of Tau in the presence of poly-L-glutamate (poly-Glu) as an enhancer of Tau aggregation. To study cross-seeding between Tau polypeptides and the role of the conformational memory effect in induction of Tau amyloid polymorphism, kinetic assays, transmission electron microscopy, infrared spectroscopy and limited proteolysis have been employed. The fastest fibrillization was observed for FL Tau monomers seeded with preformed K18 amyloid yielding daughter fibrils with unique trypsin digestion patterns. Morphological features of daughter FL Tau fibrils induced by K18 and K18AK280 seeds were reminiscent of the mother fibrils (i.e. straight paired fibrils and paired helical filaments (PHFs), respectively) but disappeared in the following generations which became similar to unpaired FL Tau amyloid fibrils formed de novo. The structural evolution observed in our study was accompanied by disappearance of the unique proteolysis profile originated from K18. Our findings may have implications for understanding molecular mechanisms of the emergence and stability of Tau amyloid strains.	[Nizynski, Bartosz] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, Banacha 2C, Warsaw, Poland; [Nizynski, Bartosz; Dec, Robert; Dzwolak, Wojciech] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland; [Nieznanska, Hanna; Boyko, Solomiia; Nieznanski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland	University of Warsaw; University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Dzwolak, W (corresponding author), Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland.; Nieznanski, K (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland.	wdzwolak@chem.uw.edu.pl; k.vandijki@nencki.gov.pl	Nieznanski, Krzysztof/R-4220-2016	Nieznanski, Krzysztof/0000-0003-0440-2632; Nieznanska, Hanna/0000-0001-7055-5018; Boyko, Solomiia/0000-0003-1867-7610; Dzwolak, Wojciech/0000-0002-1407-1497	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [665735]; Polish Ministry of Science and Higher Education [3548/H2020/COFUND/2016/2]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	S. B. and K. N. have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 665735 (Bio4Med) (https://cordis.europa.eu/project/rcn/196367_en.html) and the funding from Polish Ministry of Science and Higher Education within 2016-2020 funds for the implementation of international projects (agreement No 3548/H2020/COFUND/2016/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoury E, 2016, PROTEIN SCI, V25, P1010, DOI 10.1002/pro.2911; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Atsmon-Raz Y, 2016, J PHYS CHEM B, V120, P10649, DOI 10.1021/acs.jpcb.6b07731; Atsmon-Raz Y, 2016, ACS CHEM NEUROSCI, V7, P46, DOI 10.1021/acschemneuro.5b00204; Baram M, 2016, PHYS CHEM CHEM PHYS, V18, P2330, DOI 10.1039/c5cp03338a; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falsig J, 2008, HFSP J, V2, P332, DOI 10.2976/1.2990786; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fulara A, 2010, J PHYS CHEM B, V114, P8278, DOI 10.1021/jp102440n; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hernik A, 2015, LANGMUIR, V31, P10500, DOI 10.1021/acs.langmuir.5b02915; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kumar S, 2014, J BIOL CHEM, V289, P20318, DOI 10.1074/jbc.M114.554725; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Matsumoto SE, 2015, HUM MOL GENET, V24, P6403, DOI 10.1093/hmg/ddv351; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nizynski B, 2017, PROTEIN SCI, V26, P2126, DOI 10.1002/pro.3275; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raz Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073303; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sarell CJ, 2013, PRION, V7, P359, DOI 10.4161/pri.26415; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shammas SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8025; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Surmacz-Chwedoruk W, 2016, SCI REP-UK, V6, DOI 10.1038/srep32022; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wasiak T, 2012, MOL PHARMACEUT, V9, P458, DOI 10.1021/mp2005627; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	69	19	19	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201182	10.1371/journal.pone.0201182	http://dx.doi.org/10.1371/journal.pone.0201182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024984	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000095
J	Ringe, KI; von Falck, C; Raatschen, HJ; Wacker, F; Hinrichs, J				Ringe, Kristina, I; von Falck, Christian; Raatschen, Hans-Juergen; Wacker, Frank; Hinrichs, Jan			Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols	PLOS ONE			English	Article							HEPATIC ARTERIAL PHASE; GADOBENATE DIMEGLUMINE; LESION APPEARANCE; IMAGE-QUALITY; LIVER; ACID; OPTIMIZATION; DTPA; AGREEMENT	Purpose To evaluate transient severe respiratory motion artifacts (TSM) at gadoxetate disodium-enhanced MRI dependent on the mode of contrast agent application. Methods 200 patients (71f, 129m; mean 51y) were included in this retrospective IRB-approved study. Contrast application protocols (n = 4) differed with regards to injection rate (2ml or 1ml/sec), dose (weight-based or fixed 10ml) and supplemental oxygen administration (yes/no). SNR measurements were performed in the aorta and portal vein. Qualitatively, three readers assessed arterial phase image quality and TSM independently (4- and 5-point scale, respectively). Quantitative and qualitative results were compared (Kruskal-Wallis test, Dunn's multiple comparison test). The influence of different contrast agent application parameters on the occurrence of respiratory motion artifacts was assessed (univariate analysis). Interrater agreement and reliability were calculated (intraclass correlation coefficient, ICC)). Results Use of a lower contrast injection rate resulted in significantly higher arterial SNR in the aorta and portal vein (p<0.05). TSM was observed in 12% of examinations. Neither injection rate, contrast dose, nor oxygen had a significant influence. Interrater agreement and reliability for evaluation of image quality and respiratory motion were substantial/ almost perfect (ICC = 0.640-0.915). Conclusions Technical factors regarding the specific mode of contrast application do not seem to significantly reduce the incidence of severe transient respiratory motion artifacts.	[Ringe, Kristina, I; von Falck, Christian; Raatschen, Hans-Juergen; Wacker, Frank; Hinrichs, Jan] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany	Hannover Medical School	Ringe, KI (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.	ringe.kristina@mh.hannover.de	von Falck, Christian/AAO-2108-2020					Bashir MR, 2015, RADIOLOGY, V274, P141, DOI 10.1148/radiol.14140386; Cruite I, 2010, AM J ROENTGENOL, V195, P29, DOI 10.2214/AJR.10.4538; Davenport MS, 2014, AM J ROENTGENOL, V203, P796, DOI 10.2214/AJR.13.11587; Davenport MS, 2014, RADIOLOGY, V272, P123, DOI 10.1148/radiol.14132269; Davenport MS, 2013, RADIOLOGY, V266, P452, DOI 10.1148/radiol.12120826; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Gutzeit A, 2016, EUROPEAN C RADIOLOGY; Haradome H, 2010, J MAGN RESON IMAGING, V32, P334, DOI 10.1002/jmri.22241; Hayashi T, 2015, RADIOLOGY, V276, P756, DOI 10.1148/radiol.2015141646; Huh J, 2015, KOREAN J RADIOL, V16, P1207, DOI 10.3348/kjr.2015.16.6.1207; Kim SY, 2015, AM J ROENTGENOL, V204, P1220, DOI 10.2214/AJR.14.13677; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luetkens JA, 2015, EUR RADIOL, V25, P3207, DOI 10.1007/s00330-015-3736-x; McClellan TR, 2017, RADIOLOGY, V282, P361, DOI 10.1148/radiol.2016160482; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Motosugi U, 2016, RADIOLOGY, V279, P93, DOI 10.1148/radiol.2015150642; Park YS, 2016, INVEST RADIOL, V51, P127, DOI 10.1097/RLI.0000000000000211; Pietryga JA, 2014, RADIOLOGY, V271, P426, DOI 10.1148/radiol.13131988; Ringe KI, 2010, AM J ROENTGENOL, V195, P13, DOI 10.2214/AJR.10.4392; Schmid-Tannwald C, 2012, ACTA RADIOL, V53, P961, DOI 10.1258/ar.2012.120186; Tsuboyama T, 2016, EUROPEAN C RADIOLOGY; Van Montfoort JE, 1999, J PHARMACOL EXP THER, V290, P153; Yoo JL, 2016, INVEST RADIOL, V51, P440, DOI 10.1097/RLI.0000000000000249; Zech CJ, 2009, INVEST RADIOL, V44, P305, DOI 10.1097/RLI.0b013e3181a24512	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200887	10.1371/journal.pone.0200887	http://dx.doi.org/10.1371/journal.pone.0200887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024930	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000065
J	Scheich, S; Koenig, R; Wilke, AC; Lindner, S; Reinheimer, C; Wichelhaus, TA; Hogardt, M; Kempf, VAJ; Kessel, J; Weber, S; Martin, H; Bug, G; Serve, H; Steffen, B				Scheich, Sebastian; Koenig, Rosalie; Wilke, Anne C.; Lindner, Sarah; Reinheimer, Claudia; Wichelhaus, Thomas A.; Hogardt, Michael; Kempf, Volkhard A. J.; Kessel, Johanna; Weber, Sarah; Martin, Hans; Bug, Gesine; Serve, Hubert; Steffen, Bjoern			Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETER; GRAM-NEGATIVE BACILLI; BONE-MARROW; RISK-FACTORS; MORTALITY; BACTEREMIA; SPECTRUM; EPIDEMIOLOGY; BACTERIAL	Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers potential cure to acute myeloid leukemia (AML) patients. However, infections with commensal bacteria are an important cause for non-relapse mortality (NRM). We have previously described the impact of multidrug-resistant organism (MDRO) colonization on the survival of allo-HSCT patients. In the aforementioned publication, according to consensus, we there did not consider the opportunistic gram-negative bacterium Stenotrophomonas maltophilia (S. maltophilia) to be an MDRO. Since rate of S. maltophilia colonization is increasing, and it is not known whether this poses a risk for allo-HSCT patients, we here analyzed here its effect on the previously described and now extended patient cohort. We report on 291 AML patients undergoing allo-HSCT. Twenty of 291 patients (6.9%) were colonized with S. maltophilia. Colonized patients did not differ from non-colonized patients with respect to their age, remission status before allo-HSCT, donor type and HSCT-comorbidity index. S. maltophilia colonized patients had a worse overall survival (OS) from 6 months up to 60 months (85% vs. 88.1% and 24.7% vs. 59.7%; p = 0.007) due to a higher NRM after allo-HSCT (6 months: 15% vs. 4.8% and 60 months: 40.1% vs. 16.2% p = 0.003). The main cause of mortality in colonized patients was infection (46.2% of all deaths) and in non-colonized patients relapse (58.8% of all deaths). 5/20 colonized patients developed an invasive infection with S. maltophilia. The worse OS after allo-HSCT due to higher infection related mortality might implicate the screening of allo-HSCT patients for S. maltophilia and a closer observation of colonized patients as outpatients.	[Scheich, Sebastian; Koenig, Rosalie; Wilke, Anne C.; Lindner, Sarah; Weber, Sarah; Martin, Hans; Bug, Gesine; Serve, Hubert; Steffen, Bjoern] Goethe Univ Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany; [Scheich, Sebastian; Wilke, Anne C.; Lindner, Sarah; Reinheimer, Claudia; Wichelhaus, Thomas A.; Hogardt, Michael; Kempf, Volkhard A. J.; Kessel, Johanna; Weber, Sarah; Martin, Hans; Bug, Gesine; Serve, Hubert; Steffen, Bjoern] Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany; [Reinheimer, Claudia; Wichelhaus, Thomas A.; Hogardt, Michael; Kempf, Volkhard A. J.] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Kessel, Johanna] Univ Hosp Frankfurt, Infect Dis Unit, Dept Med, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scheich, S (corresponding author), Goethe Univ Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany.; Scheich, S (corresponding author), Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany.	sebastian.scheich@kgu.de	Bug, Gesine/H-8827-2013					[Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Boktour M, 2006, CANCER-AM CANCER SOC, V106, P1967, DOI 10.1002/cncr.21846; Cappellano P, 2007, NEW MICROBIOL, V30, P89; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Corbella X, 1996, CLIN INFECT DIS, V23, P329, DOI 10.1093/clinids/23.2.329; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Elsabbagh EM, 2017, BIOL BLOOD MARROW TR, V23, pS231, DOI 10.1016/j.bbmt.2016.12.455; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Goerner M, 2002, BIOL BLOOD MARROW TR, V8, P47, DOI 10.1053/bbmt.2002.v8.pm11858190; Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001; Jones RN, 2003, INT J ANTIMICROB AG, V22, P551, DOI 10.1016/S0924-8579(03)00245-0; Kruger W, 1999, BONE MARROW TRANSPL, V23, P589, DOI 10.1038/sj.bmt.1701614; Labarca JA, 2000, CLIN INFECT DIS, V30, P195, DOI 10.1086/313591; Lai CH, 2006, CLIN MICROBIOL INFEC, V12, P986, DOI 10.1111/j.1469-0691.2006.01511.x; Liss BJ, 2012, INFECTION, V40, P613, DOI 10.1007/s15010-012-0269-y; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Mikulska M, 2012, INFECTION, V40, P271, DOI 10.1007/s15010-011-0229-y; Mori M, 2014, ANN HEMATOL, V93, P901, DOI 10.1007/s00277-014-2028-x; Ninin E, 2001, CLIN INFECT DIS, V33, P41, DOI 10.1086/320871; Norkin Maxim, 2017, F1000Res, V6, P870, DOI 10.12688/f1000research.11233.1; Nseir S, 2006, CRIT CARE, V10, DOI 10.1186/cc5063; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Poutsiaka DD, 2007, BONE MARROW TRANSPL, V40, P63, DOI 10.1038/sj.bmt.1705690; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sader HS, 2014, ANTIMICROB AGENTS CH, V58, P2274, DOI 10.1128/AAC.02684-13; Sader HS, 2005, INT J ANTIMICROB AG, V25, P95, DOI 10.1016/j.ijantimicag.2004.10.002; Samonis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037375; Scheich S, 2017, CANCER; Scheich S, 2017, BIOL BLOOD MARROW TR; Shiratori S, 2014, CLIN TRANSPLANT, V28, P656, DOI 10.1111/ctr.12356; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sostarich AM, 2008, INFECTION, V36, P31, DOI 10.1007/s15010-007-6316-4; US Department of Health and Human Services National Institutes of Health, 2010, COMM TERM CRIT ADV E; Wang L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001931; Waters VJ, 2007, INFECT IMMUN, V75, P1698, DOI 10.1128/IAI.01469-06; Yeshurun M, 2010, INFECTION, V38, P211, DOI 10.1007/s15010-010-0023-2	40	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201169	10.1371/journal.pone.0201169	http://dx.doi.org/10.1371/journal.pone.0201169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024969	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000093
J	Shimada, E; Ahsan, FM; Nili, M; Huang, D; Atamdede, S; TeSlaa, T; Case, D; Yu, X; Gregory, BD; Perrin, BJ; Koehler, CM; Teitell, MA				Shimada, Eriko; Ahsan, Fasih M.; Nili, Mahta; Huang, Dian; Atamdede, Sean; TeSlaa, Tara; Case, Dana; Yu, Xiang; Gregory, Brian D.; Perrin, Benjamin J.; Koehler, Carla M.; Teitell, Michael A.			PNPase knockout results in mtDNA loss and an altered metabolic gene expression program	PLOS ONE			English	Article							HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; RNA-IMPORT; INTERMEMBRANE SPACE; POLY(A) POLYMERASE; ESCHERICHIA-COLI; CULTURED-CELLS; MITOCHONDRIA; PROTEIN; FAMILY; DECAY	Polynucleotide phosphorylase (PNPase) is an essential mitochondria-localized exoribonuclease implicated in multiple biological processes and human disorders. To reveal role(s) for PNPase in mitochondria, we established PNPase knockout (PKO) systems by first shifting culture conditions to enable cell growth with defective respiration. Interestingly, PKO established in mouse embryonic fibroblasts (MEFs) resulted in the loss of mitochondrial DNA (mtDNA). The transcriptional profile of PKO cells was similar to rho(0) mtDNA deleted cells, with perturbations in cholesterol (FDR = 6.35 x 10(-13)), lipid (FDR = 3.21 x 10(-11)), and secondary alcohol (FDR = 1.04x10(-12)) metabolic pathway gene expression compared to wild type parental (TM6) MEFs. Transcriptome analysis indicates processes related to axonogenesis (FDR = 4.49 x 10(-3)), axon development (FDR = 4.74 x 10(-3)), and axonal guidance (FDR = 4.74 x 10(-3)) were overrepresented in PKO cells, consistent with previous studies detailing causative PNPase mutations in delayed myelination, hearing loss, encephalomyopathy, and chorioretinal defects in humans. Overrepresentation analysis revealed alterations in metabolic pathways in both PKO and rho(0) cells. Therefore, we assessed the correlation of genes implicated in cell cycle progression and total metabolism and observed a strong positive correlation between PKO cells and rho(0) MEFs compared to TM6 MEFs. We quantified the normalized biomass accumulation rate of PKO clones at 1.7% (SD +/- 2.0%) and 2.4% (SD +/- 1.6%) per hour, which was lower than TM6 cells at 3.3% (SD +/- 3.5%) per hour. Furthermore, PKO in mouse inner ear hair cells caused progressive hearing loss that parallels human familial hearing loss previously linked to mutations in PNPase. Combined, our study reports that knockout of a mitochondrial nuclease results in mtDNA loss and suggests that mtDNA maintenance could provide a unifying connection for the large number of biological activities reported for PNPase.	[Shimada, Eriko; TeSlaa, Tara; Case, Dana; Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Interdept Program, Los Angeles, CA 90024 USA; [Ahsan, Fasih M.; Nili, Mahta; Teitell, Michael A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Huang, Dian; Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Atamdede, Sean; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Yu, Xiang; Gregory, Brian D.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Perrin, Benjamin J.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Brd Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Koehler, CM; Teitell, MA (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Interdept Program, Los Angeles, CA 90024 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.; Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Koehler, CM; Teitell, MA (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Brd Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	koehlerc@chem.ucla.edu; mteitell@mednet.ucla.edu	Yu, Xiang/H-9666-2019; Gregory, Brian D/G-2890-2010	Yu, Xiang/0000-0002-5730-8802; Ahsan, Fasih/0000-0001-8031-7056; Koehler, Carla/0000-0001-8685-2412; TeSlaa, Tara/0000-0002-0504-0998	National Institutes of Health [CA90571, CA156674, GM073981, GM114188, CA185189, GM61721, CA009120, GM007185]; California Institute of Regenerative Medicine [RT307678]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [NS076228]; Whitcome Pre-doctoral Training Program (UCLA); MBI-IDP Special Award (UCLA); Air Force Office of Scientific Research [FA9550-15-1-0406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM114188, R01GM073981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Pre-doctoral Training Program (UCLA); MBI-IDP Special Award (UCLA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health awards CA90571 (MAT), CA156674 (MAT), GM073981 (MAT and CMK), GM114188 (MAT), CA185189 (MAT), and GM61721 (CMK); California Institute of Regenerative Medicine RT307678 (CMK and MAT); National Institutes of Health Ruth L. Kirschstein National Research Service Award NS076228 (ES); Whitcome Pre-doctoral Training Program (UCLA) (ES); and an MBI-IDP Special Award (UCLA) (ES). Air Force Office of Scientific Research FA9550-15-1-0406, National Institutes of Health CA009120, National Institutes of Health GM007185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alodaib A, 2017, EUR J HUM GENET, V25, P79, DOI 10.1038/ejhg.2016.128; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Bandyra KJ, 2016, RNA, V22, P360, DOI 10.1261/rna.052886.115; Becket E, 2012, J BACTERIOL, V194, P5613, DOI 10.1128/JB.00962-12; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Bralley P, 2014, GENE, V536, P177, DOI 10.1016/j.gene.2013.10.055; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Cameron TA, 2016, J BACTERIOL, V198, P3309, DOI 10.1128/JB.00624-16; Cardenas PP, 2011, NUCLEIC ACIDS RES, V39, P9250, DOI 10.1093/nar/gkr635; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Carzaniga T, 2014, BIOCHIMIE, V97, P49, DOI 10.1016/j.biochi.2013.09.018; Carzaniga T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-270; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; Goverde RLJ, 1998, MOL MICROBIOL, V28, P555, DOI 10.1046/j.1365-2958.1998.00816.x; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Gregory Warnes BB, 2016, BILL VENABLES GPLOTS; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Kettunen P, 2007, MECH DEVELOP, V124, P868, DOI 10.1016/j.mod.2007.09.003; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Kim SH, 2009, J FOOD PROTECT, V72, P1841, DOI 10.4315/0362-028X-72.9.1841; Kolde R, 2015, PACKAGE PHEATMAP PRE; Leszczyniecka M, 2003, GENE, V316, P143, DOI 10.1016/S0378-1119(03)00752-2; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Liu PP, 2017, PROTEIN CELL, V8, P735, DOI 10.1007/s13238-017-0448-9; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matilainen S, 2017, HUM MOL GENET, V26, P3352, DOI 10.1093/hmg/ddx221; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nishimura K, 2017, STEM CELL REP, V8, P787, DOI 10.1016/j.stemcr.2017.01.026; Oster SF, 2003, DEVELOPMENT, V130, P775, DOI 10.1242/dev.00299; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Pobre V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1237-6; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Rath D, 2012, MICROBIOL-SGM, V158, P1196, DOI 10.1099/mic.0.056309-0; REINER AM, 1969, J BACTERIOL, V97, P1437, DOI 10.1128/JB.97.3.1437-1443.1969; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rosenzweig JA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00081; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009; Sarkar D, 2004, CANCER RES, V64, P7473, DOI 10.1158/0008-5472.CAN-04-1772; Sarkar D, 2006, CELL DEATH DIFFER, V13, P1541, DOI 10.1038/sj.cdd.4401829; Sato R, 2018, CLIN GENET, V93, P242, DOI 10.1111/cge.13068; Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833; Slavotinek AM, 2015, CLIN GENET, V88, P468, DOI 10.1111/cge.12543; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Sokhi UK, 2014, J CELL PHYSIOL, V229, P1952, DOI 10.1002/jcp.24645; Sokhi UK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076284; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001; von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002; Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Wu JH, 2009, BIOCHEMISTRY-US, V48, P2012, DOI 10.1021/bi801752p; Yamanaka K, 2001, J BACTERIOL, V183, P2808, DOI 10.1128/JB.183.9.2808-2816.2001; Yip JW, 2000, P NATL ACAD SCI USA, V97, P8612, DOI 10.1073/pnas.150040497; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zangle TA, 2014, NAT METHODS, V11, P1221, DOI 10.1038/nmeth.3175; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307	86	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200925	10.1371/journal.pone.0200925	http://dx.doi.org/10.1371/journal.pone.0200925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024931	Green Published, gold			2022-12-27	WOS:000439120000068
J	Takagi, J; Ichikawa, K; Arai, N; Miyamoto, Y; Uchida, K; Shoji, J; Mitamura, H				Takagi, Junichi; Ichikawa, Kotaro; Arai, Nobuaki; Miyamoto, Yoshinori; Uchida, Keiichi; Shoji, Jun; Mitamura, Hiromichi			Simultaneous observation of intermittent locomotion of multiple fish by fine-scale spatiotemporal three-dimensional positioning	PLOS ONE			English	Article							ACOUSTIC TELEMETRY; MOVEMENT PATTERNS; LIGHT CONDITIONS; ACTIVITY RHYTHM; SITE FIDELITY; BEHAVIOR; HABITAT; SEARCH; SALMON; PSEUDOLABRUS	Recent advances in biotelemetry techniques, especially positioning methods, have revealed the detailed behaviour and movement of aquatic organisms. Behavioural intermittence in animal locomotion, such as the Levy walk, is a popular topic in the field of movement ecology. Previous attempts to describe intermittent locomotion quantitatively have been constrained by the spatial and temporal resolution possible with conventional biotelemetry systems. This study developed a fine-scale spatiotemporal three-dimensional positioning method using a new biotelemetry system with a positional precision of <10 cm and positioning interval of <10 s. Using this proposed positioning method, the intermittent stop-and-go locomotion of Siebold's wrasses (Pseudolabrus sieboldi) was observed during travel from an unsuitable to a suitable location following displacement. The fish displayed behavioural intermittence in relocating to a suitable location. Initially, their movement halted for reorientation, after which they moved intermittently yet in a straight line to the suitable location. To test the positioning ability of the proposed method, data sets were resampled at intervals of 5, 10, 30, 60, and 300 s. Longer sampling intervals failed to identify reorientations and underestimated the number of stops, distance travelled, and speed. Overall, the results highlighted the adequacy and ability of the proposed positioning method to observe the intermittent locomotion of fish, such as stop-and-go behaviour, in a natural environment.	[Takagi, Junichi; Mitamura, Hiromichi] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Takagi, Junichi; Ichikawa, Kotaro; Arai, Nobuaki; Miyamoto, Yoshinori; Uchida, Keiichi; Mitamura, Hiromichi] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Ichikawa, Kotaro; Arai, Nobuaki] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan; [Miyamoto, Yoshinori; Uchida, Keiichi] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Ocean Sci, Tokyo, Japan; [Shoji, Jun] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Tokyo University of Marine Science & Technology; Hiroshima University	Takagi, J (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.; Takagi, J (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.	takagi@bre.soc.i.kyoto-u.ac.jp	MIYAMOTO, Yoshinori/O-1920-2014	Shoji, Jun/0000-0003-2293-5707; Takagi, Junichi/0000-0002-6661-6065	JST CREST, Japan [JPMJCR13A5];  [17J10603];  [25712022]	JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST)); ; 	This study was supported by a Grant-in-Aid for JSPS (the Japan Society for the Promotion of Science, https://www.jsps.go.jp) Fellowship (17J10603 to JT); a Grant-in-Aids for Young Scientist (A) (25712022 to HM), Japan (https://www.jsps.go.jp); and JST CREST Grant Number JPMJCR13A5, Japan (http://www.jst.go.jp/kisoken/crest/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KS, 2011, MAR BIOL, V158, P2377, DOI 10.1007/s00227-011-1724-5; [Anonymous], R LANG ENV STAT COMP; Arai N, 2016, J ADV MAR SCI TECHNO, V22, P5; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Berge J, 2012, FISH RES, V125, P1, DOI 10.1016/j.fishres.2012.02.008; Carlson H.R., 1995, Alaska Fishery Research Bulletin, V2, P76; Cooke SJ, 2005, MAR TECHNOL SOC J, V39, P31, DOI 10.4031/002533205787521659; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cote D, 1998, MAR TECHNOL SOC J, V32, P54; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Gjelland KO, 2013, METHODS ECOL EVOL, V4, P665, DOI 10.1111/2041-210X.12057; GOLD R, 1967, IEEE T INFORM THEORY, V13, P619, DOI 10.1109/TIT.1967.1054048; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Kessel ST, 2014, REV FISH BIOL FISHER, V24, P199, DOI 10.1007/s11160-013-9328-4; Kitahashi T, 2000, ZOOL SCI, V17, P1247, DOI 10.2108/zsj.17.1247; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; Langley R. B., 1999, GPS WORLD, P52; Lokkeborg S, 2002, HYDROBIOLOGIA, V483, P259, DOI 10.1023/A:1021312503220; Mabuchi K, 1997, ICHTHYOL RES, V44, P321, DOI 10.1007/BF02671984; Matsumoto K, 1997, ICHTHYOL RES, V44, P379, DOI 10.1007/BF02671989; Meckley TD, 2017, CAN J FISH AQUAT SCI, V74, P2045, DOI 10.1139/cjfas-2016-0412; Mitamura H, 2012, J EXP BIOL, V215, P2751, DOI 10.1242/jeb.065052; Mitamura H, 2009, FISHERIES SCI, V75, P1133, DOI 10.1007/s12562-009-0142-9; Miyamoto Y, 2011, J MAR ACOUST SOC JPN, V38, P110; Miyamoto Y., 2010, P ICA, P1; NISHI G, 1989, JPN J ICHTHYOL, V36, P350, DOI 10.1007/BF02905620; NISHI G, 1990, JPN J ICHTHYOL, V37, P170, DOI 10.1007/BF02905386; OBRIEN WJ, 1990, AM SCI, V78, P152; Pincock DG., 2008, UNDERSTANDING PERFOR; Roy R., 2014, ANIM BIOTELEM, V2, P1, DOI DOI 10.1186/2050-3385-2-1; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Ueda H, 1998, CHEM SENSES, V23, P207, DOI 10.1093/chemse/23.2.207; Voegeli FA, 1998, HYDROBIOLOGIA, V372, P35, DOI 10.1023/A:1017014903313; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Williams-Grove LJ, 2016, MAR ECOL PROG SER, V553, P233, DOI 10.3354/meps11778; Wolfe BW, 2015, MAR ENVIRON RES, V109, P69, DOI 10.1016/j.marenvres.2015.06.002; Zar JH., 2010, BIOSTAT ANAL, V5th	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201029	10.1371/journal.pone.0201029	http://dx.doi.org/10.1371/journal.pone.0201029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024958	Green Published, gold			2022-12-27	WOS:000439120000081
J	Zhang, RM; Xi, XY; Wang, CY; Pan, Y; Ge, CH; Zhang, LY; Zhang, S; Liu, HM				Zhang, Ruimei; Xi, Xiangyu; Wang, Chunying; Pan, Yong; Ge, Changhua; Zhang, Liying; Zhang, Shuo; Liu, Huimei			Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis	PLOS ONE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; SPUTUM CULTURE CONVERSION; MYCOBACTERIUM-AVIUM COMPLEX; TUMOR-NECROSIS-FACTOR; CD8 T-CELLS; PULMONARY TUBERCULOSIS; IFN-GAMMA; MEDIATED PROTECTION; INFECTION; MICE	Background Interleukin 2 (IL-2) is a cytokine secreted by activated T cells. Studies exploring recombinant human interleukin 2 (rhuIL-2) as an adjunctive immunotherapeutic agent to treat tuberculosis (TB) have shown variable results; however, the true therapeutic efficacy of rhuIL-2 administration in TB patients has not been determined. Methods A systematic review to identify publications exploring the association between rhuIL-2-based immunotherapy for TB and outcomes (sputum culture conversion, sputum smear conversion, radiographic changes, and leukocyte phenotype changes) in patients with pulmonary TB published before June 8, 2018 was performed. Data were extracted and analyzed by two investigators independently. Results A total of 2,272 records were screened. Four randomized controlled trials (RCTs) comprising 656 pulmonary TB patients were finally included. The rhuIL-2 treatment could significantly improve the sputum culture conversion of TB (RR, 1.18; 95% CI: 1.03-1.36; I-2 < 0.01; P = 0.019) after at least 3 months of anti-TB therapy and the sputum smear conversion of TB during anti-TB therapy. Treating multidrug-resistant tuberculosis (MDR-TB) with rhuIL-2 could improve the sputum culture conversion (RR, 1.28; 95% CI: 1.05-1.57; I-2 < 0.01; P = 0.016) and smear conversion (RR, 1.28; 95% CI: 1.09-1.51; I-2 < 0.01; P = 0.003) at the end of anti-TB treatment. Meanwhile, rhuIL-2-based adjunctive immunotherapy could expand the proliferation and conversion of CD4(+) and natural killer (NK) cells. Three of the included studies suggested that radiographic changes could not be improved by the use of rhuIL-2 as adjunctive immunotherapy. Publication bias did not exist. Conclusions Based on this first meta-analysis, rhuIL-2-based adjunctive immunotherapy appears to expand the proliferation and conversion of CD4(+) and NK cells, as well as improve the sputum culture (at 3 months and later) and smear conversion of TB patients.	[Zhang, Ruimei; Xi, Xiangyu; Wang, Chunying; Pan, Yong; Ge, Changhua; Zhang, Liying; Zhang, Shuo; Liu, Huimei] Xuzhou Infect Dis Hosp, Dept TB, Xuzhou, Jiangsu, Peoples R China		Liu, HM (corresponding author), Xuzhou Infect Dis Hosp, Dept TB, Xuzhou, Jiangsu, Peoples R China.	doctorliu1979@163.com						AKUFFO H, 1990, J INFECT DIS, V161, P775, DOI 10.1093/infdis/161.4.775; BERMUDEZ LEM, 1989, J IMMUNOL, V143, P2996; BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Chu Nai-hui, 2003, Zhonghua Jiehe He Huxi Zazhi, V26, P548; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Dobbs TE, 2017, MICROBIOL SPECTR, V5; Dominguez-Castellano A, 2003, INT J TUBERC LUNG D, V7, P432; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Higgins J.P.T, 2011, BMJ, V343; Hoffner S., 2016, INT J MYCOBACTERIOL, V5, P59; Bini EI, 2014, CURR RESPIR MED REV, V10, P74, DOI 10.2174/1573398X10666140807232241; JEEVAN A, 1988, INFECT IMMUN, V56, P660, DOI 10.1128/IAI.56.3.660-664.1988; Johnson BJ, 1997, TUBERCLE LUNG DIS, V78, P195, DOI 10.1016/S0962-8479(97)90026-5; JOHNSON BJ, 1995, CYTOKINES MOL THER, V1, P185; Johnson JL, 2003, AM J RESP CRIT CARE, V168, P185, DOI 10.1164/rccm.200211-1359OC; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; KAPLAN G, 1991, J EXP MED, V173, P993, DOI 10.1084/jem.173.4.993; KELSO A, 1984, J IMMUNOL, V132, P2932; KIM TC, 1984, AM REV RESPIR DIS, V129, P264; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; Lee S. K., 1995, Annals Academy of Medicine Singapore, V24, P442; LEVETON C, 1989, INFECT IMMUN, V57, P390, DOI 10.1128/IAI.57.2.390-395.1989; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Liu ZY, 1999, ARCH INTERN MED, V159, P1110, DOI 10.1001/archinte.159.10.1110; Mattila JT, 2011, J IMMUNOL, V186, P3527, DOI 10.4049/jimmunol.1003773; Mdluli K, 2015, COLD SPRING HARB PER, V5; Neelam R, 2012, INT RES J PHARM, V3, P46; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Rao Nisar Ahmed, 2007, J Pak Med Assoc, V57, P252; Ryu YJ, 2015, TUBERC RESPIR DIS, V78, P64, DOI 10.4046/trd.2015.78.2.64; Shen H, 2015, ARCH MED SCI, V11, P584, DOI 10.5114/aoms.2015.52362; Tan Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18200-5; TEPPLER H, 1993, J EXP MED, V177, P483, DOI 10.1084/jem.177.2.483; Urdahl KB, 2003, J IMMUNOL, V170, P1987, DOI 10.4049/jimmunol.170.4.1987; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vashishtha VM, 2009, INDIAN PEDIATR, V46, P401; Villemagne B, 2012, EUR J MED CHEM, V51, P1, DOI 10.1016/j.ejmech.2012.02.033; Yew WW, 2008, RESPIROLOGY, V13, P21, DOI 10.1111/j.1440-1843.2007.01180.x; YONEDA T, 1983, BRIT J DIS CHEST, V77, P185, DOI 10.1016/0007-0971(83)90026-8; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	52	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201025	10.1371/journal.pone.0201025	http://dx.doi.org/10.1371/journal.pone.0201025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024982	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000079
J	Hintaran, AD; Kliffen, SJ; Lodder, W; Pijnacker, R; Brandwagt, D; van der Bij, AK; Siedenburg, E; Sonder, GJB; Fanoy, EB; Joosten, RE				Hintaran, A. D.; Kliffen, S. J.; Lodder, W.; Pijnacker, R.; Brandwagt, D.; van der Bij, A. K.; Siedenburg, E.; Sonder, G. J. B.; Fanoy, E. B.; Joosten, R. E.			Infection risks of city canal swimming events in the Netherlands in 2016	PLOS ONE			English	Article							WATER-QUALITY INDICATORS; NOROVIRUS; OUTBREAK; EXPOSURE; ILLNESS	Introduction Swimming events in city canals are gaining popularity in the Netherlands, even though canal water is usually not officially designated for recreational use. Knowledge regarding the risk of infection after swimming in canals is limited. An outbreak was reported in 2015 following a canal swimming event in Utrecht, the Netherlands. Local governments were concerned about the health risks of such events. In order to assess the safety of canal swimming, the Public Health Service (PHS) prospectively investigated two city canal swimming events in 2015. In 2016, we repeated this study, aiming to prospectively determine the risks of infection during two urban swimming events, the Utrecht SingelSwim 2016 (USS) and the Amsterdam City Swim 2016 (ACS). Methods We sent online questionnaires to 271 USS participants and 2697 ACS participants, concerning personal characteristics, symptoms, and exposure. Participants were asked to forward the questionnaire to three relatives, i.e., non-exposed. We analyzed water samples from the USS venue taken during the event, as well as stool samples of USS participants with acute gastrointestinal illness (AGI). AGI was defined as diarrhea and/or vomiting within seven days after the event. We calculated adjusted risk ratios (RR) for AGI in the exposed group compared with non-exposed respondents, using binomial regression models. Results The questionnaire was returned by 160 USS participants (exposed) (59%) and 40 non-exposed relatives. Five percent of the exposed (n = 17) and 3% of non-exposed (n =1) reported AGI (RR = 1.69; 95% CI: 0.23-12.46). Norovirus genogroup II was detected in of six USS water samples and in none of the three stool samples. In one of three stool samples, rotavirus was detected. The questionnaire was returned by 1169 ACS participants (exposed) (43%) and 410 non-exposed relatives. Six percent of the exposed (n = 71) and 1% of non-exposed (n = 5) reported AGI (RR 4.86; 95% CI: 1.98-11.97). Conclusion Results of the ACS event showed a higher risk for AGI among the exposed, indicating that participants of events in urban canals in the Netherlands could be at a higher risk for AGI than those not participating. The inconclusive results from the USS are likely due to the small sample size. Swimming in non-monitored open water can bring health risks and more knowledge about environmental and human risk factors helps reduce the risk by being able to more specifically advise organizations and governments.	[Hintaran, A. D.; Brandwagt, D.; Fanoy, E. B.; Joosten, R. E.] Publ Hlth Serv Utrecht Reg, Zeist, Netherlands; [Kliffen, S. J.; Siedenburg, E.; Sonder, G. J. B.] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Kliffen, S. J.; Joosten, R. E.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Preparedness & Response Unit, Bilthoven, Netherlands; [Lodder, W.; Pijnacker, R.; Brandwagt, D.; Fanoy, E. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control Epidemiol & Surveillance, Bilthoven, Netherlands; [van der Bij, A. K.] Diakonessen Hosp, Dept Med Microbiol & Immunol, Utrecht, Netherlands; [Sonder, G. J. B.] Univ Amsterdam, AMC, Div Infect Dis, Dept Internal Med, Amsterdam, Netherlands; [Fanoy, E. B.] Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands	Public Health Service Amsterdam; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Diakonessenhuis; University of Amsterdam; Academic Medical Center Amsterdam	Hintaran, AD (corresponding author), Publ Hlth Serv Utrecht Reg, Zeist, Netherlands.	phintaran@ggdru.nl	fanoy, Eb/ABE-8382-2020					Arnold BF, 2013, EPIDEMIOLOGY, V24, P845, DOI 10.1097/01.ede.0000434431.06765.4a; CABELLI VJ, 1982, AM J EPIDEMIOL, V115, P606, DOI 10.1093/oxfordjournals.aje.a113342; CABELLI VJ, 1979, AM J PUBLIC HEALTH, V69, P690, DOI 10.2105/AJPH.69.7.690; Colford JM, 2007, EPIDEMIOLOGY, V18, P27, DOI 10.1097/01.ede.0000249425.32990.b9; Dorevitch S, 2012, WATER RES, V46, P4961, DOI 10.1016/j.watres.2012.06.030; European Centre for Disease Prevention and Control, 2016, SYST REV INC INF SHE; Fewtrell Lorna, 2015, Curr Environ Health Rep, V2, P85, DOI 10.1007/s40572-014-0036-6; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Haile RW, 1999, EPIDEMIOLOGY, V10, P355, DOI 10.1097/00001648-199907000-00004; Hall V, 2017, EPIDEMIOL INFECT, V145, P1246, DOI 10.1017/S0950268816003393; Harder-Lauridsen NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078371; International Organization for Standardization, 1998, 78991 ISO; International Organization for Standardization, 1998, 930831998 ISO; International Organization for Standardization, 2000, 789922000 ISO; ISO, 2014, 930812014 ISO; Joosten R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174732; KWR Watercycle Research Institute, 2006, CONTR ZWEMW CONF EUR; Lee RM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-446; Magill-Collins A, 2015, WILD ENVIRON MED, V26, P312, DOI 10.1016/j.wem.2015.02.007; Marion JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112029; Parker S, 2019, EPIDEMIOL PSYCH SCI, V28, P408, DOI [10.1017/S2045796017000749, 10.1017/S0950268817001017]; Pruss A, 1998, INT J EPIDEMIOL, V27, P1, DOI 10.1093/ije/27.1.1; Sartorius B, 2007, SCAND J INFECT DIS, V39, P323, DOI 10.1080/00365540601053006; Schets FM, 2011, EPIDEMIOL INFECT, V139, P1114, DOI 10.1017/S0950268810002347; Schets FM van Wijnen J. H, 2007, MICROBIOLOGICAL QUAL; Schets Franciska M, 2014, Ned Tijdschr Geneeskd, V158, pA7969; Schuurman T, 2007, J CLIN MICROBIOL, V45, P3692, DOI 10.1128/JCM.00896-07; StataCorp, 2013, STATA STAT SOFTW REL; Stuurgroep Water, 2013, BESL WERKW IND MET M; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Verhaelen K, 2012, INT J FOOD MICROBIOL, V160, P137, DOI 10.1016/j.ijfoodmicro.2012.10.008; Zlot A, 2015, MMWR-MORBID MORTAL W, V64, P485	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200616	10.1371/journal.pone.0200616	http://dx.doi.org/10.1371/journal.pone.0200616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052633	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600010
J	Jackson, Y; Paignon, A; Wolff, H; Delicado, N				Jackson, Yves; Paignon, Adeline; Wolff, Hans; Delicado, Noelia			Health of undocumented migrants in primary care in Switzerland	PLOS ONE			English	Article							MENTAL-HEALTH; EUROPEAN-UNION; DISEASES; ACCESS; NETHERLANDS; IMMIGRANTS; COUNTRY; BURDEN	Background Undocumented migrants endure adverse living conditions while facing barriers to access healthcare. Evidence is lacking regarding their healthcare needs, notably in regards to chronic diseases. Our goal was to investigate health conditions in undocumented migrants attended in primary care setting. Methods This study was conducted at the primary care outpatient clinic, Geneva University Hospitals, Switzerland. We retrospectively recorded and coded all medical conditions of a random sample of 731 undocumented migrants using the International Classification of Primary Care, 2nd version (ICPC-2). We dichotomized conditions as chronic or non-chronic and considered multimorbidity in the presence of three or more chronic conditions. Results Participants originated from 72 countries and were mainly female (65.5%) with a mean age of 42.4 (standard deviation [SD]: 11.4) years. They presented a mean of 2.9 (SD: 2.1; range: 1-17) health conditions. In multivariable analysis, the number of conditions was associated with female gender (p = 0.011) and older age (p <0.001), but not with origin (p = 0.373). The body systems most frequently affected were endocrine, metabolic and nutritional (n = 386; 18.4%), musculoskeletal (n = 308, 14.7%) and digestive (n = 266, 12.8%). Hypertension (17.9%; 95% CI: 15.2%, 29.9%), obesity or overweight (16%; 95% CI: 13.4%, 18.9%) and gastric problems (14.1%; 95% CI: 11.6%, 16.8%) were most prevalent. Overall, 71.8% (95% CI: 68.5%, 75%) participants had at least one chronic condition while 20% (95% CI: 17.2%, 23.1%) had three or more. In multivariable analysis, age (p <0.001) was the only predictor of presenting at least one or three or more chronic conditions. Conclusions Undocumented migrants present multiple health problems in primary care settings and bear an important burden of chronic diseases. The extent of multimorbidity highlights the need to provide and facilitate the access to comprehensive and long-term primary healthcare services.	[Jackson, Yves] Geneva Univ Hosp, Div Primary Care Med, Geneva, Switzerland; [Jackson, Yves] Univ Geneva, Global Hlth Inst, Geneva, Switzerland; [Paignon, Adeline; Delicado, Noelia] HES SO Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci, Geneva, Switzerland; [Wolff, Hans] Univ Geneva, Univ Hosp Geneva, Div Prison Hlth, Geneva, Switzerland; [Wolff, Hans] Univ Geneva, Fac Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Applied Sciences & Arts Western Switzerland; University of Geneva; University of Geneva	Jackson, Y (corresponding author), Geneva Univ Hosp, Div Primary Care Med, Geneva, Switzerland.; Jackson, Y (corresponding author), Univ Geneva, Global Hlth Inst, Geneva, Switzerland.	yves.jackson@hcuge.ch	Wolff, Hans/F-2122-2015	Wolff, Hans/0000-0002-4978-2176; Delicado, Noelia/0000-0002-3938-3403; Paignon, Adeline/0000-0003-0634-8334				Bilger V., 2011, HLTH CARE UNDOCUMENT; Bischoff A, 2009, EUR J PUBLIC HEALTH, V19, P59, DOI 10.1093/eurpub/ckn113; Bodenmann P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-34; Bozorgmehr K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131483; Casillas A, 2015, J IMMIGR MINOR HEALT, V17, P527, DOI 10.1007/s10903-013-9939-9; Chauvin P., 2009, ACCESS HEALTHCARE UN; De Vito E, 2016, PUBLIC HLTH ASPECTS; Deblonde J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2571-y; Deruaz-Luyet A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013664; Doctors of the World, 2013, ACC HEALTHC EUR TIM; Fiorini G, 2016, PUBLIC HEALTH, V141, P26, DOI 10.1016/j.puhe.2016.08.009; Ingelby D, 2016, RECOMMENDATIONS ACCE; International Organization of Migration (IOM), 2016, GLOB MIGR TRENDS FAC; Jackson Y, 2011, EURO SURVEILL, V16; Jackson Y, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1801-z; Jackson Y, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0136-7; Jackson Y, 2012, TROP MED INT HEALTH, V17, P595, DOI 10.1111/j.1365-3156.2012.02965.x; Jackson Y, 2010, J IMMIGR MINOR HEALT, V12, P909, DOI 10.1007/s10903-010-9354-4; Kaoutar B, 2014, REV MED INTERNE, V35, P709, DOI 10.1016/j.revmed.2014.05.013; Kuehne A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2268-2; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Martin Y, 2014, PREV MED, V59, P19, DOI 10.1016/j.ypmed.2013.11.006; Mipatrini D, 2017, EUR J PUBLIC HEALTH, V27, P459, DOI 10.1093/eurpub/ckx039; Morlok M, 2015, SANS PAPIERS SUISSE; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Myhrvold T, 2017, J CLIN NURS, V26, P825, DOI 10.1111/jocn.13670; N'Goran AA, 2016, FAM PRACT, V33, P439, DOI 10.1093/fampra/cmw030; O'Donnell CA, 2016, HEALTH POLICY, V120, P495, DOI 10.1016/j.healthpol.2016.03.012; Okkes IM, 2002, FAM PRACT, V19, P543, DOI 10.1093/fampra/19.5.543; Pfortmueller CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082671; Poduval S, 2015, INT J HEALTH SERV, V45, P320, DOI 10.1177/0020731414568511; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Sebo P, 2011, J IMMIGR MINOR HEALT, V13, P510, DOI 10.1007/s10903-010-9367-z; Teunisen E, 2015, SCAND J PRIM HEALTH, V33, P82, DOI 10.3109/02813432.2015.1041830; van de Sande JSO, 2017, FAM PRACT, V34, P649, DOI 10.1093/fampra/cmx032; Vandenheede H, 2012, EUR J EPIDEMIOL, V27, P109, DOI 10.1007/s10654-011-9638-6; Vogel D, 2011, INT MIGR, V49, P78, DOI 10.1111/j.1468-2435.2011.00700.x; Wahlberg A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24464; Wolff H, 2005, SOC SCI MED, V60, P2149, DOI 10.1016/j.socscimed.2004.12.007; Wolff H, BMC PUBLIC HLTH; Wolff H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-245; Woodward A, 2014, HEALTH POLICY PLANN, V29, P818, DOI [10.1093/heapol/czt061, DOI 10.1093/heapol/czt061]; World Health Organization, 2017, DEF REG GROUP	44	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201313	10.1371/journal.pone.0201313	http://dx.doi.org/10.1371/journal.pone.0201313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052674	gold, Green Submitted, Green Published			2022-12-27	WOS:000440006600037
J	Jiang, MH; Leung, NH; Ip, M; You, JHS				Jiang, Minghuan; Leung, Nok-Hang; Ip, Margaret; You, Joyce H. S.			Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection	PLOS ONE			English	Article							VANCOMYCIN; GUIDELINES; MORTALITY; DISEASE; CARE; PCR; METRONIDAZOLE; DIARRHEA; ROUTE	Background Clostridium difficile infection (CDI) caused by ribotype 002 strain is associated with poor outcomes in Chinese patients. Fecal microbiota transplantation (FMT) is an effective but costly treatment for CDI. We aimed to examine potential cost-effectiveness of ribotype-guided FMT in Chinese patients with severe CDI. Methods A decision-analytic model was designed to simulate outcomes of ribotype 002-guided FMT versus vancomycin treatment in Chinese patients with severe CDI in the hospital setting. Outcome measures included mortality rate; direct medical cost; and quality-adjusted life year (QALY) loss for CDI. Sensitivity analysis was performed to examine robustness of base-case results. Results Comparing to vancomycin treatment, ribotype-guided FMT group reduced mortality (11.6% versus 17.1%), cost (USD8,807 versus USD9,790), and saved 0.472 QALYs in base-case analysis. One-way sensitivity analysis found the ribotype-guided FMT group to remain cost-effective when patient acceptance rate of FMT was >0.6% and ribotype 002 prevalence was >0.07%. In probabilistic sensitivity analysis, ribotype-guided FMT gained higher QALYs at 100% of simulations with mean QALY gain of 0.405 QALYs (95% CI: 0.400-0.410; p<0.001). The ribotype-guided group was less costly in 97.9% of time, and mean cost-saving was USA679 (95% CI: 670 - 688;p<0.001). Conclusions In the present model, ribotype-guided FMT appears to be a potential option to save QALYs and cost when comparing with vancomycin. The cost-effectiveness of ribotype-guided FMT is subject to the patient acceptance to FMT and prevalence of ribotype 002.	[Jiang, Minghuan] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Shaanxi, Peoples R China; [Jiang, Minghuan] Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Shaanxi, Peoples R China; [Jiang, Minghuan] Xi An Jiao Tong Univ, Global Hlth Inst, Xian, Shaanxi, Peoples R China; [Jiang, Minghuan] Shaanxi Ctr Hlth Reform & Dev Res, Xian, Shaanxi, Peoples R China; [Leung, Nok-Hang; You, Joyce H. S.] Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China; [Ip, Margaret] Chinese Univ Hong Kong, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Chinese University of Hong Kong; Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	Ip, Margaret/K-1096-2013; You, Joyce H. S./C-2984-2008	Ip, Margaret/0000-0003-1291-6537; You, Joyce H. S./0000-0002-5763-7403				Aitken SL, 2015, INFECT CONT HOSP EP, V36, P1318, DOI 10.1017/ice.2015.187; Barbieri M, 2010, VALUE HEALTH, V13, P1028, DOI 10.1111/j.1524-4733.2010.00771.x; Baro E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170258; Bidet P, 2000, J CLIN MICROBIOL, V38, P2484, DOI 10.1128/JCM.38.7.2484-2487.2000; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Census and Statistics Department Hong Kong SAR, HONG KONG LIF TABL 2; Census and Statistics Department The Government of Hong Kong SAR, NAT INC; Cheng VCC, 2011, EUR J CLIN MICROBIOL, V30, P1371, DOI 10.1007/s10096-011-1231-0; Drekonja D, 2015, ANN INTERN MED, V162, P630, DOI 10.7326/M14-2693; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Gundacker ND, 2017, J HOSP INFECT, V96, P349, DOI 10.1016/j.jhin.2017.05.004; Hocquart M, 2018, CLIN INFECT DIS, V66, P645, DOI 10.1093/cid/cix762; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Kim J, 2014, CLIN MICROBIOL INFEC, V20, P1198, DOI 10.1111/1469-0691.12704; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Lagier JC, 2015, EUR J CLIN MICROBIOL, V34, P1597, DOI 10.1007/s10096-015-2394-x; Lapointe-Shaw L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149521; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; Martinson JNV, 2015, J CLIN MICROBIOL, V53, P1192, DOI 10.1128/JCM.03591-14; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]; Merlo G, 2016, J GASTROEN HEPATOL, V31, P1927, DOI 10.1111/jgh.13402; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Rao K, 2015, CLIN INFECT DIS, V61, P233, DOI 10.1093/cid/civ254; Ridley S, 2007, ANAESTHESIA, V62, P547, DOI 10.1111/j.1365-2044.2007.04997.x; Shah DN, 2016, J HOSP INFECT, V93, P286, DOI 10.1016/j.jhin.2016.04.004; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Varier R U, 2014, Clin Microbiol Infect, V20, P1343, DOI 10.1111/1469-0691.12805; Varier RU, 2015, INFECT CONT HOSP EP, V36, P438, DOI 10.1017/ice.2014.80; Wang SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161174; Wong SH, 2016, J INFECTION, V73, P115, DOI 10.1016/j.jinf.2016.05.010; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; You JHS, 2009, J EPIDEMIOL COMMUN H, V63, P906, DOI 10.1136/jech.2008.081885; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763; Zipursky JS, 2012, CLIN INFECT DIS, V55, P1652, DOI 10.1093/cid/cis809	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201539	10.1371/journal.pone.0201539	http://dx.doi.org/10.1371/journal.pone.0201539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048534	Green Submitted, gold, Green Published			2022-12-27	WOS:000439952400097
J	Lee, I; Kim, D; Park, GL; Jeon, TJ; Kim, SM				Lee, Insu; Kim, Daegyu; Park, Ga-Lahm; Jeon, Tae-Joon; Kim, Sun Min			Investigation of wound healing process guided by nano-scale topographic patterns integrated within a microfluidic system	PLOS ONE			English	Article							ORGANS-ON-CHIPS; CONTACT GUIDANCE; CELL-MIGRATION; HUMAN SKIN; IN-VITRO; DECISION-MAKING; SOFT-TISSUE; REPAIR; MECHANOTRANSDUCTION; REGENERATION	When living tissues are injured, they undergo a sequential process of homeostasis, inflammation, proliferation and maturation, which is called wound healing. The working mechanism of wound healing has not been wholly understood due to its complex environments with various mechanical and chemical factors. In this study, we propose a novel in vitro wound healing model using a microfluidic system that can manipulate the topography of the wound bed. The topography of the extracellular matrix (ECM) in the wound bed is one of the most important mechanical properties for rapid and effective wound healing. We focused our work on the topographical factor which is one of crucial mechanical cues in wound healing process by using various nano-patterns on the cell attachment surface. First, we analyzed the cell morphology and dynamic cellular behaviors of NIH-3T3 fibroblasts on the nano-patterned surface. Their morphology and dynamic behaviors were investigated for relevance with regard to the recovery function. Second, we developed a highly reproducible and inexpensive research platform for wound formation and the wound healing process by combining the nano-patterned surface and a microfluidic channel. The effect of topography on wound recovery performance was analyzed. This in vitro wound healing research platform will provide well-controlled topographic cue of wound bed and contribute to the study on the fundamental mechanism of wound healing.	[Lee, Insu; Park, Ga-Lahm; Kim, Sun Min] Inha Univ, Dept Mech Engn, Incheon, South Korea; [Kim, Daegyu; Jeon, Tae-Joon] Inha Univ, Dept Biol Engn, Incheon, South Korea; [Jeon, Tae-Joon; Kim, Sun Min] Inha Univ, WCSL Integrated Human Airway On A Chip, Incheon, South Korea	Inha University; Inha University; Inha University	Kim, SM (corresponding author), Inha Univ, Dept Mech Engn, Incheon, South Korea.; Jeon, TJ (corresponding author), Inha Univ, Dept Biol Engn, Incheon, South Korea.; Jeon, TJ; Kim, SM (corresponding author), Inha Univ, WCSL Integrated Human Airway On A Chip, Incheon, South Korea.	tjjeon@inha.ac.kr; sunmk@inha.ac.kr	Kim, Sun Min/A-1208-2007; Jeon, Tae-Joon/D-4725-2013	Kim, Sun Min/0000-0001-8420-637X; Jeon, Tae-Joon/0000-0002-4882-9040	INHA UNIVERSITY	INHA UNIVERSITY	This work was supported by INHA UNIVERSITY Research Grant; http://www.inha.ac.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/18/183001; Briquez PS, 2015, ADV WOUND CARE, V4, P479, DOI 10.1089/wound.2014.0603; Chan CY, 2013, LAB CHIP, V13, P4697, DOI 10.1039/c3lc90115g; Choi S, 2013, CELLS TISSUES ORGANS, V198, P349, DOI 10.1159/000358755; DEMARCHEZ M, 1992, TRANSPLANTATION, V54, P317, DOI 10.1097/00007890-199208000-00023; Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x; Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160; Hu MS, 2014, ANN BIOMED ENG, V42, P1494, DOI 10.1007/s10439-014-1010-z; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Jarbrink K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0400-8; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038; Kreeger PK, 2018, ANNU REV BIOMED ENG, V20, P49, DOI 10.1146/annurev-bioeng-062117-121011; Latifi-Pupovci H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0676-9; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Marmaras A, 2012, SOFT MATTER, V8, P6922, DOI 10.1039/c2sm00030j; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Murrell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024283; Nie FQ, 2007, BIOMATERIALS, V28, P4017, DOI 10.1016/j.biomaterials.2007.05.037; Paul CD, 2016, FASEB J, V30, P2161, DOI 10.1096/fj.201500199R; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Ray A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14923; Saito AC, 2014, EXP CELL RES, V327, P1, DOI 10.1016/j.yexcr.2014.05.002; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Silver FH, 2003, SKIN RES TECHNOL, V9, P3, DOI 10.1034/j.1600-0846.2003.00358.x; Stamm A., 2016, BIONANOMATERIALS, V17, P79, DOI [10.1515/bnm-2016-0002, DOI 10.1515/BNM-2016-0002]; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Sutherland J, 2005, J ANAT, V206, P581, DOI 10.1111/j.1469-7580.2005.00415.x; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Ud-Din S, 2017, WOUND REPAIR REGEN, V25, P164, DOI 10.1111/wrr.12513; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212	36	10	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201418	10.1371/journal.pone.0201418	http://dx.doi.org/10.1371/journal.pone.0201418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048525	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400087
J	Luo, WT; Gao, XB; Zhang, X				Luo, Wenting; Gao, Xubo; Zhang, Xin			Geochemical processes controlling the groundwater chemistry and fluoride contamination in the Yuncheng Basin, China-An area with complex hydrogeochemical conditions	PLOS ONE			English	Article							WATER-QUALITY; AQUEOUS GEOCHEMISTRY; NALGONDA DISTRICT; SURFACE-WATER; THAR DESERT; SALT LAKE; CL-OH; F-OH; NORTHERN; ENRICHMENT	Hydrogeochemical and stable isotope analyses and geochemical modeling were carried out to identify the major geochemical processes controlling the groundwater chemistry and fluoride contamination in the aquifers of the Yuncheng Basin, China, an area with complex hydrogeochemical conditions and severe fluoride contamination of the groundwater. The major findings of this case study include the following: 1) Cation exchange and salt effects are vital controls on the enrichment of fluoride in groundwater in the area by reducing the activity of Ca2+/F- in groundwater via ion complexation. Cation exchange increased the fluoride concentration by 2.7 mg/L when the Na/Ca molar ratio increased from 0.24 to 9.0, while the salt effect led to a ca. 5-10% increase in complex F- in groundwater due to the further dissolution of fluoride-bearing minerals in the aquifers, as suggested by a model calculation. 2) Anthropogenic contamination from pesticide and fertilizer use and industrial waste discharge is also a main source of fluoride in the groundwater. 3) Evaporation and ion effects favor the enrichment of fluoride in groundwater by encouraging the removal of Ca via precipitation. 4) The desorption of fluoride from mineral/organic matter surfaces is enhanced under alkaline conditions and a high HCO3 content in groundwater.	[Luo, Wenting; Gao, Xubo; Zhang, Xin] China Univ Geosci, Sch Environm Studies, Wuhan, Hubei, Peoples R China	China University of Geosciences	Gao, XB (corresponding author), China Univ Geosci, Sch Environm Studies, Wuhan, Hubei, Peoples R China.	xubo.gao.cug@gmail.com	gao, xubo/F-2289-2010	gao, xubo/0000-0003-2458-3063	National Natural Science Foundation of China [41521001, 41372251]; Natural Science Foundation of Hubei Province of China [2013CFB410]; Specialized Research Fund for the Doctoral Program of Higher Education [20130145120014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funded by "National Natural Science Foundation of China (41521001)-YW. National Natural Science Foundation of China (41372251)-XG. Natural Science Foundation of Hubei Province of China (2013CFB410)-XG Specialized Research Fund for the Doctoral Program of Higher Education, 20130145120014, XG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE HJ, 1987, CONTRIB MINERAL PETR, V97, P305, DOI 10.1007/BF00371994; Adams S, 2011, J HYDROL, V241, P91; Alagumuthu G., 2010, ARCH APPL SCI RES, V2, P170; Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; Apambire WB, 1997, ENVIRON GEOL, V33, P13, DOI 10.1007/s002540050221; BACK W, 1983, GEOL SOC AM BULL, V94, P1415, DOI 10.1130/0016-7606(1983)94<1415:PARODM>2.0.CO;2; Banerjee A, 2015, GEOSCI FRONT, V6, P277, DOI 10.1016/j.gsf.2014.03.003; BARNES CJ, 1988, J HYDROL, V100, P143, DOI 10.1016/0022-1694(88)90184-9; Berger T, 2016, SCI TOTAL ENVIRON, V569, P948, DOI 10.1016/j.scitotenv.2016.06.002; BISCHOFF JL, 1994, GEOLOGY, V22, P995, DOI 10.1130/0091-7613(1994)022<0995:KWCABD>2.3.CO;2; Boujelben N, 2008, J HAZARD MATER, V151, P103, DOI 10.1016/j.jhazmat.2007.05.057; Brahman KD, 2014, CHEMOSPHERE, V100, P182, DOI 10.1016/j.chemosphere.2013.11.035; Brahman KD, 2013, WATER RES, V47, P1005, DOI 10.1016/j.watres.2012.10.042; Brindha K, 2016, ENVIRON SCI POLLUT R, V23, P8302, DOI 10.1007/s11356-016-6069-7; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Carillo-Rivera J.J., 2002, MEXICO J HYDRO, V261, P24; Chae GT, 2007, SCI TOTAL ENVIRON, V385, P272, DOI 10.1016/j.scitotenv.2007.06.038; Chae GT, 2006, GEOCHEM J, V40, P95, DOI 10.2343/geochemj.40.95; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P519, DOI 10.1107/S0021889874010375; COLEMAN ML, 1982, ANAL CHEM, V54, P993, DOI 10.1021/ac00243a035; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; Cronin SJ, 2000, NEW ZEAL J AGR RES, V43, P295, DOI 10.1080/00288233.2000.9513430; Currell M, 2011, APPL GEOCHEM, V26, P540, DOI 10.1016/j.apgeochem.2011.01.012; Currell MJ, 2012, HYDROL PROCESS, V26, P4050, DOI 10.1002/hyp.9208; Currell MJ, 2010, J HYDROL, V385, P216, DOI 10.1016/j.jhydrol.2010.02.022; Datta PS, 1996, J CONTAM HYDROL, V24, P85, DOI 10.1016/0169-7722(96)00004-6; Dissanayake C. B., 1991, International Journal of Environmental Studies, V38, P137, DOI 10.1080/00207239108710658; Domenico P.A., 1998, PHYS CHEM HYDROGEOLO, V506; Dreybrodt W, 2014, GEOCHIM COSMOCHIM AC, V125, P433, DOI 10.1016/j.gca.2013.10.004; Edmunds WM, 2001, ESSENTIALS MED GEOLO, P311; El-Said GF, 2016, ENVIRON SCI POLLUT R, V23, P14240, DOI 10.1007/s11356-016-6552-1; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Farooqi A, 2007, ENVIRON POLLUT, V145, P839, DOI 10.1016/j.envpol.2006.05.007; Farooqi A, 2009, ARCH ENVIRON CON TOX, V56, P693, DOI 10.1007/s00244-008-9239-x; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Gao XB, 2007, ENVIRON GEOL, V53, P795, DOI 10.1007/s00254-007-0692-z; Gao XB, 2016, SCI TOTAL ENVIRON, V545, P1, DOI 10.1016/j.scitotenv.2015.09.109; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; Hallett BM, 2015, J HYDROL-REG STUD, V4, P111, DOI 10.1016/j.ejrh.2014.10.003; Handa B.K., 1975, GROUNDWATER, V13, P275, DOI [DOI 10.1111/J.1745-6584.1975.TB03086.X, 10.1111/j.1745-6584.1975.tb03086.x]; HEATON THE, 1984, J HYDROL, V67, P249, DOI 10.1016/0022-1694(84)90244-0; Heikens A, 2005, SCI TOTAL ENVIRON, V346, P56, DOI 10.1016/j.scitotenv.2004.12.007; Jacks G, 2005, APPL GEOCHEM, V20, P221, DOI 10.1016/j.apgeochem.2004.07.002; Jia YQ, 2000, J YUNCHENG ADV TRAIN, V3, P12; JONES BF, 1977, GEOCHIM COSMOCHIM AC, V41, P53, DOI 10.1016/0016-7037(77)90186-7; Kim K, 2005, HYDROL PROCESS, V19, P493, DOI 10.1002/hyp.5551; KLUMPP A, 1994, ENVIRON POLLUT, V85, P109, DOI 10.1016/0269-7491(94)90244-5; Kumar M, 2016, CHEMOSPHERE, V150, P227, DOI 10.1016/j.chemosphere.2016.02.019; Li CC, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5260-y; Li CC, 2015, SCI TOTAL ENVIRON, V508, P155, DOI 10.1016/j.scitotenv.2014.11.045; Li DN, 2018, ENVIRON POLLUT, V237, P430, DOI 10.1016/j.envpol.2018.02.072; Li Y, 2015, J ENVIRON SCI-CHINA, V31, P21, DOI 10.1016/j.jes.2014.10.016; Machender G, 2014, ENVIRON EARTH SCI, V72, P4017, DOI 10.1007/s12665-014-3291-9; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Moore RB, 2004, 20045093 US GEOL SUR, P30; MUNOZ JL, 1984, REV MINERAL, V13, P469; NANYARO JT, 1984, J AFR EARTH SCI, V2, P129, DOI 10.1016/S0731-7247(84)80007-5; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Olaka LA, 2016, SCI TOTAL ENVIRON, V545, P641, DOI 10.1016/j.scitotenv.2015.11.161; Ozsvath DL, 2006, ENVIRON GEOL, V50, P132, DOI 10.1007/s00254-006-0192-6; Pathak RP, 2012, INT J ENG SCI, V1, P44; Rafique T, 2015, SCI TOTAL ENVIRON, V530, P271, DOI 10.1016/j.scitotenv.2015.05.038; RAO NVR, 1993, ENVIRON GEOL, V21, P84; Ravichandran B, 2012, INT J ENVIRON POLLUT, V49, P55, DOI 10.1504/IJEP.2012.049774; Reyes-Gomez VM, 2015, ARCH ENVIRON CON TOX, V68, P292, DOI 10.1007/s00244-014-0082-y; ROBINSON GR, 2003, GEN LITHOLOGY LITHOG; Rosi M, 2003, VOLCANOES, P335; Samal AC, 2015, ENVIRON SCI POLLUT R, V22, P6220, DOI 10.1007/s11356-014-3817-4; Saxena VK, 2001, ENVIRON GEOL, V40, P1084, DOI 10.1007/s002540100290; SCHOEMAN JJ, 1987, WATER SA, V13, P229; Sharma R, 2010, PLOS ONE, V5; Singh CK, 2015, ENVIRON SCI POLLUT R, V22, P2668, DOI 10.1007/s11356-014-3504-5; Singh CK, 2013, HYDROL PROCESS, V27, P2462, DOI 10.1002/hyp.9247; Stormer JC, 1970, AM MINERAL, V55, P126; Su CL, 2013, J GEOCHEM EXPLOR, V135, P79, DOI 10.1016/j.gexplo.2012.09.003; Susheela AK, 1999, CURR SCI INDIA, V77, P1250; Taylor RP, 1997, TERRA NOVA, V9, P105; Temminghoff EJM, 1997, ENVIRON SCI TECHNOL, V31, P1109, DOI 10.1021/es9606236; Voigt M, 2016, CHEM GEOL, V430, P70, DOI 10.1016/j.chemgeo.2016.03.012; Wallin B, 2015, COMPILATION REV 87SR; Wang YX, 2009, APPL GEOCHEM, V24, P641, DOI 10.1016/j.apgeochem.2008.12.015; Yang CX, 1989, LATE CENOZOIC STRATA; Yin XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125369; Zabala ME, 2016, J HYDROL, V541, P1067, DOI [10.1016/j.jhydrol.2016.08,023, 10.1016/j.jhydrol.2016.08.023]; Zhang J, 1998, GEOLOGICAL J CHINA U, V4, P140; Zhang Jian-jie, 2016, Yingyong Shengtai Xuebao, V27, P207; ZHU C, 1991, GEOCHIM COSMOCHIM AC, V55, P1837, DOI 10.1016/0016-7037(91)90028-4	87	67	71	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0199082	10.1371/journal.pone.0199082	http://dx.doi.org/10.1371/journal.pone.0199082			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048448	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400003
J	Sood, A; Suryaprasad, A; Trickey, A; Kanchi, S; Midha, V; Foster, MA; Bennett, E; Kamili, S; Alvarez-Bognar, F; Shadaker, S; Surlikar, V; Garg, R; Mittal, P; Sharma, S; May, MT; Vickerman, P; Averhoff, F				Sood, Ajit; Suryaprasad, A.; Trickey, A.; Kanchi, S.; Midha, V.; Foster, M. A.; Bennett, E.; Kamili, S.; Alvarez-Bognar, F.; Shadaker, S.; Surlikar, V.; Garg, R.; Mittal, P.; Sharma, S.; May, M. T.; Vickerman, P.; Averhoff, F.			The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NORTHERN INDIA; GLOBAL EPIDEMIOLOGY; NATURAL-HISTORY; PREVALENCE; SURVEILLANCE; GENOTYPE; DISEASE; COHORT	Introduction Hepatitis C virus (HCV) infection prevalence is believed to be elevated in Punjab, India; however, state-wide prevalence data are not available. An understanding of HCV prevalence, risk factors and genotype distribution can be used to plan control measures in Punjab.\ Methods A cross-sectional, state-wide, population-based serosurvey using a multi-stage stratified cluster sampling design was conducted October 2013 to April 2014. Children aged >= 5 years and adults were eligible to participate. Demographic and risk behavior data were collected, and serologic specimens were obtained and tested for anti-HCV antibody, HCV Ribonucleic acid (RNA) on anti-HCV positive samples, and HCV genotype. Prevalence estimates and adjusted odds ratios for risk factors were calculated from weighted data and stratified by urban/rural residence. Results 5,543 individuals participated in the study with an overall weighted anti-HCV prevalence of 3.6% (95% Confidence Interval [ CI]: 3.0%-4.2%) and chronic infection (HCV Ribonucleic acid test positive) of 2.6% (95% CI: 2.0%-3.1%). Anti-HCV was associated with being male (adjusted odds ratio 1.52; 95% CI: 1.08-2.14), living in a rural area (adjusted odds ratio 2.53; 95% CI: 1.62-3.95) and was most strongly associated with those aged 40-49 (adjusted odds ratio 40-49 vs. 19-29-year-olds 3.41; 95% CI: 1.90-6.11). Anti-HCV prevalence increased with each blood transfusion received (adjusted odds ratio 1.36; 95% CI: 1.10-1.68) and decreased with increasing education, (adjusted odds ratio 0.37 for graduate-level vs. primary school/no education; 95% CI: 0.16-0.82). Genotype 3 (58%) was most common among infected individuals. Discussion The study findings, including the overall prevalence of chronic HCV infection, associated risk factors and demographic characteristics, and genotype distribution can guide prevention and control efforts, including treatment provision. In addition to high-risk populations, efforts targeting rural areas and adults aged >= 40 would be the most effective for identifying infected individuals.	[Sood, Ajit; Midha, V.] Dayanand Med Coll, Ludhiana, Punjab, India; [Suryaprasad, A.; Foster, M. A.; Bennett, E.; Kamili, S.; Averhoff, F.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Trickey, A.; May, M. T.; Vickerman, P.] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Kanchi, S.; Surlikar, V.] MSD India Pvt Ltd, Bombay, Maharashtra, India; [Alvarez-Bognar, F.] Merck & Co Inc, Kenilworth, NJ USA; [Shadaker, S.] CDC Fdn, Atlanta, GA USA; [Garg, R.] Guru Gobind Singh Med Coll & Hosp, Faridkot, Punjab, India; [Mittal, P.] Mittal Liver & Gastroenterol Ctr, Patiala, Punjab, India; [Sharma, S.] All India Inst Med Sci, Coll Nursing, Rishikesh, Uttarakhand, India	Dayanand Medical College & Hospital; Centers for Disease Control & Prevention - USA; University of Bristol; Merck & Company; All India Institute of Medical Sciences (AIIMS) Rishikesh	Trickey, A (corresponding author), Univ Bristol, Populat Hlth Sci, Bristol, Avon, England.	adam.trickey@bristol.ac.uk	Sharma, Suresh K/T-1696-2019	Vickerman, Peter/0000-0002-8291-5890; Trickey, Adam/0000-0003-3462-2898; Sharma, Suresh/0000-0003-1214-8865	Merck Sharp & Dohme (MSD) Pharmaceuticals India Private Limited, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA; Merck	Merck Sharp & Dohme (MSD) Pharmaceuticals India Private Limited, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA; Merck(Merck & Company)	This population survey was sponsored by Merck Sharp & Dohme (MSD) Pharmaceuticals India Private Limited, a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA. S Kanchi, F Alvarez-Bognar, and V Surlikar are, or have been, employees of Merck. The specific roles of these authors are articulated in the "author contributions" section. Ajit Sood has also received funding from Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoramoorthy G, 2017, DIGEST DIS SCI, V62, P550, DOI 10.1007/s10620-016-4436-3; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Ara A Kardashian, 2015, Gastroenterol Hepatol (N Y), V11, P458; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Balogun MA, 2002, J INFECTION, V45, P219, DOI 10.1053/jinf.2002.1059; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Dhiman RK, 2016, J CLIN EXP HEPATOL, V6, P224, DOI 10.1016/j.jceh.2016.09.005; Duseja A, 2002, Trop Gastroenterol, V23, P125; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Iles JC, 2013, INFECT GENET EVOL, V19, P386, DOI 10.1016/j.meegid.2013.01.021; Jindal N, 2008, JPN J INFECT DIS, V61, P79; Kumar T, 2015, MMWR-MORBID MORTAL W, V64, P758, DOI 10.15585/mmwr.mm6428a3; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Mahajan R, 2017, J GASTROEN HEPATOL, DOI [10.1111/jgh, DOI 10.1111/JGH]; Minhas Sukhmeet, 2011, Med J Armed Forces India, V67, P7, DOI 10.1016/S0377-1237(11)80003-1; Munjal A, 2015, J VIRAL HEPATITIS, V22, P28, DOI 10.1111/jvh.17_12425; Nadeem Ahmad, 2009, Pravara Medical Review, V4, P4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NANDI J, 1994, VOX SANG, V67, P406, DOI 10.1111/j.1423-0410.1994.tb01284.x; Nave RL, 2013, ANN EMERG MED, V62, p19A, DOI 10.1016/j.annemergmed.2013.10.013; Panda S, 2014, INT J STD AIDS, V25, P596, DOI 10.1177/0956462413515659; Petruzziello Arnolfo, 2018, Open Virol J, V12, P26, DOI 10.2174/1874357901812010026; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rajasekaran M, 2003, PUBLIC HEALTH, V117, P208, DOI 10.1016/S0033-3506(03)00065-9; Rehan HS, 2011, SAUDI J GASTROENTERO, V17, P241, DOI 10.4103/1319-3767.82576; Schietroma Ivan, 2018, Open Virol J, V12, P16, DOI 10.2174/1874357901812010016; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Singh Paramdeep, 2014, J Nat Sci Biol Med, V5, P56, DOI 10.4103/0976-9668.127288; Singh S, 2010, AIP CONF PROC, V1276, P37, DOI 10.1063/1.3504330; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sood A, 2002, Trop Gastroenterol, V23, P198; Sood A, 2017, J GASTROEN HEPATOL, V32, P894, DOI 10.1111/jgh.13628; Sood A, 2012, INDIAN J GASTROENTER, V31, P232, DOI 10.1007/s12664-012-0251-8; Strickland GT, 2010, J VIRAL HEPATITIS, V17, P305, DOI 10.1111/j.1365-2893.2010.01285.x; The Indian Express, 2017, WORLD HEP DAY PUNJ S; Wait S, 2016, LANCET GASTROENTEROL, V1, P248, DOI 10.1016/S2468-1253(16)30031-0; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; World Health Organization, 2016, COMB HEP B C REACH E	39	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200461	10.1371/journal.pone.0200461	http://dx.doi.org/10.1371/journal.pone.0200461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048454	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400008
J	Clahsen, H; Paulmann, S; Budd, MJ; Barry, C				Clahsen, Harald; Paulmann, Silke; Budd, Mary-Jane; Barry, Christopher			Morphological encoding beyond slots and fillers: An ERP study of comparative formation in English	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; LANGUAGE PRODUCTION; WORD PRODUCTION; PAST-TENSE; ELECTROPHYSIOLOGICAL EVIDENCE; COGNITIVE CONTROL; SINGLE WORD; TIME-COURSE; ADJECTIVES	One important organizational property of morphology is competition. Different means of expression are in conflict with each other for encoding the same grammatical function. In the current study, we examined the nature of this control mechanism by testing the formation of comparative adjectives in English during language production. Event-related brain potentials (ERPs) were recorded during cued silent production, the first study of this kind for comparative adjective formation. We specifically examined the ERP correlates of producing synthetic relative to analytic comparatives, e.g. angriervs. more angry. A frontal, bilaterally distributed, enhanced negative-going waveform for analytic comparatives (vis-a-vis synthetic ones) emerged approximately 300ms after the (silent) production cue. We argue that this ERP effect reflects a control mechanism that constrains grammatically-based computational processes (viz. more comparative formation). We also address the possibility that this particular ERP effect may belong to a family of previously observed negativities reflecting cognitive control monitoring, rather than morphological encoding processes per se.	[Clahsen, Harald] Univ Potsdam, PRIM, Potsdam, Germany; [Paulmann, Silke; Barry, Christopher] Univ Essex, Dept Psychol, Colchester, Essex, England; [Paulmann, Silke; Barry, Christopher] Univ Essex, Ctr Brain Sci, Colchester, Essex, England; [Budd, Mary-Jane] Univ East London, Sch Psychol, London, England	University of Potsdam; University of Essex; University of Essex; University of East London	Paulmann, S (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.; Paulmann, S (corresponding author), Univ Essex, Ctr Brain Sci, Colchester, Essex, England.	paulmann@essex.ac.uk		Clahsen, Harald/0000-0002-6190-1318; Budd, Mary-Jane/0000-0002-9964-7351	Leverhulme Trust [F/00213/U]; Alexander-von-Humboldt Professorship	Leverhulme Trust(Leverhulme Trust); Alexander-von-Humboldt Professorship(Alexander von Humboldt Foundation)	This project has been supported by a grant to H.C. and C.B. from the Leverhulme Trust (F/00213/U) and an Alexander-von-Humboldt Professorship to H.C.	Abutalebi J, 2016, BILING-LANG COGN, V19, P689, DOI 10.1017/S1366728916000225; Aronoff M., 2015, P 8 DEC TOUL CLLE ER, P1; Aronoff Mark, 2016, ATTI 47 C INT SOC LI, P39; Baayen R. H., 1993, CELEX LEXICAL DATA B; Barber C., 1964, LINGUISTIC CHANGE PR; Bolte J, 2010, NEUROSCI LETT, V469, P107, DOI 10.1016/j.neulet.2009.11.054; Bosch S, 2017, BILING-LANG COGN, V20, P435, DOI 10.1017/S1366728916000055; Boyd Jeremy Kenyon, 2007, COMPARATIVELY SPEAKI; Budd MJ, 2015, DEV COGN NEUROS-NETH, V12, P51, DOI 10.1016/j.dcn.2014.11.002; Budd MJ, 2013, BRAIN LANG, V127, P345, DOI 10.1016/j.bandl.2012.12.010; Burki A, 2016, COGNITION, V146, P90, DOI 10.1016/j.cognition.2015.09.002; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dunbar E, 2016, GLOSSA-UK, V1, DOI 10.5334/gjgl.9; Elston-Guttler KE, 2005, J COGNITIVE NEUROSCI, V17, P1593, DOI 10.1162/089892905774597245; Emonds Joseph., 1976, TRANSFORMATIONAL APP; Festman J, 2016, APPL PSYCHOLINGUIST, V37, P487, DOI 10.1017/S0142716415000089; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frank M, 1972, MODERN ENGLISH PRACT; Ganushchak LY, 2008, J COGNITIVE NEUROSCI, V20, P927, DOI 10.1162/jocn.2008.20514; GATHERCOLE VC, 1985, J EXP CHILD PSYCHOL, V40, P73, DOI 10.1016/0022-0965(85)90066-9; Giraudo H, 2000, LANG COGNITIVE PROC, V15, P421, DOI 10.1080/01690960050119652; Giraudo H, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01778; Graziano-King J, 2005, J CHILD LANG, V32, P345, DOI 10.1017/S0305000904006828; Graziano-King J., 2003, ENGLISH COMPARATIVES; Guo TM, 2011, NEUROIMAGE, V56, P2300, DOI 10.1016/j.neuroimage.2011.03.049; Hilpert M, 2008, ENGL LANG LINGUIST, V12, P395, DOI 10.1017/S1360674308002694; Hirschfeld G, 2008, NEUROREPORT, V19, P1227, DOI 10.1097/WNR.0b013e328309ecd1; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Janssen DP, 2002, LANG COGNITIVE PROC, V17, P209, DOI 10.1080/01690960143000182; Jessen A, 2017, J CHILD LANG, V44, P427, DOI 10.1017/S0305000916000118; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kunter G., 2015, NETWORDS, P32; LaFave N, 2015, U PENNSYLVANIA WORKI, V21, P1; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Lavric A, 2001, CLIN NEUROPHYSIOL, V112, P1833, DOI 10.1016/S1388-2457(01)00615-0; Leminen A, 2014, BRAIN RES, V1543, P223, DOI 10.1016/j.brainres.2013.10.038; Levy Y., LANGUAGE COMPETENCE, P323; Misra M, 2012, J MEM LANG, V67, P224, DOI 10.1016/j.jml.2012.05.001; Muller O, 2006, J COGNITIVE NEUROSCI, V18, P84, DOI 10.1162/089892906775249997; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S., 1999, WORDS RULES INGREDIE; Poser W., 1992, LEXICAL MATTERS, P111; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Runnqvist E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00379; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Scliffler NO, 2006, BRAIN RES, V1112, P201, DOI 10.1016/j.brainres.2006.07.027; Sierpowska J, 2015, BRAIN LANG, V142, P54, DOI 10.1016/j.bandl.2015.01.005; Spalek K, 2013, LANG COGNITIVE PROC, V28, P597, DOI 10.1080/01690965.2012.718088; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Verhoef K, 2009, COGNITION, V110, P84, DOI 10.1016/j.cognition.2008.10.013; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199897	10.1371/journal.pone.0199897	http://dx.doi.org/10.1371/journal.pone.0199897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044825	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000439942500022
J	Cornet, L; Meunier, L; Van Vlierberghe, M; Leonard, RR; Durieu, B; Lara, Y; Misztak, A; Sirjacobs, D; Javaux, EJ; Philippe, H; Wilmotte, A; Baurain, D				Cornet, Luc; Meunier, Loic; Van Vlierberghe, Mick; Leonard, Raphael R.; Durieu, Benoit; Lara, Yannick; Misztak, Agnieszka; Sirjacobs, Damien; Javaux, Emmanuelle J.; Philippe, Herve; Wilmotte, Annick; Baurain, Denis			Consensus assessment of the contamination level of publicly available cyanobacterial genomes	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MULTIPLE SEQUENCE ALIGNMENT; BACTERIAL DIVERSITY; EVOLUTION; ORIGIN; TOOL; QUANTIFICATION; ANNOTATION; CONSISTENT; QUALITY	Publicly available genomes are crucial for phylogenetic and metagenomic studies, in which contaminating sequences can be the cause of major problems. This issue is expected to be especially important for Cyanobacteria because axenic strains are notoriously difficult to obtain and keep in culture. Yet, despite their great scientific interest, no data are currently available concerning the quality of publicly available cyanobacterial genomes. As reliably detecting contaminants is a complex task, we designed a pipeline combining six methods in a consensus strategy to assess the contamination level of 440 genome assemblies of Cyanobacteria. Two methods are based on published reference databases of ribosomal genes (SSU rRNA 16S and ribosomal proteins), one is indirectly based on a reference database of marker genes (CheckM), and three are based on complete genome analysis. Among those genome-wide methods, Kraken and DIAMOND blastx share the same reference database that we derived from Ensembl Bacteria, whereas CONCOCT does not require any reference database, instead relying on differences in DNA tetramer frequencies. Given that all the six methods appear to have their own strengths and limitations, we used the consensus of their rankings to infer that >5% of cyanobacterial genome assemblies are highly contaminated by foreign DNA (i.e., contaminants were detected by 5 or 6 methods). Our results will help researchers to check the quality of publicly available genomic data before use in their own analyses. Moreover, we argue that journals should make mandatory the submission of raw read data along with genome assemblies in order to facilitate the detection of contaminants in sequence databases.	[Cornet, Luc; Meunier, Loic; Van Vlierberghe, Mick; Leonard, Raphael R.; Misztak, Agnieszka; Sirjacobs, Damien; Baurain, Denis] Univ Liege, InBioS PhytoSYST, Eukaryot Phylogen, Liege, Belgium; [Cornet, Luc; Javaux, Emmanuelle J.] Univ Liege, UR Geol Palaeobiogeol Palaeobot Palaeopalynol, Liege, Belgium; [Leonard, Raphael R.] Univ Liege, InBioS CIP, Macromol Crystallog, Liege, Belgium; [Durieu, Benoit; Lara, Yannick; Wilmotte, Annick] Univ Liege, Ctr Prot Engn, InBioS CIP, Liege, Belgium; [Misztak, Agnieszka] Intercollegiate Fac Biotechnol UG MUG, Gdansk, Poland; [Philippe, Herve] Ctr Biodivers Theory & Modelling, Moulis, France	University of Liege; University of Liege; University of Liege; University of Liege	Baurain, D (corresponding author), Univ Liege, InBioS PhytoSYST, Eukaryot Phylogen, Liege, Belgium.	denis.baurain@uliege.be	Baurain, Denis/S-4048-2019	Baurain, Denis/0000-0003-2388-6185; Cornet, Luc/0000-0002-3420-4488; Leonard, Raphael/0000-0003-3098-8876; Wilmotte, Annick/0000-0003-3546-3489; Misztak, Agnieszka/0000-0001-5977-3532	F.R.S.-FNRS (National Fund for Scientific Research of Belgium); European Research Council Stg ELITE [FP7/308074]; BELSPO project CCAMBIO [SD/BA/03A]; BELSPO Interuniversity Attraction Pole Planet TOPERS; TULIP Laboratory of Excellence [ANR-10-LABX-41]; Republic of Poland and Belgium (Federation Wallonie-Bruxelles); F.R.S.-FNRS [2.5020.11]; University of Liege "Credit de demarrage 2012" [SFRD-12/04]; F.R.S.-FNRS "Credit de recherche 2014" [CDR J.0080.15]	F.R.S.-FNRS (National Fund for Scientific Research of Belgium)(Fonds de la Recherche Scientifique - FNRS); European Research Council Stg ELITE(European Research Council (ERC)); BELSPO project CCAMBIO; BELSPO Interuniversity Attraction Pole Planet TOPERS; TULIP Laboratory of Excellence; Republic of Poland and Belgium (Federation Wallonie-Bruxelles); F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege "Credit de demarrage 2012"; F.R.S.-FNRS "Credit de recherche 2014"(Fonds de la Recherche Scientifique - FNRS)	This work was supported by operating funds from F.R.S.-FNRS (National Fund for Scientific Research of Belgium) (AW), the European Research Council Stg ELITE FP7/308074 (EJJ), the BELSPO project CCAMBIO (SD/BA/03A) (AW), the BELSPO Interuniversity Attraction Pole Planet TOPERS (EJJ and LC), and the TULIP Laboratory of Excellence (ANR-10-LABX-41) (HP). LC, LM, MVV, RRL and BD are all FRIA (Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture) fellows of the FRS-FNRS. AW is a Research Associate of the FRS-FNRS. AM's stay in University of Liege was partially financed by a bilateral cooperation [ARTHRO-ARN: Functional genomics-based approach for the design of genetic engineering tools in the edible cyanobacterium Arthrospira. Scientific and technical cooperation between Republic of Poland and Belgium (Federation Wallonie-Bruxelles) (2014-2016)]. Computational resources were provided by the Consortium des Equipements de Calcul Intensif (CECI), funded by the F.R.S.-FNRS (2.5020.11), and through two grants to DB (University of Liege "Credit de demarrage 2012" SFRD-12/04; F.R.S.-FNRS "Credit de recherche 2014" CDR J.0080.15).	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Alvarenga DO, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00809; Andam CP, 2011, FEMS MICROBIOL REV, V35, P756, DOI 10.1111/j.1574-6976.2011.00274.x; Ballenghien M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0366-6; Ben Hania W, 2017, ENVIRON MICROBIOL, V19, P1134, DOI 10.1111/1462-2920.13639; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Brown MW, 2018, GENOME BIOL EVOL, V10, P427, DOI 10.1093/gbe/evy014; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Christie-Oleza JA, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.100; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; Darriba D, 2018, MOL BIOL EVOL, V35, P1037, DOI 10.1093/molbev/msy014; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Engene N, 2011, FOTTEA, V11, P17, DOI 10.5507/fot.2011.003; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jauffrit F, 2016, MOL BIOL EVOL, V33, P2170, DOI 10.1093/molbev/msw088; Lima ARJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01200-13; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan MA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1268-2; Khayrullina GA, 2012, CURR MED CHEM, V19, P5187, DOI 10.2174/092986712803530485; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klassen JL, 2009, J BACTERIOL, V191, P7500, DOI 10.1128/JB.01060-09; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Komarek J, 2016, EUR J PHYCOL, V51, P346, DOI 10.1080/09670262.2016.1163738; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kozlov AM, 2016, NUCLEIC ACIDS RES, V44, P5022, DOI 10.1093/nar/gkw396; Laczny CC, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0066-1; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laurin-Lemay S, 2012, CURR BIOL, V22, pR593, DOI 10.1016/j.cub.2012.06.013; Lee JZ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00061; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Lux M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1397-7; Manen JF, 2002, INT J SYST EVOL MICR, V52, P861, DOI [10.1099/ijs.0.01981-0, 10.1099/00207713-52-3-861]; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675; Mikalsen B, 2003, J BACTERIOL, V185, P2774, DOI 10.1128/JB.185.9.2774-2785.2003; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; de Alda JAGO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5937; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Paver SF, 2013, ENVIRON MICROBIOL, V15, P2489, DOI 10.1111/1462-2920.12131; Peeters K, 2012, POLAR BIOL, V35, P543, DOI 10.1007/s00300-011-1100-4; Philippe H, 2017, EUR J TAXON, V283, P1, DOI 10.5852/ejt.2017.283; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Ponce-Toledo RI, 2017, CURR BIOL, V27, P386, DOI 10.1016/j.cub.2016.11.056; Popa O, 2017, ISME J, V11, P543, DOI 10.1038/ismej.2016.116; Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Schierwater Bernd, 2009, Communicative & Integrative Biology, V2, P403; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simion P, 2017, CURR BIOL, V27, P958, DOI 10.1016/j.cub.2017.02.031; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuart RK, 2016, ISME J, V10, P1240, DOI 10.1038/ismej.2015.180; Tennessen K, 2016, ISME J, V10, P269, DOI 10.1038/ismej.2015.100; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Tooming-Klunderud A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-256; Vinh LS, 2004, MOL BIOL EVOL, V21, P1565, DOI 10.1093/molbev/msh176; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Whitton BA, 2012, ECOLOGY CYANOBACTERI, VII, P1, DOI [10.1007/978-94-007-3855-3_1, DOI 10.1007/978-94-007-3855-3_1]; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu YW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-26; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	80	23	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200323	10.1371/journal.pone.0200323	http://dx.doi.org/10.1371/journal.pone.0200323			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044797	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500042
J	Hoffmann, CJ; Milovanovic, M; Kinghorn, A; Kim, HY; Motlhaoleng, K; Martinson, NA; Variava, E				Hoffmann, Christopher J.; Milovanovic, Minja; Kinghorn, Anthony; Kim, Hae-Young; Motlhaoleng, Katlego; Martinson, Neil A.; Variava, Ebrahim			Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MIDDLE-INCOME COUNTRIES; OPTION B PLUS; ANTIRETROVIRAL THERAPY; INITIATION; IMPROVE; LINKAGE; TIME; METAANALYSIS; MOZAMBIQUE	Introduction Inefficient clinic-level delivery of HIV services is a barrier to linkage and engagement in care. We used value stream mapping to quantify time spent on each component of a clinic visit while receiving care following a hospital admission in South Africa. Methods We described time for each clinic service ("process time") and time spent waiting for that service ("lead time"). We also determined time and patient costs associated with travel to the clinic and expenditures during the clinic visits for 15 clinic visits in South Africa. Participants were selected consecutively based on timing of scheduled clinic visit from a cohort of HIV-positive patients recently discharged from inpatient hospital care. During the mapping we asked the participants to assess challenges faced at the clinic visit. We subsequently conducted in depth interviews and included themes from the care experience in this analysis. Results The 15 clinic visits occurred at five clinics; four primary care and one hospital-based specialty clinic. Nine (64%) of the participants were women, the median age was 44 years (IQR: 32-49), three of the participants had one or more clinic visit in the prior 14 days, all but one participant was on antiretroviral therapy (ART) at the time of the clinic visit (ART was stopped following the hospital visit for that participant). The median time since hospital discharge was 131 days (interquartile range; IQR: 121-183) for the observed visits. The median travel time to and from the clinic to a place of residence was 60 minutes. The median time spent at the clinic was 3.5 hours (IQR: 2.5-5.3) of which 2.9 hours was lead time and 25 minutes was process time (registration, vital signs, clinician assessment, laboratory, and check-out). The median patient cost for transport and food while at the clinic was ZAR43/USD2.8 (median monthly household income in the district was ZAR2450/USD157). Participants highlighted long queues, repeat clinic visits, and multiple queues during the visit (median of 5 queues) as challenges. Conclusions Accessing HIV care in South Africa is time consuming, complicated by multiple queues and frequent visits. A more patient-centered approach to care may decrease the burden of receiving care and improve outcomes.	[Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Hoffmann, Christopher J.; Kim, Hae-Young] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Milovanovic, Minja; Kinghorn, Anthony; Motlhaoleng, Katlego; Martinson, Neil A.] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp Complex, Dept Internal Med, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp, South Africa	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; University of Witwatersrand	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.; Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	choffmann@jhmi.edu	Variava, Ebrahim/AAO-5717-2020; Milovanovic, Minja/J-9832-2017	Variava, Ebrahim/0000-0003-2888-789X; Milovanovic, Minja/0000-0002-4654-8755; Hoffmann, Christopher/0000-0002-9422-0519	Johns Hopkins University Center for AIDS Research [P30AI094189]; Provincial Department of Health in North West; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research; Provincial Department of Health in North West; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Johns Hopkins University Center for AIDS Research (P30AI094189) through a faculty development award to Christopher J Hoffmann.; We express our appreciation to participants for agreeing to be part of the value stream mapping and for answering our questions, the Johns Hopkins University Center for AIDS Research (P30AI094189) for a Faculty Development Award, and the Provincial Department of Health in North West who approved our work in the public clinics. We also acknowledge the hard work and dedication of the study field team: Nkateko Makwarela, Hilda Mosia, and Tlhompho Gaoshebe.	Amolloh MM A, 2012, FACTORS ASS EARLY UP; Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Carter PM, 2012, ACAD EMERG MED, V19, P338, DOI 10.1111/j.1553-2712.2012.01311.x; Colebunders R, 2007, AIDS CARE, V19, P149, DOI 10.1080/09540120600762078; Cowan JF, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0249-6; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Franse CB, 2017, AIDS CARE, V29, P326, DOI 10.1080/09540121.2016.1220475; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hoffmann CJ, 2016, AIDS EDUC PREV, V28, P351, DOI 10.1521/aeap.2016.28.4.351; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Kwena ZA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19876; Layer EH, 2014, AIDS PATIENT CARE ST, V28, P483, DOI 10.1089/apc.2014.0077; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; MacKellar DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150086; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; Martin K., 2014, VALUE STREAM MAPPING; Monroe-Wise A, 2017, INT J STD AIDS, V28, P1410, DOI 10.1177/0956462417711624; Napua M, 2016, JAIDS-J ACQ IMM DEF, V72, pS181, DOI 10.1097/QAI.0000000000001061; Rother M, 2009, LEARNING SEE; Sherr K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-55; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Wagenaar BH, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31980; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wazimap, 2017, 2011 S AFR CENS DAT	28	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201032	10.1371/journal.pone.0201032	http://dx.doi.org/10.1371/journal.pone.0201032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040836	Green Submitted, Green Published, gold			2022-12-27	WOS:000439749200022
J	Junaidi, J; Kallenbach, CM; Byrne, PF; Fonte, SJ				Junaidi, Junaidi; Kallenbach, Cynthia M.; Byrne, Patrick F.; Fonte, Steven J.			Root traits and root biomass allocation impact how wheat genotypes respond to organic amendments and earthworms	PLOS ONE			English	Article							MICROBIAL BIOMASS; SOIL CARBON; NITROGEN AVAILABILITY; PLANT DOMESTICATION; CROP PLANTS; SYSTEMS; GROWTH; COMMUNITIES; BACTERIAL; NUTRIENT	Plant-soil biological interactions are increasingly recognized as a key feature of agroecosystems, promoting both crop and soil health. However, the effectiveness of plant-soil synergies is likely modulated by both root system characteristics and soil management impacts on soil biological communities. To successfully manage for plant-soil interactions, we need to better understand how crops respond to changes in soil management, especially in terms of belowground investment. Specifically, crop genotypes that exhibit reduced plasticity in root growth and investment may not be able to take full advantage of changes in soil biological activity associated with soil health promoting practices. We hypothesized that genotypes with greater belowground investment respond more, in terms of plant growth and crop nitrogen (N) uptake, to compost and earthworm additions, agronomic factors commonly associated with soil health. We evaluated four spring wheat (Triticum aestivum) genotypes with distinct breeding and environmental histories, and one progenitor of wheat (Aegilops tauschii) under low soil fertility conditions in the greenhouse for differences in belowground root biomass and architecture. We then determined how these below-ground traits influenced genotype response to additions of compost and earthworms. Measurements included plant growth, biomass, grain yield, root characteristics, plant N uptake, and soil N. Overall, in unamended soils, genotypes differed in above and below-ground phenotypic traits. In general, Ae. tauschii had three times greater root: shoot (R:S) ratio, root length, and root biomass relative to wheat genotypes. We found that genotypes with higher R:S ratios responded more positively to compost additions compared to those with lower R:S ratios, particularly in terms of plant aboveground biomass, N uptake and soil N-cycling, and also exhibited greater plasticity in root morphology. Consequently, while higher R:S genotypes had relatively poorer yields in unamended soils, they outperformed lower R:S genotypes in total seed weight under compost treatments. Our findings suggest that genotypes with greater belowground investment may be better able to take advantage of soil health promoting practices, such as the use of organic amendments. These results highlight the need to consider soil management practices (and associated biological communities) in parallel with root phenotypic plasticity when evaluating wheat lines for improvements in plant-soil synergies.	[Junaidi, Junaidi; Kallenbach, Cynthia M.; Byrne, Patrick F.; Fonte, Steven J.] Colorado State Univ, Soil & Crop Sci Dept, Ft Collins, CO 80523 USA; [Junaidi, Junaidi] Indonesian Rubber Res Inst, Bogor, Jawa Barat, Indonesia	Colorado State University; Riset Perkebunan Nusantara; Indonesian Rubber Research Institute (IRRI)	Kallenbach, CM (corresponding author), Colorado State Univ, Soil & Crop Sci Dept, Ft Collins, CO 80523 USA.	kallenbachcm@gmail.com	Junaidi, Junaidi/U-7915-2019; Byrne, Patrick/AFP-4228-2022; , Junaidi/AAX-2747-2020	Junaidi, Junaidi/0000-0002-4968-5528; Byrne, Patrick/0000-0003-0173-3161; , Junaidi/0000-0003-2294-040X; Fonte, Steven/0000-0002-3727-2304	Institute of International Education as a Fulbright Scholarship; Department of Soil and Crop Sciences at Colorado State University	Institute of International Education as a Fulbright Scholarship; Department of Soil and Crop Sciences at Colorado State University	Funding and support for this work was provided to JJ by the Institute of International Education as a Fulbright Scholarship and to SJF from the Department of Soil and Crop Sciences at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2017, SCI HORTIC-AMSTERDAM, V216, P256, DOI 10.1016/j.scienta.2017.01.019; Araujo Y, 2004, BIOL FERT SOILS, V39, P146, DOI 10.1007/s00374-003-0696-0; Awad W, 2018, AGRON J; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baldi E, 2013, PLANT SOIL ENVIRON, V59, P221, DOI 10.17221/857/2012-PSE; Bardgett RD, 2014, TRENDS ECOL EVOL, V29, P692, DOI 10.1016/j.tree.2014.10.006; Becker SR, 2016, EUPHYTICA, V207, P213, DOI 10.1007/s10681-015-1574-1; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Bernard L, 2012, ISME J, V6, P213, DOI 10.1038/ismej.2011.87; Binet F, 1998, BIOL FERT SOILS, V27, P79, DOI 10.1007/s003740050403; Bossuyt H, 2004, EUR J SOIL SCI, V55, P393, DOI 10.1111/j.1351-0754.2004.00603.x; Brown GG, 2000, EUR J SOIL BIOL, V36, P177, DOI 10.1016/S1164-5563(00)01062-1; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Celik I, 2004, SOIL TILL RES, V78, P59, DOI 10.1016/j.still.2004.02.012; CGIAR WHEAT, 2014, CGIAR WHEAT 2013 ANN; Chaparro JM, 2012, BIOL FERT SOILS, V48, P1; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Clark JA, 1922, FARMERS B, V1301-1325, P3; Costa C, 2001, CAN J BOT, V79, P23, DOI 10.1139/cjb-79-1-23; de Graaff MA, 2013, SOIL BIOL BIOCHEM, V58, P198, DOI 10.1016/j.soilbio.2012.11.015; de Vries FT, 2017, J ECOL, V105, P913, DOI 10.1111/1365-2745.12783; de Vries FT, 2012, FRONT ECOL ENVIRON, V10, P425, DOI 10.1890/110162; Dijkstra FA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00216; Eriksen-Hamel NS, 2008, SOIL BIOL BIOCHEM, V40, P1004, DOI 10.1016/j.soilbio.2007.11.013; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Fess TL, 2011, SUSTAINABILITY-BASEL, V3, P1742, DOI 10.3390/su3101742; Fonte SJ, 2007, SOIL BIOL BIOCHEM, V39, P1014, DOI 10.1016/j.soilbio.2006.11.011; Fonte SJ, 2012, PLANT SOIL, V359, P205, DOI 10.1007/s11104-012-1199-2; Gardner JB, 2009, ECOL APPL, V19, P2167, DOI 10.1890/08-1122.1; Gaudin ACM, 2011, CROP SCI, V51, P2780, DOI 10.2135/cropsci2010.12.0686; Genesys, ACC PROF TA2374; Gioia T, 2015, J EXP BOT, V66, P5519, DOI 10.1093/jxb/erv289; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Grossman JD, 2012, EVOL APPL, V5, P850, DOI 10.1111/j.1752-4571.2012.00263.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Halvorson AD, 2015, AGRON J, V107, P1504, DOI 10.2134/agronj15.0074; HETRICK BAD, 1995, CAN J BOT, V73, P891, DOI 10.1139/b95-097; Iannucci A, 2017, FRONT PLANT SCI, P8; Inselsbacher E, 2010, SOIL BIOL BIOCHEM, V42, P360, DOI 10.1016/j.soilbio.2009.11.019; Jackson LE, 2012, CURR OPIN ENV SUST, V4, P517, DOI 10.1016/j.cosust.2012.08.003; Jain N, 2014, CEREAL RES COMMUN, V42, P426, DOI 10.1556/CRC.42.2014.3.6; Kallenbach C, 2011, AGR ECOSYST ENVIRON, V144, P241, DOI 10.1016/j.agee.2011.08.020; KAPULNIK Y, 1991, EUPHYTICA, V56, P27; Kell DB, 2011, ANN BOT-LONDON, V108, P407, DOI 10.1093/aob/mcr175; Kimball S, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1602; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; Lanning SP, 2012, CROP SCI, V52, P1145, DOI 10.2135/cropsci2011.11.0625; Lanning SP, 2000, CROP SCI, V40, P861; Leff JW, 2017, NEW PHYTOL, V214, P412, DOI 10.1111/nph.14323; Litvinenko M., 2001, WORLD WHEAT BOOK HIS, P351; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Martin-Robles N, 2018, NEW PHYTOL, V218, P322, DOI 10.1111/nph.14962; Mason HE, 2006, CAN J PLANT SCI, V86, P333, DOI 10.4141/P05-051; McCormack ML, 2015, NEW PHYTOL, V207, P505, DOI 10.1111/nph.13363; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Milla R, 2015, TRENDS ECOL EVOL, V30, P463, DOI 10.1016/j.tree.2015.06.006; Morris CF, 2001, CROP SCI, V41, P218, DOI 10.2135/cropsci2001.411218x; Muller A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01410-w; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Nie M, 2016, AGR ECOSYST ENVIRON, V224, P50, DOI 10.1016/j.agee.2016.03.032; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; Paez-Garcia Ana, 2015, Plants-Basel, V4, P334, DOI 10.3390/plants4020334; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Piovanelli C, 2006, SOIL TILL RES, V90, P84, DOI 10.1016/j.still.2005.08.013; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; Powlson DS, 2011, FOOD POLICY, V36, pS72, DOI 10.1016/j.foodpol.2010.11.025; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Reynolds John Warren, 2011, Megadrilogica, V14, P159; SATTELMACHER B, 1994, Z PFLANZ BODENKUNDE, V157, P215, DOI 10.1002/jpln.19941570309; Schmidtke J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00678; Schultz MJ, 2008, THESIS; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Soudzilovskaia NA, 2013, P NATL ACAD SCI USA, V110, P18180, DOI 10.1073/pnas.1310700110; Speratti AB, 2008, APPL SOIL ECOL, V38, P27, DOI 10.1016/j.apsoil.2007.08.009; Symko S., 2002, SINGLE SEED TRACING; Szoboszlay M, 2015, SOIL BIOL BIOCHEM, V80, P34, DOI 10.1016/j.soilbio.2014.09.001; van Bueren ETL, 2011, NJAS-WAGEN J LIFE SC, V58, P193, DOI 10.1016/j.njas.2010.04.001; van Groenigen JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06365; Verbon EH, 2016, TRENDS PLANT SCI, V21, P218, DOI 10.1016/j.tplants.2016.01.013; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Wallenstein MD, 2017, RHIZOSPHERE-NETH, V3, P230, DOI 10.1016/j.rhisph.2017.04.004; Willer H, 2021, WORLD ORGANIC AGR ST; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Wu MN, 2011, BIOL FERT SOILS, V47, P397, DOI 10.1007/s00374-010-0535-z; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhu B, 2014, SOIL BIOL BIOCHEM, V76, P183, DOI 10.1016/j.soilbio.2014.04.033; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	91	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200646	10.1371/journal.pone.0200646	http://dx.doi.org/10.1371/journal.pone.0200646			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040842	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200007
J	Kao, JH; Chen, CD; Li, ZRT; Chan, TC; Tung, TH; Chu, YH; Cheng, HY; Liu, JW; Shih, FY; Shu, PY; Lin, CC; Tsai, WH; Ku, CC; Ho, CK; King, CC				Kao, Jui-Hung; Chen, Chaur-Dong; Li, Zheng-Rong Tiger; Chan, Ta-Chien; Tung, Tsung-Hwa; Chu, Ying-Hsia; Cheng, Hau-Yuan; Liu, Jien-Wei; Shih, Fuh-Yuan; Shu, Pei-Yun; Lin, Chien-Chou; Tsai, Wu-Hsiung; Ku, Chia-Chi; Ho, Chi-Kung; King, Chwan-Chuen			The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting - Implications for Non-Endemic Countries (vol 11, e0160230, 2016)	PLOS ONE			English	Correction														SHIH, FUH-YUAN/0000-0002-7755-0110; KU, CHIA-CHI/0000-0002-5740-1505				Kao JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160230	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201502	10.1371/journal.pone.0201502	http://dx.doi.org/10.1371/journal.pone.0201502			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040847	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200040
J	Barrera, N; Guerrero, L; Debut, A; Santa-Cruz, P				Barrera, Nicole; Guerrero, Lizeth; Debut, Alexis; Santa-Cruz, Petrus			Printable nanocomposites of polymers and silver nanoparticles for antibacterial devices produced by DoD technology	PLOS ONE			English	Article							ARTEMIA-FRANCISCANA; TOXICITY; RESISTANCE	Silver nanoparticles (Ag-NPs) are known for their efficient bactericidal activity and are widely used in industry. This study aims to produce printable antibacterial devices by drop-ondemand (DoD) inkjet technology, using Ag-NPs as the active part in complex printable fluids. The synthesis of this active part is described using two methods to obtain monodisperse NPs: chemical and microwave irradiation. The synthesized NPs were characterized by UV-VIS, STEM, TEM, DLS and XRD. Two printable fluids were produced based: one with Ag-NPs and a second one, a polymeric nanocomposite, using silver nanoparticles and polyvinyl butyral (Ag-NPs/PVB). Cellulose acetate was used as a flexible substrate. The ecotoxicity analysis of fluids and substrate was performed with Artemia franciscana nauplii. Optimized electric pulse waveforms for drop formation of the functional fluids were obtained for the piezoelectric-based DoD printing. Activity of printed antibacterial devices was evaluated using the Kirby-Bauer method with Staphylococcus aureus and Escherichia coll. The results show that the printed device with Ag-NP fluids evidenced a bacterial inhibition. An important advantage in using the DoD process is the possibility of printing, layer by layer or side by side, more than one active principle, allowing an interleaved or simultaneous release of silver NP and other molecules of interest as for example with a second functional fluid to ensure effectiveness of Ag activity.	[Barrera, Nicole; Guerrero, Lizeth; Debut, Alexis] Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador; [Barrera, Nicole; Guerrero, Lizeth; Santa-Cruz, Petrus] Univ Fed Pernambuco UFPE, Dept Quim Fundamental, Recife, PE, Brazil	Escuela Politecnica Superior del Ejercito; Universidade Federal de Pernambuco	Debut, A (corresponding author), Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador.	apdebut@espe.edu.ec	Barrera, Nicole/Y-1879-2019; Santa-Cruz, Petrus/C-7413-2011; Debut, Alexis/H-8424-2019	Barrera, Nicole/0000-0002-8377-5092; Santa-Cruz, Petrus/0000-0003-2475-7764; Debut, Alexis/0000-0002-8269-7619	"Laboratorio de Arquitetura de Nanodispositivos Fotonicos e Bioinspirados" LANDFOTON-UFPE (Recife-Brazil) Group; FINEP (CT-HIDRO/NAMICRO); CNPq; FACEPE; CAPES [36]; CENCINAT "Centro de Nanociencia y Nanotecnologia" (Quito-Ecuador)	"Laboratorio de Arquitetura de Nanodispositivos Fotonicos e Bioinspirados" LANDFOTON-UFPE (Recife-Brazil) Group; FINEP (CT-HIDRO/NAMICRO); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CENCINAT "Centro de Nanociencia y Nanotecnologia" (Quito-Ecuador)	This work was funded by the "Laboratorio de Arquitetura de Nanodispositivos Fotonicos e Bioinspirados" LANDFOTON-UFPE (Recife-Brazil) Group, supported by the Brazilian Research Agencies FINEP (CT-HIDRO/NAMICRO), CNPq, FACEPE, and CAPES (Nanobiotec-Brasil Network 36), for the financing of the project carried out, the CETENE Research Center (MCTIC) and the CENCINAT "Centro de Nanociencia y Nanotecnologia" (Quito-Ecuador), for their research support in the characterization of the nanoparticles (PS-C).	Abbasi E, 2016, CRIT REV MICROBIOL, V42, P173, DOI 10.3109/1040841X.2014.912200; Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; Amutha M, 2014, J NANOTECHNOL, V2014, DOI 10.1155/2014/860875; Arroyo CR, 2016, BIOL MED, V8; Assis M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19270-9; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Belluco S, 2018, CRIT REV FOOD SCI, V58, P1084, DOI 10.1080/10408398.2016.1237468; Bergami E, 2017, AQUAT TOXICOL, V189, P159, DOI 10.1016/j.aquatox.2017.06.008; Bergami E, 2016, ECOTOX ENVIRON SAFE, V123, P18, DOI 10.1016/j.ecoenv.2015.09.021; Biswas K.R.P., 2015, INT J RECENT SCI RES, V6, P5880; Borroto Janetsy, 2011, Rev Cubana Plant Med, V16, P34; Callister W.D., 2018, MAT SCI ENG INTRO, Vtenth; Cao H., 2017, SILVER NANOPARTICLES; Chinnasamy A, 2014, SCI WORLD J, P1, DOI [10.1155/2014/256919, DOI 10.1155/2014/256919]; de Sa GF, 2000, COORDIN CHEM REV, V196, P165, DOI 10.1016/S0010-8545(99)00054-5; Dell'Erba IE, 2017, LANGMUIR, V33, P10248, DOI 10.1021/acs.langmuir.7b01936; FAO, 2017, GEN RES MICR CURR PO; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gameiro CG, 1999, MATER SCI FORUM, V315-3, P249, DOI 10.4028/www.scientific.net/MSF.315-317.249; Hadjispyrou S, 2001, ECOTOX ENVIRON SAFE, V49, P179, DOI 10.1006/eesa.2001.2059; Hong XS, 2016, ENVIRON SCI POLLUT R, V23, P4489, DOI 10.1007/s11356-015-5668-z; Icten E, 2016, AAPS PHARMSCITECH, V17, P284, DOI 10.1208/s12249-015-0348-3; Kaweeteerawat C, 2017, J TOXICOL ENV HEAL A, V80, P1276, DOI 10.1080/15287394.2017.1376727; Kumar B, 2016, BIONANOSCIENCE, V6, P15, DOI 10.1007/s12668-016-0193-1; Kumar B, 2016, SYNTH REACT INORG M, V46, P1265, DOI 10.1080/15533174.2015.1004451; Lopes NA, 2018, CRIT REV FOOD SCI, V58, P2202, DOI 10.1080/10408398.2017.1308915; Malegowd G, 2015, INT J BIOL MACROMOL, DOI [10.1016/j.ijbiomac.2015.12.026, DOI 10.1016/J.IJBIOMAC.2015.12.026]; Marslin G, 2017, INT J NANO MED, V10, P5955; Mehr FP, 2015, ORIENT J CHEM, V31, P1831; Mishra Y.K., 2018, MAT TODAY; Mogensen KB, 2014, J PHYS CHEM C, V118, P28075, DOI 10.1021/jp505632n; Naranjo LP, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2143135; Naser MN, 2016, J ENVIRON SCI ENG, V5, P261; Ng WL, 2017, MATERIALS, V10, DOI 10.3390/ma10020190; Panacek A, 2018, NAT NANOTECHNOL, V13, P65, DOI 10.1038/s41565-017-0013-y; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Podolsky SH, 2015, EMERG INFECT DIS, V21, P1093, DOI [10.3201/eid2106.150212, DOI 10.3201/EID2106.150212]; Poulose S, 2014, J NANOSCI NANOTECHNO, V14, P2038, DOI 10.1166/jnn.2014.9019; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Pradeep T., 2012, TXB NANOSCIENCE NANO, P887; Pulit-Prociak J, 2016, OPEN CHEM, V14, P76, DOI 10.1515/chem-2016-0005; Quirino W, 2011, SYNTHETIC MET, V161, P964, DOI 10.1016/j.synthmet.2011.03.001; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rajabi S, 2015, DARU, V23, DOI 10.1186/s40199-015-0105-x; Ramesh S, 2016, BIOMATER SCI-UK, V4, P1713, DOI 10.1039/c6bm00688d; Ranoszek-Soliwoda K, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-017-3973-9; Santa-Cruz PA, 2016, Patent BR, Patent No. 1020160184355; Santa-Cruz PA, 2004, BR Patent, Patent No. [PI 0403087-7, 0403087]; Schneider R, 2017, RSC ADV, V7, P41479, DOI 10.1039/c7ra07434d; Sousa FLN, 2016, MATER RES EXPRESS, V3, DOI 10.1088/2053-1591/3/4/045701; Souza F. Z., 2015, THESIS; Thakur NS, 2017, BIOINSPIRED SYNTHESI, P11; Valenti LE, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-017-3860-4; Velasco S. J., 2016, INT J FISHERIES AQUA, V3, P247; Velayudhannair Krishnakumar, 2017, International Journal of Aquatic Biology-IJAB, V5, P246, DOI 10.22034/ijab.v5i4.316; Wolny-Koladka KA, 2017, MICRO NANO LETT, V12, P772, DOI 10.1049/mnl.2017.0129	56	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200918	10.1371/journal.pone.0200918	http://dx.doi.org/10.1371/journal.pone.0200918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024925	Green Submitted, gold, Green Published			2022-12-27	WOS:000439120000067
J	Corp, N; Jordan, JL; Croft, PR				Corp, Nadia; Jordan, Joanne L.; Croft, Peter R.			Justifications for using complementary and alternative medicine reported by persons with musculoskeletal conditions: A narrative literature synthesis	PLOS ONE			English	Article							LOW-BACK-PAIN; HEALTH-CARE; RHEUMATOID-ARTHRITIS; PATIENTS PERCEPTIONS; GENERAL-POPULATION; CHINESE IMMIGRANTS; TELEPHONE SURVEY; NATIONAL-SURVEY; THERAPIES; SATISFACTION	Background Complementary and alternative medicine (CAM) is very popular with patients frequently combining it with orthodox health care. The high prevalence of CAM use and satisfaction with CAM reported by patients directly challenges an orthodox system that can only approve such use if it results from the application of biomedical concepts and science. Studies highlighting this as a cultural, sociological and historical phenomenon emphasise the value of choice for consumers of health care. Musculoskeletal conditions typify common problems for which the effectiveness of orthodox care is often unclear. We postulated that the reasons people give for using or not using CAM for musculoskeletal conditions, would therefore indicate the full range of expectations that people have of health care. Furthermore, these reasons would indicate how much people feel orthodox health care is or is not meeting their expectations. Therefore, this study aims to investigate people's reasons for choosing or avoiding CAM for non-traumatic musculoskeletal conditions. Methods A systematic search and narrative synthesis was conducted of published qualitative and quantitative studies related to CAM and non-traumatic musculoskeletal conditions. Results We identified 169 relevant papers detailing 152 separate studies, from which 1486 justifications were extracted concerning CAM use. Content analysis resulted in 11 distinct categories across four themes: practical aspects of care, clinical effectiveness, non-clinical outcomes of care, and a person's philosophy of illness and care. People provided similar rationales for both using and avoiding CAM, emphasising that, whilst CAM is perceived by many patients with musculoskeletal conditions to fill gaps in care (such as practitioner time or quality of the therapeutic relationship), orthodox care also seeks to deliver these aspects of care. However, people who used CAM also highlighted its alignment with their general philosophy and ideas about illness and health care, and often emphasised CAM's capacity to give them control over their condition and its treatment. Conclusion Currently, CAM appears to have a significant role for patients with common painful long-term conditions in providing choices to enable individual needs to be met.	[Corp, Nadia; Jordan, Joanne L.; Croft, Peter R.] Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England	Keele University	Corp, N (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England.	n.corp@keele.ac.uk	Corp, Nadia/N-3498-2019; Corp, Nadia/G-8618-2012; Jordan, Joanne/E-8186-2014	Corp, Nadia/0000-0002-6758-9513; Jordan, Joanne/0000-0002-7191-2977	Arthritis Research UK Strategic Award	Arthritis Research UK Strategic Award	The literature searches and synthesis were supported by an Arthritis Research UK Strategic Award (http://www.arthritisresearchuk.org/) awarded to PRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot N. C., 1997, FORSCH KOMPLEMENTMED, V4, P164, DOI [10.1159/000210318, DOI 10.1159/000210318]; Afari N, 1999, INTEGR MED, V2, P97; Alami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019634; Arcury TA, 1999, AM J HEALTH PROMOT, V14, P7, DOI 10.4278/0890-1171-14.1.7; Artus M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-26; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Augello JDB, 2002, THESIS; Barcan R, 2011, COMPLEMENTARY ALTERN; Barnes PM, 2008, 12 CDC NAT HLTH STAT; Barrett B, 2003, J ALTERN COMPLEM MED, V9, P937, DOI 10.1089/107555303771952271; Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Bishop FL, 2008, AM J PUBLIC HEALTH, V98, P1700, DOI 10.2105/AJPH.2007.110072; Bishop FL, 2007, J HEALTH PSYCHOL, V12, P851, DOI 10.1177/1359105307082447; Bishop FL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-129; Bivins R., 2007, ALTERNATIVE MED HIST; BLACK C, 2009, ASSESSING COMPLEMENT; Bovey M, 2005, J ALTERN COMPLEM MED, V11, P293, DOI 10.1089/acm.2005.11.293; Braunack-Mayer A, 2009, BRIT J GEN PRACT, V59, P478, DOI 10.3399/bjgp09X453495; Brown M, 2010, DISABIL REHABIL, V32, P1645, DOI 10.3109/09638281003649896; Bucker B, 2008, GESUNDHEITSWESEN, V70, P559, DOI 10.1055/s-2008-1081505; Calnan M, 2006, FAM PRACT, V23, P91, DOI 10.1093/fampra/cmi077; Candib L. M, 2004, FAMILIES SYSTEMS HLT, V22, P139; Caspi O, 2004, MED DECIS MAKING, V24, P64, DOI 10.1177/0272989X03261567; Cassidy CM, 1998, J ALTERN COMPLEM MED, V4, P17, DOI 10.1089/acm.1998.4.1-17; Chambers S, 2008, LUPUS, V17, P761, DOI 10.1177/0961203308089404; Chan HK., 2002, HONG KONG NURSING J, V38, P7; Chaudhry SI, 2013, JAMA INTERN MED, V173, P1534, DOI 10.1001/jamainternmed.2013.8732; Choi Y., 2002, REPRESENTATION COPIN; DARZI A, 2007, OUR NHS OUR FUTURE; DeBar LL, 2003, J OROFAC PAIN, V17, P224; Dessio W, 2004, ETHNIC DIS, V14, P189; Dewar AL, 2009, CHRONIC DIS CAN, V29, P162; Dimmock S, 1996, CLIN RHEUMATOL, V15, P478, DOI 10.1007/BF02229645; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; Elder NC, 1997, ARCH FAM MED, V6, P181, DOI 10.1001/archfami.6.2.181; Erickson BE, 2007, J ALTERN COMPLEM MED, V13, P375, DOI 10.1089/acm.2006.6213; Figaro MK, 2004, HEALTH PSYCHOL, V23, P324, DOI 10.1037/0278-6133.23.3.324; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gale N, 2014, SOCIOL COMPASS, V8, P805, DOI 10.1111/soc4.12182; Gerrits MMJG, 2014, PAIN, V155, P53, DOI 10.1016/j.pain.2013.09.005; Goldstein MS, 1998, ALTERN THER HEALTH M, V4, P60; GRAY D, 1985, SOC SCI MED, V21, P507, DOI 10.1016/0277-9536(85)90034-6; Hasan Shahzad S., 2010, Journal of Pharmacy Practice and Research, V40, P294; Haslam D, 2004, INNER CONSULTATION D; Herman Carla J, 2004, Prev Chronic Dis, V1, pA12; Ho KY, 2009, PAIN PHYSICIAN, V12, P685; Howell S L, 1994, Nurse Pract Forum, V5, P98; Ikuyama S, 2009, MOD RHEUMATOL, V19, P253, DOI 10.1007/s10165-009-0156-2; Kalauokalani D, 2001, SPINE, V26, P1418, DOI 10.1097/00007632-200107010-00005; Kim C, 1998, ARCH INTERN MED, V158, P2245, DOI 10.1001/archinte.158.20.2245; Kleinman A., 1980, PATIENTS HEALERS CON; la Cour P, 2008, JCR-J CLIN RHEUMATOL, V14, P332, DOI 10.1097/RHU.0b013e31817a7e1f; Lam TP, 2001, J EPIDEMIOL COMMUN H, V55, P762, DOI 10.1136/jech.55.10.762; Lewis D, 2001, J ALTERN COMPLEM MED, V7, P681, DOI 10.1089/10755530152755234; Liberati A, 2009, PLOS MED, V9; Lim ASH, 1999, PSYCHOL HEALTH, V14, P965; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; Ma GX, 1999, J COMMUN HEALTH, V24, P421, DOI 10.1023/A:1018742505785; Marsh J, 2009, CLIN ORTHOP RELAT R, V467, P2705, DOI 10.1007/s11999-009-0764-3; Mitzdorf U, 1999, J ALTERN COMPLEM MED, V5, P463, DOI 10.1089/acm.1999.5.463; Natural Therapy Pages UK, ALT MED FIND COMPL T; Nayak S, 2001, J Spinal Cord Med, V24, P54; Palinkas LA, 2000, J FAM PRACTICE, V49, P1121; Paskins Z, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-195; Paterson C, 2004, J ALTERN COMPLEM MED, V10, P791; Paterson C, 1999, BRIT J GEN PRACT, V49, P626; Peleg R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-36; Peters D, 2001, ONLINE J RURAL NURS, V2; Popay J., 2006, GUIDANCE CONDUCT NAR; PORTER R, 1985, THEOR SOC, V14, P175, DOI 10.1007/BF00157532; Qidwai Waris, 2003, J Ayub Med Coll Abbottabad, V15, P33; Randall C, 1999, Complement Ther Med, V7, P126, DOI 10.1016/S0965-2299(99)80119-8; Rao JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P619, DOI 10.1002/art.11377; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; Rao JK, 1998, ARTHRIT CARE RES, V11, P253, DOI 10.1002/art.1790110406; Rose G, 2006, MUSCULOSKELET CARE, V4, P101, DOI 10.1002/msc.82; Shah SFUH, 2010, J PAK MED ASSOC, V60, P667; Sharples FMC, 2003, COMPLEMENT THER MED, V11, P243, DOI 10.1016/S0965-2299(03)00107-9; Shmueli A, 2006, EVID-BASED COMPL ALT, V3, P273, DOI 10.1093/ecam/nel009; Shumay DM, 2001, J FAM PRACTICE, V50, P1097; Simpson N, 2001, BRIT J GEN PRACT, V51, P914; Skelton AM, 1996, BRIT J GEN PRACT, V46, P153; Smith JM, 2009, COMPLEMENT THER MED, V17, P281, DOI 10.1016/j.ctim.2009.07.001; Soler JK, 2012, FAM PRACT, V29, P272, DOI 10.1093/fampra/cmr101; Strutt R, 2008, MANUAL THER, V13, P456, DOI 10.1016/j.math.2007.05.013; Thomas K, 2004, J PUBLIC HEALTH, V26, P152, DOI 10.1093/pubmed/fdh139; US National Collaboration on Complementary and Alternative Medicine, 2008, COMPL ALT INT HLTH W; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; von Peter S, 2002, CEPHALALGIA, V22, P395, DOI 10.1046/j.1468-2982.2002.00376.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wieland LS, 2011, ALTERN THER HEALTH M, V17, P50; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; Young AE, 2011, PAIN, V152, P204, DOI 10.1016/j.pain.2010.10.033; Zhang JJ, 2002, SOC SCI MED, V55, P1795, DOI 10.1016/S0277-9536(01)00311-2	94	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200879	10.1371/journal.pone.0200879	http://dx.doi.org/10.1371/journal.pone.0200879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024952	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000439120000063
J	Hunt, D; Drake, LA; Drake, JR				Hunt, Danielle; Drake, Lisa A.; Drake, James R.			Murine macrophage TLR2-Fc gamma R synergy via Fc gamma R licensing of IL-6 cytokine mRNA ribosome binding and translation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; FRANCISELLA-TULARENSIS; DENDRITIC CELLS; IN-VIVO; CROSS-TALK; IMMUNE-RESPONSES; ACTIVATION; PROTECTION; VACCINE; VITRO	Macrophages (Mempty sets) are sentinels of the immune system that use pattern recognition receptors such as Toll-like receptors (TLR) to detect invading pathogens and immune receptors such as Fc gamma R to sense the host's immune state. Crosstalk between these two signaling pathways allows the Mempty set to tailor the cell's overall response to prevailing conditions. However, the molecular mechanisms underlying TLR-Fc gamma R crosstalk are only partially understood. Therefore, we employed an immunologically-relevant Mempty set stimulus, an inactivated gram-negative (b) under bar acterium that bears (TLR2) under bar agonists but no TLR4 agonist (iB(TLR2)) opsonized with a monoclonal antibody (mAb-iB(TLR2)), as a tool to study Fc gamma R regulation of TLR2-driven production of IL-6, a key inflammatory cytokine. We chose this particular agonist as an investigational tool because Mempty set production of any detectable IL-6 in response to mAbiBTLR2 requires both TLR2 and Fc gamma R signaling, making it an excellent system for the study of receptor synergy. Using genetic, pharmacological and immunological approaches, we demonstrate that the murine Mempty set IL-6 response to mAb-iB(TLR2) requires activation of both the TLR/NF-kappa B and Fc gamma R/ITAM signaling pathways. mAb-iB(TLR2) engagement of TLR2 drives NF-kappa B activation and up-regulation of IL-6 mRNA but fails to result in IL-6 cytokine production/release. Here, Src family kinase-driven Fc gamma R ITAM signaling is necessary to enable IL-6 mRNA incorporation into polysomes and translation. These results reveal a novel mechanism by which Fc gamma R ITAM signaling synergizes with TLR signaling, by "licensing" cytokine mRNA ribosome binding/translation to drive a strong murine Mempty set cytokine response.	[Hunt, Danielle; Drake, Lisa A.; Drake, James R.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.	drakej@amc.edu			N.I.H. [PO1 AI-056321]	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by N.I.H. grant PO1 AI-056321 to the Department of Immunology and Microbial Disease.	ATVBAHA, 2009, INFECT IMMUN, V77, P4953; BABADJANOVA Z, 1941, PUBMED, DOI DOI 10.1371/J0URNAL.P0NE.0129981; Bakema JE, 2015, J IMMUNOL, V194, P1856, DOI 10.4049/jimmunol.1303126; BITSAKTSIS C, 1957, PUBMED, DOI DOI 10.1128/IAI.02289-14; Dai S, 2016, PUBMED, V12, DOI 10.1371/journal.ppat; Dai Shipan, 2016, PLoS Pathog, V12, pe1005504, DOI 10.1371/journal.ppat.1005504; den Dunnen J, 2012, BLOOD, V120, P112, DOI 10.1182/blood-2011-12-399931; DUFFY EB, 1931, PUBMED, DOI DOI 10.1189/JLB.2A1215-555RR; Fong DC, 1996, IMMUNOL LETT, V54, P83, DOI 10.1016/S0165-2478(96)02654-5; Franchini AM, 2013, J BIOL CHEM, V288, P25098, DOI 10.1074/jbc.M113.474106; FRANZ B, 2015, PUBMED, P61064, DOI DOI 10.1155/2015/840842; Franz BJ, 2015, PUBMED, V2015, DOI 10.1155/2015/840842; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; GUNN JS, 1923, PUBMED, DOI DOI 10.1196/ANNALS.1409.006; HAJJAR AM, 1924, PUBMED, DOI DOI 10.1128/IAI.00934-06; HANSEN IS, 2006, PUBMED, DOI DOI 10.1038/S41467-018-03318-5; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; HIRSCH I, 2017, PUBMED, V394, P39271, DOI DOI 10.3389/FIMMU.2017.00394; IGLESIAS BV, 2012, PUBMED, V66, P47654, DOI DOI 10.1038/ICB.2012.66; Johnston S, 2012, NEURAL REGEN RES, V7, P1064, DOI 10.3969/j.issn.1673-5374.2012.14.004; KURTZ SL, 1988, PUBMED, DOI DOI 10.1128/IAI.01249-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEGERING DJ, 2006, MICROB PATHOG, V9, P26; LOPEZPELAEZ M, 1926, PUBMED, DOI DOI 10.1091/MBC.E12-02-0135; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Ng HP, 2015, ARTERIOSCL THROM VAS, V35, P1101, DOI 10.1161/ATVBAHA.115.305290; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Pham GH, 2014, VACCINE, V32, P5212, DOI 10.1016/j.vaccine.2014.07.050; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; PMID, 1978, PUBMED; PMID, 1998, PUBMED; PMID, 2010, PUBMED; PMID, 2006, PUBMED, V7, P7; PMID, 1985, PUBMED; Rabadi SM, 2016, J BIOL CHEM, V291, P5009, DOI 10.1074/jbc.M115.681478; RAWOOL DB, 1939, PUBMED; REN L, 1974, J BIOL CHEM, V115, P3, DOI DOI 10.1074/JBC.M115; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; SUNAGAR R, 1974, PUBMED, DOI DOI 10.2147/VDT.S85545; Sunagar R, 2016, VACCINE, V34, P3396, DOI 10.1016/j.vaccine.2016.04.054; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; van Egmond M, 2015, IMMUNOL REV, V268, P311, DOI 10.1111/imr.12333; VOGELPOEL LT, 1921, PUBMED, DOI DOI 10.1038/NC0MMS6444; Vogelpoel LT, 2015, PUBMED, V6, P79; VOGELPOEL LT, 2015, PUBMED, V79, P59693, DOI DOI 10.3389/FIMMU.2015.00079; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335	50	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200764	10.1371/journal.pone.0200764	http://dx.doi.org/10.1371/journal.pone.0200764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024985	Green Submitted, gold, Green Published			2022-12-27	WOS:000439120000048
J	Roosenhoff, R; van der Vries, E; van der Linden, A; van Amerongen, G; Stittelaar, KJ; Smits, SL; Schutten, M; Fouchier, RAM				Roosenhoff, Rueshandra; van der Vries, Erhard; van der Linden, Anne; van Amerongen, Geert; Stittelaar, Koert J.; Smits, Saskia L.; Schutten, Martin; Fouchier, Ron A. M.			Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; IMMUNIZATION PRACTICES; OSELTAMIVIR TREATMENT; ADVISORY-COMMITTEE; SEASONAL INFLUENZA; VIRAL-INFECTIONS; RECOMMENDATIONS; TRANSMISSION; INFORMATION	Influenza viruses can cause severe life threatening infections in high-risk patients, including young children, the elderly and patients with compromised immunity due to underlying medical conditions or immunosuppressive treatment. The impaired immunity of these patients causes prolonged virus infection and combined with antiviral treatment facilitates the emergence of viruses with resistance mutations. The diverse nature of their immune status makes them a challenging group to study the impact of influenza virus infection and the efficacy of antiviral therapy. Immunocompromised ferrets may represent a suitable animal model to assess influenza virus infection and antiviral treatment strategies in immunocompromised hosts. Here, ferrets were given a daily oral solution of mycophenolate mofetil, tacrolimus and prednisolone sodium phosphate to suppress their immune system. Groups of immunocompromised and immunocompetent ferrets were inoculated with an A/H3N2 influenza virus and were subsequently treated with Oseltamivir or left untreated. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was performed on the throat and nose specimens to study virus replication during the course of infection. All immunocompromised ferrets had prolonged presence of viral RNA and a higher total amount of virus shedding compared to the immunocompetent ferrets. Although Oseltamivir reduced the total amount of virus shedding from the nose and throat of treated ferrets, it also resulted in the emergence of the neuraminidase R292K resistance substitution in all these animals, as determined by mutation specific RT-PCR and next-generation sequencing. No additional mutations that could be associated with the emergence of the R292K resistance mutation were detected. The immunocompromised ferret model can be used to study A/H3N2 virus shedding and is a promising model to study new antiviral strategies and the emergence of antiviral resistance in immunocompromised hosts.	[Roosenhoff, Rueshandra; van der Linden, Anne; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Zuid Holland, Netherlands; [van der Vries, Erhard] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands; [van Amerongen, Geert; Stittelaar, Koert J.; Smits, Saskia L.] Viroclin Biosci BV, Rotterdam, Zuid Holland, Netherlands; [Schutten, Martin] Clin Virol & Diagnost, Alkmaar, Noord Holland, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Zuid Holland, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869	NIAID/NIH [HHSN272201400008C]; European Commission FP7 program ADITEC [280873]; H2020 program COMPARE [643476]; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration [304875]; Volkswagen Foundation	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Commission FP7 program ADITEC; H2020 program COMPARE; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration; Volkswagen Foundation(Volkswagen)	This research was supported by NIAID/NIH contract HHSN272201400008C, European Commission FP7 program ADITEC (280873), H2020 program COMPARE (643476) and European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration (grant 304875). Erhard van der Vries was supported by the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Belser JA, 2015, VIROLOGY, V484, P305, DOI 10.1016/j.virol.2015.06.020; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Cheung DH, 2015, J INFECT DIS, V212, P391, DOI 10.1093/infdis/jiv058; Choi SM, 2011, BLOOD, V117, P5050, DOI 10.1182/blood-2010-11-319186; Coffin SE, 2011, PEDIATR INFECT DIS J, V30, P962, DOI 10.1097/INF.0b013e318232ede9; Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087; Englund J, 2011, BIOL BLOOD MARROW TR, V17, pS2, DOI 10.1016/j.bbmt.2010.11.008; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; FLEURY H, 2009, EURO SURVEILL, V14; Fraaij PL, 2015, ANTIVIR THER, V20, P633, DOI 10.3851/IMP2957; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1; Heinonen S, 2010, CLIN INFECT DIS, V51, P887, DOI 10.1086/656408; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Ison MG, 2008, J HEART LUNG TRANSPL, V27, P282, DOI 10.1016/j.healun.2007.11.575; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Kocik J, 2014, ACTA BIOCHIM POL, V61, P509; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Koszalka P, 2017, INFLUENZA OTHER RESP, V11, P240, DOI 10.1111/irv.12446; Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lee N, 2007, ANTIVIR THER, V12, P501; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Meijer WJ, 2015, CASE REP INFECT DIS, V2015, DOI 10.1155/2015/504975; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Moore IN, 2014, J VIROL, V88, P13879, DOI 10.1128/JVI.02341-14; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Organization WH, 2017, WHO 650 000 PEOPL RE, V46, P45; Organization WH, 2017, WHO INFL UPD D 298, V56, P57; Speers DJ, 2010, MED J AUSTRALIA, V192, P166, DOI 10.5694/j.1326-5377.2010.tb03459.x; Stittelaar KJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060168; Suzuki Y, 2015, META GENE, V4, P64, DOI 10.1016/j.mgene.2015.03.003; Takahashi Kazumi, 2003, Antiviral Chemistry & Chemotherapy, V14, P235; van der Vries E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003343; van der Vries E, 2013, J MOL DIAGN, V15, P347, DOI 10.1016/j.jmoldx.2012.11.007; Waghmare A, 2016, BLOOD, V127, P2682, DOI [10.1182/blood-2016-01634873, 10.1182/blood-2016-01-634873]; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Yoo JW, 2015, J MED VIROL, V87, P1649, DOI 10.1002/jmv.24232	50	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200849	10.1371/journal.pone.0200849	http://dx.doi.org/10.1371/journal.pone.0200849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024940	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000061
J	Bove, RM; Patrick, E; McCabe, C; Srivastava, G; Schneider, JA; Bennett, DA; De Jager, PL; Chibnik, LB				Bove, Riley M.; Patrick, Ellis; McCabe, Cristin; Srivastava, Gyan; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.; Chibnik, Lori B.			Reproductive period and epigenetic modifications of the oxidative phosphorylation pathway in the human prefrontal cortex	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DNA-METHYLATION CHANGES; ALZHEIMERS-DISEASE; GENE-EXPRESSION; HUMAN BRAIN; TRANSCRIPTOME ANALYSIS; BIPOLAR DISORDER; MENOPAUSE; WOMEN; AGE	Purpose Human females have a unique duration of post-reproductive longevity, during which sex-specific mechanisms ma influence later-life mechanisms of neuronal resilience and vulnerability. The maintenance of energy metabolism, through the oxidative phosphorylation (OXPHOS) apparatus, is essential for brain health. Given the known association between reproductive period (years from menarche to menopause) and cognitive aging, we examined the hypothesis that cumulative estrogen exposure across the lifetime may be associated with differential methylation of genes in the OXPHOS pathway. Methods Using DNA methylation patterns in the post-mortem dorsolateral prefrontal cortex (DLPFC) of 426 women prospectively followed until death in the Religious Orders Study and Rush Memory and Aging Project, we examined the relationship between reproductive period (subtracting age at menarche from age at menopause) and DNA methylation of a published set of autosomal OXPHOS genes previously implicated in stroke susceptibility. We then performed an unsupervised analysis of methylation levels across the Hallmark pathways from the Molecular Signatures Database. Results We observed a strong association between reproductive period and DNA methylation status across OXPHOS CpGs. We replicated this association between reproductive period and DNA methylation in a much larger set of OXPHOS genes in our unsupervised analysis. Here, reproductive period also showed associations with methylation in genes related to E2F, MYC and MTORC1 signaling, fatty acid metabolism and DNA repair. Conclusion This study provides evidence from both a supervised and unsupervised analyses, that lifetime cumulative endogenous steroid exposures may play a role in maintenance of postmenopausal cellular balance, including in brain tissue.	[Bove, Riley M.] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Bove, Riley M.; Patrick, Ellis; De Jager, Philip L.; Chibnik, Lori B.] Harvard Med Sch, Boston, MA 02115 USA; [Patrick, Ellis; Srivastava, Gyan; De Jager, Philip L.; Chibnik, Lori B.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Patrick, Ellis; Srivastava, Gyan; De Jager, Philip L.; Chibnik, Lori B.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Patrick, Ellis; McCabe, Cristin; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Patrick, Ellis] Univ Sydney, Sch Math & Stat, Westmead, NSW, Australia; [Patrick, Ellis] Univ Sydney, Westmead Inst Med Res, Westmead, NSW, Australia; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [De Jager, Philip L.] Columbia Univ, Med Ctr, Dept Neurol, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [Srivastava, Gyan] Abbvie Pharmaceut, Cambridge, MA USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Rush University; Columbia University; AbbVie	Bove, RM (corresponding author), Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Bove, RM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Riley.Bove@ucsf.edu	Patrick, Ellis/B-1763-2013	Patrick, Ellis/0000-0002-5253-4747; Chibnik, Lori/0000-0001-6293-806X	National Institutes of Health [R01 AG036042, R01AG036836, R01 AG17917, R01AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, K25 AG041906-01, K12 HD051959]; National Multiple Sclerosis Society Career Transition Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036042, K25AG041906, RC2AG036547, RF1AG015819, RF1AG036042, R01AG036836, P30AG010161, P50AG016574, R01AG032990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Career Transition Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants: R01 AG036042, R01AG036836, R01 AG17917, R01AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, K25 AG041906-01 and K12 HD051959; as well as by the National Multiple Sclerosis Society Career Transition Grant (R.B.). GS is currently employed by Abbvie; however was not affiliated with this employer at the time of the study. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CD, 2013, STROKE, V44, P612, DOI 10.1161/STROKEAHA.112.672089; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976, DOI 10.2741/E434; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Boulware Marissa I, 2012, Curr Top Behav Neurosci, V10, P165, DOI 10.1007/7854_2011_122; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carrard A, 2011, J AFFECT DISORDERS, V132, P450, DOI 10.1016/j.jad.2011.03.018; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Connor CM, 2008, EPIGENETICS-US, V3, P55, DOI 10.4161/epi.3.2.5938; Coppus AMW, 2010, J ALZHEIMERS DIS, V19, P545, DOI 10.3233/JAD-2010-1247; Corbo RM, 2011, DEMENT GERIATR COGN, V32, P63, DOI 10.1159/000330472; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Geerlings MI, 2001, JAMA-J AM MED ASSOC, V285, P1475, DOI 10.1001/jama.285.11.1475; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Henderson VW, 2007, MENOPAUSE, V14, P572, DOI 10.1097/gme.0b013e31803df49c; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kirsch-Volders M, 2010, MUTAGENESIS, V25, P213, DOI 10.1093/mutage/geq008; Lai JC, 2005, INT J CANCER, V117, P974, DOI 10.1002/ijc.21278; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Lim ASP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004792; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Lopez-Gallardo E, 2011, MUTAT RES-REV MUTAT, V728, P98, DOI 10.1016/j.mrrev.2011.06.004; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pregelj P, 2009, PSYCHIAT DANUB, V21, P128; Qureshi IA, 2010, PROG BRAIN RES, V186, P77, DOI 10.1016/B978-0-444-53630-3.00006-3; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Yang JY, 2015, INT J BIOCHEM CELL B, V67, P58, DOI 10.1016/j.biocel.2015.05.009; Yu L, 2016, ALZHEIMERS DEMENT, V12, P942, DOI 10.1016/j.jalz.2016.02.009; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0199073	10.1371/journal.pone.0199073	http://dx.doi.org/10.1371/journal.pone.0199073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052629	Green Published, gold			2022-12-27	WOS:000440006600006
J	Plotkin, M; Bishanga, D; Kidanto, H; Jennings, MC; Ricca, J; Mwanamsangu, A; Tibaijuka, G; Lemwayi, R; Ngereza, B; Drake, M; Zougrana, J; Khadka, N; Litch, JA; Rawlins, B				Plotkin, Marya; Bishanga, Dunstan; Kidanto, Hussein; Jennings, Mary Carol; Ricca, Jim; Mwanamsangu, Amasha; Tibaijuka, Gaudiosa; Lemwayi, Ruth; Ngereza, Benny; Drake, Mary; Zougrana, Jeremie; Khadka, Neena; Litch, James A.; Rawlins, Barbara			Tracking facility-based perinatal deaths in Tanzania: Results from an indicator validation assessment	PLOS ONE			English	Article							INCOME COUNTRIES; STILLBIRTHS; MORTALITY; SETTINGS; NEWBORN; COST	Background Globally, an estimated 2.7 million babies die in the neonatal period annually, and of these, about 0.7 million die from intrapartum-related events. In Tanzania 51,000 newborn deaths and 43,000 stillbirths occur every year. Approximately two-thirds of these deaths could be potentially prevented with improvements in intrapartum and neonatal care. Routine measurement of fetal intrapartum deaths and newborn deaths that occur in health facilities can help to evaluate efforts to improve the quality of intrapartum care to save lives. However, few examples exist of indicators on perinatal mortality in the facility setting that are readily available through health management information systems (HMIS). Methods From November 2016 to April 2017, health providers at 10 government health facilities in Kagera region, Tanzania, underwent refresher training on perinatal death classification and training on the use of handheld Doppler devices to assess fetal heart rate upon admission to maternity services. Doppler devices were provided to maternity services at the study facilities. We assessed the validity of an indicator to measure facility-based pre-discharge perinatal mortality by comparing perinatal outcomes extracted from the HMIS maternity registers to a gold standard perinatal death audit. Results Sensitivity and specificity of the HMIS neonatal outcomes to predict gold standard audit outcomes were both over 98% based on analysis of 128 HMIS-gold standard audit pairs. After this validation, we calculated facility perinatal mortality indicator from HMIS data using fresh stillbirths and pre-discharge newborn death as the numerator and women admitted labour with positive fetal heart tones as the denominator. Further emphasizing the validity of the indicator, FPM values aligned with expected mortality by facility level, with lowest rates in health centers (range 0.3%-0.5%), compared to district hospitals (1.5%-2.9%) and the regional hospital (4.2%). Conclusion This facility perinatal mortality indicator provides an important health outcome measure that facilities can use to monitor levels of perinatal deaths occurring in the facility and evaluate impact of quality of care improvement activities.	[Plotkin, Marya; Ricca, Jim; Rawlins, Barbara] Jhpiego Baltimore, Baltimore, MD 21231 USA; [Bishanga, Dunstan; Mwanamsangu, Amasha; Tibaijuka, Gaudiosa; Lemwayi, Ruth; Ngereza, Benny; Drake, Mary; Zougrana, Jeremie] Jhpiego Tanzania, Dar Es Salaam, Tanzania; [Kidanto, Hussein] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Jennings, Mary Carol] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Khadka, Neena] Save Children, Washington, DC USA; [Litch, James A.] Global Alliance Prevent Prematur & Stillbirth, Lynnwood, WA USA	Jhpiego; Jhpiego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Save the Children	Plotkin, M (corresponding author), Jhpiego Baltimore, Baltimore, MD 21231 USA.	Marya.plotkin@jhpiego.org		Jennings, Mary Carol/0000-0003-1050-7035; Mwanamsangu, Amasha/0000-0003-0702-3304; Litch, James/0000-0003-0570-0308; Kidanto, Hussein Lesio/0000-0001-9167-8068	United States Agency for International Development (USAID) [AID-OAA-A-14-00028]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID), under the terms of the Cooperative Agreement AID-OAA-A-14-00028. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Armstrong CE, 2014, TROP MED INT HEALTH, V19, P1087, DOI 10.1111/tmi.12353; Baqui AH, 2016, B WORLD HEALTH ORGAN, V94, P752, DOI 10.2471/BLT.15.160945; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Chuwa FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182250; Gold KJ, 2014, INT J GYNECOL OBSTET, V125, P223, DOI 10.1016/j.ijgo.2013.12.006; Goldenberg RL, 2013, INT J GYNECOL OBSTET, V122, P230, DOI 10.1016/j.ijgo.2013.04.008; Karuri J., 2014, Journal of Health Informatics in Developing Countries, V8, P38; Kidanto HL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-45; Koblinsky M, 2017, GLOB HEALTH-SCI PRAC, V5, P333, DOI 10.9745/GHSP-D-17-00308; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Manji K., 2009, SITUATION ANAL NEWBO; Ministry of Health Zanzibar National Bureau of Statistics Dar es Salaam Office of Chief Government Statitician Zanzibar ICF USAID UNICEF, 2016, TANZ DEM HLTH SURV M; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Northern Regional Alliance Northern Youth Health Network, 2017, STAND QUAL CAR AD YO; Reproductive and Child Health Section Ministry of Health and Social Welfare, 2015, TANZ UR MAT PER DEAT; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; WHO, 2016, MAK EV BAB COUNT AUD; WHO, 2018, MON FRAM QUAL EQ DIG; WHO, 2009, MON EM OBST CAR; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, 2016, MAT PER HLTH	26	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201238	10.1371/journal.pone.0201238	http://dx.doi.org/10.1371/journal.pone.0201238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052662	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600032
J	Ramirez-Paz, J; Saxena, M; Delinois, LJ; Joaquin-Ovalle, FM; Lin, S; Chen, ZF; Rojas-Nieves, VA; Griebenow, K				Ramirez-Paz, Josell; Saxena, Manoj; Delinois, Louis J.; Joaquin-Ovalle, Freisa M.; Lin, Shiru; Chen, Zhongfang; Rojas-Nieves, Virginia A.; Griebenow, Kai			Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis	PLOS ONE			English	Article							COLI L-ASPARAGINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; SITE-SPECIFIC PEGYLATION; CRYSTALLINE L-ASPARAGINASE; ESCHERICHIA-COLI; POLYETHYLENE-GLYCOL; THERAPEUTIC PROTEINS; MONOMETHOXYPOLYETHYLENE GLYCOL; BINDING ABILITY; DISULFIDE BONDS	L-Asparaginase is an enzyme successfully being used in the treatment of acute lymphoblastic leukemia, acute myeloid leukemia, and non-Hodgkin's lymphoma. However, some disadvantages still limit its full application potential, e.g., allergic reactions, pancreatitis, and blood clotting impairment. Therefore, much effort has been directed at improving its performance. A popular strategy is to randomly conjugate L-asparaginase with mono-methoxy polyethylene glycol, which became a commercial FDA approved formulation widely used in recent years. To improve this formulation by PEGylation, herein we performed cysteine-directed conjugation of the L-asparaginase subunits to prevent dissociation-induced loss of activity. The recombinant cysteine conjugation sites were introduced by mutagenesis at surface-exposed positions on the protein to avoid affecting the catalytic activity. Three conjugates were obtained using different linear PEGs of 1000, 2000, and 5000 g/mol, with physical properties ranging from a semi-solid gel to a fully soluble state. The soluble-conjugate exhibited higher catalytic activity than the non-conjugated mutant, and the same activity than the native enzyme. The cysteine-directed crosslinking of the L-asparaginase subunits produced a higher molecular weight conjugate compared to the native tetrameric enzyme. This strategy might improve L-asparaginase efficiency for leukemia treatment by reducing glomerular filtration due to the increase in hydrodynamic size thus extending half-live, while at the same time retaining full catalytic activity.	[Ramirez-Paz, Josell; Saxena, Manoj; Delinois, Louis J.; Joaquin-Ovalle, Freisa M.; Lin, Shiru; Chen, Zhongfang; Rojas-Nieves, Virginia A.; Griebenow, Kai] Univ Puerto Rico Rio Piedras, Fac Nat Sci, Dept Chem, San Juan, PR 00931 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras	Griebenow, K (corresponding author), Univ Puerto Rico Rio Piedras, Fac Nat Sci, Dept Chem, San Juan, PR 00931 USA.	kai.griebenow@gmail.com	Lin, Shiru/B-9209-2018; Griebenow, Kai H/AAS-2754-2021; Griebenow, Kai/AGK-1725-2022; Chen, Zhongfang/A-3397-2008	Lin, Shiru/0000-0002-0159-2269; Griebenow, Kai H/0000-0003-0495-9932; Chen, Zhongfang/0000-0002-1445-9184	RISE Program at the University of Puerto Rico Rio Piedras Campus, NIH Grant [5R25GM061151-16]; RISE Program at UPR Rio Piedras NIH Grant [5R25GM061151-16]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151] Funding Source: NIH RePORTER	RISE Program at the University of Puerto Rico Rio Piedras Campus, NIH Grant; RISE Program at UPR Rio Piedras NIH Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Materials, instrumentation and research facilities provided by Kai Griebenow's laboratory at Facundo Bueso Building at the University of Puerto Rico Rio Piedras campus. Instrumentation and research facilities provided by the Molecular Sciences Research Center at the University of Puerto Rico. Research materials and student stipend provided by the RISE Program at the University of Puerto Rico Rio Piedras Campus, NIH Grant No. 5R25GM061151-16.; This work was developed with materials, instrumentation and facilities provided by Kai Griebenow's research laboratory at Facundo Bueso building at the University of Puerto Rico Rio Piedras campus, the Molecular Sciences Research Center at the UPR, and RISE Program at UPR Rio Piedras NIH Grant No. 5R25GM061151-16. We like to thank Arthur D. Tinoco for his help with the mass spectroscopy instrumentation.	Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; ASHIHARA Y, 1978, BIOCHEM BIOPH RES CO, V83, P385, DOI 10.1016/0006-291X(78)91002-1; ASSELIN BL, 1991, CANCER RES, V51, P6568; Avramis VI, 2006, INT J NANOMED, V1, P241; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Balan S, 2007, BIOCONJUGATE CHEM, V18, P61, DOI 10.1021/bc0601471; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brocchini S, 2008, ADV DRUG DELIVER REV, V60, P3, DOI 10.1016/j.addr.2007.06.014; CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418; Dozier JK, 2015, INT J MOL SCI, V16, P25831, DOI 10.3390/ijms161025831; Farkas D., 2009, GAUSSIAN 09 REVISION; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; Gesto DS, 2013, J AM CHEM SOC, V135, P7146, DOI 10.1021/ja310165u; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HANDSCHUMACHER RE, 1972, MOL PHARMACOL, V8, P59; Hashimoto Y, 2014, TOXICOL APPL PHARM, V277, P30, DOI 10.1016/j.taap.2014.03.002; HO PPK, 1969, SCIENCE, V165, P510, DOI 10.1126/science.165.3892.510; HO PPK, 1970, J BIOL CHEM, V245, P3708; JACKSON CJC, 1987, ANAL BIOCHEM, V165, P114, DOI 10.1016/0003-2697(87)90208-9; JENNINGS MP, 1990, J BACTERIOL, V172, P1491, DOI 10.1128/jb.172.3.1491-1498.1990; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; KAMISAKI Y, 1981, J PHARMACOL EXP THER, V216, P410; Khushoo A, 2005, APPL MICROBIOL BIOT, V68, P189, DOI 10.1007/s00253-004-1867-0; Khushoo A, 2004, PROTEIN EXPRES PURIF, V38, P29, DOI 10.1016/j.pep.2004.07.009; KODERA Y, 1994, BIOCONJUGATE CHEM, V5, P283, DOI 10.1021/bc00028a001; Krishnapura PR, 2016, CRIT REV MICROBIOL, V42, P720, DOI 10.3109/1040841X.2015.1022505; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Lanvers-Kaminsky C, 2017, CANCER CHEMOTH PHARM, V79, P439, DOI 10.1007/s00280-016-3236-y; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; MATSUSHIMA A, 1980, CHEM LETT, P773, DOI 10.1246/cl.1980.773; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Mishra P, 2016, ASIAN J PHARM SCI, V11, P337, DOI 10.1016/j.ajps.2015.08.011; Muharram M, 2014, AFRICAN J MICROBIOL, V8, P1610; Nair DP, 2014, CHEM MATER, V26, P724, DOI 10.1021/cm402180t; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Patel N, 2009, J CLIN INVEST, V119, P1964, DOI 10.1172/JCI37977; Qian GQ, 1997, POLYM ADVAN TECHNOL, V8, P581, DOI 10.1002/(SICI)1099-1581(199710)8:10<581::AID-PAT689>3.0.CO;2-#; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; ROBERTS J, 1968, J BACTERIOL, V95, P2117, DOI 10.1128/JB.95.6.2117-2123.1968; Rodriguez-Martinez JA, 2008, BIOTECHNOL BIOENG, V101, P1142, DOI 10.1002/bit.22014; Rodriguez-Martinez JA, 2009, BIOTECHNOL LETT, V31, P883, DOI 10.1007/s10529-009-9947-y; Sharkey I, 2001, BRIT J CANCER, V85, P23, DOI 10.1054/bjoc.2001.1859; Shaunak S, 2006, NAT CHEM BIOL, V2, P312, DOI 10.1038/nchembio786; SHIFRIN S, 1974, J BIOL CHEM, V249, P1335; Shrivastava A, 2016, CRIT REV ONCOL HEMAT, V100, P1, DOI 10.1016/j.critrevonc.2015.01.002; Soares AL, 2002, INT J PHARMACEUT, V237, P163, DOI 10.1016/S0378-5173(02)00046-7; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Stecher A L, 1999, Pharm Acta Helv, V74, P1, DOI 10.1016/S0031-6865(99)00009-6; SUTOW WW, 1971, CANCER, V28, P819, DOI 10.1002/1097-0142(1971)28:4<819::AID-CNCR2820280403>3.0.CO;2-9; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Swierczewska M, 2015, EXPERT OPIN EMERG DR, V20, P531, DOI 10.1517/14728214.2015.1113254; TALLAL L, 1970, Cancer, V25, P306, DOI 10.1002/1097-0142(197002)25:2<306::AID-CNCR2820250206>3.0.CO;2-H; TODOKORO K, 1975, FEBS LETT, V60, P259, DOI 10.1016/0014-5793(75)80726-5; Ulu A, 2017, BIOCONJUGATE CHEM, V28, P1598, DOI 10.1021/acs.bioconjchem.7b00217; Upadhyay AK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00486; van den Berg H, 2011, LEUKEMIA LYMPHOMA, V52, P168, DOI 10.3109/10428194.2010.537796; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Vidya J, 2011, FOOD TECHNOL BIOTECH, V49, P286; Vreven T, 2001, J CHEM PHYS, V115, P62, DOI 10.1063/1.1376127; Wang BC, 2012, Z NATURFORSCH C, V67, P312, DOI 10.5560/ZNC.2012.67c0312; WRISTON JC, 1985, METHOD ENZYMOL, V113, P608; Zhang C, 2012, BIODRUGS, V26, P209, DOI 10.2165/11633350-000000000-00000	65	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0197643	10.1371/journal.pone.0197643	http://dx.doi.org/10.1371/journal.pone.0197643			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052638	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600001
J	Zheng, J; Sadot, E; Vigidal, JA; Klimstra, DS; Balachandran, VP; Kingham, TP; Allen, PJ; D'Angelica, MI; DeMatteo, RP; Jarnagin, WR; Ventura, A				Zheng, Jian; Sadot, Eran; Vigidal, Joana A.; Klimstra, David S.; Balachandran, Vinod P.; Kingham, T. Peter; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Jarnagin, William R.; Ventura, Andrea			Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing	PLOS ONE			English	Article							FOCAL NODULAR HYPERPLASIA; TUMORIGENESIS; CANCER; CELLS; CLASSIFICATION; EXPRESSION; MANAGEMENT; TUMORS; PROLIFERATION; PROGRESSION	Background Hepatocellular adenomas (HCA) are benign liver tumors that may transform into hepatocellular carcinoma (HCC), but the molecular drivers of this transformation remain ill-defined. This study evaluates the molecular changes in HCA and HCC and in comparison to their adjacent non-neoplastic liver. Methods 11 patients with HCA and 10 patients with HCC without underlying hepatitis or cirrhosis were included in this pilot study. Tumor and non-tumor liver tissues were selected for immunohistochemical staining, small RNA sequencing, and targeted gene sequencing. We compared microRNA expressions and mutations between HCA and HCC and non-neoplastic liver. Results HCA were classified as inflammatory (n = 6), steatotic (n = 4), or beta-catenin activated (n = 1) subtypes. MicroRNA profile of all 3 HCA subtypes clustered between that of normal liver and HCC in principal component analysis. In both HCA and HCC, miR-200a, miR-429, and miR-490-3p were significantly downregulated compared to normal liver, whereas miR-452, miR-766, and miR-1180 were significantly upregulated. In addition, compared to HCA, HCC had significantly higher expression of members of the chromosome 19 miRNA cluster (C19MC), including miR-515-5p, miR-517a, miR-518b, and miR-520c-3p. Conclusions This study indicates that while there are significant differences in the molecular profile between HCA and HCC, several miRNAs are similarly deregulated in HCA and HCC compared to adjacent normal liver. These results may provide insights into the drivers of hepato-carcinogenesis and warrant further investigations.	[Zheng, Jian; Sadot, Eran; Balachandran, Vinod P.; Kingham, T. Peter; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Sadot, Eran] Rabin Med Ctr, Dept Surg, Petah Tiqwa, Israel; [Sadot, Eran] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Vigidal, Joana A.; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Vigidal, Joana A.] NCI, Lab Biochem & Mol Biol, Bethesda, MD 20892 USA; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rabin Medical Center; Tel Aviv University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center	Jarnagin, WR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Ventura, A (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	jarnagiw@mskcc.org; venturaa@mskcc.org		Ventura, Andrea/0000-0003-4320-9907; Zheng, Jian/0000-0003-3600-0742	NIH/NCI [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH/NCI P30 CA008748 Cancer Center Support Grant to WRJ, and there was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, CLIN GASTROENTEROL H, V13, P1221, DOI 10.1016/j.cgh.2014.05.023; Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Alberti N, 2015, CLIN RES HEPATOL GAS, V39, DOI 10.1016/j.clinre.2014.08.007; Augello C, 2012, LIVER INT, V32, P772, DOI 10.1111/j.1478-3231.2012.02795.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barthelmes Ludger, 2005, HPB (Oxford), V7, P186, DOI 10.1080/13651820510028954; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bioulac-Sage P, 2012, AM J SURG PATHOL, V36, P1691, DOI 10.1097/PAS.0b013e3182653ece; Bioulac-Sage P, 2009, HEPATOLOGY, V50, P481, DOI 10.1002/hep.22995; Bioulac-Sage P, 2009, LIVER INT, V29, P459, DOI 10.1111/j.1478-3231.2008.01849.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen S, 2015, CANCER LETT, V362, P122, DOI 10.1016/j.canlet.2015.03.029; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu HH, 2014, BIOCHEM BIOPH RES CO, V444, P104, DOI 10.1016/j.bbrc.2014.01.020; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hung CS, 2013, ANN SURG ONCOL, V20, pS360, DOI 10.1245/s10434-012-2482-4; Karkar AM, 2013, HPB, V15, P235, DOI 10.1111/j.1477-2574.2012.00584.x; Khemlina G, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0712-x; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li XL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-159; Li YC, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S89459; Nault JC, 2013, GASTROENTEROLOGY, V144, P888, DOI 10.1053/j.gastro.2013.02.032; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pinho FG, 2013, CANCER RES, V73, P5936, DOI 10.1158/0008-5472.CAN-13-0158; Rebouissou S, 2016, HEPATOLOGY, V64, P2047, DOI 10.1002/hep.28638; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roncalli M, 2016, CLIN MOL HEPATOL, V22, P199, DOI 10.3350/cmh.2016.0101; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen J, 2015, CANCER RES, V75, P754, DOI 10.1158/0008-5472.CAN-14-1301; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Wojcicka A, 2014, INT J BIOCHEM CELL B, V53, P208, DOI 10.1016/j.biocel.2014.05.020; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Wong CM, 2015, ONCOTARGET, V6, P13658, DOI 10.18632/oncotarget.3700; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhao L, 2016, ONCOTARGETS THER, V9, P4505, DOI 10.2147/OTT.S100037; Zheng QL, 2014, MOL CELL BIOCHEM, V389, P187, DOI 10.1007/s11010-013-1940-z; Zhou X, 2016, BIOMED PHARMACOTHER, V79, P315, DOI 10.1016/j.biopha.2016.02.025; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	49	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200776	10.1371/journal.pone.0200776	http://dx.doi.org/10.1371/journal.pone.0200776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052636	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600014
J	Dumont, L; Larochelle-Brunet, F; Theoret, H; Riedl, R; Senecal, S; Leger, PM				Dumont, Laurence; Larochelle-Brunet, Felix; Theoret, Hugo; Riedl, Rene; Senecal, Sylvain; Leger, Pierre-Majorique			Non-invasive brain stimulation in information systems research: A proof-of-concept study	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; COGNITIVE NEUROSCIENCE; RISK-TAKING; TDCS; HEALTHY; NEUROIS; ACCEPTANCE; PERCEPTION; ACTIVATION; INCREASES	One of the founding experiments in the field of Neuro-Information-Systems (NeuroIS), which aims at exploring the neural correlates of the technology acceptance model, suggests that perceived ease of use (PEoU) is associated with activity in the dorsolateral prefrontal cortex (DLPFC) while perceived usefulness is associated with activity in the insula, caudate nucleus and anterior cingulate cortex. To further assess the link between DLPFC and PEoU, transcranial direct current stimulation (tDCS) was applied over bilateral DLPFC (F3 and F4) immediately before an online shopping task. Forty-two participants were divided in three stimulation groups: left anodal/right cathodal, left cathodal/right anodal and sham. No change in PEoU was observed post stimulation but participants in the left anodal/right cathodal stimulation group took longer to make a purchase compared to sham stimulation and had different visual fixation patterns over the buy buttons. This is, to our knowledge, the first use of non-invasive brain stimulation in the field of NeuroIS. Although the involvement of DLPFC in PEoU could not be confirmed, the present study suggests that non-invasive brain stimulation may be a useful research tool in NeuroIS.	[Dumont, Laurence; Larochelle-Brunet, Felix; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Dumont, Laurence; Senecal, Sylvain; Leger, Pierre-Majorique] HEC Montreal, Tech3Lab, Montreal, PQ, Canada; [Riedl, Rene] Univ Linz, Dept Business Informat Informat Engn, Linz, Austria; [Riedl, Rene] Univ Appl Sci Upper Austria, Sch Management, Digital Business, Steyr, Austria	Universite de Montreal; Universite de Montreal; HEC Montreal; Johannes Kepler University Linz	Dumont, L (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Dumont, L (corresponding author), HEC Montreal, Tech3Lab, Montreal, PQ, Canada.	laurence.dumont@hec.ca		Theoret, Hugo/0000-0002-7458-8797; Dumont, Laurence/0000-0002-8081-7525	Social Sciences and Humanities Research Council [435-2012-1232]	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by a grant from the Social Sciences and Humanities Research Council (http://www.sshrc-crsh.gc.ca/) (435-2012-1232). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASB, 2008, PROJ MANAG J, V39, P5, DOI 10.1002/pmj.20041; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Benwell CSY, 2015, CORTEX, V69, P152, DOI 10.1016/j.cortex.2015.05.007; Berryhill ME, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00800; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Boggio PS, 2010, DRUG ALCOHOL DEPEN, V112, P220, DOI 10.1016/j.drugalcdep.2010.06.019; Boonstra TW, 2016, FRONT HUM NEUROSCI, V10, P1; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; DAVIS FD, 1993, INT J MAN MACH STUD, V38, P475, DOI 10.1006/imms.1993.1022; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; Dimoka A, 2011, INFORM SYST RES, V22, P687, DOI 10.1287/isre.1100.0284; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fecteau Shirley, 2012, Front Psychiatry, V3, P97, DOI 10.3389/fpsyt.2012.00097; Fregni F, 2008, APPETITE, V51, P34, DOI 10.1016/j.appet.2007.09.016; Hecht D, 2010, J NEUROSCI, V30, P4241, DOI 10.1523/JNEUROSCI.2924-09.2010; Hornbak Kasper, 2017, ACM Transactions on Computer-Human Interaction, V24, DOI 10.1145/3127358; Hortensius R, 2012, SOC COGN AFFECT NEUR, V7, P342, DOI 10.1093/scan/nsr012; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Kable Joseph W, 2011, J Neurosci Psychol Econ, V4, P63; Keinanen H, 2015, J BUS IND MARK, V30, P711, DOI 10.1108/JBIM-04-2013-0095; Kuo M-F, 2016, PHYSL TRANSCRANIAL D, P29, DOI [10.1007/978-3-319-33967-2_3, DOI 10.1007/978-3-319-33967-2_3]; Lauro LJR, 2014, CORTEX, V58, P99, DOI 10.1016/j.cortex.2014.05.003; Leite J, 2013, BRAIN STIMUL, V6, P660, DOI 10.1016/j.brs.2012.10.006; Loiacono ET, 2007, INT J ELECTRON COMM, V11, P51, DOI 10.2753/JEC1086-4415110302; Loos P, 2010, BUS INFORM SYST ENG+, V2, P395, DOI 10.1007/s12599-010-0130-8; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mancuso LE, 2016, J COGNITIVE NEUROSCI, V28, P1063, DOI 10.1162/jocn_a_00956; Minati L, 2012, COGN NEUROSCI-UK, V3, P80, DOI 10.1080/17588928.2011.628382; Mylius V, 2013, NEUROIMAGE, V78, P224, DOI 10.1016/j.neuroimage.2013.03.061; Mylius V, 2012, EUR J PAIN, V16, P974, DOI 10.1002/j.1532-2149.2011.00105.x; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Pechmann C, 1988, J CURRENT ISSUES RES, V11, P285, DOI DOI 10.1080/01633392.1988.10504936; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Riedl R, 2017, P INT C INF SYST; Riedl R., 2016, FUNDAMENTALS NEUROIS, DOI [10.1007/978-3-662-450 91-8, DOI 10.1007/978-3-662-45091-8, 10.1007/978-3-662-45091-8]; Riedl R, 2010, COMMUN ASSOC INF SYS, V27, P243; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schestatsky P, 2013, JOVE-J VIS EXP, DOI 10.3791/50426; Sela T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00022; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247	57	5	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201128	10.1371/journal.pone.0201128	http://dx.doi.org/10.1371/journal.pone.0201128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048490	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400052
J	Mahapatra, C; Brain, KL; Manchanda, R				Mahapatra, Chitaranjan; Brain, Keith L.; Manchanda, Rohit			A biophysically constrained computational model of the action potential of mouse urinary bladder smooth muscle	PLOS ONE			English	Article							POTASSIUM CHANNELS; SMALL-CONDUCTANCE; CA2+ CHANNELS; BK CHANNEL; PHARMACOLOGICAL ACTIVATION; EXCITATION-CONTRACTION; ELECTRICAL-ACTIVITY; MATHEMATICAL-MODEL; ION CHANNELS; K+ CHANNEL	Urinary incontinence is associated with enhanced spontaneous phasic contractions of the detrusor smooth muscle (DSM). Although a complete understanding of the etiology of these spontaneous contractions is not yet established, it is suggested that the spontaneously evoked action potentials (sAPs) in DSM cells initiate and modulate the contractions. In order to further our understanding of the ionic mechanisms underlying sAP generation, we present here a biophysically detailed computational model of a single DSM cell. First, we constructed mathematical models for nine ion channels found in DSM cells based on published experimental data: two voltage gated Ca2+ ion channels, an hyperpolarization-activated ion channel, two voltage-gated K+ ion channels, three Ca2+-activated K+ ion channels and a nonspecific background leak ion channel. The ion channels' kinetics were characterized in terms of maximal conductances and differential equations based on voltage or calcium-dependent activation and inactivation. All ion channel models were validated by comparing the simulated currents and current-voltage relations with those reported in experimental work. Incorporating these channels, our DSM model is capable of reproducing experimentally recorded spiketype sAPs of varying configurations, ranging from sAPs displaying after-hyperpolarizations to sAPs displaying after-depolarizations. The contributions of the principal ion channels to spike generation and configuration were also investigated as a means of mimicking the effects of selected pharmacological agents on DSM cell excitability. Additionally, the features of propagation of an AP along a length of electrically continuous smooth muscle tissue were investigated. To date, a biophysically detailed computational model does not exist for DSM cells. Our model, constrained heavily by physiological data, provides a powerful tool to investigate the ionic mechanisms underlying the genesis of DSM electrical activity, which can further shed light on certain aspects of urinary bladder function and dysfunction.	[Mahapatra, Chitaranjan; Manchanda, Rohit] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Brain, Keith L.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Birmingham	Manchanda, R (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	rmanch@iitb.com	Brain, Keith L./AFU-7168-2022	Brain, Keith L./0000-0002-0906-7012	Department of Biotechnology (DBT), India [BT/PR14326/MED/30/483/2010, BT/PR12973/MED/122/47/2016]; UK-India Education and Research Initiative (UKIERI), UK [number UKUTP 20110055]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); UK-India Education and Research Initiative (UKIERI), UK	This work is supported in part by Department of Biotechnology (DBT), India (grant number BT/PR14326/MED/30/483/2010), BT/PR12973/MED/122/47/2016 and the UK-India Education and Research Initiative (UKIERI), UK (grant number UKUTP 20110055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V62, P28, DOI 10.1016/j.urology.2003.09.050; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Afeli SAY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075875; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Aliev RR, 2000, J THEOR BIOL, V204, P21, DOI 10.1006/jtbi.2000.1069; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Anderson UA, 2009, J UROLOGY, V182, P330, DOI 10.1016/j.juro.2009.02.108; Andrej-Nikolai Spiess, 2010, BMC PHARM, V10, P6, DOI DOI 10.1186/1471-2210-10-6; [Anonymous], 2008, N-S ARCH PHARMACOL, V376, P309, DOI [10.1007/s00210-007-0241-z, DOI 10.1007/S00210-007-0241-Z]; Appukuttan S, 2015, J COMPUT NEUROSCI, V38, P167, DOI 10.1007/s10827-014-0532-6; Aydin M, 2012, BJU INT, V110, pE402, DOI 10.1111/j.1464-410X.2012.11137.x; BONEV AD, 1993, AM J PHYSIOL, V264, pC1190, DOI 10.1152/ajpcell.1993.264.5.C1190; Bootman MD, 2001, J CELL SCI, V114, P2213; Brading A F, 2011, Handb Exp Pharmacol, P375, DOI 10.1007/978-3-642-16499-6_18; Brading AF, 2006, J PHYSIOL-LONDON, V570, P13, DOI 10.1113/jphysiol.2005.097311; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; Cha CY, 2008, PROG BIOPHYS MOL BIO, V96, P399, DOI 10.1016/j.pbiomolbio.2007.07.007; Chen MY, 2009, J UROLOGY, V182, P374, DOI 10.1016/j.juro.2009.02.109; Chow KY, 2003, NEUROUROL URODYNAM, V22, P77, DOI 10.1002/nau.10081; Corrias A, 2008, AM J PHYSIOL-GASTR L, V294, pG989, DOI 10.1152/ajpgi.00528.2007; Corrias A, 2007, ANN BIOMED ENG, V35, P1595, DOI 10.1007/s10439-007-9324-8; Cox DH, 2014, BIOPHYS J, V107, P2797, DOI 10.1016/j.bpj.2014.10.069; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Ekman M, 2009, BJU INT, V104, P690, DOI 10.1111/j.1464-410X.2009.08576.x; Fry CH, 2004, UROLOGY, V63, P3, DOI 10.1016/j.urology.2003.11.005; Fry CH, 1999, J UROLOGY, V161, P660, DOI 10.1016/S0022-5347(01)61990-6; Fujii K, 1990, BRIT J PHARM, V99; Green ME, 1996, BRIT J PHARMACOL, V119, P1509, DOI 10.1111/j.1476-5381.1996.tb16066.x; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hashitani H, 2003, BRIT J PHARMACOL, V140, P159, DOI 10.1038/sj.bjp.0705320; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heppner TJ, 2009, J PHYSIOL-LONDON, V587, P5275, DOI 10.1113/jphysiol.2009.178806; Herrera GM, 2005, AM J PHYSIOL-REG I, V289, pR402, DOI 10.1152/ajpregu.00488.2004; Herrera GM, 2003, J PHYSIOL-LONDON, V551, P893, DOI 10.1113/jphysiol.2003.045914; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; Hines M. L., 2006, NEURON, V9; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hristov KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068052; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC1632, DOI 10.1152/ajpcell.00417.2011; Hristov KL, 2011, AM J PHYSIOL-CELL PH, V301, pC903, DOI 10.1152/ajpcell.00495.2010; Hristov KL, 2008, AM J PHYSIOL-CELL PH, V295, pC1344, DOI 10.1152/ajpcell.00001.2008; Hudman D, 2000, EUR J PHARMACOL, V397, P169, DOI 10.1016/S0014-2999(00)00229-6; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jacobsen JCB, 2007, AM J PHYSIOL-HEART C, V293, pH229, DOI 10.1152/ajpheart.00727.2006; John J, 2011, J BIOSCIENCES, V36, P309, DOI 10.1007/s12038-011-9039-8; Kajioka S, 2002, EUR J PHARMACOL, V443, P19, DOI 10.1016/S0014-2999(02)01593-5; Kapela A, 2008, J THEOR BIOL, V253, P238, DOI 10.1016/j.jtbi.2008.03.004; KLOCKNER U, 1985, PFLUG ARCH EUR J PHY, V405, P329, DOI 10.1007/BF00595685; Koenigsberger M, 2004, BIOPHYS J, V87, P92, DOI 10.1529/biophysj.103.037853; Korogod SM, 2014, NEUROPHYSIOLOGY+, V46, P293, DOI 10.1007/s11062-014-9447-0; Layne JJ, 2010, AM J PHYSIOL-REG I, V298, pR378, DOI 10.1152/ajpregu.00458.2009; Li LK, 2007, NEUROUROL URODYNAM, V26, P870, DOI 10.1002/nau.20392; Li N, 2018, IEEE T CONTR SYST T, V26, P1782, DOI 10.1109/TCST.2017.2723574; Mahapatra C, 2016, NEUROUROL URODYNAM, V35, pS332; Mahapatra C, 2017, J UROLOGY, V197, pE544, DOI 10.1016/j.juro.2017.02.1290; Mahapatra C, 2015, BIOPHYS J, V108, p588A, DOI 10.1016/j.bpj.2014.11.3204; Mahapatra C, 2015, I IEEE EMBS C NEUR E, P832, DOI 10.1109/NER.2015.7146752; Malysz J, 2014, AM J PHYSIOL-CELL PH, V306, pC45, DOI 10.1152/ajpcell.00047.2013; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; Miftakhov RN, 1996, BIOL CYBERN, V74, P167, DOI 10.1007/BF00204205; Morimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC388, DOI 10.1152/ajpcell.00409.2005; Nausch B, 2010, AM J PHYSIOL-REG I, V299, pR878, DOI 10.1152/ajpregu.00180.2010; Ohya S, 2001, JAPANESE J PHARM, V84, P97; Okinami T, 2014, ALTERED DETRUSOR GAP; Padmakumar M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190016; Parajuli SP, 2013, BRIT J PHARMACOL, V168, P1611, DOI 10.1111/bph.12049; Parajuli SP, 2012, J PHARMACOL EXP THER, V340, P114, DOI 10.1124/jpet.111.186213; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2001, AM J PHYSIOL-REG I, V280, pR1427, DOI 10.1152/ajpregu.2001.280.5.R1427; Poh YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042385; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; Schulson E. M., 2009, CREEP FRACTURE ICE, P101; SIBLEY GNA, 1984, J PHYSIOL-LONDON, V354, P431, DOI 10.1113/jphysiol.1984.sp015386; Soder RP, 2013, AM J PHYSIOL-REG I, V304, pR155, DOI 10.1152/ajpregu.00363.2012; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Sui GP, 2003, BJU INT, V92, P476, DOI 10.1046/j.1464-410X.2003.04356.x; Sui GP, 2001, J UROLOGY, V165, P621, DOI 10.1097/00005392-200102000-00084; Sui GP, 2001, J UROLOGY, V165, P627, DOI 10.1097/00005392-200102000-00085; Sui GP, 2007, BJU INT, V99, P436, DOI 10.1111/j.1464-410X.2006.06568.x; Svalo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117350; Svalo J, 2012, BASIC CLIN PHARMACOL, V110, P145, DOI 10.1111/j.1742-7843.2011.00765.x; Takagi H, 2016, EUR J PHARMACOL, V789, P179, DOI 10.1016/j.ejphar.2016.07.041; Thorneloe KS, 2008, AM J PHYSIOL-REG I, V294, pR1737, DOI 10.1152/ajpregu.00840.2006; Thorneloe KS, 2004, AM J PHYSIOL-CELL PH, V286, pC1246, DOI 10.1152/ajpcell.00501.2003; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Turner WH, 1997, PHARMACOL THERAPEUT, V75, P77, DOI 10.1016/S0163-7258(97)00038-7; Vogalis F, 1998, BBA-BIOMEMBRANES, V1371, P309, DOI 10.1016/S0005-2736(98)00029-7; Yanai Y, 2006, BJU INT, V97, P182, DOI 10.1111/j.1464-410X.2006.05894.x; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040	97	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200712	10.1371/journal.pone.0200712	http://dx.doi.org/10.1371/journal.pone.0200712			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048468	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400014
J	Walker, IF; Khanal, S; Hicks, JP; Lamichhane, B; Thapa, A; Elsey, H; Baral, SC; Newell, JN				Walker, Ian F.; Khanal, Sudeepa; Hicks, Joe P.; Lamichhane, Bikash; Thapa, Anil; Elsey, Helen; Baral, Sushil C.; Newell, James N.			Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study	PLOS ONE			English	Article							MENTAL-HEALTH; SEVERE DEPRESSION; PRIMARY-CARE; TRIAL; INDIA	Background and objectives People receiving treatment for multidrug-resistant tuberculosis (MDR-TB) have high rates of depression. Psychosocial support in general, and treatments for depression in particular, form an important but neglected area of patient-centred care, and a key pillar in the global End TB strategy. We assessed the feasibility and acceptability of a psychosocial support package for people receiving treatment for MDR-TB in Nepal. Methods This feasibility study used a mixed quantitative and qualitative approach. We implemented the intervention package in two National Tuberculosis Programme (NTP) MDR-TB treatment centres and 8 sub-centres. We screened patients monthly for depression and anxiety (cut-off >= 24 and >= 17 respectively on the Hopkins Symptom Checklist) and also for low social support (cut-off <= 3 on the Multidimensional Scale of Perceived Social Support). Those who screened positive on either screening tool received the Healthy Activity Program (HAP), which uses brief counselling based on behavioural activation theory. Other aspects of the psychosocial package were information/education materials and group interactions with other patients. Results We screened 135 patients, of whom 12 (9%) received HAP counselling, 115 (85%) received information materials, 80 (59%) received an education session and 49 (36%) received at least one group session. Eight group sessions were conducted in total. All aspects of the intervention package were acceptable to patients, including the screening, information, group work and counselling. Patients particularly valued having someone to talk to about their concerns and worries. We were able to successfully train individuals with no experience of psychological counselling to deliver HAP. Conclusion This psychosocial support package is acceptable to patients. The information materials we developed are feasible to deliver in the current NTP. However, the structured psychological counselling (HAP), is not feasible in the current NTP due to time constraints. This requires additional investment of counsellors in TB clinics.	[Walker, Ian F.; Hicks, Joe P.; Elsey, Helen; Newell, James N.] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Khanal, Sudeepa; Baral, Sushil C.] Hlth Res & Social Dev Forum HERD, Kathmandu, Nepal; [Lamichhane, Bikash; Thapa, Anil] Govt Nepal, Natl TB Ctr, Kathmandu, Nepal	University of Leeds	Walker, IF (corresponding author), Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England.	i.walker@leeds.ac.uk	Elsey, Helen/AAZ-1121-2020	Elsey, Helen/0000-0003-4724-0581; Walker, Ian/0000-0001-5707-6389	COMDIS-HSD, a research consortium - UK aid from the UK government (Department for International Development)	COMDIS-HSD, a research consortium - UK aid from the UK government (Department for International Development)	This study was funded by COMDIS-HSD, a research consortium funded by UK aid from the UK government (Department for International Development): however, the views expressed do not necessarily reflect the UK government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha J, 2007, Glob Public Health, V2, P404, DOI 10.1080/17441690701191610; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; Chowdhary N, 2016, BRIT J PSYCHIAT, V208, P381, DOI 10.1192/bjp.bp.114.161075; Cresswell J., 2014, CONCISE INTRO MIXED; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Government of Nepal, 2016, ANN TUB REP 2014 15; Government of Nepal, 2016, NAT STRAT APPL 2016; Jordans MJD, 2016, BRIT J PSYCHIAT, V208, pS21, DOI 10.1192/bjp.bp.114.153718; Khanal S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167559; Kohrt BA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0768-y; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Richards DA, 2016, LANCET, V388, P871, DOI 10.1016/S0140-6736(16)31140-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Thapa SB, 2005, SOC PSYCH PSYCH EPID, V40, P672, DOI 10.1007/s00127-005-0943-9; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147397; Walker IF, 2017, INT J TUBERC LUNG D, V21, P603, DOI 10.5588/ijtld.17.0135; *WHO, 2015, THE END TB STRAT; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2015, GLOB TUB REP 2015; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	25	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201163	10.1371/journal.pone.0201163	http://dx.doi.org/10.1371/journal.pone.0201163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048495	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000439952400055
J	Santaus, TM; Li, S; Ladd, P; Harvey, A; Cole, S; Stine, OC; Geddes, CD				Santaus, Tonya M.; Li, Shan; Ladd, Paula; Harvey, Amanda; Cole, Shannon; Stine, O. Colin; Geddes, Chris D.			Rapid sample preparation with Lyse-It (R) for Listeria monocytogenes and Vibrio cholerae	PLOS ONE			English	Article							METAL-ENHANCED FLUORESCENCE; ULTRA-FAST; MICROWAVE; DNA; GROWTH; EXTRACTION; CELLS; ASSAY	Sample preparation is a leading bottleneck in rapid detection of pathogenic bacteria. Here, we use Lyse-It (R) for bacterial cellular lysis, genomic DNA fragmentation, and protein release and degradation for both Listeria monocytogenes and Vibrio cholerae. The concept of Lyse-It (R) employs a conventional microwave and Lyse-It (R) slides for intensely focused microwave irradiation onto the sample. High microwave power and a <60 second irradiation time allow for rapid cellular lysis and subsequent intracellular component release. The pathogenic bacteria are identified by quantitative polymerase chain reaction (qPCR), which subsequently demonstrates the viability of DNA for amplification post microwave-induced lysis. Intracellular component release, degradation, and detection of L. monocytogenes and V. cholerae has been performed and shown in this paper. These results demonstrate a rapid, low-cost, and efficient way for bacterial sample preparation on both food and water-borne Gram-positive and -negative organisms alike.	[Santaus, Tonya M.; Ladd, Paula; Harvey, Amanda; Cole, Shannon; Geddes, Chris D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Santaus, Tonya M.; Geddes, Chris D.] Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA; [Li, Shan; Stine, O. Colin] Univ Maryland, Sch Med, Epidemiol & Publ Hlth Dept, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.; Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA.	geddes@umbc.edu		Cole, Shannon/0000-0003-1805-1407; Santaus, Tonya/0000-0002-8643-2343; Stine, O. Colin/0000-0003-3974-3752	UMBC-UMB Cholera joint training grant; National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship [T32GM066706-14]; Institute of Fluorescence; University of Maryland School Medicine departments of Public Health and Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	UMBC-UMB Cholera joint training grant; National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship; Institute of Fluorescence; University of Maryland School Medicine departments of Public Health and Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the UMBC-UMB Cholera joint training grant and the National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship (T32GM066706-14). We would also like to thank the Institute of Fluorescence and the University of Maryland School Medicine departments of Public Health and Epidemiology for their support, advice, and funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CONTR CFD; [Anonymous], KEY PHRASE HEADINGS, DOI [10.1007/s10895-005-0026-z, DOI 10.1007/S10895-005-0026-Z]; [Anonymous], 2016, VIBRIO CHOLERA; [Anonymous], 2015, CONTR CFD; Aslan K, 2006, J FLUORESC, V16, P3, DOI 10.1007/s10895-005-0026-z; Aslan K, 2008, PLASMONICS, V3, P89, DOI 10.1007/s11468-008-9059-x; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Aslan K, 2007, ANALYST, V132, P1130, DOI 10.1039/b707876e; BiologyWise, 2018, GRAM NEG GRAM POS BA; Cecchini F, 2016, TRAC-TREND ANAL CHEM, V79, P199, DOI 10.1016/j.trac.2016.01.017; Chen MW, 2004, SCANNING, V26, pI113; Diffen, 2018, GRAM POS GRAM NEG BA; Dragan A, 2014, J FLUORESC, V24, P1715, DOI 10.1007/s10895-014-1458-0; Dragan AI, 2012, ANAL BIOCHEM, V425, P54, DOI 10.1016/j.ab.2012.02.040; FARBER JM, 1988, CAN MED ASSOC J, V138, P413; FARBER JM, 1992, LETT APPL MICROBIOL, V15, P103, DOI 10.1111/j.1472-765X.1992.tb00737.x; Friedlander T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004055; Hasan D, 2016, ADV OPT MATER, V4, P943, DOI 10.1002/adom.201600014; Hu SR, 2016, ACS PHOTONICS, V3, P1647, DOI 10.1021/acsphotonics.6b00219; Javid A, 2017, PHYS CHEM CHEM PHYS, V19, P237, DOI 10.1039/c6cp06955j; Joshi LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104334; Kumar M, 2016, ARCH BIOCHEM BIOPHYS, V605, P41, DOI 10.1016/j.abb.2016.03.026; Melendez JH, 2016, ANAL BIOCHEM, V510, P33, DOI 10.1016/j.ab.2016.06.017; Melendez JH, 2013, J CLIN MICROBIOL, V51, P2913, DOI 10.1128/JCM.00980-13; Previte MJR, 2007, OPT EXPRESS, V15, P11640, DOI 10.1364/OE.15.011640; Previte MJR, 2007, J FLUORESC, V17, P279, DOI 10.1007/s10895-007-0170-8; Rodriguez-Lazaro D, 2005, APPL ENVIRON MICROB, V71, P9008, DOI 10.1128/AEM.71.12.9008-9012.2005; Rodriguez-Lazaro D, 2006, J RAPID METH AUT MIC, V14, P395, DOI 10.1111/j.1745-4581.2006.00058.x; Silva S, 2008, J FOOD PROTECT, V71, P1379, DOI 10.4315/0362-028X-71.7.1379; Sung HJ, 2014, LWT-FOOD SCI TECHNOL, V59, P754, DOI 10.1016/j.lwt.2014.05.058; Tennant SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018700; Woo IS, 2000, APPL ENVIRON MICROB, V66, P2243, DOI 10.1128/AEM.66.5.2243-2247.2000; Zhang YX, 2011, IEEE T BIO-MED ENG, V58, P781, DOI 10.1109/TBME.2010.2066275	33	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201070	10.1371/journal.pone.0201070	http://dx.doi.org/10.1371/journal.pone.0201070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044836	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500077
J	Sin, S; Lee, KH; Hur, JH; Lee, SH; Lee, YJ; Cho, YJ; Yoon, HI; Lee, JH; Lee, CT; Park, JS				Sin, Sooim; Lee, Kyung Hee; Hur, Jee Hye; Lee, Sang-Hoon; Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon Taek; Park, Jong Sun			Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis	PLOS ONE			English	Article							USUAL INTERSTITIAL PNEUMONITIS; DISEASE SEVERITY; SCORING SYSTEM; LUNG; CLASSIFICATION; INDEX; LYMPHANGIOGENESIS; PREVALENCE; VALIDATION; PHYSIOLOGY	Background Mediastinal lymph node enlargement (LNE) is common in idiopathic pulmonary fibrosis (IPF) and is known to be associated with the severity of lung fibrosis. However, the relationship between mediastinal LNE and the prognosis of IPF has not been determined to date. Methods This study included patients with IPF from the interstitial lung disease registry at Seoul National University Bundang Hospital, from January 2012 to March 2016. Two thoracic radiologists independently reviewed mediastinal LNE and lung parenchymal fibrosis and ground glass opacities in chest computed tomography scans of each patient, which were obtained upon diagnosis. Mortality and admission rates were analyzed. Results In total, 132 patients (104 [78.8%] male; median age, 72 years; range, 51-84 years) were enrolled and 73 (55.3%) patients had mediastinal LNE (short axis >= 10 mm in diameter). Mortality was significantly higher among patients with LNE than among those without LNE (hazard ratio 2.26 [95% confidence interval 1.20-4.23], p = 0.011). Of the patients with LNE, 24.7% experienced acute exacerbation and 43.8% experienced hospital admission for respiratory causes, in comparison with 16.9% and 40.0% of patients without LNE respectively. Although patients with LNE had a tendency to have increased rate of acute exacerbation, it was not statistically significant. Conclusion Mediastinal LNE in IPF is associated with increased mortality and its occurrence may be considered a poor prognostic factor in patients with IPF.	[Sin, Sooim] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea; [Lee, Kyung Hee] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea; [Hur, Jee Hye] Hanil Gen Hosp, Dept Radiol, Seoul, South Korea; [Lee, Sang-Hoon; Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae Ho; Lee, Choon Taek; Park, Jong Sun] Seoul Natl Univ, Bundang Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Coll Med, Seongnam Si, Gyeonggi Do, South Korea; [Lee, Sang-Hoon] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Inst Chest Dis,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System	Park, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Coll Med, Seongnam Si, Gyeonggi Do, South Korea.	jspark.im@gmail.com	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462; Lee, Sang Hoon/0000-0002-7706-5318; Hur, Jee Hye/0000-0001-5718-8647	Seoul National University Bundang Hospital Research Fund [11-2011-036]	Seoul National University Bundang Hospital Research Fund	This study was supported by a grant (grant No. 11-2011-036) from the Seoul National University Bundang Hospital Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attili AK, 2006, J THORAC IMAG, V21, P288, DOI 10.1097/01.rti.0000213562.55914.9a; BERGIN C, 1990, AM J ROENTGENOL, V154, P251, DOI 10.2214/ajr.154.2.2105008; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Cui Y, 2014, LYMPHAT RES BIOL, V12, P238, DOI 10.1089/lrb.2014.0012; Daccord C., 2016, F1000RESEARCH, V5; El-Chemaly Souheil, 2009, Lymphatic Research and Biology, V7, P197, DOI 10.1089/lrb.2009.0014; El-Chemaly S, 2009, P NATL ACAD SCI USA, V106, P3958, DOI 10.1073/pnas.0813368106; GARBER SJ, 1992, BRIT J RADIOL, V65, P983, DOI 10.1259/0007-1285-65-779-983; Johannson KA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0403-7; Jung JI, 2000, J COMPUT ASSIST TOMO, V24, P706, DOI 10.1097/00004728-200009000-00007; Kim ES, 2015, CHEST, V147, P430, DOI 10.1378/chest.14-0453; Kim H, 2014, J CLIN INVEST, V124, P936, DOI 10.1172/JCI71607; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Kolb M, 2014, EUR RESPIR REV, V23, P220, DOI 10.1183/09059180.00002114; Kondoh S, 2016, RESPIR INVESTIG, V54, P327, DOI 10.1016/j.resinv.2016.02.009; Lara AR, 2012, CHEST, V142, P1569, DOI 10.1378/chest.12-0029; Ley B, 2014, RADIOLOGY, V273, P570, DOI 10.1148/radiol.14130216; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Mh S, 2015, LYMPHANGIOGENESIS IT; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Pathak RR, 2014, CELL PHYSIOL BIOCHEM, V33, P1239, DOI 10.1159/000358693; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Salisbury ML, 2016, CHEST, V149, P491, DOI 10.1378/chest.15-0530; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Souza CA, 2006, AM J ROENTGENOL, V186, P995, DOI 10.2214/AJR.04.1663; Spagnolo P, 2015, CURR OPIN PULM MED, V21, P470, DOI 10.1097/MCP.0000000000000187; Stump B, 2017, AM J RESP CELL MOL, V57, P272, DOI 10.1165/rcmb.2016-0290TR; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; WATTERS LC, 1986, AM REV RESPIR DIS, V133, P97, DOI 10.1164/arrd.1986.133.1.97; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201154	10.1371/journal.pone.0201154	http://dx.doi.org/10.1371/journal.pone.0201154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044866	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500084
J	Watanabe, H; Nakamura, I; Mizutani, S; Kurokawa, Y; Mori, H; Kurokawa, K; Yamada, T				Watanabe, Hikaru; Nakamura, Issei; Mizutani, Sayaka; Kurokawa, Yumiko; Mori, Hiroshi; Kurokawa, Ken; Yamada, Takuji			Minor taxa in human skin microbiome contribute to the personal identification	PLOS ONE			English	Article							RNA GENE DATABASE; DIVERSITY; DISEASE; SEQUENCES; PROJECT; SEARCH	The human skin microbiome can vary over time, and inter-individual variability of the microbiome is greater than the temporal variability within an individual. The skin microbiome has become a useful tool to identify individuals, and one type of personal identification using the skin microbiome has been reported in a community of less than 20 individuals. However, identification of individuals based on the skin microbiome has shown low accuracy in communities larger than 80 individuals. Here, we developed a new approach for personal identification, which considers that minor taxa are one of the important factors for distinguishing between individuals. We originally established a human skin microbiome for 66 samples from 11 individuals over two years (33 samples each year). Our method could classify individuals with 85% accuracy beyond a one-year sampling period. Moreover, we applied our method to 837 publicly available skin microbiome samples from 89 individuals and succeeded in identifying individuals with 78% accuracy. In short, our results investigate that (i) our new personal identification method worked well with two different communities (our data: 11 individuals; public data: 89 individuals) using the skin microbiome, (ii) defining the personal skin microbiome requires samples from several time points, (iii) inclusion of minor skin taxa strongly contributes to the effectiveness of personal identification.	[Watanabe, Hikaru; Nakamura, Issei; Kurokawa, Ken; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, Tokyo, Japan; [Mizutani, Sayaka] Japan Soc Promot Sci, Meguro Ku, Tokyo, Japan; [Kurokawa, Yumiko] Tokyo Inst Technol, Educ Acad Computat Life Sci, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan; [Mori, Hiroshi; Kurokawa, Ken] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan; [Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Tokyo Institute of Technology; Japan Society for the Promotion of Science; Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Yamada, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Meguro Ku, Tokyo, Japan.; Yamada, T (corresponding author), Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.	takuji@bio.titech.ac.jp		Mori, Hiroshi/0000-0003-0806-7704	Education Academy of Computational Life Sciences, Tokyo Institute of Technology	Education Academy of Computational Life Sciences, Tokyo Institute of Technology	This study was supported by the Education Academy of Computational Life Sciences, Tokyo Institute of Technology.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Clarke TH, 2017, FORENSIC SCI INT-GEN, V30, P141, DOI 10.1016/j.fsigen.2017.06.008; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Edgar RC, 2018, BIOINFORMATICS, V34, P2371, DOI 10.1093/bioinformatics/bty113; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Mukherjee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36062; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ross AA, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00043-17; Salzberg S., 2014, F1000 POSTPUBLICATIO, DOI [10.3410/f.725233607.793501834, DOI 10.3410/F.725233607.793501834]; Schmedes SE, 2018, FORENSIC SCI INT-GEN, V32, P50, DOI 10.1016/j.fsigen.2017.10.004; Schmedes SE, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01672-17; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shibagaki N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10834-9; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; van Rensburg JJ, 2015, MBIO, V6, DOI 10.1128/mBio.01315-15; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkins D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0209-7; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	43	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e019947	10.1371/journal.pone.0199947	http://dx.doi.org/10.1371/journal.pone.0199947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044822	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500023
J	McGee, M				McGee, Monnie			Case for omitting tied observations in the two-sample t-test and the Wilcoxon-MannWhitney Test	PLOS ONE			English	Article								When the distributional assumptions for a t-test are not met, the default position of many analysts is to resort to a rank-based test, such as the Wilcoxon-Mann-Whitney Test to compare the difference in means between two samples. The Wilcoxon-Mann-Whitney Test presents no danger of tied observations when the observations in the data are continuous. However, in practice, observations are discretized due various logical reasons, or the data are ordinal in nature. When ranks are tied, most textbooks recommend using mid-ranks to replace the tied ranks, a practice that affects the distribution of the Wilcoxon-Mann-Whitney Test under the null hypothesis. Other methods for breaking ties have also been proposed. In this study, we examine four tie-breaking methods-average-scores, mid-ranks, jittering, and omission D for their effects on Type I and Type II error of the Wilcoxon-Mann-Whitney Test and the two-sample t-test for various combinations of sample sizes, underlying population distributions, and percentages of tied observations. We use the results to determine the maximum percentage of ties for which the power and size are seriously affected, and for which method of tie-breaking results in the best Type I and Type II error properties. Not surprisingly, the underlying population distribution of the data has less of an effect on the Wilcoxon-Mann-Whitney Test than on the t-test. Surprisingly, we find that the jittering and omission methods tend to hold Type I error at the nominal level, even for small sample sizes, with no substantial sacrifice in terms of Type II error. Furthermore, the t-test and the Wilcoxon-Mann-Whitney Test are equally effected by ties in terms of Type I and Type II error; therefore, we recommend omitting tied observations when they occur for both the two-sample t-test and the Wilcoxon-Mann-Whitney due to the bias in Type I error that is created when tied observations are left in the data, in the case of the t-test, or adjusted using mid-ranks or average-scores, in the case of the Wilcoxon-Mann-Whitney.	[McGee, Monnie] Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75205 USA	Southern Methodist University	McGee, M (corresponding author), Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75205 USA.	mmcgee@smu.edu		McGee, Monnie/0000-0001-9150-7832				Agresti A., 1984, ANAL ORDINAL CATEGOR; [Anonymous], 1908, BIOMETRIKA, V6, P1; Bellera CA, 2010, J STAT EDUC, V18, DOI 10.1080/10691898.2010.11889486; Chambers J. M., 1983, GRAPHICAL METHODS DA; Chambers JM, 1992, STAT METHODS S; deVries A, 2011, IS IT WRONG JITTER P; Dixon W.J., 1951, INTRO STAT ANAL; Duenas J, 1959, TREATMENT TIES NONPA; Eudey TL, 2010, J STAT EDUC, V18, DOI 10.1080/10691898.2010.11889473; Fay BR, 2006, J MODERN APPL STAT M, V5; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Harding T., 2009, RE R PROBLEM CANNOT; Higgins JJ., 2003, INTRO MODERN NONPARA; Hollander M., 1973, NONPARAMETRIC STAT M; Hothorn T, 2008, J STAT SOFTW, V28, P1; KENDALL M. G., 1948, Rank correlation methods.; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; LLOYD SJ, 1969, J APPL PHYSIOL, V26, P274, DOI 10.1152/jappl.1969.26.3.274; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; Moore D. S., 2016, INTRO PRACTICE STAT; PUTTER J, 1955, ANN MATH STAT, V26, P368, DOI 10.1214/aoms/1177728485; R Development Core Team, 2009, R LANG ENV STAT COMP; ROSENBAUM S, 1954, ANN MATH STAT, V25, P146, DOI 10.1214/aoms/1177728854; Siegel S., 1956, NONPARAMETRIC STAT B; Sprent P, 2007, APPL NONPARAMETRIC S, V4th; Tukey JW., 1959, TECHNOMETRICS, V1, P31, DOI [10.2307/1266308, DOI 10.1080/00401706.1959.10489847]; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wilcox Rand R, 2018, Curr Protoc Neurosci, V82, DOI 10.1002/cpns.41; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269	30	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200837	10.1371/journal.pone.0200837	http://dx.doi.org/10.1371/journal.pone.0200837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040850	gold, Green Published, Green Submitted			2022-12-27	WOS:000439749200012
J	Alangea, DO; Addo-Lartey, AA; Sikweyiya, Y; Chirwa, ED; Coker-Appiah, D; Jewkes, R; Adanu, RMK				Alangea, Deda Ogum; Addo-Lartey, Adolphina Addoley; Sikweyiya, Yandisa; Chirwa, Esnat Dorothy; Coker-Appiah, Dorcas; Jewkes, Rachel; Adanu, Richard Mawuena Kofi			Prevalence and risk factors of intimate partner violence among women in four districts of the central region of Ghana: Baseline findings from a cluster randomised controlled trial	PLOS ONE			English	Article							FOOD INSECURITY; MENTAL-HEALTH; YOUNG-PEOPLE; DEPRESSION; GENDER; ADULT; VICTIMIZATION; INSUFFICIENCY; DISABILITY; ALCOHOL	Intimate partner violence (IPV) is a significant global public health problem. Understanding risk factors is crucial for developing prevention programmes. Yet, little evidence exists on population-based prevalence and risk factors for IPV in West Africa. Our objective was to measure both lifetime and past year prevalence of IPV and to determine factors associated with past year physical or sexual IPV experience. This population-based survey involved 2000 randomly selected women aged 18 to 49 years living in 40 localities within four districts of the Central Region of Ghana. Questionnaires were interviewer-administered from February to May 2016. Respondents were currently or ever-partnered, and resident in study area >= 12months preceding the survey. Data collected included: socio-demographics; sexual behavior; mental health and substance use; employment status; 12-month and lifetime experience of violence; household food insecurity; gender norms/attitudes; partner characteristics and childhood trauma. Logistic regression modelling was used to determine factors associated with sexual or physical IPV, adjusting for age and survey design. About 34% of respondents had experienced IPV in the past year, with 21.4% reporting sexual and or physical forms. Past year experience of emotional and economic IPV were 24.6% and 7.4% respectively. Senior high school education or higher was protective of IPV (AOR = 0.51 [0.30-0.86]). Depression (AOR = 1.06[1.04-1.08], disability (AOR = 2.30[1.57-3.35]), witnessing abuse of mother (AOR = 2.1.98[1.44-2.72]), experience of childhood sexual abuse (AOR = 1.46[1.07-1.99]), having had multiple sexual partners in past year (AOR = 2.60 [1.49-4.53]), control by male partner (AOR = 1.03[1.00-1.06]), male partner alcohol use in past year (AOR = 2.65[2.12-3.31]) and male partner infidelity (AOR = 2.31[1.72-3.09]) were significantly associated with increased odds of past year physical or sexual IPV experience. Male perpetrated IPV remains a significant public health issue in Ghana. Evidence-based interventions targeting women's mental health, disabilities, exposure to violence in childhood, risky sexual behavior and unequal power in relationships will be critical in reducing IPV in this setting.	[Alangea, Deda Ogum; Adanu, Richard Mawuena Kofi] Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana; [Addo-Lartey, Adolphina Addoley] Univ Ghana, Sch Publ Hlth, Dept Epidemiol & Dis Control, Accra, Ghana; [Sikweyiya, Yandisa; Chirwa, Esnat Dorothy; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Coker-Appiah, Dorcas] Gender Studies & Human Rights Documentat Ctr, Accra, Ghana	University of Ghana; University of Ghana; South African Medical Research Council	Addo-Lartey, AA (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Epidemiol & Dis Control, Accra, Ghana.	aaddo-lartey@ug.edu.gh	Addo-Lartey, Adolphina Addoley/AAR-9556-2020; Alangea, Deda Ogum/AAB-3257-2020	Addo-Lartey, Adolphina Addoley/0000-0001-8852-7189; Alangea, Deda Ogum/0000-0001-7496-8514; Chirwa, Esnat/0000-0003-0471-4978; Jewkes, Rachel/0000-0002-4330-6267	C-RCT; UK Aid from the UK's Department for International Development (DFID); South African Medical Research Council	C-RCT; UK Aid from the UK's Department for International Development (DFID); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This document is a product from a C-RCT funded through the What Works to Prevent Violence: A Global Programme on violence Against Women and Girls VAWG (www.whatworks.co.za), funded by the UK Aid from the UK's Department for International Development (DFID). The funding was managed by the South African Medical Research Council. However, the views expressed, and information contain in it do not necessarily reflect the UK government's official policies. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Adjah ESO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3041-x; Adjei SB, 2015, J INTERPERS VIOLENCE; Alzahrani TA, 2016, SAUDI MED J, V37, P96, DOI 10.15537/smj.2016.1.13135; Amoakohene MI, 2004, SOC SCI MED, V59, P2373, DOI 10.1016/j.socscimed.2004.04.001; Amoateng-Boahen G., 2015, CULTURE SILENCE CONT; Andersson Neil, 2007, BMC Womens Health, V7, P11; Archampong EA, 2013, MARITAL RAPE WOMENS, V6; Ardayfio-Schandorf E., 2005, WORLD HLTH, P11; Barker G., 2005, YOUNG MEN CONSTRUCTI; Bashiru A. M, 2012, THESIS I SOCIAL STUD; Belachew T, 2011, PEDIATRICS, V127, pE398, DOI 10.1542/peds.2010-0944; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blossfeld HP, 2006, ROUTL ADV SOCIOL, P1; Breiding MJ, 2017, AM J PREV MED, V53, P457, DOI 10.1016/j.amepre.2017.03.021; Brownridge DA, 2006, VIOLENCE AGAINST WOM, V12, P805, DOI 10.1177/1077801206292681; Burmeister E, 2012, AUST CRIT CARE, V25, P271, DOI 10.1016/j.aucc.2012.07.002; Caetano R., 2017, DOMESTIC VIOLENCE 5; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Chilton MM, 2014, PUBLIC HEALTH NUTR, V17, P73, DOI 10.1017/S1368980013000281; Chirwa ED, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191663; Coates J., 2007, HOUSEHOLD FOOD INSEC, P34; Coker-Appiah D., 1999, BREAKING SILENCE CHA; Coker-Appiah D., GUIDE DEV COMMUNITY; Cole SM, 2011, SOC SCI MED, V73, P1071, DOI 10.1016/j.socscimed.2011.07.012; Conroy AA, 2014, J INTERPERS VIOLENCE, V29, P866, DOI 10.1177/0886260513505907; Cunradi CB, 2000, ANN EPIDEMIOL, V10, P297, DOI 10.1016/S1047-2797(00)00052-1; Cusack, 1999, VIOLENCE WOMEN CHILD; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Doku DT, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0276-0; Eldoseri HM, 2012, INTIMATE PARTNER PHY; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Fargo JD, 2009, J INTERPERS VIOLENCE, V24, P1771, DOI 10.1177/0886260508325489; FERREE MM, 1976, SOC PROBL, V23, P431, DOI 10.1525/sp.1976.23.4.03a00060; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Global W, 2013, REG EST VIOL WOM PRE; Gomez AM, 2011, J ADOLESCENT HEALTH, V49, P393, DOI 10.1016/j.jadohealth.2011.01.016; Hahn JW, 2014, J INTERPERS VIOLENCE, V29, P3063, DOI 10.1177/0886260514534527; Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014; Heise L, 2002, VIOLENCE INTIMATE PA; Hernandez DC, 2015, SOC SCI RES, V50, P292, DOI 10.1016/j.ssresearch.2014.12.007; Hernandez DC, 2014, J WOMENS HEALTH, V23, P29, DOI 10.1089/jwh.2012.4224; Institute of Development Studies (IDS) Ghana Statistical Ser-vices (GSS) and Associates, 2016, DOM VIOL GHAN INC AT; Jebena MG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0699-5; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes Rachel, 2011, PLoS One, V6, pe29590, DOI 10.1371/journal.pone.0029590; Jewkes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002381; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Lagdon S, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24794; Leonard KE, 2017, DRUG ALCOHOL REV, V36, P7, DOI 10.1111/dar.12434; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Melchior M, 2009, PEDIATRICS, V124, pE564, DOI 10.1542/peds.2009-0583; Mennen T., 2008, ADAPTING RESTORATIVE; MilesDoan R, 1997, PUBLIC HEALTH REP, V112, P135; Nanda G., 2011, COMPENDIUM GENDER SC, P360; Ouellet-Morin I, 2015, DEPRESS ANXIETY, V32, P316, DOI 10.1002/da.22347; Panamerican Health Organization, 2013, PAN AM HEAL ORGAN, V1, P1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ricks JL, 2016, PUBLIC HEALTH NUTR, V19, P914, DOI 10.1017/S1368980015001986; Sabri B, 2013, J INTERPERS VIOLENCE, V28, P3223, DOI 10.1177/0886260513496902; Smith DL, 2008, SEX DISABIL, V26, P15, DOI 10.1007/s11195-007-9064-6; Sorsdahl K, 2011, J EPIDEMIOL COMMUN H, V65, P426, DOI 10.1136/jech.2009.091462; United Nations General Assembly, 2006, IN DEPTH STUD ALL FO; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; [W.H.O Health DogaWsH-FaC], 2001, HLTH DOGAWSH FAC; Webb Patrick, 2006, J Nutr, V136, p1404S; Wehler C, 2004, AM J PUBLIC HEALTH, V94, P109, DOI 10.2105/AJPH.94.1.109; Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239; Wilson IM, 2017, DRUG ALCOHOL REV, V36, P115, DOI 10.1111/dar.12405; Wood K, 2001, DANGEROUS LOVE REFLE	72	41	42	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200874	10.1371/journal.pone.0200874	http://dx.doi.org/10.1371/journal.pone.0200874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024948	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000062
J	Crabb, HK; Allen, JL; Devlin, JM; Firestone, SM; Wilks, CR; Gilkerson, JR				Crabb, Helen Kathleen; Allen, Joanne Lee; Devlin, Joanne Maree; Firestone, Simon Matthew; Wilks, Colin Reginald; Gilkerson, James Rudkin			Salmonella spp. transmission in a vertically integrated poultry operation: Clustering and diversity analysis using phenotyping (serotyping, phage typing) and genotyping (MLVA)	PLOS ONE			English	Article							NUMBER TANDEM-REPEATS; RISK-FACTORS; SAMPLE-SIZE; DRAG SWABS; BROILER; TYPHIMURIUM; DISSEMINATION; SIMILARITY; PCR; IDENTIFICATION	The transmission of Salmonella enterica within a vertically integrated poultry operation was investigated longitudinally over an 18-month period (2013-2014). Thirty six percent of all samples collected (1503 of 4219) were positive for salmonellae with seven Salmonella enterica subsp. enterica serovars, and one Salmonella enterica subsp. salamae serovar detected. Both Salmonella enterica subsp. enterica serovars Infantis and Typhimurium were detected in all locations sampled. Salmonella Typhimurium was the most frequently detected serovar (63% of serotyped samples) with 8 phage types (PT) and 41 multiple-locus variable-number tandem-repeats analysis (MLVA) profiles identified. The most frequently identified phage types were PT135a and DT135. A total of 62 PT/MLVA combinations were observed. MLVA profiles 03-14-10-09-525 and 03-15-11-11-525 were the most frequently identified and 83% of the isolates shared at least one MLVA profile with an isolate from another phage type. The use of phage typing and MLVA profiling, on their own or in combination, were insufficient to understand the complexity of the epidemiological relationships between locations within this production system. Despite the high level of apparent diversity, cluster analysis was unable to differentiate the transmission pathways of all S. Typhimurium variants detected within the integrated enterprise. Using additional epidemiological information, the parent breeder rearing site was identified as the most likely point of introduction of two S. Typhimurium isolates into the production system with subsequent dissemination to the broiler flocks via the hatchery. This complexity is unable to be resolved in the absence of intensive sampling programs at all generations of the production system.	[Crabb, Helen Kathleen; Allen, Joanne Lee; Devlin, Joanne Maree; Firestone, Simon Matthew; Wilks, Colin Reginald; Gilkerson, James Rudkin] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia	University of Melbourne	Crabb, HK (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia.	helen.crabb@unimelb.edu.au	Allen, Joanne L/L-2354-2015	Allen, Joanne L/0000-0003-4740-9404; Devlin, Joanne/0000-0003-0400-9670; Firestone, Simon/0000-0002-3239-1419; Crabb, Helen/0000-0001-5550-3834; Gilkerson, James/0000-0003-1801-4817	Cybec Foundation, Victoria, Australia; Australian Government Research Training Program Scholarship	Cybec Foundation, Victoria, Australia; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by funding from the Cybec Foundation, Victoria, Australia, http://cybec.com.au, HKC; Australian Government Research Training Program Scholarship, https://www.education.gov.au/research-training-program, HKC. The funding body had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or the decision to submit the article for publication.	ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; [Anonymous], 2002, MODEL CODE PRACTICE, P83; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; Arzey G., 2002, NSW VIC ACCREDITATIO; Bailey JS, 2002, J FOOD PROTECT, V65, P742, DOI 10.4315/0362-028X-65.5.742; BAINS BS, 1974, POULTRY SCI, V53, P1114, DOI 10.3382/ps.0531114; Biosecurity Australia, 2008, GEN IMP RISK AN REP; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; CASON JA, 1994, AVIAN DIS, V38, P583, DOI 10.2307/1592082; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chen H P, 2016, APPL SCI, V179, P1, DOI DOI 10.1038/SREP28902; Choi SW, 2014, POULTRY SCI, V93, P1251, DOI 10.3382/ps.2013-03558; Chriel M, 1999, PREV VET MED, V40, P1, DOI 10.1016/S0167-5877(99)00016-1; Crabb HK, 2018, FOOD MICROBIOL, V71, P73, DOI 10.1016/j.fm.2017.03.008; Cutcher Z., 2015, APPL EPIDEMIOLOGY VI; Dimovski K, 2014, J BACTERIOL, V196, P3036, DOI 10.1128/JB.01820-14; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzsimmons G, 2012, COMMUN DIS INTELL, V36, pE213; Food Regulation Standing Committee, 2005, 12006 FRSC; FSANZ, 2012, PRIM PROD PROC STAND; Gan E, 2011, MICROBIOL-SGM, V157, P1056, DOI 10.1099/mic.0.047001-0; Gilbert Gwendolyn L, 2008, N S W Public Health Bull, V19, P29, DOI 10.1071/NB07116; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; HARVEY RWS, 1967, J HYG-CAMB, V65, P423, DOI 10.1017/S0022172400045939; HARVEY RWS, 1979, J APPL BACTERIOL, V46, P27, DOI 10.1111/j.1365-2672.1979.tb02580.x; Heuzenroeder MW, 2013, PRJ003419 ACT RUR IN, P1; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Humphry RW, 2004, PREV VET MED, V65, P173, DOI 10.1016/j.prevetmed.2004.07.003; IMVS, 2011, AUSTR SALM REF CTR M, P7; JACKSON CAW, 1971, AUST VET J, V47, P485, DOI 10.1111/j.1751-0813.1971.tb02029.x; Jeoffreys NJ, 2001, PATHOLOGY, V33, P66, DOI 10.1080/00313020120034939; Kardos G, 2007, LETT APPL MICROBIOL, V45, P421, DOI 10.1111/j.1472-765X.2007.02220.x; Kassambara A., FACTOEXTRA EXTRACT V; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; Kim A, 2007, J VET SCI, V8, P155, DOI 10.4142/jvs.2007.8.2.155; Kindt R., 2005, WORLD; KINGSTON DJ, 1981, AVIAN DIS, V25, P513, DOI 10.2307/1589943; Kuijpers AFA, 2014, EU INTERLABORATORY C; Kuijpers AFA, 2011, EU INTERLABORATORY C; Kuijpers AFA, 2012, EU INTERLABORATORY C; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee YJ, 2007, J VET MED SCI, V69, P399, DOI 10.1292/jvms.69.399; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Liebana E, 2002, BRIT POULTRY SCI, V43, P38, DOI 10.1080/00071660120109872; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; MACKENZIE MA, 1976, POULTRY SCI, V55, P957, DOI 10.3382/ps.0550957; Malorny B, 2003, APPL ENVIRON MICROB, V69, P290, DOI 10.1128/AEM.69.1.290-296.2003; McCrea BA, 2005, J APPL POULTRY RES, V14, P694, DOI 10.1093/japr/14.4.694; MORRIS GK, 1969, AM J VET RES, V30, P1413; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Oksansen J, 2017, VEGAN COMMUNITY ECOL; Powling J., 2014, NATL ENTERIC PATHOGE; R Core Team, 2015, R LANGUAGE ENV STAT; Research ethics and integrity, 2017, RES ETH INT AN ETH W; Rose N, 1999, PREV VET MED, V39, P265, DOI 10.1016/S0167-5877(99)00002-1; Shanmugasundaram M, 2009, WORLD J MICROB BIOT, V25, P1385, DOI 10.1007/s11274-009-0025-3; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; Singer RS, 2000, J VET DIAGN INVEST, V12, P118, DOI 10.1177/104063870001200203; Skov MN, 1999, POULTRY SCI, V78, P848, DOI 10.1093/ps/78.6.848; Standards Australia, 2009, 5013102009 SAI; Suzuki R., 2015, PVCLUST HIERARCHICAL; Thrusfield M., 2007, VET EPIDEMIOLOGY, V3rd; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Volkova VV, 2010, ZOONOSES PUBLIC HLTH, V57, P463, DOI 10.1111/j.1863-2378.2009.01263.x; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055	67	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201031	10.1371/journal.pone.0201031	http://dx.doi.org/10.1371/journal.pone.0201031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024964	gold, Green Published			2022-12-27	WOS:000439120000082
J	Fleming, D; Musser, F; Reisig, D; Greene, J; Taylor, S; Parajulee, M; Lorenz, G; Catchot, A; Gore, J; Kerns, D; Stewart, S; Boykin, D; Caprio, M; Little, N				Fleming, Daniel; Musser, Fred; Reisig, Dominic; Greene, Jeremy; Taylor, Sally; Parajulee, Megha; Lorenz, Gus; Catchot, Angus; Gore, Jeffrey; Kerns, David; Stewart, Scott; Boykin, Deborah; Caprio, Michael; Little, Nathan			Effects of transgenic Bacillus thuringiensis cotton on insecticide use, heliothine counts, plant damage, and cotton yield: A meta-analysis, 1996-2015	PLOS ONE			English	Article							HELICOVERPA-ZEA LEPIDOPTERA; RESISTANCE MANAGEMENT; VIRESCENS LEPIDOPTERA; CROSS-RESISTANCE; NOCTUIDAE; BT; TOXINS; FIELD; CORN; EFFICACY	The primary management tactic for lepidopteran pests of cotton in the United States of America (USA) is the use of transgenic cotton that produces Bacillus thuringiensis Berliner (Bt) toxins. The primary target pests of this technology are Helicoverpa zea (Boddie) and Heliothis virescens (F.) in the eastern and central Cotton Belt of the USA. Concerns over the evolution of resistance in H. zea to Bt toxins and scrutiny of the necessity of Btcrops has escalated. We reviewed published and unpublished data from field trials of Btcotton in the eastern and central Cotton Belt of the USA through 2015 to evaluate the effectiveness of Bt cotton (Bollgard, Bollgard II, WideStrike, WideStrike 3, and TwinLink). Btcotton reduced insecticide usage, reduced heliothine pest numbers and damage, and provided a yield benefit, but Bollgard II and WideStrike efficacy declined in the Midsouth over the period evaluated. In the Southeastern region, heliothine damage remained constant through 2015, but yield benefits declined from 2010 until 2015. Resistance of H. zea to several Bttoxins is the most plausible explanation for the observed changes in Btcotton efficacy. The introduction of new Bttoxins such as found in Widestrike 3 and Twinlink may preserve the benefits of Bt crops. However, while both Widestrike 3 and Twinlink had less damage than Widestrike, damage levels of both were similar to Bollgard II.	[Fleming, Daniel; Musser, Fred; Catchot, Angus; Caprio, Michael] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Reisig, Dominic] North Carolina State Univ, Vernon G James Res & Extens Ctr, Plymouth, Devon, England; [Greene, Jeremy] Clemson Univ, Edisto Res & Educ Ctr, Blackville, SC USA; [Taylor, Sally] Virginia Tech, Tidewater Agr Res & Extens Ctr, Suffolk, VA USA; [Parajulee, Megha] Texas A&M Univ, AgriLife Res & Extens Ctr, Lubbock, TX USA; [Lorenz, Gus] Univ Arkansas, Lonoke Extens Ctr, Cooperat Extens Serv, Lonoke, AR USA; [Gore, Jeffrey] Mississippi State Univ, Delta Res & Extens Ctr, Stoneville, MS USA; [Kerns, David] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Stewart, Scott] Univ Tennessee, West Tennessee Res & Educ Ctr, Jackson, TN USA; [Boykin, Deborah] USDA ARS, James Whitten Delta States Res Ctr, Stoneville, MS 38776 USA; [Little, Nathan] USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA; [Fleming, Daniel] Provivi Inc, Santa Monica, CA 90404 USA	Mississippi State University; University of North Carolina; North Carolina State University; Clemson University; Virginia Polytechnic Institute & State University; Texas A&M University System; University of Arkansas System; University of Arkansas Fayetteville; Mississippi State University; Texas A&M University System; Texas A&M University College Station; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Fleming, D; Musser, F (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.; Fleming, D (corresponding author), Provivi Inc, Santa Monica, CA 90404 USA.	dfleming@provivi.com; fmusser@entomology.msstate.edu		Little, Nathan/0000-0003-1105-3733; Musser, Fred/0000-0003-2767-8500; Reisig, Dominic/0000-0002-9979-5813	United States Department of Agriculture [USDA-SCA 58-6402-3-038]; Mississippi State University [MIS-311280]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Mississippi State University	This project was partially funded through United States Department of Agriculture Specific Cooperative Agreement USDA-SCA 58-6402-3-038 received by FM. This agreement provided support in the form of salary for one author (DF). NL was the USDA representative overseeing the agreement who participated as a co-author from idea development through paper review. Additional support came from Mississippi State University Hatch Project MIS-311280 for the support of FM.	Adamczyk J. J. Jr., 2006, Journal of Cotton Science, V10, P155; Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P1589, DOI 10.1603/0022-0493-94.6.1589; Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P284, DOI 10.1603/0022-0493-94.1.284; Adamczyk Jr JJ, 2003, P BELTW COTT C NASHV; Adamczyk Jr JJ, 2001, P BELTW COTT C AN CA; Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; Anilkumar KJ, 2008, APPL ENVIRON MICROB, V74, P462, DOI 10.1128/AEM.01612-07; Benedict JH, 1996, J ECON ENTOMOL, V89, P230, DOI 10.1093/jee/89.1.230; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; Brickle DS, 2001, J ECON ENTOMOL, V94, P86, DOI 10.1603/0022-0493-94.1.86; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Caprio MA, 1998, J ECON ENTOMOL, V91, P1021, DOI 10.1093/jee/91.5.1021; Caprio MA, 2000, J ECON ENTOMOL, V93, P173, DOI 10.1603/0022-0493-93.2.173; Caprio MA, 1999, EVALUATION INSECT RE; Chitkowski RL, 2003, J ECON ENTOMOL, V96, P755, DOI 10.1603/0022-0493-96.3.755; Crespo ALB, 2016, J ECON ENTOMOL, V109, P288, DOI 10.1093/jee/tov272; Dively GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169115; Edwards KT, 2013, J ECON ENTOMOL, V106, P382, DOI 10.1603/EC12203; EPA, 2017, INS RES MAN BT PLANT; GOODENOUGH JL, 1988, J ECON ENTOMOL, V81, P1624, DOI 10.1093/jee/81.6.1624; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Gould F, 2003, NAT BIOTECHNOL, V21, P1450, DOI 10.1038/nbt1203-1450; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; Gould F, 1998, NOW NEVER SERIOUS NE, P67; Gurevitch J, 2001, ADV ECOL RES, V32, P199, DOI 10.1016/S0065-2504(01)32013-5; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Hagerty AM, 2005, ENVIRON ENTOMOL, V34, P105, DOI 10.1603/0046-225X-34.1.105; Head G, 2005, ENVIRON ENTOMOL, V34, P1257, DOI 10.1603/0046-225X(2005)034[1257:AMLCOA]2.0.CO;2; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Huffman M, 2007, P 2007 BELTW COTT C, P1073; Ives AR, 2011, ECOL APPL, V21, P503, DOI 10.1890/09-1869.1; Jackson RE, 2006, J ECON ENTOMOL, V99, P1790, DOI 10.1603/0022-0493-99.5.1790; Jaffe G, 2009, COMPLACENCY FARM; Leigh T. F. S. H., 1996, COTTON INSECTS MITES, P17; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Micinski S, 2008, SOUTHWEST ENTOMOL, V33, P139, DOI 10.3958/0147-1724-33.2.139; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; NEUNZIG H. H., 1964, ANN ENTOMOL SOC AMER, V57, P98, DOI 10.1093/aesa/57.1.98; ParkerJr CD, 2000, THESIS; Reisig DD, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx002; Rosenberg M., 2013, HDB META ANAL ECOLOG, V61, P71; Rosenheim JA, 2017, ANNU REV ENTOMOL, V62, P399, DOI 10.1146/annurev-ento-031616-035444; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Sandstrom MA, 2007, PLANT HLTH PROGR; Seward R, 2017, IDENTIFICATION BOLLW; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Siebert MW, 2008, J ECON ENTOMOL, V101, P1950, DOI 10.1603/0022-0493-101.6.1950; Stadelbacher EA, 1986, THEORY TACTICS HELIO, P54; Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546; Storer NP, 2003, J ECON ENTOMOL, V96, P156, DOI 10.1603/0022-0493-96.1.156; Storer NP, 2003, J ECON ENTOMOL, V96, P173, DOI 10.1603/0022-0493-96.1.173; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; Tabashnik BE, 2010, SOUTHWEST ENTOMOL, V35, P417, DOI 10.3958/059.035.0326; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; TONHASCA A, 1994, ECOL ENTOMOL, V19, P239, DOI 10.1111/j.1365-2311.1994.tb00415.x; Wechsler SJ, RECENT TRENDS GE ADO; Welch KL, 2015, J INVERTEBR PATHOL, V132, P149, DOI 10.1016/j.jip.2015.10.003; Westbrook JK, 1997, ENVIRON ENTOMOL, V26, P12, DOI 10.1093/ee/26.1.12; Williams MR, 1986, COTTON INSECT LOSSES	60	25	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200131	10.1371/journal.pone.0200131	http://dx.doi.org/10.1371/journal.pone.0200131			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024919	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000016
J	Rothenbacher, D; Braig, S; Logan, CA; Feike, G; Muller, M; Koenig, W; Reister, F; Genuneit, J				Rothenbacher, Dietrich; Braig, Stefanie; Logan, Chad A.; Feike, Gertrud; Mueller, Miriam; Koenig, Wolfgang; Reister, Frank; Genuneit, Jon			Association of maternal uric acid and cystatin C serum concentrations with maternal and neonatal cardiovascular risk markers and neonatal body composition: The Ulm SPATZ Health Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PREGNANCY; PREECLAMPSIA; CREATININE; WOMEN	Purpose In utero exposure to cardiometabolic risk factors may determine health related outcomes at birth and in later life. The aim of this analysis was to describe the relationship of maternal serum uric acid (SUA) and cystatin C with maternal and neonatal cardiometabolic risk markers and with birth weight and risk of small-for-gestational age (SGA) as well as large-for gestational age (LGA). Material and methods In the Ulm SPATZ Health Study, 934 singleton newborns and their mothers were recruited during their hospital stay in the University Medical Center Ulm between 04/2012 and 05/ 2013 (overall response 49%). The association between SUA and cystatin C (both in quartiles and as continuous measures) with risk for SGA as well as with LGA was quantified by means of multivariable logistic regression. Results Overall, n = 885 mother-newborn pairs were included in the final analysis. Most of the mothers were of German nationality (85%) and were between 26 and 35 years of age at delivery (69%). Maternal SUA was associated with maternal age, body mass index, alcohol consumption and history of hypertension as well as with many other maternal and neonate cardiovascular risk markers. Cystatin C was associated with parity. No clear association of SUA with SGA and LGA was observed in fully adjusted models. However, cystatin C was negatively associated with SGA with an odds ratio (OR) of 0.35 (95% CI: 0.16-0.77; p for trend 0.04) comparing the top quartile vs. the bottom quartile and was positively associated with LGA with an OR of 5.92 (95% CI: 2.27-15.44; p for trend <0.0001) after adjustment for covariates. Conclusions We found a positive association of cystatin C with birth weight and a clearly increased risk for LGA with maternal increased cystatin C values in a population with fairly normal renal function.	[Rothenbacher, Dietrich; Braig, Stefanie; Logan, Chad A.; Feike, Gertrud; Mueller, Miriam; Genuneit, Jon] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Univ Med Ctr Ulm, Dept Internal Med Cardiol 2, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Reister, Frank] Univ Med Ctr Ulm, Dept Gynecol & Obstet, Ulm, Germany; [Genuneit, Jon] WUN, In FLAME Int Inflammat Network, West New York, NJ USA	Ulm University; Ulm University; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University	Rothenbacher, D (corresponding author), Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany.	dietrich.rothenbacher@uni-ulm.de	Genuneit, Jon/I-9323-2012	Genuneit, Jon/0000-0001-5764-1528; Logan, Chad/0000-0002-6157-3641; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603	Medical Faculty of Ulm University	Medical Faculty of Ulm University	The study was funded through an unrestricted grant by the Medical Faculty of Ulm University.	Akahori Y, 2012, GYNECOL OBSTET INVES, V73, P162, DOI 10.1159/000332391; Amini E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-104; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; Filler G, 2014, PEDIATR NEPHROL, V29, P183, DOI 10.1007/s00467-013-2426-7; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Hawkins TLA, 2012, BJOG-INT J OBSTET GY, V119, P484, DOI 10.1111/j.1471-0528.2011.03232.x; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kang DH, 2004, J HYPERTENS, V22, P229, DOI 10.1097/00004872-200402000-00001; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Laughon SK, 2009, AM J OBSTET GYNECOL, V201, P1; Logan CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149918; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Morken NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101897; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Paula LG, 2008, HYPERTENS PREGNANCY, V27, P413, DOI 10.1080/10641950801955709; Rothenbacher D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045907; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P825; Strevens H, 2001, SCAND J CLIN LAB INV, V61, P575; Yalamati Padma, 2015, Int J Reprod Contracept Obstet Gynecol, V4, P1505	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200470	10.1371/journal.pone.0200470	http://dx.doi.org/10.1371/journal.pone.0200470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024915	gold, Green Submitted, Green Published			2022-12-27	WOS:000439120000021
J	Panagiotakopulu, E; Buckland, PC; Wickler, S				Panagiotakopulu, Eva; Buckland, Paul C.; Wickler, Stephen			Is there anybody in there? Entomological evidence from a boat burial at Oksnes in Vesteralen, northern Norway	PLOS ONE			English	Article							CAT FLEA; SIPHONAPTERA; SURVIVAL; DIPTERA; DECOMPOSITION; IRRIGATION; PULICIDAE; KNOWLEDGE; PUPARIA; REMAINS	Although there are several well preserved Viking boat burials from Norway, until recently palaeoecological research on their context has often been limited. Research on fossil insect remains in particular can provide valuable forensic information even in the absence of an actual body. Here we present archaeoentomological information from a boat burial at Oksnes in Vesteralen, northeast Norway, an area where Norse and Sami traditions overlap. Excavated in 1934, organic preservation from the burial was limited to parts of the boat and a clump of bird feathers which were preserved in the Tromso University Museum, and from which fossil insects were recovered. The insect assemblage from Oksnes includes the blowfly, Protophormia terraenovae (Rob.-Des.), which indicates exposure of the body and the probable timing of the burial. The high numbers of the human flea, Pulex irritans L. from among the feathers, suggests that these, probably from a pillow under the corpse, originated from within a domestic context. Deposition of flowers as part of the burial is discussed on the basis of the insect fauna. The absence of a body and any associated post burial decay fauna implies its exhumation and disposal elsewhere and this is discussed in the context of other exhumed medieval burials and Saga and other sources.	[Panagiotakopulu, Eva] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Buckland, Paul C.] Den Bank Close, Sheffield, S Yorkshire, England; [Wickler, Stephen] Univ Tromso, Tromso Univ Museum, Dept Cultural Sci, Tromso, Norway	University of Edinburgh; UiT The Arctic University of Tromso	Panagiotakopulu, E (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.	eva.p@ed.ac.uk		PANAGIOTAKOPULU, EVA/0000-0002-3523-7775	Department of Archaeology, History, Religious studies and Theology, University of Tromso	Department of Archaeology, History, Religious studies and Theology, University of Tromso	The Department of Archaeology, History, Religious studies and Theology, University of Tromso and in particular Hans Peter Blankholm are thanked for their support during this research. The Tromso University Museum is thanked for access to the material and also Dr. Jostein Kperandsen is warmly acknowledged. A. Panayiotakopoulos is thanked for help with the illustrations. Comments by the editor, John Hart, and an anonymous reviewer were gratefully received. Last, but not least, colleagues from the research group Joint Proxies are acknowledged for helpful discussions and support.	Arvidsson Lars, 2004, Svensk Botanisk Tidskrift, V98, P213; Arwidsson G., 1942, VALSGARDE; Asingh P., 2001, MUMMIES NEW MILLENIU, P50; Asplund H, 2007, TURUN MAAKUNTAMUSEO, P9; Assing V, 2012, KALER MITTELEUROPAS, V4; Bacot A, 1914, J Hyg (Lond), V13, P447; Beltrame C, 2013, INT J NAUT ARCHAEOL, V42, P296, DOI 10.1111/1095-9270.12023; Berglund B, 2009, ACTA BOREAL, V26, P119, DOI 10.1080/08003830903372001; Blowflies Erzinclioglu Z., 1996, NATURALISTS HDB, V23; Bohhme J., 2005, FAUNISTICHE UBERSICH; Bond R, 2007, VET REC, V160, P503, DOI 10.1136/vr.160.15.503; BONDE N, 1993, ANTIQUITY, V67, P575, DOI 10.1017/S0003598X00045774; Brinck-Lindroth G, 2007, FLEAS SIPHONAPTERA F; Brondstedt J., 1966, DANMARKS OLDTID; Bruce-Mitford RLS, 1975, SUTTON HOO SHIP BURI, V1; Brundin L., 1934, COLEOPTEREN TORNETRA; Buckland PC, 2009, HOLOCENE, V19, P105, DOI 10.1177/0959683608096602; BUCKLAND PC, 1989, J BIOGEOGR, V16, P115, DOI 10.2307/2845085; Buckland PC, 1992, NORSE LATER SETTLEME, P149; Busvine JR, 1980, INSECTS AND HYGIENE; Byock J, 2013, ANN REV COTSEN I ARC, P124; Caciola N, 1996, PAST PRESENT, P3; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Chapman H., 2015, J WETLAND ARCHAEOLOG, V5, P109, DOI DOI 10.1080/14732971.2015.1112592; Dove CJ, 2016, ARCTIC, V69, P29, DOI 10.14430/arctic4546; Engelmark, 2006, P 8 NORD C APPL SCI, P17; Erzinclioglu Z., 2009, GEOL J, V44, P474; Gaudry E, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P273, DOI 10.1007/978-1-4020-9684-6_13; GAUTIER A, 1973, PALAEOGEOGR PALAEOCL, V14, P119, DOI 10.1016/0031-0182(73)90007-2; Gautier A, 1974, NATUURWETENSCHAPPELI, V55, P76; Geijer Agnes., 1938, BIRKA BIRKA; Germonpre A M, 1994, B I ROYAL SCI NATURA, V64, P265; Gjessing G, 1941, TROMSO MUSEUMS ARSHE, V58; Glob P.V., 1969, BOG PEOPLE IRON AGE; Goff M L, 1993, Forensic Sci Rev, V5, P81; Goff ML, 2009, EXP APPL ACAROL, V49, P21, DOI 10.1007/s10493-009-9284-9; Hagg I., 1991, JYSK ARKAEOLOGISK SE, V28, P155; Hagvar Sigmund, 2011, Soil Organisms, V83, P187; Hakbijl Tom, 1997, Quaternary Proceedings, V5, P129; Hansen M., 1987, FAUNA ENTOMOLOGICA S, V18; Hansson A-M., 2002, J NORDIC ARCHAEOL SC, V13, P43; Harris OJT, 2017, ANTIQUITY, V91, P191, DOI 10.15184/aqy.2016.222; Hsu MH, 2002, MED VET ENTOMOL, V16, P445, DOI 10.1046/j.1365-2915.2002.00388.x; Hyman, 1992, REV SCARCE THREATE 1; Itkonen TI, 1945, SUOMEN LAPPALAISET V; Jakobsson M., 2017, TROLL INSIDE YOU PAR; JENSEN J, 1989, ANTIQUITY, V63, P531, DOI 10.1017/S0003598X0007650X; KAMAL ADEL S., 1958, ANN ENT SOC AMER, V51, P261; Kirkinen T., 2015, PRELIMINARY RE UNPUB; Klevn?s A., 2007, ARCHAEOLOGICAL REV C, V22, P24; Klevnas A, 2015, NOR ARCHAEOL REV, V48, P1, DOI 10.1080/00293652.2015.1007892; Klevnas AM, 2011, ARCHAEOLOGY; Koch K., 1989, KAFER MITTELEUROPAS; Korvenkontio V., 1926, RES REPORT; KRASNOV B. R., 2008, FUNCTIONAL EVOLUTION; Krasnov BR, 2002, J VECTOR ECOL, V27, P70; Krasnov BR, 2001, J MED ENTOMOL, V38, P629, DOI 10.1603/0022-2585-38.5.629; Lageras P, 2000, ARKEOLOGI PALEOEKOLO, P65; Lawrence W, 2000, J VECTOR ECOL, V25, P98; Lindroth C.H., 1985, Fauna Entomologica Scandinavica, V15, P1; Lindroth CH, 1973, ENTOMOLOGICA SCAN S5; LINDROTH CH, 1960, CATALOGUS COLEOPTERO; Lynnerup N, 2015, ANAT REC, V298, P1007, DOI 10.1002/ar.23138; Maggots Erzinclioglu Z., 2000, MEN MURDER MEMORIES; Mays S, 2017, J ARCHAEOL SCI-REP, V16, P441, DOI 10.1016/j.jasrep.2017.02.023; McGrail S., 1998, ANCIENT BOATS N W EU; Muller-Wille Michael, 1974, INT J NAUTICAL ARCHA, V3, P187, DOI [10.1111/j.1095-9270.1974.tb00878.x, DOI 10.1111/J.1095-9270.1974.TB00878.X]; Munster-Swendsen M, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P29; Nordeide S.W., 2015, MARITIME SOC VIKING, P171; Nordeide SW, 2011, ACTA ARCHAEOL-DEN, V82, P7, DOI 10.1111/j.1600-0390.2011.00373.x; NUORTEVA P, 1987, ANN ENTOMOL FENN, V53, P53; Nuorteva P., 1977, FORENSIC MED, P1317; OWEN O., 1999, SCAR VIKING BOAT BUR; Panagiotakopulu E, 2004, J ARCHAEOL SCI, V31, P1675, DOI 10.1016/j.jas.2004.04.008; Panagiotakopulu E, 2017, QUATERNARY SCI REV, V156, P23, DOI 10.1016/j.quascirev.2016.11.014; Panagiotakopulu E, 2012, GEOGR ANN A, V94A, P531, DOI 10.1111/j.1468-0459.2012.00475.x; Pape Thomas, 2015, Fauna Entomologica Scandinavica, V44, P658; Pedersen WM, 2007, NORDLYS         0322; Peetes J, 2012, ARCHAEOLOGICAL FIELD, P43; Ponel Philippe, 1997, Quaternary Proceedings, V5, P207; Price J. L., 1981, B BRIT MUS NAT HIST, V35, P145; Richmond IA, 1950, ARCHAEOLOGY LIFE PAG; Rognes K., 1991, FAUNA ENTOMOLOGICA S, P24; Rotheray GE, 2012, J NAT HIST, V46, P2075, DOI 10.1080/00222933.2012.707241; ROTHSCHILD M, 1975, ANNU REV ENTOMOL, V20, P241, DOI 10.1146/annurev.en.20.010175.001325; Sadler J, 1991, ACTA ARCHAEOL, V61, P166; Sandars K, 2009, BODIES BOG ARCHAEOLO; Schanche K., 1991, OTTAR, V188, P13; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Shetelig H, 1929, BERGEN MUSEUMS SKRIF, VII; SILVERMAN J, 1981, J MED ENTOMOL, V18, P78, DOI 10.1093/jmedent/18.1.78; SILVERMAN J, 1994, J MED ENTOMOL, V31, P265, DOI 10.1093/jmedent/31.2.265; Skidmore P., 1992, DIPTERISTS DIGEST, V13, P6; Skidmore P., 1996, THESIS; Smith KGV, 1986, MANUAL FORENSIC ENTO; Sorokin P., 2003, BOATS SHIPS SHIPYARD, P190; Stead I. M., 1986, LINDOW MAN BODY BOG; Stenseth C., 1974, Forskning og Forsoek i Landbruket, V25, P191; Storli Inger, 2007, OTHERES VOYAGES LATE, V1, P76; Strand A., 1946, TROMSO MUSEUMS ARSHE, V67, P1; Thingnaes S., 2014, RAPPORT TEKSTILTEKNI; Tozer E.R., 1973, Entomologist's Monthly Magazine, V108, P193; Tranberg A, 2015, ARCHAEOLOGY OF DEATH IN POST-MEDIEVAL EUROPE, P189; Traub R., 1980, P93; Turner R., 1995, BOG BODIES NEW DISCO; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P151, DOI 10.1016/j.palaeo.2008.03.027; Vedeler M., 2014, GOTARC A, P281; Vesteinsson O., 2000, CHRISTIANIZATION ICE; Warren JA, 2013, FORENSIC SCI INT, V233, P374, DOI 10.1016/j.forsciint.2013.10.012; Westerdahl C., 2010, BAR INT SERIES, V2154, P329; Westerdahl C, 1987, THESIS; Whitaker AP, 2007, HDB IDENTIFICATIO 16, V1; Whiting MF, 2008, CLADISTICS, V24, P677, DOI 10.1111/j.1096-0031.2008.00211.x; Wickler S., 2010, BRIT ARCHAEOL REP IN, V2154, P349; Worland MR, 2000, PHYSIOL ENTOMOL, V25, P1, DOI 10.1046/j.1365-3032.2000.00159.x; Zachrisson I., 1997, STATENS HIST MUSEUM, V4; Zanetti Adriano, 2015, Gredleriana, V15, P77	117	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200545	10.1371/journal.pone.0200545	http://dx.doi.org/10.1371/journal.pone.0200545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052632	gold, Green Submitted, Green Published			2022-12-27	WOS:000440006600009
J	Engjom, T; Kavaliauskiene, G; Tjora, E; Erchinger, F; Wathle, G; Laerum, BN; Njolstad, PR; Frokjaer, JB; Gilja, OH; Dimcevski, G; Haldorsen, IS				Engjom, Trond; Kavaliauskiene, Giedre; Tjora, Erling; Erchinger, Friedemann; Wathle, Gaute; Laerum, Birger Norderud; Njolstad, Pal Rasmus; Frokjaer, Jens Brondum; Gilja, Odd Helge; Dimcevski, Georg; Haldorsen, Ingfrid Salvesen			Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI	PLOS ONE			English	Article							SYSTEM; LIVER; ULTRASONOGRAPHY; IDENTIFICATION; GUIDELINES; PATHOLOGY; CHILDREN; ADULTS; WATER; GENE	Objective Fatty infiltration of the pancreas is a dominating feature in cystic fibrosis (CF). We evaluate the association between pancreatic fat content assessed by Dixon magnetic resonance imaging (MRI), pancreatic echogenicity at ultrasonography (US) and exocrine function in CF patients and healthy controls (HC). Material and methods Transabdominal US, pancreatic Dixon-MRI and diffusion-weighted imaging (DWI) were performed in 21 CF patients and 15 HCs. Exocrine function was assessed by endoscopic secretin test and fecal elastase. Results CF patients were grouped according to exocrine pancreatic function as subjects with normal (CFS: n = 11) or reduced (CFI: n = 10) function. Among CFI 90% (9/10) had visual hypere-chogenicity. CFI also had increased echo-level values (p<0.05 vs others). All CFI (10/10) had markedly increased pancreatic fat content estimated by MRI compared to sufficient groups, p<0.001). Among CFS patients and HC, 27% (3/11) and 33% (5/15), respectively, had hyperechoic pancreas. However, all these had low pancreatic fat-content at MRI compared to CFI. In CFI, pancreatic fat content was correlated to ADC (r = -0.93, p<0.001). Conclusion Pancreas insufficient CF patients exhibit severe pancreatic fatty-infiltration at MRI and hyperechoic pancreas at US. Pancreas hyperechogenicity in pancreatic sufficient subjects does not co-exist with fatty infiltration at MRI. MRI evaluates pancreatic fatty infiltration more accurately than US and fat infiltration estimated by MRI outperforms sonographic hyperechogenicity as a marker for exocrine pancreatic failure in CF.	[Engjom, Trond; Erchinger, Friedemann; Gilja, Odd Helge; Dimcevski, Georg; Haldorsen, Ingfrid Salvesen] Univ Bergen, Dept Clin Med, Bergen, Norway; [Engjom, Trond] Haukeland Hosp, Dept Med, Bergen, Norway; [Kavaliauskiene, Giedre; Wathle, Gaute; Haldorsen, Ingfrid Salvesen] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Tjora, Erling; Njolstad, Pal Rasmus] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Tjora, Erling; Laerum, Birger Norderud; Njolstad, Pal Rasmus] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Erchinger, Friedemann] Voss Hosp, Dept Med, Voss, Norway; [Frokjaer, Jens Brondum] Aalborg Univ Hosp, Dept Radiol, Aalborg, Denmark; [Frokjaer, Jens Brondum] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Gilja, Odd Helge] Haukeland Hosp, Natl Ctr Ultrasound Gastroenterol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Aalborg University; Aalborg University Hospital; Aalborg University; University of Bergen; Haukeland University Hospital	Engjom, T; Haldorsen, IS (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.; Engjom, T (corresponding author), Haukeland Hosp, Dept Med, Bergen, Norway.; Haldorsen, IS (corresponding author), Haukeland Hosp, Dept Radiol, Bergen, Norway.	trond.engjom@helse-bergen.no; ingfrid.haldorsen@uib.no		Engjom, Trond/0000-0002-2207-5455	University of Bergen; Norwegian Gastroenterology Association; Norwegian cystic fibrosis Association	University of Bergen; Norwegian Gastroenterology Association; Norwegian cystic fibrosis Association	This study has received funding from the University of Bergen (TE, PhD scholarship), the Norwegian Gastroenterology Association (TE, FE, GD, Limited grants) and The Norwegian cystic fibrosis Association (TE, Limited grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Borowitz D, 2004, J PEDIATR-US, V145, P322, DOI 10.1016/j.jpeds.2004.04.049; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dietrich CF, 2002, J ULTRAS MED, V21, P409, DOI 10.7863/jum.2002.21.4.409; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; DURIE PR, 1989, J ROY SOC MED, V82, P2; Engjom T, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0259-3; Engjom T, 2015, PANCREAS, V44, P1266, DOI 10.1097/MPA.0000000000000425; Engjom T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121121; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Feigelson J, 2000, J PEDIATR GASTR NUTR, V30, P145, DOI 10.1097/00005176-200002000-00010; FIEL SB, 1987, CHEST, V91, P181, DOI 10.1378/chest.91.2.181; Friedrich-Rust M, 2013, J CYST FIBROS, V12, P431, DOI 10.1016/j.jcf.2012.12.013; Frokjaer JB, 2013, PANCREAS, V42, P1182, DOI 10.1097/MPA.0b013e31829628f4; Glaser J, 2000, GERONTOLOGY, V46, P93, DOI 10.1159/000022141; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; GRAHAM N, 1985, CLIN RADIOL, V36, P199, DOI 10.1016/S0009-9260(85)80120-3; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; KOPITO LE, 1976, PEDIATR RES, V10, P742, DOI 10.1203/00006450-197610080-00010; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Madzak A, 2017, PANCREATOLOGY, V17, P228, DOI 10.1016/j.pan.2017.01.009; Manning P, 2017, J MAGN RESON IMAGING, V46, P1149, DOI 10.1002/jmri.25663; MARKS WM, 1980, RADIOLOGY, V137, P475, DOI 10.1148/radiology.137.2.7433680; MURAYAMA S, 1990, PEDIATR RADIOL, V20, P536, DOI 10.1007/BF02011384; O'Sullivan BP, 2013, J PEDIATR-US, V162, P808, DOI 10.1016/j.jpeds.2012.10.008; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; THAM RTOTA, 1991, RADIOLOGY, V179, P183, DOI 10.1148/radiology.179.1.2006275; Wathle GK, 2013, JMAGN RESONIMAGING; WILSONSHARP RC, 1984, ARCH DIS CHILD, V59, P923, DOI 10.1136/adc.59.10.923; WMA general assembly, 2015, WORLD MED ASS DECL H; WORTHEN NJ, 1982, AM J ROENTGENOL, V139, P1095, DOI 10.2214/ajr.139.6.1095; Yoon JH, 2016, RADIOLOGY, V279, P140, DOI 10.1148/radiol.2015142254	36	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201019	10.1371/journal.pone.0201019	http://dx.doi.org/10.1371/journal.pone.0201019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048483	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400040
J	Serrano-Oviedo, L; Ortega-Muelas, M; Garcia-Cano, J; Valero, MLI; Cimas, FJ; Pascual-Serra, R; Fernandez-Aroca, DM; Roche, O; Ruiz-Hidalgo, MJ; Belandia, B; Gimenez-Bachs, JM; Salinas, AS; Sanchez-Prieto, R				Serrano-Oviedo, Leticia; Ortega-Muelas, Marta; Garcia-Cano, Jesus; Valero, Maria L. I.; Cimas, Francisco J.; Pascual-Serra, Raquel; Fernandez-Aroca, Diego M.; Roche, Olga; Ruiz-Hidalgo, Maria J.; Belandia, Borja; Gimenez-Bachs, Jose M.; Salinas, Antonio S.; Sanchez-Prieto, Ricardo			Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LUNG-CANCER CELLS; ACQUIRED-RESISTANCE; IN-VITRO; ANTITUMOR-ACTIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAY; TYROSINE KINASE; LEUKEMIA CELLS; GROWTH	Objectives To fully clarify the role of Mitogen Activated Protein Kinase in the therapeutic response to Sorafenib in Renal Cell Carcinoma as well as the cell death mechanism associated to this kinase inhibitor, we have evaluated the implication of several Mitogen Activated Protein Kinases in Renal Cell Carcinoma-derived cell lines. Materials and methods An experimental model of Renal Cell Carcinoma-derived cell lines (ACHN and 786-O cells) was evaluated in terms of viability by MTT assay, induction of apoptosis by caspase 3/7 activity, autophagy induction by LC3 lipidation, and p62 degradation and kinase activity using phospho-targeted antibodies. Knock down of ATG5 and ERK5 was performed using lentiviral vector coding specific shRNA Results Our data discard Extracellular Regulated Kinase 1/2 and 5 as well as p38 Mitogen Activated Protein Kinase pathways as mediators of Sorafenib toxic effect but instead indicate that the inhibitory effect is exerted through the PI3K/Akt signalling pathway. Furthermore, we demonstrate that inhibition of Akt mediates cell death associated to Sorafenib without caspase activation, and this is consistent with the induction of autophagy, as indicated by the use of pharmacological and genetic approaches. Conclusion The present report demonstrates that Sorafenib exerts its toxic effect through the induction of autophagy in an Akt-dependent fashion without the implication of Mitogen Activated Protein Kinase. Therefore, our data discard the use of inhibitors of the RAF-MEK-ERK1/2 signalling pathway in RCC and support the use of pro-autophagic compounds, opening new therapeutic opportunities for Renal Cell Carcinoma.	[Serrano-Oviedo, Leticia; Ortega-Muelas, Marta; Garcia-Cano, Jesus; Valero, Maria L. I.; Cimas, Francisco J.; Pascual-Serra, Raquel; Fernandez-Aroca, Diego M.; Roche, Olga; Ruiz-Hidalgo, Maria J.] UCLM, Unidad Asociada Biomed, Unidad Asociada, Lab Oncol,Unidad Med Mol,Ctr Reg Invest Biomed,CS, Albacete, Spain; [Roche, Olga; Sanchez-Prieto, Ricardo] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain; [Ruiz-Hidalgo, Maria J.] Univ Castilla La Mancha, Fac Med, Area Bioquim & Biol Mol, Albacete, Spain; [Belandia, Borja; Sanchez-Prieto, Ricardo] UCLM, Unidad Asociada Biomed, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Biol Canc,Unidad Asociada,CSIC, Madrid, Spain; [Gimenez-Bachs, Jose M.; Salinas, Antonio S.] Complejo Hosp Albacete, Fac Med, Unidad Invest, Serv Urol, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Castilla-La Mancha	Sanchez-Prieto, R (corresponding author), Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete, Spain.; Sanchez-Prieto, R (corresponding author), UCLM, Unidad Asociada Biomed, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Biol Canc,Unidad Asociada,CSIC, Madrid, Spain.	rsprieto@iib.uam.es	García-Cano, Jesús/J-3581-2012; Sanchez-Prieto, Ricardo/AAY-4271-2021; Prieto, Ricardo/AAZ-7221-2021; Fernandez Aroca, Diego Manuel/AAB-7423-2022; Roche, UCLM/F-5697-2019; García-Cano, Jesús/AAA-9257-2020; Sanchez-Prieto, Ricardo/B-6877-2008; Ruiz-Hidalgo, Maria J/L-1956-2014	García-Cano, Jesús/0000-0002-8312-2622; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Fernandez Aroca, Diego Manuel/0000-0003-2699-7374; Roche, UCLM/0000-0003-1884-8256; García-Cano, Jesús/0000-0002-8312-2622; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Ruiz-Hidalgo, Maria J/0000-0003-2508-8398; Serrano Oviedo, Leticia/0000-0003-3876-2919; Cimas, Francisco J./0000-0001-9241-331X	Fundacion Leticia Castillejo Castillo, Ministerio de Economia y Competitividad [SAF2012-30862, SAF2015-64215R]; European Community through the Regional Development Funding Program (FEDER); University of Castilla La Mancha (UCLM)	Fundacion Leticia Castillejo Castillo, Ministerio de Economia y Competitividad; European Community through the Regional Development Funding Program (FEDER); University of Castilla La Mancha (UCLM)	This work was supported by grants from Fundacion Leticia Castillejo Castillo, Ministerio de Economia y Competitividad (SAF2012-30862, SAF2015-64215R) to RSP and MJRH. RSP and MJRH Research Institutes, and the work carried out in their laboratories received support from the European Community through the Regional Development Funding Program (FEDER). OR has a contract for accessing the Spanish System of Science, Technology and Innovation (SECTI) funded by the University of Castilla La Mancha (UCLM).	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; Ahmad T, 2004, CLIN CANCER RES, V10, p6388S, DOI 10.1158/1078-0432.CCR-040028; Arias-Gonzalez L, 2013, NEOPLASIA, V15, P649, DOI 10.1593/neo.121896; Buonato JM, 2014, CANCER RES, V74, P309, DOI 10.1158/0008-5472.CAN-12-4721; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Cheng Y, 2011, CANCER RES, V71, P2654, DOI 10.1158/0008-5472.CAN-10-2889; Cho D, 2013, CANCER J, V19, P311, DOI 10.1097/PPO.0b013e31829d5cea; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Deschenes-Simard X, 2014, CANCER RES, V74, P412, DOI 10.1158/0008-5472.CAN-13-2381; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fecteau JF, 2012, MOL MED, V18, P19, DOI 10.2119/molmed.2011.00164; Fouladi F, 2015, LEUKEMIA LYMPHOMA, V56, P2690, DOI 10.3109/10428194.2014.1003055; Fukazawa H, 2000, CANCER RES, V60, P2104; Gadaleta-Caldarola G, 2015, FUTURE ONCOL, V11, P1863, DOI [10.2217/fon.15.85, 10.2217/FON.15.85]; Garcia-Cano J, 2015, ONCOTARGET, V6, P15551, DOI 10.18632/oncotarget.3902; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Grimaldi A, 2015, CANCER BIOL THER, V16, P567, DOI 10.1080/15384047.2015.1018494; Harada K, 2014, CLIN TRANSL ONCOL, V16, P801, DOI 10.1007/s12094-013-1151-9; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Katz SI, 2009, CANCER BIOL THER, V8, P2406, DOI 10.4161/cbt.8.24.10824; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kiprianova I, 2015, NEOPLASIA, V17, P564, DOI 10.1016/j.neo.2015.07.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lin JC, 2013, INT IMMUNOPHARMACOL, V15, P333, DOI 10.1016/j.intimp.2013.01.006; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu XY, 2016, CELL MOL NEUROBIOL, V36, P1197, DOI 10.1007/s10571-015-0318-z; Valero ML, 2014, CELL CYCLE, V13, P52, DOI 10.4161/cc.26754; Lohmeyer J, 2018, CLIN EXP IMMUNOL, V193, P64, DOI 10.1111/cei.13128; Lu XC, 2010, J SURG ONCOL, V102, P821, DOI 10.1002/jso.21661; Martin-Liberal J, 2014, EXPERT OPIN DRUG SAF, V13, P483, DOI 10.1517/14740338.2014.892578; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pignochino Y, 2013, CLIN CANCER RES, V19, P2117, DOI 10.1158/1078-0432.CCR-12-2293; Piscazzi A, 2012, J CLIN ENDOCR METAB, V97, pE898, DOI 10.1210/jc.2011-3269; Porta C, 2014, CANCER MED-US, V3, P1517, DOI 10.1002/cam4.302; Prieto-Dominguez N, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00151; Rosenberg L, 2018, CARCINOGENESIS, V39, P681, DOI 10.1093/carcin/bgy038; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Rusconi P, 2012, CURR MED CHEM, V19, P1164; Sakai I, 2013, BJU INT, V112, pE211, DOI 10.1111/j.1464-410X.2012.11655.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Spirli C, 2012, HEPATOLOGY, V56, P2363, DOI 10.1002/hep.25872; Tai WT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.18; Takahashi M, 2003, HEPATOL RES, V26, P232, DOI 10.1016/S1386-6346(03)00112-8; Tei H, 2015, HUM CELL, V28, P114, DOI 10.1007/s13577-015-0112-8; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2010, BIOCHEM PHARMACOL, V80, P561, DOI 10.1016/j.bcp.2010.03.019; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xargay-Torrent S, 2013, CLIN CANCER RES, V19, P586, DOI 10.1158/1078-0432.CCR-12-1935; Yi HQ, 2016, CRIT REV ONCOL HEMAT, V100, P137, DOI 10.1016/j.critrevonc.2016.02.006; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J; Yuen JSP, 2011, BRIT J CANCER, V104, P941, DOI 10.1038/bjc.2011.55; Yuen JSP, 2012, INT J ONCOL, V41, P712, DOI 10.3892/ijo.2012.1494; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043; Zhang YN, 2014, MOL MED REP, V9, P365, DOI 10.3892/mmr.2013.1782; Zhang ZG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-23	69	20	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200878	10.1371/journal.pone.0200878	http://dx.doi.org/10.1371/journal.pone.0200878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048489	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400026
J	Lachmann, R; Loenenbach, A; Waterboer, T; Brenner, N; Pawlita, M; Michel, A; Thamm, M; Poethko-Muller, C; Wichmann, O; Wiese-Posselt, M				Lachmann, Raskit; Loenenbach, Anna; Waterboer, Tim; Brenner, Nicole; Pawlita, Michael; Michel, Angelika; Thamm, Michael; Poethko-Mueller, Christina; Wichmann, Ole; Wiese-Posselt, Miriam			Cytomegalovirus (CMV) seroprevalence in the adult population of Germany	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS; SOCIOECONOMIC DISPARITIES; PREGNANT-WOMEN; RISK-FACTORS; INFECTION; DISEASE; PREVENTION; VACCINE; BURDEN; SEROCONVERSION	Background Infection with cytomegalovirus (CMV) remains asymptomatic in most immunocompetent hosts, but is the leading cause of congenital viral infection worldwide and can be life-threatening in immunocompromised individuals. We aimed to assess CMV seroprevalence in a nationally representative sample of adults in Germany and to identify sociodemographic factors associated with CMV seropositivity. Methods Blood samples from 6552 participants (18-79 years) of the "German National Health Interview and Examination Survey 1998", a population-based sample of the adult population in Germany, were tested for the presence of CMV antibodies using an Ig-multiplex assay. Weighted seroprevalence was calculated and weighted binomial regression was used to identify factors associated with CMV seropositivity. Results Overall CMV seroprevalence was 56.7% (95%CI: 54.8-58.7%), with a higher seroprevalence in women (62.3%) than in men (51.0%). Seroprevalence increased with age: from 31.8% to 63.7% in men and from 44.1% to 77.6% in women when comparing the 18-29 with the 70-79 year age-group, respectively. CMV seroprevalence in women of childbearing age (18-45 years) was 51.7%. Factors significantly associated with CMV seropositivity were age, country of birth, smoking status, education, living in northern Germany and number of household members. In addition, having attended child care was associated with seropositivity in men, and number of siblings and living in East Germany in women. Conclusion Our results indicate that half the women of childbearing age were susceptible for primary CMV infection during pregnancy. CMV screening during pregnancy and informing seronegative women about CMV risk reduction measures could prevent congenital CMV infections with its serious consequences.	[Lachmann, Raskit; Loenenbach, Anna; Wichmann, Ole; Wiese-Posselt, Miriam] Robert Koch Inst, Immunizat Unit, Berlin, Germany; [Lachmann, Raskit] Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany; [Lachmann, Raskit] ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Loenenbach, Anna] Charite Univ Med Berlin, Berlin, Germany; [Waterboer, Tim; Brenner, Nicole; Pawlita, Michael; Michel, Angelika] German Canc Res Ctr, Div Mol Diagnost Oncogen infect, Infect Inflammat & Canc Program, Heidelberg, Germany; [Thamm, Michael; Poethko-Mueller, Christina] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Robert Koch Institute	Lachmann, R (corresponding author), Robert Koch Inst, Immunizat Unit, Berlin, Germany.; Lachmann, R (corresponding author), Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany.; Lachmann, R (corresponding author), ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden.	LachmannR@rki.de		Wiese-Posselt, Miriam/0000-0001-9300-2563; , Raskit/0000-0003-0915-5968	German Ministry of Health; German Ministry of Education and Research; Robert Koch Institute (Berlin, Germany); Molecular Diagnostics of Oncogenic Infections Division at the German Cancer Research Center (DKFZ, Heidelberg)	German Ministry of Health; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute (Berlin, Germany); Molecular Diagnostics of Oncogenic Infections Division at the German Cancer Research Center (DKFZ, Heidelberg)	The German National Health Interview and Examination Survey 1998 was funded by the German Ministry of Health, the German Ministry of Education and Research, and the Robert Koch Institute (Berlin, Germany). Laboratory testing for CMV-specific Ig by multiplex assay was funded by the German Ministry of Health and the Robert Koch Institute (Berlin, Germany), and in-house funding from the Molecular Diagnostics of Oncogenic Infections Division at the German Cancer Research Center (DKFZ, Heidelberg).	Adler SP, 2004, J PEDIATR-US, V145, P485, DOI 10.1016/j.jpeds.2004.05.041; Alfaro-Murillo JA, 2016, VACCINE, V34, P225, DOI 10.1016/j.vaccine.2015.11.039; Antona D., 2017, EPIDEMIOL INFECT, P1; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Basha J, 2014, J PAEDIATR CHILD H, V50, P368, DOI 10.1111/jpc.12502; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bernstein DI, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00491-16; Bernstein DI, 2016, VACCINE, V34, P313, DOI 10.1016/j.vaccine.2015.11.056; Binda S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1861-z; Buxmann H, 2017, DTSCH ARZTEBL INT, V114, P45, DOI 10.3238/arztebl.2017.0045; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Deutsche Vereinigung zur Beka E mpfung der Viruskrankheiten Virologie Gf., LAB SCHWAN GERSCH VI; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Hamer M, 2016, J CLIN ENDOCR METAB, V101, P1680, DOI 10.1210/jc.2015-4208; Hecker M, 2004, VOX SANG, V86, P41, DOI 10.1111/j.0042-9007.2004.00388.x; Hyde TB, 2010, REV MED VIROL, V20, P311, DOI 10.1002/rmv.659; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Korndewal MJ, 2015, J CLIN VIROL, V63, P53, DOI 10.1016/j.jcv.2014.11.033; Lancini D, 2014, MED J AUSTRALIA, V201, P578, DOI 10.5694/mja14.00183; Loewendorf A, 2010, J INTERN MED, V267, P483, DOI 10.1111/j.1365-2796.2010.02220.x; Lopo S, 2011, EUROSURVEILLANCE, V16, P2002; Ludwig A, 2009, EUROSURVEILLANCE, V14, P26; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Marshall GS, 2005, AM J PERINAT, V22, P371, DOI 10.1055/s-2005-872590; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; Modrow S, 2018, FRAUENARZT, V59, P394; Odland ML, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003066; Olsson J, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0093-4; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Picone O, 2009, BJOG-INT J OBSTET GY, V116, P818, DOI 10.1111/j.1471-0528.2009.02139.x; Qiu FF, 2017, ONCOTARGET, V8, P268, DOI 10.18632/oncotarget.13613; Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47; Reichman O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/135416; Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003; Smith LR, 2013, VACCINES-BASEL, V1, DOI 10.3390/vaccines1040398; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Taniguchi K, 2014, J CLIN VIROL, V59, P192, DOI 10.1016/j.jcv.2013.12.013; Thackeray Rosemary, 2016, Prev Med Rep, V4, P517; Thefeld W., 1999, GESUNDHEITSWESEN, V61, pS57; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003; Vilibic-Cavlek T, 2017, WIEN KLIN WOCHENSCHR, V129, P129, DOI 10.1007/s00508-016-1069-7; Voigt S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv193; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Willame A, 2015, INT J ENV RES PUB HE, V12, P15285, DOI 10.3390/ijerph121214982	48	58	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200267	10.1371/journal.pone.0200267	http://dx.doi.org/10.1371/journal.pone.0200267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044826	gold, Green Submitted, Green Published			2022-12-27	WOS:000439942500037
J	Hanson, EA; Sandmann, C; Malyshev, A; Lundervold, A; Modersitzki, J; Hodneland, E				Hanson, Erik A.; Sandmann, Constantin; Malyshev, Alexander; Lundervold, Arvid; Modersitzki, Jan; Hodneland, Erlend			Estimating the discretization dependent accuracy of perfusion in coupled capillary flow measurements	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; STROKE PATIENTS; BOLUS TRACKING; MRI; CT; FRAMEWORK; BRAIN; MAPS	One-compartment models are widely used to quantify hemodynamic parameters such as perfusion, blood volume and mean transit time. These parameters are routinely used for clinical diagnosis and monitoring of disease development and are thus of high relevance. However, it is known that common estimation techniques are discretization dependent and values can be erroneous. In this paper we present a new model that enables systematic quantification of discretization errors. Specifically, we introduce a continuous flow model for tracer propagation within the capillary tissue, used to evaluate state-of-the-art one-compartment models. We demonstrate that one-compartment models are capable of recovering perfusion accurately when applied to only one compartment, i.e. the whole region of interest. However, substantial overestimation of perfusion occurs when applied to fractions of a compartment. We further provide values of the estimated overestimation for various discretization levels, and also show that overestimation can be observed in real-life applications. Common practice of using compartment models for fractions of tissue violates model assumptions and careful interpretation is needed when using the computed values for diagnosis and treatment planning.	[Hanson, Erik A.; Malyshev, Alexander] Univ Bergen, Dept Math, Bergen, Norway; [Sandmann, Constantin; Modersitzki, Jan] Univ Lubeck, Inst Math & Image Comp, Lubeck, Germany; [Lundervold, Arvid] Univ Bergen, Dept Biomed, Bergen, Norway; [Lundervold, Arvid] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Hodneland, Erlend] Christian Michelsen Res AS, Bergen, Norway	University of Bergen; University of Lubeck; University of Bergen; University of Bergen; Haukeland University Hospital	Hodneland, E (corresponding author), Christian Michelsen Res AS, Bergen, Norway.	erlend.hodneland@cmr.no			MedViz Research Cluster; Christian Michelsen Research; University of Lubeck; University of Bergen; Research Council of Norway [262203]	MedViz Research Cluster; Christian Michelsen Research; University of Lubeck; University of Bergen; Research Council of Norway(Research Council of Norway)	The work has partly been financed by MedViz Research Cluster as well through in-kind contributions from Christian Michelsen Research, University of Lubeck and University of Bergen. The authors Hanson, E, Lundervold, A. and Hodneland, E. received funding from the Research Council of Norway project #262203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnes JE, 2007, AN INTRODUCTION TO T; Boutelier T, 2012, IEEE T MED IMAGING, V31, P1381, DOI 10.1109/TMI.2012.2189890; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Cho YI, 2011, KOREAN CIRC J, V41, P287, DOI 10.4070/kcj.2011.41.6.287; Cookson AN, 2012, J BIOMECH, V45, P850, DOI 10.1016/j.jbiomech.2011.11.026; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; Evans LC, 1996, PARTIAL DIFFERENTIAL; Feng Q, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-33; Gruner R, 2006, J MAGN RESON IMAGING, V23, P273, DOI 10.1002/jmri.20505; Guibert R, 2013, J CEREBR BLOOD F MET, V33, P669, DOI 10.1038/jcbfm.2013.39; HENKELMAN RM, 1990, MAGNET RESON MED, V16, P470, DOI 10.1002/mrm.1910160313; Kickingereder P, 2015, RADIOLOGY, P542; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Mendrik AM, 2011, PHYS MED BIOL, V56, P3857, DOI 10.1088/0031-9155/56/13/008; Michler C, 2013, INT J NUMER METH BIO, V29, P217, DOI 10.1002/cnm.2520; Mokin M, 2015, INTERV NEUROL, V4, P104, DOI 10.1159/000442717; Mori S, 1998, PROCEEDINGS OF INTER; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Patankar SV., 2018, NUMERICAL HEAT TRANS; Rosencranz R, 2006, AM J CLIN PATHOLOG S, V125, P78, DOI DOI 10.1309/FFF7U8RRPK26VAPY; Smith AM, 2000, J MAGN RESON IMAGING, V12, P400, DOI 10.1002/1522-2586(200009)12:3<400::AID-JMRI5>3.0.CO;2-C; Sourbron S, 2014, IEEE T MED IMAGING, V33, P935, DOI 10.1109/TMI.2014.2300450; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Townsley MI, 2012, COMPR PHYSL; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Zierler K, 2000, ANN BIOMED ENG, V28, P836, DOI 10.1114/1.1308496	29	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200521	10.1371/journal.pone.0200521	http://dx.doi.org/10.1371/journal.pone.0200521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028854	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900007
J	Prestigiacomo, V; Suter-Dick, L				Prestigiacomo, Vincenzo; Suter-Dick, Laura			Nrf2 protects stellate cells from Smad-dependent cell activation	PLOS ONE			English	Article							I RECEPTOR KINASE; OXIDATIVE STRESS; LIVER-INJURY; KNOCKOUT MICE; FIBROSIS; PATHWAY; ACETAMINOPHEN; ANTIOXIDANT; MECHANISMS; INHIBITION	Hepatic stellate cells (HSC) orchestrate the deposition of extracellular matrix (ECM) and are the primary effector of liver fibrosis. Several factors, including TGF-beta 1, PDGF and oxidative stress, have been shown to trigger HSC activation. However, the involvement of cellular defence mechanisms, such as the activation of antioxidant response by Nrf2/Keap1 in the modulation of HSC activation is not known. The aim of this work was to elucidate the role of Nrf2 pathway in HSC trans-differentiation involved in the development of fibrosis. To this end, we repressed Nrf2 and Keap1 expression in HSC with specific siRNAs. We then assessed activation markers, as well as proliferation and migration, in both primary and immortalised human HSCs exposed to Smad inhibitors (SB-431542 hydrate and SB525334), TGF-beta 1 and/or PDGF. Our results indicate that knocking down Nrf2 induces HSC activation, as shown by an increase in alpha SMA-positive cells and by gene expression induction of ECM components (collagens and fibronectin). HSC with reduced Nrf2-levels also showed an increase in migration and a decrease in proliferation. We could also demonstrate that the activation of Nrf2-deficient HSC involves the TGF-beta 1/Smad pathway, as the activation was successfully inhibited with the two tested Smad inhibitors. Moreover, TGF-beta 1 elicited a stronger induction of HSC activation markers in Nrf2 deficient cells than in wild type cells. Thus, our data suggest that Nrf2 limits HSCs activation, through the inhibition of the TGF-beta 1/Smad pathway in HSCs.	[Prestigiacomo, Vincenzo; Suter-Dick, Laura] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland; [Prestigiacomo, Vincenzo] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland	FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Basel	Prestigiacomo, V (corresponding author), Univ Appl Sci Northwestern Switzerland, Sch Life Sci, Muttenz, Switzerland.; Prestigiacomo, V (corresponding author), Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland.	vincenzo.prestigiacomo@fhnw.ch	Suter-Dick, Laura/A-9093-2019	Suter-Dick, Laura/0000-0002-1449-3913	School of Life Sciences (University of Applied Sciences Northwestern Switzerland)	School of Life Sciences (University of Applied Sciences Northwestern Switzerland)	This work was partly founded by the Swiss Centre for Applied Human Toxicology (SCAHT), and partly funded by the School of Life Sciences (University of Applied Sciences Northwestern Switzerland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Cai CX, 2017, DIGEST DIS SCI, V62, P968, DOI 10.1007/s10620-017-4470-9; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chien MH, 2015, CLIN CANCER RES, V21, P4719, DOI 10.1158/1078-0432.CCR-14-2880; Churchman AT, 2009, J CELL MOL MED, V13, P2282, DOI 10.1111/j.1582-4934.2009.00874.x; Cuadrado A, 2014, J BIOL CHEM, V289, P15244, DOI 10.1074/jbc.M113.540633; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Fan Z, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.65; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Hauck PM, 2017, MOL CANCER RES, V15, P1598, DOI 10.1158/1541-7786.MCR-17-0174; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16552; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Mormone E, 2012, GASTROENTEROLOGY, V142, P612, DOI 10.1053/j.gastro.2011.11.029; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Pall Martin L., 2015, Shengli Xuebao, V67, P1; Pennock R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13113; Potteti HR, 2016, AM J PHYSIOL-RENAL, V311, pF1025, DOI 10.1152/ajprenal.00362.2016; Prestigiacomo V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179995; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Ryoo IG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093265; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Shen H, 2014, DIS ESOPHAGUS, V27, P685, DOI 10.1111/dote.12124; Sison-Young RLC, 2015, TOXICOL SCI, V147, P412, DOI 10.1093/toxsci/kfv136; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang Y, 2008, WORLD J GASTROENTERO, V14, P5186, DOI 10.3748/wjg.14.5186; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang JJ, 2014, CELL SIGNAL, V26, P2381, DOI 10.1016/j.cellsig.2014.07.016	44	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201044	10.1371/journal.pone.0201044	http://dx.doi.org/10.1371/journal.pone.0201044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028880	gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900034
J	Hage-Hulsmann, J; Grunberger, A; Thies, S; Santiago-Schubel, B; Klein, AS; Pietruszka, J; Binder, D; Hilgers, F; Domrose, A; Drepper, T; Kohlheyer, D; Jaeger, KE; Loeschcke, A				Hage-Huelsmann, Jennifer; Gruenberger, Alexander; Thies, Stephan; Santiago-Schuebel, Beatrix; Klein, Andreas Sebastian; Pietruszka, Joerg; Binder, Dennis; Hilgers, Fabienne; Domroese, Andreas; Drepper, Thomas; Kohlheyer, Dietrich; Jaeger, Karl-Erich; Loeschcke, Anita			Natural biocide cocktails: Combinatorial antibiotic effects of prodigiosin and biosurfactants	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SERRATIA-MARCESCENS; ANTIMICROBIAL ACTIVITY; CORYNEBACTERIUM-GLUTAMICUM; BACILLUS-SUBTILIS; SERRAWETTIN W1; SINGLE; BIOSYNTHESIS; PROTEIN; CELLS	Bacterial secondary metabolites are naturally produced to prevail amongst competitors in a shared habitat and thus represent a valuable source for antibiotic discovery. The transformation of newly discovered antibiotic compounds into effective drugs often requires additional surfactant components for drug formulation. Nature may also provide blueprints in this respect: A cocktail of two compounds consisting of the antibacterial red pigment prodigiosin and the biosurfactant serrawettin W1 is naturally produced by the bacterium Serratia marcescens, which occurs in highly competitive habitats including soil. We show here a combinatorial antibacterial effect of these compounds, but also of prodigiosin mixed with other (bio)surfactants, against the soil-dwelling bacterium Corynebacterium glutamicum taken as a model target bacterium. Prodigiosin exerted a combinatorial inhibitory effect with all tested surfactants in a disk diffusion assay which was especially pronounced in combination with N-myristoyltyrosine. Minimal inhibitory and bactericidal concentrations (MIC and MBC) of the individual compounds were 2.56 mu g/mL prodigiosin and 32 mu g/mL N-myristoyltyrosine, and the MIC of prodigiosin was decreased by 3 orders of magnitude to 0.005 mu g/mL in the presence of 16 mu g/mL N-myristoyltyrosine, indicative of synergistic interaction. Investigation of bacterial survival revealed similar combinatorial effects; moreover, antagonistic effects were observed at higher compound concentrations. Finally, the investigation of microcolony formation under combined application of concentrations just below the MBC revealed heterogeneity of responses with cell death or delayed growth. In summary, this study describes the combinatorial antibacterial effects of microbial biomolecules, which may have ecological relevance by inhibiting cohabiting species, but shall furthermore inspire drug development in the combat of infectious disease.	[Hage-Huelsmann, Jennifer; Thies, Stephan; Binder, Dennis; Hilgers, Fabienne; Domroese, Andreas; Drepper, Thomas; Jaeger, Karl-Erich; Loeschcke, Anita] Heinrich Heine Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany; [Gruenberger, Alexander; Pietruszka, Joerg; Kohlheyer, Dietrich; Jaeger, Karl-Erich] Forschungszentrum Julich, IBG Biotechnol 1, Julich, Germany; [Gruenberger, Alexander] Bielefeld Univ, Multiscale Bioengn, Bielefeld, Germany; [Thies, Stephan; Loeschcke, Anita] Forschungszentrum Julich, Bioecon Sci Ctr BioSC, Julich, Germany; [Santiago-Schuebel, Beatrix] Forschungszentrum Julich, Cent Div Analyt Chem ZEA Analyt Biospec 3, Julich, Germany; [Klein, Andreas Sebastian; Pietruszka, Joerg] Heinrich Heine Univ Dusseldorf, Inst Bioorgan Chem, Forschungszentrum Julich, Julich, Germany; [Kohlheyer, Dietrich] Rhein Westfal TH Aachen, Aachener Verfahrenstech AVT MSB, Aachen, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Bielefeld; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; RWTH Aachen University	Loeschcke, A (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany.	a.loeschcke@fz-juelich.de	Knapp, Fabienne/AAD-5729-2022; Kohlheyer, Dietrich/A-9645-2012; Thies, Stephan/H-3749-2015; Drepper, Thomas/ABA-8291-2020; drepper, thomas/ABB-4717-2020; jaeger, karl/ABB-1955-2020	Knapp, Fabienne/0000-0002-8749-284X; Kohlheyer, Dietrich/0000-0001-6215-1857; Thies, Stephan/0000-0003-4240-9149; Drepper, Thomas/0000-0002-0096-8084; drepper, thomas/0000-0002-0096-8084; Domrose, Andreas/0000-0003-4274-1432; Klein, Andreas Sebastian/0000-0001-8075-3480	Forschungsgemeinschaft via CEPLAS-Cluster of Excellence on Plant Science [EXC1028]; Ministry of Culture and Science of the German Federal State of North Rhine-Westphalia; Heinrich-Heine-University DuEsseldorf (CLIB Graduate Cluster Industrial Biotechnology); German Helmholtz Association [VH-NG-1029]; Ministry of Culture and Science of the German State of North Rhine-Westphalia (NRW Strategieprojekt BioSC) [313/323-400-00213]; Helmholtz Association [PD-311]	Forschungsgemeinschaft via CEPLAS-Cluster of Excellence on Plant Science; Ministry of Culture and Science of the German Federal State of North Rhine-Westphalia; Heinrich-Heine-University DuEsseldorf (CLIB Graduate Cluster Industrial Biotechnology); German Helmholtz Association(Helmholtz Association); Ministry of Culture and Science of the German State of North Rhine-Westphalia (NRW Strategieprojekt BioSC); Helmholtz Association(Helmholtz Association)	JHH was funded by the Deutsche Forschungsgemeinschaft via CEPLAS-Cluster of Excellence on Plant Science (EXC1028). We gratefully acknowledge the Ministry of Culture and Science of the German Federal State of North Rhine-Westphalia and the Heinrich-Heine-University DuEsseldorf (scholarships within the CLIB Graduate Cluster Industrial Biotechnology for AD and ASK). DK work was supported by the German Helmholtz Association (VH-NG-1029). ST and AL are funded by the Ministry of Culture and Science of the German State of North Rhine-Westphalia (through NRW Strategieprojekt BioSC (No. 313/323-400-00213). AG is supported by a postdoctoral grant provided by the Helmholtz Association (PD-311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Abu-Ghunmi L, 2014, J SURFACTANTS DETERG, V17, P833, DOI 10.1007/s11743-014-1584-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2012, AGENCY TOXIC SUBSTAN; BARNESS R, 1988, J BACTERIOL, V170, P4361, DOI 10.1128/jb.170.9.4361-4364.1988; Barraud O, 2011, EMERG INFECT DIS, V17, P2078, DOI 10.3201/eid1711.110282; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Baumgart M, 2016, J BACTERIOL, V198, P3045, DOI 10.1128/JB.00406-16; Belda E, 2016, ENVIRON MICROBIOL, V18, P3403, DOI 10.1111/1462-2920.13230; Ben Khedher S, 2017, J INVERTEBR PATHOL, V144, P11, DOI 10.1016/j.jip.2017.01.006; Bhadoriya SS, 2013, BIOCHEM PHARMACOL, DOI [DOI 10.4172/2167-0501.1000113, 10.4172/2167-0501.1000113]; Binder D, 2014, INTEGR BIOL-UK, V6, P755, DOI 10.1039/c4ib00027g; Bnyan R, 2018, J PHARM SCI-US, V107, P1237, DOI 10.1016/j.xphs.2018.01.005; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; Brady SF, 2004, APPL ENVIRON MICROB, V70, P6865, DOI 10.1128/AEM.70.11.6865-6870.2004; Brady SF, 2000, J AM CHEM SOC, V122, P12903, DOI 10.1021/ja002990u; Brothers KM, 2015, INFECT IMMUN, V83, P4373, DOI 10.1128/IAI.00466-15; Burkovski A, 2003, FEMS MICROBIOL REV, V27, P617, DOI 10.1016/S0168-6445(03)00067-6; Busschaert N, 2013, ANGEW CHEM INT EDIT, V52, P1374, DOI 10.1002/anie.201207535; Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006; Cassella M, 2005, J BIOL CONTRL, Patent No. 6926892; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Charlop-Powers Z, 2016, P NATL ACAD SCI USA, V113, P14811, DOI 10.1073/pnas.1615581113; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; D'aes J, 2010, ENV MICROBIOL REP, V2, P359, DOI 10.1111/j.1758-2229.2009.00104.x; Danevcic T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162412; Danevcic T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00027; Darshan N, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0222-z; Das Ghatak P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19175-7; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deziel E, 2000, BBA-MOL CELL BIOL L, V1485, P145, DOI 10.1016/S1388-1981(00)00039-1; Domrose A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00972; Dwivedi D, 2008, J NAT PROD, V71, P637, DOI 10.1021/np7007126; Escobar-Diaz E, 2005, LEUKEMIA, V19, P572, DOI 10.1038/sj.leu.2403679; FENG JS, 1982, APPL ENVIRON MICROB, V43, P850, DOI 10.1128/AEM.43.4.850-853.1982; Fischbach MA, 2011, CURR OPIN MICROBIOL, V14, P519, DOI 10.1016/j.mib.2011.08.003; Fischbach MA, 2009, CURR OPIN MICROBIOL, V12, P520, DOI 10.1016/j.mib.2009.07.002; FRACCHIA L, 2014, BIOSURFACTANTS PRODU, P245, DOI DOI 10.1201/B17599-15; Giri AV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-11; Grunberger A, 2015, CYTOM PART A, V87A, P1101, DOI 10.1002/cyto.a.22779; Gruenberger A, 2013, JOVE-J VIS EXP, DOI 10.3791/50560; Grunberger A, 2014, CURR OPIN BIOTECH, V29, P15, DOI 10.1016/j.copbio.2014.02.008; Grunberger A, 2012, LAB CHIP, V12, P2060, DOI [10.1039/c2lc40156h, 10.1039/c21c40156h]; Gudina EJ, 2010, LETT APPL MICROBIOL, V50, P419, DOI 10.1111/j.1472-765X.2010.02818.x; Gudina EJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14020038; Guo XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14720; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; HORREVORTS AM, 1987, EUR J CLIN MICROBIOL, V6, P502, DOI 10.1007/BF02013128; Jadon PS, 2009, AAPS PHARMSCITECH, V10, P1186, DOI 10.1208/s12249-009-9325-z; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Kadouri DE, 2013, RES MICROBIOL, V164, P821, DOI 10.1016/j.resmic.2013.06.002; Kalam MA, 2016, DRUG DELIV, V23, P896, DOI 10.3109/10717544.2014.920432; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Khanafari A, 2006, INT J BIOL SCI, DOI [10.3844/ojbsci.2006.1.13, DOI 10.3844/OJBSCI.2006.1.13]; Klein AS, 2017, ACS SYNTH BIOL, V6, P1757, DOI 10.1021/acssynbio.7b00099; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lapenda JC, 2015, WORLD J MICROB BIOT, V31, P399, DOI 10.1007/s11274-014-1793-y; Leao PN, 2010, P NATL ACAD SCI USA, V107, P11183, DOI 10.1073/pnas.0914343107; Li H, 2005, MICROBIOL IMMUNOL, V49, P303, DOI 10.1111/j.1348-0421.2005.tb03734.x; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Majik MS, 2014, BIOORG MED CHEM LETT, V24, P2863, DOI 10.1016/j.bmcl.2014.04.097; MATSUYAMA T, 1985, FEMS MICROBIOL LETT, V28, P125, DOI 10.1111/j.1574-6968.1985.tb00777.x; Matsuyama T, 2011, MICROBIOL MONOGR, V20, P93, DOI 10.1007/978-3-642-14490-5_4; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Muller H, 2009, FEMS MICROBIOL ECOL, V67, P468, DOI 10.1111/j.1574-6941.2008.00635.x; Munck C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009940; Nasiri MJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00681; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Perez-Tomas R, 2010, CURR MED CHEM, V17, P2222, DOI 10.2174/092986710791331103; Perneel M, 2008, ENVIRON MICROBIOL, V10, P778, DOI 10.1111/j.1462-2920.2007.01501.x; Probst C, 2015, ANAL METHODS-UK, V7, P91, DOI 10.1039/c4ay02257b; Roberts DP, 2007, SOIL BIOL BIOCHEM, V39, P2275, DOI 10.1016/j.soilbio.2007.03.029; Rodriguez H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-127; Rossi CC, 2016, LETT APPL MICROBIOL, V63, P215, DOI 10.1111/lam.12611; Sambrook J., 2001, MOL CLONING LAB MANU; Shanks RMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057634; SHEMYAKIMM, 1965, EXPERIENTIA, V21, P548, DOI DOI 10.1007/BF02138991; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Siliakus MF, 2017, EXTREMOPHILES, V21, P651, DOI 10.1007/s00792-017-0939-x; Sotirova A, 2012, CURR MICROBIOL, V65, P534, DOI 10.1007/s00284-012-0191-7; Soto-Cerrato V, 2005, BIOCHEM PHARMACOL, V71, P32, DOI 10.1016/j.bcp.2005.10.020; Stella NA, 2015, J BACTERIOL, V197, P2468, DOI 10.1128/JB.00136-15; Stokes JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.28; Straight PD, 2006, J BACTERIOL, V188, P4918, DOI 10.1128/JB.00162-06; Su C, 2017, J BIOTECHNOL, V245, P9, DOI 10.1016/j.jbiotec.2017.01.011; Su C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3171-7; Suryawanshi RK, 2017, NAT PROD RES, V31, P572, DOI 10.1080/14786419.2016.1195380; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Thies S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27035; Thies S, 2014, J BIOTECHNOL, V181, P27, DOI 10.1016/j.jbiotec.2014.03.037; Till Tiso, 2017, CONSEQUENCES MICROBI, V35, P1, DOI [10.1007/978-3-319-31421-1_388-1, DOI 10.1007/978-3-319-31421-1_388-1]; Troeschel SC, 2010, METHODS MOL BIOL, V668, P117, DOI 10.1007/978-1-60761-823-2_8; Van Der Voort M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00693; Vijay S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00463; Voget S, 2015, J BIOTECHNOL, V204, P3, DOI 10.1016/j.jbiotec.2015.03.022; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; WANG F, 2013, ELECTRON J BIOTECHN, V16, DOI DOI 10.2225/V0L16-ISSUE4-FULLTEXT-7; Wang XD, 2004, BIOTECHNOL APPL BIOC, V40, P277; WASSERMAN HH, 1962, J AM CHEM SOC, V84, P2978, DOI 10.1021/ja00874a028; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Yin Xihou, 2014, US Patent Application for Formulations combining ramoplanin and rhamnolipids for combating bacterial infection, Patent No. [20,140,294,925, 20140294925]	107	30	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200940	10.1371/journal.pone.0200940	http://dx.doi.org/10.1371/journal.pone.0200940			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024935	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000071
J	Kahaki, SMM; Arshad, H; Nordin, MJ; Ismail, W				Kahaki, Seyed M. M.; Arshad, Haslina; Nordin, Md Jan; Ismail, Waidah			Geometric feature descriptor and dissimilarity-based registration of remotely sensed imagery	PLOS ONE			English	Article							POINT DISTANCE ACCUMULATION; SPACE CORNER DETECTOR; CLASSIFICATION; CURVATURE; TRANSLATION; REGION	Image registration of remotely sensed imagery is challenging, as complex deformations are common. Different deformations, such as affine and homogenous transformation, combined with multimodal data capturing can emerge in the data acquisition process. These effects, when combined, tend to compromise the performance of the currently available registration methods. A new image transform, known as geometric mean projection transform, is introduced in this work. As it is deformation invariant, it can be employed as a feature descriptor, whereby it analyzes the functions of all vertical and horizontal signals in local areas of the image. Moreover, an invariant feature correspondence method is proposed as a point matching algorithm, which incorporates new descriptor's dissimilarity metric. Considering the image as a signal, the proposed approach utilizes a square Eigenvector correlation (SEC) based on the Eigenvector properties. In our experiments on standard test images sourced from "Featurespace" and "IKONOS" datasets, the proposed method achieved higher average accuracy relative to that obtained from other state of the art image registration techniques. The accuracy of the proposed method was assessed using six standard evaluation metrics. Furthermore, statistical analyses, including t-test and Friedman test, demonstrate that the method developed as a part of this study is superior to the existing methods.	[Kahaki, Seyed M. M.; Arshad, Haslina; Nordin, Md Jan] Natl Univ Malaysia UKM, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Bangi, Selangor, Malaysia; [Ismail, Waidah] Univ Sains Islam Malaysia, Fac Sci & Technol, Nilai, Negeri Sembilan, Malaysia	Universiti Kebangsaan Malaysia; Universiti Sains Islam Malaysia	Kahaki, SMM (corresponding author), Natl Univ Malaysia UKM, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Bangi, Selangor, Malaysia.	kahaki@siswa.ukm.edu.my	Kahaki, Seyed Mostafa Mousavi/H-3906-2015; Ismail, Waidah/AAF-3346-2019; arshad, haslina/AAF-8737-2019; Ismail, Waidah/AAP-2575-2020; Nordin, Jan/B-9579-2011	Kahaki, Seyed Mostafa Mousavi/0000-0002-0249-3238; Ismail, Waidah/0000-0002-4544-636X; Nordin, Jan/0000-0002-7524-5665	national university of Malaysia [TD-2016-003, DIP-2016-018]	national university of Malaysia	This work was supported by TD-2016-003 and DIP-2016-018 from the national university of Malaysia (www.ukm.edu.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtari AH, 2015, IEEE T IMAGE PROCESS, V24, P3370, DOI 10.1109/TIP.2015.2440763; Awrangjeb M, 2008, IEEE T IMAGE PROCESS, V17, P2425, DOI 10.1109/TIP.2008.2006441; Awrangjeb M, 2008, IEEE T MULTIMEDIA, V10, P1059, DOI 10.1109/TMM.2008.2001384; Chen HM, 2003, INT J REMOTE SENS, V24, P3701, DOI 10.1080/0143116031000117047; Chen TZ, 2014, IEEE GEOSCI REMOTE S, V11, P906, DOI 10.1109/LGRS.2013.2281729; Cole-Rhodes AA, 2003, IEEE T IMAGE PROCESS, V12, P1495, DOI 10.1109/TIP.2003.819237; Cui CH, 2013, IEEE T IMAGE PROCESS, V22, P2876, DOI 10.1109/TIP.2013.2246521; Dutta A, 2011, PATTERN RECOGN LETT, V32, P712, DOI 10.1016/j.patrec.2010.12.006; Eugenio F, 2002, INT GEOSCI REMOTE SE, P3390, DOI 10.1109/IGARSS.2002.1027192; GFDRD, 2016, GEOM FEAT DESCR IM R; GOSHTASBY A, 1985, IEEE T PATTERN ANAL, V7, P338, DOI 10.1109/TPAMI.1985.4767663; Goshtasby AA, 2011, IMAGE REGISTRATION FOR REMOTE SENSING, P153; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Han JH, 2001, PATTERN RECOGN LETT, V22, P1133, DOI 10.1016/S0167-8655(01)00063-0; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; He XC, 2004, INT C PATT RECOG, P791, DOI 10.1109/ICPR.2004.1334377; Ji R. R., 2014, ACM T INTELLIGENT SY, V6, P1; Jia Y-B, 2013, TRANSFORMATIONS HOMO; Kahaki SMM, 2016, NEUROCOMPUTING, V175, P1009, DOI 10.1016/j.neucom.2015.09.106; Kahaki SMM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149710; Kahaki SMM, 2014, SENSORS-BASEL, V14, P4126, DOI 10.3390/s140304126; Li W, 2004, IEEE T IMAGE PROCESS, V13, P1115, DOI 10.1109/TIP.2004.828435; Liu Z., 2014, SENS TRANSDUCERS, V163, P82; Ma JY, 2015, IEEE T GEOSCI REMOTE, V53, P6469, DOI 10.1109/TGRS.2015.2441954; Ma JY, 2015, IEEE T SIGNAL PROCES, V63, P1115, DOI 10.1109/TSP.2014.2388434; Ma JY, 2014, IEEE T IMAGE PROCESS, V23, P1706, DOI 10.1109/TIP.2014.2307478; Mattes D, 2001, PROC SPIE, V4322, P1609, DOI 10.1117/12.431046; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mokhtarian F, 2006, COMPUT VIS IMAGE UND, V102, P81, DOI 10.1016/j.cviu.2005.11.001; Mokhtarian F, 1998, IEEE T PATTERN ANAL, V20, P1376, DOI 10.1109/34.735812; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Orchard J, 2005, LECT NOTES COMPUT SC, V3656, P116, DOI 10.1007/11559573_15; Palenichka RM, 2010, IEEE T GEOSCI REMOTE, V48, P2864, DOI 10.1109/TGRS.2010.2043677; Reddy BS, 1996, IEEE T IMAGE PROCESS, V5, P1266, DOI 10.1109/83.506761; Scott DW, 2001, TECHNOMETRICS, V43, P274, DOI 10.1198/004017001316975880; Shui PL, 2013, IEEE T IMAGE PROCESS, V22, P3204, DOI 10.1109/TIP.2013.2259834; Srivastava R., 2013, RES DEV COMPUTER VIS; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Sun WH, 2012, BIOMED SIGNAL PROCES, V7, P599, DOI 10.1016/j.bspc.2012.05.006; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195; Wei ZQ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090904; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wu Z, 2012, IEEE T IMAGE PROCESS, V21, P2464, DOI 10.1109/TIP.2012.2185941; Yang K, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060581; Zhang XH, 2007, PATTERN RECOGN LETT, V28, P545, DOI 10.1016/j.patrec.2006.10.006; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zhang YD, 2011, SENSORS-BASEL, V11, P4721, DOI 10.3390/s110504721; Zhang YD, 2009, SENSORS-BASEL, V9, P7516, DOI 10.3390/s90907516; Zhou DX, 2004, IEEE INT CONF ROBOT, P2730; Zhu Min, 2014, PLOS ONE, V9; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	53	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200676	10.1371/journal.pone.0200676	http://dx.doi.org/10.1371/journal.pone.0200676			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024921	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000040
J	Matsuda, Y; Hashimoto, R; Takemoto, S; Yoshioka, Y; Uehara, T; Kawasaki, Y				Matsuda, Yukihisa; Hashimoto, Reiko; Takemoto, Sachiko; Yoshioka, Yuka; Uehara, Takashi; Kawasaki, Yasuhiro			Educational benefits for nurses and nursing students of the dementia supporter training program in Japan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SCALE DEVELOPMENT; KNOWLEDGE; ATTITUDES; PEOPLE; CARE	In Japan, which is thought to be a rapidly growing super-aging society, a national campaign named "the Dementia Supporter Caravan" has been deployed. The aim of this study was to assess the educational benefits of the dementia supporter training program for nurses and nursing students. We conducted dementia supporter training, and measured knowledge and attitudes regarding people with dementia as educational benefits pre- and post-training. Data sets of 134 nursing students and 63 nurses were analyzed. The results indicated that the two groups gained knowledge, understanding, and the confidence to care for people with dementia after attending the dementia supporter training program. Moreover, the two groups derived different benefits from the program. Nursing students gained substantial knowledge and learnt the importance of early detection and treatment, to levels similar to those of nurses prior to training. The training program reduced the difficulties of nurses to interact with and care for people with dementia. We can conclude that the dementia supporter training program has considerable educational benefits for nurses and nursing students.	[Matsuda, Yukihisa] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima, Japan; [Matsuda, Yukihisa; Hashimoto, Reiko; Takemoto, Sachiko; Yoshioka, Yuka; Uehara, Takashi; Kawasaki, Yasuhiro] Kanazawa Med Univ, Dept Neuropsychiat, Uchinada, Ishikawa, Japan	Fukuyama University; Kanazawa Medical University	Matsuda, Y (corresponding author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Hiroshima, Japan.; Matsuda, Y (corresponding author), Kanazawa Med Univ, Dept Neuropsychiat, Uchinada, Ishikawa, Japan.	y-matsuda@fupharm.fukuyama-u.ac.jp		Matsuda, Yukihisa/0000-0003-0030-6918	National Key R&D Program of China [2016YFC0401601, 2017YFC0804607]; National Natural Science Foundation of China [51739003, 51479054, 51779086, 51579086, 51379068, 51579083, 51579085, 51609074]; Priority Academic Program Development of Jiangsu Higher Education Institutions [YS11001]; Jiangsu Natural Science Foundation [BK20160872]; Special Project Funded of National Key Laboratory [20145027612, 20165042112]; Key R&D Program of Guangxi [AB17195074]; Central University Basic Research Project [2017B11114]; Fundamental Research Funds for the Central Universities [2017B617X14]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYZZ16_0283, KYCX17_0424]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Special Project Funded of National Key Laboratory; Key R&D Program of Guangxi; Central University Basic Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported by National Key R&D Program of China (2016YFC0401601, 2017YFC0804607), National Natural Science Foundation of China (Grant Nos. 51739003, 51479054, 51779086, 51579086, 51379068, 51579083, 51579085, and 51609074), Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (YS11001), Jiangsu Natural Science Foundation (Grant No. BK20160872), Special Project Funded of National Key Laboratory (20145027612, 20165042112), Key R&D Program of Guangxi (AB17195074), Central University Basic Research Project (2017B11114), the Fundamental Research Funds for the Central Universities (Grant No. 2017B617X14), Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant Nos. KYZZ16_0283, KYCX17_0424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Disease International, 2016, DEM FRIENDL COMM GLO; Annear MJ, 2015, J AM GERIATR SOC, V63, P2375, DOI 10.1111/jgs.13707; Austrom MG, 2015, DEMENTIA-LONDON, V14, P682, DOI 10.1177/1471301214544338; Buffington ALH, 2013, J AM OSTEOPATH ASSOC, V113, P768, DOI 10.7556/jaoa.2013.046; Carpenter BD, 2009, GERONTOLOGIST, V49, P236, DOI 10.1093/geront/gnp023; Community-Care Policy Network, 2016, NUMB DEM SUPP CUM 20; Eccleston CEA, 2015, NURS EDUC TODAY, V35, P800, DOI 10.1016/j.nedt.2015.02.019; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; GILLEARD C, 1994, BRIT J CLIN PSYCHOL, V33, P529, DOI 10.1111/j.2044-8260.1994.tb01149.x; Goldberg LR, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0344-z; Hattink B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4025; Kang Y, 2017, SCAND J CARING SCI, V31, P631, DOI 10.1111/scs.12377; Kimzey M, 2016, NURS EDUC TODAY, V46, P57, DOI 10.1016/j.nedt.2016.08.031; Kitwood Tom, 1992, Ageing Soc, V12, P269, DOI 10.1017/S0144686X0000502X; Korczyn AD, 2002, ANN NY ACAD SCI, V977, P129, DOI 10.1111/j.1749-6632.2002.tb04807.x; KOROLEV IO, 2014, MED STUDENT RES J, V4, P24, DOI DOI 10.3402/MSRJ.V3I0.201333; Kuhn Daniel, 2005, Am J Alzheimers Dis Other Demen, V20, P41, DOI 10.1177/153331750502000108; McCurry J, 2015, LANCET, V386, P1523, DOI 10.1016/S0140-6736(15)00525-5; Ministry of Health Labour and Welfare, 2012, 5 YEAR PLAN PROM MEA; Ministry of Health Labour and Welfare, 2016, LONG TERM CAR INS SY; Ministry of Health Labour and Welfare, 2015, COMPR STRAT ACC DEM; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; Saito Miki, 2015, Journal of the Acarological Society of Japan, V24, P19, DOI 10.2300/acari.24.19; Shin JH, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0116-4; Statistics Bureau, 2016, MONTHL REP; Sugawara H., 2014, NINCHISHO DEMENTIA S; Toye C, 2014, DEMENTIA-LONDON, V13, P248, DOI 10.1177/1471301212471960; Warren JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4827; World Health Organization, 2017, GLOB ACT PLAN PUB HL GLOB ACT PLAN PUB HL; World Health Organization, 2018, WORLD REP AG HLTH; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190	32	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200586	10.1371/journal.pone.0200586	http://dx.doi.org/10.1371/journal.pone.0200586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024922	gold, Green Submitted, Green Published			2022-12-27	WOS:000439120000031
J	Goh, Y; Dan, YY; Chua, W; Jagmohan, P; Lee, JKT; Thian, YL				Goh, Yonggeng; Dan, Yock Young; Chua, Wynne; Jagmohan, Pooja; Lee, Joseph King-Tak; Thian, Yee Liang			Diagnostic utility of whole body CT scanning in patients with unexplained weight loss	PLOS ONE			English	Article							COLORECTAL-CANCER	Background Unexplained weight loss is a non-specific complaint with myriad potential etiologies. Increasingly, whole body CT studies are being performed in patients with unexplained weight loss to exclude organic etiologies such as malignancy. Our study aims to assess the diagnostic accuracy and yield of whole body CT in these patients. Methods and materials Patients who had a whole body CT scan for investigation of unexplained weight loss as their primary complaint from 2009-2012 were retrospectively reviewed. CT scans were classified into 4 categories: (1) Definite/highly suspicious for underlying organic cause (2) Indeterminate for underlying organic cause (3) No findings accounting for weight loss and only incidental findings and (4) Normal study. Scan findings were correlated with the final diagnosis after all investigations. Univariate logistic regression was performed to determine associations between patient's baseline variables and positive CT scan findings. Results Of 301 eligible patients during the study period, 101 patients were excluded due to known history of malignancy, inadequate follow-up or inadequate scan technique. 200 patients were included in the final analyses. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of CT for organic pathology were 72.0%, 90.7%, 87.0%, 78.9% and 82.0% respectively. Additional symptoms, abnormal physical examinations, anemia, and raised tumor markers were significantly correlated with positive CT findings. Overall, the diagnostic yield of whole body CT scan for patients with unexplained weight loss was 33.5%. Conclusions Whole body CT imaging may be a useful investigation for the noninvasive workup of patients with unexplained weight loss, with diagnostic yield of 33.5% and good sensitivity, specificity, positive and negative predictive values for organic etiologies.	[Goh, Yonggeng; Chua, Wynne; Jagmohan, Pooja; Lee, Joseph King-Tak; Thian, Yee Liang] Natl Univ Singapore Hosp, Dept Radiol, Singapore, Singapore; [Dan, Yock Young] Natl Univ Singapore Hosp, Dept Gastroenterol, Singapore, Singapore	National University of Singapore; National University of Singapore	Thian, YL (corresponding author), Natl Univ Singapore Hosp, Dept Radiol, Singapore, Singapore.	yee_liang_thian@nuhs.edu.sg		Thian, Yee Liang/0000-0001-9899-205X				Alibhai SMH, 2005, CAN MED ASSOC J, V172, P773, DOI 10.1503/cmaj.1031527; Bouras EP, 2001, MAYO CLIN PROC, V76, P923; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Furtado CD, 2005, RADIOLOGY, V237, P385, DOI 10.1148/radiol.2372041741; HARDY C, 1986, J AM GERIATR SOC, V34, P219, DOI 10.1111/j.1532-5415.1986.tb04207.x; Hernandez JL, 2003, AM J MED, V114, P631, DOI 10.1016/S0002-9343(03)00115-3; Lankisch PG, 2001, J INTERN MED, V249, P41, DOI 10.1046/j.1365-2796.2001.00771.x; MARTON KI, 1981, ANN INTERN MED, V95, P568, DOI 10.7326/0003-4819-95-5-568; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Metalidis C, 2008, EUR J INTERN MED, V19, P345, DOI 10.1016/j.ejim.2007.09.019; Pickhardt PJ, 2007, AM J ROENTGENOL, V189, P290, DOI 10.2214/AJR.07.2136; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; REIFE CM, 1995, MED CLIN N AM, V79, P299, DOI 10.1016/S0025-7125(16)30069-4; Smith S, CLIN RADIOLOGY, V67, pS8; Than M, 2015, ANN GASTROENTEROL, V28, P94; THOMPSON MP, 1991, J AM GERIATR SOC, V39, P497, DOI 10.1111/j.1532-5415.1991.tb02496.x; Wallace JI, 1997, CLIN GERIATR MED, V13, P717; Yee J, 2002, RADIOGRAPHICS, V22, P1525, DOI 10.1148/rg.226025064	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200686	10.1371/journal.pone.0200686	http://dx.doi.org/10.1371/journal.pone.0200686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052642	gold, Green Published, Green Submitted			2022-12-27	WOS:000440006600011
J	Hussain, MS; Kwon, M; Oh, DH				Hussain, Mohammad Shakhawat; Kwon, Minyeong; Oh, Deog-Hwan			Impact of manganese and heme on biofilm formation of Bacillus cereus food isolates	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; MASTER REGULATOR; STRAINS; SPORULATION; RESISTANCE; SUBTILIS; PROTEIN; GROWTH; ACID	The objective of this study was to determine the impact of manganese (Mn2+) and heme on the biofilm formation characteristics of six B. cereus food isolates and two reference strains (ATCC 10987 and ATCC 14579). The data obtained from the crystal violet assay revealed that addition of a combination of Mn2+ and heme to BHI growth medium induced B. cereus biofilm formation. However, the induction of biofilm formation was strictly strain-dependent. In all of the induced strains, the impact of Mn2+ was greater than that of heme. The impact of these two molecules on the phenotypic characteristics related to biofilm formation, such as cell density, sporulation and swarming ability, was determined in a selected food isolate (GIHE 72-5). Addition of Mn2+ and heme to BHI significantly (p < 0.05) increased the number of cells, which was correlated with the results of crystal violet assays as well as scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) analyses. In addition, induced biofilms showed higher numbers of spores and greater resistance to benzalkonium chloride. The swarming ability of B. cereus planktonic cells was increased in the presence of Mn2+ and heme in BHI. The expression levels of a number of selected genes, which are involved in mobility and extracellular polymeric substances (EPS) formation in B. cereus, were positively correlated with biofilm formation in the presence of Mn2+ and heme in BHI. These results further confirming the role of these molecules in swarming mobility and making matrix components related to B. cereus biofilm formation. These data indicate that signaling molecules present in the food environment might substantially trigger B. cereus biofilm formation, which could pose a threat to the food industry.	[Hussain, Mohammad Shakhawat; Kwon, Minyeong; Oh, Deog-Hwan] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, Gangwon, South Korea	Kangwon National University	Oh, DH (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, Gangwon, South Korea.	deoghwa@kangwon.ac.kr		DeogHwan, Oh/0000-0002-7472-0436; Hussain, Mohammad/0000-0003-1538-1451	Brain Korea (BK) 21 Plus project - Korean Government [22A20153713433]; Kangwon National University	Brain Korea (BK) 21 Plus project - Korean Government; Kangwon National University	This work was supported by a grant from the Brain Korea (BK) 21 Plus project (grant no. 22A20153713433) funded by the Korean Government. It was also supported by a grant from Kangwon National University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bojsen R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21874; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Caro-Astorga Joaquin, 2014, Front Microbiol, V5, P745, DOI 10.3389/fmicb.2014.00745; Castelijn GAA, 2012, BIOFOULING, V28, P51, DOI 10.1080/08927014.2011.648927; Chai YR, 2011, EMBO J, V30, P1402, DOI 10.1038/emboj.2011.36; CHARNEY J, 1951, J BACTERIOL, V62, P145, DOI 10.1128/JB.62.2.145-148.1951; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Forghani F, 2016, J FOOD PROTECT, V79, P810, DOI 10.4315/0362-028X.JFP-15-428; Gao TT, 2015, MICROBIOLOGYOPEN, V4, P452, DOI 10.1002/mbo3.251; Gopal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01418; Granger AC, 2011, APPL ENVIRON MICROB, V77, P32, DOI 10.1128/AEM.01965-10; Halstead FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136190; Hayrapetyan H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00842; Hayrapetyan H, 2015, INT J FOOD MICROBIOL, V200, P72, DOI 10.1016/j.ijfoodmicro.2015.02.005; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Huecker M.R., 2017, BIOCH IRON ABSORPTIO; Hussain MS, 2017, FOOD CONTROL, V77, P270, DOI 10.1016/j.foodcont.2017.02.014; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lucking G, 2009, MICROBIOL-SGM, V155, P922, DOI 10.1099/mic.0.024125-0; Ma WT, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0013-6; Majed R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01054; McLoon AL, 2011, J BACTERIOL, V193, P679, DOI 10.1128/JB.01186-10; Mhatre E, 2016, MICROBIOL-SGM, V162, P1468, DOI 10.1099/mic.0.000320; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; Poimenidou SV, 2016, INT J FOOD MICROBIOL, V237, P164, DOI 10.1016/j.ijfoodmicro.2016.08.029; Radolf J.D., 2011, CLIN INFECT DIS, V52, P965, DOI [10.1093/cid/cir083, DOI 10.1093/CID/CIR528]; Ryu JH, 2005, J FOOD PROTECT, V68, P1734, DOI 10.4315/0362-028X-68.8.1734; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; VASANTHA N, 1979, J GEN MICROBIOL, V112, P329, DOI 10.1099/00221287-112-2-329; Wani AM, 2007, J FOOD SCI TECH MYS, V44, P138; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Xu SD, 2017, MOL PLANT MICROBE IN, V30, P603, DOI [10.1094/MPMI-02-17-0042-R, 10.1094/mpmi-02-17-0042-r]; Yan F, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00561-17	37	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200958	10.1371/journal.pone.0200958	http://dx.doi.org/10.1371/journal.pone.0200958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048488	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400037
J	Loturco, I; Contreras, B; Kobal, R; Fernandes, V; Moura, N; Siqueira, F; Winckler, C; Suchomel, T; Pereira, LA				Loturco, Irineu; Contreras, Bret; Kobal, Ronaldo; Fernandes, Victor; Moura, Neilton; Siqueira, Felipe; Winckler, Ciro; Suchomel, Timothy; Pereira, Lucas Adriano			Vertically and horizontally directed muscle power exercises: Relationships with top-level sprint performance	PLOS ONE			English	Article							SOCCER PLAYERS; RUNNING PERFORMANCE; JUMP SQUATS; STRENGTH; SPEED; LOAD; TESTS; PHASE	The capacity to rapidly generate and apply a great amount of force seems to play a key role in sprint running. However, it has recently been shown that, for sprinters, the technical ability to effectively orient the force onto the ground is more important than its total amount. The force-vector theory has been proposed to guide coaches in selecting the most adequate exercises to comprehensively develop the neuromechanical qualities related to the distinct phases of sprinting. This study aimed to compare the relationships between vertically-directed (loaded and unloaded vertical jumps, and half-squat) and horizontally-directed (hip-thrust) exercises and the sprint performance of top-level track and field athletes. Sixteen sprinters and jumpers (including three Olympic athletes) executed vertical jumps, loaded jump squats and hip-thrusts, and sprinting speed tests at 10-, 20-, 40-, 60-, 100-, and 150-m. Results indicated that the hip-thrust is more associated with the maximum acceleration phase (i.e., from zero to 10-m; r = 0.93), whereas the loaded and unloaded vertical jumps seem to be more related to top-speed phases (i.e., distances superior to 40-m; r varying from 0.88 to 0.96). These findings reinforce the mechanical concepts supporting the force-vector theory, and provide coaches and sport scientists with valuable information about the potential use and benefits of using vertically-or horizontally-based training exercises.	[Loturco, Irineu; Kobal, Ronaldo; Pereira, Lucas Adriano] NAR Nucleus High Performance Sport, Sao Paulo, Brazil; [Contreras, Bret] Auckland Univ Technol, Sport Performance Res Inst New Zealand, Auckland, New Zealand; [Fernandes, Victor; Moura, Neilton] B3 Track & Field Club, Sao Paulo, Brazil; [Fernandes, Victor; Siqueira, Felipe] ADAPT Assoc High Performance Training & Sports De, Sao Paulo, Brazil; [Siqueira, Felipe] Pinheiros Sport Club, Sao Paulo, Brazil; [Winckler, Ciro] Brazilian Paralymp Comm, Sao Paulo, Brazil; [Suchomel, Timothy] Carroll Univ, Dept Human Movement Sci, Waukesha, WI USA	Auckland University of Technology	Loturco, I (corresponding author), NAR Nucleus High Performance Sport, Sao Paulo, Brazil.	irineu.loturco@terra.com.br	Kobal, Ronaldo/AAU-8415-2021; PEREIRA, LUCAS/HHZ-5877-2022; Loturco, Irineu/AAH-4916-2019; Winckler, Ciro/G-2220-2012; Pereira, Lucas/S-3110-2019	Kobal, Ronaldo/0000-0003-0243-2133; Loturco, Irineu/0000-0003-1309-2568; Winckler, Ciro/0000-0002-9595-8144; Pereira, Lucas/0000-0003-1079-2446	B3 Track & Field Club, Sao Paulo, Brazil; ADAPT - Association of High-Performance Training & Sports Development, Sao Paulo, Brazil; Pinheiros Sport Club, Sao Paulo, Brazil; Brazilian Paralympic Committee, Sao Paulo, Brazil	B3 Track & Field Club, Sao Paulo, Brazil; ADAPT - Association of High-Performance Training & Sports Development, Sao Paulo, Brazil; Pinheiros Sport Club, Sao Paulo, Brazil; Brazilian Paralympic Committee, Sao Paulo, Brazil	The researchers Victor Fernandes, Neilton Moura, Felipe Siqueira, and Ciro Winckler of the study entitled: Vertically and horizontally directed muscle power exercises: relationships with top-level sprint performance, declare that they have commercial affiliation with the following funders: B3 Track & Field Club, Sao Paulo, Brazil; ADAPT - Association of High-Performance Training & Sports Development, Sao Paulo, Brazil; Pinheiros Sport Club, Sao Paulo, Brazil; Brazilian Paralympic Committee, Sao Paulo, Brazil. The funder provided support in the form of salaries for authors VF, NM, FS, CW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Baker D, 2001, J STRENGTH COND RES, V15, P92; Baker D., 1995, STRENGTH COND COACH, V3, P8; Bishop C, 2017, J STRENGTH COND RES; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Contreras B, 2017, J STRENGTH COND RES, V31, P999, DOI 10.1519/JSC.0000000000001510; Cronin J, 2005, SPORTS MED, V35, P213, DOI 10.2165/00007256-200535030-00003; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Delecluse C, 1997, SPORTS MED, V24, P147, DOI 10.2165/00007256-199724030-00001; Harris NK, 2008, J STRENGTH COND RES, V22, P691, DOI 10.1519/JSC.0b013e31816d8d80; Hopkins WG., 2005, SPORTSCIENCE, V9, P17, DOI DOI 10.1123/SSJ.20.1.17; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kale M, 2009, J STRENGTH COND RES, V23, P2272, DOI 10.1519/JSC.0b013e3181b3e182; Loturco I, 2016, INT J SPORTS MED, V37, P1051, DOI 10.1055/s-0042-107249; Loturco I, 2017, J STRENGTH COND RES; Loturco I, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01034; Loturco I, 2017, J STRENGTH COND RES, V31, P2579, DOI 10.1519/JSC.0000000000002086; Loturco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140102; Loturco I, 2015, J STRENGTH COND RES, V29, P2771, DOI 10.1519/JSC.0000000000000951; Loturco I, 2015, J STRENGTH COND RES, V29, P1966, DOI 10.1519/JSC.0000000000000849; Loturco I, 2015, J SPORT SCI, V33, P1283, DOI 10.1080/02640414.2015.1022574; Loturco I, 2015, J STRENGTH COND RES, V29, P758, DOI 10.1519/JSC.0000000000000660; Loturco I, 2013, J SPORT SCI MED, V12, P109; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; MERO A, 1992, SPORTS MED, V13, P376, DOI 10.2165/00007256-199213060-00002; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Randell AD, 2010, STRENGTH COND J, V32, P100, DOI 10.1519/SSC.0b013e3181e91eec; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Slawinski J, 2017, SCAND J MED SCI SPOR, V27, P45, DOI 10.1111/sms.12627	30	45	47	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201475	10.1371/journal.pone.0201475	http://dx.doi.org/10.1371/journal.pone.0201475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048538	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400091
J	Segboer, CL; Fokkens, WJ; Terreehorst, I; van Drunen, CM				Segboer, Christine L.; Fokkens, Wytske J.; Terreehorst, Ingrid; van Drunen, Cornelis M.			Endotyping of non-allergic, allergic and mixed rhinitis patients using a broad panel of biomarkers in nasal secretions	PLOS ONE			English	Article							AIRWAY INFLAMMATION; IDIOPATHIC RHINITIS; VASOMOTOR RHINITIS; ATOPIC-DERMATITIS; EUROPEAN ACADEMY; HYPERREACTIVITY; CELLS; RHINOSINUSITIS; EXPRESSION; IL-1-BETA	Background Endotyping chronic rhinitis has proven hardest for the subgroup of non-allergic rhinitis (NAR) patients. While IgE-related inflammation is typical for allergic rhinitis (AR), no markers have been found that can be seen to positively identify NAR. A further complication is that AR and NAR might co-exist in patients with mixed rhinitis. As previous studies have considered only a limited number of inflammatory mediators, we wanted to explore whether a wider panel of mediators could help us refine the endotyping in chronic rhinitis patients. Objective To endotype chronic rhinitis, and non-allergic rhinitis in particular, with help of molecular or cellular markers. Method In this study we included 23 NAR patients without allergen sensitizations and with persistent rhinitis symptoms, 22 pollen sensitized rhinitis patients with seasonal symptoms, 21 mixed rhinitis patients with pollen-related symptoms and persistent symptoms outside of the pollen season, and 23 healthy controls without any symptoms. Nasal secretions were collected outside of pollen season and differences between the endotypes were assessed for a broad range of inflammatory mediators and growths factors using a multiplex ELISA. Results Although we were able to identify two new nasal secretion makers (IL-12 and HGF) that were low in mixed and AR patients versus NAR and healthy controls, the most intriguing outcome is that despite investigating 29 general inflammatory mediators and growth factors no clear profile of non-allergic or mixed rhinitis could be found. Conclusion Classical inflammatory markers are not able to differentiate between non-allergic or mixed rhinitis patients and healthy controls.	[Segboer, Christine L.; Fokkens, Wytske J.; Terreehorst, Ingrid; van Drunen, Cornelis M.] Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Segboer, CL (corresponding author), Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands.	christinesegboer@gmail.com	Fokkens, Wytske WJ/ABF-2185-2020	van Drunen, Cornelis M/0000-0001-5503-066X				Bachert C, 2016, J ALLERGY CLIN IMMUN, V138, P1277, DOI 10.1016/j.jaci.2016.09.008; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; BLOM HM, 1995, EUR ARCH OTO-RHINO-L, V252, pS33, DOI 10.1007/BF02484432; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; BRONSKY EA, 1995, J ALLERGY CLIN IMMUN, V95, P1117, DOI 10.1016/S0091-6749(95)70215-6; Campo P, 2016, IMMUNOL ALLERGY CLIN, V36, P321, DOI 10.1016/j.iac.2015.12.008; Comoglu S, 2012, AM J RHINOL ALLERGY, V26, pE55, DOI 10.2500/ajra.2012.26.3725; De Greve G, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0157-8; FOKKENS WJ, 2012, RHINOLOGY, V50, P1, DOI DOI 10.4193/Rhino50E2; Gehanno P, 2001, ORL-J OTO-RHIN-LARYN, V63, P76, DOI 10.1159/000055714; Gevorgyan A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010591.pub2; Hellings PW, 2017, ALLERGY, V72, P1657, DOI 10.1111/all.13200; Junghans V, 1998, J INVEST DERMATOL, V111, P1184, DOI 10.1046/j.1523-1747.1998.00409.x; Klimek L, 2013, HNO, V61, P217, DOI 10.1007/s00106-012-2584-0; Krohn IK, 2018, ALLERGY, V73, P837, DOI 10.1111/all.13340; Muraro A, 2016, J ALLERGY CLIN IMMUN, V137, P1347, DOI 10.1016/j.jaci.2016.03.010; Okunishi K, 2009, INT ARCH ALLERGY IMM, V149, P14, DOI 10.1159/000210648; Papadopoulos NG, 2015, ALLERGY, V70, P474, DOI 10.1111/all.12573; Papadopoulos NG, 2016, IMMUNOL ALLERGY CLIN, V36, P215, DOI 10.1016/j.iac.2015.12.001; Reh DD, 2010, AM J RHINOL ALLERGY, V24, P266, DOI 10.2500/ajra.2010.24.3485; Ricca V, 2000, J ALLERGY CLIN IMMUN, V105, P54, DOI 10.1016/S0091-6749(00)90177-5; Robinson SR, 2006, AM J RHINOL, V20, P197, DOI 10.1177/194589240602000216; Roschmann KIL, 2011, CLIN EXP ALLERGY, V41, P830, DOI 10.1111/j.1365-2222.2011.03713.x; Segboer CL, 2018, ALLERGY, V73, P1094, DOI 10.1111/all.13356; Segboer CL, 2013, ALLERGY, V68, P1427, DOI 10.1111/all.12255; Togo S, 2010, EXP CELL RES, V316, P3501, DOI 10.1016/j.yexcr.2010.09.006; Van Gerven L, 2012, RHINOLOGY, V50, P227, DOI [10.4193/Rhino11.152, 10.4193/Rhino.11.152]; Van Gerven L, 2014, J ALLERGY CLIN IMMUN, V133, P1332, DOI 10.1016/j.jaci.2013.08.026; van Rijswijk JB, 2005, ALLERGY, V60, P1471, DOI 10.1111/j.1398-9995.2005.00975.x; Van Rijswijk JB, 2003, ALLERGY, V58, P754, DOI 10.1034/j.1398-9995.2003.00203.x; van Rijswijk JB, 2003, RHINOLOGY, V41, P25; Vroling AB, 2008, AM J RESP CELL MOL, V38, P293, DOI 10.1165/rcmb.2007-0278OC	33	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200366	10.1371/journal.pone.0200366	http://dx.doi.org/10.1371/journal.pone.0200366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048449	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400007
J	Wheeler, AC; Ventura, CV; Ridenour, T; Toth, D; Nobrega, LALL; Dantas, LCSD; Rocha, C; Bailey, DB; Ventura, LO				Wheeler, Anne C.; Ventura, Camila V.; Ridenour, Ty; Toth, Danielle; Nobrega, Lucelia Lima; Silva de Souza Dantas, Lana Claudia; Rocha, Camilla; Bailey, Donald B., Jr.; Ventura, Liana O.			Skills attained by infants with congenital Zika syndrome: Pilot data from Brazil	PLOS ONE			English	Article							VIRUS; AGE; NORMS; SLEEP	The recent Zika outbreak and its link to microcephaly and other birth defects in infants exposed in utero have garnered widespread international attention. Based on the severity of birth defects the extent of impairment in these infants is expected to be profound; however, virtually nothing is known regarding the developmental and behavioral sequela of congenital Zika syndrome. This pilot study collected parent-reported patterns of development and sleep in 47 infants with confirmed congenital Zika syndrome who are being followed for clinical services at the Altino Ventura Foundation (FAV) in Recife, Brazil. With assistance from clinicians at FAV, caregivers completed Brazilian Portuguese versions of the Ages and Stages Questionnaire, 3 rd edition (ASQ-3) and the Brief Infant Sleep Questionnaire (BISQ). All infants were between 13-22 months of age at the time of the assessment. At 16 months of age, none of the children displayed age appropriate developmental skills. Most (similar to 75%) mastered some communication and gross motor skills at around a 6-8-month level. Communication and gross motor skills were relative strengths for the sample, while problem-solving and fine motor skills were relative weaknesses. Sleep was noted to be a problem for around 18% of the sample. In utero exposure to the Zika virus will have lifelong consequences for affected children and their families. Understanding the developmental and behavioral trajectories of affected infants will help identify appropriate family supports to improve quality of life.	[Wheeler, Anne C.; Ridenour, Ty; Toth, Danielle; Bailey, Donald B., Jr.] RTI Int, RTI Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC USA; [Ventura, Camila V.; Nobrega, Lucelia Lima; Silva de Souza Dantas, Lana Claudia; Rocha, Camilla; Ventura, Liana O.] Altino Ventura Fdn FAV, Rehabil Ctr Menina dos Olhos, Recife, PE, Brazil	Research Triangle Institute	Wheeler, AC (corresponding author), RTI Int, RTI Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC USA.	acwheeler@rti.org	Ventura, Liana Vieira O/N-6151-2018; Ventura, Camila/N-2654-2018	Ventura, Liana Vieira O/0000-0001-6529-6883; Wheeler, Anne/0000-0003-2693-5616; Ridenour, Ty/0000-0002-9709-6808; Ventura, Camila/0000-0002-2927-4684; Bailey, Donald/0000-0002-0513-9330	NICHD [1R01HD093572-01]; RTI International; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD093572] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); RTI International; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NICHD 1R01HD093572-01 to DB, CV, and AW; RTI International to DB and AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Center on the Developing Child, 2007, SCI EARL CHILDH DEV; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004; Filgueiras A, 2013, EARLY HUM DEV, V89, P561, DOI 10.1016/j.earlhumdev.2013.02.005; Mindell JA, 2015, INFANT BEHAV DEV, V41, P102, DOI 10.1016/j.infbeh.2015.08.004; Moore CA, 2016, JAMA PEDIAT; Nunes ML, 2012, SLEEP SCI, V5, P89; Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16; Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009; Salomao SR, 2008, ARQ BRAS OFTALMOL, V71, P475, DOI 10.1590/S0004-27492008000400002; SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Squires J, 2009, AGES STAGES QUESTION; Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]	14	25	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201495	10.1371/journal.pone.0201495	http://dx.doi.org/10.1371/journal.pone.0201495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048541	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400096
J	Hao, Y; Purtha, W; Cortesio, C; Rui, H; Gu, Y; Chen, H; Sickmier, EA; Manzanillo, P; Huang, X				Hao, Yue; Purtha, Whitney; Cortesio, Christa; Rui, Huan; Gu, Yan; Chen, Hao; Sickmier, E. Allen; Manzanillo, Paolo; Huang, Xin			Crystal structures of human procathepsin H	PLOS ONE			English	Article							PARTICLE MESH EWALD; HUMAN CATHEPSIN-H; MINI-CHAIN; IN-VITRO; AMINOPEPTIDASE ACTIVITY; STRUCTURE REFINEMENT; MOLECULAR-DYNAMICS; ENDOPEPTIDASE; ACTIVATION; PARAMETERS	Cathepsin H is a member of the papain superfamily of lysosomal cysteine proteases. It is the only known aminopeptidase in the family and is reported to be involved in cancer and other major diseases. Like many other proteases, it is synthesized as an inactive proenzyme. Although the crystal structure of mature porcine cathepsin H revealed the binding of the mini-chain and provided structural basis for the aminopeptidase activity, detailed structural and functional information on the inhibition and activation of procathepsin H has been elusive. Here we present the crystal structures of human procathepsin H at 2.00 angstrom and 1.66 angstrom resolution. These structures allow us to explore in detail the molecular basis for the inhibition of the mature domain by the prodomain. Comparison with cathepsin H structure reveals how mini-chain reorients upon activation. We further demonstrate that procathepsin H is not auto-activated but can be trans-activated by cathepsin L.	[Hao, Yue; Rui, Huan; Sickmier, E. Allen; Huang, Xin] Amgen Inc, Dept Mol Engn, Cambridge, MA 02141 USA; [Hao, Yue] Amgen Inc, Amgen Postdoctoral Fellow Program, Cambridge, MA USA; [Purtha, Whitney; Manzanillo, Paolo] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA USA; [Cortesio, Christa] Amgen Inc, Dept Prot Technol, San Francisco, CA USA; [Gu, Yan; Chen, Hao] Amgen Inc, Dept Prot Technol, Cambridge, MA USA	Amgen; Amgen; Amgen; Amgen; Amgen	Huang, X (corresponding author), Amgen Inc, Dept Mol Engn, Cambridge, MA 02141 USA.	hxin@amgen.com	Hao, Yue/AAA-3530-2022; Hao, Yue/O-6107-2019	Hao, Yue/0000-0003-0943-0499; 	Amgen Discovery Research. Amgen Inc	Amgen Discovery Research. Amgen Inc	This work was supported by Amgen Discovery Research. Amgen Inc provided funding for all research. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAUDYS M, 1991, BIOMED BIOCHIM ACTA, V50, P569; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Case RMBDA, 2016, AMBER 2016; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Crowley MF, 1997, J SUPERCOMPUT, V11, P255, DOI 10.1023/A:1007907925007; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; del Re EC, 2000, BRIT J CANCER, V82, P1317; Dodt J, 2003, BIOL CHEM, V384, P1327, DOI 10.1515/BC.2003.149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Guncar G, 1998, STRUCTURE, V6, P51; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOGA H, 1992, CHEM PHARM BULL, V40, P965; Kos J, 1997, CLIN CANCER RES, V3, P1815; MACH L, 1994, J BIOL CHEM, V269, P13030; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rojnik M, 2012, EUR J CELL BIOL, V91, P757, DOI 10.1016/j.ejcb.2012.05.004; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; TAKAHASHI T, 1988, J BIOL CHEM, V263, P10952; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vasiljeva O, 2003, BIOCHEMISTRY-US, V42, P13522, DOI 10.1021/bi035355k; Verma S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00107; Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woods RJ, GA20052018	38	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200374	10.1371/journal.pone.0200374	http://dx.doi.org/10.1371/journal.pone.0200374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044821	gold, Green Submitted, Green Published			2022-12-27	WOS:000439942500049
J	Li, M; Zhao, LZ; Zhang, C; Wang, X; Hong, WX; Sun, J; Liu, R; Yu, L; Wang, JH; Zhang, FC; Jin, X				Li, Min; Zhao, Lingzhai; Zhang, Chao; Wang, Xin; Hong, Wenxin; Sun, Jin; Liu, Ran; Yu, Lei; Wang, Jianhua; Zhang, Fuchun; Jin, Xia			Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; PRINCIPAL TARGET-CELLS; IN-VITRO; MONONUCLEAR-CELLS; CROSS-REACTIVITY; T-CELLS; B-CELLS; TRANSMISSION; PATHOGENESIS; REPLICATION	Antibody dependent enhancement (ADE) has most often been associated with dengue virus (DENV). Studies using leukemia cell lines suggest that DENV specific antibodies can enhance Zika virus (ZIKV) infectivity, and vice versa. To examine the mechanisms of ADE of ZIKV infection in primary human cells, we assessed 40 serum samples obtained from convalescent DENV-1 or DENV-3 infected subjects. All sera tested exhibited high binding potency, while modest or none neutralization activities against ZIKV. Primary CD14+ monocytes, rather than B and T cells in peripheral blood mononuclear cells (PBMCs), were found to be the mediators of the enhancement of ZIKV infectivity by DENV immune sera. Monocyte-derived immature dendritic cells (DCs), but not mature DCs were highly permissive to ZIKV infection, whereas neither immature nor mature DCs could mediate enhanced ZIKV infection in the presence of DENV immune sera. In addition, antibody blocking of either Fc gamma RI (CD64), or Fc gamma RII (CD32), or Fc gamma RIII (CD16) resulted in diminished ADE of ZIKV infection. Our findings provide an improved understanding of the pathogenesis of ZIKV infection, and inform rational vaccine design.	[Li, Min; Zhang, Chao; Wang, Xin; Sun, Jin; Liu, Ran; Wang, Jianhua; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Li, Min; Zhang, Chao; Wang, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Lingzhai; Hong, Wenxin; Yu, Lei; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China; [Wang, Xin] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Medical University; Shanghai University	Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Zhang, FC (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.	gz8hzfc@126.com; xjin@ips.ac.cn			Chinese Ministry of Science and Technology (National Key Program Project Grant) [2016YFC1201000, 2016YFE0133500]; National Science Foundation of China [31670941, 31370870]; Guangzhou Science and Technology Program for Public Wellbeing [2014Y2-00185, 2014Y2-00550, 201508020263]; Special Program of Guangdong Provincial Department of Science and Technology [2016A020248001, S201302001300]; Chinese Academy of Sciences (STS Grant) [KFJEWSTS098]	Chinese Ministry of Science and Technology (National Key Program Project Grant); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Program for Public Wellbeing; Special Program of Guangdong Provincial Department of Science and Technology; Chinese Academy of Sciences (STS Grant)	This project was supported by grants from Chinese Ministry of Science and Technology (National Key Program Project Grant, #2016YFC1201000 and #2016YFE0133500), National Science Foundation of China (General Grant, #31670941 and #31370870), Guangzhou Science and Technology Program for Public Wellbeing (#2014Y2-00185, #2014Y2-00550 and #201508020263), the Special Program of Guangdong Provincial Department of Science and Technology (#2016A020248001 and #S201302001300), and Chinese Academy of Sciences (STS Grant, #KFJEWSTS098).	Bardina SV, 2017, SCIENCE; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638; Charles AS, 2016, PLOS CURR; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014; Jin X, 2009, ANTIVIR THER, V14, P739, DOI 10.3851/IMP1288; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pan American Health Organization, 2016, NUMB REP CAS DENG SE; Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674; Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; ROBINSON JE, 1990, J IMMUNOL METHODS, V132, P63, DOI 10.1016/0022-1759(90)90399-G; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006; Wei HY, 2016, AM J TROP MED HYG, V95, P322, DOI 10.4269/ajtmh.15-0905; WHO, 2017, ZIK VIR COMPL 2016 P	46	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200478	10.1371/journal.pone.0200478	http://dx.doi.org/10.1371/journal.pone.0200478			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044839	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500055
J	Garcia, PJ; Hernandez-Cordova, G; Pourjavaheri, P; Gomez-Paredes, HJ; Sudar, S; Bayer, AM				Garcia, Patricia J.; Hernandez-Cordova, Gustavo; Pourjavaheri, Paria; Gomez-Paredes, Hilbert J.; Sudar, Samuel; Bayer, Angela M.			Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; LIMA; CARE; INTERVENTION; HYPERTENSION; INFECTIONS; PREVENTION; MANAGEMENT; DISTRICT	Introduction Although the worldwide incidence of tuberculosis (TB) is slowly decreasing, annual infection rates in Peru remain among the highest in the Americas. Pharmacies could play an important role in facilitating early detection of TB. However, the awareness, expertise and cooperation of pharmacy workers is fundamental. This study explored the TB-related knowledge, attitudes and practices of pharmacy workers in a district with one of the highest incidences of TB in Peru. Methods This cross-sectional study applied a questionnaire that was administered face to face using smartphones with one pharmacy worker at each of 45 randomly selected pharmacies in the El Agustino district of Lima, Peru. Results Participants were primarily female (78%) and had an average age of 31.3 years old (range 18-57 years old). Only 11% of participants were pharmacists with complete university training. The pharmacy workers' knowledge was adequate; however, workers had important knowledge gaps and myths regarding prevention of TB transmission. Most pharmacy workers (77%) reported they would send a client with a history of cough for more than two weeks to a healthcare center, while 23% reported they would offer them antitussive medication or antibiotics. Almost all workers reported talking with clients about diseases and reported respiratory symptoms as one of the most common causes for consultation (60%). Most participants expressed interest in learning more about TB and expanding their involvement in the fight against TB in their community. Conclusion Pharmacy workers have adequate knowledge about TB. However, we identified gaps in knowledge with respect to prevention of TB transmission. Pharmacy workers commonly see patients with respiratory symptoms and some offer recommendations, including for treatment. Pharmacy workers are willing to learn more and contribute to TB control and could be a valuable asset in the control and prevention of TB in Peru. To achieve this integration of pharmacy workers into TB control and prevention, more research is needed.	[Garcia, Patricia J.; Hernandez-Cordova, Gustavo; Pourjavaheri, Paria; Gomez-Paredes, Hilbert J.; Sudar, Samuel; Bayer, Angela M.] Univ Peruana Cayetano Heredia, Epidemiol STI & HIV Res Unit, Sch Publ Hlth & Adm, Lima, Peru; [Bayer, Angela M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Universidad Peruana Cayetano Heredia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bayer, AM (corresponding author), Univ Peruana Cayetano Heredia, Epidemiol STI & HIV Res Unit, Sch Publ Hlth & Adm, Lima, Peru.; Bayer, AM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	angelabayerx@gmail.com		Hernandez-Cordova, Gustavo/0000-0001-5258-2952	Fogarty International Center of the U.S. National Institutes of Health; KUSKAYA: AN INTERDISCIPLINARY TRAINING PROGRAM FOR INNOVATION IN GLOBAL HEALTH [5D43TW009375-02]	Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); KUSKAYA: AN INTERDISCIPLINARY TRAINING PROGRAM FOR INNOVATION IN GLOBAL HEALTH	This study was funded by the Fogarty International Center of the U.S. National Institutes of Health, through a grant to PJG. The grant title is KUSKAYA: AN INTERDISCIPLINARY TRAINING PROGRAM FOR INNOVATION IN GLOBAL HEALTH and the grant number is 5D43TW009375-02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Faham Z, 2011, J INFECT DEV COUNTR, V5, P396, DOI 10.3855/jidc.1248; Alarcon Valentina, 2017, Rev Peru Med Exp Salud Publica, V34, P299, DOI 10.17843/rpmesp.2017.342.2384; Bell CA, 2012, INT J TUBERC LUNG D, V16, P1086, DOI 10.5588/ijtld.11.0669; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Castañeda-Hernández Diana M, 2013, Rev. perú. med. exp. salud publica, V30, P560; Cheema E, 2014, BRIT J CLIN PHARMACO, V78, P1238, DOI 10.1111/bcp.12452; De Blasio Francesco, 2011, Cough, V7, P7, DOI 10.1186/1745-9974-7-7; Dongo Víctor, 2009, Rev. perú. med. exp. salud publica, V26, P517; Pham DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074882; Fathima Mariam, 2013, Pharmacy Practice (Internet), V11, P228, DOI 10.4321/s1886-36552013000400008; Garcia PJ, 2007, SEX TRANSM INFECT, V83, P142, DOI 10.1136/sti.2006.022657; Garcia PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047750; Garcia PJ, 2012, LANCET, V379, P1120, DOI 10.1016/S0140-6736(11)61846-1; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Islam QS, 2014, INT HEALTH, V6, P225, DOI 10.1093/inthealth/ihu025; Jakeman B, 2015, J AM PHARM ASSOC, V55, P307, DOI 10.1331/JAPhA.2015.14141; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783, DOI 10.3855/jidc.335; Lambert ML, 2005, TROP MED INT HEALTH, V10, P246, DOI 10.1111/j.1365-3156.2004.01383.x; Larsson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166019; McGuire TR, 2007, J EVAL CLIN PRACT, V13, P146, DOI 10.1111/j.1365-2753.2007.00677.x; Ministerio de Salud del Peru A (MINSA), 2013, NORM TECN CONTR TUB; Ministerio de Salud (MINSA), 2014, AN SIT SAL DISA 4 LI; MINSA, 2011, SIT TUB PER; Munayco CV, 2015, REV PANAM SALUD PUBL, V38, P177; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Said K, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0276-4; Saldarriaga EM, 2017, ANN GLOB HEALTH, V83, P394, DOI 10.1016/j.aogh.2017.03.514; Sarker M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2181-8; Soumya R, 2016, INDIAN J PHARMACOL, V48, P360, DOI 10.4103/0253-7613.186204; Steen TW, 1998, INT J TUBERC LUNG D, V2, P627; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625; WHO, 2017, GLOB TUB REP 2017; WHO, 2008, PHARMAFORUM 0121	36	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0196648	10.1371/journal.pone.0196648	http://dx.doi.org/10.1371/journal.pone.0196648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040825	gold, Green Published			2022-12-27	WOS:000439749200001
J	Ma, H; Lee, Y; Hayama, T; Van Dyken, C; Marti-Gutierrez, N; Li, Y; Ahmed, R; Koski, A; Kang, E; Darby, H; Gonmanee, T; Park, Y; Wolf, DP; Kim, CJ; Mitalipov, S				Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Marti-Gutierrez, Nuria; Li, Ying; Ahmed, Riffat; Koski, Amy; Kang, Eunju; Darby, Hayley; Gonmanee, Thanasup; Park, Younjung; Wolf, Don P.; Kim, Chong Jai; Mitalipov, Shoukhrat			Germline and somatic mtDNA mutations in mouse aging	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; POINT MUTATIONS; CLONAL EXPANSION; HUMAN BRAIN; MUTATOR MICE; DELETIONS; DISEASE; HETEROPLASMY; ACCUMULATION; REPLICATION	The accumulation of acquired mitochondrial genome (mtDNA) mutations with aging in somatic cells has been implicated in mitochondrial dysfunction and linked to age-onset diseases in humans. Here, we asked if somatic mtDNA mutations are also associated with aging in the mouse. MtDNA integrity in multiple organs and tissues in young and old (2 +/- 34 months) wild type (wt) mice was investigated by whole genome sequencing. Remarkably, no acquired somatic mutations were detected in tested tissues. However, we identified several non-synonymous germline mtDNA variants whose heteroplasmy levels (ratio of normal to mutant mtDNA) increased significantly with aging suggesting clonal expansion of inherited mtDNA mutations. Polg mutator mice, a model for premature aging, exhibited both germline and somatic mtDNA mutations whose numbers and heteroplasmy levels increased significantly with age implicating involvement in premature aging. Our results suggest that, in contrast to humans, acquired somatic mtDNA mutations do not accompany the aging process in wt mice.	[Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Marti-Gutierrez, Nuria; Li, Ying; Ahmed, Riffat; Koski, Amy; Kang, Eunju; Darby, Hayley; Gonmanee, Thanasup; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97201 USA; [Ma, Hong; Lee, Yeonmi; Hayama, Tomonari; Van Dyken, Crystal; Marti-Gutierrez, Nuria; Li, Ying; Ahmed, Riffat; Koski, Amy; Kang, Eunju; Darby, Hayley; Gonmanee, Thanasup; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Lee, Yeonmi; Kang, Eunju; Park, Younjung; Kim, Chong Jai] ASAN Med Ctr, ASAN Inst Life Sci, Stem Cell Ctr, Seoul, South Korea	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of Ulsan; Asan Medical Center	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97201 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu		Gonmanee, Thanasup/0000-0001-9108-6476; Koski, Amy/0000-0003-1918-528X	National Institutes of Health [R56AG045137, P51OD011092]; Burroughs Wellcome Fund; OHSU Institutional Funds; National Research Foundation of Korea [NRF-2015K1A4A3046807]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); OHSU Institutional Funds; National Research Foundation of Korea(National Research Foundation of Korea); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by grants from the National Institutes of Health R56AG045137 and P51OD011092, Burroughs Wellcome Fund, OHSU Institutional Funds, and National Research Foundation of Korea (NRF-2015K1A4A3046807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004; Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje; Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Keogh M, 2013, CELL METAB, V18, P463, DOI 10.1016/j.cmet.2013.09.015; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Khrapko K, 2004, ANN NY ACAD SCI, V1019, P240, DOI 10.1196/annals.1297.040; Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8; Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Morris J, 2017, CELL REP, V21, P2706, DOI 10.1016/j.celrep.2017.11.031; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990	60	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201304	10.1371/journal.pone.0201304	http://dx.doi.org/10.1371/journal.pone.0201304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040856	gold, Green Published, Green Submitted			2022-12-27	WOS:000439749200036
J	Wang, HL; Du, HM; Li, HY; Huang, Y; Ding, JZ; Liu, C; Wang, N; Lan, H; Zhang, SZ				Wang, Hongling; Du, Hanmei; Li, Hongyou; Huang, Ying; Ding, Jianzhou; Liu, Chan; Wang, Ning; Lan, Hai; Zhang, Suzhi			Identification and functional characterization of the ZmCOPT copper transporter family in maize	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR MECHANISMS; ARABIDOPSIS-THALIANA; GENE FAMILY; YEAST; HOMEOSTASIS; EXPRESSION; COMPLEMENTATION; METALS	Copper (Cu) is an essential micronutrient for plant growth and development; Cu homeostasis in plant is maintained by the important functions of Ctr/COPT-type Cu transporters. Although the COPT genes have been identified in Arabidopsis thaliana and rice, little is known about Cu transporters in maize. In this study, three-members of putative maize Cu transporters (ZmCOPT 1, 2 and 3) are identified. ZmCOPT genes have expression in all of the tested tissues, including roots, stems, leaves and flowers (male and female), and their expression levels vary responding to stress due to Cu-deficiency and excess. Functional complementation and overexpression together with Cu uptake measurements in ZmCOPTs-transformed ctr1 Delta ctr2 Delta mutant strain or the wild type strain of Saccharomyces cerevisiae show that the three ZmCOPT members possess the ability to be Cu transporters. Among these, ZmCOPT1 and ZmCOPT2 have high-affinity while ZmCOPT3 has low-affinity. In addition, ZmCOPT2 tend to specifically transport Cu (I) but no other bivalent metal ions.	[Wang, Hongling; Du, Hanmei; Li, Hongyou; Huang, Ying; Ding, Jianzhou; Liu, Chan; Wang, Ning; Lan, Hai; Zhang, Suzhi] Sichuan Agr Univ, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Agr Dept,Maize Res Inst, Chengdu, Sichuan, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Zhang, SZ (corresponding author), Sichuan Agr Univ, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Agr Dept,Maize Res Inst, Chengdu, Sichuan, Peoples R China.	suzhi1026@163.com			National High Technology Research and Development Program of China [2016YFD0101206]; National Natural Science Foundation of China [30800687, 31071434]; Major Project of Education Department in Sichan [15ZA0022]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Education Department in Sichan	This work was supported by the National High Technology Research and Development Program of China (2016YFD0101206); the National Natural Science Foundation of China [No. 30800687, 31071434], Major Project of Education Department in Sichan [No. 15ZA0022].SZ received the funding.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Koch KA, 1996, MOL CELL BIOL, V16, P724; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Li H, 2016, PLANT CELL PHYSL; Li HX, 2014, PLANT CELL ENVIRON, V37, P1561, DOI 10.1111/pce.12263; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Liu LH, 2012, BIOCHEM BIOPH RES CO, V420, P600, DOI 10.1016/j.bbrc.2012.03.040; Martins V, 2014, PLANTA, V240, P91, DOI 10.1007/s00425-014-2067-5; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Puig S., 2014, ADV BOT, V2014, DOI DOI 10.1155/2014/476917; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Sancenon V, 2004, J BIOL CHEM, V279, P15348, DOI 10.1074/jbc.M313321200; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vatansever R., 2016, INTERDISCIPLINARY SC, P1, DOI DOI 10.1007/S12539-015-0014-1; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012; Yuan M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-69; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	43	13	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199081	10.1371/journal.pone.0199081	http://dx.doi.org/10.1371/journal.pone.0199081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036360	Green Published, Green Submitted, gold			2022-12-27	WOS:000439429200002
J	Batista, DFA; Neto, OCD; de Almeida, AM; Maboni, G; de Carvalho, TF; de Carvalho, TP; Barrow, PA; Berchieri, A				Alves Batista, Diego Felipe; de Freitas Neto, Oliveiro Caetano; de Almeida, Adriana Maria; Maboni, Grazieli; de Carvalho, Tatiane Furtado; de Carvalho, Thaynara Parente; Barrow, Paul Andrew; Berchieri Junior, Angelo			Evaluation of pathogenicity of Salmonella Gallinarum strains harbouring deletions in genes whose orthologues are conserved pseudogenes in S. Pullorum	PLOS ONE			English	Article							ENTERICA SEROVARS; HOST ADAPTATION; INFECTION; EXPRESSION; METABOLISM; MICE; IDENTIFICATION; EVOLUTIONARY; ENTERITIDIS; MACROPHAGES	The diseases caused by Salmonella Gallinarum and S. Pullorum in chickens known as fowl typhoid and pullorum disease, respectively, pose a great threat to the poultry industry mainly in developing countries, since they have already been controlled in the developed ones. These bacteria are very similar at the genomic level but develop distinct host-pathogen relationships with chickens. Therefore, a deep understanding of the molecular mechanisms whereby S. Gallinarum and S. Pullorum interact with the host could lead to the development of new approaches to control and, perhaps, eradicate both diseases from the chicken flocks worldwide. Based on our previous study, it was hypothesised that metabolism-related pseudogenes, fixed in S. Pullorum genomes, could play a role in the distinct host-pathogen interaction with susceptible chickens. To test this idea, three genes (idnT, idnO and ccmH) of S. Gallinarum str. 287/91, which are pseudogenes on the S. Pullorum chromosomes, were inactivated by mutations. These genetically engineered strains grew well on the solid media without any colony morphology difference. In addition, similar growth curves were obtained by cultivation in M9 minimal medium containing D-gluconate as the sole carbon source. Infection of chickens with idnTO mutants led to increased numbers of bacteria in the livers and spleens at 5 days post-infection, but with slightly decreased heterophil infiltration in the spleens when compared to the wild-type strain. On the other hand, no significant phenotypic change was caused by mutation to ccmH genes. Apart from the above-mentioned alterations, all S. Gallinarum strains provoked similar infections, since mortality, clinical signs, macroscopic alterations and immune response were similar to the infected chickens. Therefore, according to the model applied to this study, mutation to the idnTO and ccmH genes showed minor impact on the fowl typhoid pathogenesis and so they may be relics from the ancestor genome. Our data hints at a more complex mechanism driving the distinct host-pathogen interaction of S. Gallinarum/Pullorum with chickens than differential inactivation of a few genes.	[Alves Batista, Diego Felipe; de Freitas Neto, Oliveiro Caetano; de Almeida, Adriana Maria; Berchieri Junior, Angelo] Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Post Grad Program Agr & Livestock Microbiol, Dept Vet Pathol, Campus Jaboticabal, Sao Paulo, Brazil; [de Freitas Neto, Oliveiro Caetano] Univ Fed Paraiba, Dept Vet Sci, Areia, Paraiba, Brazil; [Maboni, Grazieli; Barrow, Paul Andrew] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [de Carvalho, Tatiane Furtado; de Carvalho, Thaynara Parente] Fed Univ Minas Gerais UFMG, Sch Vet, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil	Universidade Estadual Paulista; Universidade Federal da Paraiba; University of Nottingham; Universidade Federal de Minas Gerais	Neto, OCD (corresponding author), Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Post Grad Program Agr & Livestock Microbiol, Dept Vet Pathol, Campus Jaboticabal, Sao Paulo, Brazil.; Neto, OCD (corresponding author), Univ Fed Paraiba, Dept Vet Sci, Areia, Paraiba, Brazil.	oliveirocaetano@yahoo.com.br	de, Freitas Neto O. C./E-8713-2012; Batista, Diego F. A./F-3467-2012; Berchieri Junior, Angelo/ABA-2618-2021	de, Freitas Neto O. C./0000-0002-1437-069X; Berchieri Junior, Angelo/0000-0003-2522-6500; MABONI, GRAZIELI/0000-0002-6952-1598	Sao Paulo Research Foundation [2013/26127-7, 2013/22920-4]; National Council of Technological and Scientific Development (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES); Sao Paulo Research Foundation (FAPESP), Brazil; Coordination of Improvement of Higher Education Personnel (CAPES), Brazil; Council of Technological and Scientific Development (CNPq), Brazil	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination of Improvement of Higher Education Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Council of Technological and Scientific Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by Sao Paulo Research Foundation: http://www.fapesp.br/en/ (Grant numbers 2013/26127-7 and 2013/22920-4) AB and DB; The National Council of Technological and Scientific Development (CNPq) and the Coordination of Improvement of Higher Education Personnel (CAPES), Dr. Oliveiro Caetano de Freitas Neto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like thank the Sao Paulo Research Foundation (FAPESP), the National Council of Technological and Scientific Development (CNPq) and the Coordination of Improvement of Higher Education Personnel (CAPES), Brazil, for funding this research. We are also grateful to Dr. Denadai, J. and to the Avian Diseases laboratory team (Unesp), for their technical support, and to Dr. Santos, R. L. from the School of Veterinary D Federal University of Minas Gerais (UFMG) for allowing us to use his laboratory to perform histopathology analysis.	Batista DFA, 2015, INFECT GENET EVOL, V30, P74, DOI 10.1016/j.meegid.2014.12.007; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrow PA, 2011, AVIAN PATHOL, V40, P1, DOI 10.1080/03079457.2010.542575; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Berchieri A, 2001, AVIAN PATHOL, V30, P221, DOI 10.1080/03079450120054631; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brinsmade SR, 2017, CURR GENET, V63, P417, DOI 10.1007/s00294-016-0656-5; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Choby JE, 2016, CELL CHEM BIOL, V23, P1351, DOI 10.1016/j.chembiol.2016.09.012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Neto OCD, 2013, VET MICROBIOL, V165, P425, DOI 10.1016/j.vetmic.2013.04.015; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Ezema WS, 2009, COMP CLIN PATHOL, V18, P395, DOI DOI 10.1007/S00580-009-0812-0; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059427; Grove J, 1996, MOL MICROBIOL, V19, P467, DOI 10.1046/j.1365-2958.1996.383914.x; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Henderson SC, 1999, INFECT IMMUN, V67, P3580, DOI 10.1128/IAI.67.7.3580-3586.1999; Jelsbak L, 2016, INFECT IMMUN, V84, P2076, DOI 10.1128/IAI.00182-16; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; Kogut MH, 2008, INNATE IMMUN-LONDON, V14, P213, DOI 10.1177/1753425908094416; Langridge GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/pnas.1416707112; LI J, 1993, J MED MICROBIOL, V38, P129, DOI 10.1099/00222615-38-2-129; Lopes PD, 2016, VET J, V214, P40, DOI 10.1016/j.tvjl.2016.05.006; Njoroge JW, 2012, MBIO, V3, DOI 10.1128/mBio.00280-12; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; Okon E, 2017, INT J MED MICROBIOL, V307, P83, DOI 10.1016/j.ijmm.2016.09.007; Peekhaus N, 1997, FEMS MICROBIOL LETT, V147, P233, DOI 10.1111/j.1574-6968.1997.tb10247.x; Sambrook J., 2001, MOL CLONING LAB MANU; Setta A, 2012, VET IMMUNOL IMMUNOP, V146, P212, DOI 10.1016/j.vetimm.2012.03.008; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; Shivaprasad HL, 2004, DIS POULTRY; Tanapongpipat S, 1998, BIOCHEM J, V334, P355, DOI 10.1042/bj3340355; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wigley P, 2005, INFECT IMMUN, V73, P2986, DOI 10.1128/IAI.73.5.2986-2990.2005; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	38	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200585	10.1371/journal.pone.0200585	http://dx.doi.org/10.1371/journal.pone.0200585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028856	gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900008
J	Thyagarajan, HM; Lancaster, JN; Lira, SA; Ehrlich, LIR				Thyagarajan, Hiran M.; Lancaster, Jessica N.; Lira, Sergio A.; Ehrlich, Lauren I. R.			CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction	PLOS ONE			English	Article							REGULATORY T-CELLS; CHEMOKINE RECEPTOR CCR8; HEMATOPOIETIC PROGENITORS; NEGATIVE SELECTION; MEDULLA MIGRATION; GENE-EXPRESSION; DENDRITIC CELLS; DIFFERENTIATION; ACTIVATION; SURVIVAL	Following positive selection, thymocytes migrate into the medulla where they encounter diverse self-antigens that induce central tolerance. Thymocytes expressing T cell receptors (TCRs) with high affinity for self-antigens displayed by medullary antigen presenting cells (APCs) undergo either negative selection or diversion to the regulatory T cell (Treg) lineage, thus ensuring maturation of non-autoreactive T cells. Because many self-antigens are expressed by only a small percentage of medullary thymic epithelial cells, thymocytes must enter the medulla and efficiently scan APCs therein to encounter the full array of self-antigens that induce central tolerance. Chemokine receptors play a critical role in promoting medullary entry and rapid motility of post-positive selection thymocytes. We found that the chemokine receptor CCR8 is expressed by post-positive selection CD4(+) single positive (SP) thymocytes in mice, while the corresponding chemokine ligands are expressed by medullary APCs, and thus hypothesized that CCR8 would promote thymocyte medullary entry and/or rapid motility to induce negative selection. However, despite a subtle decline in thymocyte medullary accumulation and the presence of autoantibodies in aged CCR8-deficient mice, CCR8 was not required for thymocyte differentiation, rapid motility, or negative selection.	[Thyagarajan, Hiran M.; Lancaster, Jessica N.; Ehrlich, Lauren I. R.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Lira, Sergio A.] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Ehrlich, Lauren I. R.] Univ Texas Austin, Livestrong Canc Inst, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Austin	Ehrlich, LIR (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.; Ehrlich, LIR (corresponding author), Univ Texas Austin, Livestrong Canc Inst, Dell Med Sch, Austin, TX 78712 USA.	lehrlich@austin.utexas.edu	Lancaster, Jessica Naomi/O-7762-2019	Lancaster, Jessica Naomi/0000-0003-0398-9988; Lira, Sergio/0000-0002-6742-3089; Ehrlich, Lauren/0000-0002-1697-1755	National Institute of Allergy and Infectious Disease [R01AI104870]; Cancer Research Institute of Texas [R1003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104870] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Disease (https://www.niaid.nih.gov) R01AI104870 to L.I.R.E., and by a grant from the Cancer Research Institute of Texas (http://www.cprit.state.tx.us) R1003 to L.I.R.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Barsheshet Y, 2017, P NATL ACAD SCI USA, V114, P6086, DOI 10.1073/pnas.1621280114; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Coghill JM, 2013, BLOOD, V122, P825, DOI 10.1182/blood-2012-06-435735; Cowan JE, 2014, J IMMUNOL, V193, P1204, DOI 10.4049/jimmunol.1400993; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hu ZC, 2017, CELL REP, V21, P168, DOI 10.1016/j.celrep.2017.09.016; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Ki S, 2017, EUR J IMMUNOL, V14, P377; Ki S, 2014, CELL REP, V9, P402, DOI 10.1016/j.celrep.2014.08.070; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kozai M, 2017, J EXP MED, V214, P1925, DOI 10.1084/jem.20161864; Kremer L, 2001, J IMMUNOL, V166, P218, DOI 10.4049/jimmunol.166.1.218; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Lancaster JN, 2018, TRENDS IMMUNOL, V39, P86, DOI 10.1016/j.it.2017.10.007; Lancaster JN, 2017, METHODS MOL BIOL, V1591, P9, DOI 10.1007/978-1-4939-6931-9_2; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Spinetti G, 2003, J LEUKOCYTE BIOL, V73, P201, DOI 10.1189/jlb.0302105; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Trampont PC, 2009, NAT IMMUNOL, V11, P162, DOI 10.1038/blood-2009-07-235721; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; VanSnick J, 1996, J IMMUNOL, V157, P2570; Wang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030793; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Yabe R, 2015, INT IMMUNOL, V27, P169, DOI 10.1093/intimm/dxu098; Zingoni A, 1998, J IMMUNOL, V161, P547; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200765	10.1371/journal.pone.0200765	http://dx.doi.org/10.1371/journal.pone.0200765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024927	Green Submitted, gold, Green Published			2022-12-27	WOS:000439120000049
J	Chan, E; Foster, S; Sambell, R; Leong, P				Chan, Evelyn; Foster, Samantha; Sambell, Ryan; Leong, Paul			Clinical efficacy of virtual reality for acute procedural pain management: A systematic review and meta-analysis	PLOS ONE			English	Review							BURN WOUND DEBRIDEMENT; DISTRACTION; ANXIETY; FEASIBILITY; CHILDREN; THERAPY	Background Acutely painful procedures are commonplace. Current approaches to pain most often involve pharmacotherapy, however, there is interest in virtual reality (VR) as a non-pharmacological alternative. A methodologically rigorous systematic review and meta-analysis is lacking. Methods Following PRISMA guidelines, we searched the Cochrane Library, Ovid MEDLINE, Embase, CINAHL, ERIC, NIHR Centre for Review and Dissemination, Proquest, the System for Information on Grey Literature in Europe and the WHO International Clinical Trials Registry Platform from inception to 5 November 2017. Included studies were randomised with an experimental trial design, included a non-VR control group and examined the efficacy of VR with regards to an acutely painful clinical intervention. Bias was assessed along Cochrane guidelines, with performance bias not assessed due to the non-blindable nature of VR. We extracted summary data for maximal pain score and used standard mean difference DerSimonian-Laird random-effects meta-analysis (RevMan 5.3). This review was prospectively registered (PROSPERO CRD42017058204). Findings Of the 12,450 studies identified, 20 studies were eligible for the systematic review. No trials reported in sufficient detail to judge their risk of bias, and 10 studies were at high risk of bias in at least one domain. 16 studies (9 randomised controlled trials, 7 crossover studies) examining 656 individuals were included in quantitative synthesis. Pain scales were heterogenous, but mostly employed 100-point scales. Across all trials, meta-analysis was suggestive of a -0.49 (95% CI -0.83 to -0.41, p = 0.006) standardised mean difference reduction in pain score with VR. However there was a high degree of statistical heterogeneity (chi(2) p<0.001, I-2 81%, 95% CI for I-2 70-88%), driven by randomised studies, with substantial clinical heterogeneity. Conclusion These data suggest that VR may have a role in acutely painful procedures, however included studies were clinically and statistically heterogenous. Further research is required to validate findings, establish cost efficacy and optimal clinical settings for usage. Future trials should report in accordance with established guidelines.	[Chan, Evelyn] Monash Med Ctr, Dept Paediat, Clayton, Vic, Australia; [Chan, Evelyn; Foster, Samantha; Sambell, Ryan; Leong, Paul] Monash Med Ctr, Southern Clin Sch, Clayton, Vic, Australia; [Leong, Paul] Monash Med Ctr, Monash Lung & Sleep, Clayton, Vic, Australia	Monash University; Monash University; Monash University	Leong, P (corresponding author), Monash Med Ctr, Southern Clin Sch, Clayton, Vic, Australia.; Leong, P (corresponding author), Monash Med Ctr, Monash Lung & Sleep, Clayton, Vic, Australia.	paul.leong@monash.edu.au	Foster, Samantha Michelle/GQI-0807-2022	Leong, Paul/0000-0002-7409-9328				Carrougher GJ, 2009, J BURN CARE RES, V30, P785, DOI 10.1097/BCR.0b013e3181b485d3; Chan EA, 2006, J CLIN NURS, V15, P661, DOI 10.1111/j.1365-2702.2006.01345.x; CHOINIERE M, 1994, BURNS, V20, P229, DOI 10.1016/0305-4179(94)90188-0; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Das Debashish A, 2005, BMC Pediatr, V5, P1, DOI 10.1186/1471-2431-5-1; Dascal Julieta, 2017, Innov Clin Neurosci, V14, P14; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120519; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Frieden TR, 2016, NEW ENGL J MED, V374, P1501, DOI 10.1056/NEJMp1515917; Garrett B, 2014, CLIN J PAIN, V30, P1089, DOI 10.1097/AJP.0000000000000064; Gershon J, 2004, J AM ACAD CHILD PSY, V43, P1243, DOI 10.1097/01.chi.0000135621.23145.05; Gold JI, 2018, J PEDIATR PSYCHOL, V43, P266, DOI 10.1093/jpepsy/jsx129; Gold JI, 2006, CYBERPSYCHOL BEHAV, V9, P207, DOI 10.1089/cpb.2006.9.207; Guo CL, 2015, J CLIN NURS, V24, P115, DOI 10.1111/jocn.12626; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoffman HG, 2008, CLIN J PAIN, V24, P299, DOI 10.1097/AJP.0b013e318164d2cc; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; JahaniShoorab N, 2015, IRAN J MED SCI, V40, P219; Jeffs D, 2014, J BURN CARE RES, V35, P395, DOI 10.1097/BCR.0000000000000019; Kenney M.P., 2016, PSYCHOL CONSCIOUS, V3, P199, DOI [DOI 10.1016/J.CPR.2010.07.001, DOI 10.1037/CNS0000084]; Kipping B, 2012, BURNS, V38, P650, DOI 10.1016/j.burns.2011.11.010; Konstantatos AH, 2009, BURNS, V35, P491, DOI 10.1016/j.burns.2008.08.017; Maani CV, 2011, J TRAUMA, V71, pS125, DOI 10.1097/TA.0b013e31822192e2; MCGRATH PJ, 1985, ADV PAIN RES THER, V9, P395; McSherry T, 2018, J BURN CARE RES, V39, P278, DOI 10.1097/BCR.0000000000000589; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morris LD, 2010, BURNS, V36, P659, DOI 10.1016/j.burns.2009.09.005; Orsini N., 2006, HETEROGI STATA MODUL; Sakel, 2017, BR J NEUROSCI NURS, V13, P133, DOI [10.12968/bjnn.2017.13.3.133, DOI 10.12968/BJNN.2017.13.3.133]; Sander Wint Suzanne, 2002, Oncol Nurs Forum, V29, pE8; SAVEDRA MC, 1993, NURS RES, V42, P5; Schmitt YS, 2011, BURNS, V37, P61, DOI 10.1016/j.burns.2010.07.007; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tighe P, 2015, PAIN MED, V16, P1806, DOI 10.1111/pme.12760; Upp J, 2013, PAIN MED, V14, P124, DOI 10.1111/pme.12015; van Twillert B, 2007, J BURN CARE RES, V28, P694, DOI 10.1097/BCR.0B013E318148C96F; Walker MR, 2014, MIL MED, V179, P891, DOI 10.7205/MILMED-D-13-00343; Wolitzky K, 2005, PSYCHOL HEALTH, V20, P817, DOI 10.1080/14768320500143339; Won AS, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4070052; Wong D L, 1988, Pediatr Nurs, V14, P9	44	59	61	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200987	10.1371/journal.pone.0200987	http://dx.doi.org/10.1371/journal.pone.0200987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052655	gold, Green Published, Green Submitted			2022-12-27	WOS:000440006600020
J	Marcucci, L; Canato, M; Protasi, F; Stienen, GJM; Reggiani, C				Marcucci, Lorenzo; Canato, Marta; Protasi, Feliciano; Stienen, Ger J. M.; Reggiani, Carlo			A 3D diffusional-compartmental model of the calcium dynamics in cytosol, sarcoplasmic reticulum and mitochondria of murine skeletal muscle fibers	PLOS ONE			English	Article							BINDING PROTEIN; CA2+ RELEASE; INTRACELLULAR CA2+; CARDIAC-MUSCLE; TWITCH FIBERS; MOUSE MUSCLE; CALSEQUESTRIN; MICE; SIMULATION; CONTRACTION	Variations of free calcium concentration ([Ca2+]) are powerful intracellular signals, controlling contraction as well as metabolism in muscle cells. To fully understand the role of calcium redistribution upon excitation and contraction in skeletal muscle cells, the local [Ca2+] in different compartments needs to be taken into consideration. Fluorescent probes allow the determination of [Ca2+] in the cytosol where myofibrils are embedded, the lumen of the sarcoplasmic reticulum (SR) and the mitochondrial matrix. Previously, models have been developed describing intracellular calcium handling in skeletal and cardiac muscle cells. However, a comprehensive model describing the kinetics of the changes in free calcium concentration in these three compartments is lacking. We designed a new 3D compartmental model of the half sarcomere with radial symmetry, which accounts for diffusion of Ca2+ into the three compartments and simulates its dynamics at rest and at various rates of stimulation in mice skeletal muscle fibers. This model satisfactorily reproduces both the amplitude and time course of the variations of [Ca2+] in the three compartments in mouse fast fibers. As an illustration of the applicability of the model, we investigated the effects of Calsequestrin (CSQ) ablation. CSQ is the main Ca2+ buffer in the SR, localized in close proximity of its calcium release sites and near to the mitochondria. CSQ knock-out mice muscles still preserve a near-normal contractile behavior, but it is unclear whether this is caused by additional SR calcium buffering or a significant contribution of calcium entry from extracellular space, via stored-operated calcium entry (SOCE). The model enabled quantitative assessment of these two scenarios by comparison to measurements of local calcium in the cytosol, the SR and the mitochondria. In conclusion, the model represents a useful tool to investigate the impact of protein ablation and of pharmacological interventions on intracellular calcium dynamics in mice skeletal muscle.	[Marcucci, Lorenzo; Canato, Marta; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Protasi, Feliciano] CeSI Met Ctr Res Ageing & Translat Med, Chieti, Italy; [Protasi, Feliciano] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Stienen, Ger J. M.] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands	University of Padua; G d'Annunzio University of Chieti-Pescara; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Marcucci, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	lorenzo.marcucci@gmail.com	Marcucci, Lorenzo/AAD-5771-2020	Marcucci, Lorenzo/0000-0002-9542-4417	Telethon [GGP13213]; Italian Ministry of Instruction, University and Research [PRIN 2015ZZR4W3]	Telethon(Fondazione Telethon); Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR))	LM, CR and FP were supported by Telethon GGP13213. CR and FP were also supported by Italian Ministry of Instruction, University and Research PRIN 2015ZZR4W3.	[Anonymous], ACCELERATED ACTIVATI; Baylor SM, 1998, J GEN PHYSIOL, V112, P297, DOI 10.1085/jgp.112.3.297; Baylor SM, 2007, J GEN PHYSIOL, V130, P283, DOI 10.1085/jgp.200709827; Boncompagni S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14134-0; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Boyman L, 2014, BIOPHYS J, V107, P1289, DOI 10.1016/j.bpj.2014.07.045; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; CANNELL MB, 1984, BIOPHYS J, V45, P913, DOI 10.1016/S0006-3495(84)84238-1; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Crank J., 1979, MATH DIFFUSION; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; Divet A, 2007, J CELL PHYSIOL, V213, P464, DOI 10.1002/jcp.21121; Fenelon K, 2012, J GEN PHYSIOL, V140, P403, DOI 10.1085/jgp.201110730; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hatano A, 2011, BIOPHYS J, V101, P2601, DOI 10.1016/j.bpj.2011.10.020; Hollingworth S, 2000, J PHYSIOL-LONDON, V526, P551, DOI 10.1111/j.1469-7793.2000.t01-1-00551.x; Hollingworth S, 2012, J PHYSIOL-LONDON, V590, P575, DOI 10.1113/jphysiol.2011.220780; Jiang YH, 1999, BIOPHYS J, V77, P2333, DOI 10.1016/S0006-3495(99)77072-4; Lamboley CRH, 2015, J GEN PHYSIOL, V145, P127, DOI 10.1085/jgp.201411250; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; LUFF AR, 1971, J CELL BIOL, V51, P369, DOI 10.1083/jcb.51.2.369; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michelucci A, 2017, FASEB J, V31, P3649, DOI 10.1096/fj.201601292R; MOBLEY BA, 1975, J GEN PHYSIOL, V66, P31, DOI 10.1085/jgp.66.1.31; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Novo D, 2003, BIOPHYS J, V85, P1080, DOI 10.1016/S0006-3495(03)74546-9; OSTWALD TJ, 1974, J BIOL CHEM, V249, P974; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/634075; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Protasi F, 2011, J MUSCLE RES CELL M, V32, P257, DOI 10.1007/s10974-011-9277-2; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Reane DV, 2016, MOL CELL, V64, P760, DOI 10.1016/j.molcel.2016.10.001; Rios E, 2015, J GEN PHYSIOL, V145, P459, DOI 10.1085/jgp.201411321; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Scorzeto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074919; Selvin D, 2015, AM J PHYSIOL-REG I, V308, pR467, DOI 10.1152/ajpregu.00144.2014; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; Tran K, 2009, BIOPHYS J, V96, P2029, DOI 10.1016/j.bpj.2008.11.045; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WESTERBLAD H, 1994, J PHYSIOL-LONDON, V474, P291, DOI 10.1113/jphysiol.1994.sp020022; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Wust RCI, 2017, J PHYSIOL-LONDON, V595, P2001, DOI 10.1113/JP273589; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200	56	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201050	10.1371/journal.pone.0201050	http://dx.doi.org/10.1371/journal.pone.0201050			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048500	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400044
J	Qu, Z; Ju, FR; Guo, Y; Bai, L; Chen, K				Qu, Zhong; Ju, Fang-Rong; Guo, Yang; Bai, Ling; Chen, Kuo			Concrete surface crack detection with the improved pre-extraction and the second percolation processing methods	PLOS ONE			English	Article							ALGORITHM; IMAGES	Monitoring the instantaneous and changing concrete surface condition is paramount to cost-effectively managing tunnel assets. In practice, detecting cracks efficiently and accurately is a very challenging task due to concrete blebs, stains, and illumination over the concrete surface. Unclear and tiny cracks cannot be detected effectively. In this paper, we proposed an ultra-efficient crack detection algorithm (CrackHHP) and an improved pre-extraction and second percolation process based on the percolation model to address these issues. Our contributions are shown as follows: 1) apply the overlapping grids and weight-based, redefined pixel value to obtain the candidate dark pixel image while preserving the cracks. 2) introduce the second percolation processing to generate a high-accuracy crack detection algorithm, which can connect the tiny fractures and detect the tiny cracks. 3) construct a high-efficiency and high-accuracy crack detection algorithm combining the improved pre-extraction and the second percolation process. The experimental results demonstrate that CrackHHP can significantly improve the efficiency and accuracy of crack detection.	[Qu, Zhong; Ju, Fang-Rong; Chen, Kuo] Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China; [Qu, Zhong; Guo, Yang; Bai, Ling] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; Chongqing University of Posts & Telecommunications	Qu, Z (corresponding author), Chongqing Univ Posts & Telecommun, Sch Software Engn, Chongqing, Peoples R China.; Qu, Z (corresponding author), Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China.	quzhong@cqupt.edu.cn		Qu, Zhong/0000-0001-7013-4854; Bai, Ling/0000-0002-2135-5404	Chongqing Basic and Frontier Research Project [cstc2015jcyjBX0090, cstc2014jcyjA40033, cstc2014 jcyjA10051, cstc2015jcyjA40034]; Outstanding Achievements Transformation Projects of University in Chongqing [KJZH14219]	Chongqing Basic and Frontier Research Project; Outstanding Achievements Transformation Projects of University in Chongqing	This work was supported by Chongqing Basic and Frontier Research Project under Grant No. cstc2015jcyjBX0090, cstc2014jcyjA40033, cstc2014 jcyjA10051, and cstc2015jcyjA40034 (ZQ), and Outstanding Achievements Transformation Projects of University in Chongqing under Grant No. KJZH14219.	Amhaz R, 2016, IEEE T INTELL TRANSP, V17, P2718, DOI 10.1109/TITS.2015.2477675; Annum R, 2011, SIGNAL IMAGE VIDEO P, P1; Barazzetti L, 2009, ISPRS J PHOTOGRAMM, V64, P285, DOI 10.1016/j.isprsjprs.2009.02.004; Cabaleiro M, 2017, CONSTR BUILD MATER, V130, P41, DOI 10.1016/j.conbuildmat.2016.11.032; Cha YJ, 2017, COMPUT-AIDED CIV INF, V32, P361, DOI 10.1111/mice.12263; Chambon S, 2011, INT J GEOPHYS, V2011, DOI 10.1155/2011/989354; Cui LM, 2015, LECT NOTES COMPUT SC, V9208, P95, DOI 10.1007/978-3-319-24474-7_14; Lee BY, 2013, STRUCT INFRASTRUCT E, V9, P567, DOI 10.1080/15732479.2011.593891; Lu S, 2016, J COMPUT CIVIL ENG, V30, P1; Niharika N, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION CONTROL AND COMPUTING TECHNOLOGIES (ICACCCT), P809, DOI 10.1109/ICACCCT.2014.7019204; Nouri F, 2017, SIGNAL IMAGE VIDEO P, P1; Oliveira H, 2013, IEEE T INTELL TRANSP, V14, P155, DOI 10.1109/TITS.2012.2208630; Prasanna P, 2016, IEEE T AUTOM SCI ENG, V13, P591, DOI 10.1109/TASE.2014.2354314; Qu Z, 2016, IMAGING SCI J, V64, P119, DOI 10.1080/13682199.2016.1146816; Qu Z, 2015, IEEJ T ELECTR ELECTR, V10, P214, DOI 10.1002/tee.22056; Schnebele E, 2015, EUR TRANSP RES REV, V7, DOI 10.1007/s12544-015-0156-6; Shi Y, 2016, IEEE T INTELL TRANSP, V17, P3434, DOI 10.1109/TITS.2016.2552248; Sinha SK, 2006, AUTOMAT CONSTR, V15, P47, DOI 10.1016/j.autcon.2005.02.007; Nguyen TS, 2011, IEEE IMAGE PROC, P1069, DOI 10.1109/ICIP.2011.6115610; Tsai YC, 2010, J TRANSP ENG, V136, P11, DOI 10.1061/(ASCE)TE.1943-5436.0000051; Tsai Y, 2014, IEEE IMAGE PROC, P773, DOI 10.1109/ICIP.2014.7025155; Valenca J, 2017, CONSTR BUILD MATER, V146, P668, DOI 10.1016/j.conbuildmat.2017.04.096; Valenca J, 2013, MEASUREMENT, V46, P433, DOI 10.1016/j.measurement.2012.07.019; Valenca J, 2012, CONSTR BUILD MATER, V28, P607, DOI 10.1016/j.conbuildmat.2011.08.082; Xu W, 2013, IEEE IMAGE PROC, P4093, DOI 10.1109/ICIP.2013.6738843; Yamaguchi T, 2010, MACH VISION APPL, V21, P797, DOI 10.1007/s00138-009-0189-8; Yokoyama S, 2017, PROCEDIA ENGINEER, V171, P1250, DOI 10.1016/j.proeng.2017.01.418; Zhang B, 2015, MATER RES INNOV, V19, P144; Zou Q, 2012, PATTERN RECOGN LETT, V33, P227, DOI 10.1016/j.patrec.2011.11.004	29	14	15	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201109	10.1371/journal.pone.0201109	http://dx.doi.org/10.1371/journal.pone.0201109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048514	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400050
J	Rossi, A; Pappalardo, L; Cintia, P; Iaia, FM; Fernandez, J; Medina, D				Rossi, Alessio; Pappalardo, Luca; Cintia, Paolo; Iaia, F. Marcello; Fernandez, Javier; Medina, Daniel			Effective injury forecasting in soccer with GPS training data and machine learning	PLOS ONE			English	Article							PLAYERS; MODEL; RISK; LOADS	Injuries have a great impact on professional soccer, due to their large influence on team performance and the considerable costs of rehabilitation for players. Existing studies in the literature provide just a preliminary understanding of which factors mostly affect injury risk, while an evaluation of the potential of statistical models in forecasting injuries is still missing. In this paper, we propose a multi-dimensional approach to injury forecasting in professional soccer that is based on GPS measurements and machine learning. By using GPS tracking technology, we collect data describing the training workload of players in a professional soccer club during a season. We then construct an injury forecaster and show that it is both accurate and interpretable by providing a set of case studies of interest to soccer practitioners. Our approach opens a novel perspective on injury prevention, providing a set of simple and practical rules for evaluating and interpreting the complex relations between injury risk and training performance in professional soccer.	[Rossi, Alessio; Pappalardo, Luca] Univ Pisa, Dept Comp Sci, Pisa, Italy; [Pappalardo, Luca; Cintia, Paolo] CNR, ISTI, Pisa, Italy; [Iaia, F. Marcello] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Fernandez, Javier] FC Barcelona, Sports Sci & Hlth Dept, Barcelona, Spain; [Medina, Daniel] Philadelphia 76Ers, Athlet Care Dept, Philadelphia, PA USA	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" (ISTI-CNR); University of Milan	Rossi, A (corresponding author), Univ Pisa, Dept Comp Sci, Pisa, Italy.	alessio.rossi2@gmail.com	Iaia, F. Marcello/L-6067-2015; Pappalardo, Luca/F-7726-2018; Rossi, Alessio/AAN-4755-2020; Cintia, Paolo/AAV-4068-2020; Cintia, Paolo/AFU-4998-2022	Iaia, F. Marcello/0000-0003-0981-6471; Pappalardo, Luca/0000-0002-1547-6007; ROSSI, ALESSIO/0000-0002-6400-5914; Cintia, Paolo/0000-0002-8085-9338	European Community's H2020 Program [INFRAIA-1-2014-2015, 654024]	European Community's H2020 Program	This work is partially supported by the European Community's H2020 Program under the funding scheme "INFRAIA-1-2014-2015: Research Infrastructures" grant agreement 654024, www.sobigdata.eu, "SoBigData". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Anderson L, 2003, J STRENGTH COND RES, V17, P734; Brink MS, 2010, BRIT J SPORT MED, V44, P809, DOI 10.1136/bjsm.2009.069476; Cintia P, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (IEEE DSAA 2015), P392; Duncan MJ, 2009, J SCI MED SPORT, V12, P549, DOI 10.1016/j.jsams.2008.10.010; Ehrmann FE, 2016, J STRENGTH COND RES, V30, P360, DOI 10.1519/JSC.0000000000001093; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P953, DOI 10.1519/JSC.0b013e3182302023; Gabbett TJ, 2010, J STRENGTH COND RES, V24, P2593, DOI 10.1519/JSC.0b013e3181f19da4; Gabbett TJ, 2004, BRIT J SPORT MED, V38, P743, DOI 10.1136/bjsm.2003.008391; Gudmundsson J, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3054132; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Hagglund M, 2013, BRIT J SPORT MED, DOI [10.1136/bjsports-2013-092215, DOI 10.1136/BJSPORTS-2013-092215,2013]; He H., 2008, IEEE INT JOINT C NEU; Hulin BT, 2014, BRIT J SPORT MED, V48, P708, DOI 10.1136/bjsports-2013-092524; Hurley OA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00807; James G., 2017, INTRO STAT LEARNING; Kampakis S., 2016, PREDICTIVE MODELLING; Kazemitabar J, 31 C NEUR INF PROC S; Kirkendall DT, 2010, PHYSICIAN SPORTSMED, V38, P147, DOI 10.3810/psm.2010.04.1772; Lehmann E.E., 2008, APPL EC Q, V54, P59, DOI DOI 10.3790/AEQ.54.1.59; Murray NB, 2017, BRIT J SPORT MED, V51, P749, DOI 10.1136/bjsports-2016-097152; Pappalardo L, 2018, ADV COMPLEX SYST, V21, DOI 10.1142/S021952591750014X; Pastor-Barrn I, 2010, 15 ANN C EUR COLL SP; Rogalski B, 2013, J SCI MED SPORT, V16, P499, DOI 10.1016/j.jsams.2012.12.004; Rossi A, 2016, INT CONF DAT MIN WOR, P160, DOI 10.1109/ICDMW.2016.0030; Stein M, 2017, DATA, V2, DOI 10.3390/data2010002; Talukder H, 2016, MIT SLOAN AN C BOST; Venturelli M, 2011, J SCI MED SPORT, V14, P293, DOI 10.1016/j.jsams.2011.02.013	30	85	85	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201264	10.1371/journal.pone.0201264	http://dx.doi.org/10.1371/journal.pone.0201264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044858	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500098
J	Zhan, YH; Qu, YC; Zhu, LJ; Shen, CJ; Feng, XP; Yu, CL				Zhan, Yihua; Qu, Yinchao; Zhu, Longjing; Shen, Chenjia; Feng, Xuping; Yu, Chenliang			Transcriptome analysis of tomato (Solanum lycopersicum L.) shoots reveals a crosstalk between auxin and strigolactone	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; GENE FAMILY; REPRODUCTIVE DEVELOPMENT; BIOSYNTHESIS; INDUCTION; RECEPTOR; DYNAMICS; HOMOLOG; ACID; PEA	Auxin and strigolactone (SL) are two important phytohormones involved in shoot branching and morphology. Tomato (Solanum lycopersicum L.), a member of the Solanaceae family, is one of the most popular food crops with high economic value in the world. To seek a better understanding of the responses to exogenous hormones, transcriptome analyses of the tomato shoots treated with exogenous auxin and SL, separately or together, were performed. A total of 2326, 260 and 1379 differential expressed genes (DEGs) were identified under the IAA, GR24 and IAA+GR24 treatments, respectively. Network analysis pointed out two enriched interaction clusters, including "ethylene biosynthesis" and "photosynthesis". Several ethylene biosynthesis and metabolism-related genes were up-regulated under both IAA and IAA+GR24 treatments, suggesting their involvement in the regulation of ethylene biosynthesis. Besides, auxin-SLs-triggered the expression of several CAB genes may lead to systemic increases in the induction of photosynthesis. Several auxin-activated metabolic pathways could be reduced by the GR24 treatment, indicated that the crosstalk between auxin and SLs may be involved in the metabolic regulation of tomato. Further analysis showed that SLs affect the responses of tomato shoots to auxin by inducing the expression of a series of auxin downstream genes. On the other hand, auxin regulated the biosynthesis of SLs by affecting the genes in the "Carotenoid biosynthesis" pathway. Our data will give us an opportunity to reveal the crosstalk between auxin and SLs in the shoots of tomato.	[Zhan, Yihua] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou, Zhejiang, Peoples R China; [Qu, Yinchao; Yu, Chenliang] Zhejiang Acad Agr Sci, Vegetable Res Inst, Hangzhou, Zhejiang, Peoples R China; [Zhu, Longjing] Wenzhou Vocat Coll Sci & Technol, Wenzhou, Zhejiang, Peoples R China; [Shen, Chenjia] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Feng, Xuping] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Hangzhou Normal University; China Jiliang University	Yu, CL (corresponding author), Zhejiang Acad Agr Sci, Vegetable Res Inst, Hangzhou, Zhejiang, Peoples R China.; Feng, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	pimmmx@163.com; 21007030@zju.edu.cn			National Natural Science Foundation of China [31701967]; Natural Science Foundation of Zhejiang Province, China [LQ17C150003]; young talent training project of Zhejiang Academy of Agricultural Sciences [2016R23R08E05]; Research Project of seed and seedling of Wenzhou City [Z20160009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); young talent training project of Zhejiang Academy of Agricultural Sciences; Research Project of seed and seedling of Wenzhou City	This work was supported by the National Natural Science Foundation of China (Grant no. 31701967) (CY), the Natural Science Foundation of Zhejiang Province, China (Grant No. LQ17C150003) (CY), the young talent training project of Zhejiang Academy of Agricultural Sciences (2016R23R08E05) (CY), and the Research Project of seed and seedling of Wenzhou City (No. Z20160009) (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant no. 31701967), the Natural Science Foundation of Zhejiang Province, China (Grant No. LQ17C150003), the young talent training project of Zhejiang Academy of Agricultural Sciences (2016R23R08E05), and the Research Project of seed and seedling of Wenzhou City (No. Z20160009).	Albacete A, 2009, PLANT CELL ENVIRON, V32, P928, DOI 10.1111/j.1365-3040.2009.01973.x; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Boureau L, 2016, PLANT MOL BIOL, V90, P485, DOI 10.1007/s11103-016-0436-0; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Cheng X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00392; Chersicola M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00464; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Dixit R, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1113363; Ercolano MR, 2012, PLANT CELL REP, V31, P973, DOI 10.1007/s00299-012-1234-z; Estan MT, 2005, J EXP BOT, V56, P703, DOI 10.1093/jxb/eri027; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Foo E, 2013, J PLANT PHYSIOL, V170, P523, DOI 10.1016/j.jplph.2012.11.002; French E, 2017, MOL PLANT MICROBE IN, V2018, P31; Goldental-Cohen S, 2017, PLANT CELL PHYSIOL, V58, P1661, DOI 10.1093/pcp/pcx102; Guillotin B, 2017, NEW PHYTOL, V213, P1124, DOI 10.1111/nph.14246; Guo ZX, 2016, PLANT PHYSIOL, V172, P1259, DOI 10.1104/pp.16.01202; Hao YW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005649; Hao YW, 2014, J EXP BOT, V65, P1013, DOI 10.1093/jxb/ert440; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Ito S, 2017, PLANT PHYSIOL, V174, P1250, DOI 10.1104/pp.17.00301; Kharshiing EV, 2010, PLANT SIGNAL BEHAV, V5, P1379, DOI 10.4161/psb.5.11.13035; Khatun K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051056; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kohlen W, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22785; Kohlen W, 2012, NEW PHYTOL, V196, P535, DOI 10.1111/j.1469-8137.2012.04265.x; Koltai H, 2015, J EXP BOT, V66, P4855, DOI 10.1093/jxb/erv178; Koltai H, 2010, J EXP BOT, V61, P1739, DOI 10.1093/jxb/erq041; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Z, 2014, J PROTEOME RES, V13, P1359, DOI 10.1021/pr400925t; Liu W, 2011, PLANT CELL, V23, P3853, DOI 10.1105/tpc.111.089771; Lopez-Raez JA, 2010, NEW PHYTOL, V187, P343, DOI 10.1111/j.1469-8137.2010.03291.x; Lopez-Raez JA, 2008, PLANT SIGNAL BEHAV, V3, P963, DOI 10.4161/psb.6126; Ma N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01671; Matsuoka K, 2016, PLANT CELL PHYSIOL, V57, P2620, DOI 10.1093/pcp/pcw177; Mayzlish-Gati E, 2010, J EXP BOT, V61, P3129, DOI 10.1093/jxb/erq138; Pandya-Kumar N, 2014, NEW PHYTOL, V202, P1184, DOI 10.1111/nph.12744; Qiu LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3182-4; Ren ZX, 2011, J EXP BOT, V62, P2815, DOI 10.1093/jxb/erq455; Sang DJ, 2014, P NATL ACAD SCI USA, V111, P11199, DOI 10.1073/pnas.1411859111; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shaharuddin NA, 2006, FEBS LETT, V580, P6579, DOI 10.1016/j.febslet.2006.11.005; Shen CJ, 2016, J EXP BOT, V67, P4179, DOI 10.1093/jxb/erw196; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0495-4; Sun WH, 2014, BIOL PLANTARUM, V58, P99, DOI 10.1007/s10535-013-0360-y; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168287; Wu J, 2012, GENE, V509, P38, DOI 10.1016/j.gene.2012.08.002; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu YL, 2017, PLANTA, V245, P583, DOI 10.1007/s00425-016-2625-0; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xu DB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00676; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yu CN, 2017, TREE PHYSIOL, V37, P1659, DOI 10.1093/treephys/tpx091; Yuan HW, 2017, IND CROP PROD, V108, P814, DOI 10.1016/j.indcrop.2017.07.026; Zhou T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00836	59	8	8	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201124	10.1371/journal.pone.0201124	http://dx.doi.org/10.1371/journal.pone.0201124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044859	gold, Green Submitted, Green Published			2022-12-27	WOS:000439942500082
J	Kelner, A; Tinti, M; Guther, MLS; Foth, BJ; Chappell, L; Berriman, M; Cowling, VH; Ferguson, MAJ				Kelner, Anna; Tinti, Michele; Guther, Maria Lucia S.; Foth, Bernardo J.; Chappell, Lia; Berriman, Matthew; Cowling, Victoria Haigh; Ferguson, Michael A. J.			The mRNA cap methyltransferase gene TbCMT1 is not essential in vitro but is a virulence factor in vivo for bloodstream form Trypanosoma brucei	PLOS ONE			English	Article							TSETSE-FLY; METHYLATION; EXPRESSION; GROWTH; DONOR	Messenger RNA is modified by the addition of a 50 methylated cap structure, which protects the transcript and recruits protein complexes that mediate RNA processing and/or the initiation of translation. Two genes encoding mRNA cap methyltransferases have been identified in T. brucei: TbCMT1 and TbCGM1. Here we analysed the impact of TbCMT1 gene deletion on bloodstream form T. brucei cells. TbCMT1 was dispensable for parasite proliferation in in vitro culture. However, significantly decreased parasitemia was observed in mice inoculated with TbCMT1 null and conditional null cell lines. Using RNA-Seq, we observed that several cysteine peptidase mRNAs were downregulated in TbCMT1 null cells lines. The cysteine peptidase Cathepsin-L was also shown to be reduced at the protein level in TbCMT1 null cell lines. Our data suggest that TbCMT1 is not essential to bloodstream form T. brucei growth in vitro or in vivo but that it contributes significantly to parasite virulence in vivo.	[Kelner, Anna; Tinti, Michele; Guther, Maria Lucia S.; Ferguson, Michael A. J.] Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Dundee, Scotland; [Foth, Bernardo J.; Chappell, Lia; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Cowling, Victoria Haigh] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland	University of Dundee; Wellcome Trust Sanger Institute; University of Dundee	Ferguson, MAJ (corresponding author), Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Dundee, Scotland.; Cowling, VH (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland.	v.h.cowling@dundee.ac.uk; ma.a.j.ferguson@dundee.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Chappell, Lia/0000-0002-2317-3524; Ferguson, Michael/0000-0003-1321-8714; Cowling, Victoria/0000-0001-7638-4870; Tinti, Michele/0000-0002-0051-017X	Wellcome Trust [101842/Z13/Z, 093712/Z/10/Z]; Medical Research Council (U.K.) [MR/K024213/1]; MRC [MR/K024213/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (U.K.)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust 101842/Z13/Z to MAJF and Wellcome Trust 093712/Z/10/Z to AK and Medical Research Council (U.K.) MR/K024213/1 to VHC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004130; Aregger M, 2016, MOL CELL, V61, P734, DOI 10.1016/j.molcel.2016.02.008; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Cox FEG, 2004, INFECT DIS CLIN N AM, V18, P231, DOI 10.1016/j.idc.2004.01.004; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Denise H, 2003, INFECT IMMUN, V71, P3190, DOI 10.1128/IAI.71.6.3190-3195.2003; Fernandez-Cortes F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06501-8; FREISTADT MS, 1987, NUCLEIC ACIDS RES, V15, P9861, DOI 10.1093/nar/15.23.9861; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Grasso L, 2016, CELL REP, V16, P1352, DOI 10.1016/j.celrep.2016.06.089; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guther MLS, 2001, EMBO J, V20, P4923, DOI 10.1093/emboj/20.17.4923; Hall MP, 2006, RNA, V12, P488, DOI 10.1261/rna.2250606; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; Mottram JC, 2004, CURR OPIN MICROBIOL, V7, P375, DOI 10.1016/j.mib.2004.06.010; MOTTRAM JC, 1989, MOL BIOCHEM PARASIT, V37, P115, DOI 10.1016/0166-6851(89)90108-4; Pina-Vazquez Carolina, 2012, Journal of Parasitology Research, P748206, DOI 10.1155/2012/748206; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; Silva E, 1998, MOL CELL BIOL, V18, P4612, DOI 10.1128/MCB.18.8.4612; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Takagi Y, 2007, J BIOL CHEM, V282, P15995, DOI 10.1074/jbc.M701569200; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201263	10.1371/journal.pone.0201263	http://dx.doi.org/10.1371/journal.pone.0201263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040830	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200034
J	Shao, JX; Haider, I; Xiong, LZ; Zhu, XY; Hussain, RMF; Overnas, E; Meijer, AH; Zhang, GS; Wang, M; Bouwmeester, HJ; Ouwerkerk, PBF				Shao, Jingxia; Haider, Imran; Xiong, Lizhong; Zhu, Xiaoyi; Hussain, Rana Muhammad Fraz; Overnas, Elin; Meijer, Annemarie H.; Zhang, Gaisheng; Wang, Mei; Bouwmeester, Harro J.; Ouwerkerk, Pieter B. F.			Functional analysis of the HD-Zip transcription factor genes Oshox12 and Oshox14 in rice	PLOS ONE			English	Article							CLASS-I; SALT TOLERANCE; HOMEODOMAIN; ARABIDOPSIS; EXPRESSION; GROWTH; PROTEINS; IDENTIFICATION; DROUGHT; FAMILY	The homeodomain-leucine zipper (HD-Zip) transcription factor family plays vital roles in plant development and morphogenesis as well as responses to biotic and abiotic stresses. In barley, a recessive mutation in Vrs1 (HvHox1) changes two-rowed barley to six-rowed barley, which improves yield considerably. The Vrs1 gene encodes an HD-Zip subfamily I transcription factor. Phylogenetic analysis has shown that the rice HD-Zip I genes Oshox12 and Oshox14 are the closest homologues of Vrs1. Here, we show that Oshox12 and Oshox14 are ubiquitously expressed with higher levels in developing panicles. Trans-activation assays in yeast and rice protoplasts demonstrated that Oshox12 and Oshox14 can bind to a specific DNA sequence, AH1 (CAAT(A/T)ATTG), and activate reporter gene expression. Overexpression of Oshox12 and Oshox14 in rice resulted in reduced panicle length and a dwarf phenotype. In addition, Oshox14 overexpression lines showed a deficiency in panicle exsertion. Our findings suggest that Oshox12 and Oshox14 may be involved in the regulation of panicle development. This study provides a significant advancement in understanding the functions of HD-Zip transcription factors in rice.	[Shao, Jingxia] Northwest A&F Univ, Coll Life Sci, Xianyang, Shaanxi, Peoples R China; [Shao, Jingxia; Haider, Imran; Hussain, Rana Muhammad Fraz; Meijer, Annemarie H.; Wang, Mei; Ouwerkerk, Pieter B. F.] Leiden Univ, Inst Biol IBL, Leiden, Netherlands; [Haider, Imran; Bouwmeester, Harro J.] Wageningen Univ & Res Ctr, Lab Plant Physiol, Wageningen, Netherlands; [Xiong, Lizhong] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Zhu, Xiaoyi] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Overnas, Elin] Uppsala Univ, Dept Physiol Bot, EBC, Uppsala, Sweden; [Zhang, Gaisheng] Northwest A&F Univ, Coll Agron, Xianyang, Shaanxi, Peoples R China; [Wang, Mei] Leiden Univ, European Ctr Chinese Med & Nat Cpds, Leiden, Netherlands; [Haider, Imran] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Bouwmeester, Harro J.] Univ Amsterdam, Swammerdam Inst Life Sci, Plant Hormone Biol Grp, Amsterdam, Netherlands	Northwest A&F University - China; Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Uppsala University; Northwest A&F University - China; Leiden University; Leiden University - Excl LUMC; King Abdullah University of Science & Technology; University of Amsterdam	Ouwerkerk, PBF (corresponding author), Leiden Univ, Inst Biol IBL, Leiden, Netherlands.	p.b.f.ouwerkerk.2@gmail.com	Xiong, Lizhong/AAE-6984-2019; Haider, Imran/ABG-1774-2021; Bouwmeester, Harro J/C-1414-2008; Meijer, Annemarie/W-3726-2019	Haider, Imran/0000-0002-0100-2513; Meijer, Annemarie H./0000-0002-1325-0725; Bouwmeester, Harro/0000-0003-0907-2732	China Scholarship Council (CSC) [2007U27088]; National Natural Science Foundation of China [31770345]; Higher Education Commission (HEC) of Pakistan; King Abdullah University of Science and Technology (KAUST); KNAW Program Scientific Alliance [04-PSA-BD-04]; TF-STRESS [QLK3-CT-2000-00328]; CEDROME [INCO-CT-2005-015468]; TNO, the Netherlands; KNAW project	China Scholarship Council (CSC)(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); KNAW Program Scientific Alliance; TF-STRESS; CEDROME; TNO, the Netherlands; KNAW project	This work was supported by funding to JS from China Scholarship Council (CSC, 2007U27088, http.//www.csc.edu.cn/) and National Natural Science Foundation of China (31770345, littpliwww.nsfc.gov.cn/). This work was supported by the Higher Education Commission (HEC) of Pakistan and the King Abdullah University of Science and Technology (KAUST) to IH. MW and PBFO were supported by the KNAW Program Scientific Alliance (04-PSA-BD-04, www.knaw.nI). AHM was supported by TF-STRESS (QLK3-CT-2000-00328). PBFO was also supported by CEDROME (INCO-CT-2005-015468). TNO, the Netherlands (https://mmtno.nlien/) provided funding in the form of salary for MW; MW was also supported by the KNAW projects via a subsidy allowing travel and purchasing consumables for the PhD students working on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank all the contributing members of the Rice Research Group of the IBL, Leiden University. This work was supported by funding to JS from China Scholarship Council (CSC, 2007U27088) and National Natural Science Foundation of China (31770345). This work was supported by the Higher Education Commission (HEC) of Pakistan and the King Abdullah University of Science and Technology (KAUST) to IH. MW and PBFO were supported by the KNAW Program Scientific Alliance (04-PSA-BD-04). AHM was supported by TF-STRESS (QLK3-CT-2000-00328). PBFO was also supported by CEDROME (INCO-CT-2005-015468).	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Arce AL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-42; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Ariel FD, 2010, PLANT SIGNAL BEHAV, V5, P1666, DOI 10.4161/psb.5.12.14020; Bhattacharjee A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00628; Bhattacharjee A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00627; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt R, 2014, J INTEGR PLANT BIOL, V56, P518, DOI 10.1111/jipb.12185; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Capella M, 2014, PLANT CELL REP, V33, P955, DOI 10.1007/s00299-014-1576-9; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dai MQ, 2008, PLANT MOL BIOL, V66, P289, DOI 10.1007/s11103-007-9270-8; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Perotti MF, 2017, IUBMB LIFE, V69, P280, DOI 10.1002/iub.1619; Gao SP, 2016, PLANT CELL, V28, P680, DOI 10.1105/tpc.15.01021; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Hur YS, 2015, NEW PHYTOL, V205, P316, DOI 10.1111/nph.12998; Jain M, 2008, PLANT SIGNAL BEHAV, V3, P1024, DOI 10.4161/psb.6770; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; KAO KN, 1975, PLANTA, V126, P105, DOI 10.1007/BF00380613; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kuijt SJH, 2014, PLANT PHYSIOL, V164, P1952, DOI 10.1104/pp.113.222836; Li Q, 2015, J EXP BOT, V66, P2515, DOI 10.1093/jxb/erv046; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Liu W, 2013, GENE, V531, P279, DOI 10.1016/j.gene.2013.08.089; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Meijer AH, 1998, YEAST, V14, P1407, DOI 10.1002/(SICI)1097-0061(199811)14:15<1407::AID-YEA325>3.0.CO;2-M; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Meijer AH, 2000, MOL GEN GENET, V263, P12, DOI 10.1007/PL00008671; Memelink J, 1994, PLANT MOL BIOL MANUA, pF1; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Ohgishi M, 2001, PLANT J, V25, P389, DOI 10.1046/j.1365-313x.2001.00966.x; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Ouwerkerk P B, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1212s55; Ouwerkerk PBF, 2011, METHODS MOL BIOL, V678, P211, DOI 10.1007/978-1-60761-682-5_16; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pereira A, 1998, METH MOL B, V82, P329; Re DA, 2011, J EXP BOT, V62, P155, DOI 10.1093/jxb/erq252; Ren XF, 2014, GENOME, V57, P239, DOI 10.1139/gen-2014-0039; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Sakuma S, 2010, FUNCT INTEGR GENOMIC, V10, P123, DOI 10.1007/s10142-009-0134-y; Scarpella E, 2000, DEVELOPMENT, V127, P3655; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Shen SH, 2003, BIOL PHARM BULL, V26, P129, DOI 10.1248/bpb.26.129; Skinner DJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-29; Son O, 2005, BIOCHEM BIOPH RES CO, V326, P203, DOI 10.1016/j.bbrc.2004.11.014; Takada K, 1977, GAMMA FIELD S, V16, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang QQ, 2017, J PLANT BIOL, V60, P207, DOI 10.1007/s12374-016-0413-9; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang SX, 2012, PLANT MOL BIOL, V80, P571, DOI 10.1007/s11103-012-9967-1; Zhao Y, 2014, PLANT CELL PHYSIOL, V55, P1142, DOI 10.1093/pcp/pcu054; Zhu L, 2011, PLANT MOL BIOL, V77, P475, DOI 10.1007/s11103-011-9825-6	65	20	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0199248	10.1371/journal.pone.0199248	http://dx.doi.org/10.1371/journal.pone.0199248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028850	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900004
J	Su, NX; Li, TT; Zheng, J; Hu, X; Fan, T; Luo, L				Su, Ningxin; Li, Tongtong; Zheng, Jun; Hu, Xiao; Fan, Tian; Luo, Liang			How font size affects judgments of learning: Simultaneous mediating effect of item-specific beliefs about fluency and moderating effect of beliefs about font size and memory	PLOS ONE			English	Article							ENCODING FLUENCY; PERCEPTUAL FLUENCY; PROCESSING FLUENCY; METACOGNITIVE ILLUSIONS; METAMEMORY; INFORMATION; INTELLIGENCE; RELATEDNESS; DIFFICULTY; RETRIEVAL	Numerous studies have provided experience-based or theory-based frameworks for the basis of judgment of learning (JOL). However, few studies have directly measured processing experience and beliefs related to the same cue in one experiment and examined their joint contribution to JOLs. The present study focused on font-size effects and aimed to examine the simultaneous contribution of processing fluency and beliefs to the effect of font size on JOLs. We directly measured processing fluency via self-paced study time. We also directly measured participants' beliefs via two approaches: pre-study global differentiated predictions (GPREDs) as an indicator of preexisting beliefs about font size and memory and ease of learning judgments (EORs) as online generated item-specific beliefs about fluency. In Experiment 1, EORs partially mediated the font-size effect, whereas self-paced study time did not. In Experiments 2a and 2b, EORs mediated the font-size effect; at the same time, beliefs about font size and memory moderated the font-size effect. In summary, the present study demonstrates a major role of beliefs underlying the font-size effect.	[Su, Ningxin; Zheng, Jun; Hu, Xiao; Fan, Tian; Luo, Liang] Beijing Normal Univ, Collaborat Innovat Ctr Assessment Basic Educ Qual, Beijing, Peoples R China; [Su, Ningxin; Zheng, Jun; Hu, Xiao; Luo, Liang] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Li, Tongtong] Hefei Univ Technol, Mental Hlth Educ & Counseling Ctr, Hefei, Anhui, Peoples R China; [Luo, Liang] Beijing Normal Univ, Inst Dev Psychol, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Hefei University of Technology; Beijing Normal University	Luo, L (corresponding author), Beijing Normal Univ, Collaborat Innovat Ctr Assessment Basic Educ Qual, Beijing, Peoples R China.; Luo, L (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Luo, L (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing, Peoples R China.	luoliang@bnu.edu.cn		Hu, Xiao/0000-0002-8899-6273	Natural Science Foundation of China [31671130]; National Social Science Fund of China [16ZDA229]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Fund of China	This study was supported by the Natural Science Foundation of China [grant number 31671130], http://www.nsfc.gov.cn/, and Major Projects of National Social Science Fund of China [grant number 16ZDA229], http://www.npopss-cn. gov.cn/. Liang Luo is the funding recipient for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; Besken M, 2014, J EXP PSYCHOL LEARN, V40, P429, DOI 10.1037/a0034407; Besken M, 2013, MEM COGNITION, V41, P897, DOI 10.3758/s13421-013-0307-8; Bjork RA, 2013, ANNU REV PSYCHOL, V64, P417, DOI 10.1146/annurev-psych-113011-143823; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Efklides A, 2011, EDUC PSYCHOL-US, V46, P6, DOI 10.1080/00461520.2011.538645; Frank DJ, 2017, J EXP PSYCHOL LEARN, V43, P680, DOI 10.1037/xlm0000332; Hertzog C, 2003, J EXP PSYCHOL LEARN, V29, P22, DOI 10.1037/0278-7393.29.1.22; Hu X, 2016, MEMORY, V24, P383, DOI 10.1080/09658211.2015.1009470; Hu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142351; Jia XY, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01995; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Koriat A, 2005, J MEM LANG, V52, P478, DOI 10.1016/j.jml.2005.01.001; Koriat A, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P483; Kornell N, 2011, PSYCHOL SCI, V22, P787, DOI 10.1177/0956797611407929; Li P, 2016, MEM COGNITION, V44, P696, DOI 10.3758/s13421-016-0598-7; Lu Z., 2016, MATH PROBL ENG, V2016, P1; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Matvey G, 2001, MEM COGNITION, V29, P222, DOI 10.3758/BF03194916; Miele DB, 2011, PSYCHOL SCI, V22, P320, DOI 10.1177/0956797610397954; Miele DB, 2010, J EXP PSYCHOL GEN, V139, P535, DOI 10.1037/a0019745; Mueller ML, 2017, J MEM LANG, V93, P245, DOI 10.1016/j.jml.2016.10.008; Mueller ML, 2016, Q J EXP PSYCHOL, V69, P781, DOI 10.1080/17470218.2015.1058404; Mueller ML, 2014, J MEM LANG, V70, P1, DOI 10.1016/j.jml.2013.09.007; Mueller ML, 2013, PSYCHON B REV, V20, P378, DOI 10.3758/s13423-012-0343-6; Muthen L.K., 2013, MPLUS 7 11; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; Nelson TO., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Rhodes MG, 2009, PSYCHON B REV, V16, P550, DOI 10.3758/PBR.16.3.550; Robinson AE, 2006, AGING NEUROPSYCHOL C, V13, P458, DOI 10.1080/13825580600572983; Susser JA, 2016, J EXP PSYCHOL LEARN, V42, P657, DOI 10.1037/xlm0000189; Susser JA, 2015, PSYCHON B REV, V22, P1014, DOI 10.3758/s13423-014-0768-1; Undorf M, 2017, J MEM LANG, V92, P293, DOI 10.1016/j.jml.2016.07.003; Undorf M, 2015, MEM COGNITION, V43, P647, DOI 10.3758/s13421-014-0479-x; Undorf M, 2013, Q J EXP PSYCHOL, V66, P2060, DOI 10.1080/17470218.2013.777751; Undorf M, 2011, J EXP PSYCHOL LEARN, V37, P1264, DOI 10.1037/a0023719; Winkielman P, 2001, PSYCHOL SCI, V12, P176, DOI 10.1111/1467-9280.00330; Witherby AE, 2017, MEM COGNITION, V45, P639, DOI 10.3758/s13421-016-0681-0; Yang CL, 2018, J MEM LANG, V99, P99, DOI 10.1016/j.jml.2017.11.005; ZECHMEISTER EB, 1980, B PSYCHONOMIC SOC, V15, P41	42	13	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200888	10.1371/journal.pone.0200888	http://dx.doi.org/10.1371/journal.pone.0200888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028846	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900021
J	Yoo, B; Greninger, P; Stein, GT; Egan, RK; McClanaghan, J; Moore, A; Benes, CH; Medarova, Z				Yoo, Byunghee; Greninger, Patricia; Stein, Giovanna T.; Egan, Regina K.; McClanaghan, Joseph; Moore, Anna; Benes, Cyril H.; Medarova, Zdravka			Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin	PLOS ONE			English	Article							MICRORNA-B-10; METASTASIS; EXPRESSION; INVASION; OVEREXPRESSION; PROLIFERATION; GLIOBLASTOMA; MIGRATION; THERAPY	Since microRNAs (miRNAs, miRs) have been implicated in oncogenesis, many of them have been identified as therapeutic targets. Previously we have demonstrated that miRNA-10b acts as a master regulator of the viability of metastatic tumor cells and represents a target for therapeutic intervention. We designed and synthesized an inhibitor of miR-10b, termed MN-anti-miR10b. We showed that treatment with MN-anti-miR10b led to durable regression/elimination of established metastases in murine models of metastatic breast cancer. Since miRNA-10b has been associated with various metastatic and non-metastatic cancers, in the present study, we investigated the effect of MN-anti-miR10b in a panel of over 600 cell lines derived from a variety of human malignancies. We observed an effect on the viability of multiple cell lines within each cancer type and a mostly dichotomous response with cell lines either strongly responsive to MN-anti-miR10b or not at all even at maximum dose tested, suggesting a very high specificity of the effect. Genomic modeling of the drug response showed enrichment of genes associated with the proto-oncogene, c-Jun.	[Yoo, Byunghee; Moore, Anna; Medarova, Zdravka] Massachusetts Gen Hosp, Mol Imaging Lab, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Boston, MA 02114 USA; [Yoo, Byunghee; Greninger, Patricia; Stein, Giovanna T.; Egan, Regina K.; McClanaghan, Joseph; Moore, Anna; Benes, Cyril H.; Medarova, Zdravka] Harvard Med Sch, Boston, MA 02115 USA; [Greninger, Patricia; Stein, Giovanna T.; Egan, Regina K.; McClanaghan, Joseph; Benes, Cyril H.] Massachusetts Gen Hosp, Ctr Mol Therapeut, Canc Ctr, Boston, MA 02114 USA; [Moore, Anna] Michigan State Univ, Radiol & Physiol, E Lansing, MI 48824 USA; [Moore, Anna] Michigan State Univ, Precis Hlth Program, E Lansing, MI 48824 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Michigan State University; Michigan State University	Moore, A; Medarova, Z (corresponding author), Massachusetts Gen Hosp, Mol Imaging Lab, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Boston, MA 02114 USA.; Moore, A; Benes, CH; Medarova, Z (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Benes, CH (corresponding author), Massachusetts Gen Hosp, Ctr Mol Therapeut, Canc Ctr, Boston, MA 02114 USA.; Moore, A (corresponding author), Michigan State Univ, Radiol & Physiol, E Lansing, MI 48824 USA.; Moore, A (corresponding author), Michigan State Univ, Precis Hlth Program, E Lansing, MI 48824 USA.	moorea57@msu.edu; cbenes@mgh.harvard.edu; zmedarova@mgh.harvard.edu			Burroughs Wellcome Fund [102696]; National Cancer Institute [R01CA16346101A1]; NATIONAL CANCER INSTITUTE [R01CA163461] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Anna Moore and Zdravka Medarova are Founders, Members of the Board of Directors and Scientific Advisory Board Members of TransCode Therapeutics, Inc. However, they received no funding support from TransCode Therapeutics, Inc. in the form of authors' salaries and/or research materials. Also, TransCode Therapeutics, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The study was funded by the Burroughs Wellcome Fund 102696 to CB and National Cancer Institute R01CA16346101A1 to ZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmaksoud-Dammak R, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695916; Ahmad A, 2014, AM J TRANSL RES, V6, P384; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Chen WJ, 2013, TUMOR BIOL, V34, P455, DOI 10.1007/s13277-012-0570-5; Guessous F, 2013, J NEURO-ONCOL, V112, P153, DOI 10.1007/s11060-013-1047-0; Hou R, 2017, ONCOL LETT, V13, P5009, DOI 10.3892/ol.2017.6033; Huang JC, 2015, MOL BIOSYST, V11, P2051, DOI 10.1039/c4mb00752b; Hur K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju492; Jiang H, 2016, CANCER MED-US, V5, P2934, DOI 10.1002/cam4.789; Jikuzono T, 2013, INT J ONCOL, V42, P1858, DOI 10.3892/ijo.2013.1879; Kim JC, 2016, CANCER RES, V76, P6424, DOI 10.1158/0008-5472.CAN-16-1571; Knirsh R, 2016, ONCOTARGET, V7, P59932, DOI 10.18632/oncotarget.11000; Li G, 2010, CANCER LETT, V299, P29, DOI 10.1016/j.canlet.2010.07.021; Li QJ, 2012, TUMOR BIOL, V33, P1455, DOI 10.1007/s13277-012-0396-1; Li YW, 2016, CANCER BIOL THER, V17, P272, DOI 10.1080/15384047.2016.1139242; Liu Y, 2012, MED SCI MONITOR, V18, pBR299, DOI 10.12659/MSM.883262; Liu Zhisheng, 2012, REFRIGERATION AIR CO, V01, P24; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Meseguer S, 2011, J BIOL CHEM, V286, P4150, DOI 10.1074/jbc.M110.167817; Min WL, 2014, MED SCI MONIT BASIC, V20, P97, DOI 10.12659/MSMBR.891246; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Parrella P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-142; Preis M, 2011, CLIN CANCER RES, V17, P5812, DOI 10.1158/1078-0432.CCR-11-0695; Saldanha G, 2016, MODERN PATHOL, V29, P112, DOI 10.1038/modpathol.2015.149; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Tian Wenhong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P809; Tong P, 2015, BIOINFORMATICS, V31, P1692, DOI 10.1093/bioinformatics/btv028; Wang R, 2015, AM J CANCER RES, V5, P32; Wang YF, 2015, ONCOL REP, V33, P1275, DOI 10.3892/or.2015.3737; Xiao HB, 2014, ONCOL REP, V31, P1832, DOI 10.3892/or.2014.3048; Yang YL, 2015, TUMOR BIOL, V36, P7069, DOI 10.1007/s13277-015-3366-6; Yigit MV, 2013, ONCOGENE, V32, P1530, DOI 10.1038/onc.2012.173; Yoo B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45060; Yoo B, 2015, CANCER RES, V75, P4407, DOI 10.1158/0008-5472.CAN-15-0888; Yoo B, 2014, J BIOMED NANOTECHNOL, V10, P1114, DOI 10.1166/jbn.2014.1795; Zhang J, 2015, CLIN TRANSL ONCOL, V17, P209, DOI 10.1007/s12094-014-1213-7; Zhao FL, 2012, J INT MED RES, V40, P859, DOI 10.1177/147323001204000304	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201046	10.1371/journal.pone.0201046	http://dx.doi.org/10.1371/journal.pone.0201046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028875	gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900035
J	Lakusta, M; Danilenko, I; Volkova, G; Loladze, L; Burchovetskiy, V; Konstantinova, T				Lakusta, Marharyta; Danilenko, Igor; Volkova, Galina; Loladze, Larisa; Burchovetskiy, Valeriy; Konstantinova, Tetyana			Comparative analyses of the IV group oxides additives influence on the sintering kinetics of zirconia nanopowders	PLOS ONE			English	Article							CONSTANT RATES; ALUMINA; POWDER; YTTRIA; STAGE; MECHANISM; CERAMICS; NIO	Ceramics materials based on yttria stabilised tetragonal zirconia nanopowders (3Y-TZP) are widely used in the production fuel cells, oxygen sensors, refractories, etc. and intensively studied due to their outstanding mechanical and electrical properties. To obtain ceramics with specific properties different additives can be used. This allow for control over the features of a nanopowder' structure and its consolidation during the sintering process. It is important examine in detail the initial sintering stage of tetragonal zirconia based nanopowders modified by third element additives. The present paper shows the impact of SiO2 and SnO2 additives and the influence of different methods of dopant addition (co-precipitation and mechanical mixing) on the kinetics of the initial sintering stage of tetragonal zirconia nanopowders. It demonstrates that sintering mechanism is changed by the addition of a small amount SiO2 and SnO2 by volume to the grain boundary diffusion in 3Y-TZP nanopowders obtained by the co-precipitation method. This change led to increased activation energy. This paper explores the reasons for the acceleration in the sintering process of nanopowders 3Y-TZP with SiO2 and SnO2 additives obtained by the mixing method. It shows that the sintering mechanism is the same as that of the initial 3Y-TZP powder obtained by the co-precipitation technique. The volume diffusion mechanism was the predominant mechanism at the initial sintering stage and was accompanied by a decrease in the activation energy of the sintering process.	[Lakusta, Marharyta; Danilenko, Igor; Volkova, Galina; Loladze, Larisa; Burchovetskiy, Valeriy; Konstantinova, Tetyana] NAS Ukraine, Dept Mat Sci, DIPE, Kiev, Ukraine	National Academy of Sciences Ukraine	Lakusta, M (corresponding author), NAS Ukraine, Dept Mat Sci, DIPE, Kiev, Ukraine.	marharyta.lakusta@outlook.com	Lakusta, Marharyta/AAJ-6253-2020; Danilenko, Igor/AAB-9253-2020	Lakusta, Marharyta/0000-0003-3845-4449; Danilenko, Igor/0000-0002-0016-1045				Danilenko I, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-1901-7; Danilenko I, 2015, J CERAM SCI TECHNOL, V6, P191, DOI 10.4416/JCST2015-00020; Geguzin I.A.E., 1984, PHYS OF SINTERING; Hannink RHJ, 2000, J AM CERAM SOC, V83, P461, DOI 10.1111/j.1151-2916.2000.tb01221.x; Krogstad JA, 2011, J AM CERAM SOC, V94, P4548, DOI 10.1111/j.1551-2916.2011.04862.x; Lakusta M, 2016, PHYS TECH HIGH PRESS, V26, P68; Lakusta M, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2178-6; Lakusta M, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1452-3; LONGO V, 1981, J MATER SCI, V16, P839, DOI 10.1007/BF02402807; Maca K, 2005, REV ADV MATER SCI, V10, P84; Matsui K., 2004, J CERAM SOC JPN, V112, P343; Matsui K, 2008, J MATER SCI, V43, P852, DOI 10.1007/s10853-007-2179-4; Matsui K, 2008, J MATER SCI, V43, P2745, DOI 10.1007/s10853-008-2493-5; Matsui K, 2008, J AM CERAM SOC, V91, P2534, DOI 10.1111/j.1551-2916.2008.02516.x; Matsui K, 2006, J CERAM SOC JPN, V114, P763, DOI 10.2109/jcersj.114.763; Song XC, 2011, J EUR CERAM SOC, V31, P2621, DOI 10.1016/j.jeurceramsoc.2011.03.025; Strekalovsky VN, 2011, PHASE TRANSFORMATION; Suarez G, 2010, CERAM INT, V36, P879, DOI 10.1016/j.ceramint.2009.11.003; Uhlmann, 1976, INTRO CERAMICS; Vasylkiv O, 2004, J AM CERAM SOC, V11, P84; WANG JD, 1990, J AM CERAM SOC, V73, P1172, DOI 10.1111/j.1151-2916.1990.tb05175.x; WANG JD, 1991, J AM CERAM SOC, V74, P1959, DOI 10.1111/j.1151-2916.1991.tb07815.x; Weber A, 2004, J POWER SOURCES, V127, P273, DOI 10.1016/j.jpowsour.2003.09.024; Young W. S., 1970, Journal of the American Ceramic Society, V53, P659, DOI 10.1111/j.1151-2916.1970.tb12036.x	24	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200869	10.1371/journal.pone.0200869	http://dx.doi.org/10.1371/journal.pone.0200869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052673	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600018
J	Shin, SH; Ye, MK; Lee, DW; Che, MH				Shin, Seung-Heon; Ye, Mi-Kyung; Lee, Dong-Won; Che, Mi-Hyun			Effect of microencapsulated essential oil form Chamaecyparis obtusa on monocyte-derived dendritic cell activation and CD4(+) T cell polarization	PLOS ONE			English	Article							ALTERNARIA; LIPOPOLYSACCHARIDE; ANTIBACTERIAL; INFLAMMATION; MACROPHAGES; ANTIFUNGAL; CYTOKINES; PATHWAY; ASTHMA; FUNGUS	The essential oil of Chamaecyparis obtusa (C. obtusa), which is used in soap, toothpaste, and aromatic agents, has been known to have anti-inflammatory properties. In this study, we investigated the effects of microencapsulated C. obtusa essential oil on airborne fungus-induced dendritic cell (DC) activation and Th immune responses. We stimulated monocyte-derived DCs with Alternaria alternate and lipopolysaccharide (LPS). To determine the anti-inflammatory effects, we pre-treated DCs with various concentrations of microencapsulated C. obtusa essential oil and collected the supernatants to measure interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), and we determined the expression of cell surface molecules. The effects of the essential oil on CD4(+) T cells polarization was determine by culturing stimulated DCs and autologous CD4(+ )T cells. Alternaria enhanced the production of IL-6 and TNF-alpha from DCs, and pretreating DCs with 0.001, 0.01, and 0.05% of the essential oil significantly inhibited their production. Increased CD80 and CD86 expression by Alternaria was significantly inhibited with 0.05% of the essential oil. Alternaria-induced IL-5, IL-10, and interferon-gamma from CD4(+) T cells were significantly inhibited with C. obtusa essential oil in a dose dependent manner. C. obtusa influenced both Alternaria- and LPS-induced Th1 and Th2 polarization of CD4(+) T cells. These results suggest a novel pharmacological use for C. obtusa essential oil to treat inflammatory airway diseases.	[Shin, Seung-Heon; Ye, Mi-Kyung; Lee, Dong-Won; Che, Mi-Hyun] Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea	Catholic University of Daegu	Shin, SH (corresponding author), Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea.	hsseung@cu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931622]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03931622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, MED MYCOL, V49, pS150, DOI 10.3109/13693786.2010.504752; An BS, 2013, MOL MED REP, V8, P255, DOI 10.3892/mmr.2013.1459; Andersson M, 2003, PEDIAT ALLERG IMM-UK, V14, P100, DOI 10.1034/j.1399-3038.2003.00031.x; Carvalho IT, 2016, INT J COSMETIC SCI, V38, P109, DOI 10.1111/ics.12232; Chou ST, 2013, INT J MOL SCI, V14, P12978, DOI 10.3390/ijms140712978; Guimaraes AG, 2013, PHYTOTHER RES, V27, P1, DOI 10.1002/ptr.4686; Gupta SK, 2013, RES VET SCI, V95, P930, DOI 10.1016/j.rvsc.2013.07.015; Joo SS, 2010, J DERMATOL SCI, V60, P122, DOI 10.1016/j.jdermsci.2010.08.008; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Lai XL, 2008, INT J PHARM, V352, P66, DOI 10.1016/j.ijpharm.2007.10.011; Lima DKS, 2012, J ETHNOPHARMACOL, V142, P274, DOI 10.1016/j.jep.2012.05.016; Marchese A, 2016, FOOD CHEM, V210, P402, DOI 10.1016/j.foodchem.2016.04.111; Matsuwaki Y, 2011, INT ARCH ALLERGY IMM, V155, P123, DOI 10.1159/000327498; Mohammadi A, 2015, BIOTECH HISTOCHEM, V90, P445, DOI 10.3109/10520295.2015.1017536; Park HS, 2010, MOLECULES, V15, P6810, DOI 10.3390/molecules15106810; Park Y, 2016, MOL MED REP, V13, P3335, DOI 10.3892/mmr.2016.4905; Park Y, 2015, INT IMMUNOPHARMACOL, V29, P320, DOI 10.1016/j.intimp.2015.10.034; Reichling J, 2009, FORSCH KOMPLEMENTMED, V16, P79, DOI 10.1159/000207196; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Yang JK, 2007, FITOTERAPIA, V78, P149, DOI 10.1016/j.fitote.2006.09.026	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201233	10.1371/journal.pone.0201233	http://dx.doi.org/10.1371/journal.pone.0201233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052657	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600031
J	Brailovskaia, J; Rohmann, E; Bierhoff, HW; Margraf, J				Brailovskaia, Julia; Rohmann, Elke; Bierhoff, Hans-Werner; Margraf, Juergen			The brave blue world: Facebook flow and Facebook Addiction Disorder (FAD)	PLOS ONE			English	Article							SOCIAL MEDIA; TELEPRESENCE; VALIDATION; ATTACHMENT; INTERNET; TRAITS; HEALTH; MODEL; USAGE	The present study investigated the relationship between flow experienced when using Face-book (Facebook flow; i.e., experience of intensive enjoyment and pleasure generated by Facebook use due to which the Facebook activity is continued even at high costs of this behavior) and Facebook Addiction Disorder (FAD). In a sample of 398 Facebook users (age: M (SD) = 33.01 (11.23), range: 18-64), the significant positive association between Facebook flow and FAD was positively moderated by the intensity of Facebook use. Exploratory factor analysis revealed that all six items assessing FAD loaded on the same factor as two items belonging to the subscale telepresence of Facebook flow. Therefore, the close link between Facebook flow and FAD may in particular result from the immersion in an attractive online world created by Facebook, where users escape to forget their everyday obligations and problems. Present results provide first evidence that Facebook flow may be an anteceded of FAD and indicate the mechanisms that may contribute to its development and maintenance. Practical applications for future studies and limitations of present results are discussed.	[Brailovskaia, Julia; Margraf, Juergen] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany; [Rohmann, Elke; Bierhoff, Hans-Werner] Ruhr Univ Bochum, Dept Social Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Brailovskaia, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany.	julia.brailovskaia@rub.de	Margraf, Jürgen/A-6873-2008; Brailovskaia, Julia/AAN-7333-2021	Margraf, Jürgen/0000-0001-5207-7016; Brailovskaia, Julia/0000-0001-7607-1305	Alexander von Humboldt Professorship; Alexander von Humboldt Foundation; Ruhr-Universitat Bochum	Alexander von Humboldt Professorship(Alexander von Humboldt Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Ruhr-Universitat Bochum	This study was supported by Alexander von Humboldt Professorship awarded to airgen Margraf by the Alexander von Humboldt Foundation. Furthermore, we acknowledge support by the Open Access Publication Funds of the Ruhr-Universitat Bochum awarded to Julia Brailovskaia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen CS, 2012, PSYCHOL REP, V110, P501, DOI 10.2466/02.09.18.PR0.110.2.501-517; Andreassen CS, 2016, PSYCHOL ADDICT BEHAV, V30, P252, DOI 10.1037/adb0000160; Andreassen CS, 2013, J BEHAV ADDICT, V2, P90, DOI 10.1556/JBA.2.2013.003; [Anonymous], 2018, NUTZERZAHLEN FACEBOO; Berzonsky M. D., 1989, J ADOLESCENT RES, V4, P267, DOI DOI 10.1177/074355488943002; Blanche PA, 2010, NATURE, V468, P80, DOI 10.1038/nature09521; Bodford JE, 2017, CYBERPSYCH BEH SOC N, V20, P320, DOI 10.1089/cyber.2016.0500; Bowlby J., 1969, ATTACHMENT LOSS; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Brailovskaia J, 2018, COMPUT HUM BEHAV, V86, P199, DOI 10.1016/j.chb.2018.04.045; Brailovskaia J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191810; Brailovskaia J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189719; Brailovskaia J, 2016, COMPUT HUM BEHAV, V55, P251, DOI 10.1016/j.chb.2015.09.018; Casale S, 2018, ADDICT BEHAV, V76, P312, DOI 10.1016/j.addbeh.2017.08.038; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CSIKSZENTMIHALYI M, 1975, J HUMANIST PSYCHOL, V15, P41; Csikszentmihalyi M, 1990, FLOW PSYCHOL OPTIMAL; Field A., 2013, DISCOVERING STAT USI; Hoffman DL, 2009, J INTERACT MARK, V23, P23, DOI 10.1016/j.intmar.2008.10.003; Hong FY, 2014, TELEMAT INFORM, V31, P597, DOI 10.1016/j.tele.2014.01.001; Hull DC, 2013, J BEHAV ADDICT, V2, P145, DOI 10.1556/JBA.2.2013.005; Kaur P, 2016, COMPUT HUM BEHAV, V59, P358, DOI 10.1016/j.chb.2016.02.039; Khang H, 2013, COMPUT HUM BEHAV, V29, P2416, DOI 10.1016/j.chb.2013.05.027; King DL, 2012, J CLIN PSYCHOL, V68, P1185, DOI 10.1002/jclp.21918; Koc M, 2013, CYBERPSYCH BEH SOC N, V16, P279, DOI 10.1089/cyber.2012.0249; Kraemer HC, 1997, ARCH GEN PSYCHIAT, V54, P337; Kwak KT, 2014, COMPUT HUM BEHAV, V31, P294, DOI 10.1016/j.chb.2013.10.046; Lin CY, 2017, J BEHAV ADDICT, V6, P620, DOI 10.1556/2006.6.2017.071; Monacis L, 2017, INT J MENT HEALTH AD, V15, P853, DOI 10.1007/s11469-017-9768-5; Monacis L, 2017, J BEHAV ADDICT, V6, P178, DOI 10.1556/2006.6.2017.023; Nowak KL, 2003, PRESENCE-TELEOP VIRT, V12, P481, DOI 10.1162/105474603322761289; Phanasathit Muthita, 2015, Journal of the Medical Association of Thailand, V98, pS108; Pontes HM, 2016, INT J MENT HEALTH AD, V14, P1062, DOI 10.1007/s11469-016-9694-y; Ryan T, 2014, J BEHAV ADDICT, V3, P133, DOI 10.1556/JBA.3.2014.016; Schonfeld P, 2017, INT J CLIN HLTH PSYC, V17, P197, DOI 10.1016/j.ijchp.2017.06.003; Sweetser P., 2012, J CREATIVE TECHNOLOG, V2012, P1; Trivedi RH, 2017, CYBERPSYCH BEH SOC N, V20, P180, DOI 10.1089/cyber.2016.0453; Twenge JM, 2008, J PERS, V76, P875, DOI 10.1111/j.1467-6494.2008.00507.x; Wu TC, 2013, LEISURE SCI, V35, P203, DOI 10.1080/01490400.2013.780497	39	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201484	10.1371/journal.pone.0201484	http://dx.doi.org/10.1371/journal.pone.0201484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048544	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400093
J	Sloan, TJ; Jalanka, J; Major, GAD; Krishnasamy, S; Pritchard, S; Abdelrazig, S; Korpela, K; Singh, G; Mulvenna, C; Hoad, CL; Marciani, L; Barrett, DA; Lomer, MCE; de Vos, WM; Gowland, PA; Spiller, RC				Sloan, Tim J.; Jalanka, Jonna; Major, Giles A. D.; Krishnasamy, Shanthi; Pritchard, Sue; Abdelrazig, Salah; Korpela, Katri; Singh, Gulzar; Mulvenna, Claire; Hoad, Caroline L.; Marciani, Luca; Barrett, David A.; Lomer, Miranda C. E.; de Vos, Willem M.; Gowland, Penny A.; Spiller, Robin C.			A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA; SYMPTOMS; BIFIDOBACTERIA; TIME; BACTERIAL; DATABASE; TRANSIT; ALTERS; TRIAL	Background & aims Ingestion of poorly digested, fermentable carbohydrates (fermentable oligo-, di-, mono-saccharides and polyols; FODMAPs) have been implicated in exacerbating intestinal symptoms and the reduction of intake with symptom alleviation. Restricting FODMAP intake is believed to relieve colonic distension by reducing colonic fermentation but this has not been previously directly assessed. We performed a randomised controlled trial comparing the effect of a low FODMAP diet combined with either maltodextrin or oligofructose on colonic contents, metabolites and microbiota. Methods A parallel randomised controlled trial in healthy adults (n = 37). All subjects followed a low FODMAP diet for a week and supplemented their diet with either maltodextrin (MD) or oligofructose (OF) 7g twice daily. Fasted assessments performed pre- and post-diet included MRI to assess colonic volume, breath testing for hydrogen and methane, and stool collection for microbiota analysis. Results The low FODMAP diet was associated with a reduction in Bifidobacterium and breath hydrogen, which was reversed by oligofructose supplementation. The difference in breath hydrogen between groups post-intervention was 27ppm (95% CI 7 to 50, P<0.01). Colonic volume increased significantly from baseline in both groups (OF increased 110ml (19.6%), 95% CI 30ml to 190ml, P = 0.01; MD increased 90ml (15.5%), 95% CI 6ml to 175ml, P = 0.04) with no significant difference between them. Colonic volumes correlated with total breath hydrogen + methane. A divergence in Clostridiales abundance was observed with increased abundance of Ruminococcaceae in the maltodextrin group, while in the oligofructose group, Lachnospiraceae decreased. Subjects in either group with high methane production also tended to have high microbial diversity, high colonic volume and greater abundance of methanogens. Conclusion A low FODMAP diet reduces total bacterial count and gas production with little effect on colonic volume.	[Sloan, Tim J.; Jalanka, Jonna; Major, Giles A. D.; Krishnasamy, Shanthi; Pritchard, Sue; Abdelrazig, Salah; Singh, Gulzar; Mulvenna, Claire; Hoad, Caroline L.; Marciani, Luca; Barrett, David A.; Gowland, Penny A.; Spiller, Robin C.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr BRC, Nottingham, England; [Sloan, Tim J.; Jalanka, Jonna; Major, Giles A. D.; Krishnasamy, Shanthi; Pritchard, Sue; Abdelrazig, Salah; Singh, Gulzar; Mulvenna, Claire; Hoad, Caroline L.; Marciani, Luca; Barrett, David A.; Gowland, Penny A.; Spiller, Robin C.] Univ Nottingham, Nottingham, England; [Sloan, Tim J.] Univ Nottingham, Sch Life Sci, Nottingham, England; [Sloan, Tim J.] NottinghamUnivers Hosp NHS Trust, Dept Clin Microbiol, Nottingham, England; [Jalanka, Jonna; Major, Giles A. D.; Krishnasamy, Shanthi; Singh, Gulzar; Mulvenna, Claire; Marciani, Luca; Spiller, Robin C.] Univ Nottingham, Sch Med, Nottingham Digest Dis Ctr, Nottingham, England; [Jalanka, Jonna; Korpela, Katri; de Vos, Willem M.] Univ Helsinki, Immunobiol Res Program, Helsinki, Finland; [Pritchard, Sue; Hoad, Caroline L.; Gowland, Penny A.] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imaging Ctr, Nottingham, England; [Abdelrazig, Salah; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Adv Mat & Healthcare Technol Div, Nottingham, England; [Lomer, Miranda C. E.] Kings Coll London, Dept Nutr Sci, London, England	Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of Nottingham; University of Helsinki; University of Nottingham; University of Nottingham; University of London; King's College London	Spiller, RC (corresponding author), Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr BRC, Nottingham, England.; Spiller, RC (corresponding author), Univ Nottingham, Nottingham, England.; Spiller, RC (corresponding author), Univ Nottingham, Sch Med, Nottingham Digest Dis Ctr, Nottingham, England.	Robin.Spiller@nottingham.ac.uk	spiller, robin/ABE-6690-2021; Krishnasamy, Shanthi/AAL-1125-2020; Major, Giles/AAF-4207-2019; Gowland, Penny A./I-9016-2012	spiller, robin/0000-0001-6371-4500; Gowland, Penny A./0000-0002-4900-4817; jalanka, jonna/0000-0002-3847-8136; Sloan, Tim/0000-0003-3668-7775; Hoad, Caroline/0000-0001-5483-1027; Lomer, Miranda/0000-0002-9369-8115; Major, Giles/0000-0001-7944-3709	COST Action [BM1106 GENIEUR]	COST Action(European Cooperation in Science and Technology (COST))	We would like to acknowledge the work of Yirge Falcone and Melanie Lingaya in assisting with the extraction of faecal DNA. We would also like to recognise the support of the COST Action BM1106 GENIEUR in facilitating collaboration between the University of Nottingham and University of Helsinki. Finally, we would like to thank the study participants who made this research possible.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennet SMP, 2018, GUT, V67, P872, DOI 10.1136/gutjnl-2016-313128; Bohn L, 2015, GASTROENTEROLOGY, V149, P1399, DOI 10.1053/j.gastro.2015.07.054; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Chaddock G, 2014, NEUROGASTROENT MOTIL, V26, P205, DOI 10.1111/nmo.12249; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Di Stefano M, 2015, AM J GASTROENTEROL, V110, P891, DOI 10.1038/ajg.2015.47; Dore J., 2015, INT HUMAN MICROBIOME; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eswaran SL, 2016, AM J GASTROENTEROL, V111, P1824, DOI 10.1038/ajg.2016.434; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gibson PR, 2005, ALIMENT PHARM THER, V21, P1399, DOI 10.1111/j.1365-2036.2005.02506.x; Halmos EP, 2015, GUT, V64, P93, DOI 10.1136/gutjnl-2014-307264; Halmos EP, 2014, GASTROENTEROLOGY, V146, P67, DOI [10.1053/j.gastro.2013.09.046, 10.1053/j.gastro.2014.04.034]; Hynonen U, 2016, ANAEROBE, V39, P60, DOI 10.1016/j.anaerobe.2016.03.001; Johnston C, 2010, J APPL MICROBIOL, V109, P1946, DOI 10.1111/j.1365-2672.2010.04824.x; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; McCance, 2015, MCCANC WIDD COMP FOO; McIntosh K, 2017, GUT, V66, P1241, DOI 10.1136/gutjnl-2015-311339; Murray K, 2014, AM J GASTROENTEROL, V109, P110, DOI 10.1038/ajg.2013.386; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Ong DK, 2010, J GASTROEN HEPATOL, V25, P1366, DOI 10.1111/j.1440-1746.2010.06370.x; Petry N, 2012, AM J CLIN NUTR, V96, P325, DOI 10.3945/ajcn.112.035717; Pritchard SE, 2014, NEUROGASTROENT MOTIL, V26, P124, DOI 10.1111/nmo.12243; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rajilic-Stojanovic M, 2015, AM J GASTROENTEROL, V110, P278, DOI 10.1038/ajg.2014.427; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Shepherd SJ, 2008, CLIN GASTROENTEROL H, V6, P765, DOI 10.1016/j.cgh.2008.02.058; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Soret R, 2010, GASTROENTEROLOGY, V138, P1772, DOI 10.1053/j.gastro.2010.01.053; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; Staudacher HM, 2012, J NUTR, V142, P1510, DOI 10.3945/jn.112.159285; Staudacher HM, 2017, GASTROENTEROLOGY, V153, P936, DOI 10.1053/j.gastro.2017.06.010; Vandeputte D, 2017, GUT, V66, P1968, DOI 10.1136/gutjnl-2016-313271; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065	39	58	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201410	10.1371/journal.pone.0201410	http://dx.doi.org/10.1371/journal.pone.0201410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048547	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400086
J	Goll, JC; Charlesworth, G; Scior, K; Stott, J				Goll, Johanna C.; Charlesworth, Georgina; Scior, Katrina; Stott, Joshua			Barriers to Social Participation among Lonely Older Adults: The Influence of Social Fears and Identity (vol 10, e0116664, 2015)	PLOS ONE			English	Correction													stott, josh/AAX-6275-2021	Scior, Katrina/0000-0002-4679-0090				Goll JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116664	1	4	4	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201510	10.1371/journal.pone.0201510	http://dx.doi.org/10.1371/journal.pone.0201510			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044856	gold, Green Published			2022-12-27	WOS:000439942500106
J	Ongwandee, S; Lertpiriyasuwat, C; Khawcharoenporn, T; Chetchotisak, P; Thiansukhon, E; Leerattanapetch, N; Leungwaranan, B; Manopaiboon, C; Phoorisri, T; Visavakum, P; Jetsawang, B; Poolsawat, M; Nookhai, S; Vasanti-Uppapokakorn, M; Karuchit, S; Kittinunvorakoon, C; Mock, P; Prybylski, D; Sukkul, AC; Roels, T; Martin, M				Ongwandee, Sumet; Lertpiriyasuwat, Cheewanan; Khawcharoenporn, Thana; Chetchotisak, Ploenchan; Thiansukhon, Ekkachai; Leerattanapetch, Niramon; Leungwaranan, Banlang; Manopaiboon, Chomnad; Phoorisri, Thanongsri; Visavakum, Prin; Jetsawang, Bongkoch; Poolsawat, Monsicha; Nookhai, Somboon; Vasanti-Uppapokakorn, Monthinee; Karuchit, Samart; Kittinunvorakoon, Chonticha; Mock, Philip; Prybylski, Dimitri; Sukkul, Ake-Chittra; Roels, Thierry; Martin, Michael			Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; PREEXPOSURE PROPHYLAXIS; BANGKOK TENOFOVIR; DRUG-USERS; YOUNG MEN; INFECTION; THERAPY; ADHERENCE; EPIDEMIC; TRIAL	Introduction Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at five hospitals in four provinces of Thailand to increase HIV testing, help those who test positive start antiretroviral therapy, and increase access to pre-exposure prophylaxis (PrEP). Methods We implemented rapid HIV testing and trained staff on immediate antiretroviral initiation at the five hospitals and offered PrEP at two hospitals. We recruited MSM and transgender women who walked-in to clinics and used a peer-driven intervention to expand recruitment. We used logistic regression to determine factors associated with prevalent HIV infection and the decision to start antiretroviral therapy and PrEP. Results During 2015 and 2016, 1880 people enrolled. Participants recruited by peers were younger (p<0.0001), less likely to be HIV-infected (p<0.0001), and those infected had higher CD4 counts (p = 0.04) than participants who walked-in to the clinics. Overall, 16% were HIV-positive: 18% of MSM and 9% of transgender women; 86% started antiretroviral therapy and 46% of eligible participants started PrEP. A higher proportion of participants at hospitals with one-stop HIV services started antiretroviral therapy than other hospitals. Participants who started PrEP were more likely to report sex with an HIV-infected partner (p = 0.002), receptive anal intercourse (p = 0.02), and receiving PrEP information from a hospital (p<0.0001). Conclusions We implemented a Test, Treat, and Prevent HIV Program offering rapid HIV testing and immediate access to antiretroviral therapy and PrEP. Peer-driven recruitment reached people at high risk of HIV and people early in HIV illness, providing an opportunity to promote HIV prevention services including PrEP and early antiretroviral therapy. Sites with one-stop HIV services had a higher uptake of antiretroviral therapy and PrEP.	[Ongwandee, Sumet; Lertpiriyasuwat, Cheewanan; Phoorisri, Thanongsri; Vasanti-Uppapokakorn, Monthinee] Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Khawcharoenporn, Thana] Thammasat Univ Hosp, Pathum Thani, Thailand; [Chetchotisak, Ploenchan] Srinagarind Univ Hosp, Khon Kaen, Thailand; [Thiansukhon, Ekkachai] Udon Thani Hosp, Udon Thani, Thailand; [Leerattanapetch, Niramon] Khon Kaen Hosp, Khon Kaen, Thailand; [Leungwaranan, Banlang] Lerdsin Hosp, Bangkok, Thailand; [Manopaiboon, Chomnad; Visavakum, Prin; Jetsawang, Bongkoch; Poolsawat, Monsicha; Nookhai, Somboon; Karuchit, Samart; Kittinunvorakoon, Chonticha; Mock, Philip; Prybylski, Dimitri; Sukkul, Ake-Chittra; Roels, Thierry; Martin, Michael] US Ctr Dis Control & Prevent, Div HIV AIDS & TB Thailand, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Thammasat University	Manopaiboon, C (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS & TB Thailand, Nonthaburi, Thailand.	hpy0@cdc.gov		Roels, Thierry/0000-0002-0886-5645	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5U2GGH000616]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of 5U2GGH000616.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Broadhead RS, 1999, PUBLIC HEALTH, V113, P42; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; FHI360, 2008, AS EP MOD AEM PROJ H; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Institute for Population and Social Research, 2013, EV NAT HIV PREV PROG; James SE., 2016, REPORT 2015 US TRANS; Johnston LG, 2016, AIDS BEHAV, V20, P2023, DOI 10.1007/s10461-016-1336-7; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, 90 90 90 AMB TREATM; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Martin M, 2017, LANCET HIV, V4, pE59, DOI 10.1016/S2352-3018(16)30207-7; Pawa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077113; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Siraprapasiri T, 2013, JOURNEY UNIVERSAL AC; Thailand Ministry of Public Health, 2014, NAT OP PLAN END AIDS; Thailand Ministry of Public Health, 2013, GUID HIV COUNS TEST; Thailand Ministry of Public Health Thai AIDS Society., 2014, THAIL NAT GUID HIV A; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, GLOB AIDS RESP PROGR; van Griensven F, 2015, LANCET HIV, V2, pE64, DOI 10.1016/S2352-3018(14)00031-9; van Griensven F, 2014, SEX HEALTH, V11, P180, DOI 10.1071/SH13119; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e	32	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201171	10.1371/journal.pone.0201171	http://dx.doi.org/10.1371/journal.pone.0201171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044867	gold, Green Submitted, Green Published			2022-12-27	WOS:000439942500087
J	Patel, U; Gingerich, A; Widman, L; Sarr, D; Tripp, RA; Rada, B				Patel, Urmi; Gingerich, Aaron; Widman, Lauren; Sarr, Demba; Tripp, Ralph A.; Rada, Balazs			Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system	PLOS ONE			English	Article							A VIRUS; EPITHELIAL-CELLS; DUAL OXIDASE; B VIRUS; AIRWAY; IODIDE; HEMAGGLUTININ; INACTIVATION	Lactoperoxidase (LPO) is an enzyme found in several exocrine secretions including the airway surface liquid producing antimicrobial substances from mainly halide and pseudohalide substrates. Although the innate immune function of LPO has been documented against several microbes, a detailed characterization of its mechanism of action against influenza viruses is still missing. Our aim was to study the antiviral effect and substrate specificity of LPO to inactivate influenza viruses using a cell-free experimental system. Inactivation of different influenza virus strains was measured in vitro system containing LPO, its substrates, thiocyanate (SCN-) or iodide (I-), and the hydrogen peroxide (H2O2)-producing system, glucose and glucose oxidase (GO). Physiologically relevant concentrations of the components of the LPO/H2O2/(SCN-I-) antimicrobial system were exposed to twelve different strains of influenza A and B viruses in vitro and viral inactivation was assessed by determining plaque-forming units of non-inactivated viruses using Madin-Darby canine kidney cells (MDCK) cells. Our data show that LPO is capable of inactivating all influenza virus strains tested: H1N1, H1N2 and H3N2 influenza A viruses (IAV) and influenza B viruses (IBV) of both, Yamagata and Victoria lineages. The extent of viral inactivation, however, varied among the strains and was in part dependent on the LPO substrate. Inactivation of H1N1 and H1N2 viruses by LPO showed no substrate preference, whereas H3N2 influenza strains were inactivated significantly more efficiently when iodide, not thiocyanate, was the LPO substrate. Although LPO-mediated inactivation of the influenza B strains tested was strain-dependent, it showed slight preference towards thiocyanate as the substrate. The results presented here show that the LPO/H2O2/(SCN-/I-) cell-free, in vitro experimental system is a functional tool to study the specificity, efficiency and the molecular mechanism of action of influenza inactivation by LPO. These studies tested the hypothesis that influenza strains are all susceptible to the LPO-based antiviral system but exhibit differences in their substrate specificities. We propose that a LPO-based antiviral system is an important contributor to anti-influenza virus defense of the airways.	[Patel, Urmi; Gingerich, Aaron; Widman, Lauren; Sarr, Demba; Tripp, Ralph A.; Rada, Balazs] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Rada, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	radab@uga.edu	Sarr, Demba/GOG-9376-2022; Sarr, Demba/AAP-7125-2020	Sarr, Demba/0000-0002-8306-0433; Gingerich, Aaron/0000-0002-8139-611X	National Institutes of Health, National Institute of Allergy and Infectious Diseases [R21AI124189-01A1]; startup funds by the Office of Vice President for Research; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124189] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); startup funds by the Office of Vice President for Research; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was mainly supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases R21AI124189-01A1 (Rada, Tripp), URL: https://www.niaid.nih.gov; startup funds (Rada) provided by the Office of Vice President for Research, URL: https://research.uga.edu; and the Georgia Research Alliance (Tripp), URL: http://gra.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahariz M, 2010, CLIN COSMET INVESTIG, V2, P69; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P281; Bafort F, 2014, ENZYME RES, V2014, DOI DOI 10.1155/2014/517164; Belongia Edward A, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334554; Burnham AJ, 2013, ANTIVIR RES, V100, P520, DOI 10.1016/j.antiviral.2013.08.023; Cegolon L, 2014, INT J HYG ENVIR HEAL, V217, P17, DOI 10.1016/j.ijheh.2013.03.001; Clark AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188267; Conner GE, 2002, AM J RESP CRIT CARE, V166, pS57, DOI 10.1164/rccm.2206018; DAS D, 1995, BIOCHEM J, V305, P59, DOI 10.1042/bj3050059; Derscheid RJ, 2014, AM J RESP CELL MOL, V50, P389, DOI 10.1165/rcmb.2012-0529OC; Dlugolenski D, 2015, J VIROL, V89, P5651, DOI 10.1128/JVI.00087-15; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gerson C, 2000, AM J RESP CELL MOL, V22, P665, DOI 10.1165/ajrcmb.22.6.3980; Gingerich A, 2016, INFLAMM RES, V65, P71, DOI 10.1007/s00011-015-0892-z; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473; Jackson D, 2011, J GEN VIROL, V92, P1, DOI 10.1099/vir.0.026187-0; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; KEMBLE GW, 1992, J VIROL, V66, P4940, DOI 10.1128/JVI.66.8.4940-4950.1992; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P7782, DOI 10.1073/pnas.85.20.7782; Kordyukova LV, 2019, J BIOMOL STRUCT DYN, V37, P671, DOI 10.1080/07391102.2018.1436089; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Leonard AS, 2016, J VIROL, V90, P11247, DOI 10.1128/JVI.01657-16; Li HYS, 2007, ENDOCRINOLOGY, V148, P2747, DOI 10.1210/en.2007-0082; Liang X, 2018, J TRACE ELEM MED BIO, V47, P89, DOI 10.1016/j.jtemb.2018.01.018; Londino JD, 2017, AM J PHYSIOL-LUNG C, V313, pL845, DOI 10.1152/ajplung.00244.2017; Lowen AC, 2017, ANNU REV VIROL, V4, P105, DOI 10.1146/annurev-virology-101416-041726; Mandelboim M, 2016, ONCOTARGET, V7, P1185, DOI 10.18632/oncotarget.6746; MOGABGAB WJ, 1955, P SOC EXP BIOL MED, V89, P654, DOI 10.3181/00379727-89-21907; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; Ogata N, 2012, J GEN VIROL, V93, P2558, DOI 10.1099/vir.0.044263-0; Peng WJ, 2017, CELL HOST MICROBE, V21, P23, DOI 10.1016/j.chom.2016.11.004; Pinsent A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-015-1298-9; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025; Rada B, 2009, IMMUNOL RES, V43, P198, DOI 10.1007/s12026-008-8071-8; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Retamal M, 2014, J GEN VIROL, V95, P2377, DOI 10.1099/vir.0.067819-0; Ross GR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6302869; Sakudo Akikazu, 2014, Front Biosci (Elite Ed), V6, P69; Schlorke D, 2016, FREE RADICAL RES, V50, P1287, DOI 10.1080/10715762.2016.1235789; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Spanakis N, 2014, EXPERT REV ANTI-INFE, V12, P1325, DOI 10.1586/14787210.2014.966083; Sriwilaijaroen N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-124; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Sundararajan A, 2010, ANTIVIR RES, V88, P1, DOI 10.1016/j.antiviral.2010.06.014; Verma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175733; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC	50	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199167	10.1371/journal.pone.0199167	http://dx.doi.org/10.1371/journal.pone.0199167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044776	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500009
J	Vloeberghs, V; Verheyen, G; Santos-Ribeiro, S; Staessen, C; Verpoest, W; Gies, I; Tournaye, H				Vloeberghs, Veerle; Verheyen, Greta; Santos-Ribeiro, Samuel; Staessen, Catherine; Verpoest, Willem; Gies, Inge; Tournaye, Herman			Is genetic fatherhood within reach for all azoospermic Klinefelter men?	PLOS ONE			English	Article							TESTICULAR SPERM EXTRACTION; NONOBSTRUCTIVE AZOOSPERMIA; ICSI; INFERTILITY; RETRIEVAL; RECOVERY; MEIOSIS; CELLS; IVF	Background Multidisciplinary management of Klinefelter cases is now considered good clinical practice in order to ensure optimal quality of life. Reproductive performance of Klinefelter men is an important issue however literature in this domain is limited and prone to bias. Study design This was a retrospective longitudinal cohort study performed at a tertiary referral University Centre for Reproductive Medicine and Genetics. One hundred thirty-eight non-mosaic azoospermic Klinefelter patients undergoing their first testicular biopsy (TESE) between 1994 and 2013, followed by intracytoplasmic sperm injection (ICSI) with fresh or frozen-thawed testicular sperm in the female partner, were followed-up longitudinally. The main outcome measure was cumulative live birth rate per Klinefelter patient embarking on TESE-ICSI. Findings In forty-eight men (48/138) sperm were successfully retrieved at the first TESE (34.8%). The mean age of the patients was 32.4 years. Younger age at first TESE was associated with a higher sperm retrieval rate (p<0.001). Overall 39 couples underwent 62 ICSI cycles and 13 frozen embryo transfer cycles resulting in in 20 pregnancies and 14 live birth deliveries (16 children). The mean age of the female partner was 28.1 years. The crude cumulative delivery rate after four ICSI cycles was 35.9%. Per intention-to-treat however, only 10.1% (14/138) of the Klinefelter men starting treatment succeeded in having their biologically own child(ren). Conclusion Non-mosaic Klinefelter patients with azoospermia seeking treatment by TESE-ICSI should be counseled that by intention-to-treat the chance of retrieving sperm is fair, however only a minority will eventually father genetically own children.	[Vloeberghs, Veerle; Verheyen, Greta; Santos-Ribeiro, Samuel; Verpoest, Willem; Tournaye, Herman] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium; [Staessen, Catherine] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Med Genet, Brussels, Belgium; [Gies, Inge] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Pediat, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	Vloeberghs, V (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium.	veerle.vloeberghs@uzbrussel.be	Santos-Ribeiro, Samuel/Q-1203-2017; Gies, Inge/D-5870-2016	Santos-Ribeiro, Samuel/0000-0003-2476-7858; verpoest, willem/0000-0002-5020-2888; Verheyen, Greta/0000-0003-4677-2084; Vloeberghs, Veerle/0000-0002-7095-3996; Gies, Inge/0000-0002-8571-0858				Aksglaede L, 2013, EUR J ENDOCRINOL, V168, pR67, DOI 10.1530/EJE-12-0934; Bakircioglu ME, 2011, FERTIL STERIL, V95, P1696, DOI 10.1016/j.fertnstert.2011.01.005; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Corona G, 2017, HUM REPROD UPDATE, V23, P265, DOI 10.1093/humupd/dmx008; COZZI J, 1994, HUM GENET, V93, P32; Crabbe E, 1998, HUM REPROD, V13, P2791, DOI 10.1093/humrep/13.10.2791; Foresta C, 1999, J CLIN ENDOCR METAB, V84, P3807, DOI 10.1210/jc.84.10.3807; Fullerton G, 2010, HUM REPROD, V25, P588, DOI 10.1093/humrep/dep431; Griesinger G, 2016, HUM REPROD, V31, P249, DOI 10.1093/humrep/dev322; Groth KA, 2013, J CLIN ENDOCR METAB, V98, P20, DOI 10.1210/jc.2012-2382; HULL MGR, 1992, BRIT MED J, V304, P1465, DOI 10.1136/bmj.304.6840.1465; Kitamura M, 2000, INT J UROL, V7, P88, DOI 10.1046/j.1442-2042.2000.00145.x; Kolibianakis EM, 2004, HUM REPROD, V19, P2550, DOI 10.1093/humrep/deh447; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; Plotton I, 2015, J CLIN ENDOCR METAB, V100, P961, DOI 10.1210/jc.2014-3083; Raheem AA, 2013, BJU INT, V112, P258, DOI 10.1111/j.1464-410X.2012.11714.x; Rohayem J, 2016, ANDROLOGY-US, V4, P1178, DOI 10.1111/andr.12249; Sabbaghian M, 2014, UROLOGY, V83, P107, DOI 10.1016/j.urology.2013.09.021; Samango-Sprouse C, 2017, PRENAT DIAGN, V37, P487; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Staessen C, 1996, HUM REPROD, V11, P1650; Tournaye H, 1996, HUM REPROD, V11, P1644; Van Landuyt L, 2006, REPROD BIOMED ONLINE, V13, P765, DOI 10.1016/S1472-6483(10)61022-X; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Verheyen G, 2004, HUM REPROD, V19, P2822, DOI 10.1093/humrep/deh490; Vloeberghs V, 2015, HUM REPROD, V30, P1790, DOI 10.1093/humrep/dev139; Wikstrom AM, 2008, HORM RES, V69, P317, DOI 10.1159/000117387	28	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200300	10.1371/journal.pone.0200300	http://dx.doi.org/10.1371/journal.pone.0200300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044810	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500039
J	Tso, FY; Kang, GB; Kwon, EH; Julius, P; Li, QS; West, JT; Wood, C				Tso, For Yue; Kang, Guobin; Kwon, Eun Hee; Julius, Peter; Li, Qingsheng; West, John T.; Wood, Charles			Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; COMBINED ANTIRETROVIRAL THERAPY; PROVIRAL DNA LOAD; CD4(+) T-CELLS; INFECTED PATIENTS; VIRUS; AIDS; TISSUES; INFLAMMATION; INDIVIDUALS	Subtype C HIV-1 is responsible for the largest proportion of people living with HIV-1 infection. However, there is limited information about the roles of the brain and its cell types as a potential sanctuary for this subtype and how the sanctuary may be affected by the administration of anti-retroviral therapy (ART). To address this issue, we collected postmortem brain tissues from ART treated HIV-1 infected Zambian individuals who experienced complete viral suppression and those who did not. Tissues from various brain compartments were collected from each individual as frozen and formalin-fixed paraffin embedded brain specimens, for detection and quantification of HIV-1 genomes and identification of the infected cell type. Genomic DNA and RNA were extracted from frozen brain tissues. The extracted DNA and RNA were then subjected to droplet digital PCR for HIV-1 quantification. RNA/DNAscope in situ hybridization (ISH) for HIV-1 was performed on formalin-fixed paraffin embedded brain tissues in conjugation with immunohistochemistry to identify the infected cell types. Droplet digital PCR revealed that HIV-1 gag DNA and RNA were detectable in half of the cases studied regardless of ART success or failure. The presence of HIV-1 lacked specific tissue compartmentalization since detection was random among various brain tissues. When combined with immunohistochemistry, RNA/DNAscope ISH demonstrated colocalization of HIV-1 DNA with CD68 expressing cells indicative of microglia or peripheral macrophage. Our study showed that brain is a potential sanctuary for subtype C HIV-1, as HIV-1 can be detected in the brain of infected individuals irrespective of ART treatment outcome and no compartmentalization of HIV-1 to specific brain compartments was evident.	[Tso, For Yue; Kang, Guobin; Kwon, Eun Hee; Li, Qingsheng; West, John T.; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Tso, For Yue; Kang, Guobin; Kwon, Eun Hee; Li, Qingsheng; West, John T.; Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Julius, Peter] Univ Teaching Hosp, Dept Pathol & Microbiol, Nationalist Rd, Lusaka, Zambia	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Zambia	Wood, C (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.; Wood, C (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	cwood1@unl.edu	Tso, For Yue/AAF-1131-2019; Wood, Charles/AAH-4536-2021	Wood, Charles/0000-0002-4256-1530	American Foundation for AIDS Research [109123-57-RGR]; National Institutes of Health (NIH) [NS074903, CA75903, P30 GM103509, Fogarty D43 TW01492, TW010354]; NIAID [UM1AI126620 BEAT-HIV]; FOGARTY INTERNATIONAL CENTER [D43TW010354] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074903] Funding Source: NIH RePORTER	American Foundation for AIDS Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by American Foundation for AIDS Research (109123-57-RGR), and the National Institutes of Health (NIH) Grants (NS074903, CA75903, P30 GM103509 and Fogarty D43 TW01492 and TW010354) to C.W; NIAID UM1AI126620 BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy to Q.L.; P.J. is a Fogarty Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the families of all tissue donors for their participation in this study. This work is supported in part by American Foundation for AIDS Research (109123-57-RGR), and the National Institutes of Health (NIH) Grants (NS074903, CA75903, P30 GM103509 and Fogarty D43 TW01492 and TW010354) to C.W; NIAID UM1AI126620 BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy to Q.L.; P.J. is a Fogarty Fellow.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Cysique LA, 2011, J NEUROVIROL, V17, P176, DOI 10.1007/s13365-011-0021-x; Dahl V, 2014, J INFECT DIS, V209, P1618, DOI 10.1093/infdis/jit805; De Pablo-Bernal RS, 2014, J ANTIMICROB CHEMOTH, V69, P3041, DOI 10.1093/jac/dku263; Deleage Claire, 2016, Pathog Immun, V1, P68; Fujimura RK, 1997, J ACQ IMMUN DEF SYND, V16, P146, DOI 10.1097/00042560-199711010-00002; Gama L, 2017, AIDS, V31, P5, DOI 10.1097/QAD.0000000000001267; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Letendre Scott, 2011, Top Antivir Med, V19, P137; Li QS, 2015, JAIDS-J ACQ IMM DEF, V69, P519, DOI 10.1097/QAI.0000000000000687; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mahadevan A, 2007, J NEUROPATH EXP NEUR, V66, P799, DOI 10.1097/NEN.0b013e3181461d3e; Mishra M, 2015, J NEUROVIROL, V21, P399, DOI 10.1007/s13365-015-0328-0; Mouton JP, 2016, EXPERT REV CLIN PHAR, V9, P1493, DOI 10.1080/17512433.2016.1221760; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Strazielle N, 2005, REV MED VIROL, V15, P105, DOI 10.1002/rmv.454; Sturdevant CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003094; Tavazzi E, 2014, CURR HIV RES, V12, P97, DOI 10.2174/1570162X12666140526114956; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Wiley CA, 1998, BRAIN PATHOL, V8, P277; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Zhao L, 2009, SCI CHINA SER C, V52, P651, DOI 10.1007/s11427-009-0085-5	40	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201325	10.1371/journal.pone.0201325	http://dx.doi.org/10.1371/journal.pone.0201325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040863	Green Published, gold			2022-12-27	WOS:000439749200037
J	Spengler, JR; McElroy, AK; Harmon, JR; Coleman-McCray, JD; Welch, SR; Keck, JG; Nichol, ST; Spiropoulou, CF				Spengler, Jessica R.; McElroy, Anita K.; Harmon, Jessica R.; Coleman-McCray, JoAnn D.; Welch, Stephen R.; Keck, James G.; Nichol, Stuart T.; Spiropoulou, Christina F.			Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice	PLOS ONE			English	Article							VIRUS-INFECTION; TRANSCRIPTION; RESPONSES; PROTEIN; DISEASE; MODELS; NSS	Rift Valley fever (RVF) in humans is usually mild, but, in a subset of cases, can progress to severe hepatic and neurological disease. Rodent models of RVF generally develop acute severe clinical disease. Here, we inoculated humanized NSG-SGM3 mice with Rift Valley fever virus (RVFV) to investigate whether the presence of human immune cells in mice would alter the progression of RVFV infection to more closely model human disease. Despite increased human cytokine expression, including responses mirroring those seen in human disease, and decreased hepatic viral RNA levels at terminal euthanasia, both high-and low-dose RVFV inoculation resulted in lethal disease in all mice with comparable time-to-death as unengrafted mice.	[Spengler, Jessica R.; McElroy, Anita K.; Harmon, Jessica R.; Coleman-McCray, JoAnn D.; Welch, Stephen R.; Nichol, Stuart T.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [McElroy, Anita K.] Emory Univ, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [McElroy, Anita K.] Univ Pittsburgh, Div Pediat Infect Dis, Pittsburgh, PA USA; [Keck, James G.] Jackson Lab, Vivo Serv, Sacramento, CA USA	Centers for Disease Control & Prevention - USA; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory	Spengler, JR (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	JSpengler@cdc.gov	Spengler, Jessica R./AAN-9099-2020	Spengler, Jessica R./0000-0002-5383-0513; McElroy, Anita/0000-0001-6764-7536; Welch, Stephen/0000-0002-6905-8521	Burroughs Wellcome Career Award [1013362.01]; NIH [K08 AI 119448]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI119448] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by a Burroughs Wellcome Career Award (1013362.01) and NIH K08 AI 119448 [AKM].	Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2007, J CLIN MICROBIOL, V45, P3506, DOI 10.1128/JCM.00936-07; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Dodd KA, 2013, J VIROL, V87, P6161, DOI 10.1128/JVI.00337-13; Erickson AK, 2015, J GEN VIROL, V96, P1328, DOI 10.1099/vir.0.000075; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020; McElroy AK, 2012, VIROLOGY, V422, P6, DOI 10.1016/j.virol.2011.09.023; Njenga MK, 2009, J CLIN MICROBIOL, V47, P1166, DOI 10.1128/JCM.01905-08; Ross TM, 2012, VIRUS RES, V163, P417, DOI 10.1016/j.virusres.2011.10.023; Smith DR, 2010, VIROLOGY, V407, P256, DOI 10.1016/j.virol.2010.08.016; Spengler JR, 2017, J INFECT DIS, V216, P1386, DOI 10.1093/infdis/jix215; Spengler JR, 2017, CURR OPIN VIROL, V25, P90, DOI 10.1016/j.coviro.2017.07.028; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; van Vuren PJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0392-3; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Zivcec M, 2013, J INFECT DIS, V207, P1909, DOI 10.1093/infdis/jit061	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201104	10.1371/journal.pone.0201104	http://dx.doi.org/10.1371/journal.pone.0201104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028878	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900039
J	Cardenas-Lopez, FA; Lamata, L; Retamal, JC; Solano, E				Cardenas-Lopez, F. A.; Lamata, L.; Retamal, J. C.; Solano, E.			Multiqubit and multilevel quantum reinforcement learning with quantum technologies	PLOS ONE			English	Article							CIRCUITS; MEMORY; GATES	We propose a protocol to perform quantum reinforcement learning with quantum technologies. At variance with recent results on quantum reinforcement learning with superconducting circuits, in our current protocol coherent feedback during the learning process is not required, enabling its implementation in a wide variety of quantum systems. We consider diverse possible scenarios for an agent, an environment, and a register that connects them, involving multiqubit and multilevel systems, as well as open-system dynamics. We finally propose possible implementations of this protocol in trapped ions and superconducting circuits. The field of quantum reinforcement learning with quantum technologies will enable enhanced quantum control, as well as more efficient machine learning calculations.	[Cardenas-Lopez, F. A.; Retamal, J. C.] Univ Santiago Chile USACH, Dept Fis, Santiago, Chile; [Cardenas-Lopez, F. A.; Retamal, J. C.] Estn Cent, Ctr Dev Nanosci & Nanotechnol, Santiago, Chile; [Lamata, L.; Solano, E.] Univ Basque Country, UPV EHU, Dept Phys Chem, Bilbao, Spain; [Solano, E.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Solano, E.] Shanghai Univ, Dept Phys, Shanghai, Peoples R China	Universidad de Santiago de Chile; University of Basque Country; Basque Foundation for Science; Shanghai University	Cardenas-Lopez, FA (corresponding author), Univ Santiago Chile USACH, Dept Fis, Santiago, Chile.; Cardenas-Lopez, FA (corresponding author), Estn Cent, Ctr Dev Nanosci & Nanotechnol, Santiago, Chile.	francisco.cardenas@usach.cl	Retamal, Juan Carlos/G-6425-2010; Lamata, Lucas/CAG-6488-2022; Lamata, Lucas/B-2439-2009	Retamal, Juan Carlos/0000-0002-7174-7879; Lamata, Lucas/0000-0002-9504-8685; Lamata, Lucas/0000-0002-9504-8685; SOLANO VILLANUEVA, ENRIQUE LEONIDAS/0000-0002-8602-1181; Cardenas, Francisco/0000-0002-2916-2826	CEDENNA basal grant [FB0807]; Direccion de Postgrado USACH; FONDECYT [1140194]; Spanish MINECO/FEDER [FIS2015-69983-P]; Basque Government [IT986-16]; Ramon y Cajal Grant [RYC-2012-11391]	CEDENNA basal grant; Direccion de Postgrado USACH; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish MINECO/FEDER; Basque Government(Basque Government); Ramon y Cajal Grant(Spanish Government)	We acknowledge support from CEDENNA basal grant No. FB0807 and Direccion de Postgrado USACH (FAC-L), FONDECYT under grant No. 1140194 (JCR), Spanish MINECO/FEDER FIS2015-69983-P and Basque Government IT986-16 (LL and ES), and Ramon y Cajal Grant RYC-2012-11391 (LL).	Adcock J., 2015, ARXIV PREPRINT ARXIV; Alber G, 2000, QUANTPH0008022 ARXIV; Alvarez-Rodriguez U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13378-0; Ballance CJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060504; Barends R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.080502; Benedetti M, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aabd98; Benedetti M, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.022308; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Biamonte J, 2017, NATURE, V549, P195, DOI 10.1038/nature23474; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Blais A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032329; Bonner R., 2003, QUANTUM COMPUTATION, P106; Brown KR, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.030303; Cai XD, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.110504; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Crawford D, 2016, ARXIV161205695; Paparo GD, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031002; Dunjko V, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/2/023006; Dunjko V, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aab406; Dunjko V, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.130501; Friis N, 2015, SCI REP-UK, V5, DOI 10.1038/srep18036; Gaebler JP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060505; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; Harty TP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140501; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Lamata L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01711-6; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Lee K.-F., 1989, ICASSP-89: 1989 International Conference on Acoustics, Speech and Signal Processing (IEEE Cat. No.89CH2673-2), P445, DOI 10.1109/ICASSP.1989.266459; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Li ZK, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.140504; Lloyd S., 2013, ARXIV13070411; Michalski R S., 2013, MACHINE LEARNING ART; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Perdomo-Ortiz A, 2017, ARXIV170809757; Pfeiffer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29507; Plamondon R, 2000, IEEE T PATTERN ANAL, V22, P63, DOI 10.1109/34.824821; Rebentrost P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.130503; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Riste D., 2015, ARXIV150801385; Russell S. J., 2010, ARTIF INTELL, V3rd; Salmilehto J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42044; Sanz M, 2018, APL PHOTONICS, V3, DOI 10.1063/1.5036596; Schuld M, 2015, CONTEMP PHYS, V56, P172, DOI 10.1080/00107514.2014.964942; Shevchenko SN, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.014006; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sriarunothai T., ARXIV170901366; Sutton R. S., 1998, REINFORCEMENT LEARNI, V1; Wendin G, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa7e1a	55	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200455	10.1371/journal.pone.0200455	http://dx.doi.org/10.1371/journal.pone.0200455			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024914	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000020
J	Mah, RL; Connolly, JF				Mah, Richard L.; Connolly, John F.			A framework for the extended monitoring of levels of cognitive function in unresponsive patients	PLOS ONE			English	Article							SUBJECTS OWN NAME; BRAIN POTENTIAL ERP; MISMATCH NEGATIVITY; IMPAIRED CONSCIOUSNESS; SELECTIVE-ATTENTION; COMATOSE PATIENTS; NEURAL RESPONSES; P300; DISORDERS; N400	Generally, prognostication of coma outcome currently combines behavioral, reflex, and possibly neuroimaging tests that are interpreted by an attending physician. Electroencephalography, particularly, event-related brain potentials (ERP) have received attention due to evidence demonstrating the positive predictive value of certain ERP including the mismatch negativity (MMN) and the P3a, for coma emergence. We describe a set of ERP paradigms designed to require and reflect increasing levels of cognitive processing with the added objective of determining the influence of each paradigm's context strength on its ability to elicit ERPs. These paradigms were then used without explicit instructions to participants to attend to the stimuli to determine which paradigms possessed sufficient context "strength" to elicit ERPs in the absence of active participation on the part of the subject; a circumstance often encountered in brain injury patients. These paradigms were then validated on two groups of adults-younger and older, and the difference due to active participation was validated on another group of younger adults. Results show that paradigms with stronger stimulus context features performed better than those with weaker contexts, and that older adults generally had significantly attenuated and delayed responses compared to younger adults. Based on these findings, it is recommended the use of the auditory oddball paradigm that includes novel stimuli to elicit the mismatch negativity and P300, and semantic violation sentences to elicit the N400. These findings also reinforce the procedure of instructing participants about the requirements of a protocol-regardless of the patient's diagnosis or apparent state-in order to help those who are able to attend to show the most robust responses possible.	[Mah, Richard L.; Connolly, John F.] McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada; [Mah, Richard L.; Connolly, John F.] McMaster Univ, Ctr Adv Res Expt & Appl Linguist, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Mah, RL; Connolly, JF (corresponding author), McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada.; Mah, RL; Connolly, JF (corresponding author), McMaster Univ, Ctr Adv Res Expt & Appl Linguist, Hamilton, ON, Canada.; Connolly, JF (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.; Connolly, JF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.	mahrl@mcmaster.ca; jconnol@mcmaster.ca		Connolly, John/0000-0001-8869-5369; Mah, Richard/0000-0003-2121-5185	Canada Foundation for Innovation [20889]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	JFC was supported by an infrastructure grant from the Canada Foundation for Innovation (#20889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V38, P55, DOI 10.1016/S0167-8760(00)00130-6; Connolly JF, 1999, J CLIN EXP NEUROPSYC, V21, P444, DOI 10.1076/jcen.21.4.444.879; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Cooper RJ, 2006, NEUROBIOL AGING, V27, P752, DOI 10.1016/j.neurobiolaging.2005.03.012; Cruse D, 2014, NEUROIMAGE-CLIN, V4, P788, DOI 10.1016/j.nicl.2014.05.001; DEGIORGIO CM, 1993, ACTA NEUROL SCAND, V87, P423; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gabriel D, 2016, BRAIN, V139, pE30, DOI 10.1093/brain/aww065; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; Harrison AH, 2013, NEUROSCI BIOBEHAV R, V37, P1403, DOI 10.1016/j.neubiorev.2013.05.004; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Howell D.C., 2012, STAT METHODS PSYCHOL, V8th; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Morlet D, 2017, PSYCHOPHYSIOLOGY, V54, P1644, DOI 10.1111/psyp.12954; Muller HM, 1996, NEUROREPORT, V8, P221; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1995, EAR HEARING, V16, P6; Naccache L, 2016, BRAIN, V139, pE31, DOI 10.1093/brain/aww060; NEMO Consortium, 2012, TR2012008 NEMO CONS; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekkonen E, 1996, EXP AGING RES, V22, P171, DOI 10.1080/03610739608254005; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1994, INT J PSYCHOPHYSIOL, V17, P25, DOI 10.1016/0167-8760(94)90052-3; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Public Health Agency of Canada, 2017, CAN CHRON DIS SURV; Rohaut B, 2015, NEUROPSYCHOLOGIA, V66, P279, DOI 10.1016/j.neuropsychologia.2014.10.014; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schroeder MM, 1995, ANN NY ACAD SCI, V769, P399, DOI 10.1111/j.1749-6632.1995.tb38155.x; Sculthorpe LD, 2011, CLIN NEUROPHYSIOL, V122, P2236, DOI 10.1016/j.clinph.2011.04.018; Statland B.E., 1987, CLIN DECISION LEVELS, V2nd; TEASDALE G, 1974, LANCET, V2, P81; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Wechsler D., 1991, WISC 3 WECHSLER INTE; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; WOODS DL, 1992, ELECTROEN CLIN NEURO, V84, P456, DOI 10.1016/0168-5597(92)90033-8; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; Zeelenberg R, 2003, PSYCHON B REV, V10, P653, DOI 10.3758/BF03196528	55	3	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200793	10.1371/journal.pone.0200793	http://dx.doi.org/10.1371/journal.pone.0200793			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024945	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000053
J	Manalil, S; Ali, HH; Chauhan, BS				Manalil, Sudheesh; Ali, Hafiz Haider; Chauhan, Bhagirath Singh			Germination ecology of turnip weed (Rapistrum rugosum (L.) All.) in the northern regions of Australia	PLOS ONE			English	Article							MUSTARD SISYMBRIUM-ORIENTALE; AFFECTING SEED-GERMINATION; SOUTHERN AUSTRALIA; ENVIRONMENTAL-FACTORS; MYAGRUM-PERFOLIATUM; GRAIN REGION; EMERGENCE; WATER; DORMANCY; MANAGEMENT	In Australia, turnip weed has been rapidly emerging as one of the major weeds in conservation agricultural systems. Germination and emergence of turnip weed were examined for two populations collected from Gatton and St George regions of Australia; two locations with high and low rainfall, respectively. The seeds of turnip weed germinated at all the tested temperatures, but germination was the lowest at 15/5 degrees C, intermediate at 20/10 degrees C and highest at 25/15 degrees C and 30/20 degrees C. The results indicated a high adaptability of turnip weed to warm environmental conditions, although it is a major problem in the winter season. Germination was higher in dark than light/dark regimes except at 30/20 degrees C. Three was a concomitant reduction in germination as the osmotic potential values decreased from 0 to -1.0 MPa. There was 2 and 4% germination at -0.8 MPa for Gatton and St George populations, respectively, and no germination occurred at an osmotic potential of -1.0 MPa. There was a reduction in germination when the sodium chloride (NaCl) concentration was increased from 0 to 150 mM, and no germination was observed at 200 and 250 mM of NaCl. Turnip weed germinated over a broad range of pH (4 to 10). Seedling emergence was higher at 1 cm depth compared to 0.5 cm or at the soil surface. There was 28 and 33% emergence at the surface for the Gatton and St George populations, respectively, compared to 48 and 56% emergence from 1 cm depth for the Gatton and St George populations, respectively and no emergence was observed from 6 cm depth. The results indicated that tillage leading to shallow burial would promote the emergence of turnip weed; on the contrary, tillage that could bury seeds deep into the soil profile might minimise the emergence. Under ideal conditions and lack of integrated weed management programmes, this weed will emerge, set seeds and enrich the soil seed bank and thereby continue to be a problem in the northern grain region of Australia.	[Manalil, Sudheesh; Chauhan, Bhagirath Singh] Univ Queensland, QAAFI, Ctr Crop Sci, Gatton, Qld, Australia; [Manalil, Sudheesh] Univ Western Australia, Inst Agr, Sch Plant Biol, Perth, Crawley, Australia; [Manalil, Sudheesh] Amrita Univ, Coimbatore, Tamil Nadu, India; [Ali, Hafiz Haider] Univ Sargodha, Univ Coll Agr, Dept Agron, Sargodha, Punjab, Pakistan	University of Queensland; University of Western Australia; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Coimbatore; Bahauddin Zakariya University; University of Sargodha	Manalil, S (corresponding author), Univ Queensland, QAAFI, Ctr Crop Sci, Gatton, Qld, Australia.; Manalil, S (corresponding author), Univ Western Australia, Inst Agr, Sch Plant Biol, Perth, Crawley, Australia.; Manalil, S (corresponding author), Amrita Univ, Coimbatore, Tamil Nadu, India.	s.manalil@uq.edu.au	Manalil, Sudheesh/GQR-0450-2022; Ali, Hafiz Haider/ABE-6457-2021; Chauhan, Bhagirath/G-8892-2014	Ali, Hafiz Haider/0000-0002-8262-6327; Chauhan, Bhagirath/0000-0003-1540-4668	Grains Research Development Corporation (GRDC), Australia [UA00156]	Grains Research Development Corporation (GRDC), Australia(Grains R&D Corp)	This work was supported by a grant from Grains Research Development Corporation (GRDC), Australia under project UA00156.	Adkins SW, 1997, WEED RES, V37, P343, DOI 10.1046/j.1365-3180.1997.d01-56.x; Ahmed S, 2015, WEED SCI, V63, P491, DOI 10.1614/WS-D-14-00115.1; [Anonymous], JORDAN J BIOL SCI; ASRIS, 2017, NAT SOIL GRIDS; Australia Government, 2017, CLIM STAT AUSTR LOC; Boutsalis P, 1998, WEED RES, V38, P389, DOI 10.1046/j.1365-3180.1998.00109.x; Chauhan BS, 2008, WEED SCI, V56, P567, DOI 10.1614/WS-07.200.1; Chauhan BS, 2006, WEED SCI, V54, P1032, DOI 10.1614/WS-06-060R1.1; Chauhan BS, 2006, WEED SCI, V54, P1025, DOI 10.1614/WS-06-092.1; Chauhan BS, 2006, WEED SCI, V54, P854, DOI 10.1614/WS-06-047R.1; Chauhan BS, 2006, WEED SCI, V54, P891, DOI 10.1614/WS-06-053R.1; Chauhan BS, 2009, WEED SCI, V57, P36, DOI 10.1614/WS-08-015.1; CottonInfo, 2016, STEW RED RISK RES; COUSENS R, 1994, WEED RES, V34, P127, DOI 10.1111/j.1365-3180.1994.tb01980.x; Dalal RC, 2004, AUST J EXP AGR, V44, P1013, DOI 10.1071/EA03166; Dang YP, 2006, AUST J AGR RES, V57, P983, DOI 10.1071/AR05268; Dang YP, 2015, SOIL TILL RES, V152, P104, DOI 10.1016/j.still.2015.03.009; Dang YP, 2016, AGRONOMY-BASEL, V6, DOI 10.3390/agronomy6040055; Eslami SV, 2010, INT J PLANT PROD, V4, P159; Gorecki MJ, 2012, ANN BOT-LONDON, V109, P1369, DOI 10.1093/aob/mcs067; GRDC, 2017, GROW REG; Hatami ZM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00169; Honarmand SJ, 2016, WEED BIOL MANAG, V16, P186, DOI 10.1111/wbm.12110; Karimmojeny H, 2014, BRAZ J BOT, V37, P121, DOI 10.1007/s40415-014-0058-1; Kleemann SGL, 2007, WEED SCI, V55, P481, DOI 10.1614/WS-06-197.1; Kleemann SGL, 2013, WEED SCI, V61, P222, DOI 10.1614/WS-D-12-00083.1; Lu P, 2006, WEED SCI, V54, P452, DOI 10.1614/WS-05-174R1.1; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Nandula VK, 2006, WEED SCI, V54, P898, DOI 10.1614/WS-06-006R2.1; Nosratti I, 2017, WEED BIOL MANAG, V17, P144, DOI 10.1111/wbm.12128; Ohadi S, 2011, WEED SCI, V59, P483, DOI 10.1614/WS-D-10-00153.1; Opena JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092261; Osten VA, 2007, AUST J EXP AGR, V47, P57, DOI 10.1071/EA05141; R Development Core Team, R LANG ENV STAT COMP; Ramesh K., ADV AGRON, V131, P251; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Simmons MT, 2005, RESTOR ECOL, V13, P609, DOI 10.1111/j.1526-100X.2005.00078.x; Whish JPM, 2002, AUST J AGR RES, V53, P1335, DOI 10.1071/AR01168; Widderick M., 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P535; Wilson BJ, 1981, 6 AUSTR WEEDS C GOLD	40	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201023	10.1371/journal.pone.0201023	http://dx.doi.org/10.1371/journal.pone.0201023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024963	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000078
J	Mendes, MD; da Silva, I; Ramires, V; Reichert, F; Martins, R; Ferreira, R; Tomasi, E				Mendes, Marcio de Almeida; da Silva, Inacio; Ramires, Virgilio; Reichert, Felipe; Martins, Rafaela; Ferreira, Rodrigo; Tomasi, Elaine			Metabolic equivalent of task (METs) thresholds as an indicator of physical activity intensity	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; EPIDEMIOLOGIC RESEARCH; PUBLIC-HEALTH; EXERCISE; FITNESS; RECOMMENDATION; ACCELEROMETER; PREVENTION; ADULTS; OUTPUT	The purpose of the study was to identify and compare validity parameters of different absolute intensity thresholds in METs, using relative intensity classification as criterion measure. Convenience sampling was used to recruit total of 112 adults. The participants carried out an incremental maximal cycle ergometer test and asked to perform nine free-living activities. The oxygen uptake was measured by a VO2000 (R) gas analyser throughout the tests. The intensity thresholds were identified using Receiver Operator Characteristic (ROC) curve analysis, having relative intensity categories as criterion measure. A total of 103 participants attended the two visits. Among 54 men and 49 women, the mean (+/- SD) ages were 36.1 (+/- 11.1) and 33.9 (+/- 10.6) years, respectively. The intensity thresholds identified were 4.9 METs for moderate and 6.8 METs for vigorous physical activity. In conclusion, the physical activity thresholds, generated according to the entire sample, were higher and presented improved specificity when compared to thresholds currently recommended. Moreover, these parameters presented relatively high accuracy, even when applied to specific groups such as sex, age, nutritional status and physical fitness.	[Mendes, Marcio de Almeida; Martins, Rafaela; Tomasi, Elaine] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [da Silva, Inacio; Reichert, Felipe; Ferreira, Rodrigo] Univ Fed Pelotas, Phys Educ Sch, Pelotas, Brazil; [Ramires, Virgilio] Sul Rio Grandense Fed Inst Educ Sci & Technol, Camaqua, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Mendes, MD (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	marciopenha.esef@yahoo.com.br	Tomasi, Elaine/AAH-2226-2021; Silva, Inacio C M/L-9896-2017; Martins, Rafaela C/E-2819-2014	Silva, Inacio C M/0000-0001-5390-8360; Costa Martins, Rafaela/0000-0003-3538-7228; de Almeida Mendes, Marcio/0000-0002-5590-5750				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; du Prel JB, 2009, DTSCH ARZTEBL INT, V106, P335, DOI 10.3238/arztebl.2009.0335; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Ferguson B, 2014, J CAN CHIROPR ASS, V58, P328; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Guedes DP, 2006, PRACTICAL GUIDE PHYS; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Midgley AW, 2009, APPL PHYSIOL NUTR ME, V34, P115, DOI 10.1139/H08-146; Neder JA, CLIN PHYSL EXERCISE; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Phillips LRS, 2013, J SCI MED SPORT, V16, P124, DOI 10.1016/j.jsams.2012.05.013; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Shephard RJ, 2001, MED SCI SPORT EXER, V33, pS400, DOI 10.1097/00005768-200106001-00008; Shephard RJ, 2015, J PHYS ACT HEALTH, V12, P454, DOI 10.1123/jpah.2013-0473; Sterne JAC, 2001, PHYS THER, V81, P1464, DOI 10.1093/ptj/81.8.1464; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Wahrlich V, 2006, CLIN NUTR, V25, P687, DOI 10.1016/j.clnu.2006.01.002; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; World OH, 2000, WHO TECHN REP SER	25	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200701	10.1371/journal.pone.0200701	http://dx.doi.org/10.1371/journal.pone.0200701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024953	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000043
J	Romagnoli, N; Pagnanelli, G; Lambertini, C; Drayton, E; Buonacucina, A; Peli, A				Romagnoli, Noemi; Pagnanelli, Giacomo; Lambertini, Carlotta; Drayton, Emily; Buonacucina, Alessandra; Peli, Angelo			Cardiorespiratory effects of medetomidine and dexmedetomidine combined with tiletamine-zolazepam for the immobilization of Asiatic black bears (Ursus thibetanus) under isoflurane general anesthesia	PLOS ONE			English	Article							KETAMINE	The aim of this paper was to compare the cardiorespiratory effects of the two combinations (medetomidine-tiletamine-zolazepam (MTZ) or dexmedetomidine-tiletamine-zolazepam (DTZ)) used for Asiatic black bear (Ursus thibetanus) immobilization. A retrospective analysis was carried out, reviewing the anesthetic records of captive bears. Sixty-six records were reviewed. The bears were immobilized, and general anesthesia was maintained with isoflurane vaporized in 100% oxygen. The mean sedation time and score were evaluated. The cardiorespiratory parameters were recorded every 10 minutes from intubation until extubation. Mean sedation time was 26.1 +/- 14.5 minutes for the MTZ group and 25.6 +/- 19.4 minutes for the DTZ group. The heart rate and the respiratory rate were higher in the bears immobilized with DTZ (66 +/- 19 beats/min; 13 +/- 5.2 breaths/min) as compared with the bears immobilized with MTZ (57 +/- 14.5 beats/min; 10 +/- 4.7 breaths/min) whereas the mean arterial pressure did not differ significantly between the groups. The body temperature was in the normal range throughout the procedures in all bears (MTZ 36.3 +/- 0.9 degrees C; DTZ 37 +/- 1 degrees C). In conclusion, the two protocols used in this study have been proven to be safe and reliable for the immobilization of Asiatic black bears, and the DTZ combination seemed to be associated with less cardiorespiratory depression than the MTZ one.	[Romagnoli, Noemi; Pagnanelli, Giacomo; Lambertini, Carlotta; Peli, Angelo] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Buonacucina, Alessandra] Univ Bologna, Centralized Vet Serv, Bologna, Italy; [Drayton, Emily] Chengdu Bear Rescue Ctr, Chengdu, Sichuan, Peoples R China	University of Bologna; University of Bologna	Lambertini, C (corresponding author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	carlotta.lambertini2@unibo.it	Lambertini, Carlotta/AAY-7825-2020; PELI, ANGELO/AAX-8423-2021	Lambertini, Carlotta/0000-0002-3604-5337; PELI, ANGELO/0000-0003-3488-2948				Asano M, 2007, J VET MED SCI, V69, P433, DOI 10.1292/jvms.69.433; Cattet MRL, 1999, J ZOO WILDLIFE MED, V30, P354; Caulkett N, 2002, ZOOL RESTRAINT ANEST, P2; Caulkett NA, 1997, J WILDLIFE DIS, V33, P618, DOI 10.7589/0090-3558-33.3.618; Caulkett NA, 1999, J ZOO WILDLIFE MED, V30, P504; Coltrane JA, 2015, WILDLIFE SOC B, V39, P378, DOI 10.1002/wsb.538; Fahlman A, 2014, J WILDLIFE DIS, V50, P574, DOI 10.7589/2013-06-148; Fahlman A, 2011, J ZOO WILDLIFE MED, V42, P1, DOI 10.1638/2008-0117.1; Fandos Esteruelas N, 2017, PLOS ONE, V12, P83, DOI [10.7589/2012-11-273, DOI 10.7589/2012-11-273]; IUCN, IUCN RED LIST THREAT; Jeong DH, 2017, J VET MED SCI, V79, P153, DOI 10.1292/jvms.16-0290; Laricchiuta P, 2008, J ZOO WILDLIFE MED, V39, P558, DOI 10.1638/2007-0130.1; Onuma M, 2003, J ZOO WILDLIFE MED, V34, P202, DOI 10.1638/1042-7260(2003)034[0202:IOSBHM]2.0.CO;2; Teisberg JE, 2014, J WILDLIFE DIS, V50, P74, DOI 10.7589/2012-11-273; White TH, 1996, WILDLIFE SOC B, V24, P521	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200833	10.1371/journal.pone.0200833	http://dx.doi.org/10.1371/journal.pone.0200833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024923	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000057
J	van Dijk, H; Meyer, B; van Engen, M				van Dijk, Hans; Meyer, Bertolt; van Engen, Marloes			If it doesn't help, it doesn't hurt? Information elaboration harms the performance of gender-diverse teams when attributions of competence are inaccurate	PLOS ONE			English	Article							GROUP DECISION-MAKING; EMOTIONAL INTELLIGENCE; GROUP IDENTIFICATION; MODERATING ROLE; PERSPECTIVE; FAULTLINES; OUTCOMES; BELIEFS; IMPACT; MATTER	Information elaboration-the act of exchanging, discussing, and integrating information and perspectives through verbal communication-tends to be considered as the silver bullet that drives the performance of diverse teams. We challenge this notion by proposing that the effect of information elaboration on team performance depends on the accuracy of within-group competence attributions, i.e. the extent to which attributions of task competence among team members correspond with members' actual task competence. We argue that information elaboration may actually harm performance when within-group competence attributions are inaccurate, given that in such teams decisions are likely to be based on suggestions from members who have much influence but little competence. We conducted an experiment with 97 gender-heterogeneous teams working on gender-typical problems and coded their interactions. Our findings support our hypotheses that members who are perceived as more competent are more influential in the information elaboration process, and that information elaboration harms performance when competence attributions are not accurate. In contrast to our expectations, pro-diversity beliefs did not mitigate this negative effect of inaccurate competence attributions. We argue that this speaks to the robustness of our findings regarding the detrimental effects of information elaboration when competence attributions are inaccurate.	[van Dijk, Hans] Tilburg Univ, Dept Org Studies, Tilburg, Netherlands; [Meyer, Bertolt] Tech Univ Chemnitz, Dept Org & Econ Psychol, Chemnitz, Germany; [van Engen, Marloes] Tilburg Univ, Dept Human Resource Studies, Tilburg, Netherlands	Tilburg University; Technische Universitat Chemnitz; Tilburg University	van Dijk, H (corresponding author), Tilburg Univ, Dept Org Studies, Tilburg, Netherlands.	j.vandijk1@uvt.nl	van Dijk, Hans/AAL-4194-2020	van Dijk, Hans/0000-0001-6962-870X; Meyer, Bertolt/0000-0003-4695-9252				Aiken L.S., 1991, MULTIPLE REGRESSION; Allport G.W., 1954, NATURE PREJUDICE; Bales RF, 1951, AM SOCIOL REV, V16, P461, DOI 10.2307/2088276; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barton MA, 2014, ORGAN PSYCHOL REV, V4, P228, DOI 10.1177/2041386613508975; Bell ST, 2007, J APPL PSYCHOL, V92, P595, DOI 10.1037/0021-9010.92.3.595; Bell ST, 2011, J MANAGE, V37, P709, DOI 10.1177/0149206310365001; Bendersky C., 2018, ANN REV ORG IN PRESS, V5; Bendersky C, 2013, ACAD MANAGE J, V56, P387, DOI 10.5465/amj.2011.0316; BERGER J, 1972, AM SOCIOL REV, V37, P241, DOI 10.2307/2093465; Berger J., 1974, EXPECTATION STATES T; Bonito JA, 2011, SMALL GR RES, V42, P343, DOI 10.1177/1046496410385472; Boos M., 1995, SELBSTORGANISATION D, P209; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Brodbeck FC, 2007, ACAD MANAGE REV, V32, P459, DOI 10.5465/AMR.2007.24351441; Bunderson JS, 2003, ADMIN SCI QUART, V48, P557, DOI 10.2307/3556637; Burke MJ, 1999, ORGAN RES METHODS, V2, P49, DOI 10.1177/109442819921004; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Carter JD, 2006, J RES PERS, V40, P1103, DOI 10.1016/j.jrp.2005.11.005; Chatman JA, 2008, ORGAN BEHAV HUM DEC, V107, P141, DOI 10.1016/j.obhdp.2008.02.006; Chattopadhyay P, 2010, ACAD MANAGE J, V53, P808, DOI 10.5465/AMJ.2010.52814603; Correll S.J., 2003, HDB SOCIAL PSYCHOL, P29, DOI DOI 10.1007/0-387-36921-X_2; Cuddy AJC, 2011, RES ORGAN BEHAV, V31, P73, DOI 10.1016/j.riob.2011.10.004; Daniel M., 2000, SELF SCORING EMOTION; de Kwaadsteniet EW, 2006, J EXP SOC PSYCHOL, V42, P509, DOI 10.1016/j.jesp.2005.06.004; de Kwaadsteniet EW, 2010, J EXP SOC PSYCHOL, V46, P515, DOI 10.1016/j.jesp.2010.01.005; De Pater IE, 2010, GENDER WORK ORGAN, V17, P433, DOI 10.1111/j.1468-0432.2009.00477.x; Dunlap WP, 2003, J APPL PSYCHOL, V88, P356, DOI 10.1037/0021-9010.88.2.356; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Esser JK, 1998, ORGAN BEHAV HUM DEC, V73, P116, DOI 10.1006/obhd.1998.2758; Filzmoser P, 2005, COMPUT GEOSCI-UK, V31, P579, DOI 10.1016/j.cageo.2004.11.013; FISCH R, 1994, GRUPPENDYNAMIK, V25, P149; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Foschi M, 2000, ANNU REV SOCIOL, V26, P21, DOI 10.1146/annurev.soc.26.1.21; Franz TM, 2002, SMALL GR RES, V33, P383, DOI 10.1177/104649640203300401; Gould RV, 2002, AM J SOCIOL, V107, P1143, DOI 10.1086/341744; Harrison DA, 2002, ACAD MANAGE J, V45, P1029, DOI 10.2307/3069328; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Haslam S. A., 2004, PSYCHOL ORG SOCIAL I; Hecht L., 1986, TECHNICAL REPORT TES; Hinsz VB, 1997, PSYCHOL BULL, V121, P43, DOI 10.1037/0033-2909.121.1.43; Hoever IJ, 2012, J APPL PSYCHOL, V97, P982, DOI 10.1037/a0029159; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Homan AC, 2007, J APPL PSYCHOL, V92, P1189, DOI 10.1037/0021-9010.92.5.1189; Horwitz SK, 2007, J MANAGE, V33, P987, DOI 10.1177/0149206307308587; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Huguet P, 2007, J EDUC PSYCHOL, V99, P545, DOI 10.1037/0022-0663.99.3.545; Inzlicht M, 2000, PSYCHOL SCI, V11, P365, DOI 10.1111/1467-9280.00272; Janis I.L., 1972, VICTIMS GROUPTHINK P; Joshi A, 2015, ACAD MANAGE J, V58, P59, DOI 10.5465/amj.2013.0718; Joshi A, 2009, ACAD MANAGE J, V52, P599, DOI 10.5465/AMJ.2009.41331491; Kearney E, 2009, J APPL PSYCHOL, V94, P77, DOI 10.1037/a0013077; Larson JR, 1996, J PERS SOC PSYCHOL, V71, P315, DOI 10.1037/0022-3514.71.2.315; Leslie LM, 2017, J MANAGE, V43, P426, DOI 10.1177/0149206314535436; Liao H, 2008, ORGAN BEHAV HUM DEC, V106, P106, DOI 10.1016/j.obhdp.2008.01.002; Loyd DL, 2013, ORGAN SCI, V24, P757, DOI 10.1287/orsc.1120.0761; MACKIE DM, 1990, J PERS SOC PSYCHOL, V58, P812, DOI 10.1037/0022-3514.58.5.812; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Mangold, 2011, INT VERS 9 COMP SOFT; Mast MS, 2002, HUM COMMUN RES, V28, P420, DOI 10.1111/j.1468-2958.2002.tb00814.x; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Meeussen L, 2016, EUR J WORK ORGAN PSY, V25, P200, DOI 10.1080/1359432X.2015.1028378; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Meyer B, 2012, EUR J WORK ORGAN PSY, V21, P456, DOI 10.1080/1359432X.2011.560383; Meyer B, 2011, SMALL GR RES, V42, P257, DOI 10.1177/1046496411398396; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Popper K., 1963, CONJECTURES REFUTATI; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Purdie-Vaughns V, 2008, J PERS SOC PSYCHOL, V94, P615, DOI 10.1037/0022-3514.94.4.615; R Development Core Team, 2009, R LANG ENV STAT COMP; Resick CJ, 2014, ORGAN BEHAV HUM DEC, V124, P165, DOI 10.1016/j.obhdp.2014.03.005; RIDGEWAY C, 1991, SOC FORCES, V70, P367, DOI 10.2307/2580244; Ridgeway CL, 1998, AM SOCIOL REV, V63, P331, DOI 10.2307/2657553; RIDGEWAY CL, 1982, AM SOCIOL REV, V47, P76, DOI 10.2307/2095043; Roberts RD, 2001, EMOTION, V1, P196, DOI 10.1037//1528-3542.1.3.196; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P157, DOI 10.1037/0022-3514.87.2.157; Schermuly CC, 2012, COMMUN METHODS MEAS, V6, P12, DOI 10.1080/19312458.2011.651346; Srikanth K, 2016, ACAD MANAG ANN, V10, P453, DOI 10.1080/19416520.2016.1120973; Stegmann S., 2011, THESIS; Steiner I. D, 1972, GROUP PROCESSES PROD; STEWART DD, 1995, J PERS SOC PSYCHOL, V69, P619, DOI 10.1037/0022-3514.69.4.619; Tajfel H., 1986, DIFFERENTIATION SOCI, V5, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Thomas-Hunt MC, 2003, MANAGE SCI, V49, P464, DOI 10.1287/mnsc.49.4.464.14425; van Dick R, 2008, HUM RELAT, V61, P1463, DOI 10.1177/0018726708095711; van Dijk H, 2017, ACAD MANAG ANN, V11, P517, DOI 10.5465/annals.2014.0046; van Dijk H, 2013, J OCCUP ORGAN PSYCH, V86, P223, DOI 10.1111/joop.12014; van Dijk H, 2012, ORGAN BEHAV HUM DEC, V119, P38, DOI 10.1016/j.obhdp.2012.06.003; van Engen M.L., 1996, NEDERLANDS TIJDSCHRI, V51, P72; van Ginkel WP, 2008, ORGAN BEHAV HUM DEC, V105, P82, DOI 10.1016/j.obhdp.2007.08.005; van Knippenberg D, 2004, J APPL PSYCHOL, V89, P1008, DOI 10.1037/0021-9010.89.6.1008; van Knippenberg D., INT HDB ORG TEAMWORK; van Knippenberg D, 2007, GROUP DYN-THEOR RES, V11, P207, DOI 10.1037/1089-2699.11.3.207; van Knippenberg D, 2007, ANNU REV PSYCHOL, V58, P515, DOI 10.1146/annurev.psych.58.110405.085546; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Wang S, 2015, SMALL GR RES, V46, P324, DOI 10.1177/1046496415578010; Williams KY, 1998, RES ORGAN BEHAV, V20, P77; Wittenbaum GM, 2000, COMMUN RES, V27, P379, DOI 10.1177/009365000027003005; Wittenbaum GM, 1998, SMALL GR RES, V29, P57, DOI 10.1177/1046496498291003; Wittenbaum GM, 2005, RES MANAG GROUP TEAM, V7, P143, DOI 10.1016/S1534-0856(05)07007-6; Zellmer-Bruhn ME, 2008, ORGAN BEHAV HUM DEC, V107, P41, DOI 10.1016/j.obhdp.2008.01.004	100	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201180	10.1371/journal.pone.0201180	http://dx.doi.org/10.1371/journal.pone.0201180			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024972	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000094
J	Wohlfahrt, A; Campos, A; Iversen, MD; Gagne, JJ; Massarotti, E; Solomon, DH; Feldman, CH				Wohlfahrt, Alyssa; Campos, Anarosa; Iversen, Maura D.; Gagne, Joshua J.; Massarotti, Elena; Solomon, Daniel H.; Feldman, Candace H.			Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; UNINTENTIONAL NONADHERENCE; ARTHRITIS; MORTALITY	Objective Adherence to medications among patients with rheumatic diseases is often suboptimal. Patient navigators, individuals trained in care coordination, motivational interviewing and basic rheumatology and pharmacology, have not been employed to explore and address this issue. We piloted a single-site, single arm intervention to determine the feasibility and acceptability of using rheumatology-specific navigators to understand and reduce barriers to adherence to oral disease modifying anti-rheumatic drugs (DMARDs). We analyzed our qualitative findings from navigator-patient interactions as well as patient satisfaction with the intervention. Methods We recruited patients >= 18 years with a systemic rheumatic disease who initiated an oral DMARD within the prior 6 months. Navigators conducted baseline needs assessments and 2-4 week follow-up calls to understand and address issues related to medication adherence. We analyzed patient-navigator encounters qualitatively using content analysis to identify key themes related to barriers to adherence and navigator actions performed in response to the barriers described. We also categorized intentional and unintentional nonadherent behavior and assessed satisfaction with the navigator experience (range 0-5,5 = most satisfied). Results 107 rheumatology patients were followed for up to 6 months. Mean patient age was 55 years (+/- 17) and 93% were female; 36% described one or more episode of intentional or unintentional nonadherence. The three most common themes identified as barriers to adherence were fear of adverse events (raised by 54%), concerns about medication effectiveness (43%), and challenges with medication acquisition (32%). 86% of participants described at least one adherence-related barrier. Frequent navigator actions included facilitation of patient-doctor communication (38%), medication and diagnosis education (27%), and development of individualized strategies to improve adherence (16%). Patients were satisfied with the navigator experience (mean 4.4 +/- 0.9). Conclusion Navigators uncovered and addressed a number of medication adherence-related concerns and patients were satisfied with the services provided.	[Wohlfahrt, Alyssa; Campos, Anarosa; Iversen, Maura D.; Massarotti, Elena; Solomon, Daniel H.; Feldman, Candace H.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Iversen, Maura D.] Northeastern Univ, Dept Phys Therapy, Movement & Rehabil Sci, Boston, MA 02115 USA; [Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Northeastern University; Harvard University; Brigham & Women's Hospital	Feldman, CH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	chfeldman@partners.org	iversen, maura daly/O-5388-2015	iversen, maura daly/0000-0003-4708-9914	Pfizer Pharmaceuticals (PI: DHS); NIH/NIAMS [K23 AR071500]; Rheumatology Research Foundation Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR071500] Funding Source: NIH RePORTER	Pfizer Pharmaceuticals (PI: DHS); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by Pfizer Pharmaceuticals (PI: DHS). Funding was also received from NIH/NIAMS K23 AR071500 (CHF) and the Rheumatology Research Foundation Investigator Award (CHF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259; Brandstetter S, 2016, PSYCHOL HEALTH, V31, P675, DOI 10.1080/08870446.2016.1139111; Cannon GW, 2011, ARTHRIT CARE RES, V63, P1680, DOI 10.1002/acr.20629; Cho JY, 2014, QUAL REP, V19, DOI 10.7838/jsebs.2014.19.1.001; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Conn DL, 2013, CLIN RHEUMATOL, V32, P49, DOI 10.1007/s10067-012-2090-5; Daleboudt GMN, 2011, ARTHRIT CARE RES, V63, P342, DOI 10.1002/acr.20411; de Achaval S, 2010, J MUSCULOSKELET MED, V27; Feldman CH, 2015, ARTHRIT CARE RES, V67, P1712, DOI 10.1002/acr.22636; Feldman CH, 2017, ARTHRITIS CARE RES H, DOI [10.1002/acr, DOI 10.1002/ACR]; Galo JS, 2016, ANN RHEUM DIS, V75, P667, DOI 10.1136/annrheumdis-2014-206593; Innala L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3442; Julian LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P240, DOI 10.1002/art.24236; Kelly E, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0019-1; Lasser Karen E, 2013, J Ethn Subst Abuse, V12, P374, DOI 10.1080/15332640.2013.819311; Lehane E, 2007, INT J NURS STUD, V44, P1468, DOI 10.1016/j.ijnurstu.2006.07.010; Lehane E, 2007, J CLIN NURS, V16, P698, DOI 10.1111/j.1365-2702.2005.01538.x; Lowry KP, 2005, ANN PHARMACOTHER, V39, P1198, DOI 10.1345/aph.1E594; Mathijssen EGE, 2018, PATIENT PREFER ADHER, V12, P349, DOI 10.2147/PPA.S152759; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pasma A, 2015, J RHEUMATOL, V42, P379, DOI 10.3899/jrheum.140693; Rapoff MA, 2002, HEALTH PSYCHOL, V21, P620, DOI 10.1037//0278-6133.21.6.620; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; van den Bemt BJF, 2009, J RHEUMATOL, V36, P2164, DOI 10.3899/jrheum.081204; Waimann CA, 2013, ARTHRITIS RHEUM-US, V65, P1421, DOI 10.1002/art.37917; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Wroe AL, 2002, J BEHAV MED, V25, P355, DOI 10.1023/A:1015866415552	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200886	10.1371/journal.pone.0200886	http://dx.doi.org/10.1371/journal.pone.0200886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024938	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000064
J	Kundu, S; Cheng, YC; Shin, M; Manyam, G; Mallick, BK; Baladandayuthapani, V				Kundu, Suprateek; Cheng, Yichen; Shin, Minsuk; Manyam, Ganiraju; Mallick, Bani K.; Baladandayuthapani, Veerabhadran			Bayesian variable selection with graphical structure learning: Applications in integrative genomics	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; COPY NUMBER; HUMAN-COLON; GENE; CANCER; REGRESSION; MODELS; LASSO; INFORMATION; ACTIVATION	Significant advances in biotechnology have allowed for simultaneous measurement of molecular data across multiple genomic, epigenomic and transcriptomic levels from a single tumor/patient sample. This has motivated systematic data-driven approaches to integrate multi-dimensional structured datasets, since cancer development and progression is driven by numerous co-ordinated molecular alterations and the interactions between them. We propose a novel multi-scale Bayesian approach that combines integrative graphical structure learning from multiple sources of data with a variable selection framework D to determine the key genomic drivers of cancer progression. The integrative structure learning is first accomplished through novel joint graphical models for heterogeneous (mixed scale) data, allowing for flexible and interpretable incorporation of prior existing knowledge. This subsequently informs a variable selection step to identify groups of co-ordinated molecular features within and across platforms associated with clinical outcomes of cancer progression, while according appropriate adjustments for multicollinearity and multiplicities. We evaluate our methods through rigorous simulations to establish superiority over existing methods that do not take the network and/or prior information into account. Our methods are motivated by and applied to a glioblastoma multiforme (GBM) dataset from The Cancer Genome Atlas to predict patient survival times integrating gene expression, copy number and methylation data. We find a high concordance between our selected prognostic gene network modules with known associations with GBM. In addition, our model discovers several novel cross-platform network interactions (both cis and trans acting) between gene expression, copy number variation associated gene dosing and epigenetic regulation through promoter methylation, some with known implications in the etiology of GBM. Our framework provides a useful tool for biomedical researchers, since clinical prediction using multi-platform genomic information is an important step towards personalized treatment of many cancers.	[Kundu, Suprateek] Emory Univ, Dept Biostat & Bioinformat, 1518 Clifton Rd, Atlanta, GA 30322 USA; [Cheng, Yichen] Georgia State Univ, Robinson Coll Business, 35 Brd St NW, Atlanta, GA 30303 USA; [Shin, Minsuk; Mallick, Bani K.] Texas A&M, Dept Stat, 155 Ireland St, College Stn, TX 77843 USA; [Manyam, Ganiraju; Baladandayuthapani, Veerabhadran] MD Anderson Canc Res Ctr, Dept Biostat, Houston, TX 77030 USA	Emory University; University System of Georgia; Georgia State University; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center	Kundu, S (corresponding author), Emory Univ, Dept Biostat & Bioinformat, 1518 Clifton Rd, Atlanta, GA 30322 USA.	suprateek.kundu@emory.edu	Manyam, Ganiraju C/B-5890-2014; Manyam, Ganiraju/E-9150-2012; Shin, Minsuk/R-1270-2019	Manyam, Ganiraju/0000-0001-6006-8961; Kundu, Suprateek/0000-0002-1767-4875	NIH [R01CA160736]; Cancer Center Support Grant (CCSG) [P30 CA016672]; National Cancer Institute of the National Institutes of Health [R01CA194391]; NATIONAL CANCER INSTITUTE [R01CA160736, R01CA194391, P30CA016672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant (CCSG); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	VB was partially supported by NIH grant R01CA160736 and the Cancer Center Support Grant (CCSG, P30 CA016672). BKM and VB were also supported by National Cancer Institute of the National Institutes of Health under award number R01CA194391.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Anjum S, 2009, BIOINFORMATICS, V25, P2929, DOI 10.1093/bioinformatics/btp485; Baladandayuthapani V, 2010, J AM STAT ASSOC, V105, P1358, DOI 10.1198/jasa.2010.ap09250; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Bondell HD, 2012, J AM STAT ASSOC, V107, P1610, DOI 10.1080/01621459.2012.716344; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Buschges R, 1999, BRAIN PATHOL, V9, P435; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Canale A, 2011, J AM STAT ASSOC, V106, P1528, DOI 10.1198/jasa.2011.tm10552; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen X, 2012, ANN APPL STAT, V6, P719, DOI 10.1214/11-AOAS514; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Choi HW, 2010, J COMPUT BIOL, V17, P121, DOI 10.1089/cmb.2009.0019; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DAWID AP, 1993, ANN STAT, V21, P1272, DOI 10.1214/aos/1176349260; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Hamid JS, 2009, HUMAN GENOMICS PROTE, V1, P1, DOI [10.4061/2009/869093, DOI 10.4061/2009/869093]; Huang PH, 2009, ONCOGENIC EGFR SIGNA, V2, DOI [10.1126/scisignal.287re6, DOI 10.1126/SCISIGNAL.287RE6]; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Isci S, 2014, BIOINFORMATICS, V30, P860, DOI 10.1093/bioinformatics/btt643; Jennings EM, 2013, EURASIP J BIOINFORMA, V1, P1687; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Li F., 2010, J AM STAT ASSOC, V105, P1978; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Melott JM, 2016, BIOINFORMATICS, V32, P312, DOI 10.1093/bioinformatics/btv554; Pan W, 2010, BIOMETRICS, V66, P474, DOI 10.1111/j.1541-0420.2009.01296.x; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Praveen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067410; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Rockova V, 2014, BAYESIAN ANAL, V9, P221, DOI 10.1214/13-BA846; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Solomon DA, 2008, CANCER RES, V68, P8657, DOI 10.1158/0008-5472.CAN-08-2084; Stingo FC, 2011, ANN APPL STAT, V5, P1978, DOI 10.1214/11-AOAS463; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Sun SW, 2016, PHYS LETT A, V380, P1912, DOI 10.1016/j.physleta.2016.03.048; Sun SW, 2015, APPL MATH COMPUT, V252, P249, DOI 10.1016/j.amc.2014.12.044; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Veronika Rockova, 2017, J AM STAT ASS; Wang H, 2012, BAYESIAN ANAL, V7, P867, DOI 10.1214/12-BA729; Wang WT, 2013, BIOINFORMATICS, V29, P149, DOI 10.1093/bioinformatics/bts655; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0195070	10.1371/journal.pone.0195070	http://dx.doi.org/10.1371/journal.pone.0195070			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059495	gold, Green Published, Green Submitted			2022-12-27	WOS:000440251600002
J	Avet, C; Denoyelle, C; L'Hote, D; Petit, F; Guigon, CJ; Cohen-Tannoudji, J; Simon, V				Avet, Charlotte; Denoyelle, Chantal; L'Hote, David; Petit, Florence; Guigon, Celine J.; Cohen-Tannoudji, Joelle; Simon, Violaine			GnRH regulates the expression of its receptor accessory protein SET in pituitary gonadotropes	PLOS ONE			English	Article							ACTIVATING FACTOR-I; ACUTE UNDIFFERENTIATED LEUKEMIA; PHOSPHATASE 2A; ABNORMAL HYPERPHOSPHORYLATION; NEGATIVE REGULATION; HORMONE RECEPTOR; GENE PROMOTER; CANCER-CELLS; BETA; TRANSCRIPTION	Reproductive function is under the control of the neurohormone GnRH, which activates a G-protein-coupled receptor (GnRHR) expressed in pituitary gonadotrope cells. GnRHR activates a complex signaling network to regulate synthesis and secretion of the two gonadotropin hormones, luteinizing hormone and follicle-stimulating hormone, both regulating gametogenesis and steroidogenesis in gonads. Recently, in an attempt to identify the mechanisms underlying GnRHR signaling plasticity, we identified the first interacting partner of GnRHR, the proto-oncogene SET. We showed that SET binds to intracellular domains of GnRHR to enhance its coupling to cAMP pathway in alpha T3-1 gonadotrope cells. Here, we demonstrate that SET protein is rapidly regulated by GnRH, which increases SET phosphorylation state and decreases dose-dependently SET protein level. Our results highlight a post-translational regulation of SET protein involving the proteasome pathway. We determined that SET phosphorylation upon GnRH stimulation is mediated by PKC and that PKC mediates GnRH-induced SET down-regulation. Phosphorylation on serine 9 targets SET for degradation into the proteasome. Furthermore, a non-phosphorylatable SET mutant on serine 9 is resistant to GnRH-induced down-regulation. Altogether, these data suggest that GnRH-induced SET phosphorylation on serine 9 mediates SET protein down-regulation through the proteasome pathway. Noteworthy, SET down-regulation was also observed in response to pulsatile GnRH stimulation in L beta T2 gonadotrope cells as well as in vivo in prepubertal female mice supporting its physiological relevance. In conclusion, this study highlights a regulation of SET protein by the neurohormone GnRH and identifies some of the mechanisms involved.	[Avet, Charlotte; Denoyelle, Chantal; L'Hote, David; Petit, Florence; Guigon, Celine J.; Cohen-Tannoudji, Joelle; Simon, Violaine] Univ Paris Diderot, Sorbonne Paris Cite, CNRS,Biol Fonct & Adaptat Physiol Axe Gonadotrope, INSERM,UMR 8251,U1133, Paris, France; [Avet, Charlotte] Univ Montreal, Inst Res Immunol & Canc, Dept Biochem & Mol Med, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	Simon, V (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS,Biol Fonct & Adaptat Physiol Axe Gonadotrope, INSERM,UMR 8251,U1133, Paris, France.	violaine.simon@univ-paris-diderot.fr	LHOTE, David/AAD-5390-2020; L'Hote, David/L-2653-2017; guigon, celine/L-3518-2017	PETIT, Florence/0000-0002-0363-280X; simon, violaine/0000-0002-4417-127X; L'Hote, David/0000-0001-5658-5018; guigon, celine/0000-0002-4489-4304	Paris 7 University; CNRS; INSERM	Paris 7 University; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from Paris 7 University, CNRS and INSERM.	ADACHI Y, 1994, FEBS LETT, V340, P231, DOI 10.1016/0014-5793(94)80144-4; Aguilar-Rojas A, 2009, ONCOL REP, V22, P981, DOI 10.3892/or_00000525; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; Avet C, 2013, J BIOL CHEM, V288, P2641, DOI 10.1074/jbc.M112.388876; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bergstralh DT, 2007, EXP CELL RES, V313, P65, DOI 10.1016/j.yexcr.2006.09.016; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chambon JP, 2013, CURR BIOL, V23, P485, DOI 10.1016/j.cub.2013.02.004; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Cohen-Tannoudji Joelle, 2012, Front Endocrinol (Lausanne), V3, P107, DOI 10.3389/fendo.2012.00107; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Dulka EA, 2017, ENDOCRINOLOGY, V158, P3943, DOI 10.1210/en.2017-00768; Ekmekci SS, 2012, TUMORI J, V98, P252, DOI 10.1700/1088.11938; Farrell AS, 2014, MOL CANCER RES, V12, P924, DOI 10.1158/1541-7786.MCR-13-0542; Francois CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46222; Fukukawa C, 2005, INT J ONCOL, V26, P751; Granger A, 2004, ENDOCRINOLOGY, V145, P983, DOI 10.1210/en.2003-0881; Hung MH, 2016, ONCOTARGET, V7, P638, DOI 10.18632/oncotarget.6313; Ichijo T, 2008, MOL CELL ENDOCRINOL, V283, P19, DOI 10.1016/j.mce.2007.10.014; Irie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051242; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; Kandilci A, 2004, LEUKEMIA, V18, P337, DOI 10.1038/sj.leu.2403227; Karetsou Z, 2005, BIOCHEM BIOPH RES CO, V335, P322, DOI 10.1016/j.bbrc.2005.06.210; Kato K, 2011, J CELL SCI, V124, P3254, DOI 10.1242/jcs.083139; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Kim DW, 2010, BIOCHEM BIOPH RES CO, V400, P419, DOI 10.1016/j.bbrc.2010.08.093; Lam BD, 2012, CYTOM PART A, V81A, P81, DOI 10.1002/cyto.a.21153; Leopoldino AM, 2012, MOL CELL BIOCHEM, V363, P65, DOI 10.1007/s11010-011-1158-x; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu GP, 2012, NEUROBIOL AGING, V33, P254, DOI 10.1016/j.neurobiolaging.2010.01.016; Loganathan J, 2014, INT J ONCOL, V44, P2009, DOI 10.3892/ijo.2014.2375; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Poulin B, 2009, NEUROENDOCRINOLOGY, V89, P252, DOI 10.1159/000164694; Qi ST, 2013, J CELL SCI, V126, P1595, DOI 10.1242/jcs.116541; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schang AL, 2011, ENDOCRINOLOGY, V152, P568, DOI 10.1210/en.2010-0840; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Simon V, 2012, MOL PHARMACOL, V82, P17, DOI 10.1124/mol.111.075523; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Thompson JW, 2014, J BIOL CHEM, V289, P28942, DOI 10.1074/jbc.M114.573352; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Yang XF, 2012, TOXICOL LETT, V209, P232, DOI 10.1016/j.toxlet.2011.12.019; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648; Zhang PL, 2001, DNA CELL BIOL, V20, P613, DOI 10.1089/104454901753340604; Zhang Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00146; Zhang WP, 2015, MOL MED REP, V12, P1506, DOI 10.3892/mmr.2015.3468	63	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201494	10.1371/journal.pone.0201494	http://dx.doi.org/10.1371/journal.pone.0201494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052687	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600048
J	Zhou, M; Aziz, M; Ochani, M; Yang, WL; Sharma, A; Wang, P				Zhou, Mian; Aziz, Monowar; Ochani, Manhendar; Yang, Weng-Lang; Sharma, Archna; Wang, Ping			The protective role of human ghrelin in sepsis: Restoration of CD4 T cell proliferation	PLOS ONE			English	Article							PROFOUND DEPLETION; UP-REGULATION; SEPTIC SHOCK; FAS-LIGAND; APOPTOSIS; IMMUNOSUPPRESSION; ACTIVATION; RATS; SECRETAGOGUE; LYMPHOCYTES	Decrease of CD4 T cell numbers causes immunosuppression in sepsis. We previously showed the beneficial role of ghrelin in sepsis. We hypothesize that the protective outcome of ghrelin in sepsis is mediated partially through the restoration of CD4 T cells' proliferation. Sepsis was induced in mice by cecal ligation and puncture (CLP). The percentage of CD4 T cells in spleen was assessed by flow cytometry and their proliferation was determined by carboxyfluorescein succinimidyl ester (CSFE). Compared to sham mice, the percentages of splenic CD4 T cells were reduced by 20%, 21%, and 29% at day 1, 2 and 3 after CLP, respectively. Human ghrelin was given to 3 day septic mice by s.c. injection at 5 and 24 h after CLP. Treatment with ghrelin restored the loss of CD4 T cells by increasing their proliferation in septic mice. The expression of cyclin D1 and B1 was significantly increased, while the expression of p57 was decreased in ghrelin-treated mice compared to vehicle-treated mice in sepsis. Treatment with human ghrelin significantly increased the p-AKT levels in the spleen compared to vehicle-treated septic mice. Human ghrelin plays an important role in reestablishing the proliferation of CD4 T cells and serves as a promising therapeutic agent in sepsis.	[Zhou, Mian; Aziz, Monowar; Ochani, Manhendar; Yang, Weng-Lang; Sharma, Archna; Wang, Ping] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA; [Yang, Weng-Lang; Wang, Ping] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Dept Surg & Mol Med, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA.; Wang, P (corresponding author), Hofstra Northwell, Donald & Barbara Zucker Sch Med, Dept Surg & Mol Med, Manhasset, NY 11030 USA.	pwang@northwell.edu		Aziz, Monowar/0000-0002-8195-4505; Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R35GM118337]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) grant R35GM118337 to Ping Wang.	Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Ayala A, 2003, SCAND J INFECT DIS, V35, P593, DOI 10.1080/00365540310015656; Ayala A, 1999, IMMUNOLOGY, V97, P45; Aziz M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.488; Aziz M, 2014, J IMMUNOL, V192, P2305, DOI 10.4049/jimmunol.1302160; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Balivada S, 2016, AUTON NEUROSCI-BASIC, V201, P68, DOI 10.1016/j.autneu.2016.08.011; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369; Dembinski A, 2003, J PHYSIOL PHARMACOL, V54, P561; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Garin MC, 2013, J CLIN ENDOCR METAB, V98, P1826, DOI 10.1210/jc.2012-4247; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, SCAND J INFECT DIS, V35, P585, DOI 10.1080/00365540310015692; Hu D, 2015, CELL IMMUNOL, V295, P92, DOI 10.1016/j.cellimm.2015.03.009; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Koo GC, 2001, J IMMUNOL, V166, P4195, DOI 10.4049/jimmunol.166.6.4195; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Narula T, 2015, AM J RESP CELL MOL, V53, P437, DOI 10.1165/rcmb.2014-0226TR; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Sharma A, 2015, IMMUNOL LETT, V168, P41, DOI 10.1016/j.imlet.2015.09.005; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stieglitz D, 2015, IMMUN INFLAMM DIS, V3, P374, DOI 10.1002/iid3.75; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Taub DD, 2010, CURR OPIN PHARMACOL, V10, P408, DOI 10.1016/j.coph.2010.04.015; Theil MM, 2009, J IMMUNOL, V183, P2859, DOI 10.4049/jimmunol.0803362; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Wang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118213; Ward PA, 2014, TRENDS MOL MED, V20, P189, DOI 10.1016/j.molmed.2014.02.003; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Wirth T, 2014, BRAIN BEHAV IMMUN, V38, P100, DOI 10.1016/j.bbi.2014.01.007; Wu JT, 2004, ANN SURG, V239, P464, DOI 10.1097/01.sla.0000118561.54919.61; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1296, DOI 10.1152/ajpheart.00852.2003; Yang WL, 2016, MOL MED, V22, P124, DOI 10.2119/molmed.2015.00255; Zhou M, 2017, BBA-MOL BASIS DIS, V1863, P2584, DOI 10.1016/j.bbadis.2017.01.014; Zukerberg LR, 1996, BLOOD, V88, P268, DOI 10.1182/blood.V88.1.268.bloodjournal881268	56	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201139	10.1371/journal.pone.0201139	http://dx.doi.org/10.1371/journal.pone.0201139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052667	gold, Green Published, Green Submitted			2022-12-27	WOS:000440006600024
J	Cho, U; Park, HS; Im, SY; Yoo, CY; Jung, JH; Suh, YJ; Choi, HJ				Cho, Uiju; Park, Hong Sik; Im, So Young; Yoo, Chang Young; Jung, Ji Han; Suh, Young Jin; Choi, Hyun Joo			Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer	PLOS ONE			English	Article							PLATELET-LYMPHOCYTE RATIO; PANCREATIC DUCTAL ADENOCARCINOMA; PRETREATMENT NEUTROPHIL; RADICAL CYSTECTOMY; BLADDER-CANCER; POOR-PROGNOSIS; SURVIVAL; CARCINOMA; OUTCOMES; LYMPHOPENIA	Systemic inflammatory markers derived from peripheral blood cell, such as the neutrophil-lymphocyte ratio (NLR), derived neutrophil-lymphocyte ratio (dNLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR), have been demonstrated as prognostic markers in several types of malignancy. Here, we investigated and compared the association between systemic inflammatory markers and survival and developed a prognostic nomogram in breast cancer patients. We reviewed the clinical and pathological records of 661 patients diagnosed with invasive breast carcinoma between 1993 and 2011. The NLR, dNLR, PLR and LMR in the immediate preoperative period were assessed. We analyzed the relationship between these inflammatory markers and clinicopathologic variables, disease-specific survival (DSS), and disease-free survival (DFS) in patients. A nomogram was developed to predict 3-and 5-year DSS for breast cancer. In the univariate analysis, high NLR, dNLR, PLR and low LMR were all significantly associated with poor DSS and DFS. In the multivariate analysis, only the PLR (HR 3.226, 95% CI 1.768-5.885 for DSS and HR 1.824, 95% CI 1.824-6.321 for DFS) was still identified as an independent predictor of outcomes. A subgroup analysis revealed that the PLR was the sole independent marker predicting poor DSS in patients with lymph node metastasis (HR 2.294, 95% CI 1.102-4.777) and with luminal subtype (HR 4.039, 95% CI 1.905-8.562). The proposed nomogram, which includes the PLR, shows good accuracy in predicting DSS with a concordance index of 0.82. PLR is an indicator of systemic inflammation as a part of the host immune response. As an independent prognostic factor, an elevated preoperative PLR is superior to the NLR, dNLR, and LMR in predicting clinical outcomes in patients with breast cancer. Moreover, the nomogram incorporating the PLR could accurately predict individualized survival probability in breast cancer.	[Cho, Uiju; Park, Hong Sik; Im, So Young; Yoo, Chang Young; Jung, Ji Han; Choi, Hyun Joo] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Hosp Pathol, Seoul, South Korea; [Suh, Young Jin] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Surg, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Choi, HJ (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Hosp Pathol, Seoul, South Korea.	chj0103@catholic.ac.kr		CHOI, HYUN JOO/0000-0003-2292-424X; Cho, Uiju/0000-0002-6229-8418				Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allred DC, 1998, MODERN PATHOL, V11, P155; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Bhindi B, 2016, BRIT J CANCER, V114, P207, DOI 10.1038/bjc.2015.432; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Dolan RD, 2017, CRIT REV ONCOL HEMAT, V116, P134, DOI 10.1016/j.critrevonc.2017.06.002; Dominguez I, 2008, WORLD J SURG, V32, P1051, DOI 10.1007/s00268-007-9423-6; Edge SB, 2010, AJCC CANC STAGING MA; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hermanns T, 2014, BRIT J CANCER, V111, P444, DOI 10.1038/bjc.2014.305; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Howlader N., 2016, SEER CANC STAT REV 1; Ishii Y, 2017, PATHOL INT, V67, P235, DOI 10.1111/pin.12530; Jia WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143061; Jiang K, 2017, J SURG ONCOL, V116, P281, DOI 10.1002/jso.24683; Kano S, 2017, HEAD NECK-J SCI SPEC, V39, P247, DOI 10.1002/hed.24576; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Kou FR, 2016, CANCER MED-US, V5, P778, DOI 10.1002/cam4.638; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Papouchado BG, 2010, AM J SURG PATHOL, V34, P767, DOI 10.1097/PAS.0b013e3181d96231; Pistelli M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1204-2; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Radziwon-Balicka A, 2012, BRIT J PHARMACOL, V167, P787, DOI 10.1111/j.1476-5381.2012.01991.x; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Song X, 2016, ONCOTARGETS THER, V9, P1399, DOI 10.2147/OTT.S97520; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Szkandera J, 2014, INT J CANCER, V135, P362, DOI 10.1002/ijc.28677; Templeton AJ, 2014, CANCER EPIDEM BIOMAR, V23, P1204, DOI 10.1158/1055-9965.EPI-14-0146; Teng JJ, 2016, ONCOTARGETS THER, V9, DOI 10.2147/OTT.S94458; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Wariss BR, 2017, MATURITAS, V101, P51, DOI 10.1016/j.maturitas.2017.04.015; Yao MY, 2014, ONCOTARGETS THER, V7, P1743, DOI 10.2147/OTT.S69657; Ying HQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0305-0; Zhang GM, 2015, TUMOR BIOL, V36, P8537, DOI 10.1007/s13277-015-3613-x; Zhang M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9503025; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101119; Zhu YY, 2017, ONCOTARGET, V8, P1023, DOI 10.18632/oncotarget.13714; Zou ZY, 2016, ONCOL LETT, V11, P2241, DOI 10.3892/ol.2016.4216	52	69	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200936	10.1371/journal.pone.0200936	http://dx.doi.org/10.1371/journal.pone.0200936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048474	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400033
J	Hakak, S; Kamsin, A; Shivakumara, P; Idris, MYI; Gilkar, GA				Hakak, Saqib; Kamsin, Amirrudin; Shivakumara, Palaiahnakote; Idris, Mohd Yamani Idna; Gilkar, Gulshan Amin			A new split based searching for exact pattern matching for natural texts	PLOS ONE			English	Article								Exact pattern matching algorithms are popular and used widely in several applications, such as molecular biology, text processing, image processing, web search engines, network intrusion detection systems and operating systems. The focus of these algorithms is to achieve time efficiency according to applications but not memory consumption. In this work, we propose a novel idea to achieve both time efficiency and memory consumption by splitting query string for searching in Corpus. For a given text, the proposed algorithm split the query pattern into two equal halves and considers the second (right) half as a query string for searching in Corpus. Once the match is found with second halves, the proposed algorithm applies brute force procedure to find remaining match by referring the location of right half. Experimental results on different S1 Dataset, namely Arabic, English, Chinese, Italian and French text databases show that the proposed algorithm outperforms the existing S1 Algorithm in terms of time efficiency and memory consumption as the length of the query pattern increases.	[Hakak, Saqib; Kamsin, Amirrudin; Shivakumara, Palaiahnakote; Idris, Mohd Yamani Idna] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Gilkar, Gulshan Amin] Shaqra Univ, Coll Comp & Informat Technol, Shaqraa, Saudi Arabia	Universiti Malaya; Shaqra University	Hakak, S; Kamsin, A (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	saqibhakak@ieee.org; amir@um.edu.my	Idris, Mohd. Yamani Idna/B-5232-2010; Palaiahnakote, Shivakumara/B-6261-2013; KAMSIN, AMIRRUDIN/B-8220-2010; Hakak, Saqib/AAC-5134-2021; Idris, Mohd. Yamani Idna/GPP-2401-2022	Idris, Mohd. Yamani Idna/0000-0003-4894-0838; KAMSIN, AMIRRUDIN/0000-0003-2796-3459; hakak, saqib/0000-0002-8718-0336	Fundamental Research Grant (FRGS) through the University Malaya [FP003-2016]; IPPP research fund [PG017-2015B]	Fundamental Research Grant (FRGS) through the University Malaya; IPPP research fund	This work was supported by the Fundamental Research Grant (FRGS) through the University Malaya under Project No. FP003-2016 and IPPP research fund (PG017-2015B) (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MK., 2014, ENHANCED BOYER MOORE; Al-Ssulami AM, 2015, J INF SCI, V41, P82, DOI 10.1177/0165551514555668; Berry TaR S., 2001, P PRAG STR CLUB WORK; Bobroff N, 2016, US Patent, Patent No. [20,160,110,225, 206010225]; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; CROCHEMORE M, 1994, ALGORITHMICA, V12, P247, DOI 10.1007/BF01185427; Faro S, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431212; Frakes WB, 1992, INFORM RETRIEVAL DAT; HORSPOOL RN, 1980, SOFTWARE PRACT EXPER, V10, P501, DOI 10.1002/spe.4380100608; Kim J-S, 2000, ACM SIGMETRICS PERFO; Lecroq T, 2007, INFORM PROCESS LETT, V102, P229, DOI 10.1016/j.ipl.2007.01.002; Lin J, 2014, ALGORITHMS, V7, DOI 10.3390/a7020253; Michailidis PD, 2002, INT J COMPUT MATH, V79, P867, DOI 10.1080/00207160212111; Rafiq ANME, 2004, COMPUT COMMUN, V27, P1524, DOI 10.1016/j.comcom.2004.06.005; Shaham R, 2001, ACM SIGPLAN NOTICES; SUNDAY DM, 1990, COMMUN ACM, V33, P132, DOI 10.1145/79173.79184; Yang T, 2004, P 4 INT S MEM MAN	18	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200912	10.1371/journal.pone.0200912	http://dx.doi.org/10.1371/journal.pone.0200912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048486	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400029
J	Knibb, G; Roberts, CA; Robinson, E; Rose, A; Christiansen, P				Knibb, Graeme; Roberts, Carl. A.; Robinson, Eric; Rose, Abi; Christiansen, Paul			The effect of beliefs about alcohol's acute effects on alcohol priming and alcohol-induced impairments of inhibitory control	PLOS ONE			English	Article							STOP-SIGNAL PARADIGM; SOCIAL DRINKERS; INDIVIDUAL-DIFFERENCES; RESPONSE-INHIBITION; QUESTIONNAIRE DAQ; SEEKING BEHAVIOR; CONSUMPTION; DRINKING; EXPECTANCIES; MECHANISMS	Acute alcohol administration can lead to a loss of control over drinking. Several models argue that this 'alcohol priming effect' is mediated by the effect of alcohol on inhibitory control. Alternatively, beliefs about how alcohol affects behavioural regulation may also underlie alcohol priming and alcohol-induced inhibitory impairments. Here two studies examine the extent to which the alcohol priming effect and inhibitory impairments are moderated by beliefs regarding the effects of alcohol on the ability to control behaviour. In study 1, following a priming drink (placebo or .5g/kg of alcohol), participants were provided with bogus feedback regarding their performance on a measure of inhibitory control (stop-signal task; SST) suggesting that they had high or average self-control. However, the bogus feedback manipulation was not successful. In study 2, before a SST, participants were exposed to a neutral or experimental message suggesting acute doses of alcohol reduce the urge to drink and consumed a priming drink and this manipulation was successful. In both studies craving was assessed throughout and a bogus taste test which measured ad libitum drinking was completed. Results suggest no effect of beliefs on craving or ad lib consumption within either study. However, within study 2, participants exposed to the experimental message displayed evidence of alcohol-induced impairments of inhibitory control, while those exposed to the neutral message did not. These findings do not suggest beliefs about the effects of alcohol moderate the alcohol priming effect but do suggest beliefs may, in part, underlie the effect of alcohol on inhibitory control.	[Knibb, Graeme; Roberts, Carl. A.; Robinson, Eric; Rose, Abi; Christiansen, Paul] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England	University of Liverpool	Knibb, G (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England.	GKnibb@liv.ac.uk		/0000-0001-9974-834X; Rose, Abi/0000-0003-3267-7318	Alcohol Research UK small grant [SG13-14 189]; Institute of psychology health and society at the University of Liverpool	Alcohol Research UK small grant; Institute of psychology health and society at the University of Liverpool	Study 2 was partly funded by an Alcohol Research UK small grant (SG13-14 189). Both studies were also funded via a PhD studentship awarded to GK from the Institute of psychology health and society at the University of Liverpool. There was no additional external funding received for either study.	Abroms BD, 2004, EXP CLIN PSYCHOPHARM, V12, P243, DOI 10.1037/1064-1297.12.4.243; Abroms BD, 2006, PSYCHOPHARMACOLOGY, V188, P324, DOI 10.1007/s00213-006-0524-y; Christiansen P, 2017, PSYCHOPHARMACOLOGY, V234, P827, DOI 10.1007/s00213-016-4518-0; Christiansen P, 2016, PSYCHOL ADDICT BEHAV, V30, P383, DOI 10.1037/adb0000148; Christiansen P, 2013, J PSYCHOPHARMACOL, V27, P84, DOI 10.1177/0269881112450787; Clarkson JJ, 2010, J PERS SOC PSYCHOL, V98, P29, DOI 10.1037/a0017539; de Wit H, 2000, BEHAV NEUROSCI, V114, P830, DOI 10.1037//0735-7044.114.4.830; DEWIT H, 1993, BEHAV PHARMACOL, V4, P29; deWit H, 1996, EXP CLIN PSYCHOPHARM, V4, P5, DOI 10.1037/1064-1297.4.1.5; Duka T, 1998, BEHAV PHARMACOL, V9, P643, DOI 10.1097/00008877-199811000-00019; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Erskine-Shaw M, 2017, DRUG ALCOHOL DEPEN, V179, P341, DOI 10.1016/j.drugalcdep.2017.07.032; Fernie G, 2012, J PSYCHOPHARMACOL, V26, P1017, DOI 10.1177/0269881111434621; Field M, 2017, PSYCHOPHARMACOLOGY, V234, P2979, DOI 10.1007/s00213-017-4694-6; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Fillmore MT, 1994, EXP CLIN PSYCHOPHARM, V2, P319, DOI 10.1037/1064-1297.2.4.319; FILLMORE MT, 1994, PSYCHOPHARMACOLOGY, V115, P383, DOI 10.1007/BF02245081; FILLMORE MT, 1995, J STUD ALCOHOL, V56, P90, DOI 10.15288/jsa.1995.56.90; HODGSON R, 1979, BEHAV RES THER, V17, P379, DOI 10.1016/0005-7967(79)90009-3; Huizenga HM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00126; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Jones A, 2016, PSYCHOPHARMACOLOGY, V233, P917, DOI 10.1007/s00213-015-4171-z; Jones A, 2012, PSYCHOL ADDICT BEHAV, V26, P325, DOI 10.1037/a0025546; Kramer JR, 2010, J STUD ALCOHOL DRUGS, V71, P150, DOI 10.15288/jsad.2010.71.150; Lau-Barraco C, 2009, ADDICT RES THEORY, V17, P306, DOI 10.1080/16066350802346201; Love A, 1998, ADDICTION, V93, P1091, DOI 10.1046/j.1360-0443.1998.937109113.x; LUDWIG AM, 1974, ARCH GEN PSYCHIAT, V30, P539; Marczinski CA, 2005, PSYCHOPHARMACOLOGY, V182, P452, DOI 10.1007/s00213-005-0116-2; MARLATT GA, 1973, J ABNORM PSYCHOL, V81, P233, DOI 10.1037/h0034532; McGrath E, 2016, PSYCHOPHARMACOLOGY, V233, P1227, DOI 10.1007/s00213-016-4205-1; Moss AC, 2015, ADDICT BEHAV, V44, P94, DOI 10.1016/j.addbeh.2014.11.035; Nordgren LF, 2009, PSYCHOL SCI, V20, P1523, DOI 10.1111/j.1467-9280.2009.02468.x; Pasche SC, 2013, J STUD ALCOHOL DRUGS, V74, P950, DOI 10.15288/jsad.2013.74.950; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Rose AK, 2007, ALCOHOL ALCOHOLISM, V42, P544, DOI 10.1093/alcalc/agm073; Rose AK, 2008, BEHAV PHARMACOL, V19, P284, DOI 10.1097/FBP.0b013e328308f1b2; Rose AK, 2008, ALCOHOL CLIN EXP RES, V32, P1096, DOI 10.1111/j.1530-0277.2008.00672.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Verbruggen F, 2008, BEHAV RES METHODS, V40, P479, DOI 10.3758/BRM.40.2.479; Verbruggen F, 2007, COGNITION EMOTION, V21, P391, DOI 10.1080/02699930600625081; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Weafer J, 2008, PSYCHOPHARMACOLOGY, V201, P315, DOI 10.1007/s00213-008-1284-7	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201042	10.1371/journal.pone.0201042	http://dx.doi.org/10.1371/journal.pone.0201042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048471	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400042
J	Rathod, J; Tu, HP; Chang, YI; Chu, YH; Tseng, YY; Jean, JS; Wu, WS				Rathod, Jagat; Tu, Hao-Ping; Chang, Yung-I; Chu, Yu-Han; Tseng, Yan-Yuan; Jean, Jiin-Shuh; Wu, Wei-Sheng			YARG: A repository for arsenic-related genes in yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CADMIUM TOLERANCE; TOXICITY; EXPRESSION; TUSC1; IDENTIFICATION; TARGET; CANCER	Arsenic is a toxic metalloid. Moderate levels of arsenic exposure from drinking water can cause various human health problems such as skin lesions, circulatory disorders and cancers. Thus, arsenic toxicity is a key focus area for environmental and toxicological investigations. Many arsenic-related genes in yeast have been identified by experimental strategies such as phenotypic screening and transcriptional profiling. These identified arsenic-related genes are valuable information for studying arsenic toxicity. However, the literature about these identified arsenic-related genes is widely dispersed and cannot be easily acquired by researchers. This prompts us to develop YARG (Yeast Arsenic-Related Genes) database, which comprehensively collects 3396 arsenic-related genes in the literature. For each arsenic-related gene, the number and types of experimental evidence (phenotypic screening and/or transcriptional profiling) are provided. Users can use both search and browse modes to query arsenic-related genes in YARG. We used two case studies to show that YARG can return biologically meaningful arsenic-related information for the query gene(s). We believe that YARG is a useful resource for arsenic toxicity research.	[Rathod, Jagat; Jean, Jiin-Shuh] Natl Cheng Kung Univ, Dept Earth Sci, Tainan, Taiwan; [Tu, Hao-Ping; Chang, Yung-I; Chu, Yu-Han; Wu, Wei-Sheng] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan; [Tseng, Yan-Yuan] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA	National Cheng Kung University; National Cheng Kung University; Wayne State University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019	Rathod, Jagat/0000-0002-5235-835X	National Cheng Kung University; Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2, MOST-106-2628-E-006-006-MY2]	National Cheng Kung University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2 and MOST-106-2628-E-006-006-MY2]. Funding for open access charge: Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar062; Chen Y, 2009, TOXICOL APPL PHARM, V239, P184, DOI 10.1016/j.taap.2009.01.010; Cherry JM, 2015, COLD SPRING HARB PRO, V2015; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Farrugia G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00064; Fuchs SM, 2014, DRUG DISCOV TODAY DI, V12, P1, DOI DOI 10.1016/J.DDMOD.2014.04.004; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Guo L, 2016, G3-GENES GENOM GENET, V6, P3317, DOI 10.1534/g3.116.033829; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hosiner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083330; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Jo WJ, 2009, TOXICOL SCI, V111, P424, DOI 10.1093/toxsci/kfp162; Johnson AJ, 2016, METALLOMICS, V8, P228, DOI 10.1039/c5mt00261c; Kanda M, 2014, J SURG ONCOL, V110, P136, DOI 10.1002/jso.23614; Kumar NV, 2016, MOL CELL BIOL, V36, P913, DOI 10.1128/MCB.00842-15; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Pan XW, 2010, GENETICS, V186, P725, DOI 10.1534/genetics.110.117655; Ray PD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00201; Serero A, 2008, DNA REPAIR, V7, P1262, DOI 10.1016/j.dnarep.2008.04.005; Shan ZH, 2004, ONCOGENE, V23, P6612, DOI 10.1038/sj.onc.1207857; Shimizu D, 2014, ONCOL REP, V31, P1305, DOI 10.3892/or.2013.2939; Thorsen M, 2007, PHYSIOL GENOMICS, V30, P35, DOI 10.1152/physiolgenomics.00236.2006; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; van Leeuwen JS, 2012, CURR DRUG METAB, V13, P1464; Vujcic M, 2007, CANCER RES, V67, P9740, DOI 10.1158/0008-5472.CAN-07-1962; Wu WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-522; Wysocki R, CELLULAR EFFECTS HEA; Zhang R, 2017, CELL MOL NEUROBIOL, V37, P37, DOI 10.1007/s10571-016-0339-2; Zhou X, 2009, GENOMICS, V94, P294, DOI 10.1016/j.ygeno.2009.07.003	30	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201204	10.1371/journal.pone.0201204	http://dx.doi.org/10.1371/journal.pone.0201204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048518	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400061
J	Figueiredo, PHS; Lima, MMO; Costa, HS; Martins, JB; Flecha, OD; Goncalves, PF; Alves, FL; Rodrigues, VGB; Maciel, EHB; Mendonca, VA; Lacerda, ACR; Vieira, ELM; Teixeira, AL; de Paula, F; Balthazar, CH				Scheidt Figueiredo, Pedro Henrique; Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Martins, Jeanne Brenda; Flecha, Olga Dumont; Goncalves, Patricia Furtado; Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique; Mendonca, Vanessa Amaral; Rodrigues Lacerda, Ana Cristina; Marciano Vieira, Erica Leandro; Teixeira, Antonio Lucio; de Paula, Fabricio; Balthazar, Claudio Heitor			Effects of the inspiratory muscle training and aerobic training on respiratory and functional parameters, inflammatory biomarkers, redox status and quality of life in hemodialysis patients: A randomized clinical trial	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SHUTTLE WALK TEST; OXIDATIVE STRESS; REFERENCE VALUES; PHYSICAL FUNCTION; FAILURE PATIENTS; SERUM RESISTIN; ADIPONECTIN; STRENGTH; EXERCISE	Objective Evaluate and compare the isolated and combined effects of Inspiratory Muscle Training (IMT) and Aerobic Training (AT) on respiratory and functional parameters, inflamatory biomarkers, redox status and health-related quality of life (HRQoL) in hemodialysis patients. Methods A randomised controlled trial with factorial allocation and intention-to-treat analysis was performed in hemodialysis patients. Volunteers were randomly assigned to performe 8-weeks of IMT at 50% of maximal inspiratory pressure (MIP), low intensity AT or combined training (CT). Before the interventions, all the volunteers went 8-weeks through a control period (without training). Measures are taken at baseline, 8-week (after control period) and 16week (after the interventions). Primary outcomes were functional capacity (incremental shuttle walk test), MIP and lower limbs strength (Sit-to-Stand test of 30 seconds). Plasma levels of interleukin-6 (IL-6), soluble tumor necrosis factor receptor 1 (sTNFR1) and 2 (sTNFR2), adiponectin, resistin and leptin, redox status parameters and HRQoL (KDQOL-SF questionnaire) were the scondary outcomes. Data analyses were performed by two-way repeated measurements ANOVA. Results 37 hemodialysis patients aged 48.2 years old (IC95% 43.2-54.7) were randomized. Increase of MIP, functional capacity, lower limbs strength and resistin levels, and reduction of sTNFR2 levels in 16-week, compared to baseline and 8-week, were observed in all the groups (p< 0.001). IMT improved functional capacity, MIP and lower limbs strength in 96.7m (IC95% 5.6-189.9), 34.5cmH(2)O (IC95% 22.4-46.7) and 2.2repetitions (IC95% 1.1-3.2) respectively. Increase in resistin leves and reduction in sTNFR2 leves after IMT was 0.8ng/dL (IC95% 0.5-1.1) and 0.8ng/dL (IC95% 0.3-1.3), respectively, without between-group differences. Compared to baseline and 8-week, adiponectin levels (p< 0.001) and fatigue domain of the HRQoL (p< 0.05) increased in 16-week only in CT. Conclusion IMT, AT and CT improved functional parameters and modulated inflammatory biomarkers, in addition, IMT provoked a similar response to low intensity AT in hemodialysis patients.	[Scheidt Figueiredo, Pedro Henrique; Martins, Jeanne Brenda; Mendonca, Vanessa Amaral; Rodrigues Lacerda, Ana Cristina; Balthazar, Claudio Heitor] Univ Fed Vales Jequitinhonha & Mucuri, PMPGCF, Diamantina, MG, Brazil; [Scheidt Figueiredo, Pedro Henrique; Oliveira Lima, Marcia Maria; Mendonca, Vanessa Amaral; Rodrigues Lacerda, Ana Cristina; Balthazar, Claudio Heitor] Univ Fed Vales Jequitinhonha & Mucuri, Phys Therapy Sch, Diamantina, MG, Brazil; [Costa, Henrique Silveira; Marciano Vieira, Erica Leandro; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Flecha, Olga Dumont; Goncalves, Patricia Furtado] Univ Fed Vales Jequitinhonha & Mucuri, Sch Dent, Diamantina, MG, Brazil; [Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique; de Paula, Fabricio] Santa Casa Caridade Diamantina Hosp, Hemodialysis Unit, Diamantina, MG, Brazil; [Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique] Univ Fed Vales Jequitinhonha & Mucuri, Sch Med, Diamantina, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Figueiredo, PHS (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, PMPGCF, Diamantina, MG, Brazil.; Figueiredo, PHS (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Phys Therapy Sch, Diamantina, MG, Brazil.	phsfig@yahoo.com.br	Vieira, Erica L M/A-1976-2013; Teixeira, Antonio L/N-3315-2014; Mendonça, Vanessa Amaral/T-7958-2019; Costa, Henrique Silveira/H-8286-2014; Figueiredo, Pedro Henrique/AAP-2158-2020; Lacerda, Ana Cristina/J-2181-2012	Vieira, Erica L M/0000-0002-4147-5614; Teixeira, Antonio L/0000-0002-9621-5422; Mendonça, Vanessa Amaral/0000-0002-1696-6091; Costa, Henrique Silveira/0000-0002-1426-7246; Lacerda, Ana Cristina/0000-0001-5366-3754	Fundacao de Amparo a Pesquisa do Estado de Minas gerais [APQ-03093-15]	Fundacao de Amparo a Pesquisa do Estado de Minas gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas gerais, APQ-03093-15; Authors who received the funding: MMOL; http://www.fapemig.br/arquivos/site/chamadas/analise/20151215114952-2015-01-universal-aprovados.pdf.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Alves R, 2016, EUR J PHYS REHAB MED, V52, P20; Beetham KS, 2015, REDOX REP, V20, P126, DOI 10.1179/1351000214Y.0000000114; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bo S, 2005, INT J OBESITY, V29, P1315, DOI 10.1038/sj.ijo.0803037; Bostrom EA, 2011, ARTHRITIS RHEUM-US, V63, P2894, DOI 10.1002/art.30527; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Medeiros AIC, 2017, J PHYSIOTHER, V63, P76, DOI 10.1016/j.jphys.2017.02.016; Chen CT, 2013, THESCIENTIFICWORLDJO, V5, P2; Chung W, 2012, J KOREAN MED SCI, V27, P377, DOI 10.3346/jkms.2012.27.4.377; Chung YC, 2017, J CLIN NURS, V26, P1801, DOI 10.1111/jocn.13514; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; da Cunha IT, 2007, AM J PHYS MED REHAB, V86, P574, DOI 10.1097/PHM.0b013e31806de721; den Hoedt CH, 2014, CLIN J AM SOC NEPHRO, V9, P318, DOI 10.2215/CJN.04470413; Dourado VZ, 2013, J BRAS PNEUMOL, V39, P190, DOI 10.1590/S1806-37132013000200010; Duarte PS, 2005, BRAZ J MED BIOL RES, V38, P261, DOI 10.1590/S0100-879X2005000200015; Figueiredo RR, 2012, CLIN REHABIL, V26, P724, DOI 10.1177/0269215511431088; GLASS GA, 1981, BIOCHEM BIOPH RES CO, V103, P1245, DOI 10.1016/0006-291X(81)90256-4; Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810; Houchen-Wolloff L, 2015, EUR J PREV CARDIOL, V22, P972, DOI 10.1177/2047487314540840; Jackson MJ, 2015, J APPL PHYSIOL, V119, P163, DOI 10.1152/japplphysiol.00760.2014; Jakel J, 2005, EPIDEMIOLOGIA BIOEST; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Kato A, 2001, NEPHROL DIAL TRANSPL, V16, P1838, DOI 10.1093/ndt/16.9.1838; Mandoorah QM, 2014, SAUDI J KIDNEY DIS T, V25, P432, DOI 10.4103/1319-2442.128613; Montemezzo D, 2014, ARCH PHYS MED REHAB, V95, P1398, DOI 10.1016/j.apmr.2014.02.022; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Neirynck N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122073; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ohashi N, 2008, INTERNAL MED, V47, P485, DOI 10.2169/internalmedicine.47.0614; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Painter P, 2013, CLIN J AM SOC NEPHRO, V8, P861, DOI 10.2215/CJN.06590712; Pellizzaro CO, 2013, RENAL FAILURE, V35, P189, DOI 10.3109/0886022X.2012.745727; Perseghin G, 2006, DIABETOLOGIA, V49, P1893, DOI 10.1007/s00125-006-0267-7; Probst VS, 2012, RESP MED, V106, P243, DOI 10.1016/j.rmed.2011.07.023; Rashidlamir A, 2012, SCI SPORT, V27, P351, DOI 10.1016/j.scispo.2011.11.004; Rusu Crina Claudia, 2016, Clujul Med, V89, P250, DOI 10.15386/cjmed-537; Sallam N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7239639; Figueiredo PHS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173159; Silva Vanessa Giendruczak da, 2011, Braz. J. Nephrol., V33, P62; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Siri W., 1961, TECHNIQUES MEASURING, P223; Smart NA, 2013, J SCI MED SPORT, V16, P406, DOI 10.1016/j.jsams.2013.01.005; Song WJ, 2012, J KOREAN ACAD NURS, V42, P947, DOI 10.4040/jkan.2012.42.7.947; Spoto B, 2013, NEPHROL DIAL TRANSPL, V28, P181, DOI 10.1093/ndt/gft365; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Thompson S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012085; Viana JL, 2014, J AM SOC NEPHROL, V25, P2121, DOI 10.1681/ASN.2013070702; Wang AYM, 2004, J AM SOC NEPHROL, V15, P3134, DOI 10.1097/01.ASN.0000144206.29951.B2; Wang ZV, 2016, J MOL CELL BIOL, V8, P93, DOI 10.1093/jmcb/mjw011; Weiner Palteil, 1996, Harefuah, V130, P73; Wilkinson TJ, 2019, PHYSIOTHER THEOR PR, V35, P565, DOI 10.1080/09593985.2018.1455249; Wilund KR, 2010, NEPHROL DIAL TRANSPL, V25, P2695, DOI 10.1093/ndt/gfq106	53	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200727	10.1371/journal.pone.0200727	http://dx.doi.org/10.1371/journal.pone.0200727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048473	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400016
J	Adler, FR; Stockmann, C; Ampofo, K; Pavia, AT; Byington, CL				Adler, Frederick R.; Stockmann, Chris; Ampofo, Krow; Pavia, Andrew T.; Byington, Carrie L.			( )Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure	PLOS ONE			English	Article							RESPIRATORY VIRUSES; PULMONARY EXACERBATIONS; VIRAL-INFECTIONS; 1ST YEAR; CHILDREN; ILLNESS; EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; TRACT	Background Common cold viruses create significant health and financial burdens, and understanding key loci of transmission would help focus control strategies. This study (1) examines factors that influence when individuals transition from a negative to positive test (acquisition) or a positive to negative test (loss) of rhinovirus (HRV) and other respiratory tract viruses in 26 households followed weekly for one year, (2) investigates evidence for intrahousehold and interhousehold transmission and the characteristics of individuals implicated in transmission, and (3) builds data-based simulation models to identify factors that most strongly affect patterns of prevalence. Methods We detected HRV, coronavirus, paramyxovirus, influenza and bocavirus with the FilmArray polymerase chain reaction (PCR) platform (BioFire Diagnostics, LLC). We used logistic regression to find covariates affecting acquisition or loss of HRV including demographic characteristics of individuals, their household, their current infection status, and prevalence within their household and across the population. We apply generalized linear mixed models to test robustness of results. Results Acquisition of HRV was less probable in older individuals and those infected with a coronavirus, and higher with a higher proportion of other household members infected. Loss of HRV is reduced with a higher proportion of other household members infected. Within households, only children and symptomatic individuals show evidence for transmission, while between households only a higher number of infected older children (ages 5-19) increases the probability of acquisition. Coronaviruses, paramyxoviruses and bocavirus also show evidence of intrahousehold transmission. Simulations show that age-dependent susceptibility and transmission have the largest effects on mean HRV prevalence. Conclusions Children are most likely to acquire and most likely to transmit HRV both within and between households, with infectiousness concentrated in symptomatic children. Simulations predict that the spread of HRV and other respiratory tract viruses can be reduced but not eliminated by practices within the home.	[Adler, Frederick R.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Adler, Frederick R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Stockmann, Chris; Ampofo, Krow; Pavia, Andrew T.] Univ Utah, Dept Pediat Med, Salt Lake City, UT USA; [Byington, Carrie L.] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Adler, FR (corresponding author), Univ Utah, Dept Math, Salt Lake City, UT 84112 USA.; Adler, FR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	adler@math.utah.edu	PAN, ZEQIANG/X-6341-2018		21st Century Science Initiative Grant from the James S McDonnell Foundation; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [5U01AI082482]; NIH/National Institute of Child Health and Human Development [K24HD047249]; NIH/National Center for Advancing Translational Sciences [1UL1TR001067]; HA and Edna Benning Presidential Endowment; Primary Children's Hospital Foundation; Pediatric Clinical and Translational Scholars Program; NIH/NAID [1R01AI125642-01]; NIH [R01 HL125520]; NIH-CSBC [U54 CA209978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD047249] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA209978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125520] Funding Source: NIH RePORTER	21st Century Science Initiative Grant from the James S McDonnell Foundation; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/National Center for Advancing Translational Sciences; HA and Edna Benning Presidential Endowment; Primary Children's Hospital Foundation; Pediatric Clinical and Translational Scholars Program; NIH/NAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-CSBC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a 21st Century Science Initiative Grant from the James S McDonnell Foundation (F.R.A.); the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases 5U01AI082482 (C.L.B., K.A., C.S.); NIH/National Institute of Child Health and Human Development K24HD047249 (C.L.B.); NIH/National Center for Advancing Translational Sciences 1UL1TR001067 (C.L.B.); The HA and Edna Benning Presidential Endowment (C.L.B.); The Primary Children's Hospital Foundation (K.A.); and the Pediatric Clinical and Translational Scholars Program (K.A.). Additional support comes from NIH/NAID 1R01AI125642-01 (K.A., A.T.P.), NIH R01 HL125520 (F.R.A.), and NIH-CSBC: U54 CA209978 (F.R.A.).	Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arden KE, 2010, REV MED VIROL, V20, P156, DOI 10.1002/rmv.644; Asner S, 2012, J CYST FIBROS, V11, P433, DOI 10.1016/j.jcf.2012.04.006; BADGER GF, 1953, AM J HYG, V58, P41, DOI 10.1093/oxfordjournals.aje.a119589; BADGER GF, 1953, AM J HYG, V58, P31, DOI 10.1093/oxfordjournals.aje.a119588; Bolker B., 2020, BBMLE TOOLS GEN MAXI; Brostrom G., 2011, GLMMML GEN LINEAR MO; Byington CL, 2015, CLIN INFECT DIS, V61, P1217, DOI 10.1093/cid/civ486; Canini L, 2016, SCI REPORTS, P6; Cauchemez S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004310; Cousin M, 2016, INFLUENZA OTHER RESP, V10, P109, DOI 10.1111/irv.12353; DOUGLAS RG, 1966, AM REV RESPIR DIS, V94, P159; FOX JP, 1975, AM J EPIDEMIOL, V101, P122, DOI 10.1093/oxfordjournals.aje.a112078; Gern JE, 2015, CLIN EXP ALLERGY, V45, P32, DOI 10.1111/cea.12428; Glass K, 2011, EPIDEMICS-NETH, V3, P152, DOI 10.1016/j.epidem.2011.05.001; Granados A, 2015, DIAGN MICR INFEC DIS, V82, P292, DOI 10.1016/j.diagmicrobio.2015.05.001; Greenberg SB, 2016, SEMIN RESP CRIT CARE, V37, P555, DOI 10.1055/s-0036-1584797; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Harris JM, 1996, CLIN INFECT DIS, V23, P1287, DOI 10.1093/clinids/23.6.1287; Hastie T, 2013, GAM GEN ADDITIVE MOD; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; HENDLEY JO, 1969, AM J EPIDEMIOL, V89, P184, DOI 10.1093/oxfordjournals.aje.a120928; Hendley JO, 1999, ADV VIRUS RES, V54, P453, DOI 10.1016/S0065-3527(08)60375-9; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; Hershenson MB, 2006, AM J RESP CRIT CARE, V174, P1284, DOI 10.1164/rccm.200609-1387ED; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howard LM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw001; Hung IFN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020259; Ironmonger, 1999, J POPULATION RES, V16, P65, DOI DOI 10.1007/BF03029455; Jackson DJ, 2008, J ALLERGY CLIN IMMUN, V121, P667, DOI 10.1016/j.jaci.2007.12.249; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Karppinen S, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.002; KETLER A, 1969, AM J EPIDEMIOL, V90, P244, DOI 10.1093/oxfordjournals.aje.a121067; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Kwok KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022089; Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132; Louie JK, 2005, CLIN INFECT DIS, V41, P262, DOI 10.1086/430915; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCaw JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-345; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; MONTO AS, 1987, J INFECT DIS, V156, P43, DOI 10.1093/infdis/156.1.43; Monto AS, 2014, J INFECT DIS; Peltola V, 2013, CLIN MICROBIOL INFEC, V19, pE322, DOI 10.1111/1469-0691.12193; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Piotrowska Z, 2009, PEDIATR INFECT DIS J, V28, P25, DOI 10.1097/INF.0b013e3181861da0; Sacri AS, 2014, PEDIATR INFECT DIS J, V33, P583, DOI 10.1097/INF.0000000000000220; Taylor S, 2017, J INFECTION, V74, P29, DOI 10.1016/j.jinf.2016.09.003; Team RC., 2013, R LANG ENV STAT COMP; Tsang TK, 2016, TRENDS MICROBIOL, V24, P123, DOI 10.1016/j.tim.2015.10.012; van der Zalm MM, 2011, J CLIN VIROL, V52, P317, DOI 10.1016/j.jcv.2011.09.003; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Yang Y, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21056; [No title captured]	58	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199388	10.1371/journal.pone.0199388	http://dx.doi.org/10.1371/journal.pone.0199388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044794	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500011
J	Eberl, C; Winkler, I; Pawelczack, S; Trobitz, E; Rinck, M; Becker, ES; Lindenmeyer, J				Eberl, Carolin; Winkler, Isabell; Pawelczack, Steffen; Troebitz, Eva; Rinck, Mike; Becker, Eni S.; Lindenmeyer, Johannes			Self-esteem consistency predicts the course of therapy in depressed patients	PLOS ONE			English	Article							SUICIDAL IDEATION; CLINICAL DEPRESSION; AUTOMATIC SELF; IMPLICIT; EXPLICIT; DISCREPANCIES; SYMPTOMS; NAME	Previous studies on self-esteem and depression demonstrated the usefulness of both implicit and explicit self-esteem as well as their congruence (also known as self-esteem consistency) to predict future depressive symptoms. High self-esteem consistency describes when implicit and explicit self-esteem match (e.g., both high or both low). In the current study, we investigated if implicit and explicit self-esteem and self-esteem consistency predict the course of treatment efficacy of a cognitive behavioral depression therapy. Explicit self-esteem was assessed by the Rosenberg Self-Esteem Scale, implicit self-esteem by a priming task. Participants were 31 patients with a major depressive or recurrent depressive disorder receiving cognitive behavioral therapy treatment in an inpatient setting. Self-esteem measures were administered before treatment. The development of depression symptoms during treatment and at the 4-month follow-up was measured on the Beck Depression Inventory. Implicit and explicit self-esteem did not predict the course of the therapy. Patients with congruent self-esteem, however, improved faster and showed lower severity of symptoms throughout treatment. In contrast, neither explicit nor implicit self-esteem nor self-esteem consistency predicted the stability of effects after treatment. Practical implications such as targeting discrepancies in self-esteem during treatment are discussed.	[Eberl, Carolin; Becker, Eni S.] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands; [Winkler, Isabell] Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany; [Pawelczack, Steffen; Lindenmeyer, Johannes] Salus Clin Lindow, Lindow, Germany; [Troebitz, Eva] Univ Leipzig, Inst Psychol, Leipzig, Germany; [Rinck, Mike] Ruhr Univ Bochum, Fac Psychol, Bochum, Germany	Radboud University Nijmegen; Technische Universitat Chemnitz; Leipzig University; Ruhr University Bochum	Winkler, I (corresponding author), Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany.	isabell.winkler@psychologie.tu-chemnitz.de	Rinck, Mike/A-6944-2010; Becker, Eni S/A-2668-2010	Becker, Eni S/0000-0003-3524-426X	German Research Foundation/DFG; Technische Universitat Chemnitz; Deutsche Rentenversicherung Bund; Behavioural Science Institute, Radboud University Nijmegen	German Research Foundation/DFG(German Research Foundation (DFG)); Technische Universitat Chemnitz; Deutsche Rentenversicherung Bund; Behavioural Science Institute, Radboud University Nijmegen	The publication costs of this article were funded by the German Research Foundation/DFG and the Technische Universitat Chemnitz in the funding programme Open Access Publishing. Deutsche Rentenversicherung Bund (http://www.deutsche-rentenversicherung.de/Allgemein/de/Navigation/0_Home/home_node.html); Behavioural Science Institute, Radboud University Nijmegen (http://www.ru.nl/bsi/). The funders provided support in the form of salaries for authors SP and JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beck A.T., 1987, BECK DEPRESSION INVE; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Beevers CG, 2005, CLIN PSYCHOL REV, V25, P975, DOI 10.1016/j.cpr.2005.03.003; Berry D. C., 1993, IMPLICIT LEARNING TH; Beutel ME, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-117; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Brinol P, 2006, J PERS SOC PSYCHOL, V91, P154, DOI 10.1037/0022-3514.91.1.154; Clark D.A., 1999, SCI FDN COGNITIVE TH; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; Creemers DHM, 2012, J BEHAV THER EXP PSY, V43, P638, DOI 10.1016/j.jbtep.2011.09.006; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; De Houwer J., 2006, HDB IMPLICIT COGNITI, P11, DOI [10.4135/9781412976237.n2, DOI 10.4135/9781412976237.N2]; de Jong PJ, 2012, PSYCHOL MED, V42, P475, DOI 10.1017/S0033291711001358; De Raedt R, 2006, BEHAV RES THER, V44, P1017, DOI 10.1016/j.brat.2005.08.003; DeHart T, 2006, J EXP SOC PSYCHOL, V42, P1, DOI 10.1016/j.jesp.2004.12.005; Derogatis LR., 1992, SYMPTOM CHECKLIST; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V86, P345, DOI 10.1037/0022-3514.86.2.345; Dozois DJA, 2003, COGNITION EMOTION, V17, P933, DOI 10.1080/02699930244000363; Dozois DJA, 2001, J CONSULT CLIN PSYCH, V69, P914, DOI 10.1037//0022-006X.69.6.914; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Franck E, 2008, COGNITION EMOTION, V22, P1588, DOI 10.1080/02699930801921271; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Franck E, 2007, J BEHAV THER EXP PSY, V38, P75, DOI 10.1016/j.jbtep.2006.05.003; Franke G., 1995, SCL 90 R SYMPTOM CHE; Glashouwer KA, 2010, J PSYCHOPATHOL BEHAV, V32, P428, DOI 10.1007/s10862-009-9156-y; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Harter S., 1993, SELF ESTEEM PUZZLE L, P87, DOI [DOI 10.1007/978-1-4684-8956-9_5, 10.1007/978-1-4684-8956-9_5]; Hautzinger M., 2003, KOGNITIVE VERHALTENS; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391; Kernis MH, 2003, PSYCHOL INQ, V14, P1, DOI 10.1207/S15327965PLI1401_01; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Krause S, 2008, INT J PSYCHOL, V43, P282; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Nezlek JB, 2006, PSYCHOL RUNDSCH, V57, P213, DOI 10.1026/0033-3042.57.4.213; Pelham BW, 2005, J EXP SOC PSYCHOL, V41, P84, DOI 10.1016/j.jesp.2003.10.008; Phillips WJ, 2016, J PERS, V84, P79, DOI 10.1111/jopy.12141; Raudenbush S.W., 2011, HLM 7 FOR WINDOWS; Raudenbush SW, 2002, HIERARCHICAL LINEAR; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Rudman LA, 2007, J PERS SOC PSYCHOL, V93, P798, DOI 10.1037/0022-3514.93.5.798; Schroder-Abe M, 2007, INT J PSYCHOL, V42, P174, DOI 10.1080/00207590601068134; Schroder-Abe M, 2007, EUR J PERSONALITY, V21, P319, DOI 10.1002/per.626; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; SWANN WB, 1995, PERS SOC PSYCHOL B, V21, P1307, DOI 10.1177/01461672952112008; van Tuijl LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166116; von Collani G., 2003, Z F R DIFFERENTIELLE, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Weinberger J, 2011, SOCIAL PSYCHOL FDN C, P461; Wentura D, 2005, J EXP SOC PSYCHOL, V41, P654, DOI 10.1016/j.jesp.2004.02.005; World Health Organization, 2008, ICD 10 INT STAT CLAS; Zeigler-Hill V, 2006, J PERS, V74, P119, DOI 10.1111/j.1467-6494.2005.00371.x	52	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199957	10.1371/journal.pone.0199957	http://dx.doi.org/10.1371/journal.pone.0199957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044801	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500024
J	Holldobler, B; Kwapich, CL; Haight, KL				Hoelldobler, Bert; Kwapich, Christina L.; Haight, Kevin L.			Behavior and exocrine glands in the myrmecophilous beetle Lomechusoides strumosus (Fabricius, 1775) (formerly called Lomechusa strumosa) (Coleoptera: Staphylinidae: Aleocharinae)	PLOS ONE			English	Article							ATEMELES; COMMUNICATION; MORPHOLOGY; BIOLOGY; ANTS	To become integrated into an ant society, myrmecophilous parasites must overcome both the defenses and the communication system of their hosts. Some aleocharine staphylinid beetles employ chemical and tactile strategies to invade colonies, where they later consume ant brood and participate in parasitic trophallaxis with host ants. By producing compounds that both appease their hosts and stimulate adoption, the beetles are able to live in and deposit their own eggs in the well defended ant nest. In the current paper, previous findings on the myrmecophilous behavior and morphological features of the staphylinid beetle Lomechusoides (formerly Lomechusa) strumosus are reviewed and re-evaluated. Hitherto unpublished results concerning the beetles' ability to participate in the social food flow of their host ants are reported. Furthermore, we present an analysis and documentation of the behavioral interactions between beetles and host ants during the adoption process, and we report new histological and scanning electron microscopic analyses of the exocrine glands and morphological adaptations that underlie the myrmecophilous behavior of L. strumosus. The main features of L. strumosus are compared with those of the staphilinid myrmecophile Lomechusa (formerly Atemeles) pubicollis. The paper concludes with a description of the life trajectory of L. strumosus and presents a brief history and discussion of the hypotheses concerning the evolution of myrmecophily in L. strumosus and other highly adapted myrmecophilous parasites.	[Hoelldobler, Bert; Kwapich, Christina L.; Haight, Kevin L.] Arizona State Univ, Social Insect Res Grp, Sch Life Sci, Tempe, AZ 85281 USA; [Hoelldobler, Bert] Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B; Kwapich, CL (corresponding author), Arizona State Univ, Social Insect Res Grp, Sch Life Sci, Tempe, AZ 85281 USA.; Holldobler, B (corresponding author), Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany.	bert.hoelldobler@asu.edu; ckwapich@asu.edu		Kwapich, Christina/0000-0001-5141-7605				[Anonymous], 1971, INSECT SOC; Billen Johan, 2011, Formosan Entomologist, V31, P75; BLUM MS, 1971, ANN ENTOMOL SOC AM, V64, P975, DOI 10.1093/aesa/64.4.975; Donisthorpe HSJK., 1927, GUESTS BRIT ANTS THE; Escherich K, 1898, ZOOLOGISCHE JB SGBT, V12, P27; GACK C, 1994, ZOOMORPHOLOGY, V114, P227, DOI 10.1007/BF00416861; Hlavac P, 2005, SOCIOBIOLOGY, V46, P203; Holldobler B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180847; HOLLDOBL.B, 1967, Z VERGL PHYSIOL, V56, P1, DOI 10.1007/BF00333561; HOLLDOBLER B, 1970, Z VERGL PHYSIOL, V66, P215, DOI 10.1007/BF00297780; Holldobler B., 1990, pi; HOLLDOBLER B, 1971, SCI AM, V224, P86; Holldobler B., 1972, VERHANDLUNGEN DTSCH, V65, P137; Holldobler K, 1948, Z PARASITENKD, V14, P3; HOLLDOLBER B, 1981, Psyche (Cambridge), V88, P347, DOI 10.1155/1981/75317; Jordan KHC, 1913, Z WISS ZOOL ABT A, V107, P346; Kloft W., 1960, ZOOL BEITR, V5, P519; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Parker J, 2016, MYRMECOL NEWS, V22, P65; PASTEELS J M, 1968, Archives de Biologie, V79, P381; RATHMAYER W, 1962, NATURE, V196, P1148, DOI 10.1038/1961148a0; ROMEIS B, 1948, MIKROSKOPISCHE TECHN; Sawada Kohei, 1994, Contributions from the Biological Laboratory Kyoto University, V28, P357; SCHILOW W F, 1981, Reichenbachia, V19, P213; Schilow WF., 1977, REICHENBACHIA, V16, P323; Schilow WF, 1997, DTSCH ENTOMOLOGISCHE, V24, P371; Wasmann E, 1915, Z WISS ZOOL ABT A, V114, P233; Wasmann E., 1903, Biologisches Zentralblatt, Vxxiii, P63; Wasmann E., 1897, Zoologischer Anzeiger, P463; Wasmann E., 1920, GASTPFLEGE AMEISEN; Wasmann E, 1903, BIOLISCHES ZENTRALBL, V23, P61; Wasmann E, 1903, BIOLISCHES ZENTRALBL, V23, P98; Wasmann E, 1903, BIOLISCHES ZENTRALBL, V23, P32; Wasmann E, 1903, BIOL ZENTRALBL, V23, P195; Wheeler W. M, 1910, ANTS	35	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200309	10.1371/journal.pone.0200309	http://dx.doi.org/10.1371/journal.pone.0200309			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044803	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500040
J	Narita, K; Asano, K; Morimoto, Y; Igarashi, T; Nakane, A				Narita, Kouji; Asano, Krisana; Morimoto, Yukihiro; Igarashi, Tatsushi; Nakane, Akio			Chronic irradiation with 222-nm UVC light induces neither DNA damage nor epidermal lesions in mouse skin, even at high doses	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTION; SURGICAL SITE INFECTIONS; ULTRAVIOLET-RADIATION; PREVENTION; SURGERY; MICE	Surgical site infections (SSIs) represent an important clinical problem associated with increased levels of surgical morbidity and mortality. UVC irradiation during surgery has been considered to represent a possible strategy to prevent the development of SSI. 254-nm UVC induces marked levels of DNA damage by generating cyclobutyl pyrimidine dimers (CPD) in microorganisms. However, this effect is elicited not only in microorganisms, but also in human cells, and chronic exposure to 254-nm UVC has been established to represent a human health hazard. In contrast, despite short wavelength-UVC light, especially 222-nm UVC, having been demonstrated to elicit a bactericidal effect, single irradiation with a high dose of 222-nm UVC energy has been reported to not induce mutagenic or cytotoxic DNA lesions in mammalian cells. However, the effect of chronic irradiation with a high dose of 222-nm UVC to mammalian cells has not been determined. In this study, it was demonstrated that large numbers of CPD-expressing cells were induced in the epidermis of mice following treatment with a small amount of single exposure 254-nm UVC, and then less than half of these cells reduced within 24 h. Chronic 254-nm UVC irradiation was revealed to induce sunburn and desquamation in mouse skin. Histological analysis demonstrated that small numbers of CPD-expressing cells were detected only in hyperkeratotic stratum corneum after chronic irradiation with a high dose of 254-nm UVC, and that significant hyperplasia and intercellular edema were also induced in the epidermis of mice. In contrast, chronic irradiation with 222-nm UVC light was revealed not to induce mutagenic or cytotoxic effects in the epidermis of mice. These results indicated that 222-nm UVC light emitted from the lamp apparatus (or device), which was designed to attenuate harmful light present in wave-lengths of more than 230 nm, represents a promising tool for the reduction of SSI incidence in patients and hospital staff.	[Narita, Kouji; Asano, Krisana; Nakane, Akio] Hirosaki Univ, Dept Microbiol & Immunol, Grad Sch Med, Hirosaki, Aomori, Japan; [Narita, Kouji] Hirosaki Univ, Inst Anim Experimentat, Grad Sch Med, Hirosaki, Aomori, Japan; [Asano, Krisana; Nakane, Akio] Hirosaki Univ, Dept Biopolymer & Hlth Sci, Grad Sch Med, Hirosaki, Aomori, Japan; [Morimoto, Yukihiro; Igarashi, Tatsushi] Ushio Inc, Chiyoda Ku, Tokyo, Japan	Hirosaki University; Hirosaki University; Hirosaki University	Nakane, A (corresponding author), Hirosaki Univ, Dept Microbiol & Immunol, Grad Sch Med, Hirosaki, Aomori, Japan.; Nakane, A (corresponding author), Hirosaki Univ, Dept Biopolymer & Hlth Sci, Grad Sch Med, Hirosaki, Aomori, Japan.	a27k03n0@hirosaki-u.ac.jp			USHIO Inc., Tokyo, Japan	USHIO Inc., Tokyo, Japan	This work was supported by USHIO Inc., Tokyo, Japan. The funder provided support in the form of salaries for authors [Y. M. and T. I.] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEMEIER WA, 1968, SURG CLIN N AM, V48, P227; Anderson DJ, 2009, INFECT DIS CLIN N AM, V23, P53, DOI 10.1016/j.idc.2008.10.004; Berton TR, 1997, J INVEST DERMATOL, V109, P340, DOI 10.1111/1523-1747.ep12335984; Buonanno M, 2017, RADIAT RES, V187, P483, DOI 10.1667/RR0010CC.1; Buonanno M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138418; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; CHANG JCH, 1985, APPL ENVIRON MICROB, V49, P1361, DOI 10.1128/AEM.49.6.1361-1365.1985; Dai TH, 2012, ANTIMICROB AGENTS CH, V56, P3841, DOI 10.1128/AAC.00161-12; GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; Gupta A, 2013, ADV WOUND CARE, V2, P422, DOI 10.1089/wound.2012.0366; HOWORTH FH, 1985, LANCET, V1, P386; Kaye KS, 2008, CLIN INFECT DIS, V46, P1568, DOI 10.1086/587673; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Lee CH, 2013, INT J MOL SCI, V14, P6414, DOI 10.3390/ijms14036414; Mallet JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162212; Narita K, 2018, J PHOTOCH PHOTOBIO B, V178, P10, DOI 10.1016/j.jphotobiol.2017.10.030; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Ponnaiya B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192053; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Reichman David E, 2009, Rev Obstet Gynecol, V2, P212; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; STERENBORG HJCM, 1988, PHOTOCHEM PHOTOBIOL, V47, P245, DOI 10.1111/j.1751-1097.1988.tb02722.x; VINK AA, 1991, CARCINOGENESIS, V12, P861, DOI 10.1093/carcin/12.5.861; Welch D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21058-w	27	56	60	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201259	10.1371/journal.pone.0201259	http://dx.doi.org/10.1371/journal.pone.0201259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044862	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500096
J	Ohmichi, T; Kasai, T; Kosaka, T; Shikata, K; Tatebe, H; Ishii, R; Shinomoto, M; Mizuno, T; Tokuda, T				Ohmichi, Takuma; Kasai, Takashi; Kosaka, Tadashi; Shikata, Keisuke; Tatebe, Harutsugu; Ishii, Ryotaro; Shinomoto, Makiko; Mizuno, Toshiki; Tokuda, Takahiko			Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease	PLOS ONE			English	Article							CAFFEINE; NEUROPROTECTION; PROGRESSION; VALIDATION; CRITERIA; MODEL; TIME; CSF	Caffeine has been considered a neuroprotective agent against Parkinson's disease (PD). Recent metabolomic analysis showed that levels of caffeine and its metabolites were decreased in sera from patients with PD compared with those from healthy controls. We focused on theophylline, which is one of the primary caffeine metabolites, as a candidate biomarker of PD because: (1) its serum level can be measured in hospital laboratories by standardized immunoassay kits for therapeutic drug monitoring and (2) because it is less markedly affected by caffeine intake. This was a pilot study to measure the levels of theophylline in sera of 31 patients with PD and 33 age-matched disease controls using an immunoassay kit. We confirmed the previous finding of significantly lower levels of serum theophylline in the PD group compared with control group (PD: 0.07 +/- 0.09 mu g/mL, control: 0.18 +/- 0.24 mu g/mL, p<0.05). Using such an approach of applying known medical biomarkers for neurodegenerative diseases may allow us to skip the process from the discovery phase to clinical application, and subsequently shorten the period of time necessary for biomarker development.	[Ohmichi, Takuma; Kasai, Takashi; Tatebe, Harutsugu; Ishii, Ryotaro; Shinomoto, Makiko; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Kosaka, Tadashi; Shikata, Keisuke] Kyoto Prefectural Univ Med, Univ Hosp, Dept Pharm, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare Med, Kyoto, Japan; [Ishii, Ryotaro] Kyoto Prefectural Univ Med, North Med Ctr, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan; [Tokuda, Takahiko] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	kasaita@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020; Ishii, Ryotaro/K-4595-2019		Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/ MINDS)); Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09319, 18K07506]; Dainippon Sumitomo Pharma Research grant; Dainippon Sumitomo Pharma	Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/ MINDS))(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dainippon Sumitomo Pharma Research grant; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.)	This work was supported in part by a grant from the Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/ MINDS)) (to T.T.) and by a Grant-in-Aid (Nos. 15K09319 and 18K07506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.K. and Dainippon Sumitomo Pharma Research grant (2017 to TK and 2018 to TO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a grant from the Japan Agency for Medical Research and Development (AMED-CREST, program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)) (to T.T.), by a Grant-in-Aid (Nos. 15K09319 and 18K07506) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.K, and research grants from Dainippon Sumitomo Pharma in 2018 (to T.O.) and 2017 (to T.K.).	Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Chen F, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3900; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Daly J W, 1987, Prog Clin Biol Res, V230, P41; del Campo M, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00202; Fujimaki M, 2018, NEUROLOGY, V90, pE404, DOI 10.1212/WNL.0000000000004888; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hatano T, 2016, J NEUROL NEUROSUR PS, V87, P295, DOI 10.1136/jnnp-2014-309676; Ko D-H, 2016, J LAB MED QUAL ASSUR, V38, P11; Kruse N, 2015, NEUROBIOL AGING, V36, P2587, DOI 10.1016/j.neurobiolaging.2015.05.003; LeWitt PA, 2017, NEUROLOGY, V88, P862, DOI 10.1212/WNL.0000000000003663; Lue LF, 2017, NEUROL THER, V6, pS25, DOI 10.1007/s40120-017-0074-8; Molinuevo JL, 2014, ALZHEIMERS DEMENT, V10, P808, DOI 10.1016/j.jalz.2014.03.003; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Mizuno Y, 2013, MOVEMENT DISORD, V28, P1138, DOI 10.1002/mds.25418; Moccia M, 2016, PARKINSONISM RELAT D, V32, P116, DOI 10.1016/j.parkreldis.2016.08.005; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Postuma RB, 2012, NEUROLOGY, V79, P651, DOI 10.1212/WNL.0b013e318263570d; Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; Schwarzschild Michael A., 2003, Neurology, V61, pS55; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006; Yamazaki H, 1998, CHEM RES TOXICOL, V11, P659, DOI 10.1021/tx970217f; Zhou B, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/567386	27	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201260	10.1371/journal.pone.0201260	http://dx.doi.org/10.1371/journal.pone.0201260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044870	gold, Green Submitted, Green Published			2022-12-27	WOS:000439942500097
J	Wang, JB; Olgin, JE; Nah, G; Vittinghoff, E; Cataldo, JK; Pletcher, MJ; Marcus, GM				Wang, Julie B.; Olgin, Jeffrey E.; Nah, Gregory; Vittinghoff, Eric; Cataldo, Janine K.; Pletcher, Mark J.; Marcus, Gregory M.			Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study	PLOS ONE			English	Article							TERM E-CIGARETTE; ELECTRONIC CIGARETTES; SMOKING-CESSATION; RESPIRATORY HEALTH; UNITED-STATES; NICOTINE; PREFERENCES; RELIABILITY; VALIDITY; ADULTS	E-cigarettes are promoted as healthier alternatives to conventional cigarettes. Many cigarette smokers use both products. It is unknown whether the additional use of e-cigarettes among cigarette smokers (dual users) is associated with reduced exposure to tobaccorelated health risks. Cross-sectional analysis was performed using baseline data from the Health eHeart Study, among English-speaking adults, mostly from the United States. Cigarette use (# cigarettes/day) and/or e-cigarette use (# days, # cartridges, and # puffs) were compared between cigarette only users vs. dual users. Additionally, we examined cardiopulmonary symptoms/ conditions across product use: no product (neither), e-cigarettes only, cigarettes only, and dual use. Among 39,747 participants, 573 (1.4%) reported e-cigarette only use, 1,693 (4.3%) reported cigarette only use, and 514 (1.3%) dual use. Dual users, compared to cigarette only users, reported a greater median (IQR) number of cigarettes per day, 10.0 (4.0-20.0) vs. 9.0 (3.0-15.0) (p < .0001), a lower (worse) median (IQR) SF-12 general health score, 3.3 (2.8-3.8) vs. 3.5 (2.8-3.9) (p = .0014), and a higher (worse) median (IQR) breathing difficulty score in the past month, 2.0 (1.0-2.0) vs. 1.0 (1.0-2.0) (p = .1). Of the 19 cardiopulmonary symptoms/ conditions, having a history of arrhythmia was significantly different between cigarette only users (14.2%) and dual users (17.8%) (p= .2). In this sample, dual use was not associated with reduced exposure to either (i) cigarettes, compared to cigarette only users or (ii) e-cigarettes, compared to e-cigarette only users. E-cigarette only use, compared to no product use, was associated with lower general health scores, higher breathing difficulty scores (typically and past month), and greater proportions of those who responded 'yes' to having chest pain, palpitations, coronary heart disease, arrhythmia, COPD, and asthma. These data suggest the added use of e-cigarettes alone may have contributed to cardiopulmonary health risks particularly respiratory health risks.	[Wang, Julie B.] 24K Data, Washington, DC USA; [Wang, Julie B.; Olgin, Jeffrey E.; Nah, Gregory; Marcus, Gregory M.] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA; [Wang, Julie B.; Cataldo, Janine K.] Univ Calif San Francisco, Sch Nursing, Physiol Nursing, San Francisco, CA 94143 USA; [Vittinghoff, Eric; Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA.	greg.marcus@ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Wang, Julie/0000-0001-7039-6061	Office of Behavioral and Social Sciences Research of the National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health; National Institute of Neurological Disorders and Stroke of the National Institutes of Health; National Heart, Lung, and Blood Institute of the National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [1U2CEB021881]; National Institutes of Health/National Cancer Institute [2T32CA113710-11]; Patient Centered Outcomes Research Institute [PPRN-1306-04709]; 24K Data	Office of Behavioral and Social Sciences Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); 24K Data	This study was supported by Office of Behavioral and Social Sciences Research, National Institute of Biomedical Imaging and Bioengineering, National Institute of Neurological Disorders and Stroke, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health (1U2CEB021881), National Institutes of Health/National Cancer Institute (2T32CA113710-11), the Patient Centered Outcomes Research Institute (PPRN-1306-04709), and 24K Data (http://24Kdata.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant information: 1U2CEB021881: JO, MP, GM (http://grantome.com/grant/NIH/U2C-EB021881-01), 2T32CA113710-11: JW (via PL) (http://grantome.com/grant/NIH/T32-CA113710-11), PPRN-1306-04709: JO, MP, GM (URL not available).	Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; [Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1177, DOI 10.15585/mmwr.mm6542a7; Ayers JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170702; Barrington-Trimis JL, 2014, JAMA-J AM MED ASSOC, V312, P2493, DOI 10.1001/jama.2014.14830; Benowitz NL, 2017, NAT REV CARDIOL, V14, P447, DOI 10.1038/nrcardio.2017.36; Benowitz NL, 2017, ADDICTION, V112, P6, DOI 10.1111/add.13534; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Borland R, 2010, NICOTINE TOB RES, V12, pS45, DOI 10.1093/ntr/ntq038; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Clapp PW, 2017, AM J PHYSIOL-LUNG C, V313, pL278, DOI 10.1152/ajplung.00452.2016; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Douglas CE, 1998, TOB CONTROL, V7, P215, DOI 10.1136/tc.7.3.215; Etter JF, 2014, ADDICT BEHAV, V39, P491, DOI 10.1016/j.addbeh.2013.10.028; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Farsalinos KE, 2016, ADDICTION, V111, P2032, DOI 10.1111/add.13506; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Flower M, 2017, RESPIROL CASE REP, V5, DOI 10.1002/rcr2.230; Food and Drug Administration (FDA), 2010, FED REGISTER, V75, P13225; Foulds J, 2011, INT J CLIN PRACT, V65, P1037, DOI 10.1111/j.1742-1241.2011.02751.x; Gerloff Janice, 2017, Appl In Vitro Toxicol, V3, P28, DOI 10.1089/aivt.2016.0030; Goniewicz ML, 2013, DRUG ALCOHOL REV, V32, P133, DOI 10.1111/j.1465-3362.2012.00512.x; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grana RA, 2014, JAMA INTERN MED, V174, P812, DOI 10.1001/jamainternmed.2014.187; Guo XF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02232-y; Hagstromer M, 2017, INT PHYS ACTIVITY QU, DOI [10.1079/PHN2005898, DOI 10.1079/PHN2005898]; Heydari G, 2017, LUNG INDIA, V34, P25, DOI 10.4103/0970-2113.197119; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lippi G, 2014, SEMIN THROMB HEMOST, V40, P60, DOI 10.1055/s-0033-1363468; Moazed F, 2017, AM J RESP CRIT CARE, V195, P974, DOI 10.1164/rccm.201611-2259ED; Popova L, 2013, AM J PUBLIC HEALTH, V103, P923, DOI 10.2105/AJPH.2012.301070; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; Schoenborn CA, 2014, ELECT CIGARETTE USE; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Sherwood CL, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0369-9; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Vansickel AR, 2010, CANCER EPIDEM BIOMAR, V19, P1945, DOI 10.1158/1055-9965.EPI-10-0288; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Vickerman KA, 2013, NICOTINE TOB RES, V15, P1787, DOI 10.1093/ntr/ntt061; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Warren GW, 2014, CANCER-AM CANCER SOC, V120, P1914, DOI 10.1002/cncr.28695; Zhu SH, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3262; Zhuang YL, 2016, TOB CONTROL, V25, pi90, DOI 10.1136/tobaccocontrol-2016-053096	49	107	109	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0198681	10.1371/journal.pone.0198681	http://dx.doi.org/10.1371/journal.pone.0198681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044773	gold, Green Published			2022-12-27	WOS:000439942500008
J	Goncalves, B; Coutinho, D; Travassos, B; Folgado, H; Caixinha, P; Sampaio, J				Goncalves, Bruno; Coutinho, Diogo; Travassos, Bruno; Folgado, Hugo; Caixinha, Pedro; Sampaio, Jaime			Speed synchronization, physical workload and match-to-match performance variation of elite football players	PLOS ONE			English	Article							HIGH-INTENSITY ACTIVITY; PHYSIOLOGICAL PERFORMANCES; SOCCER PLAYERS; VARIABILITY; REDUCTION; DYNAMICS; POSITION; BEHAVIOR	This study aimed to: (i) examine whether the speed synchronization and physical performance of an elite football team changed between the first and the second half, using match time blocks of 15-min, and (ii) explore the match-to-match variation of players' speed synchronization performance. Twenty-eight outfield elite footballers participated in 51 official matches. Positional data were gathered and used to calculate the total distance covered as a physical workload indicator. For all the outfield teammate dyad combinations (45 pairs), it was processed the percentage of time that players' speed was synchronized during walking, jogging and running using relative phase (Hilbert Transform). Also, the match-to-match variation of the players' speed synchronization, expressed in coefficient of variation was computed. The differences in the total distance covered from all players within the different match's time block periods revealed a moderate decrease in the distance covered in the last 15-min of the match compared to the first 15-min (-6.5; +/- 1.07%, most likely: change in means with 95% confidence limits). However, when compared the last minutes from both halves a small increase was observed (2.7; +/- 1.2%, likely) from first to second half. The synchronization of the players' speed displacements revealed small to moderate decreases in the % of synchronization in the second half periods for the jogging and running speed, while the opposite was found for the walking speed (similar to 13 to 24% more, most likely). The playing position analysis for the walking zone showed similar trends between the groups, with small to moderate higher values in the second half, with the exception of [30'-45'] vs [75'-90'] in the midfielder's dyads and in [15'-30'] vs [60'-75'] match periods for forwards. Similar trend was found during the running speed, in which small to moderate higher synchronization was found during the first half periods, with the exception of [15'-30'] vs [60'-75'] and [30'-45'] vs [75'-90'] in midfielder's dyads. Regarding to the match-to-match variation of the players' speed synchronization, overall results showed small to moderate increases in coefficient of variation during jogging and running displacements from the beginning to the end of the match (32.1; +/- 13.2% increase in jogging and 26.2; +/- 10.5% in running, both comparisons most likely). The higher distance covered during most of the first half periods and the higher dyadic synchronization at high speeds might have limited players' performance in the second half. In addition, the decrease trend in speed synchronization during the second half periods might have resulted from accumulated muscular and mental fatigue towards the match. Within, the match-to-match variation in tactical-related variables increased across the match duration, with especial focus in the midfielder dyads. Dyadic speed synchronization might provide relevant information concerning the individual and collective performance.	[Goncalves, Bruno; Coutinho, Diogo; Caixinha, Pedro; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Vila Real, Portugal; [Goncalves, Bruno; Coutinho, Diogo; Travassos, Bruno; Folgado, Hugo; Sampaio, Jaime] CreativeLab Res Community, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Vila Real, Portugal; [Travassos, Bruno] Univ Beira Interior, Covilha, Portugal; [Folgado, Hugo] Univ Evora, Evora, Portugal	University of Tras-os-Montes & Alto Douro; Universidade da Beira Interior; University of Evora	Goncalves, B (corresponding author), Univ Tras Os Montes & Alto Douro, Vila Real, Portugal.; Goncalves, B (corresponding author), CreativeLab Res Community, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, Vila Real, Portugal.	air.bruno.23@gmail.com	Travassos, Bruno/G-4478-2013; Coutinho, D./H-7313-2016; Gonçalves, Bruno/M-5361-2013; Sampaio, Jaime/B-7392-2008; Folgado, Hugo/D-4501-2013	Travassos, Bruno/0000-0002-2165-2687; Coutinho, D./0000-0001-6605-9505; Gonçalves, Bruno/0000-0001-7874-4104; Sampaio, Jaime/0000-0003-2335-9991; Folgado, Hugo/0000-0002-9432-1950	Project NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics [NORTE-01-0145-FEDER-000016]; Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE 2020	Project NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics; Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE 2020	This work was supported by Project NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics, NORTE-01-0145-FEDER-000016, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) - NORTE 2020.	[Anonymous], [No title captured]; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bourbousson J, 2010, J SPORT SCI, V28, P339, DOI 10.1080/02640410903503632; Bradley PS, 2013, HUM MOVEMENT SCI, V32, P808, DOI 10.1016/j.humov.2013.06.002; Bradley PS, 2010, J STRENGTH COND RES, V24, P2343, DOI 10.1519/JSC.0b013e3181aeb1b3; Bradley PS, 2013, J SPORTS SCI, P1, DOI [10.1080/02640414.2012.720701, DOI 10.1080/02640414.2012.720701]; Buchheit M, 2016, INT J SPORT PHYSIOL, V11, P551, DOI 10.1123/IJSPP.2016-0214; Carling C, 2013, J SPORTS SCI, P1; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Carling C, 2016, J SPORT SCI, V34, P2215, DOI 10.1080/02640414.2016.1176228; Carling C, 2011, J SPORT SCI, V29, P63, DOI 10.1080/02640414.2010.521945; Coutinho D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01645; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Duarte R, 2013, J SYST SCI COMPLEX, V26, P62, DOI 10.1007/s11424-013-2290-3; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Fernandes O, 2010, INT J SPORT PSYCHOL, V41, P63; Folgado H, 2018, RES SPORTS MED, V26, P51, DOI 10.1080/15438627.2017.1393754; Folgado H, 2015, J SPORT SCI, V33, P1238, DOI 10.1080/02640414.2015.1022576; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Goncalves B, 2018, J HUM KINET; Goncalves B, 2017, J STRENGTH COND RES, V31, P2398, DOI 10.1519/JSC.0000000000001700; Goncalves B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171156; Goncalves BV, 2014, J SPORT SCI, V32, P191, DOI 10.1080/02640414.2013.816761; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Kempton T, 2015, J SCI MED SPORT, V18, P109, DOI 10.1016/j.jsams.2013.12.006; Lago-Penas C, 2010, J HUM KINET, V25, P93, DOI 10.2478/v10078-010-0036-z; Lago-Peuas C., 2009, INT J PERF ANAL SPOR, V9, P218, DOI DOI 10.1080/24748668.2009.11868478; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; Memmert D, 2016, SPORTS MED; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Palut Y, 2005, J SPORT SCI, V23, P1021, DOI 10.1080/02640410400021682; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Ric A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180773; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Smith MR, 2016, J SPORT SCI, V34, P1297, DOI 10.1080/02640414.2016.1156241; Spencer M, 2014, INT J SPORT PHYSIOL, V9, P5, DOI [10.1123/IJSPP.2012-0382, 10.1123/ijspp.2012-0382]; Stergiou N., 2013, KINESIOL REV, V2, P93, DOI DOI 10.1123/KRJ.2.1.93; Stergiou N., 2016, NONLINEAR ANAL HUMAN; Travassos B, 2012, HUM MOVEMENT SCI, V31, P932, DOI 10.1016/j.humov.2011.10.004; Travassos B, 2013, INT J PERF ANAL SPOR, V13, P83, DOI 10.1080/24748668.2013.11868633; Trewin J, 2018, J SCI MED SPORT, V21, P196, DOI 10.1016/j.jsams.2017.05.009; Weston M, 2011, INT J SPORT PHYSIOL, V6, P174, DOI 10.1123/ijspp.6.2.174	48	17	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200019	10.1371/journal.pone.0200019	http://dx.doi.org/10.1371/journal.pone.0200019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040849	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200003
J	Wang, XH; Jiao, Y; Li, LH				Wang, Xun-Heng; Jiao, Yun; Li, Lihua			Mapping individual voxel-wise morphological connectivity using wavelet transform of voxel-based morphology	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; LOW-FREQUENCY; SMALL-WORLD; BRAIN; MORPHOMETRY; ORGANIZATION; RELIABILITY; NETWORKS; HUBS; MRI	Mapping individual brain networks has drawn significant research interest in recent years. Most individual brain networks developed to date have been based on fMRI or diffusion MRI. Given recent concerns regarding confounding artifacts, various preprocessing steps are generally included in functional or structural brain networks. Notably, voxel-based morphometry (VBM) derived from anatomical MRI exhibits high signal-to-noise ratios and has been applied to individual interregional morphological networks. To the best of our knowledge, individual voxel-wise morphological networks remain unexplored. The goal of this research is twofold: to build novel metrics for individual voxel-wise morphological networks and to test the reliability of the proposed morphological connectivity. To this end, anatomical scans of a cohort of healthy subjects were obtained from a public database. The anatomical datasets were preprocessed and normalized to the standard brain space. For each individual, wavelet-transform was applied on the VBM measures to obtain voxel-wise hierarchical features. The voxel-wise morphological connectivity was computed based on the wavelet features. Reliable brain hubs were detected by the z-scores of degree centrality. High reliability was discovered by test-retest analysis. No effects of wavelet scale, network threshold or network type were found on hubs of group-level degree centrality. However, significant effects of wavelet scale, network threshold and network type were found on individual-level degree centrality. Significant effects of network threshold and network type were found on reliability of degree centrality. The results suggested that the voxel-wise morphological connectivity was reliable and exhibited a hub structure. Moreover, the voxel-wise morphological connectivity could reflect individual differences. In summary, individual voxel-wise wavelet-based features can probe morphological connectivity and may be beneficial for investigating the brain morphological connectomes.	[Wang, Xun-Heng; Li, Lihua] Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Peoples R China; [Jiao, Yun] Southeast Univ, Zhongda Hosp, Dept Radiol, Jiangsu Key Lab Mol & Funct Imaging,Med Sch, Nanjing, Jiangsu, Peoples R China	Hangzhou Dianzi University; Southeast University - China	Wang, XH; Li, LH (corresponding author), Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Peoples R China.	xhwang@hdu.edu.cn; lilh@hdu.edu.cn		Wang, Xun-Heng/0000-0002-0094-6862	National Natural Science Foundation of China [61601155, 81501453, 61731008, 61271063]; 973 Program [2013CB329502]; National Distinguished Young Research Scientist Award [60788101]; Zhejiang Provincial Natural Science Foundation of China [LZ15F010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Distinguished Young Research Scientist Award; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by grants from the National Natural Science Foundation of China (61601155, 81501453, 61731008, and 61271063), http://www.nsfc.gov.cn, 973 Program (2013CB329502), http://program.most.gov.cn, the National Distinguished Young Research Scientist Award (60788101), http://www.nsfc.gov.cn, and the Zhejiang Provincial Natural Science Foundation of China (LZ15F010001), http://www.zjnsf.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baum GL, 2018, NEUROIMAGE, V173, P275, DOI 10.1016/j.neuroimage.2018.02.041; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Dai Z., 2014, CEREB CORTEX, V25, P3723, DOI [10.1093/cercor/bhu246, DOI 10.1093/CERCOR/BHU246]; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Guo XJ, 2015, J MAGN RESON IMAGING, V42, P261, DOI 10.1002/jmri.24780; Hackmack K, 2012, NEUROIMAGE, V62, P48, DOI 10.1016/j.neuroimage.2012.05.022; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Canales-Rodriguez EJ, 2013, NEUROIMAGE, V72, P214, DOI 10.1016/j.neuroimage.2013.01.058; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Kong XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141840; Kong XZ, 2014, J NEUROSCI METH, V237, P103, DOI 10.1016/j.jneumeth.2014.09.003; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Pantazatos SP, 2014, NEUROIMAGE, V88, P61, DOI 10.1016/j.neuroimage.2013.11.011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schnack HG, 2010, HUM BRAIN MAPP, V31, P1967, DOI 10.1002/hbm.20991; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wang H, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.448; Wang X, 2013, NEUROSCIENCE, V254, P404, DOI 10.1016/j.neuroscience.2013.09.009; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	39	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201243	10.1371/journal.pone.0201243	http://dx.doi.org/10.1371/journal.pone.0201243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040855	gold, Green Submitted, Green Published			2022-12-27	WOS:000439749200033
J	Sander, S; Kappenstein, O; Ebner, I; Fritsch, KA; Schmidt, R; Pfaff, K; Luch, A				Sander, Stefan; Kappenstein, Oliver; Ebner, Ingo; Fritsch, Kai-Andre; Schmidt, Roman; Pfaff, Karla; Luch, Andreas			Release of aluminium and thallium ions from uncoated food contact materials made of aluminium alloys into food and food simulant	PLOS ONE			English	Article							DISSOLUTION; INCLUSIONS; FOIL	In order to investigate the release of aluminium ions from food contact materials, three different types of uncoated aluminium menu trays for single use were tested with the foodstuffs sauerkraut juice, apple sauce and tomato puree, as well as with the food simulants 5 g/L citric acid solution and artificial tap water. To mimic a consumer relevant exposure scenario, the aluminium trays were studied using time and temperature gradients according to the Cook & Chill method, also taking into account storage time at elevated temperatures during the delivery period. The release of aluminium was found to exceed the specific release limit (SRL) of 5 mg aluminium per kilogram of food specified by the Council of Europe by up to six times. Furthermore, a release of thallium was also detected unexpectedly. Kinetic studies showed a comparable behaviour in the release of aluminium, manganese and vanadium as components of the aluminium alloy itself. In contrast, thallium could be identified as a surface contaminant or impurity because of an entirely different kinetic curve. Kinetic studies also allowed activation energy calculations. Additional camping saucepans were tested as an article for repeated use. In three subsequent release experiments with citric acid (5 g/L), artificial tap water and tomato puree as benchmark foodstuffs, the results were comparable to those of the uncoated wrought alloy aluminium trays.	[Sander, Stefan; Kappenstein, Oliver; Ebner, Ingo; Fritsch, Kai-Andre; Schmidt, Roman; Pfaff, Karla; Luch, Andreas] Natl Reference Lab Food Contact Mat, Dept Chem & Prod Safety, German Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment	Kappenstein, O (corresponding author), Natl Reference Lab Food Contact Mat, Dept Chem & Prod Safety, German Fed Inst Risk Assessment, Berlin, Germany.	oliver.kappenstein@bfr.bund.de	Kappenstein, Oliver/GQH-4523-2022; Kappenstein, Oliver/AAB-4365-2020; Oliver, Kappenstein/L-1573-2019	Kappenstein, Oliver/0000-0003-0857-460X; Ebner, Ingo/0000-0003-1418-6312	Bundesinstitut fur Risikobewertung (BfR) [SFP 1322-513]	Bundesinstitut fur Risikobewertung (BfR)	This work was funded by Bundesinstitut fur Risikobewertung (BfR), project no. SFP 1322-513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.754; [Anonymous], 2008, 32645200811 DIN; [Anonymous], 2016, 10536 DIN; BfR, 2017, UNV AL MEN ERST FORS; BfR, THALL NAT MIN; BfR, 2015, SICH VERPFL BES EMPF; Brunner B, 1999, FLEISCHWIRTSCHAFT, V79, P110; Charles E., 2010, CHEMIE THIEME; CoE, 2004, VER EG NR 1935 2004; Czeslik HS C., 2010, BASISWISSEN PHYSIKAL; Davis J.R., 1999, CORROSION ALUMINIUM; DIN DIfNeV, 2004, 602 DIN EN, P2004; DIN DIfNeV, 2012, 10508 DIN; DIN DIfNeV, 2011, 10531 DIN; EDQM, 2013, MET ALL US FOOD CONT; Ewender J, 2014, PACKAG TECHNOL SCI, V27, P963, DOI 10.1002/pts.2085; Fekete V, 2012, FOOD ADDIT CONTAM A, V29, P1322, DOI 10.1080/19440049.2012.688068; Holleman A. F., 1995, WIBERG LEHRBUCH ANOR; JOHNSON E, 1993, PHIL MAG LETT, V68, P131, DOI 10.1080/09500839308240954; Karbouj R., 2008, TRANSFERT ALUMINIUM; Karbouj R, 2009, FOOD CHEM TOXICOL, V47, P571, DOI 10.1016/j.fct.2008.12.028; PALRECHA MM, 1986, ANALYST, V111, P375, DOI 10.1039/an9861100375; Poonam Rajwanshi VS, 1997, ENVIRON GEOCHEM HLTH, V19, P1; Rajwanshi P, 1997, ENVIRON GEOCHEM HLTH, V19, P1; Scancar J, 2004, FOOD CHEM, V85, P151, DOI 10.1016/j.foodchem.2003.07.028; Sorensen AH, 1997, PHILOS MAG A, V75, P1533, DOI 10.1080/01418619708223742; Stahl T., 2017, MIGRATION ALUMINUM 3; Stahl T, 2011, ALUMINIUM CONTENT SE, P1; Takeda Y, 1998, J FOOD HYG SOC JPN, V39, P178; Takeda Y, 1998, J FOOD HYG SOC JPN, V39, P266, DOI 10.3358/shokueishi.39.4_266	30	11	11	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200778	10.1371/journal.pone.0200778	http://dx.doi.org/10.1371/journal.pone.0200778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036389	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200015
J	Wu, JMT; Zhan, J; Chobe, S				Wu, Jimmy Ming-Tai; Zhan, Justin; Chobe, Sanket			Mining Association rules for Low-Frequency itemsets	PLOS ONE			English	Article							HIGH UTILITY ITEMSETS; ALGORITHM; PATTERNS; DISCOVERY	High utility itemset mining has become an important and critical operation in the Data Mining field. High utility itemset mining generates more profitable itemsets and the association among these itemsets, to make business decisions and strategies. Although, high utility is important, it is not the sole measure to decide efficient business strategies such as discount offers. It is very important to consider the pattern of itemsets based on the frequency as well as utility to predict more profitable itemsets. For example, in a supermarket or restaurant, beverages like champagne or wine might generate high utility (profit), but also sell less frequently compared to other beverages like soda or beer. In previous studies, it is observed that people who buy milk, bread, or diapers from a supermarket, also tend to buy beer or soda. But the items like milk, diapers, beer, or soda generate less utility (profit value) compared to beverages like champagne or wine. If we combine items like champagne or wine having high utility but less frequency, with the frequently sold items like milk, diaper, or beer, we can increase the utility of the transaction by providing some discount offers on champagne or wine. In this paper, we are integrating low-frequency itemsets with high-frequency itemsets, both having low or high utility, and provide different association rules for this combination of itemsets. In this way, we can generate a more accurate measure of pattern mining for various business strategies.	[Wu, Jimmy Ming-Tai; Zhan, Justin; Chobe, Sanket] Univ Nevada, Dept Comp Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Zhan, J (corresponding author), Univ Nevada, Dept Comp Sci, Las Vegas, NV 89154 USA.	justin.zhan@unlv.edu			United States Department of Defense [W91 1 NF-13-1-0130, 72140-NS-RIP]; National Science Foundation [1625677, 1560625, 1710716]; United Healthcare Foundation [1592]	United States Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); United Healthcare Foundation	This work was supported in part by the United States Department of Defense under Grant W91 1 NF-13-1-0130 and Grant 72140-NS-RIP, in part by the National Science Foundation under Grant 1625677, Grant 1560625, and Grant 1710716, and in part by the United Healthcare Foundation under Grant 1592. We gratefully acknowledge all the organizations for their support.r This work was supported in part by the United States Department of Defense under Grant W91 1 NF-13-1-0130 and Grant 72140-NS-RIP, in part by the National Science Foundation under Grant 1625677, Grant 1560625, and Grant 1710716, and in part by the United Healthcare Foundation under Grant 1592. We gratefully acknowledge all the organizations for their support.	Adinarayanareddy B, 2012, INT J COMPUTER APPL, V58, P25; Agrawal R, 1994, P 20 INT C VER LARG, P487, DOI DOI 10.1055/S-2007-996789; Ahmed CF, 2009, IEEE T KNOWL DATA EN, V21, P1708, DOI 10.1109/TKDE.2009.46; Vo B, 2013, EXPERT SYST APPL, V40, P1256, DOI 10.1016/j.eswa.2012.08.065; Chan R, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P19; Chen MS, 1996, IEEE T KNOWL DATA EN, V8, P866, DOI 10.1109/69.553155; Chu CJ, 2009, APPL MATH COMPUT, V215, P767, DOI 10.1016/j.amc.2009.05.066; Fournier-Viger Philippe, 2014, Foundations of Intelligent Systems. 21st International Symposium, ISMIS 2014. Proceedings: LNCS 8502, P83, DOI 10.1007/978-3-319-08326-1_9; Fournier-Viger P, 2016, LECT NOTES ARTIF INT, V9853, P36, DOI 10.1007/978-3-319-46131-1_8; Fournier-Viger P, 2016, LECT NOTES ARTIF INT, V9648, P53, DOI 10.1007/978-3-319-32034-2_5; Han JW, 2000, SIGMOD RECORD, V29, P1; Li YC, 2005, LECT NOTES ARTIF INT, V3614, P551; Lin CW, 2014, APPL INTELL, V40, P343, DOI 10.1007/s10489-013-0467-z; Liu JQ, 2012, IEEE DATA MINING, P984, DOI 10.1109/ICDM.2012.20; Liu Y, 2005, LECT NOTES ARTIF INT, V3518, P689; Mengchi Liu, 2012, P 21 ACM INT C INF K; Nathiarasan AS, 2014, 2014 INTERNATIONAL CONFERENCE ON CIRCUITS, COMMUNICATION, CONTROL AND COMPUTING (I4C), P317, DOI 10.1109/CIMCA.2014.7057815; Shankar S., 2010, INT J COMPUTER APPL, V1, P87; Shao JY, 2016, 2016 IEEE/CSAA INTERNATIONAL CONFERENCE ON AIRCRAFT UTILITY SYSTEMS (AUS), P1164, DOI 10.1109/AUS.2016.7748234; Shao JY, 2015, PROCEEDINGS OF THE 2015 IEEE INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (IEEE DSAA 2015), P549; Song W, 2014, APPL INTELL, V40, P29, DOI 10.1007/s10489-013-0443-7; Tseng V. S., 2010, KDD, P253, DOI [DOI 10.1145/1835804.1835839, 10.1145/1835804.1835839]; Tseng VS, 2013, IEEE T KNOWL DATA EN, V25, P1772, DOI 10.1109/TKDE.2012.59; Tzung-Pei Hong, 2001, Intelligent Data Analysis, V5, P111; Wang J, 2007, LECT NOTES COMPUT SC, V4489, P685; Xing S, 2015 8 INT S COMP IN; Yao H, 2004, SIAM PROC S, P482; Yao H, 2006, DATA KNOWL ENG, V59, P603, DOI 10.1016/j.datak.2005.10.004; Yen SJ, 2007, LECT NOTES COMPUT SC, V4654, P283; Yun U, 2014, KNOWL-BASED SYST, V55, P49, DOI 10.1016/j.knosys.2013.10.011; Yun U, 2013, INTELL DATA ANAL, V17, P917, DOI 10.3233/IDA-130612; Zida S, 2015, ADV ARTIFICIAL INTEL	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0198066	10.1371/journal.pone.0198066	http://dx.doi.org/10.1371/journal.pone.0198066			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036359	Green Published, gold			2022-12-27	WOS:000439429200001
J	Hernandez-Candia, CN; Casas-Flores, S; Gutierrez-Medina, B				Noemi Hernandez-Candia, Carmen; Casas-Flores, Sergio; Gutierrez-Medina, Braulio			Light induces oxidative damage and protein stability in the fungal photoreceptor Vivid	PLOS ONE			English	Article							LOV2 DOMAIN; AVENA-SATIVA; OXYGEN; FLAVOPROTEIN; AGGREGATION; PHOTOADAPTATION; PHOTOTROPIN; ARABIDOPSIS; NEUROSPORA; SCATTERING	Flavin-binding photoreceptor proteins sense blue-light (BL) in diverse organisms and have become core elements in recent optogenetic applications. The light-oxygen-voltage (LOV) protein Vivid (VVD) from the filamentous fungus Neurospora crassa is a classic BL photoreceptor, characterized by effecting a photocycle based on light-driven formation and subsequent spontaneous decay of a flavin-cysteinyl adduct. Here we report that VVD presents alternative outcomes to light exposure that result in protein self-oxidation and, unexpectedly, rise of stability through kinetic control. Using optical absorbance and mass spectrometry we show that purified VVD develops amorphous aggregates with the presence of oxidized residues located at the cofactor binding pocket. Light exposure increases oxidative levels in VVD and specific probe analysis identifies singlet oxygen production by the flavin. These results indicate that VVD acts alternatively as a photosensitizer, inducing self-oxidative damage and subsequent aggregation. Surprisingly, BL illumination has an additional, opposite effect in VVD. We show that light-induced adduct formation establishes a stable state, delaying protein aggregation until photoadduct decay occurs. In accordance, repeated BL illumination suppresses VVD aggregation altogether. Furthermore, photoadduct formation confers VVD stability against chemical denaturation. Analysis of the aggregation kinetics and testing of stabilizers against aggregation reveal that aggregation in VVD proceeds through light-dependent kinetic control and dimer formation. These results uncover the aggregation pathway of a photosensor, where light induces a remarkable interplay between protein damage and stability.	[Noemi Hernandez-Candia, Carmen; Casas-Flores, Sergio; Gutierrez-Medina, Braulio] Inst Potosino Invest Cient & Tecnol, Div Mol Biol, San Luis Potosi, Mexico; [Gutierrez-Medina, Braulio] Inst Potosino Invest Cient & Tecnol, Div Adv Mat, San Luis Potosi, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; Instituto Potosino Investigacion Cientifica y Tecnologica	Gutierrez-Medina, B (corresponding author), Inst Potosino Invest Cient & Tecnol, Div Mol Biol, San Luis Potosi, Mexico.; Gutierrez-Medina, B (corresponding author), Inst Potosino Invest Cient & Tecnol, Div Adv Mat, San Luis Potosi, Mexico.	bgutierrez@ipicyt.edu.mx	Casas-Flores, Sergio/S-6985-2019	Casas-Flores, Sergio/0000-0002-9612-9268; Gutierrez-Medina, Braulio/0000-0003-2810-6774	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico) [SEP-CB-2013-01-223377, IFC-2015-2/1144, SEP-CB-2013-01-220791, LINAN-56787, INFRA-2013-01-204373]; CONACYT [CVU-330541]	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico, www.conacyt.gob.mx), grants SEP-CB-2013-01-223377 and IFC-2015-2/1144 to B.G.-M., SEP-CB-2013-01-220791 to S.C.-F., LINAN-56787 and INFRA-2013-01-204373. C.N.H.-C. is indebted to CONACYT for a Ph.D. scholarship, CVU-330541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Borgia MB, 2013, J AM CHEM SOC, V135, P6456, DOI 10.1021/ja308852b; Buckley AM, 2015, CURR OPIN CHEM BIOL, V27, P39, DOI 10.1016/j.cbpa.2015.05.011; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Conrad KS, 2014, NAT CHEM BIOL, V10, P801, DOI [10.1038/NCHEMBIO.1633, 10.1038/nchembio.1633]; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Finn TE, 2012, J BIOL CHEM, V287, P21530, DOI 10.1074/jbc.M112.372961; Gin E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.24; Grewal RK, 2015, BIOINFORMATICS, V31, P3608, DOI 10.1093/bioinformatics/btv429; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hunt SM, 2007, GENE DEV, V21, P1964, DOI 10.1101/gad.437107; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Lee CT, 2014, J MOL BIOL, V426, P601, DOI 10.1016/j.jmb.2013.10.035; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Losi A, 2017, PHOTOCHEM PHOTOBIOL, V93, P141, DOI 10.1111/php.12674; Massey V, 2002, INT CONGR SER, V1233, P3, DOI 10.1016/S0531-5131(02)00519-8; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Penzkofer A, 2007, CHEM PHYS, V342, P55, DOI 10.1016/j.chemphys.2007.09.014; Schuttrigkeit TA, 2003, CHEM PHYS, V294, P501, DOI 10.1016/S0301-0104(03)00390-2; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Vaidya AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001945; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; Yee EF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10079; Zoltowski B. D., 2009, THESIS; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201028	10.1371/journal.pone.0201028	http://dx.doi.org/10.1371/journal.pone.0201028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028876	Green Submitted, gold, Green Published			2022-12-27	WOS:000439396900033
J	Biswas, C; Rao, S; Slade, K; Hyman, D; Dersh, D; Mantegazza, AR; Zoltick, PW; Marks, MS; Argon, Y; Behrens, EM				Biswas, Chhanda; Rao, Sheila; Slade, Katharine; Hyman, David; Dersh, Devin; Mantegazza, Adriana R.; Zoltick, Philip W.; Marks, Michael S.; Argon, Yair; Behrens, Edward M.			Tyrosine 870 of TLR9 is critical for receptor maturation rather than phosphorylation-dependent ligand-induced signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOPLASMIC-RETICULUM; GENE-REGULATION; TETRACYCLINE RESISTANCE; PROTEOLYTIC CLEAVAGE; ADAPTER PROTEIN-3; MASTER CHAPERONE; STRUCTURAL BASIS; INNATE IMMUNITY; TET REPRESSOR	Toll like receptors (TLRs) share a conserved structure comprising the N-terminal ectodomain, a transmembrane segment and a C-terminal cytoplasmic Toll/IL-1 receptor (TIR) domain. Proper assembly of the TIR domain is crucial for signal transduction; however, the contribution of individual motifs within the TIR domain to TLR trafficking and signaling remains unclear. We targeted a highly conserved tyrosine (Y870) located in the box 1 region of the TIR domain of most TLRs, including TLR9, previously described to be a critical site of phosphorylation in TLR4. We reconstituted bone marrow-derived dendritic cells (BMDC) from Tlr9(-/-) mice WT TLR9 or Y870F or Y870A mutants. Despite normal interactions with the luminal chaperones GRP94 and UNC93B1, Y870F conferred only partial responsiveness to CpG, and Y870A had no activity and functioned as a dominant negative inhibitor when coexpressed with endogenous TLR9. This loss of function correlated with reduction or absence, respectively, of the 80 kDa mature form of TLR9. In Y870E-expressing cells, CpG-dependent signaling correlated directly with levels of the mature form, suggesting that signaling did not require tyrosine phosphorylation but rather that the Y870F mutation conferred reduced receptor levels due to defective processing or trafficking. Microscopy revealed targeting of the mutant protein to an autophagolysosome-like structure for likely degradation. Collectively we postulate that the conserved Y870 in the TIR domain does not participate in phosphorylation-induced signaling downstream of ligand recognition, but rather is crucial for proper TIR assembly and ER egress, resulting in maturation-specific stabilization of TLR9 within endolysosomes and subsequent pro-inflammatory signaling.	[Biswas, Chhanda; Rao, Sheila; Slade, Katharine; Hyman, David; Zoltick, Philip W.; Behrens, Edward M.] Childrens Hosp Philadelphia, Div Pediat Rheumatol, Philadelphia, PA 19104 USA; [Dersh, Devin; Mantegazza, Adriana R.; Marks, Michael S.; Argon, Yair] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Behrens, EM (corresponding author), Childrens Hosp Philadelphia, Div Pediat Rheumatol, Philadelphia, PA 19104 USA.	Behrens@email.chop.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262; Mantegazza, Adriana/0000-0002-7583-0231	Nancy Taylor Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121323] Funding Source: NIH RePORTER	Nancy Taylor Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Nancy Taylor Foundation to EMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dennis MK, 2015, J CELL BIOL, V209, P563, DOI 10.1083/jcb.201410026; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Hasan M, 2016, J LEUKOCYTE BIOL, V100, P525, DOI 10.1189/jlb.2A0815-337R; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Mantegazza AR, 2012, IMMUNITY, V36, P782, DOI 10.1016/j.immuni.2012.02.018; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medvedev AE, 2013, J INTERF CYTOK RES, V33, P467, DOI 10.1089/jir.2012.0140; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sinha SS, 2016, J IMMUNOL, V197, P1343, DOI 10.4049/jimmunol.1502357; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200913	10.1371/journal.pone.0200913	http://dx.doi.org/10.1371/journal.pone.0200913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024926	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000066
J	De Leon, MP; Montecillo, AD; Pinili, DS; Siringan, MAT; Park, DS				De Leon, Marian P.; Montecillo, Andrew D.; Pinili, Dale S.; Siringan, Maria Auxilia T.; Park, Doo-Sang			Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RESERVOIR HOSTS; ECOLOGY; HISTOPLASMOSIS; ENVIRONMENTS; PATHOGENS; CARRIAGE; GENOMICS; TRINIDAD; VIRUSES	Bats are highly diverse and ecologically valuable mammals. They serve as host to bacteria, viruses and fungi that are either beneficial or harmful to its colony as well as to other groups of cave organisms. The bacterial diversity of two bat guano samples, C1 and C2, from Cabalyorisa Cave, Mabini, Pangasinan, Philippines were investigated using 16S rRNA gene amplicon sequencing. V3-V4 hypervariable regions were amplified and then sequenced using Illumina MiSeq 250 PE system. Reads were processed using Mothur and QIIME pipelines and assigned 12,345 OTUs for C1 and 5,408 OTUs for C2. The most dominant OTUs in C1 belong to the Proteobacteria (61.7%), Actinobacteria (19.4%), Bacteroidetes (4.2%), Firmicutes (2.7%), Chloroflexi (2.5%), candidate phylum TM7 (2.3%) and Planctomycetes (1.9%) while Proteobacteria (61.7%) and Actinobacteria (34.9%) dominated C2. Large proportion of sequence reads mainly associated with unclassified bacteria indicated possible occurrence of novel bacteria in both samples. XRF spectrophotometric analyses of C1 and C2 guano revealed significant differences in the composition of both major and trace elements. C1 guano recorded high levels of Si, Fe, Mg, Al, Mn, Ti and Cu while C2 samples registered high concentrations of Ca, P, S, Zn and Cr. Community structure of the samples were compared with other published community profiling studies from Finland (SRR868695), Meghalaya, Northeast India (SRR1793374) and Maharashtra State, India (CGS). Core microbiome among samples were determined for comparison. Variations were observed among previously studied guano samples and the Cabalyorisa Cave samples were attributed to either bat sources or age of the guano. This is the first study on bacterial diversity of guano in the Philippines through high-throughput sequencing.	[De Leon, Marian P.] Univ Philippines Los Banos, Museum Nat Hist, Microbial Culture Collect, Laguna, Philippines; [Montecillo, Andrew D.] Univ Philippines Los Banos, Coll Arts & Sci, Inst Biol Sci, Microbiol Div, Laguna, Philippines; [Pinili, Dale S.] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Laguna, Philippines; [Siringan, Maria Auxilia T.] Univ Philippines Diliman, Nat Sci Res Inst, Microbiol Res & Serv Lab, Quezon City, Philippines; [Park, Doo-Sang] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Korean Collect Type Cultures, Jeongeup, South Korea	University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos; CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Diliman; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	De Leon, MP (corresponding author), Univ Philippines Los Banos, Museum Nat Hist, Microbial Culture Collect, Laguna, Philippines.	mpdeleon1@up.edu.ph		Pulido De Leon, Marian/0000-0002-7542-6175	Department of Agriculture-Bureau of Agricultural Research (DA-BAR); University of the Philippines Diliman, Natural Sciences Research Institute (UP NSRI); Next Generation Sequencing by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea [NRF-2016M3A9A5919255]; University of the Philippines Diliman Natural Sciences Research Institute (UP NSRI)	Department of Agriculture-Bureau of Agricultural Research (DA-BAR); University of the Philippines Diliman, Natural Sciences Research Institute (UP NSRI); Next Generation Sequencing by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea; University of the Philippines Diliman Natural Sciences Research Institute (UP NSRI)	The post-doctoral research fellowship was funded by the Department of Agriculture-Bureau of Agricultural Research (DA-BAR) and University of the Philippines Diliman, Natural Sciences Research Institute (UP NSRI) and the Next Generation Sequencing by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea (NRF-2016M3A9A5919255).; The authors acknowledge the Department of Agriculture-Bureau of Agricultural Research (DA-BAR) and University of the Philippines Diliman Natural Sciences Research Institute (UP NSRI) for providing the Post-Doctoral Fellowship to Dr. Marian P. De Leon. The fellowship host scientist, Dr. Maria Auxilia T. Siringan, Curator of the University of the Philippines Culture Collection (UPCC) and Head of Microbiological Research and Services Laboratory (MRSL) and the MRSL Researchers and Administrative staff for the assistance in the conduct of the laboratory experiments. The Next Generation Sequencing was funded by the project of Dr. Doo-Sang Park through the National Research Foundation of Korea (NRF-2016M3A9A5919255). Mr. James DV. Alvarez, Mr. Edison A. Cosico and Mr. Manuel M. Baldovino of the UPLB Museum of Natural History and Mr. John Mark A. Encinares of Institute of Biological Science, UPLB provided the technical and field assistance during the sample collection and identification of bats in Cabalyorisa Cave. The Balincaguin Conservancy, Inc. (BC), especially to Mr. Rawen Balmana, Mr. Guillermo Rendon, Mr. Oliver Barao and his son, Mr. Russel Barao, who accompanied Dr. De Leon in the fieldwork, conducted photo documentation and ensured the safety of the team. The local government of Mabini, headed by the former Honorable Mayor Carlitos Reyes, for the provision of technical and manpower assistance during the fieldwork and the Department of Environment and Natural Resources for the issuance of gratuitous permit.	Adesiyun AA, 2009, J WILDLIFE DIS, V45, P952, DOI 10.7589/0090-3558-45.4.952; Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Allocati N, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.48; Banskar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36948; Banskar S, 2016, MICROBIOL RES, V182, P99, DOI 10.1016/j.micres.2015.10.006; Reyes AWB, 2011, ACTA SCI VET, V39; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; BROWN D, 1988, JAMA-J AM MED ASSOC, V260, P2510, DOI 10.1001/jama.1988.03410170058033; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrillo-Araujo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00447; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Cooper Lisa Noelle, 2013, P3; D'Auria SRN, 2010, VECTOR-BORNE ZOONOT, V10, P459, DOI 10.1089/vbz.2009.0070; De Mandal S, 2015, GENOM DATA, V4, P99, DOI 10.1016/j.gdata.2015.04.001; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Encinares JMA, 2016, THESIS; Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348; Fenton MB, 2003, WILDLIFE SOC B, V31, P6; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Goodman SM, 2006, ORYX, V40, P225, DOI 10.1017/S0030605306000354; Groth I, 1999, GEOMICROBIOL J, V16, P1, DOI 10.1080/014904599270703; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hazeleger W. C., 2010, 15 BAT RES C PRAQ CZ, P72; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hoyt JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121329; Ingle NR, 1992, FIELDIANA; IUCN SSC, 2014, IUCN SSC GUID MIN NE; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Jones G., 2009, ENDANGER SPECIES RES, V8, P3; Kasso M, 2013, ECOLOGICAL EC IMPORT, V2013, P1; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Kobayashi Y, 2006, J VET MED SCI, V68, P1097, DOI 10.1292/jvms.68.1097; Kuzmin IV, 2011, VECTOR-BORNE ZOONOT, V11, P1465, DOI 10.1089/vbz.2011.0663; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee S, 2014, ISME J, V8, P493, DOI 10.1038/ismej.2013.167; Lei BNR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002738; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lyon GM, 2004, AM J TROP MED HYG, V70, P438, DOI 10.4269/ajtmh.2004.70.438; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Municipal Government of Mabini [LGU-Mabini], 2014, MUN COMP LAND USE PL; Niyomvong N, 2012, CHIANG MAI J SCI, V39, P373; Northup DE, 1997, NATL SPELEO SOC NEW, V55, P11; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; Poisot T, 2013, ECOL EVOL, V3, P1125, DOI 10.1002/ece3.508; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rahuma N, 2005, ANN TROP MED PARASIT, V99, P795, DOI 10.1179/136485905X65134; Rapin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112285; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHACKLETTE MH, 1962, SCIENCE, V135, P1135, DOI 10.1126/science.135.3509.1135; Smythe LD, 2002, J WILDLIFE DIS, V38, P182, DOI 10.7589/0090-3558-38.1.182; Tomova I, 2013, INT J SPELEOL, V42, P65, DOI 10.5038/1827-806X.42.1.8; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Wales AD, 2010, ZOONOSES PUBLIC HLTH, V57, P299, DOI 10.1111/j.1863-2378.2008.01222.x; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zdanowski MK, 2004, FEMS MICROBIOL ECOL, V50, P163, DOI 10.1016/j.femsec.2004.06.012	66	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200095	10.1371/journal.pone.0200095	http://dx.doi.org/10.1371/journal.pone.0200095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024917	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000015
J	Mazzeo, MF; Cacace, G; Iovieno, P; Massarelli, I; Grillo, S; Siciliano, RA				Mazzeo, Maria Fiorella; Cacace, Giuseppina; Iovieno, Paolo; Massarelli, Immacolata; Grillo, Stefania; Siciliano, Rosa Anna			Response mechanisms induced by exposure to high temperature in anthers from thermo-tolerant and thermo-sensitive tomato plants: A proteomic perspective	PLOS ONE			English	Article							HEAT-STRESS RESPONSE; MALE REPRODUCTIVE DEVELOPMENT; ADENOSYL-L-METHIONINE; ORYZA-SATIVA L.; LYCOPERSICON-ESCULENTUM; RICE ANTHERS; PHYSIOLOGICAL PROCESSES; SOLANUM-LYCOPERSICON; MOLECULAR-MECHANISMS; POLLEN DEVELOPMENT	Constant global warming is one of the most detrimental environmental factors for agriculture causing significant losses in productivity as heat stress (HS) conditions damage plant growth and reproduction. In flowering plants such as tomato, HS has drastic repercussions on development and functionality of male reproductive organs and pollen. Response mechanisms to HS in tomato anthers and pollen have been widely investigated by transcriptomics; on the contrary, exhaustive proteomic evidences are still lacking. In this context, a differential proteomic study was performed on tomato anthers collected from two genotypes (thermo-tolerant and thermo-sensitive) to explore stress response mechanisms and identify proteins possibly associated to thermo-tolerance. Results showed that HS mainly affected energy and amino acid metabolism and nitrogen assimilation and modulated the expression of proteins involved in assuring protein quality and ROS detoxification. Moreover, proteins potentially associated to thermo-tolerant features, such as glutamine synthetase, S-adenosylmethionine synthase and polyphenol oxidase, were identified.	[Mazzeo, Maria Fiorella; Cacace, Giuseppina; Siciliano, Rosa Anna] Natl Res Council Italy, CNR ISA, Inst Food Sci, Avellino, Italy; [Iovieno, Paolo; Massarelli, Immacolata; Grillo, Stefania] Natl Res Council Italy, CNR IBBR, Inst Biosci & Bioresources, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Mazzeo, MF (corresponding author), Natl Res Council Italy, CNR ISA, Inst Food Sci, Avellino, Italy.	fmazzeo@isa.cnr.it	Iovieno, Paolo/ABF-2160-2020; Mazzeo, Maria Fiorella/AAX-7262-2020; Siciliano, Rosa Anna/G-9822-2013; Iovieno, Paolo/P-2747-2018	Mazzeo, Maria Fiorella/0000-0003-1542-0027; Iovieno, Paolo/0000-0002-6938-2735	Italian Ministry of Education, University and Scientific Research (GenoPOM Project) [12 DM 593/00]	Italian Ministry of Education, University and Scientific Research (GenoPOM Project)	This work was supported by funding from the Italian Ministry of Education, University and Scientific Research (GenoPOM Project, art 12 DM 593/00) to RAS and SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz A, 2009, PEPTIDES, V30, P1600, DOI 10.1016/j.peptides.2009.06.005; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bita CE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-384; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; Brukhin V, 2003, SEX PLANT REPROD, V15, P311, DOI 10.1007/s00497-003-0167-7; Chaturvedi P, 2016, PLANT REPROD, V29, P119, DOI 10.1007/s00497-016-0283-9; Chaturvedi P, 2015, J PROTEOME RES, V14, P4463, DOI 10.1021/pr501240n; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P1881, DOI 10.1111/pce.12396; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Ghatak A, 2017, J PROTEOMICS, V169, P41, DOI 10.1016/j.jprot.2017.05.016; Giorno Filomena, 2013, Plants-Basel, V2, P489, DOI 10.3390/plants2030489; Giorno F, 2010, J EXP BOT, V61, P453, DOI 10.1093/jxb/erp316; Gong B, 2014, PLANT BIOTECHNOL J, V12, P694, DOI 10.1111/pbi.12173; Gonzalez-Schain N, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv174; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; HURKMAN WJ, 1988, ELECTROPHORESIS, V9, P781, DOI 10.1002/elps.1150091114; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; IWAHORI S., 1966, Engei Gakkai Zasshi = Journal of the Japanese Society of Horticultural Science, V35, P379; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jang SJ, 2012, MOL CELLS, V34, P251, DOI 10.1007/s10059-012-0067-5; Johnova P, 2016, BBA-PROTEINS PROTEOM, V1864, P916, DOI 10.1016/j.bbapap.2016.02.007; Kim M, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/238704; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kosova K, 2015, INT J MOL SCI, V16, P20913, DOI 10.3390/ijms160920913; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Liu JX, 2011, MOL PLANT, V4, P59, DOI 10.1093/mp/ssq039; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Mazzeo MF, 2014, PLANT PHYSIOL BIOCH, V74, P42, DOI 10.1016/j.plaphy.2013.10.031; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mu QL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091811; Muller F, 2016, PLANT REPROD, V29, P107, DOI 10.1007/s00497-016-0282-x; Nguyen TN, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0717-4; Paupiere MJ, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1927-z; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Pucciariello C, 2012, PLANT PHYSIOL BIOCH, V59, P3, DOI 10.1016/j.plaphy.2012.02.016; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Robbins ML, 2013, J PROTEOMICS, V93, P254, DOI 10.1016/j.jprot.2013.06.018; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Sarhadi E, 2012, PLANT PHYSIOL BIOCH, V58, P280, DOI 10.1016/j.plaphy.2012.07.013; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; Sato S, 2002, J EXP BOT, V53, P1187, DOI 10.1093/jexbot/53.371.1187; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; Singh RP, 2013, ADV AGRON, V118, P49, DOI 10.1016/B978-0-12-405942-9.00002-5; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Uvackova L, 2012, J PROTEOMICS, V75, P1886, DOI 10.1016/j.jprot.2011.12.033; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; XU JM, 2017, EUPHYTICA, V213; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zhang ZB, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600458; Zhou SP, 2011, J AM SOC HORTIC SCI, V136, P219, DOI 10.21273/JASHS.136.3.219	53	17	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201027	10.1371/journal.pone.0201027	http://dx.doi.org/10.1371/journal.pone.0201027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024987	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000080
J	Tang, JF; Lee, CH; Hsu, TH; Lo, HC				Tang, Ju-Fang; Lee, Chien-Hsing; Hsu, Tai-Hao; Lo, Hui-Chen			Potential activities and mechanisms of extracellular polysaccharopeptides from fermented Trametes versicolor on regulating glucose homeostasis in insulin-resistant HepG2 cells	PLOS ONE			English	Article							MEDICINAL MUSHROOMS; POLYSACCHARIDES; CULTURE; METABOLISM; MANAGEMENT; 2-NBDG	Polysaccharides derived from mushrooms have potential to control blood sugar, reduce insulin resistance and prevent diabetic complications. The intracellular polysaccharopeptides of Trametes versicolor (TV) have been used as immunologic and oncologic adjuvants. The aim of this study was to investigate the potential activities and mechanisms of extracellular polysaccharopeptides (ePSP) obtained from TV strain LH-1 on regulating glucose homeostasis. Human hepatoma HepG2 cells incubated with normal glucose (5.5 mM, NG model), high glucose (33 mM, HG model), or high glucose (33 mM) plus high insulin (10(-7) M, HGI model) concentrations were administered with TV LH-1 ePSP (50, 100, and 1000 mu g/ml) for 24 hr. Glucose uptake of HepG2 cells, determined by flow cytometry, was significantly decreased in the HG and HGI models with insulin stimulation, suggesting insulin resistance of these cells; however, ePSP reversed this decrease in a dose-dependent manner (one-way ANOVA, p<0.05). In the HG and HGI models, ePSP significantly increased glycogen content, insulin receptor substrate-2 protein and phosphorylated AMP-activated protein kinase (AMPK), as determined by western blot analysis. In addition, ePSP significantly increased glucokinase in the NG and HG models, increased membrane glucose transporter-1 and decreased glycogen synthase kinase-3 beta in the HGI model, and increased glucose-6-phosphatase in the NG and HGI models (one-way ANOVA, p<0.05). In summary, TV LH-1 ePSP may elevate cellular glucose uptake to regulate glucose homeostasis via the activation of AMPK and glycogen synthesis in an insulin-independent manner. These results suggest that TV LH-1 ePSP may be a nutraceutical with anti-hyperglycemic activity.	[Tang, Ju-Fang; Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei, Taiwan; [Lee, Chien-Hsing] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Lee, Chien-Hsing] China Med Univ, Dept Surg, Div Pediat Surg, Childrens Hosp, Taichung, Taiwan; [Hsu, Tai-Hao] Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan; [Hsu, Tai-Hao] Da Yeh Univ, Dept Med Bot & Hlth Care, Changhua, Taiwan	Fu Jen Catholic University; China Medical University Taiwan; China Medical University Taiwan; Da Yeh University; Da Yeh University	Lo, HC (corresponding author), Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei, Taiwan.	041663@mail.fju.edu.tw	Lo, Hui-Chen/AAN-5906-2021		Ministry of Economic Affairs of Taiwan [97-EC-17-A-17-S1-115]	Ministry of Economic Affairs of Taiwan(Ministry of Economic Affairs, Taiwan)	This study was supported by a grant from the Ministry of Economic Affairs (97-EC-17-A-17-S1-115) of Taiwan.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Chang TJ, 2012, J FORMOS MED ASSOC, V111, P605, DOI 10.1016/j.jfma.2012.09.011; Chang YJ, 2017, DISCOV MED, V23, P207; Chay WY, 2017, J ALTERN COMPLEM MED, V23, P648, DOI 10.1089/acm.2016.0136; Chen CH, 2015, J AGR FOOD CHEM, V63, P9232, DOI 10.1021/acs.jafc.5b02668; Donatini B, 2014, INT J MED MUSHROOMS, V16, P497, DOI 10.1615/IntJMedMushrooms.v16.i5.80; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Guo W, 2006, AM J PHYSIOL-GASTR L, V290, pG528, DOI 10.1152/ajpgi.00386.2005; Hsu WK, 2013, CARBOHYD POLYM, V92, P297, DOI 10.1016/j.carbpol.2012.10.001; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jhan MH, 2016, MOLECULES, V21, DOI 10.3390/molecules21091215; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Knezevic A., 2015, SCI WORLD J, P1, DOI DOI 10.1155/2015/146378; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Lai CH, 2011, INT J MED MUSHROOMS, V13, P227, DOI 10.1615/IntJMedMushr.v13.i3.20; Lin FY, 2008, FOOD CHEM, V110, P446, DOI 10.1016/j.foodchem.2008.02.023; Lo HC, 2011, INT J MED MUSHROOMS, V13, P401, DOI 10.1615/IntJMedMushr.v13.i5.10; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Otsuka Y., 2013, INT J NUTR FOOD SCI, V2, P85, DOI DOI 10.11648/j.ijnfs.20130202.19; Pandey A, 2011, J PHARM BIOALLIED SC, V3, P504, DOI 10.4103/0975-7406.90103; Julian MT, 2015, WORLD J DIABETES, V6, P321, DOI 10.4239/wjd.v6.i2.321; Yang JP, 2012, CARBOHYD POLYM, V90, P174, DOI 10.1016/j.carbpol.2012.05.011; Yeung JHK, 2012, PHYTOMEDICINE, V19, P457, DOI 10.1016/j.phymed.2011.09.077; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yu ZT, 2013, PLANT FOOD HUM NUTR, V68, P107, DOI 10.1007/s11130-013-0342-4; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang HJ, 2009, J FOOD SCI, V74, pH1, DOI 10.1111/j.1750-3841.2008.00976.x; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	31	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201131	10.1371/journal.pone.0201131	http://dx.doi.org/10.1371/journal.pone.0201131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024975	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000091
J	Fleischmann-Struzek, C; Thomas-Ruddel, DO; Schettler, A; Schwarzkopf, D; Stacke, A; Seymour, CW; Haas, C; Dennler, U; Reinhart, K				Fleischmann-Struzek, Carolin; Thomas-Rueddel, Daniel O.; Schettler, Anna; Schwarzkopf, Daniel; Stacke, Angelika; Seymour, Christopher W.; Haas, Christoph; Dennler, Ulf; Reinhart, Konrad			Comparing the validity of different ICD coding abstraction strategies for sepsis case identification in German claims data	PLOS ONE			English	Article							30-DAY MORTALITY-RATES; UNITED-STATES; DEFINITIONS; FRAMEWORK	Introduction Administrative data are used to generate estimates of sepsis epidemiology and can serve as source for quality indicators. Aim was to compare estimates on sepsis incidence and mortality based on different ICD-code abstraction strategies and to assess their validity for sepsis case identification based on a patient sample not pre-selected for presence of sepsis codes. Materials and methods We used the national DRG-statistics for assessment of population-level sepsis incidence and mortality. Cases were identified by three previously published International Statistical Classification of Diseases (ICD) coding strategies for sepsis based on primary and secondary discharge diagnoses (clinical sepsis codes (R-codes), explicit coding (all sepsis codes) and implicit coding (combined infection and organ dysfunction codes)). For the validation study, a stratified sample of 1120 adult patients admitted to a German academic medical center between 2007 +/- 2013 was selected. Administrative diagnoses were compared to a gold standard of clinical sepsis diagnoses based on manual chart review. Results In the validation study, 151/937 patients had sepsis. Explicit coding strategies performed better regarding sensitivity compared to R-codes, but had lower PPV. The implicit approach was the most sensitive for severe sepsis; however, it yielded a considerable number of false positives. R-codes and explicit strategies underestimate sepsis incidence by up to 3.5-fold. Between 2007 +/- 2013, national sepsis incidence ranged between 231-1006/100,000 person-years depending on the coding strategy. Conclusions In the sample of a large tertiary care hospital, ICD-coding strategies for sepsis differ in their accuracy. Estimates using R-codes are likely to underestimate the true sepsis incidence, whereas implicit coding overestimates sepsis cases. Further multi-center evaluation is needed to gain better understanding on the validity of sepsis coding in Germany.	[Fleischmann-Struzek, Carolin; Thomas-Rueddel, Daniel O.; Schwarzkopf, Daniel; Reinhart, Konrad] Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany; [Thomas-Rueddel, Daniel O.; Schettler, Anna; Stacke, Angelika; Reinhart, Konrad] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Seymour, Christopher W.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Seymour, Christopher W.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Haas, Christoph; Dennler, Ulf] Jena Univ Hosp, Div Med Controlling, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Friedrich Schiller University of Jena	Reinhart, K (corresponding author), Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany.; Reinhart, K (corresponding author), Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany.	konrad.reinhart@med.uni-jena.de	Thomas-Rüddel, Daniel/B-4380-2013; Schwarzkopf, Daniel/F-8287-2018	Thomas-Rüddel, Daniel/0000-0001-9143-8566; Schwarzkopf, Daniel/0000-0002-1568-8202; Fleischmann, Carolin/0000-0002-1104-3191	German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC) [FKZ: 01EO1002, 01EO1502]; National Institutes of Health [R35GM119519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119519] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KR, DTR, CF and DS receive grants from the German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC; FKZ: 01EO1002 and 01EO1502). KR is unpaid chairman of the Global Sepsis Alliance and shareholder of InflaRx Jena, a University spin-off that develops adjunctive therapies for systemic inflammation. CWS was supported in part by a grant from the National Institutes of Health (R35GM119519). The funding agencies played no role in the study design or analysis of data.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2016, CRIT CARE MED, V44, pE113, DOI 10.1097/CCM.0000000000001730; Bloos F, 2014, CRIT CARE, V18, DOI 10.1186/cc13755; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Falotico R., 2010, ITAL J APPL STAT, V22, P151; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Jolley RJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0847-3; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lagu T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.004; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mellhammar L., 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw207, DOI 10.1093/OFID/OFW207]; Mikolajetz A, 2018, 38 INT S INT CAR EM; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Qualita E, 2015, G IQI GERM INP QUAL, V1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reinhart K, 2010, Ger Med Sci, V8, pDoc14, DOI 10.3205/000103; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; RHEE C, 2017, AM J RESP CRIT CARE, V195; Seymour CW, 2016, CRIT CARE MED, V44, pE122, DOI 10.1097/CCM.0000000000001724; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Team RDC, 2014, R LANG ENV STAT COMP; Walkey AJ, 2015, ANN AM THORAC SOC, V12, P216, DOI 10.1513/AnnalsATS.201411-498BC; Weiner Mark G, 2006, AMIA Annu Symp Proc, P1140; Whittaker SA, 2013, CRIT CARE MED, V41, P945, DOI 10.1097/CCM.0b013e31827466f1; World Health Organization, 2017, IMPR PREV DIAGN CLIN	34	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0198847	10.1371/journal.pone.0198847	http://dx.doi.org/10.1371/journal.pone.0198847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059504	Green Published, gold, Green Submitted			2022-12-27	WOS:000440251600003
J	Stavropoulos, V; Mastrotheodoros, S; Burleigh, TL; Papadopoulos, N; Gomez, R				Stavropoulos, Vasileios; Mastrotheodoros, Stefanos; Burleigh, Tyrone L.; Papadopoulos, Nicole; Gomez, Rapson			Avoidant romantic attachment in adolescence: Gender, excessive internet use and romantic relationship engagement effects	PLOS ONE			English	Article							SEXUAL RELATIONSHIPS; YOUNG-ADULTS; ASSOCIATIONS; EXPERIENCES; ADDICTION; MULTILEVEL; STABILITY; SUPPORT; TRAJECTORIES; RESILIENCE	Romantic development is a distinctive characteristic of puberty. However, a significant proportion of adolescents present with avoidant romantic attachment (ARA) tendencies, which have significant impact on their general adaptation. ARA variations have been suggested in relation to age, gender, engagement with a romantic partner and Excessive Internet Use (EIU) behaviours. In this longitudinal, two-wave study of a normative sample of 515 Greek adolescents at 16 and 18 years, ARA was assessed with the relevant subscale of the Experiences in Close Relationships-Revised and EIU with the Internet Addiction Test. A three-level hierarchical linear model found ARA tendencies to decrease between 16 and 18 while engagement in a romantic relationship and EIU were associated with lower and higher ARA tendencies respectively. Gender did not differentiate ARA severity either at the age of 16 or its changes over time. Results highlight the need of adopting a longitudinal-contextualized approach and provide implications for prevention and intervention initiatives in relation to the romantic development of adolescents.	[Stavropoulos, Vasileios; Mastrotheodoros, Stefanos] Univ Athens, Sch Psychol, Athens, Attica, Greece; [Stavropoulos, Vasileios] Cairnmillar Inst, Sch Psychol, Melbourne, Vic, Australia; [Mastrotheodoros, Stefanos] Univ Utrecht, Res Ctr Adolescent Dev Child & Adolescent Studies, Utrecht, Netherlands; [Burleigh, Tyrone L.; Gomez, Rapson] Federat Univ, Sch Psychol, Mt Helen, Vic, Australia; [Papadopoulos, Nicole] Deakin Univ, Sch Psychol, Burwood, Vic, Australia	National & Kapodistrian University of Athens; Utrecht University; Federation University Australia; Deakin University	Mastrotheodoros, S (corresponding author), Univ Athens, Sch Psychol, Athens, Attica, Greece.; Mastrotheodoros, S (corresponding author), Univ Utrecht, Res Ctr Adolescent Dev Child & Adolescent Studies, Utrecht, Netherlands.	s.mastrotheodoros@uu.nl	Stavropoulos, Vasileios/Y-9906-2018; Mastrotheodoros, Stefanos/R-8565-2019; Mastrotheodoros, Stefanos/GRJ-7652-2022	Stavropoulos, Vasileios/0000-0001-6964-4662; Mastrotheodoros, Stefanos/0000-0002-0936-6143; Burleigh, Tyrone/0000-0002-3405-140X				Allen JP, 2004, CHILD DEV, V75, P1792, DOI 10.1111/j.1467-8624.2004.00817.x; Anderson EL, 2017, INT J ADOLESC YOUTH, V22, P430, DOI 10.1080/02673843.2016.1227716; Barbaro N, INSECURE ROMANTIC AT; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Baumgartner H., 1996, INT J RES MARK, V13, P139, DOI [10.1016/0167-8116(95)00038-0, DOI 10.1016/0167-8116(95)00038-0]; Bettmann J., 2008, J THERAPEUTIC SCH PR, V3, P116, DOI [DOI 10.19157/JTSP.ISSUE.03.01.05, 10.19157/JTSP.issue.03.01.05]; Borca G, 2015, COMPUT HUM BEHAV, V52, P49, DOI 10.1016/j.chb.2015.05.029; Branje S, 2014, EMERG ADULTHOOD, V2, P6, DOI 10.1177/2167696813515851; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Byers ES, 2016, J YOUTH ADOLESCENCE, V45, P831, DOI 10.1007/s10964-016-0447-9; Chatfield C., 2016, ANAL TIME SERIES INT; Cheng SM, 2014, INT SOCIOL, V29, P324, DOI 10.1177/0268580914538084; Collins WA, 2009, ANNU REV PSYCHOL, V60, P631, DOI 10.1146/annurev.psych.60.110707.163459; Connolly J, 2011, SOCIAL DEV RELATIONS, P180; Cooper A., 1998, CYBERPSYCHOL BEHAV, V1, P187, DOI [10.1089/cpb.1998.1.187, DOI 10.1089/CPB.1998.1.187]; Crouter A. C, 2014, ROMANCE SEX ADOLESCE; Cui M, 2012, PERS RELATIONSHIP, V19, P354, DOI 10.1111/j.1475-6811.2011.01366.x; Del Giudice M, 2016, PERS INDIV DIFFER, V88, P125, DOI 10.1016/j.paid.2015.09.004; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Del Giudice M, 2011, PERS SOC PSYCHOL B, V37, P193, DOI 10.1177/0146167210392789; Desjarlais M, 2010, COMPUT HUM BEHAV, V26, P896, DOI 10.1016/j.chb.2010.02.004; Diamond LM, 2006, J SOC PERS RELAT, V23, P205, DOI 10.1177/0265407506062470; ECCLES JS, 1993, AM PSYCHOL, V48, P90, DOI 10.1037/0003-066X.48.2.90; First MB, 2005, J ABNORM PSYCHOL, V114, P560, DOI 10.1037/0021-843X.114.4.560; Fraley C, 2000, EXPERIENCES CLOSE RE; Fraley R.C., 2000, REV GEN PSYCHOL, V4, P132, DOI [DOI 10.1037/1089-2680.4.2.132, 10.1037/1089-2680.4.2.132, DOI 10.1037/0022-3514.52.3.511, https://doi.org/10.1037/1089-2680.4.2.132]; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Furman W, 2003, ADOLESCENT ROMANTIC REALTIONS AND SEXUAL BEHAVIOR: THEORY, RESEARCH, AND PRACTICAL IMPLICATIONS, P3; Furman W, 2014, J RES ADOLESCENCE, V24, P615, DOI 10.1111/jora.12052; Hadden BW, 2014, PERS SOC PSYCHOL REV, V18, P42, DOI 10.1177/1088868313501885; Jenkins-Guarnieri MA, 2012, J APPL DEV PSYCHOL, V33, P294, DOI 10.1016/j.appdev.2012.08.001; Jones JD, 2018, CHILD DEV, V89, P871, DOI 10.1111/cdev.12775; Kafetsios K, 2006, J HEALTH PSYCHOL, V11, P863, DOI 10.1177/1359105306069084; Kafetsios K, 2014, PERS RELATIONSHIP, V21, P191, DOI 10.1111/pere.12026; Kaklamanidou B, 2011, J POPULAR ROMANCE ST, V2, P1; Kanacri BPL, 2014, J ADOLESCENCE, V37, P701, DOI 10.1016/j.adolescence.2014.03.013; Kang J, 2012, COMM COM INF SC, V342, P217; KIRKPATRICK LA, 1994, J PERS SOC PSYCHOL, V66, P502, DOI 10.1037/0022-3514.66.3.502; Kobak R, 2015, ATTACH HUM DEV, V17, P220, DOI 10.1080/14616734.2015.1006388; Korchmaros JD, 2015, J ADOLESCENCE, V40, P54, DOI 10.1016/j.adolescence.2015.01.004; Koskina N, 2010, J PSYCHOL, V144, P449, DOI 10.1080/00223980.2010.496651; Koutrelakos J, 2004, INT J PSYCHOL, V39, P95, DOI 10.1080/00207590344000213; Kroger J., 2007, IDENTITY DEV ADOLESC; Kuss DJ, 2016, WORLD J PSYCHIATR, V6, P143, DOI 10.5498/wjp.v6.i1.143; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Li TY, 2012, EUR J SOC PSYCHOL, V42, P406, DOI 10.1002/ejsp.1842; Marvin Robert, 2002, Attach Hum Dev, V4, P107, DOI 10.1080/14616730252982491; Masten AS, 2014, J YOUTH ADOLESCENCE, V43, P1018, DOI 10.1007/s10964-014-0118-7; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mastrotheodoros S, 2015, EUR J DEV PSYCHOL, V12, P344, DOI 10.1080/17405629.2015.1021327; Maunder RG, 2011, J PSYCHOSOM RES, V70, P11, DOI 10.1016/j.jpsychores.2010.09.020; McElwain AD, 2015, J ADOLESCENCE, V39, P70, DOI 10.1016/j.adolescence.2014.12.005; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; Mikulincer M., 2013, OXFORD HDB CLOSE REL, P66, DOI [10.1093/oxfordhb/9780195398694.013.0004, DOI 10.1093/OXFORDHB/9780195398694.013.0004]; Mizrahi M, 2016, EUR J SOC PSYCHOL, V46, P467, DOI 10.1002/ejsp.2184; Morey JN, 2013, COMPUT HUM BEHAV, V29, P1771, DOI 10.1016/j.chb.2013.02.019; Motti-Stefanidi F, 2012, DEV PSYCHOPATHOL, V24, P451, DOI 10.1017/S0954579412000090; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Newman DA, 2003, ORGAN RES METHODS, V6, P328, DOI 10.1177/1094428103254673; Nitzburg GC, 2013, J CLIN PSYCHOL, V69, P1183, DOI 10.1002/jclp.22045; Oldmeadow JA, 2013, COMPUT HUM BEHAV, V29, P1142, DOI 10.1016/j.chb.2012.10.006; Papastylianou D, 2016, J BELIEFS VALUES, V37, P40, DOI 10.1080/13617672.2016.1141528; Raudenbush SW, 2004, SSI; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rauer AJ, 2013, DEV PSYCHOL, V49, P2159, DOI 10.1037/a0031845; Reitz E, 2015, EUR J DEV PSYCHOL, V12, P613, DOI 10.1080/17405629.2015.1018173; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; Salerno A, 2015, PROCD SOC BEHV, V174, P932, DOI 10.1016/j.sbspro.2015.01.714; Schimmenti A, 2014, CHILD PSYCHIAT HUM D, V45, P588, DOI 10.1007/s10578-013-0428-0; Schmitt DP, 2003, PERS RELATIONSHIP, V10, P307, DOI 10.1111/1475-6811.00052; Seepersad S, 2004, CYBERPSYCHOL BEHAV, V7, P35, DOI 10.1089/109493104322820093; Soller B, 2014, J HEALTH SOC BEHAV, V55, P56, DOI 10.1177/0022146513520432; Stavropoulos V, 2017, ADDICT BEHAV, V64, P294, DOI 10.1016/j.addbeh.2015.09.001; Stavropoulos V, 2016, EUR J DEV PSYCHOL, V13, P99, DOI 10.1080/17405629.2015.1066670; Stavropoulos V, 2013, J ADOLESCENCE, V36, P565, DOI 10.1016/j.adolescence.2013.03.008; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Sung J, 2013, KOREAN J FAM MED, V34, P115, DOI 10.4082/kjfm.2013.34.2.115; Szielasko AL, 2013, J ADOLESCENCE, V36, P361, DOI 10.1016/j.adolescence.2012.12.008; Tracy JL, 2003, ADOLESCENT ROMANTIC REALTIONS AND SEXUAL BEHAVIOR: THEORY, RESEARCH, AND PRACTICAL IMPLICATIONS, P137; Trub L, 2014, COMPUT HUM BEHAV, V41, P245, DOI 10.1016/j.chb.2014.08.003; Tsagarakis M, 2007, EUR J PSYCHOL ASSESS, V23, P47, DOI 10.1027/1015-5759.23.1.47; Whitty MT, 2008, COMPUT HUM BEHAV, V24, P1837, DOI 10.1016/j.chb.2008.02.009; Widaman K.F., 2006, MONOGRAPHS SOC RES C, V71, P42, DOI DOI 10.1111/J.1540-5834.2006.00404.X; Winer ES, 2016, J CLIN PSYCHOL, V72, P947, DOI 10.1002/jclp.22298; Wood D., 2015, PSYCHOL CHANGE LIFE, P97; Young KS., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Zheng MS, 2015, ATTACH HUM DEV, V17, P96, DOI 10.1080/14616734.2014.995191	87	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201176	10.1371/journal.pone.0201176	http://dx.doi.org/10.1371/journal.pone.0201176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052689	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000440006600027
J	Aesoy, R; Muwonge, H; Asrud, KS; Sabir, M; Witsoe, SL; Bjornstad, R; Kopperud, RK; Hoivik, EA; Doskeland, SO; Bakke, M				Aesoy, Reidun; Muwonge, Haruna; Asrud, Kathrine S.; Sabir, Misbah; Witsoe, Solveig L.; Bjornstad, Ronja; Kopperud, Reidun K.; Hoivik, Erling A.; Doskeland, Stein Ove; Bakke, Marit			Deletion of exchange proteins directly activated by cAMP (Epac) causes defects in hippocampal signaling in female mice	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR TRANSCRIPTION; PITUITARY-ADRENAL AXIS; IMMEDIATE-EARLY GENES; CYCLIC-AMP; NUCLEAR TRANSLOCATION; CHRONIC STRESS; EXPRESSION; DEPRESSION; CELLS; BRAIN	Previous studies demonstrate essential roles for the exchange proteins directly activated by cAMP 1 and 2 (Epac1 and Epac2; here collectively referred to as Epac) in the brain. In the hippocampus, Epac contributes to the control of neuronal growth and differentiation and has been implicated in memory and learning as well as in anxiety and depression. In the present study we address the hypothesis that Epac affects hippocampal cellular responses to acute restraint stress. Stress causes activation of the hypothalamus-pituitary-adrenal (HPA)-axis, and glucocorticoid receptor (GR) signaling is essential for proper feedback regulation of the stress response, both in the brain and along the HPA axis. In the hippocampus, GR expression is regulated by cAMP and the brain enriched micro RNA miR-124. Epac has been associated with miR-124 expression in hippocampal neurons, but not in regulation of GR. We report that hippocampal expression of Epac1 and Epac2 increased in response to acute stress in female wild type mice. In female mice genetically deleted for Epac, nuclear translocation of GR in response to restraint stress was significantly delayed, and moreover, miR124 expression was decreased in these mice. Male mice lacking Epac also showed abnormalities in miR-124 expression, but the phenotype was less profound than in females. Serum corticosterone levels were slightly altered immediately after stress in both male and female mice deleted for Epac. The presented data indicate that Epac1 and Epac2 are involved in controlling cellular responses to acute stress in the mouse hippocampus and provide novel insights into the underlying transcriptional and signaling networks. Interestingly, we observe sex specific differences when Epac is deleted. As the incidence and prevalence of stress-related diseases are higher in women than in men, the Epac knockout models might serve as genetic tools to further elucidate the cellular mechanisms underlying differences between male and female with regard to regulation of stress.	[Aesoy, Reidun; Sabir, Misbah; Bjornstad, Ronja; Kopperud, Reidun K.; Hoivik, Erling A.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Muwonge, Haruna; Asrud, Kathrine S.; Doskeland, Stein Ove; Bakke, Marit] Univ Bergen, Dept Biomed, Bergen, Norway; [Witsoe, Solveig L.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Muwonge, Haruna] Makerere Univ, Coll Hlth Sci, Dept Physiol, Kampala, Uganda	University of Bergen; University of Bergen; University of Bergen; Makerere University	Bakke, M (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Marit.Bakke@uib.no	Muwonge, Haruna/AAT-7275-2020	Muwonge, Haruna/0000-0003-3964-2169; Sivertsen Nordhus, Kathrine/0000-0001-7951-4044; Aesoey, Reidun/0000-0001-7660-8678; Doskeland, Stein Ove/0000-0002-4009-4756	Research Council of Norway [183451/S10]; Regional Health Authorities of Western Norway [911979]	Research Council of Norway(Research Council of Norway); Regional Health Authorities of Western Norway	This work was supported by The Research Council of Norway (Grant no 183451/S10; MB) and The Regional Health Authorities of Western Norway (Grant no. 911979; SOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumo L, 2010, ENDOCRINOLOGY, V151, P2151, DOI 10.1210/en.2009-1139; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Banerjee U, 2015, GENE, V570, P157, DOI 10.1016/j.gene.2015.06.063; Bourke CH, 2013, PSYCHONEUROENDOCRINO, V38, P84, DOI 10.1016/j.psyneuen.2012.05.001; Bourke CH, 2012, HORM BEHAV, V62, P210, DOI 10.1016/j.yhbeh.2012.02.024; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Kloet ER, 1979, STRESS RES PAST PRES; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Djordjevic A, 2009, NEUROPSYCHOBIOLOGY, V59, P213, DOI 10.1159/000223733; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dwivedi Y, 2006, ARCH GEN PSYCHIAT, V63, P639, DOI 10.1001/archpsyc.63.6.639; Edland F, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0147-1; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fernandes HB, 2015, J NEUROSCI, V35, P6544, DOI 10.1523/JNEUROSCI.0314-14.2015; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fuchsl AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153164; Gloerich M, 2011, J CELL BIOL, V193, P1009, DOI 10.1083/jcb.201011126; Gray JD, 2014, MOL PSYCHIATR, V19, P1171, DOI 10.1038/mp.2013.175; Green MR, 2016, PSYCHONEUROENDOCRINO, V73, P32, DOI 10.1016/j.psyneuen.2016.07.210; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; Han QQ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00287; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Higuchi F, 2016, J NEUROSCI, V36, P7253, DOI 10.1523/JNEUROSCI.0319-16.2016; Hoivik EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067925; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Kai AKL, 2013, FASEB J, V27, P4122, DOI 10.1096/fj.13-230433; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kleppe R, 2015, CRC SERIES METHODS S; Kolber BJ, 2009, BRAIN RES, V1293, P85, DOI 10.1016/j.brainres.2009.03.061; Kopperud RK, 2017, ACTA PHYSIOL, V219, P441, DOI 10.1111/apha.12697; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Laryea G, 2015, FRONT NEUROENDOCRIN, V36, P150, DOI 10.1016/j.yfrne.2014.09.002; Laryea G, 2013, MOL ENDOCRINOL, V27, P1655, DOI 10.1210/me.2013-1187; Lee K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0130-1; Lewis AE, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00063; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannironi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073385; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; McPhee I, 2005, BIOCHEM SOC T, V33, P1330, DOI 10.1042/BST0331330; Mediero A, 2014, FASEB J, V28, P4901, DOI 10.1096/fj.14-255703; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; Mentzel CMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131650; Mifsud KR, 2017, NEUROENDOCRINOLOGY, V104, P157, DOI 10.1159/000445875; Munoz-Llancao P, 2015, J NEUROSCI, V35, P11315, DOI 10.1523/JNEUROSCI.3645-14.2015; Myers B, 2012, CELL MOL NEUROBIOL, V32, P683, DOI 10.1007/s10571-012-9801-y; Nakamura NH, 2011, NEUROSCIENCE, V187, P15, DOI 10.1016/j.neuroscience.2011.04.031; Newson MJF, 2013, J ENDOCRINOL, V216, P99, DOI 10.1530/JOE-12-0375; Niimura M, 2009, J CELL PHYSIOL, V219, P652, DOI 10.1002/jcp.21709; Noguchi T, 2010, ENDOCRINOLOGY, V151, P4344, DOI 10.1210/en.2010-0266; Nygaard G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08975-y; Ostroveanu A, 2010, HIPPOCAMPUS, V20, P1018, DOI 10.1002/hipo.20700; Parnell E, 2015, TRENDS PHARMACOL SCI, V36, P203, DOI 10.1016/j.tips.2015.02.003; Peace AG, 2011, BRAIN RES BULL, V84, P280, DOI 10.1016/j.brainresbull.2010.09.002; Pereira L, 2015, P NATL ACAD SCI USA, V112, P3991, DOI 10.1073/pnas.1416163112; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Real FM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110957; Roper JA, 2010, J NEUROENDOCRINOL, V22, P1173, DOI 10.1111/j.1365-2826.2010.02070.x; Ryabinin AE, 1999, ALCOHOL CLIN EXP RES, V23, P1272, DOI 10.1111/j.1530-0277.1999.tb04288.x; Schwede F, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002038; Sewer MB, 2003, MICROSC RES TECHNIQ, V61, P300, DOI 10.1002/jemt.10339; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Suzuki S, 2010, J BIOL CHEM, V285, P24248, DOI 10.1074/jbc.M109.094581; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang B, 2016, EXP CELL RES, V347, P360, DOI 10.1016/j.yexcr.2016.08.018; Wang PY, 2017, BIOORG MED CHEM LETT, V27, P1633, DOI 10.1016/j.bmcl.2017.02.065; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xu JJ, 2017, J PSYCHIATR RES, V95, P102, DOI 10.1016/j.jpsychires.2017.08.010; Yan JB, 2013, MOL CELL BIOL, V33, P918, DOI 10.1128/MCB.01227-12; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003; Zhang XW, 2017, MOL NEUROBIOL, V54, P2498, DOI 10.1007/s12035-016-9845-y; Zhou L, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.129	87	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200935	10.1371/journal.pone.0200935	http://dx.doi.org/10.1371/journal.pone.0200935			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048476	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400032
J	Gerofke, A; Ulbig, E; Martin, A; Muller-Graf, C; Selhorst, T; Gremse, C; Spolders, M; Schafft, H; Heinemeyer, G; Greiner, M; Lahrssen-Wiederholt, M; Hensel, A				Gerofke, Antje; Ulbig, Ellen; Martin, Annett; Mueller-Graf, Christine; Selhorst, Thomas; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Heinemeyer, Gerhard; Greiner, Matthias; Lahrssen-Wiederholt, Monika; Hensel, Andreas			Lead content in wild game shot with lead or non-lead ammunition - Does "state of the art consumer health protection" require non-lead ammunition?	PLOS ONE			English	Article							BOAR SUS-SCROFA; DEER CAPREOLUS-CAPREOLUS; RED DEER; HEAVY-METALS; RIFLE AMMUNITION; MEAT; CADMIUM; MUSCLE; LIVER; CONSUMPTION	The toxicity of lead has been known for a long time, and no safe uptake level can be derived for humans. Consumers' intake via food should therefore be kept as low as possible. Game meat can contain elevated levels of lead due to the use of lead ammunition for hunting. A risk assessment conducted in 2010 by the German Federal Institute for Risk Assessment including various consumption scenarios revealed a possible health risk for extreme consumers of game meat hunted with lead ammunition (i.e. hunters and members of hunters' households). Babies, infants, children and women of childbearing age were identified as vulnerable group with regards to the developmental neurotoxicity of lead. It was noted, that a sound data base was required in order to refine the assessment. Therefore, the research project "Safety of game meat obtained through hunting" (LEMISI) has been conducted in Germany, with the aims of determining the concentrations of lead (as well as of copper and zinc) brought into the edible parts of game meat (roe deer (Capreolus capreolus) and wild boar (Sus scrofa)) due to using either lead or non-lead hunting ammunition, whilst concurrently taking geogenic (i.e. "background") levels of lead into account. Compared to non-lead ammunition, lead ammunition significantly increased lead concentrations in the game meat. The use of both lead and non-lead ammunition deposited copper and zinc in the edible parts of game meat, and the concentrations were in the range of those detected regularly in meat of farm animals. For the average consumer of game meat in Germany the additional uptake of lead only makes a minor contribution to the average alimentary lead exposure. However, for consumers from hunters' households the resulting uptake of lead-due to lead ammunition D can be several times higher than the average alimentary lead exposure. Non-lead bullets in combination with suitable game meat hygienic measures are therefore recommended in order to ensure "state of the art consumer health protection".	[Gerofke, Antje; Ulbig, Ellen; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Lahrssen-Wiederholt, Monika] German Fed Inst Risk Assessment, Dept Safety Food Chain, Berlin, Germany; [Martin, Annett; Mueller-Graf, Christine; Selhorst, Thomas; Heinemeyer, Gerhard; Greiner, Matthias] German Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany; [Hensel, Andreas] German Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment; Federal Institute for Risk Assessment; Federal Institute for Risk Assessment	Gerofke, A (corresponding author), German Fed Inst Risk Assessment, Dept Safety Food Chain, Berlin, Germany.	antje.gerofke@bfr.bund.de	; Greiner, Matthias/D-2812-2013	Muller-Graf, Christine/0000-0002-0122-7528; Greiner, Matthias/0000-0003-4974-5970	Federal Ministry of Food and Agriculture (BMEL) in Germany; Mecklenburg-Western Pomerania; Lower Saxony; Saxony-Anhalt; Bavaria; Hesse; North Rhine-Westphalia; Hamburg; Bremen; European Poultry; Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen und Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	Federal Ministry of Food and Agriculture (BMEL) in Germany; Mecklenburg-Western Pomerania; Lower Saxony; Saxony-Anhalt; Bavaria; Hesse; North Rhine-Westphalia; Hamburg; Bremen; European Poultry; Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen und Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	The study was supported mainly by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen und Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; Alimentarius C, 2007, CODEX ALIMENTARIUS C, P177; Amici A, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e65; [Anonymous], 2014, 138052014 EN; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF MERC; BfR, 2005, BFR ENTW NEUES VERZ; BfR, 2010, BLEIB WILDBR DURCH V; BfR, 2014, FORSCH LEB JAGDL GEW; Bilandzic N, 2010, B ENVIRON CONTAM TOX, V84, P738, DOI 10.1007/s00128-010-9999-7; Bilandzic N, 2009, SCI TOTAL ENVIRON, V407, P4243, DOI 10.1016/j.scitotenv.2009.04.009; Birgisdottir BE, 2013, SCI TOTAL ENVIRON, V463, P836, DOI 10.1016/j.scitotenv.2013.06.078; Blume K, 2010, AUFNAHME UMWELTKONTA; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Buenz EJ, 2018, AM J MED, V131, pE181, DOI 10.1016/j.amjmed.2017.11.031; BVL, 2012, BER LEB 2012 LEB MON; BVL, 2012, BER LEB 2012 D LEB M; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Chiari M, 2015, FOOD ADDIT CONTAM A, V32, P1867, DOI 10.1080/19440049.2015.1087058; Danieli PP, 2012, ARCH ENVIRON CON TOX, V63, P612, DOI 10.1007/s00244-012-9791-2; Garcia MHD, 2011, J ENVIRON SCI HEAL A, V46, P109, DOI 10.1080/10934529.2011.532422; Dobrowolska A, 2008, EUR J WILDLIFE RES, V54, P231, DOI 10.1007/s10344-007-0134-y; Ehlscheid N, 2014, 51 WISSENSCHAFTLICHE; Ertl K, 2016, FOOD ADDIT CONTAM B, V9, P120, DOI 10.1080/19393210.2016.1151464; European Food Safety Authority, 2012, EFSA Journal, V10, P2831; Fustinoni S, 2017, ENVIRON RES, V155, P36, DOI 10.1016/j.envres.2017.01.041; Gasparik J, 2017, BIOL TRACE ELEM RES, V177, P258, DOI 10.1007/s12011-016-0884-z; Gottlein A, 2013, S FORSCHUNGSVORHABEN; Gremse F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102015; Gulson BL, 2003, SCI TOTAL ENVIRON, V303, P79, DOI 10.1016/S0048-9697(02)00355-8; Hacklander K., 2015, EIGNUNG BLEIFREIER B; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hecht H, 2000, AUSWIRKUNG GESCHOSSW; Hecht H., 1984, UNTERSUCHUNG KONTAMI; Human Biomonitoring Commission (HBM Commission) of the German EnvironmentAgency, 2009, BUNDESGESUNDHEITSBLA, V52, P983, DOI [10.1007/s00103-009-0936-z, DOI 10.1007/S00103-009-0936-Z]; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Kanstrup N, 2016, EUR J WILDLIFE RES, V62, P333, DOI 10.1007/s10344-016-1006-0; Knott Jeff, 2009, Conservation Evidence, V6, P71; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lehel J, 2016, ENVIRON SCI POLLUT R, V23, P4465, DOI 10.1007/s11356-015-5658-1; Lorimer MF, 2007, INT J FOOD MICROBIOL, V116, P313, DOI 10.1016/j.ijfoodmicro.2007.02.001; Makri A, 2004, J TOXICOL ENV HEAL B, V7, P417, DOI 10.1080/10937400490512465; Martin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185029; Mateo R, 2007, ECOTOX ENVIRON SAFE, V66, P119, DOI 10.1016/j.ecoenv.2005.12.010; Mateo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015892; MRI, 2008, NAT VERZ 2 NVS 2; Muller-Graf C, 2017, GAME MEAT HYGIENE: FOOD SAFETY AND SECURITY, P201, DOI 10.3920/978-90-8686-840-7_12; Nardi EP, 2009, FOOD CHEM, V112, P727, DOI 10.1016/j.foodchem.2008.06.010; Piskorova L, 2003, CZECH J ANIM SCI, V48, P134; Rudy M, 2010, FOOD ADDIT CONTAM A, V27, P464, DOI 10.1080/19440040903493785; Sager M., 2005, Ernahrung, V29, P199; Schlichting D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184946; Srebocan E, 2011, CZECH J FOOD SCI, V29, P624, DOI 10.17221/249/2010-CJFS; Taggart MA, 2011, ENVIRON INT, V37, P18, DOI 10.1016/j.envint.2010.06.007; Thomas VG, 2016, EUR J WILDLIFE RES, V62, P633, DOI 10.1007/s10344-016-1044-7; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Ulbig E., 2013, S FORSCHUNGSVORHABEN; Morales JSV, 2011, FOOD ADDIT CONTAM A, V28, P1021, DOI 10.1080/19440049.2011.583282; WHO, 10 CHEM MAJ PUBL HLT; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelm M, 2004, HOCHSTGEHALTE UMWELT; World Health Organization, 2010, CHILDH LEAD POIS	62	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200792	10.1371/journal.pone.0200792	http://dx.doi.org/10.1371/journal.pone.0200792			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048463	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400021
J	Reddi, G; Pruss, K; Cottingham, KL; Taylor, RK; Almagro-Moreno, S				Reddi, Geethika; Pruss, Kali; Cottingham, Kathryn L.; Taylor, Ronald K.; Almagro-Moreno, Salvador			Catabolism of mucus components influences motility of Vibrio cholerae in the presence of environmental reservoirs	PLOS ONE			English	Article							CHITIN UTILIZATION; EASTERN OYSTER; COLONIZATION; CHEMOTAXIS; VIRULENCE; O1; OLIGOSACCHARIDES; SELECTION; PATHWAY; BLOOMS	Vibrio cholerae O1, the etiological agent of cholera, is a natural inhabitant of aquatic ecosystems. Motility is a critical element for the colonization of both the human host and its environmental reservoirs. In this study, we investigated the molecular mechanisms underlying the chemotactic response of V. cholerae in the presence of some of its environmental reservoirs. We found that, from the several oligosaccharides found in mucin, two specifically triggered motility of V. cholerae O1:N-acetylneuraminic acid (Neu5Ac) and N-acetylglucosamine (GlcNAc). We determined that the compounds need to be internally catabolized in order to trigger motility of V. cholerae. Interestingly, the catabolism of Neu5Ac and GlcNAc converges and the production of one molecule common to both pathways, glucosamine-6-phosphate (GlcN-6P), is essential to induce motility in the presence of both compounds. Mutants unable to produce GlcN-6P show greatly reduced motility towards mucin. Furthermore, we determined that the production of GlcN-6P is necessary to induce motility of V. cholerae in the presence of some of its environmental reservoirs such as crustaceans or cyanobacteria, revealing a molecular link between the two distinct modes of the complex life cycle of V. cholerae. Finally, cross-species comparisons revealed varied chemotactic responses towards mucin, GlcNAc, and Neu5Ac for environmental (non-pathogenic) strains of V. cholerae, clinical and environmental isolates of the human pathogens Vibrio vulnificus and Vibrio parahaemolyticus, and fish and squid isolates of the symbiotic bacterium Vibrio fischeri. The data presented here suggest nuance in convergent strategies across species of the same bacterial family for motility towards suitable substrates for colonization.	[Reddi, Geethika; Almagro-Moreno, Salvador] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Pruss, Kali] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Cottingham, Kathryn L.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Taylor, Ronald K.] Dartmouth Coll, Geisel Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Almagro-Moreno, Salvador] Univ Cent Florida, Natl Ctr Integrated Coastal Res, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; Stanford University; Dartmouth College; Dartmouth College; State University System of Florida; University of Central Florida	Almagro-Moreno, S (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.; Almagro-Moreno, S (corresponding author), Univ Cent Florida, Natl Ctr Integrated Coastal Res, Orlando, FL 32816 USA.	samoreno@ucf.edu	Almagro-Moreno, Salvador/L-3036-2019; Cottingham, Kathryn L./AAV-3934-2021	Almagro-Moreno, Salvador/0000-0002-1121-1204; Cottingham, Kathryn L./0000-0003-3169-5047	Burnett School of Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025096] Funding Source: NIH RePORTER	Burnett School of Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Startup Funds from Burnett School of Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2013, CHOLERA ENV RESERVOI, V1, P149; Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; Almagro-Moreno S, 2010, GUT MICROBES, V1, P45, DOI 10.4161/gmic.1.1.10386; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BASSLER BL, 1991, J BIOL CHEM, V266, P24268; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Ceccarelli D, 2015, APPL ENVIRON MICROB, V81, P1909, DOI 10.1128/AEM.03540-14; Ceccarelli D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00256; Chaturvedi P, 2015, ECOTOX ENVIRON SAFE, V115, P67, DOI 10.1016/j.ecoenv.2015.02.001; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; EPSTEIN PR, 1993, BIOSYSTEMS, V31, P209, DOI 10.1016/0303-2647(93)90050-M; Ghosh S, 2011, MOL MICROBIOL, V80, P1549, DOI 10.1111/j.1365-2958.2011.07664.x; GUENTZEL MN, 1975, INFECT IMMUN, V11, P890, DOI 10.1128/IAI.11.5.890-897.1975; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; HOOD MA, 1981, APPL ENVIRON MICROB, V41, P559, DOI 10.1128/AEM.41.2.559-560.1981; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; HUQ A, 1986, APPL ENVIRON MICROB, V52, P586, DOI 10.1128/AEM.52.3.586-588.1986; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Islam MS, 2006, EPIDEMIOL INFECT, V134, P645, DOI 10.1017/S0950268805005297; ISLAM MS, 1994, J DIARRHOEAL DIS RES, V12, P87; ISLAM S, 1990, J TROP MED HYG, V93, P133; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004; Lee SH, 2001, P NATL ACAD SCI USA, V98, P6889, DOI 10.1073/pnas.111581598; Liu ZY, 2015, INFECT IMMUN, V83, P1114, DOI 10.1128/IAI.02841-14; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Mandel MJ, 2012, APPL ENVIRON MICROB, V78, P4620, DOI 10.1128/AEM.00377-12; Martinez RM, 2009, J BACTERIOL, V191, P5669, DOI 10.1128/JB.00632-09; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Millet YA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004405; MURPHREE RL, 1995, APPL ENVIRON MICROB, V61, P3656, DOI 10.1128/AEM.61.10.3656-3660.1995; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nahar S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00260; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Napolitano MG, 2011, INFECT GENET EVOL, V11, P423, DOI 10.1016/j.meegid.2010.12.003; O'Toole R, 1999, J BACTERIOL, V181, P4308; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Sakib SN, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00795-17; Schuster BM, 2011, APPL ENVIRON MICROB, V77, P7568, DOI 10.1128/AEM.00378-11; Shapiro BJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.240; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Sun Y, 2015, FRONT MICROBIOL, V6, P17284; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; TWEDT RM, 1981, APPL ENVIRON MICROB, V41, P1475, DOI 10.1128/AEM.41.6.1475-1478.1981; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x	56	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201383	10.1371/journal.pone.0201383	http://dx.doi.org/10.1371/journal.pone.0201383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048543	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400083
J	Tentori, K; Pighin, S; Divan, C; Crupi, V				Tentori, Katya; Pighin, Stefania; Divan, Claudio; Crupi, Vincenzo			Mind the gap: Physicians' assessment of patients' importance weights in localized prostate cancer	PLOS ONE			English	Article							SHARED DECISION-MAKING; VALUES CLARIFICATION METHODS; DESIGN-FEATURES; PREFERENCES; CARE; COMMUNICATION; DIAGNOSIS; RISK; RECOMMENDATIONS; SATISFACTION	Background The management of localized prostate cancer is challenging because of the many therapeutic options available, none of which is generally acknowledged as superior to the others in every respect. The selection of the most appropriate treatment should therefore reflect patients' preferences. Objective The purpose of the following study was to pilot a new approach for investigating whether urologists who had previously provided patients with therapeutic advice actually knew their patients' importance weights concerning the relevant aspects of the treatments at issue. Method Participants were patients recently diagnosed with localized prostate cancer (n = 20), urologists (n = 10), and non-medical professionals (architects, n = 10). These last served as a control group for the urologists and were matched to them for age and gender. Patients' importance weights were elicited by two standard methods (Direct Rating and Value Hierarchy). Each urologist was asked to estimate (with Direct Rating) his/her patient's importance weights. The same task was performed by a corresponding architect, who never met the patient and knew only the patient's age. Univariate and bivariate statistical analyses were performed to investigate the association between importance weights as elicited from patients and as estimated by urologists and architects, as well as to assess whether such agreement was attribute-dependent. Results Participants found both elicitation methods easy to use. The correlation between patients' actual importance weights and urologists' estimates was poor and comparable to that obtained between patients and architects. This result did not depend on the attribute considered, with the sole exception of the attribute "Effectiveness in curing the cancer", which was evaluated as the most important attribute by the majority of participants. Conclusion These findings demonstrate the feasibility of the employed methodology and highlight the need to support preference-sensitive decisions in clinical practice by facilitating the elicitation of patients' importance weights, as well as their communication to physicians.	[Tentori, Katya; Pighin, Stefania] Univ Trento, Ctr Mind Brain Sci, Trento, Italy; [Divan, Claudio] Santa Chiara Hosp, Div Urol, Trento, Italy; [Crupi, Vincenzo] Univ Torino, Dept Philosophy & Educ Sci, Turin, Italy	University of Trento; Santa Chiara Hospital; University of Turin	Tentori, K (corresponding author), Univ Trento, Ctr Mind Brain Sci, Trento, Italy.	katya.tentori@unitn.it	Crupi, Vincenzo/I-1190-2012; Crupi, Vincenzo/U-2446-2019	Crupi, Vincenzo/0000-0002-8727-5001; Tentori, Katya/0000-0002-5968-9936	Cassa di Risparmio of Trento and Rovereto (SMC) [40102595]; DFG as part of the priority program New Frameworks of Rationality [SPP 1516, CR 409/1-2]	Cassa di Risparmio of Trento and Rovereto (SMC); DFG as part of the priority program New Frameworks of Rationality(German Research Foundation (DFG))	Financial support for this study was provided by the Cassa di Risparmio of Trento and Rovereto (SMC, grant 40102595 to KT) and by the DFG as part of the priority program New Frameworks of Rationality (SPP 1516, grant CR 409/1-2 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2015, OPER RES, V63, P378, DOI 10.1287/opre.2015.1350; Alfandre David, 2016, J Clin Ethics, V27, P21; [Anonymous], CANC STAT REG; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; BARRY MJ, 1988, JAMA-J AM MED ASSOC, V259, P3010, DOI 10.1001/jama.259.20.3010; Bottomley PA, 2000, J MARKETING RES, V37, P508, DOI 10.1509/jmkr.37.4.508.18794; Brabers AEM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173316; Brom L, 2017, HEALTH EXPECT, V20, P69, DOI 10.1111/hex.12434; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; Chi WC, 2017, ANN FAM MED, V15, P546, DOI 10.1370/afm.2106; Chiu C, 2016, J PAIN SYMPTOM MANAG, V51, P33, DOI 10.1016/j.jpainsymman.2015.07.018; Christie DRH, 2015, PSYCHO-ONCOLOGY, V24, P1002, DOI 10.1002/pon.3776; Combs MP, 2013, MAYO CLIN PROC, V88, P666, DOI 10.1016/j.mayocp.2013.05.013; Cuypers M, 2019, HEALTH INFORM J, V25, P701, DOI 10.1177/1460458217720393; Cuypers M, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.06.015; Davison BJ, 2012, PATIENT EDUC COUNS, V87, P369, DOI 10.1016/j.pec.2011.11.009; Ellis PM, 1999, ANN MED, V31, P336, DOI 10.3109/07853899908995900; Elstein AS, 2005, HEALTH PSYCHOL, V24, pS85, DOI 10.1037/0278-6133.24.4.S85; Elstein AS, 2004, HEALTH EXPECT, V7, P115, DOI 10.1111/j.1369-7625.2004.00267.x; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Epstein RM, 2013, MED CARE RES REV, V70, p94S, DOI 10.1177/1077558712459216; Fried TR, 2016, NEW ENGL J MED, V374, P104, DOI 10.1056/NEJMp1510020; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hoffman KE, 2014, JAMA INTERN MED, V174, P1450, DOI 10.1001/jamainternmed.2014.3021; Holmes-Rovner M, 2015, MED DECIS MAKING, V35, P999, DOI 10.1177/0272989X15597226; Hurwitz LM, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.11.014; Johnson DC, 2016, J UROLOGY, V196, P1640, DOI 10.1016/j.juro.2016.06.082; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016; Mottet N, 2017, EUR UROL, V71, P618, DOI 10.1016/j.eururo.2016.08.003; Moulton B, 2013, J ROY SOC MED, V106, P391, DOI 10.1177/0141076813490686; National Cancer Institute, CANC TRENDS PROGR RE; OConnor AM, 2014, HLTH AFF, V23; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Pighin S, 2018, ANN BEHAV MED, V52, P909, DOI 10.1093/abm/kax065; Pighin S, 2015, PRENATAL DIAG, V35, P777, DOI 10.1002/pd.4606; Poyhonen M, 2001, EUR J OPER RES, V129, P569, DOI 10.1016/S0377-2217(99)00467-1; Raiffa H., 1976, DECISION ANAL MULTIP; Reamer E, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1467056; Sanda MG, 2018, J UROLOGY, V199, P683, DOI 10.1016/j.juro.2017.11.095; Scherr KA, 2017, MED DECIS MAKING, V37, P56, DOI 10.1177/0272989X16662841; Seo J, 2016, MED DECIS MAKING, V36, P550, DOI 10.1177/0272989X16632197; Sevdalis N, 2006, HEALTH EXPECT, V9, P245, DOI 10.1111/j.1369-7625.2006.00391.x; Showalter TN, 2015, PATIENT PREFER ADHER, V9, DOI 10.2147/PPA.S83333; Smith RA, 2016, CA-CANCER J CLIN, V66, P96, DOI 10.3322/caac.21336; Sommers BD, 2008, CANCER, V113, P2058, DOI 10.1002/cncr.23807; SRIVASTAVA J, 1995, ORGAN BEHAV HUM DEC, V63, P112, DOI 10.1006/obhd.1995.1066; Stalmeier PFM, 2007, J CLIN ONCOL, V25, P3096, DOI 10.1200/JCO.2006.07.4955; Stiggelbout AM, 2015, PATIENT EDUC COUNS, V98, P1172, DOI 10.1016/j.pec.2015.06.022; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; SVENSON O, 1992, ACTA PSYCHOL, V80, P143, DOI 10.1016/0001-6918(92)90044-E; Tamirisa NP, 2017, HEALTH EXPECT, V20, P1248, DOI 10.1111/hex.12564; Underwood W, 2010, CAN J UROL, V17, P5346; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Violette PD, 2015, CA-CANCER J CLIN, V65, P239, DOI 10.3322/caac.21272; Wang LL, 2017, AJIS, V21, DOI [10.3127/ajis.v21i0.1382, DOI 10.3127/AJIS.V21I0.1382]; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Witteman HO, 2016, MED DECIS MAKING, V36, P760, DOI 10.1177/0272989X16634085; Witteman HO, 2016, MED DECIS MAKING, V36, P453, DOI 10.1177/0272989X15626397; Zhong WJ, 2018, UROLOGY, V114, P1, DOI 10.1016/j.urology.2017.10.022; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200780	10.1371/journal.pone.0200780	http://dx.doi.org/10.1371/journal.pone.0200780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048485	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400019
J	Zhao, R; Gu, XX; Xue, B; Zhang, JQ; Ren, WX				Zhao, Rui; Gu, Xinxin; Xue, Bing; Zhang, Jianqiang; Ren, Wanxia			Short period PM2.5 prediction based on multivariate linear regression model	PLOS ONE			English	Article							AEROSOL OPTICAL DEPTH; GROUND-LEVEL PM2.5; UNITED-STATES; AIR-QUALITY; MITIGATION; EMISSIONS; POLLUTION; CHINA; LAND; VARIABILITY	A multivariate linear regression model was proposed to achieve short period prediction of PM2.5 (fine particles with an aerodynamic diameter of 2.5 mu m or less). The main parameters for the proposed model included data on aerosol optical depth (AOD) obtained through remote sensing, meteorological factors from ground monitoring (wind velocity, temperature, and relative humidity), and other gaseous pollutants (SO2, NO2, CO, and O-3). Beijing City was selected as a typical region for the case study. Data on the aforementioned variables for the city throughout 2015 were used to construct two regression models, which were discriminated by annual and seasonal data, respectively. The results indicated that the regression model based on annual data had (R-2 = 0.766) goodness-of-fit and (R-2 = 0.875) cross-validity. However, the regression models based on seasonal data for spring and winter were more effective, achieving 0.852 and 0.874 goodness-of-fit, respectively. Model uncertainties were also given, with the view of laying the foundation for further study.	[Zhao, Rui; Gu, Xinxin; Zhang, Jianqiang] Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu, Sichuan, Peoples R China; [Xue, Bing] Inst Adv Sustainabil Studies eV, Potsdam, Germany; [Ren, Wanxia] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Liaoning, Peoples R China	Southwest Jiaotong University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Xue, B (corresponding author), Inst Adv Sustainabil Studies eV, Potsdam, Germany.	bing.xue@iass-potsdam.de			National Natural Science Foundation of China [41571520, 41471116]; Sichuan Provincial Key Technology Support [2014GZ0168]; Fundamental Research Funds for the Central Universities [A0920502051408]; BMBF Kopernikus Project for the Energy Transition-Thematic Field No. 4 "System Integration and Networks for the Energy Supply" (ENavi); Youth Innovation Promotion Association CAS [2016181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Key Technology Support; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); BMBF Kopernikus Project for the Energy Transition-Thematic Field No. 4 "System Integration and Networks for the Energy Supply" (ENavi)(Federal Ministry of Education & Research (BMBF)); Youth Innovation Promotion Association CAS	This study is sponsored by National Natural Science Foundation of China (No. 41571520; No. 41471116), Sichuan Provincial Key Technology Support (No. 2014GZ0168), The Fundamental Research Funds for the Central Universities (No. A0920502051408), BMBF Kopernikus Project for the Energy Transition-Thematic Field No. 4 "System Integration and Networks for the Energy Supply" (ENavi), and the Youth Innovation Promotion Association CAS (Xue Bing, 2016181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boys BL, 2014, ENVIRON SCI TECHNOL, V48, P11109, DOI 10.1021/es502113p; Chang YH, 2012, ENVIRON SCI TECHNOL, V46, P7069, DOI 10.1021/es3022705; Chen W, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020110; Di Q, 2016, ATMOS ENVIRON, V131, P390, DOI 10.1016/j.atmosenv.2016.02.002; Engel-Cox J A, 2004, ATMOS ENVIRON, V38, P11118, DOI [10.1021/es502113p, DOI 10.1021/ES502113P]; Engel-Cox J, 2013, ATMOS ENVIRON, V80, P584, DOI 10.1016/j.atmosenv.2013.08.016; Grigas T., 2017, THESIS; Guan DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024010; Guo JP, 2009, ATMOS ENVIRON, V43, P5876, DOI 10.1016/j.atmosenv.2009.08.026; He XD, 2015, BUILD ENVIRON, V92, P668, DOI 10.1016/j.buildenv.2015.05.044; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Hu XF, 2014, REMOTE SENS ENVIRON, V140, P220, DOI 10.1016/j.rse.2013.08.032; Hu XF, 2013, ENVIRON RES, V121, P1, DOI 10.1016/j.envres.2012.11.003; Just AC, 2015, ENVIRON SCI TECHNOL, V49, P8576, DOI 10.1021/acs.est.5b00859; Kloog I, 2012, ENVIRON SCI TECHNOL, V46, P11913, DOI 10.1021/es302673e; Kloster S, 2008, ATMOS CHEM PHYS, V8, P6405, DOI 10.5194/acp-8-6405-2008; Kumar N, 2007, ATMOS ENVIRON, V41, P4492, DOI 10.1016/j.atmosenv.2007.01.046; Langrish JP, 2012, ENVIRON HEALTH PERSP, V120, P367, DOI 10.1289/ehp.1103898; Lee HJ, 2011, ATMOS CHEM PHYS, V11, P7991, DOI 10.5194/acp-11-7991-2011; Leibensperger EM, 2011, ATMOS ENVIRON, V45, P3318, DOI 10.1016/j.atmosenv.2011.02.023; Leitte AM, 2011, ENVIRON HEALTH PERSP, V119, P508, DOI 10.1289/ehp.1002203; Levy R. C., 2010, ATMOSPHERIC CHEM PHY, V10, P14815, DOI DOI 10.5194/ACPD-10-14815-2010; Li J, 2015, ATMOS ENVIRON, V102, P260, DOI 10.1016/j.atmosenv.2014.12.010; Liu Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI [10.1029/2004JD005025, 10.1029/2003JD003981]; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Lv BL, 2016, ENVIRON SCI TECHNOL, V50, P4752, DOI 10.1021/acs.est.5b05940; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Munchak LA, 2013, ATMOS MEAS TECH, V6, P1747, DOI 10.5194/amt-6-1747-2013; Pavese G, 2016, ENVIRON SCI POLLUT R, V23, P6546, DOI 10.1007/s11356-015-5860-1; Qu LL, 2017, ENVIRON SCI POLLUT R, V24, P2578, DOI 10.1007/s11356-016-7995-0; Rae JGL, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007826; Rogula-Kozlowska W, 2014, AIR QUAL ATMOS HLTH, V7, P41, DOI 10.1007/s11869-013-0222-y; Schaap M, 2009, ATMOS CHEM PHYS, V9, P909, DOI 10.5194/acp-9-909-2009; Shindell D, 2008, ATMOS CHEM PHYS, V8, P7101, DOI 10.5194/acp-8-7101-2008; Song WZ, 2014, REMOTE SENS ENVIRON, V154, P1, DOI 10.1016/j.rse.2014.08.008; Unger N, 2006, P NATL ACAD SCI USA, V103, P4377, DOI 10.1073/pnas.0508769103; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Walsh MP, 2014, FRONT ENV SCI ENG, V8, P1, DOI 10.1007/s11783-014-0634-4; Wang JM, 2016, ENVIRON SCI POLLUT R, V23, P8827, DOI 10.1007/s11356-016-6127-1; Xie YY, 2015, PARTICUOLOGY, V20, P141, DOI 10.1016/j.partic.2015.01.003; Xie YY, 2015, ENVIRON SCI TECHNOL, V49, P12280, DOI 10.1021/acs.est.5b01413; Xue B, 2017, P I CIVIL ENG D, P1; Yuan Y, 2012, ENVIRON SCI TECHNOL, V46, P3627, DOI 10.1021/es300984j; Zhang H, 2009, J AIR WASTE MANAGE, V59, P1358, DOI 10.3155/1047-3289.59.11.1358; Zheng YX, 2016, ATMOS ENVIRON, V124, P232, DOI 10.1016/j.atmosenv.2015.06.046; Zhou Y, 2010, ENVIRON HEALTH PERSP, V118, P1204, DOI 10.1289/ehp.1001991; Zhuang XL, 2014, J ENVIRON SCI, V26, P2, DOI 10.1016/S1001-0742(13)60376-9	47	27	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201011	10.1371/journal.pone.0201011	http://dx.doi.org/10.1371/journal.pone.0201011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048475	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400039
J	Fujito, NT; Satta, Y; Hane, M; Matsui, A; Yashima, K; Kitajima, K; Sato, C; Takahata, N; Hayakawa, T				Fujito, Naoko T.; Satta, Yoko; Hane, Masaya; Matsui, Atsushi; Yashima, Kenta; Kitajima, Ken; Sato, Chihiro; Takahata, Naoyuki; Hayakawa, Toshiyuki			Positive selection on schizophrenia-associated ST8SIA2 gene in post-glacial Asia	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; EAST-ASIA; GENOME SEQUENCE; POLYSIALIC ACID; POLYSIALYLTRANSFERASE; POLYMORPHISMS; DISTRIBUTIONS; ENVIRONMENT; IMMIGRANTS; SIMULATION	A number of loci are associated with highly heritable schizophrenia and the prevalence of this mental illness has had considerable negative fitness effects on human populations. Here we focused on one particular schizophrenia-associated gene that encodes a sialyl-transferase (ST8SIA2) and is expressed preferentially in the brain with the level being largely determined by three SNPs in the promoter region. It is suggested that the expression level of the ST8SIA2 gene is a genetic determinant of schizophrenia risk, and we found that a geographically differentiated non-risk SNP type (CGC-type) has significantly reduced promoter activity. A newly developed method for detecting ongoing positive selection was applied to the ST8SIA2 genomic region with the identification of an unambiguous sweep signal in a rather restricted region of 18 kb length surrounding the promoter. We also found that while the CGC-type emerged in anatomically modern humans in Africa over 100 thousand years ago, it has increased its frequency in Asia only during the past 20-30 thousand years. These findings support that the positive selection is driven by psychosocial stress due to changing social environments since around the last glacial maximum, and raise a possibility that schizophrenia extensively emerged during the Upper Paleolithic and Neolithic era.	[Fujito, Naoko T.; Satta, Yoko; Yashima, Kenta; Takahata, Naoyuki] SOKENDAI, Sch Adv Sci, Hayama, Kanagawa, Japan; [Hane, Masaya; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan; [Matsui, Atsushi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan; [Hayakawa, Toshiyuki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Fukuoka, Japan; [Hayakawa, Toshiyuki] Kyushu Univ, Fac Arts & Sci, Fukuoka, Fukuoka, Japan	Graduate University for Advanced Studies - Japan; Nagoya University; Kyoto University; Kyushu University; Kyushu University	Satta, Y (corresponding author), SOKENDAI, Sch Adv Sci, Hayama, Kanagawa, Japan.; Hayakawa, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Fukuoka, Japan.; Hayakawa, T (corresponding author), Kyushu Univ, Fac Arts & Sci, Fukuoka, Fukuoka, Japan.	satta@soken.ac.jp; thayakawa@artsci.kyushu-u.ac.jp	Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Naganawa, Shinji/0000-0002-0214-613X; Satta, Yoko/0000-0002-5305-493X	Japanese Society for Promotion of Science [JP23570271, JP25101705, JP16K07535, JP16H04821]; Scientific Research on Innovative Area, a MEXT	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Area, a MEXT	This research was supported by the Japanese Society for Promotion of Science (JP23570271, JP25101705, and JP16K07535 to T.H.; and JP16H04821 to Y.S.); and by Scientific Research on Innovative Area, a MEXT Grant-in-Aid Project (FY2016-2020 to N.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bae CJ, 2017, SCIENCE, V358, DOI 10.1126/science.aai9067; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Charlesworth B, 2012, ELEMENTS EVOLUTIONAR; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clarkson C, 2017, NATURE, V547, P306, DOI 10.1038/nature22968; DeVylder JE, 2013, SCHIZOPHR RES, V150, P223, DOI 10.1016/j.schres.2013.07.040; Di D, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0512-0; Di D, 2014, IMMUNOGENETICS, V66, P153, DOI 10.1007/s00251-014-0757-6; DYKHUIZEN DE, 1990, TRENDS ECOL EVOL, V5, P257, DOI 10.1016/0169-5347(90)90067-N; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Fan SH, 2016, SCIENCE, V354, P54, DOI 10.1126/science.aaf5098; Fay JC, 2000, GENETICS, V155, P1405; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Fujito NT, 2018, GENES GENET SYST; Gilabert-Juan J, 2013, PSYCHIAT RES, V210, P1293, DOI 10.1016/j.psychres.2013.09.001; GILLESPIE JH, 1989, GENETICS, V121, P129; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; GRIFFITHS RC, 1994, THEOR POPUL BIOL, V46, P131, DOI 10.1006/tpbi.1994.1023; Hane M, 2016, BIOCHEM BIOPH RES CO, V478, P1123, DOI 10.1016/j.bbrc.2016.08.079; Hayakawa T., 2012, POSTGENOME BIOL PRIM, P123; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Holt BM, 2008, YEARB PHYS ANTHROPOL, V51, P70, DOI 10.1002/ajpa.20950; Howes OD, 2017, BIOL PSYCHIAT, V81, P9, DOI 10.1016/j.biopsych.2016.07.014; Howes OD, 2014, LANCET, V383, P1677, DOI 10.1016/S0140-6736(13)62036-X; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Krocher T, 2015, BRAIN STRUCT FUNCT, V220, P71, DOI 10.1007/s00429-013-0638-z; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sato C, 2016, BBA-GEN SUBJECTS, V1860, P1739, DOI 10.1016/j.bbagen.2016.04.015; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; TAJIMA F, 1989, GENETICS, V123, P585; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir B. S., 1996, GENETIC DATA ANAL; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	66	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200278	10.1371/journal.pone.0200278	http://dx.doi.org/10.1371/journal.pone.0200278			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044798	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500038
J	Fusco, R; Gugliandolo, E; Campolo, M; Evangelista, M; Di Paola, R; Cuzzocrea, S				Fusco, Roberta; Gugliandolo, Enrico; Campolo, Michela; Evangelista, Maurizio; Di Paola, Rosanna; Cuzzocrea, Salvatore			Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome (vol 12, e0178553, 2017)	PLOS ONE			English	Correction													evangelista, maurizio/G-6820-2012; Gugliandolo, Enrico/AAB-9972-2019; FUSCO, Roberta/AAC-1745-2019; Campolo, Michela/K-6432-2016; di paola, rosanna/U-4356-2019	Gugliandolo, Enrico/0000-0001-6840-3154; FUSCO, Roberta/0000-0003-0223-1403; di paola, rosanna/0000-0001-6725-8581; Cuzzocrea, Salvatore/0000-0001-6131-3690; Campolo, Michela/0000-0002-5124-3876				Fusco R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178553; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703	3	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201501	10.1371/journal.pone.0201501	http://dx.doi.org/10.1371/journal.pone.0201501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044864	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500104
J	Jang, JY; Shin, H; Lim, JW; Ahn, JH; Jo, YH; Lee, KY; Hwang, BY; Jung, SJ; Kang, SY; Lee, MK				Jang, Jae Young; Shin, Hyeji; Lim, Jae-Woong; Ahn, Jong Hoon; Jo, Yang Hee; Lee, Ki Yong; Hwang, Bang Yeon; Jung, Sung-Ju; Kang, So Young; Lee, Mi Kyeong			Comparison of antibacterial activity and phenolic constituents of bark, lignum, leaves and fruit of Rhus verniciflua	PLOS ONE			English	Article							IN-VITRO; STOKES; FLAVONOIDS; CELLS; FISH; INHIBITION; VIRUSES	Rhus verniciflua is commonly known as a lacquer tree in Korea. The bark of R. verniciflua has been used as an immunostimulator in traditional medicine, but also causes allergic dermatitis due to urushiol derivatives. For the development of active natural resources with less toxicity, the antibacterial activity of various parts of R. verniciflua such as bark, lignum, leaves and fruit, together with chemical composition, were investigated. Among the various parts of R. verniciflua, lignum showed the most potent antibacterial activity against fish pathogenic bacteria such as Edwardsiella tarda, Vibrio anguillarum and Streptococcus iniae. Measurement of total phenolic content and flavonoid content clearly showed a high content of phenolic and flavonoids in lignum among the various parts of R. verniciflua. Further analysis showed a close correlation between antibacterial activity and phenolic content. In addition, methyl gallate and fustin, the major constituents of bark and lignum, showed antibacterial activity, which suggested phenolic constituents as active constituents. The content of urushiols, however, was highest in bark, but there was a trace amount in lignum. LC-MS-MS and PCA analysis showed good discrimination with the difference of phenolic composition in various parts of R. verniciflua. Taken together, phenolic compounds are responsible for the antibacterial activity of R. verniciflua. The lignum of R. verniciflua contains high content of phenolic compounds with less urushiols, which suggests efficient antibacterial activity with less toxicity. Therefore, the lignum of R. verniciflua is suggested as a good source for antibacterial material to use against fish bacterial diseases.	[Jang, Jae Young; Ahn, Jong Hoon; Jo, Yang Hee; Hwang, Bang Yeon; Lee, Mi Kyeong] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea; [Shin, Hyeji; Lee, Ki Yong] Korea Univ, Coll Pharm, Sejong, South Korea; [Lim, Jae-Woong; Jung, Sung-Ju; Kang, So Young] Chonnam Natl Univ, Dept Aqualife Med, Yeosu, South Korea	Chungbuk National University; Korea University; Chonnam National University	Lee, MK (corresponding author), Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea.	mklee@chungbuk.ac.kr			Ministry of Oceans and Fisheries [20160024]	Ministry of Oceans and Fisheries	This work was supported by the Ministry of Oceans and Fisheries (https://www.mof.go.kr) grant no. 20160024 to MKL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agu KC, 2017, FOOD SCI NUTR, V5, P1029, DOI 10.1002/fsn3.498; Ahmad A, 2017, BIOMED PHARMACOTHER, V92, P772, DOI 10.1016/j.biopha.2017.05.124; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Calzada F, 2017, PHARMACOGN MAG, V13, P240, DOI 10.4103/0973-1296.204564; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Elmasri WA, 2017, J PROTEOME RES, V16, P2579, DOI 10.1021/acs.jproteome.7b00137; Farag MA, 2017, MOLECULES, V22, DOI 10.3390/molecules22050761; Guijarro JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00700; Jeong GS, 2011, BIOL PHARM BULL, V34, P97, DOI 10.1248/bpb.34.97; Jung CH, 2007, J ETHNOPHARMACOL, V110, P490, DOI 10.1016/j.jep.2006.10.013; Kang SY, 2012, J MICROBIOL, V50, P293, DOI 10.1007/s12275-012-2068-7; KangSoyoung, 2005, [JOURNAL OF FISH PATHOLOGY, 한국어병학회지], V18, P227; Kim JS, 2010, FOOD CHEM, V120, P539, DOI 10.1016/j.foodchem.2009.10.051; Kim KH, 2013, PHYTOCHEMISTRY, V92, P113, DOI 10.1016/j.phytochem.2013.05.005; Kim SA, 2013, FOOD CHEM, V141, P3813, DOI 10.1016/j.foodchem.2013.06.068; Ko JH, 2005, TOXICOL IN VITRO, V19, P353, DOI 10.1016/j.tiv.2004.10.006; Lee JH, 2009, PHYTOMEDICINE, V16, P188, DOI 10.1016/j.phymed.2008.10.009; 한상미, 2011, [JOURNAL OF FISH PATHOLOGY, 한국어병학회지], V24, P113; Lim JW, 2016, PLANTA MED, V81, pS1; Mizunoe S, 2006, J INFECTION, V53, pE255, DOI 10.1016/j.jinf.2006.03.001; Mustapha B., 2014, IOSR J PHARM BIOL SC, V9, P70; Oh PS, 2007, BIOL PHARM BULL, V30, P111, DOI 10.1248/bpb.30.111; Park Joon-Woo, 2016, Lab Anim Res, V32, P87, DOI 10.5625/lar.2016.32.2.87; Park KY, 2004, J ETHNOPHARMACOL, V90, P73, DOI 10.1016/j.jep.2003.09.043; Ulrich-Merzenich G, 2010, INDIAN J EXP BIOL, V48, P208; Yang NY, 2010, NAT PROD RES, V24, P1843, DOI 10.1080/14786419.2010.482057; Zeng HT, 2017, MOLECULES, V22, DOI 10.3390/molecules22050771; Ziolkowska A, 2016, FOOD CHEM, V213, P714, DOI 10.1016/j.foodchem.2016.06.120	28	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200257	10.1371/journal.pone.0200257	http://dx.doi.org/10.1371/journal.pone.0200257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044823	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500036
J	Rogalska, A; Gajek, A; Lukawska, M; Oszczapowicz, I; Marczak, A				Rogalska, Aneta; Gajek, Arkadiusz; Lukawska, Malgorzata; Oszczapowicz, Irena; Marczak, Agnieszka			Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE DEATH; OXIDATIVE STRESS; IN-VITRO; DOXORUBICIN; MECHANISMS; RESISTANCE; 3-METHYLADENINE; SENSITIVITY; CALCIUM; PATHWAY	Chemical modification of known, effective drugs are one method to improve the chemotherapy of tumors. We reported ability of oxazoline analogs of doxorubicin (O-DOX) and daunorubicin (O-DAU) to induce apoptosis and autophagy in ovarian and liver cancer cells. Reactive oxygen and nitrogen species (ROS and RNS, respectively), together with intracellular calcium-mediated downstream signaling, are essential for the anticancer effect of these new anthracycline analogs. The changes of mitochondrial membrane potential and induction of the ceramide pathway suggests that these compounds induce cell death by apoptosis. In addition, a significant increase of autophagosome formation was observed by fluorescence assay and acridine orange staining, indicating that the new analogs also induce autophagic cell death. Compared to free DOX-and DAU-treated cells, we observed inhibition of colony formation and migration, a time-dependency between ROS/RNS levels and a greater fall in mitochondrial membrane potential. Altogether, our research broadens the base of molecular oxazolinoanthracyclines targets and reveals that derivatives mediated oxidative stress, ceramide production and increase in intracellular calcium level by mitochondria. Furthermore, our data highlight the importance of mitochondria that simultaneously assume the role of activator of autophagy and apoptosis signals.	[Rogalska, Aneta; Gajek, Arkadiusz; Marczak, Agnieszka] Univ Lodz, Fac Biol & Environm Protect, Inst Biophys, Dept Med Biophys, Lodz, Poland; [Lukawska, Malgorzata; Oszczapowicz, Irena] Inst Biotechnol & Antibiot, Dept Modified Antibiot, Warsaw, Poland	University of Lodz; Institute of Biotechnology & Antibiotics (IBA)	Rogalska, A (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Inst Biophys, Dept Med Biophys, Lodz, Poland.	aneta.rogalska@biol.uni.lodz.pl		Rogalska, Aneta/0000-0002-4170-1693; Gajek, Arkadiusz/0000-0003-3475-441X; Marczak, Agnieszka/0000-0003-3439-9032	 [B1611000000190.01]		The investigation was supported by a statutory research admitted for Department of Medical Biophysics (B1611000000190.01).	Barraud L, 2005, J HEPATOL, V42, P736, DOI 10.1016/j.jhep.2004.12.035; Breton-Romero R, 2014, REDOX BIOL, V2, P529, DOI 10.1016/j.redox.2014.02.005; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Denel-Bobrowska M, 2017, LIFE SCI, V178, P1, DOI 10.1016/j.lfs.2017.04.009; Denel-Bobrowska M, 2016, TOXICOL APPL PHARM, V313, P159, DOI 10.1016/j.taap.2016.10.018; Failli P, 2002, NITRIC OXIDE-BIOL CH, V7, P277, DOI 10.1016/S1089-8603(02)00120-9; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Fulbright JM, 2015, CANCER CHEMOTH PHARM, V76, P1297, DOI 10.1007/s00280-015-2879-4; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Gong XL, 2016, WORLD J GASTROENTERO, V22, P6582, DOI 10.3748/wjg.v22.i29.6582; Hajj C, 2015, BIOL CHEM, V396, P669, DOI 10.1515/hsz-2014-0302; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jana A, 2007, J NEUROIMMUNE PHARM, V2, P184, DOI 10.1007/s11481-007-9066-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Lanceley A, 2017, INT J GYNECOL CANCER, V27, P59, DOI 10.1097/IGC.0000000000000877; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li L, 2007, OTOLARYNG HEAD NECK, V137, P659, DOI 10.1016/j.otohns.2007.04.026; Liu J, 2015, ONCOL REP, V33, P1551, DOI 10.3892/or.2015.3730; Lukawska M, 2012, ANTICANCER RES, V32, P2959; Lukawska M, 2010, INVEST NEW DRUG, V28, P600, DOI 10.1007/s10637-009-9299-4; Mordente A, 2017, CURR MED CHEM, V24, P1607, DOI 10.2174/0929867323666161214120355; Nussler AK, 2006, NAT PROTOC, V1, P2223, DOI 10.1038/nprot.2006.341; Oh SH, 2017, ANAL BIOCHEM, V530, P57, DOI 10.1016/j.ab.2017.05.003; Oyama K, 2009, J CLIN BIOCHEM NUTR, V45, P361, DOI 10.3164/jcbn.09-47; Parra V, 2013, BBA-MOL BASIS DIS, V1832, P1334, DOI 10.1016/j.bbadis.2013.04.009; Patel AG, 2012, ELIFE, V1, DOI 10.7554/eLife.00387; Pedrini I, 2014, MOL PHARMACEUT, V11, P3068, DOI 10.1021/mp500257s; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Ren F, 2016, BBA-REV CANCER, V1866, P266, DOI 10.1016/j.bbcan.2016.10.001; Sagi JC, 2016, PHARMACOGENOMICS, V17, P1075, DOI 10.2217/pgs-2016-0036; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sikora Adam, 2005, Acta Pol Pharm, V62, P31; Sishi BJN, 2013, BIOCHEM PHARMACOL, V85, P124, DOI 10.1016/j.bcp.2012.10.005; Srankova J, 2016, BASIC CLIN PHARMACOL, V119, P443, DOI 10.1111/bcpt.12606; Su WT, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0460-z; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Valcovici M, 2016, ARCH MED SCI, V12, P428, DOI 10.5114/aoms.2016.59270; Wang YD, 2017, MOL PHARMACEUT, V14, P2323, DOI 10.1021/acs.molpharmaceut.7b00184; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xiao Y, 2014, LIFE SCI, V112, P33, DOI 10.1016/j.lfs.2014.07.016; Xu JH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0487-8; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Xu XM, 2012, J PHARMACOL EXP THER, V341, P183, DOI 10.1124/jpet.111.189589; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhao DX, 2014, MOL MED REP, V9, P1975, DOI 10.3892/mmr.2014.2055	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201296	10.1371/journal.pone.0201296	http://dx.doi.org/10.1371/journal.pone.0201296			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040861	gold, Green Submitted, Green Published			2022-12-27	WOS:000439749200035
J	Atreya, CE; Kubo, A; Borno, HT; Rosenthal, B; Campanella, M; Rettger, JP; Joseph, G; Allen, IE; Venook, AP; Altschuler, A; Dhruva, A				Atreya, Chloe E.; Kubo, Ai; Borno, Hala T.; Rosenthal, Blake; Campanella, Matthew; Rettger, John P.; Joseph, Galen; Allen, I. Elaine; Venook, Alan P.; Altschuler, Andrea; Dhruva, Anand			Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ALTERNATIVE MEDICINE USE; EXPRESSIVE GROUP-THERAPY; BREAST-CANCER; STRESS REDUCTION; PSYCHOLOGICAL DISTRESS; FAMILY CAREGIVERS; LUNG-CANCER; DEPRESSIVE SYMPTOMS	A metastatic cancer diagnosis is associated with high levels of distress in patients and caregivers. Mindfulness interventions can reduce distress and improve quality of life in cancer patients. However, standard mindfulness training relies on in-person instruction, which is often not practical for either patients receiving chemotherapy or their caregivers. In the Being Present single arm pilot study, we designed and tested an 8-week audio-based mindfulness meditation program for patients with metastatic colorectal cancer receiving chemotherapy with or without a participating caregiver. The study accrued 33 of 74 (45%) eligible patients consenting together with 20 family caregivers (53 participants total) within nine months. Forty-one participants were evaluable (77%); 10 of 12 cases of attrition were attributable to hospitalization or death. Median participant age was 51 (range 21-78 years); 38% were men. Baseline levels of distress were similar in patients and caregivers. The top reasons for participation cited in pre-intervention interviews were to increase relaxation/calm, improve mood/emotions, and reduce stress/anxiety. In measures of adherence, 59% of responses to weekly texts asking: "Have you practiced today?" were "Yes" and 59% of interviewees reported practicing >50% of the time. Compared to baseline, post-intervention surveys demonstrated significantly reduced distress (p = 0.01) and anxiety (p = 0.03); as well as increased non-reactivity (p<0.01), and feeling at peace (p<0.01). Post-intervention qualitative interviews, where 71% of participants reported benefit, were consistent with quantitative findings. In the interviews, participants spontaneously described reduced stress/anxiety and increased relaxation/calm. Benefits appeared to be accentuated in patient-caregiver pairs as compared to unpaired patients. Seventy-nine percent of participants reported plans for continued practice after study completion. We conclude that the Being Presentaudio-based mindfulness meditation program is of interest to, feasible, and acceptable for patients with metastatic colorectal cancer and caregivers, with initial evidence of efficacy. These results will guide plans for a follow-up study.	[Atreya, Chloe E.; Borno, Hala T.; Rosenthal, Blake; Campanella, Matthew; Venook, Alan P.; Dhruva, Anand] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Atreya, Chloe E.; Borno, Hala T.; Rosenthal, Blake; Campanella, Matthew; Venook, Alan P.; Dhruva, Anand] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr HFCCC, San Francisco, CA 94143 USA; [Kubo, Ai; Altschuler, Andrea] Kaiser Permanente, Div Res, Oakland, CA USA; [Rettger, John P.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Joseph, Galen] UCSF, Dept Anthropol Hist & Social Med, San Francisco, CA USA; [Allen, I. Elaine] UCSF, Dept Epidemiol & Biostat, San Francisco, CA USA; [Dhruva, Anand] UCSF, Osher Ctr Integrat Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Atreya, CE (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Atreya, CE (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr HFCCC, San Francisco, CA 94143 USA.	chloe.atreya@ucsf.edu		Atreya, Chloe/0000-0003-2954-1727	Mount Zion Health Fund; NIH; NCI [KL2TR000143, K08CA175143, K07CA166143]; UCSF Open Access Publishing Fund; NATIONAL CANCER INSTITUTE [K07CA166143, K08CA175153, K08CA127143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER	Mount Zion Health Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCSF Open Access Publishing Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a grant from the Mount Zion Health Fund and the NIH and NCI under Award Numbers KL2TR000143 (CEA and AK); K08CA175143 (CEA) and K07CA166143 (AK), and the UCSF Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We extend gratitude to all Being Present study participants; to Kameron Allen, graphic design; Michael Starita, sound engineer; Lucid Dawn, female voice; Mark Silva, male voice; Hilary Chan, RedCap surveys; Emily Mitchell, back-up research coordinator; Amy J. Markowitz, editorial assistance; as well as to Christopher Webb for inspiration; and to Andrew Avins and James Mitchell for guidance. We also acknowledge the UCSF Open Access Publishing Fund.	Altschuler A, 2012, SUPPORT CARE CANCER, V20, P1291, DOI 10.1007/s00520-011-1216-7; Atreya CE, 2016, J NATL COMPR CANC NE, V14, P1536, DOI 10.6004/jnccn.2016.0165; Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108; Bidstrup PE, 2015, ACTA ONCOL, V54, P789, DOI 10.3109/0284186X.2014.1002571; Birnie K, 2010, PSYCHO-ONCOLOGY, V19, P1004, DOI 10.1002/pon.1651; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Braun M, 2007, J CLIN ONCOL, V25, P4829, DOI 10.1200/JCO.2006.10.0909; Broderick Joan E, 2013, EGEMS (Wash DC), V1, P1015, DOI 10.13063/2327-9214.1015; Brown KW, 2003, PSYCHOSOM MED, V65, P636, DOI 10.1097/01.PSY.0000077503.96903.A6; Carlson LE, 2004, PSYCHO-ONCOL, V13, P837, DOI 10.1002/pon.832; Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Carlson LE, 2013, J CLIN ONCOL, V31, P3119, DOI 10.1200/JCO.2012.47.5210; Carney S, 2011, J CLIN ONCOL, V29, P1001, DOI 10.1200/JCO.2010.30.9104; Chambers SK, 2017, J CLIN ONCOL, V35, P291, DOI 10.1200/JCO.2016.68.8788; Elwert F, 2008, AM J PUBLIC HEALTH, V98, P2092, DOI 10.2105/AJPH.2007.114348; Fang CY, 2001, HEALTH PSYCHOL, V20, P452, DOI 10.1037//0278-6133.20.6.452; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; Fish J, 2016, MINDFULNESS, V7, P1011, DOI 10.1007/s12671-016-0548-2; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Giese-Davis J, 2011, J CLIN ONCOL, V29, P413, DOI 10.1200/JCO.2010.28.4455; GIVEN CW, 1993, HEALTH PSYCHOL, V12, P277, DOI 10.1037/0278-6133.12.4.277; Golant M, 2008, CANCER J, V14, P420, DOI 10.1097/PPO.0b013e31818d894a; Greenlee H, 2009, BREAST CANCER RES TR, V117, P653, DOI 10.1007/s10549-009-0315-3; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Huebner J, 2014, ONCOL RES TREAT, V37, DOI 10.1159/000362616; Johannsen M, 2016, J CLIN ONCOL, V34, P3390, DOI 10.1200/JCO.2015.65.0770; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Kim Y, 2015, PSYCHO-ONCOLOGY, V24, P95, DOI 10.1002/pon.3580; Kissane D, 2009, PSYCHO-ONCOLOGY, V18, P1, DOI 10.1002/pon.1493; Lengacher CA, 2018, PSYCHO-ONCOLOGY, V27, P524, DOI 10.1002/pon.4491; Lengacher CA, 2016, J CLIN ONCOL, V34, P2827, DOI 10.1200/JCO.2015.65.7874; Lengacher CA, 2012, J HOLIST NURS, V30, P170, DOI 10.1177/0898010111435949; Morrison EJ, 2017, CLIN LUNG CANCER, V18, P497, DOI 10.1016/j.cllc.2017.02.008; Musial F, 2011, FORSCH KOMPLEMENTMED, V18, P192, DOI 10.1159/000330714; National Cancer Institute, PALL CAR CANC; National Comprehensive Cancer Network, 2018, DISTR MAN CLIN PRACT; National Comprehensive Cancer Network (NCCN), NCCN DISTR THERM PRO; Nipp RD, 2017, CANCER-AM CANCER SOC, V123, P4720, DOI 10.1002/cncr.30912; Piet J, 2012, J CONSULT CLIN PSYCH, V80, P1007, DOI 10.1037/a0028329; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pirl WF, 2014, CANCER-AM CANCER SOC, V120, P2946, DOI 10.1002/cncr.28750; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Ringdal GI, 2004, PALLIATIVE MED, V18, P108, DOI 10.1191/0269216304pm878oa; Roscoe JA, 2002, SUPPORT CARE CANCER, V10, P329, DOI 10.1007/s00520-001-0317-0; Schellekens MPJ, 2017, PSYCHO-ONCOLOGY, V26, P2118, DOI 10.1002/pon.4430; Schellekens MPJ, 2017, J BEHAV MED, V40, P414, DOI 10.1007/s10865-016-9799-6; Schellekens MPJ, 2016, SUPPORT CARE CANCER, V24, P1813, DOI 10.1007/s00520-015-2954-8; Segal Z. V., 2002, MINDFULNESS BASED CO; Segrin C, 2012, HEALTH PSYCHOL, V31, P70, DOI 10.1037/a0025394; Shaw JM, 2016, SUPPORT CARE CANCER, V24, P585, DOI 10.1007/s00520-015-2817-3; Shumay DM, 2002, J ALTERN COMPLEM MED, V8, P661, DOI 10.1089/107555302320825183; Steinhauser KE, 2006, ARCH INTERN MED, V166, P101, DOI 10.1001/archinte.166.1.101; Trevino KM, 2018, PSYCHO-ONCOLOGY, V27, P243, DOI 10.1002/pon.4441; Venook AP, 2017, JAMA-J AM MED ASSOC, V317, P2392, DOI 10.1001/jama.2017.7105; Walker MS, 2006, PSYCHO-ONCOLOGY, V15, P684, DOI 10.1002/pon.997; Yates JS, 2005, SUPPORT CARE CANCER, V13, P806, DOI 10.1007/s00520-004-0770-7; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6; Zernicke KA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-34	59	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199423	10.1371/journal.pone.0199423	http://dx.doi.org/10.1371/journal.pone.0199423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036361	Green Published, gold			2022-12-27	WOS:000439429200004
J	Nad'o, L; Kanuch, P				Nad'o, Ladislav; Kanuch, Peter			Why sampling ratio matters: Logistic regression and studies of habitat use	PLOS ONE			English	Article							CHALINOLOBUS-TUBERCULATUS; ROOSTING BEHAVIOR; NYCTALUS-NOCTULA; SELECTION; VESPERTILIONIDAE; CONSERVATION; CHIROPTERA; BATS; FOREST; LONG	Logistic regression (LR) models are among the most frequently used statistical tools in ecology. With LR one can infer if a species' habitat use is related to environmental factors and estimate the probability of species occurrence based on the values of these factors. However, studies often use inadequate sampling with regards to the arbitrarily chosen ratio between occupied and unoccupied (or available) locations, and this has a profound effect on the inference and predictive power of LR models. To demonstrate the effect of various sampling strategies/efforts on the quality of LR models, we used a unique census dataset containing all the used roosting cavities of the tree-dwelling bat Nyctalus leisleri and all cavities where the species was absent. We compared models constructed from randomly selected data subsets with varying ratios of occupied and unoccupied cavities (1:1, 1:5, 1:10) with a full dataset model (ratio 1:31). These comparisons revealed that the power of LR models was low when the sampling did not reflect the population ratio of occupied and unoccupied cavities. The use of weights improved the subsampled models. Thus, this study warns against inadequate data sampling and highly encourages a randomized sampling procedure to estimate the true ratio of occupied:unoccupied locations, which can then be used to optimize a manageable sampling effort and apply weights to improve the LR model. Such an approach may provide robust and reliable models suitable for both inference and prediction.	[Nad'o, Ladislav; Kanuch, Peter] Slovak Acad Sci, Inst Forest Ecol, Zvolen, Slovakia; [Kanuch, Peter] PJ Safar Univ Kosice, Fac Sci, Inst Biol & Ecol, Kosice, Slovakia	Slovak Academy of Sciences	Nad'o, L (corresponding author), Slovak Acad Sci, Inst Forest Ecol, Zvolen, Slovakia.	ladislav.nado@gmail.com	Kanuch, Peter/A-5416-2011; Naďo, Ladislav/G-5699-2013	Kanuch, Peter/0000-0003-2001-4541; Nado, Ladislav/0000-0002-1718-901X	Ministerstvo skolstva, vedy, vyskumu a sportu Slovenskej republiky [VEGA - 2/0131/17]	Ministerstvo skolstva, vedy, vyskumu a sportu Slovenskej republiky	This work was funded by the Ministerstvo skolstva, vedy, vyskumu a sportu Slovenskej republiky, VEGA - 2/0131/17, to Dr. Ladislav Nado. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, BIOL CONSERV, V111, P435, DOI 10.1016/S0006-3207(02)00313-0; Bihari Z, 2004, MAMMALIA, V68, P329, DOI 10.1515/mamm.2004.032; Campbell S, 2009, AUST J ZOOL, V57, P89, DOI 10.1071/ZO09006; Dietz C., 2009, BATS BRITAIN EUROPE; Drew CA, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7390-0; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Menard S., 2002, APPL LOGISTIC REGRES; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pullin AS, 2003, J NAT CONSERV, V11, P83, DOI 10.1078/1617-1381-00040; R Development Core Team, 2016, R LANG ENV STAT COMP; Ruczynski I, 2005, J MAMMAL, V86, P921, DOI 10.1644/1545-1542(2005)86[921:RCSBNN]2.0.CO;2; Russo D, 2004, BIOL CONSERV, V117, P73, DOI 10.1016/S0006-3207(03)00266-0; Sedgeley JA, 2003, NEW ZEAL J ZOOL, V30, P227, DOI 10.1080/03014223.2003.9518341; Sedgeley JA, 2001, J APPL ECOL, V38, P425, DOI 10.1046/j.1365-2664.2001.00607.x; Swarming P., 2015, BEHAV PROCESS, V120, P80	17	12	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200742	10.1371/journal.pone.0200742	http://dx.doi.org/10.1371/journal.pone.0200742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036369	gold, Green Published, Green Submitted			2022-12-27	WOS:000439429200014
J	van Rijn, S				van Rijn, Sophie			Salivary testosterone in relation to social cognition and social anxiety in children and adolescents with 47,XXY (Klinefelter syndrome)	PLOS ONE			English	Article							SPECTRUM DISORDERS; SERUM TESTOSTERONE; FETAL TESTOSTERONE; DIURNAL-VARIATION; SHORT-FORMS; MEN; AUTISM; BEHAVIOR; PUBERTY; BOYS	Background Approximately 1 in 650 boys are born with an extra X chromosome. Boys and men with 47, XXY (Klinefelter syndrome) are at risk for neurodevelopmental disorders and specific cognitive impairments. This study was focused on social anxiety and social cognition. The aim was to assess if these aspects of the phenotype are related to testosterone deficiency, which is typically seen in 47,XXY from puberty onwards. Methods In the study 20 boys with 47,XXY and 25 non-clinical controls between 8 and 19 years participated. None had ever used testosterone supplements. Cognitive tests measuring the labeling of facial expressions and perspective taking (Theory of Mind) were administered. Self-report questionnaires were used to assess social anxiety. Testosterone was measured in saliva. Results Within the 47,XXY group lower levels of salivary testosterone were significantly associated with higher levels of social anxiety. The correlation was strong, andindependent of age and pubertal development. However, salivary levels of testosterone were uncorrelated to social cognitive skills. Discussion These findings point out that lower testosterone levels might contribute to high social anxiety in 47,XXY, suggesting that anxiety should be monitored in pubertal boys with XXY presenting with testosterone deficiency. This should be done in addition to exploring cognitive behavioral therapy or psychopharmacologic treatments targeting anxiety, which are more evidence based. In contrast, testosterone levels were not associated with social cognitive functioning, suggesting that other mechanisms are driving vulnerabilities in this domain.	[van Rijn, Sophie] Leiden Univ, Clin Child & Adolescent Studies, Leiden, Netherlands; [van Rijn, Sophie] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	van Rijn, S (corresponding author), Leiden Univ, Clin Child & Adolescent Studies, Leiden, Netherlands.; van Rijn, S (corresponding author), Leiden Inst Brain & Cognit, Leiden, Netherlands.	srijn@fsw.leidenuniv.nl		van rijn, sophie/0000-0002-9179-7515	VENI grant from the Netherlands Organization for Scientific Research [016.095.060, 016.165.397]	VENI grant from the Netherlands Organization for Scientific Research	This work was supported by a VENI grant (grant number 016.095.060 to SvR) and VIDI grant (grant number 016.165.397 to SvR) from the Netherlands Organization for Scientific Research (www.nwo.nl).	Aksglaede L, 2013, EUR J ENDOCRINOL, V168, pR67, DOI 10.1530/EJE-12-0934; [Anonymous], 1991, MANUAL CHILD BEHAV C; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bialek M, 2004, POL J PHARMACOL, V56, P509; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; BUTLER GE, 1989, CLIN ENDOCRINOL, V30, P587, DOI 10.1111/j.1365-2265.1989.tb01431.x; Campbell JM, 1998, PSYCHOL ASSESSMENT, V10, P431, DOI 10.1037/1040-3590.10.4.431; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Cederlof M, 2014, J PSYCHIATR RES, V48, P128, DOI 10.1016/j.jpsychires.2013.10.001; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Coleman L, 2002, J ADOLESCENCE, V25, P535, DOI 10.1006/jado.2002.0494; Coleman N, 2008, J INTELLECT DISABILI, V12, P49, DOI 10.1177/1744629507086608; Cordeiro L, 2012, RES DEV DISABIL, V33, P1254, DOI 10.1016/j.ridd.2012.02.013; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P191, DOI 10.1111/j.2044-8260.1992.tb00983.x; Dekking YM., 1983, HANDLEIDING SOCIALE; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Granger DA, 2003, DEV PSYCHOPATHOL, V15, P431, DOI 10.1017/S0954579403000233; HANDA RJ, 1994, PHYSIOL BEHAV, V55, P117, DOI 10.1016/0031-9384(94)90018-3; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Host C, 2014, ASIAN J ANDROL, V16, P185, DOI 10.4103/1008-682X.122201; Knickmeyer R, 2006, HORM BEHAV, V49, P282, DOI 10.1016/j.yhbeh.2005.08.010; Lee NR, 2011, INT REV RES DEV DISA, V40, P139, DOI 10.1016/B978-0-12-374478-4.00006-X; Lee NR, 2011, J INT NEUROPSYCH SOC, V17, P522, DOI 10.1017/S1355617711000312; McHenry J, 2014, FRONT NEUROENDOCRIN, V35, P42, DOI 10.1016/j.yfrne.2013.09.001; Mohatt J, 2014, AM J PSYCHIAT, V171, P741, DOI 10.1176/appi.ajp.2014.13101337; Morley JE, 2006, AGING MALE, V9, P165, DOI 10.1080/13685530600907993; Oates RD, 2012, FERTIL STERIL, V98, P266, DOI 10.1016/j.fertnstert.2012.06.024; Rilling JK, 1996, STEROIDS, V61, P374, DOI 10.1016/0039-128X(96)00043-8; Ross JL, 2017, J PEDIATR-US, V185, P193, DOI 10.1016/j.jpeds.2017.02.036; Samango-Sprouse CA, 2013, AM J MED GENET A, V161A, P501, DOI 10.1002/ajmg.a.35769; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Ung D, 2015, CHILD PSYCHIAT HUM D, V46, P533, DOI 10.1007/s10578-014-0494-y; Van Manen TG., 2009, MANUAL SOCIAL COGNIT; van Rijn S, 2006, SCHIZOPHR RES, V84, P194, DOI 10.1016/j.schres.2006.02.020; van Rijn S, 2015, GENES BRAIN BEHAV, V14, P200, DOI 10.1111/gbb.12203; van Rijn S, 2014, GENES BRAIN BEHAV, V13, P459, DOI 10.1111/gbb.12134; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; van Rijn S, 2014, J AUTISM DEV DISORD, V44, P310, DOI 10.1007/s10803-013-1860-5; van Rijn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084721; van Wingen G, 2010, PSYCHONEUROENDOCRINO, V35, P105, DOI 10.1016/j.psyneuen.2009.09.007; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; Viau V, 1996, J NEUROSCI, V16, P1866; Visootsak J, 2009, DEV DISABIL RES REV, V15, P328, DOI 10.1002/ddrr.76; WANG C, 1981, J CLIN ENDOCR METAB, V53, P1021, DOI 10.1210/jcem-53-5-1021; Wechsler D., 2005, WECHSLER ADULT INTEL; Wosnitzer MS, 2013, AM J MED GENET C, V163C, P16, DOI 10.1002/ajmg.c.31350	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200882	10.1371/journal.pone.0200882	http://dx.doi.org/10.1371/journal.pone.0200882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036387	gold, Green Published			2022-12-27	WOS:000439429200021
J	Zhang, YH; Qi, L; Xu, LS; Sun, XG; Liu, WY; Zhou, SR; van de Vosse, F; Greenwald, SE				Zhang, Yahui; Qi, Lin; Xu, Lisheng; Sun, Xingguo; Liu, Wenyan; Zhou, Shuran; van de Vosse, Frans; Greenwald, Stephen E.			Effects of exercise modalities on central hemodynamics, arterial stiffness and cardiac function in cardiovascular disease: Systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							CHRONIC HEART-FAILURE; CENTRAL BLOOD-PRESSURE; LEFT-VENTRICULAR FUNCTION; ALL-CAUSE MORTALITY; AEROBIC EXERCISE; ENDOTHELIAL FUNCTION; ENDURANCE EXERCISE; POSTMENOPAUSAL WOMEN; RESISTANCE EXERCISE; WAVE REFLECTION	Background Exercise is accepted as an important contribution to the rehabilitation of patients with cardiovascular disease (CVD). This study aims to better understand the possible causes for lack of consensus and reviews the effects of three exercise modalities (aerobic, resistance and combined exercise) on central hemodynamics, arterial stiffness and cardiac function for better rehabilitation strategies in CVD. Methods The electronic data sources, Cochrane Library, MEDLINE, Web of Science, EBSCO (CINAHL), and ScienceDirect from inception to July 2017 were searched for randomized controlled trials (RCTs) investigating the effect of exercise modalities in adult patients with CVD. The effect size was estimated as mean differences (MD) with 95% confidence intervals (CI). Subgroup analysis and meta-regression were used to study potential moderating factors. Results Thirty-eight articles describing RCTs with a total of 2089 patients with CVD were included. The pooling revealed that aerobic exercise [MD(95% CI) = -5.87 (-8.85, -2.88), P = 0.0001] and resistance exercise [MD(95% CI) = -7.62 (-10.69, -4.54), P<0.00001] significantly decreased aortic systolic pressure (ASP). Resistance exercise significantly decreased aortic diastolic pressure [MD(95% CI) = -4(-5.63, -2.37), P<0.00001]. Aerobic exercise significantly decreased augmentation index (AIx) based on 24-week exercise duration and patients aged 50-60 years. Meanwhile, aerobic exercise significantly improved carotid-femoral pulse wave velocity (cf-PWV) [MD(95% CI) = -0.42 (-0.83, -0.01), P = 0.04], cardiac output (CO) [MD(95% CI) = 0.36(0.08, 0.64), P = 0.01] and left ventricular ejection fraction (LVEF) [MD(95% CI) = 3.02 (2.11, 3.93), P<0.00001]. Combined exercise significantly improved cf-PWV [MD(95% CI) = -1.15 (-1.95, -0.36), P = 0.004] and CO [MD(95% CI) = 0.9 (0.39, 1.41), P = 0.0006]. Conclusions Aerobic and resistance exercise significantly decreased ASP, and long-term aerobic exercise reduced AIx. Meanwhile, aerobic and combined exercise significantly improved central arterial stiffness and cardiac function in patients with CVD. These findings suggest that a well-planned regime could optimize the beneficial effects of exercise and can provide some evidence-based guidance for those involved in cardiovascular rehabilitation of patients with CVD.	[Zhang, Yahui; Qi, Lin; Xu, Lisheng; Liu, Wenyan; Zhou, Shuran; van de Vosse, Frans] Northeastern Univ, Sinodutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China; [Xu, Lisheng] Northeastern Univ, Key Lab Med Image Comp, Minist Educ, Shenyang, Liaoning, Peoples R China; [Sun, Xingguo] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Key Lab Cardiovasc Dis, Beijing, Peoples R China; [van de Vosse, Frans] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Greenwald, Stephen E.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England	Northeastern University - China; Northeastern University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Eindhoven University of Technology; University of London; Queen Mary University London	Xu, LS (corresponding author), Northeastern Univ, Sinodutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China.; Xu, LS (corresponding author), Northeastern Univ, Key Lab Med Image Comp, Minist Educ, Shenyang, Liaoning, Peoples R China.	xuls@bmie.neu.edu.cn	Stefanadis, Christodoulos/ABH-2232-2020; liu, wen/HGE-3071-2022; van de Vosse, Frans N/I-4006-2013; Xu, Lisheng/AAX-7181-2020; Greenwald, Stephen E/C-6928-2012; Boutouyrie, Pierre/J-8592-2015	Stefanadis, Christodoulos/0000-0001-5974-6454; van de Vosse, Frans N/0000-0002-4084-2064; Xu, Lisheng/0000-0001-8360-3605; Greenwald, Stephen/0000-0002-8471-7070; Boutouyrie, Pierre/0000-0002-4375-3569	National Natural Science Foundation of China [61773110, 61374015, 61202258]; Fundamental Research Funds for the Central Universities [N161904002, N172008008, N171904009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research reported here was, in part, supported by the National Natural Science Foundation of China (Nos. 61773110, 61374015, and 61202258 to LX), and the Fundamental Research Funds for the Central Universities (N161904002 to LX, N172008008 to LQ and N171904009 to LX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acanfora D, 2016, INT J CARDIOL, V225, P313, DOI 10.1016/j.ijcard.2016.10.026; Acar RD, 2015, ECHOCARDIOGR-J CARD, V32, P443, DOI 10.1111/echo.12701; Adamopoulos S, 2011, EUR HEART J, V32, P183; Aksoy S, 2015, AM J PHYS MED REHAB, V94, P898, DOI 10.1097/PHM.0000000000000306; Andersen LJ, 2014, SCAND J MED SCI SPOR, V24, P27, DOI 10.1111/sms.12237; Ashor AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110034; Beck DT, 2013, AM J HYPERTENS, V26, P1093, DOI 10.1093/ajh/hpt080; Beer M, 2008, J AM COLL CARDIOL, V51, P1883, DOI 10.1016/j.jacc.2007.09.075; Belardinelli R, 1998, CIRCULATION, V97, P553; BELARDINELLI R, 1995, J AM COLL CARDIOL, V26, P975, DOI 10.1016/0735-1097(95)00267-1; Belardinelli R, 1996, AM HEART J, V132, P61, DOI 10.1016/S0002-8703(96)90391-9; Bilinska M, 2010, CIRC J, V74, P2598, DOI 10.1253/circj.CJ-10-0104; Blumenthal JA, 2000, ARCH INTERN MED, V160, P1947, DOI 10.1001/archinte.160.13.1947; Brown MD, 2002, J APPL PHYSIOL, V92, P1434, DOI 10.1152/japplphysiol.00477.2001; Brubaker PH, 2009, J AM GERIATR SOC, V57, P1982, DOI 10.1111/j.1532-5415.2009.02499.x; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cheetham C, 2002, J APPL PHYSIOL, V93, P175, DOI 10.1152/japplphysiol.01240.2001; Chrysohoou C, 2015, INT J CARDIOL, V179, P269, DOI 10.1016/j.ijcard.2014.11.067; COATS AJS, 1992, CIRCULATION, V85, P2119, DOI 10.1161/01.CIR.85.6.2119; Crisafulli A, 2011, J PHYSIOL SCI, V61, P385, DOI 10.1007/s12576-011-0163-x; Croymans DM, 2014, J HUM HYPERTENS, V28, P157, DOI 10.1038/jhh.2013.81; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Davies JE, 2010, AM J PHYSIOL-HEART C, V298, pH580, DOI 10.1152/ajpheart.00875.2009; Donley DA, 2014, J APPL PHYSIOL, V116, P1396, DOI 10.1152/japplphysiol.00151.2014; Dubach P, 1997, J AM COLL CARDIOL, V29, P1591, DOI 10.1016/S0735-1097(97)82540-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehlken N, 2016, EUR HEART J, V37, P35, DOI 10.1093/eurheartj/ehv337; Faulkner J, 2017, J HUM HYPERTENS, V31, P172, DOI 10.1038/jhh.2016.72; Figueroa A, 2014, J HUM HYPERTENS, V28, P143, DOI 10.1038/jhh.2013.83; Figueroa A, 2014, MENOPAUSE, V21, P131, DOI 10.1097/GME.0b013e318294528c; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Giallauria F, 2013, EUR J NUCL MED MOL I, V40, P315, DOI 10.1007/s00259-012-2302-x; Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Guimaraes GV, 2010, HYPERTENS RES, V33, P627, DOI 10.1038/hr.2010.42; Hambrecht R, 2000, JAMA-J AM MED ASSOC, V283, P3095, DOI 10.1001/jama.283.23.3095; Haykowsky MJ, 2007, J AM COLL CARDIOL, V49, P2329, DOI 10.1016/j.jacc.2007.02.055; Heffernan KS, 2013, HYPERTENS RES, V36, P422, DOI 10.1038/hr.2012.198; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Huang C, 2016, SCAND J MED SCI SPOR, V26, P478, DOI 10.1111/sms.12495; Huang SC, 2014, EUR J APPL PHYSIOL, V114, P1853, DOI 10.1007/s00421-014-2913-y; Iellamo F, 2000, CIRCULATION, V102, P2588; Kaess BM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002693; Kawano H, 2008, EXP PHYSIOL, V93, P296, DOI 10.1113/expphysiol.2007.039867; Kitzman DW, 2013, J AM COLL CARDIOL, V62, P584, DOI 10.1016/j.jacc.2013.04.033; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Krustrup P, 2013, MED SCI SPORT EXER, V45, P553, DOI 10.1249/MSS.0b013e3182777051; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee YH, 2015, AM J PHYS MED REHAB, V94, P687, DOI 10.1097/PHM.0000000000000233; Li YL, 2015, EUR J SPORT SCI, V15, P443, DOI 10.1080/17461391.2014.955129; Liao DP, 2000, ANN MED, V32, P383, DOI 10.3109/07853890008995943; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Madden KM, 2013, J HUM HYPERTENS, V27, P335, DOI 10.1038/jhh.2012.38; Mendis S, 2015, STROKE, V46, pE121, DOI 10.1161/STROKEAHA.115.008097; Mitchell GF, 2008, HYPERTENSION, V51, P105, DOI 10.1161/HYPERTENSIONAHA.107.099721; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Miyachi M, 2004, CIRCULATION, V110, P2858, DOI 10.1161/01.CIR.0000146380.08401.99; Miyachi M, 2013, BRIT J SPORT MED, V47, P393, DOI 10.1136/bjsports-2012-090488; Molmen-Hansen HE, 2012, EUR J PREV CARDIOL, V19, P151, DOI 10.1177/1741826711400512; Montero D, 2015, INT J CARDIOL, V178, P69, DOI 10.1016/j.ijcard.2014.10.147; Montero D, 2014, INT J CARDIOL, V173, P361, DOI 10.1016/j.ijcard.2014.03.072; Nualnim N, 2012, AM J CARDIOL, V109, P1005, DOI 10.1016/j.amjcard.2011.11.029; Oliveira NL, 2015, ATHEROSCLEROSIS, V239, P150, DOI 10.1016/j.atherosclerosis.2014.12.057; Parker KH, 2012, MED BIOL ENG COMPUT, V50, P419, DOI 10.1007/s11517-012-0872-1; Parnell MM, 2002, CLIN SCI, V102, P1, DOI 10.1042/CS20010107; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Sakuragi S, 2010, INT J CARDIOL, V138, P112, DOI 10.1016/j.ijcard.2009.04.027; Seals DR, 2001, J AM COLL CARDIOL, V38, P506, DOI 10.1016/S0735-1097(01)01348-1; Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067; Stewart KJ, 2005, ARCH INTERN MED, V165, P756, DOI 10.1001/archinte.165.7.756; Stohr EJ, 2012, J PHYSIOL-LONDON, V590, P2107, DOI 10.1113/jphysiol.2012.227850; Su MYM, 2011, J MAGN RESON IMAGING, V34, P60, DOI 10.1002/jmri.22597; Taaffe DR, 2007, J HUM HYPERTENS, V21, P96, DOI 10.1038/sj.jhh.1002115; Tang A, 2014, INT J STROKE, V9, P883, DOI 10.1111/ijs.12156; Van Craenenbroeck AH, 2015, AM J KIDNEY DIS, V66, P285, DOI 10.1053/j.ajkd.2015.03.015; Vanhees L, 2012, EUR J PREV CARDIOL, V19, P1333, DOI 10.1177/2047487312437063; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang KL, 2009, J HYPERTENS, V27, P461, DOI 10.1097/HJH.0b013e3283220ea4; Westhoff TH, 2008, J HYPERTENS, V26, P1336, DOI 10.1097/HJH.0b013e3282ffac13; Wildman RP, 2003, HYPERTENSION, V42, P468, DOI 10.1161/01.HYP.0000090360.78539.CD; Zhang YH, 2016, J EXERC SCI FIT, V14, P67, DOI 10.1016/j.jesf.2016.08.001; Zhang Y, 2017, J SPORT MED PHYS FIT, V57, P595, DOI 10.23736/S0022-4707.16.06378-7	86	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200829	10.1371/journal.pone.0200829	http://dx.doi.org/10.1371/journal.pone.0200829			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036390	gold, Green Published, Green Submitted			2022-12-27	WOS:000439429200019
J	Bossier, S; Palacz, AP; Nielsen, JR; Christensen, A; Hoff, A; Maar, M; Gislason, H; Bastardie, F; Gorton, R; Fulton, EA				Bossier, Sieme; Palacz, Artur P.; Nielsen, J. Rasmus; Christensen, Asbjorn; Hoff, Ayoe; Maar, Marie; Gislason, Henrik; Bastardie, Francois; Gorton, Rebecca; Fulton, Elizabeth A.			The Baltic Sea Atlantis: An integrated end-to-end modelling framework evaluating ecosystem-wide effects of human-induced pressures	PLOS ONE			English	Article							SOUTHERN BENGUELA; TROPHIC CASCADES; FOOD-WEB; MANAGEMENT; FISHERIES; NITROGEN; IMPACT; FISH; EUTROPHICATION; COMMUNITIES	Achieving good environmental status in the Baltic Sea region requires decision support tools which are based on scientific knowledge across multiple disciplines. Such tools should integrate the complexity of the ecosystem and enable exploration of different natural and anthropogenic pressures such as climate change, eutrophication and fishing pressures in order to compare alternative management strategies. We present a new framework, with a Baltic implementation of the spatially-explicit end-to-end Atlantis ecosystem model linked to two external models, to explore the different pressures on the marine ecosystem. The HBM-ERGOM initializes the Atlantis model with high-resolution physical-chemical-biological and hydrodynamic information while the FISHRENT model analyses the fisheries economics of the output of commercial fish biomass for the Atlantis terminal projection year. The Baltic Atlantis model composes 29 subareas, 9 vertical layers and 30 biological functional groups. The balanced calibration provides realistic levels of biomass for, among others, known stock sizes of top predators and of key fish species. Furthermore, it gives realistic levels of phytoplankton biomass and shows reasonable diet compositions and geographical distribution patterns for the functional groups. By simulating several scenarios of nutrient load reductions on the ecosystem and testing sensitivity to different fishing pressures, we show that the model is sensitive to those changes and capable of evaluating the impacts on different trophic levels, fish stocks, and fisheries associated with changed benthic oxygen conditions. We conclude that the Baltic Atlantis forms an initial basis for strategic management evaluation suited for conducting medium to long term ecosystem assessments which are of importance for a number of pan-Baltic stakeholders in relation to anthropogenic pressures such as eutrophication, climate change and fishing pressure, as well as changed biological interactions between functional groups.	[Bossier, Sieme; Nielsen, J. Rasmus; Christensen, Asbjorn; Gislason, Henrik; Bastardie, Francois] Tech Univ Denmark, Natl Inst Aquat Resources, Lyngby, Denmark; [Palacz, Artur P.] Polish Acad Sci, Inst Oceanol, Int Ocean Carbon Coordinat Project, Sopot, Poland; [Hoff, Ayoe] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark; [Maar, Marie] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Gorton, Rebecca; Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Fulton, Elizabeth A.] Univ Tasmania, Ctr Marine Socioecol, Battery Point, Tas, Australia	Technical University of Denmark; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; University of Copenhagen; Aarhus University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Bossier, S (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Lyngby, Denmark.	siebo@aqua.dtu.dk	Maar, Marie/C-5837-2008; Nielsen, J. Rasmus/AAG-2647-2021; Gislason, Henrik/C-1357-2008; Fulton, Beth/A-2871-2008; Gislason, Henrik/R-9567-2019	Maar, Marie/0000-0001-8594-2993; Nielsen, J. Rasmus/0000-0002-2833-3873; Gislason, Henrik/0000-0003-0242-3333; Fulton, Beth/0000-0002-5904-7917; Bastardie, Francois/0000-0002-2669-6179; Hoff, Ayoe/0000-0002-3679-3431; Christensen, Asbjorn/0000-0002-4286-7409; Palacz, Artur/0000-0002-1634-7880; Bossier, Sieme/0000-0003-2548-0410	Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE) [09-067259]; EU [266445]; EU-H2020 Climate change and European Aquatic RESources (CERES) [678193]; Cooperation. in Fisheries, Aquaculture and Sea Food Processing (European Commission FP7 ERA-NET PRIME TRADEOFFS) [321553]	Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE); EU(European Commission); EU-H2020 Climate change and European Aquatic RESources (CERES); Cooperation. in Fisheries, Aquaculture and Sea Food Processing (European Commission FP7 ERA-NET PRIME TRADEOFFS)	This work was supported by (i) The Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE, Grant no. 09-067259), author receiving funding: RN; (ii) the EU "Vectors of Change in Oceans and Seas, Marine Life, Impact and Economic Sectors"(Vectors, FP7/2010-2013, Grant Agreement no. 266445), http://www.marinevectors.eu/, author receiving funding: RN; (iii) the EU-H2020 Climate change and European Aquatic RESources (CERES, Grant agreement no. 678193), http.//ceresprojecteu, author receiving funding: RN; (iv) Cooperation. in Fisheries, Aquaculture and Sea Food Processing (European Commission FP7 ERA-NET PRIME TRADEOFFS, Grant agreement no. 321553), http://old.uefscdi.ro/artcole/3275/COFASP Cooperation- in-Fisheries-Aquaculture-and -Sea-foodProcessng.html, Stefan Neuenfeldt, DTU Aqua is main receiver of the funding, but Sieme Bossier also received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the extensive cooperation we have had on this work from research under: (i) The Danish Council for Strategic Research to the project "Integrated Management of Agriculture, Fishery, Environment and Economy" (IMAGE, Grant no. 09-067259), (ii) the EU "Vectors of Change in Oceans and Seas, Marine Life, Impact and Economic Sectors" (Vectors, FP7/2010-2013, Grant Agreement no. 266445), (iii) the EU-H2020 CERES (Grant agreement no. 678193) Project and (iv) the COFASP ERA-NET PRIME-TRA-DEOFFS project (Grant agreement no. 321553, EU-FP7).	Al-Hamdani K. Z., 2007, GEOLOGICAL SURVEY DE, V13, P61; Audzijonyte A., 2017, ATLANTIS USERS GUI 1; BADEN SP, 1990, AMBIO, V19, P113; Bastardie F, 2015, 2015M03 ICES ASC CM; Bastardie F, 2015, ICES J MAR SCI, V72, P824, DOI 10.1093/icesjms/fsu215; Bastardie F, 2014, CAN J FISH AQUAT SCI, V71, P366, DOI 10.1139/cjfas-2013-0126; Bergstom S., 1992, SMHI REPORTS RV; BEVERTON RJH, 1957, DYNAMICS EXPLOITED F, V2; Bonsdorff E, 1999, AUST J ECOL, V24, P312, DOI 10.1046/j.1442-9993.1999.00986.x; Bonsdorff E, 2002, HYDROBIOLOGIA, V475, P371, DOI 10.1023/A:1020395526898; Borja A, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00072; Bostrom C, 2014, AQUAT CONSERV, V24, P410, DOI 10.1002/aqc.2424; Bucas M, 2009, OCEANOLOGIA, V51, P341, DOI 10.5697/oc.51-3.359; Cerco CF, 2010, ENVIRON MODELL SOFTW, V25, P562, DOI 10.1016/j.envsoft.2009.09.008; Deutsch B, 2010, BIOGEOSCIENCES, V7, P3259, DOI 10.5194/bg-7-3259-2010; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dutz J, 2012, MAR ECOL PROG SER, V462, P51, DOI 10.3354/meps09830; Eilola K, 2011, J MARINE SYST, V88, P267, DOI 10.1016/j.jmarsys.2011.05.004; Eriksson BK, 2005, ESTUAR COAST SHELF S, V62, P109, DOI 10.1016/j.ecss.2004.08.009; Fleming-Lehtinen V, 2015, ECOL INDIC, V48, P380, DOI 10.1016/j.ecolind.2014.08.022; Frost H., 2009, EIAA MODEL METHODOLO; Frost H, 2013, CAN J AGR ECON, V61, P283, DOI 10.1111/cjag.12014; Fulton E. A., 2004, R991546 AUSTR FISH M, P116, DOI DOI 10.1017/CBO9781107415324.004; Fulton EA, 2015, ENVIRON SCI POLICY, V48, P44, DOI 10.1016/j.envsci.2014.12.006; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gardmark A, 2013, ECOL APPL, V23, P742, DOI 10.1890/12-0267.1; Girardin R, 2018, ESTUAR COAST SHELF S, V201, P208, DOI 10.1016/j.ecss.2016.10.016; Hagerman L, 1998, HYDROBIOLOGIA, V375-76, P241, DOI 10.1023/A:1017033711985; Hallfors H, 2013, HYDROBIOLOGIA, V707, P109, DOI 10.1007/s10750-012-1414-4; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen C, 2016, SET UP NORDIC BARENT, P1; Hansen J., 2013, NOVANA VIDENSKABELIG; Harvey CJ, 2003, ICES J MAR SCI, V60, P939, DOI 10.1016/S1054-3139(03)00098-5; Hasler B., 2015, MODELLERING OMKOSTNI; HELCOM, 2010, HELCOM BALT SEA ENV; HELCOM, 2007, HELCOM ENV P, V111; HELCOM, 2014, BALT SEA ENV P; HELCOM, 2013, BALT SEA ENV P, P1; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2015, CAN J FISH AQUAT SCI, V72, P1433, DOI 10.1139/cjfas-2015-0062; Hilborn R, 2011, FISH RES, V108, P235, DOI 10.1016/j.fishres.2010.12.030; Horne P.J., 2010, TECHNICAL REPORT; ICES, 2013, BALT SEA COD SUBD 22; ICES, 2012, STOCK SUMM ADV JUN 2; ICES, 2013, 2013ACOM06 ICES CM; ICES, 2013, 20133 ICES WGNSSK; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jorgensen L, 2014, BIOGEOCHEMISTRY, V117, P455, DOI 10.1007/s10533-013-9890-9; Kahru M, 1997, MONITORING ALGAL BLOOMS: NEW TECHNIQUES FOR DETECTING LARGE-SCALE ENVIRONMENTAL CHANGE, P43; Kaplan IC, 2014, ICES J MAR SCI, V71, P308, DOI 10.1093/icesjms/fst114; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kaplan IC, 2009, FISH FISH SER, V31, P77, DOI 10.1007/978-1-4020-9210-7_5; Karlson B, 2001, SKAGERRAK ENV STATE; Korpinen S, 2012, ECOL INDIC, V15, P105, DOI 10.1016/j.ecolind.2011.09.023; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Laane A, 2005, GIWA REGIONAL ASSESS, V17; Lewy P, 2004, STOCHASTIC AGE LENGT, P33; Link J. S., 2010, ECOSYSTEM BASED FISH; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; Lundstrom K, 2010, ICES J MAR SCI, V67, P1230, DOI 10.1093/icesjms/fsq022; Lyngsgaard MM, 2014, LIMNOL OCEANOGR, V59, P1679, DOI 10.4319/lo.2014.59.5.1679; Maar M, 2016, ECOL MODEL, V320, P258, DOI 10.1016/j.ecolmodel.2015.09.023; Maar M, 2011, ECOL MODEL, V222, P1696, DOI 10.1016/j.ecolmodel.2011.03.006; MacKenzie BR, 2000, MAR ECOL PROG SER, V193, P143, DOI 10.3354/meps193143; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; Morzaria-Luna HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042917; Murawski SA, 2010, ICES J MAR SCI, V67, P1, DOI 10.1093/icesjms/fsp221; Nehring D., 1991, ACTA ICHTHYOL PISCAT, V21, P152; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Neumann T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001450; Nielsen JR, 2018, FISH FISH, V19, P1, DOI 10.1111/faf.12232; Nielsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070668; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Osterblom H, 2017, ECOSYSTEMS, V20, P54, DOI 10.1007/s10021-016-9998-6; Osterblom H, 2013, BIOSCIENCE, V63, P735, DOI 10.1093/bioscience/63.9.735; Pecuchet L, 2015, ICES J MAR SCI, V72, P1323, DOI 10.1093/icesjms/fsu220; Petersen ME, 2017, J MARINE SYST, V169, P25, DOI 10.1016/j.jmarsys.2017.01.006; Plaganyi E.E., 2007, FAO FISH TECH PAP; Ramos J, 2015, ICES J MAR SCI, V72, P720, DOI 10.1093/icesjms/fsu095; Rose KA, 2010, MAR COAST FISH, V2, P115, DOI 10.1577/C09-059.1; Ross SD, 2016, MAR MAMMAL SCI, V32, P1491, DOI 10.1111/mms.12318; Rumohr H, 1996, ARCH FISH MAR RES, V44, P179; Savchuk OP, 2009, HYDROBIOLOGIA, V629, P209, DOI 10.1007/s10750-009-9775-z; Savchuk OP, 2005, J MARINE SYST, V56, P1, DOI 10.1016/j.jmarsys.2004.08.005; Savchuk OP, 2012, 5 BALT NEST I; Schinke H, 1998, CONT SHELF RES, V18, P67, DOI 10.1016/S0278-4343(97)00071-X; Siegel H, 2015, SEA SURFACE TEMPERAT; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Smith ADM, 2008, FISH RES, V94, P373, DOI 10.1016/j.fishres.2008.06.006; Smith MD, 2015, AFR J MAR SCI, V37, P65, DOI 10.2989/1814232X.2015.1013501; Smith MD, 2015, ENVIRON MODELL SOFTW, V69, P23, DOI 10.1016/j.envsoft.2015.03.002; Soma K., 2010, STUDY REMUNERATION S; Soma K, 2014, ICES J MAR SCI, V71, P2630, DOI 10.1093/icesjms/fst193; Timmermann K, 2012, J MARINE SYST, V105, P60, DOI 10.1016/j.jmarsys.2012.06.001; Timmermann K, 2010, J MARINE SYST, V82, P111, DOI 10.1016/j.jmarsys.2010.04.008; Tomczak MT, 2012, ECOL MODEL, V230, P123, DOI 10.1016/j.ecolmodel.2011.12.014; Tomczak MT, 2009, PROG OCEANOGR, V81, P111, DOI 10.1016/j.pocean.2009.04.017; Unverzagt S., 2001, GREIFSWALDER GEOGRAP, V19, P99; UZARS D, 1994, ICES MAR SC, V198, P612; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Wan Z, 2012, OCEAN SCI, V8, P683, DOI 10.5194/os-8-683-2012; Weijerman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144165; Wennhage H, 2007, MAR ECOL PROG SER, V335, P187, DOI 10.3354/meps335187; Windolf J, 2011, J ENVIRON MONITOR, V13, P2645, DOI 10.1039/c1em10139k; Winterhalter B., 1981, BALTIC SEA, P105; Wulff FV, 2013, SYSTEMS ANAL BALTIC, V148	107	25	25	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0199168	10.1371/journal.pone.0199168	http://dx.doi.org/10.1371/journal.pone.0199168			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028849	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000439396900003
J	Wang, C; Hipp, JR; Butts, CT; Lakon, CM				Wang, Cheng; Hipp, John R.; Butts, Carter T.; Lakon, Cynthia M.			The interdependence of cigarette, alcohol, and marijuana use in the context of school-based social networks	PLOS ONE			English	Article							ADOLESCENT FRIENDSHIP NETWORKS; NICOTINE DEPENDENCE; PEER SELECTION; DRUG-USE; QUALITATIVE EXPLORATION; SUBSTANCE USE; TOBACCO USE; SMOKING; CANNABIS; STUDENTS	The concurrent or sequential usage of multiple substances during adolescence is a serious public health problem. Given the importance of understanding interdependence in substance use during adolescence, the purpose of this study is to examine the co-evolution of cigarette smoking, alcohol, and marijuana use within the ever-changing landscape of adolescent friendship networks, which are a primary socialization context for adolescent substance use. Utilizing Stochastic Actor-Based models, we examine how multiple simultaneous social processes co-evolve with adolescent smoking, drinking, and marijuana use within adolescent friendship networks using two school samples from early waves of the National Longitudinal Study of Adolescent to Adult Health (Add Health). We also estimate two separate models examining the effects from using one substance to the initiation and cessation of other substances for each sample. Based on the initial model results, we simulate the model forward in time by turning off one key effect in the estimated model at a time, and observe how the distribution of use of each substance changes. We find evidence of a unilateral causal relationship from marijuana use to subsequent smoking and drinking behaviors, resulting in the initiation of drinking behavior. Marijuana use is also associated with smoking initiation in a school with a low substance use level, and smoking cessation in a school with a high substance use level. In addition, in a simulation model excluding the effect from marijuana use to smoking and drinking behavior, the number of smokers and drinkers decreases precipitously. Overall, our findings indicate some evidence of sequential drug use, as marijuana use increased subsequent smoking and drinking behavior and indicate that an adolescent's level of marijuana use affects the initiation and continuation of smoking and drinking.	[Wang, Cheng] Univ Notre Dame, Dept Sociol, Notre Dame, IN 46556 USA; [Hipp, John R.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA USA; [Hipp, John R.; Butts, Carter T.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [Lakon, Cynthia M.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	University of Notre Dame; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wang, C (corresponding author), Univ Notre Dame, Dept Sociol, Notre Dame, IN 46556 USA.	cwang3@nd.edu	Wang, Cheng/E-5189-2015	Wang, Cheng/0000-0002-4693-6424	Cascades of Network Structure and Function: Pathways to Adolescent Substance Use [1 R21 DA031152-01A1]; National Institute on Drug Abuse	Cascades of Network Structure and Function: Pathways to Adolescent Substance Use; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by Grant #1 R21 DA031152-01A1, Cascades of Network Structure and Function: Pathways to Adolescent Substance Use to CML; National Institute on Drug Abuse (https://www.drugabuse.gov/), administered through the Program in Public Health at the University of California Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, DRUG ALCOHOL DEPEN, V95, P107, DOI 10.1016/j.drugalcdep.2007.12.017; Agrawal A, 2009, DRUG ALCOHOL DEPEN, V99, P240, DOI 10.1016/j.drugalcdep.2008.08.007; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amos A, 2004, ADDICTION, V99, P77, DOI 10.1111/j.1360-0443.2004.00531.x; BAILEY SL, 1992, AM J PUBLIC HEALTH, V82, P1220, DOI 10.2105/AJPH.82.9.1220; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Brooks TL, 2002, J ADOLESCENT HEALTH, V31, P240, DOI 10.1016/S1054-139X(02)00385-3; de la Haye K, 2013, J RES ADOLESCENCE, V23, P474, DOI 10.1111/jora.12018; Dee TS, 1999, J HEALTH ECON, V18, P769, DOI 10.1016/S0167-6296(99)00018-1; Dobashi S., PERSONAL PORTABLE PE; Forster M, 2015, J SCHOOL HEALTH, V85, P82, DOI 10.1111/josh.12230; GOLUB A, 1994, J STUD ALCOHOL, V55, P607, DOI 10.15288/jsa.1994.55.607; Haas SA, 2014, J HEALTH SOC BEHAV, V55, P126, DOI 10.1177/0022146514532817; Harris KM, 2009, NATL LONGITUDINAL ST; Highet G, 2004, HEALTH EDUC RES, V19, P635, DOI 10.1093/her/cyg089; Hipp JR, 2015, SOC NETWORKS, V41, P56, DOI 10.1016/j.socnet.2014.12.004; Hopfer C, 2014, SUBST ABUS, V35, P331, DOI 10.1080/08897077.2014.943386; Huisman M, 2008, SOC NETWORKS, V30, P297, DOI 10.1016/j.socnet.2008.04.004; Humfleet GL, 2004, ADDICTION, V99, P5, DOI 10.1111/j.1360-0443.2004.00596.x; KANDEL D, 1975, SCIENCE, V190, P912, DOI 10.1126/science.1188374; KANDEL DB, 1978, LONGITUDINAL RES DRU, P3; Kim Y, 2016, MEDIA CULT SOC, V38, P525, DOI 10.1177/0163443715613638; Lakon CM, 2015, AM J PUBLIC HEALTH, V105, P2438, DOI 10.2105/AJPH.2015.302789; Lakon CM, 2015, J YOUTH ADOLESCENCE, V44, P1767, DOI 10.1007/s10964-014-0187-7; Latane B, 1996, J COMMUN, V46, P13, DOI 10.1111/j.1460-2466.1996.tb01501.x; Lipperman-Kreda S, 2011, J DRUG ISSUES, V41, P509, DOI 10.1177/002204261104100404; MackesyAmiti ME, 1997, DRUG ALCOHOL DEPEN, V45, P185, DOI 10.1016/S0376-8716(97)00032-X; Mathys C, 2013, J RES ADOLESCENCE, V23, P513, DOI 10.1111/jora.12031; McKee SA, 2004, NICOTINE TOB RES, V6, P111, DOI 10.1080/14622200310001656939; Orlando M, 2005, SUBST USE MISUSE, V40, P1051, DOI 10.1081/JA-200030789; Patton GC, 2005, ADDICTION, V100, P1518, DOI 10.1111/j.1360-0443.2005.01220.x; Pearson M., 2006, CONNECTIONS, V27, P47; Peters EN, 2010, DRUG ALCOHOL DEPEN, V106, P111, DOI 10.1016/j.drugalcdep.2009.07.027; Ripley R, 2011, MANUAL SIENA VERSION; Schaefer DR, 2013, HEALTH EDUC BEHAV, V40, p24S, DOI 10.1177/1090198113493091; Schaefer David R, 2012, Am J Public Health, V102, pe12, DOI 10.2105/AJPH.2012.300705; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Snijders T. A. B., 2011, SAGE HDB SOCIAL NETW, P501; Snijders T, 2007, EUR ASSOC METHODOL S, P41; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Stoltz A D, 2000, J Sch Nurs, V16, P28; Timberlake DS, 2007, DRUG ALCOHOL DEPEN, V88, P272, DOI 10.1016/j.drugalcdep.2006.11.005; TORABI MR, 1993, J SCHOOL HEALTH, V63, P302, DOI 10.1111/j.1746-1561.1993.tb06150.x; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 2005, J ADOLESCENT HEALTH, V37, P323, DOI 10.1016/j.jadohealth.2004.10.016; Vega WA, 2005, ADDICTION, V100, P1358, DOI 10.1111/j.1360-0443.2005.01141.x; Wang C, 2017, PREV SCI, V18, P382, DOI 10.1007/s11121-017-0773-5; Wang C, 2016, SOC NETWORKS, V45, P89, DOI 10.1016/j.socnet.2015.12.003; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119965	50	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200904	10.1371/journal.pone.0200904	http://dx.doi.org/10.1371/journal.pone.0200904			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028843	gold, Green Submitted, Green Published			2022-12-27	WOS:000439396900024
J	Margaryan, S; Witkowicz, A; Arakelyan, A; Partyka, A; Karabon, L; Manukyan, G				Margaryan, Sona; Witkowicz, Agata; Arakelyan, Arsen; Partyka, Anna; Karabon, Lidia; Manukyan, Gayane			sFasL-mediated induction of neutrophil activation in patients with type 2 diabetes mellitus	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; SOLUBLE FAS LIGAND; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; NLRP3 INFLAMMASOME; EXPRESSION; OBESITY; DEATH; FORM; MACROPHAGES	Fas/Fas ligand system was shown to be related to insulin resistance and type 2 diabetes mellitus (T2DM). However, the role of soluble Fas ligand (sFasL) in functioning of immune cells in type 2 diabetes mellitus (T2DM) has not been studied yet. The aim of the present study was to determine in vitro effects of sFasL on neutrophil activation and apoptosis. We demonstrate here that sFasL exhibited proinflammatory effect and induced mRNA levels of caspase-1, NF-kappa B, IL-1 beta and CD18 expression. At the same time, sFasL induced reactive oxygen species (ROS) production. Activation of caspase-1 activity abolished sFasL-dependent apoptosis, and suppressed Fas expression and mRNA levels of caspase-3 in neutrophils from T2DM patients. Collectively, our findings identify a novel proinflammatory role of sFasL in T2DM neutrophils that is dependent of caspase activity. Thus, sFasL enhances inflammatory response of neutrophils from T2DM patients without increasing apoptosis suggesting its triggering role in T2DM inflammation.	[Margaryan, Sona; Arakelyan, Arsen; Manukyan, Gayane] Russian Armenian Univ, Yerevan, Armenia; [Margaryan, Sona; Manukyan, Gayane] Inst Mol Biol, Lab Mol & Cellular Immunol, Yerevan, Armenia; [Witkowicz, Agata; Partyka, Anna; Karabon, Lidia] Polish Acad Sci, L Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Therapy, Wroclaw, Poland; [Arakelyan, Arsen] Inst Mol Biol, Bioinformat Grp, Yerevan, Armenia	Russian Armenian Slavonic University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA	Manukyan, G (corresponding author), Russian Armenian Univ, Yerevan, Armenia.; Manukyan, G (corresponding author), Inst Mol Biol, Lab Mol & Cellular Immunol, Yerevan, Armenia.	gaya.manukyan@gmail.com	Karabon, Lidia/J-1148-2019; Manukyan, Gayane/AAR-7421-2020	Karabon, Lidia/0000-0001-8172-0971; Manukyan, Gayane/0000-0001-7541-5743; Arakelyan, Arsen/0000-0002-6851-1056	U-GENE, 7. PR UE PEOPLE Marie Curie International Research Staff Exchange Scheme (IRSES) [319010]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation	U-GENE, 7. PR UE PEOPLE Marie Curie International Research Staff Exchange Scheme (IRSES); Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation	This work was supported by the U-GENE, 7. PR UE PEOPLE Marie Curie International Research Staff Exchange Scheme (IRSES) number 319010, and Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, as well as Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation. The cost of publication was covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Bamri-Ezzine S, 2003, LAB INVEST, V83, P1069, DOI 10.1097/01.LAB.0000078687.21634.69; Bluher M, 2014, J CLIN ENDOCR METAB, V99, pE36, DOI 10.1210/jc.2013-2488; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cosson E, 2005, DIABETES METAB, V31, P47, DOI 10.1016/S1262-3636(07)70166-0; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Engstrom G, 2003, DIABETES, V52, P442, DOI 10.2337/diabetes.52.2.442; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Guillot R, 2001, DIABETES METAB, V27, P315; Hatanaka E, 2006, CLIN EXP IMMUNOL, V146, P443, DOI 10.1111/j.1365-2249.2006.03229.x; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Hou HW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29410; Item F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00566-9; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje; Keane KN, 2017, EUR J CLIN NUTR, V71, P904, DOI 10.1038/ejcn.2017.45; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lee CTC, 2014, CLIN ENDOCRINOL, V81, P536, DOI 10.1111/cen.12390; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maedler K, 2002, P NATL ACAD SCI USA, V99, P8236, DOI 10.1073/pnas.122686299; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mitsiades N, 1998, AM J PATHOL, V153, P1947, DOI 10.1016/S0002-9440(10)65708-2; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mogi M, 2001, LAB INVEST, V81, P177, DOI 10.1038/labinvest.3780225; Mondal Avijit, 2012, Indian J Endocrinol Metab, V16, pS465, DOI 10.4103/2230-8210.104133; Niinobu T, 2000, AM J PHYSIOL-CELL PH, V279, pC504, DOI 10.1152/ajpcell.2000.279.2.C504; O'Donnell JA, 2015, J LEUKOCYTE BIOL, V97, P321, DOI 10.1189/jlb.3AB1113-594RR; Ottonello L, 1999, J IMMUNOL, V162, P3601; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Ristic T, 2010, VOJNOSANIT PREGL, V67, P537, DOI 10.2298/VSP1007537R; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; Shimizu M, 2002, J AM COLL CARDIOL, V39, P585, DOI 10.1016/S0735-1097(01)01800-9; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tomita T, 2016, BOSNIAN J BASIC MED, V16, P162, DOI 10.17305/bjbms.2016.919; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yamaguchi S, 1999, AM J CARDIOL, V83, P1500, DOI 10.1016/S0002-9149(99)00133-2; Zhang HM, 2017, J DIABETES COMPLICAT, V31, P31, DOI 10.1016/j.jdiacomp.2016.10.029	46	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201087	10.1371/journal.pone.0201087	http://dx.doi.org/10.1371/journal.pone.0201087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024959	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000090
J	Baldock, KL; Paquet, C; Howard, NJ; Coffee, NT; Taylor, AW; Daniel, M				Baldock, Katherine L.; Paquet, Catherine; Howard, Natasha J.; Coffee, Neil T.; Taylor, Anne W.; Daniel, Mark			Gender-specific associations between perceived and objective neighbourhood crime and metabolic syndrome	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MEDIATION ANALYSIS; BUILT ENVIRONMENT; SAFETY; WALKING; FEAR; PERCEPTIONS; HEALTH; RISK; POPULATION	Much research has considered the relationship between neighbourhood crime and physical activity, but few studies have assessed clinical outcomes consequent to behaviour, such as cardiometabolic risk. Fewer still have simultaneously assessed perceived and objective measures of crime. Perceptions of crime and actual victimisation vary according to gender; thus, this study sought to assess: 1) correspondence between perceived and objective neighbourhood crime; and 2) gender-specific associations between perceived and reported crime and metabolic syndrome, representing cardiometabolic risk. The indirect effect of neighbourhood crime on metabolic syndrome via walking was additionally evaluated. An Australian population-based biomedical cohort study (2004-2007) collected biomedical, socio-demographic, and neighbourhood perceptions data from n = 1,172 urban-dwelling, adults. Area-level reported crime rates were standardised and linked to individual data based on participants' residential location. Correspondence between actual and perceived crime measures was assessed using Pearson correlation coefficients. Cross-sectional associations between crime and metabolic syndrome were analysed using generalised estimating equations regression models accounting for socio-demographic factors and area-level income. Correspondence between perceived and objective crime was small to medium among men and women (r = 0.17 to 0.33). Among men, metabolic syndrome was related to rates of violent (OR = 1.21, 95% CI 1.08-1.35) and total crime (OR = 1.17, 95% CI 1.04-1.32), after accounting for perceived crime. Among women, metabolic syndrome was related to perceived crime (OR = 1.35, 95% CI 1.14-1.60) after accounting for total reported crime. Among women, there were indirect effects of perceived crime and property crime on metabolic syndrome through walking. Results indicate that crime, an adverse social exposure, is linked to clinical health status. Crime rates, and perceptions of crime and safety, differentially impact upon cardiometabolic health according to gender. Social policy and public health strategies targeting crime reduction, as well as strategies to increase perceptions of safety, have potential to contribute to improved cardiometabolic outcomes.	[Baldock, Katherine L.; Paquet, Catherine] Univ South Australia, Sansom Inst Hlth Res, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Howard, Natasha J.] Univ South Australia, Sansom Inst Hlth Res, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia; [Coffee, Neil T.; Daniel, Mark] Univ Canberra, Fac Hlth, Hlth Res Inst, Ctr Res & Act Publ Hlth, Canberra, ACT, Australia; [Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Daniel, Mark] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Daniel, Mark] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of South Australia; University of South Australia; University of Canberra; University of Adelaide; St Vincent's Hospital Melbourne; University of Melbourne; South Australian Health & Medical Research Institute (SAHMRI)	Baldock, KL (corresponding author), Univ South Australia, Sansom Inst Hlth Res, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA, Australia.	katherine.baldock@unisa.edu.au	Paquet, Catherine/C-3894-2009; Baldock, Katherine/S-8151-2019; Howard, Natasha/A-1214-2011; Taylor, Anne/F-5708-2010; Coffee, Neil/F-4357-2013	Paquet, Catherine/0000-0002-6877-7903; Howard, Natasha/0000-0002-8099-3107; Baldock, Katherine L/0000-0003-3527-1057; Taylor, Anne/0000-0002-4422-7974; Daniel, Mark/0000-0001-9112-134X; Coffee, Neil/0000-0002-5075-0737	National Health and Medical Research Council [631917, 570150]; Research SA Research Chair (Social Epidemiology); National Health and Medical Research Council Post-doctoral Training Research Fellowship [570139]; National Health and Medical Research Council Program [0631947]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Research SA Research Chair (Social Epidemiology); National Health and Medical Research Council Post-doctoral Training Research Fellowship; National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia)	The Spatial Epidemiology and Evaluation Research Group, Centre for Population Health Research at the University of South Australia in collaboration with the South Australian Department of Health conducted this research supported in part under National Health and Medical Research Council Projects (no. 631917 and no. 570150) investigating the relationships between place and metabolic syndrome (PAMS). Additional support was from a Research SA Research Chair (Social Epidemiology) awarded to MD. NJH was supported by National Health and Medical Research Council grants no. 631917 and no. 570150. CP was funded by a National Health and Medical Research Council Post-doctoral Training Research Fellowship (#570139) and salary support from a National Health and Medical Research Council Program Grant (#0631947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2007, BAS COMM PROF DATAPA; Australian Bureau of Statistics, 2003, NAT HLTH SURV US GUI; Australian Bureau of Statistics, 2008, AD SOC ATL 2006 CENS; Australian Bureau of Statistics, 2006, STAT GEOGR; Baldock K, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/589409; Ball K, 2007, J EPIDEMIOL COMMUN H, V61, P108, DOI 10.1136/jech.2006.048520; Ball K, 2010, SOC SCI MED, V71, P807, DOI 10.1016/j.socscimed.2010.04.041; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Boehmer TK, 2007, INT J OBESITY, V31, P968, DOI 10.1038/sj.ijo.0803531; Boehmer T.K., 2006, J PHYS ACT HEALTH, V3, P22, DOI [DOI 10.1123/JPAH.3.1.22, 10.1123/jpah.3.1.22.]; Boehmer TK, 2006, AM J HEALTH PROMOT, V20, P411, DOI 10.4278/0890-1171-20.6.411; Brown BB, 2014, PREV MED, V66, P140, DOI 10.1016/j.ypmed.2014.06.021; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Burdette AM, 2008, SOC SCI MED, V67, P38, DOI 10.1016/j.socscimed.2008.03.029; Burdette HL, 2006, OBESITY, V14, P518, DOI 10.1038/oby.2006.67; Cameron AJ, 2009, DIABETIC MED, V26, P306, DOI 10.1111/j.1464-5491.2009.02681.x; Castle C, 2010, JANCO CLASSIFICATION; Chaix B, 2008, J EPIDEMIOL COMMUN H, V62, P62, DOI 10.1136/jech.2006.056960; Christian H, 2011, PREV MED, V53, P57, DOI 10.1016/j.ypmed.2011.05.004; Daniel M, 2008, HEALTH PLACE, V14, P117, DOI 10.1016/j.healthplace.2007.05.003; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Evenson KR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-146; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fish JS, 2010, AM J PUBLIC HEALTH, V100, P2296, DOI 10.2105/AJPH.2009.183293; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Foster S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0343-4; Foster S, 2010, HEALTH PLACE, V16, P1156, DOI 10.1016/j.healthplace.2010.07.007; Gebel K, 2009, ANN BEHAV MED, V37, P228, DOI 10.1007/s12160-009-9098-3; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; HARTNAGEL TF, 1979, SOC FORCES, V58, P176, DOI 10.2307/2577792; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hjorth MF, 2014, INT J OBESITY, V38, P959, DOI 10.1038/ijo.2013.229; Kerr Z, 2015, PREV MED, V73, P88, DOI 10.1016/j.ypmed.2015.01.017; Kirtland KA, 2003, AM J PREV MED, V24, P323, DOI 10.1016/S0749-3797(03)00021-7; LAGRANGE RL, 1989, CRIMINOLOGY, V27, P697, DOI 10.1111/j.1745-9125.1989.tb01051.x; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Leslie E, 2005, HEALTH PLACE, V11, P227, DOI 10.1016/j.healthplace.2004.05.005; Lorenc T, 2012, HEALTH PLACE, V18, P757, DOI 10.1016/j.healthplace.2012.04.001; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mason P, 2013, SOC SCI MED, V91, P15, DOI 10.1016/j.socscimed.2013.04.011; May DC., 2010, CRIMINAL JUSTICE REV, V35, P159, DOI [10.1177/0734016809349166, DOI 10.1177/0734016809349166]; McDonald NC, 2008, AM J HEALTH PROMOT, V22, P433, DOI 10.4278/ajhp.22.6.433; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McGinn AP, 2008, J PHYS ACT HEALTH, V5, P117, DOI 10.1123/jpah.5.1.117; Medway D, 2016, J ENVIRON PSYCHOL, V45, P135, DOI 10.1016/j.jenvp.2015.12.002; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Nielsen L, 2008, SCAND J PUBLIC HEALT, V36, P369, DOI 10.1177/1403494807088456; Office of Crime Statistics and Research, 2006, TOT 2006 OFF PERS PR; Office of Crime Statistics and Research, 2007, CRIM JUST S AUSTR 20; Oh AY, 2010, J PHYS ACT HEALTH, V7, P432, DOI 10.1123/jpah.7.4.432; Openshaw S., 1984, MODIFIABLE AREAL UNI; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Peterson NA, 2004, HEALTH EDUC RES, V19, P533, DOI 10.1093/her/cyg057; Piro FN, 2006, J EPIDEMIOL COMMUN H, V60, P626, DOI 10.1136/jech.2005.042697; Preacher K. J., 2008, MONTE CARLO METHOD A; Reiss A., 1993, UNDERSTANDING PREVEN; Rennie KL, 2003, INT J EPIDEMIOL, V32, P600, DOI 10.1093/ije/dyg179; Richmond RC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001618; Robinette JW, 2016, SSM-POPUL HLTH, V2, P525, DOI 10.1016/j.ssmph.2016.06.004; Ross CE, 2000, SOC SCI MED, V51, P265, DOI 10.1016/S0277-9536(99)00451-7; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Schafer JA, 2006, J CRIM JUST, V34, P285, DOI 10.1016/j.jcrimjus.2006.03.003; Shareck M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-930; SKOGAN WG, 1974, SOC SCI QUART, V55, P25; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4	77	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201336	10.1371/journal.pone.0201336	http://dx.doi.org/10.1371/journal.pone.0201336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048521	Green Published, gold, Green Accepted			2022-12-27	WOS:000439952400078
J	Hino, S; Grodensky, C; Rutstein, SE; Golin, C; Smith, MK; Christmas, L; Miller, W; Phiri, S; Massa, C; Kamanga, G; Pettifor, A				Hino, Sayaka; Grodensky, Catherine; Rutstein, Sarah E.; Golin, Carol; Smith, M. Kumi; Christmas, Lawrenson; Miller, William; Phiri, Sam; Massa, Cecilia; Kamanga, Gift; Pettifor, Audrey			HIV status disclosure during acute HIV infection in Malawi	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; PARTNER SERVICES; SEXUAL PARTNERS; PREVENTION; TRANSMISSION; STIGMA; METAANALYSIS; COUNTRIES; HIV/AIDS; AFRICA	Diagnosis of acute HIV infection (AHI) presents an opportunity to prevent HIV transmission during a highly infectious period. Disclosure is important during AHI as a means to facilitate safer sex practices and notify partners, particularly as those with AHI may be better able to identify the source of their infection because of the recency of HIV acquisition. However, little is known about disclosure during AHI. We conducted 40 semi-structured interviews with Malawians diagnosed with AHI (24 men; 21 married). Most participants reported disclosing to a sexual partner within a month of diagnosis, and knew or had a strong suspicion about the source of their infection. Participants often assumed their source had knowingly infected them, contributing to anger and feeling that disclosure is futile if the source already knew their HIV status. Assisted partner notification, individual and couples counseling, and couples HIV testing may facilitate disclosure during AHI.	[Hino, Sayaka; Rutstein, Sarah E.; Golin, Carol; Smith, M. Kumi; Miller, William; Pettifor, Audrey] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA; [Grodensky, Catherine; Golin, Carol] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27515 USA; [Rutstein, Sarah E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27515 USA; [Golin, Carol; Christmas, Lawrenson] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Massa, Cecilia; Kamanga, Gift] Univ N Carolina, Project Malawi, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Golin, C (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA.; Golin, C (corresponding author), Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27515 USA.; Golin, C (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA.	carol_golin@med.unc.edu	Miller, William C/H-4800-2014; Pettifor, Audrey/H-6793-2019	Miller, William C/0000-0002-1934-7827; Pettifor, Audrey/0000-0002-3387-0817; Smith, M. Kumi/0000-0001-5861-8100	NIH/NIAID [R01 AI083059]; NIH/NIMH [F30 MH098731]; NIH/NIGMS [T32-GM008719]; NIAID [T32 AI102623, R01 AI114320]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K24- HD06920]; University of North Carolina Center for AIDS Research (CFAR) [P30 AI50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI102623, R01AI114320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098731] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of North Carolina Center for AIDS Research (CFAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIH/NIAID (R01 AI083059 to AM). SER was supported by NIH/NIMH (F30 MH098731) and NIH/NIGMS (T32-GM008719). MKS was supported by NIAID (T32 AI102623). Dr. Golin's salary was partly supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development K24- HD06920. WM was partly supported by NIAID (R01 AI114320). Additional support for this work was provided to C Grodensky and C Golin by the University of North Carolina Center for AIDS Research (CFAR) (P30 AI50410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye-Agboola DI, 2016, PUBLIC HEALTH, V136, P13, DOI 10.1016/j.puhe.2016.02.021; Brown LB, 2011, JAIDS-J ACQ IMM DEF, V56, P437, DOI 10.1097/QAI.0b013e318202bf7d; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dlamini PS, 2007, PUBLIC HEALTH NURS, V24, P389, DOI 10.1111/j.1525-1446.2007.00649.x; Grodensky CA, 2018, PATIENT EDUC COUNS, V101, P1103, DOI 10.1016/j.pec.2018.02.004; Henley C, 2013, SEX TRANSM DIS, V40, P909, DOI 10.1097/OLQ.0000000000000032; Hogben M, 2016, SEX TRANSM DIS, V43, pS53, DOI 10.1097/OLQ.0000000000000328; Kennedy Caitlin E, 2015, AIDS, V29 Suppl 1, pS7, DOI 10.1097/QAD.0000000000000671; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Mulrenan C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006907; Musheke M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-97; Olley ABO, 2004, SELF DISCL HIV SEROS, V8, P71; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Przybyla SM, 2013, AIDS CARE, V25, P566, DOI 10.1080/09540121.2012.722601; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHO, 2016, GUID HIV SELF TEST P; Wolpaw BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105459; World Health Organization, 2012, GUID OR PREEXP PROPH	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201265	10.1371/journal.pone.0201265	http://dx.doi.org/10.1371/journal.pone.0201265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048496	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400067
J	Iwasaki, K; Arimura, S; Takihara, Y; Takamura, Y; Inatani, M				Iwasaki, Kentaro; Arimura, Shogo; Takihara, Yuji; Takamura, Yoshihiro; Inatani, Masaru			Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation	PLOS ONE			English	Article							FOLLOW-UP; PSEUDOEXFOLIATION SYNDROME; VALVE IMPLANTATION; TRABECULECTOMY TVT; ANTERIOR-CHAMBER; AQUEOUS SHUNTS; DENSITY; TUBE; MORPHOLOGY; EYES	Purpose To evaluate corneal endothelial cell loss after Baerveldt glaucoma implantation. Methods We prospectively evaluated changes in endothelial cell density (ECD) in the cornea of 59 patients (59 eyes) who underwent Baerveldt glaucoma implantation. Tubes were inserted into the anterior chamber in 45 eyes and pars plana in 14 eyes. The primary outcome measure was the change in corneal ECD after Baerveldt glaucoma implantation. Secondary outcome measures included relationships between corneal ECD and optical coherence tomography images of tube parameters (tube-cornea distance and tube-cornea angle) and prognostic factors for corneal ECD loss. Results Corneal ECD decreased significantly by 9.2% at 12 months after surgery (P = 0.001). In the anterior chamber Baerveldt glaucoma implantation group, corneal ECD at the tube insertion quadrant decreased significantly by 9.6% at 3 months (P = < 0.001), 10.7% at 6 months (P = < 0.001), and 13.1% at 12 months (P = < 0.001). Corneal ECD at the center decreased significantly at 6 months after surgery (7.2% loss; P = 0.012) and at 12 months after surgery (12.1% loss; P = 0.001). Corneal ECD at the contralateral quadrant decreased significantly at 12 months after surgery only (10.3% loss; P = 0.004). In the pars plana Baerveldt glaucoma implantation group, no significant loss of corneal ECD was found in any corneal areas at any post-surgery follow-up visits. Tube-cornea angle was negatively correlated with the rate of corneal ECD loss at the tube insertion quadrant; r = -0.55 (P = 0.0013). In multivariable analyses, exfoliation glaucoma and narrower tube-cornea angle were significant prognostic factors for severe corneal ECD loss (P = 0.0068 and P = 0.046, respectively). Conclusions Anterior chamber Baerveldt glaucoma implantation causes corneal endothelial cell loss. Corneal endothelial cell loss starts at the tube insertion quadrant. Exfoliation glaucoma and narrower tube-corneal angle are associated with severe loss of corneal endothelial cells.	[Iwasaki, Kentaro; Arimura, Shogo; Takihara, Yuji; Takamura, Yoshihiro; Inatani, Masaru] Univ Fukui, Dept Ophthalmol, Fac Med Sci, Fukui, Japan	University of Fukui	Inatani, M (corresponding author), Univ Fukui, Dept Ophthalmol, Fac Med Sci, Fukui, Japan.	inatani@u-fukui.ac.jp						Arora KS, 2015, OPHTHALMOLOGY, V122, P1615, DOI 10.1016/j.ophtha.2015.04.015; Campagnoli TR, 2015, INT J OPHTHALMOL-CHI, V8, P916, DOI 10.3980/j.issn.2222-3959.2015.05.11; Chihara E, 2012, JPN J OPHTHALMOL, V56, P119, DOI 10.1007/s10384-011-0108-1; Gedde SJ, 2007, AM J OPHTHALMOL, V143, P23, DOI 10.1016/j.ajo.2006.07.022; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P804, DOI 10.1016/j.ajo.2011.10.024; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Hau S, 2011, CORNEA, V30, P50, DOI 10.1097/ICO.0b013e3181e16d7d; Hayashi K, 2013, J CATARACT REFR SURG, V39, P881, DOI 10.1016/j.jcrs.2013.01.032; Kim CS, 2008, CLIN EXP OPHTHALMOL, V36, P142, DOI 10.1111/j.1442-9071.2008.01683.x; Kim KN, 2016, BRIT J OPHTHALMOL, V100, P933, DOI 10.1136/bjophthalmol-2015-306894; Kim Min Su, 2016, Korean J Ophthalmol, V30, P416; Koo EB, 2015, CORNEA, V34, P37, DOI 10.1097/ICO.0000000000000301; Lee EK, 2009, AM J OPHTHALMOL, V148, P361, DOI 10.1016/j.ajo.2009.04.016; MCDERMOTT ML, 1993, AM J OPHTHALMOL, V115, P93, DOI 10.1016/S0002-9394(14)73530-5; Mendrinos E, 2009, EYE, V23, P1836, DOI 10.1038/eye.2008.321; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; MIYAKE K, 1989, AM J OPHTHALMOL, V108, P49, DOI 10.1016/S0002-9394(14)73259-3; Seo JW, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/486832; Tan AN, 2017, ACTA OPHTHALMOL, V95, P91, DOI 10.1111/aos.13161; Tomaszewski BT, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/123683; Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X; Wang LL, 1999, OPHTHALMOLOGICA, V213, P387, DOI 10.1159/000027460; Zimmermann N, 2014, KLIN MONATSBL AUGENH, V231, P158, DOI 10.1055/s-0033-1360308	23	26	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201342	10.1371/journal.pone.0201342	http://dx.doi.org/10.1371/journal.pone.0201342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048529	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400080
J	Averianov, A; Martin, T; Lopatin, A; Skutschas, P; Schellhorn, R; Kolosov, P; Vitenko, D				Averianov, Alexander; Martin, Thomas; Lopatin, Alexey; Skutschas, Pavel; Schellhorn, Rico; Kolosov, Petr; Vitenko, Dmitry			A high-latitude fauna of mid-Mesozoic mammals from Yakutia, Russia	PLOS ONE			English	Article							OSSIFIED MECKELS CARTILAGE; CRETACEOUS MAMMALS; VERTEBRATE FAUNA; NORTHWEST CHINA; JUNGGAR-BASIN; SIBERIA; DINOSAURS; ORIGIN; ALASKA; EAR	The Early Cretaceous (?Berriasian-Barremian) Teete vertebrate locality in Western Yakutia, East Siberia, Russia, has produced mammal remains that are attributed to three taxa: Eleutherodontidae indet. cf. Sineleutherus sp. (Haramiyida; an upper molariform tooth), Khorotherium yakutensis gen. et sp. nov. (Tegotheriidae, Docodonta; maxillary fragment with three molariform teeth and dentary fragment with one molariform tooth), and Sangarotherium aquilonium gen. et sp. nov. (Eutriconodonta incertae sedis; dentary fragment with one erupted molariform tooth and one tooth in crypt). This is the second occurrence of Mesozoic mammals in high latitudes (paleolatitude estimate N 63-70 degrees) of the Northern Hemisphere. In spite of the presumed Early Cretaceous age based on freshwater mollusks, the Teete mammal assemblage has a distinctive Jurassic appearance, being most similar to the Middle-Late Jurassic mammal assemblages known from Siberia, Russia and Xinjiang, China. The smooth transition from Jurassic to Cretaceous biota in Northern Asia is best explained by stable environmental conditions.	[Averianov, Alexander] Russian Acad Sci, Inst Zool, St Petersburg, Russia; [Averianov, Alexander] St Petersburg State Univ, Inst Earth Sci, St Petersburg, Russia; [Averianov, Alexander] Kazan Fed Univ, Inst Geol & Petr Technol, Kazan, Russia; [Martin, Thomas; Schellhorn, Rico] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Lopatin, Alexey] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia; [Skutschas, Pavel; Vitenko, Dmitry] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Kolosov, Petr] Russian Acad Sci, Siberian Branch, Inst Diamond & Precious Met Geol, Yakutsk, Russia	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Saint Petersburg State University; Kazan Federal University; University of Bonn; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences; Saint Petersburg State University; Diamond & Precious Metal Geology Institute Siberian Branch of Russian Academy of Sciences; Russian Academy of Sciences	Averianov, A (corresponding author), Russian Acad Sci, Inst Zool, St Petersburg, Russia.; Averianov, A (corresponding author), St Petersburg State Univ, Inst Earth Sci, St Petersburg, Russia.; Averianov, A (corresponding author), Kazan Fed Univ, Inst Geol & Petr Technol, Kazan, Russia.	dzharakuduk@mail.ru	Lopatin, Alexey/P-7465-2015; Skutschas, Pavel/AAK-1811-2021; Skutschas, Pavel/D-5143-2013; Averianov, Alexander/M-8490-2013	Skutschas, Pavel/0000-0001-8093-2905; Skutschas, Pavel/0000-0001-8093-2905; Schellhorn, Rico/0000-0003-4890-3025; Averianov, Alexander/0000-0001-5948-0799	Russian Foundation for Basic Research [17-54-12041-NNIO]; Deutsche Forschungsgemeinschaft [MA 1643/22-1]; Zoological Institute, Russian Academy of Sciences [AAAA-A17-117022810195-3]; Program of the Russian Academy of Sciences Presidium "Evolution of the organic world"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zoological Institute, Russian Academy of Sciences(Russian Academy of Sciences); Program of the Russian Academy of Sciences Presidium "Evolution of the organic world"	This work was supported by Russian Foundation for Basic Research, http://www.rfbr.ru/rffi/ru/, 17-54-12041-NNIO (Dr. Alexander Averianov); Deutsche Forschungsgemeinschaft, http://www.dfg.de/, MA 1643/22-1 (Prof. Thomas Martin); Zoological Institute, Russian Academy of Sciences, AAAA-A17-117022810195-3 (Dr. Alexander Averianov); and Program of the Russian Academy of Sciences Presidium "Evolution of the organic world". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P121; Averianov Alexander, 2016, Global Geology - English Edition, V19, P187; Averianov A, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1293070; Averianov A, 2015, GEOBIOS-LYON, V48, P131, DOI 10.1016/j.geobios.2015.02.004; Averianov A, 2015, CRETACEOUS RES, V54, P145, DOI 10.1016/j.cretres.2014.12.007; Averianov AO, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1363767; Averianov AO, 2005, ACTA PALAEONTOL POL, V50, P789; BROUWERS EM, 1987, SCIENCE, V237, P1608, DOI 10.1126/science.237.4822.1608; Butler PM, 1997, J VERTEBR PALEONTOL, V17, P435, DOI 10.1080/02724634.1997.10010988; Charlesworth E, REPORT BRIT ASS ADVA, P80; Chow M., 1984, Journal of Vertebrate Paleontology, V3, P226; Chumakov N. M., 1959, TEKTONIKA SSSR, V4, P345; CLEMENS WA, 1993, GEOLOGY, V21, P503, DOI 10.1130/0091-7613(1993)021<0503:PIOATV>2.3.CO;2; Crompton AW, 1993, MAMMAL PHYLOGENY, V1, P30, DOI DOI 10.1007/978-1-4613-9249-1; Eberle JJ, 2012, GEOL SOC AM BULL, V124, P3, DOI 10.1130/B30571.1; Eberle JJ, 2010, EARTH PLANET SC LETT, V296, P481, DOI 10.1016/j.epsl.2010.06.005; Eberle JJ, 2017, J VERTEBRATE PALEONT; Fanti F, 2013, CRETACEOUS RES, V41, P256, DOI 10.1016/j.cretres.2012.12.010; Fiorillo AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091287; Fiorillo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065802; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Gangloff RA, 2005, J PALEONTOL, V79, P997, DOI 10.1666/0022-3360(2005)079[0997:TFPDFT]2.0.CO;2; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P7; Grinenko VS, 2017, NAUKA I OBRAZOVANIE, P33; Hammer W.H., 1997, ENCY DINOSAURS, P562; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kolosov PN, 2009, PALEONTOL J+, V43, P201, DOI 10.1134/S0031030109020129; KRETZOI MIKLOS, 1946, ANN MUS NATION HUNGARLCI, V39, P108; Kurzanov SM, 2003, PALEONTOLOG J, V37, P53; Kurzanov SM, 2000, MAT REG C GEOL SIB F, VII, P356; Linnaeus C., 1758, SYSTEMA NATURAE PER, V1; Lopatin A V, 2017, Dokl Biol Sci, V477, P210, DOI [10.7868/S0869565217310243, 10.1134/S0012496617060011]; Lopatin A V, 2008, Dokl Biol Sci, V419, P107, DOI 10.1134/S0012496608020117; Lopatin AV, 2009, PALEONTOL J+, V43, P453, DOI 10.1134/S0031030109040157; Lopatin A, 2015, J MAMM EVOL, V22, P17, DOI 10.1007/s10914-014-9267-4; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo Zhe-Xi, 2004, Bulletin of Carnegie Museum of Natural History, V36, P159, DOI 10.2992/0145-9058(2004)36[159:EODRIM]2.0.CO;2; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo Zhe-Xi, 2007, Bulletin of Carnegie Museum of Natural History, V39, P27, DOI 10.2992/0145-9058(2007)39[27:AOMSAP]2.0.CO;2; Maisch MW, 2005, NATURWISSENSCHAFTEN, V92, P40, DOI 10.1007/s00114-004-0584-y; Mannion PD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9438; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Marsh O. C., 1887, American Journal of Science (3), Vxxxiii, P327; Martin T, 2004, J VERTEBR PALEONTOL, V24, P195, DOI 10.1671/15; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Martinson GG., 1956, GUID MESOZOIC CENOZO; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Maschenko E.N., 2002, RUSSIAN J THERIOLOGY, V1, P75, DOI DOI 10.15298/rusjtheriol.01.2.01; Matsumoto R, 2015, HIST BIOL, V27, P583, DOI 10.1080/08912963.2014.898296; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Nauka, 1975, TECT YAK; Nicholson DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8848; Osborn H. F., 1888, J ACAD NAT SCI PHILA, V9, P186; PARRINGTON FR, 1971, PHILOS T R SOC B, V261, P231, DOI 10.1098/rstb.1971.0055; Parrington FR., 1978, BIOL SCI, V282, P177; Pfretzschner HU, 2005, ACTA PALAEONTOL POL, V50, P799; Rich TH, 2002, SCIENCE, V295, P979, DOI 10.1126/science.1068920; Rozhdestvensky A.K., 1973, PALEONTOLOGICHESKII, V2, P90; Sigogneau-Russell D, 2003, ACTA PALAEONTOL POL, V48, P357; Skutschas PP, 2017, CRETACEOUS RES, V77, P79, DOI 10.1016/j.cretres.2017.05.004; Skutschas PP, 2015, FOSSIL VERTEBRATES R, P7; Sullivan C, 2014, J VERTEBR PALEONTOL, V34, P243, DOI 10.1080/02724634.2013.787316; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P347; TATARINOV LP, 1994, PALEONTOL ZH, P97; Tennant JP, 2017, BIOL REV, V92, P776, DOI 10.1111/brv.12255; Tuchkov I. I., 1973, PALEOGEOGRAPHY HIST; Vakhrameev V. A., 1957, P INT STRAT C SIB LE, P19; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Zhang Fakui, 1998, Vertebrata Palasiatica, V36, P197; Zhou ZH, 2004, CHINESE SCI BULL, V49, P754, DOI 10.1360/04wd0120; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	76	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199983	10.1371/journal.pone.019998	http://dx.doi.org/10.1371/journal.pone.019998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044817				2022-12-27	WOS:000439942500027
J	Shimamoto, K; Miura, F; Shimatani, Y; Nishioka, K; Inoue, I				Shimamoto, Keiko; Miura, Fumiharu; Shimatani, Yuji; Nishioka, Kenji; Inoue, Ichiro			Pulmonary vein volume predicts the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation	PLOS ONE			English	Article							SINUS RHYTHM; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; VENOUS ANATOMY; FOLLOW-UP; AMIODARONE; SIZE; METAANALYSIS; RECURRENCE; CONVERSION	Purpose Catheter ablation of atrial fibrillation (AF) is an effective therapy for selected groups of patients. We evaluated whether quantification of left atrium (LA) or pulmonary vein (PV) by using multi-detector computed tomography (MDCT) may predict the success rate of PV isolation procedure. Methods We included 118 patients younger than 65 years with symptomatic AF (73 paroxysmal, PAF; 45 non-paroxysmal, non-PAF). All patients underwent 256-slice MDCT prior to circumferential PV isolation to evaluate anatomy, volume and dimensions of LA and PV. Results After a mean follow-up of 14 months, complete success was achieved in 50 patients (68.5%) of PAF and in 26 patients (57.8%) of non-PAF. In the PAF group, total PV volume was found to be an independent predictor of AF recurrence, whereas LA volume was not. Logistic regression analysis showed that the probability of AF recurrence was higher in patients with total PV volume greater than 12.0 cm(3)/BSA (m(2)) (AUC 0.682, 95%CI 0.541-0.822). In the non-PAF group, no independent risk factor of LA or PV size was observed for the postoperative recurrence. Conclusions The PV volume quantification may predict the success of AF ablation in patients.	[Shimamoto, Keiko; Miura, Fumiharu; Shimatani, Yuji; Nishioka, Kenji; Inoue, Ichiro] Hiroshima City Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan; [Shimamoto, Keiko] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Res Inst, Suita, Osaka, Japan; [Miura, Fumiharu] Hiroshima Prefectural Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan; [Shimatani, Yuji] Nishinomiya Watanabe Cardiovasc Ctr, Dept Cardiol, Nishinomiya, Hyogo, Japan; [Inoue, Ichiro] Hiroshima City Funairi Citizens Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan	Hiroshima City Hospital; National Cerebral & Cardiovascular Center - Japan	Shimamoto, K (corresponding author), Hiroshima City Hosp, Dept Cardiol, Hiroshima, Hiroshima, Japan.; Shimamoto, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Res Inst, Suita, Osaka, Japan.	shima@kyosai.or.jp		Shimamoto, Keiko/0000-0001-6296-150X				Abecasis J, 2009, EUROPACE, V11, P1289, DOI 10.1093/europace/eup198; Al-Khatib SM, 2014, ANN INTERN MED, V160, P760, DOI 10.7326/M13-1467; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Atwood JE, 2007, AM HEART J, V153, P566, DOI 10.1016/j.ahj.2006.12.020; Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Cozma D, 2007, PACE, V30, pS147; CRIJNS HJGM, 1988, EUR HEART J, V9, P634, DOI 10.1093/oxfordjournals.eurheartj.a062553; den Uijl DW, 2011, AM J CARDIOL, V107, P243, DOI 10.1016/j.amjcard.2010.08.069; Doyle JF, 2009, MAYO CLIN PROC, V84, P234, DOI 10.1016/S0025-6196(11)61140-3; Duytschaever A, 2005, CARDIOVASC RES, V67, P69, DOI 10.1016/j.cardiores.2005.02.019; Ehrlich JR, 2003, J PHYSIOL-LONDON, V551, P801, DOI 10.1113/jphysiol.2003.046417; Falk RH, 2006, J AM COLL CARDIOL, V48, P731, DOI 10.1016/j.jacc.2006.05.022; Floria M, 2009, J INTERV CARD ELECTR, V25, P167, DOI 10.1007/s10840-008-9349-4; FUNG YC, 1997, BIOMECHANICS CIRCULA, P404, DOI DOI 10.1161/01.CIR.0000047065.49852.8F; Gaspo R, 1997, CIRC RES, V81, P1045; Gebhard C, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/179632; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hamaguchi S, 2016, BIOL PHARM BULL, V39, P1216, DOI 10.1248/bpb.b15-01013; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Hocini M, 2002, CIRCULATION, V105, P2442, DOI 10.1161/01.CIR.0000016062.80020.11; Hof I, 2009, J CARDIOVASC ELECTR, V20, P1005, DOI 10.1111/j.1540-8167.2009.01504.x; Jongbloed MRM, 2005, J AM COLL CARDIOL, V45, P343, DOI 10.1016/j.jacc.2004.10.040; Kalifa J, 2003, CIRCULATION, V108, P668, DOI 10.1161/01.CIR.0000086979.39843.7B; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato R, 2003, CIRCULATION, V107, P2004, DOI 10.1161/01.CIR.0000061951.81767.4E; Knecht S, 2008, EUROPACE, V10, P931, DOI 10.1093/europace/eun145; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; McLellan AJA, 2014, HEART RHYTHM, V11, P549, DOI 10.1016/j.hrthm.2013.12.025; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; RAWLES JM, 1990, BRIT HEART J, V63, P225; Reddy VY, 2012, HEART RHYTHM, V9, P1789, DOI 10.1016/j.hrthm.2012.07.016; Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x; Tsao HM, 2001, J CARDIOVASC ELECTR, V12, P809, DOI 10.1046/j.1540-8167.2001.00809.x; Tsao HM, 2005, J CARDIOVASC ELECTR, V16, P7, DOI 10.1046/j.1540-8167.2005.04407.x; van der Velden HMW, 2002, CARDIOVASC RES, V54, P270, DOI 10.1016/S0008-6363(01)00557-0; Viskin S, 1999, EUR HEART J, V20, P1429, DOI 10.1053/euhj.1999.1632; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093817; Wittkampf FHM, 2003, CIRCULATION, V107, P21, DOI 10.1161/01.CIR.0000047065.49852.8F; Wozniak-Skowerska I, 2011, INT J CARDIOL, V146, P181, DOI 10.1016/j.ijcard.2009.06.047; Yamase M, 2012, HEART, V98, P1067, DOI 10.1136/heartjnl-2012-302017; Zhuang JH, 2012, EUROPACE, V14, P638, DOI 10.1093/europace/eur364	48	10	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201199	10.1371/journal.pone.0201199	http://dx.doi.org/10.1371/journal.pone.0201199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044877	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500090
J	Wong, ML; Shi, Y; Fung, KZ; Ngo, S; Elicker, BM; Brown, JK; Hiatt, RA; Tang, VL; Walter, LC				Wong, Melisa L.; Shi, Ying; Fung, Kathy Z.; Ngo, Sarah; Elicker, Brett M.; Brown, James K.; Hiatt, Robert A.; Tang, Victoria L.; Walter, Louise C.			Age, comorbidity, life expectancy, and pulmonary nodule follow-up in older veterans	PLOS ONE			English	Article							LUNG-BIOPSY; CANCER; DISTRESS	Background Pulmonary nodule guidelines do not indicate how to individualize follow-up according to comorbidity or life expectancy. Objectives To characterize comorbidity and life expectancy in older veterans with incidental, symptom-detected, or screen-detected nodules in 2008-09 compared to 2013-14. To determine the impact of these patient factors on four-year nodule follow-up among the 2008-09 subgroup. Design Retrospective cohort study. Setting Urban Veterans Affairs Medical Center. Participants 243 veterans age >65 with newly diagnosed pulmonary nodules in 2008-09 (followed for four years through 2012 or 2013) and 446 older veterans diagnosed in 2013-14. Measurements The primary outcome was receipt of any follow-up nodule imaging and/or biopsy within four years after nodule diagnosis. Primary predictor variables included age, Charlson-Deyo Comorbidity Index (CCI), and life expectancy. Favorable life expectancy was defined as age 65-74 with CCI 0 while limited life expectancy was defined as age >85 with CCI >1 or age >65 with CCI >4. Interaction by nodule size was also examined. Results From 2008-09 to 2013-14, the number of older veterans diagnosed with new pulmonary nodules almost doubled, including among those with severe comorbidity and limited life expectancy. Overall among the 2008-09 subgroup, receipt of nodule follow-up decreased with increasing comorbidity (CCI >= 4 versus 0: adjusted RR 0.61, 95% CI 0.39-0.95) with a trend towards decreased follow-up among those with limited life expectancy (adjusted RR 0.69, 95% CI 0.48-1.01). However, we detected an interaction effect with nodule size such that comorbidity and life expectancy were associated with decreased follow-up only among those with nodules <= 6 mm. Conclusions We found some individualization of pulmonary nodule follow-up according to comorbidity and life expectancy in older veterans with smaller nodules only. As increased imaging detects nodules in sicker patients, guidelines need to be more explicit about how to best incorporate comorbidity and life expectancy to maximize benefits and minimize harms for patients with nodules of all sizes.	[Wong, Melisa L.] Univ Calif San Francisco, Div Hematol Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Shi, Ying; Fung, Kathy Z.; Ngo, Sarah; Tang, Victoria L.; Walter, Louise C.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Shi, Ying; Fung, Kathy Z.; Ngo, Sarah; Elicker, Brett M.; Tang, Victoria L.; Walter, Louise C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Elicker, Brett M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Brown, James K.] San Francisco VA Med Ctr, Pulm Crit Care & Sleep Med Sect, San Francisco, CA USA; [Hiatt, Robert A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Wong, ML (corresponding author), Univ Calif San Francisco, Div Hematol Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	melisa.wong@ucsf.edu	Hiatt, Robert/AAQ-1537-2021	Wong, Melisa/0000-0001-6390-6959	National Institute on Aging at the National Institutes of Health [T32AG000212, K24AG041180, P30AG044281]; National Center for Advancing Translational Sciences [KL2TR001870]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000212, P30AG044281] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging at the National Institutes of Health (https://www.nia.nih.gov/; T32AG000212 to MLW; K24AG041180 to LCW; P30AG044281 to MLW, LCW) and the National Center for Advancing Translational Sciences (https://ncats.nih.gov/; KL2TR001870 to MLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najafi Saif, 2016, Curr Treat Options Cardiovasc Med, V18, P70; American College of Radiology, LUNG CT SCREEN REP D; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Detterbeck FC, 2012, THORAX, V67, P842, DOI 10.1136/thoraxjnl-2012-201779; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eapen GA, 2013, CHEST, V143, P1044, DOI 10.1378/chest.12-0350; Evison M, 2014, J THORAC ONCOL, V9, P370, DOI 10.1097/JTO.0000000000000085; Freiman MR, 2016, J THORAC ONCOL, V11, P700, DOI 10.1016/j.jtho.2016.01.018; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Ko MS, 2016, J AM GERIATR SOC, V64, pE109, DOI 10.1111/jgs.14409; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; McEvoy JW, 2016, JACC-CARDIOVASC IMAG, V9, P994, DOI 10.1016/j.jcmg.2016.03.012; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Ridge CA, 2014, J COMPUT ASSIST TOMO, V38, P89, DOI 10.1097/RCT.0b013e3182a939a5; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Slatore CG, 2015, ANN AM THORAC SOC, V12, P184, DOI 10.1513/AnnalsATS.201406-283OC; So C, 2012, J GEN INTERN MED, V27, P653, DOI 10.1007/s11606-011-1945-9; Tang VL, 2016, JAMA INTERN MED, V176, P654, DOI 10.1001/jamainternmed.2016.0695; Tukey MH, 2012, RESP MED, V106, P1559, DOI 10.1016/j.rmed.2012.08.008; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wiener RS, 2014, JAMA INTERN MED, V174, P871, DOI 10.1001/jamainternmed.2014.561; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	26	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200496	10.1371/journal.pone.0200469	http://dx.doi.org/10.1371/journal.pone.0200469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044854	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500057
J	Knight, R; Krusi, A; Carson, A; Fast, D; Shannon, K; Shoveller, J				Knight, Rod; Krusi, Andrea; Carson, Anna; Fast, Danya; Shannon, Kate; Shoveller, Jean			Criminalization of HIV non-disclosure: Narratives from young men living in Vancouver, Canada	PLOS ONE			English	Article							PUBLIC-HEALTH; PROSECUTIONS; STIGMA; SEX; TRANSMISSION	Background Previous research has identified the impacts of legal frameworks that criminalize HIV non-disclosure among people living with HIV (e.g., elevated stigma and violence). However, far less is known about the perspectives or experiences of peopleparticularly, menwho are HIV-seronegative or who are unaware of their status. The objective of this paper is to describe the health and social risks that young men perceive to be associated with an HIV diagnosis in the context of Canadas current legal framework pertaining to HIV non-disclosure. Methods We analyzed data from 100 in-depth interviews (20132016) conducted with 85 young men ages 1830 in Vancouver on the topic of the criminalization of HIV non-disclosure. Results Our analysis revealed two dominant narratives in relation to HIV criminalization: (a) interrogation and (b) justification. An interrogation narrative problematized the moral permissibility of criminalizing HIV non-disclosure. In this narrative, Canadas HIV non-disclosure legal framework was characterized as creating unjust barriers to HIV testing uptake, as well as impeding access to and reducing retention in care for those living with HIV. Conversely, a justification narrative featured a surprising number of references to HIV as a "death sentence", despite effective treatments being universally available in Canada. However, most of those who presented the justification narrative asserted that the criminalization of HIV non-disclosure was morally justified in light of the perceived negative stigma-related impacts of HIV (e.g., discrimination; being ostracized from sex or romantic partners, friends, family). The justification narrative often reflected a belief that the legal framework provides both punishment and deterrence, which were perceived to supersede any barriers to care for both HIV-positive and -negative individuals. Conclusion Public education regarding contemporary medical advances in HIV may help contest lay understandings of HIV as a "death sentence", which is particularly relevant to destabilizing justification narratives. However, significant strengthening of HIV stigma-reduction efforts will be needed to move society away from narratives that attempt to justify Canadas current HIV non-disclosure legal framework.	[Knight, Rod; Fast, Danya] British Columbia Ctr Subst Use, Vancouver, BC, Canada; [Knight, Rod; Fast, Danya; Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Krusi, Andrea; Carson, Anna; Shoveller, Jean] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Krusi, Andrea; Shannon, Kate] Gender & Sexual Hlth Initiat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Knight, R (corresponding author), British Columbia Ctr Subst Use, Vancouver, BC, Canada.; Knight, R (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	rod.knight@bccsu.ubc.ca		Knight, Rod/0000-0002-1464-1584; Fast, Danya/0000-0001-5994-3669	Canadian Institutes of Health Research (CIHR) [PJT-148818, HHP-123778, EPP-122906]; US National Institutes of Health [1R01DA043408]; Michael Smith Foundation for Health Research (MSFHR); CIHR; MSFHR; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA038886] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Canadian Institutes of Health Research (CIHR) (PJT-148818, HHP-123778 and EPP-122906) (JS) and the US National Institutes of Health (1R01DA043408). Knight and Fast are supported by Scholar Awards from the Michael Smith Foundation for Health Research (MSFHR). Krusi holds Post-Doctoral Fellowships from CIHR and MSFHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2008, AIDS EDUC PREV, V20, P420, DOI 10.1521/aeap.2008.20.5.420; Adam BD, 2016, CAN J LAW SOC, V31, P1, DOI 10.1017/cls.2016.3; Adam BD, 2014, SEX RES SOC POLICY, V11, P39, DOI 10.1007/s13178-013-0131-8; Adam Barry D, 2011, J Int AIDS Soc, V14 Suppl 2, pS2, DOI 10.1186/1758-2652-14-S2-S2; Ammirati RJ, 2015, AIDS CARE, V27, P926, DOI 10.1080/09540121.2015.1018863; [Anonymous], QUALITATIVE RES YOUN; [Anonymous], 2016, SUMM MEAS CAN PROGR; [Anonymous], 2016, HIV HUMAN RIGHTS ORG; [Anonymous], 2010, CAN HIV AIDS LEG NET; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; British Columbia Centre for Disease Control, 2015, HIV BRIT COL ANN SUR; Callander D, 2013, J HIV-AIDS SOC SERV, V12, P205, DOI 10.1080/15381501.2013.790869; Canadian HIV/ AIDS Legal Network, 2017, RETH JUST 7 S HIV LA; Clandinin D.J., 2000, NARRATIVE INQUIRY EX; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cortazzi M, 2001, INT J LANG COMM DIS, V36, P252, DOI 10.3109/13682820109177893; Dej E, 2012, CAN J LAW SOC, V27, P55, DOI 10.3138/cjls.27.1.055; Department of Justice, 2017, CRIM JUST SYST RESP; Dodds C, 2008, AIDS CARE, V20, P509, DOI 10.1080/09540120701867131; Gilbert M, 2015, HLTH LITERACY SEXUAL; Good B, 1994, MED RATIONALITY EXPE; Government of British Columbia, POP EST BRIT COLUMBI; Grant I, 2011, PROSECUTION NONDISCL; Harsono D, 2017, AIDS BEHAV, V21, P27, DOI 10.1007/s10461-016-1540-5; Hastings C., 2017, HIV CRIMINALIZATION; Joint United Nations Programme on HIV/ AIDS, 2013, END BROAD CRIM HIV N; Kippax S, 2016, AIDS, V30, P2898, DOI 10.1097/QAD.0000000000001260; Knight R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146513; Lieblich A., 1998, NARRATIVE RES READIN, DOI 10.4135/9781412985253; Loutfy M, 2014, CAN J INFECT DIS MED, V25, P135, DOI 10.1155/2014/498459; Maluwa M., 2002, HEALTH HUM RIGHTS, V6, P1, DOI [https://doi.org/10.2307/4065311, DOI 10.2307/4065311]; Mattingly C., 1998, HEALING DRAMAS CLIN; Mishler E.G., 1991, RES INTERVIEWING; MISHLER E. G., 1986, RES INTERVIEWING CON; Mykhalovskiy E., 2010, HIV NONDISCLOSURE CR; Mykhalovskiy E, 2016, COLD DELIBERATELY DU; Mykhalovskiy E, 2014, PUBL HLTH IMPL CRIM; Mykhalovskiy E, 2012, CAN J LAW SOC, V27, P31, DOI 10.3138/cjls.27.1.031; Mykhalovskiy E, 2011, SOC SCI MED, V73, P668, DOI 10.1016/j.socscimed.2011.06.051; O'Byrne P, 2013, MED HUMANIT, V39, P85, DOI 10.1136/medhum-2013-010366; O'Byrne P, 2013, J ASSOC NURSE AIDS C, V24, P81, DOI 10.1016/j.jana.2012.01.009; Ochs E., 2001, LIVING NARRATIVE CRE; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Patterson S, 2015, INT J EPIDEMIOL, V44, P58, DOI 10.1093/ije/dyu046; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Stein NL, 1997, CONT ISSUES ED; Wood E, 2006, HARM REDUCT J, V3, P18, DOI DOI 10.1186/1477-7517-3-18	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201110	10.1371/journal.pone.0201110	http://dx.doi.org/10.1371/journal.pone.0201110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040831	Green Submitted, Green Published, gold			2022-12-27	WOS:000439749200027
J	Ruzin, A; Pastula, ST; Levin-Sparenberg, E; Jiang, XH; Fryzek, J; Tovchigrechko, A; Lu, B; Qi, YP; Liu, H; Jin, H; Yu, L; Hackett, J; Villafana, T; Esser, MT				Ruzin, Alexey; Pastula, Susan T.; Levin-Sparenberg, Elizabeth; Jiang, Xiaohui; Fryzek, Jon; Tovchigrechko, Andrey; Lu, Bin; Qi, Yanping; Liu, Hui; Jin, Hong; Yu, Li; Hackett, Judith; Villafana, Tonya; Esser, Mark T.			Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL-ANTIBODY; YOUNG-CHILDREN; INFECTION; INFANTS; PALIVIZUMAB; RISK; PREVENTION; INFLUENZA; ILLNESS	Background Respiratory syncytial virus (RSV) is an established cause of serious lower respiratory disease in infants, elderly and high-risk populations. The OUTSMART surveillance program aims to characterize patient populations and currently circulating RSV strains, and monitor temporal and geographic evolution of RSV F and G proteins in the U.S. Methods The OUTSMART 2016-17 study collected RSV-positive samples from 25 RSVAlert (R) laboratories from 4 U.S. regions and Puerto Rico during November 2016 through March 2017. Frequencies of A and B subtypes and genotypes were determined for several demographic and geographic variables. To gauge the representativeness of the OUTSMART patients, results were compared to discharge data from the NEDS and NIS databases. Results A total of 1,041 RSV-positive samples with associated demographic data were obtained and the RSV F gene and second variable region of the G gene were sequenced. The majority of samples (76.0%) came from children under 2 years old: <1 year (48.4%), 1-2 years (27.6%). The OUTSMART patient sample was similar to NEDS and NIS for age, gender, and geographic location. Both OUTSMART and national RSV cases peaked in January. Of OUTSMART samples, 45.3% were subtype A, 53.7% were subtype B and 1.0% were mixed A and B. The percentage of RSV B cases increased with increasing age. Hospitalization (length of hospital stay, LOS, >24 hrs) occurred in 29.0% of patients of which 52.0% had RSV B. Outpatients (LOS <24 hrs) were 64.4% of total of which 73.3% were diagnosed in the ER and discharged, while only 6% were diagnosed in other outpatient settings. Conclusions The OUTSMART 2016-17 study was representative of the U.S. RSV experience. Geographic and temporal information from the RSV surveillance program will be used to establish a molecular baseline of RSV F and G sequence variability and to help inform development of novel agents for RSV prophylaxis and treatment.	[Ruzin, Alexey; Tovchigrechko, Andrey; Yu, Li; Hackett, Judith; Villafana, Tonya; Esser, Mark T.] AstraZeneca MedImmune, Gaithersburg, MD 20878 USA; [Pastula, Susan T.; Levin-Sparenberg, Elizabeth; Jiang, Xiaohui; Fryzek, Jon] Epidstat Inst, Ann Arbor, MI USA; [Lu, Bin; Qi, Yanping; Liu, Hui; Jin, Hong] AstraZeneca MedImmune, Mountain View, CA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Ruzin, A (corresponding author), AstraZeneca MedImmune, Gaithersburg, MD 20878 USA.	ruzina@medimmune.com		Levin-Sparenberg, Elizabeth/0000-0002-2231-3361	AstraZeneca/MedImmune	AstraZeneca/MedImmune(AstraZeneca)	This work was supported by AstraZeneca/MedImmune. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2017, PEDIATR INFECT DIS J, V36, P699, DOI [10.1097/INF.0000000000001533, 10.1097/inf.0000000000001533]; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Binder W, 2017, AM J EMERG MED, V35, P1162, DOI 10.1016/j.ajem.2017.06.022; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Boron ML, 2008, PEDIATR INFECT DIS J, V27, P1095, DOI 10.1097/INF.0b013e3181812c8e; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Broberg EK, 2018, EUROSURVEILLANCE, V23, P9, DOI 10.2807/1560-7917.ES.2018.23.5.17-00284; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Gimferrer L, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.013; Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012; Griffin MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01714-16, 10.1128/aac.01714-16]; Hall Caroline Breese, 2012, Infectious Disorders - Drug Targets, V12, P92; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hcup, 2015, INTR HCUP NAT INP SA; HCUP, 2017, INTR HCUP NAT EM DEP; Higgins D, 2016, VACCINE, V34, P2870, DOI 10.1016/j.vaccine.2016.03.109; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Obando-Pacheco P, 2018, J INFECT DIS, V217, P1356, DOI 10.1093/infdis/jiy056; Pangesti KNA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1968; Paramore LC, 2004, PHARMACOECONOMICS, V22, P275, DOI 10.2165/00019053-200422050-00001; Radin JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114871; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Rose EB, 2018, MMWR-MORBID MORTAL W, V67, P71, DOI 10.15585/mmwr.mm6702a4; Schanzer DL, 2018, INFLUENZA OTHER RESP, V12, P113, DOI 10.1111/irv.12497; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Simoes EAF, 1996, J PEDIATR-US, V129, P214, DOI 10.1016/S0022-3476(96)70245-7; Storch GA, 1998, PEDIATRICS, V102, P648, DOI 10.1542/peds.102.3.648; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Villafana T, 2017, EXPERT REV VACCINES, V16, P737, DOI 10.1080/14760584.2017.1333425; Walsh EE, 2017, CLIN CHEST MED, V38, P29, DOI 10.1016/j.ccm.2016.11.010; Yu XF, 2015, J CLIN VIROL, V69, P1, DOI 10.1016/j.jcv.2015.05.015; Zhu Q, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1928; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200319	10.1371/journal.pone.0200319	http://dx.doi.org/10.1371/journal.pone.0200319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040837	Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200004
J	Mustonen, T; Nuutinen, M; Vainio, L; Hakkinen, J				Mustonen, Terhi; Nuutinen, Mikko; Vainio, Lari; Hakkinen, Jukka			Upper nasal hemifield location and nonspatial auditory tones accelerate visual detection during dichoptic viewing	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; BINOCULAR-RIVALRY; HEMISPHERIC ASYMMETRIES; CONTRAST SENSITIVITY; LATERAL GENICULATE; SOUND SYMBOLISM; FIELD; RESOLUTION; ATTENTION; TASK	Visual performance is asymmetric across the visual field, but locational biases that occur during dichoptic viewing are not well understood. In this study, we characterized horizontal, vertical and naso-temporal biases in visual target detection during dichoptic stimulation and explored whether the detection was facilitated by non-spatial auditory tones associated with the target's location. The detection time for single monocular targets that were suppressed from view with a 10 Hz dynamic noise mask presented to the other eye was measured at the 4 degrees intercardinal location of each eye with the breaking Continuous Flash Suppression (b-CFS) technique. Each target was either combined with a sound (i.e., high or low pitch tone) that was congruent or incongruent with its vertical location (i.e., upper or lower visual field) or presented without a sound. The results indicated faster detection of targets in the upper rather than lower visual field and faster detection of targets in the nasal than temporal hemifield of each eye. Sounds generally accelerated target detection, but the tone pitch-elevation congruency did not further enhance performance. These findings suggest that visual detection during dichoptic viewing differs from standard viewing conditions with respect to location-related perceptual biases and crossmodal modulation of visual perception. These differences should be carefully considered in experimental designs employing dichoptic stimulation techniques and in display applications that utilize dichoptic viewing.	[Mustonen, Terhi; Nuutinen, Mikko; Vainio, Lari; Hakkinen, Jukka] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland	University of Helsinki	Mustonen, T (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland.	terhi.mustonen@helsinki.fi	Häkkinen, Jukka/A-4122-2019	Häkkinen, Jukka/0000-0003-0215-2238; Nuutinen, Mikko/0000-0002-7429-3710; Mustonen, Terhi/0000-0002-8565-8164; Vainio, Lari/0000-0001-7754-9745				Alsius A, 2013, PSYCHOL SCI, V24, P423, DOI 10.1177/0956797612457378; [Anonymous], 1987, 2261987 ISO; Berger A, 2000, J COGNITIVE NEUROSCI, V12, P421, DOI 10.1162/089892900562246; BERTELSON P, 1969, ACTA PSYCHOL, V30, P145, DOI 10.1016/0001-6918(69)90047-X; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bourne VJ, 2006, LATERALITY, V11, P373, DOI 10.1080/13576500600633982; Carrasco M, 2001, SPATIAL VISION, V15, P61, DOI 10.1163/15685680152692015; Chen XC, 2003, VISION RES, V43, P2207, DOI 10.1016/S0042-6989(03)00359-6; Chen YC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00212; Chiou R, 2012, PERCEPTION, V41, P339, DOI 10.1068/p7161; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; Conrad V, 2010, J VISION, V10, DOI 10.1167/10.10.27; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Drain M, 1996, J EXP PSYCHOL GEN, V125, P139, DOI 10.1037/0096-3445.125.2.139; Duecker F, 2015, NEUROPSYCHOLOGIA, V74, P21, DOI 10.1016/j.neuropsychologia.2014.11.023; Durad AC, 1910, J AMER MED ASSOC, V55, P369, DOI 10.1001/jama.1910.04330050007004; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; FAHLE M, 1988, VISION RES, V28, P293, DOI 10.1016/0042-6989(88)90157-5; Feng J, 2014, I-PERCEPTION, V5, P97, DOI 10.1068/i0625rep; Gayet S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00460; Handa T, 2004, OPTOMETRY VISION SCI, V81, P377, DOI 10.1097/01.opx.0000135085.54136.65; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hung SM, 2017, PSYCHOL SCI, V28, P263, DOI 10.1177/0956797616677313; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Kanai R, 2006, CURR BIOL, V16, P2332, DOI 10.1016/j.cub.2006.10.001; Kauffmann L, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00037; KAUSHALL P, 1975, AM J OPTOM PHYS OPT, V52, P509; Kleiner M, 2007, PERCEPTION, V36, P14; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Laramee R. S., 2002, ACM Transactions on Computer-Human Interaction, V9, P238, DOI 10.1145/568513.568516; Levine MW, 2005, VISION RES, V45, P2820, DOI 10.1016/j.visres.2005.04.001; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Lunghi C, 2014, J NEUROSCI, V34, P784, DOI 10.1523/JNEUROSCI.2732-13.2014; Moors P, 2015, I-PERCEPTION, V6, P48, DOI 10.1068/i0678; Mossbridge JA, 2011, COGNITION, V121, P133, DOI 10.1016/j.cognition.2011.06.003; Mustonen T, 2013, J EXP PSYCHOL-APPL, V19, P333, DOI 10.1037/a0034635; Niebauer CL, 1998, PSYCHON B REV, V5, P147, DOI 10.3758/BF03209471; Niemeier M, 2008, BRAIN COGNITION, V67, P115, DOI 10.1016/j.bandc.2007.12.002; Nuutinen M, 2018, BEHAV RES METHODS, V50, P1933, DOI 10.3758/s13428-017-0961-z; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Patterson R, 2007, HUM FACTORS, V49, P1083, DOI 10.1518/001872007X249947; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Silva MF, 2008, VISION RES, V48, P127, DOI 10.1016/j.visres.2007.10.018; Silva MF, 2010, J VISION, V10, DOI 10.1167/10.6.26; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stein T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00387; STERZER P, 2014, FRONT PSYCHOL, V5, DOI DOI 10.3389/FPSYG.2014.00453; Sylvester R, 2007, J NEUROPHYSIOL, V97, P1495, DOI 10.1152/jn.00835.2006; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; VIRSU V, 1979, EXP BRAIN RES, V37, P475; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang E, 2010, INVEST OPHTH VIS SCI, V51, P588, DOI 10.1167/iovs.08-3076; Yang YH, 2014, EXP BRAIN RES, V232, P1109, DOI 10.1007/s00221-014-3820-5; Yang YH, 2011, CONSCIOUS COGN, V20, P223, DOI 10.1016/j.concog.2010.07.005; Yovel G, 2001, J EXP PSYCHOL HUMAN, V27, P1369, DOI 10.1037/0096-1523.27.6.1369; Zadbood A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00135	68	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199962	10.1371/journal.pone.0199962	http://dx.doi.org/10.1371/journal.pone.0199962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036400	Green Published, Green Submitted, gold			2022-12-27	WOS:000439429200008
J	Flanagan, PR; Fletcher, J; Boyle, H; Sulea, R; Moran, GP; Sullivan, DJ				Flanagan, Peter R.; Fletcher, Jessica; Boyle, Hannah; Sulea, Razvan; Moran, Gary P.; Sullivan, Derek J.			Expansion of the TLO gene family enhances the virulence of Candida species	PLOS ONE			English	Article							ALBICANS; DUBLINIENSIS; EXPRESSION; PATHOGEN; YEASTS	The TLO genes are a family of subtelomeric ORFs in the fungal pathogens Candida albicans and C. dubliniensis encoding a subunit of the Mediator complex homologous to Med2. The more virulent pathogen C. albicans has 15 copies of the gene whereas the less pathogenic species C. dubliniensis has only two. To investigate if expansion of the TLO repertoire in C. dubliniensis has an effect on phenotype and virulence we expressed three representative C. albicans TLO genes (TLO beta 2, TLO gamma 11 and TLO alpha 12) in a wild type C. dubliniensis background, under the control of either their native or the ACT1 promoter. Expression of TLO beta 2 resulted in a hyperfilamentous phenotype, while overexpression of TLO gamma 11 and TLO gamma 12 resulted in enhanced resistance to oxidative stress. Expression of all three TLO genes from the ACT1 promoter resulted in increased virulence in the Galleria infection model. In order to further investigate if individual TLO genes exhibit differences in function we expressed six representative C. albicans TLO genes in a C. dubliniensis Delta tlo 1/Delta tlo2 double mutant. Differences were observed in the ability of the expressed CaTLOs to complement the various phenotypes of the mutant. All TLO genes with the exception of TLO gamma 7 could restore filamentation, however only TLO alpha 9, gamma 11 and alpha 12could restore chlamydospore formation. Differences in the ability of CaTLO genes to restore growth in the presence of H2O2, calcofluor white, Congo red and at 42 degrees C were observed. Only TLO alpha 3 restored wildtype levels of virulence in the Galleria infection model. These data show that expansion of the TLO gene family in C. dubliniensis results in gain of function and that there is functional diversity amongst members of the gene family. We propose that this expansion of the TLO family contributes to the success of C. albicans as a commensal and opportunistic pathogen.	[Flanagan, Peter R.; Fletcher, Jessica; Boyle, Hannah; Sulea, Razvan; Moran, Gary P.; Sullivan, Derek J.] Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin, Ireland; [Flanagan, Peter R.; Fletcher, Jessica; Boyle, Hannah; Sulea, Razvan; Moran, Gary P.] Univ Dublin, Trinity Coll Dublin, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Moran, GP; Sullivan, DJ (corresponding author), Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin, Ireland.; Moran, GP (corresponding author), Univ Dublin, Trinity Coll Dublin, Dublin, Ireland.	Gary.Moran@dental.tcd.ie; Derek.Sullivan@dental.tcd.ie	Sullivan, Derek/A-8269-2008; Flanagan, Peter R/ABB-3713-2021; Moran, Gary/F-3116-2012	Flanagan, Peter R/0000-0002-4690-0560; Moran, Gary/0000-0003-0469-1788; Fletcher, Jessica/0000-0002-8737-1538	Dublin Dental University Hospital; Science Foundation Ireland [11/RFP.1/GEN/3042]	Dublin Dental University Hospital; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The project was supported by the Dublin Dental University Hospital and Science Foundation Ireland (11/RFP.1/GEN/3042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MZ, 2015, GENETICS, V200, P907, DOI 10.1534/genetics.115.177451; Anderson MZ, 2012, EUKARYOT CELL, V11, P1268, DOI 10.1128/EC.00230-12; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Dunn MJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007326; Flanagan PR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00477-17; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Haran J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004658; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hirakawa MP, 2015, GENOME RES, V25, P413, DOI 10.1101/gr.174623.114; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Lee KL, 2009, SABOURAUDIA J MED VE, V13, P148; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu ZL, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01342-17; Liu ZL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006373; Lu Y, 2014, TRENDS MICROBIOL, V22, P707, DOI 10.1016/j.tim.2014.09.001; Moran GP, 2007, MOL MICROBIOL, V66, P915, DOI 10.1111/j.1365-2958.2007.05965.x; Moran GP, 2012, INT J MICROBIOL, V2012, DOI [10.1155/2012/, DOI 10.1155/2012/]; Nishikawa JL, 2016, NATURE, V530, P485, DOI 10.1038/nature16963; Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Staib P, 2001, J BACTERIOL, V183, P2859, DOI 10.1128/JB.183.9.2859-2865.2001; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Uwamahoro N, 2012, PLOS GENET, V8, P54, DOI 10.1371/journal.pgen.1002613; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; Yang Yun-Liang, 2003, Journal of Microbiology Immunology and Infection, V36, P223; Zhang AD, 2012, EUKARYOT CELL, V11, P874, DOI 10.1128/EC.00095-12	29	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200852	10.1371/journal.pone.0200852	http://dx.doi.org/10.1371/journal.pone.0200852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028853	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900019
J	Kerrick, WGL; Xu, YY; Percival, JM				Kerrick, W. Glenn L.; Xu, Yuanyuan; Percival, Justin M.			nNOS splice variants differentially regulate myofilament function but are dispensable for intracellular calcium and force transients in cardiac papillary muscles	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CA2+ ACTIVATION; S-NITROSYLATION; RATE-CONSTANT; CONTRACTION; FIBERS; HEART; LEAK; DISSOCIATION; BETA	Cardiac muscle expresses three neuronal nitric oxide synthase (nNOS) splice variants: nNOS alpha, nNOS mu and nNOS beta. The functions of these nNOS splice variants in cardiac muscle, particularly myofilament-associated nNOS beta are unclear. To decipher cardiac nNOS splice variant function we investigated myofilament function and intracellular calcium and force transients in demembranated and intact papillary muscles from two lines of nNOS knockout mice. The first line (KN1) lacks nNOS alpha and nNOS mu. The second line (KN2) lacks active nNOS alpha, nNOS mu and nNOS beta. Demembranated KN1 papillary muscles exhibited reduced myofilament ATPase activity (-35%) and specific force (-10%) relative to controls. Demembranated KN2 muscles exhibited a smaller decrease in myofilament ATPase activity (-21 %), but a greater reduction in specific force (-26%) relative to controls. Myofilament calcium sensitivity in demembranated KN1 and KN2 papillary muscles was similar to controls. Thus, papillary muscle-expressed nNOS splice variants are necessary for control levels of myofilament ATPase activity and force generation, but dispensable for myofilament calcium sensitivity. The greater reduction in myofilament ATPase relative to specific force in KN1, but not KN2 muscle, reduced the energy cost of muscle contraction, suggesting that nNOS beta increased the energetic efficiency of contraction in the absence of nNOS mu and nNOS alpha. Analyses of intact KN1 and KN2 papillary muscles showed that both intracellular calcium transients and their evoked force transients were similar to controls at stimulation frequencies between 1 and 3 Hz. Therefore, nNOS was dispensable for baseline excitation-contraction coupling. In summary, these data suggest that nNOS splice variants differentially regulate myofilament function, but not baseline calcium handling in papillary muscles. More importantly, they suggest that nNOS beta is a novel modulator of myofilament function, and ultimately the energetic efficiency of cardiac papillary muscle contraction.	[Kerrick, W. Glenn L.; Xu, Yuanyuan] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Xu, Yuanyuan; Percival, Justin M.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami; University of Miami	Percival, JM (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	j.percival@med.miami.edu		Percival, Justin/0000-0002-7482-4841				Allen K, 2000, J APPL PHYSIOL, V88, P180, DOI 10.1152/jappl.2000.88.1.180; Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; Carnicer R, 2017, CARDIOVASC RES, V113, P321, DOI 10.1093/cvr/cvx002; Carnicer R, 2013, ANTIOXID REDOX SIGN, V18, P1078, DOI 10.1089/ars.2012.4824; Dulce RA, 2015, CIRC RES, V116, P46, DOI 10.1161/CIRCRESAHA.116.305172; Dulce RA, 2013, J BIOL CHEM, V288, P6522, DOI 10.1074/jbc.M112.412130; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; Evangelista AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011209; Figueiredo-Freitas C, 2015, ANTIOXID REDOX SIGN, V23, P1017, DOI 10.1089/ars.2015.6275; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; GUTH K, 1986, PFLUG ARCH EUR J PHY, V407, P552, DOI 10.1007/BF00657515; Gyurko R, 2002, ENDOCRINOLOGY, V143, P2767, DOI 10.1210/en.143.7.2767; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Jang JH, 2015, NITRIC OXIDE-BIOL CH, V50, P20, DOI 10.1016/j.niox.2015.07.005; KERRICK WGL, 1991, J MUSCLE RES CELL M, V12, P53, DOI 10.1007/BF01781174; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Percival Justin M, 2011, Biophys Rev, V3, P209, DOI 10.1007/s12551-011-0060-9; Percival JM, 2010, J CLIN INVEST, V120, P816, DOI 10.1172/JCI40736; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; Robinson JM, 2002, J MOL BIOL, V322, P1065, DOI 10.1016/S0022-2836(02)00855-0; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Szczesna-Cordary D, 2007, FASEB J, V21, P3974, DOI 10.1096/fj.07-8630com; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Zhang YH, 2014, J PHYSIOL-LONDON, V592, P3189, DOI 10.1113/jphysiol.2013.270306; Ziolo MT, 2014, ANTIOXID REDOX SIGN, V21, P2044, DOI 10.1089/ars.2014.5873	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200834	10.1371/journal.pone.0200834	http://dx.doi.org/10.1371/journal.pone.0200834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028847	gold, Green Submitted, Green Published			2022-12-27	WOS:000439396900018
J	Huang, HW; Yan, LM; Yang, YL; He, X; Sun, XM; Wang, YM; Zhang, GB; Zhou, JX				Huang, Hua-Wei; Yan, Li-Mei; Yang, Yan-Lin; He, Xuan; Sun, Xiu-Mei; Wang, Yu-Mei; Zhang, Guo-Bin; Zhou, Jian-Xin			Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study	PLOS ONE			English	Article							TENSION PNEUMOCEPHALUS; NEUROSURGICAL PATIENTS; SUPRATENTORIAL CRANIOTOMY; INFRATENTORIAL CRANIOTOMY; EMERGENCE AGITATION; GENERAL-ANESTHESIA; DELAYED EXTUBATION; INTRACRANIAL AIR; SUPINE POSITION; DELIRIUM	Postoperative agitation frequently occurs after general anesthesia and may be associated with serious consequences. However, studies in neurosurgical patients have been in- adequate. We aimed to investigate the incidence and risk factors for early postoperative agitation in patients after craniotomy, specifically focusing on the association between post- operative pneumocephalus and agitation. Adult intensive care unit admitted patients after elective craniotomy under general anesthesia were consecutively enrolled. Patients were assessed using the Sedation-Agitation Scale during the first 24 hours after operation. The patients were divided into two groups based on their maximal Sedation-Agitation Scale: the agitation (Sedation-Agitation Scale >= 5) and non-agitation groups (Sedation-Agitation Scale <= 4). Preoperative baseline data, intraoperative and intensive care unit admission data were recorded and analyzed. Each patient's computed tomography scan obtained within six hours after operation was retrospectively reviewed. Modified Rankin Scale and hospital length of stay after the surgery were also collected. Of the 400 enrolled patients, agitation occurred in 13.0% (95% confidential interval: 9.7-16.3%). Body mass index, total intrave- nous anesthesia, intraoperative fluid intake, intraoperative bleeding and transfusion, consciousness after operation, endotracheal intubation kept at intensive care unit admission and mechanical ventilation, hyperglycemia without a history of diabetes, self-reported pain and postoperative bi-frontal pneumocephalus were used to build a multivariable model. Bi-frontal pneumocephalus and delayed extubation after the operation were identified as inde- pendent risk factors for postoperative agitation. After adjustment for confounding, postoperative agitation was independently associated with worse neurologic outcome (odd ratio: 5.4, 95% confidential interval: 1.1-28.9, P = 0.048). Our results showed that early postoperative agitation was prevalent among post-craniotomy patients and was associated with adverse outcomes. Improvements in clinical strategies relevant to bi-frontal pneumocephalus should be considered.	[Huang, Hua-Wei; Yan, Li-Mei; Yang, Yan-Lin; He, Xuan; Sun, Xiu-Mei; Wang, Yu-Mei; Zhou, Jian-Xin] Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Yan, Li-Mei] Inner Mongolia Peoples Hosp, Dept Crit Care Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Guo-Bin] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhou, JX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Crit Care Med, Beijing, Peoples R China.	zhoujx.cn@icloud.com		Zhou, Jianxin/0000-0003-1320-0979	Beijing Municipal Administration of Hospital [DFL20150502]	Beijing Municipal Administration of Hospital	This study was supported by grants from the Beijing Municipal Administration of Hospital (DFL20150502). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastola P, 2015, INDIAN J ANAESTH, V59, P287, DOI 10.4103/0019-5049.156868; Bruder N, 1999, ANESTH ANALG, V89, P674, DOI 10.1097/00000539-199909000-00027; Bruder N, 1999, J NEUROSURG ANESTH, V11, P282, DOI 10.1097/00008506-199910000-00009; Bruder Nicolas J, 2002, Curr Opin Anaesthesiol, V15, P477, DOI 10.1097/00001503-200210000-00001; Bui JQH, 2011, J NEUROSURG, V115, P1236, DOI 10.3171/2011.8.JNS11105; Cai YH, 2013, J INT MED RES, V41, P208, DOI 10.1177/0300060513475964; Card E, 2015, BRIT J ANAESTH, V115, P411, DOI 10.1093/bja/aeu442; Cata JP, 2011, J NEUROSURG ANESTH, V23, P25, DOI 10.1097/ANA.0b013e3181eee548; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114239; Chevrolet JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5787; Citerio G, 2012, EUR J ANAESTH, V29, P371, DOI 10.1097/EJA.0b013e32835422db; Dabdoub Carlos B, 2015, Surg Neurol Int, V6, P155, DOI 10.4103/2152-7806.166195; Fabregas N, 2007, BEST PRACT RES-CLIN, V21, P431, DOI 10.1016/j.bpa.2007.06.006; Gruenbaum SE, 2017, ANESTH ANALG, V125, P556, DOI 10.1213/ANE.0000000000001946; Hernandez BA, 2017, BRIT J ANAESTH, V119, P288, DOI 10.1093/bja/aex197; Ihab Zidan, 2012, Asian J Neurosurg, V7, P66, DOI 10.4103/1793-5482.98647; ISHIWATA Y, 1988, J NEUROSURG, V68, P58, DOI 10.3171/jns.1988.68.1.0058; Kanaya N, 2002, CAN J ANAESTH, V49, P638, DOI 10.1007/BF03017400; Kim HJ, 2015, CLIN EXP OTORHINOLAR, V8, P46, DOI 10.3342/ceo.2015.8.1.46; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Munk L, 2016, ACTA ANAESTH SCAND, V60, P1059, DOI 10.1111/aas.12717; Oh YS, 2008, J KOREAN NEUROSURG S, V43, P143, DOI 10.3340/jkns.2008.43.3.143; OSBORN AG, 1978, J NEUROSURG, V48, P355, DOI 10.3171/jns.1978.48.3.0355; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Prabhakar H, 2003, J NEUROSURG ANESTH, V15, P278, DOI 10.1097/00008506-200307000-00019; Radtke FM, 2010, MINERVA ANESTESIOL, V76, P394; REASONER DK, 1994, ANESTHESIOLOGY, V80, P1008, DOI 10.1097/00000542-199405000-00009; Reponen E, 2016, WORLD NEUROSURG, V91, P567, DOI 10.1016/j.wneu.2016.03.102; Rhondali O, 2011, J NEUROSURG ANESTH, V23, P118, DOI 10.1097/ANA.0b013e318206d5f8; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Satapathy GC, 2000, BRIT J ANAESTH, V84, P115, DOI 10.1093/oxfordjournals.bja.a013368; Sinclair AG, 2010, RADIOGRAPHICS, V30, P461, DOI 10.1148/rg.302095115; TODD MM, 1993, ANESTHESIOLOGY, V78, P1005, DOI 10.1097/00000542-199306000-00002; TOUNG TJK, 1986, ANESTH ANALG, V65, P65; Wannemuehler TJ, 2016, OTOL NEUROTOL, V37, pE322, DOI 10.1097/MAO.0000000000001141; Wu YX, 2017, J NEUROSURG ANESTH, V29, P281, DOI 10.1097/ANA.0000000000000311; Yu DH, 2010, CAN J ANESTH, V57, P843, DOI 10.1007/s12630-010-9338-9; Zhao LH, 2017, J NEUROSURG ANESTH, V29, P132, DOI 10.1097/ANA.0000000000000260; Ziai WC, 2003, CRIT CARE MED, V31, P2782, DOI 10.1097/01.CCM.0000098860.52812.24; Zimmerman JE, 1998, NEUROSURGERY, V42, P91, DOI 10.1097/00006123-199801000-00019	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201064	10.1371/journal.pone.0201064	http://dx.doi.org/10.1371/journal.pone.0201064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024979	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000086
J	Schmid, S; Bogner, FX				Schmid, Sarah; Bogner, Franz X.			Is there more than the sewage plant? University freshmen's conceptions of the urban water cycle	PLOS ONE			English	Article							MISCONCEPTIONS; STUDENTS; KNOWLEDGE; GENETICS	The concepts of 340 university freshmen concerning urban water cycles include various misconceptions (or intuitive conceptions) which severely contrast with correct scientific ones. Almost no student knew the correct urban water cycle in total, including cycle steps in the appropriate sequence: consumer (given), sewage-plant, nature and waterworks. Concepts mainly omit nature and waterworks, only the sewage plant is included in almost all concepts. This reflects an exaggeration of the importance of the cycle-step sewage plant relative to the other steps, when the topic is taught in school. Students acquired knowledge from two main sources: School and media. Most students are aware of the origin of drinking water, although several concepts reflect a pipe-to-pipe system, where wastewater is cleared in sewage plants and brought back to consumers, skipping the roles of nature and waterworks. Everyday matters with an important impact on our life-standards, like the urban water cycle, need specific attention during school time. Currently, only primary school syllabi include the issue of urban water cycles in Germany. More effort is needed to explain wastewater and drinking water issues in order to correct misconceptions.	[Schmid, Sarah; Bogner, Franz X.] Univ Bayreuth, Dept Biol Educ, ZMNU Ctr Math & Sci Educ, Bayreuth, Bavaria, Germany	University of Bayreuth	Schmid, S (corresponding author), Univ Bayreuth, Dept Biol Educ, ZMNU Ctr Math & Sci Educ, Bayreuth, Bavaria, Germany.	Sarah.schmid@uni-bayreuth.de			BMBF (Federal Ministry of Education and Research) [WAVE2015-820-3290-055]; German Research Foundation (DFG); University of Bayreuth; TrinkWave: Planungsoptionen und Technologien der Wasserwiederverwendung zur Stutzung der Trinkwasserversorgung in urbanen Wasserkreislaufen	BMBF (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth; TrinkWave: Planungsoptionen und Technologien der Wasserwiederverwendung zur Stutzung der Trinkwasserversorgung in urbanen Wasserkreislaufen	This study was funded by the BMBF (Federal Ministry of Education and Research): WAVE2015-820-3290-055; TrinkWave: Planungsoptionen und Technologien der Wasserwiederverwendung zur Stutzung der Trinkwasserversorgung in urbanen Wasserkreislaufen. All statements made by the authors need not necessarily reflect the opinion of the BMBF. Furthermore the study was funded by the German Research Foundation (DFG), and the University of Bayreuth in the funding program Open Access Publishing.	Andresen L., UNDERSTANDING ADULT, P225; Assaraf OB, 2012, CULT STUD SCI EDUCAT, V7, P451, DOI 10.1007/s11422-012-9391-5; Bahar M., 2003, EDUC SCI-THEOR PRACT, V3, P55; Bartel H., 2014, WASSERWIRTSCHATT DEU; Ben-zvi-assaraf O, 2001, NARST ERIC; BMJV, 2001, VER QUAL WASS MENSCH; Bortz J., 2010, FORSCHUNGSMETHODEN E; Brody M.J., 1993, ANN M AM ED RES ASS; Dekker S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00429; diSessa A., 1988, CONSTRUCTISIM COMPUT; Duit R, 2003, INT J SCI EDUC, V25, P671, DOI 10.1080/09500690305016; Fremerey C., 2014, Journal of Water Resource and Protection, V6, P1112, DOI 10.4236/jwarp.2014.612104; Fremerey C, 2015, STUD EDUC EVAL, V44, P9, DOI 10.1016/j.stueduc.2014.11.002; Futschek G., 2013, 10 WORLD C COMP ED J; Gilbert JK, 1982, SCI EDUC, V66, P623, DOI DOI 10.1002/SCE.3730660412; Gropengiesser H., THESIS, P105; Gunckel KL, 2012, J RES SCI TEACH, V49, P843, DOI 10.1002/tea.21024; Hammer D, 1996, AM J PHYS, V64, P1316, DOI 10.1119/1.18376; HEWSON MG, 1983, J RES SCI TEACH, V20, P731, DOI 10.1002/tea.3660200804; Hewson P. W., 1981, European Journal of Science Education, V3, P383, DOI 10.1080/0140528810304004; LAWSON AE, 1988, J RES SCI TEACH, V25, P733, DOI 10.1002/tea.3660250904; Lieflander A.K, 2016, PSYECOLOGY, V7, P25, DOI 10.1080/21711976.2015.1114216; Mayring P., 2015, QUALITATIVE INHALTSA, Vtwelfth; Ministerium fr Kultus,, 2014, JUG SPORT BAD WURTT; Ministerium fur Kultus, 2016, JUG SPORT BAD WURTT; Mohapatra A.K., 2009, INDIAN J SCI TECHNOL, V2, P72; Osterlind K, 2005, INT J SCI EDUC, V27, P891, DOI 10.1080/09500690500038264; Pajares F, 2002, THEOR PRACT, V41, P116, DOI 10.1207/s15430421tip4102_8; Posner G.J., 1982, SCI ED, V66, P211, DOI [10.1002/sce.3730660207, https://doi.org/10.1002/sce.3730660207]; Schmid S, 2015, EDUC RES INT, V2015, DOI 10.1155/2015/826734; Senatsverwaltung fur Bildung, 2006, JUG SPORT BERL RAHM; Senatsverwaltung fur Bildung Jugend und Familie (Berlin) Ministeriums fur Bildung, 2017, JUG SPORT LAND BRAND; Shaw KRM, 2008, GENETICS, V178, P1157, DOI 10.1534/genetics.107.084194; Smith J.P., 1993, J LEARN SCI, V3, P115, DOI [https://doi.org/10.1207/s15327809jls0302_1, DOI 10.1207/S15327809JLS0302_1, 10.1207/s15327809jls0302_1]; Staatsinstitut fur Schulqualitat und Bildungsforschung (ISB), 2004, LEHRPL GYMN BAYERN; Staatsinstitut fur Schulqualitat und Bildungsforschung (ISB), 2017, LEHRPL PLUS GRUNDSCH; Tekkaya C., 2003, RES SCI TECHNOLOGICA, V21, P5, DOI DOI 10.1080/02635140308340; Umweltbundesamt, 2015, BER BUND GES UMW BBG; van Merrienboer JJG, 2005, EDUC PSYCHOL REV, V17, P147, DOI 10.1007/s10648-005-3951-0; Wandersee J. H., 1994, HDB RES SCI TEACHING, P177	40	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200928	10.1371/journal.pone.0200928	http://dx.doi.org/10.1371/journal.pone.0200928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024937	gold, Green Published, Green Submitted			2022-12-27	WOS:000439120000069
J	Hughes, SM; Ferree, AL; Yanduram, SE; Shetler, C; Baker, CAR; Calienes, F; Levy, CN; Astronomo, RD; Shu, ZQ; Lent, GM; Fialkow, M; Kirby, AC; McElrath, MJ; Sinclair, E; Rohan, LC; Anderson, PL; Shacklett, BL; Dezzutti, CS; Gao, DY; Hladik, F				Hughes, Sean M.; Ferree, April L.; Yanduram, Sarah E.; Shetler, Cory; Baker, Chris A. R.; Calienes, Fernanda; Levy, Claire N.; Astronomo, Rena D.; Shu, Zhiquan; Lent, Gretchen M.; Fialkow, Michael; Kirby, Anna C.; McElrath, M. Juliana; Sinclair, Elizabeth; Rohan, Lisa C.; Anderson, Peter L.; Shacklett, Barbara L.; Dezzutti, Charlene S.; Gao, Dayong; Hladik, Florian			Cryopreservation of human mucosal tissues	PLOS ONE			English	Article							EX-VIVO; TOPICAL MICROBICIDES; EXPLANT CULTURE; SKIN SAMPLES; VITRIFICATION; CELLS; RABBIT; HIV-1; PREVENTION; INFECTION	Background Cryopreservation of leukocytes isolated from the cervicovaginal and colorectal mucosa is useful for the study of cellular immunity (see Hughes SM et al. PLOS ONE 2016). However, some questions about mucosal biology and sexually transmitted infections are better addressed with intact mucosal tissue, for which there is no standard cryopreservation protocol. Methods and findings To find an optimal preservation protocol for mucosal tissues, we tested slow cooling (1 E C/min) with 10% dimethylsulfoxide (designated "cryopreservation:) and fast cooling (plunge in liquid nitrogen) with 20% dimethylsulfoxide and 20% ethylene glycol ("vitrification"). We compared fresh and preserved human cervicovaginal and colorectal tissues in a range of assays, including metabolic activity, human immunodeficiency virus infection, cell phenotype, tissue structure by hematoxylin-and-eosin staining, cell number and viability, production of cytokines, and microbicide drug concentrations. Metabolic activity, HIV infectability, and tissue structure were similar in cryopreserved and vitrified vaginal tissues. However, vitrification led to poor cell recovery from the colorectal mucosa, with 90% fewer cells recovered after isolation from vitrified colorectal tissues than from cryopreserved. HIV infection rates were similar for fresh and cryopreserved ectocervical tissues, whereas cryopreserved colorectal tissues were less easily infected than fresh tissues (hazard ratio 0.7 [95% confidence interval 0.4, 1.2]). Finally, we compared isolation of cells before and after cryopreservation. Cell recoveries were higher when cells were isolated after freezing and thawing (71% [59 +/- 84%]) than before (50% [38 +/- 62%]). Cellular function was similar to fresh tissue in both cases. Microbicide drug concentrations were lower in cryopreserved explants compared to fresh ones. Conclusions Cryopreservation of intact cervicovaginal and colorectal tissues with dimethylsulfoxide works well in a range of assays, while the utility of vitrification is more limited. Cell yields are higher from cryopreserved intact tissue pieces than from thawed cryopreserved single cell suspensions isolated before freezing, but T cell functions are similar.	[Hughes, Sean M.; Levy, Claire N.; Lent, Gretchen M.; Fialkow, Michael; Kirby, Anna C.; Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Ferree, April L.; Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Yanduram, Sarah E.; Shetler, Cory; Rohan, Lisa C.; Dezzutti, Charlene S.] Magee Womens Res Inst, Pittsburgh, PA USA; [Yanduram, Sarah E.] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Baker, Chris A. R.; Sinclair, Elizabeth] Univ Calif San Francisco, Core Immunol Lab, San Francisco, CA 94143 USA; [Baker, Chris A. R.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA; [Calienes, Fernanda; Astronomo, Rena D.; McElrath, M. Juliana; Hladik, Florian] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Shu, Zhiquan; Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Shu, Zhiquan] Washington State Univ, Sch Mech & Mat Engn, Everett, WA USA; [McElrath, M. Juliana; Hladik, Florian] Univ Washington, Dept Med, Seattle, WA 98104 USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Rohan, Lisa C.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Anderson, Peter L.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Div Infect Dis, Dept Med, Sacramento, CA 95817 USA; [Dezzutti, Charlene S.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Gao, Dayong] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Statens Serum Institut; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle	Hladik, F (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Hladik, F (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Hladik, F (corresponding author), Univ Washington, Dept Med, Seattle, WA 98104 USA.	florian@uw.edu	Hladik, Florian/G-1041-2012; Shacklett, Barbara/A-7288-2009	Hladik, Florian/0000-0002-0375-2764; Shacklett, Barbara/0000-0002-7067-732X; Calienes, Fernanda/0000-0002-9471-1617; Baker, Chris/0000-0002-6248-654X; Shu, Zhiquan/0000-0002-9261-5832; Hughes, Sean/0000-0002-9409-9405; Levy, Claire/0000-0003-3204-211X; Yandura, Sarah Elizabeth/0000-0003-4279-0664	Bill & Melinda Gates Foundation [OPP1032522]; National Institutes of Health [R33 AI0094412]; HIV Vaccine Trials Network Mucosal Immunology Group Award [R01 AI057020, FAME U19 AI082637, U19 AI120249, MTN UM1 AI106707];  [P30CA047904]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106707, R01AI116292, R01AI057020] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Vaccine Trials Network Mucosal Immunology Group Award; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Bill & Melinda Gates Foundation (OPP1032522 to DG and FH; https://www.gatesfoundation.org) and the National Institutes of Health (Supplement to R33 AI0094412 to FH and DG; HIV Vaccine Trials Network Mucosal Immunology Group Award to FH; an Administrative Supplement to R01 AI057020 to BLS; FAME U19 AI082637 and U19 AI120249 to CSD, LCR, PLA; and MTN UM1 AI106707 to CSD, LCR, PLA; https://www.nih.gov). The University of Pittsburgh Medical Center Hillman Cancer Center and Tissue and Research Pathology/Health Sciences Tissue Bank shared resource, which is supported in part by award P30CA047904, and provided surgical remainders for the work in Dr. Charlene Dezzutti's laboratory. The NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH provided tenofovir; International Partnership for Microbicides provided dapivirine; and Merck & Co., Inc., Kenilworth, NJ USA provided MK-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Astronomo RD, 2016, EBIOMEDICINE, V14, P97, DOI 10.1016/j.ebiom.2016.11.024; Baert Y, 2013, HUM REPROD, V28, P1816, DOI 10.1093/humrep/det100; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Da-Croce L, 2013, CELL TISSUE BANK, V14, P65, DOI 10.1007/s10561-012-9301-9; Dezzutti CS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004174; Dezzutti CS, 2013, JAIDS-J ACQ IMM DEF, V63, P548, DOI 10.1097/QAI.0b013e318291f331; Dezzutti CS, 2013, CURR HIV-AIDS REP, V10, P12, DOI 10.1007/s11904-012-0148-2; Ducar C, 2014, J IMMUNOL METHODS, V409, P9, DOI 10.1016/j.jim.2014.03.024; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fox JM, 2017, CRYOBIOLOGY, V77, P14, DOI 10.1016/j.cryobiol.2017.06.004; Fujita T, 2000, J BURN CARE REHABIL, V21, P304, DOI 10.1067/mbc.2000.107745; Gupta P, 2006, AIDS RES HUM RETROV, V22, P419, DOI 10.1089/aid.2006.22.419; Harrell F.E.J., 2020, HMISC HARRELL MISCEL; Hughes SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156293; Liu JA, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108951; M Hughes S., 2016, J OPEN SOURCE SOFTW, V1, P106, DOI [10.21105/joss.00106, DOI 10.21105/JOSS.00106]; McGowan I, 2012, AIDS RES HUM RETROV, V28, P1509, DOI [10.1089/AID.2012.0062, 10.1089/aid.2012.0062]; Pinheiro J, 2015, NLME LINEAR NONLINEA; Promprasit D, 2015, CURR EYE RES, V40, P274, DOI 10.3109/02713683.2014.917191; Richardson-Harman N, 2017, AIDS RES HUM RETROV, V33, P395, DOI [10.1089/aid.2016.0073, 10.1089/AID.2016.0073]; Rienzi L, 2017, HUM REPROD UPDATE, V23, P139, DOI 10.1093/humupd/dmw038; Shu ZQ, 2016, BIOPRESERV BIOBANK, V14, P307, DOI 10.1089/bio.2015.0079; Shu ZQ, 2016, CRYOBIOLOGY, V72, P93, DOI 10.1016/j.cryobiol.2016.03.003; Silvestre MA, 2004, CRYOBIOLOGY, V49, P221, DOI 10.1016/j.cryobiol.2004.08.001; Silvestre MA, 2003, THERIOGENOLOGY, V59, P1469, DOI 10.1016/S0093-691X(02)01185-8; Silvestre MA, 2002, THERIOGENOLOGY, V58, P69, DOI 10.1016/S0093-691X(02)00830-0; Stroncek DE, 2011, TRANSFUSION, V51, P2647, DOI 10.1111/j.1537-2995.2011.03210.x; Team RC., 2013, R LANG ENV STAT COMP; Veeraputhiran M, 2010, CYTOTHERAPY, V12, P764, DOI 10.3109/14653241003745896; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie Y., 2015, DYNAMIC DOCUMENTS R, VSecond edition; Xu H, 2009, CRYOBIOLOGY, V58, P225, DOI 10.1016/j.cryobiol.2008.12.009; ZHU ZM, 1994, CHINESE MED J-PEKING, V107, P574	37	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0200653	10.1371/journal.pone.0200653	http://dx.doi.org/10.1371/journal.pone.0200653			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059507	gold, Green Published, Green Submitted			2022-12-27	WOS:000440251600012
J	De Marchi, BR; Kinene, T; Wainaina, JM; Krause-Sakate, R; Boykin, L				De Marchi, Bruno Rossitto; Kinene, Tonny; Wainaina, James Mbora; Krause-Sakate, Renate; Boykin, Laura			Comparative transcriptome analysis reveals genetic diversity in the endosymbiont Hamiltonella between native and exotic populations of Bemisia tabaci from Brazil	PLOS ONE			English	Article							SPECIES COMPLEX; HEMIPTERA ALEYRODIDAE; BIOTYPE B; TRANSMISSION; VIRUS; BACTERIOCYTE; RICKETTSIA; WHITEFLIES; INFERENCE; INSECTS	The whitefly, Bemisia tabaci, is a species complex of more than 40 cryptic species and a major agricultural pest. It causes extensive damage to plants mainly by transmitting plant viruses. There is still a lack of genomic data available for the different whitefly species found in Brazil and their bacterial endosymbionts. Understanding the genetic and transcriptomic composition of these insect pests, the viruses they transmit and the microbiota is crucial to sustainable solutions for farmers to control whiteflies. Illumina RNA-Seq was used to obtain the transcriptome of individual whiteflies from 10 different populations from Brazil including Middle East-Asia Minor 1 (MEAM1), Mediterranean (MED) and New World 2 (NW2). Raw reads were assembled using CLC Genomics Workbench and subsequently mapped to reference genomes. We obtained whitefly complete mitochondrial genomes and draft genomes from the facultative bacterial endosymbiont Hamiltonella for further phylogenetic analyses. In addition, nucleotide sequences of the GroEL chaperonin gene from Hamiltonella from different populations were obtained and analysed. There was concordance in the species clustering using the whitefly complete mitogenome and the mtCOI gene tree. On the other hand, the phylogenetic analysis using the 12 ORF's of Hamiltonella clustered the native species NW2 apart from the exotics MEAM1 and MED. In addition, the amino acid analysis of GroEL chaperonin revealed a deletion only in Hamiltonella infecting NW2 among whiteflies populations analysed which was further confirmed by PCR and Sanger sequencing. The genomic data obtained in this study will aid understanding the functions that Hamiltonella may have in whitefly biology and serve as a reference for further studies regarding whiteflies in Brazil.	[De Marchi, Bruno Rossitto; Krause-Sakate, Renate] UNESP Univ Estadual Paulista, Fac Ciencias Agron, Botucatu, SP, Brazil; [Kinene, Tonny; Wainaina, James Mbora; Boykin, Laura] Univ Western Australia, Sch Mol Sci, Perth, WA, Australia; [Kinene, Tonny; Wainaina, James Mbora; Boykin, Laura] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Perth, WA, Australia	Universidade Estadual Paulista; University of Western Australia; University of Western Australia	Boykin, L (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA, Australia.; Boykin, L (corresponding author), Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Perth, WA, Australia.	laura.boykin@uwa.edu.au	De Marchi, Bruno Rossitto/G-8861-2018; Krause-Sakate, Renate/N-7292-2014; Boykin, Laura/H-8876-2014	De Marchi, Bruno Rossitto/0000-0002-4401-2594; Krause-Sakate, Renate/0000-0001-7526-640X; Boykin, Laura/0000-0002-6101-1921	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2017/21588-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [200826/2015-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RKS is a grant recipient from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br) Process Number 2017/21588-7. BRDM is a grant recipient from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br) Process Number 200826/2015-8.	Aberer AJ, 2014, MOL BIOL EVOL, V31, P2553, DOI 10.1093/molbev/msu236; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Barbosa LD, 2014, PEST MANAG SCI, V70, P1440, DOI 10.1002/ps.3731; Barbosa LD, 2015, PEST MANAG SCI, V71, P501, DOI 10.1002/ps.3909; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Marchi BR, 2017, TROP PLANT PATHOL, V42, P495, DOI 10.1007/s40858-017-0186-9; De Moraes Aparecida L, DISTRIBUTION P UNPUB; de Moraes LA, 2017, PHYTOPARASITICA, V45, P517, DOI 10.1007/s12600-017-0607-9; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Gauthier N, 2014, PEST MANAG SCI, V70, P1477, DOI 10.1002/ps.3733; Gorovits R., 2013, MOONLIGHTING CELL ST, V7, P173; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kontseclalov S, 2009, PEST MANAG SCI, V65, P5, DOI 10.1002/ps.1636; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Luan JB, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0580; Luan JB, 2018, CURR BIOL, V28, P459, DOI 10.1016/j.cub.2017.12.041; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Marubayashi JM, 2013, J APPL ENTOMOL, V137, P113, DOI 10.1111/j.1439-0418.2012.01714.x; Marubayashi JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108363; Marubayashi Julio Massaharu, 2010, Summa phytopathol., V36, P158, DOI 10.1590/S0100-54052010000200009; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Parrella G, 2014, PEST MANAG SCI, V70, P1514, DOI 10.1002/ps.3686; Polston JE, 2014, PEST MANAG SCI, V70, P1547, DOI 10.1002/ps.3738; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Rao Q, 2012, J BACTERIOL, V194, P3558, DOI 10.1128/JB.00069-12; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sseruwagi Peter, 2017, Gates Open Res, V1, P16, DOI 10.12688/gatesopenres.12783.2; Su Q, 2013, ENVIRON ENTOMOL, V42, P1265, DOI 10.1603/EN13182; Tay WT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00528-7; Tay WT, 2016, MITOCHONDRIAL DNA A, V27, P972, DOI 10.3109/19401736.2014.926511; Tay WT, 2017, GENOME BIOL EVOL, V9, P2732, DOI 10.1093/gbe/evx173; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang HL, 2016, MITOCHONDRIAL DNA A, V27, P3500, DOI 10.3109/19401736.2015.1066367; Wang HL, 2016, MITOCHONDRIAL DNA A, V27, P98, DOI 10.3109/19401736.2013.873921; Wang HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-401; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zanardo LG, 2017, TROP PLANT PATHOL, V42, P417, DOI 10.1007/s40858-017-0168-y	49	9	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201411	10.1371/journal.pone.0201411	http://dx.doi.org/10.1371/journal.pone.0201411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052670	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600043
J	Bhowmick, SS; Saha, I; Bhattacharjee, D; Genovese, LM; Geraci, F				Bhowmick, Shib Sankar; Saha, Indrajit; Bhattacharjee, Debotosh; Genovese, Loredana M.; Geraci, Filippo			Genome- wide analysis of NGS data to compile cancer- specific panels of miRNA biomarkers	PLOS ONE			English	Article							FEATURE-SELECTION; DIFFERENTIAL EVOLUTION; TARGET INTERACTIONS; MUTUAL INFORMATION; COMPONENT ANALYSIS; CLASSIFICATION; MICRORNAS; IDENTIFICATION; ALGORITHMS; INJURY	MicroRNAs are small non-coding RNAs that influence gene expression by binding to the 3' UTR of target mRNAs in order to repress protein synthesis. Soon after discovery, microRNA dysregulation has been associated to several pathologies. In particular, they have often been reported as differentially expressed in healthy and tumor samples. This fact suggested that microRNAs are likely to be good candidate biomarkers for cancer diagnosis and personalized medicine. With the advent of Next-Generation Sequencing (NGS), measuring the expression level of the whole miRNAome at once is now routine. Yet, the collaborative effort of sharing data opens to the possibility of population analyses. This context motivated us to perform an in-silico study to distill cancer-specific panels of microRNAs that can serve as biomarkers. We observed that the problem of finding biomarkers can be modeled as a twoclass classification task where, given the miRNAomes of a population of healthy and cancerous samples, we want to find the subset of microRNAs that leads to the highest classification accuracy. We fulfill this task leveraging on a sensible combination of data mining tools. In particular, we used: differential evolution for candidate selection, component analysis to preserve the relationships among miRNAs, and SVM for sample classification. We identified 10 cancer-specific panels whose classification accuracy is always higher than 92%. These panels have a very little overlap suggesting that miRNAs are not only predictive of the onset of cancer, but can be used for classification purposes as well. We experimentally validated the contribution of each of the employed tools to the selection of discriminating miRNAs. Moreover, we tested the significance of each panel for the corresponding cancer type. In particular, enrichment analysis showed that the selected miRNAs are involved in oncogenesis pathways, while survival analysis proved that miRNAs can be used to evaluate cancer severity. Summarizing: results demonstrated that our method is able to produce cancerspecific panels that are promising candidates for a subsequent in vitro validation.	[Bhowmick, Shib Sankar; Bhattacharjee, Debotosh] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, India; [Bhowmick, Shib Sankar] Heritage Inst Technol, Dept Elect & Commun Engn, Kolkata, India; [Saha, Indrajit] Natl Inst Tech Teachers Training & Res, Dept Comp Sci & Engn, Kolkata, India; [Genovese, Loredana M.; Geraci, Filippo] CNR, Inst Informat & Telemat, Pisa, Italy	Jadavpur University; Heritage Institute of Technology (HITK); National Institute of Technical Teachers Training & Research, Kolkata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR)	Saha, I (corresponding author), Natl Inst Tech Teachers Training & Res, Dept Comp Sci & Engn, Kolkata, India.	indrajit@nitttrkol.ac.in	Bhattacharjee, Debotosh/Q-4065-2019	Bhattacharjee, Debotosh/0000-0002-1163-6413; GERACI, FILIPPO/0000-0001-6993-6761	Department of Science and Technology, India [DST/INT/POL/P-36/2016]; Istituto Toscano Tumori	Department of Science and Technology, India(Department of Science & Technology (India)); Istituto Toscano Tumori	The authors declare the following funding: Department of Science and Technology, India, DST/INT/POL/P-36/2016 (Dr. Indrajit Saha); Istituto Toscano Tumori, "Eligibility of miRNAs modified by docetaxel in prostate cancer cells to plasma biomarkers in patients responsive or no more responsive to docetaxel (Dr Filippo Geraci). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bickel P. J., 2015, MATH STAT BASIC IDEA, VI; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Carbonell J, 2012, GENOME MED, V4, DOI 10.1186/gm363; Church RJ, 2014, TOXICOL RES-UK, V3, P384, DOI 10.1039/c4tx00051j; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Fabbri M, 2013, CURR MOL MED, V13, P751, DOI 10.2174/1566524011313050006; Gao XJ, 2016, ONCOTARGET, V7, P81670, DOI 10.18632/oncotarget.13164; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hollander M, 1999, NONPARAMETRIC STAT M, V2; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Jenssen R, 2010, IEEE T PATTERN ANAL, V32, P847, DOI 10.1109/TPAMI.2009.100; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; Kok MGM, 2015, FASEB J, V29, P3853, DOI 10.1096/fj.15-271312; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu Huiqing, 2002, Genome Inform, V13, P51; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Maulik U, 2009, PATTERN RECOGN, V42, P2135, DOI 10.1016/j.patcog.2009.01.011; Miao JY, 2016, PROCEDIA COMPUT SCI, V91, P919, DOI 10.1016/j.procs.2016.07.111; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Sethi S, 2014, CLIN GENET, V86, P68, DOI 10.1111/cge.12362; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sourvinou IS, 2013, J MOL DIAGN, V15, P827, DOI 10.1016/j.jmoldx.2013.07.005; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Uncu O, 2007, INFORM SCIENCES, V177, P449, DOI 10.1016/j.ins.2006.03.022; Wu L, 2015, CHEM SOC REV, V44, P2963, DOI 10.1039/c4cs00370e; Yang H., 1999, P INT ICSC S ADV INT, P22; Zhou H, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0167-0	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200353	10.1371/journal.pone.0200353	http://dx.doi.org/10.1371/journal.pone.0200353			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048452	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400006
J	Huppi, R; Felber, R; Krauss, M; Six, J; Leifeld, J; Fuss, R				Huppi, Roman; Felber, Raphael; Krauss, Maike; Six, Johan; Leifeld, Jens; Fuss, Roland			Restricting the nonlinearity parameter in soil greenhouse gas flux calculation for more reliable flux estimates	PLOS ONE			English	Article							NITROUS-OXIDE FLUXES; N2O EMISSIONS; CHAMBERS; ATMOSPHERE; EXCHANGE; BIOCHAR; IMPACT; CARBON; MODEL	The static chamber approach is often used for greenhouse gas (GHG) flux measurements, whereby the flux is deduced from the increase of species concentration after closing the chamber. Since this increase changes diffusion gradients between chamber air and soil air, a nonlinear increase is expected. Lateral gas flow and leakages also contribute to non linearity. Several models have been suggested to account for this non linearity, the most recent being the Hutchinson-Mosier regression model (HMR). However, the practical application of these models is challenging because the researcher needs to decide for each flux whether a nonlinear fit is appropriate or exaggerates flux estimates due to measurement artifacts. In the latter case, a flux estimate from the linear model is a more robust solution and introduces less arbitrary uncertainty to the data. We present the new, dynamic and reproducible flux calculation scheme, KAPPA. MAX, for an improved trade-off between bias and uncertainty (i.e. accuracy and precision). We develop a tool to simulate, visualise and optimise the flux calculation scheme for any specific static N2O chamber measurement system. The decision procedure and visualisation tools are implemented in a package for the R software. Finally, we demonstrate with this approach the performance of the applied flux calculation scheme for a measured flux dataset to estimate the actual bias and uncertainty. The KAPPA. MAX method effectively improved the decision between linear and nonlinear flux estimates reducing the bias at a minimal cost of uncertainty.	[Huppi, Roman; Six, Johan] Swiss Fed Inst Technol, Inst Agr Sci, Dept Environm Sci, Zurich, Switzerland; [Huppi, Roman; Felber, Raphael; Leifeld, Jens] Agroscope, Climate & Agr Grp, Zurich, Switzerland; [Krauss, Maike] Res Inst Organ Agr FiBL, Dept Soil Sci, Frick, Switzerland; [Fuss, Roland] Thunen Inst Climate Smart Agr, Braunschweig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; Johann Heinrich von Thunen Institute	Huppi, R (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Dept Environm Sci, Zurich, Switzerland.; Huppi, R (corresponding author), Agroscope, Climate & Agr Grp, Zurich, Switzerland.	roman.hueppi@usys.ethz.ch	Leifeld, Jens/GYR-0349-2022; Leifeld, Jens/A-3298-2014; Krauss, Maike/AAR-4252-2021; Fuß, Roland/F-3866-2011; six, johan/J-5228-2015	Leifeld, Jens/0000-0002-7245-9852; Leifeld, Jens/0000-0002-7245-9852; Fuß, Roland/0000-0002-0274-0809; six, johan/0000-0001-9336-4185; Felber, Raphael/0000-0002-0285-2894	Swiss National Science Foundation (SNF) [200021_140448]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (SNF) Project ID 200021_140448.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANTHONY WH, 1995, SOIL SCI SOC AM J, V59, P1308, DOI 10.2136/sssaj1995.03615995005900050015x; Bain WG, 2005, AGR FOREST METEOROL, V131, P225, DOI 10.1016/j.agrformet.2005.06.004; Cambareri G, 2017, CAN J SOIL SCI, V97, P532, DOI 10.1139/cjss-2016-0108; Collier SM, 2014, JOVE-J VIS EXP, DOI 10.3791/52110; Conen F, 2000, EUR J SOIL SCI, V51, P111, DOI 10.1046/j.1365-2389.2000.00292.x; De Klein C, 2013, NITROUS OXIDE CHAMBE; Deppe M, 2016, AGR ECOSYST ENVIRON, V219, P138, DOI 10.1016/j.agee.2015.12.015; FLESSA H, 1995, J GEOPHYS RES-ATMOS, V100, P23115, DOI 10.1029/95JD02270; Fuss R, 2017, FUNCTION VERSION 0 3; Huppi R, 2015, SOIL DISCUSSIONS, V2, P793, DOI [10.5194/soild-2-793-2015, DOI 10.5194/SOILD-2-793-2015]; Huppi R, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/8/084013; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Kandel TP, 2016, ATMOS ENVIRON, V141, P245, DOI 10.1016/j.atmosenv.2016.06.062; Krauss M, 2017, AGR ECOSYST ENVIRON, V239, P324, DOI 10.1016/j.agee.2017.01.029; Leiber-Sauheitl K, 2014, BIOGEOSCIENCES, V11, P749, DOI 10.5194/bg-11-749-2014; Levy PE, 2011, EUR J SOIL SCI, V62, P811, DOI 10.1111/j.1365-2389.2011.01403.x; Livingston GP, 2006, SOIL SCI SOC AM J, V70, P1459, DOI 10.2136/sssaj2005.0322; Parkin TB, 2012, J ENVIRON QUAL, V41, P705, DOI 10.2134/jeq2011.0394; Pedersen AR, 2010, EUR J SOIL SCI, V61, P888, DOI 10.1111/j.1365-2389.2010.01291.x; Pedersen AR, 2017, FLUX ESTIMATION STAT; Rochette P, 2008, SOIL SCI SOC AM J, V72, P331, DOI 10.2136/sssaj2007.0215; Ruser R, 2017, AGR ECOSYST ENVIRON, V249, P57, DOI 10.1016/j.agee.2017.07.039; Venterea RT, 2008, SOIL SCI SOC AM J, V72, P1410, DOI 10.2136/sssaj2008.0019; Venterea RT, 2013, SOIL SCI SOC AM J, V77, P709, DOI 10.2136/sssaj2013.01.0010; Venterea RT, 2010, J ENVIRON QUAL, V39, P126, DOI 10.2134/jeq2009.0231; Venterea RT, 2009, SOIL SCI SOC AM J, V73, P1087, DOI 10.2136/sssaj2008.0307; Verhoeven E, 2014, AGR ECOSYST ENVIRON, V191, P27, DOI 10.1016/j.agee.2014.03.008; Walter K, 2015, BIOMASS BIOENERG, V81, P556, DOI 10.1016/j.biombioe.2015.08.011	30	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200876	10.1371/journal.pone.0200876	http://dx.doi.org/10.1371/journal.pone.0200876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048522	Green Published, gold			2022-12-27	WOS:000439952400025
J	Kim, S; Yang, HK; Hwang, JM				Kim, Seonghwan; Yang, Hee Kyung; Hwang, Jeong-Min			Surgical outcomes of unilateral recession and resection in intermittent exotropia according to forced duction test results	PLOS ONE			English	Article							LATERAL RECTUS RECESSION; SURGERY; OVERCORRECTION; CHILDREN; ANGLE	Purpose To compare the surgical outcomes of unilateral lateral rectus recession-medial rectus resection (RR) according to forced duction test (FDT) results with those of conventional RR in intermittent exotropia. Methods A total of 129 patients aged 3 to 10 years with intermittent exotropia who underwent RR between 2006 and 2011 were included. The operator compared the tension of the lateral rectus (LR) between both eyes. When FDT results were asymmetric, RR was performed on the eye with more LR tension. RR was performed on the nondominant eye when FDT results were symmetric. Patients were divided into two groups; one group (n = 64) underwent RR without FDT (RR group) and the other group (n = 65) underwent RR considering FDT results (RR-FDT group). Success, recurrence, reoperation rates and cumulative probabilities of success were evaluated in both groups. Surgical outcome was considered satisfactory if the distance deviation in the primary position was between <= 10 PD of exophoria/tropia and <= 10 PD of esophoria/tropia. Recurrence was defined as an alignment of > 10 PD of exophoria/tropia, and overcorrection defined as > 10 PD of esophoria/tropia. Reoperation for recurrence was recommended for constant exotropia >= 14 PD at distance. Results The total follow-up periods were 4.4 +/- 2.3 years in the RR group, and 3.9 +/- 2.0 years in the RR-FDT group (P =.310). In the RR group, 50 patients (78.1%) were successful, 13 patients (20.3%) had recurrence, and 1 patient (1.6%) had overcorrection at 2 years after surgery. In the RR-FDT group, 58 patients (89.2%) were successful, 5 patients (7.7%) had recurrence, and 2 patients (3.1%) were overcorrected. The recurrence rate at 2 years after operation was significantly lower in the RR-FDT group (P =.045). Recurrence rates during the followup period were 5.6% per person-year in the RR group and 2.7% per person-year in the RR-FDT group. Reoperation for recurrence was performed on 7 patients ( 10.8%) in the RR- FDT group and 16 patients ( 25.0%) in the RR group ( P =.035). Postoperative sensory outcomes were similar between both groups. Conclusions The forced duction test was useful in reducing the risk of recurrence at 2 years after surgery when RR was performed on the eye with more passive tension of the LR. Intraoperative FDT may be considered to choose which eye to operate on when planning RR in intermittent	[Kim, Seonghwan; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea.	hjm@snu.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A2B4011450]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2B4011450) (JMH).	Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; CLARKE WN, 1981, CAN J OPHTHALMOL, V16, P66; Dell R, 1999, BRIT J ANAESTH, V82, P761, DOI 10.1093/bja/82.5.761; Duane A., 1897, ANN OPHTHALMOL OTOLA, V84, P247, DOI [10.1016/S0002-9394(42)92411-5, DOI 10.1016/S0002-9394(42)92411-5]; Govindan M, 2005, OPHTHALMOLOGY, V112, P104, DOI 10.1016/j.ophtha.2004.07.033; Heo H, 2013, JPN J OPHTHALMOL, V57, P475, DOI 10.1007/s10384-013-0260-x; Jampolsky A, 1986, Trans New Orleans Acad Ophthalmol, V34, P201; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Kim C, 2005, EYE, V19, P637, DOI 10.1038/sj.eye.6701604; Kim H, 2016, AM J OPHTHALMOL, V163, P11, DOI 10.1016/j.ajo.2015.12.003; Kim KE, 2014, AM J OPHTHALMOL, V157, P1214, DOI 10.1016/j.ajo.2014.02.038; Kim TW, 2005, OPHTHALMOLOGICA, V219, P237, DOI 10.1159/000085734; Lee SY, 2007, J AAPOS, V11, P266, DOI 10.1016/j.jaapos.2007.02.014; Maruo T, 2001, Binocul Vis Strabismus Q, V16, P265; METZ HS, 1985, INT OPHTHALMOL CLIN, V25, P13, DOI 10.1097/00004397-198502540-00004; Nusz KJ, 2006, OPHTHALMOLOGY, V113, P1154, DOI 10.1016/j.ophtha.2006.01.033; Preslan MW, 1996, OPHTHALMOLOGY, V103, P105, DOI 10.1016/S0161-6420(96)30753-7; ROSENBAUM AL, 1980, OPHTHALMOLOGY, V87, P158; Stephens K F, 1967, Trans Am Acad Ophthalmol Otolaryngol, V71, P324; Vishwanath M, 2009, STRABISMUS, V17, P41, DOI 10.1080/09273970802678354; von Noorden GK, 1996, BINOCULAR VISION OCU, P343; Wright KJ., 2000, COLOR ATLAS STRABISM, V2, P249; Zou LL, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/828919	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200741	10.1371/journal.pone.0200741	http://dx.doi.org/10.1371/journal.pone.0200741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048470	Green Published, gold			2022-12-27	WOS:000439952400017
J	Strang, BL; Asquith, CRM; Moshrif, HF; Ho, CMK; Zuercher, WJ; Al-Ali, H				Strang, Blair L.; Asquith, Christopher R. M.; Moshrif, Hanan F.; Ho, Catherine M-K; Zuercher, William J.; Al-Ali, Hassan			Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data	PLOS ONE			English	Article							STRUCTURE-BASED DESIGN; VIRUS ENTRY REQUIRES; WEST-NILE-VIRUS; GENETIC SCREEN; HOST FACTORS; HIV-1 REPLICATION; PROTEIN-KINASE; POTENT; MUTATIONS; MARIBAVIR	Chemogenomic approaches involving highly annotated compound sets and cell based high throughput screening are emerging as a means to identify novel drug targets. We have previously screened a collection of highly characterized kinase inhibitors (Khan et al., Journal of General Virology, 2016) to identify compounds that increase or decrease expression of a human cytomegalovirus (HCMV) protein in infected cells. To identify potential novel anti-HCMV drug targets we used a machine learning approach to relate our phenotypic data from the aforementioned screen to kinase inhibition profiling of compounds used in this screen. Several of the potential targets had no previously reported role in HCMV replication. We focused on one potential anti-HCMV target, MAPK4K, and identified lead compounds inhibiting MAP4K4 that have anti-HCMV activity with little cellular cytotoxicity. We found that treatment of HCMV infected cells with inhibitors of MAP4K4, or an siRNA that inhibited MAP4K4 production, reduced HCMV replication and impaired detection of IE2-60, a viral protein necessary for efficient HCMV replication. Our findings demonstrate the potential of this machine learning approach to identify novel anti-viral drug targets, which can inform the discovery of novel anti-viral lead compounds.	[Strang, Blair L.; Moshrif, Hanan F.; Ho, Catherine M-K] St Georges Univ London, Inst Infect & Immun, London, England; [Asquith, Christopher R. M.; Zuercher, William J.] Univ N Carolina, UNC Eshelman Sch Pharm, Struct Genom Consortium, Chapel Hill, NC 27515 USA; [Zuercher, William J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Al-Ali, Hassan] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Dept Neurol Surg, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Katz Drug Discovery Ctr, Miami, FL USA; [Al-Ali, Hassan] Univ Miami, Dept Med, Miami, FL USA	St Georges University London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Strang, BL (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	bstrang@sgul.ac.uk	Moshrif, Hanan F/L-1892-2017	Asquith, Christopher/0000-0001-5871-3458; Al-Ali, Hassan/0000-0002-8899-3443; Strang, Blair/0000-0001-9407-1974	St George's, University of London; PARK/WestFocus Award; Kingdom of Saudi Arabia; Miami Project to Cure Paralysis; The Wallace H Coulter Foundation; NINDS [R01 NS100531-01A1]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA) [115766]; Janssen; Merck KGaA Darmstadt Germany; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome [106169/ZZ14/Z]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100531] Funding Source: NIH RePORTER	St George's, University of London; PARK/WestFocus Award; Kingdom of Saudi Arabia; Miami Project to Cure Paralysis; The Wallace H Coulter Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA Darmstadt Germany; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BLS and CMKH were supported by New Investigator funds from St George's, University of London and a PARK/WestFocus Award. HFM was supported by a studentship from the Kingdom of Saudi Arabia. HAA was supported by The Miami Project to Cure Paralysis, The Wallace H Coulter Foundation, and NINDS R01 NS100531-01A1. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z]. The funders had no role in experimental design, data collection, data interpretation or the decision to submit the work for publication.	Al-Ali H, 2015, ACS CHEM BIOL, V10, P1939, DOI 10.1021/acschembio.5b00289; Ammirati M, 2015, ACS MED CHEM LETT, V6, P1128, DOI 10.1021/acsmedchemlett.5b00215; Beelontally R, 2017, ANTIVIR RES, V138, P61, DOI 10.1016/j.antiviral.2016.12.006; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chou SW, 2007, J INFECT DIS, V196, P91, DOI 10.1086/518514; Chou SW, 2017, ANTIVIR RES, V148, P1, DOI 10.1016/j.antiviral.2017.10.019; Chou SW, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01325-17; Chou SW, 2015, ANTIMICROB AGENTS CH, V59, P6588, DOI 10.1128/AAC.01623-15; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; Chou SW, 2004, J VIROL, V78, P7124, DOI 10.1128/JVI.78.13.7124-7130.2004; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Crawford TD, 2014, J MED CHEM, V57, P3484, DOI 10.1021/jm500155b; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Fusco DN, 2013, GASTROENTEROLOGY, V144, P1438, DOI 10.1053/j.gastro.2013.02.026; Gao X, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0121-7; Gaspar M, 2006, P NATL ACAD SCI USA, V103, P2821, DOI 10.1073/pnas.0511148103; Haas DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003737; Heaton BE, 2017, CELL REP, V20, P1503, DOI 10.1016/j.celrep.2017.07.060; Ho CMK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150339; Hoffmann HH, 2017, CELL HOST MICROBE, V22, P460, DOI 10.1016/j.chom.2017.09.002; Huang HB, 2012, ACS MED CHEM LETT, V3, P1059, DOI 10.1021/ml300278f; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Hutterer C, 2017, ANTIVIR RES, V143, P113, DOI 10.1016/j.antiviral.2017.04.003; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Khan AS, 2017, J GEN VIROL, V98, P754, DOI 10.1099/jgv.0.000713; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Koyuncu E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003333; Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lin YT, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006329; Martinez GJ, 2017, J EXP MED, V214, P1205, DOI 10.1084/jem.20170571; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Mocarski E. S., 2015, FIELDS VIROLOGY, P1960; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P913, DOI 10.1021/acsmedchemlett.5b00174; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Polachek WS, 2016, J VIROL, V90, P8360, DOI 10.1128/JVI.01134-16; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Raaben M, 2017, CELL HOST MICROBE, V22, P688, DOI 10.1016/j.chom.2017.10.002; Reitsma JM, 2013, ANTIVIR RES, V100, P321, DOI 10.1016/j.antiviral.2013.09.011; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Strang BL, 2017, ANTIVIR RES, V144, P21, DOI 10.1016/j.antiviral.2017.05.004; Tan XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132148; Terry LJ, 2012, P NATL ACAD SCI USA, V109, P3071, DOI 10.1073/pnas.1200494109; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Virbasius JV, 2016, TRENDS ENDOCRIN MET, V27, P484, DOI 10.1016/j.tem.2016.04.006; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; White EA, 2007, J VIROL, V81, P2573, DOI 10.1128/JVI.02454-06; Wilkinson GWG, 2015, MED MICROBIOL IMMUN, V204, P273, DOI 10.1007/s00430-015-0411-4; Xuan BQ, 2009, J VIROL, V83, P3463, DOI 10.1128/JVI.02307-08; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	62	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201321	10.1371/journal.pone.0201321	http://dx.doi.org/10.1371/journal.pone.0201321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048526	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000439952400077
J	Beogo, I; Darboe, A; Adesanya, OA; Rojas, BM				Beogo, Idrissa; Darboe, Amadou; Adesanya, Oluwafunmilade A.; Rojas, Bomar Mendez			Choosing between nurse-led and medical doctor-led from private for-profit versus non-for-profit health facilities: A household survey in urban Burkina Faso	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; PHYSICIAN ASSISTANTS; UNITED-STATES; PRACTITIONERS; SECTOR; TRENDS; COST; SATISFACTION; INDIA	Background Providers' qualification (Medical doctor [MD] or nurse); type of care facility ownership (for-profit [FP] or not-for-profit [NFP]) may all influence individuals' healthcare-seeking behavior and therefore merits empirical assessment to provide valuable evidence-informed policy orientation in the present context of private health system development. Previous studies have not examined these factors in combination, especially within the urban context of sub-Sahara Africa, where the private sector is rapidly growing. This study aims to explore factors associated with urban residents' preferences between private MD-led and private nurse-led outpatient care and how these factors vary by type of private health facility ownership (FP and NFP) and levels of disease severity (severe and non-severe cases). Methods A cross-sectional household survey was conducted in July-November 2011 on a random final sample of 2064 adults (646 households). We used a face-to-face interview to capture participants' choice of provider and their associated factors. A multivariable logistic regression was applied. Results For severe conditions, participants, almost equally sought FP and NFP facilities, only 36.4% preferred nurses compared to MDs, while for non-severe cases 53.2% preferred FP facilities and only 29.2% patronized nurses. For non-severe conditions, university educated were more likely to use MDs-led FP compared to nurse-led FP facilities (Odds Ratio [OR] = 4.66, 95% confidence interval [CI] = 2.62-8.30) and MD-led FP over MD-led NFP facilities (OR = 1.03, 95%CI= 1.01-1.04), for severe health conditions. Having insurance predicted MD-led FP preference over nurse-led FP. Furthermore, insurance predicted the preference for MDled FP over MD-led NFP facilities. Employment did not distinguish participants' choice of provider. Conclusion The findings suggest that, at different levels, MDs and nurses from FP and NFP facilities importantly contribute to health services delivery regardless of the severity of health conditions. The results offer some valuable evidence for policy orientation in the current rising tide of the private system, including workforce development, and practitioners' role definition. We suggested that health insurance mechanism would reinforce the private health services utilization and could enhance progress towards the attainment of Sustainable Development Goals.	[Beogo, Idrissa] Univ Laval, Ctr Rech Gest Serv Sante, FSA ULaval CHU Quebec UL IUCPQ UL, Pavillon Palasis Prince, Quebec City, PQ, Canada; [Beogo, Idrissa] Eole Natl Sante Publ Ouagadougou, Ouagadougou, Burkina Faso; [Darboe, Amadou] Univ Melbourne, Sch Populat & Global Hlth, Parkville, Vic, Australia; [Adesanya, Oluwafunmilade A.; Rojas, Bomar Mendez] Natl Yang Ming Univ, Inst Publ Hlth, Int Hlth Program, Taipei, Taiwan	Laval University; University of Melbourne; National Yang Ming Chiao Tung University	Beogo, I (corresponding author), Univ Laval, Ctr Rech Gest Serv Sante, FSA ULaval CHU Quebec UL IUCPQ UL, Pavillon Palasis Prince, Quebec City, PQ, Canada.; Beogo, I (corresponding author), Eole Natl Sante Publ Ouagadougou, Ouagadougou, Burkina Faso.	kone23ide@gmail.com	Darboe, Amadou/O-9830-2016	Darboe, Amadou/0000-0002-6213-5707; Beogo, Idrissa/0000-0003-1467-2169	National Yang Ming University	National Yang Ming University	National Yang Ming University provide a travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesanya AO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188281; Akhtar A, 2011, HLTH CARE REGULATION; [Anonymous], 2016, ANN STAT 2015; Arts EEA, 2012, J ADV NURS, V68, P1224, DOI 10.1111/j.1365-2648.2011.05797.x; Atwater A, 2008, DM-DIS MON, V54, P728, DOI 10.1016/j.disamonth.2008.08.002; Benkert R, 2008, J AM ACAD NURSE PRAC, V20, P273, DOI 10.1111/j.1745-7599.2008.00317.x; BENNETT S, 1992, HEALTH POLICY PLANN, V7, P97, DOI 10.1093/heapol/7.2.97; Beogo Idrissa, 2016, BMC Res Notes, V9, P34, DOI 10.1186/s13104-016-1846-4; Beogo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097521; Bodenheimer TS, 2013, HEALTH AFFAIR, V32, P1881, DOI 10.1377/hlthaff.2013.0234; Cipher DJ, 2006, J AM ACAD NURSE PRAC, V18, P291, DOI 10.1111/j.1745-7599.2006.00133.x; [Congress U. S Assessment OoT], 1986, HLTH TECHN CAS STUD, V37; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Dierick-van Daele ATM, 2009, J ADV NURS, V65, P391, DOI 10.1111/j.1365-2648.2008.04888.x; Druss BG, 2003, NEW ENGL J MED, V348, P130, DOI 10.1056/NEJMsa020993; Everett CM, 2009, J RURAL HEALTH, V25, P407, DOI 10.1111/j.1748-0361.2009.00252.x; Federman DG, 2005, AM J MANAG CARE, V11, P561; Fiedler JL, 2003, INT J HEALTH PLAN M, V18, P179, DOI 10.1002/hpm.709; Fleming V, 2006, BACKGROUND PAPER NUR; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; Ha N, 2011, HEALTH POLICY PLANN, V26, pi53, DOI 10.1093/heapol/czr028; Hall J. J., 2003, MED J AUSTRALIA, V178, P17; Hall P, 2005, J INTERPROFESSION S1, V19, P188, DOI DOI 10.1080/13561820500081745; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Howard DH, 2004, HEALTH SERV RES, V39, P2013, DOI 10.1111/j.1475-6773.2004.00330.x; KULYS R, 1987, Health and Social Work, V12, P101; Lutfiyya MN, 2016, J ADV NURS; Marsh G, 1995, BMJ, V310; Martin-Misener R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007167; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; Matteliano MA, 2012, J AM ACAD NURSE PRAC, V24, P425, DOI 10.1111/j.1745-7599.2012.00701.x; McMurray R, 2011, HUM RELAT, V64, P801, DOI 10.1177/0018726710387949; Ministere Sante A BF, 2010, SANT DAPR ENQ STAT N; Nyamtema AS, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-28; Olivier J, 2015, LANCET, V386, P1765, DOI 10.1016/S0140-6736(15)60251-3; Phillips RL, 2002, HEALTH AFFAIR, V21, P133, DOI 10.1377/hlthaff.21.5.133; Reese DJ, 2001, HEALTH SOC WORK, V26, P167, DOI 10.1093/hsw/26.3.167; Roblin DW, 2004, HEALTH SERV RES, V39, P607, DOI 10.1111/j.1475-6773.2004.00247.x; Roblin DW, 2004, MED CARE, V42, P579, DOI 10.1097/01.mlr.0000128005.27364.72; Running A, 2006, J AM ACAD NURSE PRAC, V18, P228, DOI 10.1111/j.1745-7599.2006.00120.x; Sambo LG, 2011, INT ARCH MED, V4, P1, DOI DOI 10.1186/1755-7682-4-1; Schmid B, 2008, CONTRIBUTION RELIG E; Shum C, 2000, BRIT MED J, V320, P1038, DOI 10.1136/bmj.320.7241.1038; Uys LR, 2000, GUIDELINES BASIC NUR; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; World bank, 2015, OUT POCK HLTH EXP; World Health Organization, 2005, STAK M NURS MID CONT; World Health Organization, 2011, 64 WORLD HLTH ASS RE; Yoong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013243	50	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200233	10.1371/journal.pone.0200233	http://dx.doi.org/10.1371/journal.pone.0200233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044796	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500034
J	Ferreira, RC; Ribeiro, MTD; Vargas-Ferreira, F; Sampaio, AA; Pereira, ACM; Vargas, AMD; de Jesus, RM; Ferreira, EFE				Ferreira, Raquel Conceicao; de Freitas Ribeiro, Marco Tulio; Vargas-Ferreira, Fabiana; Sampaio, Aline Araujo; Marinho Pereira, Ana Cristina; Duarte Vargas, Andrea Maria; de Jesus, Rafaella Mendes; Ferreira e Ferreira, Efigenia			Assistive technologies for improving the oral hygiene of leprosy patients residing in a former leprosy colony in Betim, Minas Gerais, Brazil	PLOS ONE			English	Article							DEVICES; HEALTH; NEED	Background This study deals with management of a group of elderly patients with a history of leprosy and hand deformities by a multidisciplinary team of dentists and occupational therapists. Assistive technology devices have been developed to allow such patients to obtain independence in oral self-care and can be a cost-effective approach to improving oral care in this population. The objective of this study was to describe the development of assistive devices to facilitate daily oral hygiene in older people with enduring leprosy-related impairments. Methodology Case study realized among elders with a history of leprosy residents in a former isolation colony in Betim, Minas Gerais, Brazil. The elders were evaluated for dependence on others for denture hygiene and mouthwash using the Daily Oral Hygiene Activity Index (ADOH). Those deemed partially or completely dependent on others were eligible for an intervention based on assistive technology. We adopted a personalized approach to each case, taking into account medical history, physical impairment and living environment. Six months after the intervention, the participants were assessed again using the ADOH and an unstructured interview about use of the devices. Principal findings Assistive devices for denture hygiene and mouthwash were developed for 16 elders. These devices facilitated oral hygiene in most patients and there was no worsening in any of the cases. Patients' report suggested they were satisfied with the devices provided. Conclusions This study demonstrated that assistive devices can facilitate oral hygiene activities in leprosy patients. It also reinforces the importance of using a multidisciplinary team for the rehabilitation of these patients.	[Ferreira, Raquel Conceicao; Vargas-Ferreira, Fabiana; Sampaio, Aline Araujo; Duarte Vargas, Andrea Maria; de Jesus, Rafaella Mendes; Ferreira e Ferreira, Efigenia] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil; [de Freitas Ribeiro, Marco Tulio; Marinho Pereira, Ana Cristina] Fundacao Hosp Estado Minas Gerais, Casa Sau Santa Isabel, Betim, Brazil	Universidade Federal de Minas Gerais	Vargas-Ferreira, F (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil.	fabivfer@yahoo.com.br	Ferreira, Efigenia/AAF-5226-2021; Ferreira, Raquel Conceição/J-5236-2015; De Freitas Ribeiro, Marco Túlio/AAF-9938-2020; Vargas-Ferreira, Fabiana/V-6274-2017	Ferreira, Efigenia/0000-0002-0665-211X; Ferreira, Raquel Conceição/0000-0001-8897-9345; Araujo Sampaio, Aline/0000-0002-8704-5994; Vargas-Ferreira, Fabiana/0000-0003-3567-4737	Minas Gerais State Research Foundation - FAPEMIG in Brazil [APQ 03462-14]; Minas Gerais State Research Foundation - FAPEMIG in Brazil (Programa Pesquisador Mineiro) [PPM 00686 - 16]	Minas Gerais State Research Foundation - FAPEMIG in Brazil; Minas Gerais State Research Foundation - FAPEMIG in Brazil (Programa Pesquisador Mineiro)	This study was supported by Minas Gerais State Research Foundation - FAPEMIG (http://www.fapemig.br) located in Brazil - (Award numbers - APQ 03462-14 and Programa Pesquisador Mineiro PPM 00686 - 16). Both of them were received by the author RCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P501; [Anonymous], 2015, Wkly Epidemiol Rec, V91, P405; Araújo Marcelo Grossi, 2003, Rev. Soc. Bras. Med. Trop., V36, P373, DOI 10.1590/S0037-86822003000300010; Bauer J G, 2001, Spec Care Dentist, V21, P63, DOI 10.1111/j.1754-4505.2001.tb00227.x; Boku N, 2010, LEPROSY REV, V81, P111; Borg J, 2009, LEPROSY REV, V80, P13; Carmona IT, 2003, ARCH GERONTOL GERIAT, V36, P49, DOI 10.1016/S0167-4943(02)00054-7; Chen TY, 2000, OCCUP THER J RES, V20, P179, DOI 10.1177/153944920002000303; Cheng SP, 2012, REHABIL NURS, V37, P88, DOI 10.1002/RNJ.00015; Almeida JRDS, 2013, CIENC SAUDE COLETIVA, V18, P817, DOI 10.1590/S1413-81232013000300027; Hartmann KD, 2010, WORK, V36, P399, DOI 10.3233/WOR-2010-1048; Hirota K, 2017, J APPL MICROBIOL, V122, P321, DOI 10.1111/jam.13330; Maia FB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004644; Matsumoto M. C., 2008, VERSAO BRASILEIRA IN, P98; Mojon Philippe, 2002, J Can Dent Assoc, V68, P340; Montandon Andreia A B, 2006, J Dent Educ, V70, P1261; Savassi LCM, 2014, QUAL LIFE RES, V23, P1345, DOI 10.1007/s11136-013-0590-7; Muniz LD, 2016, REV SOC BRAS MED TRO, V49, P644, DOI 10.1590/0037-8682-0097-2016; Orellano-Colon EM, 2016, J RACIAL ETHN HEALTH, V3, P676, DOI 10.1007/s40615-015-0186-8; Peek STM, 2014, INT J MED INFORM, V83, P235, DOI 10.1016/j.ijmedinf.2014.01.004; Phillips B, 1993, Assist Technol, V5, P36; Pinto DM, 2011, TEXTO CONTEXTO ENFER, V3, P493; Price V E, 1980, Dent Hyg (Chic), V54, P467; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Santos VS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003900; Scherer MJ, 2011, DISABIL REHABIL, V33, P811, DOI 10.3109/09638288.2010.511418; Shay K, 2002, CLIN INFECT DIS, V34, P1215, DOI 10.1086/339865; Silva AD, 2014, REV SOC BRAS MED TRO, V47, P212, DOI 10.1590/0037-8682-0012-2014; Silva EP, 2013, REV BRAS CIENC SAUDE, V17, P197; van Brakel WH, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18394; Verza R, 2006, MULT SCLER J, V12, P88, DOI 10.1191/1352458506ms1233oa; WASSON JH, 1990, J GEN INTERN MED, V5, P46, DOI 10.1007/BF02602309; White C, 2015, CLIN MICROBIOL REV, V28, P80, DOI 10.1128/CMR.00079-13; World Health Organisation, 2006, GLOB STRAT FURTH RED; World Health Organization, 2008, ENH GLOB STRAT FURTH; World Health Organization Regional Office for South-East Asia New Delhi, 2006, GLOB STRAT FURTH RED, V77, P1	36	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200503	10.1371/journal.pone.0200503	http://dx.doi.org/10.1371/journal.pone.0200503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044849	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500058
J	Jeon, HM; Lee, JY; Jeong, GM; Choi, SI				Jeon, Hong-Min; Lee, Je-Yeol; Jeong, Gu-Min; Choi, Sang-Il			Data reconstruction using iteratively reweighted L1-principal component analysis for an electronic nose system	PLOS ONE			English	Article							GAS SENSOR; FACE RECOGNITION; CLASSIFICATION; EIGENFACES; SELECTION; ARRAY; LDA	We propose a method to reconstruct damaged data based on statistical learning during data acquisition. In the process of measuring the data using a sensor, the damage of the data caused by the defect of the sensor or the environmental factor greatly degrades the performance of data classification. Instead of the traditional PCA based on L2-norm, the PCA features were extracted based on L1-norm and updated by iteratively reweighted fitting using the generalized objective function to obtain robust features for the outlier data. The damaged data samples were reconstructed using weighted linear combination using these features and the projection vectors of L1-norm based PCA. The experimental results on various types of volatile organic compounds (VOCs) data show that the proposed method can be used to reconstruct the damaged data to the original form of the undamaged data and to prevent degradation of classification performance due to data corruption through data reconstruction.	[Jeon, Hong-Min] Dankook Univ, Dept Data Sci, 152 Jukjeon Ro, Yongin 16890, Gyeonggi Do, South Korea; [Lee, Je-Yeol; Choi, Sang-Il] Dankook Univ, Dept Comp Sci & Engn, 152 Jukjeon Ro, Yongin 16890, Gyeonggi Do, South Korea; [Jeong, Gu-Min] Kookmin Univ, Elect Engn, 861-1 Jeongneung Dong, Seoul 02707, South Korea	Dankook University; Dankook University; Kookmin University	Choi, SI (corresponding author), Dankook Univ, Dept Comp Sci & Engn, 152 Jukjeon Ro, Yongin 16890, Gyeonggi Do, South Korea.	choisi@dankook.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2018R1A2B6001400]; Human Resources Program in Energy Technology of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy, Republic of Korea [20174030201740]	National Research Foundation of Korea (NRF) - Korea government (MSIT); Human Resources Program in Energy Technology of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy, Republic of Korea	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1A2B6001400) and was also supported by the Human Resources Program in Energy Technology of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry and Energy, Republic of Korea (20174030201740).	Ampuero S, 2003, SENSOR ACTUAT B-CHEM, V94, P1, DOI 10.1016/S0925-4005(03)00321-6; Barsan N, 2007, SENSOR ACTUAT B-CHEM, V121, P18, DOI 10.1016/j.snb.2006.09.047; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Cevikalp H, 2005, IEEE T PATTERN ANAL, V27, P4, DOI 10.1109/TPAMI.2005.9; Chen LF, 2000, PATTERN RECOGN, V33, P1713, DOI 10.1016/S0031-3203(99)00139-9; Choi SI, 2017, IEEE SENS J, V17, P5954, DOI 10.1109/JSEN.2017.2716967; Choi SI, 2014, SENSORS-BASEL, V14, P6938, DOI 10.3390/s140406938; Choi SI, 2010, SENSORS-BASEL, V10, P10387, DOI 10.3390/s101110387; Duda R. O., 1973, PATTERN CLASSIFICATI; Fonollosa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037809; Fukunaga K., 2013, INTRO STAT PATTERN R; GARDNER JW, 1994, SENSOR ACTUAT B-CHEM, V18, P211; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; Ha SC, 2005, SENSOR ACTUAT B-CHEM, V105, P549, DOI 10.1016/j.snb.2004.01.019; Janata J, 2003, NAT MATER, V2, P19, DOI 10.1038/nmat768; Kim C, 2007, PATTERN RECOGN, V40, P2958, DOI 10.1016/j.patcog.2007.02.008; Kim YS, 2005, SENSOR ACTUAT B-CHEM, V108, P285, DOI 10.1016/j.snb.2004.11.067; Kwak N, 2008, IEEE T PATTERN ANAL, V30, P1672, DOI 10.1109/TPAMI.2008.114; Li S., 2014, P SIAM INT C DATA MI, P163, DOI DOI 10.1137/1.9781611973440.19; Li S, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P989, DOI 10.1145/2983323.2983780; Li S, 2016, IEEE T NEUR NET LEAR, V27, P2160, DOI 10.1109/TNNLS.2015.2464090; Liu L., 2009, ENCY DATABASE SYSTEM, V6; Martinez A.M., 1998, CVC TECHNICAL REPORT; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Martnez A., 1998, 24 CVC; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vergara A, 2012, SENSOR ACTUAT B-CHEM, V166, P320, DOI 10.1016/j.snb.2012.01.074; Wang ZM, 2007, CIS WORKSHOPS 2007: INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY WORKSHOPS, P304, DOI 10.1109/CIS.Workshops.2007.33; WATSON J, 1984, SENSOR ACTUATOR, V5, P29, DOI 10.1016/0250-6874(84)87004-3; Yang YS, 2005, SENSOR ACTUAT B-CHEM, V106, P263, DOI 10.1016/j.snb.2004.08.008; Zhang Z. Q., 2016, IEEE T CYBERNETICS, V10, P1109, DOI DOI 10.1109/TIP.2016.2547180; Zuo WM, 2006, LECT NOTES COMPUT SC, V4261, P844	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200605	10.1371/journal.pone.0200605	http://dx.doi.org/10.1371/journal.pone.0200605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044840	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500063
J	Usman, MS; Hussein, MZ; Fakurazi, S; Masarudin, MJ; Saad, FFA				Usman, Muhammad Sani; Hussein, Mohd Zobir; Fakurazi, Sharida; Masarudin, Mas Jaffri; Saad, Fathinul Fikri Ahmad			A bimodal theranostic nanodelivery system based on [graphene oxide-chlorogenic acid-gadolinium/gold] nanoparticles	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TARGETED DELIVERY; CARRIER	We have synthesized a bimodal theranostic nanodelivery system (BIT) that is based on graphene oxide (GO) and composed of a natural chemotherapeutic agent, chlorogenic acid (CA) used as the anticancer agent, while gadolinium (Gd) and gold nanoparticles (AuNPs) were used as contrast agents for magnetic resonance imaging (MRI) modality. The CA and Gd guest agents were simultaneously loaded on the GO nanolayers using chemical interactions, such as hydrogen bonding and rr-rr non-covalent interactions to form GOGCA nano-composite. Subsequently, the AuNPs were doped on the surface of the GOGCA by means of electrostatic interactions, which resulted in the BIT. The physico-chemical studies of the BIT affirmed its successful development. The X-ray diffractograms (XRD) collected of the various stages of BIT synthesis showed the successive development of the hybrid system, while 90% of the chlorogenic acid was released in phosphate buffer solution (PBS) at pH 4.8. This was further reaffirmed by the in vitro evaluations, which showed stunted HepG2 cancer cells growth against the above 90% cell growth in the control cells. A reverse case was recorded for the 3T3 normal cells. Further, the acquired T1-weighted image of the BIT doped samples obtained from the MRI indicated contrast enhancement in comparison with the plain Gd and water references. The abovementioned results portray our BIT as a promising future chemotherapeutic for anticancer treatment with diagnostic modalities.	[Usman, Muhammad Sani; Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol ITMA, Mat Synth & Characterizat Lab, Serdang, Selangor, Malaysia; [Fakurazi, Sharida] Univ Putra Malaysia, Dept Human Anat, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Masarudin, Mas Jaffri] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [Saad, Fathinul Fikri Ahmad] Univ Putra Malaysia, Ctr Diagnost & Nucl Imaging, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Usman, MS; Hussein, MZ (corresponding author), Univ Putra Malaysia, Inst Adv Technol ITMA, Mat Synth & Characterizat Lab, Serdang, Selangor, Malaysia.	muhusma@gmail.com; mzobir@upm.edu.my	Saad, Fathinul Fikri Ahmad/C-4116-2014	Saad, Fathinul Fikri Ahmad/0000-0002-0499-7747; MASARUDIN, MAS JAFFRI/0000-0003-0695-2136; FAKURAZI, SHARIDA/0000-0001-8986-876X; USMAN, MUHAMMAD/0000-0002-3211-6310	Universiti Putra Malaysia (UPM) [5526300]; Ministry of Higher Education of Malaysia (MOHE) [5526300]	Universiti Putra Malaysia (UPM); Ministry of Higher Education of Malaysia (MOHE)	Universiti Putra Malaysia (UPM) and the Ministry of Higher Education of Malaysia (MOHE) provided the funds for the research under a NanoMITe grant Vot No. 5526300.	Akhavan O, 2014, RSC ADV, V4, P20441, DOI 10.1039/c4ra01550a; Balcioglu M, 2013, J MATER CHEM B, V1, P6187, DOI 10.1039/c3tb20992j; Baradaran S, 2014, CARBON, V69, P32, DOI 10.1016/j.carbon.2013.11.054; Barahuie F, 2017, MAT SCI ENG C-MATER, V74, P177, DOI 10.1016/j.msec.2016.11.114; Begum A, 2014, CHEM-EUR J, V20, P16657, DOI 10.1002/chem.201404461; Bullo S., 2015, INT J NANOMED, V10; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Dorniani D, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1712-2; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Ehrlich P., THE COLLECTED PAPERS; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Guo YQ, 2012, CARBON, V50, P2513, DOI 10.1016/j.carbon.2012.01.074; Hancock Y, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/47/473001; He H, 2011, BIOMATERIALS, V32, P478, DOI 10.1016/j.biomaterials.2010.09.002; Hedlund A, 2011, INT J NANOMED, V6, P3233, DOI 10.2147/IJN.S23940; Huang YS, 2017, J MAGN MAGN MATER, V427, P34, DOI 10.1016/j.jmmm.2016.10.042; Kim KS, 2014, BIOMATERIALS, V35, P337, DOI 10.1016/j.biomaterials.2013.10.004; Kolodynska D, 2016, NANOSCALE RES LETT, V11, P1, DOI 10.1186/s11671-016-1371-3; Kuila T, 2011, COMPOS PART A-APPL S, V42, P1856, DOI 10.1016/j.compositesa.2011.08.014; Kura AU, 2014, CHEM CENT J, V8; Le WJ, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040065; Lu YY, 2013, J SEP SCI, V36, P2210, DOI 10.1002/jssc.201300260; Luo K, 2010, J NANOSCI NANOTECHNO, V10, P540, DOI 10.1166/jnn.2010.1742; Muhulet A, 2018, FUNDAMENTALS SCOPES, V30, P154; Nasir S, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7070182; Nguyen Ngoc L., 2009, J PHYS C SER, V187; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ovid'ko IA, 2013, REV ADV MATER SCI, V34, P1; Rana VK, 2011, MACROMOL MATER ENG, V296, P131, DOI 10.1002/mame.201000307; Shen AJ, 2012, J BIOMED MATER RES A, V100A, P2499, DOI 10.1002/jbm.a.34148; Shen AJ, 2012, J BIOMED MAT RES A, V100; Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642; Sun X, 2008, NANO RES, V1; Tang LAL, 2012, SMALL, V8, P423, DOI 10.1002/smll.201101690; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Usman MS, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7090244; Usman MS, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0275-3; Verma S, 2011, CHEM COMMUN, V47, P12673, DOI 10.1039/c1cc15230k; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wang L, 2013, BIOMATERIALS, V34; Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c; Zhang BM, 2017, MAT SCI ENG C-MATER, V75, P198, DOI 10.1016/j.msec.2017.02.048; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200760	10.1371/journal.pone.0200760	http://dx.doi.org/10.1371/journal.pone.0200760			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044841	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500065
J	Watling, J; Shock, MP; Mongelo, GZ; Almeida, FO; Kater, T; De Oliveira, PE; Neves, EG				Watling, Jennifer; Shock, Myrtle P.; Mongelo, Guilherme Z.; Almeida, Fernando O.; Kater, Thiago; De Oliveira, Paulo E.; Neves, Eduardo G.			Direct archaeological evidence for Southwestern Amazonia as an early plant domestication and food production centre	PLOS ONE			English	Article							MANIOC MANIHOT-ESCULENTA; BALSAS RIVER VALLEY; STARCH GRAINS; PHYTOLITH EVIDENCE; PHASEOLUS-VULGARIS; NEW-WORLD; HOLOCENE; BASIN; MAIZE; SITES	Southwestern Amazonia is considered an early centre of plant domestication in the New World, but most of the evidence for this hypothesis comes from genetic data since systematic archaeological fieldwork in the area is recent. This paper provides first-hand archaeobotanical evidence of food production from early and middle Holocene (ca. 9,000-5000 cal. BP) deposits at Teotonio, an open-air site located on a 40 m-high bluff on the south bank of the Madeira river. Such evidence includes the presence of local and exotic domesticates such as manioc (Manihot esculenta), squash (Cucurbita sp.) and beans (Phaseolus sp.), alongside edible fruits such as pequia (Caryocar sp.) and guava (Psidium sp.) that point to the beginnings of landscape domestication. The results contribute to an ever-growing number of studies that posit southwest Amazonia as an important centre for early crop domestication and experimentation, and which highlight the longue-duree of human impacts on tropical forest biodiversity around the world.	[Watling, Jennifer; Mongelo, Guilherme Z.; Neves, Eduardo G.] Univ Sao Paulo, Museum Archaeol & Ethnol, Sao Paulo, Brazil; [Shock, Myrtle P.] Fed Univ Western Para, Inst Social Sci, Anthropol & Archaeol Program, Santarem, Para, Brazil; [Almeida, Fernando O.; Kater, Thiago] Univ Fed Sergipe, Dept Archaeol, Aracaju, Sergipe, Brazil; [De Oliveira, Paulo E.] Univ Sao Paulo, Inst Geosci, Sao Paulo, Brazil; [De Oliveira, Paulo E.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA	Universidade de Sao Paulo; Universidade Federal do Oeste do Para; Universidade Federal de Sergipe; Universidade de Sao Paulo; Field Museum of Natural History (Chicago)	Watling, J (corresponding author), Univ Sao Paulo, Museum Archaeol & Ethnol, Sao Paulo, Brazil.	jenny.g.watling@gmail.com	De Oliveira, Paulo E./B-4559-2017	De Oliveira, Paulo E./0000-0003-1040-4001; Watling, Jennifer/0000-0001-7897-5105; Kater, Thiago/0000-0003-4687-2210; Mongelo, Guilherme/0000-0002-2841-0007	Fundacao de Amparo a Pesquisa do Estado do Sao Paulo [2014/21207-5]	Fundacao de Amparo a Pesquisa do Estado do Sao Paulo	This research was supported by Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (Grant 2014/21207-5 to Dr. Jennifer Watling and Prof. Eduardo G. Neves); http://www.fapesp.br/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA Fernando Ozorio de, 2016, CERAMICA POLICROMA R, P402; Alves RP, 2016, ECON BOT, V70, P198, DOI 10.1007/s12231-016-9340-4; Alves-Pereira A, 2018, ANN BOT-LONDON, V121, P625, DOI 10.1093/aob/mcx190; Amos GL., 1952, BULL, V267; Arroyo-Kalin M., 2010, Diversity, V2, P473; Arroyo-Kalin M., 2016, OXFORD HDB HIST ECOL, P90; Babot M.P., 2003, TERRA AUSTRALIS, V19, P69; Brugger SO, 2016, QUATERNARY SCI REV, V132, P114, DOI 10.1016/j.quascirev.2015.11.001; Caldarelli S., 2017, ESPECIARIA CADERNOS, V17, P229; Castillo N, 2014, LAT AM ANTIQ, V17, P561; Chandler-Ezell K, 2006, ECON BOT, V60, P103, DOI 10.1663/0013-0001(2006)60[103:RATPAS]2.0.CO;2; Clement Charles Roland, 2016, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V11, P193, DOI 10.1590/1981.81222016000100010; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Clement CR, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P159, DOI 10.1007/1-4020-2597-1_9; Cohen MCL, 2014, PALAEOGEOGR PALAEOCL, V415, P37, DOI 10.1016/j.palaeo.2013.12.025; Collura LV, 2017, QUATERN INT, V434, P142, DOI 10.1016/j.quaint.2015.12.070; Crevels M, 2008, STUD LANG C, V90, P151; Crowther A, 2014, J ARCHAEOL SCI, V49, P90, DOI 10.1016/j.jas.2014.04.023; de Almeida FO, 2017, REV BRAS HIST, V37, P39, DOI 10.1590/1806-93472017v37n75-02a; de Almeida FO, 2013, THESIS; Dickau R, 2012, J ARCHAEOL SCI, V39, P357, DOI 10.1016/j.jas.2011.09.021; Dillehay TD, 2007, SCIENCE, V316, P1890, DOI 10.1126/science.1141395; Erickson C, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P455, DOI 10.1007/1-4020-2597-1_23; Falcao N. P. S., 2009, P213, DOI 10.1007/978-1-4020-9031-8_11; Fuller DQ, 2014, P NATL ACAD SCI USA, V111, P6147, DOI 10.1073/pnas.1308937110; German LA, 2003, GEODERMA, V111, P307, DOI 10.1016/S0016-7061(02)00270-7; Goulding M., 1979, ECOLOGIA PESCA RIO M; Hecht SB, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P355, DOI 10.1007/1-4020-2597-1_18; Henry AG, 2009, J ARCHAEOL SCI, V36, P915, DOI 10.1016/j.jas.2008.11.008; Hilbert L, 2017, NAT ECOL EVOL, V1, P1693, DOI 10.1038/s41559-017-0322-4; Iriarte J, 2009, CURR ANTHROPOL, V50, P677, DOI 10.1086/605493; Isendahl C, 2011, LAT AM ANTIQ, V22, P452, DOI 10.7183/1045-6635.22.4.452; Juggins S., 2010, C2 SOFTWARE VERSION; Junqueira, 2015, ANTHROPOGENIC SOILS; Junqueira AB, 2010, BIODIVERS CONSERV, V19, P1933, DOI 10.1007/s10531-010-9813-1; Kaplan L, 1999, ECON BOT, V53, P261, DOI 10.1007/BF02866636; Kater T., 2018, THESIS; Killion TW, 2013, CURR ANTHROPOL, V54, P569, DOI 10.1086/673140; Kwak M, 2009, CROP SCI, V49, P554, DOI 10.2135/cropsci2008.07.0421; Lathrap DW., 1977, ORIGINS AGR, P713, DOI [10.1515/9783110813487.713, DOI 10.1515/9783110813487.713]; Latrubesse EM, 2008, GEOMORPHOLOGY, V101, P130, DOI 10.1016/j.geomorph.2008.05.035; Lehmann J, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P105, DOI 10.1007/1-4020-2597-1_6; LIMA HC, 2015, LISTA ESPECIES FLORA; Lombardo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072746; Magalhaes MP, 2016, AMAZONIA ANTROPOGENI, P259; Major J, 2005, AGR ECOSYST ENVIRON, V111, P1, DOI 10.1016/j.agee.2005.04.019; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; McMichael CH, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00141; Miller, 1992, ARQUEOLOGIA NOS EMPR; Mongelo GZ., 2015, THESIS; Montanez SA, 2005, ARQUEOBOTANICA AMAZO; Mora S, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P205, DOI 10.1007/1-4020-2597-1_11; Mora S., 2003, U PITTSBURGH LATIN A, V3; Morcote-Rios G, 2001, BOT REV, V67, P309, DOI 10.1007/BF02858098; Morcote-Rios G, 2016, BOT J LINN SOC, V182, P348, DOI 10.1111/boj.12438; Motta-Aldana JR, 2010, CROP SCI, V50, P1773, DOI 10.2135/cropsci2009.12.0706; Oliver JR, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P185, DOI 10.1007/978-0-387-74907-5_12; Oliver JR, 2001, UNKNOWN AMAZON CULTU, P50; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Pagan-Jimenez JR, 2016, QUATERN INT, V404, P137, DOI 10.1016/j.quaint.2015.08.025; Pagan-Jimenez JR, 2015, QUATERNARY SCI REV, V123, P231, DOI 10.1016/j.quascirev.2015.07.005; Pagan-Jimenez JR., 2015, ALMIDONES GUIA MAT C, V1; Pearsall DeborahM., 2015, PALEOETHNOBOTANY HDB, V3rd ed; Perigolo NA, 2017, BRITTONIA, V69, P423, DOI 10.1007/s12228-017-9505-1; Perry L, 2002, INTERCIENCIA, V27, P635; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P46; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Piperno DR, 2008, P NATL ACAD SCI USA, V105, P19622, DOI 10.1073/pnas.0808752105; Piperno DR, 1998, J ARCHAEOL SCI, V25, P765, DOI 10.1006/jasc.1997.0258; Piperno DR, 2000, J ARCHAEOL SCI, V27, P193, DOI 10.1006/jasc.1999.0443; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Pugliese F.A., 2017, SIETE MARAVILLAS AMA, P27; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Roberts P, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.93; Roosevelt AC, 2013, ANTHROPOCENE, V4, P69, DOI 10.1016/j.ancene.2014.05.001; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Santos Muhlen G, 2013, TIPITI J SOC ANTHR L, V11, P66; Schmidt MJ, 2014, J ARCHAEOL SCI, V42, P152, DOI 10.1016/j.jas.2013.11.002; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Smith BD, 2001, J ARCHAEOL RES, V9, P1, DOI 10.1023/A:1009436110049; Tizuka MM., 2013, THESIS; Torrence R., 2006, ANCIENT STARCH RES; Vidotto Elaine, 2007, Acta Amaz., V37, P385, DOI 10.1590/S0044-59672007000300010; Watling J, 2015, J ARCHAEOL SCI-REP, V4, P541, DOI 10.1016/j.jasrep.2015.10.014; Watling J, 2013, QUATERN INT, V287, P162, DOI 10.1016/j.quaint.2012.10.030; Winklerprins A. M. G. A., 2009, P205, DOI 10.1007/978-1-4020-9031-8_10; Zimpel C.A., 2016, CERAMICAS ARQUEOLOGI, P420; Zizumbo-Villarreal D, 2010, GENET RESOUR CROP EV, V57, P813, DOI 10.1007/s10722-009-9521-4; Zuse S, 2014, THESIS	93	47	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199868	10.1371/journal.pone.0199868	http://dx.doi.org/10.1371/journal.pone.0199868			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044799	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500021
J	Patel, A; Patel, S; Gregg, R; O'Connor, L				Patel, Ajay; Patel, Sumaiya; Gregg, Rebecca; O'Connor, Laura			A qualitative analysis of the enforcement of the regulation of nutrition and health claims made for foods and its implications for health	PLOS ONE			English	Article							MARKET; POLICY	In common with local government organisations across the world, local authorities in the UK have responsibility for promoting health. A key part of this function is the frontline enforcement activities of officers responsible for compliance with health and nutrition claims. This study identifies attitudes, values and practices of enforcers: namely trading standards and environmental health officers, when faced with the problem of non-compliance with the Regulation. Semi-structured interviews with frontline enforcers from local authority regulatory services to investigate challenges with the enforcement of Regulation (EC) 1924/2006. Twenty participants were interviewed; sixteen were based in North West England and two in the North and two in the South of England. The participants were selected for their specialist knowledge and experience of enforcement of nutrition and health claims. Regulation (EC) No. 1924/2006 on nutrition and health claims presents particular challenges for enforcers seeking to apply an optimal strategy to flawed regulatory design. As with other regulations, when faced with non-compliance, enforcers, specifically trading standards and environmental health officers have a wide discretion to determine their response: ranging from the deterrent or accommodative styles of enforcement. The participants reported using advice rather than action and by doing so confronting their bifurcating identity of prosecutor and advisor. Enforcers used advice as a regulatory tool in enforcing the law relating to nutrition and health claims.	[Patel, Ajay; Patel, Sumaiya; Gregg, Rebecca; O'Connor, Laura] Manchester Metropolitan Univ, Dept Hlth Profess, Fac Hlth Psychol & Social Care, Cavendish Bldg, Manchester, Lancs, England	Manchester Metropolitan University	Patel, A (corresponding author), Manchester Metropolitan Univ, Dept Hlth Profess, Fac Hlth Psychol & Social Care, Cavendish Bldg, Manchester, Lancs, England.	a.k.patel@mmu.ac.uk	O'Connor, Laura/ABD-7999-2021	O'Connor, Laura/0000-0002-6022-2022; Patel, Ajay/0000-0001-5978-117X				AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Attride-Stirling J., 2001, QUAL RES, V1, P385, DOI [DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Ayres I, 1992, RESPONSIVE REGULATIO, P21; Baldwin R., 2012, UNDERSTANDING REGULA, V2nd ed.; BEESLEY ME, 1989, RAND J ECON, V20, P454, DOI 10.2307/2555582; Black J, 2010, LAW POLICY, V32, P181, DOI 10.1111/j.1467-9930.2010.00318.x; Boyatzis R., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Braithwaite J, 2002, J LAW SOC, V29, P12, DOI 10.1111/1467-6478.00209; Braithwaite J, 1987, LAW POLICY, V9, P323, DOI DOI 10.1111/J.1467-9930.1987.TB00414.X; BRDO, 2016, EXT SIMPL PRIM AUTH; Caraher M, 2004, PUBLIC HEALTH NUTR, V7, P591, DOI 10.1079/PHN2003575; Caswell J, 1998, AGR RESOURCE EC REV, V27; Caswell JA, 1996, AM J AGR ECON, V78, P1248, DOI 10.2307/1243501; Cranston R, 1979, REGULATING BUSINESS; Harrison M, 1997, T I BRIT GEOGR, V22, P473, DOI 10.1111/j.0020-2754.1997.00473.x; Hawkins K., 1993, LAW POLICY, V15, P199, DOI DOI 10.1111/J.1467-9930.1993.TB00103.X; Hawkins K., 2002, LAW LAST RESORT PROS; Healy J, 2006, MED J AUSTRALIA, V184, pS56; HELM D, 1994, OXFORD REV ECON POL, V10, P17, DOI 10.1093/oxrep/10.3.17; Helm D, 2006, OXFORD REV ECON POL, V22, P169, DOI 10.1093/oxrep/grj011; Hillary R, 1995, SMALL FIRMS ENV GROU; Hutter BM, 1997, COMPLIANCE REGULATIO; Law MT, 2006, J LAW ECON ORGAN, V22, P459, DOI 10.1093/jleo/ewj014; LEGRAND J, 1991, BRIT J POLIT SCI, V21, P423, DOI 10.1017/S0007123400006244; Patel A, 2012, TRENDS FOOD SCI TECH, V28, P15, DOI 10.1016/j.tifs.2012.06.006; Reiss A.J., 1984, ENFORCING REGULATION, P23; STIGLER GJ, 1961, J POLIT ECON, V69, P213, DOI 10.1086/258464; Tansey O, 2007, PS-POLIT SCI POLIT, V40, P765, DOI 10.1017/S1049096507071211; Yapp C, 2006, FOOD CONTROL, V17, P42, DOI 10.1016/j.foodcont.2004.08.007	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201178	10.1371/journal.pone.0201178	http://dx.doi.org/10.1371/journal.pone.0201178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040857	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000439749200030
J	Chapman, SN; Pettay, JE; Landenpera, M; Lummaa, V				Chapman, Simon N.; Pettay, Jenni E.; Landenpera, Mirkka; Lummaa, Virpi			Grandmotherhood across the demographic transition	PLOS ONE			English	Article							GRANDPARENTAL INVESTMENT; TIME ALLOCATION; EVOLUTION; SURVIVAL; FAMILY; MORTALITY; SELECTION; LONG; CHILDREN; FINLAND	Grandmothers provide key care to their grandchildren in both contemporary and historic human populations. The length of the grandmother-grandchild relationship provides a basis for such interactions, but its variation and determinants have rarely been studied in different contexts, despite changes in age-specific mortality and fertility rates likely having affected grandmotherhood patterns across the demographic transition. Understanding how often and long grandmothers have been available for their grandchildren in different conditions may help explain the large differences between grandmaternal effects found in different societies, and is vital for developing theories concerning the evolution of menopause, post-reproductive longevity, and family living. Using an extensive genealogical dataset from Finland spanning the demographic transition, we quantify the length of grandmotherhood and its determinants from 1790-1959. We found that shared time between grandmothers and grandchildren was consistently low before the demographic transition, only increasing greatly during the 20th century. Whilst reduced childhood mortality and increasing adult longevity had a role in this change, grandmaternal age at birth remained consistent across the study period. Our findings further understanding of the temporal context of grandmother-grandchild relationships, and emphasise the need to consider the demography of grandmotherhood in a number of disciplines, including biology (e.g. evolution of the family), sociology (e.g. changing family structures), population health (e.g. changing age structures), and economics (e.g. workforce retention).	[Chapman, Simon N.; Pettay, Jenni E.; Landenpera, Mirkka; Lummaa, Virpi] Univ Turku, Dept Biol, Turku, Finland	University of Turku	Chapman, SN (corresponding author), Univ Turku, Dept Biol, Turku, Finland.	sinich@utu.fi	Lummaa, Virpi/AHB-0181-2022	Lahdenpera, Mirkka/0000-0003-0062-6284; Chapman, Simon/0000-0003-2342-3383	Academy of Finland [292368]; Kone Foundation	Academy of Finland(Academy of Finland); Kone Foundation	This study was funded by the Academy of Finland (292368 VL, SNC, JEP; http://www.aka.fi/en) and the Kone Foundation (ML; https://koneensaatio.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpino B, 2014, EUR J POPUL, V30, P369, DOI 10.1007/s10680-014-9319-8; Beise J., 2002, DEMOGR RES, DOI [10.4054/DemRes.2002.7.13, DOI 10.4054/DEMRES.2002.7.13]; Beise J., 2005, GRANDMOTHERHOOD EVOL, P215; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Blustein J, 2004, HEALTH SERV RES, V39, P1671, DOI 10.1111/j.1475-6773.2004.00312.x; Bolund E, 2015, EVOLUTION, V69, P747, DOI 10.1111/evo.12598; Bove RB, 2002, HUM NATURE-INT BIOS, V13, P457, DOI 10.1007/s12110-002-1003-8; Chapman SN, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0651; Chapman Simon N., 2017, FINNISH YB POPULATIO, V52, P3, DOI [10.23979/fypr.65346, DOI 10.23979/FYPR.65346]; Coall DA, 2010, BEHAV BRAIN SCI, V33, P1, DOI 10.1017/S0140525X09991105; Crittenden AN, 2008, HUM NATURE-INT BIOS, V19, P249, DOI 10.1007/s12110-008-9043-3; Danielsbacka M, 2016, PERS RELATIONSHIP, V23, P787, DOI 10.1111/pere.12160; Di Gessa G, 2016, J GERONTOL B-PSYCHOL, V71, P867, DOI 10.1093/geronb/gbv055; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; European Commission, 2016, EUR SEM THEM FACTSH; Gille H, 1949, POP STUD-J DEMOG, V3, P3, DOI 10.2307/2172491; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hayward AD, 2016, P NATL ACAD SCI USA, V113, P8951, DOI 10.1073/pnas.1519820113; Hilbrand S, 2017, EVOL HUM BEHAV, V38, P397, DOI 10.1016/j.evolhumbehav.2016.11.010; Hjerppe R., 1989, FINNISH EC 1860; Holopainen J, 2009, HUM ECOL, V37, P213, DOI 10.1007/s10745-009-9225-6; Kim HJ, 2017, J FAM STUD, V23, P118, DOI 10.1080/13229400.2016.1194306; Kotavaara O, 2011, J INTERDISCIPL HIST, V42, P89, DOI 10.1162/JINH_a_00206; Kramer KL, 2005, EVOL ANTHROPOL, V14, P224, DOI 10.1002/evan.20082; Lahdenpera M, 2007, P ROY SOC B-BIOL SCI, V274, P2437, DOI 10.1098/rspb.2007.0688; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lahdenpera M, 2012, ECOL LETT, V15, P1283, DOI 10.1111/j.1461-0248.2012.01851.x; Leopold T, 2015, SOC FORCES, V94, P801, DOI 10.1093/sf/sov066; Leopold T, 2015, J MARRIAGE FAM, V77, P441, DOI 10.1111/jomf.12169; Liu JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029259; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Margolis R, 2017, DEMOGRAPHY, V54, P2073, DOI 10.1007/s13524-017-0620-0; Margolis R, 2016, J MARRIAGE FAM, V78, P610, DOI 10.1111/jomf.12286; Meehan CL, 2005, HUM NATURE-INT BIOS, V16, P58, DOI 10.1007/s12110-005-1007-2; Moring B, 1999, Hist Fam, V4, P159, DOI 10.1016/S1081-602X(99)00012-3; MORING B, 1993, J FAM HIST, V18, P395, DOI 10.1177/036319909301800407; Moring B, 1996, CONTINUITY CHANGE, V11, P91, DOI 10.1017/S0268416000003106; Nitsch A, 2014, BEHAV ECOL, V25, P424, DOI 10.1093/beheco/art126; Nitsch A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2313; Pavelka MSM, 2002, ANIM BEHAV, V64, P407, DOI 10.1006/anbe.2002.3085; PITKANEN KJ, 1993, EUR J POPUL, V9, P1, DOI 10.1007/BF01267899; R Development Core Team, 2009, R LANG ENV STAT COMP; Saarivirta T., 2012, INT J BUS SOC SCI, V3, P243, DOI [10.13039/501100002341, DOI 10.13039/501100002341]; Scranton K, 2016, ECOL LETT, V19, P854, DOI 10.1111/ele.12619; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2011, POPUL DEV REV, V37, P81, DOI 10.1111/j.1728-4457.2011.00379.x; Strassmann BI, 2011, P NATL ACAD SCI USA, V108, P10894, DOI 10.1073/pnas.1100306108; SUNDIN J, 1992, SOC SCI HIST, V16, P99, DOI 10.2307/1171323; Tanskanen AO, 2012, PERS INDIV DIFFER, V53, P985, DOI 10.1016/j.paid.2012.07.019; Therneau T., 2015, PACKAGE SURVIVAL ANA; Uhlenberg P, 1996, GERONTOLOGIST, V36, P681, DOI 10.1093/geront/36.5.681; Uhlenberg P., ANN REV GERONTOLOGY; United Nations Department of Economic and Social Affairs PD, 2015, STESASERA390 UN DEP; Voland E, 2002, BEHAV ECOL SOCIOBIOL, V52, P435, DOI 10.1007/s00265-002-0539-2	57	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200963	10.1371/journal.pone.0200963	http://dx.doi.org/10.1371/journal.pone.0200963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036378	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200022
J	Trivedi, MS; Oltra, E; Sarria, L; Rose, N; Beljanski, V; Fletcher, MA; Klimas, NG; Nathanson, L				Trivedi, Malay S.; Oltra, Elisa; Sarria, Leonor; Rose, Natasha; Beljanski, Vladimir; Fletcher, Mary Ann; Klimas, Nancy G.; Nathanson, Lubov			Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns	PLOS ONE			English	Article							RESEARCH CASE-DEFINITION; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; CYSTEINE UPTAKE; HYPOMETHYLATION; EPIGENETICS; PREVALENCE; DISCOVERY; SEQUENCES; CRITERIA	Background Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex condition involving multiple organ systems and characterized by persistent/relapsing debilitating fatigue, immune dysfunction, neurological problems, and other symptoms not curable for at least 6 months. Disruption of DNA methylation patterns has been tied to various immune and neurological diseases; however, its status in ME/CFS remains uncertain. Our study aimed at identifying changes in the DNA methylation patterns that associate with ME/CFS. Methods We extracted genomic DNA from peripheral blood mononuclear cells from 13 ME/CFS study subjects and 12 healthy controls and measured global DNA methylation by ELISA-like method and site-specific methylation status using Illumina MethylationEPIC microarrays. Pyrosequencing validation included 33 ME/CFS cases and 31 controls from two geographically distant cohorts. Results Global DNA methylation levels of ME/CFS cases were similar to those of controls. However, microarray-based approach allowed detection of 17,296 differentially methylated CpG sites in 6,368 genes across regulatory elements and within coding regions of genes. Analysis of DNA methylation in promoter regions revealed 307 differentially methylated promoters. Ingenuity pathway analysis indicated that genes associated with differentially methylated promoters participated in at least 15 different pathways mostly related to cell signaling with a strong immune component. Conclusions This is the first study that has explored genome-wide epigenetic changes associated with ME/CFS using the advanced Illumina MethylationEPIC microarrays covering about 850,000 CpG sites in two geographically distant cohorts of ME/CFS cases and matched controls. Our results are aligned with previous studies that indicate a dysregulation of the immune system in ME/CFS. They also suggest a potential role of epigenetic de-regulation in the pathobiology of ME/CFS. We propose screening of larger cohorts of ME/CFS cases to determine the external validity of these epigenetic changes in order to implement them as possible diagnostic markers in clinical setting.	[Trivedi, Malay S.; Rose, Natasha] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA; [Oltra, Elisa] Catholic Univ Valencia, Sch Med & Dent, Valencia, Spain; [Sarria, Leonor; Fletcher, Mary Ann; Klimas, Nancy G.; Nathanson, Lubov] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA; [Beljanski, Vladimir] Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Cell Therapy Inst, Ft Lauderdale, FL 33314 USA; [Fletcher, Mary Ann; Klimas, Nancy G.] Miami VAMC, Miami, FL USA	Nova Southeastern University; Universidad Catolica de Valencia San Vicente Martir; Nova Southeastern University; Nova Southeastern University	Nathanson, L (corresponding author), Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Inst Neuro Immune Med, Ft Lauderdale, FL 33314 USA.	lnathanson@nova.edu	Nathanson, Lubov/ABC-2642-2021; Oltra, Elisa/I-3642-2015	Oltra, Elisa/0000-0003-0598-2907; Nathanson, Lubov/0000-0003-1038-9083	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R15NS087604-01A1]; Presidential Faculty Research and Development Grant from Nova Southeastern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS087604] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Presidential Faculty Research and Development Grant from Nova Southeastern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the grant R15NS087604-01A1 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and by Presidential Faculty Research and Development Grant from Nova Southeastern University (both awarded to LN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola A, 2015, EUR J HUM GENET, V23, P1308, DOI 10.1038/ejhg.2015.26; An Y, 2017, J CELL MOL MED, V21, P185, DOI 10.1111/jcmm.12952; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Brenu EW, 2012, J AFFECT DISORDERS, V141, P261, DOI 10.1016/j.jad.2012.03.037; Brenu EW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-1; Brenu EW, 2014, J CLIN CELL IMMUNOL, V5, P228, DOI [10.4172/2155-9899.1000228, DOI 10.4172/2155-9899.1000228]; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Castelein H, 1997, BIOCHEM BIOPH RES CO, V233, P91, DOI 10.1006/bbrc.1997.6395; Chandler HK, 2008, DISABIL REHABIL, V30, P1185, DOI 10.1080/09638280701500109; Cheekatla SS, 2017, J IMMUNOL, V199, P2815, DOI 10.4049/jimmunol.1601231; Christopher MA, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0150-4; de Andrade DC, 2017, PAIN, V158, P1473, DOI 10.1097/j.pain.0000000000000932; de Vega WC, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0248-3; de Vega WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104757; Demitrack MA, 1997, J PSYCHIATR RES, V31, P69, DOI 10.1016/S0022-3956(96)00059-3; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Falkenberg VR, 2013, GENET EPIGENETICS, V5, P1, DOI 10.4137/GEG.S10944; Fluge O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129898; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Galicia JC, 2014, GENES IMMUN, V15, P333, DOI 10.1038/gene.2014.24; Gambuzza ME, 2015, CNS NEUROL DISORD-DR, V14, P903, DOI 10.2174/1871527314666150325235247; Hardie DL, 2011, IMMUNOLOGY, V133, P288, DOI 10.1111/j.1365-2567.2011.03437.x; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jason LA, 2017, FATIGUE, V5, P89, DOI 10.1080/21641846.2017.1299077; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lattie EG, 2013, FATIGUE, V1, P210, DOI 10.1080/21641846.2013.843255; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lee Y, 2015, J CLIN INVEST, V125, P4011, DOI 10.1172/JCI75933; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003; Mahurkar S, 2016, NEUROGASTROENT MOTIL, V28, P410, DOI 10.1111/nmo.12741; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ospelt C, 2017, SEMIN IMMUNOPATHOL, V39, P409, DOI 10.1007/s00281-017-0621-5; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; PATARCA R, 1994, CLIN INFECT DIS, V18, pS147, DOI 10.1093/clinids/18.Supplement_1.S147; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Rowe PC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00121; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P935, DOI 10.2214/ajr.162.4.8141020; SEMLER G, 1987, EUR ARCH PSY CLIN N, V236, P214, DOI 10.1007/BF00383851; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stepanov GA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/206849; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Trivedi MS, 2014, J NUTR BIOCHEM, V25, P1011, DOI 10.1016/j.jnutbio.2014.05.004; Vangeel E, 2015, PSYCHOSOM MED, V77, P853, DOI 10.1097/PSY.0000000000000224; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weil AF, 2013, P NATL ACAD SCI USA, V110, pE448, DOI 10.1073/pnas.1219702110; Zandi S, 2012, P NATL ACAD SCI USA, V109, P15871, DOI 10.1073/pnas.1210144109; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	68	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201066	10.1371/journal.pone.0201066	http://dx.doi.org/10.1371/journal.pone.0201066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036399	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200025
J	Barisnikov, K; Lejeune, F				Barisnikov, Koviljka; Lejeune, Fleur			Social knowledge and social reasoning abilities in a neurotypical population and in children with Down syndrome	PLOS ONE			English	Article							EXECUTIVE FUNCTION; EARLY-CHILDHOOD; COGNITION; AUTISM; ADULTS; SKILLS; MIND; ADOLESCENCE; BEHAVIOR; PRETERM	Social knowledge refers to the ability to analyze and reason about social situations in relation to social rules which are essential to the development of social skills and social behavior. The present research aimed to assess these abilities with the "Social resolution task" in a neurotypical population of 351 children (4 to 12 years) and 39 young adults, and in 20 participants (10 to 18 years) with Down syndrome. Results showed that young children aged 4 to 6 were well able to distinguish between appropriate and inappropriate social behavior but they had significantly more difficulties in judging and identifying social cues for the transgression of conventional rules than for moral ones. Between age 4 and 8, their social reasoning was mainly based on factual answers, while older children showed significantly more social awareness, making more reference to emotional and social consequences for the "victims". The representation of a more universal applicability of social rules seemed to develop later in childhood, as of age 8. In contrast, participants with Down syndrome exhibited significantly more difficulties in judging, identifying and reasoning about transgression of social rules without social awareness. In conclusion, the results have shown that social reasoning abilities develop throughout childhood. Social awareness seems to have a long developmental course, which includes a sensibility about welfare and intersubjectivity, critical for the development of prosocial behavior. The clinical population with difficulties in social interaction and socio-emotional behavior could benefit from an early assessment and from learning social reasoning abilities to improve social skills.	[Barisnikov, Koviljka; Lejeune, Fleur] Univ Geneva, Child Clin Neuropsychol Unit, FPSE, Geneva, Switzerland	University of Geneva	Barisnikov, K (corresponding author), Univ Geneva, Child Clin Neuropsychol Unit, FPSE, Geneva, Switzerland.	Koviljka.Barisnikov@unige.ch			Swiss National Science Foundation [100014-120657/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant No 100014-120657/1 from the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx) awarded to the first author, KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Baillargeon R, 2016, ANNU REV PSYCHOL, V67, P159, DOI 10.1146/annurev-psych-010213-115033; Barisnikov K, 2005, TA CHE RE SOLUTION S; Barisnikov K, 2012, BASIC EXECUTIVE FUNC, P372; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Bornstein MH, 2010, DEV PSYCHOPATHOL, V22, P717, DOI 10.1017/S0954579410000416; Cebula KR, 2010, J INTELL DISABIL RES, V54, P113, DOI 10.1111/j.1365-2788.2009.01215.x; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; COOK ET, 1994, J ABNORM CHILD PSYCH, V22, P205, DOI 10.1007/BF02167900; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Dunn L. M., 1993, PEABODY PICTURE VOCA; Fenning RM, 2011, CHILD DEV, V82, P717, DOI 10.1111/j.1467-8624.2010.01569.x; Fine SE, 2003, DEV PSYCHOPATHOL, V15, P331, DOI 10.1017/S095457940300018X; Fischi-Gomez E, 2015, CEREB CORTEX, V25, P2793, DOI 10.1093/cercor/bhu073; Freeman SFN, 2002, AM J MENT RETARD, V107, P16, DOI 10.1352/0895-8017(2002)107<0016:CAQOTP>2.0.CO;2; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Grant CM, 2005, AUTISM, V9, P317, DOI 10.1177/1362361305055418; Gunbey HP, 2017, EUR RADIOL, V27, P3013, DOI 10.1007/s00330-016-4626-6; Guralnick MJ, 2011, J APPL RES INTELLECT, V24, P310, DOI 10.1111/j.1468-3148.2010.00619.x; Guralnick MJ, 2009, AJIDD-AM J INTELLECT, V114, P340, DOI 10.1352/1944-7558-114.5.340; Helwig C. C., 2011, WILEY BLACKWELL HDB, P567; Hippolyte L, 2010, J INTELL DISABIL RES, V54, P714, DOI 10.1111/j.1365-2788.2010.01299.x; Houssa M., 2014, J ED TRAINING STUDIE, V2, P139; Houssa M, 2016, J PSYCHOL ABNORM S; Houssa M, 2016, J ED TRAIN STUD, V5, P110; Hughes C., 2011, SOCIAL UNDERSTANDING; Jambon M, 2017, CHILD DEV, P1; KASARI C, 1995, AM J MENT RETARD, V100, P128; Kasari C, 2003, J CHILD PSYCHOL PSYC, V44, P424, DOI 10.1111/1469-7610.00132; Lachavanne A, 2013, EUR REV APPL PSYCHOL, V63, P345, DOI 10.1016/j.erap.2013.09.002; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lejeune F, 2016, EARLY HUM DEV, V103, P49, DOI 10.1016/j.earlhumdev.2016.07.010; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Loveland KA, 2001, J AUTISM DEV DISORD, V31, P367, DOI 10.1023/A:1010608518060; Margoni F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01478; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Nucci L, 2001, ED MORAL DOMAIN, DOI DOI 10.1017/CBO9780511605987; Parker JG, 2006, DEV PSYCHOPATHOL, P419, DOI DOI 10.1002/9780470939383.CH12; Peterson CC, 2012, CHILD DEV, V83, P469, DOI 10.1111/j.1467-8624.2011.01728.x; Pujol J, 2015, CORTEX, V64, P148, DOI 10.1016/j.cortex.2014.10.012; Revermann M, 2017, CULT HISTOR, P1; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shulman C, 2012, J AUTISM DEV DISORD, V42, P1364, DOI 10.1007/s10803-011-1369-8; SMETANA JG, 1990, MERRILL PALMER QUART, V36, P329; SMETANA JG, 1985, DEV PSYCHOL, V21, P18, DOI 10.1037/0012-1649.21.1.18; Tanaka C, 2012, DEV NEUROSCI-BASEL, V34, P477, DOI 10.1159/000345152; Turiel E., 1998, HDB CHILD PSYCHOL, V3, P863, DOI DOI 10.1002/9780470147658.CHPSY0313; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Turiel E, 2008, COGNITIVE DEV, V23, P136, DOI 10.1016/j.cogdev.2007.04.001; van Gameren-Oosterom HBM, 2013, J PEDIATR-US, V163, P1396, DOI 10.1016/j.jpeds.2013.06.054; Wainryb CE., 2008, SOCIAL DEV SOCIAL IN; Wellman H. M, 1990, CHILDS THEORY MIND; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; White SF, 2017, COGN AFFECT BEHAV NE; Wishart JG, 2007, J INTELL DISABIL RES, V51, P996, DOI 10.1111/j.1365-2788.2007.01007.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126; Zalla T, 2011, COGNITION, V121, P115, DOI 10.1016/j.cognition.2011.06.004	61	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200932	10.1371/journal.pone.0200932	http://dx.doi.org/10.1371/journal.pone.0200932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028865	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900026
J	Mora, MA; Luyckx, K; Sparud-Lundin, C; Peeters, M; van Staa, A; Sattoe, J; Bratt, EL; Moons, P				Mora, Mariela Acuna; Luyckx, Koen; Sparud-Lundin, Carina; Peeters, Marielle; van Staa, AnneLoes; Sattoe, Jane; Bratt, Ewa-Lena; Moons, Philip			Patient empowerment in young persons with chronic conditions: Psychometric properties of the Gothenburg Young Persons Empowerment Scale (GYPES)	PLOS ONE			English	Article							QUESTIONNAIRE; INSTRUMENT; CONSTRUCT; VALIDITY; CRITERIA; DISEASE	Purpose Empowerment in patients can lead to a higher participation in care and self-management skills. However, there are a limited number of high-quality instruments to assess empowerment and its various dimensions in young persons. The aim was to develop and assess the psychometric properties of the Gothenburg Young Persons Empowerment Scale (GYPES). Methods The GYPES is a 15-item questionnaire designed to measure patient empowerment in young persons with chronic conditions. Three studies were conducted to evaluate the psychometric properties of the scale. Studies I and II assessed face, content and factorial validity, as well as responsiveness and reliability in young persons with congenital heart disease and diabetes. After these studies problematic items were identified and reworded and the final version of the GYPES was tested in young persons with diabetes in study III. Results The content and face validity of the scale was confirmed in study I. Confirmatory factor analyses (CFA) in study II supported the five-factor structure of the GYPES. However, one item had a low factor loading. The scale was revised and evaluated in study III. CFA of this version supported adequate model fit with factor loadings ranging from 0.385-0.941. A second-order model had an adequate fit to the data. Cronbach's alpha for the overall scale was 0.858 and for each subscale, alphas range from 0.609-0.858. Conclusions GYPES was developed to measure patient empowerment in young persons with chronic conditions. Preliminary evidence supports that the GYPES may be a valid and reliable tool for assessing young persons' empowerment.	[Mora, Mariela Acuna; Sparud-Lundin, Carina; Bratt, Ewa-Lena; Moons, Philip] Univ Gothenburg, Inst Hlth & Care Sci, Gothenburg, Sweden; [Mora, Mariela Acuna; Moons, Philip] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Luyckx, Koen] Katholieke Univ Leuven, Sch Psychol & Dev Context, Leuven, Belgium; [Peeters, Marielle; van Staa, AnneLoes; Sattoe, Jane] Rotterdam Univ Appl Sci, Res Ctr Innovat Care, Rotterdam, Netherlands; [Bratt, Ewa-Lena] Queen Silvia Childrens Hosp, Dept Pediat Cardiol, Gothenburg, Sweden; [Moons, Philip] Univ Cape Town, Dept Paediat & Child Hlth, Rondebosch, South Africa	University of Gothenburg; KU Leuven; KU Leuven; Queen Silvia Children's Hospital; University of Cape Town	Moons, P (corresponding author), Univ Gothenburg, Inst Hlth & Care Sci, Gothenburg, Sweden.; Moons, P (corresponding author), Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium.; Moons, P (corresponding author), Univ Cape Town, Dept Paediat & Child Hlth, Rondebosch, South Africa.	philip.moons@kuleuven.be	Bratt, Ewa-Lena/AAF-5068-2019; Mora, Mariela Acuña/N-9475-2016; Sattoe, Jane/AAI-3272-2020; Moons, Philip/AGJ-5080-2022; Acuna Mora, Mariela/HHC-1022-2022; Moons, Philip/AAR-5585-2020	Bratt, Ewa-Lena/0000-0003-4051-7031; Mora, Mariela Acuña/0000-0002-9326-6339; Sattoe, Jane/0000-0002-0433-5022; van Staa, AnneLoes/0000-0003-4496-3207; Moons, Philip/0000-0002-8609-4516	Swedish Heart-Lung Foundation [20150535]; Swedish Research Council for Health, Working Life and Welfare-FORTE [STYA-2015/0003]; Swedish Children Heart Association; Swedish Research Council-Vetenskapsradet [2015-02503]; Institute of Health and Care Sciences of the University of Gothenburg; FNO [101.325]; Diabetes Fund [2015.30.1852]	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council for Health, Working Life and Welfare-FORTE; Swedish Children Heart Association; Swedish Research Council-Vetenskapsradet(Swedish Research Council); Institute of Health and Care Sciences of the University of Gothenburg; FNO; Diabetes Fund	Study I and II were supported by research grants from the Swedish Heart-Lung Foundation (grant 20150535, https://www.hjart-lungfonden.se/, PM); Swedish Research Council for Health, Working Life and Welfare-FORTE (grant STYA-2015/0003, http://forte.se/, PM); Swedish Children Heart Association (http:/www.hjartebarn.se/, E-LB); Swedish Research Council-Vetenskapsradet (grant 2015-02503, https://www.vr.se/, PM); and the Institute of Health and Care Sciences of the University of Gothenburg (http://caresci.gu.se/, MAM). Study III was conducted in the context of the Dutch Better Transition in Diabetes project (AVS). We acknowledge the contribution of FNO (grant 101.325, https://www.fnozorgvoorkansen.nl/, AVS) and the Diabetes Fund (grant 2015.30.1852, https://www.diabetesfonds.nl/home). Petra and Karl Erik Hedborgs Foundation (MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739; [Anonymous], 2016, SWEDCON UPPS CLIN RE; Arvidsson S, 2012, MUSCULOSKELET CARE, V10, P101, DOI 10.1002/msc.1005; Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; Barr PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126553; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bravo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0907-z; Bulsara C, 2006, J PSYCHOSOC ONCOL, V24, P1, DOI 10.1300/J077v24n02_01; Castro EM, 2016, PATIENT EDUC COUNS, V99, P1923, DOI 10.1016/j.pec.2016.07.026; Cerezo PG, 2016, REV ESC ENFERM USP, V50, P664, DOI 10.1590/S0080-623420160000500018; Dillman DA, 1983, HDB SURV RES, P359; Entwistle VA, 2018, HEALTH CARE ANAL, V26, P48, DOI 10.1007/s10728-016-0335-1; Faulkner M, 2001, J ADV NURS, V34, P676, DOI 10.1046/j.1365-2648.2001.01797.x; Funnell M.M., 2004, CLIN DIABETES, V22, P123, DOI [10.2337/diaclin.22.3.123, DOI 10.2337/DIACLIN.22.3.123]; GIBSON CH, 1991, J ADV NURS, V16, P354, DOI 10.1111/j.1365-2648.1991.tb01660.x; GUYATT GH, 1989, J CLIN EPIDEMIOL, V42, P403, DOI 10.1016/0895-4356(89)90128-5; Herbert Rosemary J, 2009, Res Theory Nurs Pract, V23, P107; Hilton A, 2002, CANCER NURS, V25, P1, DOI 10.1097/00002820-200202000-00001; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Kim S C, 2001, Clin Nurs Res, V10, P314; Knapp TR, 1998, NURS RES, V47, P60, DOI 10.1097/00006199-199801000-00011; Lopez JE, 2010, AM J GERIAT PSYCHIAT, V18, P21, DOI 10.1097/JGP.0b013e3181b2090b; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Mora MA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014593; Nolte E., 2008, CARING PEOPLE CHRONI, P64; Osborne J.W., 2008, BEST PRACT QUANT MET, DOI DOI 10.4135/9781412995627.D18; Roach KE, 2006, J PROSTHET ORTHOT, P8, DOI DOI 10.1097/00008526-200601001-00003; Small N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-263; Svedberg P, 2007, J PSYCHIATR MENT HLT, V14, P566, DOI 10.1111/j.1365-2850.2007.01129.x; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; The American Educational Research Association The American Psychological Association & The National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; World Health Organization(WHO), 2012, HLTH 2020 POL FRAM S	35	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201007	10.1371/journal.pone.0201007	http://dx.doi.org/10.1371/journal.pone.0201007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028863	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900029
J	Peiravan, A; Bertolini, F; Rothschild, MF; Simpson, KW; Jergens, AE; Allenspach, K; Werling, D				Peiravan, Atiyeh; Bertolini, Francesca; Rothschild, Max F.; Simpson, Kenneth W.; Jergens, Albert E.; Allenspach, Karin; Werling, Dirk			Genome-wide association studies of inflammatory bowel disease in German shepherd dogs	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; POLYMERASE-CHAIN-REACTION; CROHNS-DISEASE; ULCERATIVE-COLITIS; T-CELLS; CHRONIC ENTEROPATHIES; DUODENAL MUCOSA; COLONIC-MUCOSA; HEALTHY DOGS; CYTOKINE	Canine Inflammatory Bowel Disease (IBD) is considered a multifactorial disease caused by complex interactions between the intestinal immune system, intestinal microbiota and environmental factors in genetically susceptible individuals. Although IBD can affect any breed, German shepherd dogs (GSD) in the UK are at increased risk of developing the disease. Based on previous evidence, the aim of the present study was to identify single nucleotide polymorphisms (SNPs), which may confer genetic susceptibility or resistance to IBD using a genome-wide association study (GWAS). Genomic DNA was extracted from EDTA blood or saliva samples of 96 cases and 98 controls. Genotyping of cases and controls was performed on the Canine lllumina HD SNP array and data generated was analyzed using PLINK. Several SNPs and regions on chromosomes 7,9,11 and 13 were detected to be associated with IBD using different SNP-by-SNP association methods and F-ST windows approach. Searching one Mb up-and down-stream of the most significant SNPs, as identified by single SNP analysis as well as 200Kb before and after the start and the end position of the associated regions identified by F-ST windows approach, we identified 63 genes. Using a combination of pathways analysis and a list of genes that have been reported to be involved in human IBD, we identified 16 candidate genes potentially associated with IBD in GSD.	[Peiravan, Atiyeh; Werling, Dirk] Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, England; [Bertolini, Francesca; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Jergens, Albert E.; Allenspach, Karin] Iowa State Univ, Coll Vet Med, Ames, IA USA	University of London; University of London Royal Veterinary College; Iowa State University; Cornell University; Iowa State University	Peiravan, A (corresponding author), Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, England.	apeiravan@rvc.ac.uk	bertolini, francesca/AAX-3836-2021; Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Bertolini, Francesca/0000-0003-4181-3895	BBSRC [BB/J01236X/1]; Laboklin GmBH; Bad Kissingen, GE	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Laboklin GmBH; Bad Kissingen, GE	We declare that the work described in this manuscript was funded through a BBSRC iCase PhD studentship stipend (BB/J01236X/1 to DW) and part-funded by Laboklin GmBH, Bad Kissingen, GE. Funding was also provided by the Ensminger fund, State of Iowa and Hatch funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahenspach K, 2006, J COMP PATHOL, V134, P1, DOI 10.1016/j.jcpa.2005.06.003; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2006, J VET INTERN MED, V20, P239, DOI 10.1892/0891-6640(2006)20[239:PACEOC]2.0.CO;2; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bhan AK, 1999, CURR OPIN GASTROEN, V15, P285, DOI 10.1097/00001574-199907000-00002; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; De Majo M, 2008, VET RES COMMUN, V32, pS275, DOI 10.1007/s11259-008-9127-x; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garside P, 1999, CLIN EXP IMMUNOL, V118, P337; German AJ, 2003, J VET INTERN MED, V17, P33, DOI 10.1111/j.1939-1676.2003.tb01321.x; German AJ, 2000, DIGEST DIS SCI, V45, P7, DOI 10.1023/A:1005436721798; Gunawardana SC, 1997, J AM VET MED ASSOC, V211, P318; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Iijima H, 1999, J EXP MED, V190, P607, DOI 10.1084/jem.190.5.607; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Jergens AE, 1996, AM J VET RES, V57, P697; Jergens AE, 1999, VET CLIN N AM-SMALL, V29, P501, DOI 10.1016/S0195-5616(99)50032-6; Jergens AE, 2009, COMPARATIVE MED, V59, P153; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Junginger J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-23; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kathrani A, 2014, VET IMMUNOL IMMUNOP, V161, P32, DOI 10.1016/j.vetimm.2014.06.003; Kathrani A, 2011, VET REC, V169, P635, DOI 10.1136/vr.d5380; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Kimmel SE, 2000, J AM VET MED ASSOC, V217, P703, DOI 10.2460/javma.2000.217.703; Luckschander N, 2006, J VET INTERN MED, V20, P221, DOI 10.1892/0891-6640(2006)20[221:PACAAR]2.0.CO;2; Maeda S, 2016, VET PATHOL, V53, P102, DOI 10.1177/0300985815591081; Mandigers PJJ, 2010, J VET INTERN MED, V24, P1350, DOI 10.1111/j.1939-1676.2010.0632.x; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; MULLIN GE, 1992, GASTROENTEROLOGY, V102, P1620, DOI 10.1016/0016-5085(92)91722-G; NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428; OGarra A., 1998, J IMMUNOL, V161, P547; Papadakis KA, 1999, GASTROENTEROL CLIN N, V28, P283, DOI 10.1016/S0889-8553(05)70057-1; Peiravan A, 2016, VET IMMUNOL IMMUNOP, V182, P101, DOI 10.1016/j.vetimm.2016.10.012; Peters IR, 2005, J VET INTERN MED, V19, P644, DOI 10.1892/0891-6640(2005)19[644:CMQIDM]2.0.CO;2; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; Plevy SE, 1997, J IMMUNOL, V159, P6276; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridyard AE, 2002, VET IMMUNOL IMMUNOP, V86, P205, DOI 10.1016/S0165-2427(02)00039-9; Roberts RL, 2012, J GASTROEN HEPATOL, V27, P1546, DOI 10.1111/j.1440-1746.2012.07220.x; Sandborn WJ, 2004, INFLAMM BOWEL DIS, V10, pS35, DOI 10.1097/00054725-200402001-00008; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Stonehewer J, 1998, RES VET SCI, V65, P59, DOI 10.1016/S0034-5288(98)90028-5; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Volkmann M, 2014, VET J, V202, P630, DOI 10.1016/j.tvjl.2014.10.012; Westermarck E, 2005, J VET INTERN MED, V19, P177, DOI 10.1892/0891-6640(2005)19&lt;177:TCDID&gt;2.0.CO;2; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	57	19	19	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200685	10.1371/journal.pone.0200685	http://dx.doi.org/10.1371/journal.pone.0200685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028859	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000439396900012
J	Radenkovic, S; Velickovic, N; Ssymank, A; Vidakovic, DO; Djan, M; Stahls, G; Veselic, S; Vujic, A				Radenkovic, Snezana; Velickovic, Nevena; Ssymank, Axel; Vidakovic, Dragana Obreht; Djan, Mihajla; Stahls, Gunilla; Veselic, Sanja; Vujic, Ante			Close relatives of Mediterranean endemorelict hoverflies (Diptera, Syrphidae) in South Africa: Morphological and molecular evidence in the Merodon melanocerus subgroup	PLOS ONE			English	Article							RUFICORNIS GROUP DIPTERA; MEIGEN; DIVERSITY; EVOLUTION; REVISION	An ongoing study of the genus Merodon Meigen, 1803 in the Republic of South Africa (RSA) has revealed the existence of new species related to M. melanocerus Bezzi, 1915. The M. melanocerus subgroup belongs to the Afrotropical lineage of the M. desuturinus group. Revision of all available material from museums and detailed analyses of newly -collected specimens from our own expeditions to RSA resulted in delimitation of five species: M. capensis Hurkmans sp. n., M. commutabilis Radenkovic et Vujic sp. n., M. drakonis Vujic et Radenkovic sp. n., M. flavocerus Hurkmans sp. n. and M. melanocerus. In addition to classical morphological characters, sequences of the mitochondrial COI gene are provided for four related taxa. Results of molecular phylogenetic analyses supports monophyly of the M. desuturinus group and confirmed delimitation between species. Links between Palaearctic and Afrotropical faunas of this group, as well as possible evolutionary paths, are discussed. Based on phylogenetic analyses, four lineages (putative subgenera) have been recognized within the genus Merodon; besides the three previously established ones, albifrons+desuturinus, aureus (sensu lato) and avidus-nigritarsis, one new lineage named natans is distinguished.	[Radenkovic, Snezana; Velickovic, Nevena; Vidakovic, Dragana Obreht; Djan, Mihajla; Veselic, Sanja; Vujic, Ante] Univ Novi Sad, Dept Biol & Ecol, Novi Sad, Serbia; [Ssymank, Axel] Bundesamt Nat Schutz, Bonn, Germany; [Stahls, Gunilla] Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland	University of Novi Sad; University of Helsinki	Velickovic, N (corresponding author), Univ Novi Sad, Dept Biol & Ecol, Novi Sad, Serbia.	nevena.velickovic@dbe.uns.ac.rs	Velickovic, Nevena/ABG-4787-2020; Vujic, Ante/AAG-2996-2020	Velickovic, Nevena/0000-0003-0797-269X; Djan, Mihajla/0000-0002-2427-0676; Radenkovic, Snezana/0000-0002-7805-9614; Vujic, Ante/0000-0002-8819-8079; Stahls, Gunilla/0000-0003-0505-0691	European Union [645636]; RSA SAEON network, a member of International Long-Term Ecological Research Network (ILTER); Ministry of Education, Science and Technological Development of the Republic of Serbia [OI173002, III43002]	European Union(European Commission); RSA SAEON network, a member of International Long-Term Ecological Research Network (ILTER); Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was funded by a project of the European Union: Horizon 2020, Marie Sklodowska-Curie action, Research and Innovation Staff Exchange (RISE) Programme: FlyHigh - Insect-plant relationships: insights into biodiversity and new applications (project number 645636, 2015-2018); and partially by the RSA SAEON network, a member of International Long-Term Ecological Research Network (ILTER) and Ministry of Education, Science and Technological Development of the Republic of Serbia (OI173002 to AV and III43002).	Andric A, 2014, ACTA ENT MUS NAT PRA, V54, P741; Marcos-Garcia MA, 2011, CAN ENTOMOL, V143, P332, DOI 10.4039/n11-013; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Doczkal D, 2009, SYST ENTOMOL, V34, P559, DOI 10.1111/j.1365-3113.2009.00478.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francuski L, 2011, J INSECT CONSERV, V15, P379, DOI 10.1007/s10841-010-9311-5; Francuski L, 2009, ZOOL SCI, V26, P301, DOI 10.2108/zsj.26.301; Gaston KJ, 2004, PHILOS T R SOC B, V359, P655, DOI 10.1098/rstb.2003.1442; Goloboff P. A, 1999, NONA COMPUTER PROGRA; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hijmans RJ, 2012, DIVA GIS VSN 7 5 GEO; Hippa H, 2005, MORPHOLOGICAL CHARAC; Hurkmans Willem, 1993, Tijdschrift voor Entomologie, V136, P147; Jordaens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140264; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Manning J., 2002, The color encyclopedia of Cape bulbs; Marcos-Garcia MA, 2007, EUR J ENTOMOL, V104, P531, DOI 10.14411/eje.2007.073; Martinez-Azorin M, 2011, ANN BOT-LONDON, V107, P1, DOI 10.1093/aob/mcq207; Mengual Ximo, 2006, Zootaxa, V1377, P1; Milankov V, 2008, J ZOOL SYST EVOL RES, V46, P143, DOI 10.1111/j.1439-0469.2007.00448.x; Milankov V, 2005, EUR J ENTOMOL, V102, P125, DOI 10.14411/eje.2005.020; Milankov V, 2008, EUR J ENTOMOL, V105, P197, DOI 10.14411/eje.2008.028; Nedeljkovic Z, 2015, CONTRIB ZOOL, V84, P285, DOI 10.1163/18759866-08404002; Nixon K.C., 2002, WINCLADA VERSION 1 0; Petanidou T, 2011, ANN SOC ENTOMOL FR, V47, P168, DOI 10.1080/00379271.2011.10697709; Pfosser MF, 2004, PLANT SYST EVOL, V246, P245, DOI 10.1007/s00606-004-0153-z; Preradovic J, 2018, ZOOTAXA, V4420, P229, DOI 10.11646/zootaxa.4420.2.5; R/gl F., 1998, ANN NATURHIST MUS A, V99A, P279, DOI DOI 10.2307/41702129; Radenkovic S, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2735.1.5; Rambaut A., 2014, TRACER V16; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ricarte A, 2008, ENTOMOL FENNICA, V19, P129, DOI 10.33338/ef.84424; Ricarte A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189852; Ricarte Antonio, 2012, Zootaxa, V3175, P1; Rotheray G. E., 2011, NATURAL HIST HOVERFL; Sasic L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160001; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stahls G, 2009, MOL ECOL RESOUR, V9, P1431, DOI 10.1111/j.1755-0998.2009.02592.x; Stahls G, 2008, ANN ZOOL FENN, V45, P149, DOI 10.5735/086.045.0206; Stahls G, 2016, ECOL EVOL, V6, P2226, DOI 10.1002/ece3.2021; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Thompson F. C., 1999, Contributions on Entomology, International, V3, P321; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vujic A., 1995, EKOLOGIYA, V30, P65; Vujic A, 2007, ANN SOC ENTOMOL FR, V43, P319, DOI 10.1080/00379271.2007.10697527; Vujic A, 2018, ZOOKEYS, P105, DOI 10.3897/zookeys.771.20481; Vujic A, 2015, ZOOTAXA, V4006, P439, DOI 10.11646/zootaxa.4006.3.2; Vujic A, 2013, ZOOTAXA, V3640, P442, DOI 10.11646/zootaxa.3640.3.7; Vujic A, 2012, SYST ENTOMOL, V37, P578, DOI 10.1111/j.1365-3113.2012.00631.x; Vujic A, 2011, ANN SOC ENTOMOL FR, V47, P78, DOI 10.1080/00379271.2011.10697699; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	54	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200805	10.1371/journal.pone.0200805	http://dx.doi.org/10.1371/journal.pone.0200805			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028840	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900015
J	Yu, ZH; Wang, X; Bien, HY; Jiao, L; Wu, WB; Dai, HQ				Yu, Zhihuai; Wang, Xiu; Bien, Huiyang; Jiao, Liang; Wu, Weibing; Dai, Hongqi			Enhancement of the heat conduction performance of boron nitride/cellulosic fibre insulating composites	PLOS ONE			English	Article							POLYMER NANOCOMPOSITES; THERMAL-CONDUCTIVITY; NITRIDE; FUNCTIONALIZATION; DEGRADATION; POLYIMIDE; FILMS	The continuous development of high electrical equipment towards high power output requires better heat dissipation performance of internal insulation structure. It challenges the traditional paper-based insulating materials, with poor thermal conductivity. Introducing thermally conductive and electrically insulating filler into cellulose-based insulating material can enhance heat conduction performance. This work provided a method to prepare thermally conductive and electrically insulating BN/cellulosic fibre composites. And the thermal conductivity of the composites was remarkably increased via grafting APTES and adding dual-sized fillers. The thermal conductivity of the composite reached 0.682 W/(m.k) that increased by 387% with h-BN loading of 41.08 wt%. Simultaneously, BN fillers improved the insulating properties of the resultant composites. The dielectric constant, breaking strength of and volume resistivity of the composites reached 4.75, 9.2 kV/mm(-1) and 4.72x10(14) Omega.m, respectively. The resultant insulating material which has better heat conduction property may have a vast potential for future development in electrical equipment.	[Yu, Zhihuai; Wang, Xiu; Bien, Huiyang; Jiao, Liang; Wu, Weibing; Dai, Hongqi] Nanjing Forestry Univ, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat F, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Dai, HQ (corresponding author), Nanjing Forestry Univ, Jiangsu Coinnovat Ctr Efficient Proc & Utilizat F, Nanjing, Jiangsu, Peoples R China.	hgdhq@njfu.edu.cn		Wu, Weibing/0000-0003-2786-9585	National Natural Science of China [31470599]; Priority Academic Program Development of Jiangsu Higher Education Institutions in China	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions in China	The authors were funded by National Natural Science of China (Project No.31470599) and the Priority Academic Program Development of Jiangsu Higher Education Institutions in China.r The authors were funded by National Natural Science of China (Project No.31470599) and the Priority Academic Program Development of Jiangsu Higher Education Institutions in China.	AGARI Y, 1991, J APPL POLYM SCI, V42, P1665, DOI 10.1002/app.1991.070420621; Chen J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604754; Chen L, 2017, PLOS ONE, V12; Chowdhury ZZ, 2014, BIORESOURCES, V9, P1787; Fofana I, 2010, ELECTR POW SYST RES, V80, P91, DOI 10.1016/j.epsr.2009.08.008; Han ZD, 2011, PROG POLYM SCI, V36, P914, DOI 10.1016/j.progpolymsci.2010.11.004; Hollertz R, 2015, IEEE T DIELECT EL IN, V22, P2339, DOI 10.1109/TDEI.2015.005017; Hollertz R, 2015, ADV FUNCTIONAL MAT, V22, P2339, DOI 10.1103/PhysRevE.86.011912; Hou J, 2014, RSC ADV, V4, P44282, DOI 10.1039/c4ra07394k; Huang M, 2015, J POLYM SCI B, V37, P2360; Huang XY, 2011, IEEE ELECTR INSUL M, V27, P8, DOI 10.1109/MEI.2011.5954064; Jin WQ, 2013, APPL SURF SCI, V270, P561, DOI 10.1016/j.apsusc.2013.01.086; Karim MZ, 2016, SCI ADV MATER, V8, P534, DOI 10.1166/sam.2016.2712; Kim K, 2014, POLYM ADVAN TECHNOL, V25, P791, DOI 10.1002/pat.3291; Kumari S, 2016, RSC ADV, V6, P21119, DOI 10.1039/c5ra28037k; Latini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105788; Li Q, 2015, NATURE, V523, P576, DOI 10.1038/nature14647; Li Qing, 2014, Science & Technology Review, V32, P51; Liao RJ, 2012, J APPL POLYM SCI, V126, pE290, DOI 10.1002/app.36891; Marconnett AM, 2011, ACS NANO, V5, P4818, DOI 10.1021/nn200847u; Moore AL, 2014, MATER TODAY, V17, P163, DOI 10.1016/j.mattod.2014.04.003; [秦丽丽 Qin Lili], 2013, [高分子材料科学与工程, Polymer Materials Science & Engineering], V29, P175; Sato K, 2010, J MATER CHEM, V20, P2749, DOI 10.1039/b924997d; Tang CC, 2006, J PHYS CHEM B, V110, P10354, DOI 10.1021/jp0607014; Thakur VK, 2012, POLYM CHEM-UK, V3, P962, DOI 10.1039/c2py00612j; Tsai MH, 2014, ACS APPL MATER INTER, V6, P8639, DOI 10.1021/am501323m; Verma P, 2004, J POLYM MATER, V21, P361; Wang FF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19394; Wroblewska-Krepsztul J, 2018, INT J POLYM ANAL CH, V23, P383, DOI 10.1080/1023666X.2018.1455382; Yung KC, 2007, J APPL POLYM SCI, V106, P3587, DOI 10.1002/app.27027; Zeng XL, 2013, J APPL POLYM SCI, V128, P1353, DOI 10.1002/app.38276; Zhou LH, 2016, ACS APPL MATER INTER, V8, P28838, DOI 10.1021/acsami.6b09471	32	16	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200842	10.1371/journal.pone.0200842	http://dx.doi.org/10.1371/journal.pone.0200842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024928	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000058
J	Gao, BM; Peng, C; Chen, Q; Zhang, JQ; Shi, Q				Gao, Bingmiao; Peng, Chao; Chen, Qin; Zhang, Junqing; Shi, Qiong			Mitochondrial genome sequencing of a vermivorous cone snail Conus quercinus supports the correlative analysis between phylogenetic relationships and dietary types of Conus species	PLOS ONE			English	Article							NEOGASTROPODA CONIDAE; HIGH-THROUGHPUT; VENOMICS REVEALS; DIVERSITY; EVOLUTION; REPLICATION; CONOTOXINS; GASTROPODA; ALIGNMENT; PEPTIDES	Complete mitochondrial genome (mitogenome) sequence of a worm-hunting cone snail, Conus quercinus, was reported in this study. Its mitogenome, the longest one (16,460 bp) among reported Conus specie, is composed of 13 protein-coding genes (PCGs), 22 transfer RNA (tRNA) genes, two ribosomal RNA (rRNA) genes and one D-loop region. The mitochondrial gene arrangement is highly-conserved and identical to other reported. However, the D-loop region of C. quercinus is the longest (943 bp) with the higher A+T content (71.3%) and a long AT tandem repeat stretch (68 bp). Subsequent phylogenetic analysis demonstrated that three different dietary types (vermivorous, molluscivorous and piscivorous) of cone snails are clustered separately, suggesting that the phylogenetics of cone snails is related to their dietary types. In conclusion, our current work improves our understanding of the mitogenomic structure and evolutionary status of the vermivorous C. quercinus, which support the putative hypothesis that the Conus ancestor was vermivorous.	[Gao, Bingmiao; Zhang, Junqing] Hainan Med Univ, Hainan Prov Key Lab Res & Dev Trop Med Plants, Haikou, Hainan, Peoples R China; [Peng, Chao; Shi, Qiong] BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom, Guangdong Prov Key Lab Mol Breeding Marine Econ A, BGI,BGI Marine, Shenzhen, Peoples R China; [Chen, Qin] Hainan Radio & TV Univ, Sch Agr & Forestry Sci & Technol, Haikou, Hainan, Peoples R China	Hainan Medical University; Beijing Genomics Institute (BGI)	Zhang, JQ (corresponding author), Hainan Med Univ, Hainan Prov Key Lab Res & Dev Trop Med Plants, Haikou, Hainan, Peoples R China.; Shi, Q (corresponding author), BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom, Guangdong Prov Key Lab Mol Breeding Marine Econ A, BGI,BGI Marine, Shenzhen, Peoples R China.	jqzhang2011@163.com; shiqiong@genomics.cn	Gao, Bingmiao/ABE-9834-2020	Gao, Bingmiao/0000-0003-1042-1768	Natural Science Foundation of Hainan Province [317170]; Shenzhen Dapeng Special Project for Industrial Development [PT20170302]; National Natural Science Foundation of China [81560611]	Natural Science Foundation of Hainan Province; Shenzhen Dapeng Special Project for Industrial Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of Hainan Province (No. 317170), Shenzhen Dapeng Special Project for Industrial Development (No. PT20170302), and National Natural Science Foundation of China (No. 81560611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, NUCLEIC ACIDS RES, V39, pD210, DOI 10.1093/nar/gkq1007; Aman JW, 2015, P NATL ACAD SCI USA, V112, P5087, DOI 10.1073/pnas.1424435112; Bandyopadhyay PK, 2008, MOL PHYLOGENET EVOL, V46, P215, DOI 10.1016/j.ympev.2007.08.002; Barghi N, 2016, MITOCHONDRIAL DNA A, V27, P4451, DOI 10.3109/19401736.2015.1089566; Barghi N, 2015, MAR BIOTECHNOL, V17, P81, DOI 10.1007/s10126-014-9595-7; Bouchet P, 2011, J MOLLUS STUD, V77, P273, DOI 10.1093/mollus/eyr017; Brauer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051528; Chen PW, 2016, MITOCHONDRIAL DNA B, V1, P493, DOI 10.1080/23802359.2016.1192502; Chen PW, 2016, MITOCHONDRIAL DNA B, V1, P520, DOI 10.1080/23802359.2016.1197060; Chen PW, 2016, MITOCHONDRIAL DNA A, V27, P2738, DOI 10.3109/19401736.2015.1046172; Cheng JK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-95; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Himaya SWA, 2015, J PROTEOME RES, V14, P4372, DOI 10.1021/acs.jproteome.5b00630; Jin AH, 2013, MOL CELL PROTEOMICS, V12, P3824, DOI 10.1074/mcp.M113.030353; Kumar PS, 2015, ASIAN PAC J TROP MED, V8, P337, DOI 10.1016/S1995-7645(14)60342-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavergne V, 2015, P NATL ACAD SCI USA, V112, pE3782, DOI 10.1073/pnas.1501334112; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Modica MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102160; Olivera BM, 2015, BRAIN BEHAV EVOLUT, V86, P58, DOI 10.1159/000438449; Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011; Peng C, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0122-9; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Phuong MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2755-6; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prashanth JR, 2016, MOL ECOL, V25, P598, DOI 10.1111/mec.13504; Prashanth JR, 2014, FUTURE MED CHEM, V6, P1659, DOI [10.4155/FMC.14.99, 10.4155/fmc.14.99]; Puillandre N, 2014, MOL PHYLOGENET EVOL, V78, P290, DOI 10.1016/j.ympev.2014.05.023; Remigio EA, 2008, MOL ECOL, V17, P1156, DOI 10.1111/j.1365-294X.2007.03627.x; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Safavi-Hemami H, 2016, P NATL ACAD SCI USA, V113, P3227, DOI 10.1073/pnas.1525790113; Sahyoun AH, 2014, MITOCHONDRION, V17, P56, DOI 10.1016/j.mito.2014.05.009; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Uribe JE, 2017, MOL PHYLOGENET EVOL, V107, P142, DOI 10.1016/j.ympev.2016.10.008; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xing Y, 2005, BIOINFORMATICS, V21, P3701, DOI 10.1093/bioinformatics/bti613	45	12	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0193053	10.1371/journal.pone.0193053	http://dx.doi.org/10.1371/journal.pone.0193053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059499	gold, Green Submitted, Green Published			2022-12-27	WOS:000440251600001
J	Luo, XD; Bhakta, T; Jakobsen, M; Naevdal, G				Luo, Xiaodong; Bhakta, Tuhin; Jakobsen, Morten; Naevdal, Geir			Efficient big data assimilation through sparse representation: A 3D benchmark case study in petroleum engineering	PLOS ONE			English	Article							PSEUDOPERIODIC TIME-SERIES; ENSEMBLE KALMAN FILTER; SEISMIC DATA; SATURATION CHANGES; COMPLEX NETWORK; FRAMEWORK; SMOOTHER; PRESSURE	Data assimilation is an important discipline in geosciences that aims to combine the information contents from both prior geophysical models and observational data (observations) to obtain improved model estimates. Ensemble-based methods are among the state-of-the-art assimilation algorithms in the data assimilation community. When applying ensemble-based methods to assimilate big geophysical data, substantial computational resources are needed in order to compute and/or store certain quantities (e.g., the Kalman-gain-type matrix), given both big model and data sizes. In addition, uncertainty quantification of observational data, e.g., in terms of estimating the observation error covariance matrix, also becomes computationally challenging, if not infeasible. To tackle the aforementioned challenges in the presence of big data, in a previous study, the authors proposed a wavelet-based sparse representation procedure for 2D seismic data assimilation problems (also known as history matching problems in petroleum engineering). In the current study, we extend the sparse representation procedure to 3D problems, as this is an important step towards real field case studies. To demonstrate the efficiency of the extended sparse representation procedure, we apply an ensemble-based seismic history matching framework with the extended sparse representation procedure to a 3D benchmark case, the Brugge field. In this benchmark case study, the total number of seismic data is in the order of O(10(6)). We show that the wavelet-based sparse representation procedure is extremely efficient in reducing the size of seismic data, while preserving the salient features of seismic data. Moreover, even with a substantial data-size reduction through sparse representation, the ensemble-based seismic history matching framework can still achieve good estimation accuracy.	[Luo, Xiaodong; Bhakta, Tuhin; Jakobsen, Morten; Naevdal, Geir] IRIS, Bergen, Norway; [Jakobsen, Morten] Univ Bergen, Bergen, Norway	University of Bergen	Luo, XD (corresponding author), IRIS, Bergen, Norway.	xiaodong.luo@iris.no	Naevdal, Geir/A-1551-2009; Luo, Xiaodong/G-5953-2011	Naevdal, Geir/0000-0003-2497-198X; Luo, Xiaodong/0000-0002-0734-862X	CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Eni [243680]; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Petrobras [243680]; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Total [243680]; Research Council of Norway (PETROMAKS); 4D seismic project (Research Council of Norway) - Research Council of Norway [230303]; ConocoPhillips Skandinavia AS; Aker BP ASA; Eni Norge AS; Maersk Oil Norway AS; Lundin Norway AS; Halliburton AS; DEA Norge AS; Neptune Energy Norge AS; Schlumberger Norge AS; Wintershall Norge AS of The National IOR Centre of Norway	CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Eni; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Petrobras; CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway) - Total; Research Council of Norway (PETROMAKS)(Research Council of Norway); 4D seismic project (Research Council of Norway) - Research Council of Norway(Research Council of Norway); ConocoPhillips Skandinavia AS; Aker BP ASA; Eni Norge AS; Maersk Oil Norway AS; Lundin Norway AS; Halliburton AS; DEA Norge AS; Neptune Energy Norge AS; Schlumberger Norge AS(Schlumberger); Wintershall Norge AS of The National IOR Centre of Norway	XL acknowledges partial financial supports from the CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway project number 243680), which is funded by industry partners, Eni (www.eni.com), Petrobras (www.petrobras.com), and Total (wvvw.total.com), as well as the Research Council of Norway (PETROMAKS) (ww.forskningsradet.no). All authors acknowledge financial supports from the 4D seismic project (Research Council of Norway project number 230303), which is supported by the Research Council of Norway and the industry partners-ConocoPhillips Skandinavia AS(www.conocophillips.no), Aker BP ASA, Eni Norge AS (www.eninorge.com), Maersk Oil Norway AS (www.maerskoil.com), Orsted AS (https://orsted.com/en/), EquiNor Petroleum AS (www.equinor.com), Lundin Norway AS (lundinnorway.no), Halliburton AS (wm.halliburton.no), DEA Norge AS (www.dea-norge.com), Neptune Energy Norge AS (www.neptuneenergy.com), Schlumberger Norge AS (www.slb.com), Wintershall Norge AS (www.wintershall.no)-of The National IOR Centre of Norway,. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Takemasa Miyoshi and two anonymous reviewers for their valuable comments on the work, and Schlumberger for providing us academic software licenses to ECLIPSE. XL acknowledges partial financial supports from the CIPR/IRIS cooperative research project "4D Seismic History Matching" (Research Council of Norway project number 243680), which is funded by industry partners, Eni (www.eni.com), Petrobras (www.petrobras.com), and Total (www.total.com), as well as the Research Council of Norway (PETROMAKS) (www.forskningsradet.no). All authors acknowledge financial supports from the 4D seismic project (Research Council of Norway project number 230303), which is supported by the Research Council of Norway and the industry partners-ConocoPhillips Skandinavia AS (www.conocophillips.no), Aker BP ASA, Eni Norge AS (www.ernnorge.com), Maersk Oil Norway AS (www.maerskoil.com), Orsted AS (https://orsted.com/en/), EquiNor Petroleum AS (www.equinor.com), Lundin Norway AS (lundin-norway.no), Halliburton AS (www.halliburton.no), DEA Norge AS (www.dea-norge.corn), Neptune Energy Norge AS (www.neptuneenergy.com), Schlumberger Norge AS (www.slb.com), Wintershall Norge AS (www.wintershall.no)-of The National IOR Centre of Norway,. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanonsen S, 2003, SPE RES SIM S SOC PE; Aanonsen SI, 2009, SPE J, V14, P393, DOI 10.2118/117274-PA; [Anonymous], 72 EAGE C EXH; [Anonymous], 2013, SPE RES SIM S SOC PE; [Anonymous], 2013, SPE RES SIM S SOC PE; Avseth P., 2010, QUANTITATIVE SEISMIC; Awotunde AA, 2014, COMPUTAT GEOSCI, V18, P677, DOI 10.1007/s10596-014-9414-2; Bhakta T, 2014, GEOPHYSICS, V79, pM35, DOI 10.1190/GEO2013-0434.1; Buland A, 2003, GEOPHYSICS, V68, P185, DOI 10.1190/1.1543206; Chen Y, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011144; Chen Y, 2010, COMPUTAT GEOSCI, V14, P579, DOI 10.1007/s10596-009-9174-6; Dadashpour M, 2008, J GEOPHYS ENG, V5, P54, DOI 10.1088/1742-2132/5/1/006; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Elsheikh AH, 2013, ADV WATER RESOUR, V56, P14, DOI 10.1016/j.advwatres.2013.02.002; Emerick A, 2011, COMPUTAT GEOSCI, V15, P251, DOI 10.1007/s10596-010-9198-y; Emerick AA, 2016, J PETROL SCI ENG, V139, P219, DOI 10.1016/j.petrol.2016.01.029; Emerick AA, 2012, COMPUTAT GEOSCI, V16, P639, DOI 10.1007/s10596-012-9275-5; Engl H. W., 2000, REGULARIZATION INVER; Evensen G, 2000, MON WEATHER REV, V128, P1852, DOI 10.1175/1520-0493(2000)128<1852:AEKSFN>2.0.CO;2; EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572; Evensen G., 2009, DATA ASSIMILATION EN; Evensen G.J.O.d., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gassmann F., 1951, VIERTEL NAT GES ZURI, V96, P1; Gentilhomme T, 2015, COMPUTAT GEOSCI, V19, P999, DOI 10.1007/s10596-015-9517-4; George AK, 2008, I S BIOMED IMAGING, P1489, DOI 10.1109/ISBI.2008.4541290; Gorszczyk A, 2015, GEOPHYS PROSPECT, V63, P903, DOI 10.1111/1365-2478.12234; Houtekamer PL, 2016, MON WEATHER REV, V144, P4489, DOI 10.1175/MWR-D-15-0440.1; Jack I., 2001, 1 BREAK, V19, P24; Jafarpour B, 2010, MATH GEOSCI, V42, P1, DOI 10.1007/s11004-009-9247-z; Jansen M., 2012, NOISE REDUCTION WAVE, V161; Jazwinski A.H., 2007, STOCHASTIC PROCESSES, P93; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Katterbauer K, 2017, GEOPHYS PROSPECT, V65, P337, DOI 10.1111/1365-2478.12371; Katterbauer K, 2015, SPE J, V20, P923, DOI 10.2118/173896-PA; Katterbauer K, 2015, J PETROL SCI ENG, V128, P160, DOI 10.1016/j.petrol.2015.02.016; Khaninezhad MM, 2014, COMPUTAT GEOSCI, V18, P3, DOI 10.1007/s10596-013-9378-7; Landro M, 2001, GEOPHYSICS, V66, P836, DOI 10.1190/1.1444973; Leeuwenburgh O, 2014, COMPUTAT GEOSCI, V18, P535, DOI 10.1007/s10596-014-9434-y; Luo X, 2016, SPE J; Luo XD, 2017, COMPUTAT GEOSCI, V21, P205, DOI 10.1007/s10596-016-9605-0; Luo XD, 2015, SPE J, V20, P962, DOI 10.2118/176023-PA; Mallat S., 2008, WAVELET TOUR SIGNAL; Mavko G., 2009, ROCK PHYS HDB TOOLS, DOI 10.1192/bjp.182.2.123; MINDLIN RD, 1949, J APPL MECH-T ASME, V16, P259; Miyoshi T, 2016, P IEEE, V104, P2155, DOI 10.1109/JPROC.2016.2602560; Miyoshi T, 2016, B AM METEOROL SOC, V97, P1347, DOI 10.1175/BAMS-D-15-00144.1; Naevdal G, 2002, SPE DOE IMPROVED OIL, P13; NUR A, 1991, SHEAR WAVES IN MARINE SEDIMENTS, P131; Nur A., 1998, LEAD EDGE, V17, P357, DOI [DOI 10.1190/1.1437977, 10.1190/1.1437977]; Pan M, 2008, REMOTE SENS ENVIRON, V112, P1282, DOI 10.1016/j.rse.2007.02.039; Peters E, 2010, SPE RESERV EVAL ENG, V13, P391, DOI 10.2118/119094-PA; Rehman MHU, 2016, INT J INFORM MANAGE, V36, P917, DOI 10.1016/j.ijinfomgt.2016.05.013; Reichle RH, 2002, MON WEATHER REV, V130, P103, DOI 10.1175/1520-0493(2002)130<0103:HDAWTE>2.0.CO;2; Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104; Sahni I, 2005, SPE RESERV EVAL ENG, V8, P53, DOI 10.2118/87820-PA; Sana F, 2016, IEEE J-STARS, V9, P2242, DOI 10.1109/JSTARS.2016.2563163; Shi L, 2016, SCI REPORTS, V6; Skjervheim JA, 2007, SPE J, V12, P282, DOI 10.2118/95789-PA; SPANIAS AS, 1991, IEEE T GEOSCI REMOTE, V29, P407, DOI 10.1109/36.79431; Stai E, 2016, IEEE NETWORK, V30, P11, DOI 10.1109/MNET.2016.7389825; Starck JL, 2009, ASTRON ASTROPHYS, V504, P641, DOI 10.1051/0004-6361/200811388; Sweldens W, 1998, SIAM J MATH ANAL, V29, P511, DOI 10.1137/S0036141095289051; Talagrand O, 1997, J METEOROL SOC JPN, V75, P191, DOI 10.2151/jmsj1965.75.1B_191; Trani M, 2013, SPE J, V18, P159, DOI 10.2118/163043-PA; vanLeeuwen PJ, 1996, MON WEATHER REV, V124, P2898, DOI 10.1175/1520-0493(1996)124<2898:DAAIMI>2.0.CO;2; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008	71	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0198586	10.1371/journal.pone.0198586	http://dx.doi.org/10.1371/journal.pone.0198586			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052628	Green Submitted, Green Published, gold			2022-12-27	WOS:000440006600003
J	Abaraogu, U; Ezenwankwo, E; Dall, P; Tew, G; Stuart, W; Brittenden, J; Seenan, C				Abaraogu, Ukachukwu; Ezenwankwo, Elochukwu; Dall, Philippa; Tew, Garry; Stuart, Wesley; Brittenden, Julie; Seenan, Chris			Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program	PLOS ONE			English	Review							PERIPHERAL ARTERIAL-DISEASE; HOME-BASED EXERCISE; PHYSICAL-ACTIVITY BEHAVIOR; SOCIAL COGNITIVE THEORY; SUPERVISED EXERCISE; RISK-FACTORS; THERAPY; INTERVENTION; EXPERIENCES; BELIEFS	Background Walking limitation in patients with peripheral arterial disease (PAD) and intermittent claudication (IC) contributes to poorer disease outcomes. Identifying and examining barriers to walking may be an important step in developing a comprehensive patient-centered self-management intervention to promote walking in this population. Aim To systematically review the literature regarding barriers and enablers to walking exercise in individuals with IC. Methods A systematic review was conducted utilizing integrative review methodology. Five electronic databases and the reference lists of relevant studies were searched. Findings were categorized into personal, walking activity related, and environmental barriers and enablers using a social cognitive framework. Results Eighteen studies including quantitative (n = 12), qualitative (n = 5), and mixed method (n = 1) designs, and reporting data from a total of 4376 patients with IC, were included in the review. The most frequently reported barriers to engaging in walking were comorbid health concerns, walking induced pain, lack of knowledge (e.g. about the disease pathology and walking recommendations), and poor walking capacity. The most frequently reported enablers were cognitive coping strategies, good support systems, and receiving specific instructions to walk.Findings suggest additionally that wider behavioral and environmental obstacles should be addressed in a patient-centeredself-management intervention. Conclusions This review has identified multidimensional factors influencing walking in patients with IC. Within the social cognitive framework, these factors fall within patient level factors (e.g. comorbid health concerns), walking related factors (e.g. claudication pain), and environmental factors (e.g. support systems). These factors are worth considering when developing self-management interventions to increase walking in patients with IC.	[Abaraogu, Ukachukwu; Ezenwankwo, Elochukwu] Univ Nigeria, Dept Med Rehabil, Enugu, Nigeria; [Abaraogu, Ukachukwu; Dall, Philippa; Seenan, Chris] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Tew, Garry] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle, England; [Stuart, Wesley] Vasc Surg NHS Greater Glasgow & Clyde Hlth Board, Glasgow, Lanark, Scotland; [Brittenden, Julie] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Nigeria; Glasgow Caledonian University; Northumbria University; University of Glasgow	Abaraogu, U (corresponding author), Univ Nigeria, Dept Med Rehabil, Enugu, Nigeria.; Abaraogu, U (corresponding author), Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland.	ukachukwu.abara.gu@unn.edu.ng	Abaraogu, Ukachukwu/N-2082-2019; Seenan, Chris/G-9215-2019; Ezenwankwo, Elochukwu Fortune/AAZ-5135-2020; Abaraogu, Ukachukwu O/N-8174-2015	Abaraogu, Ukachukwu/0000-0002-1967-1459; Seenan, Chris/0000-0003-4379-7913; Ezenwankwo, Elochukwu Fortune/0000-0001-8483-9302; Tew, Garry/0000-0002-8610-0613; Dall, Philippa/0000-0002-1958-1517	University of Nigeria through the TETFUND	University of Nigeria through the TETFUND	UA received funding for his PhD from the University of Nigeria through the TETFUND, of which this forms part. However University of Nigeria or TETFUND do not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraogu UO, 2017, EUR J VASC ENDOVASC, V54, P58, DOI 10.1016/j.ejvs.2017.04.003; Aherne TM, 2017, VASA, V46, P219, DOI 10.1024/0301-1526/a000612; Al-Jundi W, 2013, EUR J VASC ENDOVASC, V46, P690, DOI 10.1016/j.ejvs.2013.09.004; Askew CD, 2014, J SCI MED SPORT, V17, P623, DOI 10.1016/j.jsams.2013.10.251; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Barbosa JP, 2015, INT J BEHAV MED, V22, P70, DOI 10.1007/s12529-014-9408-4; Bartelink ML, 2004, BRIT J GEN PRACT, V54, P196; Bentley AJ, 2018, J GERONTOL NURS, V44, P43, DOI 10.3928/00989134-20170908-01; Berard AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0037882; Bloemenkamp DGM, 2002, AM J MED, V113, P462, DOI 10.1016/S0002-9343(02)01258-5; Broome M., 2000, CONCEPT DEV NURSING, V231, P250; Cavalcante BR, 2015, ARCH PHYS MED REHAB, V96, P248, DOI 10.1016/j.apmr.2014.09.009; Cheetham DR, 2004, EUR J VASC ENDOVASC, V27, P17, DOI 10.1016/j.ejvs.2003.09.012; Collins TC, 2011, DIABETES CARE, V34, P2174, DOI 10.2337/dc10-2399; Cornelis N, 2018, VASA, V47, P109, DOI 10.1024/0301-1526/a000654; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Critical Appraisal Skills Programme (CASP), 2014, CASP CHECKL; Cunningham MA, 2012, BRIT J SURG, V99, P49, DOI 10.1002/bjs.7714; Dorenkamp S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146828; Egberg L, 2012, J VASC NURS, V30, P5, DOI 10.1016/j.jvn.2011.11.001; Farah BQ, 2013, CLINICS, V68, P537, DOI 10.6061/clinics/2013(04)16; Galea MN, 2008, J AGING PHYS ACTIV, V16, P69, DOI 10.1123/japa.16.1.69; Galea MN, 2007, J CARDIOPULM REHABIL, V27, P107; Gallanagh Siobhan, 2011, ISRN Neurol, V2011, P953818, DOI 10.5402/2011/953818; Gardner AW, 2008, J VASC SURG, V47, P117, DOI 10.1016/j.jvs.2007.09.033; Gardner AW, 2016, INT J VASC MED, V2016, DOI 10.1155/2016/2191350; Gardner AW, 2015, VASC MED, V20, P424, DOI 10.1177/1358863X15596237; Gardner AW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001107; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; Garg PK, 2006, CIRCULATION, V114, P242, DOI 10.1161/CIRCULATIONAHA.105.605246; Gorely T, 2015, J VASC NURS, V33, P4, DOI 10.1016/j.jvn.2014.12.001; Hamburg NM, 2017, CIRC J, V81, P281, DOI 10.1253/circj.CJ-16-1286; Harwood AE, 2017, J VASC NURS, V35, P131, DOI 10.1016/j.jvn.2017.03.001; Holmes MNG, 2017, J HEALTH PSYCHOL, V22, P255, DOI 10.1177/1359105315600238; Iso Y, 2015, E J CARDIOL PRACT, V13; Kruidenier LM, 2009, EUR J VASC ENDOVASC, V38, P449, DOI 10.1016/j.ejvs.2009.04.020; Lauret GJ, 2012, EUR J VASC ENDOVASC, V43, P308, DOI 10.1016/j.ejvs.2011.12.013; Layden J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4947; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Li YH, 2015, ANN VASC SURG, V29, DOI 10.1016/j.avsg.2014.10.010; Maillet A, 2017, ANGIOLOGY, V68, P893, DOI 10.1177/0003319717699501; Makris GC, 2012, EUR J VASC ENDOVASC, V44, P569, DOI 10.1016/j.ejvs.2012.09.009; Mays Ryan J, 2013, Curr Treat Options Cardiovasc Med, V15, P188, DOI 10.1007/s11936-013-0231-z; McDermott MM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001659; McDermott MM, 2015, CIRC RES, V116, P1540, DOI 10.1161/CIRCRESAHA.114.303517; Melnyk BM., 2011, EVIDENCE BASED PRACT; Meneses AL, 2011, J VASC NURS, V29, P81, DOI 10.1016/j.jvn.2011.01.002; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; National Institute for Health and Clinical Excellence, 2012, PER ART DIS DIAGN MA; O'Donnell M E, 2011, Ulster Med J, V80, P33; Parmenter BJ, 2015, VASC MED, V20, P30, DOI 10.1177/1358863X14559092; Parmenter BJ, 2015, SPORTS MED, V45, P231, DOI 10.1007/s40279-014-0261-z; Plotnikoff RC, 2013, PREV MED, V56, P245, DOI 10.1016/j.ypmed.2013.01.013; Sharath SE, 2017, VASC MED, V22, P378, DOI 10.1177/1358863X17709944; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Tougas ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134977; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Young MD, 2014, OBES REV, V15, P983, DOI 10.1111/obr.12225	62	29	29	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201095	10.1371/journal.pone.0201095	http://dx.doi.org/10.1371/journal.pone.0201095			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048501	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000439952400047
J	Bhasuran, B; Natarajan, J				Bhasuran, Balu; Natarajan, Jeyakumar			Automatic extraction of gene-disease associations from literature using joint ensemble learning	PLOS ONE			English	Article							TEXT-MINING SYSTEM; DRUGS; DATABASE; ENTITY	A wealth of knowledge concerning relations between genes and its associated diseases is present in biomedical literature. Mining these biological associations from literature can provide immense support to research ranging from drug-targetable pathways to biomarker discovery. However, time and cost of manual curation heavily slows it down. In this current scenario one of the crucial technologies is biomedical text mining, and relation extraction shows the promising result to explore the research of genes associated with diseases. By developing automatic extraction of gene-disease associations from the literature using joint ensemble learning we addressed this problem from a text mining perspective. In the proposed work, we employ a supervised machine learning approach in which a rich feature set covering conceptual, syntax and semantic properties jointly learned with word embedding are trained using ensemble support vector machine for extracting gene-disease relations from four gold standard corpora. Upon evaluating the machine learning approach shows promised results of 85.34%, 83.93%, 87.39% and 85.57% of F-measure on EUADR, GAD, CoMAGC and PolySearch corpora respectively. We strongly believe that the presented novel approach combining rich syntax and semantic feature set with domain-specific word embedding through ensemble support vector machines evaluated on four gold standard corpora can act as a new baseline for future works in gene-disease relation extraction from literature.	[Bhasuran, Balu; Natarajan, Jeyakumar] DRDO BU Ctr Life Sci, Bharathiar Univ Campus, Coimbatore, Tamil Nadu, India; [Natarajan, Jeyakumar] Bharathiar Univ, Dept Bioinformat, Data Min & Text Min Lab, Coimbatore, Tamil Nadu, India	Bharathiar University; Defence Research & Development Organisation (DRDO); DRDO BU Center Life Sciences; Bharathiar University	Natarajan, J (corresponding author), DRDO BU Ctr Life Sci, Bharathiar Univ Campus, Coimbatore, Tamil Nadu, India.; Natarajan, J (corresponding author), Bharathiar Univ, Dept Bioinformat, Data Min & Text Min Lab, Coimbatore, Tamil Nadu, India.	n.jeyakumar@yahoo.co.in	BHASURAN, BALU/AAB-1583-2021; Natarajan, Jeyakumar/C-9319-2013	BHASURAN, BALU/0000-0002-9890-4627; Natarajan, Jeyakumar/0000-0003-3981-619X	DRDO BU Centre for Life Sciences, Bharathiar University, Coimbatore, Tamilnadu, India	DRDO BU Centre for Life Sciences, Bharathiar University, Coimbatore, Tamilnadu, India	This work received funding from DRDO BU Centre for Life Sciences, Bharathiar University, Coimbatore, Tamilnadu, India. BB acknowledges the fellowship received from the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bhasuran B, 2016, J BIOMED INFORM, V64, P1, DOI 10.1016/j.jbi.2016.09.009; Bravo A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253128; Bravo A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0472-9; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cano C, 2009, J BIOMED INFORM, V42, P967, DOI 10.1016/j.jbi.2009.02.001; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Chun Hong-Woo, 2006, Pac Symp Biocomput, P4; Claesen M, 2014, J MACH LEARN RES, V15, P141; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dai QG, 2016, CURR PROTEOMICS, V13, P143, DOI 10.2174/157016461302160514005420; Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Hou W-J, 2016, ELECT J COMPUT SCI I, V4, P1; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Karimi S, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2719920; Kemper B, 2010, BIOINFORMATICS, V26, pI374, DOI 10.1093/bioinformatics/btq221; Kilicoglu H., 2017, BRIEFINGS BIOINFORMA; Krallinger M, 2005, DRUG DISCOV TODAY, V10, P439, DOI 10.1016/S1359-6446(05)03376-3; Leaman Robert, 2008, Pac Symp Biocomput, P652; Lee HJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-323; Lee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164680; Levy O, 2014, ADV NEUR IN, V27; Liu RL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-286; Liu YF, 2015, NUCLEIC ACIDS RES, V43, pW535, DOI 10.1093/nar/gkv383; McCormick C., 2015, STATEW AGR L USE BAS, V1, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Mikolov T., 2013, PREPRINT; Mikolov T, 2013, P 2013 C N AM CHAPT, DOI DOI 10.3109/10826089109058901; Mikolov T., 2013, ADV NEURAL INFORM PR, V26, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Murugesan G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187379; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Neufer PD, CELL METABOLISM; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Pons E, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw046; Singh-Blom UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058977; Song M, 2015, J BIOMED INFORM, V57, P320, DOI 10.1016/j.jbi.2015.08.008; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Van Landeghem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055814; van Mulligen EM, 2012, J BIOMED INFORM, V45, P879, DOI 10.1016/j.jbi.2012.04.004; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Ware M., 2015, STM REPORT OVERVIEW; Williams C. K. I., 2003, J AM STAT ASSOC, V98, P489, DOI DOI 10.1198/JASA.2003.S269; Xu D, 2016, BIOINFORMATICS, V32, P3619, DOI 10.1093/bioinformatics/btw503; Yu M, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P545, DOI 10.3115/v1/p14-2089; Zahid S, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/209814; Zhang DW, 2015, EXPERT SYST APPL, V42, P1857, DOI 10.1016/j.eswa.2014.09.011; Zheng S, 2016, JOINT EUR C MACH LEA, P443, DOI DOI 10.1007/978-3-319-46128-1; Zhou HY, 2016, BIOINFORMATICS, V32, P2831, DOI 10.1093/bioinformatics/btw358	55	25	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200699	10.1371/journal.pone.0200699	http://dx.doi.org/10.1371/journal.pone.0200699			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048465	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400012
J	Rao, GK; Wong, A; Collinge, M; Sarhan, J; Yarovinsky, TO; Ramgolam, VS; Gaestel, M; Pardi, R; Bender, JR				Rao, Gautham K.; Wong, Albert; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Gaestel, Matthias; Pardi, Ruggero; Bender, Jeffrey R.			T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and K	PLOS ONE			English	Article							PROTEIN-KINASE; POSTTRANSCRIPTIONAL REGULATION; ACTIVATED PROTEIN-KINASE-2; BINDING PROTEIN; NUCLEAR EXPORT; IN-VIVO; HUR; STABILITY; TARGET; BIOSYNTHESIS	Activation of the beta(2) integrin lymphocyte function-associated antigen-1 (LFA-1) in T cells induces stabilization of proinflammatory AU-rich element (ARE)-bearing mRNAs, by triggering the nuclear-to-cytoplasmic translocation of the mRNA-binding and-stabilizing protein HuR. However, the mechanism by which LFA-1 engagement controls HuR localization is not known. Here, we identify and characterize four key regulators of LFA-1-induced changes in HuR activity: the p38 pathway kinase MK2 and the constitutive nuclear proteins hnRNPs C, H1 and K. LFA-1 engagement results in rapid, sequential activation of p38 and MK2. Post-LFA-1 activation, MK2 inducibly associates with both hnRNPC and HuR, resulting in the dissociation of HuR from hnRNPs C, H1 and K. Freed from the three hnRNPs, HuR translocates from the nucleus to the cytoplasm, and mediates the stabilization of labile cytokine transcripts. Our results suggest that the modulation of T cell cytokine mRNA half-life is an intricate process that is negatively regulated by hnRNPs C, H1 and K and requires MK2 as a critical activator.	[Rao, Gautham K.; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Rao, Gautham K.; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Bender, Jeffrey R.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rao, Gautham K.; Wong, Albert; Collinge, Mark; Sarhan, Joseph; Yarovinsky, Timur O.; Ramgolam, Vinod S.; Bender, Jeffrey R.] Raymond & Beverly Sackler Fdn Cardiovasc Lab, New Haven, CT 06511 USA; [Wong, Albert] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Gaestel, Matthias] Med Sch Hannover, Inst Biochem, Hannover, Germany; [Pardi, Ruggero] Univ Vita Salute San Raffaele, Fac Med & Surg, Milan, Italy	Yale University; Yale University; Yale University; Hannover Medical School; Vita-Salute San Raffaele University	Bender, JR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Cardiovasc Res Ctr, New Haven, CT 06510 USA.; Bender, JR (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	jeffrey.bender@yale.edu	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652	National Institutes of Health [R01HL043331, T32 GM007223]; American Heart Association [13PRE17110006]; Raymond and Beverly Sackler Foundation [M117394]; Fondazione Cariplo; State of Connecticut Department of Public Health [AWDS01772]; Cariplo Foundation; American Heart Association Predoctoral Fellowship Award [AHA 13PRE14790042]; State of Connecticut Biomedical Research Award [DPH AWDS01772]; NIH [T32 GM007223, R01 HL043331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126412, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Raymond and Beverly Sackler Foundation; Fondazione Cariplo(Fondazione Cariplo); State of Connecticut Department of Public Health; Cariplo Foundation(Fondazione Cariplo); American Heart Association Predoctoral Fellowship Award(American Heart Association); State of Connecticut Biomedical Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: 1. National Institutes of Health: R01HL043331 (JB), https://www.nhlbi.nih.gov/; 2. American Heart Association: 13PRE17110006 (AW), http://professional.heart.org/professional/ResearchPrograms/UCM_316889_Research.jsp; 3. Raymond and Beverly Sackler Foundation M117394 (JB); 4. National Institutes of Health T32 GM007223 (AW), https://researchtraining.nih.gov/programs/training-grants/t32; 5. Fondazione Cariplo (IT), (RP); and 6. State of Connecticut Department of Public Health AWDS01772 (JB).; We are grateful to Jonathan Bogan, Fred Gorelick and Carla Rothlin for helpful advice and feedback, and Dana Brenckle for assistance in the manuscript preparation. The work was supported by a grant from the Cariplo Foundation (R.P., J.R.B.), American Heart Association Predoctoral Fellowship Award AHA 13PRE14790042 (A.W.), State of Connecticut Biomedical Research Award DPH AWDS01772 (J.R.B.), NIH T32 GM007223 (A.W.) and R01 HL043331 (J.R.B.).	Akindahunsi AA, 2005, COMPUT BIOL CHEM, V29, P13, DOI 10.1016/j.compbiolchem.2004.11.002; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Esnault S, 2003, J IMMUNOL, V171, P6780, DOI 10.4049/jimmunol.171.12.6780; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Kim CY, 2008, EXP MOL MED, V40, P669, DOI 10.3858/emm.2008.40.6.669; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Ramgolam VS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014450; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Velusamy T, 2008, BIOCHEMISTRY-US, V47, P6508, DOI 10.1021/bi702338y; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Wang SW, 1999, INFLAMM RES, V48, P533, DOI 10.1007/s000110050499; Wang XY, 1998, LEUKEMIA, V12, P520, DOI 10.1038/sj.leu.2400975	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201103	10.1371/journal.pone.0201103	http://dx.doi.org/10.1371/journal.pone.0201103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048492	Green Submitted, gold, Green Published			2022-12-27	WOS:000439952400049
J	Yan, Y; Yin, XC; Yang, C; Li, SJ; Zhang, BW				Yan, Yan; Yin, Xu-Cheng; Yang, Chun; Li, Sujian; Zhang, Bo-Wen			Biomedical literature classification with a CNNs-based hybrid learning network	PLOS ONE			English	Article							TEXT DETECTION; RECOGNITION; VIDEO; ALGORITHM	Deep learning techniques, e.g., Convolutional Neural Networks (CNNs), have been explosively applied to the research in the fields of information retrieval and natural language processing. However, few research efforts have addressed semantic indexing with deep learning. The use of semantic indexing in the biomedical literature has been limited for several reasons. For instance, MEDLINE citations contain a large number of semantic labels from automatically annotated MeSH terms, and for a great deal of the literature, only the information of the title and the abstract is readily available. In this paper, we propose a Boltzmann Convolutional neural network framework (B-CNN) for biomedicine semantic indexing. In our hybrid learning framework, the CNN can adaptively deal with features of documents that have sequence relationships, and can capture context information accordingly; the Deep Boltzmann Machine (DBM) merges global (the entity in each document) and local information through its training with undirected connections. Additionally, we have designed a hierarchical coarse to fine style indexing structure for learning and classifying documents, and a novel feature extension approach with word sequence embedding and Wikipedia categorization. Comparative experiments were conducted for semantic indexing of biomedical abstract documents; these experiments verified the encouraged performance of our B-CNN model.	[Yan, Yan] China Univ Min & Technol, Sch Mech Elect & Informat Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China; [Yin, Xu-Cheng; Yang, Chun; Zhang, Bo-Wen] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China; [Li, Sujian] Peking Univ, Key Lab Computat Linguist, Minist Educ, Beijing 100871, Peoples R China	China University of Mining & Technology; University of Science & Technology Beijing; Peking University	Yan, Y (corresponding author), China Univ Min & Technol, Sch Mech Elect & Informat Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China.; Yin, XC (corresponding author), Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Dept Comp Sci & Technol, Beijing 100083, Peoples R China.	yanyanustb@126.com; xuchengyin@ustb.edu.cn		Yan, Yan/0000-0002-0187-7010	National Natural Science Foundation of China [61175020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (61175020) by Xu-Cheng Yin. There was no additional external funding received for this study.	Ananiadou S, 2004, J BIOMED INFORM, V37, P393, DOI 10.1016/j.jbi.2004.08.011; Aronson AR, 2007, P WORKSH BIONLP 2007, P105; Bai B, 2009, LECT NOTES COMPUT SC, V5478, P761; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Collobert R., 2008, P 25 ICML, V25, P160, DOI DOI 10.1145/1390156.1390177; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Dahl GE, 2012, IEEE T AUDIO SPEECH, V20, P30, DOI 10.1109/TASL.2011.2134090; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Dos Santos C., 2014, P COLING 2014 25 INT, P69; Drakopoulos G, 2016, INT C INF INT SYST A; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Feng MW, 2015, 2015 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P813, DOI 10.1109/ASRU.2015.7404872; Fieschi M, 2004, MEDINFO, V107, P287; Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010; Ge ZY, 2015, IEEE IMAGE PROC, P4112, DOI 10.1109/ICIP.2015.7351579; Glorot X., 2011, PROC 14 INT C ARTIFI, V15, P315; Hingmire S, 2013, SIGIR'13: THE PROCEEDINGS OF THE 36TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH & DEVELOPMENT IN INFORMATION RETRIEVAL, P877; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Hu XH, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P389; Huang SC, 2013, IEEE T NEUR NET LEAR, V24, P1920, DOI 10.1109/TNNLS.2013.2270314; Huang SC, 2011, IEEE T CIRC SYST VID, V21, P1, DOI 10.1109/TCSVT.2010.2087812; Inoue N, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P851, DOI 10.1145/2733373.2806347; Jessen WJ, 2015, NATURE PRECEDINGS; Jimeno-Yepes A, 2013, AMIA 2013; Jung C, 2012, IEEE T IMAGE PROCESS, V21, P1272, DOI 10.1109/TIP.2011.2164420; Karami A, 2014, ACL 2014 WORKSH BION, P128; Krizhevsky A., P 25 INT C NEUR INF, P1097; Lai SW, 2015, AAAI CONF ARTIF INTE, P2267; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee H., 2009, P 26 ANN INT C MACH, P609, DOI [DOI 10.1145/1553374.1553453, 10.1145/1553374.1553453]; Li YJ, 2016, COMPUT ELECTR ENG, V54, P68, DOI 10.1016/j.compeleceng.2016.08.008; Liu JZ, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P115, DOI 10.1145/3077136.3080834; McAuliffe J.D., 2008, ADV NEURAL INFORM PR, P121; McCallum, 2002, MALLET MACHINE LEARN; Mikolov T., 2013, PREPRINT; Mikolov T, 2013, P 2013 C N AM CHAPT, DOI DOI 10.3109/10826089109058901; Mikolov T, 2012, IEEE W SP LANG TECH, P234, DOI 10.1109/SLT.2012.6424228; Mimno DM, 2012, CORR, V2012; Mirowski P., 2010, P 24 ANN C NEURAL IN, P1; Mishra AK, 2012, IEEE T PATTERN ANAL, V34, P639, DOI 10.1109/TPAMI.2011.171; Montavon Gregoire, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P621, DOI 10.1007/978-3-642-35289-8_33; Mori K, 2014, P IEICE GEN C; Ng AY, 2002, ADV NEUR IN, V14, P841; Nie L, 2014, MED INF RETR WORKSH, P24; Nie LQ, 2015, IEEE T KNOWL DATA EN, V27, P2107, DOI 10.1109/TKDE.2015.2399298; Nie LQ, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1245, DOI 10.1145/2600428.2611176; Nie YP, 2017, FRONT INFORM TECH EL, V18, P535, DOI 10.1631/FITEE.1601232; Podlesnaya A., 2016, P SAI INT SYST C, P359; Read J, 2011, MACH LEARN, V85, P333, DOI 10.1007/s10994-011-5256-5; Reed Scott, 2014, ARXIV14126596; Reynolds C, 2017, ERS INT C, pPA406; Salakhutdinov R., 2010, P 13 INT C ARTIFICIA, P693; Settles B., 2004, P INT JOINT WORKSH N, DOI DOI 10.3115/1567594.1567618; Severyn A, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P373, DOI 10.1145/2766462.2767738; Shen YL, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P373, DOI 10.1145/2567948.2577348; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Steyvers M, 2007, HDB LATENT SEMANTIC; Thabtah FA, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P217, DOI 10.1109/ICDM.2004.10117; Trieschnigg D, 2009, BIOINFORMATICS, V25, P1412, DOI 10.1093/bioinformatics/btp249; Tu YH, 2014, INT CONF SIGN PROCES, P532, DOI 10.1109/ICOSP.2014.7015061; Turian J, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P384; Wang YQ, 2015, INT CONF ACOUST SPEE, P4984, DOI 10.1109/ICASSP.2015.7178919; Wu H., 2014, P WORKSH SEM MATCH I, P46; Xiao T, 2014, APPL 2 LEVEL ATTENTI, V40, P842; Yepes AJ, 2014, P 12 ANN WORKSH AUST, V123; Yin XC, 2016, IEEE T IMAGE PROCESS, V25, P2752, DOI 10.1109/TIP.2016.2554321; Yin XC, 2015, IEEE T PATTERN ANAL, V37, P1930, DOI 10.1109/TPAMI.2014.2388210; Yin XC, 2014, IEEE T PATTERN ANAL, V36, P970, DOI 10.1109/TPAMI.2013.182; Zeng D., 2014, COLING; Zhang SP, 2014, INFORM SCIENCES, V281, P635, DOI 10.1016/j.ins.2013.12.052; Zhang Tong, 2014, ARXIV PREPRINT ARXIV; Zhou J, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2048-y; Zhou P, 2012, INT CONF SIGN PROCES, P557, DOI 10.1109/ICoSP.2012.6491549	81	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0197933	10.1371/journal.pone.0197933	http://dx.doi.org/10.1371/journal.pone.0197933			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048461	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400001
J	Lee, KC; Hsu, WH; Chou, PH; Yiin, JJ; Muo, CH; Lin, YP				Lee, Kwo-Chen; Hsu, Wen-Hsuan; Chou, Po-Han; Yiin, Jia-Jean; Muo, Chih-Hsin; Lin, Yun-Ping			Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; END-STAGE DEMENTIA; ALZHEIMERS-DISEASE; RISK-FACTORS; MORTALITY; PREDICTORS; SCALE; CARE; PREVALENCE; PEOPLE	Background Dementia is characterized by prolonged progressive disability. Therefore, predicting mortality is difficult. An accurate prediction tool may be useful to ensure that end-of-life patients with dementia receive timely palliative care. Purpose This study aims to establish a survival prediction model for elderly patients with dementia in Taiwan. Methods Data from the 2001 to 2010 National Health Insurance Research Database in Taiwan were used to identify 37,289 patients with dementia aged >= 65 years for inclusion in this retrospective longitudinal study. Moreover, this study examined the mortality indicators for dementia among demographic characteristics, chronic physical comorbidities, and medical procedures. A Cox proportional hazards model with time-dependent covariates was used to estimate mortality risk, and risk score functions were formulated using a point system to establish a survival prediction model. The prediction model was then tested using the area under the receiver operating characteristic curve. Results Thirteen mortality risk factors were identified: age, sex, stroke, chronic renal failure, liver cirrhosis, cancer, pressure injury, and retrospectively retrieved factors occurring in the 6 months before death, including nasogastric tube placement, supplemental oxygen supply, >= 2 hospitalization, receiving >= 1 emergency services, >= 2 occurrences of cardiopulmonary resuscitation, and receiving >= 2 endotracheal intubations. The area under the receiver operating characteristic curves for this prediction model for mortality at 6 and 12 months were 0.726 and 0.733, respectively. Conclusions The survival prediction model demonstrated moderate accuracy for predicting mortality at 6 and 12 months before death in elderly patients with dementia. This tool may be valuable for helping health care providers and family caregivers to make end-of-life care decisions.	[Lee, Kwo-Chen; Lin, Yun-Ping] China Med Univ, Sch Nursing, Taichung, Taiwan; [Lee, Kwo-Chen; Hsu, Wen-Hsuan; Lin, Yun-Ping] China Med Univ Hosp, Dept Nursing, Taichung, Taiwan; [Lee, Kwo-Chen] China Med Univ Hosp, Brain Dis Res Ctr, Taichung, Taiwan; [Chou, Po-Han] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Chou, Po-Han] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chou, Po-Han] Natl Chiao Tung Univ, Dept Photon, Hsinchu, Taiwan; [Chou, Po-Han] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yiin, Jia-Jean] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taichung, Taiwan; [Yiin, Jia-Jean] Natl Def Med Ctr, Inst Med Sci, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lin, YP (corresponding author), China Med Univ, Sch Nursing, Taichung, Taiwan.; Lin, YP (corresponding author), China Med Univ Hosp, Dept Nursing, Taichung, Taiwan.	yunping@mail.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	The reason why we have the access to the data used in this study is that the authors (K-CL, W-HH, C-HM, Y-PL) are the employees of the China Medical University Hospital, and that fees for using the dataset were paid by the hospital. However, the fees were supported by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital; the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital; the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Aminoff BZ, 2004, ARCH GERONTOL GERIAT, V38, P123, DOI 10.1016/j.archger.2003.08.007; Brown MA, 2013, PALLIATIVE MED, V27, P389, DOI 10.1177/0269216312465649; Cereda E, 2013, ARCH GERONTOL GERIAT, V56, P437, DOI 10.1016/j.archger.2012.12.001; Chen TF, 2007, NEUROEPIDEMIOLOGY, V28, P142, DOI 10.1159/000102142; Chou PH, 2012, PSYCHOSOMATICS, V53, P463, DOI 10.1016/j.psym.2012.03.007; Connors MH, 2016, J ALZHEIMERS DIS, V52, P967, DOI 10.3233/JAD-150946; Department of Health, 2016, STAT CAUS DEATH 6, V6, P3; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heun R, 2013, EUR PSYCHIAT, V28, P40, DOI 10.1016/j.eurpsy.2011.06.001; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jaul E, 2016, EXP AGING RES, V42, P382, DOI 10.1080/0361073X.2016.1191863; Lunawat A, 2016, INT J SURG, V3, P1414; Marsh GW, 2000, APPL NURS RES, V13, P187, DOI 10.1053/apnr.2000.7654; Mitchell SL, 2004, JAMA-J AM MED ASSOC, V291, P2734, DOI 10.1001/jama.291.22.2734; Mitchell SL, 2010, J PAIN SYMPTOM MANAG, V40, P639, DOI 10.1016/j.jpainsymman.2010.02.014; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Nicholas LH, 2014, HEALTH AFFAIR, V33, P667, DOI 10.1377/hlthaff.2013.1258; Prabhakaran S, 2012, SCAND J SURG, V101, P147, DOI 10.1177/145749691210100302; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Sampson EL, 2013, INT J GERIATR PSYCH, V28, P1015, DOI 10.1002/gps.3919; SCHAAFSMA J, 1994, QUAL LIFE RES, V3, P413, DOI 10.1007/BF00435393; Schonwetter Ronald S, 2003, Am J Hosp Palliat Care, V20, P105, DOI 10.1177/104990910302000208; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Tsai PH, 2007, J GERIATR PSYCH NEUR, V20, P172, DOI 10.1177/0891988707301864; van de Vorst IE, 2016, J AM GERIATR SOC, V64, P37, DOI 10.1111/jgs.13835; van der Steen JT, 2006, J CLIN EPIDEMIOL, V59, P970, DOI 10.1016/j.jclinepi.2005.12.005; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; World Health Organization, 2017, 10 FACTS ON DEM	37	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0178997	10.1371/journal.pone.0178997	http://dx.doi.org/10.1371/journal.pone.0178997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044781	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500001
J	Liu, J; Zhu, YX; Qu, B				Liu, Jie; Zhu, Yaxin; Qu, Bo			Reliability and validity of the Chinese version of the Medical Outcomes Study HIV Health Survey (MOS-HIV) in people living with HIV/AIDS (PLWHA) in China	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFECTED PATIENTS; VALIDATION; DISEASE; QUESTIONNAIRE; INDIVIDUALS; TRANSLATION; INSTRUMENTS; SCORES; IMPACT	Objective The aim of the study was to assess the psychometric properties of the Medical Outcomes Study HIV Health Survey (MOS-HIV) in people living with HIV/AIDS (PLWHA) in mainland China. Methods A cross-sectional survey was conducted in 646 PLWHA between May 2015 and March 2016 in Dalian, Ningbo, and Zhengzhou City, China. The MOS-HIV includes 35 items and measures 10 scales. These ten scales can be effectively calculated under two summary scale scores, the physical health score (PHS) and the mental health score (MHS), with the physical functioning, pain and role functioning scales contributing to the PHS, the mental health, health distress, quality of life and cognitive function scales contributing to the MHS, and the energy/fatigue, general health and social functioning contributing to both factors. Reliability was measured in terms of internal consistency and test-retest reliability. The internal consistency of the questionnaire was analyzed using Cronbach's alpha coefficient, and test-retest reliability was assessed using Pearson's correlation coefficient. Validity was analyzed via construct validity, convergent and discriminant validity, and known group validity. Confirmatory factor analyses (CFA) were used to test construct validity. A multiple-group CFA analysis was conducted to investigate whether the MOS-HIV measured the same constructs across gender groups. Results The MOS-HIV questionnaire was reliable and valid. Reliability of the PHS and MHS scales was 0.87 and 0.89, respectively. While the Cronbach's alpha coefficients for each of the dimen- sions were > 0.70. According to the results of the confirmatory factor analysis (CFA), the hypothesized model was acceptable. The instrument showed factorial invariance across gender groups. All correlation coefficients were greater than 0.40, with a range of 0.60-0.94. The correlation coefficients observed between items and other dimensions were lower than the coefficients for the correlations between items and hypothesized dimensions for all scales, suggesting good convergent and discriminant validity. Patients with CD4 counts >500 cells/mm(3) demonstrated better QOL than those with lower CD4 counts on six scales and the PHS (p<0.05) and symptomatic respondents had significantly lower scores than asymptomatic respondents on all the scales except health transition scales (p<0.05) suggesting good known group validity. Conclusions The results of this study provide evidence that the MOS-HIV may be an acceptable, valid and reliable instrument for evaluating QOL of PLWHA in mainland China.	[Liu, Jie; Zhu, Yaxin; Qu, Bo] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Liaoning, Peoples R China	China Medical University	Qu, B (corresponding author), China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang, Liaoning, Peoples R China.	qubo6666@163.com			National Natural Science Foundation of China [71473269, 71673301]; Natural Science Foundation of Liaoning Province, China [2015020469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	This study was supported by projects from National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/, grant 71473269 and 71673301, BQ) and Natural Science Foundation of Liaoning Province, China (http://www.lninfo.gov.cn/, grant 2015020469, JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Badia X, 1999, AIDS, V13, P1727, DOI 10.1097/00002030-199909100-00017; Basavaraj K H, 2010, Indian J Sex Transm Dis AIDS, V31, P75, DOI 10.4103/0253-7184.74971; Bing EG, 2000, QUAL LIFE RES, V9, P55, DOI 10.1023/A:1008919227665; Call SA, 2000, QUAL LIFE RES, V9, P977, DOI 10.1023/A:1016668802328; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; Chariyalertsak S, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-15; Chinese Center for Disease Control and Prevention, 2016, 2014 NAT REP NOT INF, V7, P18; Davis EA, 2001, ANN PHARMACOTHER, V35, P546, DOI 10.1345/aph.10222; Delate T, 2001, CLIN INFECT DIS, V32, pE47, DOI 10.1086/318492; Duro D, 2010, J NEUROL, V257, P728, DOI 10.1007/s00415-009-5399-5; Epino HM, 2012, AIDS CARE, V24, P1576, DOI 10.1080/09540121.2012.661840; Gibson K, 2011, AIDS PATIENT CARE ST, V25, P371, DOI 10.1089/apc.2010.0165; Henderson WA, 2010, AIDS CARE, V22, P483, DOI 10.1080/09540120903207292; Holmes WC, 1999, QUAL LIFE RES, V8, P515, DOI 10.1023/A:1008931006866; Hsiung PC, 2005, QUAL LIFE RES, V14, P141, DOI 10.1007/s11136-004-6252-z; Hsiung PC, 2011, QUAL LIFE RES, V20, P281, DOI 10.1007/s11136-010-9733-2; Huang ZJ, 2013, QUAL LIFE RES, V22, P403, DOI 10.1007/s11136-012-0148-0; Ichikawa M, 2004, QUAL LIFE RES, V13, P601, DOI 10.1023/B:QURE.0000021319.73865.5a; Kohli RM, 2005, INDIAN J MED RES, V122, P297; Kowal J, 2008, J PAIN SYMPTOM MANAG, V36, P247, DOI 10.1016/j.jpainsymman.2007.10.012; Krentz HB, 2003, AIDS, V17, P631, DOI 10.1097/00002030-200303070-00022; Lau JTF, 2006, QUAL LIFE RES, V15, P1079, DOI 10.1007/s11136-005-5914-9; Marin A, 2006, QUAL LIFE RES, V15, P767, DOI 10.1007/s11136-005-5001-2; Mast TC, 2004, AIDS CARE, V16, P81, DOI 10.1080/09540120310001633994; Meng YJ, 2008, PUBLIC HEALTH, V122, P404, DOI 10.1016/j.puhe.2007.06.007; Murri R, 1997, J ACQ IMMUN DEF SYND, V16, P350, DOI 10.1097/00042560-199712150-00007; Niu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153489; Paton NI, 2002, INT J STD AIDS, V13, P456, DOI 10.1258/09564620260079608; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; Schifano P, 2003, QUAL LIFE RES, V12, P1137, DOI 10.1023/A:1026151931248; Scott-Lennox JA, 1999, MED CARE, V37, P908, DOI 10.1097/00005650-199909000-00007; Shahriar Jim, 2003, Health Qual Life Outcomes, V1, P25, DOI 10.1186/1477-7525-1-25; Shamos S, 2009, QUAL HEALTH RES, V19, P1678, DOI 10.1177/1049732309353910; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Skevington SM, 2010, AIDS CARE, V22, P614, DOI 10.1080/09540120903311466; Stangl AL, 2012, QUAL LIFE RES, V21, P1655, DOI 10.1007/s11136-011-0075-5; Stasinopoulou PG, 2010, QUAL LIFE RES, V19, P199, DOI 10.1007/s11136-009-9573-0; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Tate D, 2003, AIDS PATIENT CARE ST, V17, P115, DOI 10.1089/108729103763807936; Wu AW, 1997, QUAL LIFE RES, V6, P531, DOI 10.1023/A:1018460132567; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011; Yang F., 2007, CHINA PUBLIC HLTH, V23, P981; Yekaninejad MS, 2015, SUPPORT CARE CANCER, V23, P1215, DOI 10.1007/s00520-014-2468-9; Yu D, 2008, CHINESE J AIDS STD, V5, P454; 董选军, 2015, [中国卫生统计, Chinese Journal of Health Statistics], V32, P619	46	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201177	10.1371/journal.pone.0201177	http://dx.doi.org/10.1371/journal.pone.0201177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044881	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500088
J	Roman, C; Ernst, B; Thiel, M; Manriquez, P; Chamorro, J				Roman, Catalina; Ernst, Billy; Thiel, Martin; Manriquez, Pablo; Chamorro, Julio			Spatio-temporal migratory dynamics of Jasus frontalis (Milne Edwards, 1837) in Alexander Selkirk Island, Juan Fernandez archipelago, Chile	PLOS ONE			English	Article							SOUTHERN ROCK LOBSTER; CRAB CHIONOECETES-OPILIO; SPINY LOBSTER; MOVEMENT PATTERNS; DECAPOD CRUSTACEANS; ECOLOGICAL RESERVE; HOMARUS-AMERICANUS; SCYLLARIDES-LATUS; PANULIRUS-ARGUS; FISHERY	Knowledge about the spatial patterns and movements of crustaceans has gained importance since the creation of marine protected areas and the development of spatial management for benthic ecosystems. The Juan Fernandez spiny lobster (Jasus frontalis) is an endemic marine species and most valuable resource that exhibits migratory dynamics in a highly spatially regulated fishery. To study movement patterns around Alexander Selkirk Island, a mark-recapture program was implemented in 2008, when approximately 7000 non-commercial (undersized) lobsters were tagged and followed for nearly 14 months. Using quantitative georeferenced data, this study revealed spatial structuring of Juan Fernandez spiny lobster and tested hypotheses about alongshore and inshore-offshore movements. Eight clusters were identified around Alexander Selkirk Island, with moderate time-varying connectivity between them. Seasonal inshore-offshore movements were detected all around the island, but more conspicuously to the north. Average travelling distance was 1.2 km (1.7 sd). Our results confirmed that towards the end of austral spring males and females embark in a seasonal offshore migration to deeper waters, returning to shallower waters only during winter. These findings quantitatively consolidate the conceptual migratory model that local fishermen had already inferred for this resource from about a century of sustainable fishing.	[Roman, Catalina; Manriquez, Pablo] Univ Concepcion, Programa Magister Ciencias Menc Pesquerias, Concepcion, Chile; [Roman, Catalina] Inst Fomento Pesquero, Valparaiso, Chile; [Ernst, Billy; Manriquez, Pablo; Chamorro, Julio] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile; [Ernst, Billy] Nucleo Milenio INVASAL, Concepcion, Chile; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Coquimbo, Chile; [Thiel, Martin] Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Thiel, Martin] CEAZA, Coquimbo, Chile	Universidad de Concepcion; Instituto de Fomento Pesquero (Valparaiso); Universidad de Concepcion; Universidad Catolica del Norte	Ernst, B (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile.; Ernst, B (corresponding author), Nucleo Milenio INVASAL, Concepcion, Chile.	biernst@oceanografia.udec.cl			Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica); FIP (Fondo de Investigacion Pesquera) project "DINAMICA POBLACIONAL Y PESQUERA DE LA LANGOSTA EN LA ISLA ALEJANDRO SELKIRK [FIP 2008-24]; Nucleo Milenio INVASAL; Chile's government program, Iniciativa Cientifica Milenio from Ministerio de Economia, Fomento y Turismo; Fondo de Investigacion Pesquera [FIP 2008-24]	Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FIP (Fondo de Investigacion Pesquera) project "DINAMICA POBLACIONAL Y PESQUERA DE LA LANGOSTA EN LA ISLA ALEJANDRO SELKIRK; Nucleo Milenio INVASAL; Chile's government program, Iniciativa Cientifica Milenio from Ministerio de Economia, Fomento y Turismo; Fondo de Investigacion Pesquera	Catalina Roman received funding from Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica, http://www.conicyt.cl/becasconicyt/) scholarship. Billy Ernst received funding from FIP (Fondo de Investigacion Pesquera) during the development of the project "DINAMICA POBLACIONAL Y PESQUERA DE LA LANGOSTA EN LA ISLA ALEJANDRO SELKIRK, FIP 2008-24 and Nucleo Milenio INVASAL, funded by Chile's government program, Iniciativa Cientifica Milenio from Ministerio de Economia, Fomento y Turismo. The Fondo de Investigacion Pesquera (grant FIP 2008-24) also provided funding. The funding agencies did not have a role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abesamis RA, 2006, FISH B-NOAA, V104, P360; Ahumada M, 2014, LAT AM J AQUAT RES, V42, P213, DOI 10.3856/vol42-issue1-fulltext-18; Arana E. P., 1987, ISLAS OCEANICAS CHIL, P319; Arana P, 1985, INVEST MAR, P188; Arana P, 1976, REV COMITE PERMANENT, V4, P117; Arana P, 1983, ANALISIS PESQUERIAS, P77; Arana P., 1985, INVEST MAR, P157; Arana P, 1992, CIENC TEC MAR, V15, P49; Arana P, 1985, 382 U CAT VALP, P96; Arana P., 1985, INVESTIGACIONES MARI, P125; Arana Patricio M., 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P83; Atkinson L., 2001, THESIS; Atkinson LJ, 2003, AFR J MAR SCI, V25, P387, DOI 10.2989/18142320309504026; Barrett N, 2009, MAR FRESHWATER RES, V60, P417, DOI 10.1071/MF07154; Bauer R.T., 2018, NATURAL HIST CRUSTAC, V5, P203; Bertelsen RD, 2013, FISH RES, V144, P91, DOI 10.1016/j.fishres.2012.12.008; BOOTH JD, 1984, NEW ZEAL J MAR FRESH, V18, P275, DOI 10.1080/00288330.1984.9516049; Booth JD, 1997, B MAR SCI, V61, P111; Brownie C., 1985, STAT INFERENCE BAND, V156; Castilla J. C., 1987, ISLAS OCEANICAS CHIL, P15; Childress Michael J., 2006, P78, DOI 10.1002/9780470995969.ch3; COOPER RA, 1975, T AM FISH SOC, V104, P669, DOI 10.1577/1548-8659(1975)104<669:SAOTAL>2.0.CO;2; COOPER RA, 1971, SCIENCE, V171, P288, DOI 10.1126/science.171.3968.288; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Ernst B, 2005, CAN J FISH AQUAT SCI, V62, P250, DOI 10.1139/F04-201; Ernst B, 2013, 201315 FIP U CONC; Ernst B, 2010, 200824 U CONC DEP OC, P1; Ernst B, 2013, PROYECTO 472836LP12; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Ernst B, 2010, B MAR SCI, V86, P315; Factor JR, 1995, BIOL LOBSTER HOMARUS; Fernandes PG, 1999, GEOENVII, V10, P201; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fraley C, 2007, J STAT SOFTW, V18; Freeman DJ, 2009, MAR ECOL PROG SER, V388, P159, DOI 10.3354/meps08122; Freire J, 1998, HYDROBIOLOGIA, V372, P123, DOI 10.1023/A:1017066920151; Frusher SD, 2001, CAN J FISH AQUAT SCI, V58, P2490, DOI 10.1139/cjfas-58-12-2490; Gardner C, 2003, B MAR SCI, V73, P653; Goldstein JS, 2015, MAR ECOL PROG SER, V524, P197, DOI 10.3354/meps11192; Hartnoll R.G., 1982, P111; Herrnkind W.F., 1980, P349; Herrnkind W.F., 1975, Science Bull nat Hist Mus Los Ang Cty, VNo. 20, P31; KANCIRUK P, 1978, B MAR SCI, V28, P601; Kelly S, 2003, NEW ZEAL J MAR FRESH, V37, P149, DOI 10.1080/00288330.2003.9517153; Kelly S, 2001, MAR FRESHWATER RES, V52, P323, DOI 10.1071/MF00028; Law MH, 2003, ADV NEURAL INFORM PR, P625; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Linnane A, 2005, NEW ZEAL J MAR FRESH, V39, P335, DOI 10.1080/00288330.2005.9517314; Linnane A, 2015, MAR FRESHWATER RES, V66, P623, DOI 10.1071/MF13334; MacDiarmid A.B., 1992, P 2 INT TEMP REEF S, P47; MACDIARMID AB, 1991, MAR ECOL PROG SER, V70, P129, DOI 10.3354/meps070129; MACDIARMID AB, 1989, MAR BIOL, V103, P303, DOI 10.1007/BF00397263; Manriquez P, 2016, THESIS; MARTINS HR, 1985, J CRUSTACEAN BIOL, V5, P294, DOI 10.2307/1547877; MCKOY JL, 1983, NEW ZEAL J MAR FRESH, V17, P357, DOI 10.1080/00288330.1983.9516011; MCKOY JL, 1982, NEW ZEAL J MAR FRESH, V16, P141, DOI 10.1080/00288330.1982.9515957; Mendo T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166343; MONTGOMERY SS, 1995, CRUSTACEANA, V68, P257, DOI 10.1163/156854095X01411; MOORE R, 1984, AUST J MAR FRESH RES, V35, P197; MORALES E, 1985, INVEST MAR, P15; Nichol DG, 2015, FISH B-NOAA, V113, P313, DOI 10.7755/FB.113.3.7; Orensanz J. M., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P441; PARIN NV, 1991, B MAR SCI, V49, P671; Pavez P, 1982, INFORME FINAL SUBSEC, V16, P1; Pequeno R. German, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P27; Pewsey A, 2013, CIRCULAR STAT R; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; R Development Core Team, 2014, R LANG ENV STAT COMP; Rao JS., 2001, TOPICS CIRCULAR STAT; RODDICK DL, 1992, CAN J FISH AQUAT SCI, V49, P1486, DOI 10.1139/f92-164; Rueda M, 2001, ICES J MAR SCI, V58, P1219, DOI 10.1006/jmsc.2001.1122; Sanchez-Carnero N, 2008, P 1 INT C INF TECHN; Skottsberg C, 1918, GEOGR REV, V5, P362, DOI 10.2307/207467; SPANIER E, 1988, MAR ECOL PROG SER, V42, P247, DOI 10.3354/meps042247; Stelzenmuller V, 2007, BIOL CONSERV, V136, P571, DOI 10.1016/j.biocon.2007.01.002; Street RJ, 1973, N Z MIN AGR FISH TEC, P116; Swain DP, 2003, CAN J FISH AQUAT SCI, V60, P897, DOI 10.1139/F03-076; Talavera L., 2000, Intelligent Data Analysis, V4, P19; Tomalin B, 1993, THESIS; Waddington K, 2005, NEW ZEAL J MAR FRESH, V39, P365, DOI 10.1080/00288330.2005.9517317; Wieland K, 2001, SARSIA, V86, P503, DOI 10.1080/00364827.2001.10420489; Wilcox C, 2003, N AM J FISH MANAGE, V23, P241, DOI 10.1577/1548-8675(2003)023<0241:DCFAAM>2.0.CO;2; Ziegler PE, 2003, FISH RES, V61, P107, DOI 10.1016/S0165-7836(02)00240-0	84	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200146	10.1371/journal.pone.0200146	http://dx.doi.org/10.1371/journal.pone.0200146			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044805	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500030
J	Taller, D; Balint, J; Gyula, P; Nagy, T; Barta, E; Baksa, I; Szittya, G; Taller, J; Havelda, Z				Taller, Denes; Balint, Jeannette; Gyula, Peter; Nagy, Tibor; Barta, Endre; Baksa, Ivett; Szittya, Gyorgy; Taller, Janos; Havelda, Zoltan			Expansion of Capsicum annum fruit is linked to dynamic tissue-specific differential expression of miRNA and siRNA profiles	PLOS ONE			English	Article							DEEP SEQUENCING DISCOVERY; SMALL RNAS; CONSERVED MICRORNAS; PROVIDES INSIGHTS; BIOGENESIS; SECONDARY; SUITE; IDENTIFICATION; FUNCTIONALITY; DIVERSITY	Small regulatory RNAs, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs) have emerged as important transcriptional and post-transcriptional regulators controlling a wide variety of physiological processes including fruit development. Data are, however, limited for their potential roles in developmental processes determining economically important traits of crops. The current study aimed to discover and characterize differentially expressed miRNAs and siRNAs in sweet pepper (Capsicum annuum) during fruit expansion. High-throughput sequencing was employed to determine the small regulatory RNA expression profiles in various fruit tissues, such as placenta, seed, and flesh at 28 and 40 days after anthesis. Comparative differential expression analyses of conserved, already described and our newly predicted pepper-specific miRNAs revealed that fruit expansion is accompanied by an increasing level of miRNA-mediated regulation of gene expression. Accordingly, ARGONAUTE1 protein, the primary executor of miRNA-mediated regulation, continuously accumulated to an extremely high level in the flesh. We also identified numerous pepper-specific, heterochromatin-associated 24-nt siRNAs (hetsiRNAs) which were extremely abundant in the seeds, as well as 21-nt and 24-nt phased siRNAs (phasiRNAs) that were expressed mainly in the placenta and the seeds. This work provides comprehensive tissue-specific miRNA and siRNA expression landscape for a developing pepper fruit. We identified several novel, abundantly expressing tissue- and pepper-specific small regulatory RNA species. Our data show that fruit expansion is associated with extensive changes in sRNA abundance, raising the possibility that manipulation of sRNA pathways may be employed to improve the quality and quantity of the pepper fruit.	[Taller, Denes; Balint, Jeannette; Gyula, Peter; Nagy, Tibor; Barta, Endre; Baksa, Ivett; Szittya, Gyorgy; Havelda, Zoltan] Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Godollo, Hungary; [Taller, Janos] Univ Pannonia, Georgikon Fac, Dept Plant Sci & Biotechnol, Keszthely, Hungary	University of Pannonia	Havelda, Z (corresponding author), Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Godollo, Hungary.	havelda.zoltan@abc.naik.hu	Barta, Endre/B-1166-2008; Szittya, Gyorgy/A-2905-2012; Taller, Janos/ABB-9586-2021; Gyula, Péter/N-4445-2014; Szittya, Gyorgy/M-9199-2019	Barta, Endre/0000-0002-6753-0714; Szittya, Gyorgy/0000-0003-2040-2851; Gyula, Péter/0000-0002-3574-2827; Szittya, Gyorgy/0000-0003-2040-2851; Nagy, Tibor/0000-0002-4451-0796; Havelda, Zoltan/0000-0002-6349-7646	National Research, Development and Innovation Office [NKFI-K109438, NKFI-K116602, NKFI-K119701]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by grants from the National Research, Development and Innovation Office (http://nkfih.gov.hu; NKFI-K109438 and NKFI-K116602 were granted to ZH, NKFI-K119701 was granted to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S, FASTQC QUALITY CONTR; Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Baksa I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2209-6; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Bond DM, 2014, TRENDS CELL BIOL, V24, P100, DOI 10.1016/j.tcb.2013.08.001; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dotto MC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004826; Fei QL, 2015, PLANT J, V83, P451, DOI 10.1111/tpj.12900; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Gao C, 2015, PLANT BIOTECHNOL J, V13, P370, DOI 10.1111/pbi.12297; Garcia D, 2008, SEMIN CELL DEV BIOL, V19, P586, DOI 10.1016/j.semcdb.2008.07.013; Ge AJ, 2013, PHYSIOL PLANTARUM, V148, P387, DOI 10.1111/j.1399-3054.2012.01713.x; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hwang DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064238; Kamthan A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00208; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar R, 2014, APPL BIOCHEM BIOTECH, V174, P93, DOI 10.1007/s12010-014-0914-2; Li BB, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1366397; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Li H, 2013, PLANTA, V238, P695, DOI 10.1007/s00425-013-1917-x; Liu ZB, 2017, GENE, V608, P66, DOI 10.1016/j.gene.2017.01.020; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez de Alba AE, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Qin ZR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00586; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Zhai JX, 2015, P NATL ACAD SCI USA, V112, P3146, DOI 10.1073/pnas.1418918112; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhang CQ, 2014, BIOINFORMATICS, V30, P1045, DOI 10.1093/bioinformatics/btt746; Zhang H, 2015, CURR OPIN PLANT BIOL, V27, P84, DOI 10.1016/j.pbi.2015.06.011; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	58	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200207	10.1371/journal.pone.0200207	http://dx.doi.org/10.1371/journal.pone.0200207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044813	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500033
J	Zoll, J; Verweij, PE; Melchers, WJG				Zoll, Jan; Verweij, Paul E.; Melchers, Willem J. G.			Discovery and characterization of novel Aspergillus fumigatus mycoviruses	PLOS ONE			English	Article							AZOLE RESISTANCE; DNA MYCOVIRUS; HYPOVIRULENCE; TRANSMISSION; DSRNAS	In the last few years, increasing numbers of viruses infecting fungi have been identified. In this study, we used an in silico approach for the analysis of deep RNA sequencing data in order to discover and characterize putative genomic ssRNA or dsRNA mycovirus sequences in Aspergillus fumigatus. RNA sequencing reads of A. fumigatus strains were mapped against the A. fumigatus Af293 reference genome. Unmapped reads were collected for de novo assembly. Contigs were analyzed by Blastx comparison with a mycovirus protein database. Assembled viral genomes were used as template for remapping of RNA sequencing reads. In total, deep RNA sequencing results from 11 A. fumigatus strains were analyzed for the presence of mycoviral genomic RNAs. In 9 out of 11 strains, putative mycoviral RNA genomes were identified. Three strains were infected with two different mycovirus species. Two strains were infected with Aspergillus fumigatus polymycovirus type-1 (AfuPmV-1). Four strains contained fully recovered genomic RNA of unknown narna-like viruses designated as Aspergillus fumigatus narnavirus-1 and Aspergillus fumigatus narnavirus-2 (AfuNV-1 and AfuNV-2). Both viruses showed 38% amino acid sequence identity to Beihai narna-like virus-21. Three strains contained partially recovered genomic RNA of an unknown narna-like virus. Two strains contained fully recovered genomic RNAs of an unknown partitivirus designated as Aspergillus fumigatus partitivirus-2 (AfuPV-2) which showed 50% amino acid sequence identity to Alternaria alternata partitivirus-1. Finally, one strain contained fully recovered genomic RNA of an unknown mitovirus designated as Aspergillus fumigatus mitovirus-1 (AfuMV-1) which showed 34% amino acid sequence identity to Sclerotina sclerotiorum mitovirus. In silico analysis of deep RNA sequencing results showed that a majority of the A. fumigatus strains used here were infected with mycoviruses. Four novel A. fumigatus RNA mycoviruses could be identified: two different Aspergillus fumigatus narna-like viruses, one Aspergillus fumigatus partitivirus, and one Aspergillus fumigatus mitovirus.	[Zoll, Jan] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; Ctr Expertise Mycol Radboudumc CWZ, Nijmegen, Netherlands	Radboud University Nijmegen	Zoll, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands.	jan.zoll@radboudumc.nl	Melchers, Willem/C-8819-2015; Verweij, P.E./H-8108-2014; Zoll, G.J./L-4776-2015	Melchers, Willem/0000-0002-5446-2230; Verweij, P.E./0000-0002-8600-9860; Zoll, G.J./0000-0003-2155-7935				Ballard E, 2018, FUNGAL GENET BIOL, V113, P1, DOI 10.1016/j.fgb.2018.02.003; Bartholomaus A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165965; Bhatti MF, 2012, MYCOPATHOLOGIA, V174, P323, DOI 10.1007/s11046-012-9556-5; Bhatti MF, 2011, ARCH VIROL, V156, P1677, DOI 10.1007/s00705-011-1045-5; Brusini J, 2013, J VIROL METHODS, V187, P435, DOI 10.1016/j.jviromet.2012.11.025; Ghabrial SA, 2015, VIROLOGY, V479, P356, DOI 10.1016/j.virol.2015.02.034; Kanhayuwa L, 2015, P NATL ACAD SCI USA, V112, P9100, DOI 10.1073/pnas.1419225112; Kotta-Loizou I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01699; Kotta-Loizou I, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006183; Liu WX, 2008, VIRUS GENES, V37, P322, DOI 10.1007/s11262-008-0265-6; Marzano SYL, 2016, J VIROL, V90, P6846, DOI 10.1128/JVI.00357-16; Mu F, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02540; Niu YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23807-3; Okada R, 2015, J GEN PLANT PATHOL, V81, P103, DOI 10.1007/s10327-014-0575-6; Osaki H, 2016, VIRUS GENES, V52, P835, DOI 10.1007/s11262-016-1379-x; Refos JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077381; Rowley PA, 2017, YEAST, V34, P279, DOI 10.1002/yea.3234; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; van de Sande WWJ, 2010, EUR J CLIN MICROBIOL, V29, P755, DOI 10.1007/s10096-010-0946-7; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; Verweij Paul E, 2016, Lancet Infect Dis, V16, pe251, DOI 10.1016/S1473-3099(16)30138-4; Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885; Wang LP, 2014, J VIROL, V88, P7517, DOI 10.1128/JVI.00538-14; Xavier AD, 2018, VIRUS RES, V244, P21, DOI 10.1016/j.virusres.2017.10.007; Xie JT, 2014, ANNU REV PHYTOPATHOL, V52, P45, DOI 10.1146/annurev-phyto-102313-050222; Yu X, 2013, P NATL ACAD SCI USA, V110, P1452, DOI 10.1073/pnas.1213755110; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107	27	25	26	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200511	10.1371/journal.pone.0200511	http://dx.doi.org/10.1371/journal.pone.0200511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044844	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500059
J	Vos, AM; Jurak, E; de Gijsel, P; Ohm, RA; Henrissat, B; Lugones, LG; Kabel, MA; Wosten, HAB				Vos, Aurin M.; Jurak, Edita; de Gijsel, Peter; Ohm, Robin A.; Henrissat, Bernard; Lugones, Luis G.; Kabel, Mirjam A.; Wosten, Han A. B.			Production of alpha-1,3-L-arabinofuranosidase active on substituted xylan does not improve compost degradation by Agaricus bisporus	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASES; MUSHROOM-COMPOST; SCYTALIDIUM-THERMOPHILUM; BIFIDOBACTERIUM-ADOLESCENTIS; WHEAT; POLYSACCHARIDES; HEMICELLULOSES; ARABINOXYLAN; PURIFICATION; SPECIFICITY	Agaricus bisporus consumes carbohydrates contained in wheat straw based compost used for commercial mushroom production. Double substituted arabinoxylan is part of the similar to 40% of the compost polysaccharides that are not degraded by A. bisporus during its growth and development. Genes encoding alpha-1,3-L- arabinofuranosidase (AXHd3) enzymes that act on xylosyl residues doubly substituted with arabinosyl residues are absent in this mushroom forming fungus. Here, the AXHd3 encoding hgh43 gene of Humicola insolens was expressed in A. bisporus with the aim to improve its substrate utilization and mushroom yield. Transformants secreted active AXHd3 in compost as shown by the degradation of double substituted arabinoxylan oligomers in an in vitro assay. However, carbohydrate composition and degree of arabinosyl substitution of arabinoxylans were not affected in compost possibly due to inaccessibility of the doubly substituted xylosyl residues.	[Vos, Aurin M.; Ohm, Robin A.; Lugones, Luis G.; Wosten, Han A. B.] Univ Utrecht, Dept Biol, Microbiol, Utrecht, Netherlands; [Jurak, Edita; de Gijsel, Peter; Kabel, Mirjam A.] Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Vos, Aurin M.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Jurak, Edita] Aalto Univ, Dept Bioprod & Biosyst, Espoo, Finland	Utrecht University; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Delft University of Technology; Aalto University	Vos, AM (corresponding author), Univ Utrecht, Dept Biol, Microbiol, Utrecht, Netherlands.; Vos, AM (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	A.M.Vos@tudelft.nl	Wösten, Han AB/K-2769-2016; Henrissat, Bernard/J-2475-2012; Ohm, Robin A/I-6689-2016; Jurak, Edita/AAM-2163-2020; Kabel, Mirjam/M-1051-2016	Wösten, Han AB/0000-0002-0399-3648; Henrissat, Bernard/0000-0002-3434-8588; Ohm, Robin A./0000-0003-2548-0074; Kabel, Mirjam/0000-0002-2787-7852; Jurak, Edita/0000-0003-4253-4556	Technology Foundation STW [11108]; technology programme of the Ministry of Economic Affairs	Technology Foundation STW(Technologiestichting STW); technology programme of the Ministry of Economic Affairs	This research was supported and approved by the Technology Foundation STW (11108; http://www.stw.nl/nl/content/how-mushrooms-feed-sugars), applied science division of NWO and the technology programme of the Ministry of Economic Affairs (The Netherlands) CNC Grondstoffen B.V. provided compost used in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baars JJP, 2013, BLOK C INPUT OUTPUT; Borsenberger V, 2014, BBA-GEN SUBJECTS, V1840, P3106, DOI 10.1016/j.bbagen.2014.07.001; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; Ferre H, 2000, EUR J BIOCHEM, V267, P6633, DOI 10.1046/j.1432-1327.2000.01758.x; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Gerrits JPG, 1988, CULTIVATION MUSHROOM, P29; Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A; Grabber JH, 2009, J SCI FOOD AGR, V89, P122, DOI 10.1002/jsfa.3418; Jurak E., 2015, THESIS WAGENINGEN U; Jurak E, 2015, PLOS ONE, V10, P1; Jurak E, 2015, CARBOHYD POLYM, V132, P359, DOI 10.1016/j.carbpol.2015.06.065; Jurak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134169; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kabel MA, 2017, APPL MICROBIOL BIOT, V101, P4363, DOI 10.1007/s00253-017-8294-5; KORMELINK FJM, 1993, J BIOTECHNOL, V27, P249, DOI 10.1016/0168-1656(93)90089-6; Koutaniemi S, 2016, J BIOTECHNOL, V229, P22, DOI 10.1016/j.jbiotec.2016.04.050; Kristensen JB, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-5; Lagaert S, 2010, BIOCHEM BIOPH RES CO, V402, P644, DOI 10.1016/j.bbrc.2010.10.075; LAWTHER JM, 1995, J AGR FOOD CHEM, V43, P667, DOI 10.1021/jf00051a021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez PM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0519-9; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Patyshakuliyeva A, 2015, ENVIRON MICROBIOL, V17, P3098, DOI 10.1111/1462-2920.12967; Pelkmans JF, 2016, APPL MICROBIOL BIOT, V100, P7151, DOI 10.1007/s00253-016-7574-9; PULS J, 1987, ENZYME MICROB TECH, V9, P83, DOI 10.1016/0141-0229(87)90147-5; ROSS RC, 1983, SCI HORTIC-AMSTERDAM, V20, P61, DOI 10.1016/0304-4238(83)90112-7; Sabotic J, 2016, APPL MICROBIOL BIOT, V100, P91, DOI 10.1007/s00253-015-7075-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; STRAATSMA G, 1993, MYCOL RES, V97, P321, DOI 10.1016/S0953-7562(09)81129-5; STRAATSMA G, 1989, J GEN MICROBIOL, V135, P751; STRAATSMA G, 1994, APPL ENVIRON MICROB, V60, P3049, DOI 10.1128/AEM.60.9.3049-3054.1994; Sun RC, 2002, IND CROP PROD, V15, P179, DOI 10.1016/S0926-6690(01)00112-1; Sun RC, 1996, CARBOHYD POLYM, V29, P325, DOI 10.1016/S0144-8617(96)00018-5; Sun RC, 1998, J AGR FOOD CHEM, V46, P2804, DOI 10.1021/jf971078a; SUN RC, 1995, IND CROP PROD, V4, P127, DOI 10.1016/0926-6690(95)00025-8; Sun XF, 2005, J AGR FOOD CHEM, V53, P860, DOI 10.1021/jf040456q; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V51, P606, DOI 10.1007/s002530051439; Vos AM, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0424-z	46	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201090	10.1371/journal.pone.0201090	http://dx.doi.org/10.1371/journal.pone.0201090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040824	Green Published, Green Submitted, gold			2022-12-27	WOS:000439749200024
J	Annibali, O; Piccioni, L; Tomarchio, V; Circhetta, E; Sarlo, C; Franceschini, L; Cantonetti, M; Rizzo, E; Angeletti, S; Tirindelli, MC; Scagnolari, C; Statzu, M; Avvisati, G; Riva, E				Annibali, Ombretta; Piccioni, Livia; Tomarchio, Valeria; Circhetta, Erika; Sarlo, Chiara; Franceschini, Luca; Cantonetti, Maria; Rizzo, Emanuela; Angeletti, Silvia; Tirindelli, Maria Cristina; Scagnolari, Carolina; Statzu, Maura; Avvisati, Giuseppe; Riva, Elisabetta			Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENETIC-VARIATION; INTERLEUKIN 28B; HCV CLEARANCE; IL28B; EXPRESSION; THERAPY; INFECTION; DISEASE	Cytomegalovirus (CMV) infection represents one of the main cause mortality after Stem Cell Transplantation. Recently, a protective effect of the T allele of rs12979860 IL28B Single Nucleotide Polymorphisms (SNPs) against CMV infection in the allogenic stem cell transplantation was suggested. We investigate whether the rs12979860 IL28B SNP and the relative rs368234815 (IFN lambda 4) genotype may affect the incidence of active CMV infection in Autologous stem cell transplantation (Auto-SCT) setting. The study included 99 patients who underwent to Auto-SCT. 1L28 and IFN Delta 4 SNPs were correlated with CMV reactivation along with other clinical and treatment parameters. CMV reactivation by CMV DNAemia was evaluated once a week until day 100 from Auto-SCT. CMV reactivation was documented in 50% (TT-Delta G/Delta G), 35% (CC-TT/TT) and 29.2% (CT-TT/Delta G) of the patients respectively. No differences in CMV copies number were recorded at reactivation between different IL28/IFN lambda 4 genotypes. The analysis of patients older than 60 years showed a significantly higher incidence of active CMV infection in the TT-Delta G/Delta G (83%) population with respect to CC-TT/TT (21%) and CT-TT/Delta G (40%) patients. Our data suggest a negative role of TT-Delta G/Delta G genotype in the CMV reactivation in Auto-SCT. The exposure to rituximab and the pre-infusion presence of anti CMV IgG also significantly influenced CMV reactivation.	[Annibali, Ombretta; Tomarchio, Valeria; Circhetta, Erika; Sarlo, Chiara; Avvisati, Giuseppe] Campus Biomed Univ, Unit Hematol, Stem Cell Transplantat, Rome, Italy; [Piccioni, Livia; Riva, Elisabetta] Campus Biomed Univ, Lab Virol, Rome, Italy; [Franceschini, Luca; Cantonetti, Maria; Rizzo, Emanuela] Tor Vergata Univ, Hematol & Stem Cell Transplant Unit, Rome, Italy; [Angeletti, Silvia] Campus Biomed Univ, Lab Pathol & Microbiol, Rome, Italy; [Tirindelli, Maria Cristina] Campus Biomed Univ, Transfus Med & Cellular Therapy, Rome, Italy; [Scagnolari, Carolina; Statzu, Maura] Sapienza Univ, Dept Mol Med, Lab Virol, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Sapienza University Rome	Riva, E (corresponding author), Campus Biomed Univ, Lab Virol, Rome, Italy.	e.riva@unicampus.it	riva, elisabetta/H-7729-2016; Piccioni, Livia/AAA-5032-2020; Cantonetti, Maria/AAB-9806-2019; SCAGNOLARI, CAROLINA/G-3837-2011	riva, elisabetta/0000-0002-6870-8780; CANTONETTI, Maria/0000-0003-4586-0920; SCAGNOLARI, CAROLINA/0000-0003-1044-1478				Assone T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003199; Bibert S, 2014, AIDS, V28, P1885, DOI 10.1097/QAD.0000000000000379; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bravo D, 2014, J MED VIROL, V86, P838, DOI 10.1002/jmv.23865; Chinnaswamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075495; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Egli A, 2014, J INFECT DIS, V210, P717, DOI 10.1093/infdis/jiu144; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Griffiths SJ, 2015, J INNATE IMMUN, V7, P231, DOI 10.1159/000369902; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Honda M, 2014, HEPATOLOGY, V59, P828, DOI 10.1002/hep.26788; Kamihira S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-40; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Loeffler J, 2006, J CLIN MICROBIOL, V44, P1847, DOI 10.1128/JCM.44.5.1847-1850.2006; Manuel O, 2015, J INFECT DIS, V211, P906, DOI 10.1093/infdis/jiu557; Marchesi Francesco, 2015, World J Transplant, V5, P129, DOI 10.5500/wjt.v5.i3.129; Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x; Murakawa M, 2015, J GASTROEN HEPATOL, V30, P1075, DOI 10.1111/jgh.12902; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rallon NI, 2012, J ANTIMICROB CHEMOTH, V67, P1246, DOI 10.1093/jac/dkr598; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Riva E, 2012, J VIRAL HEPATITIS, V19, P650, DOI 10.1111/j.1365-2893.2012.01606.x; Scagnolari C, 2012, VIRUS RES, V165, P236, DOI 10.1016/j.virusres.2012.02.018; Selvaggi C, 2014, J INFECTION, V68, P467, DOI 10.1016/j.jinf.2013.12.010; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	33	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200221	10.1371/journal.pone.0200221	http://dx.doi.org/10.1371/journal.pone.0200221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036376	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200010
J	Young, N; Taegtmeyer, M; Aol, G; Bigogo, GM; Phillips-Howard, PA; Hill, J; Laserson, KF; Ter Kuile, F; Desai, M				Young, Nicole; Taegtmeyer, Miriam; Aol, George; Bigogo, Godfrey M.; Phillips-Howard, Penelope A.; Hill, Jenny; Laserson, Kayla F.; Ter Kuile, Feiko; Desai, Meghna			Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INTERMITTENT PREVENTIVE TREATMENT; PREGNANT-WOMEN; CHILD HEALTH; SULFADOXINE-PYRIMETHAMINE; MIDDLE-INCOME; BURDEN; PREVALENCE; EPIDEMIOLOGY; COINFECTION	Background In sub-Saharan Africa, HIV, syphilis, malaria and anaemia are leading preventable causes of adverse pregnancy outcomes. In Kenya, policy states women should be tested for all four conditions (malaria only if febrile) at first antenatal care(ANC) visit. In practice, while HIV screening is conducted, coverage of screening for the others is suboptimal and early pregnancy management of illnesses is compromised. This is particularly evident at rural dispensaries that lack laboratories and have parallel programmes for HIV, reproductive health and malaria, resulting in fractured and inadequate care for women. Methods A longitudinal eight-month implementation study integrating point-of-care diagnostic tests for the four conditions into routine ANC was conducted in seven purposively selected dispensaries in western Kenya. Testing proficiency of healthcare workers was observed at initial training and at three monthly intervals thereafter. Adoption of testing was compared using ANC register data 8.5 months before and eight months during the intervention. Fidelity to clinical management guidelines was determined by client exit interviews with success defined as >= 90% adherence. Findings For first ANC visits at baseline (n = 529), testing rates were unavailable for malaria,low for syphilis (4.3%) and anaemia (27.8%),and near universal for HIV (99%). During intervention, over 95% of first attendees (n = 586) completed four tests and of those tested positive,. 70.6% received penicillin or erythromycin for syphilis, 65.5% and 48.3% received cotrimoxazole and antiretrovirals respectively for HIV, and 76.4% received artemether/lumefantrine, quinine or dihydroartemisinin-piperaquine correctly for malaria. Iron and folic supplements were given to nearly 90% of women but often at incorrect doses. Conclusions Integrating point-of-care testing into ANC at dispensaries with established HIV testing programmes resulted in a significant increase in testing rates, without disturbing HIV testing rates. While more cases were detected and treated, treatment fidelity still requires strengthening and an integrated monitoring and evaluation system needs to be established.	[Young, Nicole; Taegtmeyer, Miriam] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England; [Young, Nicole; Phillips-Howard, Penelope A.; Hill, Jenny; Ter Kuile, Feiko] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Aol, George; Bigogo, Godfrey M.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Laserson, Kayla F.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Desai, Meghna] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA	Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Young, N (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England.; Young, N (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.	niconico.young@gmail.com	Kuile, Feiko ter/ABD-6681-2020; Bigogo, Godfrey/W-3591-2019; Hill, Jenny/C-3839-2017	Kuile, Feiko ter/0000-0003-3663-5617; Hill, Jenny/0000-0003-1588-485X; Phillips-Howard, Penelope A/0000-0003-1018-116X; Taegtmeyer, Miriam/0000-0002-5377-2536	United States Agency for International Development; U.S. Centers for Disease Control and Prevention; U.S. CDC; KEMRI; crowd-sourced INDIEGOGO campaign; USAID	United States Agency for International Development(United States Agency for International Development (USAID)); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); KEMRI; crowd-sourced INDIEGOGO campaign; USAID(United States Agency for International Development (USAID))	This is a product of activities implemented as part of the learning agenda of the United States Government's Global Health Initiative in Kenya. The study was funded by United States Agency for International Development (https://www.usaid.gov/) through an inter-agency agreement with the U.S. Centers for Disease Control and Prevention and a cooperative agreement between U.S. CDC and KEMRI, as well as a crowd-sourced INDIEGOGO campaign (https://www.indiegogo.com/projects/protect-pregnant-women-and-their-unborn-children#/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript has been approved by the Director of KEMRI, and is a product of activities implemented as part of the learning agenda of the United States Government's Global Health Initiative in Kenya. The study was funded by USAID and a crowd-sourced INDIEGOGO campaign.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Baker Ulrika, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS43, DOI 10.1016/j.ijgo.2015.04.017; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Huynh BT, 2015, CLIN INFECT DIS, V60, P598, DOI 10.1093/cid/ciu848; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Chico RM, 2011, TROP MED INT HEALTH, V16, P774, DOI 10.1111/j.1365-3156.2011.02765.x; Colombini M, 2014, AIDS CARE, V26, P914, DOI 10.1080/09540121.2013.869539; Cuadros DF, 2011, INT J EPIDEMIOL, V40, P931, DOI 10.1093/ije/dyq256; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; de Jongh TE, 2016, BJOG-INT J OBSTET GY, V123, P549, DOI 10.1111/1471-0528.13898; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Desai M, 2016, CLIN INFECT DIS, V62, P323, DOI 10.1093/cid/civ881; Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4; Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4; Druce N, 2006, STRENGTHENING LINKAG; Druce N, 2007, REPROD HEALTH MATTER, V15, P190, DOI 10.1016/S0968-8080(07)30337-6; Eaton JW, 2014, AIDS, V28, pS507, DOI 10.1097/QAD.0000000000000412; Eleanor Fleming JO, 2013, J SEXUALLY TRANSMITT; FIUMARA N J, 1975, Clinical Obstetrics and Gynecology, V18, P183, DOI 10.1097/00003081-197503000-00016; Fowkes FJI, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0753-9; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/ERI.11.167, 10.1586/eri.11.167]; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Heiby J, 2014, INT J QUAL HEALTH C, V26, P117, DOI 10.1093/intqhc/mzt093; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064913; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Kavle JA, 2008, J HEALTH POPUL NUTR, V26, P232; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lara AM, 2005, J CLIN PATHOL, V58, P56, DOI 10.1136/jcp.2004.018366; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Mallma P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149568; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Marum E, 2012, JAIDS-J ACQ IMM DEF, V60, pS63, DOI 10.1097/QAI.0b013e31825f313b; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Ministry of Health Kenya, 2012, NAT GUID QUAL OBST P; Ministry of Health Kenya, 2016, KEN REPR MAT NEWB CH; Ministry of Health Kenya, 2013, NAT IR FOL AC SUPPL; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; Newman Owiredu Morkor, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS27, DOI 10.1016/j.ijgo.2015.04.010; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Orish VN, 2013, INT J GYNECOL OBSTET, V120, P236, DOI 10.1016/j.ijgo.2012.09.021; Otieno-Nyunya B, 2011, SEX TRANSM INFECT, V87, P521, DOI 10.1136/sextrans-2011-050026; Ouma PO, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-1; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Peeling RW, 2004, LANCET, V364, P1561, DOI 10.1016/S0140-6736(04)17327-3; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Riley C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145616; Rogerson SJ, 2018, LANCET INFECT DIS, V18, pE107, DOI 10.1016/S1473-3099(18)30066-5; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Stoltzfus RJ, 2011, J NUTR, V141, p756S, DOI 10.3945/jn.110.128793; Tagbor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132247; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; The Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2012, REG FACT SHEET 2012; The Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2015, FAST TRACK ACC ACT E; The United States Agency for International Development, DEM HLTH SURV PROGR; The United States Agency for International Development (USAID), 2017, MAL OP PLAN FY 2017; The United States Agency for International Development (USAID) Population Council, 2006, ACC SUST WHO FOC ANT; Turan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044181; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Walker PGT, 2014, LANCET GLOB HEALTH, V2, pE460, DOI 10.1016/S2214-109X(14)70256-6; WHO, 2016, WHO TECH REP SER, V997, P1; WHO, 2011, WHO TECH REP SER, V959, P1; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2016, WHO GUIDELINES TREAT; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X	77	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0198784	10.1371/journal.pone.0198784	http://dx.doi.org/10.1371/journal.pone.0198784			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028852	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900001
J	Castellote, JM; Kofler, M				Castellote, Juan M.; Kofler, Markus			StartReact effects in first dorsal interosseous muscle are absent in a pinch task, but present when combined with elbow flexion	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; MOVEMENT-RELATED ACTIVATION; STARTLING ACOUSTIC STIMULI; CHOICE-REACTION TIME; AUDITORY STARTLE; FUNCTIONAL-ORGANIZATION; ELECTRICAL-STIMULATION; DESCENDING PATHWAYS; MOTOR PREPARATION; STROKE SURVIVORS	Objective To provide a neurophysiological tool for assessing sensorimotor pathways, which may differ for those involving distal muscles in simple tasks from those involving distal muscles in a kinetic chain task, or proximal muscles in both. Methods We compared latencies and magnitudes of motor responses in a reaction time paradigm in a proximal (biceps brachii, BB) and a distal (first dorsal interosseous, FDI) muscle following electrical stimuli used as imperative signal (IS) delivered to the index finger. These stimuli were applied during different motor tasks: simple tasks involving either one muscle, e.g. flexing the elbow for BB (FLEX), or pinching a pen for FDI (PINCH); combined tasks engaging both muscles by pinching and flexing simultaneously (PINCH-FLEX). Stimuli were of varying intensity and occasionally elicited a startle response, and a StartReact effect. Results In BB, response latencies decreased gradually and response amplitudes increased progressively with increasing IS intensities for non-startling trials, while for trials containing startle responses, latencies were uniformly shortened and response amplitudes similarly augmented across all IS intensities in both FLEX and PINCH-FLEX. In FDI, response latencies decreased gradually and response amplitudes increased progressively with increasing IS intensities in both PINCH and PINCH-FLEX for non-startling trials, but, unlike in BB for the simple task, in PINCH for trials containing startle responses as well. In PINCH-FLEX, FDI latencies were uniformly shortened and amplitudes similarly increased across all stimulus intensities whenever startle signs were present. Conclusions Our results suggest the presence of different sensorimotor pathways supporting a dissociation between simple tasks that involve distal upper limb muscles (FDI in PINCH) from simple tasks involving proximal muscles (BB in FLEX), and combined tasks that engage both muscles (FDI and BB in PINCH-FLEX), all in accordance with differential importance in the control of movements by cortical and subcortical structures. Significance Simple assessment tools may provide useful information regarding the differential involvement of sensorimotor pathways in the control of both simple and combined tasks that engage proximal and distal muscles.	[Castellote, Juan M.] Carlos III Inst Hlth, Natl Sch Occupat Med, Madrid, Spain; [Castellote, Juan M.] Univ Complutense Madrid, Radiol, Rehabil & Physiotherapy, Madrid, Spain; [Kofler, Markus] Hochzirl Hosp, Dept Neurol, Zirl, Austria	Instituto de Salud Carlos III; Escuela Nacional de Medicina del Trabajo (ENMT); Complutense University of Madrid	Castellote, JM (corresponding author), Carlos III Inst Hlth, Natl Sch Occupat Med, Madrid, Spain.; Castellote, JM (corresponding author), Univ Complutense Madrid, Radiol, Rehabil & Physiotherapy, Madrid, Spain.	jmcastel@isciii.es	Kofler, Markus/P-5585-2019; Castellote, Juan M./ABG-4178-2020	Kofler, Markus/0000-0002-2962-0903; Castellote, Juan/0000-0002-7242-8730	Instituto de Salud Carlos III [ESPY-112/18]; Government of Spain [PRX12/00349]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of Spain(Spanish Government)	All the funding received during this study are grants ESPY-112/18 from Instituto de Salud Carlos III and PRX12/00349 from Government of Spain to J. M. Castellote. There was no additional external funding received for this study.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Alvarez-Blanco S, 2009, EXP BRAIN RES, V195, P285, DOI 10.1007/s00221-009-1784-7; Baker S. N., 2017, J NEUROSCI, V37, P3368, DOI DOI 10.1523/JNEUROSCI.3368-16; BALDISSERA F, 1993, EXP BRAIN RES, V96, P513; Bernstein N A., 1967, COORDINATION REGULAT; Blouin JS, 2006, J PHYSIOL-LONDON, V573, P857, DOI 10.1113/jphysiol.2006.108274; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; BRUHN P, 1977, CORTEX, V13, P373, DOI 10.1016/S0010-9452(77)80018-X; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; Carlsen AN, 2003, EXP BRAIN RES, V152, P510, DOI 10.1007/s00221-003-1575-5; Carlsen AN, 2007, EXP BRAIN RES, V176, P199, DOI 10.1007/s00221-006-0610-8; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2010, BRAIN RES, V1322, P38, DOI 10.1016/j.brainres.2010.01.076; Carlsen AN, 2009, J NEUROPHYSIOL, V101, P306, DOI 10.1152/jn.00878.2007; Castellote JM, 2015, CLIN NEUROPHYSIOL, V126, P1879, DOI 10.1016/j.clinph.2015.01.028; Castellote JM, 2004, EXP BRAIN RES, V158, P35, DOI 10.1007/s00221-004-1866-5; Castellote JM, 2007, EXP BRAIN RES, V177, P129, DOI 10.1007/s00221-006-0659-4; Castellote JM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8471546; Castellote JM, 2012, J NEUROPHYSIOL, V108, P2501, DOI 10.1152/jn.01111.2011; Cattell J.M., 1886, BRAIN, V8, P512, DOI [DOI 10.1093/BRAIN/8.4.512, 10.1093/brain/8.4.512]; Chae J, 1998, AM J PHYS MED REHAB, V77, P516, DOI 10.1097/00002060-199811000-00013; Chae J, 2000, ASSIST TECHNOL, V12, P33, DOI 10.1080/10400435.2000.10132008; COLEBATCH JG, 1990, BRAIN, V113, P1843, DOI 10.1093/brain/113.6.1843; Davis M, 2008, REV NEUROSCIENCE, V19, P171; de Noordhout AM, 1999, BRAIN, V122, P1327, DOI 10.1093/brain/122.7.1327; Dean JC, 2013, EXERC SPORT SCI REV, V41, P36, DOI 10.1097/JES.0b013e3182724bb0; Dean LR, 2017, J NEUROPHYSIOL, V117, P1713, DOI 10.1152/jn.01009.2015; Delval A, 2012, NEUROSCIENCE, V219, P166, DOI 10.1016/j.neuroscience.2012.05.032; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Ferber-Viart C, 1999, ACTA OTO-LARYNGOL, V119, P6; Grosse P, 2003, J NEUROPHYSIOL, V90, P1654, DOI 10.1152/jn.00125.2003; Haaland KY, 2012, ARCH PHYS MED REHAB, V93, P1957, DOI 10.1016/j.apmr.2012.05.011; HATAYAMA T, 1993, PERCEPT MOTOR SKILL, V76, P1139, DOI 10.2466/pms.1993.76.3c.1139; Honeycutt CF, 2015, CLIN NEUROPHYSIOL, V126, P160, DOI 10.1016/j.clinph.2014.05.025; Honeycutt CF, 2013, J NEUROPHYSIOL, V110, P1476, DOI 10.1152/jn.00866.2012; Ibitoye MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149024; Ilamkar KR, 2014, J CLIN DIAGN RES, V8, P124, DOI 10.7860/JCDR/2014/7221.4026; JASKOWSKI P, 1994, PERCEPT MOTOR SKILL, V79, P995; Jones TA, 2015, PHYSIOLOGY, V30, P358, DOI 10.1152/physiol.00014.2015; Kesar TM, 2010, PHYS THER, V90, P55, DOI 10.2522/ptj.20090140; Kofler M, 2003, CLIN NEUROPHYSIOL, V114, P973, DOI 10.1016/S1388-2457(03)00060-9; Kofler M, 2001, BRAIN RES, V921, P206, DOI 10.1016/S0006-8993(01)03120-1; Kofler M, 2001, CLIN NEUROPHYSIOL, V112, P1053, DOI 10.1016/S1388-2457(01)00540-5; KOHFELD DL, 1971, J EXP PSYCHOL, V88, P251, DOI 10.1037/h0030891; Kuypers H. G. J. M, 1981, HDB PHYSL 1 1, VII; Lakhani B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036407; Landis C, 1939, STARTLE PATTERN; Lang CE, 2007, NEUROREHAB NEURAL RE, V21, P279, DOI 10.1177/1545968306296964; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; LEMON RN, 1995, J NEUROSCI, V15, P6145; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; MacDonald SWS, 2008, PSYCHOL AGING, V23, P595, DOI 10.1037/0882-7974.23.3.595; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Marinovic W, 2016, NEUROSCI LETT, V618, P134, DOI 10.1016/j.neulet.2016.03.009; Marinovic W, 2015, PSYCHOPHYSIOLOGY, V52, P1698, DOI 10.1111/psyp.12540; Marinovic W, 2015, J NEUROPHYSIOL, V113, P3455, DOI 10.1152/jn.00154.2015; Marinovic W, 2014, J PHYSIOL-LONDON, V592, P153, DOI 10.1113/jphysiol.2013.254581; Marinovic W, 2013, J NEUROPHYSIOL, V109, P996, DOI 10.1152/jn.01119.2011; Maslovat D, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12300; Maslovat D, 2014, J EXP PSYCHOL HUMAN, V40, P2005, DOI 10.1037/a0037522; Maslovat D, 2011, BEHAV NEUROSCI, V125, P226, DOI 10.1037/a0022567; MATSUMOTO J, 1992, ANN NEUROL, V32, P41, DOI 10.1002/ana.410320108; Nieuwenhuijzen PHJA, 2000, J NEUROPHYSIOL, V84, P65, DOI 10.1152/jn.2000.84.1.65; Nonnekes J, 2014, J NEUROL, V261, P943, DOI 10.1007/s00415-014-7304-0; Nonnekes J, 2014, J NEUROSCI, V34, P275, DOI 10.1523/JNEUROSCI.2948-13.2014; Pertovaara A, 1996, EXP BRAIN RES, V107, P497; Pieron H, 1913, ANN PSYCHOL, V20, P17; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; POSNER MI, 1966, SCIENCE, V152, P1712, DOI 10.1126/science.152.3730.1712; Queralt A, 2008, J PHYSIOL-LONDON, V586, P4453, DOI 10.1113/jphysiol.2008.156042; Queralt A, 2008, EXP BRAIN RES, V185, P603, DOI 10.1007/s00221-007-1185-8; Queralt A, 2010, GAIT POSTURE, V31, P185, DOI 10.1016/j.gaitpost.2009.10.003; Ramchurn A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00557; Reynolds RF, 2007, J PHYSIOL-LONDON, V583, P1107, DOI 10.1113/jphysiol.2007.136192; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Sanegre MT, 2004, EXP BRAIN RES, V155, P527, DOI 10.1007/s00221-004-1849-6; Sathian K, 2011, NEUROREHAB NEURAL RE, V25, p21S, DOI 10.1177/1545968311410941; Serrien B, 2017, HUM MOVEMENT SCI, V55, P156, DOI 10.1016/j.humov.2017.08.009; Sheffler LR, 2015, PHYS MED REH CLIN N, V26, P611, DOI 10.1016/j.pmr.2015.06.006; Siegmund GP, 2001, J PHYSIOL-LONDON, V535, P289, DOI 10.1111/j.1469-7793.2001.00289.x; Stevenson AJT, 2014, NEUROSCIENCE, V269, P21, DOI 10.1016/j.neuroscience.2014.03.041; Stuss D., 1994, NEUROPSYCHOLOGY, V8, P316, DOI [DOI 10.1037/0894-4105.8.3.316, DOI 10.1037//0894-4105.8.3.316]; Thevathasan W, 2011, BRAIN, V134, P2085, DOI 10.1093/brain/awr131; Tresilian JR, 2006, NEUROSCIENCE, V142, P579, DOI 10.1016/j.neuroscience.2006.06.029; Valldeoriola F, 1998, NEUROLOGY, V51, P1315, DOI 10.1212/WNL.51.5.1315; Valls-Sole J, 2005, EXP BRAIN RES, V165, P541, DOI 10.1007/s00221-005-2332-8; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole Josep, 2004, Suppl Clin Neurophysiol, V57, P554; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; Valls-Sole J, 2012, J PAIN, V13, P620, DOI 10.1016/j.jpain.2011.11.003; Valls-Sole J, 2012, CLIN NEUROPHYSIOL, V123, P13, DOI 10.1016/j.clinph.2011.04.029; VallsSole J, 1997, BRAIN RES, V751, P155, DOI 10.1016/S0006-8993(97)00027-9; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Varoqui D, 2011, MOTOR CONTROL, V15, P187, DOI 10.1123/mcj.15.2.187; Winges SA, 2008, J NEUROPHYSIOL, V99, P1119, DOI 10.1152/jn.01059.2007; Yeomans JS, 2002, NEUROSCI BIOBEHAV R, V26, P1, DOI 10.1016/S0149-7634(01)00057-4; Zaaimi B, 2018, J NEUROPHYSIOL, V119, P235, DOI 10.1152/jn.00672.2017; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	101	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201301	10.1371/journal.pone.0201301	http://dx.doi.org/10.1371/journal.pone.0201301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048503	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400071
J	Mirzakhalili, E; Epureanu, BI; Gourgou, E				Mirzakhalili, Ehsan; Epureanu, Bogdan I.; Gourgou, Eleni			A mathematical and computational model of the calcium dynamics in Caenorhabditis elegans ASH sensory neuron	PLOS ONE			English	Article							C-ELEGANS; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NERVOUS-SYSTEM; TRP CHANNELS; CA2+ ATPASE; RECEPTOR; RETICULUM; EXPRESSION; GENE	We propose a mathematical and computational model that captures the stimulus-generated Ca2+ transients in the C. elegans ASH sensory neuron. The rationale is to develop a tool that will enable a cross-talk between modeling and experiments, using modeling results to guide targeted experimental efforts. The model is built based on biophysical events and molecular cascades known to unfold as part of neurons' Ca2+ homeostasis mechanism, as well as on Ca2+ signaling events. The state of ion channels is described by their probability of being activated or inactivated, and the remaining molecular states are based on biochemically defined kinetic equations or known biochemical motifs. We estimate the parameters of the model using experimental data of hyperosmotic stimulus-evoked Ca2+ transients detected with a FRET sensor in young and aged worms, unstressed and exposed to oxidative stress. We use a hybrid optimization method composed of a multi-objective genetic algorithm and nonlinear least-squares to estimate the model parameters. We first obtain the model parameters for young unstressed worms. Next, we use these values of the parameters as a starting point to identify the model parameters for stressed and aged worms. We show that the model, in combination with experimental data, corroborates literature results. In addition, we demonstrate that our model can be used to predict ASH response to complex combinations of stimulation pulses. The proposed model includes for the first time the ASH Ca2+ dynamics observed during both "on" and "off" responses. This mathematical and computational effort is the first to propose a dynamic model of the Ca2+ transients' mechanism in C. elegans neurons, based on biochemical pathways of the cell's Ca2+ homeostasis machinery. We believe that the proposed model can be used to further elucidate the Ca2+ dynamics of a key C. elegans neuron, to guide future experiments on C. elegans neurobiology, and to pave the way for the development of more mathematical models for neuronal Ca2+ dynamics.	[Mirzakhalili, Ehsan; Epureanu, Bogdan I.; Gourgou, Eleni] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Gourgou, Eleni] Univ Michigan, Sch Med, Dept Internal Med, Div Geriatr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gourgou, E (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Gourgou, E (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Geriatr, Ann Arbor, MI 48109 USA.	egourgou@umich.edu	Gourgou, Eleni/AAC-9120-2019; Mirzakhalili, Ehsan/ABD-1511-2021	Gourgou, Eleni/0000-0003-1561-5545; Mirzakhalili, Ehsan/0000-0002-1926-0035	National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation [1161874]	National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation(National Science Foundation (NSF))	The authors acknowledge the National Science Foundation Division of Civil, Mechanical and Manufacturing Innovation for the support of this work (Grant 1161874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Alemany R, 2007, BBA-BIOMEMBRANES, V1768, P964, DOI 10.1016/j.bbamem.2006.09.024; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bansaghi S, 2014, J BIOL CHEM; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bargmann Cornelia I, 2006, WormBook, P1; Baylis HA, 1999, J MOL BIOL, V294, P467, DOI 10.1006/jmbi.1999.3229; Baylis HA, 2012, BBA-GEN SUBJECTS, V1820, P1253, DOI 10.1016/j.bbagen.2011.11.009; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bogeski I, 2014, ANTIOXID REDOX SIGN, V21, P859, DOI 10.1089/ars.2014.6019; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; Cho JH, 2000, GENE, V261, P211, DOI 10.1016/S0378-1119(00)00536-9; Chokshi TV, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3615821; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Chung SH, 2013, IN VIVO NEURONAL CAL; Croisier H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069598; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Gao J, 1998, PFLUG ARCH EUR J PHY, V435, P479, DOI 10.1007/s004240050542; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Goodman MB, 2012, METHOD CELL BIOL, V107, P409, DOI 10.1016/B978-0-12-394620-1.00014-X; Gourgou E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38147; Gower NJD, 2001, J MOL BIOL, V306, P145, DOI 10.1006/jmbi.2000.4388; Guo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6655; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616; Kato HK, 2012, J PHYSIOL-LONDON, V590, P3019, DOI 10.1113/jphysiol.2012.232942; Kato S, 2014, NEURON, V81, P616, DOI 10.1016/j.neuron.2013.11.020; KAY AR, 1987, J PHYSIOL-LONDON, V392, P603, DOI 10.1113/jphysiol.1987.sp016799; Keener J., 2009, MATH PHYSL, V1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kilts JD, 2002, J BIOL CHEM, V277, P31257, DOI 10.1074/jbc.M203640200; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kraev A, 1999, J BIOL CHEM, V274, P4254, DOI 10.1074/jbc.274.7.4254; Krzyzanowski MC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003619; Kuramochi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168415; Larsch J, 2015, CELL REP, V12, P1748, DOI 10.1016/j.celrep.2015.08.032; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Laurent P, 2015, ELIFE, V4, DOI 10.7554/eLife.04241; Lee JC, 2014, J MOL HISTOL, V45, P497, DOI 10.1007/s10735-014-9578-z; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; Li G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13234; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Lindsay TH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1304; Lockery SR, 2009, NAT NEUROSCI, V12, P365, DOI 10.1038/nn0409-365; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; Lombardi MS, 2002, MOL PHARMACOL, V62, P379, DOI 10.1124/mol.62.2.379; Lushington GH, 2005, J MOL GRAPH MODEL, V24, P175, DOI 10.1016/j.jmgm.2005.07.003; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Michaelis ML, 1996, LIFE SCI, V59, P405, DOI 10.1016/0024-3205(96)00319-0; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Murchison D, 1999, CELL CALCIUM, V25, P439, DOI 10.1054/ceca.1999.0048; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; Nikoletopoulou Vassiliki, 2012, Frontiers in Genetics, V3, P200, DOI 10.3389/fgene.2012.00200; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nishida M, 2013, BIOCHEM BIOPH RES CO, V434, P210, DOI 10.1016/j.bbrc.2013.03.040; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; Ogawa N, 2016, J BIOL CHEM, V291, P4197, DOI 10.1074/jbc.M115.700278; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Praitis V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003506; Rakowski F, 2013, FRONTIERS COMPUTATIO, V7, P11911, DOI [10.1523/JNEUROSCI.0594-09.2009, DOI 10.1523/JNEUROSCI.0594-09.2009]; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Roayaie K, 1998, NEURON; Sassa T, 2013, NEUROSCI LETT, V555, P248, DOI 10.1016/j.neulet.2013.06.001; Sharma V, 2017, J BIOL CHEM; Sharma V, 2013, GENETICS, V195, P611, DOI 10.1534/genetics.113.153106; Shipley FB, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00028; Tang YH, 1996, BIOPHYS J, V70, P246, DOI 10.1016/S0006-3495(96)79567-X; Tanimoto Y, 2017, ELIFE, V6, DOI 10.7554/eLife.21629; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Thiele TR, 2009, J NEUROSCI, V29, P11904, DOI 10.1523/JNEUROSCI.0594-09.2009; Todorovic SM, 2014, ANTIOXID REDOX SIGN, V21, P880, DOI 10.1089/ars.2013.5610; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Wang W, 2015, BIOCHEM BIOPH RES CO, V461, P463, DOI 10.1016/j.bbrc.2015.04.017; Williams PDE, 2018, J NEUROSCIENCE; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Xiao R, 2011, ADV EXP MED BIOL, V704, P323, DOI 10.1007/978-94-007-0265-3_18; Ye JX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062714; Zahratka JA, 2015, J NEUROPHYSIOL, V113, P1041, DOI 10.1152/jn.00665.2014; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhao J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00058; Zou W, 2017, POLYM RESPONSES C EL, V7, P42295, DOI [10.1038/srep42295, DOI 10.1038/SREP42295]; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	111	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201302	10.1371/journal.pone.0201302	http://dx.doi.org/10.1371/journal.pone.0201302			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048509	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400072
J	Popov, VV; Nechaev, DI; Supin, AY; Sysueva, EV				Popov, Vladimir V.; Nechaev, Dmitry I.; Supin, Alexander Ya.; Sysueva, Evgeniya V.			Adaptation processes in the auditory system of a beluga whale Delphinapterus leucas	PLOS ONE			English	Article							SHORT-TERM ADAPTATION; NERVE FIBERS; RESPONSES; MASKING; POTENTIALS; RECOVERY; STIMULI; RANGE; MODEL	The effects of prolonged sound stimuli (tone pip trains) on evoked potentials (the rate following response, RFR) were investigated in a beluga whale. The stimuli (rhythmic tone pips) were of 64 kHz frequency at levels from 80 to 140 dB re 1 mu Pa. During stimulation, every 1000 ms stimulus level either was kept constant (the steady-state stimulation) or changed up/down by 20 or 40 dB. With such stimulus presentation manner, RFR amplitude varied as follows. (i) After a stimulus level increase, the response amplitude increased quickly and then decayed slowly. The more the level increased, the higher the response amplitude increased. (ii) After a stimulus level decrease, the response amplitude was suppressed and then recovered slowly. The more the level decreased, the stronger was the response suppression. (iii) At the end of the 1000 ms window, the response amplitude approached, but did not reach, the amplitude characteristic of the steady-state stimulation. As a result, both after a sound level increase and decrease, the responses were almost stabilized during an analysis time as short as 1 s. This stabilization is attributed to an adaptation process. RFR decay after initial increase could be approximated by an exponent with a time constant of 59.4 +/- 1.8 (standard error) ms; RFR recovery after initial decrease could be approximated by an exponent with a time constant of 139.2 +/- 9.9 ms.	[Popov, Vladimir V.; Nechaev, Dmitry I.; Supin, Alexander Ya.; Sysueva, Evgeniya V.] Russian Acad Sci, Inst Ecol & Evolut, Lab Sensory Syst Vertebrates, Moscow, Russia	Russian Academy of Sciences	Popov, VV (corresponding author), Russian Acad Sci, Inst Ecol & Evolut, Lab Sensory Syst Vertebrates, Moscow, Russia.	popov.vl.vl@gmail.com	Popov, Vladimir V/J-6534-2018	Popov, Vladimir/0000-0002-7542-9093	Russian Foundation for Basic Research [15-04-01068]; Russian Science Foundation [17-74-20107]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The Russian Foundation for Basic Research (grant 15-04-01068 http://www.rfbr.ru/rffi/eng) awarded to V.V.P. had a role in the study design and methodology. The Russian Science Foundation (project No.17-74-20107 http://rscf.ru/en) awarded to E.V.S. had a role in providing the research resource base, data collection and analysis and animal care.	Au W. W., 1993, SONAR DOLPHINS; Au W.W.L., 2008, PRINCIPLES MARINE BI; CHIMENTO TC, 1991, J ACOUST SOC AM, V90, P263, DOI 10.1121/1.401296; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; EGGERMONT JJ, 1973, AUDIOLOGY, V12, P221; EGGERMONT JJ, 1985, HEARING RES, V18, P57, DOI 10.1016/0378-5955(85)90110-8; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; HEWITT MJ, 1991, J ACOUST SOC AM, V90, P904, DOI 10.1121/1.401957; HUANG CM, 1981, ELECTROEN CLIN NEURO, V52, P394, DOI 10.1016/0013-4694(81)90021-3; Kiang NYS, 1965, DISCHARGE PATTERNS S; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; MEDDIS R, 1988, J ACOUST SOC AM, V83, P1056, DOI 10.1121/1.396050; Popov VV, 2016, J ACOUST SOC AM, V139, P1101, DOI 10.1121/1.4943554; Popov VV, 1998, J COMP PHYSIOL A, V183, P9; SMITH RL, 1979, J ACOUST SOC AM, V65, P166, DOI 10.1121/1.382260; SMITH RL, 1977, J NEUROPHYSIOL, V40, P1098, DOI 10.1152/jn.1977.40.5.1098; SMITH RL, 1980, BRAIN RES, V184, P499, DOI 10.1016/0006-8993(80)90817-3; SMITH RL, 1975, BIOL CYBERN, V17, P169, DOI 10.1007/BF00364166; SMITH RL, 1982, BIOL CYBERN, V44, P107, DOI 10.1007/BF00317970; Supin A.Y., 2001, SENSORY PHYSL AQUATI, DOI 10.1007/978-1-4615-1647-7; Wen B, 2012, J NEUROPHYSIOL, V108, P69, DOI 10.1152/jn.00055.2012; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; Wiemeister NF, 1988, HEARING RES, V34, P367; YOUNG E, 1973, J ACOUST SOC AM, V54, P1535, DOI 10.1121/1.1914451	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201121	10.1371/journal.pone.0201121	http://dx.doi.org/10.1371/journal.pone.0201121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048516	Green Submitted, gold, Green Published			2022-12-27	WOS:000439952400051
J	Taito, S; Taito, M; Banno, M; Tsujimoto, H; Kataoka, Y; Tsujimoto, Y				Taito, Shunsuke; Taito, Mahoko; Banno, Masahiro; Tsujimoto, Hiraku; Kataoka, Yuki; Tsujimoto, Yasushi			Rehabilitation for patients with sepsis: A systematic review and meta-analysis	PLOS ONE			English	Review							INTENSIVE-CARE-UNIT; ACUTE RESPIRATORY-FAILURE; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; CRITICAL ILLNESS; PHYSICAL REHABILITATION; MECHANICAL VENTILATION; CLINICAL-RESEARCH; SURVIVORS; MOBILIZATION	The objective of this systematic review was to determine whether rehabilitation impacts clinically relevant outcomes among adult patients with sepsis. Randomized controlled trials from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PEDro, and the World Health Organization International Clinical Trials Platform Search Portal, as well as conference proceedings and reference lists of relevant articles were collected. Two reviewers independently identified randomized controlled trials on the rehabilitation of patients with sepsis, and the two reviewers independently abstracted trial level data including population characteristics, interventions, comparisons, and clinical outcomes. Our primary outcomes were quality of life (QOL), activity of daily living (ADL), and mortality. Our secondary outcomes were length of stay, return to work, muscle strength, delirium, and all adverse events. The quality of evidence was determined using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. We included two trials enrolling 75 patients. The mean difference (95% confidence interval [CI]) of physical function and physical role in QOL measured by SF-36 were 21.10 (95% CI: 6.57 +/- 35.63) and 44.40 (95% CI: 22.55 +/- 66.05), respectively. Rehabilitation did not significantly decrease intensive care unit (ICU) mortality (risk ratio, 2.02 [95% CI: 0.46 +/- 8.91], I-2 = 0%; n = 75). ICU length of stay and hospital length of stay and muscle strength were not statistically significantly different and no adverse events were reported in both studies. The certainty of the evidence for these outcomes was "very low." Data on ADL, return to work, and delirium were not available in any of the trials. Rehabilitation of patients with sepsis might not decrease ICU mortality, but might improve QOL. Further, well-designed trials measuring important outcomes will be needed to determine the benefit and harm of rehabilitation among patients with sepsis.	[Taito, Shunsuke] Hiroshima Univ Hosp, Dept Clin Practice & Support, Div Rehabil, Hiroshima, Japan; [Taito, Mahoko] Hiroshima Univ Hosp, Dept Nursing, Hiroshima, Japan; [Banno, Masahiro] Seichiryo Hosp, Dept Psychiat, Nagoya, Aichi, Japan; [Banno, Masahiro] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi, Japan; [Tsujimoto, Hiraku; Kataoka, Yuki] Hyogo Prefectural Amagasaki Gen Med Ctr, Hosp Care Res Unit, Amagasaki, Hyogo, Japan; [Kataoka, Yuki] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan; [Tsujimoto, Yasushi] Kyoto Univ, Grad Sch Med, Dept Healthcare Epidemiol, Sch Publ Hlth, Kyoto, Japan; [Tsujimoto, Yasushi] Kyoritsu Hosp, Dept Nephrol & Dialysis, Himeji, Hyogo, Japan	Hiroshima University; Hiroshima University; Nagoya University; Kyoto University	Taito, S (corresponding author), Hiroshima Univ Hosp, Dept Clin Practice & Support, Div Rehabil, Hiroshima, Japan.	shutaitou@gmail.com	KATAOKA, Yuki/GRR-4808-2022; Banno, Masahiro/E-5341-2010; KATAOKA, Yuki/I-6026-2019; Taito, Shunsuke/V-3664-2019; Tsujimoto, Hiraku/AAL-7554-2020	KATAOKA, Yuki/0000-0001-7982-5213; Banno, Masahiro/0000-0002-2539-1031; KATAOKA, Yuki/0000-0001-7982-5213; Tsujimoto, Hiraku/0000-0002-5847-4132; Tsujimoto, Yasushi/0000-0002-7214-5589	JSPS KAKENHI [JP18K17719]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP18K17719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Battle CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116304; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Connolly B, 2016, J CACHEXIA SARCOPENI, V7, P520, DOI 10.1002/jcsm.12146; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc12616; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Garnacho-Montero J, 2001, INTENS CARE MED, V27, P1288, DOI 10.1007/s001340101009; Girard TD, 2017, AM J RESP CRIT CARE, V195, P120, DOI 10.1164/rccm.201610-2075ST; Govindan S, 2015, J HOSP MED, V10, P54, DOI 10.1002/jhm.2281; Greening NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4315; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Hodgson CL, 2017, INTENS CARE MED, V43, P992, DOI 10.1007/s00134-017-4830-0; Hopkins RO, 2012, AM J RESP CRIT CARE, V186, P1220, DOI 10.1164/rccm.201206-1022CP; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kayambu G, 2015, INTENS CARE MED, V41, P865, DOI 10.1007/s00134-015-3763-8; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Major ME, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1508-x; Mayr FB, 2017, JAMA-J AM MED ASSOC, V317, P530, DOI 10.1001/jama.2016.20468; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Naidech AM, 2013, AM J RESP CRIT CARE, V188, P1331, DOI 10.1164/rccm.201307-1256OC; Needham DM, 2017, AM J RESP CRIT CARE, V196, P1122, DOI 10.1164/rccm.201702-0372OC; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Pandharipande PP, 2017, INTENS CARE MED, V43, P1329, DOI 10.1007/s00134-017-4860-7; Paratz JD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004966; Perner A, 2014, INTENS CARE MED, V40, P927, DOI 10.1007/s00134-014-3311-y; Reinhart Konrad, 2013, Rev. bras. ter. intensiva, V25, P3, DOI 10.1590/S0103-507X2013000100002; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shen SY, 2017, INT J GERONTOL, V11, P41, DOI 10.1016/j.ijge.2017.01.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stehr SN, 2013, SHOCK, V39, P3, DOI 10.1097/SHK.0b013e31828fad61; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Tipping CJ, 2017, INTENS CARE MED, V43, P171, DOI 10.1007/s00134-016-4612-0; Turnbull AE, 2017, CRIT CARE MED, V45, P1001, DOI 10.1097/CCM.0000000000002435; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658; [No title captured]; [No title captured]	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201292	10.1371/journal.pone.0201292	http://dx.doi.org/10.1371/journal.pone.0201292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048540	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400070
J	Lopin, P; Lopin, KV				Lopin, Prattana; Lopin, Kyle V.			PSoC-Stat: A single chip open source potentiostat based on a Programmable System on a Chip	PLOS ONE			English	Article							BISMUTH-FILM ELECTRODES; ANODIC-STRIPPING VOLTAMMETRY; SCAN CYCLIC VOLTAMMETRY; BLOOD LEAD LEVELS; TRACE-METALS; GLUCOSE; BIOSENSOR; EXPOSURE; CHILDREN; SENSORS	In this paper we demonstrate a potentiostat built with a single commercially available integrated circuit (IC) that does not require any external electronic components to perform electrochemical experiments. This is done using the capabilities of the Programmable System on a Chip (PSoC (R)) by Cypress Semiconductor, which integrates all of the necessary electrical components. This is in contrast to other recent papers that have developed potentiostats but require technical skills or specialized equipment to produce. This eliminates the process of having to make a printed circuit board and soldering on electronic components. To control the device, a graphical user interface (GUI) was developed in the python programming language. Python is open source, with a style that makes it easy to read and write programs, making it an ideal choice for open source projects. As the developed device is open source and based on a PSoC, modification to implement other electrochemical techniques is straightforward and only requires modest programming skills, but no expensive equipment or difficult techniques. The potentiostat developed here adds to the growing amount of open source laboratory equipment. To demonstrate the PSoC potentiostat in a wide range of applications, we performed cyclic voltammetry (to measure vitamin C concentration in orange juice), amperometry (to measure glucose with a glucose strip), and stripping voltammetry experiments (to measure lead in water). The device was able to perform all experiments and could accurately measure Vitamin C, glucose, and lead.	[Lopin, Prattana] Naresuan Univ, Dept Biol, Fac Sci, Phitsanulok, Thailand; [Lopin, Kyle V.] Naresuan Univ, Dept Phys, Fac Sci, Phitsanulok, Thailand	Naresuan University; Naresuan University	Lopin, KV (corresponding author), Naresuan Univ, Dept Phys, Fac Sci, Phitsanulok, Thailand.	KyleL@nu.ac.th	Lopin, Kyle/AAS-4879-2020	Lopin, Kyle/0000-0001-8635-9572	Higher Education Research Promotion under the Office of the Higher Education Commission, Ministry of Education, Thailand [R2559A014]	Higher Education Research Promotion under the Office of the Higher Education Commission, Ministry of Education, Thailand	KVL and PL recieved funding from the Higher Education Research Promotion under the Office of the Higher Education Commission, Ministry of Education, Thailand, grant number: R2559A014. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainla A, 2018, ANAL CHEM, V90, P6240, DOI 10.1021/acs.analchem.8b00850; Amor-Gutierrez O, 2017, J CHEM EDUC, V94, P806, DOI 10.1021/acs.jchemed.6b00948; Ayers S, 2007, IEEE T CIRCUITS-I, V54, P736, DOI 10.1109/TCSI.2006.888777; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Bard A. J., 2001, ELECTROCHEMICAL METH; Beach RD, 2005, IEEE T INSTRUM MEAS, V54, P61, DOI 10.1109/TIM.2004.839757; Bruce GR, 1999, J CHEM EDUC, V76, P805, DOI 10.1021/ed076p805; Carrel M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177930; CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018; Castle Jessica R, 2010, J Diabetes Sci Technol, V4, P221; Crouch E, 2005, BIOSENS BIOELECTRON, V21, P712, DOI 10.1016/j.bios.2005.01.003; da Costa ET, 2014, ELECTROPHORESIS, V35, P2370, DOI 10.1002/elps.201400128; David IG, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/1905968; Dejang Nuchjira, 2017, Applied Mechanics and Materials, V866, P240, DOI 10.4028/www.scientific.net/AMM.866.240; Demetriades D, 2004, ANAL CHIM ACTA, V519, P167, DOI 10.1016/j.aca.2004.05.008; Dobbelaere T, 2017, HARDWAREX, V2, P34, DOI 10.1016/j.ohx.2017.08.001; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Economou A, 2005, TRAC-TREND ANAL CHEM, V24, P334, DOI 10.1016/j.trac.2004.11.006; Erickson JS, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081769; Fick A., 1855, ANN PHYS-NEW YORK, V94, P59, DOI [10.1002/andp.18551700105, DOI 10.1002/ANDP.18551700105]; Food and Drug Administration, 2016, SELF MON BLOOD GLUC; FORSBERG G, 1975, ANAL CHEM, V47, P1586, DOI 10.1021/ac60359a057; Franke W, 1939, LIEBIGS ANN CHEM, V541, P117, DOI [10.1002/jlac.19395410107, DOI 10.1002/JLAC.19395410107]; Goldcamp MJ, 2008, J CHEM EDUC, V85, P976, DOI 10.1021/ed085p976; Gooding JJ, 2001, J CHEM EDUC, V78, P788, DOI 10.1021/ed078p788; Gopinath A. V., 2005, CHEM ED, V6, P1; Goyer RA, 1996, ENVIRON HEALTH PERSP, V104, P1050, DOI 10.2307/3433116; Hanna-Attisha M, 2016, AM J PUBLIC HEALTH, V106, P283, DOI 10.2105/AJPH.2015.303003; Heller A, 2008, CHEM REV, V108, P2482, DOI 10.1021/cr068069y; Hobbs JM, 2013, J CHEM EDUC, V90, P1222, DOI 10.1021/ed300429a; Huang CT, 2009, EURASIP J ADV SIG PR, V2009, P1; Jou AFJ, 2014, ELECTROANAL, V26, P1816, DOI 10.1002/elan.201400140; Kakerow RG, 1995, P INT SOL STAT SENS, V1, P142; Kawde AN, 2016, RSC ADV, V6, P91325, DOI 10.1039/c6ra17466c; Kefala G, 2004, ANALYST, V129, P1082, DOI 10.1039/b404978k; Kefala G, 2003, TALANTA, V61, P603, DOI 10.1016/S0039-9140(03)00350-3; Kennedy Chinaro, 2016, MMWR Morb Mortal Wkly Rep, V65, P650, DOI 10.15585/mmwr.mm6525e1; Kimura M, 2009, IEEE T ELECTRON DEV, V56, P2114, DOI 10.1109/TED.2009.2026120; King D, 2010, J CHEM EDUC, V87, P507, DOI 10.1021/ed800151x; Kost GJ, 2013, POINT CARE, V12, P1; Kwakye S, 2007, SENSOR ACTUAT B-CHEM, V123, P336, DOI 10.1016/j.snb.2006.08.032; Long G. G., 1978, ENCY CHEM TECHNOLOGY, P912; March G, 2015, BIOSENSORS-BASEL, V5, P241, DOI 10.3390/bios5020241; Meloni GN, 2016, J CHEM EDUC, V93, P1320, DOI 10.1021/acs.jchemed.5b00961; Nemiroski A, 2014, P NATL ACAD SCI USA, V111, P11984, DOI 10.1073/pnas.1405679111; Pearce JM, 2014, NATURE, V505, P618, DOI 10.1038/505618d; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Phenrat T, 2016, ENVIRON HEALTH PERSP, V124, P1511, DOI 10.1289/EHP215; Pratumvinit Busadee, 2016, J Diabetes Sci Technol, V10, P1094, DOI 10.1177/1932296816633485; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Samasilp P, 2014, AM J PHYSIOL-CELL PH, V306, pC831, DOI 10.1152/ajpcell.00291.2013; Sennequier P, AN4348 D SIGNAL COND; SG8 9AZ, J MATTH TECHN REV; Silver MK, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0148-6; Skoog D.A., 2017, CENGAGE LEARNING; Sulkin MS, 2013, AM J PHYSIOL-HEART C, V305, pH1569, DOI 10.1152/ajpheart.00599.2013; Sun A, 2016, IEEE T BIOMED CIRC S, V10, P945, DOI 10.1109/TBCAS.2016.2586504; Sun A, 2014, BIOMED CIRC SYST C, P312, DOI 10.1109/BioCAS.2014.6981725; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Texas Instruments, 2013, 1798 DES EL CHEM SEN; Thongsaw A., 2017, Malaysian Journal of Analytical Sciences, V21, P72; US EPA O, 2015, LEAD COPP RUL; Wang G, 2016, IEEE INT SYMP CIRC S, P321, DOI 10.1109/ISCAS.2016.7527235; WIPF DO, 1988, ANAL CHEM, V60, P306, DOI 10.1021/ac00155a006; Yoo EH, 2010, SENSORS-BASEL, V10, P4558, DOI 10.3390/s100504558	66	34	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201353	10.1371/journal.pone.0201353	http://dx.doi.org/10.1371/journal.pone.0201353			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044878	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500101
J	Berry, S; Weinmann, O; Fritz, AK; Rust, R; Wolfer, D; Schwab, ME; Gerber, U; Ster, J				Berry, Stewart; Weinmann, Oliver; Fritz, Ann-Kristina; Rust, Ruslan; Wolfer, David; Schwab, Martin E.; Gerber, Urs; Ster, Jeanne			Loss of Nogo-A, encoded by the schizophrenia risk gene Rtn4, reduces mGlu3 expression and causes hyperexcitability in hippocampal CA3 circuits	PLOS ONE			English	Article							MORRIS WATER MAZE; SYNAPTIC PLASTICITY; THETA OSCILLATIONS; NEURAL REPRESENTATIONS; NETWORK OSCILLATIONS; PATTERN COMPLETION; DELETION SYNDROME; BIPOLAR DISORDER; PLACE AVOIDANCE; SLICE CULTURES	Recent investigations of Nogo-A, a well characterized protein inhibitor of neurite outgrowth in the brain, have revealed additional functions including a role in neuropsychiatric disorders such as schizophrenia. Here we examined Nogo-A functions in mouse CA3 hippocampal circuitry. Patch clamp recordings showed that the absence of Nogo-A results in a hyperactive network. In addition, mGlu3 metabotropic glutamate receptors, which exhibit mutations in certain forms of schizophrenia, were downregulated specifically in the CA3 area. Furthermore, Nogo-A(-/-) mice showed disordered theta oscillations with decreased incidence and frequency, similar to those observed in mGlu3(-/-) mice. As disruptions in theta rhythmicity are associated with impaired spatial navigation, we tested mice using modified Morris water maze tasks. Mice lacking Nogo-A exhibited altered search strategies, displaying greater dependence on global as opposed to local reference frames. This link between Nogo-A and mGlu3 receptors may provide new insights into mechanisms underlying schizophrenia.	[Berry, Stewart; Weinmann, Oliver; Rust, Ruslan; Schwab, Martin E.; Gerber, Urs; Ster, Jeanne] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Fritz, Ann-Kristina; Wolfer, David] Univ Zurich, Inst Anat, Zurich, Switzerland; [Rust, Ruslan; Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Ster, Jeanne] CNRS, UMR 5203, Montpellier, France; [Ster, Jeanne] INSERM, U1191, Inst Genom Fonct, Montpellier, France; [Ster, Jeanne] Univ Montpellier I, Montpellier, France; [Ster, Jeanne] Univ Montpellier 2, UMR 5203, Montpellier, France	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Ster, J (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.; Ster, J (corresponding author), CNRS, UMR 5203, Montpellier, France.; Ster, J (corresponding author), INSERM, U1191, Inst Genom Fonct, Montpellier, France.; Ster, J (corresponding author), Univ Montpellier I, Montpellier, France.; Ster, J (corresponding author), Univ Montpellier 2, UMR 5203, Montpellier, France.	Jeanne.Ster@igf.cnrs.fr	Wolfer, David P/B-3293-2016; Rust, Ruslan/ABA-2514-2020	Wolfer, David P/0000-0002-5957-1401; Rust, Ruslan/0000-0003-3376-3453; Ster, Jeanne/0000-0002-7277-9135	Swiss National Science Foundation [31003A_143373 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation grant 31003A_143373 / 1 to U.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; Brunner J, 2013, J NEUROSCI, V33, P7285, DOI 10.1523/JNEUROSCI.4537-12.2013; Butler JL, 2015, CURR OPIN NEUROBIOL, V31, P40, DOI 10.1016/j.conb.2014.07.025; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Entlerova M, 2013, PHYSIOL BEHAV, V120, P11, DOI 10.1016/j.physbeh.2013.06.024; Fischer Y, 2004, J PHYSIOL-LONDON, V554, P156, DOI 10.1113/jphysiol.2003.055558; Fischer Y, 1999, J PHYSIOL-LONDON, V519, P405, DOI 10.1111/j.1469-7793.1999.0405m.x; Fischer Y, 2002, J PHYSIOL-LONDON, V539, P857, DOI 10.1113/jphysiol.2001.013050; Fujioka R, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-31; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Huber AB, 2002, J NEUROSCI, V22, P3553; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Knierim JJ, 2011, PHYSIOL REV, V91, P1245, DOI 10.1152/physrev.00021.2010; Koukkou M, 2000, J PSYCHIATR RES, V34, P57, DOI 10.1016/S0022-3956(99)00040-0; Lee H, 2015, NEURON, V87, P1093, DOI 10.1016/j.neuron.2015.07.012; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Mayhew TM, 2002, J MICROSC-OXFORD, V205, P153, DOI 10.1046/j.0022-2720.2001.00977.x; Mazhari S, 2010, PSYCHIAT RES, V179, P253, DOI 10.1016/j.psychres.2009.09.002; Mossner R, 2008, EUR NEUROPSYCHOPHARM, V18, P768, DOI 10.1016/j.euroneuro.2008.05.007; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Neunuebel JP, 2013, J NEUROSCI, V33, P9246, DOI 10.1523/JNEUROSCI.0946-13.2013; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; Petrasek T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00090; Petrasek T, 2014, NEUROBIOL LEARN MEM, V107, P42, DOI 10.1016/j.nlm.2013.10.015; Petrinovic MM, 2013, P NATL ACAD SCI USA, V110, P1083, DOI 10.1073/pnas.1214255110; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Sauer JF, 2015, ELIFE, V4, DOI 10.7554/eLife.04979; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Stephany CE, 2014, J NEUROSCI, V34, P11631, DOI 10.1523/JNEUROSCI.0545-14.2014; Ster J, 2011, P NATL ACAD SCI USA, V108, P9993, DOI 10.1073/pnas.1100548108; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suh J, 2013, NEURON, V80, P484, DOI 10.1016/j.neuron.2013.09.014; Tan EC, 2005, MOL BRAIN RES, V139, P212, DOI 10.1016/j.molbrainres.2005.05.010; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Wang XX, 2002, J NEUROSCI, V22, P5505; Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x; Willi R, 2013, NEUROBIOL DIS, V54, P150, DOI 10.1016/j.nbd.2013.01.011; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Zagrebelsky M, 2017, NEUROBIOL LEARN MEM, V138, P154, DOI 10.1016/j.nlm.2016.06.022; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zemmar A, 2018, CEREB CORTEX, V28, P2109, DOI 10.1093/cercor/bhx116; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014	53	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200896	10.1371/journal.pone.0200896	http://dx.doi.org/10.1371/journal.pone.0200896			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040841	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000439749200015
J	Birceanu, O; Wilkie, MP				Birceanu, Oana; Wilkie, Michael Patrick			Post-exposure effects of the piscicide 3-trifluoromethyl-4-nitrophenol (TFM) on the stress response and liver metabolic capacity in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							LAMPREY PETROMYZON-MARINUS; SEA LAMPREY; ENVIRONMENTAL LEVELS; GLUCOSE-HOMEOSTASIS; GLYCOGEN-METABOLISM; ROUTINE TREATMENT; FOOD-DEPRIVATION; LAMPRICIDE TFM; ACUTE TOXICITY; LAKE STURGEON	The piscicide 3-trifluoromethyl-4-nitrophenol (TFM) has been used to control invasive sea lamprey (Petromyzon marinus) populations in the Great Lakes for almost 60 years. Applied to rivers and streams containing larval lampreys, TFM seldom harms non-target fishes, but the effects of sub-lethal treatments on fish physiology are not well understood. We examined the effects of 9 h exposure to TFM on the stress axis and liver metabolic capacity of rainbow trout (Oncorhynchus mykiss) using in vivo and in vitro approaches. The fish that had been acutely exposed to TFM in vivo had increased plasma cortisol levels at 12 h post-treatment, but TFM exposure did not interfere with in vitro cortisol production in head kidney preparations. Subjecting trout to an acute handling stressor 12 h post-TFM exposure resulted in a relative attenuation of the plasma cortisol and glucose response compared to pre-stress levels. We conclude that routine TFM treatments can lead to elevations of plasma cortisol following exposure, plus a relative dampening of the stress response in rainbow trout, with high cortisol levels lasting at least 12 h post-treatment. Since the ability of the fish to produce cortisol and the liver metabolic capacity were not compromised following TFM exposure, it is likely that their ability to cope with other stressors is not altered in the long-term.	[Birceanu, Oana; Wilkie, Michael Patrick] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada	Wilfrid Laurier University	Birceanu, O (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada.	obirceanu@gmail.com	Birceanu, Oana/J-9137-2019	Birceanu, Oana/0000-0002-3345-8769	Wilfrid Laurier University; Great Lakes Fishery Commission Grant	Wilfrid Laurier University; Great Lakes Fishery Commission Grant	This work was supported by a Category A Internal grant (2015 competition) from Wilfrid Laurier University, awarded to OB and MPW, and by a Great Lakes Fishery Commission Grant Awarded to MPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Aluru N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010741; Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; BANHEGYI G, 1988, BIOCHIM BIOPHYS ACTA, V967, P429, DOI 10.1016/0304-4165(88)90106-7; Begg K, 2004, J FISH BIOL, V64, P133, DOI 10.1111/j.1095-8649.2004.00290.x; Best C, 2014, AQUAT TOXICOL, V155, P190, DOI 10.1016/j.aquatox.2014.06.014; Bills TD, 2003, J GREAT LAKES RES, V29, P510, DOI 10.1016/S0380-1330(03)70512-7; Birceanu O., 2014, COMP BIOCH PHYSL C, V160, P873; Birceanu O, 2015, AQUAT TOXICOL, V168, P11, DOI 10.1016/j.aquatox.2015.09.002; Birceanu O, 2015, AQUAT TOXICOL, V161, P51, DOI 10.1016/j.aquatox.2015.01.028; Birceanu O, 2011, COMP BIOCHEM PHYS C, V153, P342, DOI 10.1016/j.cbpc.2010.12.005; Birceanu O, 2009, AQUAT TOXICOL, V94, P265, DOI 10.1016/j.aquatox.2009.07.012; Bleau H, 1996, AQUAT TOXICOL, V34, P221, DOI 10.1016/0166-445X(95)00040-B; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boogaard MA, 2003, J GREAT LAKES RES, V29, P529, DOI 10.1016/S0380-1330(03)70514-0; Boogaard MA, 2015, ENVIRON TOXICOL CHEM, V34, P1634, DOI 10.1002/etc.2959; Bussy U, 2017, ANAL BIOANAL CHEM, V28, P1; CAMPBELL PM, 1994, AQUACULTURE, V120, P151, DOI 10.1016/0044-8486(94)90230-5; CLARKE DJ, 1991, AQUAT TOXICOL, V20, P35, DOI 10.1016/0166-445X(91)90040-G; Clifford AM, 2012, T AM FISH SOC, V141, P1697, DOI 10.1080/00028487.2012.713887; Dawson VK, 2002, J AGR FOOD CHEM, V50, P6780, DOI 10.1021/jf020443h; DiBattista JD, 2005, J EXP BIOL, V208, P2707, DOI 10.1242/jeb.01690; Faught E., 2016, R SOC, V3, P1; Fierro-Castro C, 2015, COMP BIOCHEM PHYS A, V190, P39, DOI 10.1016/j.cbpa.2015.09.002; Geslin M, 2004, GEN COMP ENDOCR, V135, P70, DOI 10.1016/S0016-6480(03)00283-1; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; GLFC, 2011, STRAT VIS GREAT LAK; Henry M, 2015, COMP BIOCHEM PHYS C, V169, P35, DOI 10.1016/j.cbpc.2014.12.003; Ings JS, 2012, AQUAT TOXICOL, V108, P53, DOI 10.1016/j.aquatox.2011.09.009; Ings JS, 2011, ENVIRON SCI TECHNOL, V45, P2368, DOI 10.1021/es103122g; KANE AS, 1994, T AM FISH SOC, V123, P217, DOI 10.1577/1548-8659(1994)123<0217:UGKFTN>2.3.CO;2; Laursen DC, 2013, PHYSIOL BEHAV, V122, P147, DOI 10.1016/j.physbeh.2013.08.026; LECH JJ, 1972, COMPARATIVE, V3, P160, DOI 10.1016/0010-4035(72)90021-3; LECH JJ, 1974, BIOCHEM PHARMACOL, V23, P2403, DOI 10.1016/0006-2952(74)90231-7; Madaro A, 2015, J EXP BIOL, V218, P2538, DOI 10.1242/jeb.120535; Madison BN, 2015, CAN J FISH AQUAT SCI, V72, P673, DOI 10.1139/cjfas-2014-0409; McConville MB, 2016, ENVIRON SCI TECHNOL, V50, P9998, DOI 10.1021/acs.est.6b02607; McDonald DG, 2007, J GREAT LAKES RES, V33, P20, DOI 10.3394/0380-1330(2007)33[20:RTGTUO]2.0.CO;2; Middaugh CR, 2014, J GREAT LAKES RES, V40, P1010, DOI 10.1016/j.jglr.2014.09.010; Miller LL, 2011, TOXICOL APPL PHARM, V253, P137, DOI 10.1016/j.taap.2011.03.021; Miller LL, 2009, J APPL TOXICOL, V29, P681, DOI 10.1002/jat.1458; Milligan CL, 2003, J EXP BIOL, V206, P3167, DOI 10.1242/jeb.00538; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; O'Connor LM, 2017, J GREAT LAKES RES, V43, P189, DOI 10.1016/j.jglr.2016.10.011; Panserat S, 2000, AM J PHYSIOL-REG I, V278, pR1164, DOI 10.1152/ajpregu.2000.278.5.R1164; POTTINGER TG, 1992, FISH PHYSIOL BIOCHEM, V10, P55, DOI 10.1007/BF00004654; Rawlings NC, 1998, J TOXICOL ENV HEAL A, V54, P21, DOI 10.1080/009841098159006; Sakamoto K, 2016, ENVIRON SCI TECHNOL, V50, P3462, DOI 10.1021/acs.est.6b01051; Sandhu N, 2014, AQUAT TOXICOL, V146, P20, DOI 10.1016/j.aquatox.2013.10.010; Sandhu N, 2011, AQUAT TOXICOL, V103, P92, DOI 10.1016/j.aquatox.2011.02.011; Shanghavi DS, 1999, J EXP BIOL, V202, P2161; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soengas JL, 1998, PHYSIOL ZOOL, V71, P285, DOI 10.1086/515925; Vijayan MM, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P182, DOI 10.1079/9781845935535.0182; Vijayan MM, 1996, J EXP BIOL, V199, P2467; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; VIJAYAN MM, 1994, CAN J ZOOL, V72, P379, DOI 10.1139/z94-054; VIJAYAN MM, 1992, CAN J FISH AQUAT SCI, V49, P2260, DOI 10.1139/f92-247; Vue C, 2002, J AGR FOOD CHEM, V50, P6786, DOI 10.1021/jf0204708; Wilkie MP, 2007, CAN J FISH AQUAT SCI, V64, P1174, DOI 10.1139/F07-082; Yeh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079406; Zolderdo AJ, 2016, J EXP BIOL, V219, P1237, DOI 10.1242/jeb.135798	61	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200782	10.1371/journal.pone.0200782	http://dx.doi.org/10.1371/journal.pone.0200782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036372	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200017
J	Northcutt, AJ; Fischer, EK; Puhl, JG; Mesce, KA; Schulz, DJ				Northcutt, Adam J.; Fischer, Eva K.; Puhl, Joshua G.; Mesce, Karen A.; Schulz, David J.			An annotated CNS transcriptome of the medicinal leech, Hirudo verbana: De novo sequencing to characterize genes associated with nervous system activity	PLOS ONE			English	Article							IDENTIFIED LEECH NEURONS; HIRUDO-MEDICINALIS; INWARD CURRENTS; LEAK CHANNELS; MOTOR PATTERN; P-NEURONS; EXPRESSION; ACETYLCHOLINE; SEROTONIN; MODULATION	The medicinal leech is one of the most venerated model systems for the study of fundamental nervous system principles, ranging from single-cell excitability to complex sensorimotor integration. Yet, molecular analyses have yet to be extensively applied to complement the rich history of electrophysiological study that this animal has received. Here, we generated the first de novo transcriptome assembly from the entire central nervous system of Hirudo verbana, with the goal of providing a molecular resource, as well as to lay the foundation for a comprehensive discovery of genes fundamentally important for neural function. Our assembly generated 107,704 contigs from over 900 million raw reads. Of these 107,704 contigs, 39,047 (36%) were annotated using NCBI's validated RefSeq sequence database. From this annotated central nervous system transcriptome, we began the process of curating genes related to nervous system function by identifying and characterizing 126 unique ion channel, receptor, transporter, and enzyme contigs. Additionally, we generated sequence counts to estimate the relative abundance of each identified ion channel and receptor contig in the transcriptome through Kallisto mapping. This transcriptome will serve as a valuable community resource for studies investigating the molecular underpinnings of neural function in leech and provide a reference for comparative analyses.	[Northcutt, Adam J.; Schulz, David J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Fischer, Eva K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Puhl, Joshua G.; Mesce, Karen A.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Puhl, Joshua G.; Mesce, Karen A.] Univ Minnesota, Grad Program Neurosci, St Paul, MN 55108 USA	University of Missouri System; University of Missouri Columbia; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schulz, DJ (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	schulzd@missouri.edu		Northcutt, Adam/0000-0001-5815-1854; Schulz, David/0000-0003-4532-5362; Fischer, Eva K/0000-0002-2916-0900	National Science Foundation (DBS-IOS) [1454904]	National Science Foundation (DBS-IOS)	This work was funded by a grant from the National Science Foundation (DBS-IOS #1454904) awarded to Karen Mesce and David Schulz.	Aisemberg GO, 2001, DEV GENES EVOL, V211, P589, DOI 10.1007/s00427-001-0183-2; Angstadt JD, 1999, J COMP PHYSIOL A, V184, P49, DOI 10.1007/s003590050305; Ashburner M, 2001, GENOME RES, V11, P1425; Baker MW, 2006, J NEUROSCI METH, V156, P145, DOI 10.1016/j.jneumeth.2006.02.026; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BIGIANI A, 1990, J EXP BIOL, V151, P423; Bisson G, 2011, J NEUROPHYSIOL, V106, P78, DOI 10.1152/jn.01043.2010; Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x; Blackshaw SE, 2003, J NEUROBIOL, V55, P355, DOI 10.1002/neu.10214; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; BRODFUEHRER PD, 1995, J NEUROBIOL, V27, P403, DOI 10.1002/neu.480270312; Burland T G, 2000, Methods Mol Biol, V132, P71; Choi SL, 2010, J NEUROGENET, V24, P75, DOI 10.3109/01677061003770614; CLINE HT, 1983, J COMP NEUROL, V215, P351, DOI 10.1002/cne.902150309; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crisp KM, 2004, J EXP BIOL, V207, P4535, DOI 10.1242/jeb.01315; Crisp KM, 2003, J COMP PHYSIOL A, V189, P461, DOI 10.1007/s00359-003-0424-0; Crisp KM, 2002, J COMP NEUROL, V442, P115, DOI 10.1002/cne.10077; Dierkes PW, 2004, BRAIN RES, V1013, P159, DOI 10.1016/j.brainres.2004.03.038; Dykes IM, 2006, DEV GENES EVOL, V216, P185, DOI 10.1007/s00427-005-0048-1; GASCOIGNE L, 1991, COMP BIOCHEM PHYS C, V99, P369, DOI 10.1016/0742-8413(91)90258-U; GERASIMO.VD, 1967, NATURE, V214, P1351, DOI 10.1038/2141351b0; Gerry SP, 2011, BIOL LETTERS, V7, P885, DOI 10.1098/rsbl.2011.0303; GOLDERMANN M, 1994, J COMP PHYSIOL A, V174, P231; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grey KB, 2009, INVERTEBR NEUROSCI, V9, P11, DOI 10.1007/s10158-008-0085-3; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harley CM, 2015, J NEUROPHYSIOL, V113, P3610, DOI 10.1152/jn.00135.2015; Harley CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086120; Harley CM, 2013, J EXP BIOL, V216, P1890, DOI 10.1242/jeb.075911; Hibsh D, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.15; Hibsh D, 2014, BIOINFORMATICS, V30, P310, DOI 10.1093/bioinformatics/btt570; HOCHSTRATE P, 1995, GLIA, V15, P43, DOI 10.1002/glia.440150106; Kandarian B, 2012, DEV GENES EVOL, V222, P29, DOI 10.1007/s00427-011-0387-z; Klees G, 2005, J MEMBRANE BIOL, V208, P27, DOI 10.1007/s00232-005-0816-x; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; KRISTAN WB, 1976, J EXP BIOL, V65, P643; KRISTAN WB, 1979, BRAIN RES, V167, P215, DOI 10.1016/0006-8993(79)90282-8; LENT CM, 1988, SCI AM, V258, P98, DOI 10.1038/scientificamerican0688-98; Lohr C, 1997, J EXP BIOL, V200, P2565; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; MacManes M. D., 2016, BIORXIV, DOI [10.1101/035642, DOI 10.1101/035642]; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; McClellan AD, 2008, J NEUROSCI, V28, P650, DOI 10.1523/JNEUROSCI.3840-07.2008; McGrath LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2373-3; Mesce KA, 2002, BRAIN BEHAV EVOLUT, V60, P339, DOI 10.1159/000067793; Mesce KA, 2001, J NEUROPHYSIOL, V85, P2039, DOI 10.1152/jn.2001.85.5.2039; Mesce KA, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.175687; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Mullins OJ, 2012, J NEUROPHYSIOL, V107, P2730, DOI 10.1152/jn.00107.2012; Nikitina A, 2016, MITOCHONDRIAL DNA B, V1, P254, DOI 10.1080/23802359.2016.1157774; Northcutt AJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3215-z; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pastor J, 1996, J NEUROPHYSIOL, V75, P2268, DOI 10.1152/jn.1996.75.6.2268; Petrauskien L, 2009, INVERTEBR BIOL, V128, P324, DOI 10.1111/j.1744-7410.2009.00180.x; Pipkin JE, 2016, J COMP NEUROL, V524, P3677, DOI 10.1002/cne.24120; Puhl JG, 2008, J NEUROSCI, V28, P4192, DOI 10.1523/JNEUROSCI.0136-08.2008; Ransdell JL, 2013, J NEUROPHYSIOL, V110, P42, DOI 10.1152/jn.00009.2013; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; SARGENT PB, 1977, J NEUROPHYSIOL, V40, P453, DOI 10.1152/jn.1977.40.2.453; SCHLUE WR, 1976, J NEUROPHYSIOL, V39, P1176, DOI 10.1152/jn.1976.39.6.1176; SCHMIDT J, 1992, J EXP BIOL, V171, P329; Sergeeva S S, 1998, Ross Fiziol Zh Im I M Sechenova, V84, P735; Siddall ME, 2007, P R SOC B, V274, P1481, DOI 10.1098/rspb.2007.0248; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; SIMONI A, 1990, BRAIN RES, V522, P118, DOI 10.1016/0006-8993(90)91585-5; STEWART RR, 1989, J EXP BIOL, V141, P1; Summers T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06114-1; Summers T, 2014, J EXP BIOL, V217, P4167, DOI 10.1242/jeb.110049; Thorogood MSE, 1999, J COMP NEUROL, V405, P334, DOI 10.1002/(SICI)1096-9861(19990315)405:3<334::AID-CNE4>3.0.CO;2-I; Tribut F, INVERTEBR NEUROSCI, V4, P25, DOI [10.1007/s101589900003, DOI 10.1007/S101589900003]; Trontelj P, 2004, PARASITOL RES, V94, P118, DOI 10.1007/s00436-004-1181-x; Trueta C, 2003, J PHYSIOL-LONDON, V547, P405, DOI 10.1113/jphysiol.2002.030684; Vergote D, 2004, J BIOL CHEM, V279, P43828, DOI 10.1074/jbc.M403073200; Wagenaar DA, 2015, J EXP BIOL, V218, P3353, DOI 10.1242/jeb.113860; WALLACE BG, 1982, J NEUROSCI, V2, P1108; Wang Y, 2015, NEUROSCIENCE, V298, P397, DOI 10.1016/j.neuroscience.2015.04.040; Wang YQ, 2016, J NEUROPHYSIOL, V116, P619, DOI 10.1152/jn.00235.2016; Yazdani N, 2013, DEV NEUROBIOL, V73, P571, DOI 10.1002/dneu.22082	81	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201206	10.1371/journal.pone.0201206	http://dx.doi.org/10.1371/journal.pone.0201206			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028871	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900045
J	Yang, PS; Pak, HN; Park, DH; Yoo, J; Kim, TH; Uhm, JS; Kim, YD; Nam, HS; Joung, B; Lee, MH; Heo, JH				Yang, Pil-Sung; Pak, Hui-Nam; Park, Dong-Hyuk; Yoo, Joonsang; Kim, Tae-Hoon; Uhm, Jae-Sun; Kim, Young Dae; Nam, Hyo Suk; Joung, Boyoung; Lee, Moon-Hyoung; Heo, Ji Hoe			Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke	PLOS ONE			English	Article							THROMBOEMBOLISM; PREVENTION; FREQUENCY; CHADS(2)	Introduction Cardioembolic (CE) risks is usually considered as the main mechanism of ischemic stroke in non-valvular atrial fibrillation (NVAF) patients. However, a substantial number of ischemic strokes in NVAF patients are related to non-CE mechanisms. The aim of this study was to investigate the non-CE risk factors in ischemic stroke patients had NVAF. Methods We included 401 patients (65.6% male, 68.6 +/- 9.6 years old) who had been hospitalized due to ischemic stroke and had a known or newly diagnosed NVAF. The CE (intracardiac thrombus, dense spontaneous echo contrast, or low left atrial appendage flow velocity) and non-CE (complex aortic plaque, significant carotid stenosis, or intracranial arterial stenosis) risk factors were investigated at the time of the index stroke. Results The number of CE and non-CE risk factors increased with increasing CHA(2)DS(2)-VASc scores (p for trends < 0.001). The presence of CE risk factors was independently associated with persistent atrial fibrillation (p < 0.001), body mass index (p = 0.003), heart failure (p = 0.003), and left atrial volume index (p < 0.001). In contrast, the presence of non-CE risk factors was independently associated with age (p < 0.001), hypertension (p = 0.049), diabetes (p = 0.030), and coronary artery calcium score (CACS; p < 0.001). CACS had the added value in predicting non-CE risk factors of ischemic stroke regardless of the CHA(2)DS(2)-VASc risk category (p < 0.001). Conclusion Non-CE risk factors in ischemic stroke patients with NVAF are associated with high CHA(2)DS(2)-VASc score and CACS. Atherosclerotic non-CE risk factors should be considered as potential mechanisms of stroke even in patients with AF-associated ischemic stroke.	[Yang, Pil-Sung; Pak, Hui-Nam; Park, Dong-Hyuk; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung] Yonsei Univ Hlth Syst, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Yoo, Joonsang; Kim, Young Dae; Nam, Hyo Suk; Heo, Ji Hoe] Yonsei Univ Hlth Syst, Dept Neurol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Dept Internal Med, Div Cardiol, Seoul, South Korea.; Heo, JH (corresponding author), Yonsei Univ Hlth Syst, Dept Neurol, Seoul, South Korea.	hnpak@yuhs.ac; jhheo@yuhs.ac	; Pak, Hui-Nam/C-4266-2015	Yoo, Joonsang/0000-0003-1169-6798; Lee, Moon-Hyoung/0000-0002-7268-0741; Kim, Young Dae/0000-0001-5750-2616; Uhm, Jae-Sun/0000-0002-1611-8172; Joung, Boyoung/0000-0001-9036-7225; Pak, Hui-Nam/0000-0002-3256-3620; Kim, Tae-Hoon/0000-0003-4200-3456; Yang, Pil-sung/0000-0002-6552-1742; Heo, Ji Hoe/0000-0001-9898-3321; NAM, HYO SUK/0000-0002-4415-3995	Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea [A085136]	Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (https://www.htdream.kr/) [A085136 to HNP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bernhardt P, 2005, J AM COLL CARDIOL, V45, P1807, DOI 10.1016/j.jacc.2004.11.071; Borissoff JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055784; CHA M, 2012, EUR J NEUROL, V19, pDS2; Chang YJ, 2002, CEREBROVASC DIS, V13, P16, DOI 10.1159/000047740; Evans A, 2001, STROKE, V32, P2828, DOI 10.1161/hs1201.099520; Ganesan AN, 2016, EUR HEART J, V37, P1591, DOI 10.1093/eurheartj/ehw007; GOESSENS BM, 1991, STROKE, DOI DOI 10.1161/STR0KEAHA.106.477091; Goldman ME, 1999, J AM SOC ECHOCARDIOG, V12, P1080, DOI 10.1016/S0894-7317(99)70105-7; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006; Hermann DM, 2013, STROKE, V44, P1008, DOI 10.1161/STROKEAHA.111.678078; Holmstedt CA, 2013, LANCET NEUROL, V12, P1106, DOI 10.1016/S1474-4422(13)70195-9; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim YD, 2011, STROKE, V42, P930, DOI 10.1161/STROKEAHA.110.602987; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lee IO, 2012, J PHARMACOL EXP THER, V343, P253, DOI 10.1124/jpet.112.194837; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Liu FD, 2016, ANN MED, V48, P367, DOI 10.1080/07853890.2016.1179390; Malik R, 2016, NEUROLOGY, V86, P1217, DOI 10.1212/WNL.0000000000002528; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mitchell LB, 2014, HEART, V100, P1524, DOI 10.1136/heartjnl-2013-305303; Nakamura A, 2016, CEREBROVASC DIS, V42, P196, DOI 10.1159/000445723; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; RAGOSTA M, 1994, CIRCULATION, V89, P1262, DOI 10.1161/01.CIR.89.3.1262; REDDY VY, 1961, CIRCULATION, V112, P720, DOI DOI 10.1161/CIRCULATI0NAHA.112; Tremblay-Gravel M, 2015, J CARDIOVASC ELECTR, V26, P509, DOI 10.1111/jce.12652; Yarmohammadi H, 2013, AM J CARDIOL, V112, P678, DOI 10.1016/j.amjcard.2013.04.047; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; THROMB HAEMOST, P268	32	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201062	10.1371/journal.pone.0201062	http://dx.doi.org/10.1371/journal.pone.0201062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028885	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900038
J	Ballot, A; Scherer, PI; Wood, SA				Ballot, Andreas; Scherer, Pia, I; Wood, Susanna A.			Variability in the anatoxin gene clusters of Cuspidothrix issatschenkoi from Germany, New Zealand, China and Japan	PLOS ONE			English	Article							ANABAENA-FLOS-AQUAE; IN-SILICO PCR; 1ST REPORT; APHANIZOMENON-ISSATSCHENKOI; CYANOBACTERIAL TOXINS; HOMOANATOXIN-A; BIOSYNTHESIS; STRAIN; IDENTIFICATION; MICROCYSTIN	Anatoxin-a and homoanatoxin-a are neurotoxic cyanotoxins produced by benthic and planktonic cyanobacteria worldwide. These toxins are produced by the cyanobacterial genera Dolichospermum, Cuspidothrix, Phormidium, Oscillatoria, Tychonema and Cylindrospermum. In the present study the ana gene clusters (anaA-anaG; c. 21.1 kilobases) of two anatoxin producing Cuspidothrix issatschenkoi strains from Germany: (NIVA-CYA 711) and New Zealand (CAWBG02) were sequenced and compared with the ana gene clusters of two C. issatschenkoi strains from Japan (RM-6 and LBRI48) and one from China (CHABD3). All five ana gene clusters are characterized by the same gene order for anaA-anaG. Similarities were highest (99.56-99.57%) between German (NIVA-CYA 711), New Zealand (CAWBG02) and Chinese (CHABD3) strains. Similarities were lower (91.40-91.67%) when compared to the Japanese strains (RM-6 and LBRI48). Collectively, 2,037 variable sites (328 single nucleotide polymorphisms and 9 insertions/deletions, comprising 1,709 nucleotides) were found in the ana gene clusters of the German, New Zealand and Japanese strains compared to the Chinese strain (CHABD3). The ana gene clusters of the German (NIVA-CYA 711), New Zealand (CAWBG02) and Japanese (RM-6 and LBRI48) strains were characterized by 83, 84, 255 and 231 SNP's compared to the Chinese strain (CHABD3), respectively. The anaE and anaF genes showed the highest variability in all five strains and are recommended as the best genetic markers for further phylogenetic studies of the ana gene cluster from C. issatschenkoi.	[Ballot, Andreas] Norwegian Inst Water Res, Oslo, Norway; [Scherer, Pia, I] Tech Univ Munich, Limnol Res Stn Iffeldorf, Munich, Germany; [Wood, Susanna A.] Cawthron Inst, Private Bag 2, Nelson, New Zealand	Norwegian Institute for Water Research (NIVA); Technical University of Munich; Cawthron Institute	Ballot, A (corresponding author), Norwegian Inst Water Res, Oslo, Norway.	andreas.ballot@niva.no	Ballot, Andreas/G-7752-2019	Ballot, Andreas/0000-0002-4088-0677	New Zealand Ministry of Business, Innovation and Employment [UOWX1503, CAWX1317]; European Cooperation in Science and Technology COST Action [ES1105 CYANOCOST]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); European Cooperation in Science and Technology COST Action(European Cooperation in Science and Technology (COST))	SAW thanks the New Zealand Ministry of Business, Innovation and Employment for funding through the 'Enhancing the health and resilience of New Zealand lakes' (UOWX1503) and the 'Safe New Zealand Seafood' (CAWX1317) programmes.; We want to thank the European Cooperation in Science and Technology COST Action ES1105 CYANOCOST for networking and knowledge transfer support.	Ballot A, 2010, TOXICON, V56, P964, DOI 10.1016/j.toxicon.2010.06.021; Ballot A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167552; Brown NM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2738-7; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Bruno M., 2016, HDB CYANOBACTERIAL M, P138; Bumke-Vogt C, 1999, ENVIRON TOXICOL, V14, P117, DOI 10.1002/(SICI)1522-7278(199902)14:1<117::AID-TOX15>3.0.CO;2-V; Christiansen G, 2006, APPL ENVIRON MICROB, V72, P117, DOI 10.1128/AEM.72.1.117-123.2006; Cires S, 2016, HARMFUL ALGAE, V54, P21, DOI 10.1016/j.hal.2015.09.007; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; DEVLIN JP, 1977, CAN J CHEM, V55, P1367, DOI 10.1139/v77-189; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Duchene S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000094; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; GALLON JR, 1994, PHYTOCHEMISTRY, V35, P1195, DOI 10.1016/S0031-9422(00)94821-0; Gugger M, 2005, TOXICON, V45, P919, DOI 10.1016/j.toxicon.2005.02.031; Gugger M, 2018, CYLINDROSPER MUM STA; Hepperle D., 2008, SEQUENTIX DIGITAL DN; Hodoki Y, CUSPIDOTHRIX ISSATSC; Jiang YG, 2015, HARMFUL ALGAE, V46, P43, DOI 10.1016/j.hal.2015.05.005; Kaebernick M, 2001, ENVIRON MICROBIOL, V3, P669, DOI 10.1046/j.1462-2920.2001.00241.x; Kalendar R, 2014, METHODS MOL BIOL, V1116, P271, DOI 10.1007/978-1-62703-764-8_18; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; KomuYrek J., 2013, SUSSWASSERFLORA MITT, V19/3, P1; Kumar S., 2016, MOL BIOL EVOLUTION, DOI [DOI 10.1093/M0LBEV/MSW054, 10.1093/molbev/msw054]; Mann S, 2011, BIOCHEMISTRY-US, V50, P7184, DOI 10.1021/bi200892a; Mejean A, 2014, TOXICON, V91, P15, DOI 10.1016/j.toxicon.2014.07.016; Mejean A, 2010, J BACTERIOL, V192, P5264, DOI 10.1128/JB.00704-10; Quiblier C, 2013, WATER RES, V47, P5464, DOI 10.1016/j.watres.2013.06.042; Rantala-Ylinen A, 2011, APPL ENVIRON MICROB, V77, P7271, DOI 10.1128/AEM.06022-11; Shah SAA, 2017, MAR DRUGS, V15, DOI 10.3390/md15110354; Shams S, 2015, WATER RES, V69, P68, DOI 10.1016/j.watres.2014.11.006; SKULBERG OM, 1992, ENVIRON TOXICOL CHEM, V11, P321, DOI [10.1897/1552-8618(1992)11[321:IOANOS]2.0.CO;2, 10.1002/etc.5620110306]; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Watanabe MF, 2003, PHYCOLOGIA, V42, P364, DOI 10.2216/i0031-8884-42-4-364.1; Wood SA, 2007, TOXICON, V50, P292, DOI 10.1016/j.toxicon.2007.03.025; Wood SA, 2007, J PHYCOL, V43, P356, DOI 10.1111/j.1529-8817.2007.00318.x	36	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200774	10.1371/journal.pone.0200774	http://dx.doi.org/10.1371/journal.pone.0200774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024929	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000439120000051
J	Shariatpanahi, AM; Yassi, M; Nouraie, M; Sahebkar, A; Tabrizi, FV; Kerachian, MA				Shariatpanahi, Afsaneh Mojtabanezhad; Yassi, Maryam; Nouraie, Mehdi; Sahebkar, Amirhossein; Tabrizi, Fatemeh Varshoee; Kerachian, Mohammad Amin			The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis	PLOS ONE			English	Article							MELTING MS-HRM; FECAL DNA; PROMOTER METHYLATION; ABERRANT METHYLATION; POTENTIAL BIOMARKER; SAMPLES; HYPERMETHYLATION; SFRP2; NEOPLASIA; MARKER	A large number of tumor-related methylated genes have been suggested to be of diagnostic and prognostic values for CRC when analyzed in patients' stool samples; however, reported sensitivities and specificities have been inconsistent and widely varied. This meta-analysis was conducted to assess the detection accuracy of stool DNA methylation assay in CRC, early stages of CRC (advanced adenoma, non-advanced adenomas) and hyperplastic polyps, separately. We searched MEDLINE, Web of Science, Scopus and Google Scholar databases until May 1, 2016. From 469 publications obtained in the initial literature search, 38 studies were included in the final analysis involving 4867 individuals. The true positive, false positive, true negative and false negative of a stool-based DNA methylation biomarker using all single-gene tests considering a certain gene; regardless of a specific gene were pooled and studied in different categories. The sensitivity of different genes in detecting different stages of CRC ranged from 0% to 100% and the specificities ranged from 73% to 100%. Our results elucidated that SFRP1 and SFRP2 methylation possessed promising accuracy for detection of not only CRC (DOR: 31.67; 95%CI, 12.31-81.49 and DOR: 35.36; 95% CI, 18.71-66.84, respectively) but also the early stages of cancer, adenoma (DOR: 19.72; 95% CI, 6.68-58.25 and DOR: 13.20; 95%CI, 6.01-28.00, respectively). Besides, NDRG4 could be also considered as a significant diagnostic marker gene in CRC (DOR: 24.37; 95%CI, 10.11-58.73) and VIM in adenoma (DOR: 15.21; 95%CI, 2.72-85.10). In conclusion, stool DNA hypermethylation assay based on the candidate genes SFRP1, SFRP2, NDRG4 and V/Mcould offer potential diagnostic value for CRC based on the findings of this meta-analysis.	[Shariatpanahi, Afsaneh Mojtabanezhad; Yassi, Maryam; Tabrizi, Fatemeh Varshoee; Kerachian, Mohammad Amin] Reza Radiotherapy & Oncol Ctr, Canc Genet Res Unit, Mashhad, Iran; [Nouraie, Mehdi] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Kerachian, Mohammad Amin] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Iran; [Kerachian, Mohammad Amin] Mashhad Univ Med Sci, Fac Med, Dept Med Genet, Mashhad, Iran	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science	Kerachian, MA (corresponding author), Reza Radiotherapy & Oncol Ctr, Canc Genet Res Unit, Mashhad, Iran.; Kerachian, MA (corresponding author), Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Iran.; Kerachian, MA (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Med Genet, Mashhad, Iran.	amin.kerachian@mail.mcgill.ca	Kerachian, Mohammad Amin/M-6585-2015; Nouraie, Seyed Mehdi/O-4071-2018; Sahebkar, Amirhossein/B-5124-2018	Kerachian, Mohammad Amin/0000-0001-5016-2882; Nouraie, Seyed Mehdi/0000-0001-7465-0581; 				Abbaszadegan MR, 2007, WORLD J GASTROENTERO, V13, P1528, DOI 10.3748/wjg.v13.i10.1528; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Amiot A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099233; Arani SH, 2017, CURR ONCOL, V24, pE131, DOI 10.3747/co.23.3226; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Azuara D, 2010, CLIN COLORECTAL CANC, V9, P168, DOI 10.3816/CCC.2010.n.023; Baek YH, 2009, DIS COLON RECTUM, V52, P1452, DOI 10.1007/DCR.0b013e3181a79533; Bailey JR, 2016, GUT LIVER, V10, P204, DOI 10.5009/gnl15420; Bosch LJW, 2012, CANCER PREV RES, V5, P464, DOI 10.1158/1940-6207.CAPR-11-0315; Chang E, 2010, HEPATO-GASTROENTEROL, V57, P720; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Draht MXG, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0211-8; El Bairi K, 2018, CANCER GENET-NY, V220, P49, DOI 10.1016/j.cancergen.2017.11.001; Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Guo Q, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0695-4; Hashimoto Y, 2016, EPIGENOMICS-UK, V8, P685, DOI 10.2217/epi-2015-0013; He CG, 2014, ONCOL LETT, V7, P1639, DOI 10.3892/ol.2014.1923; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Huang ZH, 2007, WORLD J GASTROENTERO, V13, P950, DOI 10.3748/wjg.v13.i6.950; Itzkowitz S, 2008, AM J GASTROENTEROL, V103, P2862, DOI 10.1111/j.1572-0241.2008.02088.x; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Carmona FJ, 2013, CANCER PREV RES, V6, P656, DOI 10.1158/1940-6207.CAPR-12-0501; KIM MS, 2009, PLOS ONE, V4, DOI DOI 10.1371/JOURNAL.PONE.0006555; Kolodziej MA, 2016, ANTICANCER RES, V36, P887; Kormi SMA, 2017, COLORECTAL CANCER, V6, P63, DOI 10.2217/crc-2017-0007; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Lenhard K, 2005, CLIN GASTROENTEROL H, V3, P142, DOI 10.1016/S1542-3565(04)00624-X; Leung WK, 2007, AM J GASTROENTEROL, V102, P1483, DOI 10.1111/j.1572-0241.2007.01229.x; Leung WK, 2004, CLIN CHEM, V50, P2179, DOI 10.1373/clinchem.2004.039305; Li BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155095; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Li WH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/657570; Lu HN, 2014, ONCOL LETT, V8, P1751, DOI 10.3892/ol.2014.2413; Luo YX, 2011, INT J CLIN PRACT, V65, P1313, DOI 10.1111/j.1742-1241.2011.02800.x; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muller HM, 2004, LANCET, V363, P1283, DOI 10.1016/S0140-6736(04)16002-9; Nagasaka T, 2009, JNCI-J NATL CANCER I, V101, P1244, DOI 10.1093/jnci/djp265; Oberwalder M, 2008, INT J COLORECTAL DIS, V23, P15, DOI 10.1007/s00384-007-0355-2; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Oort FA, 2010, ALIMENT PHARM THER, V31, P432, DOI 10.1111/j.1365-2036.2009.04184.x; Petko Z, 2005, CLIN CANCER RES, V11, P1203; Qian LY, 2014, J CANCER RES THER, V10, pC287, DOI 10.4103/0973-1482.151534; Rawson JB, 2011, CARCINOGENESIS, V32, P741, DOI 10.1093/carcin/bgr020; Rokni P, 2018, GENES GENOM, V40, P423, DOI 10.1007/s13258-017-0644-2; Salehi R, 2012, Adv Biomed Res, V1, P87, DOI 10.4103/2277-9175.105169; Tang D, 2008, J NANJING MED U, V22, P96, DOI DOI 10.1016/S1007-4376(08)60020-9; Tang D, 2011, CLIN INVEST MED, V34, pE88; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang DR, 2008, WORLD J GASTROENTERO, V14, P524, DOI 10.3748/wjg.14.524; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xiao W, 2015, ONCOL LETT, V9, P1383, DOI 10.3892/ol.2014.2815; Xiao ZJ, 2014, CLIN CHIM ACTA, V431, P154, DOI 10.1016/j.cca.2014.01.044; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhai RL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002129; Zhang H, 2013, INT J MED SCI, V10, P230, DOI 10.7150/ijms.5278; Zhang H, 2014, WORLD J GASTROENTERO, V20, P14040, DOI 10.3748/wjg.v20.i38.14040; Zhang H, 2014, WORLD J GASTROENTERO, V20, P6329, DOI 10.3748/wjg.v20.i20.6329; Zhang JP, 2012, CANCER EPIDEMIOL, V36, P73, DOI 10.1016/j.canep.2011.04.006; Zhang W, 2007, DIS COLON RECTUM, V50, P1618, DOI 10.1007/s10350-007-0286-6	62	23	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200735	10.1371/journal.pone.0200735	http://dx.doi.org/10.1371/journal.pone.0200735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024936	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000045
J	Mendoza, W; Mendola, D; Kim, J; Yarish, C; Velloze, A; Mitchell, BG				Mendoza, Wilson; Mendola, Dominick; Kim, Jang; Yarish, Charles; Velloze, Alyssa; Mitchell, B. Greg			Land-based drip-irrigated culture of Ulva compressa: the effect of culture platform design and nutrient concentration on biomass production and protein content (vol 13, e0199287, 2018)	PLOS ONE			English	Correction									[Kim, Jang] Incheon Natl Univ, Dept Ecol & Evolutionary Biol, Sch Nat Sci, 119 Acad Ro, Incheon 22012, South Korea; [Kim, Jang] Incheon Natl Univ, Dept Marine Sci, Sch Nat Sci, 119 Acad Ro, Incheon 22012, South Korea	Incheon National University; Incheon National University								Mendoza W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199287	1	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201675	10.1371/journal.pone.0201675	http://dx.doi.org/10.1371/journal.pone.0201675			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052680	Green Submitted, gold, Green Published			2022-12-27	WOS:000440006600051
J	Donovan, BM; Nidey, NL; Jasper, EA; Robinson, JG; Bao, W; Saftlas, AF; Ryckman, KK				Donovan, Brittney M.; Nidey, Nichole L.; Jasper, Elizabeth A.; Robinson, Jennifer G.; Bao, Wei; Saftlas, Audrey F.; Ryckman, Kelli K.			First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis	PLOS ONE			English	Review							PLASMA PROTEIN-A; HUMAN CHORIONIC-GONADOTROPIN; BIOCHEMICAL MARKERS; PAPP-A; GREY LITERATURE; BETA-HCG; PREGNANCY; ASSOCIATION; MANAGEMENT; WOMEN	Biomarkers commonly assessed in prenatal screening have been associated with a number of adverse perinatal and birth outcomes. However, it is not clear whether first trimester measurements of prenatal screening biomarkers are associated with subsequent risk of gestational diabetes mellitus (GDM). We aimed to systematically review and statistically summarize studies assessing the relationship between first trimester prenatal screening biomarker levels and GDM development. We comprehensively searched PubMed/MEDLINE, EMBASE, CINAHL, and Scopus (from inception through January 2018) and manually searched the reference lists of all relevant articles. We included original, published, observational studies examining the association of first trimester pregnancy associated plasma protein- A (PAPP-A) and/or free beta-human chorionic gonadotropin (free beta-hCG) levels with GDM diagnosis. Mean differences were calculated comparing PAPP-A and free beta-hCG multiples of median (MoM) levels between women who developed GDM and those who did not and were subsequently pooled using two-sided random-effects models. Our meta-analysis of 13 studies on PAPP-A and nine studies on free beta-hCG indicated that first trimester MoM levels for both biomarkers were lower in women who later developed GDM compared to women who remained normoglycemic throughout pregnancy (MD -0.17; 95% CI -0.24, -0.10; MD -0.04; 95% CI -0.07 +/- 0.01). There was no evidence for between-study heterogeneity among studies on free beta-hCG (I-2 = 0%). A high level of between-study heterogeneity was detected among the studies reporting on PAPP-A (I-2 = 90%), but was reduced after stratifying by geographic location, biomarker assay method, and timing of GDM diagnosis. Our meta-analysis indicates that women who are diagnosed with GDM have lower first trimester levels of both PAPP-A and free beta-hCG than women who remain normoglycemic throughout pregnancy. Further assessment of the predictive capacity of these biomarkers within large, diverse populations is needed.	[Donovan, Brittney M.; Nidey, Nichole L.; Jasper, Elizabeth A.; Robinson, Jennifer G.; Bao, Wei; Saftlas, Audrey F.; Ryckman, Kelli K.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA	University of Iowa	Ryckman, KK (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA.	kelli-ryckman@uiowa.edu	Snyder, Brittney/Y-5788-2019; , Jennifer/AAD-8336-2019; Bao, Wei/AAG-2431-2019	Snyder, Brittney/0000-0001-8356-3965; Bao, Wei/0000-0002-7301-5786; Ryckman, Kelli/0000-0002-9496-4147	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Baer RJ, 2016, EUR J OBSTET GYN R B, V198, P1, DOI 10.1016/j.ejogrb.2015.12.019; Bao W, 2015, METABOLISM, V64, P756, DOI 10.1016/j.metabol.2015.01.013; Beneventi F, 2014, AM J REPROD IMMUNOL, V72, P413, DOI 10.1111/aji.12270; Beneventi F, 2011, PRENATAL DIAG, V31, P523, DOI 10.1002/pd.2733; Borenstein M., 2009, INTRO METAANALYSIS; Brink HS, 2016, ENDOCR CONNECT, V5, pR26, DOI 10.1530/EC-16-0033; Browne JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159592; Caughey AB, 2017, OBSTET GYNECOL, V130, pE17, DOI 10.1097/AOG.0000000000002159; Chen X, 2014, GLUCOSE FOETAL GROWT, P3; Cheuk QKY, 2016, HONG KONG MED J, V22, P30, DOI 10.12809/hkmj144470; Cheung KW, 2011, REPROD SYS SEXUAL DI, P2, DOI [10.4172/2161-038X.S2-002, DOI 10.4172/2161-038X.S2-002]; Di X, 2018, J DIABETES INVEST, V9, P204, DOI 10.1111/jdi.12672; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farina A, 2017, REPROD SCI, V24, P954, DOI 10.1177/1933719116675057; Garrison A, 2015, AM FAM PHYSICIAN, V91, P460; Gurram P, 2014, J CLIN MED, V3, P480, DOI 10.3390/jcm3020480; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Husslein H, 2012, J MATERN-FETAL NEO M, V25, P2230, DOI 10.3109/14767058.2012.684170; Jelliffe-Pawlowski LL, 2015, BJOG-INT J OBSTET GY, V122, P1484, DOI 10.1111/1471-0528.13495; Lakhi N, 2012, OBSTET GYNAECOL, V14, P267, DOI 10.1111/j.1744-4667.2012.00132.x; Lovati E, 2013, DIABETES RES CLIN PR, V100, P340, DOI 10.1016/j.diabres.2013.04.002; Lowe WL, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0709-z; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mahood Q, 2014, RES SYNTH METHODS, V5, P221, DOI 10.1002/jrsm.1106; Martin JLR, 2005, EUR PSYCHIAT, V20, P550, DOI 10.1016/j.eurpsy.2005.03.011; Moyer VA, 2014, ANN INTERN MED, V160, P414, DOI 10.7326/M13-2905; Pellitero S, 2007, DIABETES CARE, V30, P3083, DOI 10.2337/dc07-1092; Quattrocchi T, 2015, FETAL DIAGN THER, V37, P33, DOI 10.1159/000365147; Riskin-Mashiah S, 2009, DIABETES CARE, V32, P1639, DOI 10.2337/dc09-0688; Rose S, 2008, NOTE RISK PREDICTION; Ryan R., 2017, HETEROGENEITY SUBGRO; Savvidou MD, 2012, BJOG-INT J OBSTET GY, V119, P410, DOI 10.1111/j.1471-0528.2011.03253.x; Sayam NC, 2008, ARCH GYNECOL OBSTET, V277, P47, DOI 10.1007/s00404-007-0421-6; Shiefa S, 2013, INDIAN J CLIN BIOCHE, V28, P3, DOI 10.1007/s12291-012-0269-9; Sirikunalai P, 2016, J OBSTET GYNAECOL, V36, P178, DOI 10.3109/01443615.2015.1036400; Spencer K, 2000, PRENATAL DIAG, V20, P491, DOI 10.1002/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeting A, 2015, BEST PRACT RES CL OB, V29, P183, DOI 10.1016/j.bpobgyn.2014.09.006; Syngelaki A, 2015, METABOLISM, V64, P1485, DOI 10.1016/j.metabol.2015.07.015; The Cochrane Collaboration, 2014, REV MAN REVMAN COMP; Tugwell P., 2017, EUR J EPIDEMIOL; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wells G, 2015, J CLIN ENDOCR METAB, V100, P2372, DOI 10.1210/jc.2014-4103	44	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201319	10.1371/journal.pone.0201319	http://dx.doi.org/10.1371/journal.pone.0201319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048548	Green Published, gold			2022-12-27	WOS:000439952400075
J	da Silva, DTG; Dias, E; Ebdon, J; Taylor, H				Gomes da Silva, Diogo Trajano; Dias, Edgard; Ebdon, James; Taylor, Huw			Assessment of recommended approaches for containment and safe handling of human excreta in emergency settings	PLOS ONE			English	Article							WASTE-WATER TREATMENT; EBOLA-VIRUS; FECAL-COLIFORMS; DISINFECTION; LIME; INACTIVATION; PERSISTENCE; BACTERIOPHAGES; BACTERIA; REMOVAL	Ebola and cholera treatment centres (ETC and CTC) generate considerable quantities of excreta that can further the transmission of disease amongst patients and health workers. Therefore, approaches for the safe handling, containment and removal of excreta within such settings are needed to minimise the likelihood of onward disease transmission. This study compared the performance and suitability of three chlorine-based approaches (0.5% HTH, NaDCC and NaOCl (domestic bleach)) and three lime-based approaches (10%, 20% and 30% Ca(OH)(2)). The experiments followed recent recommendations for Ebola Treatment Centres. Three excreta matrices containing either raw municipal wastewater, or raw municipal wastewater plus 10% or 20% (w/v) added faecal sludge, were treated in 14 litre buckets at a ratio of 1: 10 (chlorine solutions or lime suspensions: excreta matrix). The effects of mixing versus non-mixing and increasing contact time (10 and 30 mins) were also investigated. Bacterial (faecal coliforms (FC) and intestinal enterococci (IE)) and viral (somatic coliphages (SOMPH), F+ specific phages (F+PH) and Bacteroides fragilis phages (GB-124PH)) indicators were used to determine the efficacy of each approach. Lime-based approaches provided greater treatment efficacy than chlorine-based approaches, with lime (30% w/v) demonstrating the greatest efficacy (log reductions values, FC = 4.75, IE = 4.16, SOMPH = 2.85, F+PH = 5.13 and GB124PH = 5.41). There was no statistical difference in efficacy between any of the chlorine-based approaches, and the highest log reduction values were: FC = 2.90, IE = 2.36, SOMPH = 3.01, F+PH = 2.36 and GB124PH = 0.74. No statistical difference was observed with respect to contact time for any of the approaches, and no statistical differences were observed with respect to mixing for the chlorine-based approaches. However, statistically significant increases in the efficacy of some lime-based approaches were observed following mixing. These findings provide evidence and practical advice to inform safe handling and containment of excreta and ensure more effective health protection in future emergency settings.	[Gomes da Silva, Diogo Trajano; Ebdon, James; Taylor, Huw] Univ Brighton, Sch Environm & Technol, Environm & Publ Hlth Res Grp, Brighton, E Sussex, England; [Dias, Edgard] Fed Univ Juiz de Fora UFJF, Fac Engn, Dept Sanit & Environm Engn, Juiz De Fora, MG, Brazil	University of Brighton; Universidade Federal de Juiz de Fora	da Silva, DTG (corresponding author), Univ Brighton, Sch Environm & Technol, Environm & Publ Hlth Res Grp, Brighton, E Sussex, England.	D.TrajanoGomesDaSilva2@brighton.ac.uk	Dias, Edgard/GRX-4775-2022	Dias, Edgard/0000-0002-7085-6977; Ebdon, James/0000-0003-0649-8076; Trajano Gomes da Silva, Diogo/0000-0003-1971-2799	United States Agency for International Development, Office of Foreign Disaster Assistance [USAID-OFDA-A-15-00026]; University of Brighton [USAID-OFDA-A-15-00026]; Southern Water Ltd (UK); OXFAM (UK)	United States Agency for International Development, Office of Foreign Disaster Assistance(United States Agency for International Development (USAID)); University of Brighton; Southern Water Ltd (UK); OXFAM (UK)	This study was funded by a grant from the United States Agency for International Development, Office of Foreign Disaster Assistance to Tufts University with University of Brighton as sub-contractor ((USAID-OFDA-A-15-00026) https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflict-and-humanitarian-assistance/office-us). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Christine Sinclair, Suzanne Armsden, Adam Taylor, Chloe Goacher (UoB), Prapamart Jackson (SW), Southern Water Ltd (UK) and OXFAM (UK) for supporting this study.	Anderson C, 2015, INT J ENV RES PUB HE, V12, P13871, DOI 10.3390/ijerph121113871; [Anonymous], 2001, 107054 ISO; [Anonymous], 2015, INT REC CLEAN HOUS S; [Anonymous], 2001, 107051 ISO; [Anonymous], 2001, 107052 ISO; [Anonymous], 2000, 930812000 ISO; [Anonymous], 2014, EB VIR DIS KEY QUEST; [Anonymous], 2000, 789922000 ISO; APHA, 2012, STAND METH EX WAT WA; Bibby K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005299; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P245, DOI 10.1021/acs.estlett.5b00193; Bina B., 2004, IRAN J ENVIRON HEALT, V1, P34; Branz A, 2017, WATERLINES, P1; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Casanova LM, 2015, ENVIRON SCI TECH LET, V2, P76, DOI 10.1021/acs.estlett.5b00029; Centers for Disease Control and Prevention, 2014, INT GUID ENV INF CON; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; de Carvalho NA, 2017, ENVIRON SCI TECHNOL, V51, P8692, DOI 10.1021/acs.est.7b01296; Donnermair MM, 2003, WATER RES, V37, P1557, DOI 10.1016/S0043-1354(02)00522-5; Feachem RG, 1983, INT J ENV; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Gallandat K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177943; GAMBRILL MP, 1989, WATER SCI TECHNOL, V21, P79, DOI 10.2166/wst.1989.0082; Gensch R., 2018, COMPENDIUM SANITATIO; Girovich MJ., 1996, BIOSOLIDS TREATMENT, DOI [10.1201/9781482273489, DOI 10.1201/9781482273489]; GRABOW WOK, 1986, APPL ENVIRON MICROB, V52, P430, DOI 10.1128/AEM.52.3.430-433.1986; GRABOW WOK, 1978, APPL ENVIRON MICROB, V35, P663, DOI 10.1128/AEM.35.4.663-669.1978; GRABOW WOK, 1969, WATER RES, V3, P943, DOI 10.1016/0043-1354(69)90077-3; HAVELAAR AH, 1984, J APPL BACTERIOL, V56, P439, DOI 10.1111/j.1365-2672.1984.tb01372.x; Hijikata N, 2016, J ENVIRON MANAGE, V181, P721, DOI 10.1016/j.jenvman.2016.08.026; Iqbal Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156136; JOFRE J, 1995, APPL ENVIRON MICROB, V61, P3227, DOI 10.1128/AEM.61.9.3227-3231.1995; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; LECHEVALLIER MW, 1981, APPL ENVIRON MICROB, V42, P159, DOI 10.1128/AEM.42.1.159-167.1981; Lisle JT, 1998, APPL ENVIRON MICROB, V64, P4658; MARIS P, 1995, REV SCI TECH OIE, V14, P47, DOI 10.20506/rst.14.1.829; Mignotte-Cadiergues B, 2001, WATER SCI TECHNOL, V43, P195, DOI 10.2166/wst.2001.0737; Morrison S.M., 1973, EPA660273017; Nasser AM, 1999, WATER RES, V33, P1748, DOI 10.1016/S0043-1354(98)00380-7; Payan A, 2005, APPL ENVIRON MICROB, V71, P5659, DOI 10.1128/AEM.71.9.5659-5662.2005; POLPRASERT C, 1981, WATER RES, V15, P31, DOI 10.1016/0043-1354(81)90179-2; Rose C, 2015, CRIT REV ENV SCI TEC, V45, P1827, DOI 10.1080/10643389.2014.1000761; Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Schouw NL, 2002, SCI TOTAL ENVIRON, V286, P155, DOI 10.1016/S0048-9697(01)00973-1; Semerjian L, 2003, ADV ENVIRON RES, V7, P389, DOI 10.1016/S1093-0191(02)00009-6; SHUVAL HI, 1973, WATER RES, V7, P537, DOI 10.1016/0043-1354(73)90053-5; SOBSEY MD, 1989, WATER SCI TECHNOL, V21, P179, DOI 10.2166/wst.1989.0098; Sozzi E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003776; Sterk E, 2008, FILOVIRUS HAEMORRHAG; STEWART MH, 1992, APPL ENVIRON MICROB, V58, P2649, DOI 10.1128/AEM.58.8.2649-2653.1992; TAYLOR HD, 1994, WATER SCI TECHNOL, V29, P247, DOI 10.2166/wst.1994.0620; Taylor HD, 1994, RES MONOGRAPHS TROPI, P3; Torodel B., 2010, SANITATION VENTURES; Trajano DGS, 2016, 39 WEDC INT C KUM GH; Tree JA, 2003, APPL ENVIRON MICROB, V69, P2038, DOI 10.1128/AEM.69.4.2038-2043.2003; VENKOBACHAR C, 1977, WATER RES, V11, P727, DOI 10.1016/0043-1354(77)90114-2; Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254; Wells E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152442; Wigginton KR, 2012, ENVIRON SCI TECHNOL, V46, P12069, DOI 10.1021/es3029473; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization (WHO), 2016, EB DAT STAT LAT AV S; 2013, WORLD MAL REP 2013, P1	64	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201344	10.1371/journal.pone.0201344	http://dx.doi.org/10.1371/journal.pone.0201344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048542	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400082
J	Cuypers, L; Perez, AB; Chueca, N; Aldamiz-Echevarria, T; Alados, JC; Martinez-Sapina, AM; Merino, D; Pineda, JA; Tellez, F; Espinosa, N; Salmeron, J; Rivero-Juarez, A; Vivancos, MJ; Hontanon, V; Vandamme, AM; Garcia, F				Cuypers, Lize; Belen Perez, Ana; Chueca, Natalia; Aldamiz-Echevarria, Teresa; Carlos Alados, Juan; Maria Martinez-Sapina, Ana; Merino, Dolores; Antonio Pineda, Juan; Tellez, Francisco; Espinosa, Nuria; Salmeron, Javier; Rivero-Juarez, Antonio; Jesus Vivancos, Maria; Hontanon, Victor; Vandamme, Anne-Mieke; Garcia, Federico			Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; VIRUS-INFECTION; INJECT DRUGS; RISK-FACTORS; HCV INFECTION; HIV; PEOPLE; TRANSMISSION; RESISTANCE; GENOTYPE	Despite high response rates associated to hepatitis C virus (HCV) treatment, no protective immunity is acquired, allowing for reinfection and continued infectiousness. Distinguishing between relapse and reinfection is crucial for patient counselling and to choose the most appropriate retreatment. Here, refined phylogenetic analysis using multiple genes served to assess genotype and reinfection for 53 patients for whom the virus was sampled before start of therapy and at time of sustained virological response evaluation at week 12. At baseline, genotypes were determined as HCV1a (41.5%), HCV1b (24.5%), HCV4 (18.9%) and HCV3a (15.1%), while six cases revealed to be discordantly assigned by phylogeny and commercial assays. Overall, 60.4% was co-infected with HIV. The large majority was classified as people who inject drugs (78.6%), often co-infected with HIV. Transmission was sexual in seven cases, of which five in HIV-positive men-who-have-sex-with-men. Overall, relapse was defined for 44 patients, while no conclusion was drawn for four patients. Five patients were reinfected with a different HCV strain, of which three with a different genotype, showing that phylogeny is needed not only to determine the genotype, but also to distinguish between relapse and intra-subtype reinfection. Of note, phylogenies are more reliable when longer fragments of the viral genome are being sequenced.	[Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Cuypers, Lize] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Belen Perez, Ana; Chueca, Natalia; Garcia, Federico] Univ Hosp San Cecilio Granada, Dept Clin Microbiol, Inst Invest Ibs, Granada, Spain; [Aldamiz-Echevarria, Teresa] Hosp Gregorio Maranon, Infect Dis Unit, Madrid, Spain; [Carlos Alados, Juan] Univ Hosp Jerez, Clin Microbiol, Cadiz, Spain; [Maria Martinez-Sapina, Ana] Hosp Miguel Servet, Clin Microbiol, Zaragoza, Spain; [Merino, Dolores] Hosp Infanta Elena, Clin Microbiol, Huelva, Spain; [Antonio Pineda, Juan] Univ Hosp Valme, Infect Dis Unit, Seville, Spain; [Tellez, Francisco] Hosp La Linea, AGS Campo Gibraltar, UGC Enfermedades Infecciosas & Microbiol, Cadiz, Spain; [Espinosa, Nuria] Hosp Virgen del Rocio, Clin Microbiol, Seville, Spain; [Salmeron, Javier] Univ Hosp San Cecilio Granada, Inst Invest Ibs, CIBERehd, Hepatol Unit, Granada, Spain; [Rivero-Juarez, Antonio] Univ Cordoba, Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Jesus Vivancos, Maria] Hosp Ramon & Cajal, Clin Microbiol, Madrid, Spain; [Hontanon, Victor] Univ Hosp La Paz, Clin Microbiol, Madrid, Spain; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Hyg & Trop Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal	KU Leuven; University of Oxford; Instituto de Investigacion Biosanitaria IBS Granada; General University Gregorio Maranon Hospital; Miguel Servet University Hospital; Hospital Valme; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Cuypers, L (corresponding author), Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.; Cuypers, L (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.	lize.cuypers@kuleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Pineda, Juan A./AAO-9312-2021; Garcia, Federico/AAA-3175-2020; Chueca, Natalia/T-9734-2019; Rivero-Juarez, Antonio/E-4528-2019; Cuypers, Lize/D-9460-2018	Vandamme, Anne-Mieke/0000-0002-6594-2766; Pineda, Juan A./0000-0002-3751-0296; Garcia, Federico/0000-0001-7611-781X; Chueca, Natalia/0000-0002-3420-3290; Perez, Ana Belen/0000-0001-9655-817X; Rivero-Juarez, Antonio/0000-0002-5813-6889; ALADOS ARBOLEDAS, JUAN CARLOS/0000-0001-5361-3968; Espinosa, Nuria/0000-0003-2249-2352; Hontanon Antonana, Victor/0000-0003-3070-2647; Cuypers, Lize/0000-0002-9433-8752; Tellez, Francisco/0000-0002-9997-6761	FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen) [G.0B23.17N]; Fondo de Investigacion Sanitaria [PI15/00713]; Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER [RD16/0025/0040]; Fundacion Progreso y salud, Junta de Andalucia [PI-0411-2014]; GEHEP-SEIMC [GEHEP-004]	FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER; Fundacion Progreso y salud, Junta de Andalucia(Junta de Andalucia); GEHEP-SEIMC	Part of this research was sponsored by FWO (Fonds Wetenschappelijk Onderzoek - Vlaanderen) grant G.0B23.17N. This work was supported in part by grants from Fondo de Investigacion Sanitaria (www.isciii.es) (PI15/00713), Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER (www.red.es/redes/inicio) (RD16/0025/0040), Fundacion Progreso y salud, Junta de Andalucia (http://www.juntadeandalucia.es/fundacionprogresoysalud/es) (PI-0411-2014), and GEHEP-SEIMC (GEHEP-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD/IDSA/IAS-USA, 2017, REC TEST MAN TREAT H; Abdel-Hakeem MS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00274; Abdelrahman T, 2015, HEPATOLOGY, V61, P88, DOI 10.1002/hep.27192; Aguilera A, 2017, J VIRAL HEPATITIS, V24, P725, DOI 10.1111/jvh.12700; Al-Qahtani AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44947; Apers L, 2015, JAIDS-J ACQ IMM DEF, V68, P585, DOI 10.1097/QAI.0000000000000528; Arrais TC, 2008, J MED VIROL, V80, P80, DOI 10.1002/jmv.21050; Bollepalli S, 2008, DIGEST DIS SCI, V53, P517, DOI 10.1007/s10620-007-9856-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chueca N, 2016, PLOS ONE, V11; Cunningham EB, 2015, NAT REV GASTRO HEPAT, V12, P218, DOI 10.1038/nrgastro.2015.36; Cuypers L, 2016, REV MED VIROL, V26, P408, DOI 10.1002/rmv.1895; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; European Association for the Study of the Liver, 2018, J HEPATOL; Fernandez-Caballero JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175564; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Grebely J, 2017, NAT REV GASTRO HEPAT, V14, P641, DOI 10.1038/nrgastro.2017.106; Hagan H, 2015, AIDS, V29, P2335, DOI 10.1097/QAD.0000000000000834; Hoornenborg E, 2017, AIDS, V31, P1603, DOI 10.1097/QAD.0000000000001522; Islam N, 2017, LANCET GASTROENTEROL, V2, P200, DOI 10.1016/S2468-1253(16)30182-0; Jacka B, 2016, J HEPATOL, V64, P1247, DOI 10.1016/j.jhep.2016.02.031; Jacka B, 2014, HEPATOLOGY, V60, P1571, DOI 10.1002/hep.27310; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Lea T, 2013, SEX HEALTH, V10, P448, DOI 10.1071/SH13042; Lemey P, 2005, AIDS, V19, P1551, DOI 10.1097/01.aids.0000182519.92030.ce; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Martin DP, 2017, METHODS MOL BIOL, V1525, P433, DOI 10.1007/978-1-4939-6622-6_17; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; Olmstead AD, 2015, INFECT GENET EVOL, V33, P101, DOI 10.1016/j.meegid.2015.04.017; Paraschiv S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185866; Perez AB, 2017, J HEPATOL, V66, pS313, DOI 10.1016/S0168-8278(17)30947-9; Poordad FF, 2009, ANTIVIR THER, V14, P303; Pradat P, 2017, J INFECTION, V75, P234, DOI 10.1016/j.jinf.2017.05.008; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quer J, 2015, J CLIN MICROBIOL, V53, P219, DOI 10.1128/JCM.02093-14; Robaeys G, 2016, J HEPATOL, V65, P1094, DOI 10.1016/j.jhep.2016.07.042; Sarrazin C, 2017, CLIN INFECT DIS, V64, P44, DOI 10.1093/cid/ciw676; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Silberstein FC, 2016, HEPATOLOGY, V63, P1058, DOI 10.1002/hep.27895; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Sorbo MC, 2018, DRUG RESIST UPDATE, V37, P17, DOI 10.1016/j.drup.2018.01.004; Stamatakis Alexandros, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi0614s51; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Urbanus AT, 2014, AIDS, V28, P781, DOI 10.1097/QAD.0000000000000126; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van der Meer AJ, 2016, J HEPATOL, V65, pS95, DOI 10.1016/j.jhep.2016.07.039	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201268	10.1371/journal.pone.0201268	http://dx.doi.org/10.1371/journal.pone.0201268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044871	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500099
J	Hammerman, M; Dietrich-Zagonel, F; Blomgran, P; Eliasson, P; Aspenberg, P				Hammerman, Malin; Dietrich-Zagonel, Franciele; Blomgran, Parmis; Eliasson, Pernilla; Aspenberg, Per			Different mechanisms activated by mild versus strong loading in rat Achilles tendon healing	PLOS ONE			English	Article							GENE-EXPRESSION; RUPTURE; REPAIR; INJURY	Background Mechanical loading stimulates Achilles tendon healing. However, various degrees of loading appear to have different effects on the mechanical properties of the healing tendon, and strong loading might create microdamage in the tissue. This suggests that different mechanisms might be activated depending on the magnitude of loading. The aim of this study was to investigate these mechanisms further. Methods Female rats had their right Achilles tendon cut transversely and divided into three groups: 1) unloading (calf muscle paralysis by Botox injections, combined with joint fixation by a steel-orthosis), 2) mild loading (Botox only), 3) strong loading (free cage activity). Gene expression was analyzed by PCR, 5 days post-injury, and mechanical testing 8 days post-injury. The occurrence of microdamage was analyzed 3, 5, or 14 days post-injury, by measuring leakage of injected fluorescence-labelled albumin in the healing tendon tissue. Results Peak force, peak stress, and elastic modulus of the healing tendons gradually improved with increased loading as well as the expression of extracellular matrix genes. In contrast, only strong loading increased transverse area and affected inflammation genes. Strong loading led to higher fluorescence (as a sign of microdamage) compared to mild loading at 3 and 5 days post-injury, but not at 14 days. Discussion Our results show that strong loading improves both the quality and quantity of the healing tendon, while mild loading only improves the quality. Strong loading also induces microdamage and alters the inflammatory response. This suggests that mild loading exert its effect via mechanotransduction mechanisms, while strong loading exert its effect both via mechanotransduction and the creation of microdamage. Conclusion In conclusion, mild loading is enough to increase the quality of the healing tendon without inducing microdamage and alter the inflammation in the tissue. This supports the general conception that early mobilization of a ruptured tendon in patients is advantageous.	[Hammerman, Malin; Dietrich-Zagonel, Franciele; Blomgran, Parmis; Eliasson, Pernilla; Aspenberg, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Orthoped, Linkoping, Sweden	Linkoping University	Eliasson, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Orthoped, Linkoping, Sweden.	pernilla.eliasson@gmail.com	Dietrich, Franciele/W-2316-2019; Eliasson, Pernilla/AAY-2126-2020	Dietrich, Franciele/0000-0003-4871-8268; Eliasson, Pernilla/0000-0001-6718-034X; Blomgran, Parmis/0000-0002-2654-1361	Swedish Research Council; Swedish Research Council for Sports Science; Ostergotland County (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Sports Science; Ostergotland County (ALF)	Grants were received from the Swedish Research Council, the Swedish Research Council for Sports Science, and Ostergotland County (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2012, J APPL PHYSIOL, V113, P1398, DOI 10.1152/japplphysiol.00491.2012; Andersson T, 2009, J APPL PHYSIOL, V107, P417, DOI 10.1152/japplphysiol.00414.2009; Blomgran P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29824; Carvalho FA, 2016, BRIT J SPORT MED, V50, P829, DOI 10.1136/bjsports-2016-096093; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Eliasson P, 2013, J APPL PHYSIOL, V114, P1519, DOI 10.1152/japplphysiol.01500.2012; Eliasson P, 2012, J APPL PHYSIOL, V112, P279, DOI 10.1152/japplphysiol.00858.2011; Eliasson P, 2012, J ORTHOP RES, V30, P274, DOI 10.1002/jor.21511; Freedman BR, 2016, J ORTHOP RES, V34, P2172, DOI 10.1002/jor.23253; Galloway MT, 2013, J BONE JOINT SURG AM, V95A, P1620, DOI 10.2106/JBJS.L.01004; Hachinski V, 2010, INT J STROKE, V5, P238, DOI 10.1111/j.1747-4949.2010.00442.x; Hammerman M, 2017, J APPL PHYSIOL, V123, P800, DOI 10.1152/japplphysiol.00323.2017; Hammerman M, 2014, J APPL PHYSIOL, V116, P54, DOI 10.1152/japplphysiol.00741.2013; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Kunes P, 2012, MEDIATORS INFLAMM, V2012, P10, DOI DOI 10.1155/2012/920517; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Palmes D, 2002, J ORTHOPAED RES, V20, P939, DOI 10.1016/S0736-0266(02)00032-3; Schepull T, 2013, AM J SPORT MED, V41, P2550, DOI 10.1177/0363546513501785; Schulze-Tanzil G, 2011, SCAND J MED SCI SPOR, V21, P337, DOI 10.1111/j.1600-0838.2010.01265.x; Singh D, 2017, BRIT J SPORT MED, V51, P1158, DOI 10.1136/bjsports-2016-h4722rep; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Yang D, 2017, IMMUNOL REV, V280, P41, DOI 10.1111/imr.12577	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201211	10.1371/journal.pone.0201211	http://dx.doi.org/10.1371/journal.pone.0201211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044869	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500092
J	Hellwig, S; Nix, DA; Gligorich, KM; O'Shea, JM; Thomas, A; Fuertes, CL; Bhetariya, PJ; Marth, GT; Bronner, MP; Underhill, HR				Hellwig, Sabine; Nix, David A.; Gligorich, Keith M.; O'Shea, John M.; Thomas, Alun; Fuertes, Carrie L.; Bhetariya, Preetida J.; Marth, Gabor T.; Bronner, Mary P.; Underhill, Hunter R.			Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing	PLOS ONE			English	Article							FETAL DNA; MOLECULAR DIAGNOSTICS; MATERNAL PLASMA; CANCER PATIENTS; DIGITAL PCR; MUTATIONS; SEPARATION; EVOLUTION; ORIGIN	Circulating tumor-derived cell-free DNA (ctDNA) enables non-invasive diagnosis, monitoring, and treatment susceptibility testing in human cancers. However, accurate detection of variant alleles, particularly during untargeted searches, remains a principal obstacle to widespread application of cell-free DNA in clinical oncology. In this study, isolation of short cell-free DNA fragments is shown to enrich for tumor variants and improve correction of PCR- and sequencing-associated errors. Subfractions of the mononucleosome of circulating cell-free DNA (ccfDNA) were isolated from patients with melanoma, pancreatic ductal adenocarcinoma, and colorectal adenocarcinoma using a high-throughput-capable automated gel-extraction platform. Using a 128-gene (128 kb) custom next-generation sequencing panel, variant alleles were on average 2-fold enriched in the short fraction (median insert size: similar to 142 bp) compared to the original ccfDNA sample, while 0.7-fold reduced in the fraction corresponding to the principal peak of the mononucleosome (median insert size: similar to 167 bp). Size-selected short fractions compared to the original ccfDNA yielded significantly larger family sizes (i.e., PCR duplicates) during in silico consensus sequence interpretation via unique molecular identifiers. Increments in family size were associated with a progressive reduction of PCR and sequencing errors. Although consensus read depth also decreased at larger family sizes, the variant allele frequency in the short ccfDNA fraction remained consistent, while variant detection in the original ccfDNA was commonly lost at family sizes necessary to minimize errors. These collective findings support the automated extraction of short ccfDNA fragments to enrich for ctDNA while concomitantly reducing false positives through in silico error correction.	[Hellwig, Sabine] ARUP Labs, Salt Lake City, UT USA; [Nix, David A.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Gligorich, Keith M.; Fuertes, Carrie L.; Bronner, Mary P.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [O'Shea, John M.] Univ Utah, Huntsman Canc Inst, Biorepository & Mol Pathol, Salt Lake City, UT USA; [Thomas, Alun] Univ Utah, Div Genet Epidemiol, Dept Family & Prevent Med, Salt Lake City, UT USA; [Thomas, Alun] Univ Utah, Div Publ Hlth, Dept Family & Prevent Med, Salt Lake City, UT USA; [Bhetariya, Preetida J.; Marth, Gabor T.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Underhill, Hunter R.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA; [Underhill, Hunter R.] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Underhill, HR (corresponding author), Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA.; Underhill, HR (corresponding author), Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA.	Hunter.Underhill@hsc.utah.edu	Bhetariya, Preetida/K-4132-2018	Bhetariya, Preetida/0000-0002-1988-3830; Underhill, Hunter/0000-0002-7389-1487; Hellwig, Sabine/0000-0002-9809-947X	Cancer Center Support Grant by the National Cancer Institute of the National Institutes of Health [P30CA042014]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [5UL1TR001067-05]; Biorepository and Molecular Pathology Shared Resource; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER	Cancer Center Support Grant by the National Cancer Institute of the National Institutes of Health; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Biorepository and Molecular Pathology Shared Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was conducted with support from the Biorepository and Molecular Pathology Shared Resource and the Cancer Biostatistics Shared Resource supported by the Cancer Center Support Grant awarded to the Huntsman Cancer Institute by the National Cancer Institute of the National Institutes of Health (P30CA042014). This investigation was supported in part with funding from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 5UL1TR001067-05 (formerly 8UL1TR000105 and UL1RR025764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chan KCA, 2004, CLIN CHEM, V50, P757, DOI 10.1373/clinchem.2003.029934; Donaldson J, 2018, ANNU REV MED, V69, P223, DOI 10.1146/annurev-med-041316-085721; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Garrigou S, 2016, CLIN CHEM, V62, P1129, DOI 10.1373/clinchem.2015.253609; Hahn T, 2009, CLIN CHEM, V55, P2144, DOI 10.1373/clinchem.2009.127480; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Jorgez CJ, 2009, FETAL DIAGN THER, V25, P314, DOI 10.1159/000235877; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kou RQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146638; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lui YNYN, 2002, CLIN CHEM, V48, P421; Manley Leigh J, 2016, J Biomol Tech, V27, P125; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Milbury Coren A, 2014, Biomol Detect Quantif, V1, P8; Murtaza M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9760; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Paweletz CP, 2016, CLIN CANCER RES, V22, P915, DOI 10.1158/1078-0432.CCR-15-1627-T; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; Uyaguari-Diaz MI, 2015, JOVE-J VIS EXP, DOI 10.3791/52685; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111	33	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0197333	10.1371/journal.pone.0197333	http://dx.doi.org/10.1371/journal.pone.0197333			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044795	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500004
J	Mariotto, AB; Zou, ZH; Johnson, CJ; Scoppa, S; Weir, HK; Huang, B				Mariotto, Angela B.; Zou, Zhaohui; Johnson, Christopher J.; Scoppa, Steve; Weir, Hannah K.; Huang, Bin			Geographical, racial and socio-economic variation in life expectancy in the US and their impact on cancer relative survival	PLOS ONE			English	Article							UNITED-STATES; POPULATION; TABLES; SMOKING; LUNG	Purpose Despite gains in life expectancy between 1992 to 2012, large disparities in life expectancy continue to exist in the United States between subgroups of the population. This study aimed to develop detailed life tables (LT), accounting for mortality differences by race, geography, and socio-economic status (SES), to more accurately measure relative cancer survival and life expectancy patterns in the United States. Methods We estimated an extensive set of County SES-LT by fitting Poisson regression models to deaths and population counts for U.S. counties by age, year, gender, race, ethnicity and county-level SES index. We reported life expectancy patterns and evaluated the impact of the County SES-LT on relative survival using data from the Surveillance Epidemiology and End Results (SEER) Program cancer registries. Results Between 1992 and 2012, the largest increase in life expectancy was among black men (6.8 years), however there were still large geographical differences. Life expectancy was highest for Asian or Pacific Islanders (API), and lowest for American Indians and Alaskan Natives (AIAN). In 2010, life expectancies by state ranged from 73 to 82 years for white males, 78 to 86 years for white females, 66 to 75 for black males, and 75 to 81 for black females. Comparisons of relative survival using National LT and the new County SES-LT showed that relative survival using County SES-LT improved relative survival estimates for some demographic groups, particularly in low and high SES areas, among Hispanics and AIAN, and among older male cancer patients. Relative survival using County SES-LT was 7.3% and 6.7% survival points closer to cause-specific survival compared to the National LT relative survival for AIAN and Hispanic cancer patients diagnosed between ages 75 and 84 years, respectively. Importantly, the County SES-LT relative survival estimates were higher in lower SES areas and lower in higher SES areas, reducing differences in relative survival comparisons. Conclusion The use of these new socio-economic life tables (County SES-LT) can provide more accurate estimates of relative survival, improve comparisons of relative survival among registries, better illustrate disparities and cancer control efforts, and should be used as default for cancer relative survival using U.S. data.	[Mariotto, Angela B.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Zou, Zhaohui; Scoppa, Steve] Informat Management Serv Inc, Calverton, MD USA; [Johnson, Christopher J.] Canc Data Registry Idaho, Boise, ID USA; [Weir, Hannah K.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA; [Huang, Bin] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Centers for Disease Control & Prevention - USA; University of Kentucky	Mariotto, AB (corresponding author), NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA.	mariotta@mail.nih.gov						Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 2018, SEER CANC STAT REV; Arias E, 2014, AM J PUBLIC HEALTH, V104, pS312, DOI 10.2105/AJPH.2013.301635; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; Arias Elizabeth, 2008, Natl Vital Stat Rep, V57, P1; Azzani M, 2015, SUPPORT CARE CANCER, V23, P889, DOI 10.1007/s00520-014-2474-y; Baili P, 2008, TUMORI J, V94, P658; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cho H HN, 2011, 201101 NCI; Ederer F, 1959, INSTRUCTIONS IBM 650; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Elandt-Johnson RC, 1990, SURVIVAL MODELS DATA; Ellis L, 2014, BRIT J CANCER, V111, P195, DOI 10.1038/bjc.2014.217; Fuchs VR, 2016, JAMA-J AM MED ASSOC, V316, P1869, DOI 10.1001/jama.2016.14398; Hinchliffe SR, 2012, CANCER EPIDEMIOL, V36, P148, DOI 10.1016/j.canep.2011.09.007; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; Johnson CJ, 2017, CANC N AM 2010 2014, VFour; Mariotto, 2011, J NATL CANCER I, V103, DOI 10.1093/jnci/djr059; Mariotto Angela B, 2014, J Natl Cancer Inst Monogr, V2014, P145, DOI 10.1093/jncimonographs/lgu024; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Skyrud KD, 2014, INT J CANCER, V135, P196, DOI 10.1002/ijc.28645; Stroup Antoinette M., 2014, Journal of the National Cancer Institute Monographs, P218, DOI 10.1093/jncimonographs/lgu017; VERDECCHIA A, 1989, STAT MED, V8, P201, DOI 10.1002/sim.4780080207; Wei Rong, 2012, Natl Vital Stat Rep, V60, P1; Xu J., 2017, NATL VITAL STAT REPO, V66, P4; Yu MD, 2014, CANCER CAUSE CONTROL, V25, P81, DOI 10.1007/s10552-013-0310-1	29	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201034	10.1371/journal.pone.0201034	http://dx.doi.org/10.1371/journal.pone.0201034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044829	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500074
J	Oakley, MS; Chorazeczewski, JK; Aleshnick, M; Anantharaman, V; Majam, V; Chawla, B; Myers, TG; Su, Q; Okoth, WA; Takeda, K; Akue, A; KuKuruga, M; Aravind, L; Kumar, S				Oakley, Miranda S.; Chorazeczewski, Joanna K.; Aleshnick, Maya; Anantharaman, Vivek; Majam, Victoria; Chawla, Bhavna; Myers, Timothy G.; Su, Qin; Okoth, Winter A.; Takeda, Kazuyo; Akue, Adovi; KuKuruga, Mark; Aravind, L.; Kumar, Sanjai			TCR beta-expressing macrophages induced by a pathogenic murine malaria correlate with parasite burden and enhanced phagocytic activity	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; RED PULP MACROPHAGES; ALPHA-BETA; FALCIPARUM-MALARIA; T-CELLS; RECEPTOR; ANEMIA; ATHEROSCLEROSIS; CHILDREN; MICE	Macrophages express a wide array of invariant receptors that facilitate host defense and mediate pathogenesis during pathogen invasion. We report on a novel population of CD11b(high)CD14(+)F4/80(+) macrophages that express TCR beta. This population expands dramatically during a Plasmodium berghei ANKA infection and sequesters in the brain during experimental cerebral malaria. Importantly, measurement of TCR beta transcript and protein levels in macrophages in wildtype versus nude and Rag1 knockout mice establishes that the observed expression is not a consequence of passive receptor expression due to phagocytosis or trogocytosis of peripheral T cells or nonspecific antibody staining to an Fc receptor or cross reactive epitope. We also demonstrate that TCR beta on brain sequestered macrophages undergoes productive gene rearrangements and shows preferential V beta usage. Remarkably, there is a significant correlation in the proportion of macrophages that express TCR beta and peripheral parasitemia. In addition, presence of TCR beta on the macrophage also correlates with a significant increase (1.9 fold) in the phagocytosis of parasitized erythrocytes. By transcriptional profiling, we identify a novel set of genes and pathways that associate with TCR beta expression by the macrophage. Expansion of TCR beta-expressing macrophages points towards a convergence of the innate and adaptive immune responses where both arms of the immune system cooperate to modulate the host response to malaria and possibly other infections.	[Oakley, Miranda S.; Chorazeczewski, Joanna K.; Okoth, Winter A.; Takeda, Kazuyo; Akue, Adovi; KuKuruga, Mark] US FDA, Div Bacterial Parasit & Allergen Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Aleshnick, Maya; Majam, Victoria; Chawla, Bhavna; Kumar, Sanjai] US FDA, Div Emerging & Transfus Transmitted Dis, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Anantharaman, Vivek; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Myers, Timothy G.; Su, Qin] NIAID, Genom Technol Sect, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Oakley, MS (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	miranda.oakley@fda.hhs.gov	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009; Myers, Timothy Gene/0000-0002-7059-5906; Aleshnick, Maya/0000-0001-5471-4242	Food and Drug Administration; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER	Food and Drug Administration(United States Department of Health & Human Services); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by intramural funding from the Food and Drug Administration.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Adu B, 2014, J INFECT DIS, V209, P285, DOI 10.1093/infdis/jit422; Beham AW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002375; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Boubou MI, 1999, INT IMMUNOL, V11, P1553, DOI 10.1093/intimm/11.9.1553; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541; CURFS JHAJ, 1993, PARASITOLOGY, V107, P125, DOI 10.1017/S0031182000067226; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Fauser S, 2000, J NEUROIMMUNOL, V111, P234, DOI 10.1016/S0165-5728(00)00368-4; Fuchs T, 2017, IMMUNOBIOLOGY, V222, P39, DOI 10.1016/j.imbio.2015.09.022; Fuchs T, 2015, BIOCHEM BIOPH RES CO, V456, P59, DOI 10.1016/j.bbrc.2014.11.034; Fuchs T, 2012, LANCET, V379, P1364, DOI 10.1016/S0140-6736(11)61939-9; Galvan MD, 2012, J LEUKOCYTE BIOL, V92, P489, DOI 10.1189/jlb.0212099; Giha HA, 2011, INFECT GENET EVOL, V11, P1674, DOI 10.1016/j.meegid.2011.06.015; Hochman SE, 2015, MBIO, V6, DOI 10.1128/mBio.01390-15; Kai OK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-24; Kim WJ, 2007, IMMUNOL LETT, V111, P57, DOI 10.1016/j.imlet.2007.05.004; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kopper TJ, 2018, J NEUROSCI RES, V96, P969, DOI 10.1002/jnr.24114; Kremen M, 2008, P NATL ACAD SCI USA, V105, P17109, DOI 10.1073/pnas.0808650105; Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; Legrand F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005926; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Montaudouin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010238; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Oakley MS, 2008, INFECT IMMUN, V76, P4518, DOI 10.1128/IAI.00525-08; Oakley MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166814; Oakley MS, 2014, EUR J IMMUNOL, V44, P2680, DOI 10.1002/eji.201344437; Oakley MS, 2013, J IMMUNOL, V191, P4699, DOI 10.4049/jimmunol.1300396; Oakley MS, 2011, INFECT IMMUN, V79, P1244, DOI 10.1128/IAI.00964-10; Oakley MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006793; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; Quigley Maire F, 2011, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1033s94; Stoute JA, 2011, CELL MICROBIOL, V13, P1441, DOI 10.1111/j.1462-5822.2011.01648.x; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185	49	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201043	10.1371/journal.pone.0201043	http://dx.doi.org/10.1371/journal.pone.0201043			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044851	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500075
J	Tagawa, M; Kurashima, C; Takagi, S; Maekawa, N; Konnai, S; Shimbo, G; Matsumoto, K; Inokuma, H; Kawamoto, K; Miyahara, K				Tagawa, Michihito; Kurashima, Chihiro; Takagi, Satoshi; Maekawa, Naoya; Konnai, Satoru; Shimbo, Genya; Matsumoto, Kotaro; Inokuma, Hisashi; Kawamoto, Keiko; Miyahara, Kazuro			Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma	PLOS ONE			English	Article							DEATH LIGAND 1; IMMUNE CHECKPOINT BLOCKADE; NON-HODGKIN-LYMPHOMA; VISCERAL LEISHMANIASIS; PD-1 EXPRESSION; CANCER-THERAPY; T-LYMPHOCYTES; PROGNOSIS; MALIGNANCIES; LEUKEMIA	B cell high grade lymphoma is the most common hematopoietic malignancy in dogs. Although the immune checkpoint molecules, programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), and immune checkpoint inhibitors have been evaluated for the treatment of various human lymphoid malignancies, the expression of those molecules and their relationship with prognosis remain unknown in canine lymphoma. The objective of this study was to evaluate the expression of costimulatory molecules on peripheral blood lymphocytes and tumor infiltrating lymphocytes, in addition to associated ligand expression in the lymph nodes of patients with B cell multicentric high grade lymphoma. Eighteen patients diagnosed with B cell high grade lymphoma and nine healthy control dogs were enrolled. Flow cytometric analysis revealed that the expression of PD-1 on CD4+ peripheral and tumor infiltrating lymphocytes and CTLA-4 on CD4+ peripheral lymphocytes was significantly higher in the lymphoma group than in the control group. The expression level of CD80 mRNA was significantly lower in the lymphoma group than in the control group. In contrast, there were no significant differences in PD-L1, PD-L2, and CD86 expression between the groups. Dogs with CTLA-4 levels below the cutoff values, which were determined based on receiver operating characteristic curves, on peripheral CD4+, CD8+, and tumor infiltrating CD4+ lymphocytes had significantly longer survival than dogs with values above the cutoff. Although it is uncertain whether the expression of immune checkpoint molecules affect the biological behavior of canine lymphoma, one possible explanation is that PD-1 and CTLA-4 might be associated with the suppression of antitumor immunity in dogs with B cell high grade lymphoma, particularly through CD4+ T cells.	[Tagawa, Michihito; Kurashima, Chihiro; Shimbo, Genya; Miyahara, Kazuro] Obihiro Univ Agr & Vet Med, Vet Med Ctr, Obihiro, Hokkaido, Japan; [Takagi, Satoshi] Hokkaido Univ, Vet Teaching Hosp, Fac Vet Med, Dept Vet Clin Sci, Sapporo, Hokkaido, Japan; [Maekawa, Naoya; Konnai, Satoru] Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Matsumoto, Kotaro; Inokuma, Hisashi] Obihiro Univ Agr & Vet Med, Dept Clin Vet Sci, Obihiro, Hokkaido, Japan; [Kawamoto, Keiko] Obihiro Univ Agr & Vet Med, Res Ctr Global Agromed, Obihiro, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University; Hokkaido University; Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine	Tagawa, M (corresponding author), Obihiro Univ Agr & Vet Med, Vet Med Ctr, Obihiro, Hokkaido, Japan.	mtagawa@obihiro.ac.jp		TAKAGI, Satoshi/0000-0001-6653-5890; Satoru, Konnai/0000-0002-3230-7109				Aresu L, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00077; Bai J F, 2016, Zhonghua Xue Ye Xue Za Zhi, V37, P916, DOI 10.3760/cma.j.issn.0253-2727.2016.10.021; Bryan LJ, 2015, BLOOD REV, V29, P25, DOI 10.1016/j.blre.2014.09.004; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chiku VM, 2016, IMMUNOBIOLOGY, V221, P879, DOI 10.1016/j.imbio.2016.03.007; Dakappagari N, 2012, CYTOM PART B-CLIN CY, V82B, P112, DOI 10.1002/cyto.b.20631; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Filley A, 2018, J NEURO-ONCOL, V137, P469, DOI 10.1007/s11060-018-2753-4; Folk A, 2010, VET IMMUNOL IMMUNOP, V134, P33, DOI 10.1016/j.vetimm.2009.10.006; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hartley G, 2018, VET COMP ONCOL, V16, P352, DOI 10.1111/vco.12386; Hu LY, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0262-z; Hu PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42913; Hude I, 2017, HAEMATOLOGICA, V102, P30, DOI 10.3324/haematol.2016.150656; Kamphorst AO, 2013, IMMUNOTHERAPY-UK, V5, P975, DOI 10.2217/imt.13.91; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kiyasu J, 2015, BLOOD, V126, P2193, DOI 10.1182/blood-2015-02-629600; Kumar SR, 2017, VET COMP ONCOL, V15, P1527, DOI 10.1111/vco.12297; Lenz JA, 2016, J SMALL ANIM PRACT, V57, P429, DOI 10.1111/jsap.12500; Luczynski W, 2006, NEOPLASMA, V53, P301; Maekawa N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09444-2; Maekawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157176; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nakayama S, 2017, BLOOD ADV, V1, P486, DOI 10.1182/bloodadvances.2016000885; Owen L.N., 1980, TNM CLASSIFICATION T, pp46; Panjwani PK, 2018, HUM PATHOL, V71, P91, DOI 10.1016/j.humpath.2017.10.029; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Shosu K, 2016, IN VIVO, V30, P195; Siedlecki CT, 2006, CAN VET J, V47, P52; Tagawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150030; Thanarajasingam G, 2016, FEBS J, V283, P2233, DOI 10.1111/febs.13668; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vail DM., 2013, WITHROW MACEWENS SMA, P608; Waki K, 2014, CANCER SCI, V105, P1229, DOI 10.1111/cas.12502; Wulfing C, 2014, NAT IMMUNOL, V15, P408, DOI 10.1038/ni.2870; Xu-Monette ZY, 2018, BLOOD, V131, P68, DOI 10.1182/blood-2017-07-740993; Yang ZZ, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.1; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang W, 2016, CANCER MED-US, V5, P3077, DOI 10.1002/cam4.874	43	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0201222	10.1371/journal.pone.0201222	http://dx.doi.org/10.1371/journal.pone.0201222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040869	gold, Green Published, Green Submitted			2022-12-27	WOS:000439749200032
J	Bai, EH; Guol, WB; Tan, Y; Yang, DM				Bai, Erhu; Guol, Wenbing; Tan, Yi; Yang, Darning			The analysis and application of granular backfill material to reduce surface subsidence in China's northwest coal mining area	PLOS ONE			English	Article							PREDICTION	In China's northwest coal mining area, the excavation of shallow buried thick coal seams has caused serious damage to the phreatic water layer and induced deterioration of the ecological environment. Backfilling is a basic method of controlling the loss of groundwater and reducing surface subsidence. In order to reduce the porosity of the backfill material and control the compression ratio of the backfill body, the grain gradation of the local aeolian sand was studied based on the geological conditions of the shallow buried coal seam in the Yulin mining area, Shaanxi province. Subsequently, aeolian sand was selected as the backfilling aggregate, and tests were implemented. The optimum proportion and slurry concentration of the backfill material were then obtained. The engineering application shows that the strength and stability of the backfill body based on the close packing theory can satisfy the requirements of supporting the overlying strata, and the integrity of overburden strata is competent. The maximum accumulated surface subsidence was measured to be 38mm, indicating that the aeolian sand-based backfill material in shallow and thick underground coal seam mining is able to protect the eco-environment and control the geo-environmental hazards, which are critical for the sustainable development of the mining industry and economic growth.	[Bai, Erhu; Guol, Wenbing; Tan, Yi; Yang, Darning] Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China; [Guol, Wenbing; Tan, Yi] Synergism Innovat Ctr Coal Safety Prod Henan Prov, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University	Bai, EH (corresponding author), Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China.	baieh@foxmail.com		Bai, Erhu/0000-0002-8885-3125	National Natural Science Foundation of China [51374092, 51774111]; Key Project of the National Natural Science Foundation of China [U1261206]; Innovation and Outstanding Talent Project of Henan Province Science and Technology [184200510003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation and Outstanding Talent Project of Henan Province Science and Technology	This work was supported by National Natural Science Foundation of China (grant no. 51374092 and 51774111, Wenbing Guo), the Key Project of the National Natural Science Foundation of China (grant no. U1261206, Wenbing Guo) and Innovation and Outstanding Talent Project of Henan Province Science and Technology (grant no.184200510003, Wenbing Guo).; The authors gratefully acknowledge the financial support for this work provided by the National Natural Science Foundation of China (grant no. 51374092, 51774111), the Key Project of the National Natural Science Foundation of China (grant no. U1261206), and the Innovation and Outstanding Talent Project of Henan Province Science and Technology (grant no. 184200510003).	Adibee N, 2013, ENVIRON EARTH SCI, V70, P1581, DOI 10.1007/s12665-013-2243-0; An BF, 2016, INT J MIN SCI TECHNO, V26, P301, DOI 10.1016/j.ijmst.2015.12.017; Basarir H, 2015, INT J ROCK MECH MIN, V76, P88, DOI 10.1016/j.ijrmms.2015.03.001; Bian ZF, 2012, SCIENCE, V337, P702, DOI 10.1126/science.1224757; Brijes M, 2015, INT J MIN SCI TECHNO, V25, P933, DOI 10.1016/j.ijmst.2015.09.009; Danian Y., 1991, CHIN J GEOCHEM, V10, P180, DOI [10.1007/BF02837718, DOI 10.1007/BF02837718]; Esterhuizen E., 2010, P 29 INT C GROUND CO, P19; Funk J.E., 1992, INTERCERAM, V41, P10; Guo GL, 2014, T NONFERR METAL SOC, V24, P3302, DOI 10.1016/S1003-6326(14)63470-1; Kostecki T, 2015, INT J ROCK MECH MIN, V76, P55, DOI 10.1016/j.ijrmms.2014.11.011; [刘鹏亮 Liu Pengliang], 2017, [煤炭学报, Journal of China Coal Society], V42, P118; Pappas D., REPORT INVESTIGATION, P2022; [苏承东 Su Chengdong], 2012, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V31, P18; Sun K.H., 2016, METAL MINE, V478, P172; Sun Q, 2017, ENERGIES, V10, DOI 10.3390/en10060786; Szczepanska J, 1999, ENVIRON GEOL, V38, P249, DOI 10.1007/s002540050422; Wang JA, 2012, ROCK MECH ROCK ENG, V45, P533, DOI 10.1007/s00603-011-0216-8; [王金华 Wang Jinhua], 2013, [煤炭学报, Journal of China Coal Society], V38, P2089; Xu JM., 2011, J MINING SAFETY ENG, V28, P158, DOI DOI 10.1007/CNKI:SUN:KSYL.0.2011-01-032; Yavuz H, 2004, INT J ROCK MECH MIN, V41, P193, DOI 10.1016/S1365-1609(03)00082-0; Zhang JX, 2014, MATER RES INNOV, V18, P960, DOI 10.1179/1432891714Z.000000000510; Zhang JX, 2017, POWDER TECHNOL, V305, P12, DOI 10.1016/j.powtec.2016.09.049; Zhang JX, 2015, ENVIRON EARTH SCI, V74, P1439, DOI 10.1007/s12665-015-4133-0; Zhang Q, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5234-5; Zhou N, 2016, POWDER TECHNOL, V297, P220, DOI 10.1016/j.powtec.2016.04.026	25	23	23	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201112	10.1371/journal.pone.0201112	http://dx.doi.org/10.1371/journal.pone.0201112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036401	Green Published, Green Submitted, gold			2022-12-27	WOS:000439429200027
J	Hong, WS; Haimovich, AD; Taylor, RA				Hong, Woo Suk; Haimovich, Adrian Daniel; Taylor, R. Andrew			Predicting hospital admission at emergency department triage using machine learning	PLOS ONE			English	Article							HEALTH INFORMATION EXCHANGE; MEDICAL-RECORDS; BIG DATA; INDEX; VALIDITY; TEXT	Objective To predict hospital admission at the time of ED triage using patient history in addition to information collected at triage. Methods This retrospective study included all adult ED visits between March 2014 and July 2017 from one academic and two community emergency rooms that resulted in either admission or discharge. A total of 972 variables were extracted per patient visit. Samples were randomly partitioned into training (80%), validation (10%), and test (10%) sets. We trained a series of nine binary classifiers using logistic regression (LR), gradient boosting (XGBoost), and deep neural networks (DNN) on three dataset types: one using only triage information, one using only patient history, and one using the full set of variables. Next, we tested the potential benefit of additional training samples by training models on increasing fractions of our data. Lastly, variables of importance were identified using information gain as a metric to create a low-dimensional model. Results A total of 560,486 patient visits were included in the study, with an overall admission risk of 29.7%. Models trained on triage information yielded a test AUC of 0.87 for LR (95% Cl 0.860.87), 0.87 for XGBoost (95% Cl 0.87-0.88) and 0.87 for DNN (95% Cl 0.87-0.88). Models trained on patient history yielded an AUC of 0.86 for LR (95% Cl 0.86-0.87), 0.87 for XGBoost (95% Cl 0.87-0.87) and 0.87 for DNN (95% Cl 0.87-0.88). Models trained on the full set of variables yielded an AUC of 0.91 for LR (95% Cl 0.91-0.91), 0.92 for XGBoost (95% Cl 0.92-0.93) and 0.92 for DNN (95% Cl 0.92-0.92). All algorithms reached maximum performance at 50% of the training set or less. A low-dimensional XGBoost model built on ESI level, outpatient medication counts, demographics, and hospital usage statistics yielded an AUC of 0.91 (95% Cl 0.91-0.91). Conclusion Machine learning can robustly predict hospital admission using triage information and patient history. The addition of historical information improves predictive performance significantly compared to using triage information alone, highlighting the need to incorporate these variables into prediction models.	[Hong, Woo Suk; Haimovich, Adrian Daniel] Yale Sch Med, New Haven, CT USA; [Taylor, R. Andrew] Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA	Yale University; Yale University	Taylor, RA (corresponding author), Yale Sch Med, Dept Emergency Med, New Haven, CT 06510 USA.	richard.taylor@yale.edu	PAN, ZEQIANG/X-6341-2018	/0000-0002-9082-6644	James G. Hirsch Endowed Medical Student Research Fellowship at Yale University School of Medicine; National Institutes of Health [1F30CA196191, T32GM007205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	James G. Hirsch Endowed Medical Student Research Fellowship at Yale University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WH is supported by the James G. Hirsch Endowed Medical Student Research Fellowship at Yale University School of Medicine. AH is supported by National Institutes of Health grants 1F30CA196191 and T32GM007205. RT received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E, 2004, ST CLASS DAT ANAL, P639; Adams JG, 2016, JAMA-J AM MED ASSOC, V315, P659, DOI 10.1001/jama.2015.19484; [Anonymous], 2016, P P 22 ACM SIGKDD IN, P785; Arnold TB, 2017, J OPEN SOURCE SOFTWA, DOI [10.21105/joss.00231, DOI 10.21105/JOSS.00231, 10.21105/joss.00296, DOI 10.21105/JOSS.00296]; Banerjee A, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-22; Bara-Corren Y, 2017, EMERG MED J, V34, P308, DOI 10.1136/emermed-2014-203819; Barak-Corren Y, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2785; Baumann MR, 2007, ANN EMERG MED, V49, P234, DOI 10.1016/j.annemergmed.2006.04.011; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Cameron A, 2018, EMERG MED J, V35, P247, DOI 10.1136/emermed-2017-207246; Cameron A, 2017, EMERG MED J, V34, P2, DOI 10.1136/emermed-2014-204455; de Fortuny EJ, 2013, BIG DATA-US, V1, pBD215, DOI 10.1089/big.2013.0037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desautels T, 2016, JMIR MED INF, V4, P67, DOI 10.2196/medinform.5909; Dinh MM, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0111-4; Ebker-White AA, 2018, EMERG MED AUSTRALAS, V30, P511, DOI 10.1111/1742-6723.12940; Ford E, 2016, J AM MED INFORM ASSN, V23, P1007, DOI 10.1093/jamia/ocv180; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Jiang HJ, 2009, HCUP STAT BRIEF 72; Kangovi S, 2013, HEALTH AFFAIR, V32, P1196, DOI 10.1377/hlthaff.2012.0825; Kuhn M., 2013, APPL PREDICTIVE MODE, P27; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Leegon Jeffrey, 2006, AMIA Annu Symp Proc, P1004; Leegon Jeffrey, 2005, AMIA Annu Symp Proc, P1022; Levin S, 2018, ANN EMERG MED, V71, P565, DOI 10.1016/j.annemergmed.2017.08.005; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Lucini FR, 2017, INT J MED INFORM, V100, P1, DOI 10.1016/j.ijmedinf.2017.01.001; Lucke JA, 2018, EMERG MED J, V35, P18, DOI 10.1136/emermed-2016-205846; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Peck JS, 2012, ACAD EMERG MED, V19, pE1045, DOI 10.1111/j.1553-2712.2012.01435.x; Poulin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085733; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Savage D., 2017, CAN J EMERG MED, V19, pS116, DOI [10.1017/cem.2017.314, DOI 10.1017/CEM.2017.314]; Schenkel SM, 2018, ANN EMERG MED, V71, P578, DOI 10.1016/j.annemergmed.2018.02.010; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; Shapiro JS, 2006, ANN EMERG MED, V48, P426, DOI 10.1016/j.annemergmed.2006.03.032; Shapiro JS, 2013, HEALTH AFFAIR, V32, P2193, DOI 10.1377/hlthaff.2013.0167; Stekhoven DJ, 2015, ASTROPHYS SOURCE COD; Sun Y, 2011, ACAD EMERG MED, V18, P844, DOI 10.1111/j.1553-2712.2011.01125.x; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Taylor RA, 2016, ACAD EMERG MED, V23, P269, DOI 10.1111/acem.12876; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	52	97	98	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201016	10.1371/journal.pone.0201016	http://dx.doi.org/10.1371/journal.pone.0201016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028888	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900031
J	Suhlrie, L; Bartram, J; Burns, J; Joca, L; Tomaro, J; Rehfuess, E				Suhlrie, Laura; Bartram, Jamie; Burns, Jacob; Joca, Lauren; Tomaro, John; Rehfuess, Eva			The role of energy in health facilities: A conceptual framework and complementary data assessment in Malawi	PLOS ONE			English	Article								Background Modern energy enables health service delivery. Access to electricity is, however, unreliable in many health facilities in developing countries. Little research has explored the relationships between energy and service delivery. Methods Based on extensive literature searches and iterative discussions within the research team, we first develop a conceptual framework of the role of energy in health facilities. We then use this framework to explore how characteristics of electricity supply affect distinct energy uses in health facilities (e.g. lighting), and how functional or non-functional lighting affects the provision of night-time care services in Malawi. To do so we apply descriptive statistics and conduct logistic and multinomial regressions using data from the Service Provision Assessment (SPA) of the Demographic and Health Surveys (DHS) for all health facilities in Malawi in 2013/2014. Results The conceptual framework depicts the pathways from different energy types and their characteristics, through to distinct energy uses in health facilities (e.g. medical devices) and health-relevant service outputs (e.g. safe medical equipment). These outputs can improve outcomes for patients (e.g. infection control), facilities (e.g. efficiency) and staff (e.g. working conditions) at facilities level and, ultimately, contribute to better population health outcomes. Our exploratory analysis suggests that energy uses were less likely to be functional in facilities with lower-quality electricity supply. Descriptive statistics revealed a critical lack of functional lighting in facilities offering child delivery and night-time care; surprisingly, the provision of night-time care was not associated with whether facilities had functional lighting. Overall, the DHS SPA dataset is not well-suited for assessing the relationships depicted within the framework. Conclusion The framework conceptualizes the role of energy in health facilities in a comprehensive manner. Over time, it should be empirically validated through a combination of different research approaches, including tracking of indicators, detailed energy audits, qualitative and intervention studies.	[Suhlrie, Laura; Burns, Jacob; Rehfuess, Eva] Ludwig Maximilians Univ Munchen, Pettenkofer Sch Publ Hlth, Inst Med Informat Proc Biometry & Epidemiol, Munich, Bavaria, Germany; [Suhlrie, Laura; Bartram, Jamie; Joca, Lauren; Tomaro, John; Rehfuess, Eva] Univ N Carolina, Gillings Sch Global Publ Hlth, Water Inst, Chapel Hill, NC 27515 USA	University of Munich; University of North Carolina; University of North Carolina Chapel Hill	Suhlrie, L (corresponding author), Ludwig Maximilians Univ Munchen, Pettenkofer Sch Publ Hlth, Inst Med Informat Proc Biometry & Epidemiol, Munich, Bavaria, Germany.; Suhlrie, L (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Water Inst, Chapel Hill, NC 27515 USA.	Laura.Suhlrie@campus.lmu.de	Rehfuess, Eva Annette/ABD-8167-2021	Bartram, Jamie/0000-0002-6542-6315				Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; Angelou N., 2013, GLOBAL TRACKING FRAM; [Anonymous], 2008, WELF IMP RUR EL, DOI DOI 10.1596/978-0-8213-7367-5; [Anonymous], 2015, MEAS SERV AV READ; [Anonymous], MAL HLTH SECT STRAT; [Anonymous], 2010, BAS COUNTR SURV MED; Arvidson A., 2006, ROLE ENERGY SERVICES; Bhatia M, 2015, CONNECTIONS ENERGY A; Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692; International Energy Agency/OECD, 2016, WORLD EN OUTL 2016; Jamison DT, 2006, PROVIDING INTERVENTI; Kaunda Chiyembekezo S., 2013, International Journal of Energy and Environment, V4, P481; Marks J, 2014, AFRICAN ENERGY ATLAS; Pearson L, 2004, CHILDBIRTH CARE OPPO; Pfadenhauer LM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0552-5; Putti VR, 2015, STATE GLOBAL CLEAN I; Rohwer A, 2017, J CLIN EPIDEMIOL, V83, P37, DOI 10.1016/j.jclinepi.2016.06.012; Sustainable Energy for All, 2013, GLOB TRACK FRAM; United Nations Sustainable Development Goals, 2016, AFF CLEAN EN WHY IT; Voluntary Service Overseas (VSO), OUR SID STOR UG HLTH; WHO, 2016, INT LIST PRIOR MED D; World Health Organization, 2014, ACC MOD EN SERV HLTH	22	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200261	10.1371/journal.pone.0200261	http://dx.doi.org/10.1371/journal.pone.0200261			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028861	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900006
J	Gupta, S; Silveira, DA; Mombach, JCM				Gupta, Shantanu; Silveira, Daner A.; Mombach, Jose Carlos M.			Modeling the role of microRNA-449a in the regulation of the G2/M cell cycle checkpoint in prostate LNCaP cells under ionizing radiation	PLOS ONE			English	Article							DNA-DAMAGE; CANCER; P53; E2F1; ATM; MIR-449A; MYC	Recent studies showed that induced microRNA-449a (miR-449a) enhances a G2/M cell cycle checkpoint arrest in prostate cancer (LNCaP) and lung adenocarcinoma cell lines. In the case of LNCaP cells, upregulated miR-449a directly downregulates c-Myc that is required to induce the cell cycle regulators Cdc25A and Cdc2/CyclinB whose inactivation blocks G2 to M phase transition. However, the molecular mechanisms involved are yet unclear, although in other prostate cancer cells the interactions among p53, miR-449a and Sirt-1 can affect the induction of the G2/M arrest. In order to clarify these molecular mechanisms, in this work we propose a boolean model of the G2/M checkpoint arrest regulation contemplating the influence of miR-449a. The model shows that the cell fate determination between two cellular phenotypes: G2/M-Arrest for DNA repair and G2/M-induced apoptosis is stochastic and influenced by miR-449a state of activation. The results were compared with experimental data available presenting agreement. We also found that several feedback loops are involved in this cell fate regulation and we indicate, through in silico gain or loss of function perturbations of genes, which of these feedback loops are more efficient to favor a specific phenotype.	[Gupta, Shantanu; Silveira, Daner A.; Mombach, Jose Carlos M.] Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM)	Mombach, JCM (corresponding author), Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil.	jcmombach@ufsm.br	Mombach, Jose C. M./L-1484-2013	Mombach, Jose C. M./0000-0002-6602-3905; Gupta, Shantanu/0000-0001-7110-6564; Acunha Silveira, Daner/0000-0003-0621-8345	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [145708/2017-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CAPES; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 145708/2017-9 to DS and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior to SG. S. Gupta and D. A. Silveira acknowledge partial support from CAPES and CNPq, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude W, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00094; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Chappell WH, 2012, CELL CYCLE, V11, P4579, DOI 10.4161/cc.22852; Chen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20067; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chen W, 2017, INT J ONCOL, V51, P435, DOI 10.3892/ijo.2017.4038; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Kauffman S. A., 1992, SPIN GLASSES BIOL, V6, P61, DOI [10.1142/9789814415743_0003, DOI 10.1142/9789814415743_]; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kim JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065242; Kitadate A, 2016, ONCOGENE, V35, P3692, DOI 10.1038/onc.2015.435; Kumar P, 2016, ONCOTARGET, V7, P22791, DOI 10.18632/oncotarget.8061; Li Q, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0435-5; Lin WC, 2001, GENE DEV, V15, P1833; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062383; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064759; Mao AH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27346; Mendes N. D., 2014, ARXIV14113539; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scott SL, 2003, CANCER RES, V63, P7190; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200768	10.1371/journal.pone.0200768	http://dx.doi.org/10.1371/journal.pone.0200768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024932	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000050
J	Mitsui, N; Asakura, S; Takanobu, K; Watanabe, S; Toyoshima, K; Kako, Y; Ito, YM; Kusumi, I				Mitsui, Nobuyuki; Asakura, Satoshi; Takanobu, Keisuke; Watanabe, Shinya; Toyoshima, Kuniyoshi; Kako, Yuki; Ito, Yoichi M.; Kusumi, Ichiro			Prediction of major depressive episodes and suicide-related ideation over a 3-year interval among Japanese undergraduates	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; COLLEGE-STUDENTS; UNIVERSITY-STUDENTS; TEMPERAMENT; CHARACTER; PERSONALITY; PREVALENCE; PHQ-9; RISK; POPULATION	Background Suicide has been a leading cause of death among young adult populations in Japan. The aim of this study was to predict major depressive episodes (MDEs) and suicide-related ideation among university students using the Patient Health Questionnaire-9 (PHQ-9) and the Temperament and Character Inventory (TCI). Methods The subjects were 2194 university students who completed the PHQ-9 and TCI in the 1st year (T1) and the PHQ-9 in the 4th year (T2) of university. Multiple logistic regression analysis was performed to predict MDEs and suicide-related ideation at T2. Moreover, recursive partitioning analyses were conducted to reveal the future risk of MDEs and suicide-related ideation. Results The multiple logistic regression analyses of MDEs and suicide-related ideation at T2 revealed that depressive episodes, suicide-related ideation, and low self-directedness(SD) scores at T1 were significant predictors. The area under the curve of the model for MDEs was 0.858 and that for suicide-related ideation was 0.741. The recursive partitioning analyses revealed that a PHQ-9 summary score >= 15 at T1 predicted a high risk of MDEs at T2 and that both a PHQ-9 summary score >= 5 and a PHQ-9 #9 score >= 1 predicted a high risk of suicide-related ideation at T2. Conclusions MDEs, suicide-related ideation, and low SD scores are significant predictors of future MDEs and suicide-related ideation.	[Mitsui, Nobuyuki; Asakura, Satoshi; Takanobu, Keisuke; Watanabe, Shinya; Toyoshima, Kuniyoshi; Kako, Yuki; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Mitsui, Nobuyuki; Asakura, Satoshi] Hokkaido Univ, Hlth Care Ctr, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Mitsui, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.; Mitsui, N (corresponding author), Hokkaido Univ, Hlth Care Ctr, Sapporo, Hokkaido, Japan.	nmitsui@med.hokudai.ac.jp		Ito, Yoichi M./0000-0001-5073-0827; Mitsui, Nobuyuki/0000-0002-0788-7690	Japan Society for Promotion of Science KAKENHI [JP15K09853]	Japan Society for Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for Promotion of Science KAKENHI Grant Number JP15K09853 (SA).	Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Farmer RF, 2009, DEPRESS ANXIETY, V26, P371, DOI 10.1002/da.20459; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hill RM, 2015, J AFFECT DISORDERS, V174, P1, DOI 10.1016/j.jad.2014.11.025; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Inoue T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-73; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kijima N., 1996, ARCH PSYCHIAT DIAGN, V7, P379, DOI DOI 10.1002/(SICI)1097-4679(199812)54:83.0.CO;2-A; King M, 2008, ARCH GEN PSYCHIAT, V65, P1368, DOI 10.1001/archpsyc.65.12.1368; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lu X., 2012, DEPRESS RES TREAT, V2012, P604, DOI [DOI 10.1155/2012/604684, 10.1155/2012/604684]; Mitsui N, 2013, COMPR PSYCHIAT, V54, P1215, DOI 10.1016/j.comppsych.2013.05.014; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Naito M, 2000, J CLIN PSYCHOL, V56, P1579, DOI 10.1002/1097-4679(200012)56:12<1579::AID-8>3.0.CO;2-K; Patten SB, 2009, COMPR PSYCHIAT, V50, P26, DOI 10.1016/j.comppsych.2008.05.012; Rosenstrom T, 2014, J AFFECT DISORDERS, V158, P139, DOI 10.1016/j.jad.2014.01.017; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Silverman MM, 2007, SUICIDE LIFE-THREAT, V37, P264, DOI 10.1521/suli.2007.37.3.264; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Takeuchi M, 2011, COMPR PSYCHIAT, V52, P109, DOI 10.1016/j.comppsych.2010.04.002; Uchida C, 2017, J CLIN PSYCHIAT, V78, pE404, DOI 10.4088/JCP.16m10807; Whitlock J, 2006, PEDIATRICS, V117, P1939, DOI 10.1542/peds.2005-2543; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004	30	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201047	10.1371/journal.pone.0201047	http://dx.doi.org/10.1371/journal.pone.0201047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024966	gold, Green Published, Green Submitted			2022-12-27	WOS:000439120000084
J	Prieto, A; Mayas, J; Ballesteros, S				Prieto, Antonio; Mayas, Julia; Ballesteros, Soledad			Alpha and beta band correlates of haptic perceptual grouping: Results from an orientation detection task	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; EVENT-RELATED POTENTIALS; TACTILE DISCRIMINATION; CONFIGURAL PROPERTIES; GESTALT PSYCHOLOGY; NEURAL MECHANISMS; CORTICAL ACTIVITY; WORKING-MEMORY; VISUAL-CORTEX; MOTOR IMAGERY	Behavioral and neurophysiological findings in vision suggest that perceptual grouping is not a unitary process and that different grouping principles have different processing requirements and neural correlates. The present study aims to examine whether the same occurs in the haptic modality using two grouping principles widely studied in vision, spatial proximity and texture similarity. We analyzed behavioral responses (accuracy and response times) and conducted an independent component analysis of brain oscillations in alpha and beta bands for haptic stimuli grouped by spatial proximity and texture similarity, using a speeded orientation detection task performed on a novel haptic device (MonHap). Behavioral results showed faster response times for patterns grouped by spatial proximity relative to texture similarity. Independent component clustering analysis revealed the activation of a bilateral network of sensorimotor and parietal areas while performing the task. We conclude that, as occurs in visual perception, grouping the elements of the haptic scene by means of their spatial proximity is faster than forming the same objects by means of texture similarity. In addition, haptic grouping seems to involve the activation of a network of widely distributed bilateral sensorimotor and parietal areas as reflected by the consistent event-related desynchronization found in alpha and beta bands.	[Prieto, Antonio; Mayas, Julia; Ballesteros, Soledad] Univ Nacl Educ Distancia, Fac Psicol, Studies Aging & Neurodegenerat Dis Res Grp, Dept Psicol Basica 2, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED)	Prieto, A (corresponding author), Univ Nacl Educ Distancia, Fac Psicol, Studies Aging & Neurodegenerat Dis Res Grp, Dept Psicol Basica 2, Madrid, Spain.	antonioprieto@psi.uned.es	Mayas, Julia/L-3679-2014; Prieto, Antonio/A-6370-2012; Ballesteros, Soledad/ABG-8762-2020; Prieto, Antonio/AAI-7946-2021	Mayas, Julia/0000-0001-5003-4995; Prieto, Antonio/0000-0002-3394-5962; Ballesteros, Soledad/0000-0002-8391-9615; Prieto, Antonio/0000-0002-3394-5962	Ministerio de educacion Cultura y Deporte [FPU13/05914]; Ministerio de Economoia y competitividad [PSI2013-41409R]; Universidad Nacional de Educacion a Distancia [2014-028-UNED-PROY]	Ministerio de educacion Cultura y Deporte(Spanish Government); Ministerio de Economoia y competitividad; Universidad Nacional de Educacion a Distancia	A Doctoral Fellowship from Ministerio de educacion Cultura y Deporte (https://www.mecd.gob.es/portada-mecd/)granted to AP (FPU13/05914) supported this work. It was also partially supported by grants from the Ministerio de Economoia y competitividad (http://www.mineco.gob.es/) (PSI2013-41409R) awarded to SB and from the Universidad Nacional de Educacion a Distancia (www.uned.es) (2014-028-UNED-PROY) awarded to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095541; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Baraldi P, 1999, NEUROSCI LETT, V269, P95, DOI 10.1016/S0304-3940(99)00433-4; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Blum J, 2007, EXP BRAIN RES, V182, P59, DOI 10.1007/s00221-007-0963-7; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; Chang D., 2007, P 8 AUSTR C US INT A, V64, P79; Chang D, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P15; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Davis NJ, 2012, J NEUROSCI, V32, P403, DOI 10.1523/JNEUROSCI.5106-11.2012; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; FAGOT J, 1992, BEHAV RES METH INSTR, V24, P54, DOI 10.3758/BF03203470; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Flevaris AV, 2016, NEUROPSYCHOLOGIA, V83, P192, DOI 10.1016/j.neuropsychologia.2015.10.024; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gallace A, 2011, PSYCHOL BULL, V137, P538, DOI 10.1037/a0022335; Gardony AL, 2017, BRAIN COGNITION, V118, P1, DOI 10.1016/j.bandc.2017.07.003; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Grunwald M., 2008, HUMAN HAPTIC PERCEPT; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Han SH, 2004, NEUROSCI LETT, V367, P40, DOI 10.1016/j.neulet.2004.05.098; Han SH, 2002, NEUROSCI LETT, V319, P29, DOI 10.1016/S0304-3940(01)02502-2; Han SH, 2001, PSYCHOPHYSIOLOGY, V38, P926, DOI 10.1111/1469-8986.3860926; Hegner YL, 2007, NEUROIMAGE, V37, P1362, DOI 10.1016/j.neuroimage.2007.07.003; Hummel F, 2003, CLIN NEUROPHYSIOL, V114, P605, DOI 10.1016/S1388-2457(02)00417-0; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Kaas AL, 2013, HUM BRAIN MAPP, V34, P1148, DOI 10.1002/hbm.21500; Karhu J, 1999, J NEUROPHYSIOL, V81, P2017, DOI 10.1152/jn.1999.81.5.2017; Kimchi R, 2004, PSYCHON B REV, V11, P687, DOI 10.3758/BF03196621; Kimchi R, 1998, PSYCHON B REV, V5, P135, DOI 10.3758/BF03209469; KIMCHI R, 1994, PERCEPTION, V23, P489, DOI 10.1068/p230489; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klostermann F, 2007, EUR J NEUROSCI, V25, P1604, DOI 10.1111/j.1460-9568.2007.05417.x; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lin CL, 2012, NEUROIMAGE, V60, P2258, DOI 10.1016/j.neuroimage.2012.02.008; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; Mao LH, 2004, CHINESE SCI BULL, V49, P819, DOI 10.1360/04wc0004; Martinovic J, 2012, FRONT HUM NEUROSCI, V6, P1, DOI 10.3389/fnhum.2012.00049; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Melnik A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04757-8; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Neisser U., 1967, THINKINGJUDGEMENT DE, P61, DOI [10.1037/0096-1523.8.2.194, DOI 10.1037/0096-1523.8.2.194]; Nikolaev AR, 2008, EXP BRAIN RES, V186, P107, DOI 10.1007/s00221-007-1214-7; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Overvliet KE, 2016, VISION RES, V126, P52, DOI 10.1016/j.visres.2015.04.016; Overvliet KE, 2016, PERCEPTION, V45, P71, DOI 10.1177/0301006615594958; Overvliet KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065412; Overvliet KE, 2012, J EXP PSYCHOL HUMAN, V38, P817, DOI 10.1037/a0029222; PFURTSCHELLER G, 1990, Brain Topography, V3, P85, DOI 10.1007/BF01128865; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; POMERANTZ JR, 1989, J EXP PSYCHOL HUMAN, V15, P635, DOI 10.1037/0096-1523.15.4.635; Razpurker-Apfeld I, 2007, PERCEPT PSYCHOPHYS, V69, P732, DOI 10.3758/BF03193775; Revesz G, 1953, PSYCHOL FORSCH, V24, P215, DOI 10.1007/BF00424461; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Sadato N, 1997, J NEUROSCI, V17, P9667; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Sebastian M, 2012, NEUROIMAGE, V60, P7, DOI 10.1016/j.neuroimage.2011.11.060; Sebastian M, 2011, NEUROPSYCHOLOGIA, V49, P3967, DOI 10.1016/j.neuropsychologia.2011.10.013; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Snow JC, 2014, J COGNITIVE NEUROSCI, V26, P1154, DOI 10.1162/jocn_a_00548; Stephan KM, 1999, BRAIN, V122, P351, DOI 10.1093/brain/122.2.351; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Talairach J., 1988, COPLANAR STEREOTAXIS; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tibbetts P.E., 2009, Q REV BIOL, DOI [DOI 10.1086/603482, 10.1086/603482]; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; van Wijk BCM, 2012, EUR J NEUROSCI, V36, P2088, DOI 10.1111/j.1460-9568.2012.08122.x; Verlaers K, 2015, ATTEN PERCEPT PSYCHO, V77, P353, DOI 10.3758/s13414-014-0770-8; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Volberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054085; Vukelic M, 2014, NEUROIMAGE, V87, P147, DOI 10.1016/j.neuroimage.2013.10.003; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zaretskaya N, 2015, NEUROIMAGE, V112, P61, DOI 10.1016/j.neuroimage.2015.02.049; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107	100	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201194	10.1371/journal.pone.0201194	http://dx.doi.org/10.1371/journal.pone.0201194			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024961	gold, Green Submitted, Green Published			2022-12-27	WOS:000439120000097
J	Migliorini, RP; Peters, FB; Favarini, MO; Kasper, CB				Migliorini, Raissa Prior; Peters, Felipe Bortolotto; Favarini, Marina Ochoa; Kasper, Carlos Benhur			Trophic ecology of sympatric small cats in the Brazilian Pampa	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; GEOFFROYS CAT; FOOD-HABITS; SOUTHEASTERN BRAZIL; LEOPARDUS-GEOFFROYI; CARNIVORA FELIDAE; PUMA-YAGOUAROUNDI; FEEDING ECOLOGY; SOUTHERN BRAZIL; ARGENTINA	Information about resource partitioning among small cat species that live in sympatry in South America is fairly incomplete. Knowledge about feeding habits is essential for understanding the role of these predators in the environment, the impact on prey populations, and potential competition among themselves and with other carnivores. This study aimed to describe and compare the diet of four sympatric small cats in the grasslands of southern Brazil. We analysed the stomach contents of 37 Geoffroy's cats (Leopardus geoffroi), 27 margays (Leopardus wiedii), 14 pampas cats (Leopardus colocola), and 20 jaguarundis (Herpailurus yagouaroundi) obtained as road kill in the Brazilian Pampa in southern Brazil. Small mammals were the most representative class consumed by all cats, followed by Ayes, Reptilia, and Amphibia. Some items, such as rodents Ca via aperea, Akodon sp., Oligoryzomys sp. and Passeriformes were consumed by all cat species. Niche overlap varied widely, from 10% (margay x jaguarundi) to 92% (jaguarundi x pampas cat). Niche breadth indicated that jaguarundi were the most specialized of the cats (B-sta = 0.24) in this region, with a diet closely associated to C. aperea. Margay consumed more items associated with arboreal behaviour than other cat species, but consumed more terrestrial items than arboreal ones. The pampas cat consumed mostly terrestrial species associated with open fields. Geoffroy's cat consumed mammals found in a diversity of habitats, indicating high ecological flexibility. Species with more similarity in diet such as jaguarundi and pampas cat probably present temporal segregation in activity. In conclusion, despite their habitat and diet similarities, these four species explore distinct microhabitats by foraging different prey groups, what favor them to live in sympatry.	[Migliorini, Raissa Prior; Kasper, Carlos Benhur] Univ Fed Pampa, LABIMAVE Lab Biol Mamiferos & Aves, Sao Gabriel, SP, Brazil; [Peters, Felipe Bortolotto; Favarini, Marina Ochoa] Area Vida Consultoria Ambiental, Canoas, RS, Brazil	Universidade Federal do Pampa	Migliorini, RP (corresponding author), Univ Fed Pampa, LABIMAVE Lab Biol Mamiferos & Aves, Sao Gabriel, SP, Brazil.	raissa.biopampa@gmail.com		Kasper, Carlos Benhur/0000-0002-7089-6119; Migliorini, Raissa/0000-0002-4999-4275				Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Bencke GA, 2010, IHERINGIA SER ZOOL, V100, P519, DOI 10.1590/S0073-47212010000400022; Bianchi RD, 2011, ZOOLOGIA-CURITIBA, V28, P127, DOI 10.1590/S1984-46702011000100018; Bisceglia SBC, 2011, J ARID ENVIRON, V75, P1024, DOI 10.1016/j.jaridenv.2011.03.016; Bisceglia SBC, 2008, J ARID ENVIRON, V72, P1120, DOI 10.1016/j.jaridenv.2007.11.003; Bonvicino CR., 2008, GUIA ROEDORES BRASIL, V2008, p120p; Canepuccia AD, 2007, MAMM BIOL, V72, P163, DOI 10.1016/j.mambio.2006.07.003; Christoff AU, 2013, MAMIFEROS RIO GRANDE, P343; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Costa Henrique Caldeira, 2015, Herpetologia Brasileira, V4, P75; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; DAY MG, 1966, J ZOOL, V148, P201, DOI 10.1111/j.1469-7998.1966.tb02948.x; de Oliveira Tadeu G., 2010, P559; de Oliveira Tadeu G., 1998, Mammalian Species, V579, P1; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Eisenberg J.M., 1989, CARNIVORE BEHAV ECOL, P1, DOI [10.1007/978-1-4757-4716-4_1, DOI 10.1007/978-1-4757-4716-4_1]; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Facure KG, 1996, MAMMALIA, V60, P499; Fajardo Ursula, 2014, Rev. peru biol., V21, P061, DOI 10.15381/rpb.v21i1.8248; Gardner A.L., 2007, MAMMALS S AM; Gonzalez E.M., 2012, MAMIFEROS URUGUAY GU; GREENE HW, 1983, OIKOS, V40, P151, DOI 10.2307/3544212; Guichon ML, 1998, MAMMALIA, V62, P23, DOI 10.1515/mamm.1998.62.1.23; Hammar O, 2001, PALAEONTOL ELECTRON; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kasper CB, 2016, BRAZ J BIOL, V76, P228, DOI 10.1590/1519-6984.19414; Kasper CB, 2016, MAMMALIA, V80, P143, DOI 10.1515/mammalia-2014-0126; KILTIE RA, 1984, OECOLOGIA, V61, P411, DOI 10.1007/BF00379644; Kitchener A.C., 2017, REVISED TAXONOMY FEL; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; KLEIMAN DG, 1973, ANIM BEHAV, V21, P637, DOI 10.1016/S0003-3472(73)80088-0; Kruuk H., 1986, P353; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; LEVINS RICHARD, 1968; Macdonald David W., 2010, P3; Magezi GS, 2013, THESIS; Manfredi C, 2004, J MAMMAL, V85, P1111, DOI 10.1644/BWG-133.1; Manfredi C, 2011, MAMM BIOL, V76, P313, DOI 10.1016/j.mambio.2011.01.009; Mazim F. D., 2016, SERIE EDITORIAL FAUN, P311; Mittermeier R.A., 2009, HDB MAMMALS WORLD CA, V1; Napolitano C, 2008, MOL ECOL, V17, P678, DOI 10.1111/j.1365-294X.2007.03606.x; Nilsen EB, 2012, TECH ECOL CONSERVAT, P256; Oliveira TG., 2005, GUIA CAMPO FELINOS B; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; PATTA PILLAR V. DE, 2009, CAMPOS SULINOS CONSE; Patton J.L., 2015, MAMMALS S AM, V2; Pereira JA, 2012, J ARID ENVIRON, V76, P36, DOI 10.1016/j.jaridenv.2011.08.006; Pereira JA, 2010, J ARID ENVIRON, V74, P1106, DOI 10.1016/j.jaridenv.2010.03.017; Pinkas L, 1971, FISH B, V152, P1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Reis N.R., 2011, MAMIFEROS BRASIL, V2nd ed., P347; Rinaldi Alcides Ricieri, 2015, Biotemas, V28, P155; Rocha-Mendes F, 2010, BIOTA NEOTROP, V10, P21, DOI 10.1590/S1676-06032010000400001; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Segalla MV, 2014, S AM J HERPETOL, V5, P34; Sigrist T, 2014, GUIA CAMPO AVES BRAS; Silva-Pereira JE, 2011, MAMM BIOL, V76, P308, DOI 10.1016/j.mambio.2010.09.001; Sousa KS, 2008, MAMM BIOL, V73, P303, DOI 10.1016/j.mambio.2007.04.001; Tofoli CF, 2009, BRAZ J BIOL, V69, P871, DOI 10.1590/S1519-69842009000400015; Tortato MA, 2013, BIODIVERSIDADE BRASI, P76; Trigo T.C., 2013, MAMIFEROS RIO GRANDE, P343; Wang E, 2002, STUD NEOTROP FAUNA E, V37, P207, DOI 10.1076/snfe.37.3.207.8564; WORLD WILDLIFE FUND (WWF), 2017, TERR EC WORLD	65	7	11	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201257	10.1371/journal.pone.0201257	http://dx.doi.org/10.1371/journal.pone.0201257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052676	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600034
J	Chen, YS; Fan, YH; Tien, CF; Yueh, A; Chang, RY				Chen, Yi-Shiuan; Fan, Yi-Hsin; Tien, Chih-Feng; Yueh, Andrew; Chang, Ruey-Yi			The conserved stem-loop II structure at the 3' untranslated region of Japanese encephalitis virus genome is required for the formation of subgenomic flaviviral RNA	PLOS ONE			English	Article							ELEMENTS; INTERFERENCE; SEQUENCES; NUCLEASE; DUPLICATIONS; PSEUDOKNOT; CELLS	Flaviviruses accumulate abundant subgenomic RNA (sfRNA) in infected cells. It has been reported that sfRNA results from stalling of host 5'-to-3' exoribonuclease XRN1 at the highly structured RNA of the 3' untranslated region (UTR). Although XRN1 digestion of a 3'-terminal 800-nt RNA could stall at a position to generate the sfRNA in vitro, we found that knocking out XRN1 had no effect on the accumulation of sfRNA in Japanese encephalitis virus (JEV) infected cells. Mutagenesis studies revealed that the stemloop II (SLII) at the 3' UTR is required for the accumulation of sfRNA. According to the results of an in vitro RNA-dependent RNA polymerase (RdRp) assay, the (-)10431-10566 RNA fragment, containing the putative promoter on the antigenome for the sfRNA transcription, binds to RdRp protein and exhibits a strong promoter activity. Taken together, our results indicate that the JEV sfRNA could be transcribed initially and then be trimmed by XRN1 or other unidentified exoribonucleases.	[Chen, Yi-Shiuan; Fan, Yi-Hsin; Tien, Chih-Feng; Chang, Ruey-Yi] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan; [Yueh, Andrew] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan	National Dong Hwa University; National Health Research Institutes - Taiwan	Chang, RY (corresponding author), Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan.	rchang@gms.ndhu.edu.tw		Chang, Ruey-Yi/0000-0003-2528-2211	Ministry of Science and Technology, Taiwan, Republic of China [MOST 103-2320-B-259-002-MY3]	Ministry of Science and Technology, Taiwan, Republic of China	This work was supported by grant MOST 103-2320-B-259-002-MY3 from the Ministry of Science and Technology, Taiwan, Republic of China (https://www.most.gov.tw/) to R-YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026; Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737; Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16; Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015; Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599; Kim YG, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-59; Li WM, 2006, J VIROL, V80, P3395, DOI 10.1128/JVI.80.7.3395-3405.2006; Li XF, 2010, J GEN VIROL, V91, P1218, DOI 10.1099/vir.0.013854-0; Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004; Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030; Liu RK, 2016, J VIROL, V90, P7864, DOI 10.1128/JVI.00869-16; Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016; Maeda A, 2008, VIROLOGY, V371, P130, DOI 10.1016/j.virol.2007.09.018; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009; Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535; Pu SY, 2014, J GEN VIROL, V95, P1493, DOI 10.1099/vir.0.064915-0; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Yun SI, 2009, J VIROL, V83, P7909, DOI 10.1128/JVI.02541-08	45	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201250	10.1371/journal.pone.0201250	http://dx.doi.org/10.1371/journal.pone.0201250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048535	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400066
J	Armoiry, X; Tsertsvadze, A; Connock, M; Royle, P; Melendez-Torres, GJ; Souquet, PJ; Clarke, A				Armoiry, Xavier; Tsertsvadze, Alexander; Connock, Martin; Royle, Pamela; Melendez-Torres, G. J.; Souquet, Pierre-Jean; Clarke, Aileen			Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis	PLOS ONE			English	Review							RANDOMIZED PHASE-III; EGFR MOLECULAR ABERRATIONS; TRIAL CHECKMATE 057; PLUS DOCETAXEL DOC; 2ND-LINE TREATMENT; NIVOLUMAB NIVO; EXPLORATORY ANALYSIS; FRONTLINE THERAPIES; SUBGROUP ANALYSES; NSCLC HISTOLOGY	Purpose This systematic review with network meta-analysis compared the efficacy and safety of currently licensed second-line treatments in patients with late stage non-small cell lung cancer (NSCLC). Methods Randomised controlled trials (RCTs) of participants with advanced/metastatic NSCLC receiving second/third line treatments were screened. We searched electronic databases (MEDLINE; EMBASE; Web of Science) from January, 2000 to July, 2017. Two reviewers screened bibliographic records, extracted data, and assessed risk of bias of included studies. The outcomes were overall survival (OS), progression-free survival (PFS), and drug-related grade 3 +/- 5 adverse-events (AEs). We pooled study-specific hazard ratios (HR; for OS and PFS) and risk ratios (RR; for AEs) using conventional and network-meta-analyses, and ranked interventions by the surface under the cumulative ranking curve. Findings We included 11 RCTs (7,581 participants) comparing nine drugs. All drugs except for erlotinib significantly improved OS compared to docetaxel. Nivolumab was the highest ranking drug followed by atezolizumab and pembrolizumab. There was no significant difference in OS across these three drugs (HR = 0.98, 95% CI 0.79, 1.21 for nivolumab vs atezolizumab; HR = 0.98, 95% CI 0.77, 1.25 for nivolumab vs pembrolizumab). For PFS, ramucirumab + docetaxel and nivolumab were the drugs with the highest ranking. All interventions except ramucirumab + docetaxel had a reduced risk for severe drug-related AEs vs. docetaxel. Of the drugs with the highest ranking on AEs, nivolumab was significantly safer compared to atezolizumab (RR = 0.55, 95% CI 0.38, 0.79) or pembrolizumab (RR = 0.52, 95% CI 0.34, 0.81).	[Armoiry, Xavier; Tsertsvadze, Alexander; Connock, Martin; Royle, Pamela; Melendez-Torres, G. J.; Clarke, Aileen] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England; [Tsertsvadze, Alexander] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Souquet, Pierre-Jean] Hosp Civils Lyon, Grp Hosp Sud, Serv Pneumol Oncol, Pierre Benite, France	University of Warwick; University of Ottawa; CHU Lyon	Armoiry, X (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England.	armoiryxa@gmail.com	Clarke, Aileen/I-5679-2012	Clarke, Aileen/0000-0001-8299-3146; Melendez-Torres, G.J./0000-0002-9823-4790	NIHR CLAHRC West Midlands+ initiative	NIHR CLAHRC West Midlands+ initiative	A.C. is funded by the NIHR CLAHRC West Midlands+ initiative. This paper presents independent research and the views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. X.A., A.C., M.C. and P.R. are commissioned by the NIHR HTA Programme to undertake reviews and evidence synthesis on the clinical and cost-effectiveness of health care interventions for a range of research funders and policy makers, including the National Institute for Health and Care Excellence (NICE). The views expressed in this report are those of the authors and not necessarily those of the NIHR HTA Programme. Any errors are the responsibility of the authors.	Barlesi F, 2016, ANN ONC C 41 EUR SOC, V27; Barlesi F, 2016, ASIA-PAC J CLIN ONCO, V12, P115; Bidoli P, 2015, ANN ONC C 17 NAT C M, V26; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Clegg A, 2001, Health Technol Assess, V5, P1; Crequit P, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0954-x; Demarinis F, 2006, J CLIN ONCOLOGY, V24; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Garon EB, 2016, J CLIN ONCOLOGY C, V34; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Goss GD, 2015, EUR J CANCER, V51, pS626, DOI 10.1016/S0959-8049(16)31725-7; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Heigener D, 2016, ANN ONC C 41 EUR SOC, V27; Herbst RS, 2015, ANN ONCOL, V26, P162; Herbst RS, 2016, ANN ONC C 41 EUR SOC, V27; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horn L, 2016, ONCOL RES TREAT, V39, P27; Horn L, 2015, ANN ONCOL, V26, P125; Horn L, 2015, EUR J CANCER, V51, pS599, DOI 10.1016/S0959-8049(16)31655-0; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Karampeazis A, 2013, CANCER-AM CANCER SOC, V119, P2754, DOI 10.1002/cncr.28132; Loveman E, 2016, WARWICK EVIDENCE; Mellemgaard A, 2015, SUPPORT CARE CANCER, pS349; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Ohe Y, 2008, CLIN CANCER RES, V14, P4206, DOI 10.1158/1078-0432.CCR-07-5143; Park K, 2015, ANN ONCOL, V26, P135; Park K, 2016, CANCER RES TREAT, V48, P1177, DOI 10.4143/crt.2015.401; Paz-Ares L, 2015, J CLIN ONCOLOGY, V33; Paz-Ares L, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.18_suppl.lba109; Peng TR, 2017, INT IMMUNOPHARMACOL, V49, P85, DOI 10.1016/j.intimp.2017.05.019; Perol M, 2014, J CLIN ONCOLOGY, V32; Pujol JL, 2007, J THORAC ONCOL, V2, P397, DOI 10.1097/01.JTO.0000268672.57002.69; Rechamp K, 2015, ASIA-PAC J CLIN ONCO, V11, P130; Reck M, 2016, ONCOL RES TREAT, V39, P166; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Reck M, 2015, J THORAC ONCOL, V10, pS324; Reck M, 2015, LUNG CANCER, V90, P267, DOI 10.1016/j.lungcan.2015.08.003; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Royal College of Physicians, 2015, NAT LUNG CANC AUD; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Scagliotti G, 2009, J THORAC ONCOL, V4, pS325; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Schuette W, 2016, ONCOL RES TREAT, V39, P90; Schulz C, 2016, ONCOL RES TREAT, V39, P104; Smith DA, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9028; Soria JC, 2015, J CLIN ONCOLOGY, V33; Soria JC, 2015, LANCET ONCOL, V16, P897, DOI 10.1016/S1470-2045(15)00006-6; Spigel DR, 2015, J CLIN ONCOLOGY, V33; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vamvakas L, 2010, J CLIN ONCOLOGY, V28; Vansteenkiste J, 2015, EUR J CANCER, V51, pS716, DOI 10.1016/S0959-8049(15)30072-1; Weiss, 2006, J CLIN ONCOL, V24, P5477, DOI 10.1200/JCO.2006.10.001	59	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199575	10.1371/journal.pone.0199575	http://dx.doi.org/10.1371/journal.pone.0199575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044785	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500013
J	Hooijberg, EH; Miller, M; Cray, C; Buss, P; Steenkamp, G; Goddard, A				Hooijberg, Emma H.; Miller, Michele; Cray, Carolyn; Buss, Peter; Steenkamp, Gerhard; Goddard, Amelia			Serum protein electrophoresis in healthy and injured southern white rhinoceros (Ceratotherium simum simum)	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; ACUTE-PHASE PROTEINS; REFERENCE INTERVALS; BIOCHEMICAL VALUES; DICEROS-BICORNIS; PLASMA-PROTEINS; HORSES; BLOOD; FRACTIONS; CHEMISTRY	Investigation of globulin fractions by serum protein electrophoresis (SPE) is the first step towards evaluation of the proteome in the southern white rhinoceros (Ceratotherium simum simum). Furthermore, identification of changes in globulins in animals with poaching and other injuries can guide discovery of potentially useful biomarkers of inflammation. The aim of this study was to develop reference intervals for agarose gel SPE in healthy white rhinoceros and to compare these serum protein electrophoresis results to those from animals with tissue trauma. Reference intervals for total serum protein and agarose gel electrophoretic albumin and globulin fractions were generated using serum samples from 49 healthy free-ranging adult white rhinoceros. A standardised gating system together with identification of specific proteins by mass spectrometry aided in fraction identification. Six globulin fractions were identified: alpha 1a, alpha 1b, alpha 2, beta 1, beta 2 and gamma. Reference intervals were generated for total serum protein (76-111 g/L), albumin (10-27 g/L) and globulin fractions (alpha 1a: 1.6-3.2 g/L; alpha 1b: 1.7-3.6 g/L; alpha 2: 16.1-26.6 g/L; beta 1: 6.6-18.2 g/L; beta 2: 11.8-30.4 g/L; gamma: 10.4-23.1 g/L; albumin: globulin ratio: 0.12-0.39). Results were compared to those from 30 animals with various degrees and chronicities of tissue trauma. Wounded animals had lower concentrations of total serum protein, albumin, total globulin, alpha and beta 1 globulins, lower percentages of alpha 2 and beta 1 globulins, and higher percentages of beta 2 and gamma globulins. These protein changes are similar to those seen in human patients with wounds rather than classic acute phase or chronic inflammatory responses.	[Hooijberg, Emma H.; Steenkamp, Gerhard; Goddard, Amelia] Univ Pretoria, Dept Compan Anim Clin Studies, Fac Vet Sci, Pretoria, South Africa; [Miller, Michele] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sci & Technol,Div Mol Biol & Human Genet, Natl Res Fdn Ctr Excellence Biomed TB Res,Med Res, Stellenbosch, South Africa; [Cray, Carolyn] Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Miami, FL 33136 USA; [Buss, Peter] South African Natl Pk, Vet Wildlife Serv, Kruger Natl Pk, Skukuza, South Africa	University of Pretoria; National Research Foundation - South Africa; Stellenbosch University; University of Miami	Hooijberg, EH (corresponding author), Univ Pretoria, Dept Compan Anim Clin Studies, Fac Vet Sci, Pretoria, South Africa.	emma.hooijberg@up.ac.za	Hooijberg, Emma/AAR-9821-2020; Steenkamp, Gerhard/AAP-3362-2021; Miller, Michele/ABA-1332-2020	Hooijberg, Emma/0000-0002-4367-799X; Goddard, Amelia/0000-0002-8415-4802; Steenkamp, Gerhard/0000-0001-8428-7309; Miller, Michele/0000-0002-5883-6076	Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, South Africa; Health and Welfare Sector Education and Training Authority, South Africa	Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, South Africa; Health and Welfare Sector Education and Training Authority, South Africa	Funding for this project was provided by: The Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, South Africa; Postgraduate research bursary from the Health and Welfare Sector Education and Training Authority, South Africa.	Alberghina D, 2013, CAN J VET RES, V77, P293; Alberghina D, 2011, J VET DIAGN INVEST, V23, P111, DOI 10.1177/104063871102300119; Andriansyah, 2013, J ZOO WILDLIFE MED, V44, P280, DOI 10.1638/2012-0046R2.1; Atherton MJ, 2013, VET J, V196, P320, DOI 10.1016/j.tvjl.2012.12.010; Atherton MJ, 2013, VET J, V196, P315, DOI 10.1016/j.tvjl.2012.12.011; Baker R J, 1986, Vet Clin Pathol, V15, P20, DOI 10.1111/j.1939-165X.1986.tb00653.x; BAKER RJ, 1988, CAN J VET RES, V52, P308; Barrera R, 2010, ARCH MED VET, V42, P173, DOI 10.4067/S0301-732X2010000300008; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Chromy BA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-281; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Crisman MV, 2008, VET CLIN N AM-EQUINE, V24, P285, DOI 10.1016/j.cveq.2008.03.004; Department of Environmental Affairs RoSA, 2016, MIN EDN MOL HIGHL PR; Eckersall PD, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P117; French J. M., 1995, Equine Veterinary Education, V7, P33, DOI 10.1111/j.2042-3292.1995.tb01179.x; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; FURUKAWA T, 1986, JPN J VET SCI, V48, P643; Geffre A, 2009, VET CLIN PATH, V38, P477, DOI 10.1111/j.1939-165X.2009.00155.x; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Gerou-Ferriani M, 2011, VET CLIN PATH, V40, P159, DOI 10.1111/j.1939-165X.2011.00310.x; Gimenez M, 2010, VET CLIN PATH, V39, P227, DOI 10.1111/j.1939-165X.2009.00204.x; Giordano A, 2010, VET CLIN PATH, V39, P464, DOI 10.1111/j.1939-165X.2010.00255.x; Govender D, 2011, J S AFR VET ASSOC, V82, P36; HATTINGH J, 1980, COMP BIOCHEM PHYS A, V67, P203, DOI 10.1016/0300-9629(80)90432-6; HATTINGH J, 1983, COMP BIOCHEM PHYS A, V75, P441, DOI 10.1016/0300-9629(83)90107-X; Hooijberg E, 2015, P 25 ANN ECVIM CA C; Hooijberg EH, 2017, VET CLIN PATH, V46, P287, DOI 10.1111/vcp.12490; Interlab S. r. l, 2016, EL PROC SER PROT BET; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Keffen RH, 1994, P S RHIN GAM RANCH A; Knapp SE, 1997, J WILDLIFE DIS, V33, P492, DOI 10.7589/0090-3558-33.3.492; KOCK MD, 1990, J ZOO WILDLIFE MED, V21, P283; KRISTENSEN F, 1977, AM J VET RES, V38, P1089; KRISTENSEN F, 1977, AM J VET RES, V38, P399; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; Lehnhardt M, 2005, BURNS, V31, P159, DOI 10.1016/j.burns.2004.08.015; Marco I, 1999, RES VET SCI, V66, P81, DOI 10.1053/rvsc.1998.0248; Mathebula N, 2012, J ZOO WILDLIFE MED, V43, P530, DOI 10.1638/2011-0259R.1; MATTHEWS AG, 1982, EQUINE VET J, V14, P322, DOI 10.1111/j.2042-3306.1982.tb02443.x; Miller M, 2015, J WILDLIFE DIS, V51, P916, DOI 10.7589/2015-03-081; Miller M, 2012, J ZOO WILDLIFE MED, V43, pS55, DOI 10.1638/2011-0147.1; Modise A., 2017, MINISTER MOLEWA HIGH; MUSOKE AJ, 1982, IMMUNOLOGY, V45, P663; Nagyova V, 2016, SMALL RUMINANT RES, V144, P145, DOI 10.1016/j.smallrumres.2016.09.016; OSBALDISTON GW, 1972, BRIT VET J, V128, P386, DOI 10.1016/S0007-1935(17)36832-X; Otiende MY, 2015, BMC VET RES, V11, DOI 10.1186/s12917-014-0316-2; Piccione G, 2014, J APPL ANIM RES, V42, P123, DOI 10.1080/09712119.2013.795900; PIENAAR D J, 1991, Koedoe, V34, P97; Pompeo M, 2007, OSTOMY WOUND MANAG, V53, P30; Quain AM, 2015, WOUNDS, V27, P327; Riond B, 2009, VET CLIN PATH, V38, P73, DOI 10.1111/j.1939-165X.2008.00100.x; Rosenthal KL, 2005, AM J VET RES, V66, P375, DOI 10.2460/ajvr.2005.66.375; Sample SH, 2015, VET CLIN PATH, V44, P194, DOI 10.1111/vcp.12248; Seal U.S., 1976, Journal Zool Anim Med, V7, P11; Stockham S.L., 2008, FUNDAMENTALS VET CLI, V2nd ed., P369, DOI [10.1186/s13071-021-04626-4, DOI 10.1186/S13071-021-04626-4]; Taylor SS, 2010, J FELINE MED SURG, V12, P643, DOI 10.1016/j.jfms.2010.03.018; Teare JA., 2013, SPECIES360 PHYSIOLOG; THOMAS LA, 1992, AM J VET RES, V53, P2241; VAHALA J, 1994, ACTA VET BRNO, V63, P99, DOI 10.2754/avb199463020099; Vance CK, 2004, J ZOO WILDLIFE MED, V35, P435, DOI 10.1638/04-014; VANHEERDEN J, 1985, J S AFR VET ASSOC, V56, P187	62	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200347	10.1371/journal.pone.0200347	http://dx.doi.org/10.1371/journal.pone.0200347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044807	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500045
J	Lee, J; Choi, D; Sael, L				Lee, Jungwoo; Choi, Dongjin; Sael, Lee			CTD: Fast, accurate, and interpretable method for static and dynamic tensor decompositions	PLOS ONE			English	Article								How can we find patterns and anomalies in a tensor, i.e., multi-dimensional array, in an efficient and directly interpretable way? How can we do this in an online environment, where a new tensor arrives at each time step? Finding patterns and anomalies in multi-dimensional data have many important applications, including building safety monitoring, health monitoring, cyber security, terrorist detection, and fake user detection in social networks. Standard tensor decomposition results are not directly interpretable and few methods that propose to increase interpretability need to be made faster, more memory efficient, and more accurate for large and quickly generated data in the online environment. We propose two versions of a fast, accurate, and directly interpretable tensor decomposition method we call CTD that is based on efficient sampling method. First is the static version of CTD, i.e., CTD-S, that provably guarantees up to 11 x higher accuracy than that of the state-of-the-art method. Also, CTD-S is made up to 2.3x faster and up to 24x more memory-efficient than the state-of-theart method by removing redundancy. Second is the dynamic version of CTD, i.e. CTD-D, which is the first interpretable dynamic tensor decomposition method ever proposed. It is also made up to 82x faster than the already fast CTD-S by exploiting factors at previous time step and by reordering operations. With CTD, we demonstrate how the results can be effectively interpreted in online distributed denial of service (DDoS) attack detection and online troll detection.	[Lee, Jungwoo; Choi, Dongjin; Sael, Lee] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea	Seoul National University (SNU)	Sael, L (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	saellee@snu.ac.kr	Sael, Lee/AAD-9185-2021	Sael, Lee/0000-0002-9066-5756	Basic Science Research Program through the Korea National Research Foundation [NRF-2015R1C1A2A01055739]	Basic Science Research Program through the Korea National Research Foundation(National Research Foundation of Korea)	LS received support from Basic Science Research Program through the Korea National Research Foundation (http://www.nrf.re.kr/) grant number (NRF-2015R1C1A2A01055739).	Allanach J, 2004, AEROSP CONF PROC, P3246, DOI 10.1109/AERO.2004.1368130; Arulselvan A, 2009, COMPUT OPER RES, V36, P2193, DOI 10.1016/j.cor.2008.08.016; Caiafa CF, 2010, LINEAR ALGEBRA APPL, V433, P557, DOI 10.1016/j.laa.2010.03.020; Cao Q., 2012, 9 USENIX S NETW SYST, P197; Cyganek B, 2015, IEEE INT C BIOINFORM, P1383, DOI 10.1109/BIBM.2015.7359880; Drineas P, 2008, SIAM J MATRIX ANAL A, V30, P844, DOI 10.1137/07070471X; Drineas P, 2007, LINEAR ALGEBRA APPL, V420, P553, DOI 10.1016/j.laa.2006.08.023; Harshman R.A, 1970, FDN PARAFAC PROCEDUR; Kontaxis G., 2011, 2011 IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops 2011). PerCom-Workshops 2011: 2011 IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops 2011), P295, DOI 10.1109/PERCOMW.2011.5766886; Korolov M., 2016, CSO NEWS; Mahoney MW, 2008, SIAM J MATRIX ANAL A, V30, P957, DOI 10.1137/060665336; Khoa NLD, 2015, LECT NOTES ARTIF INT, V9077, P459, DOI 10.1007/978-3-319-18038-0_36; Perros I, 2015, IEEE DATA MINING, P943, DOI 10.1109/ICDM.2015.29; Phua C., 2010, INT C INT COMP TECHN, V1, P50, DOI DOI 10.1109/ICICTA.2010.831; Prada MA, 2012, NEUROCOMPUTING, V80, P119, DOI 10.1016/j.neucom.2011.07.030; Sun J., 2006, ACM SIGKDD INT C KNO, P374, DOI DOI 10.1145/1150402.1150445; Sun JM, 2006, IEEE DATA MINING, P1076; Sun JM, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P366; Thuraisingham B, 2008, EUC 2008: PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON EMBEDDED AND UBIQUITOUS COMPUTING, VOL 2, WORKSHOPS, P585, DOI 10.1109/EUC.2008.62; Tong, 2008, P 14 ACM SIGKDD INT, P686, DOI DOI 10.1145/1401890.1401973; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Wang YC, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1265, DOI 10.1145/2783258.2783395; Zhou S, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1375, DOI 10.1145/2939672.2939763	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200579	10.1371/journal.pone.0200579	http://dx.doi.org/10.1371/journal.pone.0200579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044837	gold, Green Published			2022-12-27	WOS:000439942500062
J	Shackleton, CM				Shackleton, Charlie M.			Urban street names: An opportunity to examine biocultural relationships?	PLOS ONE			English	Article							BIODIVERSITY; DIVERSITY; POLITICS; PLACE; SENSE	With increasing urbanisation there is concern regarding loss of experience and knowledge of biodiversity amongst urban populations. Yet biodiversity representations are retained in many art and functional forms, including names of places, buildings, institutions and streets. These manifestations offer a window to examine the relationship between humans and their experienced or imagined environment using a biocultural lens. I quantified the current prevalence of urban streets named after animals or plant species, the diversity of species represented, whether they are native or non-native, whether representative of the biome in which the town was situated and the change in prevalence through time. The street names of 48 towns in a one degree wide south-north belt across seven of South African's biomes were captured and analysed. Of the 4,359 street names, 11.1% were named after plants (218 species) and 5.3% after animals (131 species), although some towns had none and others more than 40%. Approximately half of the plants were native to South Africa, whereas over 80% of the animals were. There was no correspondence between the species composition reflected in street names and the biome in which towns were located. The proportion of streets named after plants or animals has generally increased over the last two hundred years. These results provide insights into the bioculturally defined plants and animals that are valued by past and present urban communities, showing that they are generally from a wider array than can be found or experienced in the local setting.	[Shackleton, Charlie M.] Rhodes Univ, Dept Environm Sci, Grahamstown, South Africa	Rhodes University	Shackleton, CM (corresponding author), Rhodes Univ, Dept Environm Sci, Grahamstown, South Africa.	c.shackleton@ru.ac.za	Shackleton, Charlie/GLV-1260-2022; Shackleton, Charlie M/F-4177-2014	Shackleton, Charlie/0000-0002-8489-6136; 	national Research Foundation of South Africa	national Research Foundation of South Africa(National Research Foundation - South Africa)	This work was funded by the national Research Foundation of South Africa (http://www.nrf.ac.za/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman DH, 2003, AREA, V35, P163, DOI 10.1111/1475-4762.00250; Augustins G., 2004, HIST ANTHR, V15, P289; Azaryahu M, 1997, POLIT GEOGR, V16, P479, DOI 10.1016/S0962-6298(96)00053-4; Azaryahu M, 1996, ENVIRON PLANN D, V14, P311, DOI 10.1068/d140311; Baker S, 2015, LOCAL ENVIRON, V20, P321, DOI 10.1080/13549839.2013.842964; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Bobo KS, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-2; Bonie M, 2015, ENVIRON SCI POLICY, V54, P487, DOI 10.1016/j.envsci.2015.05.009; Botzat A, 2016, GLOBAL ENVIRON CHANG, V39, P220, DOI 10.1016/j.gloenvcha.2016.04.008; Cocks M, 2006, HUM ECOL, V34, P185, DOI 10.1007/s10745-006-9013-5; Czembrowski P, 2016, URBAN FOR URBAN GREE, V20, P89, DOI 10.1016/j.ufug.2016.07.010; DEAT, 2012, SOUTH AFR ENV OUTL; Elands BHM, 2015, BIODIVERS CONSERV, V24, P3347, DOI 10.1007/s10531-015-0985-6; Fagundez J, 2016, APPL GEOGR, V74, P23, DOI 10.1016/j.apgeog.2016.06.012; Garibaldi A, 2004, ECOL SOC, V9; Gavin MC, 2015, TRENDS ECOL EVOL, V30, P140, DOI 10.1016/j.tree.2014.12.005; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; Guyot S, 2007, S AFR GEOGR J, V89, P55, DOI 10.1080/03736245.2007.9713873; Horwitz P, 2001, ECOSYST HEALTH, V7, P253, DOI 10.1046/j.1526-0992.2001.01044.x; Kerley GIH, 2003, S AFR J WILDL RES, V33, P13; McCracken DP, 2012, CRIT ARTS, V26, P447, DOI 10.1080/02560046.2012.723800; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Posey DA, 2009, CULTURAL SPIRITUAL V, P1; Pretty J., 2009, CONSERV SOC, V7, P100, DOI DOI 10.4103/0972-4923.58642; Rangnekar D, 2004, 8 UNCTADICTSD; Rohrschneider R, 2015, CIVIC CULTURE TRANSF, P193; Shoval N, 2013, T I BRIT GEOGR, V38, P612, DOI 10.1111/tran.12003; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Stedman RC, 2003, SOC NATUR RESOUR, V16, P671, DOI 10.1080/08941920309189; Teuber R, 2010, J INT FOOD AGRIBUS M, V22, P277, DOI 10.1080/08974431003641612; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x	33	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200891	10.1371/journal.pone.0200891	http://dx.doi.org/10.1371/journal.pone.0200891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044855	Green Submitted, gold, Green Published			2022-12-27	WOS:000439942500068
J	Lunn, TJ; Gerwin, M; Buettel, JC; Brook, BW				Lunn, Tamika J.; Gerwin, Melissa; Buettel, Jessie C.; Brook, Barry W.			Impact of intense disturbance on the structure and composition of wet-eucalypt forests: A case study from the Tasmanian 2016 wildfires	PLOS ONE			English	Article							MOUNTAIN ASH FOREST; PACIFIC-NORTHWEST; FIRE; REGENERATION; ABUNDANCE; ESTABLISHMENT; CONSERVATION; COMMUNITIES; BAKER,R.T.; RESPONSES	Fire is a key process in eucalypt communities, exerting a strong influence on the composition, structure and functioning of forests. Much of the research on the fire response of temperate, wet-sclerophyll trees in Australia comes from Victoria, where the dominant eucalypt is Eucalyptus regnans. In contrast, central and northern Tasmanian forests, dominated by Eucalyptus delegatensis, are relatively understudied. There is a need to determine whether Tasmanian wet-sclerophyll forests, though the same forest type in name, are functionally different in floristics and response to fire. Here we document the forest community response to a natural wildfire event in Tasmania-using opportunistic before/after control/impact (BACI) data from pre-existing monitoring plots. Uniting pre- and post-fire floristic data, we quantified mortality and regeneration of eucalypt, acacia and other dominant tree species, and tree ferns, Dicksonia antarctica, in response to wildfire. We also evaluated the density of eucalypt and acacia seedling establishment between burnt and unburnt forests, and quantified faunal responses to fire. Despite moderate-to-high intensity burning in patches across the plot, mortality of eucalypts, acacias and tree ferns due to fire were low. By contrast, fire-sensitive rainforest species showed low survival, though were able to persist in unburnt refugia. Eucalypt and acacia seedling regeneration was high in the burnt plot, suggesting that E. delegatensis forests regenerate without stand-replacing fire events. This contrasts to Victorian E. regnans forests, whose persistence is dependent on high-severity stand-replacing events. We also found some group-specific avifaunal and invertebrate responses to the fire event, which are broadly reflective of responses documented in other Victorian-based studies. Our results have implications for Tasmanian wet-forest silvicultural practices, which are based on the principle of stand-replacement after fire. The broader relevance of this work to forest ecology is in demonstrating the serendipitous opportunities that can arise with baseline monitoring plots.	[Lunn, Tamika J.; Gerwin, Melissa; Buettel, Jessie C.; Brook, Barry W.] Univ Tasmania, Sch Nat Sci, ARC Ctr Excellence Australian Biodivers & Heritag, Sandy Bay, Tas, Australia	University of Tasmania	Lunn, TJ (corresponding author), Univ Tasmania, Sch Nat Sci, ARC Ctr Excellence Australian Biodivers & Heritag, Sandy Bay, Tas, Australia.	tamika.lunn@utas.edu.au	Lunn, Tamika J/AAL-2093-2020; CABAH, ARC/T-6419-2019	Lunn, Tamika J/0000-0003-4439-2045; Buettel, Jessie/0000-0001-6737-7468	Australian Research Council [FL160100101]	Australian Research Council(Australian Research Council)	All authors were supported by an Australian Laureate Fellowship, awarded to BWB by the Australian Research Council (FL160100101, http://www.arc.gov.au/australian-laureate-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P301, DOI 10.1016/0378-1127(94)90115-5; BATTAGLIA M, 1993, AUST J BOT, V41, P119, DOI 10.1071/BT9930119; Benyon RG, 2013, FOREST ECOL MANAG, V294, P197, DOI 10.1016/j.foreco.2012.04.003; Bowman D, 1984, J BIOGEOGR, P427; Bowman DMJS, 2014, GLOBAL CHANGE BIOL, V20, P1008, DOI 10.1111/gcb.12433; Bowman DM, 2017, NATURE ECOLOGY EVOLU, V1, P1; BOWMAN DMJS, 1986, AUST J BOT, V34, P63, DOI 10.1071/BT9860063; Buddle CM, 2000, ECOGRAPHY, V23, P424, DOI 10.1034/j.1600-0587.2000.230405.x; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cremer K., 1977, DISTANCE SEED DISPER; CREMER K. W., 1965, AUSTRALIAN J BOT, V13, P303; Fuchs SA, 2003, CAN J FOREST RES, V33, P1408, DOI [10.1139/x03-070, 10.1139/X03-070]; Hickey J. E., 1999, Australian Forestry, V62, P66; HILL RS, 1984, AUST J BOT, V32, P481, DOI 10.1071/BT9840481; HOWARD TM, 1973, AUST J BOT, V21, P79, DOI 10.1071/BT9730079; Jones DT, 2005, METH ECOL, P221, DOI 10.1002/9780470750513.ch10; KIRKPATRICK JB, 1982, SEARCH, V13, P136; Lane PNJ, 2010, ENVIRON MODELL SOFTW, V25, P467, DOI 10.1016/j.envsoft.2009.11.001; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Linden DW, 2013, FOREST ECOL MANAG, V310, P1045, DOI 10.1016/j.foreco.2013.08.059; Loyn Richard H., 1997, Pacific Conservation Biology, V3, P221; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; Marris E, 2016, NATURE, V530, P137, DOI 10.1038/nature.2016.19308; McCarthy MA, 1998, FOREST ECOL MANAG, V104, P43, DOI 10.1016/S0378-1127(97)00231-4; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; OKSANEN J, 1983, VEGETATIO, V52, P181, DOI 10.1007/BF00044995; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Ough K, 2004, FOREST ECOL MANAG, V199, P153, DOI 10.1016/j.foreco.2004.05.030; Ough K., 1996, Australian Forestry, V59, P178; Pausas JG, 2015, FUNCT ECOL, V29, P315, DOI 10.1111/1365-2435.12372; Pearson SF, 2001, ECOL APPL, V11, P840, DOI 10.1890/1051-0761(2001)011[0840:BBRTRB]2.0.CO;2; Perry GLW, 2008, J VEG SCI, V19, P705, DOI 10.3170/2008-8-18441; Prior LD, 2016, AUST J BOT, V64, P193, DOI 10.1071/BT15259; RIDPATH MG, 1966, IBIS, V108, P348; Skvarla M. J., 2014, Journal of the Entomological Society of Ontario, V145, P15; Smith AL, 2014, ECOSYSTEMS, V17, P258, DOI 10.1007/s10021-013-9721-9; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Verner J., 1985, Current Ornithology, V2, P247; Vivian LM, 2008, AUSTRAL ECOL, V33, P55, DOI 10.1111/j.1442-9993.2007.01790.x; Ward DF, 2001, J INSECT CONSERV, V5, P47, DOI 10.1023/A:1011317423622; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wood SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137811; York A, 1999, J INSECT CONSERV, V3, P191, DOI 10.1023/A:1009643627781; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	47	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200905	10.1371/journal.pone.0200905	http://dx.doi.org/10.1371/journal.pone.0200905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028860	Green Published, gold, Green Accepted			2022-12-27	WOS:000439396900025
J	Okura, T; Nakamura, R; Fujioka, Y; Kawamoto-Kitao, S; Ito, Y; Matsumoto, K; Shoji, K; Sumi, K; Matsuzawa, K; Izawa, S; Ueta, E; Kato, M; Imamura, T; Taniguchi, S; Yamamoto, K				Okura, Tsuyoshi; Nakamura, Risa; Fujioka, Yohei; Kawamoto-Kitao, Sonoko; Ito, Yuichi; Matsumoto, Kazuhisa; Shoji, Kyoko; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Ueta, Etsuko; Kato, Masahiko; Imamura, Takeshi; Taniguchi, Shin-ichi; Yamamoto, Kazuhiro			Body mass index >= 23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; GLUCOSE-METABOLISM; SENSITIVITY; MUSCLE; LIVER; DIET; BMI	Background Screening for undiagnosed type 2 diabetes mellitus is recommended for Asian Americans with a body mass index >= 23. However, the optimal body mass index cut-off score for predicting the risk of diabetes mellitus in Japanese people is not well known. The aim of this study was to determine the best body mass index cut-off score for predicting insulin resistance and diabetes mellitus in the Japanese population. Methods This study had two parts, a clinical investigation and a retrospective observational investigation. In the clinical part of the study, 58 participants (26 with type 2 diabetes mellitus and 32 non-diabetics) underwent a hyperinsulinemic-euglycemic clamp from which their glucose disposal rate was measured. For the retrospective part of the study, medical check-up data from 88,305 people in the Tottori Prefecture were analyzed for clinical evidence of diabetes mellitus. The optimal BMI cut-off scores for prediction of insulin resistance and diabetes mellitus were determined. Results In the clamp study, the optimal body mass index cut-off score to predict insulin resistance in non-diabetic patients was 22.7. All participants with type 2 diabetes mellitus were insulin resistant, and the optimal body mass index cut-off score for prediction of severe insulin resistance was 26.2. When the data from the type 2 diabetic and the non-diabetic participants were combined, the optimal body mass index cut-off score for prediction of insulin resistance was 23.5. Analysis of 88,305 medical check-up records yielded an optimal body mass index cut-off score for prediction of diabetes mellitus of 23.6. Conclusions These results suggest that having a body mass index >= 23 is a risk factor for insulin resistance and diabetes mellitus in the Japanese population.	[Okura, Tsuyoshi; Nakamura, Risa; Fujioka, Yohei; Kawamoto-Kitao, Sonoko; Ito, Yuichi; Matsumoto, Kazuhisa; Shoji, Kyoko; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan; [Ueta, Etsuko] Tottori Univ, Fac Med, Sch Hlth Sci, Yonago, Tottori, Japan; [Imamura, Takeshi] Tottori Univ, Fac Med, Div Mol Pharmacol, Yonago, Tottori, Japan; [Taniguchi, Shin-ichi] Tottori Univ, Fac Med, Dept Reg Med, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Okura, T (corresponding author), Tottori Univ, Fac Med, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori, Japan.	ohkura@tottori-u.ac.jp		Okura, Tsuyoshi/0000-0003-3713-6617	JSPS KAKENHI [16K08935]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS KAKENHI Grant-in-Aid for Scientific Research (C) grant number 16K08935.	AKAZAWA Y, 1994, DIABETES RES CLIN PR, V24, pS23, DOI 10.1016/0168-8227(94)90223-2; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Kakehi S, 2016, AM J PHYSIOL-ENDOC M, V310, pE32, DOI 10.1152/ajpendo.00220.2015; Kang ES, 2005, METABOLISM, V54, P206, DOI 10.1016/j.metabol.2004.08.014; Kawaguchi M, 2014, J CLIN ENDOCR METAB, V99, P3343, DOI 10.1210/jc.2014-1896; Kawamori R, 1998, DIABETES RES CLIN PR, V41, P35, DOI 10.1016/S0168-8227(98)00056-4; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ohkura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-21; Okura T, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5139750; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Sakurai Y, 2011, J DIABETES INVEST, V2, P310, DOI 10.1111/j.2040-1124.2010.00091.x; Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Takeno K, 2016, J CLIN ENDOCR METAB, V101, P3676, DOI 10.1210/jc.2016-1650; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; The Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology, 2002, ETH GUID EP RES; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Yamauchi K, 2014, ACTA DIABETOL, V51, P441, DOI 10.1007/s00592-013-0535-1; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201052	10.1371/journal.pone.0201052	http://dx.doi.org/10.1371/journal.pone.0201052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028879	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900036
J	Duman-Scheel, M; Eggleson, KK; Achee, NL; Grieco, JP; Hapairai, LK				Duman-Scheel, Molly; Eggleson, Kathleen K.; Achee, Nicole L.; Grieco, John P.; Hapairai, Limb K.			Mosquito control practices and perceptions: An analysis of economic stakeholders during the Zika epidemic in Belize, Central America	PLOS ONE			English	Article							AEDES-AEGYPTI; WEST	The tourist-based economy of Belize, a tropical hub for eco-tourism, is at high risk to be disproportionately impacted by established and emerging mosquito-borne diseases such as Zika. An online survey was used to probe economic stakeholders working in the Belize tourism industry about their mosquito control practices and perceptions. Responses demonstrated that the respondents have good working knowledge of mosquitoes and mosquito-borne illnesses. Most businesses surveyed engage in some means of mosquito control, either through larval source reduction or use of insecticides on the premises. Larvicide use was significantly correlated with a general willingness to use insecticides, as well as belief that treatment of water will reduce mosquito densities and disease transmission. A majority of the respondents agreed that they would be interested in buying a new larvicide to be used on the business premises if it were shown to be safe and effective. The safety of mosquito control products for humans, animals, plants, and the environment in general, followed by product effectiveness, are the most critical determinants of mosquito control purchasing decisions. A majority of respondents agreed that control of mosquitoes and mosquito-borne illnesses is central to the success of their tourist-based industry. Respondents expressed significant concern that the Zika epidemic was over-sensationalized by the media, and that this negatively impacted their livelihoods. The respondents, many of whom are associated with eco/sustainable businesses, also voiced concerns that chemical pesticides could have a negative impact on human health and the environment and expressed a desire for balance between effective mosquito control and preservation of the rich biodiversity of Belize. This study provided a framework for further engagement activities in Belize and other Caribbean nations, uncovered both concerns and support for emerging mosquito control technologies, and revealed opportunities for further debate and educational outreach efforts.	[Duman-Scheel, Molly; Hapairai, Limb K.] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA; [Duman-Scheel, Molly; Eggleson, Kathleen K.; Achee, Nicole L.; Grieco, John P.; Hapairai, Limb K.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Duman-Scheel, Molly; Achee, Nicole L.; Grieco, John P.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Eggleson, Kathleen K.] Indiana Univ Sch Med, Dept Med, South Bend, IN USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Duman-Scheel, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	mscheel@nd.edu		Hapairai, Limb/0000-0002-2943-1061; Grieco, John/0000-0002-2080-8598; Achee, Nicole/0000-0001-6939-2055	United States Agency for International Development [AID-OAA-F-16-00097]	United States Agency for International Development(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development (https://www.usaid.gov/) award #AID-OAA-F-16-00097 to MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, MEXICO J; [Anonymous], 2016, AED AEG GELBF; Blamey RK, 2001, PRINCIPLES ECOTOURIS; Blersch David M., 2013, Environment Development and Sustainability, V15, P67, DOI 10.1007/s10668-012-9374-4; Brown DM, 2014, VECTOR-BORNE ZOONOT, V14, P291, DOI 10.1089/vbz.2013.1364; CDC, 2018, TRAV HLTH; CDC, 2018, NAT CTR EM ZOON INF; CDC, 2018, DENGUE; CDC, 2018, ZIK PREGN; CDC, 2018, ZIK VIR; Chadee DD, 2007, ACTA TROP, V104, P1, DOI 10.1016/j.actatropica.2007.06.006; Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1792; Cruise complete, 2018, BEL CRUIS; Despain D., 2015, AM ATTITUDES GMO FOO; Destinations Belize, 2018, VAC PLANN PLAC PEN B; Dusfour I, 2010, J PEST SCI, V83, P41, DOI 10.1007/s10340-009-0268-7; Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035; Finke MS, 2004, J AGROBIOTECHNOLOGY, V6, P7; Funk C, PUBLIC OPINION FOOD; Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y; Hapairai LK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13566-y; Honey M., 2008, ECOTOURISM SUSTAINAB; Kumar A., 2013, MALARIAWORLD J, V4, P1, DOI DOI 10.1038/NC0MMS3618; Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009; Magnusson MK, 2002, APPETITE, V39, P9, DOI 10.1006/appe.2002.0486; Moerbeek H., 2005, International Journal of Consumer Studies, V29, P308, DOI 10.1111/j.1470-6431.2005.00441.x; Mysore K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2112-5; Naturally Belize, 2018, BEL ECOT; Oliva CF, 2014, ACTA TROP, V132, pS130, DOI 10.1016/j.actatropica.2013.11.019; Online-Utility.org, 2018, TEXT AN; PAHO, 2017, DENG FEV AM; PAHO, 2017, ZIK EPID REP; Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961; Subramaniam TSS, 2012, BIOTECHNOL J, V7, P1323, DOI 10.1002/biot.201200282; Van Ekert E, 2014, J INSECT PHYSIOL, V70, P143, DOI 10.1016/j.jinsphys.2014.08.001; von Schomberg R., 2011, TECH NIKFOLGEN ABSCH; Wagman J., 2014, SPATIAL REPELLENCY F; WHO, 2018, ZIK VIR; WHO, 2018, VECT SURV CONTR; Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; World Health Organization, 2009, DENGUE GUIDELINES DI	42	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201075	10.1371/journal.pone.0201075	http://dx.doi.org/10.1371/journal.pone.0201075			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024951	gold, Green Published, Green Submitted			2022-12-27	WOS:000439120000089
J	Pujades-Rodriguez, M; Assi, V; Gonzalez-Izquierdo, A; Wilkinson, T; Schnier, C; Sudlow, C; Hemingway, H; Whiteley, WN				Pujades-Rodriguez, Mar; Assi, Valentina; Gonzalez-Izquierdo, Arturo; Wilkinson, Tim; Schnier, Christian; Sudlow, Cathie; Hemingway, Harry; Whiteley, William N.			The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England (vol 13, e0199026, 2018)	PLOS ONE			English	Correction													Pujades-Rodriguez, Mar/T-1129-2018; Schnier, Christian/AAV-7458-2021; Hemingway, Harry/C-1219-2009	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Schnier, Christian/0000-0001-7238-7871; Whiteley, William/0000-0002-4816-8991; Gonzalez-Izquierdo, Arturo/0000-0002-0984-5830; Hemingway, Harry/0000-0003-2279-0624; Sudlow, Cathie/0000-0002-7725-7520	Chief Scientist Office [SCAF/17/01] Funding Source: Medline	Chief Scientist Office		Pujades-Rodriguez M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199026; PUJADESRODRIGUE, 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0199026	2	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201213	10.1371/journal.pone.0201213	http://dx.doi.org/10.1371/journal.pone.0201213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024957	Green Published, gold			2022-12-27	WOS:000439120000098
J	Meincke, J; Hewitt, M; Reischl, M; Rupp, R; Schmidt-Samoa, C; Liebetanz, D				Meincke, Jonna; Hewitt, Manuel; Reischl, Markus; Rupp, Ruediger; Schmidt-Samoa, Carsten; Liebetanz, David			Cortical representation of auricular muscles in humans: A robot-controlled TMS mapping and fMRI study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; BRAIN-STIMULATION; RAPID REORGANIZATION; FACIAL-MUSCLES; HAND; COIL; ORGANIZATION; EXCITATION; INTENSITY	Background Most humans have the ability to activate the auricular muscles. Although (intentional) control suggests an involvement of higher cortical centers underlying posterior auricular muscle (PAM) activation, the cortical representation of the auricular muscles is still unknown. Methods With the purpose of identifying a possible cortical representation area we performed automated robotic and image-guided transcranial magnetic stimulation (TMS) mapping (n = 8) and functional magnetic resonance imaging (fMRI) (n = 13). For topographical comparison, a similar experimental protocol was applied for the first dorsal interosseus muscle (FDI) of the hand. Results The calculated centers of gravity (COGs) of both muscles were located on the precentral gyrus with the PAM COGs located more laterally compared to the FDI. The distance between the mean PAM and mean FDI COG was 26.3 mm. The TMS mapping results were confirmed by fMRI, which showed a dominance of cortical activation within the precentral gyrus during the corresponding motor tasks. The correspondence of TMS and fMRI results was high. Conclusion The involvement of the primary motor cortex in PAM activation might point to an evolved function of the auricular muscles in humans and/or the ability of intentional (and selective) muscle activation.	[Meincke, Jonna; Hewitt, Manuel; Liebetanz, David] Georg August Univ Gottingen, Univ Med Ctr, Clin Clin Neurophysiol, Gottingen, Germany; [Reischl, Markus] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany; [Rupp, Ruediger] Heidelberg Univ Hosp, Spinal Cord Injury Ctr, Heidelberg, Germany; [Schmidt-Samoa, Carsten] Georg August Univ Gottingen, Univ Med Ctr, Dept Cognit Neurol, Gottingen, Germany	University of Gottingen; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; University of Gottingen	Liebetanz, D (corresponding author), Georg August Univ Gottingen, Univ Med Ctr, Clin Clin Neurophysiol, Gottingen, Germany.	dliebet@gwdg.de	Reischl, Markus/H-6970-2013	Reischl, Markus/0000-0002-7780-6374; Meincke, Jonna/0000-0003-0714-1116	German Ministry of Education and Reearch [FKZ 01EZ1122A]; German Federal Ministry of Education and Research [FKZ 01EZ1122A]	German Ministry of Education and Reearch; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by the German Ministry of Education and Reearch (FKZ 01EZ1122A). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Federal Ministry of Education and Research (FKZ 01EZ1122A). We thank N. Focke and F. Awiszus for technical advice and C. Crozier for improving the English.	AMASSIAN VE, 1992, ELECTROEN CLIN NEURO, V85, P291, DOI 10.1016/0168-5597(92)90105-K; [Anonymous], 1861, ORIGIN SPECIES MEANS; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Bashir S, 2013, J CLIN NEUROPHYSIOL, V30, P390, DOI 10.1097/WNP.0b013e31829dda6b; BERZIN F, 1993, ANN ANAT, V175, P195, DOI 10.1016/S0940-9602(11)80182-2; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Bischoff C, 1993, Electromyogr Clin Neurophysiol, V33, P265; Cattaneo L, 2014, NEUROSCI BIOBEHAV R, V38, P135, DOI 10.1016/j.neubiorev.2013.11.002; Cattaneo L, 2010, J CLIN NEUROPHYSIOL, V27, P126, DOI 10.1097/WNP.0b013e3181d65031; CODY DTR, 1969, LARYNGOSCOPE, V79, P400, DOI 10.1288/00005537-196903000-00007; Cruccu G, 1997, MUSCLE NERVE, V20, P418, DOI 10.1002/(SICI)1097-4598(199704)20:4<418::AID-MUS3>3.0.CO;2-D; Di Lazzaro V, 2001, EXP BRAIN RES, V138, P268; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Grabski K, 2012, HUM BRAIN MAPP, V33, P2306, DOI 10.1002/hbm.21363; HACKLEY SA, 1993, PSYCHOPHYSIOLOGY, V30, P415, DOI 10.1111/j.1469-8986.1993.tb02065.x; Henle J, 1858, HDB SYSTEMATISCHEN A, V1, P137; Herwig U, 2002, CLIN NEUROPHYSIOL, V113, P462, DOI 10.1016/S1388-2457(02)00026-3; JENNY AB, 1987, NEUROLOGY, V37, P930, DOI 10.1212/WNL.37.6.930; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kantelhardt SR, 2010, ACTA NEUROCHIR, V152, P333, DOI 10.1007/s00701-009-0565-1; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Kiang NY-S, 1963, POSTAURICULAR ELECT; Kiziltan ME, 2010, J ELECTROMYOGR KINES, V20, P508, DOI 10.1016/j.jelekin.2009.07.009; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krings T, 1998, ELECTROMYOGR MOTOR C, V109, P85, DOI 10.1016/S0924-980X(97)00078-7; Lang N, 2011, CEREB CORTEX, V21, P2299, DOI 10.1093/cercor/bhr003; Liepert J, 1999, NEUROSCI LETT, V272, P33, DOI 10.1016/S0304-3940(99)00574-1; Lotze M, 2003, CLIN NEUROPHYSIOL, V114, P306, DOI 10.1016/S1388-2457(02)00380-2; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; MACCABEE PJ, 1993, J PHYSIOL-LONDON, V460, P201, DOI 10.1113/jphysiol.1993.sp019467; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Meincke J, 2016, NEUROIMAGE, V124, P509, DOI 10.1016/j.neuroimage.2015.09.013; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; Morecraft RJ, 2004, NEUROLOGIST, V10, P235, DOI 10.1097/01.nrl.0000138734.45742.8d; Niyazov DM, 2005, CLIN NEUROPHYSIOL, V116, P1601, DOI 10.1016/j.clinph.2005.02.028; O'Beirne GA, 1999, HEARING RES, V138, P115, DOI 10.1016/S0378-5955(99)00159-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Paradiso GO, 2005, J PHYSIOL-LONDON, V567, P323, DOI 10.1113/jphysiol.2005.088542; Richter L, 2013, BRAIN STIMUL, V6, P315, DOI 10.1016/j.brs.2012.06.002; Richter L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060358, 10.1371/journal.pone.0081647]; Rijntjes M, 1997, ANN NEUROL, V41, P621, DOI 10.1002/ana.410410511; Rodel RMW, 2003, ANN OTO RHINOL LARYN, V112, P71; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Saisanen L, 2015, NEUROSURGERY, V77, P394, DOI 10.1227/NEU.0000000000000798; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; Schmalfuss L, 2016, RESTOR NEUROL NEUROS, V34, P79, DOI 10.3233/RNN-150579; Schmidt S, 2015, HUM BRAIN MAPP, V36, P40, DOI 10.1002/hbm.22611; Schwalbe G, 1897, HDB ANATOMIE MENSCHE, V5, P40; Serra G, 1986, Electromyogr Clin Neurophysiol, V26, P661; Terao Y, 1998, EXP BRAIN RES, V121, P145, DOI 10.1007/s002210050446; van de Ruit M, 2016, BRAIN TOPOGR, V29, P56, DOI 10.1007/s10548-015-0447-1; WASSERMANN EM, 1994, EXP BRAIN RES, V100, P121; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Weiss C, 2013, NEUROIMAGE, V66, P531, DOI 10.1016/j.neuroimage.2012.10.046	59	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201277	10.1371/journal.pone.0201277	http://dx.doi.org/10.1371/journal.pone.0201277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052653	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600035
J	Russell, MS; Muralidharan, A; Larocque, L; Cao, JX; Deschambault, Y; Varga, J; Raman, SNT; Li, XG				Russell, Marsha S.; Muralidharan, Abenaya; Larocque, Louise; Cao, Jingxin; Deschambault, Yvon; Varga, Jessie; Raman, Sathya N. Thulasi; Li, Xuguang			Identification and characterisation of the CD40-ligand of Sigmodon hispidus	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IMMUNOSUPPRESSED ANIMAL-MODEL; TUMOR-NECROSIS-FACTOR; COTTON RAT; CD40 LIGAND; DENDRITIC CELLS; PROTECTIVE IMMUNITY; INFLUENZA-VIRUS; B-CELLS; INFECTION	Cotton rats are an important animal model to study infectious diseases. They have demonstrated higher susceptibility to a wider variety of human pathogens than other rodents and are also the animal model of choice for pre-clinical evaluations of some vaccine candidates. However, the genome of cotton rats remains to be fully sequenced, with much fewer genes cloned and characterised compared to other rodent species. Here we report the cloning and characterization of CD40 ligand, whose human and murine counterparts are known to be expressed on a range of cell types including activated T cells and B cells, dendritic cells, granulocytes, macrophages and platelets and exerts a broad array of immune responses. The cDNA for cotton rat CD4OL we isolated is comprised of 1104 nucleotides with an open reading frame (ORF) of 783bp coding for a 260 amino acid protein. The recombinant cotton rat CD4OL protein was recognized by an antibody against mouse CD4OL. Moreover, it demonstrated functional activities on immature bone marrow dendritic cells by upregulating surface maturation markers (CD40, CD54, CD80, and CD86), and increasing IL-6 gene and protein expression. The availability of CD4OL gene identity could greatly facilitate mechanistic research on pathogen-induced-immunopathogenesis and vaccine-elicited immune responses.	[Russell, Marsha S.; Muralidharan, Abenaya; Larocque, Louise; Raman, Sathya N. Thulasi; Li, Xuguang] Hlth Canada, HPFB, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON, Canada; [Russell, Marsha S.; Muralidharan, Abenaya; Larocque, Louise; Raman, Sathya N. Thulasi; Li, Xuguang] WHO Collaborating Ctr Standardizat & Evaluat Biol, Ottawa, ON, Canada; [Muralidharan, Abenaya; Li, Xuguang] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Cao, Jingxin; Deschambault, Yvon; Varga, Jessie] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Health Canada; University of Ottawa; Public Health Agency of Canada	Li, XG (corresponding author), Hlth Canada, HPFB, Ctr Biol Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON, Canada.; Li, XG (corresponding author), WHO Collaborating Ctr Standardizat & Evaluat Biol, Ottawa, ON, Canada.; Li, XG (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	sean.li@canada.ca		Muralidharan, Abenaya/0000-0003-4065-3922; Li, Xuguang (Sean)/0000-0003-1155-9128	Health Canada	Health Canada	Dr Xuguang Li was supported by a grant from Health Canada. The funders had no role in design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Armstrong C, 1939, PUBLIC HEALTH REP, V54, P1719, DOI 10.2307/4583031; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boukhvalova M, 2015, J VIROL, V89, P9825, DOI 10.1128/JVI.01387-15; Boukhvalova MS, 2013, CURR TOP MICROBIOL, V372, P347, DOI 10.1007/978-3-642-38919-1_17; Chan KH, 2007, CLIN VACCINE IMMUNOL, V14, P1433, DOI 10.1128/CVI.00056-07; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Eichelberger MC, 2007, VIRAL IMMUNOL, V20, P243, DOI 10.1089/vim.2007.0017; Faith RE, 1997, LAB ANIM SCI, V47, P337; Fiumara P, 2001, BRIT J HAEMATOL, V113, P265, DOI 10.1046/j.1365-2141.2001.02593.x; GRAMMER AC, 1995, J IMMUNOL, V154, P4996; Gravel C, 2015, VACCINE, V33, P1129, DOI 10.1016/j.vaccine.2015.01.034; Green MG, 2013, LAB ANIMAL, V42, P170, DOI 10.1038/laban.188; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grossmann ME, 1997, HUM GENE THER, V8, P1935, DOI 10.1089/hum.1997.8.16-1935; Gurunathan S, 1998, J IMMUNOL, V161, P4563; Hashem AM, 2014, J IMMUNOL, V193, P722, DOI 10.4049/jimmunol.1300093; Hauser H, 2004, GENE THER, V11, P924, DOI 10.1038/sj.gt.3302160; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Langley RJ, 1998, P NATL ACAD SCI USA, V95, P14355, DOI 10.1073/pnas.95.24.14355; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Mann J, 2002, J BIOL CHEM, V277, P17125, DOI 10.1074/jbc.M109250200; Masten BJ, 1997, AM J RESP CELL MOL, V16, P335, DOI 10.1165/ajrcmb.16.3.9070619; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Niewiesk S, 2002, LAB ANIM-UK, V36, P357, DOI 10.1258/002367702320389026; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Noelle RJ, 1997, ANN NY ACAD SCI, V815, P384, DOI 10.1111/j.1749-6632.1997.tb52089.x; Ottolini MG, 1999, BONE MARROW TRANSPL, V24, P41, DOI 10.1038/sj.bmt.1701813; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Ottolini MG, 2002, BONE MARROW TRANSPL, V29, P117, DOI 10.1038/sj.bmt.1703326; PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; PORTER DD, 1991, J VIROL, V65, P103, DOI 10.1128/JVI.65.1.103-111.1991; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Reynolds CR, J MOL BIOL; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Saez-Llorens X, 1998, PEDIATR INFECT DIS J, V17, P787, DOI 10.1097/00006454-199809000-00007; Singh-Jasuja H, 2013, IMMUNOBIOLOGY, V218, P28, DOI 10.1016/j.imbio.2012.01.021; Song Y, 2015, CURR DRUG TARGETS, V16, P393, DOI 10.2174/1389450116666150223115628; TSAI JC, 1992, ARCH OPHTHALMOL-CHIC, V110, P1167, DOI 10.1001/archopht.1992.01080200147043; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; van Mierlo GJD, 2002, P NATL ACAD SCI USA, V99, P5561, DOI 10.1073/pnas.082107699; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Williams JV, 2005, J VIROL, V79, P10944, DOI 10.1128/JVI.79.17.10944-10951.2005; Wyde PR, 2000, VACCINE, V19, P42, DOI 10.1016/S0264-410X(00)00151-1	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0199067	10.1371/journal.pone.0199067	http://dx.doi.org/10.1371/journal.pone.0199067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052641	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600005
J	Al-Ajmi, K; Lophatananon, A; Ollier, W; Muir, KR				Al-Ajmi, Kawthar; Lophatananon, Artitaya; Ollier, William; Muir, Kenneth R.			Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors	PLOS ONE			English	Article							SEX-HORMONES; FAMILY-HISTORY; WOMEN; EPIDEMIOLOGY; PREMENOPAUSAL; METAANALYSIS; REANALYSIS; PROPORTION; MENOPAUSE; MENARCHE	Background Anthropometric and reproductive factors have been reported as being established risk factors for breast cancer (BC). This study explores the contribution of anthropometric and reproductive factors in UK females developing BC in a large longitudinal cohort. Methods Data from the UK Biobank prospective study of 273,467 UK females were analyzed. Relative risks (RRs) and 95% confidence intervals (CIs) for each factor were adjusted for age, family history of BC and deprivation score. The analyses were stratified by the menopausal status. Results Over the 9 years of follow up the total number of BC cases were 14,231 with 3,378 (23.7%) incident cases with an incidence rate of 2.09 per 1000 person-years. In pre-menopausal, increase in age, height, having low BMI, low waist to hip ratio, first degree family history of BC, early menarche age, nulliparous, late age at first live birth, high reproductive interval index, and long contraceptive use duration were all significantly associated with an increased BC risk. In post-menopausal, getting older, being taller, having high BMI, first degree BC family history, nulliparous, late age at first live birth, and high reproductive interval index were all significantly associated with an increased risk of BC. The population attributable fraction (PAF) suggested that an early first live birth, lower reproductive interval index and increased number of children can contribute to BC risk reduction up to 50%. Conclusions This study utilizes the UK Biobank study to confirm associations between anthropometric and reproductive factors and the risk of breast cancer development. Result of attributable fraction of risk contributed by each risk factor suggested that lifetime risk of BC can be reduced by controlling weight, reassessing individual approaches to the timing of childbirth and options for contraception and considering early screening for women with family history in the first degree relative.	[Al-Ajmi, Kawthar; Lophatananon, Artitaya; Ollier, William; Muir, Kenneth R.] Univ Manchester, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Manchester	Muir, KR (corresponding author), Univ Manchester, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Fac Biol Med & Hlth, Manchester, Lancs, England.	kenneth.muir@manchester.ac.uk			ICEP - CRUK [C18281/A19169]; Ministry of Higher Education in Oman; MRC [G0100594, G0600237, G0901461, MC_PC_12028] Funding Source: UKRI	ICEP - CRUK; Ministry of Higher Education in Oman; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Kenneth R. Muir and Artitaya Lophatananon received funding through the ICEP supported by CRUK [grant number C18281/A19169]). We also would like to thank Ministry of Higher Education in Oman for their financial support to the first author (Kawthar Al-Ajmi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Zj, 2014, BIRTH WEIGHT CHILDHO, DOI [10.1186/bcr3596, DOI 10.1186/BCR3596]; [Anonymous], 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675; Bates P, 1995, MAMMARY CANC TRANSGE; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Cancer IAfRo, 2008, MON EV CARC RISKS HU, P91; Cancer Research UK, 2014, CANC STAT BREAST CAN; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Cleary MP, 2009, ENDOCRINOLOGY, V150, P2537, DOI 10.1210/en.2009-0070; Dartois L, 2016, INT J CANCER, V138, P2415, DOI 10.1002/ijc.29987; Ebrahim S, 2013, INT J EPIDEMIOL, V42, P1022, DOI 10.1093/ije/dyt105; Folkerd E, 2013, BREAST, V22, pS38, DOI 10.1016/j.breast.2013.07.007; Friedenreich CM, 2001, EUR J CANCER PREV, V10, P15, DOI 10.1097/00008469-200102000-00003; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hewitt J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009161; Horn J, 2013, REPRODUCTIVE FACTORS, DOI [10.1007/s10549-013-2531-0, DOI 10.1007/S10549-013-2531-0]; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; Kelsey JL, 1993, REPROD FACTORS BREAS; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Lahmann PH, 2004, BODY SIZE BREAST CAN, V111, P771; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morris DH, 2010, BRIT J CANCER, V103, P1760, DOI 10.1038/sj.bjc.6605978; Newson R., 2012, STATA MODULE COMPUTE; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Papa V, 1993, INSULIN GROWTH FACTO; Petrisek A, 2000, CANCER PRACT, V8, P135, DOI 10.1046/j.1523-5394.2000.83007.x; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sprague BL, 2008, AM J EPIDEMIOL, V168, P404, DOI 10.1093/aje/kwn143; Thorbjarnardottir T, 2014, ACTA ONCOL, V53, P752, DOI 10.3109/0284186X.2013.878471; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; Winters S, 2017, PROG MOL BIOL TRANSL, V151, P1, DOI 10.1016/bs.pmbts.2017.07.002; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wright CE, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-014-0023-9; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Zhang B, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv219	48	20	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201097	10.1371/journal.pone.0201097	http://dx.doi.org/10.1371/journal.pone.0201097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048498	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400048
J	Lima, SAM; El Dib, RP; Rodrigues, MRK; Ferraz, GAR; Molina, AC; Neto, CAP; de Lima, MAF; Rudge, MVC				Molina Lima, Silvana Andrea; El Dib, Regina Paolucci; Kron Rodrigues, Meline Rossetto; Rago Ferraz, Guilherme Augusto; Molina, Ana Claudia; Pilan Neto, Carlos Alberto; Ferraz de Lima, Marcelo Aparecido; Cunha Rudge, Marilza Vieira			Is the risk of low birth weight or preterm labor greater when maternal stress is experienced during pregnancy? A systematic review and meta-analysis of cohort studies	PLOS ONE			English	Review							PRENATAL STRESS; PROBLEM BEHAVIOR; CORTISOL-LEVELS; ANXIETY; HEALTH; TEMPERAMENT; DEPRESSION; PREDICTION; RECEPTORS; DISTRESS	Antenatal stress is linked to fetal risks that increase the chances of neonatal complications and reduction of child cognitive ability. Therefore, we aimed to evaluate if maternal stress affects fetal, neonatal or child development. The following databases were searched: MEDLINE (1966 to May 2016), Embase (1980 to May 2016), LILACS (1982 to May 2016) and CENTRAL (1972 to May 2016). Observational studies published in English and Portuguese were included whether there was any relationship between fetal and neonatal outcome, such as birth weight, preterm labor, child development with pregnant women that were subjected to any stress type during at least one month of follow-up. Two independent reviewers screened eligible articles, extracted data and assessed the risk of bias. Thus, 8 cohort studies with about 8,271 pregnant women and 1,081,151 children proved eligible. Results suggested a significant association between antenatal stress exposure and increasing rates of low birth weight (Odds ratio (OR) 1.68 [95% Confidential Interval (CI) 1.19, 2.38]). However, there was no statistically significance difference between non-exposed and exposed groups related to preterm labor (OR 1.98 [95% CI 0.91 to 4.31]; I2 = 68%, p = 0.04). Although, results were inconsistent with primary analysis suggesting a significant association between antenatal stress exposure and the occurrence of higher rates of preterm birth (OR 1.42 [95% CI 1.05 to 1.91]; I2 = 68%, p = 0.04) in the sensitivity analysis. Furthermore, the current review has suggested that stress perceived during antenatal negatively influences fetal life and child development. Yet, further studies are necessary with adequate sample size and longer follow-up time to confirm our findings.	[Molina Lima, Silvana Andrea] UNESP Univ Estadual Paulista, Botucatu Med Sch, Nursing Dept, Botucatu, SP, Brazil; [El Dib, Regina Paolucci] UNESP, Dept Biosci & Oral Diag, Inst Sci & Technol, Sao Jose Dos Campos, Brazil; [Kron Rodrigues, Meline Rossetto; Rago Ferraz, Guilherme Augusto; Cunha Rudge, Marilza Vieira] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Nursing Dept Gynecol & Obstet, Botucatu, SP, Brazil; [Molina, Ana Claudia] Municipal Author Botucatu, Sao Paulo, Brazil; [Pilan Neto, Carlos Alberto] Univ Fed Minas Gerais, Minas Gerais Med Sch, Belo Horizonte, MG, Brazil; [Ferraz de Lima, Marcelo Aparecido] Botucatu Med Sch, Dept Collect Hlth, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Lima, SAM (corresponding author), UNESP Univ Estadual Paulista, Botucatu Med Sch, Nursing Dept, Botucatu, SP, Brazil.	smolinalima@gmail.com	Rudge, Marilza/S-9057-2018; Dib, Regina El/ABC-8178-2020; Rodrigues, Meline R Kron/R-9253-2018; Vieira Cunha Rudge, Marilza/C-8338-2012	Dib, Regina El/0000-0002-4081-803X; Rodrigues, Meline R Kron/0000-0003-2174-268X; Ferraz, Guilherne/0000-0001-6596-8782; Vieira Cunha Rudge, Marilza/0000-0002-9227-832X	Brazilian National Research Council [CNPq 310953/2015-4]; Ministry of Science, Technology and Innovation, through its Coordination Office for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science, Technology and Innovation, through its Coordination Office for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Regina El Dib received a scholarship from the Brazilian National Research Council (CNPq 310953/2015-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Ministry of Science, Technology and Innovation, through its Coordination Office for the Improvement of Higher Education Personnel (CAPES), and the National Council for Scientific and Technological Development (CNPq) for the scholarship granted for the studies.	BARLOW SM, 1975, TERATOLOGY, V12, P97, DOI 10.1002/tera.1420120202; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Berger MA, 2002, NEUROCHEM RES, V27, P1525, DOI 10.1023/A:1021656607278; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bodecs T, 2011, EUR J OBSTET GYN R B, V154, P45, DOI 10.1016/j.ejogrb.2010.08.021; Bolten MI, 2011, ARCH WOMEN MENT HLTH, V14, P33, DOI 10.1007/s00737-010-0183-1; Carmichael SL, 2000, EPIDEMIOLOGY, V11, P30, DOI 10.1097/00001648-200001000-00008; Chuang CH, 2011, J PAEDIATR CHILD H, V47, P34, DOI 10.1111/j.1440-1754.2010.01887.x; Class QA, 2011, PSYCHOSOM MED, V73, P234, DOI 10.1097/PSY.0b013e31820a62ce; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Pinto-Dussan MC, 2010, UNIV PSYCHOL, V9, P749, DOI 10.11144/Javeriana.upsy9-3.epmp; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; Dent-Gersham W, 2000, NEUROENDOCRINOLOGY, V71, P333, DOI [10.1159/000054554, DOI 10.1159/000054554]; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Dominguez TP, 2005, ANN BEHAV MED, V29, P12, DOI 10.1207/s15324796abm2901_3; El Dib R, 20 COCHR C OR SESS B; Endara SM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-252; Everard C, 2011, AM J OBSTET GYNECO S, V204; FERRARESE C, 1993, PSYCHONEUROENDOCRINO, V18, P3, DOI 10.1016/0306-4530(93)90051-L; Goedhart G, 2010, PSYCHONEUROENDOCRINO, V35, P644, DOI 10.1016/j.psyneuen.2009.10.003; Goldberg D, 1991, USERS GUIDE GEN HLTH; Grandi C, 2008, REV HOSP MATERNOINFA, V27; GRAYTOFT P, 1981, J BEHAV ASSESS, V3, P11, DOI 10.1007/BF01321348; Grizenko N, 2008, J PSYCHIATR NEUROSCI, V33, P10; Gutteling BM, 2005, EUR CHILD ADOLES PSY, V14, P41, DOI 10.1007/s00787-005-0435-1; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Huizink AC, 2000, THESIS; Kleinhaus K, 2012, EUROPEAN PSYCHIAT S1, V27; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Ladewig J., 1987, Biology of stress in farm animals: an integrative approach, P13; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Loomans EM, 2011, EARLY HUM DEV, V87, P565, DOI 10.1016/j.earlhumdev.2011.04.014; Maric NP, 2010, ARCH WOMEN MENT HLTH, V13, P83, DOI 10.1007/s00737-009-0099-9; Niederhofer H, 2000, PSYCHOL REP, V86, P526, DOI 10.2466/PR0.86.2.526-528; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; OHRLANDER S, 1976, OBSTET GYNECOL, V48, P381; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Rothenberger SE, 2011, EARLY HUM DEV, V87, P129, DOI 10.1016/j.earlhumdev.2010.11.014; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Spielberger CD, 1970, MANUAL STATE TRAIT A; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TANDU-UMBA B, 2014, OPEN J OBSTET GYNECO, V4, P361, DOI DOI 10.4236/ojog.2014.47054; Tegethoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014478; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; Tollenaar MS, 2011, STRESS, V14, P53, DOI 10.3109/10253890.2010.499485; Topol D, 2011, EARLY HUM DEV, DOI [10.1016/j.earlhumdev.2011.04.014, DOI 10.1016/J.EARLHUMDEV.2011.04.014]; Tortoriello DV, 2002, J CLIN INVEST, V110, P749, DOI 10.1172/JCI200216700; Useche SA, 2017, ACCIDENT ANAL PREV, V104, P106, DOI 10.1016/j.aap.2017.04.023; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Whitehouse AJO, 2010, EARLY HUM DEV, V86, P487, DOI 10.1016/j.earlhumdev.2010.06.009; Xiong X, 2008, AM J MED SCI, V336, P111, DOI 10.1097/MAJ.0b013e318180f21c	57	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200594	10.1371/journal.pone.0200594	http://dx.doi.org/10.1371/journal.pone.0200594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048456	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400010
J	Ebine, N; Aoki, T; Itoh, M; Fukuoka, Y				Ebine, Naoyuki; Aoki, Tomoko; Itoh, Masahiro; Fukuoka, Yoshiyuki			Differential kinetics of the cardiac, ventilatory, and gas exchange variables during walking under moderate hypoxia	PLOS ONE			English	Article							HEART-RATE; CARDIORESPIRATORY DYNAMICS; NORMOBARIC HYPOXIA; EXERCISE HYPERPNEA; SINUSOIDAL WORK; O-2 UPTAKE; HUMANS	We investigated the effects of moderate hypoxia (FiO(2) = 15%) on different kinetics between pulmonary ventilation ((V)( )over dot(E)) and heart rate (HR) during treadmill walking. Breath-by-breath (V)( )over dot(E), oxygen uptake ((V)( )over dotO(2)), carbon dioxide output ((V)( )over dotCO(2)), and HR were measured in 13 healthy young adults. The treadmill speed was sinusoidally changed from 3 to 6 km.h(-1) with four oscillation periods of 1, 2, 5, and 10 min. The amplitude (Amp), phase shift (PS) and mean values of these kinetics were obtained by harmonic analysis. The mean values of all of these responses during walking at a sinusoidally changing speed became greater under hypoxia compared to normoxia (FiO(2) = 21%), indicating that moderate hypoxia could achieve an increased energy expenditure (increased (V)( )over dotO(2) and (V)( )over dotCO(2)) V and hyperventilation. The Amp values of the (V)( )over dot(E), (V)( )over dotVO(2), and (V)( )over dotCO(2) kinetics were not significantly different between normoxia and hypoxia at most periods, although a significantly smaller Amp of the HR was observed at faster oscillation periods (1 or 2 min).The PS of the HR was significantly greater under hypoxia than normoxia at the 2, 5, and 10 min periods, whereas the PS of the (V)( )over dot(E), (V)( )over dotO(2), and (V)( )over dotCO(2) responses was not significantly different between normoxia and hypoxia at any period. These findings suggest that the lesser changes in Amp and PS in ventilatory and gas exchange kinetics during walking at a sinusoidally changing speed were remarkably different from a deceleration in HR kinetics under moderate hypoxia.	[Ebine, Naoyuki; Fukuoka, Yoshiyuki] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan; [Aoki, Tomoko; Fukuoka, Yoshiyuki] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto, Japan; [Itoh, Masahiro] Kumamoto Univ, Dept Physiol, Grad Sch Life Sci, Chyo Ku, Kumamoto, Japan	Doshisha University; Kumamoto University	Fukuoka, Y (corresponding author), Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan.; Fukuoka, Y (corresponding author), Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto, Japan.	nebine@mail.doshisha.ac.jp		Fukuoka, Yoshiyuki/0000-0001-6409-2694	Japan Society for the Promotion of Science [23680068, 22370091]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported in part by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23680068 to NE, 22370091 to YF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON EA, 1992, J APPL PHYSIOL, V72, P1810, DOI 10.1152/jappl.1992.72.5.1810; Babb TG, 1997, J APPL PHYSIOL, V82, P746, DOI 10.1152/jappl.1997.82.3.746; BAKKER HK, 1980, J APPL PHYSIOL, V48, P289, DOI 10.1152/jappl.1980.48.2.289; BENNETT FM, 1988, J APPL PHYSIOL, V65, P2011, DOI 10.1152/jappl.1988.65.5.2011; CASABURI R, 1977, J APPL PHYSIOL, V42, P300, DOI 10.1152/jappl.1977.42.2.300; Engelen M, 1996, J APPL PHYSIOL, V81, P2500, DOI 10.1152/jappl.1996.81.6.2500; FORSTER HV, 1993, J APPL PHYSIOL, V75, P1385, DOI 10.1152/jappl.1993.75.3.1385; Fukuoka Y, 2002, CLIN SCI, V102, P31, DOI 10.1042/CS20010059; FUKUOKA Y, 1995, ACTA PHYSIOL SCAND, V153, P117, DOI 10.1111/j.1748-1716.1995.tb09842.x; Fukuoka Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168517; Gatterer H, 2015, OBESITY FACTS, V8, P200, DOI 10.1159/000431157; GRIFFITHS TL, 1986, J PHYSIOL-LONDON, V380, P387, DOI 10.1113/jphysiol.1986.sp016292; HAOUZI P, 1992, EUR J APPL PHYSIOL, V64, P410, DOI 10.1007/BF00625059; Haouzi P, 2004, J PHYSIOL-LONDON, V559, P315, DOI 10.1113/jphysiol.2003.057729; Haufe S, 2008, MED SCI SPORT EXER, V40, P1939, DOI 10.1249/MSS.0b013e31817f1988; Horiuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05068-8; Horiuchi M, 2016, BIOL OPEN, V5, P1408, DOI 10.1242/bio.019810; Hotta N, 2008, J SPORT MED PHYS FIT, V48, P129; HUGHSON RL, 1995, RESP PHYSIOL, V101, P87, DOI 10.1016/0034-5687(95)00009-3; Kong ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158589; LINNARSSON D, 1974, ACTA PHYSIOL SCAND, P1; MITCHELL GS, 1990, J APPL PHYSIOL, V69, P718, DOI 10.1152/jappl.1990.69.2.718; MIYAMOTO Y, 1983, JPN J PHYSIOL, V33, P971, DOI 10.2170/jjphysiol.33.971; MURPHY PC, 1989, CARDIOVASC RES, V23, P825, DOI 10.1093/cvr/23.10.825; ROWELL LB, 1986, AM J PHYSIOL, V251, P1038; Tipton MJ, 2017, J PHYSIOL-LONDON, V595, P5729, DOI 10.1113/JP274596; WARD SA, 1987, J APPL PHYSIOL, V63, P2001, DOI 10.1152/jappl.1987.63.5.2001; WASSERMAN K, 1975, J APPL PHYSIOL, V39, P354, DOI 10.1152/jappl.1975.39.3.354; Wiesner S, 2010, OBESITY, V18, P116, DOI 10.1038/oby.2009.193; XING HC, 1991, J APPL PHYSIOL, V71, P2394, DOI 10.1152/jappl.1991.71.6.2394; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1136, DOI 10.1152/jappl.1991.71.3.1136	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200186	10.1371/journal.pone.0200186	http://dx.doi.org/10.1371/journal.pone.0200186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044809	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500031
J	Evans, H; Balasegaram, S; Douthwaite, S; Hunter, L; Kulasegaram, R; Wong, T; Querol-Rubiera, A; Nebbia, G				Evans, Hannah; Balasegaram, Sooria; Douthwaite, Sam; Hunter, Laura; Kulasegaram, Ranjababu; Wong, Terry; Querol-Rubiera, Antonio; Nebbia, Gaia			An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department	PLOS ONE			English	Article							C VIRUS-INFECTION; LIVER-DISEASE; ENGLAND; PREVALENCE; ETHNICITY	Therapies that halt progression of chronic hepatitis B virus (HBV) and achieve a cure for chronic hepatitis C virus (HCV) have encouraged development of innovative strategies to diagnose and link patients to care. We describe the prevalence and risk factors for HBV and HCV infections and use of an opt-out hepatitis testing and integrated linkage to care pathway in a London Emergency Department (ED). ED patients aged >= 16 years having routine blood tests from 15 February-28 March 2016 were tested for hepatitis, unless opted out. Hepatitis B surface antigen (HBsAg) and hepatitis C antibody tests (HCV-Ab, including a confirmatory hepatitis C antigen test (HCV-Ag)) were pre-selected on electronic blood test requests. Linkage to care (attending one clinic appointment) was offered to HBsAg and HCV-Ag patients (new or known-disengaged with care diagnoses). Weighted prevalence estimates and risk factors for seropositivity adjusted by demographics and survey weights were calculated using logistic regression. Hepatitis testing uptake was 56% (3,290/5,865). Overall, 26 HBsAg (10 new diagnoses) and 63 HCV-Ab patients were identified of which 32 were HCV-Ag positive (10 new diagnoses). Weighted seroprevalence of HBsAg was 0.50% (95% CI 0.3-0.8%); HCV-Ab 2.0% (95% CI 1.5-2.7%) and HCV-Ag 1.2% (95% CI 0.8-1.7%). Risk factors for infection were being male (HBsAg: aOR 4.1, 95% CI 1.5-11.3), of non-White British ethnicity (HBsAg: aOR>11) or being homeless (HCV-Ag: aOR 18.9, 95% CI 6.9-51.4). We achieved a high linkage to care uptake for HBsAg (93%) and HCV-Ag (78%) among patients who were contacted and required linkage. A pre-selected hepatitis testing ordering system facilitated a high testing uptake. New and disengaged with care diagnoses and a high HCV prevalence were identified demonstrating the potential to identify and link patients to care in this setting. Strategies connecting clinical care with community outreach services are key for improving patient linkage to care.	[Evans, Hannah; Balasegaram, Sooria] Publ Hlth England, United Kingdom Field Epidemiol Training Programme, London, England; [Evans, Hannah; Balasegaram, Sooria] Publ Hlth England, Field Epidemiol Serv, Natl Infect Serv, London, England; [Douthwaite, Sam; Querol-Rubiera, Antonio; Nebbia, Gaia] Guys & St Thomas NHS Trust, Dept Infect, London, England; [Hunter, Laura] Guys & St Thomas NHS Trust, Emergency Dept, London, England; [Kulasegaram, Ranjababu] Guys & St Thomas NHS Trust, Dept HIV GU Med, London, England; [Wong, Terry] Guys & St Thomas NHS Trust, Gastroenterol & Hepatol Dept, London, England	Public Health England; Public Health England; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Evans, H (corresponding author), Publ Hlth England, United Kingdom Field Epidemiol Training Programme, London, England.; Evans, H (corresponding author), Publ Hlth England, Field Epidemiol Serv, Natl Infect Serv, London, England.	hannah.evans@phe.gov.uk		WONG, TERENCE/0000-0002-5236-9139	educational grant via the Gilead UK; Ireland Fellowship Programme	educational grant via the Gilead UK; Ireland Fellowship Programme	This project has been supported with an educational grant via the Gilead UK and Ireland Fellowship Programme (http://www.ukifellowshipprogramme.com/) to the recipients LH, SD and GN at Guy's & St Thomas' NHS Foundation Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 2015, LIVER INT, V35, P78, DOI 10.1111/liv.12710; Cresswell FV, 2015, CLIN INFECT DIS, V60, P263, DOI 10.1093/cid/ciu782; Department of Health, 2002, REP CHIEF MED OFF; Department of Health, 2009, REF GUID CONS EX TRE; Department of Health, 2017, IMM INF DIS; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Galbraith JW, 2015, HEPATOLOGY, V61, P776, DOI 10.1002/hep.27410; Galbraith JW, 2014, CLIN INFECT DIS, V59, P755, DOI 10.1093/cid/ciu427; Harris M, 2016, J VIRAL HEPATITIS, V23, P479, DOI 10.1111/jvh.12513; Harris RJ, 2016, J VIRAL HEPATITIS, V23, P631, DOI 10.1111/jvh.12529; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Harris RJ, 2012, EUR J PUBLIC HEALTH, V22, P187, DOI 10.1093/eurpub/ckr083; Hempling MC, 2016, INT J STD AIDS, V27, P1267, DOI 10.1177/0956462415613727; Hepatitis C in the UK, 2015, HEP C UK 2015 REP; Homeless Link, 2014, UNHEALTHY STATE HOME; Homeless Link, 2017, HOM SUPP ENGL; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; National Institute for Health and Care Excellence, 2015, HEP B CHRON DIAGN MA; National Institute for Health and Care Excellence, 2012, HEP B C TEST PEOPL R; NHS England, 2015, CLIN COMM POL STAT T; NHS England and Data Services for Commissioners, 2016, COMM ASS METH FLOW C; O'Connell S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150546; Orkin C, 2016, HIV MED, V17, P222, DOI 10.1111/hiv.12364; Patruni B, 2013, TECHNICAL REPORT; Public Health England, 2016, DAT TABL UNL AN MON; Public Health England, 2017, HEP C ENGL 2017 HEAD; Public Health England, 2015, HEP C LOND 2015 REP; Public Health England, 2013, HEP B EP LOND 2012 D; Public Health England, 2016, ANN REP SENT SURV ST; Public Health England, 2017, ANT INF SCREEN LOND; Public Health England, 2015, TURN EV PRACT IMPR A; Russmann S, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-5; Smith T., 2015, ENGLISH INDICES DEPR; Tillmann HL, 2014, WORLD J GASTROENTERO, V20, P6701, DOI 10.3748/wjg.v20.i22.6701; Uddin G, 2010, J VIRAL HEPATITIS, V17, P327, DOI 10.1111/j.1365-2893.2009.01240.x; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041206; World Health Organization, 2016, GLOB HLTH SECT STRAT	37	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0198520	10.1371/journal.pone.0198520	http://dx.doi.org/10.1371/journal.pone.0198520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044779	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500007
J	Shen, KL; Wasserman, M; Liu, DD; Yang, YH; Yang, JF; Guzauskas, GF; Wang, BCM; Hilton, B; Farkouh, R				Shen, Kunling; Wasserman, Matthew; Liu, Dongdong; Yang, Yong-Hong; Yang, Junfeng; Guzauskas, Greg F.; Wang, Bruce C. M.; Hilton, Betsy; Farkouh, Raymond			Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE BURDEN; UNITED-STATES; HEALTH; IMPACT; USA; POPULATION; PREVENTION	Background The burden of pneumococcal disease in China is high, and a 13-valent pneumococcal conjugate vaccine (PCV13) recently received regulatory approval and is available to Chinese infants. PCV13 protects against the most prevalent serotypes causing invasive pneumococcal disease (IPD) in China, but will not provide full societal benefits until made broadly available through a national immunization program (NIP). Objective To estimate clinical and economic benefits of introducing PCV13 into a NIP in China using local cost estimates and accounting for variability in vaccine uptake and indirect (herd protection) effects. Methods We developed a population model to estimate the effect of PCV13 introduction in China. Modeled health states included meningitis, bacteremia, pneumonia (PNE), acute otitis media, death and sequelae, and no disease. Direct healthcare costs and disease incidence data for IPD and PNE were derived from the China Health Insurance and Research Association database; all other parameters were derived from published literature. We estimated total disease cases and associated costs, quality-adjusted life years (QALYs), and deaths for three scenarios from a Chinese Payer Perspective: (1) direct effects only, (2) direct+indirect effects for IPD only, and (3) direct+indirect effects for IPD and inpatient PNE. Results Scenario (1) resulted in 370.3 thousand QALYs gained and 12.8 thousand deaths avoided versus no vaccination. In scenarios (2) and (3), the PCV13 NIP gained 383.2 thousand and 3,580 thousand QALYs, and avoided 13.1 thousand and 147.5 thousand deaths versus no vaccination, respectively. In all three scenarios, the vaccination cost was offset by cost reductions from prevented disease yielding net costs of (sic)29,362.32 million, (sic)29,334.29 million, and (sic)13,524.72 million, respectively. All resulting incremental cost-effectiveness ratios fell below a 2x China GDP cost-effectiveness threshold across a range of potential vaccine prices. Discussion Initiation of a PCV13 NIP in China incurs large upfront costs but is good value for money, and is likely to prevent substantial cases of disease among children and non-vaccinated individuals.	[Shen, Kunling] Capital Med Univ, Beijing Childrens Hosp, Dept Resp Dis, Natl Ctr Childrens Hlth, Beijing, Peoples R China; [Wasserman, Matthew] Pfizer Inc, New York, NY 10017 USA; [Liu, Dongdong; Yang, Junfeng] Pfizer Inc, Beijing, Peoples R China; [Yang, Yong-Hong] Capital Med Univ, Natl Clin Res Ctr Resp Dis,Beijing Pediat Res Ins, Beijing Key Lab Pediat Resp Infect Dis,Lab Microb, Key Lab Major Dis Children,Minist Educ,Beijing Ch, Beijing, Peoples R China; [Yang, Yong-Hong] Capital Med Univ, Natl Clin Res Ctr Resp Dis,Beijing Pediat Res Ins, Beijing Key Lab Pediat Resp Infect Dis,Lab Microb, Natl Key Discipline Pediat,Minist Educ,Beijing Ch, Beijing, Peoples R China; [Guzauskas, Greg F.; Wang, Bruce C. M.] Elysia Grp LLC, New York, NY USA; [Hilton, Betsy; Farkouh, Raymond] Pfizer Inc, Collegeville, PA USA	Capital Medical University; Pfizer; Pfizer; Capital Medical University; Capital Medical University; Pfizer	Wasserman, M (corresponding author), Pfizer Inc, New York, NY 10017 USA.	Matt.Wasserman@pfizer.com		Wasserman, Matthew/0000-0003-3300-2742	Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was sponsored by Pfizer Inc. MW, DL, JY, BH, and RF are employees of Pfizer Inc. The specific roles of these authors are articulated in the 'author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Cao L, 2012, CHI J VACCINE IMMUNI, V5, P419; (CDC) CfDC, GLOB PNEUM DIS VACC; Chan J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021512; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; China Ministry of Health, 1994, NOT ENH REP COV ROUT; Dinleyici EC, 2008, EXPERT REV VACCINES, V7, P1367, DOI 10.1586/14760584.7.9.1367; Earnshaw SR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-101; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Guan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011721; Hausdorff WP, 2002, PEDIATR INFECT DIS J, V21, P1008, DOI 10.1097/00006454-200211000-00007; Ho YC, 2015, HUM VACC IMMUNOTHER, V11, P1081, DOI 10.1080/21645515.2015.1023969; Hu Shanlian, 2014, Value Health Reg Issues, V3, P197, DOI 10.1016/j.vhri.2014.04.007; Klok RM, 2013, CLIN THER, V35, P119, DOI 10.1016/j.clinthera.2012.12.006; Li Y, 2017, HUM VACC IMMUNOTHER, V13, P1681, DOI 10.1080/21645515.2017.1304335; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Maurer KA, 2016, VACCINE, V34, P6343, DOI 10.1016/j.vaccine.2016.10.051; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Mo XT, 2016, PEDIATR INFECT DIS J, V35, pE353, DOI 10.1097/INF.0000000000001288; Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Morrow A, 2007, CAN J INFECT DIS MED, V18, P121, DOI 10.1155/2007/713576; Mucino-Ortega E, 2011, VALUE HEALTH, V14, pS65, DOI 10.1016/j.jval.2011.05.025; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Rose M, 2009, EXPERT REV VACCINES, V8, P1351, DOI [10.1586/erv.09.78, 10.1586/ERV.09.78]; Saokaew S, 2016, PHARMACOECONOMICS, V34, P1211, DOI 10.1007/s40273-016-0439-3; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Strutton DR, 2012, J INFECTION, V64, P54, DOI 10.1016/j.jinf.2011.10.015; The State Council, 2011, PLAN DEV CHIN CHILDR; The State Council, 1992, PLAN DEV CHIN CHILDR; Wagner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097800; Wang B, 2014, VALUE HEALTH, V17, pA275, DOI 10.1016/j.jval.2014.03.1600; Wasserman M., 2016, OPEN FORUM INFECT DI; World Health Organization, 2008, EST HIB PNEUM DEATHS; Wu DBC, 2015, VACCINE, V33, P1633, DOI 10.1016/j.vaccine.2015.01.081; Xia L, 2015, J GERIATR CARDIOL, V12, P502, DOI 10.11909/j.issn.1671-5411.2015.05.021; Yao KH, 2008, VACCINE, V26, P4425, DOI 10.1016/j.vaccine.2008.06.052; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; Zheng JS., 2012, CHIN J VACCINES IMMU, V18, P233, DOI 10.13683/j.wph.2017.06.014; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619	45	13	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201245	10.1371/journal.pone.0201245	http://dx.doi.org/10.1371/journal.pone.0201245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044865	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500094
J	Kannegieter, NM; Hesselink, DA; Dieterich, M; de Graav, GN; Kraaijeveld, R; Baan, CC				Kannegieter, Nynke M.; Hesselink, Dennis A.; Dieterich, Marjolein; de Graav, Gretchen N.; Kraaijeveld, Rens; Baan, Carla C.			Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients	PLOS ONE			English	Article							REGULATED GENE-EXPRESSION; SOLID-ORGAN TRANSPLANTATION; CALCINEURIN INHIBITORS; GLUCOCORTICOID-RECEPTOR; RENAL-TRANSPLANTATION; CYCLOSPORINE-A; IMMUNOSUPPRESSION; AUTOREGULATION; TRANSCRIPTION; BELATACEPT	Background Therapeutic drug monitoring (TDM) of tacrolimus, based on blood concentrations, shows an imperfect correlation with the occurrence of rejection. Here, we tested whether measuring NFATc1 amplification, a member of the calcineurin pathway, is suitable for TDM of tacrolimus. Materials and methods NFATc1 amplification was monitored in T cells of kidney transplant recipients who received either tacrolimus- (n = 11) or belatacept-based (n = 10) therapy. Individual drug effects on NFATc1 amplification were studied in vitro, after spiking blood samples of healthy volunteers with either tacrolimus, belatacept or mycophenolate mofetil. Results At day 30 after transplantation, in tacrolimus-treated patients, NFATc1 amplification was inhibited in CD4(+)T cells expressing the co-stimulation receptor CD28 (mean inhibition 37%; p = 0.01) and in CD8(+)CD28(+)T cells (29% inhibition; p = 0.02), while this was not observed in CD8(+)CD28(-)T cells or belatacept-treated patients. Tacrolimus pre-dose concentrations of these patients correlated inversely with NFATc1 amplification in CD28(+)T cells (r(s) = -0.46; p < 0.01). In vitro experiments revealed that 50 ng/ml tacrolimus affected NFATc1 amplification by 58% (mean; p = 0.02). Conclusion In conclusion, measuring NFATc1 amplification is a direct tool for monitoring biological effects of tacrolimus on T cells in whole blood samples of kidney transplant recipients. This technique has potential that requires further development before it can be applied in daily practice.	[Kannegieter, Nynke M.; Hesselink, Dennis A.; Dieterich, Marjolein; de Graav, Gretchen N.; Kraaijeveld, Rens; Baan, Carla C.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam Transplant Grp, Dept Internal Med,Sect Transplantat & Nephrol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kannegieter, NM (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam Transplant Grp, Dept Internal Med,Sect Transplantat & Nephrol, Rotterdam, Netherlands.	n.kannegieter@erasmusmc.nl		, Nynke/0000-0003-2025-9426; Baan, Carla/0000-0003-2274-2788	Erasmus MC; Bristol-Myers Squibb	Erasmus MC; Bristol-Myers Squibb(Bristol-Myers Squibb)	The funding for this project was provided by the Erasmus MC and by a research grant from Bristol-Myers Squibb (received by C.C. Baan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kahaar E, 2016, THER DRUG MONIT, V38, P711, DOI 10.1097/FTD.0000000000000340; Andrews LM, 2017, EXPERT OPIN DRUG MET, V13, P1225, DOI 10.1080/17425255.2017.1395413; Baan CC, 2016, TRANSPLANTATION, V100, P2507, DOI 10.1097/TP.0000000000001518; Baan CC, 2016, TRANSPLANTATION, V100, P1833, DOI 10.1097/TP.0000000000001226; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Bergan S, 2016, CLIN BIOCHEM, V49, P411, DOI 10.1016/j.clinbiochem.2015.10.001; Betjes MGH, 2016, TRANSPL INT, V29, P274, DOI 10.1111/tri.12658; Bouamar R, 2013, AM J TRANSPLANT, V13, P1253, DOI 10.1111/ajt.12191; Brandt C, 2010, CYTOM PART A, V77A, P607, DOI 10.1002/cyto.a.20928; Brunet M, 2016, THER DRUG MONIT, V38, pS1, DOI 10.1097/FTD.0000000000000287; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Colovai AI, 2003, HUM IMMUNOL, V64, P31, DOI 10.1016/S0198-8859(02)00742-5; de Graav GN, 2017, TRANSPLANTATION, V101, P2571, DOI 10.1097/TP.0000000000001755; de Graav GN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148604; Giese T, 2004, NEPHROL DIAL TRANSPL, V19, P55, DOI 10.1093/ndt/gfh1043; Han SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153491; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hock M, 2013, J IMMUNOL, V190, P2345, DOI 10.4049/jimmunol.1201591; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kannegieter NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15542-y; Kannegieter NM, 2017, THER DRUG MONIT, V39, P463, DOI 10.1097/FTD.0000000000000426; Keller F, 2017, CLIN NEPHROL, V87, P93, DOI 10.5414/CN108893; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Maguire O, 2013, CYTOM PART A, V83, P1096, DOI 10.1002/cyto.a.22401; Matas AJ, 2015, AM J TRANSPLANT, V15, DOI 10.1111/ajt.13195; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Moscato D, 2010, CLIN CHIM ACTA, V411, P77, DOI 10.1016/j.cca.2009.10.008; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; Pan MG, 2007, J IMMUNOL, V178, P4315, DOI 10.4049/jimmunol.178.7.4315; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Shi WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127995; Shuker N, 2015, TRANSPLANT REV-ORLAN, V29, P78, DOI 10.1016/j.trre.2015.01.002; Sommerer C, 2018, TRANSPLANTATION, V102, P510, DOI 10.1097/TP.0000000000001973; Sommerer C, 2015, CLIN NEPHROL, V84, P165, DOI 10.5414/CN108623; Sommerer C, 2012, CLIN CHIM ACTA, V413, P1379, DOI 10.1016/j.cca.2011.09.041; Streitz M, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-17; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vincenti F, 2012, KIDNEY INT, V82, P1054, DOI 10.1038/ki.2012.194; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Whalen HR, 2017, TRANSPLANTATION, V101, P430, DOI 10.1097/TP.0000000000001129; Wong SHY, 2001, CLIN CHIM ACTA, V313, P241, DOI 10.1016/S0009-8981(01)00678-7; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201113	10.1371/journal.pone.0201113	http://dx.doi.org/10.1371/journal.pone.0201113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036394	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200028
J	Prakash, K; Gianella, S; Dube, K; Taylor, J; Lee, G; Smith, DM				Prakash, Katya; Gianella, Sara; Dube, Karine; Taylor, Jeff; Lee, GaYoung; Smith, Davey M.			Willingness to participate in HIV research at the end of life (EOL)	PLOS ONE			English	Article							I CANCER TRIALS; CURE RESEARCH; ETHICAL CONSIDERATIONS; CLINICAL-RESEARCH; PHASE-1 ONCOLOGY; PALLIATIVE CARE; ALTRUISM; VACCINE; CHALLENGES; PREVENTION	Introduction Animal models have been vital for scientific discovery but have limitations, especially in infectious disease research. It is essential to develop a means to study these diseases in human models. We hypothesized that altruistic people would willingly participate in research near the end-of-life (EOL), for the benefit of science and to provide one last gift to society. Methodology Two surveys were administered to 377 self-reported HIV-negative and 96 HIV-positive individuals. Hypothetical questions assessed their willingness to participate in altruistic research in the last 6 months of life, which might result in a shortened lifespan or physical discomforts. The self-reported HIV-negative group was also asked about willingness to be exposed to infectious pathogens for the sake of research. Results Almost all responders expressed willingness to participate in research at the EOL, regardless of HIV-status. The majority of participants were willing to endure physical discomfort for the sake of research. 'Blood draws' was identified as the most tolerable physical discomfort (>70% in both groups). In both groups, >60% were willing to shorten their lifespans for the sake of research. A third of the self-reported HIV-negative group expressed willingness to be exposed to at least one infectious agent to participate in EOL research. Conclusions Our exploratory study demonstrates that people would welcome the opportunity to participate in altruistic research near the EOL. Such research could greatly impact the way infectious disease research is conducted. This study is limited however by its hypothetical nature. Further research is necessary to confirm this interest in those with terminal illness before any further clinical research effort at the EOL can be performed.	[Prakash, Katya; Gianella, Sara; Smith, Davey M.] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA; [Dube, Karine] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Taylor, Jeff] AntiViral Res Ctr AVRC San Diego, CAB, San Diego, CA USA; [Lee, GaYoung] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol Immunol, Baltimore, MD USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Gianella, S (corresponding author), Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA.	gianella@ucsd.edu	Prakash, Katya/ABB-2140-2021; Smith, David/GQQ-8257-2022	Gianella, Sara/0000-0002-9927-0849; Prakash, Katya/0000-0002-8653-4657; Smith, Davey/0000-0003-3603-1733	National Institutes of Health; University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, California HIV Reserch Program [P30-AI027763]; department of Veterans Affairs; James B. Pendleton Charitable Trust; National Institutes of Health [AI100665, MH100974, MH097520, DA034978, AI007384, AI027763, AI106039, AI43638, AI074621, AI036214, MH101012, UL1TR000100, CARE U19 AI096113, AI068636-09]; California HIV Reserch Program Ideal award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI007036, U19AI096113, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, California HIV Reserch Program(University of California System); department of Veterans Affairs(US Department of Veterans Affairs); James B. Pendleton Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV Reserch Program Ideal award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported primarily by a grant from the National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30-AI027763 (CNIHR), California HIV Reserch Program Ideal award to Sara Gianella, by the department of Veterans Affairs, the James B. Pendleton Charitable Trust and additional grants from the National Institutes of Health: AI100665, MH100974, MH097520, DA034978, AI007384, AI027763, AI106039, AI43638, AI074621, AI036214, MH101012, UL1TR000100, CARE U19 AI096113 and AI068636-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2003, J PAIN SYMPTOM MANAG, V25, pS25, DOI 10.1016/S0885-3924(03)00057-5; Agrawal M, 2003, JAMA-J AM MED ASSOC, V290, P1075, DOI 10.1001/jama.290.8.1075; Allmark P, 2016, TRANSL LUNG CANCER R, V5, P219, DOI 10.21037/tlcr.2016.03.04; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Beauchamp T, 1989, PRINCIPLES BIOMEDICA; Bolt EE, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1879-3; Casarett D, 2001, J Palliat Med, V4, P441, DOI 10.1089/109662101753381566; Cassel JB, 2016, J PAIN SYMPTOM MANAG, V52, P437, DOI 10.1016/j.jpainsymman.2016.02.014; County of San Diego Health and Human Services Agency (HHSA), MONTHL STD REP, V1; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Dezzutti CS, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20301; Doukas DJ, 2014, CAMB Q HEALTHC ETHIC, V23, P397, DOI 10.1017/S0963180114000073; Dube K, 2017, J VIRUS ERAD, V3, P40; Dube K, 2014, TRENDS MICROBIOL, V22, P547, DOI 10.1016/j.tim.2014.08.003; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Enzinger AC, 2014, J PAIN SYMPTOM MANAG, V47, P1078, DOI 10.1016/j.jpainsymman.2013.07.004; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; Faden R., 1986, HIST THEORY INFORM C; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; FREIREICH EJ, 1979, ANNU REV PHARMACOL, V19, P547, DOI 10.1146/annurev.pa.19.040179.002555; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gianella S, 2017, AIDS, V31, P1, DOI 10.1097/QAD.0000000000001300; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; Gysels MH, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-123; Hajar Rachel, 2011, Heart Views, V12, P42, DOI 10.4103/1995-705X.81548; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Henderson, 2014, AIDS RES HUM RETROV, V31, P1; Henry B, 2012, ACCOUNT RES, V19, P1, DOI 10.1080/08989621.2011.622173; Holm S., 2001, PRINCIPLES BIOMEDICA, P454, DOI 10.1136/jme.28.5.332-a[332-a-332]; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Jansen Lynn A, 2006, IRB, V28, P13; Jansen LA, 2011, J MED ETHICS, V37, P563, DOI 10.1136/jme.2010.038943; Joffe S, 2006, J CLIN ONCOL, V24, P2987, DOI 10.1200/JCO.2005.04.9296; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; Mackin ML, 2009, RES GERONTOL NURS, V2, P162, DOI 10.3928/19404921-20090421-05; Miller FG, 2008, CLIN TRIALS, V5, P617, DOI 10.1177/1740774508097576; Pentz RD, 2012, CANCER-AM CANCER SOC, V118, P4571, DOI 10.1002/cncr.27397; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; PRATT CB, 1991, MED PEDIATR ONCOL, V19, P304, DOI 10.1002/mpo.2950190417; Quinn GP, 2013, MED HEALTH CARE PHIL, V16, P857, DOI 10.1007/s11019-013-9480-6; Rinck GC, 1997, J CLIN ONCOL, V15, P1697, DOI 10.1200/JCO.1997.15.4.1697; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Sanghavi DM, NYTIMES; Shilts R., 1987, BAND PLAYED POLITICS; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stiel S, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0020-4; Sugarman J, 2013, ANN INTERN MED, V159, P490, DOI 10.7326/00030003-4819-159-7-201310010-00694; Weber JS, 2015, J CLIN ONCOL, V33, P278, DOI 10.1200/JCO.2014.58.2635	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199670	10.1371/journal.pone.0199670	http://dx.doi.org/10.1371/journal.pone.0199670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8PM	30036365	Green Submitted, gold, Green Published			2022-12-27	WOS:000439429200006
J	Protti, A; Jones, KL; Bonal, DM; Qin, L; Politi, LS; Kravets, S; Nguyen, QD; Van den Abbeele, AD				Protti, Andrea; Jones, Kristen L.; Bonal, Dennis M.; Qin, Lei; Politi, Letterio S.; Kravets, Sasha; Quang-De Nguyen; Van den Abbeele, Annick D.			Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model	PLOS ONE			English	Article							ATTENUATED INVERSION-RECOVERY; MAGNETIZATION; OPTIMIZATION; EVOLUTION; READOUT; FLAIR	Background Magnetic Resonance Imaging (MRI) relies on optimal scanning parameters to achieve maximal signal-to-noise ratio (SNR) and high contrast-to-noise ratio (CNR) between tissues resulting in high quality images. The optimization of such parameters is often laborious, time consuming, and user-dependent, making harmonization of imaging parameters a difficult task. In this report, we aim to develop and validate a computer simulation technique that can reliably provide "optimal in vivo scanning parameters" ready to be used for in vivo evaluation of disease models. Methods A glioblastoma murine model was investigated using several MRI imaging methods. Such MRI methods underwent a simulated and an in vivo scanning parameter optimization in pre- and post-contrast conditions that involved the investigation of tumor, brain parenchyma and cerebrospinal fluid (CSF) CNR values in addition to the time relaxation values of the related tissues. The CNR tissues information were analyzed and the derived scanning parameters compared in order to validate the simulated methodology as a reliable technique for "optimal in vivo scanning parameters" estimation. Results The CNRs and the related scanning parameters were better correlated when spin-echo-based sequences were used rather than the gradient-echo-based sequences due to augmented in homogeneity artifacts affecting the latter methods. "Optimal in vivo scanning parameters" were generated successfully by the simulations after initial scanning parameter adjustments that conformed to some of the parameters derived from the in vivo experiment. Conclusion Scanning parameter optimization using the computer simulation was shown to be a valid surrogate to the in vivo approach in a glioblastoma murine model yielding in a better delineation and differentiation of the tumor from the contralateral hemisphere. In addition to drastically reducing the time invested in choosing optimal scanning parameters when compared to an in vivo approach, this simulation program could also be used to harmonize MRI acquisition parameters across scanners from different vendors.	[Protti, Andrea; Jones, Kristen L.; Bonal, Dennis M.; Qin, Lei; Quang-De Nguyen; Van den Abbeele, Annick D.] Harvard Med Sch, Dana Farber Canc Inst, Ctr Biomed Imaging Oncol, Dept Imaging,Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Politi, Letterio S.] Harvard Med Sch, Boston Childrens Hosp, Radiol Dept, Neuroimaging Res, Boston, MA USA; [Politi, Letterio S.] Univ Massachusetts, Med Sch, Radiol Dept, Worcester, MA USA; [Politi, Letterio S.] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA; [Kravets, Sasha] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Van den Abbeele, Annick D.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Protti, A (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Ctr Biomed Imaging Oncol, Dept Imaging,Lurie Family Imaging Ctr, Boston, MA 02115 USA.	andrea_protti@DFCI.harvard.edu	Politi, Letterio Salvatore/AAB-1092-2021; Van den Abbeele, Annick/AAK-9792-2020	Politi, Letterio Salvatore/0000-0002-6190-6688; Qin, Lei/0000-0002-6708-1285				Ali TS, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.3.036002; [Anonymous], 2003, MRI PICTURE PROTON; Assili S, 2015, J Biomed Phys Eng, V5, P157; Barnett Gene H, 2006, Clin Neurosurg, V53, P154; Benoit-Cattin H, 2005, J MAGN RESON, V173, P97, DOI 10.1016/j.jmr.2004.09.027; Castillo M, 2014, RADIOLOGY, V273, pS111, DOI 10.1148/radiol.14140130; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chagla GH, 2008, INVEST RADIOL, V43, P547, DOI 10.1097/RLI.0b013e3181814d28; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; CONTURO TE, 1987, MAGNET RESON MED, V4, P282, DOI 10.1002/mrm.1910040309; DiFrancesco MW, 2008, MED PHYS, V35, P3972, DOI 10.1118/1.2968092; Drevelegas A, 2011, IMAGING OF BRAIN TUMORS WITH HISTOLOGICAL CORRELATIONS, SECOND EDITION, P1, DOI 10.1007/978-3-540-87650-2; Eggers H, 2007, IEEE T MED IMAGING, V26, P374, DOI 10.1109/TMI.2006.891502; GOWLAND PA, 1992, MAGNET RESON MED, V26, P79, DOI 10.1002/mrm.1910260109; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Jost SC, 2007, NEUROSURGERY, V60, P70, DOI [10.1227/01.NEU.0000249264.80579.37, DOI 10.1227/01.NEU.0000249264.80579.37]; Koutcher JA, 2002, NEOPLASIA, V4, P480, DOI 10.1038/sj.neo.7900269; Lost SC, 2007, NEUROSURGERY, V60, P360, DOI 10.1227/01.NEU.0000249264.80579.37; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Meara SJP, 2005, MAGNET RESON MED, V54, P241, DOI 10.1002/mrm.20541; Mitchell M R, 1986, Radiographics, V6, P245; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; OLSSON MBE, 1995, MAGNET RESON MED, V34, P612, DOI 10.1002/mrm.1910340418; Saranathan M, 2014, INVEST RADIOL, V49, P290, DOI 10.1097/RLI.0000000000000041; Stocker T, 2010, MAGN RESON MED, V64, P186, DOI 10.1002/mrm.22406; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096899; Williams LA, 2007, MAGN RESON IMAGING, V25, P1162, DOI 10.1016/j.mri.2007.01.119; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010; Young RJ, 2006, J MAGN RESON IMAGING, V24, P709, DOI 10.1002/jmri.20704; Zwanenburg JJM, 2010, EUR RADIOL, V20, P915, DOI 10.1007/s00330-009-1620-2	33	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200611	10.1371/journal.pone.0200611	http://dx.doi.org/10.1371/journal.pone.0200611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036367	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200012
J	Hearn, AJ; Cushman, SA; Ross, J; Goossens, B; Hunter, LTB; Macdonald, DW				Hearn, Andrew J.; Cushman, Samuel A.; Ross, Joanna; Goossens, Benoit; Hunter, Luke T. B.; Macdonald, David W.			Spatio-temporal ecology of sympatric felids on Borneo. Evidence for resource partitioning?	PLOS ONE			English	Article							CAT PRIONAILURUS-BENGALENSIS; ACTIVITY PATTERNS; HABITAT SELECTION; CAMERA TRAP; FOREST; LANDSCAPE; PREDATION; OVERLAP; SABAH	Niche differentiation, the partitioning of resources along one or more axes of a species' niche hyper-volume, is widely recognised as an important mechanism for sympatric species to reduce interspecific competition and predation risk, and thus facilitate co-existence. Resource partitioning may be facilitated by behavioural differentiation along three main niche dimensions: habitat, food and time. In this study, we investigate the extent to which these mechanisms can explain the coexistence of an assemblage of five sympatric felids in Borneo. Using multi-scale logistic regression, we show that Bornean felids exhibit differences in both their broad and fine-scale habitat use. We calculate temporal activity patterns and overlap between these species, and present evidence for temporal separation within this felid guild. Lastly, we conducted an all-subsets logistic regression to predict the occurrence of each felid species as a function of the co-occurrence of a large number of other species and showed that Bornean felids co-occurred with a range of other species, some of which could be candidate prey. Our study reveals apparent resource partitioning within the Bornean felid assemblage, operating along all three niche dimension axes. These results provide new insights into the ecology of these species and the broader community in which they live and also provide important information for conservation planning for this guild of predators.	[Hearn, Andrew J.; Ross, Joanna; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, Oxford, England; [Cushman, Samuel A.] US Forest Serv, Rocky Mt Res Stn, Flagstaff, AZ USA; [Goossens, Benoit] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg,Museum Ave, Cardiff, S Glam, Wales; [Goossens, Benoit] Cardiff Univ, Sustainable Pl Res Inst, Cardiff, S Glam, Wales; [Hunter, Luke T. B.] Panthera, New York, NY USA	University of Oxford; United States Department of Agriculture (USDA); United States Forest Service; Cardiff University; Cardiff University	Hearn, AJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, Oxford, England.	Andrew.hearn@zoo.ox.ac.uk	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544	Darwin Initiative; Recanati-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Dr. Holly Reed Conservation Fund award; Point Defiance Zoo and Aquarium; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera; Wild About Cats	Darwin Initiative; Recanati-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Dr. Holly Reed Conservation Fund award; Point Defiance Zoo and Aquarium; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera; Wild About Cats	This research was primarily funded by the Darwin Initiative (www.gov.uk/government/groups/the-darwin-initiative); Recanati-Kaplan Foundation [DWM]; Robertson Foundation (http://www.robertsonfoundation.org/) [DWM]; Sime Darby Foundation (www.yayasansimedarby.com/). The authors received additional funding from Clouded Leopard project (http://www.cloudedleopard.org/) [AJH and JR]; Dr. Holly Reed Conservation Fund award, Point Defiance Zoo and Aquarium (www.pdza.org)[AJH]; Felidae Conservation Fund (www.felidaefund.org) [AJH and JR]; Houston Zoo (www.houstonzoo.org) [AJH]; HG Wills International Trust for Nature Conservation [AJH, JR], Panthera (www.panthera.org) [AJH]; Wild About Cats [AJH and JR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Bezuijen MR, 2000, ORYX, V34, P222, DOI 10.1017/S0030605300031227; Borries C, 2014, RAFFLES B ZOOL, V62, P561; Burnham K P, 2003, MODEL SELECT MULTIMO; Carbone C, 1999, NATURE, V402, P442, DOI 10.1038/46607; Cheyne SM, 2011, ORYX, V45, P119, DOI 10.1017/S003060531000133X; Chua MAH, 2016, MAMMAL RES, V61, P99, DOI 10.1007/s13364-015-0259-4; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Davis DD, 1962, B SINGAPORE NATL MUS, V31, P3; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Fernando N, 2013, THAI J VET MED, V43, P445; Gordon Chris H., 2007, Cat News, V47, P12; Grand J, 2004, CONSERV BIOL, V18, P1063, DOI 10.1111/j.1523-1739.2004.00555.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Hearn AJ, 2019, ORYX, V53, P643, DOI 10.1017/S0030605317001065; Hearn AJ, 2018, BIOL CONSERV, V222, P232, DOI 10.1016/j.biocon.2018.04.016; Hearn AJ, 2016, RAFFLES B ZOOL, P165; Hearn AJ, 2016, RAFFLES B ZOOL, P149; Hearn AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151046; Hearn AJ, 2013, RAFFLES B ZOOL, V61, P871; Jackson P., 1996, BIOL CONSERVATION; Jaksic F.M., 2007, ECOLOGIA COMUNIDADES, V2; Jarvis A, 2008, HOLE FILLED SEAMLESS; Karanth KU, 2000, J ZOOL, V250, P255; Kelly MJ, 2008, ANIM CONSERV, V11, P182, DOI 10.1111/j.1469-1795.2008.00179.x; Kitchener AC, 2004, MAMM BIOL, V69, P349, DOI 10.1078/1616-5047-00154; Krishnamurthy R, 2016, LANDSCAPE ECOL, V31, P1355, DOI 10.1007/s10980-016-0363-0; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; Macdonald David W., 2010, P125; Sanchez MCM, 2014, INT J GEOGR INF SCI, V28, P1531, DOI 10.1080/13658816.2013.776684; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Meredith M., 2016, OVERLAP ESTIMATES CO; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; MILLS MGL, 1992, J ANIM ECOL, V61, P693, DOI 10.2307/5624; Mohamed A, 2009, CAT NEWS, V51, P12; Mohamed A, 2016, RAFFLES B ZOOL, P180; Mohamed A, 2013, J MAMMAL, V94, P82, DOI 10.1644/11-MAMM-A-394.1; Najera F, 2017, J VET MED SCI, V79, P1892, DOI 10.1292/jvms.17-0259; Palomares F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155626; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Rajaratnam R., 2000, THESIS; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ross J, 2013, J ZOOL, V290, P96, DOI 10.1111/jzo.12018; Rustam, 2016, RAFFLES B ZOOL, P157; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Selous E. M., 1935, Sarawak Museum Journal, V4, P263; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Sunquist ME, 2002, WILD CATS WORLD; Sunquist Mel, 1994, Oryx, V28, P67; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Wasserman T., 2012, USDA FOREST SERVICE; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Wilting A, 2016, RAFFLES B ZOOL, P173; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Zeller KA, 2016, LANDSCAPE ECOL, V31, P1319, DOI 10.1007/s10980-015-0301-6	60	38	41	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200828	10.1371/journal.pone.0200828	http://dx.doi.org/10.1371/journal.pone.0200828			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028844	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000439396900016
J	Roettl, J; Terlutter, R				Roettl, Johanna; Terlutter, Ralf			The same video game in 2D, 3D or virtual reality - How does technology impact game evaluation and brand placements?	PLOS ONE			English	Article							LIMITED-CAPACITY MODEL; COGNITIVE LOAD; PRODUCT PLACEMENTS; MEDIATING ROLE; EFFECT SIZE; ATTITUDES; RESPONSES; 3-D; MEMORY; PROMINENCE	Video game technology is changing from 2D to 3D and virtual reality (VR) graphics. In this research, we analyze how an identical video game that is either played in a 2D, stereoscopic 3D or Head-Mounted-Display (HMD) VR version is experienced by the players, and how brands that are placed in the video game are affected. The game related variables, which are analyzed, are presence, attitude towards the video game and arousal while playing the video game. Brand placement related variables are attitude towards the placed brands and memory (recall and recognition) for the placed brands. 237 players took part in the main study and played a jump'n'run game consisting of three levels. Results indicate that presence was higher in the HMD VR than in the stereoscopic 3D than in the 2D video game, but neither arousal nor attitude towards the video game differed. Memory for the placed brands was lower in the HMD VR than in the stereoscopic 3D than in the 2D video game, whereas attitudes towards the brands were not affected. A post hoc study (n = 53) shows that cognitive load was highest in the VR game, and lowest in the 3D game. Subjects reported higher levels of dizziness and motion-sickness in the VR game than in the 3D and in the 2D game. Limitations are addressed and implications for researchers, marketers and video game developers are outlined.	[Roettl, Johanna; Terlutter, Ralf] Alpen Adria Univ Klagenfurt, Dept Mkt & Int Management, Klagenfurt, Austria	University of Klagenfurt	Roettl, J (corresponding author), Alpen Adria Univ Klagenfurt, Dept Mkt & Int Management, Klagenfurt, Austria.	johanna.roettl@aau.at	Molina, Allison/ABH-2269-2021		"Verein zur Forderung der Wirtschaftswissenschaften an der Alpen-Adria-Universitat Klagenfurt" (Association for the Promotion of Economics at the Alpen-Adria University Klagenfurt)	"Verein zur Forderung der Wirtschaftswissenschaften an der Alpen-Adria-Universitat Klagenfurt" (Association for the Promotion of Economics at the Alpen-Adria University Klagenfurt)	This research was supported by grants from the "Verein zur Forderung der Wirtschaftswissenschaften an der Alpen-Adria-Universitat Klagenfurt" (Association for the Promotion of Economics at the Alpen-Adria University Klagenfurt). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaker D.A., 2012, BUILDING STRONG BRAN; [Anonymous], 2008, HDB RES EFFECTIVE EL; [Anonymous], 2017, WHATS DEFINITION ACT; [Anonymous], CNBC; Balasubramanian SK, 2006, J ADVERTISING, V35, P115, DOI 10.2753/JOA0091-3367350308; BIOCCA F, 1992, J COMMUN, V42, P5, DOI 10.1111/j.1460-2466.1992.tb00810.x; BIU, 2015, DTSCH GES DIG SPIEL; Bolls PD, 2001, COMMUN RES, V28, P627, DOI 10.1177/009365001028005003; Bradshaw T., 2016, VIRTUAL REALITY 4 WA; Brunken R, 2003, EDUC PSYCHOL-US, V38, P53, DOI 10.1207/S15326985EP3801_7; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Casual Games Association, 2015, SE AS GAM MARK; CHANDLER P, 1991, COGNITION INSTRUCT, V8, P293, DOI 10.1207/s1532690xci0804_2; Choi YK, 2014, J BUS RES, V67, P2164, DOI 10.1016/j.jbusres.2014.04.026; Choi YK, 2013, J ADVERTISING, V42, P219, DOI 10.1080/00913367.2013.775798; Coelho C., 2006, EMERGING COMMUNICATI, P25, DOI DOI 10.1089/CPB.2008.0023; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Collins K., 2015, PLAY STATION VR; Cowley E, 2008, J ADVERTISING, V37, P89, DOI 10.2753/JOA0091-3367370107; D'Astous A., 2000, J CURRENT ISSUES RES, V22, P31, DOI [10.1080/10641734.2000.10505106, DOI 10.1080/10641734.2000.10505106]; Dardis F. E., 2012, J INTERACTIVE ADVERT, V12, P1, DOI DOI 10.1080/15252019.2012.10722192; Debbabi S, 2010, J MARKET MANAG, V26, P967, DOI 10.1080/02672570903498819; Dens N, 2012, J ADVERTISING, V41, P35, DOI 10.2753/JOA0091-3367410303; Digi-Capital, 2015, AUGM VIRT REAL HIT 1; Eichenbaum H, 1996, MIND-BRAIN CONTINUUM, P173; Entertainment Software Association, 2016, ESS FACTS COMP VID G; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gibson B, 2008, J CONSUM RES, V35, P178, DOI 10.1086/527341; Glass Z., 2007, J INTERACTIVE ADVERT, V8, P23; Gorini A, 2010, CYBERPSYCHOLOGY BEHA, V14, P99; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Grigorovici D.M., 2004, J INTERACTIVE ADVERT, V5, P22, DOI [10.1080/15252019.2004.10722091, DOI 10.1080/15252019.2004.10722091]; Gross ML, 2010, COMPUT HUM BEHAV, V26, P1259, DOI 10.1016/j.chb.2010.03.034; Gupta P.B., 1998, J CURRENT ISSUES RES, V20, P47, DOI DOI 10.1080/10641734.1998.10505076; Harwell D., 2016, WASHINGTON POST; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Held R.M., 1992, PRESENCE TELEOPERATO, V1, P109, DOI [10.1121/1.404500, 10.1162/pres.1992.1.1.109, DOI 10.1162/PRES.1992.1.1.109]; Hernandez M.D., 2011, J PROMOTION MANAGEME, V17, P315, DOI DOI 10.1080/10496491.2011.596761; Herrewijn L, 2015, COMPUT HUM BEHAV, V53, P544, DOI 10.1016/j.chb.2014.06.012; Hollywood Branded Inc, 2016, VIRT RAL THE FUT PRO; Huynh-Thu Q, 2010, IEEE IMAGE PROC, P4025, DOI 10.1109/ICIP.2010.5650571; Ijsselsteijn W, 2001, PRESENCE-TELEOP VIRT, V10, P298, DOI 10.1162/105474601300343621; Johnson D, 2016, COMPUT HUM BEHAV, V63, P805, DOI 10.1016/j.chb.2016.06.028; Jones T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167523; Kim T., 2006, J COMPUT-MEDIAT COMM, V3; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lang A, 2000, J COMMUN, V50, P46, DOI 10.1111/j.1460-2466.2000.tb02833.x; Law S, 2000, PSYCHOL MARKET, V17, P1059, DOI 10.1002/1520-6793(200012)17:12<1059::AID-MAR3>3.0.CO;2-V; Lee KY, 2012, INT J ADVERT, V31, P377, DOI 10.2501/IJA-31-2-377-396; Lee M, 2007, J ADVERTISING, V36, P75, DOI 10.2753/JOA0091-3367360406; Li HR, 2002, J ADVERTISING, V31, P43, DOI 10.1080/00913367.2002.10673675; Limperos A, 2015, PRESENCE-TELEOP VIRT, V23, P341, DOI 10.1162/PRES_a_00204; Lombard M., 1997, J COMPUT-MEDIAT COMM, V3, P1, DOI DOI 10.1111/J.1083-6101.1997.TB00072.X; McMahan R. P., 2006, P ACM S VIRT REAL SO, P108, DOI [DOI 10.1145/1180495.1180518, 10.1145/1180495.1180518]; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Merhi O, 2007, HUM FACTORS, V49, P920, DOI 10.1518/001872007X230262; Mun S, 2012, NEUROSCI LETT, V525, P89, DOI 10.1016/j.neulet.2012.07.049; Murphy K.R., 2014, STAT POWER ANAL SIMP, V4th ed., DOI 10.4324/9781315773155; Nelson MR, 2006, J ADVERTISING, V35, P87, DOI 10.2753/JOA0091-3367350406; Nelson MR, 2002, J ADVERTISING RES, V42, P80, DOI 10.2501/JAR-42-2-80-92; Nicas J, 2016, WALL STR J; Osborne J., 2016, JUST DEEMED VR FUTUR; PAAS FGWC, 1993, HUM FACTORS, V35, P737, DOI 10.1177/001872089303500412; Persky S, 2008, PRESENCE-TELEOP VIRT, V17, P57, DOI 10.1162/pres.17.1.57; Persky S, 2009, HEALTH COMMUN, V24, P677, DOI 10.1080/10410230903263982; Phillips L, 2012, PRESENCE-VIRTUAL AUG, V21, P119, DOI 10.1162/PRES_a_00100; Planet Virtual Boy, 1994, NINT INTR VID GAM PL; Porter, 2010, J INTERACTIVE ADVERT, V10, P46, DOI [10.1080/15252019.2010.10722169, DOI 10.1080/15252019.2010.10722169]; Porter CE, 2006, J BUS RES, V59, P999, DOI 10.1016/j.jbusres.2006.06.003; Rajae-Joordens RJE, 2008, PHILIPS RES BOOK SER, V8, P77, DOI 10.1007/978-1-4020-6593-4_7; Rheinberg F., 2003, DIAGNOSTIK MOTIVATIO, P261, DOI DOI 10.1007/S11031-008-9102-4; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Riva G., 2015, IMMERSED IN MEDIA, P283, DOI DOI 10.1007/978-3-319-10190-3_12; Riva G., 2014, OXFORD HDB VIRTUALIT, P205, DOI [10.1093/oxfordhb/9780199826162.013.015, DOI 10.1093/OXFORDHB/9780199826162.013.015]; Riva G, 2012, INTERACT COMPUT, V24, P203, DOI 10.1016/j.intcom.2012.04.007; Riva G, 2011, NEW IDEAS PSYCHOL, V29, P24, DOI 10.1016/j.newideapsych.2009.11.002; Riva G, 2008, EMERG COMMUN-STUD NE, V10, P97; Rooney B, 2013, MEDIA PSYCHOL, V16, P441, DOI 10.1080/15213269.2013.838905; Rosnow RL, 2009, Z PSYCHOL, V217, P6, DOI 10.1027/0044-3409.217.1.6; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schild J., 2012, P SIGCHI C HUM FACT, P89, DOI [10.1145/2207676.2207690, DOI 10.1145/2207676.2207690]; Sebrechts MM, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P3, DOI 10.1145/312624.312634; Shamdasani PN, 2001, J ADVERTISING RES, V41, P7, DOI 10.2501/JAR-41-4-7-21; Simon J-P, 2015, VIDEO GAMES IND CHIN; SLATER M, 1993, IEEE VIRTUAL REALITY ANNUAL INTERNATIONAL SYMPOSIUM, P90, DOI 10.1109/VRAIS.1993.380793; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Solimini AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056160; Solomon MR., 2019, CONSUMER BEHAV EUROP, V7; Spangenberg, 1998, J CONSUM PSYCHOL, V7, P159, DOI [DOI 10.1207/S15327663JCP0702_03, 10.1207/s15327663jcp0702_03]; Statista, 2016, GENR BREAKD VID GAM; Statista, 2018, VIRT REAL VR VID GAM; Statista, 2018, GLOB VR GAM MARK SIZ; Statista, 2017, VID GAM IND SAL SPAI; Statista, 2018, VAL GLOB VID GAM MAR; Statista, 2020, GLOB MARK VAL NAT OR; Stephen AT, 2005, AM MARKETING ASS C P, P28; Stuart K., 2017, 10 MOST INFLUENTIAL; Szoldra P., 2016, IVE NEVER FELT EMOTI; Takatalo J, 2011, MEDIA PSYCHOL, V14, P387, DOI 10.1080/15213269.2011.620538; Terlutter R, 2016, MEDIA PSYCHOL, V19, P505, DOI 10.1080/15213269.2016.1142377; Terlutter R, 2013, J ADVERTISING, V42, P95, DOI 10.1080/00913367.2013.774610; The Entertainment Software Association. E, 2015, ESS FACTS COMP VID G; Tina W., 2006, J INTERACT ADVERT, P3, DOI DOI 10.1080/15252019.2006.10722123; Triberti S, 2016, COMPUT HUM BEHAV, V64, P163, DOI 10.1016/j.chb.2016.06.044; Triberti S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02052; van der Land S, 2013, COMPUT HUM BEHAV, V29, P1054, DOI 10.1016/j.chb.2012.09.006; Van Kerrebroeck H, 2017, VIRTUAL REAL-LONDON, V21, P177, DOI 10.1007/s10055-017-0306-3; van Reijmersdal EA, 2012, J INTERACT MARK, V26, P33, DOI 10.1016/j.intmar.2011.04.005; Vive, 2018, VIV DISC VIRT REAL I; VRS, 2017, HEAD MOUNT DISP HMDS; Waiguny MKJ, 2013, J ADVERTISING, V42, P155, DOI 10.1080/00913367.2013.774590; Walsh P., 2008, Sport Marketing Quarterly, V17, P201; Warman P., 2015, ROLLING SE ASIAN GAM; Waterworth J, 2014, PALGRAVE PIVOT, P1, DOI 10.1057/9781137431677; Wei W., 2016, HERSHEY, P48; Williams KD, 2014, COMPUT HUM BEHAV, V38, P142, DOI 10.1016/j.chb.2014.05.040; Wise K., 2008, J INTERACTIVE ADVERT, V9, P27, DOI [DOI 10.1080/15252019.2008.10722145, 10.1080/15252019.2008.10722145]; Yatani K, 2016, HUM-COMPUT INT-SPRIN, P87, DOI 10.1007/978-3-319-26633-6_5; Yim MYC, 2018, INT J ADVERT, V37, P958, DOI 10.1080/02650487.2017.1347366; Yim MYC, 2012, J ADVERTISING, V41, P113, DOI 10.2753/JOA0091-3367410208; Zahorik P, 1998, PRESENCE-VIRTUAL AUG, V7, P78, DOI 10.1162/105474698565541	122	56	58	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200724	10.1371/journal.pone.0200724	http://dx.doi.org/10.1371/journal.pone.0200724			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028839	gold, Green Submitted, Green Published			2022-12-27	WOS:000439396900014
J	Barua, M; Van Driel, F; Jansen, W				Barua, Mrittika; Van Driel, Francien; Jansen, Willy			Tuberculosis and the sexual and reproductive lives of women in Bangladesh	PLOS ONE			English	Article							RURAL MAHARASHTRA; GENDER; MARRIAGE; STIGMA; TB; PREVALENCE; VIOLENCE; INDIA	When they do not meet norms related to sexuality and reproduction, Bangladeshi women often face abandonment and are thus deprived of an active sexual life, a marital relationship, and motherhood. Little is known about how a stigmatised disease such as tuberculosis (TB) may constrain the reproductive health and sexual lives of women. This article, derived from a larger study on the impact of TB on women's sexual and reproductive health and rights in Narsingdi district and Dhaka, Bangladesh, aims to fill this gap. Based on interviews with nine married women who have or had TB, four husbands, and two mothers-in-law, this article highlights that the ways in which TB impedes on the sexual and reproductive lives of women depends on the stigma within their family and community, their relationships with their husbands, motherhood, their living arrangements, their economic contribution to the family and/or their disclosure of their TB diagnosis. Women with children and supportive husbands retain a stronger position among their in-laws and are less likely to be isolated or rejected. The patients' narratives revealed that the instructions of health workers influenced their decisions about intercourse or abstinence. Future studies should examine the instructions patients receive from health workers regarding their living and sleeping arrangements, sexual intercourse, and pregnancy, as well as policy documents on TB treatment and prevention.	[Barua, Mrittika] Radboud Univ Nijmegen, Radboud Gender & Divers Studies, Nijmegen, Netherlands; [Barua, Mrittika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Van Driel, Francien] Radboud Univ Nijmegen, Anthropol & Dev Studies, Nijmegen, Netherlands; [Jansen, Willy] Radboud Univ Nijmegen, Gender Studies, Nijmegen, Netherlands	Radboud University Nijmegen; Bangladesh Rural Advancement Committee BRAC; BRAC University; Radboud University Nijmegen; Radboud University Nijmegen	Barua, M (corresponding author), Radboud Univ Nijmegen, Radboud Gender & Divers Studies, Nijmegen, Netherlands.; Barua, M (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	mrittikabarua11@gmail.com	Barua, Mrittika/ABU-1532-2022	Barua, Mrittika/0000-0002-6309-234X	NUFFIC (Netherlands Universities Foundation for International Cooperation)	NUFFIC (Netherlands Universities Foundation for International Cooperation)	The research is supported financially by NUFFIC (Netherlands Universities Foundation for International Cooperation) through a PhD scholarship (MB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan G, 2004, GENDER DIFFERENCE TR; Amin S, 1998, POP STUD-J DEMOG, V52, P201, DOI 10.1080/0032472031000150376; Anwary A, 2015, WOMEN STUD INT FORUM, V50, P37, DOI 10.1016/j.wsif.2015.02.011; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Banks N, 2013, ENVIRON URBAN, V25, P95, DOI 10.1177/0956247813477357; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Bhattarai BR, 2016, J NEPAL BUS STUD, V9, P102; Choi NG, 2011, AGING MENT HEALTH, V15, P307, DOI 10.1080/13607863.2010.513042; Chowdhury M.R., 2015, SAARC J TUBERCULOSIS, V11, P21; Chowdhury MRK, 2015, JPN J INFECT DIS, V68, P461, DOI 10.7883/yoken.JJID.2014.522; Das AC, 2017, S E ASIA J PUBLIC HL, V6, P61, DOI [10.3329/seajph.v6i2.31837, DOI 10.3329/SEAJPH.V6I2.31837]; Davids T, 2009, THIRD WORLD Q, V30, P905, DOI 10.1080/01436590902959107; Dodor EA, 2008, INT J TUBERC LUNG D, V12, P1048; Dodor EA, 2009, PSYCHOL HEALTH MED, V14, P170, DOI 10.1080/13548500802199753; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Fahmida R, 2013, WOMEN STUD INT FORUM, V38, P117, DOI 10.1016/j.wsif.2013.03.002; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Garcia Jonathan, 2006, Horiz. antropol., V12, P13, DOI 10.1590/S0104-71832006000200002; Ghosh K, 2011, J POSTGRAD MED, V57, P307, DOI 10.4103/0022-3859.90082; Hardee K, 1999, INT FAM PLAN PERSPEC, V25, pS2, DOI 10.2307/2991865; Hashemi SM, 1996, WORLD DEV, V24, P635, DOI 10.1016/0305-750X(95)00159-A; Hoosen S, 2004, S AFR J PSYCHOL, V34, P487, DOI 10.1177/008124630403400309; Hossain MG, 2016, J BIOSOC SCI, V48, P530, DOI 10.1017/S0021932015000279; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; International Center for Research on Women United Nations Population Fund Ausralian Agency for International Development Asian Forum of Parliamentarian on Population and Development, 2012, CHILD MARRIAGES IN S; Jaggarajamma K, 2008, Indian J Tuberc, V55, P179; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Kabeer N, 1997, DEV CHANGE, V28, P261, DOI 10.1111/1467-7660.00043; KABEER N, 1988, NEW LEFT REV, P95; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Karim F, 2008, INT J TUBERC LUNG D, V12, P1336; Karim F, 2011, PUBLIC HEALTH, V125, P84, DOI 10.1016/j.puhe.2010.10.005; Karim Fazlul, 2007, Anthropol Med, V14, P139, DOI 10.1080/13648470701381440; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Khan M. E., 2000, J FAM WELFARE, V46, P12; Khanum Hamida, 2012, Bangladesh Journal of Zoology, V40, P213; Kiecolt-Glaser JK, 2017, ANNU REV CLIN PSYCHO, V13, P421, DOI 10.1146/annurev-clinpsy-032816-045111; Kumar G, 2014, SAARC J TUBERC LUNG, V10, P15; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Mainuddin Akm, 2015, J Family Reprod Health, V9, P65; Mason PH, 2016, J BIOSOC SCI, V48, P206, DOI 10.1017/S0021932015000115; Meuwly N, 2012, J FAM PSYCHOL, V26, P937, DOI 10.1037/a0030356; Moen T., 2006, INT J QUAL METHODS, V5, P56, DOI [DOI 10.1177/160940690600500405, 10.1177/160940690600500405]; Nahar P, 2000, REPROD HLTH MATTERS, V8; Nahar Papreen, 2011, Anthropol Med, V18, P327, DOI 10.1080/13648470.2011.615911; Padmanabhan N S, 2016, INT J COMMUNITY MED, P2817, DOI [10.18203/2394-6040.ijcmph20163367, DOI 10.18203/2394-6040.IJCMPH20163367]; Rahman M, 2014, ASIA-PAC J PUBLIC HE, V26, P160, DOI 10.1177/1010539511423301; Rashid SF, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S3; Shields SA, 2008, SEX ROLES, V59, P301, DOI 10.1007/s11199-008-9501-8; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; *UN, 1995, INT C POP DEV CAIR 5; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P837; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization (WHO), 2002, DEF SEX HLTH REP TEC; Zaman K, 2012, EPIDEMIOL INFECT, V140, P1018, DOI 10.1017/S0950268811001609	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201134	10.1371/journal.pone.0201134	http://dx.doi.org/10.1371/journal.pone.0201134			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN5RC	30024977	Green Published, Green Submitted, gold			2022-12-27	WOS:000439120000092
J	Park, N; Kang, E; Park, M; Lee, H; Kang, HG; Yoon, HJ; Kang, U				Park, Namyong; Kang, Eunjeong; Park, Minsu; Lee, Hajeong; Kang, Hee-Gyung; Yoon, Hyung-Jin; Kang, U.			Predicting acute kidney injury in cancer patients using heterogeneous and irregular data	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; BIOMARKERS; THERAPY; MODELS	How can we predict the occurrence of acute kidney injury (AKI) in cancer patients based on machine learning with serum creatinine data? Given irregular and heterogeneous clinical data, how can we make the most of it for accurate AKI prediction? AKI is a common and significant complication in cancer patients, and correlates with substantial morbidity and mortality. Since no effective treatment for AKI still exists, it is important to take timely preventive measures. While several approaches have been proposed for predicting AKI, their scope and applicability are limited as they either assume regular data measured over a short hospital stay, or do not fully utilize heterogeneous data. In this paper, we provide an AKI prediction model with a greater applicability, which relaxes the constraints of existing approaches, and fully utilizes irregular and heterogeneous data for learning the model. In a cohort of 21,022 cancer patients who were registered into Korea Central Cancer Registry (KCCR) in Seoul National University Hospital between January 1, 2004 and December 31, 2013, our method achieves 0.7892 precision, 0.7506 recall, and 0.7576 F-measure in predicting whether a patient will develop AKI during the next 14 days.	[Park, Namyong; Kang, U.] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Eunjeong] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Minsu; Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea; [Kang, Hee-Gyung] Seoul Natl Univ, Childrens Hosp, Pediat, Seoul, South Korea; [Park, Namyong] Carnegie Mellon Univ, Comp Sci Dept, Pittsburgh, PA 15213 USA; [Park, Minsu] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Carnegie Mellon University; Yonsei University; Yonsei University Health System	Kang, U (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	ukang@snu.ac.kr	Kang, Eunjeong/ABA-3646-2021	Kang, Eunjeong/0000-0002-2191-2784; Park, Namyong/0000-0002-3344-2361	Interdisciplinary Research Initiatives Program from College of Engineering, Seoul National University [80020160087]; College of Medicine, Seoul National University [80020160087]	Interdisciplinary Research Initiatives Program from College of Engineering, Seoul National University; College of Medicine, Seoul National University	This work was supported by the Interdisciplinary Research Initiatives Program from College of Engineering and College of Medicine, Seoul National University (grant no. 80020160087). The Institute of Engineering Research at Seoul National University provided research facilities for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Benoit DD, 2005, NEPHROL DIAL TRANSPL, V20, P552, DOI 10.1093/ndt/gfh637; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chang CH, 2016, INT J MED SCI, V13, P19, DOI 10.7150/ijms.13253; Christiansen CF, 2011, EUR J INTERN MED, V22, P399, DOI 10.1016/j.ejim.2011.05.005; Cruz HFD, 2016, P 7 INT S SEM MIN BI, P29; Darmon M, 2006, CRIT CARE, V10, DOI 10.1186/cc4907; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kate RJ, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0277-4; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Lam AQ, 2012, CLIN J AM SOC NEPHRO, V7, P1692, DOI 10.2215/CJN.03140312; Lameire NH, 2005, ANN MED, V37, P13, DOI 10.1080/07853890510007205; Lameire NH, 2011, KIDNEY INT, V79, P1047, DOI 10.1038/ki.2011.21; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165280; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rosner MH, 2017, NEW ENGL J MED, V376, P1770, DOI 10.1056/NEJMra1613984; Rudy J., 2017, PY EARTH; Sanchez-Pinto LN, 2016, PEDIATR CRIT CARE ME, V17, P508, DOI 10.1097/PCC.0000000000000750; Sanchez-Pinto LN, 2015, AMIA 2015 AM MED INF; Schneider DF, 2012, J BURN CARE RES, V33, P242, DOI 10.1097/BCR.0b013e318239cc24; Selby NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048580; Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869; Tirunagari S., 2016, COMP INT SSCI 2016 I, P1	31	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0199839	10.1371/journal.pone.0199839	http://dx.doi.org/10.1371/journal.pone.0199839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024918	gold, Green Published, Green Submitted			2022-12-27	WOS:000439120000011
J	Rowarth, NM; MacRae, TH				Rowarth, Nathan M.; MacRae, Thomas H.			Post-diapause synthesis of ArHsp40-2, a type 2 J-domain protein from Artemia franciscana, is developmentally regulated and induced by stress	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DROSOPHILA-MELANOGASTER; SARCOPHAGA-CRASSIPALPIS; DETYROSINATED TUBULIN; MOLECULAR CHAPERONES; ENCYSTED EMBRYOS; BRINE SHRIMP; CHILL COMA; FLESH FLY; IN-VIVO	Post-diapause cysts of Artemia franciscana undergo a well-defined developmental process whereby internal differentiation leads to rupture of the cyst shell, release of membrane-enclosed nauplii and hatching to yield swimming larvae. The post-diapause development of A. franciscana has been examined at biochemical and molecular levels, yet little is known about molecular chaperone function during this process. In addressing this we recently described ArHsp40, a type 1 J-domain protein in post-diapause A. franciscana cysts and larvae. The current report describes ArHsp40-2, a second J-domain protein from A. franciscana. ArHsp40-2 is a type 2 J-domain protein, lacking a zinc binding domain but containing other domains characteristic of these proteins. Notably, ArHsp40-2 possesses a double barrel beta-domain structure in its substrate binding region, as does ArHsp40. qPCR revealed a relatively low amount of ArHsp40-2 mRNA in 0 h cysts which increased significantly until the E1 stage, most likely as a result of enhanced transcription, after which it declined. An antibody specific to ArHsp40-2 was produced and used to show that like its mRNA, ArHsp40-2 accumulated until the E1 stage and then decreased to amounts lower than those in 0 h cysts. The synthesis of ArHsp40-2 was induced by heat shock indicating that ArHsp40-2 is involved in stress resistance in cysts and nauplii. Accumulation in cysts during early post-diapause development followed by its sharp decline suggests a role in protein disaggregation/refolding, a function of Hsp40s from other organisms, where ArHsp40-2 assists in the rescue of proteins sequestered during diapause by p26, an abundant small heat shock protein (sHsp) in A. franciscana cysts.	[Rowarth, Nathan M.; MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	MacRae, TH (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tmacrae@dal.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-04882]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Natural Sciences and Engineering Research Council of Canada; RGPIN-2016-04882; to THM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen T, 2003, INVERTEBR REPROD DEV, V44, P33, DOI 10.1080/07924259.2003.9652551; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; Clegg JS, 2011, J INSECT PHYSIOL, V57, P660, DOI 10.1016/j.jinsphys.2010.11.023; Clegg JS, 1996, PHYSIOL ZOOL, V69, P49, DOI 10.1086/physzool.69.1.30164200; Clegg JS, 1997, J EXP BIOL, V200, P467; Clegg JS, 2000, J EXP MAR BIOL ECOL, V252, P85, DOI 10.1016/S0022-0981(00)00239-2; Clegg JS, 2000, CELL TISSUE RES, V301, P433, DOI 10.1007/s004410000249; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Hand S., 2013, CRYOBIOLOGY CRYOTECH, V59, P41; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Hengherr S, 2011, COMP BIOCHEM PHYS A, V160, P137, DOI 10.1016/j.cbpa.2011.05.032; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Hwang JS, 2005, ARCH INSECT BIOCHEM, V59, P197, DOI 10.1002/arch.20057; Iryani MTM, 2017, J EXP MAR BIOL ECOL, V487, P106, DOI 10.1016/j.jembe.2016.12.004; Jackson SA, 1996, DEV GROWTH DIFFER, V38, P153; Jiang GJ, 2016, CELL STRESS CHAPERON, V21, P1077, DOI 10.1007/s12192-016-0732-2; King AM, 2013, FEBS J, V280, P4761, DOI 10.1111/febs.12442; King AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043723; Kirstein J, 2017, AGING CELL, V16, P1414, DOI 10.1111/acel.12686; LANGDON CM, 1991, DEV BIOL, V148, P147, DOI 10.1016/0012-1606(91)90325-W; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Ma WM, 2013, BIOCHEM J, V449, P285, DOI 10.1042/BJ20121259; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MacRae TH, 2016, CELL STRESS CHAPERON, V21, P9, DOI 10.1007/s12192-015-0635-7; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Marklund EG, 2018, CELL STRESS CHAPERON, V23, P723, DOI 10.1007/s12192-018-0884-3; Michaud MR, 2011, J INSECT PHYSIOL, V57, P203, DOI 10.1016/j.jinsphys.2010.11.007; Mogk A, 2018, MOL CELL, V69, P214, DOI 10.1016/j.molcel.2018.01.004; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Norouzitallab P, 2015, FISH SHELLFISH IMMUN, V42, P395, DOI 10.1016/j.fsi.2014.11.017; Pavlides SC, 2011, J INSECT PHYSIOL, V57, P635, DOI 10.1016/j.jinsphys.2011.03.022; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; Xiang H, 1995, BIOCHEM CELL BIOL, V73, P673, DOI 10.1139/o95-075; Zhang GJ, 2011, J INSECT PHYSIOL, V57, P1115, DOI 10.1016/j.jinsphys.2011.02.016; Zhou Q, 2008, MAR BIOTECHNOL, V10, P438, DOI 10.1007/s10126-007-9079-0	52	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201477	10.1371/journal.pone.0201477	http://dx.doi.org/10.1371/journal.pone.0201477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048537	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400092
J	Watt, ED; Judson, RS				Watt, Eric D.; Judson, Richard S.			Uncertainty quantification in ToxCast high throughput screening	PLOS ONE			English	Article							IN-VIVO HAZARD; ENVIRONMENTAL CHEMICALS; WILD BOOTSTRAP; PHASE-I; TOXICITY; EXPOSURE; BIOACTIVITY; DOSIMETRY; IMPACT; PRIORITIZATION	High throughput screening (HTS) projects like the U.S. Environmental Protection Agency's ToxCast program are required to address the large and rapidly increasing number of chemicals for which we have little to no toxicity measurements. Concentration-response parameters such as potency and efficacy are extracted from HTS data using nonlinear regression, and models and analyses built from these parameters are used to predict in vivo and in vitro toxicity of thousands of chemicals. How these predictions are impacted by uncertainties that stem from parameter estimation and propagated through the models and analyses has not been well explored. While data size and complexity makes uncertainty quantification computationally expensive for HTS datasets, continued advancements in computational resources have allowed these computational challenges to be met. This study uses non-parametric bootstrap resampling to calculate uncertainties in concentration-response parameters from a variety of HTS assays. Using the ToxCast estrogen receptor model for bioactivity as a case study, we highlight how these uncertainties can be propagated through models to quantify the uncertainty in model outputs. Uncertainty quantification in model outputs is used to identify potential false positives and false negatives and to determine the distribution of model values around semi-arbitrary activity cutoffs, increasing confidence in model predictions. At the individual chemical-assay level, curves with high variability are flagged for manual inspection or retesting, focusing subject-matter-expert time on results that need further input. This work improves the confidence of predictions made using HTS data, increasing the ability to use this data in risk assessment.	[Watt, Eric D.; Judson, Richard S.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Watt, Eric D.] Oak Ridge Inst Sci Educ, Oak Ridge, TN USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Judson, RS (corresponding author), US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.	Judson.richard@epa.gov		Judson, Richard/0000-0002-2348-9633; Watt, Eric/0000-0002-1211-0229	U.S. EPA	U.S. EPA(United States Environmental Protection Agency)	This work was funded by the U.S. EPA to EDW. This project was supported in part by an appointment to the Research Participation Program at the National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and EPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, SELECTED PAPERS HIRO, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Attene-Ramos MS, 2015, ENVIRON HEALTH PERSP, V123, P49, DOI 10.1289/ehp.1408642; Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015; Auerbach S, 2016, ENVIRON HEALTH PERSP, V124, P1141, DOI 10.1289/ehp.1510456; Barrier M, 2011, REPROD TOXICOL, V31, P383, DOI 10.1016/j.reprotox.2011.01.007; Beam Andrew, 2014, J Pharmacogenomics Pharmacoproteomics, V5, P1000121; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Chandler KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018540; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Davidson R, 2008, J ECONOMETRICS, V146, P162, DOI 10.1016/j.jeconom.2008.08.003; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dowle M, 2015, R SAPORTA SL CONTRIB; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1994, MONOGRAPHS STAT APPL; Filer D. L., 2016, BIOINFORMATICS, V33; Filer DL, 2016, TCPL TOXCAST DATA AN; Friedman KP, 2016, TOXICOL SCI, V151, P160, DOI 10.1093/toxsci/kfw034; Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525; Hsieh JH, 2015, J BIOMOL SCREEN, V20, P887, DOI 10.1177/1087057115581317; Huang RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05664; Huang RL, 2011, ENVIRON HEALTH PERSP, V119, P1142, DOI 10.1289/ehp.1002952; Janesick AS, 2016, ENVIRON HEALTH PERSP, V124, P1214, DOI 10.1289/ehp.1510352; Jiang H, 2012, BIOMETRIKA, V99, P973, DOI 10.1093/biomet/ass051; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kavlock RJ, 2009, RISK ANAL, V29, P485, DOI 10.1111/j.1539-6924.2008.01168.x; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kleinstreuer NC, 2013, TOXICOL SCI, V131, P40, DOI 10.1093/toxsci/kfs285; Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412; Knudsen TB, 2011, TOXICOLOGY, V282, P1, DOI 10.1016/j.tox.2010.12.010; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Lim CW, 2013, TECHNOMETRICS, V55, P150, DOI 10.1080/00401706.2012.749166; Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h; LIU RY, 1988, ANN STAT, V16, P1696, DOI 10.1214/aos/1176351062; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; MAMMEN E, 1993, ANN STAT, V21, P255, DOI 10.1214/aos/1176349025; Mansouri K, 2016, ENVIRON HEALTH PERSP, V124, P1023, DOI 10.1289/ehp.1510267; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; McDonough PM, 2011, ASSAY DRUG DEV TECHN, V9, P262, DOI 10.1089/adt.2010.0302; Meek ME, 2014, J APPL TOXICOL, V34, P1, DOI 10.1002/jat.2949; National Research Council (NRC), 2007, J TOXICOL ENV HEAL B, DOI [DOI 10.1080/10937404.2010.483176, 10.1080/10937404.2010.483176]; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Rager JE, 2016, ENVIRON INT, V88, P269, DOI 10.1016/j.envint.2015.12.008; Reif DM, 2013, BIOINFORMATICS, V29, P402, DOI 10.1093/bioinformatics/bts686; Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180; Richard AM, 2016, CHEM RES TOXICOL, V29, P1225, DOI 10.1021/acs.chemrestox.6b00135; Rotroff DM, 2013, CHEM RES TOXICOL, V26, P1097, DOI 10.1021/tx400117y; Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220; Shah I, 2016, ENVIRON HEALTH PERSP, V124, P910, DOI 10.1289/ehp.1409029; Shah I, 2016, REGUL TOXICOL PHARM, V79, P12, DOI 10.1016/j.yrtph.2016.05.008; Shah I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014584; Shockley KR, 2015, DRUG DISCOV TODAY, V20, P296, DOI 10.1016/j.drudis.2014.10.005; Shockley KR, 2012, ENVIRON HEALTH PERSP, V120, P1107, DOI 10.1289/ehp.1104688; Shukla SJ, 2010, DRUG DISCOV TODAY, V15, P997, DOI 10.1016/j.drudis.2010.07.007; Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI 10.1021/tx400021f; Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Stossi F, 2014, CHEM BIOL, V21, P743, DOI 10.1016/j.chembiol.2014.03.013; Tal TL, 2014, REPROD TOXICOL, V48, P51, DOI 10.1016/j.reprotox.2014.05.014; Team RC., 2013, R LANG ENV STAT COMP; Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178; Thomas RS, 2012, TOXICOL SCI, V128, P398, DOI 10.1093/toxsci/kfs159; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; U.S. EPA, 2014, EPAHQOPP20140614; US EPA O US EPA, 2015, TSCA CHEM SUBST INV; Wambaugh JF, 2013, ENVIRON SCI TECHNOL, V47, P8479, DOI 10.1021/es400482g; Watt ED, 2016, TOXBOOT BOOTSTRAP ME; Wetmore BA, 2014, TOXICOL SCI, V142, P210, DOI 10.1093/toxsci/kfu169; Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012; Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	73	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0196963	10.1371/journal.pone.0196963	http://dx.doi.org/10.1371/journal.pone.0196963			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044784	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500003
J	Bialkowska, K; Marciniak, W; Muszynska, M; Baszuk, P; Gupta, S; Jaworska-Bieniek, K; Sukiennicki, G; Durda, K; Gromowski, T; Prajzendanc, K; Cybulski, C; Huzarski, T; Gronwald, J; Debniak, T; Scott, RJ; Lubinski, J; Jakubowska, A				Bialkowska, Katarzyna; Marciniak, Wojciech; Muszynska, Magdalena; Baszuk, Piotr; Gupta, Satish; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Durda, Katarzyna; Gromowski, Tomasz; Prajzendanc, Karolina; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Debniak, Tadeusz; Scott, Rodney J.; Lubinski, Jan; Jakubowska, Anna			Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population	PLOS ONE			English	Article							METALLOPROTEINASE-1 PROMOTER POLYMORPHISM; COLORECTAL-CANCER; BREAST-CANCER; SINGLE-NUCLEOTIDE; INCREASED RISK; SUPPLEMENT USE; SERUM ZINC; SUSCEPTIBILITY; METALLOTHIONEIN; CARCINOMA	Introduction Prostate cancer is one of the most commonly diagnosed malignancies among men in Western populations. Evidence reported in the literature suggests that zinc may be related to prostate cancer. In this study we evaluated the association of serum zinc levels and polymorphisms in genes encoding zinc-dependent proteins with prostate cancer in Poland. Methods The study group consisted of 197 men affected with prostate cancer and 197 healthy men. Serum zinc levels were measured and 5 single nucleotide polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13, MT2A genes were genotyped. Results The mean serum zinc level was higher in prostate cancer patients than in healthy controls (898.9 +/- 12.01 mu g/I vs. 856.6 +/- 13.05 mu g/I, p<0.01). When compared in quartiles a significant association of higher zinc concentration with the incidence of prostate cancer was observed. The highest OR (OR = 4.41, 95%CI 2.07-9.37, p<0.01) was observed in 3rd quartile (>853.0-973.9 mu/I). Among five analyzed genetic variants, rs11568818 in MMP-7 appeared to be correlated with 2-fold increased prostate cancer risk (OR = 2.39, 95% CI = 1.19-4.82, p = 0.015). Conclusion Our results suggest a significant correlation of higher serum zinc levels with the diagnosis of prostate cancer. The polymorphism rs11568818 in MMP-7 gene was also associated with an increased prostate cancer risk in Poland.	[Bialkowska, Katarzyna; Baszuk, Piotr; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Durda, Katarzyna; Gromowski, Tomasz; Prajzendanc, Karolina; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Debniak, Tadeusz; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Marciniak, Wojciech; Muszynska, Magdalena; Lubinski, Jan] Read Gene SA, Grzepnica, Poland; [Gupta, Satish] Strand Life Sci, Bangalore, Karnataka, India; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW, Australia; [Scott, Rodney J.] NSW Hlth Pathol, Div Mol Med, Newcastle, NSW, Australia; [Jakubowska, Anna] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, Szczecin, Poland	Pomeranian Medical University; University of Newcastle; Pomeranian Medical University	Bialkowska, K (corresponding author), Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland.	katarzyna.kaczm@gmail.com	Huzarski, Tomasz/AAQ-2161-2021; Jakubowska, Anna/O-8050-2014; Scott, Rodney/B-2827-2013	Huzarski, Tomasz/0000-0003-3857-4854; Jakubowska, Anna/0000-0002-5650-0501; Marciniak, Wojciech/0000-0001-7270-0063; Bialkowska, Katarzyna/0000-0001-8489-6665; Lubinski, Jan/0000-0003-2931-3003; Scott, Rodney/0000-0001-7724-3404	National Science Centre [DEC-2012/07/N/NZ4/02433]; Read-Gene S.A.	National Science Centre(National Science Centre, Poland); Read-Gene S.A.	The project was financially supported by National Science Centre, grant no. DEC-2012/07/N/NZ4/02433. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Read-Gene S.A. provided support in the form of salaries for authors WM, MM, JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adabi Z, 2015, ARCH MED RES, V46, P546, DOI 10.1016/j.arcmed.2015.08.004; Asamoto M, 2001, CANCER RES, V61, P4693; Aydin A, 2006, CLIN BIOCHEM, V39, P176, DOI 10.1016/j.clinbiochem.2005.11.018; Biondi ML, 2000, CLIN CHEM, V46, P2023; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Christudoss P, 2011, INDIAN J UROL, V27, P14, DOI 10.4103/0970-1591.78405; Cybulski C, 2006, J MED GENET, V43, P863, DOI 10.1136/jmg.2006.044974; Cybulski C, 2004, CANCER RES, V64, P1215, DOI 10.1158/0008-5472.CAN-03-2502; Cybulski C, 2013, BRIT J CANCER, V108, P461, DOI 10.1038/bjc.2012.486; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Darago A, 2011, CLIN CHEM LAB MED, V49, P1699, DOI 10.1515/CCLM.2011.651; Delgado-Enciso I, 2008, GYNECOL OBSTET INVES, V65, P68, DOI 10.1159/000108282; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Epstein MM, 2011, AM J CLIN NUTR, V93, P586, DOI 10.3945/ajcn.110.004804; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Feng P, 2002, PROSTATE, V52, P311, DOI 10.1002/pros.10128; Forma E, 2012, CANCER GENET-NY, V205, P432, DOI 10.1016/j.cancergen.2012.05.005; Gallus S, 2007, EUR UROL, V52, P1052, DOI 10.1016/j.eururo.2007.01.094; Ghilardi G, 2003, CLIN CHEM, V49, P1940, DOI 10.1373/clinchem.2003.018911; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Goel T, 2006, SCAND J UROL NEPHROL, V40, P108, DOI 10.1080/00365590500368922; Gonzalez A, 2009, NUTR CANCER, V61, P206, DOI 10.1080/01635580802419749; Grindel BJ, 2014, MATRIX BIOL, V36, P64, DOI 10.1016/j.matbio.2014.04.005; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Hale V, 2014, PROSTATE CANCER, V2014, DOI 10.1155/2014/294575; Hebbring SJ, 2006, CANCER EPIDEM BIOMAR, V15, P935, DOI 10.1158/1055-9965.EPI-05-0910; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Hoffmann TJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14248; Holubova M, 2014, METALLOMICS, V6, P1240, DOI 10.1039/c4mt00065j; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Jormsjo S, 2001, ARTERIOSCL THROM VAS, V21, P1834, DOI 10.1161/hq1101.098229; Kaba M, 2014, ASIAN PAC J CANCER P, V15, P2625, DOI 10.7314/APJCP.2014.15.6.2625; Kayaalti Z, 2010, TOXICOL APPL PHARM, V245, P252, DOI 10.1016/j.taap.2010.03.007; Kesh K, 2015, J BIOL CHEM, V290, P14391, DOI 10.1074/jbc.M114.630129; Kita K, 2006, HUM GENET, V120, P553, DOI 10.1007/s00439-006-0238-6; Kluzniak W, 2013, PROSTATE, V73, P542, DOI 10.1002/pros.22594; Kratochvilova M, 2017, PROSTATE, V77, P604, DOI 10.1002/pros.23304; Kristal AR, 1999, CANCER EPIDEM BIOMAR, V8, P887; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Leitzmann MF, 2003, J NATL CANCER I, V95, P1004, DOI 10.1093/jnci/95.13.1004; Li XM, 2005, ASIAN J ANDROL, V7, P323, DOI 10.1111/j.1745-7262.2005.00044.x; Liang JY, 1999, PROSTATE, V40, P200; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; National Cancer Registry, MAL NEOPL PROST GLAN; Ouyang XS, 2001, CARCINOGENESIS, V22, P965, DOI 10.1093/carcin/22.6.965; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; Park SY, 2013, PROSTATE, V73, P261, DOI 10.1002/pros.22565; Peng QS, 2015, ONCOTARGETS THER, V8, P2519, DOI 10.2147/OTT.S83004; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Saeed HM, 2013, ASIAN PAC J CANCER P, V14, P6025, DOI 10.7314/APJCP.2013.14.10.6025; Saeed HM, 2013, ACTA BIOCHIM POL, V60, P405; Seppala EH, 2003, BRIT J CANCER, V89, P1966, DOI 10.1038/sj.bjc.6601425; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Nguyen SV, 2013, ANTICANCER RES, V33, P3247; Srivastava P, 2012, ARCH MED RES, V43, P117, DOI 10.1016/j.arcmed.2012.02.006; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Vira H, 2017, LUPUS, V26, P937, DOI 10.1177/0961203316682855; Wu J, 2013, CLIN BIOCHEM, V46, P1649, DOI 10.1016/j.clinbiochem.2013.07.015; Yamasaki M, 2007, ONCOL REP, V18, P1145; Yu CY, 2002, CANCER RES, V62, P6430; Zaichick V. Ye., 1997, International Urology and Nephrology, V29, P565, DOI 10.1007/BF02552202; Zhang JH, 2005, CARCINOGENESIS, V26, P1748, DOI 10.1093/carcin/bgi144; Zhou YF, 2005, CARCINOGENESIS, V26, P1117, DOI 10.1093/carcin/bgi057; Zhou YF, 2004, CARCINOGENESIS, V25, P399, DOI 10.1093/carcin/bgh020	67	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201065	10.1371/journal.pone.0201065	http://dx.doi.org/10.1371/journal.pone.0201065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036379	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200024
J	Nunez-Vivanco, G; Fierro, A; Moya, P; Iturriaga-Vasquez, P; Reyes-Parada, M				Nunez-Vivanco, Gabriel; Fierro, Angelica; Moya, Pablo; Iturriaga-Vasquez, Patricio; Reyes-Parada, Miguel			3D similarities between the binding sites of monoaminergic target proteins	PLOS ONE			English	Article							X-RAY STRUCTURES; OXIDASE-B; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; AMPHETAMINE DERIVATIVES; CRYSTAL-STRUCTURES; BACTERIAL HOMOLOG; LIGAND-BINDING; IN-VIVO	The study of binding site similarities can be relevant to understand the interaction of different drugs at several molecular targets. The increasing availability of protein crystal structures and the development of novel algorithms designed to evaluate three-dimensional similarities, represent a great opportunity to explore the existence of electronic and shape features shared by clinically relevant proteins, which could assist drug design and discovery. Proteins involved in the recognition of monoaminergic neurotransmitters, such as monoamine transporters or monoamine oxidases (MAO) have been related to several psychiatric and neurological disorders such as depression or Parkinson's disease. In this work, we evaluated the possible existence of similarities among the binding sites of the serotonin transporter (SERT), the dopamine transporter (DAT), MAO-A and MAO-B. This study was carried out using molecular simulation methodologies linked to the statistical algorithm PocketMatch, which was modified in order to obtain similarities profiles. Our results show that DAT and SERT exhibit a high degree of 3-D similarities all along the pathway that is presumably involved in the substrate transport process. Distinct differences, on the other hand, were found both at the extracellular and the intracellular ends of the transporters, which might be involved in the selective initial recognition of the corresponding substrate. Similarities were also found between the active (catalytic) site of MAO-A and the extracellular vestibule of SERT (the S2 binding site). These results suggest some degree of structural convergence for these proteins, which have different functions, tissue distribution and genetic origin, but which share the same endogenous ligand (serotonin). Beyond the functional implications, these findings are valuable for the design of both selective and non-selective ligands.	[Nunez-Vivanco, Gabriel] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Nunez-Vivanco, Gabriel] Univ Talca, Escuela Ingn Civil Bioinformat, Talca, Chile; [Fierro, Angelica] Pontificia Univ Catolica Chile, Santiago, Chile; [Moya, Pablo] Univ Valparaiso, Inst Fisiol, Valparaiso, Chile; [Moya, Pablo] Univ Valparaiso, CINV, Valparaiso, Chile; [Iturriaga-Vasquez, Patricio] Univ la Frontera, Fac Ingn & Ciencias, Temuco, Chile; [Reyes-Parada, Miguel] Univ Santiago Chile, Fac Med Sci, Sch Med, Santiago, Chile; [Reyes-Parada, Miguel] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Talca; Universidad de Talca; Pontificia Universidad Catolica de Chile; Universidad de Valparaiso; Universidad de Valparaiso; Universidad de La Frontera; Universidad de Santiago de Chile; Universidad Autonoma de Chile	Nunez-Vivanco, G (corresponding author), Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile.; Nunez-Vivanco, G (corresponding author), Univ Talca, Escuela Ingn Civil Bioinformat, Talca, Chile.; Reyes-Parada, M (corresponding author), Univ Santiago Chile, Fac Med Sci, Sch Med, Santiago, Chile.; Reyes-Parada, M (corresponding author), Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile.	ganunez@utalca.cl; miguel.reyes@usach.cl	Fierro, Angelica/AAJ-2533-2020	Fierro, Angelica/0000-0002-6507-4188; Nunez Vivanco, Gabriel/0000-0002-2858-1789; Moya, Pablo/0000-0001-6409-1544	Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico) [1170662, 1141272, 1150615, 1161375]; ICM MINECOM (Iniciativa Cientifica Milenio, Ministerio de Economia) [NC130011, P09-022-F]	Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM MINECOM (Iniciativa Cientifica Milenio, Ministerio de Economia)	This project was partially supported by Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico) grants 1170662 (MRP), 1141272 (PM), 1150615 (PIV), 1161375 (AF) and the ICM MINECOM (Iniciativa Cientifica Milenio, Ministerio de Economia) grants NC130011 and P09-022-F, www.conicyt.cl/fondecyt, http://www.iniciativamilenio.cl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersen J, 2016, ACS CHEM NEUROSCI, V7, P1406, DOI 10.1021/acschemneuro.6b00164; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Binda C, 2004, J MED CHEM, V47, P1767, DOI 10.1021/jm031087c; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Binda C, 2011, INT REV NEUROBIOL, V100, P1, DOI 10.1016/B978-0-12-386467-3.00001-7; Bonivento D, 2010, J BIOL CHEM, V285, P36849, DOI 10.1074/jbc.M110.169482; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; De Colibus L, 2005, THREE DIMENSIONAL ST; De Deurwaerdere P, 2017, PROG NEUROBIOL, V151, P1, DOI 10.1016/j.pneurobio.2017.02.001; Edmondson DE, 2007, ARCH BIOCHEM BIOPHYS, V464, P269, DOI 10.1016/j.abb.2007.05.006; Fierro A, 2013, AN INTEGRATED VIEW O, P405; Fierro A, 2007, BIOORGAN MED CHEM, V15, P5198, DOI 10.1016/j.bmc.2007.05.021; Gani OA, 2015, BBA-PROTEINS PROTEOM, V1854, P1605, DOI 10.1016/j.bbapap.2015.05.004; Gobbi M, 2002, J NEUROCHEM, V82, P1435, DOI 10.1046/j.1471-4159.2002.01073.x; Grouleff J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00235; Haddad Y, 2016, ACS CHEM NEUROSCI, V7, P1607, DOI 10.1021/acschemneuro.6b00242; Hidalgo S, 2017, ACS CHEM NEUROSCI, V8, P2168, DOI 10.1021/acschemneuro.7b00089; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jalencas X, 2013, MOL INFORM, V32, P976, DOI 10.1002/minf.201300082; Kazmier K, 2017, CURR OPIN STRUC BIOL, V45, P100, DOI 10.1016/j.sbi.2016.12.006; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Larsen MB, 2011, J NEUROSCI, V31, P6605, DOI 10.1523/JNEUROSCI.0576-11.2011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loland CJ, 2015, BBA-GEN SUBJECTS, V1850, P500, DOI 10.1016/j.bbagen.2014.04.011; Ma JC, 2004, J MOL BIOL, V338, P103, DOI 10.1016/j.jmb.2004.02.032; Maurer W. D., 1975, Computing Surveys, V7, P5, DOI 10.1145/356643.356645; McDonald GR, 2010, PHARMACOL RES, V62, P475, DOI 10.1016/j.phrs.2010.09.001; Moller-Acuna P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134444; Najmanovich RJ, 2017, CURR OPIN STRUC BIOL, V45, P85, DOI 10.1016/j.sbi.2016.11.024; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Purves D., 2001, TYPES EYE MOVEMENTS, V2nd; Reyes-Parada M., 2005, CURR ENZYM INHIB, V1, P85, DOI DOI 10.2174/1573408052952711; Roche DB, 2015, INT J MOL SCI, V16, P29829, DOI 10.3390/ijms161226202; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Rudnick G, 2011, BIOCHEMISTRY-US, V50, P7462, DOI 10.1021/bi200926b; Scorza MC, 1997, BIOCHEM PHARMACOL, V54, P1361, DOI 10.1016/S0006-2952(97)00405-X; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Sotomayor-Zarate R, 2012, BASIC CLIN PHARMACOL, V111, P371, DOI 10.1111/j.1742-7843.2012.00926.x; Stahl S.M., 2021, ESSENTIAL PSYCHOPHAR; Topiol S, 2016, BIOORG MED CHEM LETT, V26, P5058, DOI 10.1016/j.bmcl.2016.08.087; Vulpetti A, 2012, FUTURE MED CHEM, V4, P1971, DOI [10.4155/fmc.12.147, 10.4155/FMC.12.147]; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Zhong HL, 2012, PSYCHOPHARMACOLOGY, V219, P1, DOI 10.1007/s00213-011-2463-5; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	61	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200637	10.1371/journal.pone.0200637	http://dx.doi.org/10.1371/journal.pone.0200637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028869	Green Published, gold, Green Submitted			2022-12-27	WOS:000439396900011
J	Chen, CJ; Liao, WL; Chang, CT; Liao, HY; Tsai, FJ				Chen, Chao-Jung; Liao, Wen-Ling; Chang, Chiz-Tzung; Liao, Hsin-Yi; Tsai, Fuu-Jen			Urine proteome analysis by C-18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy	PLOS ONE			English	Article							CLARA CELL PROTEIN; RENAL-FUNCTION; AMINO-ACID; MARKERS; BETA-2-MICROGLOBULIN; IDENTIFICATION; PURIFICATION	Diabetic nephropathy (DN) is one of the most common complications in diabetic patients. New noninvasive markers are still needed for the early detection of DN before identifiable alternations in kidney function or urine albumin excretion occurs. A C-18 plate and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were used to compare the urinary protein profiles of 238 subjects from the following 4 groups: patients with type 2 diabetic (T2D) with microalbuminuria, patients with DM without micro- or macroalbuminuria, patients with micro- or macroalbuminuria due to nondiabetic disease, and healthy controls. beta 2-microglobulin (B2M) and Clara-cell protein (CC16) were found to be highly released in the urine of patients with proteinuria due to nondiabetic or diabetic diseases. In differentiating nephropathy from healthy subject, the B2M and CC16 markers have a combined sensitivity and specificity of 77.3% and 91.8%, respectively. In distinguishing T2D with microalbuminuria from T2D patients, the combined markers have sensitivity and specificity of 66% and 73%, respectively. The predictive ability of B2M and CC16 for early renal functional decline (ERFD) was validated in 125 T2D patients with a follow-up times. The odds ratio (OR) of combined B2M and CC16 markers for developing ERFD was 7.59 (95% CI: 1.97-29.24). The detection of B2M and CC16 with the C-18 plate-MALDI-TOF MS approach could be an attractive and practical assay for rapid diagnosis of nephropathy in nondiabetic/diabetic patients and as a predictor of ERFD among T2D patients who had not manifested significant kidney disease at baseline.	[Chen, Chao-Jung; Liao, Hsin-Yi] China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan; [Chen, Chao-Jung; Liao, Wen-Ling] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Liao, Wen-Ling] China Med Univ Hosp, Ctr Personalized Med, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ, Coll Med, Taichung, Taiwan; [Chang, Chiz-Tzung] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, CJ (corresponding author), China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan.; Chen, CJ (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Tsai, FJ (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan.	cjchen@mail.cmu.edu.tw; do704@mail.cmuh.org.tw	Chen, Chao-Jung/E-5481-2011	Chen, Chao-Jung/0000-0003-3834-9243	China Medical University Hospital [DMR-106-126]; Ministry of Science and Technology [MOST 105-2113-M-039-006]; Academia Sinica's Diabetes Biosignature Project [BM 10601010027]	China Medical University Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica's Diabetes Biosignature Project	This work was supported by grants from the China Medical University Hospital (DMR-106-126), the Ministry of Science and Technology (MOST 105-2113-M-039-006), and Academia Sinica's Diabetes Biosignature Project (BM 10601010027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the China Medical University Hospital (DMR-106-126), the Ministry of Science and Technology (MOST 105-2113-M-039-006), and Academia Sinica's Diabetes Biosignature Project (BM 10601010027).	BERNARD A, 1993, CLIN CHIM ACTA, V223, P189, DOI 10.1016/0009-8981(93)90077-H; BERNARD A, 1991, CLIN CHIM ACTA, V201, P231, DOI 10.1016/0009-8981(91)90374-L; BERNARD A, 1995, TOXICOL LETT, V77, P145, DOI 10.1016/0378-4274(95)03284-3; Chang CT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164846; Chang CT, 2015, CLIN CHIM ACTA, V440, P115, DOI 10.1016/j.cca.2014.11.019; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dihazi H, 2007, CLIN CHEM, V53, P1636, DOI 10.1373/clinchem.2007.088260; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hong CY, 1998, J DIABETES COMPLICAT, V12, P43, DOI 10.1016/S1056-8727(97)00045-7; Indovina P, 2013, MASS SPECTROM REV, V32, P129, DOI 10.1002/mas.21355; JACKSON PJ, 1988, J CHROMATOGR, V452, P359, DOI 10.1016/S0021-9673(01)81460-6; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liao HY, 2016, ANALYST, V141, P2183, DOI 10.1039/c6an00113k; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Martin-Granado A, 2009, PEDIATR NEPHROL, V24, P747, DOI 10.1007/s00467-008-1078-5; Moresco RN, 2013, CLIN CHIM ACTA, V421, P17, DOI 10.1016/j.cca.2013.02.019; Otu HH, 2007, DIABETES CARE, V30, P638, DOI 10.2337/dc06-1656; Papale M, 2010, DIABETES CARE, V33, P2409, DOI 10.2337/dc10-0345; PISCATOR M, 1991, KIDNEY INT, V40, pS15; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; SCHARDIJN GHC, 1987, KIDNEY INT, V32, P635, DOI 10.1038/ki.1987.255; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sharifiaghdas F, 2011, UROL J, V8, P277; SINGH G, 1988, BIOCHIM BIOPHYS ACTA, V950, P329, DOI 10.1016/0167-4781(88)90129-7; Tan HT, 2012, MASS SPECTROM REV, V31, P583, DOI 10.1002/mas.20356; Wu J, 2011, DIABETES RES CLIN PR, V91, P213, DOI 10.1016/j.diabres.2010.11.036; Yoshikawa R, 2007, DIABETES RES CLIN PR, V76, P358, DOI 10.1016/j.diabres.2006.09.004; Zhang Y, 2009, TRANSPLANTATION, V87, P1807, DOI 10.1097/TP.0b013e3181a66595	28	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200945	10.1371/journal.pone.0200945	http://dx.doi.org/10.1371/journal.pone.0200945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024955	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000072
J	Griebel, J; Utz, M; Hermisson, J; Wolinska, J				Griebel, Johanna; Utz, Margarete; Hermisson, Joachim; Wolinska, Justyna			The establishment of hybrids of the Daphnia longispina complex explained by a mathematical model incorporating different overwintering life history strategies	PLOS ONE			English	Article							SPECIES COMPLEX; TRANSGRESSIVE SEGREGATION; REPRODUCTIVE ISOLATION; SEXUAL REPRODUCTION; GENE FLOW; HYBRIDIZATION; DYNAMICS; COMMUNITIES; POPULATIONS; ADAPTATION	Interspecific hybridization (i.e. mating between species) occurs frequently in animals. Among cyclical parthenogens, hybrids can proliferate and establish through parthenogenetic reproduction, even if their sexual reproduction is impaired. In water fleas of the Daphnia longispina species complex, interspecific hybrids hatch from sexually produced dormant eggs. However, fewer hybrid genotypes contribute to the dormant egg bank and their hatching rate from dormant eggs is reduced, compared to eggs resulting from intraspecific crosses. Therefore, Daphnia hybrids would benefit from adaptations that increase their survival over winter as parthenogenetic lineages, avoiding the need to re-establish populations after winter from sexually produced dormant eggs. Here, we constructed a mathematical model to examine the conditions that could explain the frequently observed establishment of hybrids in the D. longispina species complex. Specifically, we compared the outcome of hybrid and parental taxa competition given a reduced contribution of hybrids to hatchlings from the sexually produced dormant egg bank, but their increased ability to survive winter as parthenogenetic lineages. In addition, different growth rates of parental species and differences in average annual temperatures were evaluated for their influence on hybrid production and establishment. Our model shows that increased overwinter performance as parthenogenetic females can compensate for reduced success in sexual reproduction, across all tested scenarios for varying relative growth rates of parental species. This pattern holds true for lower annual temperatures, but at higher temperatures hybrids were less successful. Consequently, hybrids might become less abundant as temperatures rise due to climate change, resulting in reduced diversity and faster differentiation of the parental species.	[Griebel, Johanna; Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Griebel, Johanna] Ludwig Maximilian Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Utz, Margarete] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Hermisson, Joachim] Univ Vienna, Dept Math, Vienna, Austria; [Wolinska, Justyna] Free Univ Berlin, Dept Biol Chem Pharm, Inst Biol, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Munich; University of Groningen; University of Vienna; Free University of Berlin	Griebel, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany.; Griebel, J (corresponding author), Ludwig Maximilian Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	j_griebel@gmx.de	Wolinska, Justyna/N-6455-2014		German Science Foundation [WO 1587/4-1, 1587/6-1]; Leibniz Association	German Science Foundation(German Research Foundation (DFG)); Leibniz Association	This research was funded by the German Science Foundation grant to JW (WO 1587/4-1 and 1587/6-1). We thank the Leibniz Association's Open Access Publishing Funds for co-financing this publication. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; [Anonymous], MATHEMATICA; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Declerck S, 2003, J PLANKTON RES, V25, P93, DOI 10.1093/plankt/25.1.93; Domis LND, 2007, OECOLOGIA, V150, P682, DOI 10.1007/s00442-006-0549-2; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Gorski PR, 1996, LIMNOL OCEANOGR, V41, P1815, DOI 10.4319/lo.1996.41.8.1815; Griebel J, 2016, J EVOLUTION BIOL, V29, P810, DOI 10.1111/jeb.12828; Griebel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140275; Janko K, 2018, MOL ECOL, V27, P248, DOI 10.1111/mec.14377; Johannesson K, 1995, EVOLUTION, V49, P1180, DOI 10.1111/j.1558-5646.1995.tb04445.x; Kagawa K, 2018, ECOL LETT, V21, P264, DOI 10.1111/ele.12891; Keller B, 2004, LIMNOL OCEANOGR, V49, P1393, DOI 10.4319/lo.2004.49.4_part_2.1393; Keller B, 2008, PHILOS T R SOC B, V363, P2943, DOI 10.1098/rstb.2008.0044; Keller B, 2007, LIMNOL OCEANOGR, V52, P984, DOI 10.4319/lo.2007.52.3.0984; Lampert W, 2010, LIMNOL OCEANOGR, V55, P1893, DOI 10.4319/lo.2010.55.5.1893; Louette G, 2007, OIKOS, V116, P419, DOI 10.1111/j.2006.0030-1299.15381.x; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Petrusek A, 2008, PHILOS T R SOC B, V363, P2931, DOI 10.1098/rstb.2008.0026; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1329; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Schalau K, 2008, OECOLOGIA, V157, P531, DOI 10.1007/s00442-008-1081-3; Scheffer M, 2001, LIMNOL OCEANOGR, V46, P1780, DOI 10.4319/lo.2001.46.7.1780; Scheffer M, 1997, OIKOS, V80, P519, DOI 10.2307/3546625; Seda J, 2007, J PLANKTON RES, V29, P619, DOI 10.1093/plankt/fbm044; Seidendorf B, 2007, LIMNOL OCEANOGR, V52, P385, DOI 10.4319/lo.2007.52.1.0385; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SPAAK P, 1995, OECOLOGIA, V104, P501, DOI 10.1007/BF00341348; STROSS RG, 1968, BIOL BULL, V134, P176, DOI 10.2307/1539976; WEIDER LJ, 1991, OECOLOGIA, V87, P506, DOI 10.1007/BF00320413; WOLF HG, 1987, HYDROBIOLOGIA, V145, P213, DOI 10.1007/BF02530282; Wolinska J, 2006, P ROY SOC B-BIOL SCI, V273, P1977, DOI 10.1098/rspb.2006.3523; Wolinska J, 2007, FRESHWATER BIOL, V52, P1198, DOI 10.1111/j.1365-2427.2007.01757.x; Yin MB, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-80; Yin MB, 2010, MOL ECOL, V19, P4168, DOI 10.1111/j.1365-294X.2010.04807.x	41	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200802	10.1371/journal.pone.0200802	http://dx.doi.org/10.1371/journal.pone.0200802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024954	Green Published, gold			2022-12-27	WOS:000439120000054
J	Sendi, H; Mead, I; Wan, MM; Mehrab-Mohseni, M; Koch, K; Atala, A; Bonkovsky, HL; Bishop, CE				Sendi, Hossein; Mead, Ivy; Wan, Meimei; Mehrab-Mohseni, Marjan; Koch, Kenneth; Atala, Anthony; Bonkovsky, Herbert L.; Bishop, Colin E.			miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; LIPID-METABOLISM; DISEASE; OVEREXPRESSION; SENSITIVITY; HOMEOSTASIS; SYSTEMS	To investigate the role of miR-122 in the development and regression of non-alcoholic fatty liver disease (NAFLD) in vitro, we used multicellular 3D human liver organoids developed in our laboratory. These organoids consist of primary human hepatocytes, Kupffer cells, quiescent stellate cells and liver sinusoidal endothelial cells. They remain viable and functional for 4 weeks expressing typical markers of liver function such as synthesis of albumin, urea, and alpha-1 p450 drug metabolism. Before mixing, hepatic cells were transduced with lentivirus to inhibit miR122 expression (ABM, CA). Immediately after the organoids were fully formed (day 4) or after 1 or 2 weeks of additional incubation (days 11 or 18), the organoids were analyzed using fluorescent live/dead staining and ATP production; total RNA was extracted for qPCR gene expression profiling. Our results show that miR-122 inhibition in liver organoids leads to inflammation, necrosis, steatosis and fibrosis. This was associated with increase in inflammatory cytokines (IL6, TNF), chemokines (CCL2, CCL3) and increase in a subset of Matrix Metaloproteinases (MMP8, MMP9). An altered expression of key genes in lipid metabolism (i.e LPL, LDLR) and insulin signaling (i.e GLUT4, IRS1) was also identified. Conclusion: Our results highlight the role of miR-122 inhibition in liver inflammation, steatofibrosis and dysregulation of insulin signaling. Patients with NAFLD are known to have altered levels of miR-122, therefore we suggest that miR-122 mimics could play a useful role in reversing liver steatofibrosis and insulin resistance seen in patients with NAFLD.	[Sendi, Hossein; Mehrab-Mohseni, Marjan; Koch, Kenneth; Bonkovsky, Herbert L.] Wake Forest Baptist Med Ctr, Sect Gastroenterol, Lab Liver Dis & Metab Disorders, Winston Salem, NC 27157 USA; [Sendi, Hossein; Mead, Ivy; Wan, Meimei; Atala, Anthony; Bishop, Colin E.] Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA; [Sendi, Hossein] UNC Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA; [Mehrab-Mohseni, Marjan] UNC Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Sendi, H (corresponding author), Wake Forest Baptist Med Ctr, Sect Gastroenterol, Lab Liver Dis & Metab Disorders, Winston Salem, NC 27157 USA.; Sendi, H (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.; Sendi, H (corresponding author), UNC Sch Pharm, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA.	hsendi@email.unc.edu	Sendi, Hossein/W-1049-2019; Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230; Sendi, Hossein/0000-0002-1054-6571	Defense Threat Reduction Agency (DTRA) under Space and Naval Warfare Systems Center Pacific (SSC PACIFIC) [N66001-13-C-2027]; NIH [R01DK110167-01A1, R15 HL 117199, U54 DK 083909 9]; Defense Threat Reduction Agency [N66001-13-C-2027]	Defense Threat Reduction Agency (DTRA) under Space and Naval Warfare Systems Center Pacific (SSC PACIFIC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	We greatly thank Defense Threat Reduction Agency Contracts N66001-13-C-2027 (AA & CEB) and NIH R01DK110167-01A1 (CEB) R15 HL 117199 (HLB), U54 DK 083909 9 (HLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbal E, 2016, WIEN KLIN WOCHENSCHR, V128, P48, DOI 10.1007/s00508-014-0680-8; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Caligiuri A, 2016, INT J MOL SCI, V17, P9, DOI [10.1111/j.1572-0241.2007.01774.x, DOI 10.1111/J.1572-0241.2007.01774.X]; Clarke JD, 2014, J APPL TOXICOL, V34, P726, DOI 10.1002/jat.2960; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Csak T, 2015, LIVER INT, V35, P532, DOI 10.1111/liv.12633; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Iimuro Y, 2008, PHARM RES-DORDR, V25, P249, DOI 10.1007/s11095-007-9311-7; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kirovski G, 2011, EXP MOL PATHOL, V91, P780, DOI 10.1016/j.yexmp.2011.08.001; Lauschke VM, 2016, CHEM RES TOXICOL, V29, P1936, DOI 10.1021/acs.chemrestox.6b00150; Lefebvre E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158156; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Liu G, 2016, J LIPID RES, V57, P1155, DOI 10.1194/jlr.M065011; Nantasanti S, 2016, STEM CELL TRANSL MED, V5, P325, DOI 10.5966/sctm.2015-0152; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sendi H, 2012, HEPAT MON, V12, P312, DOI 10.5812/hepatmon.6128; Shibata S, 2007, LIFE SCI, V80, P546, DOI 10.1016/j.lfs.2006.10.003; Skardal A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08879-x; Skardal A, 2016, DRUG DISCOV TODAY, V21, P1399, DOI 10.1016/j.drudis.2016.07.003; Sun MX, 2015, CLIN RES HEPATOL GAS, V39, pS60, DOI 10.1016/j.clinre.2015.06.015; Thakral S, 2015, CURR GENE THER, V15, P142, DOI 10.2174/1566523214666141224095610; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wu GY, 2017, CELL PHYSIOL BIOCHEM, V44, P1651, DOI 10.1159/000485765; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zeng CX, 2015, ONCOTARGET, V6, P12224, DOI 10.18632/oncotarget.3652	37	32	33	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200847	10.1371/journal.pone.0200847	http://dx.doi.org/10.1371/journal.pone.0200847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024933	gold, Green Submitted, Green Published			2022-12-27	WOS:000439120000059
J	Soares, AMS; Oliveira, JTA; Rocha, CQ; Ferreira, ATS; Perales, J; Zanatta, AC; Vilegas, W; Silvan, CR; Costa, LM				Soares, Alexandra M. S.; Oliveira, Jose T. A.; Rocha, Claudia Q.; Ferreira, Andre T. S.; Perales, Jonas; Zanatta, Ana Caroline; Vilegas, Wagner; Silvan, Carolina R.; Costa-Junior, Livio M.			Myracrodruon urundeuva seed exudates proteome and anthelmintic activity against Haemonchus contortus	PLOS ONE			English	Article							PLANT CYSTEINE PROTEINASES; IN-VITRO; GASTROINTESTINAL NEMATODES; CAENORHABDITIS-ELEGANS; DEFENSE; RESISTANCE; PROTEASES; SHEEP; VIVO; CHITINASES	Seed exudates are plant-derived natural bioactive compounds consisting of a complex mixture of organic and inorganic molecules. Plant seed exudates have been poorly studied against parasite nematodes. This study was undertaken to identify proteins in the Myracrodruon urundeuva seed exudates and to assess the anthelmintic activity against Haemonchus contortus, an important parasite of small ruminants. M. urundeuva seed exudates (SEX) was obtained after immersion of seeds in sodium acetate buffer. SEX was fractionated with ammonium sulfate at 0-90% concentration to generate the ressuspended pellet (SEXF1) and the supernatant (SEXF2). SEX, SEXF1, and SEXF2 were exhaustively dialyzed against distilled water (cut-off: 12 kDa) and the protein contents determined. Mass spectrometry analyses of SEX, SEXF1, and SEXF2 were done to identify proteins and secondary metabolites. The seed exudates contained protease, protease inhibitor, peptidase, chitinase, and lipases as well as the low molecular weight secondary compounds ellagic acid and quercetin rhamnoside. SEX inhibited H. contortus larval development (LDA) (IC50 = 0.29 mg mL(-1)), but did not affect larval exsheathment (LEIA). On the other hand, although SEXF1 and SEXF2 inhibited H. contortus LEIA (IC50 = 1.04 and 0.93 mg mL(-1), respectively), they showed even greater inhibition efficiency of H. contortus larval development (IC50 = 0.29 and 0.42 mg mL(-1), respectively). To the best of our knowledge, this study is the first to show the anthelmintic activity of plant exudates against a gastrointestinal nematode. Moreover, it suggests the potential of exuded proteins as candidates to negatively interfere with H. contortus life cycle.	[Soares, Alexandra M. S.] Univ Fed Maranhao, Exact Sci Ctr & Technol, Lab Plant Biochem, Chem Engn Program, Sao Luis, Maranhao, Brazil; [Oliveira, Jose T. A.] Univ Fed Ceara, Lab Plant Def Prot, Campus Pici, Fortaleza, Ceara, Brazil; [Rocha, Claudia Q.] Univ Fed Maranhao, Ctr Exact Sci & Technol, Dept Chem, Lab Adv Studies Phytomed, Sao Luis, Maranhao, Brazil; [Ferreira, Andre T. S.; Perales, Jonas] Fundacao Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, RJ, Brazil; [Zanatta, Ana Caroline; Vilegas, Wagner] Inst Biosci, Bioprospecting, Lab Nat Prod, Coastal Campus Sao Vicente, Sao Vicente, SP, Brazil; [Silvan, Carolina R.; Costa-Junior, Livio M.] Univ Fed Maranhao, Ctr Biol & Hlth Sci, Dept Pathol, Lab Parasite Control, Sao Luis, Maranhao, Brazil	Universidade Federal do Maranhao; Universidade Federal do Ceara; Universidade Federal do Maranhao; Fundacao Oswaldo Cruz; Universidade Federal do Maranhao	Soares, AMS (corresponding author), Univ Fed Maranhao, Exact Sci Ctr & Technol, Lab Plant Biochem, Chem Engn Program, Sao Luis, Maranhao, Brazil.; Costa, LM (corresponding author), Univ Fed Maranhao, Ctr Biol & Hlth Sci, Dept Pathol, Lab Parasite Control, Sao Luis, Maranhao, Brazil.	alexandra.ufma@gmail.com; livio.martins@ufma.br	Zanatta, Ana C./ABA-7695-2020; da Rocha, Claudia Quintino/U-8013-2019; Vilegas, Wagner/S-3209-2019; Rocha, Cláudia Quintino da/C-2320-2013; Costa-Junior, Livio M/H-7530-2012	Zanatta, Ana C./0000-0003-0199-4521; da Rocha, Claudia Quintino/0000-0002-3578-1869; Rocha, Cláudia Quintino da/0000-0002-3578-1869; Costa-Junior, Livio M/0000-0002-1475-049X; Rocha e Silva, Carolina/0000-0001-8667-1064	CNPq (The Brazilian National Council for Scientific and Technological Development) [447877/2014-3]; FAPEMA (Maranhao State Research Foundation) [PRONEM-01773/14]; CNPq; CNPq (The Brazilian National Council for Scientific and Technological Development); FAPEMA (Maranhao State Research Foundation)	CNPq (The Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMA (Maranhao State Research Foundation); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (The Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMA (Maranhao State Research Foundation)	The authors acknowledge the CNPq (The Brazilian National Council for Scientific and Technological Development) 447877/2014-3, and FAPEMA (Maranhao State Research Foundation) PRONEM-01773/14, for financial support. We also thank CNPq for awarding a fellowship to L.M. Costa-Junior and J. Perales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the CNPq (The Brazilian National Council for Scientific and Technological Development) and FAPEMA (Maranhao State Research Foundation) for financial support. We also thank CNPq for awarding a fellowship to L.M. Costa-Junior and J. Perales.	Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Anusuya Sathiyanarayanan, 2014, Archives of Phytopathology and Plant Protection, V47, P1611, DOI 10.1080/03235408.2013.853457; Araujo SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189803; Barros M, 2010, BRAZ J CHEM ENG, V27, P15, DOI 10.1590/S0104-66322010000100002; Bauri RK, 2015, INDIAN J NAT PROD RE, V6, P268; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga FR, 2014, RES VET SCI, V97, P527, DOI 10.1016/j.rvsc.2014.09.005; Carvalho CES, 2017, EXP PARASITOL, V175, P59, DOI 10.1016/j.exppara.2017.02.012; COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U; Day B, 2011, ANNU REV PHYTOPATHOL, V49, P483, DOI 10.1146/annurev-phyto-072910-095426; Demeler J, 2010, VET PARASITOL, V174, P58, DOI 10.1016/j.vetpar.2010.08.020; Duarte N.F., 2006, Planta daninha, V24, P329, DOI 10.1590/S0100-83582006000200016; Eltelib HA, 2011, J PLANT PHYSIOL, V168, P619, DOI 10.1016/j.jplph.2010.09.003; Faccin H, 2016, J CHROMATOGR A, V1427, P111, DOI 10.1016/j.chroma.2015.12.017; Feofilova EP, 2010, MICROBIOLOGY+, V79, P711, DOI 10.1134/S0026261710060019; Gadahi JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159796; Goncalves PC., 1998, MANUAL DIAGNOSTICO H; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Harder A, 2016, ADV PARASIT, V93, P69, DOI 10.1016/bs.apar.2016.02.010; Heim C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1032-x; HUBERT J, 1992, VET REC, V130, P442, DOI 10.1136/vr.130.20.442; Jackson F, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P25, DOI 10.1007/978-90-481-3297-3_3; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Kohli A, 2012, PHYSIOL PLANTARUM, V145, P165, DOI 10.1111/j.1399-3054.2012.01573.x; Levecke B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-255; Lica ICL, 2018, FOOD RES INT, V105, P1039, DOI 10.1016/j.foodres.2017.11.051; Mali R. G., 2008, Natural Product Radiance, V7, P466; MANSFIELD LS, 1992, COMP BIOCHEM PHYS B, V103, P681, DOI 10.1016/0305-0491(92)90390-D; Martinez M, 2012, PHYSIOL PLANTARUM, V145, P85, DOI 10.1111/j.1399-3054.2012.01569.x; Mondal H, 2015, PAK VET J, V35, P58; Monteiro JM, 2006, J ETHNOPHARMACOL, V105, P173, DOI 10.1016/j.jep.2005.10.016; Monteiro JM, 2012, ACTA BOT BRAS, V26, P125, DOI 10.1590/S0102-33062012000100014; Ndjonka D, 2014, J HELMINTHOL, V88, P481, DOI 10.1017/S0022149X1300045X; Pahoja V. M., 2002, Pakistan Journal of Applied Sciences, V2, P474; Pesquet E, 2012, PHYSIOL PLANTARUM, V145, P1, DOI 10.1111/j.1399-3054.2012.01614.x; de Araujo IDR, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1918-6; Rios-de Alvarez L, 2012, VET PARASITOL, V187, P267, DOI 10.1016/j.vetpar.2012.01.005; ROBERTS FHS, 1950, AUST J AGR RES, V1, P99, DOI 10.1071/AR9500099; Rocha RO, 2015, J AGR FOOD CHEM, V63, P5335, DOI 10.1021/acs.jafc.5b01109; Rose Hannah, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P209, DOI 10.1016/j.ijppaw.2014.01.001; Scarafoni A, 2013, FEBS J, V280, P1443, DOI 10.1111/febs.12140; Schiltz S, 2015, J APPL MICROBIOL, V119, P1467, DOI 10.1111/jam.12946; Souza TM, 2015, ACTA TROP, V152, P49, DOI 10.1016/j.actatropica.2015.08.010; Stepek G, 2007, PARASITOLOGY, V134, P103, DOI 10.1017/S0031182006001302; Stepek G, 2006, PARASITOLOGY, V132, P681, DOI 10.1017/S003118200500973X; Tariq KA, 2008, J HELMINTHOL, V82, P227, DOI 10.1017/S0022149X08972515; Vermeire JJ, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030039; Veronico P, 2001, MOL GENET GENOMICS, V266, P28, DOI 10.1007/s004380100513	50	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200848	10.1371/journal.pone.0200848	http://dx.doi.org/10.1371/journal.pone.0200848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024949	Green Submitted, Green Published, gold			2022-12-27	WOS:000439120000060
J	Sommer, CA; Capilla, A; Molina-Estevez, FJ; Gianotti-Sommer, A; Skvir, N; Caballero, I; Chowdhury, S; Mostoslavsky, G				Sommer, Cesar A.; Capilla, Amalia; Molina-Estevez, Francisco J.; Gianotti-Sommer, Andreia; Skvir, Nicholas; Caballero, Ignacio; Chowdhury, Sanjib; Mostoslavsky, Gustavo			Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COLORECTAL-CANCER; LACTATE-DEHYDROGENASE; HUMAN COLON; IN-VITRO; MUTATIONS; ADENOCARCINOMAS; DIFFERENTIATION; GENERATION; ORGANOIDS	Mutations in the gene Adenomatous Polyposis Coli or APC appear in most sporadic cases of colorectal cancer and it is the most frequent mutation causing hereditary Familial Adenomatous Polyposis. The detailed molecular mechanism by which APC mutations predispose to the development of colorectal cancer is not completely understood. This is in part due to the lack of accessibility to appropriate models that recapitulate the early events associated with APC mediated intestinal transformation. We have established a novel platform utilizing human induced Pluripotent Stem cells or iPSC from normal or FAP-specific APC mutant individuals and evaluated the effect of the mutation in the cells before and after differentiation into intestinal organoids. In order to minimize genetic background effects, we also established an isogenic platform using TALEN-mediated gene editing. Comparison of normal and APC mutant iPSC revealed a significant defect in cell identity and polarity due to the presence of APC in heterozygosity as well as chromosomal aberrations including abnormal anaphases and centrosome numbers. Importantly, upon specification into intestinal progeny, APC heterozygosity was responsible for a major change in the transcriptional identity of the cells with dysregulation of key signaling pathways, including metabolic reprogramming, abnormal lipid metabolism and intestinal-specific cadherin expression. In conclusion, we have developed a novel iPSC/intestinal model of APC mutagenesis and provide strong evidence that APC in heterozygosity imparts a clear phenotypic and molecular defect, affecting basic cellular functions and integrity, providing novel insights in the earlier events of APC-mediated tumorigenesis.	[Sommer, Cesar A.; Capilla, Amalia; Molina-Estevez, Francisco J.; Gianotti-Sommer, Andreia; Chowdhury, Sanjib; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Sect Gastroenterol, Boston, MA 02118 USA; [Sommer, Cesar A.; Capilla, Amalia; Molina-Estevez, Francisco J.; Gianotti-Sommer, Andreia; Skvir, Nicholas; Caballero, Ignacio; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA	Boston University; Boston University	Mostoslavsky, G (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Gastroenterol, Boston, MA 02118 USA.; Mostoslavsky, G (corresponding author), Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA.	gmostosl@bu.edu	Capilla, Amalia/AAW-5955-2021	Capilla, Amalia/0000-0002-9546-9818; Skvir, Nicholas/0000-0002-3067-4458; Molina-Estevez, F. Javier/0000-0001-9565-2199; Mostoslavsky, Gustavo/0000-0002-0784-2169	NIH [1R01CA175727-01, 1UL1TR001430]; CTSI [TL1TR001410];  [R24HL123828];  [U01TR001810]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001410, U01TR001810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were funded in part by NIH 1R01CA175727-01 to GM. A.C. is a Postdoctoral Research Fellow under a T32 CTSI Award TL1TR001410. We are grateful to Brian R. Tilton of the BUSM Flow Cytometry Core for technical assistance, supported by NIH Grant 1UL1TR001430, and Drs. Greg Miller and Marianne James of the CReM, supported by grants R24HL123828 and U01TR001810.	Amos-Landgraf JM, 2012, P NATL ACAD SCI USA, V109, P2060, DOI 10.1073/pnas.1120753109; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Blaker H, 2003, AM J CLIN PATHOL, V120, P418, DOI 10.1309/4E4WG3AYGJNCD11P; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Crespo M, 2017, NAT MED, V23, P878, DOI 10.1038/nm.4355; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Mondesir J, 2016, J BLOOD MED, V7, P171, DOI 10.2147/JBM.S70716; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nelson SA, 2012, DIS MODEL MECH, V5, P940, DOI 10.1242/dmm.008607; Panarelli NC, 2012, AM J CLIN PATHOL, V138, P211, DOI 10.1309/AJCPKSHXI3XEHW1J; Park S, 2017, STEM CELL REP, V8, P1076, DOI 10.1016/j.stemcr.2016.12.017; Patel BB, 2011, ONCOTARGET, V2, P197, DOI 10.18632/oncotarget.241; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Wang J, 2015, ONCOTARGET, V6, P19456, DOI 10.18632/oncotarget.3318; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Yeung AT, 2008, CANCER RES, V68, P7579, DOI 10.1158/0008-5472.CAN-08-0856	43	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0200657	10.1371/journal.pone.0200657	http://dx.doi.org/10.1371/journal.pone.0200657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024920	Green Submitted, gold, Green Published			2022-12-27	WOS:000439120000038
J	Liu, ZJL; Zhou, YJ; Ding, RL; Xie, F; Fu, SZ; Wu, JB; Yang, LL; Wen, QL				Liu, Zong-Jun-Lin; Zhou, Yu-Juan; Ding, Rui-Lin; Xie, Fang; Fu, Shao-Zhi; Wu, Jing-Bo; Yang, Ling-Lin; Wen, Qing-Lian			In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR-2; CANCER; ANGIOGENESIS; PATHWAYS; VEGF	The effect of apatinib on the formation of vasculogenic mimicry (VM) was studied in a malignant melanoma cell line. MUM-2B cells cultured in three-dimensional Matrigel were treated with varying concentrations (0, 0.01, 0.05, 0.1, 0.5 mu mol/L) of apatinib to test its effect on VM in vitro, followed by MTT proliferation and transwell invasion assays to determine the effect of apatinib on cell proliferation and invasion of MUM-2B cells. In vivo, we used a melanoma cancer model to test the effect of short-term apatinib (100, 200, 300 mg/kg) treatment on VM. Western blotting, immunohistochemistry staining, and CD31-PAS dual staining were performed to assess the expression of VEGFR-2, ERK-1/2, P13K, and MMP-2, and formation of VM. The results showed apatinib-treated groups formed a lesser number of VM in 3D matrigel, while the cell viability in MTT proliferation assay and the number of migration cells in transwell invasion assay were significantly lower in apatinib-treated groups. In addition, short-term apatinib treatment inhibited angiogenesis, VM formation, and tumor growth in models of melanoma cancer. Mice in apatinib-treated groups showed a markedly reduced expression of VEGFR-2, ERK-1/2, P13K, and MMP-2. In summary, apatinib could inhibit the expression of VEGFR-2, and downregulate the ERK1/2/PI3K/MMP-2 signaling cascade, which may be one of the underlying mechanisms by which apatinib inhibits angiogenesis and the development of VM in models of melanoma cancer, and restrains the formation of VM by MUM-2B cells. Apatinib shows inhibitory effects on cell proliferation and invasion of MUM-2B cells, which is a close relationship with the VM.	[Liu, Zong-Jun-Lin; Zhou, Yu-Juan; Xie, Fang; Fu, Shao-Zhi; Wu, Jing-Bo; Yang, Ling-Lin; Wen, Qing-Lian] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Sichuan, Peoples R China; [Ding, Rui-Lin] Southwest Med Univ, Affiliated Hosp, Inst Drug Clin Trial, GCP Ctr, Luzhou, Sichuan, Peoples R China	Southwest Medical University; Southwest Medical University	Wen, QL (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Sichuan, Peoples R China.	wql73115@hotmail.com	Fu, ShaoZhi/ABI-5082-2020; Fu, ShaoZhi/L-4019-2017; Wu, Jing/GZK-5063-2022	Fu, ShaoZhi/0000-0002-8666-4304; Fu, ShaoZhi/0000-0002-8666-4304; 	Jiangsu Hengrui Medicine Co., Ltd (Lianyungang, Jiangsu, China)	Jiangsu Hengrui Medicine Co., Ltd (Lianyungang, Jiangsu, China)	We are applying the grant support from Jiangsu Hengrui Medicine Co., Ltd (Lianyungang, Jiangsu, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi SA, 2010, ARCH IRAN MED, V13, P498, DOI 010136/AIM.009; Clemente M, 2010, VET PATHOL, V47, P265, DOI 10.1177/0300985809353167; Darrington E, 2012, ASIAN J ANDROL, V14, P745, DOI 10.1038/aja.2011.197; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Frenkel S, 2008, EYE, V22, P948, DOI 10.1038/sj.eye.6702783; Geng RX, 2015, EXPERT OPIN PHARMACO, V16, P117, DOI 10.1517/14656566.2015.981526; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Liu ZC, 2011, PATHOL RES PRACT, V207, P645, DOI 10.1016/j.prp.2011.07.012; Longo R, 2007, CANCER CHEMOTH PHARM, V60, P151, DOI 10.1007/s00280-006-0403-6; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Qu B, 2010, MED HYPOTHESES, V74, P360, DOI 10.1016/j.mehy.2009.08.020; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Stratmann A, 2001, INT J CANCER, V91, P273, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q; Sun W, 2013, ONCOL REP, V27, P1990; Tian S, 2011, CANCER SCI, V102, P1374, DOI 10.1111/j.1349-7006.2011.01939.x; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Wu L, 2017, IRAN J BASIC MED SCI, V20, P990, DOI 10.22038/IJBMS.2017.9263; Xie F, 2017, DRUG DELIV, V24, P1410, DOI 10.1080/10717544.2017.1378938; Xu XF, 2010, ACTA OPHTHALMOL, V88, pE160, DOI 10.1111/j.1755-3768.2010.01942.x; Xu Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-16; Yang XJ, 1996, J NEUROSCI, V16, P6089; Yao XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057188	26	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200845	10.1371/journal.pone.0200845	http://dx.doi.org/10.1371/journal.pone.0200845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052652	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600017
J	Fernandez-Cabrera, MR; Higuera-Matas, A; Fernaud-Espinosa, I; DeFelipe, J; Ambrosio, E; Miguens, M				Fernandez-Cabrera, Monica R.; Higuera-Matas, Alejandro; Fernaud-Espinosa, Isabel; DeFelipe, Javier; Ambrosio, Emilio; Miguens, Miguel			Selective effects Delta(9)-tetrahydrocannabinol on medium spiny neurons in the striatum	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; LONG-TERM POTENTIATION; DENDRITIC SPINES; CANNABINOID RECEPTOR; NUCLEUS-ACCUMBENS; HIPPOCAMPAL MORPHOLOGY; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; DISTAL DENDRITES	Derivatives from the Cannabis plant are the most commonly abused illegal substances in the world. The main psychoactive component found in the plant, Delta-9-tetrahydrocannabinol (THC), exerts its effects through the endocannabinoid system. Manipulations of this system affect some types of learning that seem to be dependent on dorsal striatum synaptic plasticity. Dendritic spines exhibit important synaptic functional attributes and a potential for plasticity, which is thought to mediate long-lasting changes in behaviour. To study the possible structural plasticity changes that prolonged THC administration might exert in the dorsal striatum, adult, male C57BL6/J mice were intraperitoneally injected with THC (10mg/kg) or vehicle for 15 days followed by a 7-day drug-free period. Using single cell intracellular injections of Lucifer Yellow, confocal microscopy, and 3D reconstruction of labelled neurons, we studied dendritic spine density and spine size in medium spiny neurons (MSNs) of the anterior dorsolateral striatum (aDLS) and posterior dorsomedial striatum (pDMS). We found that the THC treatment increased dendritic spine density in the distal part of the dendrites of MSNs in the pDMS, but no changes were found in the rest of the parameters analysed in either region studied. We also observed that dendritic spines of MSNs of pDMS presented lower volume and surface area values than MSNs of the aDLS. These results seem to indicate that THC could induce structural plasticity alterations in the circuits involving pDMS MSNs.	[Fernandez-Cabrera, Monica R.; Higuera-Matas, Alejandro; Ambrosio, Emilio] UNED, Fac Psicol, Dept Psicobiol, Madrid, Spain; [Fernaud-Espinosa, Isabel; DeFelipe, Javier; Miguens, Miguel] UPM, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain; [DeFelipe, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Miguens, Miguel] UNED, Fac Psicol, Dept Psicol Basica 1, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Universidad Nacional de Educacion a Distancia (UNED)	Miguens, M (corresponding author), UPM, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain.; Miguens, M (corresponding author), UNED, Fac Psicol, Dept Psicol Basica 1, Madrid, Spain.	mmiguens@psi.uned.es	Fernaud-Espinosa, Isabel/H-1875-2015; Higuera-Matas, Alejandro/E-6565-2013; Miguens, Miguel/L-4911-2014; DEFELIPE, JAVIER/D-1195-2014	Fernaud-Espinosa, Isabel/0000-0003-2391-0704; Higuera-Matas, Alejandro/0000-0003-3438-9387; Miguens, Miguel/0000-0002-7320-822X; DEFELIPE, JAVIER/0000-0001-5484-0660	Spanish Ministry of Health, Social Services and Equality [PND-2016I073]; Carlos III Health Institute [RTA-RD16/020/0022]; Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED) [CB06/05/0066]; Spanish Ministry of Economy and Competitiveness [SAF 2015-66603-P, PSI2016-80082-P, PSI80541-P]; Directorate General of Research of the Autonomous Community of Madrid [S-2011/BMD-2308]; European Union [JUST/2013/DPIP/AG/4823-EU MADNESS]	Spanish Ministry of Health, Social Services and Equality(Spanish Government); Carlos III Health Institute(Instituto de Salud Carlos III); Centre for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED); Spanish Ministry of Economy and Competitiveness(Spanish Government); Directorate General of Research of the Autonomous Community of Madrid; European Union(European Commission)	Funding for this study was provided by the Spanish Ministry of Health, Social Services and Equality (http://www.pnsd.msssi.gob.es;grant PND-2016I073 to E.A.); the Carlos III Health Institute (http://www.isciii.es; grant RTA-RD16/020/0022 to E.A; the Centre for Networked Biomedical Research into Neurodegenerative Diseases (https://www.ciberned.es; CIBERNED, CB06/05/0066 to J.DF.); the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/idi; grant SAF 2015-66603-P to J.DF, grant PSI2016-80082-P to MM, and grant PSI80541-P to E.A); the Directorate General of Research of the Autonomous Community of Madrid (https://www.madrimasd.org/madrid-ciencia-tecnologia/convocatorias; grant S-2011/BMD-2308, Activities Programme I+D+I CANNAB-CM to EA); and European Union (https://ec.europa.eu/info/funding-tenders_en; grant JUST/2013/DPIP/AG/4823-EU MADNESS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2017, EUR DRUG REP; Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Ballesteros-Yanez I, 2007, NEUROSCIENCE, V146, P1536, DOI 10.1016/j.neuroscience.2007.03.017; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2013, CURR OPIN NEUROBIOL, V23, P564, DOI 10.1016/j.conb.2013.01.025; Benavides-Piccione R, 2013, CEREB CORTEX, V23, P1798, DOI 10.1093/cercor/bhs154; Bosch C, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00100; Bosch C, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.2015.00060, 10.3389/fnana.7015.00060]; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Candelaria-Cook FT, 2014, BRAIN RES, V1542, P104, DOI 10.1016/j.brainres.2013.10.039; Carvalho AF, 2016, BRAIN STRUCT FUNCT, V221, P407, DOI 10.1007/s00429-014-0914-6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dumitriu D, 2012, J NEUROSCI, V32, P6957, DOI 10.1523/JNEUROSCI.5718-11.2012; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Ehlinger DG, 2017, NEUROSCIENCE, V356, P242, DOI 10.1016/j.neuroscience.2017.05.036; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; Gipson CD, 2017, GENES BRAIN BEHAV, V16, P101, DOI 10.1111/gbb.12324; Goodman J, 2015, NEUROBIOL LEARN MEM, V125, P1, DOI 10.1016/j.nlm.2015.06.008; Grutzendler J, 2002, NATURE, P420, DOI [10.1038/101038/nature01276, DOI 10.1038/101038/NATURE01276]; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hart G, 2018, J NEUROSCI, V38, P1311, DOI 10.1523/JNEUROSCI.2850-17.2017; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; Kolb B, 2006, SYNAPSE, V60, P429, DOI 10.1002/syn.20313; Kolb B, 2018, SYNAPSE, V72, DOI 10.1002/syn.22020; Konur S, 2003, J NEUROBIOL, V56, P95, DOI 10.1002/neu.10229; KREUZ DS, 1973, SCIENCE, V179, P391, DOI 10.1126/science.179.4071.391; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Li YL, 2003, NEUROPSYCHOPHARMACOL, V28, P1082, DOI 10.1038/sj.npp.1300115; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Miguens M, 2015, CEREB CORTEX, V25, P56, DOI 10.1093/cercor/bht200; Morena M, 2014, NEUROBIOL LEARN MEM, V112, P30, DOI 10.1016/j.nlm.2013.12.010; Murray JE, 2012, NEUROPSYCHOPHARMACOL, V37, P2456, DOI 10.1038/npp.2012.104; Narushima M, 2006, NEUROSCI RES, V54, P159, DOI 10.1016/j.neures.2005.12.004; Nazzaro C, 2012, NAT NEUROSCI, V15, P284, DOI 10.1038/nn.3022; Niyuhire F, 2007, J PHARMACOL EXP THER, V322, P1067, DOI 10.1124/jpet.107.119594; Oikonomou KD, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00292; Parsons LH, 2015, NAT REV NEUROSCI, V16, P579, DOI 10.1038/nrn4004; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rubino T, 2005, J NEUROCHEM, V93, P984, DOI 10.1111/j.1471-4159.2005.03101.x; Rubino T, 2009, HIPPOCAMPUS, V19, P763, DOI 10.1002/hipo.20554; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Saravia R, 2017, BIOL PSYCHIAT, V81, P625, DOI 10.1016/j.biopsych.2016.07.007; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Selvas A, 2017, ADDICT BIOL, V22, P78, DOI 10.1111/adb.12294; Shan Q, 2014, J NEUROSCI, V34, P9196, DOI 10.1523/JNEUROSCI.0313-14.2014; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; Spiga S, 2011, CURR NEUROPHARMACOL, V9, P200, DOI 10.2174/157015911795017083; Spiga S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00110; Spiga S, 2010, ADDICT BIOL, V15, P266, DOI 10.1111/j.1369-1600.2010.00218.x; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wise LE, 2012, ACS CHEM NEUROSCI, V3, P369, DOI 10.1021/cn200130s; Xu NL, 2006, J NEUROSCI, V26, P3002, DOI 10.1523/JNEUROSCI.5220-05.2006; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010	87	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200950	10.1371/journal.pone.0200950	http://dx.doi.org/10.1371/journal.pone.0200950			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048477	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400036
J	Park, C; Kim, J; Kim, J; Park, S				Park, Chihyun; Kim, JungRim; Kim, Jeongwoo; Park, Sanghyun			Machine learning-based identification of genetic interactions from heterogeneous gene expression profiles	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NETWORK; ASSOCIATION; DATABASE	The identification of disease-related genes and disease mechanisms is an important research goal; many studies have approached this problem by analysing genetic networks based on gene expression profiles and interaction datasets. To construct a gene network, correlations or associations among pairs of genes must be obtained. However, when gene expression data are heterogeneous with high levels of noise for samples assigned to the same condition, it is difficult to accurately determine whether a gene pair represents a significant gene-gene interaction (GGI). In order to solve this problem, we proposed a random forest-based method to classify significant GGIs from gene expression data. To train the model, we defined novel feature sets and utilised various high-confidence interactome datasets to deduce the correct answer set from known disease-specific genes. Using Alzheimer's disease data, the proposed method showed remarkable accuracy, and the GGIs established in the analysis can be used to build a meaningful genetic network that can explain the mechanisms underlying Alzheimer's disease.	[Park, Chihyun; Kim, JungRim; Kim, Jeongwoo; Park, Sanghyun] Yonsei Univ, Dept Comp Sci, Seoul, South Korea	Yonsei University	Park, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul, South Korea.	sanghyun@yonsei.ac.kr		Park, Chihyun/0000-0003-4995-2312	Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT [NRF 2015M3C4A7065522]	Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT	This research was supported by Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (NRF 2015M3C4A7065522).	Ahn J, 2011, BIOINFORMATICS, V27, P1846, DOI 10.1093/bioinformatics/btr283; [Anonymous], 1998, NEURAL NETWORKS COMP; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Deshpande R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068664; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; Gaiteri C, 2016, NAT REV NEUROL, V12, P413, DOI 10.1038/nrneurol.2016.84; Gov E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05298-w; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Han ZP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179677; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Hu YS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0252-z; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; John G. H., 1995, MORGAN KAUFMANN, P338; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Koo CL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/432375; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Liang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040498; Madhukar NS, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00172; Narayanan M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145304; Park C, 2017, EXPERT SYST APPL, V85, P249, DOI 10.1016/j.eswa.2017.05.042; Park C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086309; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Siangphoe U, 2017, BRIEF BIOINFORM, V18, P602, DOI 10.1093/bib/bbw050; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Upstill-Goddard R, 2013, BRIEF BIOINFORM, V14, P251, DOI 10.1093/bib/bbs024; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yang YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5232; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201056	10.1371/journal.pone.0201056	http://dx.doi.org/10.1371/journal.pone.0201056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048494	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400045
J	Pun, KD; Rishal, P; Infanti, JJ; Bjorngaard, JH; Koju, R; Schei, B; Darj, E				Pun, Kunta Devi; Rishal, Poonam; Infanti, Jennifer Jean; Bjorngaard, Johan Hakon; Koju, Rajendra; Schei, Berit; Darj, Elisabeth		ADVANCE Study Grp	Exposure to domestic violence influences pregnant women's preparedness for childbirth in Nepal: A cross-sectional study	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; BIRTH-PREPAREDNESS; COMPLICATION READINESS; MIDWIVES; DISTRICT	Objective This study aimed to evaluate if domestic violence affected women's ability to prepare for childbirth. Birth preparedness and complication readiness (BP/CR) includes saving money, arranging transportation, identifying a skilled birth attendant, a health facility, and a blood donor before childbirth. During data collection, Nepal experienced two earthquakes and therefore it was possible to examine associations between domestic violence, women's BP/CR and effects of the earthquakes. Methods Women who were between 12 and 28 weeks of gestation participated in a descriptive crosssectional study at a hospital antenatal clinic in Nepal, where they completed a structured questionnaire on sociodemographic characteristics, obstetric history, experiences of domestic violence, and BP/CR. The 5-item Abuse Assessment Screen was used to assess prevalence of domestic violence, and a questionnaire on safe motherhood obtained from Jhpiego was used to assess BP/CR status. The participants self-completed the questionnaire on a tablet computer. Those who reported at least three out of five BP/CR activities were considered prepared for childbirth. Results A total of 1011 women participated in the study: 433 pre-earthquakes and 578 post-earthquakes. With respect to BP/CR, 78% had identified a health facility for childbirth and 65% had saved money prior to childbirth. Less than 50% had identified a birth attendant to assist with the delivery, transportation to a health facility, or arranged for a potential blood donor. Prior to the earthquakes, 38% were unprepared; by contrast, almost 62% were not prepared after the earthquakes. A significant association was found between exposure to violence and not being prepared for childbirth (AOR = 2.3, 95% CI: 1.4-3.9). The women with increased odds of not being prepared for childbirth were illiterate (AOR = 9.9, 95% CI: 5.7-17), young (AOR = 3.4, 95% CI: 1.6-7.2), from the most oppressed social classes (AOR = 3.0, 95% CI: 1.2-7.6), were married to illiterate husbands (AOR = 2.5, 95% CI: 1.2-5.2), had attended fewer than four antenatal visits (AOR = 2.0, 95% CI: 1.4-2.6), had low incomes (AOR = 1.7, 95% CI: 1.1-2.9) or lived in rural settings (AOR = 1.5, 95% confidence interval CI: 1.2-2.1). Conclusion The paper identifies vulnerable women who require extra care from the health system, and draws attention to the need for interventions to reduce the harmful effects of domestic violence on women's preparations for childbirth.	[Pun, Kunta Devi; Koju, Rajendra] Kathmandu Univ, Sch Med Sci, Dhulikhel, Kavre, Nepal; [Pun, Kunta Devi; Rishal, Poonam; Infanti, Jennifer Jean; Bjorngaard, Johan Hakon; Schei, Berit; Darj, Elisabeth] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway; [Pun, Kunta Devi; Rishal, Poonam; Darj, Elisabeth] Cent Norway Reg Hlth Author, Stjordal, Norway; [Bjorngaard, Johan Hakon] St Olavs Univ Hosp, Res Ctr Broset, Trondheim, Norway; [Schei, Berit; Darj, Elisabeth] St Olavs Univ Hosp, Dept Obstet & Gynecol, Trondheim, Norway; [Darj, Elisabeth] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Kathmandu University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Uppsala University	Pun, KD (corresponding author), Kathmandu Univ, Sch Med Sci, Dhulikhel, Kavre, Nepal.; Pun, KD (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway.; Pun, KD (corresponding author), Cent Norway Reg Hlth Author, Stjordal, Norway.	kunta.devi.pun@ntnu.no			Research Council of Norway [220893]; Samarbeidsorganet [16/29034]; Research Council of Norway; Liaison Committee; Samarbeidsorganet HMN-NTNU	Research Council of Norway(Research Council of Norway); Samarbeidsorganet; Research Council of Norway(Research Council of Norway); Liaison Committee; Samarbeidsorganet HMN-NTNU	This study was funded by the Research Council of Norway, grant number 220893, http://www.forskningsradet.no/en/The_Research_ Council/1138785832539, to BS. Research Council of Norway has funded the project under its Global Health and Vaccination Research (GLOBVAC) Program: 'Evaluating interventions in antenatal care to identify and assist victims of gender based violence in Nepal and Sri Lanka'. This study is also funded by the Samarbeidsorganet, grant number 16/29034, https://helse-midt.no/samarbeidsorganet, to ED. Along with Research Council of Norway, this project was funded by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology; Samarbeidsorganet HMN-NTNU.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Ahmad J, 2016, J INTERPERS VIOLENCE, V31, P3111, DOI 10.1177/0886260515584341; August F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125978; Basile H., 2007, EDITED CTR DIS CONTR; Bhatnagar T, 2013, AIDS BEHAV, V17, P2260, DOI 10.1007/s10461-013-0414-3; Bhatta DN, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-14; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Central Bureau of Statistics, 2016, DISTR PROF KAVR 2074; Chan KL, 2011, VIOLENCE VICTIMS, V26, P364, DOI 10.1891/0886-6708.26.3.364; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; Del Barco R., 2004, TOOLS INDICATORS MAT, P330; Garcia-Moreno C, 2005, WHO MULTI COUNTRY ST; Gebre M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137570; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Idowu A, 2015, INT J MCH AIDS, V4, P47, DOI DOI 10.21106/ijma.55; Jahanfar S., 2014, INTERVENTIONS PREVEN, pCD009414; Jayatilleke AC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1674-9; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Markos D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-282; Mazumdar R, 2014, INDIA AL AMEEN J MED, V7, P52; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health New ERA Nepal Health Sector Support Program (NHSSP) Inner City fund (ICF), 2017, NEP HLTH FAC SURV 20; Mukhopadhyay Dipta Kanti, 2016, J Family Med Prim Care, V5, P404; Mukhopadhyay Dipta Kanti, 2013, Indian J Public Health, V57, P147, DOI 10.4103/0019-557X.119827; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Nursing department of Dhulikhel Hospital, 2015, REP OBST GYN WARD; O'Reilly R, 2010, TRAUMA VIOLENCE ABUS, V11, P190, DOI 10.1177/1524838010378298; Omari PK, 2016, KENYA AM J MED SCI, V6, P123; Palladino CL, 2011, OBSTET GYNECOL, V118, P1056, DOI 10.1097/AOG.0b013e31823294da; Pandey J.P., 2013, MATERNAL CHILD HLTH; Parkinson D., 2017, J INTERPERS VIOLENCE; Pun KD, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31964; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rajib Saha APS., 2014, INT J PUBLIC HLTH RE, V4, P510; Rathod SD, 2011, J INTERPERS VIOLENCE, V26, P2437, DOI 10.1177/0886260510385125; Sakurai K, 2017, DISASTER MED PUBLIC, V11, P216, DOI 10.1017/dmp.2016.109; Stenson K, 2005, MIDWIFERY, V21, P311, DOI 10.1016/j.midw.2005.01.002; Stenson K, 2001, MIDWIFERY, V17, P2, DOI 10.1054/midw.2000.0241; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations, 2016, SUSTAINABLE SEVELOPM; Urassa DP, 2012, TANZAN J HLTH RES, V14, P42; Whitney R, 2017, J STRUCT ENG, V143, DOI 10.1061/(ASCE)ST.1943-541X.0001717; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2013, LONDON SCH HYGIENE T	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200234	10.1371/journal.pone.0200234	http://dx.doi.org/10.1371/journal.pone.0200234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048459	Green Published, gold, Green Submitted			2022-12-27	WOS:000439952400005
J	Bratek, E; Ziembowicz, A; Bronisz, A; Salinska, E				Bratek, Ewelina; Ziembowicz, Apolonia; Bronisz, Agnieszka; Salinska, Elzbieta			The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia	PLOS ONE			English	Article							N-ACETYLASPARTYLGLUTAMATE; CELL-DEATH; IMMATURE RAT; AGONIST; NEUROPROTECTION; NEURONS; DAMAGE; MODEL; GLUTATHIONE; LY379268	Birth asphyxia resulting in brain hypoxia-ischemia (H-I) can cause neonatal death or lead to persistent brain damage. Recent investigations have shown that group II metabotropic glutamate receptor (mGluR2/3) activation can provide neuroprotection against H-I but the mechanism of this effect is not clear. The aim of this study was to investigate whether mGluR2/3 agonists applied a short time after H-I reduce brain damage in an experimental model of birth asphyxia, and whether a decrease in oxidative stress plays a role in neuroprotection. Neonatal H-I in 7-day-old rats was used as an experimental model of birth asphyxia. Rats were injected intra peritoneally with mGluR2 (LY 379268) or mGluR3 (NAAG) agonists 1 h or 6 h after H-I (5 mg/kg). The weight deficit of the ischemic brain hemisphere, radical oxygen species (ROS) content levels, antioxidant enzymes activity and the concentrations of reduced glutathione (GSH) were measured. Both agonists reduced weight loss in the ischemic hemisphere and mitigated neuronal degeneration in the CA1 hippocampal region and cerebral cortex. Both agonists reduced the elevated levels of ROS in the ipsilateral hemisphere observed after H-I and prevented an increase in antioxidant enzymes activity in the injured hemisphere restoring them to control levels. A decrease in GSH level was also restored after agonists application. The results show that the activation of mGluR2 and mGluR3 a short time after H-I triggers neuroprotective mechanisms that act through the inhibition of oxidative stress and ROS production. The prevention of ROS production by the inhibition of glutamate release and decrease in its extracellular concentration is likely the main mechanism involved in the observed neuroprotection.	[Bratek, Ewelina; Ziembowicz, Apolonia; Salinska, Elzbieta] Polish Acad Sci, Dept Neurochem, Mossakowski Med Res Ctr, Warsaw, Poland; [Bronisz, Agnieszka] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA USA	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Salinska, E (corresponding author), Polish Acad Sci, Dept Neurochem, Mossakowski Med Res Ctr, Warsaw, Poland.	esalinska@imdik.pan.pl	Bronisz, Agnieszka/G-5980-2019; Bronisz, Agnieszka/M-3485-2019	Bronisz, Agnieszka/0000-0002-5841-1051; Bronisz, Agnieszka/0000-0002-5841-1051; Salinska, Elzbieta/0000-0003-4212-221X	Polish Ministry of Scientific Research and Higher Education; Polish National Science Centre [2016/23/N/NZ7/01942]	Polish Ministry of Scientific Research and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Centre	This work was supported by founds from the Polish Ministry of Scientific Research and Higher Education for the MMRC-KNOW 2013-2017 project and by Polish National Science Centre grant no. 2016/23/N/NZ7/01942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Bakthavachalam P, 2017, J NEUROL SCI, V375, P417, DOI 10.1016/j.jns.2017.02.043; Barkhuizen M, 2017, NEUROSCI BIOBEHAV R, V75, P166, DOI 10.1016/j.neubiorev.2017.01.042; Berent-Spillson A, 2007, J NEUROCHEM, V101, P342, DOI 10.1111/j.1471-4159.2006.04373.x; Bond A, 1998, NEUROREPORT, V9, P1191, DOI 10.1097/00001756-199804200-00042; Bond A, 2000, J PHARMACOL EXP THER, V294, P800; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno V, 1998, J NEUROSCI, V18, P9594; Bruno V, 2017, NEUROPHARMACOLOGY, V115, P180, DOI 10.1016/j.neuropharm.2016.04.044; Buonocore G, 2001, BIOL NEONATE, V79, P180; Cai ZW, 2002, EUR J PHARMACOL, V437, P139, DOI 10.1016/S0014-2999(02)01289-X; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Caraci F, 2012, NEUROCHEM INT, V61, P559, DOI 10.1016/j.neuint.2012.01.017; Charriaut-Marlangue C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010061; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; Demarest TG, 2016, J NEUROCHEM, V137, P714, DOI 10.1111/jnc.13590; Doi K, 2012, J MATERN-FETAL NEO M, V25, P706, DOI 10.3109/14767058.2011.587061; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Folbergrova J, 2012, EXP NEUROL, V233, P421, DOI 10.1016/j.expneurol.2011.11.009; Gonda X, 2012, CURR PHARM DESIGN, V18, P1558, DOI 10.2174/138161212799958521; Hachem LD, 2016, STEM CELLS DEV, V25, P1223, DOI 10.1089/scd.2015.0389; Hascup ER, 2010, J NEUROCHEM, V115, P1608, DOI 10.1111/j.1471-4159.2010.07066.x; Imre G, 2007, CNS DRUG REV, V13, P444; Johnson EC, 2011, J NEUROCHEM, V119, P896, DOI 10.1111/j.1471-4159.2011.07480.x; Lin SH, 2001, J CEREBR BLOOD F MET, V21, P262, DOI 10.1097/00004647-200103000-00010; Lu XCM, 2000, EUR J PHARMACOL, V408, P233, DOI 10.1016/S0014-2999(00)00762-7; Lyon L, 2008, SYNAPSE, V62, P842, DOI 10.1002/syn.20553; Maiese K, 2008, OXID MED CELL LONGEV, V1, P1; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Motolese M, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0158-2; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Netto CA, 2017, J NEUROSCI RES, V95, P409, DOI 10.1002/jnr.23828; Nicoletti F, 2015, CURR OPIN PHARMACOL, V20, P89, DOI 10.1016/j.coph.2014.12.002; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rice ME, 1998, NEUROSCIENCE, V82, P1213; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Spillson AB, 2003, EXP NEUROL, V184, pS97, DOI 10.1016/j.expneurol.2003.08.001; Thomas AG, 2001, EUR J PHARMACOL, V430, P33, DOI 10.1016/S0014-2999(01)01239-0; Van Hemelrijck A, 2005, J NEUROCHEM, V95, P1287, DOI 10.1111/j.1471-4159.2005.03450.x; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; Weis SN, 2012, MITOCHONDRION, V12, P271, DOI 10.1016/j.mito.2011.10.002; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Zhang X, 2015, HIPPOCAMPUS, V25, P286, DOI 10.1002/hipo.22372; Zhou F, 2006, J NEUROSCI RES, V84, P268, DOI 10.1002/jnr.20897	52	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200933	10.1371/journal.pone.0200933	http://dx.doi.org/10.1371/journal.pone.0200933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044838	gold, Green Submitted, Green Published			2022-12-27	WOS:000439942500071
J	Crandell, KE; Smith, AF; Crino, OL; Tobalske, BW				Crandell, Kristen E.; Smith, Austin F.; Crino, Ondi L.; Tobalske, Bret W.			Coping with compliance during take-off and landing in the diamond dove (Geopelia cuneata)	PLOS ONE			English	Article							JUMPING PERFORMANCE; ANOLIS-CAROLINENSIS; PERCH COMPLIANCE; KINEMATICS; LOCOMOTION; SUBSTRATE; MECHANICS; BEHAVIOR; LIZARDS; FLIGHT	The natural world is filled with substrates of varying properties that challenge locomotor abilities. Birds appear to transition smoothly from aerial to terrestrial environments during take-offs and landings using substrates that are incredibly variable. It may be challenging to control movement on and off compliant (flexible) substrates such as twigs, yet birds routinely accomplish such tasks. Previous research suggests that birds do not use their legs to harness elastic recoil from perches. Given avian mastery of take-off and landing, we hypothesized that birds instead modulate wing, body and tail movements to effectively use compliant perches. We measured take-off and landing performance of diamond doves (Geopelia cuneata (N= 5) in the laboratory and perch selection in this species in the field (N = 25). Contrary to our hypothesis, doves do not control take-off and landing on compliant perches as effectively as they do on stiff perches. They do not recover elastic energy from the perch, and take-off velocities are thus negatively impacted. Landing velocities remain unchanged, which suggests they may not anticipate the need to compensate for compliance. Legs and wings function as independent units: legs produce lower initial velocities when taking off from a compliant substrate, which negatively impacts later flight velocities. During landing, significant stability problems arise with compliance that are ameliorated by the wings and tail. Collectively, we suggest that the diamond dove maintains a generalized take-off and landing behavior regardless of perch compliance, leading us to conclude that perch compliance represents a challenge for flying birds. Free-living diamond doves avoid the negative impacts of compliance by preferentially selecting perches of larger diameter, which tend to be stiffer.	[Crandell, Kristen E.; Smith, Austin F.; Tobalske, Bret W.] Univ Montana, Div Biol Sci, Field Res Stn Ft Missoula, Missoula, MT 59812 USA; [Crandell, Kristen E.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Crino, Ondi L.] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic, Australia	University of Montana System; University of Montana; Bangor University; Deakin University	Crandell, KE (corresponding author), Univ Montana, Div Biol Sci, Field Res Stn Ft Missoula, Missoula, MT 59812 USA.; Crandell, KE (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	kristen.crandell@gmail.com	Crandell, Kristen/Y-4610-2019	Crandell, Kristen/0000-0002-2150-3198	National Science Foundation [CMMI 1234737]; Dial-Drollinger Charitable Foundation; Montana Space Grant Consortium	National Science Foundation(National Science Foundation (NSF)); Dial-Drollinger Charitable Foundation; Montana Space Grant Consortium	This research was funded by the National Science Foundation (Grant #CMMI 1234737 to BWT), the Dial-Drollinger Charitable Foundation, and the Montana Space Grant Consortium (to KEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R M, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P315; ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Astley HC, 2015, J EXP BIOL, V218, P3360, DOI 10.1242/jeb.121715; Bonser RHC, 1999, FUNCT ECOL, V13, P102, DOI 10.1046/j.1365-2435.1999.00290.x; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Earls KD, 2000, J EXP BIOL, V203, P725; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gilman CA, 2013, FUNCT ECOL, V27, P374, DOI 10.1111/1365-2435.12063; Gilman CA, 2012, J EXP BIOL, V215, P220, DOI 10.1242/jeb.061838; Green PR, 1998, J EXP BIOL, V201, P3309; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Irschick DJ, 2005, BIOL J LINN SOC, V85, P223, DOI 10.1111/j.1095-8312.2005.00487.x; Jackson BE, 2011, J EXP BIOL, V214, P2354, DOI 10.1242/jeb.052829; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; LeBlanc S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153477; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Patel M, 2014, NEUROSCI LETT, V579, P97, DOI 10.1016/j.neulet.2014.07.010; Provini P, 2014, J EXP BIOL; Provini P, 2012, J EXP BIOL, V215, P4115, DOI 10.1242/jeb.074484; Ribak G, 2012, FUNCT ECOL, V26, P493, DOI 10.1111/j.1365-2435.2011.01943.x; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; Sellers WI, 2013, PLOS ONE, V8; Team RDC, 2008, R LANG ENV SATISTICA; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; Tobalske BW, 2004, J EXP BIOL, V207, P1345, DOI 10.1242/jeb.00889; Vogel S., 2003, COMP BIOMECHANICS LI	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199662	10.1371/journal.pone.0199662	http://dx.doi.org/10.1371/journal.pone.0199662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044804	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500015
J	Feng, SY; Gao, J; Li, Y				Feng, ShunYi; Gao, Jie; Li, Yong			A retrospective analysis of leucocyte count as a strong predictor of survival for patients with acute paraquat poisoning	PLOS ONE			English	Article							PLASMA	The aim of this study is the identification of a reliable predictor of prognosis to optimize the treatment of acute paraquat (PQ) poisoning patients. We performed a retrospective analysis on 96 patients with acute PQ poisoning to evaluate leucocyte count as a predictor of 90-day survival. These patients were admitted to the emergency department from May 2012 to February 2017. Kaplan-Meier method was used to compare the 90-day survival. Cox proportional hazard models were utilized to estimate the hazard ratios (HR) and 95% confidence intervals (CI). Receiver operating characteristic (ROC) analysis was conducted to analyze the discriminatory potential of leucocyte with respect to 90-day survival. Result showed that leucocyte was significantly higher among nonsurvivors than that among survivors (p<0.001). Leukocyte was also an independent predictor of survival according to the multi-variate Cox analysis (HR 1.103; 95%CI: 1.062-1.146; p<0.001). The area under the curve (AUC) for leucocyte (AUC 0.911; 95%CI: 0.855-0.966; p<0.001) showed a discriminatory potential similar to that of the plasma PQ concentration (AUC 0.961; 95%CI: 0.926-0.997; p<0.001) in predicting 90-day survival. The leucocyte count is a strong predictor of survival in patients with acute PQ poisoning.	[Feng, ShunYi; Gao, Jie; Li, Yong] Cangzhou Cent Hosp, Emergency Dept, Cangzhou City, Peoples R China		Li, Y (corresponding author), Cangzhou Cent Hosp, Emergency Dept, Cangzhou City, Peoples R China.	ly13333367871@hotmail.com						BISMUTH C, 1982, NOUV PRESSE MED, V11, P3239; Bismuth C, 1986, Dev Toxicol Environ Sci, V12, P347; Eddleston M, 2003, QJM-INT J MED, V96, P809, DOI 10.1093/qjmed/hcg137; Eddleston M, 2004, BMJ-BRIT MED J, V328, P42, DOI 10.1136/bmj.328.7430.42; Fengjun Jiao, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P906; Gawarammana IB, 2010, CLIN TOXICOL, V48, P347, DOI 10.3109/15563651003641794; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; HART TB, 1984, LANCET, V2, P1222; Hong SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111674; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; KAOJARERN S, 1991, VET HUM TOXICOL, V33, P115; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17299; Lin CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085354; Liu S, 2016, MED SCI MONITOR, V22, P1342, DOI 10.12659/MSM.897930; Liu Z., 2016, INT J DISTRIB SENS N, V12, P1; Mitra S, 2006, BBA-MOL BASIS DIS, V1762, P732, DOI 10.1016/j.bbadis.2006.06.011; PROUDFOOT AT, 1979, LANCET, V2, P330; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; Tan J T, 2013, Med J Malaysia, V68, P384; Wu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094697; Zhang H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130035; Zhou DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36235	26	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201200	10.1371/journal.pone.0201200	http://dx.doi.org/10.1371/journal.pone.0201200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044873	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500091
J	Gong, L; Qiu, XH; Huang, J; Xu, W; Bai, JQ; Zhang, J; Su, H; Xu, CM; Huang, ZH				Gong, Lu; Qiu, Xiao Hui; Huang, Juan; Xu, Wen; Bai, Jun Qi; Zhang, Jing; Su, He; Xu, Chu Mei; Huang, Zhi Hai			Constructing a DNA barcode reference library for southern herbs in China: A resource for authentication of southern Chinese medicine	PLOS ONE			English	Article							ITS2	Southern Chinese Medicine (SCM) is an important sect of Traditional Chinese Medicine (TCM) with its own special cultural style. Species identification is essential for TCM quality control because authentic herbs are possibly substituted with adulterants that would threaten the health of the public or even cause death. Here, we provided the first local reference DNA barcode library based on the second internal transcribed spacer (ITS2) for the molecular identification of SCM. A total of 1512 specimens of southern herbs representing 359 species were collected under the instructions and identification of taxonomic experts. Genomic DNA was extracted, and the PCR reaction proceeded according to standard procedures. After Sanger sequencing, sequence assembling and annotation, a reliable ITS2 barcode library with 1276 sequences from 309 species of Southern herbs was constructed. The PCR efficiency of the whole samples was 84.39%. Characteristics of the ITS2 barcode were analyzed, including sequence lengths and GC contents in different taxa. Neighbor-joining trees based on Kimura 2-Parameter (K2P) genetic distances showed a 67.56% successful rate of species identification with ITS2 barcode. In addition, 96.57% of species could be successfully identified at the genus level by the BLAST method. Eleven plant species were discovered to be cryptic. In addition, we found that there is an incorrect sequence existing in the public database, making a reliable local DNA barcode reference more meaningful. ITS2 barcodes exhibit advantages in TCM identification. This DNA barcode reference library could be used in Southern Chinese Medicine quality control, thus contributing to protecting public health.	[Gong, Lu; Qiu, Xiao Hui; Huang, Juan; Xu, Wen; Bai, Jun Qi; Zhang, Jing; Su, He; Xu, Chu Mei; Huang, Zhi Hai] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Gong, Lu; Qiu, Xiao Hui; Huang, Juan; Xu, Wen; Bai, Jun Qi; Zhang, Jing; Su, He; Xu, Chu Mei; Huang, Zhi Hai] China Acad Chinese Med Sci, Guangdong Branch, Guangzhou, Guangdong, Peoples R China; [Qiu, Xiao Hui] Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; China Academy of Chinese Medical Sciences; Guangzhou University of Chinese Medicine	Huang, ZH (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China.; Huang, ZH (corresponding author), China Acad Chinese Med Sci, Guangdong Branch, Guangzhou, Guangdong, Peoples R China.	zhhuang7308@163.com	Xu, Wen/H-6226-2011	Gong, Lu/0000-0002-1245-0506; , Wen/0000-0002-3913-3607; Huang, Zhihai/0000-0003-3075-4690	Guangdong Provincial Hospital of Chinese Medicine Special Fund [2015KT1817]; China Academy of Chinese Medical Sciences Special Fund for Health Service Development of Chinese Medicine [ZZ0908067]	Guangdong Provincial Hospital of Chinese Medicine Special Fund; China Academy of Chinese Medical Sciences Special Fund for Health Service Development of Chinese Medicine	This work was supported by Guangdong Provincial Hospital of Chinese Medicine Special Fund (2015KT1817, http://www.gdhtcm.com/) and the China Academy of Chinese Medical Sciences Special Fund for Health Service Development of Chinese Medicine (ZZ0908067), ZH Huang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Cyranoski David, 2017, Nature, V551, P552, DOI 10.1038/nature.2017.23038; Gu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067818; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Heubl G., 2013, EVIDENCE RATIONAL BA, P27, DOI DOI 10.1007/978-3-7091-0442-2_2; Hou G, 2017, MOL ECOL RESOUR; Huang ZH, 2017, DNA BARCODES CHINESE; Huang ZH, ECOLOGICAL SUITABILI; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Marichamy K., 2014, SCI PARK, V1, P23218045, DOI [DOI 10.9780/23218045/1202013/49, 10.9780/23218045/1202013/49]; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Nithaniyal S, 2017, GENOME, V60, P139, DOI 10.1139/gen-2015-0225; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Spouge John L, 2012, Methods Mol Biol, V858, P365, DOI 10.1007/978-1-61779-591-6_17; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Uetz P, 2017, NATURE, V545, P412, DOI 10.1038/545412c; Wang FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160611; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Xiang H, 2016, PUBLIC HEALTH, V136, P185, DOI 10.1016/j.puhe.2016.02.031; Xu SZ, 2017, MOL ECOL RESOUR, V94; Yu N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04674-w; Zhang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125995	33	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201240	10.1371/journal.pone.0201240	http://dx.doi.org/10.1371/journal.pone.0201240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044868	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500093
J	Pericak, AA; Thomas, CJ; Kroodsma, DA; Wasson, MF; Ross, MRV; Clinton, NE; Campagna, DJ; Franklin, Y; Bernhardt, ES; Amos, JF				Pericak, Andrew A.; Thomas, Christian J.; Kroodsma, David A.; Wasson, Matthew F.; Ross, Matthew R. V.; Clinton, Nicholas E.; Campagna, David J.; Franklin, Yolandita; Bernhardt, Emily S.; Amos, John F.			Mapping the yearly extent of surface coal mining in Central Appalachia using Landsat and Google Earth Engine	PLOS ONE			English	Article							MOUNTAINTOP REMOVAL; TIME-SERIES; FOREST; DOWNSTREAM; IMPACTS; MINES; DISTURBANCE; COVER	Surface mining for coal has taken place in the Central Appalachian region of the United States for well over a century, with a notable increase since the 1970s. Researchers have quantified the ecosystem and health impacts stemming from mining, relying in part on a geospatial dataset defining surface mining's extent at a decadal interval. This dataset, however, does not deliver the temporal resolution necessary to support research that could establish causal links between mining activity and environmental or public health and safety outcomes, nor has it been updated since 2005. Here we use Google Earth Engine and Landsat imagery to map the yearly extent of surface coal mining in Central Appalachia from 1985 through 2015, making our processing models and output data publicly available. We find that 2,900 km(2) of land has been newly mined over this 31-year period. Adding this more-recent mining to surface mines constructed prior to 1985, we calculate a cumulative mining footprint of 5,900 km(2). Over the study period, correlating active mine area with historical surface mine coal production shows that each metric ton of coal is associated with 12 m(2) of actively mined land. Our automated, open-source model can be regularly updated as new surface mining occurs in the region and can be refined to capture mining reclamation activity into the future. We freely and openly offer the data for use in a range of environmental, health, and economic studies; moreover, we demonstrate the capability of using tools like Earth Engine to analyze years of remotely sensed imagery over spatially large areas to quantify land use change.	[Pericak, Andrew A.; Ross, Matthew R. V.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC USA; [Thomas, Christian J.; Kroodsma, David A.; Franklin, Yolandita; Amos, John F.] SkyTruth, Shepherdstown, WV 25443 USA; [Wasson, Matthew F.] Appalachian Voices, Boone, NC USA; [Clinton, Nicholas E.] Google Inc, Google Earth Engine Team, Mountain View, CA USA; [Campagna, David J.] West Virginia Univ, Dept Geol & Geog, Morgantown, WV USA	Duke University; Google Incorporated; West Virginia University	Thomas, CJ (corresponding author), SkyTruth, Shepherdstown, WV 25443 USA.	christian@skytruth.org	Ross, Matthew R.V./AAH-5785-2020; Bernhardt, Emily/B-4541-2010; /D-9940-2011	Ross, Matthew R.V./0000-0001-9105-4255; Thomas, Christian/0000-0001-9574-224X; /0000-0003-3031-621X	Foundation for the Carolinas; National Science Foundation Graduate Research Fellowship Program; National Science Foundation Earth Sciences Hydrological Sciences [1417405]; Cornell Douglas Foundation; Wallace Genetic Foundation; SkyTruth; Appalachian Voices; Google, Inc.	Foundation for the Carolinas; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation Earth Sciences Hydrological Sciences; Cornell Douglas Foundation; Wallace Genetic Foundation; SkyTruth; Appalachian Voices; Google, Inc.(Google Incorporated)	We gratefully acknowledge financial support from the Foundation for the Carolinas (https://www.fftc.org/) to the Nicholas School of the Environment (AAP, MRVR, ESB); the National Science Foundation Graduate Research Fellowship Program (https://www.nsfgrfp.org/) and National Science Foundation Earth Sciences Hydrological Sciences (https://www.nsf.gov/div/index.jsp?div=EAR; grant 1417405) (AAP, MRVR, ESB); the Cornell Douglas Foundation (http://www. cornelldouglas.org/) (CJT, DAK, YF, JFA); and the Wallace Genetic Foundation (http://www. wallacegenetic.org/) (CJT, DAK, YF, JFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Various authors are employed by non-profit or commercial institutions; the specific roles of these authors are articulated in the 'author contributions' section. The funder SkyTruth provided support in the form of salaries for authors CJT, DAK, YF, JFA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Appalachian Voices provided support in the form of salaries for author MFW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Google, Inc., provided support in the form of salaries for author NEC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Apache Software Foundation, 2004, AP LIC VERS 2 0; Arnold MC, 2015, ENVIRON TOXICOL CHEM, V34, P1039, DOI 10.1002/etc.2885; Bier RL, 2015, ISME J, V9, P1378, DOI 10.1038/ismej.2014.222; Carter M, 1989, 89362 US GEOL SURV, P63; Daniels WL, 2016, ENVIRON POLLUT, V216, P371, DOI 10.1016/j.envpol.2016.05.044; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Fox JF, 2010, ENVIRON SCI TECHNOL, V44, P2144, DOI 10.1021/es903301j; Franklin JA, 2012, NEW FOREST, V43, P905, DOI 10.1007/s11056-012-9342-8; Fritz KM, 2010, J N AM BENTHOL SOC, V29, P673, DOI 10.1899/09-060.1; Hartman H.L., 2002, INTRO MINING ENG; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Knuckles TL, 2013, MICROCIRCULATION, V20, P158, DOI 10.1111/micc.12014; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Lutz BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073203; Maxwell A. E., 2013, Natural Science, V5, P229; Milici RC, 2000, INT J COAL GEOL, V44, P251, DOI 10.1016/S0166-5162(00)00013-6; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Odenheimer J, 2015, GEOCHEM-EXPLOR ENV A, V15, P131, DOI 10.1144/geochem2014-276; Oliphant AJ, 2017, BIOL INVASIONS, V19, P179, DOI 10.1007/s10530-016-1271-6; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Pond GJ, 2014, ENVIRON MANAGE, V54, P919, DOI 10.1007/s00267-014-0319-6; Price SJ, 2016, J APPL ECOL, V53, P459, DOI 10.1111/1365-2664.12585; Ross MRV, 2016, ENVIRON SCI TECHNOL, V50, P2064, DOI 10.1021/acs.est.5b04532; Sen S, 2012, PHOTOGRAMM ENG REM S, V78, P223, DOI 10.14358/PERS.78.3.223; SkyTruth, 2009, MOUNT REM MIN 1; Townsend PA, 2009, REMOTE SENS ENVIRON, V113, P62, DOI 10.1016/j.rse.2008.08.012; U. S. Energy Information Administration, 2016, ANN COAL REP 2015; United States Department of Labor Mine Safety and Health Administration, ACC ILLN INJ EMPL SE; Voss KA, 2017, LIMNOL OCEANOGR, V62, P1754, DOI 10.1002/lno.10531; Wickham JD, 2007, LANDSCAPE ECOL, V22, P179, DOI 10.1007/s10980-006-9040-z; Wickham J, 2013, BIOSCIENCE, V63, P335, DOI 10.1525/bio.2013.63.5.7; Zipper CE, 2011, ENVIRON MANAGE, V47, P751, DOI 10.1007/s00267-011-9670-z; [No title captured]	35	57	57	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0197758	10.1371/journal.pone.0197758	http://dx.doi.org/10.1371/journal.pone.0197758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044790	Green Published, gold			2022-12-27	WOS:000439942500005
J	Kreitschitz, A; Gorb, SN				Kreitschitz, Agnieszka; Gorb, Stanislav N.			The micro- and nanoscale spatial architecture of the seed mucilage-Comparative study of selected plant species	PLOS ONE			English	Article							PRIMARY-CELL WALLS; PECTIC ARABINAN; NEGEV DESERT; ARTEMISIA L.; CELLULOSE; GERMINATION; MICROFIBRILS; ASTERACEAE; MODELS; TAXA	The seed coat mucilage envelope is formed just after hydration and surrounds the seed as a gel-like, transparent capsule. The mucilage envelope represents a special type of modified cell wall with all of the typical polysaccharides i.e. cellulose, pectins and hemicelluloses. The chemical composition of the mucilage is well-recognized but its structural organization remains unclear. In the presented study, we visualized the spatial architecture of the seed mucilage envelope of selected taxa which produce cellulose mucilage. Using critical point drying (CPD) and scanning electron microscopy (SEM) imaging, we demonstrated the structural details of the mucilage from the micro- down to the nanoscale. The mucilage, after CPD, had a visibly spatial structure which differed between the studied taxa; for example, a tangled organization in Arabidopsis thaliana and a more ordered arrangement in Ocimum basilicum were revealed. In general, the mucilaginous fibrillary components formed network made of long, unbranched, thicker cellulose fibrils together with shorter, thinner and, often branched other polysaccharides. Cellulose fibrils built a kind of scaffold for the rest of the components which were spread between them and/or covered their surface. The cellulose fibrils were attached to the seed surface, and therefore prevent the loss of the mucilage envelope during mechanical impacts. The loose architecture and special chemical composition of the mucilaginous cell wall is important for water binding and storage, which are crucial for the proper functioning of the seed mucilage envelope.	[Kreitschitz, Agnieszka; Gorb, Stanislav N.] Univ Kiel, Dept Funct Morphol & Biomech, Kiel, Germany; [Kreitschitz, Agnieszka] Univ Wroclaw, Inst Expt Biol, Dept Plant Dev Biol, Wroclaw, Poland	University of Kiel; University of Wroclaw	Kreitschitz, A (corresponding author), Univ Kiel, Dept Funct Morphol & Biomech, Kiel, Germany.; Kreitschitz, A (corresponding author), Univ Wroclaw, Inst Expt Biol, Dept Plant Dev Biol, Wroclaw, Poland.	agnieszka.kreitschitz@uwr.edu.pl		Kreitschitz, Agnieszka/0000-0002-3045-843X	Short Term Scientific Mission; COST Action [TD0906]; European Union's Horizon 2020 research and innovation programme under the Maria Sklodowska-Curie grant [702293]	Short Term Scientific Mission; COST Action(European Cooperation in Science and Technology (COST)); European Union's Horizon 2020 research and innovation programme under the Maria Sklodowska-Curie grant	This work was supported by Short Term Scientific Mission, COST Action TD0906; European Union's Horizon 2020 research and innovation programme under the Maria Sklodowska-Curie grant agreement No 702293.	Arsovski AA, 2009, PLANT PHYSIOL, V150, P1219, DOI 10.1104/pp.109.138388; Bhatt A, 2016, J ARID ENVIRON, V128, P73, DOI 10.1016/j.jaridenv.2016.01.008; Braune W., 1975, PRAKTIKUM ANATOMII R; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Capitani MI, 2013, J SCI FOOD AGR, V93, P3856, DOI 10.1002/jsfa.6327; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Ciolacu D, 2011, CELL CHEM TECHNOL, V45, P13; Salgado-Cruz MD, 2013, IND CROP PROD, V51, P453, DOI 10.1016/j.indcrop.2013.09.036; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Donaldson LA, 2001, IAWA J, V22, P213, DOI 10.1163/22941932-90000280; FILUTOWICZ A, 1951, MIKROTECHNIKA ROSLIN; GRUBERT M, 1974, Acta Biologica Venezuelica, V8, P315; Gutterman Y, 1996, ISRAEL J PLANT SCI, V44, P125, DOI 10.1080/07929978.1996.10676641; Gutterman Y, 1997, J ARID ENVIRON, V35, P695, DOI 10.1006/jare.1996.0192; HAUGHN GW, 2012, FRONT PLANT SCI, V3, DOI DOI 10.3389/FPLS.2012.00001; Huang Z, 1999, S AFR J BOT, V65, P187, DOI 10.1016/S0254-6299(15)30972-8; Huang ZY, 1999, ISR J PLANT SCI, V47, P27, DOI 10.1080/07929978.1999.10676748; Ioelovich M, 2008, BIORESOURCES, V3, P1403; Jaddu S, 2018, J PHARM PHYTO, V7, P1320; Jarvis MC, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0045; Kreitschitz A, 2007, FLORA, V202, P570, DOI 10.1016/j.flora.2006.12.003; Kreitschitz A, 2017, FLORA, V229, P9, DOI 10.1016/j.flora.2017.02.010; Kreitschitz A, 2015, ACTA BIOMATER, V17, P152, DOI 10.1016/j.actbio.2015.01.042; Kreitschitz A, 2012, SEED SCI RES, V22, P177, DOI 10.1017/S0960258512000098; Liesche J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-226; Macquet A, 2007, PLANT CELL PHYSIOL, V48, P984, DOI 10.1093/pcp/pcm068; Makouate HF, 2012, BOTHALIA, V42, P7, DOI 10.4102/abc.v42i1.4; Marga F, 2005, PLANT J, V43, P181, DOI 10.1111/j.1365-313X.2005.02447.x; McCann MC, 1990, J EXP BOT, V45, P1683; Mendu V, 2011, PLANT PHYSIOL, V157, P441, DOI 10.1104/pp.111.179069; Nakashima J, 1997, PLANT CELL PHYSIOL, V38, P818, DOI 10.1093/oxfordjournals.pcp.a029240; Naran R, 2008, PLANT PHYSIOL, V148, P132, DOI 10.1104/pp.108.123513; North HM, 2014, ANN BOT-LONDON, V114, P1251, DOI 10.1093/aob/mcu011; Prajapati VD, 2013, CARBOHYD POLYM, V92, P1685, DOI 10.1016/j.carbpol.2012.11.021; Ryding O, 2002, SYST GEOGR PLANTS, V71, P503; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; SATIATJEUNEMAITRE B, 1992, PROTOPLASMA, V167, P33, DOI 10.1007/BF01353578; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sullivan S, 2011, PLANT PHYSIOL, V156, P1725, DOI 10.1104/pp.111.179077; Sun Y, 2012, AUST J BOT, V60, P439, DOI 10.1071/BT11314; Terashima N, 2009, J WOOD SCI, V55, P409, DOI 10.1007/s10086-009-1049-x; Tsai AYL, 2017, PLANT PHYSIOL, V173, P1059, DOI 10.1104/pp.16.01600; Voiniciuc C, 2015, PLANT PHYSIOL, V169, P403, DOI 10.1104/pp.15.00851; Voiniciuc C, 2015, INT J MOL SCI, V16, P3452, DOI 10.3390/ijms16023452; Voiniciuc C, 2013, PLANT CELL, V25, P944, DOI 10.1105/tpc.112.107888; Western TL, 2012, SEED SCI RES, V22, P1, DOI 10.1017/S0960258511000249; Windsor JB, 2000, PLANT J, V22, P483, DOI 10.1046/j.1365-313x.2000.00756.x; Yang XJ, 2012, PERSPECT PLANT ECOL, V14, P434, DOI 10.1016/j.ppees.2012.09.002; Zykwinska A, 2007, J EXP BOT, V58, P1795, DOI 10.1093/jxb/erm037	51	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200522	10.1371/journal.pone.0200522	http://dx.doi.org/10.1371/journal.pone.0200522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040844	gold, Green Published, Green Submitted			2022-12-27	WOS:000439749200006
J	Linke, D; Link, D; Lames, M				Linke, Daniel; Link, Daniel; Lames, Martin			Validation of electronic performance and tracking systems EPTS under field conditions	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; CENTER-OF-MASS; TEAM SPORTS; GPS DEVICES; MOVEMENT PATTERNS; ELITE SOCCER; HZ GPS; RELIABILITY; ACCURACY; FOOTBALL	The purpose of this study was to assess the measurement accuracy of the most commonly used tracking technologies in professional team sports (i.e., semi-automatic multiple-camera video technology (VID), radar-based local positioning system (LPS), and global positioning system (GPS)). The position, speed, acceleration and distance measures of each technology were compared against simultaneously recorded measures of a reference system (VICON motion capture system) and quantified by means of the root mean square error RMSE. Fourteen male soccer players (age: 17.4 +/- 0.4 years, height: 178.6 +/- 4.2 cm, body mass: 70.2 +/- 6.2 kg) playing for the U19 Bundesliga team FC Augsburg participated in the study. The test battery comprised a sport-specific course, shuttle runs, and small sided games on an outdoor soccer field. The validity of fundamental spatiotemporal tracking data differed significantly between all tested technologies. In particular, LPS showed higher validity for measuring an athlete's position (23 +/- 7 cm) than both VID (56 +/- 16 cm) and GPS (96 +/- 49 cm). Considering errors of instantaneous speed measures, GPS (0.28 +/- 0.07 m-s(-1)) and LPS (0.25 +/- 0.06 m-s(-1)) achieved significantly lower error values than VID (0.41 +/- 0.08 Equivalent accuracy differences were found for instant acceleration values (GPS: 0.67 +/- 0.21 LPS: 0.68 +/- 0.14 VID: 0.91 +/- 0.19 m-s(-2)). During small-sided games, lowest deviations from reference measures have been found in the total distance category, with errors ranging from 2.2% (GPS) to 2.7% (VID) and 4.0% (LPS). All technologies had in common that the magnitude of the error increased as the speed of the tracking object increased. Especially in performance indicators that might have a high impact on practical decisions, such as distance covered with high speed, we found >40% deviations from the reference system for each of the technologies. Overall, our results revealed significant between-system differences in the validity of tracking data, implying that any comparison of results using different tracking technologies should be done with caution.	[Linke, Daniel; Link, Daniel; Lames, Martin] Tech Univ Munich, Chair Performance Anal & Sports Informat, Munich, Germany	Technical University of Munich	Linke, D (corresponding author), Tech Univ Munich, Chair Performance Anal & Sports Informat, Munich, Germany.	daniel.linke@tum.de		Linke, Danel/0000-0002-5494-917X	German Research Foundation (DFG); Technical University of Munich (TUM); STATS LLC	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM); STATS LLC	The publication of the study was supported by the German Research Foundation (DFG, www.dfg.de) and the Technical University of Munich (TUM, www.tum.de) in the framework of the Open Access Publishing Program. This research was also supported by a research fund that was received from STATS LLC (www.stats.com). The Technical University of Munich, represented by the Chair of Training Science and Sports Informatics, functioned as an independent third party for conducting this validation study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The terms of this arrangement have been reviewed and approved by the Technical University of Munich in accordance with its policy on objectivity in research.; The authors would like to thank the coaches and players from FC Augsburg for their supportive collaboration. We also thank Sebastian Wenninger, Thomas Blobel, Philipp Hofmann, and Philipp Wanner (from the Chair for Training Science and Sports Informatics) for their participation during the preparation and execution of the test. This research was supported by a research fund that was received from STATS LLC. The Technical University of Munich, represented by the Chair of Training Science and Sports Informatics, functioned as an independent third party for conducting this validation study. The terms of this arrangement have been reviewed and approved by the Technical University of Munich in accordance with its policy on objectivity in research.	Aguiar M, 2015, J SPORT SCI, V33, P1259, DOI 10.1080/02640414.2015.1022571; Akenhead R, 2016, INT J SPORT PHYSIOL, V11, P587, DOI 10.1123/ijspp.2015-0331; Akenhead R, 2014, J SCI MED SPORT, V17, P562, DOI 10.1016/j.jsams.2013.08.005; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P295, DOI 10.1123/ijspp.6.3.295; Bahrami Mojtaba, 2010, 2010 IEEE/ION Position, Location and Navigation Symposium - PLANS 2010, P70, DOI 10.1109/PLANS.2010.5507202; Beato M, 2016, J HUM KINET, V54, P15, DOI 10.1515/hukin-2016-0031; Beetz M, 2005, IEEE PERVAS COMPUT, V4, P33, DOI 10.1109/MPRV.2005.53; Buchheit M, 2017, INT J SPORT PHYSIOL, V12, P35, DOI 10.1123/ijspp.2016-0499; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Chalko T.J., 2007, NU J DISCOV, V4, P1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Di Salvo V., 2006, INT J PERF ANAL SPOR, V6, P108, DOI 10.1080/24748668.2006.11868359; Duffield R, 2010, J SCI MED SPORT, V13, P523, DOI 10.1016/j.jsams.2009.07.003; Frencken WGP, 2010, J SCI MED SPORT, V13, P641, DOI 10.1016/j.jsams.2010.04.003; Goncalves BV, 2014, J SPORT SCI, V32, P191, DOI 10.1080/02640414.2013.816761; Hoppe MW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192708; Johnston RJ, 2014, J STRENGTH COND RES, V28, P1649, DOI 10.1519/JSC.0000000000000323; Koklu Y, 2015, J SPORT MED PHYS FIT, V55, P471; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; Ogris G, 2012, J SPORT SCI, V30, P1503, DOI 10.1080/02640414.2012.712712; Rampinini E, 2015, INT J SPORTS MED, V36, P49, DOI 10.1055/s-0034-1385866; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Rawstorn JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093693; Redwood-Brown A, 2012, INT J SPORTS MED, V33, P635, DOI 10.1055/s-0032-1306326; Saini M, 1998, J BIOMECH ENG-T ASME, V120, P133, DOI 10.1115/1.2834293; Schutz Y, 2000, MED SCI SPORT EXER, V32, P642, DOI 10.1097/00005768-200003000-00014; Scott MTU, 2016, J STRENGTH COND RES, V30, P1470, DOI 10.1519/JSC.0000000000001221; Siegle M, 2013, J SPORT SCI, V31, P166, DOI 10.1080/02640414.2012.723131; Stevens TGA, 2014, INT J SPORT PHYSIOL, V9, P446, DOI [10.1123/IJSPP.2013-0340, 10.1123/ijspp.2013-0340]; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Vickery WM, 2014, J STRENGTH COND RES, V28, P1697, DOI 10.1519/JSC.0000000000000285; Virmavirta M, 2014, J BIOMECH, V47, P1909, DOI 10.1016/j.jbiomech.2014.04.001; Zhang J, 2006, J GEODESY, V80, P104, DOI 10.1007/s00190-006-0038-8	36	89	89	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199519	10.1371/journal.pone.0199519	http://dx.doi.org/10.1371/journal.pone.0199519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036364	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200005
J	Torres, KL; Marino, JM; Rocha, DAP; de Mello, MB; Farah, HHD; Reis, RD; Alves, VDR; Gomes, E; Martins, TR; Soares, AC; de Oliveire, CM; Levi, JE				Torres, Katia Luz; Marino, Josiane Montanho; Pires Rocha, Danielle Albuquerque; de Mello, Monica Bandeira; de Melo Farah, Heydy Halanna; Reis, Renato dos Santos; Rodrigues Alves, Valquiria do Carmo; Gomes, Edson; Martins, Toni Ricardo; Soares, Ana Carolina; de Oliveire, Cristina Mendes; Levi, Jose Eduardo			Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas	PLOS ONE			English	Article							CANCER SCREENING-PROGRAM; HUMAN-PAPILLOMAVIRUS; LATIN-AMERICA; RURAL CHINA; METAANALYSIS; IMPLEMENTATION; COLLECTION; TRIALS; TESTS; WOMEN	Objective To evaluate both the performance and acceptability of a method coupling self-sampling with detection of cervical malignancy via elevated HPV 16 and 18 E6 oncoproteins (OncoE6((TM)) Cervical Test) in remote areas in Brazil. Methods Women living in rural villages in proximity to Coari city, Amazonas, Brazil were invited to participate in a cervical cancer screening study. 412 subjects were enrolled; there were no refusals. In addition to E6 protein detection, DNA was extracted from the brushes and evaluated for HPV genotypes by PCR (PGMY09/11), followed by typing by the Papillocheck (TM) if positive. Subjects who were found to be positive for OncoE6 or HPV-DNA were referred for colposcopy. Results For 110 subjects (27%) this was the first cervical cancer exam. Overall the HPV-DNA prevalence was 19.1% (n = 79); 1.4% (n = 6) were positive by the OncoE6 Test. Fifty-six women attended the invitation for colposcopy where nine had an abnormal cervix and were subsequently biopsied. Histopathological analysis revealed 2 CIN3, 2 carcinomas and 5 CIN1. OncoE6 called two out of the three HPV 16 or 18 associated CIN3+ lesions. Conclusions The findings suggest that self-administered sample collection in combination with OncoE6 Test is feasible in this population. This could enable expanded screening coverage while ensuring a high specificity which is imperative given the remote geographic location, since women bearing abnormal test results would necessitate travel and logistical burden to access colposcopy and treatment.	[Torres, Katia Luz; Pires Rocha, Danielle Albuquerque] Univ Fed Amazonas UFAM, Programa Posgrad Ciencias Saude, Manaus, Amazonas, Brazil; [Torres, Katia Luz; de Melo Farah, Heydy Halanna; Rodrigues Alves, Valquiria do Carmo] Univ Fed Amazonas UFAM, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Torres, Katia Luz; de Mello, Monica Bandeira; Rodrigues Alves, Valquiria do Carmo] Fundacao Ctr Oncol Estado Amazonas FCECON, Manaus, Amazonas, Brazil; [Marino, Josiane Montanho; Pires Rocha, Danielle Albuquerque; Reis, Renato dos Santos] Univ Fed Amazonas UFAM, Coari, Amazonas, Brazil; [Gomes, Edson] Lab Sebastiao Marinho, Manaus, Amazonas, Brazil; [Martins, Toni Ricardo; Soares, Ana Carolina; de Oliveire, Cristina Mendes; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil	Universidade Federal de Amazonas; Universidade Federal de Amazonas; Universidade Federal de Amazonas; Universidade de Sao Paulo	Levi, JE (corresponding author), Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.	dudilevi@usp.br	Rocha, Danielle/HGB-8799-2022; Torres, K. L./AGN-0021-2022; Gomes, Edson/AAB-5618-2020	Torres, K. L./0000-0003-0922-5866; 	FAPEAM Grant [062.00650/2015]	FAPEAM Grant	This study was sponsored by FAPEAM Grant# 062.00650/2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa RFA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138945; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arrossi S, 2015, INT J CANCER, V137, P1709, DOI 10.1002/ijc.29530; Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Bychkovsky BL, 2016, CANCER-AM CANCER SOC, V122, P502, DOI 10.1002/cncr.29813; Carozzi FM, 2016, J CLIN VIROL, V76, pS22, DOI 10.1016/j.jcv.2015.10.025; Derchain S, 2016, REV BRAS GINECOL OBS, V38, P161, DOI 10.1055/s-0036-1582399; Diaz RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139677; Enerly E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151978; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Jeronimo J, 2016, J CLIN VIROL, V76, pS69, DOI 10.1016/j.jcv.2015.11.035; Lazcano-Ponce E, 2014, INT J CANCER, V135, P109, DOI 10.1002/ijc.28639; Mariano VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164892; Ministerio da Saude (BR). Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2017, COORD PREV VIG EST 2; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rossi PG, 2015, BRIT J CANCER, V112, P667, DOI 10.1038/bjc.2015.11; SIM-Sistema de Informac E sobre Mortalidade, DATASUS MIN SAUD; Subramaniam A, 2011, J LOW GENIT TRACT DI, V15, P110, DOI 10.1097/LGT.0b013e3181f515a2; Valdez M, 2016, INT J CANCER, V138, P1453, DOI 10.1002/ijc.29877; Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006; Zhao FH, 2013, CANCER PREV RES, V6, P938, DOI 10.1158/1940-6207.CAPR-13-0091	22	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							eO201262	10.1371/journal.pone.0201262	http://dx.doi.org/10.1371/journal.pone.0201262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036381	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200033
J	Worthy, SE; Haynes, L; Chambers, M; Bethune, D; Kan, E; Chung, K; Ota, R; Taylor, CJ; Glater, EE				Worthy, Soleil E.; Haynes, Lillian; Chambers, Melissa; Bethune, Danika; Kan, Emily; Chung, Kevin; Ota, Ryan; Taylor, Charles J.; Glater, Elizabeth E.			Identification of attractive odorants released by preferred bacterial food found in the natural habitats of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PREFERENCE; BEHAVIOR	Food choice is critical for survival because organisms must choose food that is edible and nutritious and avoid pathogenic food. Many organisms, including the nematode C. elegans, use olfaction to detect and distinguish among food sources. C. elegans exhibits innate preferences for the odors of different bacterial species. However, little is known about the preferences of C. elegans for bacterial strains isolated from their natural environment as well as the attractive volatile compounds released by preferred natural bacteria isolates. We tested food odor preferences of C. elegans for non-pathogenic bacteria found in their natural habitats. We found that C. elegans showed a preference for the odor of six of the eight tested bacterial isolates over its standard food source, E. coli HB101. Using solid-phase microextraction and gas chromatography coupled with mass spectrometry, we found that four of six attractive bacterial isolates (Alcaligenes sp. JUb4, Providenica sp. JUb5, Providencia sp. JUb39, and Flavobacteria sp. JUb43) released isoamyl alcohol, a well-studied C. elegans attractant, while both non-attractive isolates (Raoultella sp. JUb38 and Acinetobacter sp. JUb68) released very low or non-detectable amounts of isoamyl alcohol. In conclusion, we find that isoamyl alcohol is likely an ethologically relevant odor that is released by some attractive bacterial isolates in the natural environment of C. elegans.	[Worthy, Soleil E.; Taylor, Charles J.] Pomona Coll, Dept Chem, Claremont, CA 91711 USA; [Haynes, Lillian] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Chambers, Melissa; Bethune, Danika; Kan, Emily; Chung, Kevin; Ota, Ryan; Glater, Elizabeth E.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA	Claremont Colleges; Pomona College; Claremont Colleges; Harvey Mudd College; Claremont Colleges; Pomona College	Glater, EE (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	elizabeth.glater@pomona.edu	Taylor, Chuck/Q-6879-2019	Glater, Elizabeth/0000-0003-0205-8209	Pomona College; Harvey Mudd College; Pomona College Summer Undergraduate Research Program; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program; Support of Mentors and their Students in the Neurosciences Grant (SOMAS2012)	Pomona College; Harvey Mudd College; Pomona College Summer Undergraduate Research Program; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program; Support of Mentors and their Students in the Neurosciences Grant (SOMAS2012)	Funding came from Pomona College (EG, CT), Harvey Mudd College (EG), Pomona College Summer Undergraduate Research Program (DB, RO, KC), a grant to Pomona College and Harvey Mudd College from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program (SW, LH), and Support of Mentors and their Students in the Neurosciences Grant (SOMAS2012) (MC, EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Choi JI, 2016, ISME J, V10, P558, DOI 10.1038/ismej.2015.134; Collin S, 2012, J AGR FOOD CHEM, V60, P380, DOI 10.1021/jf203832c; Glater EE, 2014, G3-GENES GENOM GENET, V4, P265, DOI 10.1534/g3.113.008649; Gomila M A, 2015, FRONT MICROBIOL; Harris G, 2014, J NEUROSCI, V34, P9389, DOI 10.1523/JNEUROSCI.0012-14.2014; Hsueh YP, 2017, ELIFE, V6, DOI [10.7554/eLife.20023, 10.7554/elife.20023]; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Pereira S, 2012, J NEUROSCI, V32, P9035, DOI 10.1523/JNEUROSCI.4221-11.2012; Samuel BS, 2016, P NATL ACAD SCI USA, V113, pE3941, DOI 10.1073/pnas.1607183113; Schulenburg H, 2017, GENETICS, V206, P55, DOI 10.1534/genetics.116.195511; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Vos P, 2009, THE FIRMICUTES, V3; Worthy SE, 2018, CHEM SENSES, V43, P169, DOI 10.1093/chemse/bjy001; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134401; Zhang CM, 2016, J BIOL CHEM, V291, P23618, DOI 10.1074/jbc.M116.741132; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	25	23	23	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0201158	10.1371/journal.pone.0201158	http://dx.doi.org/10.1371/journal.pone.0201158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036396	Green Published, gold, Green Submitted			2022-12-27	WOS:000439429200031
J	McGinity, MJ; Grandhi, R; Michalek, JE; Rodriguez, JS; Trevino, AM; McGinity, AC; Seifi, A				McGinity, Michael J.; Grandhi, Ramesh; Michalek, Joel E.; Rodriguez, Jesse S.; Trevino, Aron M.; McGinity, Ashley C.; Seifi, Ali			The impact of tackle football injuries on the American healthcare system with a neurological focus (vol 13, e0195827, 2018)	PLOS ONE			English	Correction													Seifi, Ali/AAR-6163-2020					McGinity MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195827	1	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201273	10.1371/journal.pone.0201273	http://dx.doi.org/10.1371/journal.pone.0201273			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024960	Green Published, gold, Green Submitted			2022-12-27	WOS:000439120000100
J	Brown, DM; Jones, S; Daniel, ZCTR; Brearley, MC; Lewis, JE; Ebling, FJP; Parr, T; Brameld, JM				Brown, David M.; Jones, Sarah; Daniel, Zoe C. T. R.; Brearley, Madelaine C.; Lewis, Jo E.; Ebling, Francis J. P.; Parr, Tim; Brameld, John M.			Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; I DOSE-ESCALATION; SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; OLDER PERSONS; ER STRESS; PHENYLBUTYRATE; ACID; ATROPHY; SARCOPENIA	Previously, we highlighted induction of an integrated stress response (ISR) gene program in skeletal muscle of pigs treated with a beta-adrenergic agonist. Hence we tested the hypothesis that the ER-stress inhibitor, sodium 4-phenylbutyrate (PBA), would inhibit Clenbuterol-mediated muscle growth and reduce expression of genes that are known indicators of an ISR in mice. Clenbuterol (1 mg/kg/day) administered to C57BL6/J mice for 21 days increased body weight (p<0.001), muscle weights (p<0.01), and muscle fibre diameters (p<0.05). Co-administration of PBA (100mg/kg/day) did not alter the Clenbuterol-mediated phenotype, nor did PBA alone have any effects compared to that of the vehicle treated mice. Clenbuterol increased skeletal muscle mRNA expression of phosphoserine amino transferase 1 (PSAT1, p<0.001) and cyclophillin A (p<0.01) at day 3, but not day 7. Clenbuterol decreased mRNA expression of activating transcription factor (ATF) 4 and ATF5 at day 3 (p<0.05) and day 7 (p<0.01), X-box binding protein 1 (XBP1) variant 2 mRNA at day 3 only (p<0.01) and DNA damage inducible transcript 3 (DDIT3/CHOP) mRNA at day 7 only (p<0.05). Co-administration of PBA had no effect on Clenbuterol-induced changes in skeletal muscle gene expression. In contrast, treatment of C2C12 myotubes with 5mM PBA (8hr) attenuated the thapsigargin-induced ISR gene program. Prolonged (24-48hr) treatment with PBA caused atrophy (p<0.01), reduced neoprotein synthesis (p<0.0001) and decreased expression of myogenin and fast myosin heavy chain genes (p<0.01), indicating an inhibition of myogenic differentiation. In summary, Clenbuterol did not induce an ISR gene program in mouse muscle. On the contrary, it reduced expression of a number of ISR genes, but it increased expression of PSAT1 mRNA. Co-administration of PBA had no effect on Clenbuterol-mediated muscle growth or gene expression in mice, whereas PBA did inhibit thapsigargin-induced ISR gene expression in cultured C2C12 cells and appeared to inhibit myogenic differentiation, independent of altering ISR gene expression.	[Brown, David M.; Jones, Sarah; Daniel, Zoe C. T. R.; Brearley, Madelaine C.; Parr, Tim; Brameld, John M.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Lewis, Jo E.; Ebling, Francis J. P.] Univ Nottingham, Med Sch, Sch Life Sci, Nottingham, England	University of Nottingham; University of Nottingham	Brameld, JM (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	John.Brameld@Nottingham.ac.uk	Brameld, John/AAB-1745-2021; Ebling, Francis/Q-6193-2019	Brameld, John/0000-0003-4942-080X; Ebling, Francis/0000-0002-7316-9582; Lewis, Jo Edward/0000-0002-5722-6778; Parr, Tim/0000-0003-2490-9457; Sholto, Madelaine/0000-0001-7306-9242	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/MM001385/1]; Zoetis; BBSRC [BB/M001385/1, BB/M017524/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) (grant number BB/MM001385/1) and by Zoetis (formerly Pfizer Animal Health). The funders had no input into the study design, data collection and analysis or preparation of manuscript. The MF20 monoclonal antibody was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28693; Brown D. M., 2016, J CACHEXIA SARCOPE 1, V7, P626, DOI [10.1002/jcsm.12164, DOI 10.1002/JCSM.12164]; Brown DM, 2015, AGEING RES REV, V24, P263, DOI 10.1016/j.arr.2015.08.007; Brown DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114365; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; BRUSILOW SW, 1991, PEDIATR RES, V29, P147, DOI 10.1203/00006450-199102000-00009; BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503; Camacho LH, 2007, INVEST NEW DRUG, V25, P131, DOI 10.1007/s10637-006-9017-4; Cao AL, 2016, LAB INVEST, V96, P610, DOI 10.1038/labinvest.2016.44; Collins A, 1995, BLOOD, V85; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gilbert J, 2001, CLIN CANCER RES, V7, P2292; Hamilton DL, 2014, AM J PHYSIOL-ENDOC M, V307, pE365, DOI 10.1152/ajpendo.00674.2013; Hu HL, 2014, CELL PHYSIOL BIOCHEM, V33, P1899, DOI 10.1159/000362967; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jellbauer S, 2016, INFECT IMMUN, V84, P2639, DOI 10.1128/IAI.00132-16; Kim HJ, 2011, MED SCI SPORT EXER, V43, P18, DOI 10.1249/MSS.0b013e3181e4c5d1; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34036; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P130, DOI 10.1016/j.nmd.2003.11.006; NEWMARK HL, 1995, J CELL BIOCHEM, P247; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Park Y, 2017, CELL REP, V19, P1083, DOI 10.1016/j.celrep.2017.04.042; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Rubenstein R, 1998, AM J RESP CRIT CARE, V157; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Spurlock DM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-320; Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; WILEY JC, 2010, PLOONE PUBLIC LIB, V5, DOI DOI 10.1371/JOURNAL.PONE.0009135; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zeng MC, 2017, TOXICOL LETT, V271, P26, DOI 10.1016/j.toxlet.2017.02.023; Zhang L, 2016, DIS MODEL MECH, V9, P799, DOI 10.1242/dmm.023242	46	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201481	10.1371/journal.pone.0201481	http://dx.doi.org/10.1371/journal.pone.0201481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052661	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000440006600047
J	Ye, CF; Ma, T; Wu, D; Ceritoglu, C; Miller, MI; Mori, S				Ye, Chenfei; Ma, Ting; Wu, Dan; Ceritoglu, Can; Miller, Michael I.; Mori, Susumu			Atlas pre-selection strategies to enhance the efficiency and accuracy of multi-atlas brain segmentation tools	PLOS ONE			English	Article							SELECTION; ONTOLOGY; MRI	Multi-atlas brain segmentation of human brain MR images allows quantification research in structural neuroimaging. To achieve high accuracy and computational efficiency of segmentation relies on a custom subset of atlases for each target subject. However, the criterion for atlas pre-selection remains an open question. In this study, two atlas pre-selection approaches based on location-based feature matching were proposed and compared to random and mutual information-based methods using a database of 47 atlases. A varying number of atlases ranked top with hierarchical structural granularity were compared using Dice overlap. The results indicated that the proposed 4L approach consistently led to the highest level of accuracy at a given number of employed atlases in both adult and geriatric populations. In addition, the proposed two methods (4L and LV) can reduce 20 times computational time compared with the stereotypical mutual information-based method. Our pre-selection strategy would provide better segmentation performance in terms of both accuracy and efficiency. The proposed atlas pre-selection will be further implemented into our online automatic brain image segmentation system (www.mricloud.org).	[Ye, Chenfei; Ma, Ting] Harbin Inst Technol, Shenzhen Grad Sch, Dept Elect & Informat, Shenzhen, Guangdong, Peoples R China; [Ma, Ting] Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China; [Ma, Ting; Wu, Dan; Ceritoglu, Can; Mori, Susumu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Sch Med, Ctr Imaging Sci, Baltimore, MD USA; [Mori, Susumu] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA	Harbin Institute of Technology; University Town of Shenzhen; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute	Ma, T (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Elect & Informat, Shenzhen, Guangdong, Peoples R China.; Ma, T (corresponding author), Natl Clin Res Ctr Geriatr Disorders, Beijing, Peoples R China.; Ma, T (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA.	tmahit@outlook.com	Ye, Chenfei/K-9207-2016; Ma, Ting/N-3320-2014	Ye, Chenfei/0000-0001-5265-3546; Ma, Ting/0000-0001-8819-6228	Basic Research Foundation Key Project Track of Shenzhen Science and Technology Program [JCYJ20160509162237418, JCYJ20170413110656460]; Basic Research Foundation of Shenzhen Science and Technology Program [JCYJ20150403161923510]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	Basic Research Foundation Key Project Track of Shenzhen Science and Technology Program; Basic Research Foundation of Shenzhen Science and Technology Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The author T. M. received three fundings: The Basic Research Foundation Key Project Track of Shenzhen Science and Technology Program (JCYJ20160509162237418, JCYJ20170413110656460), and the Basic Research Foundation of Shenzhen Science and Technology Program (JCYJ20150403161923510).	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Ceritoglu C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00151; Chau W, 2005, NEUROIMAGE, V25, P408, DOI 10.1016/j.neuroimage.2004.12.007; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Djamanakova A, 2014, NEUROIMAGE, V101, P168, DOI 10.1016/j.neuroimage.2014.06.046; Mai J, 2007, ATLAS OF HUMAN BRAIN, P02, DOI DOI 10.1016/J.NEUROIMAGE.2014.06.046; Nam H, 2009, COMMUN NUMER METH EN, V25, P583, DOI 10.1002/cnm.1176; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Puelles L, 2013, TRENDS NEUROSCI, V36, P570, DOI 10.1016/j.tins.2013.06.004; Sanroma G, 2014, IEEE T MED IMAGING, V33, P1939, DOI 10.1109/TMI.2014.2327516; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tang XY, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00061; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065591; TANG XY, 2013, PLOS ONE, V8; Wu D, 2016, NEUROIMAGE, V125, P120, DOI 10.1016/j.neuroimage.2015.10.042; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050	17	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0200294	10.1371/journal.pone.0200294	http://dx.doi.org/10.1371/journal.pone.0200294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052643	Green Published, Green Submitted, gold			2022-12-27	WOS:000440006600007
J	Held, M; Santeramo, I; Wilm, B; Murray, P; Levy, R				Held, Marie; Santeramo, Ilaria; Wilm, Bettina; Murray, Patricia; Levy, Raphael			Ex vivo live cell tracking in kidney organoids using light sheet fluorescence microscopy	PLOS ONE			English	Article							PLANE ILLUMINATION MICROSCOPY; SINGLE-PARTICLE TRACKING; STEM-CELLS; SELF-ORGANIZATION; PROGENITOR CELLS; TISSUES; MOUSE; SUSPENSIONS; EXPRESSION; GENERATION	Screening cells for their differentiation potential requires a combination of tissue culture models and imaging methods that allow for long-term tracking of the location and function of cells. Embryonic kidney re-aggregation in vitro assays have been established which allow for the monitoring of organotypic cell behaviour in re-aggregated and chimeric renal organoids. However, evaluation of cell integration is hampered by the high photonic load of standard fluorescence microscopy which poses challenges for imaging three-dimensional systems in real-time over a time course. Therefore, we employed light sheet microscopy, a technique that vastly reduces photobleaching and phototoxic effects. We have also developed a new method for culturing the re-aggregates which involves immersed culture, generating organoids which more closely reflect development in vivo. To facilitate imaging from various angles, we embedded the organoids in a freely rotatable hydrogel cylinder. Endpoint fixing and staining were performed to provide additional biomolecular information. We succeeded in imaging labelled cells within re-aggregated kidney organoids over 15 hours and tracking their fate while simultaneously monitoring the development of organotypic morphological structures. Our results show that Wt1-expressing embryonic kidney cells obtained from transgenic mice could integrate into re-aggregated chimeric kidney organoids and contribute to developing nephrons. Furthermore, the nascent proximal tubules that formed in the re-aggregated tissues using the new culture method displayed secretory function, as evidenced by their ability to secrete an organic anion mimic into the tubular lumen.	[Held, Marie; Levy, Raphael] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England; [Santeramo, Ilaria; Wilm, Bettina; Murray, Patricia] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Levy, R (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.; Wilm, B; Murray, P (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England.	bwilm@liverpool.ac.uk; embryo@liverpool.ac.uk; rapha@liverpool.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Murray, Patricia/0000-0003-1316-148X; Held, Marie/0000-0003-0118-5898	UK Regenerative Medicine Platform [MR/K026739/1]; BBSRC [BB/L014947/1]; Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; MRC [MR/K015931/1, MR/M009114/1, MR/K026739/1] Funding Source: UKRI	UK Regenerative Medicine Platform; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Regenerative Medicine Platform (MR/K026739/1, http://www.ukrmp.org.uk/). We acknowledge the Liverpool Centre for Cell Imaging (CCI) for provision of imaging equipment, in particular the Zeiss Lightsheet Z.1 funded by BBSRC (https://www.bbsrc.ac.uk/) Alert13 grant number BB/L014947/1 and technical assistance. I.S. was funded by the Nephrotools FP7 Marie Curie training grant (http://www.nephrotools.com/), and Alder Hey Children's Kidney fund (http://www. alderheychildrenskidneyfund.org/). We would also like to thank Thomas Wilm for help with the genotyping of the mice, and Marco Marcello and David Mason for help with technical assistance and image analysis support.; This work was supported by the UK Regenerative Medicine Platform (MR/K026739/1). We acknowledge the Liverpool Centre for Cell Imaging (CCI) for provision of imaging equipment, in particular the Zeiss Lightsheet Z. 1 funded by BBSRC Alert13 grant number BB/L014947/1 and technical assistance. I.S. was funded by the Nephrotools FP7 Marie Curie training grant, and Alder Hey Children's Kidney fund. We would also like to thank Thomas Wilm for help with the genotyping of the mice, and Marco Marcello and David Mason for help with technical assistance and image analysis support.	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Davies JA, 2014, PEDIATR NEPHROL, V29, P519, DOI 10.1007/s00467-013-2579-4; Davies Jamie A, 2012, Methods Mol Biol, V886, P135, DOI 10.1007/978-1-61779-851-1_12; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; GROBSTEIN C, 1956, EXP CELL RES, V10, P424, DOI 10.1016/0014-4827(56)90016-7; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Henry KS, 2001, ENVIRON TOXICOL CHEM, V20, P2611, DOI 10.1002/etc.5620201129; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Icha J, 2016, USING LIGHT SHEET FL, DOI [10.3791/53966, DOI 10.3791/53966]; Junttila S, 2015, J AM SOC NEPHROL, V26, P1126, DOI 10.1681/ASN.2013060584; Kaufmann A, 2012, DEVELOPMENT, V139, P3242, DOI 10.1242/dev.082586; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Lawrence ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep09092; Lefevre JG, 2017, DEVELOPMENT, V144, P1087, DOI 10.1242/dev.140228; Lindstrom NO, 2015, ELIFE, V4, DOI 10.7554/eLife.04000; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Lorenzo C, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-22; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Pampaloni F, 2015, CELL TISSUE RES, V360, P129, DOI 10.1007/s00441-015-2144-5; Pampaloni F, 2015, METHODS MOL BIOL, V1251, P43, DOI 10.1007/978-1-4939-2080-8_3; Pampaloni F, 2014, INTEGR BIOL-UK, V6, P988, DOI 10.1039/c4ib00121d; Parreira KS, 2009, PFLUG ARCH EUR J PHY, V458, P745, DOI 10.1007/s00424-009-0667-x; Poguzhelskaya E, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-19; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Rak-Raszewska A, 2016, EUR J PHARMACOL, V790, P3, DOI 10.1016/j.ejphar.2016.07.011; Rak-Raszewska A, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/959807; Rak-Raszewska A, 2012, ORGANOGENESIS, V8, P125, DOI 10.4161/org.22597; Ranghini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062953; Riccio P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002382; Saarela U, 2017, DEVELOPMENT, V144, P1113, DOI 10.1242/dev.142950; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Sebinger DDR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010550; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Strnad P, 2016, NAT METHODS, V13, P139, DOI [10.1038/NMETH.3690, 10.1038/nmeth.3690]; Swoger J, 2014, COLD SPRING HARBOR P, V2014; Swoger Jim, 2014, Cold Spring Harb Protoc, V2014, P114, DOI 10.1101/pdb.prot080184; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Torres M, 1995, DEVELOPMENT, V121, P4057; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Wilm B, 2016, METHODS MOL BIOL, V1467, P23, DOI 10.1007/978-1-4939-4023-3_3; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yamashita N, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.101206	57	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0199918	10.1371/journal.pone.0199918	http://dx.doi.org/10.1371/journal.pone.0199918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048451	gold, Green Submitted, Green Published			2022-12-27	WOS:000439952400004
J	Koklic, T; Urbancic, I; Zdovc, I; Golob, M; Umek, P; Arsov, Z; Drazic, G; Pintaric, S; Dobeic, M; Strancar, J				Koklic, Tilen; Urbancic, Iztok; Zdovc, Irena; Golob, Majda; Umek, Polona; Arsov, Zoran; Drazic, Goran; Pintaric, Stefan; Dobeic, Martin; Strancar, Janez			Surface deposited one-dimensional copper-doped TiO2 nanomaterials for prevention of health care acquired infections	PLOS ONE			English	Article							OXYGEN-CENTERED RADICALS; LISTERIA-MONOCYTOGENES; TITANATE NANOTUBES; HYDROGEN-PEROXIDE; TITANIUM-DIOXIDE; FLUORESCENCE MICROSPECTROSCOPY; HETEROGENEOUS PHOTOCATALYSIS; PHOSPHORYLATED NITRONE; ANTIMICROBIAL ACTIVITY; MICROBIAL-CELLS	Bacterial infections acquired in healthcare facilities including hospitals, the so called healthcare acquired or nosocomial infections, are still of great concern worldwide and represent a significant economical burden. One of the major causes of morbidity is infection with Methicillin Resistant Staphylococcus aureus (MRSA), which has been reported to survive on surfaces for several months. Bactericidal activity of copper-TiO2 thin films, which release copper ions and are deposited on glass surfaces and heated to high temperatures, is well known even when illuminated with very weak UVA light of about 10 mu W/cm(2). Lately, there is an increased intrerest for one-dimensional TiO2 nanomaterials, due to their unique properties, low cost, and high thermal and photochemical stability. Here we show that copper doped TiO2 nanotubes produce about five times more center dot OH radicals as compared to undoped TiO2 nanotubes and that effective surface disinfection, determined by a modified ISO 22196:2011 test, can be achieved even at low intensity UVA light of 30 mu W/cm(2). The nanotubes can be deposited on a preformed surface at room temperature, resulting in a stable deposition resistant to multiple washings. Up to 10(3) microorganisms per cm(2) can be inactivated in 24 hours, including resistant strains such as Methicillin-resistant Staphylococcus aureus (MRSA) and Extended-spectrum beta-lactamase Escherichia coli (E. coli ESBL). This disinfection method could provide a valuable alternative to the current surface disinfection methods.	[Koklic, Tilen; Urbancic, Iztok; Umek, Polona; Arsov, Zoran; Strancar, Janez] Jozef Stefan Inst, Dept Condensed Matter Phys, Ljubljana, Slovenia; [Koklic, Tilen; Zdovc, Irena; Umek, Polona; Arsov, Zoran; Strancar, Janez] NAMASTE Ctr Excellence, Ljubljana, Slovenia; [Urbancic, Iztok] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Human Immunol Unit, Oxford, England; [Zdovc, Irena; Golob, Majda] Univ Ljubljana, Inst Microbiol & Parasitol, Fac Vet, Ljubljana, Slovenia; [Drazic, Goran] Natl Inst Chem, Dept Chem Mat, Ljubljana, Slovenia; [Pintaric, Stefan; Dobeic, Martin] Univ Ljubljana, Fac Vet, Inst Environm & Anim Hyg Anim Behav, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Oxford; University of Ljubljana; National Institute of Chemistry - Slovenia; University of Ljubljana	Strancar, J (corresponding author), Jozef Stefan Inst, Dept Condensed Matter Phys, Ljubljana, Slovenia.; Strancar, J (corresponding author), NAMASTE Ctr Excellence, Ljubljana, Slovenia.	janez.strancar@ijs.si	Drazic, Goran/A-2017-2008; Urbančič, Iztok/AAU-3027-2020	Drazic, Goran/0000-0001-7809-8050; Urbančič, Iztok/0000-0003-3603-6585; Arsov, Zoran/0000-0001-7894-3648; Strancar, Janez/0000-0001-8032-132X	Slovenian Research Agency ARRS, Javna Agencija za Raziskovalno Dejavnost RS [P1-0060]; NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future, ADVANCED BIO MATERIALS	Slovenian Research Agency ARRS, Javna Agencija za Raziskovalno Dejavnost RS; NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future, ADVANCED BIO MATERIALS	This study was supported by Slovenian Research Agency ARRS, Javna Agencija za Raziskovalno Dejavnost RS, research core funding no. (P1-0060), prof. Janez Strancar; and NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future, ADVANCED BIO MATERIALS, prof. Janez Strancar.	Abreu AC, 2013, J ANTIMICROB CHEMOTH, V68, P2718, DOI 10.1093/jac/dkt281; Adams EG, 1977, FREE RADICALS BIOL, p52 ; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Baureder M, 2012, FEMS MICROBIOL LETT, V331, P160, DOI 10.1111/j.1574-6968.2012.02567.x; Bhalla A, 2004, INFECT CONT HOSP EP, V25, P164, DOI 10.1086/502369; Buchalska M, 2015, ACS CATAL, V5, P7424, DOI 10.1021/acscatal.5b01562; Cadnum JL, 2015, AM J INFECT CONTROL, V43, P1357, DOI 10.1016/j.ajic.2015.07.016; Ciesla P, 2004, J MOL CATAL A-CHEM, V224, P17, DOI 10.1016/j.molcata.2004.08.043; De Jong WH, 2013, BIOMATERIALS, V34, P8333, DOI 10.1016/j.biomaterials.2013.06.048; Silva AADE, 2012, BRAZ J MICROBIOL, V43, P1620, DOI [10.1590/S1517-83822012000400047, 10.1590/S1517-838220120004000047]; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Ditta IB, 2008, APPL MICROBIOL BIOT, V79, P127, DOI 10.1007/s00253-008-1411-8; Dunlop PSM, 2010, J PHOTOCH PHOTOBIO A, V216, P303, DOI 10.1016/j.jphotochem.2010.07.004; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Emeline AV, 2005, J PHYS CHEM B, V109, P18515, DOI 10.1021/jp0523367; Foster HA, 2010, J PHOTOCH PHOTOBIO A, V216, P283, DOI 10.1016/j.jphotochem.2010.09.017; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; FREJAVILLE C, 1994, J CHEM SOC CHEM COMM, P1793, DOI 10.1039/c39940001793; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Garrido V, 2010, FOOD CONTROL, V21, P896, DOI 10.1016/j.foodcont.2009.12.007; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Herrmann JM, 2010, J PHOTOCH PHOTOBIO A, V216, P85, DOI 10.1016/j.jphotochem.2010.05.015; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Huang C, 2007, APPL PHYS A-MATER, V87, P781, DOI 10.1007/s00339-007-3902-3; HUDSON JA, 1994, J FOOD PROTECT, V57, P204, DOI 10.4315/0362-028X-57.3.204; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Kakuma Y, 2015, PHYS CHEM CHEM PHYS, V17, P18691, DOI 10.1039/c5cp02004b; Khare P, 2018, ACS SUSTAIN CHEM ENG, V6, P579, DOI 10.1021/acssuschemeng.7b02929; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kupferschmidt K, 2016, SCIENCE, V352, P758, DOI 10.1126/science.352.6287.758; Litter MI, 1999, APPL CATAL B-ENVIRON, V23, P89, DOI 10.1016/S0926-3373(99)00069-7; Lock N, 2013, DALTON T, V42, P9555, DOI 10.1039/c3dt00122a; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; Molling JW, 2014, NANOTECHNOL SCI APPL, V7, P97, DOI 10.2147/NSA.S70782; Muers M., 2007, NAT NEWS, DOI [10.1038/news070903-14, DOI 10.1038/NEWS070903-14]; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Nian JN, 2006, J PHYS CHEM B, V110, P25817, DOI 10.1021/jp064209w; Noimark S, 2013, ADV DRUG DELIVER REV, V65, P570, DOI 10.1016/j.addr.2012.07.003; Perron GG, 2015, EVOL APPL, V8, P211, DOI 10.1111/eva.12254; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Qiu XQ, 2012, ACS NANO, V6, P1609, DOI 10.1021/nn2045888; Rodrigues D, 2013, APPL SURF SCI, V270, P1, DOI 10.1016/j.apsusc.2012.11.119; ROSENOW EM, 1987, J FOOD PROTECT, V50, P452, DOI 10.4315/0362-028X-50.6.452; Rossvoll E, 2014, INT J FOOD MICROBIOL, V185, P82, DOI 10.1016/j.ijfoodmicro.2014.05.020; Sato T, 2006, BIOCHEM ENG J, V30, P199, DOI 10.1016/j.bej.2006.04.002; Selmani A, 2015, J PHYS CHEM C, V119, P19729, DOI 10.1021/acs.jpcc.5b02027; Sluban M, 2017, J CATAL, V346, P161, DOI 10.1016/j.jcat.2016.12.015; Sunada K, 2003, ENVIRON SCI TECHNOL, V37, P4785, DOI 10.1021/es034106g; Umek P, 2008, J PHYS CHEM C, V112, P15311, DOI 10.1021/jp805005k; Umek P, 2007, J NANOSCI NANOTECHNO, V7, P3502, DOI 10.1166/jnn.2007.838; Urbancic I, 2013, OPT EXPRESS, V21, P25291, DOI 10.1364/OE.21.025291; Urbancic I, 2013, BIOPHYS J, V105, P919, DOI 10.1016/j.bpj.2013.07.005; Volker C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075026; Vogel R, 2004, SPECTROCHIM ACTA A, V60, P245, DOI 10.1016/S1386-1425(03)00218-X; WATANABE T, 1977, J PHYS CHEM-US, V81, P1845, DOI 10.1021/j100534a012; Wright GD, 2007, CELL, V130, P781, DOI 10.1016/j.cell.2007.08.023; Wu B, 2010, SCI TOTAL ENVIRON, V408, P1755, DOI 10.1016/j.scitotenv.2009.11.004; Wu TX, 1998, J PHYS CHEM B, V102, P5845, DOI 10.1021/jp980922c; Xin BF, 2008, APPL SURF SCI, V254, P2569, DOI 10.1016/j.apsusc.2007.09.002; Yang MY, 2014, CHEM SOC REV, V43, P6511, DOI 10.1039/c4cs00117f; Yi J, 2012, J PHYS CHEM C, V116, P10090, DOI 10.1021/jp301405e; You M, 2010, CRYST GROWTH DES, V10, P983, DOI 10.1021/cg9012944; Zhang J, 2014, J PHYS CHEM C, V118, P10824, DOI 10.1021/jp501214m; Zhang J, 2013, J PHYS CHEM C, V117, P1383, DOI 10.1021/jp3105166	66	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201490	10.1371/journal.pone.0201490	http://dx.doi.org/10.1371/journal.pone.0201490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048536	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400094
J	Sanchez-Lanzas, R; Castano, JG				Sanchez-Lanzas, Raul; Castano, Jose G.			Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DANON DISEASE; HUMAN DJ-1; STABILITY; DEGRADATION; EXPRESSION; AUTOPHAGY; L166P	Mutations in PARK7/DJ-1 gene are associated with familial autosomal recessive Parkinson disease. Recently, lysosomes and chaperone mediated autophagy (CMA) has been reported to participate in the degradation of DJ-1/PARK7 protein. Lamp-2A isoform is considered as the lysosomal receptor for the uptake of proteins being degraded by the CMA pathway. We have used several cell lines with disrupted LAMP2 gene expression and their respective control cells to test the possible role of lysosomal degradation and in particular CMA in DJ-1/PARK7 degradation. Interruption of LAMP-2 expression did not result in an increase of the steady-state protein levels of DJ-1/PARK7, as it would have been expected. Furthermore, no change in DJ-1/PARK7 protein levels were observed upon inhibition of lysosomal function with NH4Cl or NH4Cl plus leupeptin, or after activation of CMA by serum starvation for 24h. Accordingly, we have not found any evidence that DJ-1/PARK7 protein levels are regulated via lysosomal degradation or the CMA pathway.	[Sanchez-Lanzas, Raul; Castano, Jose G.] UAM, Fac Med, Inst Invest Biomed Alberto Sols, Dept Bioquim,CSIC, Madrid, Spain; [Sanchez-Lanzas, Raul; Castano, Jose G.] UAM, Fac Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBERNED	Castano, JG (corresponding author), UAM, Fac Med, Inst Invest Biomed Alberto Sols, Dept Bioquim,CSIC, Madrid, Spain.; Castano, JG (corresponding author), UAM, Fac Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	joseg.castano@uam.es		G. Castano, Jose/0000-0002-6579-8442	MINECO [SAF-2012-34556]; CIBERNED	MINECO(Spanish Government); CIBERNED(Instituto de Salud Carlos III)	This work was supported by grants from MINECO SAF-2012-34556 and CIBERNED to JGC.	Alvarez-Castelao B, 2012, BBA-MOL CELL RES, V1823, P524, DOI 10.1016/j.bbamcr.2011.11.010; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Endo Y, 2015, ACTA NEUROPATHOL, V129, P391, DOI 10.1007/s00401-015-1385-4; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Rothaug M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0182-y; Sanchez-Lanzas R, 2016, BBA-MOL BASIS DIS, V1862, P1423, DOI 10.1016/j.bbadis.2016.04.014; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang B, 2016, APPL COMPOSITE MAT, P1, DOI [10.1080/15548627.2015.1100356, DOI 10.1080/15548627.2015.1100356]; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wisniewski JR, 2016, J PROTEOME RES, V15, P2321, DOI 10.1021/acs.jproteome.6b00403	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201152	10.1371/journal.pone.0201152	http://dx.doi.org/10.1371/journal.pone.0201152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048497	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400053
J	Sandinge, AS; Janefeldt, A; Pehrsson, S; Nylander, S				Sandinge, Ann-Sofie; Janefeldt, Annika; Pehrsson, Susanne; Nylander, Sven			Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452	PLOS ONE			English	Article							P2Y(12) RECEPTOR ANTAGONIST; ACUTE CORONARY SYNDROMES; CLOPIDOGREL; INHIBITION; ANTIDOTE; AZD6140	Ticagrelor, a P2Y(12) antagonist, is approved for prevention of thromboembolic events. MEDI2452 is a potential reversal agent for ticagrelor and ticagrelor active metabolite (TAM). The total plasma exposure of ticagrelor and TAM in patients are roughly 0.5 +/- 1 and 0.2 +/- 0.5 mu mol/L, respectively. Both have similar high potency vs. P2Y(12) (Ki 2 nmol/L) but are plasma protein-bound to 99.8% and only the 0.2% free fraction is able to inhibit the P2Y(12) receptor. Thus, for unbound concentration measurements to be a proof of mechanism bio-marker for MEDI2452 a very high sensitivity is required. Using established techniques as equilibrium dialysis and LC-MS/MS, made it possible to evaluate the efficacy of the reversal agent by measuring reduction of unbound concentration of ticagrelor in the presence of MEDI2452. With challenges such as ultra-low concentrations, small sample volumes, recovery issues and adsorption to plastic we managed to develop a highly sensitive assay for determining unbound concentration levels of ticagrelor and TAM in plasma with a quantification limit of 30 pmol/L and 45 pmol/L, respectively. With this method we were able to detect close to a 100-fold MEDI2452 mediated reduction in the unbound concentration of both ticagrelor and TAM. The assay provided proof of mechanism as MEDI2452 concentration-and dose-dependently eliminated unbound concentration of ticagrelor and reversed its antiplatelet activity in preclinical models and will support future development of MEDI2452.	[Sandinge, Ann-Sofie; Janefeldt, Annika; Pehrsson, Susanne; Nylander, Sven] AstraZeneca, Cardiovasc Renal & Metab Innovat Med & Early Dev, Gothenburg, Sweden	AstraZeneca	Sandinge, AS (corresponding author), AstraZeneca, Cardiovasc Renal & Metab Innovat Med & Early Dev, Gothenburg, Sweden.	ann-sofie.sandinge@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	The authors confirm that the funder AstraZeneca, provided support in the form of salaries for authors [AS, AJ, SP, SN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Almquist J, 2016, CPT-PHARMACOMET SYST, V5, P313, DOI 10.1002/psp4.12089; Becker RC, 2011, EUR HEART J, V32, P2933, DOI 10.1093/eurheartj/ehr422; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Buchanan A, 2015, BLOOD, V125, P3484, DOI 10.1182/blood-2015-01-622928; Dolgin E, 2015, NAT BIOTECHNOL, V33, P117, DOI 10.1038/nbt0215-117; Nilsson LB, 2013, BIOANALYSIS, V5, P3033, DOI [10.4155/BIO.13.274, 10.4155/bio.13.274]; Pehrsson S, 2017, J THROMB HAEMOST, V15, P1213, DOI 10.1111/jth.13680; Ramirez FD, 2017, CIRC RES, V120, P1916, DOI 10.1161/CIRCRESAHA.117.310628; Sillen H, 2011, J CHROMATOGR B, V879, P2315, DOI 10.1016/j.jchromb.2011.06.023; Sillen H, 2010, J CHROMATOGR B, V878, P2299, DOI 10.1016/j.jchromb.2010.06.018; Springthorpe B, 2007, BIOORG MED CHEM LETT, V17, P6013, DOI 10.1016/j.bmcl.2007.07.057; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Storey RF, 2011, HEART, V97, P1262, DOI 10.1136/hrt.2009.184242; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	15	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201202	10.1371/journal.pone.0201202	http://dx.doi.org/10.1371/journal.pone.0201202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048515	Green Published, Green Submitted, gold			2022-12-27	WOS:000439952400060
J	Snowdon, C; Brocklehurst, P; Tasker, RC; Platt, MW; Elbourne, D				Snowdon, Claire; Brocklehurst, Peter; Tasker, Robert C.; Platt, Martin Ward; Elbourne, Diana			"You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; PRAGMATIC CLINICAL-TRIALS; IMPROVING HEAD GROWTH; PRETERM INFANTS; STEERING COMMITTEES; OUTCOMES; SEPSIS; ENCEPHALOPATHY; HYPOTHERMIA	Background Data Monitoring Committees (DMCs) are essential to the good conduct of many trials. Typically they comprise a small expert group which monitors safety, efficacy, progress and early outcome data as trials recruit. DMCs can recommend protocol revisions and early stopping of a trial. As DMC meetings usually consider unblinded interim data confidentially, their deliberations are seldom exposed to research scrutiny. Although there have been some case studies from trials from mixed specialties which offer insights into some of the common issues faced by DMCs, we have, however, little empirical information about the challenges faced within specific clinical settings. Methods In-depth interviews with participants in the BRACELET Study on death and bereavement in neonatal intensive care trials produced qualitative accounts of experiences and views of a subgroup of 18 DMC members. These interviews explored views of DMC members in relation to the clinical context of neonatal intensive care and the conduct of neonatal intensive care trials. Results Interviewees felt that an understanding of both the neonatal intensive care setting and population was crucial in a DMC. They considered the neonatal intensive care researchpopulation especially vulnerable, and that outcomes that included both death and severe disability raised particular challenges rarely faced in other settings. In exploring these key outcomes they were mindful of the need to meet high scientific standards and the needs of babies in the trials and their families. DMC members discussed particular difficulties around the composite outcome of death and severe disability, especially when mortality data were available long before data on longer term disability. While statistical stopping guidance is helpful, DMC members described decisions about stopping, revising or continuing a trial being informed by a wider set of considerations and discussions than a pre-set p value. These included potentially competing needs of current trial participants and future patients, and reflections on the nature of benefit and harm. Given their cognisance of the potential impact and consequences of the decisions made by DMCs in this setting of life, death, and disability, interviewees commonly used the imagery of bravery, and described DMCs either holding or losing their nerve. Conclusions DMCs for trials in other fields may also face difficult ethical trade-offs in monitoring composite outcomes. The experience from this sample of DMC members suggest that for neonatal intensive care trials there are some very specific challenges seldom faced elsewhere. The vulnerability of the population, and the different timescales for essential data becoming available to inform decisions, presented particular challenges. We suggest that it is important to consider the challenges raised in other settings to better understand the complex work of these committees and to prepare future generations of DMC members.	[Snowdon, Claire; Elbourne, Diana] Univ London, London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Brocklehurst, Peter] Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Brocklehurst, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesia Pediat, Boston, MA USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA USA; [Tasker, Robert C.] Harvard Med Sch, Boston, MA USA; [Platt, Martin Ward] Royal Victoria Infirm, Newcastle Neonatal Serv, Newcastle Upon Tyne, Tyne & Wear, England	University of London; London School of Hygiene & Tropical Medicine; University of Birmingham; University of Oxford; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Newcastle University - UK	Snowdon, C (corresponding author), Univ London, London Sch Hyg & Trop Med, Dept Med Stat, London, England.	Claire.snowdon@lshtm.ac.uk		Snowdon, Claire/0000-0002-9133-5476	National Institute of Health Research Health Technology Assessment Programme [05/516/06]	National Institute of Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR))	Funder for grant 05/516/06 awarded to DE- National Institute of Health Research Health Technology Assessment Programme, https://www.journalslibrary.nihr.ac.uk/programmes/hta/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Brocklehurst P, 2011, NEW ENGL J MED, V365, P1201, DOI 10.1056/NEJMoa1100441; Califf RM, 2015, CLIN TRIALS, V12, P436, DOI 10.1177/1740774515598334; Carr R, 2009, LANCET, V373, P226, DOI 10.1016/S0140-6736(09)60071-4; Clemens F, 2005, CLIN TRIALS, V2, P22, DOI 10.1191/1740774505cn064oa; Conroy EJ, 2015, CLIN TRIALS, V12, P664, DOI 10.1177/1740774515589959; Corbin J., BASICS QUALITATIVE R; DeMets DL, 2016, NEW ENGL J MED, V375, P1365, DOI 10.1056/NEJMra1510066; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; DeMets DL, 2006, DATA MONITORING CLIN; Ellenberg SS., 2002, DATA MONITORING COMM; Ellenberg SS, 2015, CLIN TRIALS, V12, P530, DOI 10.1177/1740774515597697; Friese S, 2014, QUALITATIVE DATA ANA; Grant A, 2004, BRIT MED J, V329, P525, DOI 10.1136/bmj.329.7465.525; Grant AM, 2005, LANCET, V365, P711; Guillemin M, 2012, J EMPIR RES HUM RES, V7, P38, DOI 10.1525/jer.2012.7.3.38; Harman NL, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1125-z; Harper M, 2012, FORBES; Hess CN, 2014, AM HEART J, V168, P135, DOI 10.1016/j.ahj.2014.05.003; INIS Study Collaborative Group, 2008, BMC Pregnancy Childbirth, V8, P52, DOI 10.1186/1471-2393-8-52; Lopez KA, 2004, QUAL HEALTH RES, V14, P726, DOI 10.1177/1049732304263638; Marlow N, 2013, ARCH DIS CHILD-FETAL, V98, pF46, DOI 10.1136/fetalneonatal-2011-301470; Parekh SA, 2015, ARCH DIS CHILD-FETAL, V100, pF193, DOI 10.1136/archdischild-2014-306730; Perrem LM, 2017, ACTA PAEDIATR, V106, P30, DOI 10.1111/apa.13593; Snowdon C, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18420; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Tan M, 2008, ARCH DIS CHILD-FETAL, V93, pF342, DOI 10.1136/adc.2007.124255; Tan MJ, 2008, ARCH DIS CHILD-FETAL, V93, pF337, DOI 10.1136/adc.2007.124230; Walker Anne E, 2004, Clin Trials, V1, P282, DOI 10.1191/1740774504cn023oa; Zuckerman J, 2015, CLIN TRIALS, V12, P688, DOI 10.1177/1740774515591498	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201037	10.1371/journal.pone.0201037	http://dx.doi.org/10.1371/journal.pone.0201037			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048484	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000439952400041
J	Ahmad, A; Zulaily, N; Shahril, MR; Abdullah, EFHS; Ahmed, A				Ahmad, Aryati; Zulaily, Nurzaime; Shahril, Mohd Razif; Abdullah, Engku Fadzli Hasan Syed; Ahmed, Amran			Association between socioeconomic status and obesity among 12-year-old Malaysian adolescents	PLOS ONE			English	Article							CHILDHOOD OBESITY; CHILDREN; PREVALENCE; OVERWEIGHT; ADULTHOOD; INCOME	The epidemic of obesity in developed countries is commonly associated with poor dietary habit and sedentary lifestyle. However, other determinants, including education background and family income, may contribute towards the problem especially in developing countries. This study aimed to determine the influence of socioeconomic status (SES) on obesity among 12-year-old school adolescents in Terengganu, Malaysia. Body weight and height were measured and BMI was categorised based on WHO z-score cut-off points. Information was obtained from self-reported questionnaire on parents' education background, family income and occupation. A total of 3,798 school adolescents aged 12 years (44% boys and 56% girls) were recruited. There was no significant difference in BMI status between boys and girls, or between rural and urban participants. There were significant differences between BMI categories and gender, household income and SES level within rural areas. In the urban areas, significant differences were found between BMI categories and gender, parents' occupational and educational level, household income and size, and SES level. A logistic regression model found several SES factors to be predictors of obesity in this population, namely, gender, household size, father's occupation level, household income level and SES level. Each component of SES has been significantly associated with the BMI category of school adolescents, particularly in the urban areas. This suggests the requirement of multifaceted approaches, including the role of family, society and authorities, in the effort to curtail adolescent obesity.	[Ahmad, Aryati; Zulaily, Nurzaime; Shahril, Mohd Razif] Univ Sultan Zainal Abidin, Fac Hlth Sci, Gong Badak Campus, Kuala Nerus, Terengganu, Malaysia; [Abdullah, Engku Fadzli Hasan Syed] Univ Sultan Zainal Abidin, Fac Informat & Comp, Besut Campus, Besut, Terengganu, Malaysia; [Ahmed, Amran] Univ Malaysia Perlis, Inst Engn Math, Pauh Putra Campus, Arau, Perlis, Malaysia	Universiti Sultan Zainal Abidin; Universiti Sultan Zainal Abidin; Universiti Malaysia Perlis	Ahmad, A (corresponding author), Univ Sultan Zainal Abidin, Fac Hlth Sci, Gong Badak Campus, Kuala Nerus, Terengganu, Malaysia.	aryatiahmad@unisza.edu.my	Shahril, Mohd Razif/K-7320-2015	Shahril, Mohd Razif/0000-0002-8680-3087; Zulaily, Nurzaime/0000-0002-3439-3442	Malaysian Ministry of Higher Education [FRGS/2/2013/SKK/UNISZA/01/1]	Malaysian Ministry of Higher Education	This study has been funded by the Malaysian Ministry of Higher Education under Grant Number FRGS/2/2013/SKK/UNISZA/01/1 (https://www.mohe.gov.my/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their great gratitude to the Malaysian Ministry of Higher Education for funding this study (FRGS/2/2013/SKK/UNISZA/01/1), and the Malaysian Ministry of Education with Terengganu State Education Department for permission to conduct this survey. We would also like to express our enormous appreciation to the PE teachers, parents and students for their willingness to participate. Special thanks to members of the Health of Adolescents in Terengganu (HAT) study and also the enumerators for their valuable contribution to this study.	Abudayya A, 2007, NUTR RES, V27, P762, DOI 10.1016/j.nutres.2007.09.017; Anderson PM, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0001; Aris T, 2015, NATL HLTH MORBIDITY, VII; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Boey CCM, 2003, J PAEDIATR CHILD H, V39, P352, DOI 10.1046/j.1440-1754.2003.00173.x; Brown JE, 2010, SOC SCI MED, V70, P1816, DOI 10.1016/j.socscimed.2010.01.040; Fadzli SA., 2016, INT J SOFTW ENG ITS, V10, P89; Gallagher AM, 2002, PUBLIC HEALTH, V116, P332, DOI 10.1038/sj.ph.1900871; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Herforth A, 2015, FOOD SECUR, V7, P505, DOI 10.1007/s12571-015-0455-8; Hofferth SL, 2005, J POLICY ANAL MANAG, V24, P703, DOI 10.1002/pam.20134; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, V2; Khor GL, 2009, SINGAP MED J, V50, P303; Lamerz A, 2005, INT J OBESITY, V29, P373, DOI 10.1038/sj.ijo.0802914; Lee G, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-28; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Majid HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155447; Ministry of Human Resources Malaysia, 2010, MAL STAND CLASS OCC, V3rd ed.; Mok TP, 2011, ECON ANAL POLICY, V41, P203, DOI 10.1016/S0313-5926(11)50020-7; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ozguven Isil, 2010, J Clin Res Pediatr Endocrinol, V2, P111, DOI 10.4274/jcrpe.v2i3.111; Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092; Racette SB, 2001, PHYS THER, V83, P1810; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Samani-Radia D, 2011, INT J OBESITY, V35, P128, DOI 10.1038/ijo.2010.116; Shariff Z M, 2000, Malays J Nutr, V6, P17; Shariff ZM, 2015, NUTR RES PRACT, V9, P278, DOI 10.4162/nrp.2015.9.3.278; Unit Perancang Ekonomi, 2010, RANC MAL KES 2011 20; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903; WHO, 2009, WHO TECH REP SER, V958, P1; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; Zaini M Z Anuar, 2005, Asia Pac J Public Health, V17, P71, DOI 10.1177/101053950501700203; Zalilah M. S., 2006, SMJ Singapore Medical Journal, V47, P491	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200577	10.1371/journal.pone.0200577	http://dx.doi.org/10.1371/journal.pone.0200577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044842	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500061
J	Almigbal, TH; Schattner, P				Almigbal, Turky H.; Schattner, Peter			The willingness of Saudi men with type 2 diabetes to discuss erectile dysfunction with their physicians and the factors that influence this	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; HEALTH; ATTITUDES; CARE; CONSULTATION; BARRIERS; SEEKING; ISSUES	Objectives The study's objectives were to find out the proportion of Saudi men with type 2 diabetes who have been asked by their physicians about erectile dysfunction (ED) in the last year, to determine the willingness of Saudi men with type 2 diabetes to discuss ED, and to explore the factors that may be related to their willingness to discuss ED with their physicians. Methods This study employed a cross-sectional survey design using a quantitative self-administered questionnaire among 309 Saudi men with type 2 diabetes. The study was conducted in hospital-based primary care clinics at King Khalid University Hospital, Riyadh, Saudi Arabia during the period from July to September 2015. Results The mean age of the patients was 60.2 years with the mean duration of diabetes approximately 12.5 years. Few of the patients (9.7%) had been asked by their physicians about ED within the last year of attending the clinics although most patients (84.8%) were willing to discuss this issue. The presence of ED among the respondents was 89%. Two participants' characteristics were associated with a willingness to discuss ED with the physicians. These characteristics were age above 60 (OR = 0.25, 95% CI: 0.11-0.55), and having severe ED (OR = 0.26, 95% CI: 0.08-0.85). The respondents' main barriers to discussing ED with their physicians were embarrassing the doctor, ED is a personal issue, too old or too sick to address ED issues now, no effective treatment available, and the doctor is too young to discuss ED with. Conclusions Most patients who have type 2 diabetes are not asked about ED within the last year of attendance even though most are willing to discuss it with their physicians. Being older and suffering more severe ED will result in being less willing to discuss ED with their doctor. Further research is needed to explore the barriers which prevent physicians from discussing ED with their patients who have diabetes.	[Almigbal, Turky H.] King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia; [Almigbal, Turky H.; Schattner, Peter] Monash Univ, Sch Primary Hlth Care, Dept Gen Practice, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia	King Saud University; Monash University	Almigbal, TH (corresponding author), King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia.; Almigbal, TH (corresponding author), Monash Univ, Sch Primary Hlth Care, Dept Gen Practice, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.	almogbal@yahoo.com			College of Medicine Research Centre, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	College of Medicine Research Centre, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This project was supported by the College of Medicine Research Centre, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.	Al-Nozha MM, 2004, SAUDI MED J, V25, P1603; AlMogbel TA, 2014, INT J HEALTH SCI-IJH, V8, P347; Alwakeel LS, 2008, ANN SAUDI MED, V28, P260; American Diabetes Association, 2017, Diabetes Care, V40, pS88; Byrne M, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-40; Camacho ME, 2005, INT J IMPOT RES, V17, pS52, DOI 10.1038/sj.ijir.3901429; Campos C, 2012, POSTGRAD MED, V124, P90, DOI 10.3810/pgm.2012.11.2615; Corona G, 2013, J ENDOCRINOL INVEST, V36, P864, DOI 10.3275/8969; Corona G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157915; Corona G, 2014, J SEX MED, V11, P2065, DOI 10.1111/jsm.12601; Corona G, 2012, EXPERT OPIN EMERG DR, V17, P239, DOI 10.1517/14728214.2012.683411; Faraj RI, 2013, INT J MED SCI PUBLIC, V1, P09; Federation ID, 2013, IDF DIABETES ATLAS; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Flaget-Greener M, 2015, SEX RELATSH THER, V30, P10, DOI 10.1080/14681994.2014.948297; Frost M, 2012, AGE AGEING, V41, P177, DOI 10.1093/ageing/afr153; Garcia-Cruz E, 2017, ACTAS UROL ESP; Gazzaruso C, 2004, CIRCULATION, V110, P22, DOI 10.1161/01.CIR.0000133278.81226.C9; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Grant PS, 2009, ACTA DIABETOL, V46, P285, DOI 10.1007/s00592-008-0084-1; Guzu AH, 2012, J CLIN OUTCOMES MANA, V19, P551; Harding JR, 2017, EDUC GERONTOL, V43, P462, DOI 10.1080/03601277.2017.1326226; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Hermans MP, 2009, DIABETES METAB, V35, P484, DOI 10.1016/j.diabet.2009.06.003; IBM Corp, 2012, REL 2013 IBM SPSS ST; Jiann BP, 2009, J SEX MED, V6, P2008, DOI 10.1111/j.1743-6109.2009.01264.x; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403; Lo WH, 2014, ASIAN J ANDROL, V16, P755, DOI 10.4103/1008-682X.127823; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; McCabe MP, 2016, J SEX MED, V13, P153, DOI 10.1016/j.jsxm.2015.12.015; Mellor RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078802; Morsy H, 2016, HUMAN ANDROL, V6, P65; National Institute for Health and Care Excellence, 2015, TYP 2 DIAB AD MAN; Nicolai MPJ, 2013, CLIN RES CARDIOL, V102, P329, DOI 10.1007/s00392-013-0549-2; Penson DF, 2003, DIABETES CARE, V26, P1093, DOI 10.2337/diacare.26.4.1093; Perttula E, 1999, POSTGRAD MED J, V75, P83, DOI 10.1136/pgmj.75.880.83; Rahman S, 2007, DIABETES OBES METAB, V9, P767, DOI 10.1111/j.1463-1326.2006.00655.x; Rosen RC, 2009, J SEX MED, V6, P1414, DOI 10.1111/j.1743-6109.2008.01209.x; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rutte A, 2016, J SEX MARITAL THER, V42, P324, DOI 10.1080/0092623X.2015.1033578; Seid A, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0167-5; Shamloul R, 2004, INT J IMPOT RES, V16, P452, DOI 10.1038/sj.ijir.3901248; Smith ML, 2016, MATURITAS, V92, P168, DOI 10.1016/j.maturitas.2016.07.022; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Tsigarovski G, 2017, J SEX MED, V14, pE192, DOI 10.1016/j.jsxm.2017.03.230; Varkonyi T, 2009, DIABETES OLD AGE, P149; Walsh TJ, 2014, INT J IMPOT RES, V26, P112, DOI 10.1038/ijir.2013.46; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043673	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201105	10.1371/journal.pone.02011O5	http://dx.doi.org/10.1371/journal.pone.02011O5			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	30044848				2022-12-27	WOS:000439942500081
J	Beheshti, A; Ray, S; Fogle, H; Berrios, D; Costes, SV				Beheshti, Afshin; Ray, Shayoni; Fogle, Homer; Berrios, Daniel; Costes, Sylvian V.			A microRNA signature and TGF-beta 1 response were identified as the key master regulators for spaceflight response	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELL; SIMULATED MICROGRAVITY; CANCER PROGRESSION; SPACE RADIATION; IMMUNE-SYSTEM; TGF-BETA; AGE; CARCINOGENESIS; IRRADIATION	Translating fundamental biological discoveries from NASA Space Biology program into health risk from space flights has been an ongoing challenge. We propose to use NASA GeneLab database to gain new knowledge on potential systemic responses to space. Unbiased systems biology analysis of transcriptomic data from seven different rodent datasets reveals for the first time the existence of potential "master regulators" coordinating a systemic response to microgravity and/or space radiation with TGF-beta 1 being the most common regulator. We hypothesized the space environment leads to the release of biomolecules circulating inside the blood stream. Through datamining we identified 13 candidate microRNAs (miRNA) which are common in all studies and directly interact with TGF-beta 1 that can be potential circulating factors impacting space biology. This study exemplifies the utility of the GeneLab data repository to aid in the process of performing novel hypothesis-based research.	[Beheshti, Afshin; Fogle, Homer] NASA, Ames Res Ctr, WYLE, Moffett Field, CA 94035 USA; [Ray, Shayoni; Berrios, Daniel] NASA, Ames Res Ctr, USRA, Moffett Field, CA 94035 USA; [Costes, Sylvian V.] NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Beheshti, A (corresponding author), NASA, Ames Res Ctr, WYLE, Moffett Field, CA 94035 USA.; Costes, SV (corresponding author), NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA.	afshin.beheshti@nasa.gov; sylvain.v.costes@nasa.gov	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014; Costes, Sylvain/D-2522-2013	Beheshti, Afshin/0000-0003-4643-531X; Costes, Sylvain/0000-0002-8542-2389	GeneLab Project at NASA Ames Research Center, through NASA's Space Biology Program in the Division of Space Life and Physical Sciences Research and Applications (SLPSRA)	GeneLab Project at NASA Ames Research Center, through NASA's Space Biology Program in the Division of Space Life and Physical Sciences Research and Applications (SLPSRA)	Research funding was provided by the GeneLab Project at NASA Ames Research Center, through NASA's Space Biology Program in the Division of Space Life and Physical Sciences Research and Applications (SLPSRA). Any use of trade names is for descriptive purposes only and does not imply endorsement by the US Government.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Barcellos-Hoff MH, 2015, LIFE SCI SPACE RES, V6, P92, DOI 10.1016/j.lssr.2015.07.006; Barcellos-Hoff MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005474; Beheshti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22613-1; Beheshti A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170521; Beheshti A, 2015, ONCOTARGET, V6, P35419, DOI 10.18632/oncotarget.6214; Beheshti A, 2015, CANCER RES, V75, P1134, DOI 10.1158/0008-5472.CAN-14-1053; Blaber EA, 2015, STEM CELLS DEV, V24, P2605, DOI 10.1089/scd.2015.0218; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Chen YJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.80; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Elston Rebecca, 2012, J Signal Transduct, V2012, P294097, DOI 10.1155/2012/294097; Gambara G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169314; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; Jasinski-Bergner S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju257; Jessup JM, 2000, IN VITRO CELL DEV-AN, V36, P367; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kim MR, 2015, MOL CANCER RES, V13, P319, DOI 10.1158/1541-7786.MCR-14-0098-T; Komatsu S, 2014, BRIT J CANCER, V111, P1614, DOI 10.1038/bjc.2014.451; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; McCarville JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068961; McGirt LY, 2014, J INVEST DERMATOL, V134, P1101, DOI 10.1038/jid.2013.461; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Moreno-Villanueva M, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0019-7; Moyer EL, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.2; Navarro F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132767; Nguyen DH, 2011, CANCER CELL, V19, P640, DOI 10.1016/j.ccr.2011.03.011; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Ravi D, 2016, CANCER RES, V76, P3319, DOI 10.1158/0008-5472.CAN-15-2477; Ray S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003319; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang J, 2014, STEM CELLS, V32, P649, DOI 10.1002/stem.1533; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wage J, 2015, J RADIAT RES, V56, P792, DOI 10.1093/jrr/rrv043; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0; WESTERLIND KC, 1995, J BONE MINER RES, V10, P843; Worthington JJ, 2012, IMMUNOBIOLOGY, V217, P1259, DOI 10.1016/j.imbio.2012.06.009	56	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0199621	10.1371/journal.pone.0199621	http://dx.doi.org/10.1371/journal.pone.0199621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044882	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500014
J	Francois, M; Clais, B; Blanchon, T; Souty, C; Hanslik, T; Rossignol, L				Francois, Mathilde; Clais, Barbara; Blanchon, Thierry; Souty, Cecile; Hanslik, Thomas; Rossignol, Louise			Factors associated with the duration of symptoms in adult women with suspected cystitis in primary care	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ACUTE UNCOMPLICATED CYSTITIS; RANDOMIZED CONTROLLED-TRIALS; CROSS-SECTIONAL SURVEY; ANTIMICROBIAL RESISTANCE; CLINICAL-ASPECTS; GENERAL-PRACTICE; EMPIRIC THERAPY; PLACEBO; EPIDEMIOLOGY	Objective The aim of this study was to identify factors associated to the duration of symptoms of cystitis. Patients and methods We conducted a nested survival study using Druti study data. Druti was a cross-sectional survey conducted in adult women visiting a general practitioner in France, for a suspected urinary tract infection between January 2012 and February 2013. For this study, urine cultures were systematically performed for all women. The evolution of symptoms were monitored daily for two weeks. This nested study considered only women with suspected cystitis from Druti; women with pyelonephritis were excluded. To identify independent predictors for duration of symptoms, a Cox proportional hazards regression model was performed. Results In Druti, 449 patients had a suspected cystitis. Among them, 440 had a follow up at two weeks. Out of the 440 patients, 424 had a prescription of antibiotic treatment (96.4%). The urine culture was positive for 326 patients (74.1%). The median duration of symptoms after consultation was two days (interquartile 1-3). The absence of urinary frequency (median two days versus three days, p = 0.008), age over 55 years (median two days versus three days, p<0.001) and patient's bet about the presence of a urinary tract infection (median two days, p = 0.021) were associated to a longer duration of symptoms. Positive culture (p = 0.99) and presence of a multi-drug resistant organism (p = 0.38) did not influence the duration of symptoms. Conclusion In a real-life study, factors influencing the duration of symptoms are clinical factors. The delay before re-evaluation in case of persistent symptoms after treatment could be adapted according to the initial clinical examination.	[Francois, Mathilde; Hanslik, Thomas] Univ Versailles St Quentin En Yvelines, Versailles, France; [Francois, Mathilde] Univ Paris Saclay, Hop Paul Brousse, Ctr Rech Epidemiol & Sante Populat, INSERM,UMR1018, Villejuif, France; [Clais, Barbara] Univ Paris 05, Dept Med Gen, Paris, France; [Blanchon, Thierry; Souty, Cecile; Rossignol, Louise] Sorbonne Univ, IPLESP, INSERM, UMRS 1136, Paris, France; [Hanslik, Thomas] Hop Univ Ambroise Pare, AP HP, Boulogne, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Francois, M (corresponding author), Univ Versailles St Quentin En Yvelines, Versailles, France.; Francois, M (corresponding author), Univ Paris Saclay, Hop Paul Brousse, Ctr Rech Epidemiol & Sante Populat, INSERM,UMR1018, Villejuif, France.	dr.francois.m@gmail.com	BLANCHON, Thierry/AAK-6254-2020	FRANCOIS, Mathilde/0000-0001-8117-7016	Health General Direction of France (DGS); Corporate Foundation GPM; French Urology Association	Health General Direction of France (DGS); Corporate Foundation GPM; French Urology Association	This work was supported by the Health General Direction of France (DGS); the Corporate Foundation GPM; and the French Urology Association during the study period. The funders had no role in the study design, data collection, analyses, decision to publish or preparation of the manuscript.	Abrahamian FM, 2011, INFECTION, V39, P507, DOI 10.1007/s15010-011-0163-z; Afssaps, 2008, DIAGN ANT INF UR BAC; Baerheim A, 1999, SCAND J PRIM HEALTH, V17, P170, DOI 10.1080/028134399750002593; Baerheim Anders, 2003, MedGenMed, V5, P1; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Boelle P-Y, 1999, SANG THROMB VAISS, V11, P45; Bollestad M, 2015, SCAND J PRIM HEALTH, V33, P57, DOI 10.3109/02813432.2015.1041827; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Colgan R, 2011, AM FAM PHYSICIAN, V84, P771; Falagas ME, 2010, J ANTIMICROB CHEMOTH, V65, P1862, DOI 10.1093/jac/dkq237; Falagas ME, 2009, J INFECTION, V58, P91, DOI 10.1016/j.jinf.2008.12.009; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Francois M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1620-2; Grabe M, 2015, EUROPEAN ASS UROLOGY; Greendale GA, 1999, LANCET, V353, P571, DOI 10.1016/S0140-6736(98)05352-5; Guay DRP, 2008, DRUGS, V68, P1169, DOI 10.2165/00003495-200868090-00002; HARDING GKM, 1994, INT J ANTIMICROB AG, V4, P83, DOI 10.1016/0924-8579(94)90038-8; Heytens S, 2011, J WOMENS HEALTH, V20, P1117, DOI 10.1089/jwh.2010.2302; Holm A, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0629-5; Hooton TM, 2012, JAMA-J AM MED ASSOC, V307, P583, DOI 10.1001/jama.2012.80; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Keating Karen N, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P457, DOI 10.1586/14737167.5.4.457; Kinouani S, 2017, MED MALADIES INFECT, V47, P401, DOI 10.1016/j.medmal.2017.05.003; Knottnerus BJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-71; Lane DR, 2011, EMERG MED CLIN N AM, V29, P539, DOI 10.1016/j.emc.2011.04.001; Leydon GM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c279; Leydon GM, 2009, BRIT J GEN PRACT, V59, P490, DOI 10.3399/bjgp09X453459; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; Little P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5633; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McNulty CAM, 2006, J ANTIMICROB CHEMOTH, V58, P1000, DOI 10.1093/jac/dkl368; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Medina-Bombardo D, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-111; Moulin B, 2012, NEPHROLOGIE; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Neuzillet Y, 2012, MED MALADIES INFECT, V42, P66, DOI 10.1016/j.medmal.2011.07.005; Nicolle LE, 2003, INT J ANTIMICROB AG, V22, P1, DOI 10.1016/S0924-8579(03)00101-8; Raz R, 2002, CLIN INFECT DIS, V34, P1165, DOI 10.1086/339812; Rossignol L, 2017, INFECTION, V45, P33, DOI 10.1007/s15010-016-0910-2; Rossignol L, 2015, J INFECTION, V71, P302, DOI 10.1016/j.jinf.2015.05.012; Samson E, 2008, IDENTIFICATION MARQU; Savonitto S, 2016, AM J MED, V129, P1205, DOI 10.1016/j.amjmed.2016.05.031; Societe de Pathologie Infectieuse de Langue Francaise, 2014, DIAGN ANT INF URIN B; Societe Francaise de Microbiologie, 2010, REM REF MICR MED 201; STAMM WE, 1991, REV INFECT DIS, V13, P77; Team RC, 2012, R LANG ENV STAT COMP; Timsit JF, 2005, REV MAL RESPIR, V22, P1058, DOI 10.1016/S0761-8425(05)85739-0	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201057	10.1371/journal.pone.0201057	http://dx.doi.org/10.1371/journal.pone.0201057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044831	gold, Green Published, Green Submitted			2022-12-27	WOS:000439942500076
J	Mazar, J; Li, YJ; Rosado, A; Phelan, P; Kedarinath, K; Parks, GD; Alexander, KA; Westmoreland, TJ				Mazar, Joseph; Li, Yujia; Rosado, Amy; Phelan, Peter; Kedarinath, Kritika; Parks, Griffith D.; Alexander, Kenneth A.; Westmoreland, Tamarah J.			Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24	PLOS ONE			English	Article							RISK GROUP; INFECTION; SYSTEM; CANCER; ACTIVATION; HEPATITIS; CARCINOMA	Neuroblastoma is the second most common childhood tumor. Survival is poor even with intensive therapy. In a search for therapies to neuroblastoma, we assessed the oncolytic potential of Zika virus. Zika virus is an emerging mosquito-borne pathogen unique among flaviviruses because of its association with congenital defects. Recent studies have shown that neuronal progenitor cells are likely the human target of Zika virus. Neuroblastoma has been shown to be responsive to infection. In this study, we show that neuroblastoma cells are widely permissive to Zika infection, revealing extensive cytopathic effects (CPE) and producing high titers of virus. However, a single cell line appeared poorly responsive to infection, producing undetectable levels of non-structural protein 1 (NS1), limited CPE, and low virus titers. A comparison of these poorly permissive cells to highly permissive neuroblastoma cells revealed a dramatic loss in the expression of the cell surface glycoprotein CD24 in poorly permissive cells. Complementation of CD24 expression in these cells led to the production of detectable levels of NS1 expression after infection with Zika, as well as dramatic increases in viral titers and CPE. Complementary studies using the Zika virus index strain and a north African isolate confirmed these phenotypes. These results suggest a possible role for CD24 in host cell specificity by Zika virus and offer a potential therapeutic target for its treatment. In addition, Zika viral therapy can serve as an adjunctive treatment for neuroblastoma by targeting tumor cells that can lead to recurrent disease and treatment failure.	[Mazar, Joseph; Rosado, Amy; Phelan, Peter; Alexander, Kenneth A.; Westmoreland, Tamarah J.] Nemours Childrens Hosp, Dept Biomed Res, Orlando, FL 32827 USA; [Li, Yujia; Kedarinath, Kritika; Parks, Griffith D.; Alexander, Kenneth A.; Westmoreland, Tamarah J.] Univ Cent Florida, Coll Med, Burnett Sch Biol Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Mazar, J; Westmoreland, TJ (corresponding author), Nemours Childrens Hosp, Dept Biomed Res, Orlando, FL 32827 USA.; Westmoreland, TJ (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biol Sci, Orlando, FL 32816 USA.	jm0151@nemours.org; tamarah.westmoreland@nemours.org	Mazar, Joseph/AAQ-8199-2020	Mazar, Joseph/0000-0002-3713-4251	Nemours Foundation; Nemours Children's Hospital; Florida High Tech Corridor	Nemours Foundation; Nemours Children's Hospital; Florida High Tech Corridor	The Nemours Foundation and Nemours Children's Hospital along with the regional economic development initiative of the Florida High Tech Corridor supported all funding for these studies. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ONCOTARGET, V8, P6589; [Anonymous], 2017, ONCOTARGET, V8, P6589; Aref S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100294; Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT TEST T; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; GEORGIADES JERZY, 1959, BIUL INST MED MORSKIEJ W GDANSKU, V10, P49; Gilliam DT, 2017, NEUROBIOL DIS, V99, P133, DOI 10.1016/j.nbd.2016.12.011; Hadac EM, 2004, VIROLOGY, V329, P217, DOI 10.1016/j.virol.2004.08.036; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; HOSTER HA, 1949, CANCER RES, V9, P473; HOUGH MR, 1994, GENOMICS, V22, P154, DOI 10.1006/geno.1994.1356; Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026; Institute NC, 2017, NEUR TREATM PDQ PAT; Kaid C, 2018, CANC RES; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lacroix J, 2010, INT J CANCER, V127, P1230, DOI 10.1002/ijc.25168; Latchman DS, 2005, CURR OPIN MOL THER, V7, P415; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li DL, 2009, HEPATOLOGY, V50, P735, DOI 10.1002/hep.23047; Li Y, 2013, J CANCER RES CLIN, V139, P933, DOI 10.1007/s00432-013-1406-4; Lim SC, 2005, BIOMED PHARMACOTHER, V59, pS351, DOI 10.1016/S0753-3322(05)80076-9; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mazar J, 2017, ONCOTARGET, V8, P6589, DOI 10.18632/oncotarget.14244; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Papaioannou Georgia, 2005, Cancer Imaging, V5, P116, DOI 10.1102/1470-7330.2005.0104; Poncet C, 1996, ACTA NEUROPATHOL, V91, P400, DOI 10.1007/s004010050442; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8; Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; SMITH RR, 1956, CANCER, V9, P1211, DOI 10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7; SOUTHAM CM, 1952, CANCER, V5, P1025, DOI 10.1002/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; TAYLOR AW, 1953, BRIT MED J, V1, P589, DOI 10.1136/bmj.1.4810.589; Toyoda H, 2011, INT J ONCOL, V38, P81, DOI 10.3892/ijo_00000826; Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784; Zhang SC, 2012, CANCER LETT, V325, P227, DOI 10.1016/j.canlet.2012.07.008; Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093	53	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200358	10.1371/journal.pone.0200358	http://dx.doi.org/10.1371/journal.pone.0200358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044847	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500047
J	Traister, A; Patel, R; Huang, A; Patel, S; Plakhotnik, J; Lee, JE; Medina, MG; Welsh, C; Ruparel, P; Zhang, LB; Friedberg, M; Maynes, J; Coles, J				Traister, Alexandra; Patel, Rachana; Huang, Anita; Patel, Sarvatit; Plakhotnik, Julia; Lee, Jae Eun; Medina, Maria Gonzalez; Welsh, Chris; Ruparel, Prutha; Zhang, Libo; Friedberg, Mark; Maynes, Jason; Coles, John			Cardiac regenerative capacity is age- and disease-dependent in childhood heart disease	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; FAILURE; DIFFERENTIATION; CONTRACTILITY; BIOPSY; REPAIR; TRIAL	Objective We sought to define the intrinsic stem cell capacity in pediatric heart lesions, and the effects of diagnosis and of age, in order to inform evidence-based use of potential autologous stem cell sources for regenerative medicine therapy. Methods Ventricular explants derived from patients with hypoplastic left heart syndrome (HLHS), tetralogy of Fallot (TF), dilated cardiomyopathy (DCM) and ventricular septal defect (VSD) were analyzed following standard in vitro culture conditions, which yielded cardiospheres (C-spheres), indicative of endogenous stem cell capacity. C-sphere counts generated per 5 mm3 tissue explant and the presence of cardiac progenitor cells were correlated to patient age, diagnosis and echocardiographic function. Results Cardiac explants from patients less than one year of age with TF and DCM robustly generated c-kit- and/or vimentin-positive cardiac mesenchymal cells (CMCs), populating spontaneously forming C-spheres. Beyond one year of age, there was a marked reduction or absence of cardiac explant-derivable cardiac stem cell content in patients with TF, VSD and DCM. Stem cell content in HLHS and DCM strongly correlated to the echocardiographic function in the corresponding ventricular chamber, with better echocardiographic function correlating to a more robust regenerative cellular content. Conclusions We conclude that autologous cardiomyogenic potential in pediatric heart lesions is robust during the first year of life and uniformly declines thereafter. Depletion of stem cell content occurs at an earlier age in HLHS with the onset of ventricular failure in a chamber-specific pattern that correlates directly to ventricular dysfunction. These data suggest that regenerative therapies using autologous cellular sources should be implemented in the neonatal period before the potentially rapid onset of single ventricle failure in HLHS or the evolution of biventricular failure in DCM.	[Traister, Alexandra; Patel, Rachana; Huang, Anita; Patel, Sarvatit; Plakhotnik, Julia; Lee, Jae Eun; Medina, Maria Gonzalez; Welsh, Chris; Ruparel, Prutha; Zhang, Libo; Friedberg, Mark; Maynes, Jason; Coles, John] Hosp Sick Children, Labatt Family Heart Ctr, Toronto, ON, Canada; [Maynes, Jason] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Coles, J (corresponding author), Hosp Sick Children, Labatt Family Heart Ctr, Toronto, ON, Canada.	john.coles@sickkids.ca	Maynes, Jason/AAE-4344-2020	Welsh, Christopher/0000-0003-3695-2962; Friedberg, Mark/0000-0002-4108-5560	Heart and Stroke Foundation of Ontario [G-14-0006267]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	The article had the following sources of funding: Heart and Stroke Foundation of Ontario (grant # G-14-0006267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	all YHe, 2018, PEDIAT CARDIOL, P1, DOI [10.1007/s00246-017-1739-x, DOI 10.1007/S00246-017-1739-X]; Arnold RR, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00125; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bittle GJ, 2017, CIRC RES, V120, P1060, DOI 10.1161/CIRCRESAHA.117.310702; Cai CL, 2017, CIRC RES, V120, P400, DOI 10.1161/CIRCRESAHA.116.309710; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Hamid T, 2016, AM J PHYSIOL-HEART C, V311, pH1189, DOI 10.1152/ajpheart.00904.2015; Ishigami S, 2017, CIRC RES, V120, P1162, DOI 10.1161/CIRCRESAHA.116.310253; Ishigami S, 2015, CIRC RES, V116, P653, DOI 10.1161/CIRCRESAHA.116.304671; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; Lazar E, 2017, EUR HEART J, V38, P2333, DOI 10.1093/eurheartj/ehx343; Maliken BD, 2018, CIRCULATION; Mao Q, 2014, MOL CELL BIOCHEM, V397, P203, DOI 10.1007/s11010-014-2188-y; Mayourian J, 2018, CIRC RES, V122, P933, DOI 10.1161/CIRCRESAHA.118.312420; Mayourian J, 2017, CIRC RES, V121, P411, DOI 10.1161/CIRCRESAHA.117.310796; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Monsanto MM, 2017, CIRC RES, V121, P113, DOI 10.1161/CIRCRESAHA.116.310494; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Ratajczak MZ, 2017, STEM CELL REV REP, V13, P443, DOI 10.1007/s12015-017-9728-2; Ratajczak MZ, 2017, CIRC RES, V120, P166, DOI 10.1161/CIRCRESAHA.116.309362; Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975; Ruan ZB, 2016, BIOMED PHARMACOTHER, V78, P110, DOI 10.1016/j.biopha.2016.01.020; Saiki H, 2016, ANN THORAC SURG, V101, P1544, DOI 10.1016/j.athoracsur.2015.10.077; Sano T, 2018, CIRC RES, V122, P994, DOI 10.1161/CIRCRESAHA.117.312311; Sharma S, 2017, CIRC RES, V120, P816, DOI 10.1161/CIRCRESAHA.116.309782; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Tiburcy M, 2017, CIRCULATION, V135, P1832, DOI 10.1161/CIRCULATIONAHA.116.024145; Traister A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037802; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Yagi H, 2018, PEDIAT CARDIOL	30	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200342	10.1371/journal.pone.0200342	http://dx.doi.org/10.1371/journal.pone.0200342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044800	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500044
J	Unterberger, C; Brunner, L; Nabernegg, S; Steininger, KW; Steiner, AK; Stabentheiner, E; Monschein, S; Truhetz, H				Unterberger, Christian; Brunner, Lukas; Nabernegg, Stefan; Steininger, Karl W.; Steiner, Andrea K.; Stabentheiner, Edith; Monschein, Stephan; Truhetz, Heimo			Spring frost risk for regional apple production under a warmer climate	PLOS ONE			English	Article							HEMISPHERE ATMOSPHERIC BLOCKING; FRUIT-TREES; PHENOLOGICAL MODELS; DAMAGE; PROTECTION; TEMPERATURE; FUTURE	Spring frosts, as experienced in Europe in April 2016 and 2017, pose a considerable risk to agricultural production, with the potential to cause significant damages to agricultural yields. Meteorological blocking events (stable high-pressure systems) have been shown to be one of the factors that trigger cold spells in spring. While current knowledge does not allow for drawing conclusions as to any change in future frequency and duration of blocking episodes due to climate change, the combination of their stable occurrence with the biological system under a warming trend can lead to economic damage increases. To evaluate future frost risk for apple producers in south-eastern Styria, we combine a phenological sequential model with highly resolved climate projections for Austria. Our model projects a mean advance of blooming of -1.6 +/- 0.9 days per decade, shifting the bloom onset towards early April by the end of the 21st century. Our findings indicate that overall frost risk for apple cultures will remain in a warmer climate and potentially even increase due to a stronger connection between blocking and cold spells in early spring that can be identified from observational data. To prospectively deal with frost risk, measures are needed that either stabilize crop yields or ensure farmers' income by other means. We identify appropriate adaptation measures and relate their costs to the potential frost risk increase. Even if applied successfully, the costs of these measures in combination with future residual damages represent additional climate change related costs.	[Unterberger, Christian; Brunner, Lukas; Nabernegg, Stefan; Steininger, Karl W.; Steiner, Andrea K.; Truhetz, Heimo] Karl Franzens Univ Graz, Wegener Ctr Climate & Global Change, Graz, Austria; [Unterberger, Christian; Brunner, Lukas; Nabernegg, Stefan] Karl Franzens Univ Graz, FWF DK Climate Change, Graz, Austria; [Unterberger, Christian] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Brunner, Lukas] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Nabernegg, Stefan; Steininger, Karl W.] Karl Franzens Univ Graz, Dept Econ, Graz, Austria; [Steiner, Andrea K.] Karl Franzens Univ Graz, Inst Geophys Astrophys & Meteorol, Inst Phys, Graz, Austria; [Stabentheiner, Edith; Monschein, Stephan] Karl Franzens Univ Graz, Inst Biol, Graz, Austria	University of Graz; University of Graz; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Graz; University of Graz; University of Graz	Unterberger, C (corresponding author), Karl Franzens Univ Graz, Wegener Ctr Climate & Global Change, Graz, Austria.; Unterberger, C (corresponding author), Karl Franzens Univ Graz, FWF DK Climate Change, Graz, Austria.; Unterberger, C (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland.	christian.unterberger@uni-graz.at	Nabernegg, Stefan/AAP-9248-2020; Steininger, Karl/O-6971-2016; Steiner, Andrea K/F-7980-2017; Brunner, Lukas/AAP-7583-2020	Nabernegg, Stefan/0000-0003-3785-2103; Steininger, Karl/0000-0003-3850-9315; Steiner, Andrea K/0000-0003-1201-3303; Brunner, Lukas/0000-0001-5760-4524; Unterberger, Christian/0000-0001-8367-231X	Austrian Science Fund (FWF) [W 1256-G15]; Marietta Blau Grant by the Austrian Exchange Service (OeAD); Austrian Federal Ministry of Science, Research and Economy (BMWFW)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Marietta Blau Grant by the Austrian Exchange Service (OeAD); Austrian Federal Ministry of Science, Research and Economy (BMWFW)	Christian Unterberger, Lukas Brunner and Stefan Nabernegg are students in the Doctoral Programme Climate Change at the University of Graz. This programme is funded by the Austrian Science Fund (FWF) under research grant W 1256-G15 (Doctoral Programme Climate Change - Uncertainties, Thresholds and Coping Strategies). Additionally, Lukas Brunner was financially supported by a Marietta Blau Grant by the Austrian Exchange Service (OeAD), financed by funds from the Austrian Federal Ministry of Science, Research and Economy (BMWFW).	Aerts JCJH, 2011, GLOBAL ENVIRON CHANG, V21, P1045, DOI 10.1016/j.gloenvcha.2011.04.005; AGRI4CAST, 2017, JRC MARS B CROP MON, P25; #AGRI4CAST, 2016, JRC MARS B, P24; Anconelli S, 2002, PHYS CHEM EARTH, V27, P1103, DOI 10.1016/S1474-7065(02)00146-8; [Anonymous], 2017, OSTERREICHISCHE HAGE; [Anonymous], 2017, OBST PARTNER STEIERM; [Anonymous], 2017, PEP725 PAN EUR PHEN; [Anonymous], 2016, OSTERREICHISCHE HAGE; Austrian Ministry for Sustainability and Tourism, 2017, GRUN BER 2017 BER SI; Bieli M, 2015, Q J ROY METEOR SOC, V141, P98, DOI 10.1002/qj.2339; Brunner L, 2017, J CLIMATE, V30, P585, DOI 10.1175/JCLI-D-16-0518.1; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Cattiaux J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044613; Charrier G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00259; Chimani B, 2015, PROJEKTENDBERICHT; Chmielewski FM, 2011, METEOROL Z, V20, P487, DOI 10.1127/0941-2948/2011/0258; Chuine I, 2016, GLOBAL CHANGE BIOL, V22, P3444, DOI 10.1111/gcb.13383; Clements CB, 2003, J APPL METEOROL, V42, P752, DOI 10.1175/1520-0450(2003)042<0752:CSAEIA>2.0.CO;2; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Croci-Maspoli M, 2007, J CLIMATE, V20, P633, DOI 10.1175/JCLI4029.1; D'Andrea F, 1998, CLIM DYNAM, V14, P385, DOI 10.1007/s003820050230; Dantec CF, 2015, J ECOL, V103, P1044, DOI 10.1111/1365-2745.12403; Davini P, 2016, J CLIMATE, V29, P8823, DOI 10.1175/JCLI-D-16-0242.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; European Commission, 2018, APPL DASHB AGR MARK; Francis J, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0170; Francis JA, 2017, B AM METEOROL SOC, V98, P2551, DOI 10.1175/BAMS-D-17-0006.1; Frei C, 2014, INT J CLIMATOL, V34, P1585, DOI 10.1002/joc.3786; Fu YSH, 2015, NATURE, V526, P104, DOI 10.1038/nature15402; Giorgi F, 2008, WMO B, V53; Grossi P, 2005, HUEBNER INT SER RISK, V25, P1, DOI 10.1007/b100669; HAMER PJC, 1986, AGR FOREST METEOROL, V37, P159, DOI 10.1016/0168-1923(86)90006-7; Haslinger K, 2016, METEOROL Z, V25, P137, DOI 10.1127/metz/2015/0604; Hiebl J, 2016, THEOR APPL CLIMATOL, V124, P161, DOI 10.1007/s00704-015-1411-4; Hoffmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075033; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Kaukoranta T, 2010, AGR FOOD SCI, V19, P144, DOI 10.2137/145960610791542352; Kretschmer M, 2018, B AM METEOROL SOC, V99, P49, DOI 10.1175/BAMS-D-16-0259.1; Kroner N, 2017, CLIM DYNAM, V48, P3425, DOI 10.1007/s00382-016-3276-3; Kunz A, 2016, ACTA HORTIC, V1130, P49, DOI 10.17660/ActaHortic.2016.1130.7; Legave JM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01054; Lenz A, 2016, FUNCT ECOL, V30, P1480, DOI 10.1111/1365-2435.12623; Lenz A, 2013, NEW PHYTOL, V200, P1166, DOI 10.1111/nph.12452; Luttenberger W, 2017, AKTUELLE HINWEISE FR; Matsueda M, 2017, GEOPHYS RES LETT, V44, P5158, DOI 10.1002/2017GL073336; Mosedale JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141218; Perrot A., 1967, FROSTSCHUTZBEREGNUNG; Rex D. F., 1950, TELLUS, V2, P196, DOI [DOI 10.1111/J.2153-3490.1950.TB00331.X, 10.3402/tellusa.v2i3.8546, DOI 10.3402/TELLUSA.V2I3.8546, 10.1111/j.2153-3490.1950.tb00331.x]; Ribeiro AC, 2006, AGR FOREST METEOROL, V141, P71, DOI 10.1016/j.agrformet.2006.08.019; Rodrigo J, 2000, SCI HORTIC-AMSTERDAM, V85, P155, DOI 10.1016/S0304-4238(99)00150-8; Sgubin G, 2018, AGR FOREST METEOROL, V250, P226, DOI 10.1016/j.agrformet.2017.12.253; Sillmann J, 2011, J CLIMATE, V24, P5899, DOI 10.1175/2011JCLI4075.1; Statistik Austria, 2017, LAND FORSTW AGR FLAC; Statistik Austria, 2012, INT ANL NACH ART 201; Statistik Austria, 2017, ZUS PROD WIRTSCH LAN; Steinbauer L, 2016, KW17 FROST SCHNEE ST, P20; Switanek MB, 2017, HYDROL EARTH SYST SC, V21, P2649, DOI 10.5194/hess-21-2649-2017; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vaysse P, 1994, PROTECTION VERGERS C; VERGEINER I, 1987, METEOROL ATMOS PHYS, V36, P264, DOI 10.1007/BF01045154; Vitasse Y, 2018, AGR FOREST METEOROL, V248, P60, DOI 10.1016/j.agrformet.2017.09.005; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Ward PJ, 2011, NAT HAZARD EARTH SYS, V11, P3181, DOI 10.5194/nhess-11-3181-2011; Whan K, 2016, J CLIMATE, V29, P4361, DOI 10.1175/JCLI-D-15-0493.1; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	68	36	37	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200201	10.1371/journal.pone.0200201	http://dx.doi.org/10.1371/journal.pone.0200201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044808	Green Submitted, Green Published, gold			2022-12-27	WOS:000439942500032
J	Zou, YW; Laubichler, MD				Zou, Yawen; Laubichler, Manfred D.			From systems to biology: A computational analysis of the research articles on systems biology from 1992 to 2013	PLOS ONE			English	Article							CHALLENGES	Systems biology is a discipline that studies biological systems from a holistic and interdisciplinary perspective. It brings together biologists, mathematicians, computer scientists, physicists, and engineers, so it has both biology-oriented components and systems-oriented components. We applied several computational tools to analyze the bibliographic information of published articles in systems biology to answer the question: Did the research topics of systems biology become more biology-oriented or more systems-oriented from 1992 to 2013? We analyzed the metadata of 9923 articles on systems biology from the Web of Science database. We identified the most highly cited 330 references using computational tools and through close reading we divided them into nine categories of research types in systems biology. Interestingly, we found that articles in one category, namely, systems biology's applications in medical research, increased tremendously. This finding was corroborated by computational analysis of the abstracts, which also suggested that the percentages of topics on vaccines, diseases, drugs and cancers increased over time. In addition, we analyzed the institutional backgrounds of the corresponding authors of those 9923 articles and identified the most highly cited 330 authors over time. We found that before the mid-1990s, systems-oriented scientists had made the most referenced contributions. However, in recent years, researchers from biology-oriented institutions not only represented a huge percentage of the total number of researchers, but also had made the most referenced contributions. Notably, interdisciplinary institutions only produced a small percentage of researchers, but had made disproportionate contributions to this field.	[Zou, Yawen; Laubichler, Manfred D.] Arizona State Univ, Sch Life Sci, Ctr Biol & Soc, Tempe, AZ 85281 USA; [Zou, Yawen] Chinese Univ Hong Kong, Sch Humanities & Social Sci, Shenzhen, Guangdong, Peoples R China	Arizona State University; Arizona State University-Tempe; Chinese University of Hong Kong, Shenzhen	Laubichler, MD (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Biol & Soc, Tempe, AZ 85281 USA.	manfred.laubichler@asu.edu		Zou, Yawen/0000-0002-7351-5246	National Science Foundation [SES 1243575]; China Scholarship Council [2011635028]	National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council)	ML was funded through a grant from National Science Foundation held at the Arizona State University under SES 1243575. YZ received funding from the China Scholarship Council under scholarship 2011635028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Auffray C, 2003, CR BIOL, V326, P879, DOI 10.1016/j.crvi.2003.09.033; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bellomo N, 2015, PHYS LIFE REV, V12, P44, DOI 10.1016/j.plrev.2014.12.002; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Brailsford SC, 2009, J SIMUL, V3, P130, DOI 10.1057/jos.2009.10; Brigandt I, 2013, STUD HIST PHI PART C, V44, P477, DOI 10.1016/j.shpsc.2013.06.002; Calvert J, 2011, STUD HIST PHI PART C, V42, P155, DOI 10.1016/j.shpsc.2010.11.022; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Cozzens SE, 1997, EVAL PROGRAM PLANN, V20, P77, DOI 10.1016/S0149-7189(96)00038-9; De Bellis N., 2009, BIBLIOMETRICS CITATI; Garfield E, 2009, J INFORMETR, V3, P173, DOI 10.1016/j.joi.2009.03.009; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Hlavacek W., 2011, HDB STAT SYSTEMS BIO; Hong L., 2010, PROC 1 WORKSHOP SOCI, P80, DOI DOI 10.1145/1964858.1964870; Huang Sui, 2004, Briefings in Functional Genomics & Proteomics, V2, P279, DOI 10.1093/bfgp/2.4.279; Kevles D. J., 1992, THE CODE OF CODES; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2001, FDN SYSTEMS BIOL; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krohs U., 2007, SYSTEMS BIOL PHILOS, P181, DOI [10.1016/B978-044452085-2/50011-5, DOI 10.1016/B978-044452085-2/50011-5]; Lattuca L. R., 2001, CREATING INTERDISCIP; Leonelli S, 2012, STUD HIST PHI PART C, V43, P29, DOI 10.1016/j.shpsc.2011.10.003; Leonidou LC, 2010, J INT MANAG, V16, P78, DOI 10.1016/j.intman.2009.06.001; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; MacLeod M, 2014, J EXP ZOOL PART B, V322, P230, DOI 10.1002/jez.b.22568; Manning, 2008, P C EMP METH NAT LAN, P363, DOI [DOI 10.3115/1613715.1613763, DOI 10.3115/1613715]; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McCallum, 2002, MALLET MACHINE LEARN; Moed HF, 2006, CITATION ANAL RES EV, V9; Newman DJ, 2006, J AM SOC INF SCI TEC, V57, P753, DOI 10.1002/asi.20342; NOBLE D, 1960, NATURE, V188, P495, DOI 10.1038/188495b0; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Ramage D, 2001, STANFORD TOPIC MODEL; Sagner M, 2017, PROG CARDIOVASC DIS, V59, P506, DOI 10.1016/j.pcad.2016.08.002; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Von Bertalanffy L., 1969, GEN SYSTEMS THEORY; Wiener Norbert, 1948, CYBERNETICS CONTROL; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200929	10.1371/journal.pone.0200929	http://dx.doi.org/10.1371/journal.pone.0200929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044828	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500070
J	Xie, L; Liu, AG; Peng, LY; Wang, SJ; Zhang, YP; Wang, XS				Xie, Li; Liu, Ai-Guo; Peng, Li-Yan; Wang, Su-Jie; Zhang, Yin-Ping; Wang, Xian-Song			Expression of E-prostanoid receptors in nasal polyp tissues of smoking and nonsmoking patients with chronic rhinosinusitis	PLOS ONE			English	Article							PROSTAGLANDIN E-2; CIGARETTE-SMOKE; GENE-TRANSCRIPTION; INFLAMMATION; CHINESE; CELLS; PATHOGENESIS; CLASSIFICATION; ACTIVATION; FEATURES	Background Different inflammatory reactions have been observed in the polyp tissues of nonsmokers and smokers with chronic rhinosinusitis (CRS). E-prostanoid (EP) receptors play a role in the inflammatory processes. Cigarette smoke (CS) exposure regulates EP-receptor expression levels promoting inflammatory mediator release from various inflammatory cells. In this study, we characterize the EP-receptor expression profiles in the polyps of nonsmoking and smoking CRS patients to explore the possible role of CS in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP). Methods Polyp biopsies were obtained from 28 non-smoking and 21 smoking CRSwNP patients. Histopathological characteristics were observed under a light microscope. The prostaglandin E2 (PGE2), TNF-alpha, and IL-8 contents in polyp tissues were detected using enzyme-linked immunosorbent assay. Immunostaining was used to locate EP receptors in polyps. Messenger RNA and protein expression of EP receptors were examined using quantitative real-time polymerase chain reaction and Western blot, respectively. Results More severe inflammatory reactions occurred in polyp tissues of smoking CRSwNP patients. The PGE2, TNF-alpha, and IL-8 in tissue homogenate levels were significantly higher in smoking CRSwNP patients than those in nonsmoking CRSwNP patients. Moreover, the distribution of each EP receptor subtype was similar in both groups. Compared with the EP-receptor expression in nonsmokers, messenger RNA and protein of EP2 and EP4 receptor were significantly down-expressed in smoking patients, but EP1 and EP3 receptors did not show significant differences. Conclusion CS exposure downregulates the expression levels of EP2 and EP4 receptors and stimulates the production of PGE(2) and the proinflammatory cytokine IL-8 and TNF-alpha in polyp tissues of CRS patients. The down-expressed EP2 and EP4 receptors might be associated with severe inflammatory reactions in smoking CRSwNP patients.	[Xie, Li; Liu, Ai-Guo; Peng, Li-Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China; [Wang, Su-Jie] Zhengzhou Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China; [Zhang, Yin-Ping; Wang, Xian-Song] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Zhengzhou University; Huazhong University of Science & Technology	Wang, XS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan, Hubei, Peoples R China.	xiansongw@hust.edu.cn	peng, li/GQH-5153-2022		National Natural Science Foundation of China [81271072, 81270062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China grant number: 81271072 to AGL and grant number: 81270062 to XSW.	Ahn JC, 2016, JAMA OTOLARYNGOL, V142, P162, DOI 10.1001/jamaoto.2015.3142; Aso H, 2013, AM J RESP CELL MOL, V48, P322, DOI 10.1165/rcmb.2012-0158OC; Boulet LP, 2006, CHEST, V129, P661, DOI 10.1378/chest.129.3.661; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Dhong HJ, 2005, ACTA OTO-LARYNGOL, V125, P169, DOI 10.1080/00016480410015767; Erbek Selim S, 2008, Kulak Burun Bogaz Ihtis Derg, V18, P216; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gao T, 2016, INT FORUM ALLERGY RH, V6, P66, DOI 10.1002/alr.21631; Hadar T, 2009, INHAL TOXICOL, V21, P1119, DOI 10.3109/08958370902767070; Houser SM, 2008, LARYNGOSCOPE, V118, P1521, DOI 10.1097/MLG.0b013e31817d01b8; Hu Y, 2012, LARYNGOSCOPE, V122, P498, DOI 10.1002/lary.22507; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Hurbankova M, 2012, CENT EUR J PUBL HEAL, V20, P54, DOI 10.21101/cejph.a3689; Huvenne W, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-100; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kilty SJ, 2011, RHINOLOGY, V49, P533, DOI 10.4193/Rhino10.298; Konya V, 2013, J ALLERGY CLIN IMMUN, V131, P532, DOI 10.1016/j.jaci.2012.05.008; Krzeski A, 2011, RHINOLOGY, V49, P577, DOI [10.4193/Rhin10.038, 10.4193/Rhino.10.038]; Kule ZG, 2014, J CRANIOFAC SURG, V25, P946, DOI 10.1097/SCS.0000000000000731; Lee KI, 2014, AM J RHINOL ALLERGY, V28, P208, DOI 10.2500/ajra.2014.28.4055; Lin SK, 2007, AM J RHINOL, V21, P251, DOI 10.2500/ajr.2007.21.2958; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; LUND VJ, 1995, ANN OTO RHINOL LARYN, V104, P17, DOI 10.1177/000348949510410s02; Luschnig-Schratl P, 2011, CELL MOL LIFE SCI, V68, P3573, DOI 10.1007/s00018-011-0642-5; Machado-Carvalho L, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0100-7; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Morimoto K, 2014, J IMMUNOL, V192, P1130, DOI 10.4049/jimmunol.1300290; Mortuaire G, 2015, HISTOL HISTOPATHOL, V30, P1447, DOI [10.4670/HH-11-632, 10.14670/HH-11-632]; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Rahman I, 2002, MOL CELL BIOCHEM, V234, P239, DOI 10.1023/A:1015905010086; Sastry BVR, 1999, PHARMACOLOGY, V58, P70, DOI 10.1159/000028270; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Stefanelli P, 2012, PROSTAG OTH LIPID M, V99, P24, DOI 10.1016/j.prostaglandins.2012.04.002; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Uhliarova B, 2014, INHAL TOXICOL, V26, P419, DOI 10.3109/08958378.2014.910284; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang XS, 2006, ALLERGY, V61, P503, DOI 10.1111/j.1398-9995.2006.01043.x; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Xie L, 2015, AM J RHINOL ALLERGY, V29, P322, DOI 10.2500/ajra.2015.29.4205; Yang CM, 2009, AM J PHYSIOL-LUNG C, V297, pL892, DOI 10.1152/ajplung.00151.2009; Zaslona Z, 2014, J ALLERGY CLIN IMMUN, V133, P379, DOI 10.1016/j.jaci.2013.07.037; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200989	10.1371/journal.pone.0200989	http://dx.doi.org/10.1371/journal.pone.0200989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO1WA	30040868	Green Submitted, gold, Green Published			2022-12-27	WOS:000439749200020
J	Moghimi, S; Torkashvand, A; Mohammadi, M; Yaseri, M; Saunders, LJ; Lin, SC; Weinreb, RN				Moghimi, Sasan; Torkashvand, Ali; Mohammadi, Massood; Yaseri, Mehdi; Saunders, Luke J.; Lin, Shan C.; Weinreb, Robert N.			Classification of primary angle closure spectrum with hierarchical cluster analysis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LASER PERIPHERAL IRIDOPLASTY; ANTERIOR SEGMENT; QUANTITATIVE-EVALUATION; PLATEAU IRIS; IRIDOTOMY; SUBTYPES; PARAMETERS; SUSPECTS; GLAUCOMA	Purpose To classify subjects with primary angle closure into clusters based on features from anterior segment optical coherence tomography (ASOCT) imaging and to explore how these clusters correspond to disease subtypes, including primary angle closure suspect (PACS), primary angle closure glaucoma(PACG), acute primary angle closure (APAC) and fellow eyes of APAC and reveal the factors that become more predominant in each subtype of angle closure. Method A cross-sectional study of 248 eyes of 198 subjects(88 PACS eyes, 53 PACG eyes, 54 APAC eyes and 53 fellow eyes of APAC) that underwent complete examination including gonioscopy, A-scan biometry, and ASOCT. An agglomerative hierarchical clustering method was used to classify eyes based on ASOCT parameters. Results Statistical clustering analysis produced three clusters among which the anterior segment parameters were significantly different. Cluster 1(43 eyes) had the smallest anterior chamber depth(ACD) and area, as well as the greatest lens vault (p<0.001 for all). Cluster 2(113 eyes) had the thickest iris at 2000 microns(p = 0.048), and largest iris area(p<0.001), and the deepest ACD (p<0.001). Cluster 3(92 eyes) was characterized by elements of both clusters 1 and 2 and a higher iris curvature(p<0.001). There was a statistically significant difference in the distribution of clusters among subtypes of angle closure eyes(p<0.001). Although the patterns of clusters were similar in PACS and PACG eyes, with the majority of the eyes classified into cluster 2(55%, and 62%, respectively), the highest proportion of APAC and fellow eyes were assigned to clusters 1(44%) and 3 (51%), respectively. Conclusion Hierarchical cluster analysis identified three clusters with different features. Predominant anatomical components are different among subtypes of primary angle closure.	[Moghimi, Sasan; Saunders, Luke J.; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Moghimi, Sasan; Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Inst, La Jolla, CA 92093 USA; [Moghimi, Sasan; Torkashvand, Ali; Mohammadi, Massood] Univ Tehran Med Sci, Tehran Univ Res Ctr, Tehran, Iran; [Yaseri, Mehdi] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Lin, Shan C.] Univ Calif San Francisco, San Francisco Med Sch, Koret Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of California System; University of California San Francisco	Weinreb, RN (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.; Weinreb, RN (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Inst, La Jolla, CA 92093 USA.	rweinreb@ucsd.ed	mohammadi, massood/ABG-2563-2020; Yaseri, Mehdi/I-1645-2018	mohammadi, massood/0000-0002-3017-6643; Weinreb, Robert/0000-0001-9553-3202; Torkashvand, Ali/0000-0001-5779-3935; Yaseri, Mehdi/0000-0002-4066-873X				Baek S, 2013, INVEST OPHTH VIS SCI, V54, P848, DOI 10.1167/iovs.12-10391; Eslami Y, 2013, CLIN EXP OPHTHALMOL, V41, P368, DOI 10.1111/j.1442-9071.2012.02871.x; Foster PJ, 2002, SEMIN OPHTHALMOL; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Guzman CP, 2013, INVEST OPHTH VIS SCI, V54, P5281, DOI 10.1167/iovs.13-12285; He M, 2006, EYE, V20, P3, DOI 10.1038/sj.eye.6701797; He MG, 2007, OPHTHALMOLOGY, V114, P494, DOI 10.1016/j.ophtha.2006.06.053; HOW AC, 2012, OPHTHALMOLOGY, V119, DOI DOI 10.1016/J.0PHTHA.2012.01.019; Kumar RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1269, DOI 10.1001/archophthalmol.2009.241; Lam DSC, 2008, OPHTHALMOLOGY, V115, P1134, DOI 10.1016/j.ophtha.2007.10.033; Lam DSC, 2002, OPHTHALMOLOGY, V109, P1591, DOI 10.1016/S0161-6420(02)01158-2; Lee S, 2014, INVEST OPHTH VIS SCI, V55; Liu L, 2011, CLIN EXP OPHTHALMOL, V39, P614, DOI 10.1111/j.1442-9071.2011.02521.x; Lowe R F, 1962, Br J Ophthalmol, V46, P641, DOI 10.1136/bjo.46.11.641; Moghimi S, 2014, EYE, V28, P337, DOI 10.1038/eye.2013.296; Moghimi S, 2016, EYE SCI, V26, P121; Moghimi S, 2016, J CURR OPHTHALMOL, V28, P170, DOI 10.1016/j.joco.2016.06.005; Moghimi S, 2016, AM J OPHTHALMOL, V166, P133, DOI 10.1016/j.ajo.2016.03.032; Moghimi S, 2014, CLIN EXP OPHTHALMOL, V42, P615, DOI 10.1111/ceo.12285; Moghimi S, 2013, AM J OPHTHALMOL, V155, P664, DOI 10.1016/j.ajo.2012.10.014; Nolan W, 2008, CURR OPIN OPHTHALMOL, V19, P115, DOI 10.1097/ICU.0b013e3282f40bba; Nonaka A, 2007, AM J OPHTHALMOL, V143, P695, DOI 10.1016/j.ajo.2006.11.018; Nongpiur M, 2016, EYE; Nongpiur ME, 2013, OPHTHALMOLOGY, V120, P2525, DOI 10.1016/j.ophtha.2013.05.028; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Ritch R, 2004, OPHTHALMOLOGY, V111, P104, DOI 10.1016/j.ophtha.2003.05.001; Shabana N, 2012, CLIN EXP OPHTHALMOL, V40, P792, DOI 10.1111/j.1442-9071.2012.02805.x; Sng CCA, 2014, OPHTHALMOLOGY, V121, P119, DOI 10.1016/j.ophtha.2013.08.004; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017; Zhang T., 1996, ACM SIGMOD RECORD	30	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0199157	10.1371/journal.pone.0199157	http://dx.doi.org/10.1371/journal.pone.0199157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036362	gold, Green Published			2022-12-27	WOS:000439429200003
J	Gao, QF; Shi, YJ; Mo, D; Nie, JC; Yang, M; Rozelle, S; Sylvia, S				Gao, Qiufeng; Shi, Yaojiang; Mo, Di; Nie, Jingchun; Yang, Meredith; Rozelle, Scott; Sylvia, Sean			Medical waste management in three areas of rural China	PLOS ONE			English	Article							HEALTH-CARE WASTE; TREATMENT TECHNOLOGIES; PROVINCE; MODEL	Objective The purpose of this paper is to describe current practices of medical waste management, including its generation, investments, collection, storage, segregation, and disposal, and to explore the level of support from upper tiers of the government and health care system for medical waste management in rural China. Methods The authors draw on a dataset comprised of 209 randomly selected rural township health centers (THCs) in 21 counties in three provinces of China: Anhui, Shaanxi and Sichuan. Surveys were administered to health center administrators in sample THCs in June 2015. Results The results show that the generation rate of medical waste was about 0.18 kg/bed, 0.15 kg/ patient, or 0.13 kg/person per day on average. Such per capita levels are significant given China's large rural population. Although investments of medical waste facilities and personnel in THCs have improved, results show that compliance with national regulations is low. For example, less than half of hazardous medical waste was packed in sealed containers or containers labeled with bio-hazard markings. None of the THCs segregated correctly according to the categories required by formal Chinese regulations. Many THCs reported improper disposal methods of medical waste. Our results also indicate low levels of staff training and low rates of centralized disposal in rural THCs. Conclusions Medical waste is a serious environmental issue that is rising on the agenda of policymakers. While a large share of THCs has invested in medical waste facilities and personnel, it appears that actual compliance remains low. Using evidence of low rates of training and centralized disposal, we surmise that a lack of support from upper tiers of management is one contributing factor. Given these findings, we recommend that China's policymakers should enhance support from upper tiers and improve monitoring as well as incentives in order to improve medical waste management.	[Gao, Qiufeng; Shi, Yaojiang; Nie, Jingchun] Shaanxi Normal Univ, Ctr Expt Econ Educ, Xian, Shaanxi, Peoples R China; [Mo, Di; Yang, Meredith; Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Sylvia, Sean] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA	Shaanxi Normal University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sylvia, S (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	sean_sylvia@unc.edu	Jingchun, Nie/F-4974-2016	Jingchun, Nie/0000-0002-7006-5796	111 Project [B16031]; Fundamental Research Funds for the Central Universities [2016CBZ011]	111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the 111 Project (Grant number B16031) and the Fundamental Research Funds for the Central Universities (Grant number 2016CBZ011).	Abd El-Salam MM, 2010, J ENVIRON MANAGE, V91, P618, DOI 10.1016/j.jenvman.2009.08.012; Caniato M, 2015, J ENVIRON MANAGE, V153, P93, DOI 10.1016/j.jenvman.2015.01.039; Chartier Y., 2014, SAFE MANAGEMENT WAST; Chen Y, 2013, WASTE MANAGE RES, V31, P1237, DOI 10.1177/0734242X13507314; Chen Y, 2009, WASTE MANAGE, V29, P1996, DOI 10.1016/j.wasman.2008.11.031; China Department of State, 2003, HAZ WAST MED WAST TR; China Ministry of Health, 2003, MED WAST CAT; China Ministry of Health, 2011, MEAS ADM TOWNSH HLTH; Da Silva CE, 2005, WASTE MANAGE, V25, P600, DOI 10.1016/j.wasman.2004.03.002; Fryxell GE, 2003, ENVIRON PLANN C, V21, P445, DOI 10.1068/c0013w; Gai RY, 2010, WASTE MANAGE, V30, P246, DOI 10.1016/j.wasman.2008.08.023; Gai RY, 2009, WASTE MANAGE RES, V27, P336, DOI 10.1177/0734242X09104384; Geng Y, 2013, J MATER CYCLES WASTE, V15, P310, DOI 10.1007/s10163-013-0118-9; Han J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2003; Hipgrave D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001337; Liu HC, 2015, RENEW SUST ENERG REV, V41, P932, DOI 10.1016/j.rser.2014.08.061; Liu HC, 2014, ENVIRON EARTH SCI, V72, P4179, DOI 10.1007/s12665-014-3314-6; Lu C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060562; Malekahmadi F, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/s40201-014-0116-4; Mao ZM, 2011, WASTE MISMANAGEMENT; Miyazaki M, 2005, WASTE MANAGE, V25, P616, DOI 10.1016/j.wasman.2005.01.003; Muhlich M, 2003, J HOSP INFECT, V55, P260, DOI 10.1016/j.jhin.2003.08.017; National Bureau of Statistics of China, 2016, CHIN STAT YB 2015; National Bureau of Statistics of China, 2017, CHIN STAT YB 2016; National Health and Family Planning Commission, 2016, CHIN HLTH FAM PLANN; Nie Li, 2016, Journal of Environmental Protection, V7, P93, DOI 10.4236/jep.2016.71009; Nie Li, 2014, Journal of Environmental Protection, V5, P803; Patil AD, 2001, J ENVIRON MANAGE, V63, P211, DOI 10.1006/jema.2001.0453; Qian J, 2015, J ASIAN PUBLIC POLIC, V8, P19, DOI 10.1080/17516234.2014.1003454; Sabour MR, 2007, WASTE MANAGE, V27, P584, DOI 10.1016/j.wasman.2006.05.010; Shen CL, 2014, ANN ECON FINANC, V15, P135; Shi H, 2017, WASTE MANAGE, V59, P508, DOI 10.1016/j.wasman.2016.11.016; Shinee E, 2008, WASTE MANAGE, V28, P435, DOI 10.1016/j.wasman.2006.12.022; Stall NM, 2013, CAN J SURG, V56, P97, DOI 10.1503/cjs.015711; WHO, 2015, WATER SANITATION HYG; World Bank World Health Organization Ministry of Finance National Health and Family Planning Commission Ministry of Human Resources and Social Security, 2016, 107176 WORLD BANK WH, P202; World Health Organization (WHO), 2018, HLTH CAR WAST; Yan M, 2011, J MATER CYCLES WASTE, V13, P213, DOI 10.1007/s10163-011-0020-2; Yi HM, 2015, HEALTH AFFAIR, V34, P1391, DOI 10.1377/hlthaff.2014.1114; Zhang HJ, 2013, WASTE MANAGE RES, V31, P655, DOI 10.1177/0734242X13482161; Zhang Y, 2009, WASTE MANAGE, V29, P1376, DOI 10.1016/j.wasman.2008.10.023	41	7	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200889	10.1371/journal.pone.0200889	http://dx.doi.org/10.1371/journal.pone.0200889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028841	Green Published, Green Submitted, gold			2022-12-27	WOS:000439396900022
J	Salzberger, W; Martrus, G; Bachmann, K; Goebels, H; Hess, L; Koch, M; Langeneckert, A; Lunemann, S; Oldhafer, KJ; Pfeifer, C; Poch, T; Richert, L; Schramm, C; Wahib, R; Sunders, MJ; Altfeld, M				Salzberger, Wilhelm; Martrus, Gloria; Bachmann, Kai; Goebels, Hanna; Hess, Leonard; Koch, Martina; Langeneckert, Annika; Lunemann, Sebastian; Oldhafer, Karl J.; Pfeifer, Caroline; Poch, Tobias; Richert, Laura; Schramm, Christoph; Wahib, Ramez; Sunders, Madeleine J.; Altfeld, Marcus			Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; EFFECTOR FUNCTION; LYMPHOID-TISSUES; SURFACE-MARKERS; CANCER; ACTIVATION; SUBSET	Metabolism is a critical basis for immune cell functionality. It was recently shown that NK cell subsets from peripheral blood modulate their expression of nutrient receptors following cytokine stimulation, demonstrating that NK cells can adjust to changes in metabolic requirements. As nutrient availability in blood and tissues can significantly differ, we examined NK cells isolated from paired blood-liver and blood-spleen samples and compared expression of the nutrient transporters Glutl, CD98 and CD71. CD56(bright) tissue-resident (CXCR6(+)) NK cells derived from livers and spleens expressed lower levels of Glutl but higher levels of the amino acid transporter CD98 following stimulation than CD56(bright) NK cells from peripheral blood. In line with that, CD56(dim) NK cells, which constitute the main NKcell population in the peripheral blood, expressed higher levels of Glutl and lower levels of CD98 and CD71 compared to liver CD56(bright) NK cells. Our results show that NK cells from peripheral blood differ from liver- and spleen-resident NK cells in the expression profile of nutrient transporters, consistent with a cell-adaptation to the different nutritional environment in these compartments.	[Salzberger, Wilhelm; Martrus, Gloria; Goebels, Hanna; Hess, Leonard; Langeneckert, Annika; Lunemann, Sebastian; Pfeifer, Caroline; Sunders, Madeleine J.; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Viral Immunol, Hamburg, Germany; [Bachmann, Kai; Wahib, Ramez] Univ Med Ctr Hamburg, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Koch, Martina] Univ Med Ctr Hamburg, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany; [Oldhafer, Karl J.] Semmelweis Univ Med, Asklepios Hosp Barmbek, Dept Gen & Abdominal Surg, Hamburg, Germany; [Poch, Tobias; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Richert, Laura] Bordeaux Univ, INRIA SISTM, INSERM U1219, Bordeaux, France; [Schramm, Christoph] Univ Med Ctr Hamburg, Martin Zeitz Ctr Rare Dis, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Semmelweis University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Hamburg; University Medical Center Hamburg-Eppendorf	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Viral Immunol, Hamburg, Germany.	marcus.altfeld@leibniz-hpi.de	Bachmann, Kai/AAN-6043-2021; Richert, Laura/T-5801-2019; Koch, Martina/AAJ-6611-2020; Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997; Richert, Laura/0000-0002-7682-2225; Pfeifer, Caroline/0000-0001-5442-9409; Poch, Tobias/0000-0001-8178-9522; Martrus, Gloria/0000-0003-2879-3201	Deutsche Forschungsgemeinschaft [SFB841]; Deutsches Zentrum fur Infektionsforschung (DZIF); Helmut and Hannelore Greve Foundation; YAEL Foundation; Graduiertenkolleg (GRK) from the University Medical Center Hamburg-Eppendorf (UKE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Infektionsforschung (DZIF); Helmut and Hannelore Greve Foundation; YAEL Foundation; Graduiertenkolleg (GRK) from the University Medical Center Hamburg-Eppendorf (UKE)	MA received founding support from the Deutsche Forschungsgemeinschaft (SFB841). WS received funding from the Deutsches Zentrum fur Infektionsforschung (DZIF; http://www.dzif.de). CS and TP received funding support from the Helmut and Hannelore Greve Foundation (http://www.awhamburg.de/en/academy/portrait/funding.html) and the YAEL Foundation (https://yael-stiftung.de/en/home). HG and LH were financially supported by the Graduiertenkolleg (GRK) from the University Medical Center Hamburg-Eppendorf (UKE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SS, 2017, J NUCL MED, V58, P507, DOI 10.2967/jnumed.116.180729; APPELBOOM JWT, 1959, J GEN PHYSIOL, V43, P467, DOI 10.1085/jgp.43.2.467; Benjamini Y, 2001, ANN STAT, V29, P1165; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chlup R, 2015, BIOMED PAP, V159, P527, DOI 10.5507/bp.2015.007; Colovai AI, 2004, MODERN PATHOL, V17, P918, DOI 10.1038/modpathol.3800141; Cretenet G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24129; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008; Freud AG, 2014, SEMIN IMMUNOL, V26, P132, DOI 10.1016/j.smim.2014.02.008; Ganapathy-Kanniappan S, 2017, BBA-REV CANCER, V1868, P212, DOI 10.1016/j.bbcan.2017.04.002; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Hang TTN, 2012, CELL MOL LIFE SCI, V69, P3015, DOI 10.1007/s00018-012-0963-z; HAYNES BF, 1981, J IMMUNOL, V126, P1409; Hervier B, 2017, J ALLERGY CLIN IMMUN, V140, P317, DOI 10.1016/j.jaci.2017.02.042; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Hydes T, 2018, IMMUN INFLAMM DIS, V6, P34, DOI 10.1002/iid3.190; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Keating SE, 2016, J IMMUNOL, V196, P2552, DOI 10.4049/jimmunol.1501783; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Lo B, 2016, NAT GENET, V48, P10, DOI 10.1038/ng.3478; Lourido J, 2002, SCAND J CLIN LAB INV, V62, P285, DOI 10.1080/003655102760145843; Lugthart G, 2016, J IMMUNOL, V197, P78, DOI 10.4049/jimmunol.1502603; Lunemann S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06011-7; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Mah AY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95128; Marquardt N, 2017, J ALLERGY CLIN IMMUN, V139, P1321, DOI 10.1016/j.jaci.2016.07.043; Martrus G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182532; Masson Jesse Jr, 2017, Antiviral Chemistry & Chemotherapy, V25, P53, DOI 10.1177/2040206617701372; Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; MORETTA L, 1981, J EXP MED, V154, P569, DOI 10.1084/jem.154.2.569; Nicholson SE, 2019, MOL IMMUNOL, V110, P40, DOI 10.1016/j.molimm.2017.12.002; Nishida N, 2006, VASC HEALTH RISK MAN, V2, P213, DOI 10.2147/vhrm.2006.2.3.213; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Puig S, 2017, METALLOMICS, V9, P1483, DOI 10.1039/c7mt00116a; Sebastiani G, 2014, WORLD J GASTROENTERO, V20, P11033, DOI 10.3748/wjg.v20.i32.11033; Shipkova M, 2012, CLIN CHIM ACTA, V413, P1338, DOI 10.1016/j.cca.2011.11.006; Stegmann KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26157; Tekade RK, 2017, DRUG DISCOV TODAY, V22, P1637, DOI 10.1016/j.drudis.2017.08.003; Turner JE, 2018, J AM SOC NEPHROL, V29, P389, DOI 10.1681/ASN.2017060599; Waggoner SN, 2016, CURR OPIN VIROL, V16, P15, DOI 10.1016/j.coviro.2015.10.008; Walls J, 2016, SEMIN IMMUNOL, V28, P396, DOI 10.1016/j.smim.2016.09.001; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WELLS RG, 1992, J BIOL CHEM, V267, P15285; Xie H, 2017, J BIOL CHEM, V292, P16825, DOI 10.1074/jbc.R117.799973; Yokoyama WM, 2013, COLD SH Q B, V78, P149, DOI 10.1101/sqb.2013.78.020354	56	31	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201170	10.1371/journal.pone.0201170	http://dx.doi.org/10.1371/journal.pone.0201170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028872	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900041
J	Zacher, LS; Kruse, GH; Hardy, SM				Zacher, Leah Sloan; Kruse, Gordon H.; Hardy, Sarah Mincks			Autumn distribution of Bristol Bay red king crab using fishery logbooks	PLOS ONE			English	Article							LOCAL SPATIAL AUTOCORRELATION; BERING-SEA; PARALITHODES-CAMTSCHATICUS; GRAIN-SIZE; ABUNDANCE; BEHAVIOR; INVERTEBRATES	Spatial distributions of fished species must be well characterized to avoid local depletions, identify critical habitat, and predict and mitigate interactions with other fisheries. The Bristol Bay red king crab (Paralithodes camtschaticus) fishery is one of the largest crab fisheries in Alaska. Summer crab distributions have been well documented by decades of bottom trawl surveys. However, crab movement and distribution are poorly understood outside the summer survey period, which creates several management challenges. One important component of fishery management is the existence of no-trawl zones, which are intended to protect crab from bottom trawl fisheries. However, it is difficult to evaluate the placement of no-trawl zones, because most crab bycatch occurs in trawl fisheries during winter when crab distributions are unknown. Daily fishing logs, kept by skippers in the red king crab fleet since 2005, contain detailed information on the spatial distribution of catch and effort of legal sized male crab during the autumn crab fishery. However, data contained in these hand-written logbooks have not been readily accessible. We digitized daily fishing logs from 2005 to 2016 and used spatial information on catch and effort to infer geographic distributions of legal sized male king crab during the crab fishing season. Changes in distribution were tracked across this 12-yr period and comparisons were made between warm and cold temperature regimes. In warm years (2005, 2014-2016), crab aggregated in the center of Bristol Bay, Alaska, while in cold years (2007-2013) they were closer to the Alaska Peninsula. The majority of crab were caught in no-trawl areas (63.4% on average), but variations occurred among years and with temperature regime (40.0-86.8% in no-trawl zones). As temperatures continue to shift in the Bering Sea, it will be important to continue monitoring crab distributions outside the summer survey period.	[Zacher, Leah Sloan; Hardy, Sarah Mincks] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Kruse, Gordon H.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau Ctr, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Zacher, LS (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	lmsloan@alaska.edu		Mincks, Sarah/0000-0002-3328-712X	Bering Sea Fisheries Research Foundation; National Science Foundation (NSF) Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) Integrative Graduate Education and Research Traineeship (IGERT) [DGE-0801720]; Rasmuson Fisheries Research Center Graduate Fellowship	Bering Sea Fisheries Research Foundation; National Science Foundation (NSF) Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); Rasmuson Fisheries Research Center Graduate Fellowship	Financial support for digitizing Daily Fishing Logs was provided by the Bering Sea Fisheries Research Foundation (http://www.bsfrf.org/) [to LSZ]. Support for graduate student, LSZ, was provided by the National Science Foundation (NSF) Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) Integrative Graduate Education and Research Traineeship (IGERT) (#DGE-0801720) (http://www.sfos.uaf.edu/mesas/about.php) and the Rasmuson Fisheries Research Center Graduate Fellowship (http://www.uaf.edu/cfos/research/major-research-programs/rasmuson-fisheries-resear/rfrc-fellowships/). Funding organizations did not play any role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Abbott JK, 2012, ECOL APPL, V22, P762, DOI 10.1890/11-1319.1; Ackley D, 1999, LOW WAKE FI, V16, P511; ADF& G, 2014, COMM KING TANN CRAB; ADF& G staff, 2000, 4K0055 ADF G STAFF; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2003, GEODA TM 09 USERS GU; Aydin K, 2016, STOCK ASSESSMENT FIS; Blackford MG, 1979, PIONEERING MODERN SM, V6; Boots B, 2002, ECOSCIENCE, V9, P168, DOI 10.1080/11956860.2002.11682703; Bright DB, 1967, THESIS; Bush K, 2017, STOCK ASSESSMENT FIS; Chilton E. A., 2010, BIOL MANAGEMENT EXPL, P249; Christiansen JS, 2015, DIVERS DISTRIB, V21, P1004, DOI 10.1111/ddi.12321; Cressie N., 1991, SPATIAL STAT DIGITAL, P87; DALY BJ, 2016, NOAA T MEMO AFSC, V327, P1, DOI DOI 10.7289/V5/TM-AFSC-327; Dew CB, 2008, N AM J FISH MANAGE, V28, P1618, DOI 10.1577/M07-038.1; Duffy-Anderson JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178955; ESRI, 2018, ARCGIS DESKTOP RELEA; Evans D., 2012, EVALUATION ADVERSE I, P37; Falk-Petersen J, 2011, ICES J MAR SCI, V68, P479, DOI 10.1093/icesjms/fsq192; Fina M, 2005, MAR POLICY, V29, P311, DOI 10.1016/j.marpol.2004.05.005; Fissel B., 2016, STOCK ASSESSMENT FIS; Fitch H, 2011, 1222 AL DEP FISH GAM; Garber-Yonts B.E., 2016, EC STATUS REPORT SUM; Hsu C., 1987, THESIS; Kruse GH, 2010, ICES J MAR SCI, V67, P1866, DOI 10.1093/icesjms/fsq136; Loher T, 2005, FISH OCEANOGR, V14, P292, DOI 10.1111/j.1365-2419.2005.00337.x; Loher T., 2001, THESIS; McConnaughey RA, 2000, CAN J FISH AQUAT SCI, V57, P2410, DOI 10.1139/cjfas-57-12-2410; McGonigle C, 2014, ESTUAR COAST SHELF S, V147, P123, DOI 10.1016/j.ecss.2014.05.025; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Nippes WE, 1991, 4K914 AL DEP FISH GA; NPFMC, 2013, BRIST BAY RED KING C; O'Sullivan D, 2014, GEOGRAPHIC INFORM AN; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ord JK, 2001, J REGIONAL SCI, V41, P411, DOI 10.1111/0022-4146.00224; Shirley T.C., 1990, P INT S KING TANNER, P51; Simpson R. R., 1968, Int N Pacif Fish Commn, V24, P111; Smith, 1999, NMFSAFSC104 NOAA US; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stevens BG, 2014, KING CRABS OF THE WORLD: BIOLOGY AND FISHERIES MANAGEMENT, P1; STONE RP, 1993, CAN J FISH AQUAT SCI, V50, P750, DOI 10.1139/f93-086; Sundet JH, 2000, CRUSTACEAN ISS, V12, P193; Takeshita K., 1990, P INT S KING TANN CR, P427; WIESER W, 1959, LIMNOL OCEANOGR, V4, P181, DOI 10.4319/lo.1959.4.2.0181; Yeung C, 2006, MAR ECOL PROG SER, V318, P47, DOI 10.3354/meps318047; Zheng J, 2006, PROG OCEANOGR, V68, P184, DOI 10.1016/j.pocean.2006.02.002; [No title captured]	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201190	10.1371/journal.pone.0201190	http://dx.doi.org/10.1371/journal.pone.0201190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN8GG	30028882	Green Submitted, Green Published, gold			2022-12-27	WOS:000439396900044
J	Stendardo, M; Casillo, V; Schito, M; Ballerin, L; Stomeo, F; Vitali, E; Nardini, M; Maietti, E; Boschetto, P				Stendardo, Mariarita; Casillo, Valeria; Schito, Michela; Ballerin, Licia; Stomeo, Francesco; Vitali, Emanuela; Nardini, Marco; Maietti, Elisa; Boschetto, Piera			Forced expiratory volume in one second: A novel predictor of work disability in subjects with suspected obstructive sleep apnea	PLOS ONE			English	Article							LUNG-FUNCTION; EPWORTH SLEEPINESS; MANAGEMENT; ABILITY; OBESITY; SCALE; MULTIMORBIDITY; ASSOCIATION; ABSENTEEISM; POPULATION	Whether the association of work disability with obstructive sleep apnea (OSA) is mainly due to the disease, i.e. the number and frequency of apneas-hypoapneas, or to coexisting factors independent from the disease, is not well-established. In this study, we aim to evaluate work ability in a group of subjects undergoing OSA workup and to identify the major contributors of impaired work ability. In a cross-sectional study, we enrolled 146 consecutive subjects who have been working for the last five years and referred to the sleep disorders outpatients' clinic of the University-Hospital of Ferrara, Italy, with suspected OSA. After completing an interview in which the Work Ability Index (WAI) and the Epworth Sleepiness Scale (ESS) questionnaires were administered to assess work ability and excessive daytime sleepiness, respectively, subjects underwent overnight polysomnography for OSA diagnosing and spirometry. Of the 146 subjects, 140 (96%) completed the tests and questionnaires and, of these, 66 exhibited work disability (WAI < 37). OSA was diagnosed (apnea-hypopnea index >= 5) in 45 (68%) of the 66 subjects. After controlling for confounders, a lower level of forced expiratory volume at 1 second (FEV1), [odds ratio 0.97 (95% CI 0.95-1.00)], older age [1.09 (95% CI 1.03-1.15)], excessive daytime sleepiness [3.16 (95% CI 1.20-8.34)] and a worse quality of life [0.96 (95% CI 0.94-1.00)], but not OSA [1.04 (95% CI 0.41-2.62)], were associated with work disability. Patients with a higher number of diseases, in which OSA was not included, and a lower quality of life had an increased probability of absenteeism in the previous 12 months. In subjects with suspected OSA, FEV i can be an important predictor of work disability.	[Stendardo, Mariarita; Casillo, Valeria; Schito, Michela; Vitali, Emanuela; Boschetto, Piera] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Ballerin, Licia] Univ Hosp Ferrara, Resp Unit, Ferrara, Italy; [Stomeo, Francesco] Univ Hosp Ferrara, Ear Nose & Throat & Audiol Dept, Ferrara, Italy; [Nardini, Marco] Univ Hosp & Publ Hlth Serv Ferrara, Dept Prevent & Protect, Ferrara, Italy; [Maietti, Elisa] Univ Hosp Ferrara, Ctr Clin & Epidemiol Res, Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna	Boschetto, P (corresponding author), Univ Ferrara, Dept Med Sci, Ferrara, Italy.	bsp@unife.it	Boschetto, Piera/AAM-3247-2020; VARRECCHIA, TIWANA/AAJ-8712-2021	Boschetto, Piera/0000-0003-3889-1681; 				Accattoli M P, 2008, G Ital Med Lav Ergon, V30, P297; Alavinia SM, 2009, OCCUP MED-OXFORD, V59, P32, DOI 10.1093/occmed/kqn148; AlGhanim N, 2008, LUNG, V186, P7, DOI 10.1007/s00408-007-9055-5; Allen AJMH, 2015, CHEST, V147, P1422, DOI 10.1378/chest.14-1949; Aurora RN, 2011, SLEEP, V34, P1707, DOI 10.5665/sleep.1442; BaHammam AS, 2016, SLEEP BREATH, V20, P447, DOI 10.1007/s11325-015-1223-x; Basoglu OK, 2014, CLIN RESPIR J, V8, P167, DOI 10.1111/crj.12054; Boschetto P, 2016, INT J CARDIOL, V203, P798, DOI 10.1016/j.ijcard.2015.11.079; Casimirri E, 2014, INT J OCCUP MED ENV, V27, P343, DOI 10.2478/s13382-014-0256-x; CHARLSON ME, 1987, J CHRON DIS, V40, P31, DOI 10.1016/0021-9681(87)90094-4; Chervin RD, 2000, J SLEEP RES, V9, P399, DOI 10.1046/j.1365-2869.2000.0227a.x; Dean B, 2010, J OCCUP ENVIRON MED, V52, P144, DOI 10.1097/JOM.0b013e3181c99505; El Fassi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-305; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Ervasti J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079855; Frangolias DD, 2003, AM J RESP CRIT CARE, V167, P150, DOI 10.1164/rccm.2202053; Gupta MA, 2016, SLEEP MED REV, V28, P55, DOI 10.1016/j.smrv.2015.07.002; Habibi E, 2012, INT J PREVENTIVE MED, V3, P776; Hendriks SM, 2015, J AFFECT DISORDERS, V178, P121, DOI 10.1016/j.jad.2015.03.004; Huang TY, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02421-2017; Iversen KK, 2010, EUR J HEART FAIL, V12, P685, DOI 10.1093/eurjhf/hfq050; Jetha A, 2016, J OCCUP ENVIRON MED, V58, P485, DOI 10.1097/JOM.0000000000000702; Jonassen TM, 2018, CLIN RESPIR J, V12, P31, DOI 10.1111/crj.12472; Kendzerska T, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01361-2016; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Kunos L, 2017, LUNG, V195, P127, DOI 10.1007/s00408-016-9957-1; Masa JF, 2011, SLEEP BREATH, V15, P549, DOI 10.1007/s11325-010-0399-3; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Omachi TA, 2009, SLEEP, V32, P791, DOI 10.1093/sleep/32.6.791; Reynolds AC, 2017, SLEEP HEALTH, V3, P357, DOI 10.1016/j.sleh.2017.06.003; Robroek SJW, 2013, SCAND J WORK ENV HEA, V39, P233, DOI 10.5271/sjweh.3354; Sforza E, 2011, EUR RESPIR J, V37, P1137, DOI 10.1183/09031936.00043210; Shrestha N, 2016, CURR OBES REP, V5, P344, DOI 10.1007/s13679-016-0227-6; Sundstrup E, 2017, SCAND J WORK ENV HEA, V43, P146, DOI 10.5271/sjweh.3620; Teng AY, 2012, CLIN CHEST MED, V33, P731, DOI 10.1016/j.ccm.2012.09.003; Ubalde-Lopez M, 2016, INT ARCH OCC ENV HEA, V89, P667, DOI 10.1007/s00420-015-1104-4; van den Berg TIJ, 2009, OCCUP ENVIRON MED, V66, P211, DOI 10.1136/oem.2008.039883; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	41	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201045	10.1371/journal.pone.0201045	http://dx.doi.org/10.1371/journal.pone.0201045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024962	gold, Green Published, Green Submitted			2022-12-27	WOS:000439120000083
J	Xiong, QF; Xiong, T; Huang, P; Zhong, YD; Wang, HL; Yang, YF				Xiong, Qing-Fang; Xiong, Tian; Huang, Ping; Zhong, Yan-Dan; Wang, Hua-Li; Yang, Yong-Feng			Early predictors of acute hepatitis B progression to liver failure	PLOS ONE			English	Article							FULMINANT-HEPATITIS; VIRUS; DISEASE; HEPATOCYTES; INFECTION; ETIOLOGY	Background and aims 1 similar to 4% of acute hepatitis B (AHB) cases in adults progresses to acute liver failure (ALF).The predictors of ALF and prognosis for patients with ALF are not clear. This study investigated some of predictive and prognostic factors for AHB progression to ALF. Methods A retrospective analysis was used to assess the clinical and laboratory features of 293 patients diagnosed with AHB; the patients were divided into the following two groups: ALF (n = 13) and non-ALF (n = 280). Results In total,13 of the 293 (4.43%) patients developed ALF (10 recovered?3 died). The variables of age, anti-HBc IgM titers >= 10 S/CO, HBeAg negativity, and total bilirubin (TB) at admission were significantly higher in ALF patients than in non-ALF patients. Compared to non-ALF patients, ALF patients had significantly lower values for prothrombin time activity (PTA), serum albumin, and HBV DNA. At discharge, ALF patients had lower TB normalization rates and much faster clearance of HBsAg, HBeAg and HBVDNA than non-ALF patients. In multivariate analysis, TB >= 5xupper limit of normal (ULN) and HBeAg negative status were independent predictors for ALF development at admission, with 84.6% sensitivity, 85.7% specificity, a likelihood ratio of 5.91 and an area under the receiver operating characteristics curve (AUROC) of 0.850.Those who died had lower levels of peak PTA (<20%) and higher levels of peak hepatic encephalopathy (HE) grade (III-IV) than those who recovered. Conclusions Of the patients with ALF, 23.1% died. TB >= 5xULN and HBeAg negative status were the most effective and practicable factors distinguishing ALF from AHB at admission before the onset of encephalopathy. Peak PTA<20% and/or HE grade III-IV were independent predictors of a high probability of death or a need for transplantation.	[Xiong, Qing-Fang; Huang, Ping; Zhong, Yan-Dan; Wang, Hua-Li; Yang, Yong-Feng] South East Univ, Hosp Nanjing 2, Sch Med, Liver Dis Dept, Nanjing, Jiangsu, Peoples R China; [Xiong, Tian] Beijing Aerosp Gen Hosp, Dept Anesthesiol, Beijing 100076, Peoples R China	Southeast University - China	Xiong, QF; Yang, YF (corresponding author), South East Univ, Hosp Nanjing 2, Sch Med, Liver Dis Dept, Nanjing, Jiangsu, Peoples R China.	qfx12345@126.com; tongxqf@163.com		xiong, fang/0000-0003-2743-555X				Agrawal S, 2016, POSTGRAD MED J, V92, P223, DOI 10.1136/postgradmedj-2015-133715; Bianco E, 2003, DIGEST LIVER DIS, V35, P404, DOI 10.1016/S1590-8658(03)00157-9; Canbay A, 2011, DTSCH ARZTEBL INT, V108, P714, DOI 10.3238/arztebl.2011.0714; Dao DY, 2012, HEPATOLOGY, V55, P676, DOI 10.1002/hep.24732; Dhiman RK, 1998, DIGEST DIS SCI, V43, P1311, DOI 10.1023/A:1018876328561; European Assoc Study Liver, 2017, J HEPATOL, V66, P1047, DOI 10.1016/j.jhep.2016.12.003; FEUTREN G, 1984, J IMMUNOL METHODS, V75, P85, DOI 10.1016/0022-1759(84)90227-8; Fink K, 2007, J IMMUNOL, V179, P5877, DOI 10.4049/jimmunol.179.9.5877; Garfein RS, 2004, HEPATOLOGY, V40, P865, DOI 10.1002/hep.20383; Hadem J, 2008, CLIN GASTROENTEROL H, V6, P339, DOI 10.1016/j.cgh.2007.12.039; Han YN, 2008, J GASTROEN HEPATOL, V23, P1728, DOI 10.1111/j.1440-1746.2008.05600.x; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Ichai P, 2008, LIVER TRANSPLANT, V14, pS67, DOI 10.1002/lt.21612; Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271; Kanada A, 2007, INTERVIROLOGY, V50, P394, DOI 10.1159/000110651; Kantola T, 2011, SCAND J SURG, V100, P8, DOI 10.1177/145749691110000103; Kew MC, 2000, LANCET, V355, P591, DOI 10.1016/S0140-6736(99)00219-6; Lee WM, 2012, HEPATOLOGY, V55, P965, DOI 10.1002/hep.25551; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lisotti Andrea, 2008, Int J Med Sci, V5, P309; MONDELLI M, 1982, J IMMUNOL, V129, P2773; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Rantala Merja, 2008, Euro Surveill, V13; Shiffman Mitchell L, 2010, Clin Liver Dis, V14, P75, DOI 10.1016/j.cld.2009.11.013; Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x; Tillmann HL, 2014, INTERVIROLOGY, V57, P181, DOI 10.1159/000360939; Tseng TC, 2017, J INFECT DIS, V216, pS765, DOI 10.1093/infdis/jix356; Wai CT, 2005, J VIRAL HEPATITIS, V12, P192, DOI 10.1111/j.1365-2893.2005.00581.x; Wang CY, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-23; Wang DW, 2013, WORLD J GASTROENTERO, V19, P7069, DOI 10.3748/wjg.v19.i41.7069; Wei G, 2007, J INTERN MED, V262, P393, DOI 10.1111/j.1365-2796.2007.01818.x; Zhao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080991	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201049	10.1371/journal.pone.0201049	http://dx.doi.org/10.1371/journal.pone.0201049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048531	gold, Green Published, Green Submitted			2022-12-27	WOS:000439952400043
J	Mathew, B; Leon, J; Sillanpaa, MJ				Mathew, Boby; Leon, Jens; Sillanpaa, Mikko J.			Impact of residual covariance structures on genomic prediction ability in multi-environment trials	PLOS ONE			English	Article							LINEAR MIXED MODELS; HERITABILITY ESTIMATION; BREEDING POPULATIONS; SELECTION; PEDIGREE; VALUES; ACCURACY; VARIETY; TRAITS	In plant breeding, one of the main purpose of multi-environment trial (MET) is to assess the intensity of genotype-by-environment (GxE) interactions in order to select high-performing lines of each environment. Most models to analyze such MET data consider only the additive genetic effects and the part of the non-additive genetic effects are confounded with the residual terms and this may lead to the non-negligible residual covariances between the same trait measured at multiple environments. In breeding programs it is also common to have the phenotype information from some environments available and values are missing in some other environments. In this study we focused on two problems:(1) to study the impact of different residual covariance structures on genomic prediction ability using different models to analyze MET data;(2) to compare the ability of different MET analysis models to predict the missing values in a single environment. Our results suggests that, it is important to consider the heterogeneous residual covariance structure for the MET analysis and multivariate mixed model seems to be especially suitable to predict the missing values in a single environment. We also present the prediction abilities based on Bayesian and frequentist approaches with different models using field data sets (maize and rice) having different levels of GxE interactions.	[Mathew, Boby; Leon, Jens] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany; [Sillanpaa, Mikko J.] Dept Math Sci, FIN-90014 Oulu, Finland; [Sillanpaa, Mikko J.] Bioctr Oulu, FIN-90014 Oulu, Finland	University of Bonn	Mathew, B (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany.	boby.mathew@hotmail.com		Sillanpaa, Mikko J./0000-0003-2808-2768				Atlin GN, 2000, CROP SCI, V40, P7, DOI 10.2135/cropsci2000.4017; Sousa MBE, 2017, G3-GENES GENOM GENET, V7, P1995, DOI 10.1534/g3.117.042341; Bernal-Vasquez AM, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0512-8; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Burgueno J, 2011, CROP SCI, V51, P944, DOI 10.2135/cropsci2010.07.0403; Crossa J, 2006, CROP SCI, V46, P1722, DOI 10.2135/cropsci2005.11-0427; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Cuevas J, 2017, G3-GENES GENOM GENET, V7, P41, DOI 10.1534/g3.116.035584; Cullis B, 1998, BIOMETRICS, V54, P1, DOI 10.2307/2533991; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; DIAZGARCIA L, 2016, PLOS ONE, V11, DOI DOI 10.1371/J0URNAL.P0NE.0156744; Garner JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep34114; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Lopez-Cruz M, 2015, G3-GENES GENOM GENET, V5, P569, DOI 10.1534/g3.114.016097; Malosetti M, 2016, CROP SCI, V56, P2210, DOI 10.2135/cropsci2015.05.0311; Masuka B, 2017, CROP SCI, V57, P168, DOI 10.2135/cropsci2016.05.0343; Mathew B, 2012, HEREDITY, V109, P235, DOI 10.1038/hdy.2012.35; Mathew B, 2018, HEREDITY, V120, P356, DOI 10.1038/s41437-017-0023-4; Meuwissen THE, 2001, GENETICS, V157, P1819; Montesinos-Lopez OA, 2016, G3-GENES GENOM GENET, V6, P2725, DOI 10.1534/g3.116.032359; Oakey H, 2016, G3-GENES GENOM GENET, V6, P1313, DOI 10.1534/g3.116.027524; Okeke UG, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0361-y; Piepho HP, 1997, BIOMETRICS, V53, P761, DOI 10.2307/2533976; Piepho HP, 2000, GENETICS, V156, P2043; Rutkoski J, 2016, G3-GENES GENOM GENET, V6, P2799, DOI 10.1534/g3.116.032888; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang Z, 2004, CAN J ANIM SCI, V84, P1, DOI 10.4141/A03-123; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	36	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0201181	10.1371/journal.pone.0201181	http://dx.doi.org/10.1371/journal.pone.0201181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028886	Green Published, gold			2022-12-27	WOS:000439396900043
J	Hu, YX; Schafer, G; Duplay, J; Kuhn, NJ				Hu, Yaxian; Schafer, Gerhard; Duplay, Joelle; Kuhn, Nikolaus J.			Bioenergy crop induced changes in soil properties: A case study on Miscanthus fields in the Upper Rhine Region	PLOS ONE			English	Article							LAND-USE CHANGE; X GIGANTEUS; CARBON SEQUESTRATION; ENVIRONMENTAL IMPACTS; C-13 ABUNDANCE; ORGANIC-MATTER; CLIMATE-CHANGE; LOESS PLATEAU; BIOMASS; MITIGATION	Biomass as a renewable energy source has become increasingly prevalent in Europe to comply with greenhouse gas emission targets. As one of the most efficient perennial bioenergy crops, there is great potential in the Upper Rhine Region to explore biomass utilization of Miscanthus to confront climate change and land use demand in the future. Yet, the impacts of Miscanthus cultivation on soil quality have not been adequately explored. This study investigated the soil profiles of five-and 20-year-old Miscanthus fields (1 m depth) as well as grassland for reference in eastern France and Switzerland. The soil organic carbon (SOC) concentrations and delta(13) C compositions of four soil layers (0-10 cm, 10-40 cm, 40-70 cm and 70-100 cm) were determined. The CO2 emission rates of the topsoil were monitored for 42 days. Our results showed that Miscanthus, in general, could increase the SOC stocks compared to grassland, but the benefits of SOC sequestration were constrained to the surface soil. Isotopically, the Miscanthus-derived SOC ranged from 69% in the top 10 cm of soil down to only 7% in the 70 cm to 100 cm layer. This result raises the risk of overestimating the total net benefits of Miscanthus cultivation, when simply using the greater SOC stocks near the surface soil to represent the SOC-depleted deep soil layers. The Miscanthus fields had greater CO2 emissions, implying that the Miscanthus fields generated greater ecosystem respiration, rather than larger net ecosystem exchanges. Compared to the grassland soils, the surface soils of the Miscanthus fields tended to have a risk of acidification while having higher concentrations of phosphorus and potassium, calling for the inclusion of soil characteristics and SOC stability when evaluating the impacts of long-term Miscanthus cultivation on both current and future land use changes.	[Hu, Yaxian] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Hu, Yaxian; Kuhn, Nikolaus J.] Univ Basel, Dept Environm Sci, Phys Geog & Environm Change, Basel, Switzerland; [Schafer, Gerhard; Duplay, Joelle] Univ Strasbourg, CNRS, UMR 7517, Lab Hydrol & Geochim Strasbourg, Strasbourg, France	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hu, YX (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.; Hu, YX (corresponding author), Univ Basel, Dept Environm Sci, Phys Geog & Environm Change, Basel, Switzerland.	huyaxian@nwafu.edu.cn	Schäfer, Gerhard/GWV-4806-2022		Innovations for Sustainable Biomass Utilization in the Upper Rhine Region; Special Funds for Young Scientists with Oversea Doctoral Diploma from Department of Human Resources and Social Security of Shaanxi Province, China [2017036]; Fundamental Research Funds for the Central Universities [2452017191]	Innovations for Sustainable Biomass Utilization in the Upper Rhine Region; Special Funds for Young Scientists with Oversea Doctoral Diploma from Department of Human Resources and Social Security of Shaanxi Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Innovations for Sustainable Biomass Utilization in the Upper Rhine Region, and the Special Funds for Young Scientists with Oversea Doctoral Diploma from Department of Human Resources and Social Security of Shaanxi Province, China (2017036), and Fundamental Research Funds for the Central Universities (2452017191). The funders had no role in study de-sign, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2009, SOIL SCI, V174, P113, DOI 10.1097/SS.0b013e3181981ddc; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; Cattaneo F, 2014, BIOL FERT SOILS, V50, P1121, DOI 10.1007/s00374-014-0931-x; Christian DG, 1997, BIOMASS BIOENERG, V12, P21, DOI 10.1016/S0961-9534(96)00060-8; Cosentino SL, 2007, IND CROP PROD, V25, P75, DOI 10.1016/j.indcrop.2006.07.006; Danalatos NG, 2007, BIOMASS BIOENERG, V31, P145, DOI 10.1016/j.biombioe.2006.07.004; Dawson TE, 2001, CURR PLANT SCI BIOT, V40, P1; de Vries SC, 2014, EUR J AGRON, V52, P166, DOI 10.1016/j.eja.2013.09.012; Dufosse K, 2014, BIOMASS BIOENERG, V69, P198, DOI 10.1016/j.biombioe.2014.07.003; Farrelly DJ, 2013, RENEW SUST ENERG REV, V21, P712, DOI 10.1016/j.rser.2012.12.038; Foereid B, 2004, SOIL BIOL BIOCHEM, V36, P1075, DOI 10.1016/j.soilbio.2004.03.002; Hansen EM, 2004, BIOMASS BIOENERG, V26, P97, DOI 10.1016/S0961-9534(03)00102-8; Howlett DS, 2013, CATENA, V104, P127, DOI 10.1016/j.catena.2012.11.002; Kahle P, 2001, EUR J AGRON, V15, P171, DOI 10.1016/S1161-0301(01)00102-2; Kuhn NJ, 2016, AGR ECOSYST ENVIRON, V216, P155, DOI 10.1016/j.agee.2015.10.001; Kuhn NJ, 2010, NATURE GEOSCIENCE, V3, P1; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Murphy F, 2013, RENEW SUST ENERG REV, V23, P412, DOI 10.1016/j.rser.2013.01.058; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Poeplau C, 2014, GCB BIOENERGY, V6, P327, DOI 10.1111/gcbb.12043; Richter GM, 2015, AGR ECOSYST ENVIRON, V200, P169, DOI 10.1016/j.agee.2014.11.011; Robertson G., 1999, SOIL CARBON NITROGEN; Roth B, 2013, LAND-BASEL, V2, P437, DOI 10.3390/land2030437; Rowe RL, 2009, RENEW SUST ENERG REV, V13, P271, DOI 10.1016/j.rser.2007.07.008; Scordia D, 2013, BIOMASS BIOENERG, V59, P540, DOI 10.1016/j.biombioe.2013.09.011; Smeets EMW, 2009, RENEW SUST ENERG REV, V13, P1230, DOI 10.1016/j.rser.2008.09.006; Smith P, 2000, GLOB CHANGE BIOL, V6, P525, DOI 10.1046/j.1365-2486.2000.00331.x; van der Hilst F, 2012, RENEW SUST ENERG REV, V16, P2053, DOI 10.1016/j.rser.2012.01.027; Wang SF, 2014, GCB BIOENERGY, V6, P136, DOI 10.1111/gcbb.12123; Wang XY, 2008, AUST J SOIL RES, V46, P667, DOI 10.1071/SR08063; Yang J, 2011, RENEW SUST ENERG REV, V15, P2684, DOI 10.1016/j.rser.2011.02.028; Zatta A, 2014, GCB BIOENERGY, V6, P360, DOI 10.1111/gcbb.12054; Zibilske LM., 1994, METHODS SOIL ANAL 2, P835; Zimmermann J, 2013, EUR J SOIL SCI, V64, P747, DOI 10.1111/ejss.12087; Zimmermann J., 2013, SOIL CARBON SEQUESTR	38	9	9	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0200901	10.1371/journal.pone.0200901	http://dx.doi.org/10.1371/journal.pone.0200901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4DQ	30048482	Green Published, gold			2022-12-27	WOS:000439952400028
J	Borkenhagen, LK; Mallinson, KA; Tsao, RW; Ha, SJ; Lim, WH; Toh, TH; Anderson, BD; Fieldhouse, JK; Philo, SE; Chong, KS; Lindsley, WG; Ramirez, A; Lowe, JF; Coleman, KK; Gray, GC				Borkenhagen, Laura K.; Mallinson, Kerry A.; Tsao, Rick W.; Ha, Siaw-Jing; Lim, Wei-Honn; Toh, Teck-Hock; Anderson, Benjamin D.; Fieldhouse, Jane K.; Philo, Sarah E.; Chong, Kuek-Sen; Lindsley, William G.; Ramirez, Alejandro; Lowe, James F.; Coleman, Kristen K.; Gray, Gregory C.			Surveillance for respiratory and diarrheal pathogens at the human-pig interface in Sarawak, Malaysia	PLOS ONE			English	Article							PORCINE CIRCOVIRUS TYPE-2; NUCLEIC-ACID AMPLIFICATION; ORAL FLUID SAMPLES; TIME PCR ASSAY; INFLUENZA-VIRUS; MODERN AGRICULTURE; UNITED-STATES; SWINE FARMS; INFECTION; QUANTIFICATION	Background The large livestock operations and dense human population of Southeast Asia are considered a hot-spot for emerging viruses. Objectives To determine if the pathogens adenovirus (ADV), coronavirus (CoV), encephalomyocarditis virus (EMCV), enterovirus (EV), influenza A-D (IAV, IBV, ICV, and IDV), porcine circovirus 2 (PCV2), and porcine rotaviruses A and C (RVA and RVC), are aerosolized at the animalinterface, and if humans working in these environments are carrying these viruses in their nasal airways. Study This cross-sectional study took place in Sarawak, Malaysia among 11 pig farms, 2 abattoirs, and 3 animal markets in June and July of 2017. Pig feces, pig oral secretions, bioaerosols, and worker nasal wash samples were collected and analyzed via rPCR and rRT-PCR for respiratory and diarrheal viruses. Results In all, 55 pig fecal, 49 pig oral or water, 45 bioaerosol, and 78 worker nasal wash samples were collected across 16 sites. PCV2 was detected in 21 pig fecal, 43 pig oral or water, 3 bioaerosol, and 4 worker nasal wash samples. In addition, one or more bioaerosol or pig samples were positive for EV, IAV, and RVC, and one or more worker samples were positive for ADV, CoV, IBV, and IDV. Conclusions This study demonstrates that nucleic acids from a number of targeted viruses were present in pig oral secretions and pig fecal samples, and that several viruses were detected in bioaerosol samples or in the nasal passages of humans with occupational exposure to pigs. These results demonstrate the need for future research in strengthening viral surveillance at the human-animal interface, specifically through expanded bioaerosol sampling efforts and a seroepidemiological study of individuals with exposure to pigs in this region for PCV2 infection.	[Borkenhagen, Laura K.; Mallinson, Kerry A.; Tsao, Rick W.; Fieldhouse, Jane K.; Philo, Sarah E.; Gray, Gregory C.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Borkenhagen, Laura K.; Anderson, Benjamin D.; Fieldhouse, Jane K.; Philo, Sarah E.; Gray, Gregory C.] Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA; [Ha, Siaw-Jing; Toh, Teck-Hock; Chong, Kuek-Sen] SEGi Univ, Sibu Clin Campus, Sibu, Sarawak, Malaysia; [Ha, Siaw-Jing; Toh, Teck-Hock] Sibu Hosp, Dept Paediat, Sibu, Sarawak, Malaysia; [Lim, Wei-Honn; Toh, Teck-Hock] Sibu Hosp, Clin Res Ctr, Sibu, Sarawak, Malaysia; [Chong, Kuek-Sen] Div Hlth Off, Sibu, Sarawak, Malaysia; [Lindsley, William G.] NIOSH, Morgantown, WV USA; [Ramirez, Alejandro] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Lowe, James F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Integrated Food Anim Management Syst, Champaign, IL USA; [Coleman, Kristen K.; Gray, Gregory C.] Duke NUS Med Sch, Singapore, Singapore	Duke University; Duke University; SEGi University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore	Borkenhagen, LK (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Borkenhagen, LK (corresponding author), Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA.	laura.borkenhagen@duke.edu	Toh, Teck-Hock/AAW-7715-2021; Coleman, Kristen/R-9172-2019; Gray, Gregory C./ABF-1298-2020; Philo, Sarah E./AGE-3506-2022; Lim, Wei Honn/N-4108-2017	Toh, Teck-Hock/0000-0001-5909-4855; Coleman, Kristen/0000-0003-0024-3400; Philo, Sarah E./0000-0002-9894-0425; Fieldhouse, Jane/0000-0002-5450-0970; Lindsley, William/0000-0003-0720-5829; Lim, Wei Honn/0000-0002-6408-4747	Duke Global Health Institute discretionary funding; Duke Global Health Institute graduate program; Duke's Bass Connections program	Duke Global Health Institute discretionary funding; Duke Global Health Institute graduate program; Duke's Bass Connections program	This study was supported by Professor Gray's Duke Global Health Institute discretionary funding, as well as funding from the Duke Global Health Institute graduate program and Duke's Bass Connections program.; We thank the Director General of Health, Malaysia for his permission to publish this paper. This study was supported by Professor Gray's Duke Global Health Institute discretionary funding, as well as funding from the Duke Global Health Institute graduate program and Duke's Bass Connections program. We thank all of the staff at the Clinical Research Center at Sibu Hospital, especially Kamilah Binti Dahian and Jimi Bin Jipri, and the Duke One Health team who supported this research. We thank Dr. Kiong-Kheng Wong, Head of Divisional Veterinary Office in Sibu and Kapit, for providing technical advice in the design of this study. A special thanks is due to SEGi University in Sibu, Sarawak, Malaysia for providing a lab space for this study. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.	Ahuja V., 2013, ASIAN LIVESTOCK CHAL; Allan GM, 2000, ARCH VIROL, V145, P853, DOI 10.1007/s007050050678; Anderson BD, 2016, J INFECT DIS, V214, P537, DOI 10.1093/infdis/jiw180; Bil-Lula I, 2012, MED SCI MONITOR, V18, pBR221, DOI 10.12659/MSM.882898; Bird BH, 2017, ANN REV ANIMAL BIOSC, V16; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Burbelo PD, 2013, BIOLOGICALS, V41, P430, DOI 10.1016/j.biologicals.2013.09.005; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; CDC, GUID CLIN US RT PCR; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Ellis JA, 2000, J AM VET MED ASSOC, V217, P1645, DOI 10.2460/javma.2000.217.1645; Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/ World Bank, 2010, 169 FAO; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Lindsley WG, 2017, NIOSH MANUAL ANAL ME, pBA1; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Lorincz M, 2010, ACTA VET HUNG, V58, P265, DOI 10.1556/AVet.58.2010.2.12; Marthaler D, 2014, J VIROL METHODS, V209, P30, DOI 10.1016/j.jviromet.2014.08.018; Neira V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146616; O'Brien KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149083; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Pabbaraju K, 2013, INFLUENZA OTHER RESP, V7, P954, DOI 10.1111/irv.12099; Pal N, 2008, J VIROL METHODS, V149, P217, DOI 10.1016/j.jviromet.2008.02.002; Patterson AR, 2011, VET MICROBIOL, V149, P225, DOI 10.1016/j.vetmic.2010.10.021; Patterson AR, 2011, VET MICROBIOL, V149, P91, DOI 10.1016/j.vetmic.2010.10.020; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Ronald B., 2011, BIOSECURITY PIG FARM; Rose N, 2012, VIRUS RES, V164, P78, DOI 10.1016/j.virusres.2011.12.002; Sarkar A, 2012, ENVIRON RES, V115, P37, DOI 10.1016/j.envres.2012.03.005; Takemae N, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0844-z; TISCHER I, 1995, ARCH VIROL, V140, P1427, DOI 10.1007/BF01322669; Torremorell M, 2016, AVIAN DIS, V60, P637, DOI 10.1637/11395-021816-Reg.1; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yuan WZ, 2014, J VIROL METHODS, V207, P60, DOI 10.1016/j.jviromet.2014.06.004; Zhai SL, 2016, ARCH VIROL, V161, P3237, DOI 10.1007/s00705-016-3004-7	40	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0201295	10.1371/journal.pone.0201295	http://dx.doi.org/10.1371/journal.pone.0201295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4SZ	30052648	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600036
J	Kerkhof, M; Tran, TN; van den Berge, M; Brusselle, GG; Gopalan, G; Jones, RCM; Kocks, JWH; Menzies-Gow, A; Nuevo, J; Pavord, ID; Rastogi, S; Price, DB				Kerkhof, Marjan; Tran, Trung N.; van den Berge, Maarten; Brusselle, Guy G.; Gopalan, Gokul; Jones, Rupert C. M.; Kocks, Janwillem W. H.; Menzies-Gow, Andrew; Nuevo, Javier; Pavord, Ian D.; Rastogi, Sarang; Price, David B.			Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study	PLOS ONE			English	Article							HOSPITAL READMISSIONS; 30-DAY READMISSIONS; HEALTH-CARE; EXACERBATIONS; ADULTS; CORTICOSTEROIDS; PREDICTORS; INSIGHTS; DATABASE; OUTCOMES	Background Recent studies have demonstrated an association between high blood eosinophil counts and greater risk of asthma exacerbations. We sought to determine whether patients hospitalized for an asthma exacerbation were at greater risk of readmission if they had a high blood eosinophil count documented before the first hospitalization. Methods This historical cohort study drew on 2 years of medical record data (Clinical Practice Research Datalink with Hospital Episode Statistics linkage) of patients (aged >= 5 years) admitted to hospital in England for asthma, with recorded blood eosinophil count within 1 baseline year before admission. We analyzed the association between high blood eosinophil count (>= 0.35x10(9) cells/L) and readmission risk during 1 year of follow-up after hospital discharge, with adjustment for predefined, relevant confounders using forward selection. Results We identified 2,613 eligible patients with asthma-related admission, of median age 51 years (interquartile range, 36-69) and 76% women (1,997/2,613). Overall, 835/2,613 (32.0%) had a preadmission high blood eosinophil count. During the follow-up year, 130/2,613 patients (5.0%) were readmitted for asthma, including 55/835 (6.6%) with vs. 75/1,778 (4.2%) without high blood eosinophil count at baseline (adjusted hazard ratio [HR] 1.49; 95% CI 1.04-2.13, p = 0.029). The association was strongest in never-smokers (n = 1,296; HR 2.16, 95% CI 1.27-3.68, p = 0.005) and absent in current smokers (n = 547; HR 1.00, 95% CI 0.49-2.04, p = 0.997). Conclusions A high blood eosinophil count in the year before an asthma-related hospitalization is associated with increased risk of readmission within the following year. These findings suggest that patients with asthma and preadmission high blood eosinophil count require careful follow-up, with treatment optimization, after discharge.	[Kerkhof, Marjan; Kocks, Janwillem W. H.; Price, David B.] Observat & Pragmat Res Inst Pte Ltd, Singapore, Singapore; [Tran, Trung N.; Gopalan, Gokul; Rastogi, Sarang] AstraZeneca, Gaithersburg, MD USA; [van den Berge, Maarten; Kocks, Janwillem W. H.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Brusselle, Guy G.] Ghent Univ Hosp, Ghent, Belgium; [Jones, Rupert C. M.] Peninsula Coll Med & Dent, Plymouth, Devon, England; [Menzies-Gow, Andrew] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Nuevo, Javier] AstraZeneca, Madrid, Spain; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Oxford Resp NIHR BRC, Oxford, England; [Price, David B.] Univ Aberdeen, Acad Primary Care, Aberdeen, Scotland	AstraZeneca; University of Groningen; Ghent University; Ghent University Hospital; University of Plymouth; Royal Brompton & Harefield NHS Foundation Trust; University of Oxford; University of Oxford; University of Aberdeen	Price, DB (corresponding author), Observat & Pragmat Res Inst Pte Ltd, Singapore, Singapore.; Price, DB (corresponding author), Univ Aberdeen, Acad Primary Care, Aberdeen, Scotland.	dprice@opri.sg	Price, David/H-2837-2019	Price, David/0000-0002-9728-9992; van den Berge, Maarten/0000-0002-9336-7340; Brusselle, Guy/0000-0001-7021-8505	AstraZeneca; Observational and Pragmatic Research Institute Pte Ltd (OPRI)	AstraZeneca(AstraZeneca); Observational and Pragmatic Research Institute Pte Ltd (OPRI)	Data acquisition and analyses were funded by AstraZeneca. This was a collaborative study involving both employees of the sponsor and an independent steering committee. The funder of the study participated in the study design, decision to publish, and preparation of the manuscript. In addition, the funder provided support in the form of salaries for authors TNT, GG, JN, and SR. Employees of the sponsor were part of the study steering committee and participated in the study design. Writing and editorial support was funded by the Observational and Pragmatic Research Institute Pte Ltd (OPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BOST COLL DRUG SURV; Beck AF, 2016, JAMA PEDIATR, V170, P695, DOI 10.1001/jamapediatrics.2016.0269; Buyantseva LV, 2016, J ASTHMA, V53, P684, DOI 10.3109/02770903.2016.1140773; Casciano J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0263-8; Couillard S, 2017, CHEST, V151, P366, DOI 10.1016/j.chest.2016.10.003; Delmas M-C, 2011, Rev Mal Respir, V28, pe115, DOI 10.1016/j.rmr.2011.09.023; FitzGerald JM, 2018, LANCET RESP MED, V6, P51, DOI 10.1016/S2213-2600(17)30344-2; Fleishaker DL, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1135-3; Global Initiative for Asthma (GINA) NHLaBI National Institutes of Health, GINA REP GLOB STRAT; Gonzalez-Barcala FJ, 2018, IRISH J MED SCI, V187, P155, DOI 10.1007/s11845-017-1633-9; Gonzalez-Barcala FJ, 2018, EUR J INTERN MED, DOI [10.1016/j.ejim.2018.02.034, DOI 10.1016/J.EJIM.2018.02.034PMID:29514744]; Hasegawa K, 2016, CHEST, V149, P1021, DOI 10.1016/j.chest.2015.12.039; KELLGREN JH, 1951, BRIT MED J, V2, P1183, DOI 10.1136/bmj.2.4741.1183; Kerkhof M, 2018, THORAX, V73, P116, DOI 10.1136/thoraxjnl-2017-210531; Makela MJ, 2018, EUR CLIN RESPIR J, V5, DOI 10.1080/20018525.2018.1458560; Mukherjee M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0657-8; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; Petsky HL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005603.pub3; Pola-Bibian B, 2017, J INVEST ALLERG CLIN, V27, P238, DOI 10.18176/jiaci.0128; Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Roche Nicolas, 2014, Ann Am Thorac Soc, V11 Suppl 2, pS99, DOI 10.1513/AnnalsATS.201309-300RM; Sadatsafavi M, 2015, RESP MED, V109, P320, DOI 10.1016/j.rmed.2014.12.014; Salamzadeh J, 2003, J ASTHMA, V40, P645, DOI 10.1081/JAS-120019035; Sheikh A, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0546-6; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; UK National Health Service, QUAL OUTC FRAM QOF; UK National Health Service, HOSP EP STAT HES; van den Berge M, 2016, J ASTHMA ALLERGY, V9, P27, DOI 10.2147/JAA.S78900; Veeranki SP, 2017, J ASTHMA, P1, DOI 10.1080/02770903.2017.1365888; Veeranki SP, 2016, CHEST, V150, P1162, DOI 10.1016/j.chest.2016.07.043; Westerhof GA, 2016, RESP MED, V118, P122, DOI 10.1016/j.rmed.2016.08.006; Yancey SW, 2017, J ALLERGY CLIN IMMUN, V139, P1167, DOI 10.1016/j.jaci.2016.08.008; Zeiger RS, 2017, J ALLER CL IMM-PRACT, V5, P144, DOI 10.1016/j.jaip.2016.07.015	36	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201143	10.1371/journal.pone.0201143	http://dx.doi.org/10.1371/journal.pone.0201143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044863	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500083
J	Fallico, M; Russo, A; Longo, A; Pulvirenti, A; Avitabile, T; Bonfiglio, V; Castellino, N; Cennamo, G; Reibaldi, M				Fallico, Matteo; Russo, Andrea; Longo, Antonio; Pulvirenti, Alfredo; Avitabile, Teresio; Bonfiglio, Vincenza; Castellino, Niccolo; Cennamo, Gilda; Reibaldi, Michele			Internal limiting membrane peeling versus no peeling during primary vitrectomy for rhegmatogenous retinal detachment: A systematic review and meta-analysis	PLOS ONE			English	Review							PARS-PLANA VITRECTOMY; FIBER LAYER APPEARANCE; BIRDS-EYE ANALYSIS; EPIRETINAL MEMBRANE	Background Internal limiting membrane (ILM) peeling during primary vitrectomy for rhegmatogenous retinal detachment (RRD) prevents the formation of postoperative macular epiretinal membrane (ERM). However, studies that compared vitrectomy with and without ILM peeling for RRD, have reported controversial outcomes. Objective To assess the efficacy of ILM peeling versus non-ILM peeling during vitrectomy for RRD by a systematic review and meta-analysis of published studies. Methods PubMed, Medline, Web of Science, Embase databases, and the Cochrane Library were searched up to April 2018 to identify studies that compared primary vitrectomy with and without ILM peeling for RRD with at least six months follow-up. Primary outcomes were the rate of postoperative ERM formation and mean best corrected visual acuity (BCVA) change after vitrectomy. Rate of recurrence of retinal detachment (RD) was assessed as secondary outcome. Risk ratios (RRs) with 95% confidence intervals (CIs) expressed pooled results for rate of ERM formation and rate of RD recurrence in ILM peeling and non-ILM peeling groups. Pooled results for BCVA change in the two groups were expressed as Weighted Mean Difference (WMD) with 95% CIs. Results Nine studies, one of which was a randomized controlled trial (RCT), with a total number of 404 eyes in the ILM peeling group and 365 eyes in the non-ILM peeling group, were included. The analysis from pooled data indicated a significant lower rate of postoperative ERM formation in the ILM peeling group compared to the non-ILM peeling group (9 studies, 769 eyes, RR = 0.14; CI: 0.07 to 0.28; P < 0.001). There was no statistical difference in mean BCVA change (9 studies, 769 eyes, WMD = 0.02; CI: -0.11 to 0.16; P = 0.75). Rate of recurrence of RD was lower in the ILM peeling group (6 studies, 603 eyes, RR = 0.32; CI = 0.17 to 0.61; P < 0.001). Conclusion ILM peeling during vitrectomy for RRD prevents the formation of macular epiretinal membrane postoperatively and reduces the incidence of RD recurrence, but better visual outcome was not found compared to non-ILM peeling vitrectomy.	[Fallico, Matteo; Russo, Andrea; Longo, Antonio; Avitabile, Teresio; Bonfiglio, Vincenza; Castellino, Niccolo; Reibaldi, Michele] Univ Catania, Dept Ophthalmol, Catania, Italy; [Fallico, Matteo] Univ Catania, Pathol & Oncol Sect, Dept Biomed & Biotechnol Sci, Catania, Italy; [Pulvirenti, Alfredo] Univ Catania, Dept Clin & Expt Med, Catania, Italy; [Cennamo, Gilda] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Eye Clin, Naples, Italy	University of Catania; University of Catania; University of Catania; University of Naples Federico II	Reibaldi, M (corresponding author), Univ Catania, Dept Ophthalmol, Catania, Italy.	mreibaldi@libero.it	Longo, Antonio/AAC-6092-2022; Castellino, Niccolò/AAC-4717-2022; Reibaldi, Michele/AAL-1113-2021; Russo, Andrea/AAC-5349-2022; Avitabile, Teresio/AAC-6076-2022; Fallico, Matteo/AAC-5284-2022	Russo, Andrea/0000-0002-7725-5971; FALLICO, MATTEO/0000-0003-2639-1321; Castellino, Niccolo/0000-0003-1818-6686; Reibaldi, Michele/0000-0003-1368-6729; LONGO, Antonio/0000-0002-9525-1800				Akiyama K, 2016, AM J OPHTHALMOL, V171, P1, DOI 10.1016/j.ajo.2016.08.015; Aras C, 2009, GRAEF ARCH CLIN EXP, V247, P619, DOI 10.1007/s00417-008-1025-y; Blanco-Teijeiro MJ, 2018, EUR J OPHTHALMOL; Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; Chang WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179105; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eibenberger K, 2018, CURR EYE RES, V24, P1; Eissa MGAM, 2018, GRAEF ARCH CLIN EXP, V256, P249, DOI 10.1007/s00417-017-3875-7; Forlini M, 2017, RETINA; Foveau P, 2018, AM J OPHTHALMOL; Garweg JG, 2018, RETINA; HAGLER WS, 1971, BRIT J OPHTHALMOL, V55, P451, DOI 10.1136/bjo.55.7.451; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; HIGGINS JPT, 2011, BMJ BRIT MED J, V343; Hisatomi T, 2005, AM J OPHTHALMOL, V139, P1121, DOI 10.1016/j.ajo.2004.11.051; Hisatomi T, 2017, RETINA; Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P1005, DOI 10.1001/archopht.124.7.1005; Ito Y, 2005, OPHTHALMOLOGY, V112, P1415, DOI 10.1016/j.ophtha.2005.02.023; Jung JJ, 2016, RETINA-J RET VIT DIS, V36, P2101, DOI 10.1097/IAE.0000000000001055; Katira RC, 2008, RETINA-J RET VIT DIS, V28, P744, DOI 10.1097/IAE.0b013e318162b031; Kunikata H, 2010, EYE, V24, P1071, DOI 10.1038/eye.2010.41; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMI.B2700; Martinez-Castillo V, 2012, RETINA-J RET VIT DIS, V32, P1350, DOI 10.1097/IAE.0b013e318242b965; Mitamura Y, 2005, OPHTHALMOLOGY, V112, P1766, DOI 10.1016/j.ophtha.2005.04.026; Mitamura Y, 2004, AM J OPHTHALMOL, V137, P1155, DOI 10.1016/j.ajo.2004.01.052; Nam KY, 2015, RETINA-J RET VIT DIS, V35, P880, DOI 10.1097/IAE.0000000000000421; Rao RC, 2013, OPHTHALMOLOGY, V120, P1102, DOI 10.1016/j.ophtha.2012.12.010; Romano MR, 2014, RETINA-J RET VIT DIS, V34, P1182, DOI 10.1097/IAE.0000000000000076; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z	29	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2018	13	7							e0201010	10.1371/journal.pone.0201010	http://dx.doi.org/10.1371/journal.pone.0201010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN5RC	30024983	gold, Green Published, Green Submitted			2022-12-27	WOS:000439120000076
J	Feyissa, GT; Lockwood, C; Woldie, M; Munn, Z				Feyissa, Garumma Tolu; Lockwood, Craig; Woldie, Mirkuzie; Munn, Zachary			Evaluation of a guideline developed to reduce HIV-related stigma and discrimination in healthcare settings and establishing consensus	PLOS ONE			English	Article							DELPHI TECHNIQUE; FORMAL CONSENSUS; CRITERIA; STABILITY; TOOL	Background Developing guidelines and policies is critical to address HIV-related stigma and discrimination (SAD) in healthcare settings. To this end, a multidisciplinary panel developed a guideline to reduce SAD. This project evaluated the appropriateness of implementing the guideline in the Ethiopian context. Methods A consensus of the expert panel was established through a modified Delphi technique which was followed by a panel meeting. Initial tentative recommendations were distributed to experts through e-mails to be evaluated using the modified guideline implementability appraisal (GLIA) v.2.0 checklist. Results In the first round of the Delphi survey, all (13) panel members evaluated the guideline. The overall score for the general domain of the modified GLIA checklist was 96.56%. The scores for individual recommendations ranged from 68.33% to 92.76%. Maximum and minimum scores were attained for measurability (97.71%) and flexibility (59.77%) domains respectively. Percentages mean score lower than 75% was obtained for flexibility and validity domains. Participants suggested that additional tools and training should be added to the guideline. In the second round of the survey, all the recommendations received endorsement with scores above 75%. Maximum and minimum scores were attained for measurability (100%) and flexibility (86.88%) domains respectively. During the panel meeting, issues of responsibility for implementing the guideline were discussed. Conclusion The project evaluated implementability of a guideline developed to reduce HIV-related SAD in healthcare settings. The Delphi survey was followed by a half-day meeting that helped in further clarification of points.	[Feyissa, Garumma Tolu; Woldie, Mirkuzie] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia; [Feyissa, Garumma Tolu; Woldie, Mirkuzie] Jimma Univ, JBI Ctr Excellence, Ethiopian Evidence Based Hlth Care Ctr, Jimma, Ethiopia; [Feyissa, Garumma Tolu; Lockwood, Craig; Munn, Zachary] Univ Adelaide, Joanna Briggs Inst, Adelaide, SA, Australia; [Woldie, Mirkuzie] Jimma Univ, Dept Hlth Econ Management & Policy, Jimma, Ethiopia	Jimma University; Jimma University; University of Adelaide; Jimma University	Feyissa, GT (corresponding author), Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia.; Feyissa, GT (corresponding author), Jimma Univ, JBI Ctr Excellence, Ethiopian Evidence Based Hlth Care Ctr, Jimma, Ethiopia.; Feyissa, GT (corresponding author), Univ Adelaide, Joanna Briggs Inst, Adelaide, SA, Australia.	garummatolu@yahoo.com	Feyissa, Garumma/AAP-9097-2020; Munn, Zachary/AAV-9760-2021; Woldie, Mirkuzie/S-4086-2017	Feyissa, Garumma/0000-0001-6179-0024; Munn, Zachary/0000-0002-7091-5842; Woldie, Mirkuzie/0000-0002-1777-0816	Adelaide scholarship International (ASI) - University of Adelaide	Adelaide scholarship International (ASI) - University of Adelaide	This study was conducted as part of GTF's PhD project which was supported by the Adelaide scholarship International (ASI) granted by the University of Adelaide. The authors did not receive any funding for this research.	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; [Anonymous], 1998, HEALTH TECHNOL ASSES, DOI DOI 10.1186/s12888-014-0241-8; Brosseau L, 2015, CLIN REHABIL; Carr D, 2015, ACHIEVING STIGMA FRE; Catalan J, 2011, PSYCHOL HEALTH MED, V16, P588, DOI 10.1080/13548506.2011.582125; CHAFFIN WW, 1980, TECHNOL FORECAST SOC, V16, P67, DOI 10.1016/0040-1625(80)90074-8; Chibanda D, 2014, JAIDS-J ACQ IMM DEF, V67, pS54, DOI 10.1097/QAI.0000000000000258; Ciliska D, 2008, INTRO EVIDENCE INFOR; Cole F L, 1988, Clin Nurse Spec, V2, P53, DOI 10.1097/00002800-198800210-00025; DAJANI JS, 1979, TECHNOL FORECAST SOC, V13, P83, DOI 10.1016/0040-1625(79)90007-6; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Day J., 2005, ELECT J BUS RES METH, V3, P103; Egon G., 1981, ED COMMUNICATION TEC, V29, P75; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Franklin KK, 2006, INNOVATIVE HIGHER ED, V31, P237; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Halkitis PN, 2017, INTERD T GERONT GERI, V42, P187, DOI 10.1159/000448564; Harrison MB, 2012, CAN IMPLEMENT GUIDEL; Hsu CC, 2007, PARE, V12, P1; Hsu CC, 2007, PRACTICAL ASSESSMENT, V12, P62; Human SP, 2007, HLTH SA GESONDHEID, V12; James D, 2015, NURSE RES, V22, P35, DOI 10.7748/nr.22.3.35.e1297; Jordan Z, 2016, UPDATED JBI MODEL EV; Kalaian S.A., 2012, PRACT ASSESS RES EVA, V17, P5, DOI [DOI 10.7275/G48Q-JE05, 10.7275/g48q-je05]; Kashyap N, 2005, GUIDELINE IMPLEMENTA; Kastner M, 2011, EXPERT REV PHARM OUT, V11, P315, DOI [10.1586/ERP.11.32, 10.1586/erp.11.32]; Loblaw DA, 2012, J CLIN ONCOL, V30, P3136, DOI 10.1200/JCO.2012.42.0489; Loo R, 2002, POLICING, V25, P762, DOI 10.1108/13639510210450677; McMillan SS, 2016, INT J CLIN PHARM; MURRY JW, 1995, REV HIGH EDUC, V18, P423, DOI 10.1353/rhe.1995.0008; Nair R, 2011, SEMIN ARTHRITIS RHEU, V41, P95, DOI 10.1016/j.semarthrit.2010.12.001; National Institute for Health Care Excellence, 2020, DEV NICE GUID MAN; NCCMT, 2011, CRIT APPR PRACT GUID; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Phillips Kenneth D, 2011, Issues Ment Health Nurs, V32, P374, DOI 10.3109/01612840.2011.568273; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Sharkey SB, 2001, NURS EDUC TODAY, V21, P398, DOI 10.1054/nedt.2001.0573; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Shiffman RN, 2005, BMC MED INFORM DECIS, V5; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; van der Linde H, 2005, J REHABIL RES DEV, V42, P693, DOI 10.1682/JRRD.2003.11.0172; Vernon W, 2009, INT J THER REHABIL, V16, P69, DOI 10.12968/ijtr.2009.16.2.38892; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Yang Y.N., 2003, TESTING STABILITY EX; Yousuf M.I., 2007, PRACT ASSESS RES EVA, V12, P8, DOI [10.7275/rrph-t210, DOI 10.7275/RRPH-T210]; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	56	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2018	13	7							e0198781	10.1371/journal.pone.0198781	http://dx.doi.org/10.1371/journal.pone.0198781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4SZ	30052634	Green Published, gold, Green Submitted			2022-12-27	WOS:000440006600004
J	Schakel, L; Veldhuijzen, DS; van Middendorp, H; Van Dessel, P; De Houwer, J; Bidarra, R; Evers, AWM				Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Van Dessel, Pieter; De Houwer, Jan; Bidarra, Rafael; Evers, Andrea W. M.			The effects of a gamified approach avoidance training and verbal suggestions on food outcomes	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; PLACEBO ANALGESIA; APPROACH BIAS; HEALTH; EXPECTATION; BEHAVIOR; INTERVENTION; EXPECTANCIES; METAANALYSIS; OVERWEIGHT	There is initial support for the effectiveness of approach-avoidance trainings in altering food-related health behaviors. Furthermore, outcome expectancies induced by verbal suggestions might optimize the effectiveness of these interventions, as shown in placebo research. The present study investigated the effectiveness of a gamified approach-avoidance training on food-related outcomes and whether verbal suggestions could strengthen those effects. A total of 120 participants were randomly assigned to 1 of 4 conditions: serious gaming only, verbal suggestions only, serious gaming combined with verbal suggestions, or a gaming control condition. Virtual food preference and food choice were assessed with a food choice task, with pairs differing in healthiness or in healthiness and attractiveness. Implicit food preference was assessed with an Implicit Association Test and food intake with a bogus taste test. Participants in both serious gaming conditions made healthier food choices for pairs differing in healthiness and attractiveness and had healthier implicit food preferences compared to gaming control. No effects were found on food intake. These findings provide the first preliminary support for the effects of a gamified approach-avoidance training on virtual food choice and implicit food preference. Future studies should further elucidate these effects, also in other health domains such as physical activity.	[Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Fac Social & Behav Sci, Inst Psychol, Hlth Med & Neuropsychol Unit, Leiden, Netherlands; [Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Van Dessel, Pieter; De Houwer, Jan] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Bidarra, Rafael] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands; [Evers, Andrea W. M.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schakel, L (corresponding author), Leiden Univ, Fac Social & Behav Sci, Inst Psychol, Hlth Med & Neuropsychol Unit, Leiden, Netherlands.; Schakel, L (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	l.schakel@fsw.leidenuniv.nl	Evers, Andrea/GWV-9705-2022; De Houwer, Jan/ABF-6866-2021; van Middendorp, Henriet/B-8300-2013; Van Dessel, Pieter/Q-1917-2019; Evers, Andrea/U-8983-2019	De Houwer, Jan/0000-0003-0488-5224; Van Dessel, Pieter/0000-0002-3401-780X; Evers, Andrea/0000-0002-0090-5091; Veldhuijzen, Dieuwke S. (Judy)/0000-0001-9046-1019; Bidarra, Rafael/0000-0003-4281-6019	European Research Council [617700]; Scientific Research Foundation, Flanders (FWO-Vlaanderen) [FWO16/PDO/201]	European Research Council(European Research Council (ERC)European Commission); Scientific Research Foundation, Flanders (FWO-Vlaanderen)(FWO)	This study is funded by a European Research Council Consolidator Grant (ID: 617700, granted to A Evers; https://ec.europa.eu/commission/index_en). P Van Dessel is supported by a Post-Doctoral fellowship of the Scientific Research Foundation, Flanders (FWO-Vlaanderen, ID: FWO16/PDO/201; http://www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00444; Bartels DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091727; Beard C, 2012, BEHAV COGN PSYCHOTH, V40, P618, DOI 10.1017/S1352465811000671; Becker D, 2015, APPETITE, V85, P58, DOI 10.1016/j.appet.2014.11.017; Blackburne T, 2016, JMIR SERIOUS GAMES, V4, DOI 10.2196/games.5708; Boendermaker WJ, 2016, JMIR SERIOUS GAMES, V4, DOI 10.2196/games.6464; Cohen Deborah, 2008, Prev Chronic Dis, V5, pA23; Cohen-Kdoshay O, 2009, EXP PSYCHOL, V56, P128, DOI 10.1027/1618-3169.56.2.128; Colloca L, 2014, Z PSYCHOL, V222, P124, DOI 10.1027/2151-2604/a000177; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761; Dassen FCM, 2018, APPETITE, V124, P89, DOI 10.1016/j.appet.2017.05.009; DeSmet A, 2014, PREV MED, V69, P95, DOI 10.1016/j.ypmed.2014.08.026; Dickson H, 2016, APPETITE, V99, P46, DOI 10.1016/j.appet.2015.12.026; Drenowatz C, 2015, ADV NUTR, V6, P592, DOI 10.3945/an.115.008615; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Havermans RC, 2013, CURR OBES REP, V2, P165, DOI 10.1007/s13679-013-0053-z; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Horwath CC, 2010, AM J HEALTH PROMOT, V24, P324, DOI 10.4278/ajhp.071218138; Kakoschke N, 2017, J BEHAV THER EXP PSY, V55, P99, DOI 10.1016/j.jbtep.2017.01.002; Kakoschke N, 2014, EAT BEHAV, V15, P120, DOI 10.1016/j.eatbeh.2013.11.001; Kato PM, 2010, REV GEN PSYCHOL, V14, P113, DOI 10.1037/a0019441; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; O'Donnell S, 2014, J NUTR EDUC BEHAV, V46, P570, DOI 10.1016/j.jneb.2014.03.005; Pearson ES, 2012, PATIENT EDUC COUNS, V87, P32, DOI 10.1016/j.pec.2011.07.018; Peerdeman KJ, 2017, EUR J PAIN, V21, P1366, DOI 10.1002/ejp.1035; Peerdeman KJ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01270; Peerdeman KJ, 2016, PAIN, V157, P1179, DOI 10.1097/j.pain.0000000000000540; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Robinson E, 2017, APPETITE, V116, P223, DOI 10.1016/j.appet.2017.05.002; Salmon SJ, 2014, HEALTH PSYCHOL, V33, P103, DOI 10.1037/a0031785; Sardi L, 2017, J BIOMED INFORM, V71, P31, DOI 10.1016/j.jbi.2017.05.011; Schakel L, OPTIMIZING HLT UNPUB; Schumacher SE, 2016, APPETITE, V96, P219, DOI 10.1016/j.appet.2015.09.014; Shiyko M, 2016, JMIR SERIOUS GAMES, V4, pE8, DOI 10.2196/games.4977; Spagnolo PA, 2015, ALCOHOL ALCOHOLISM, V50, P282, DOI 10.1093/alcalc/agv015; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; van den Akker K, 2016, CONTEMP CLIN TRIALS, V49, P85, DOI 10.1016/j.cct.2016.06.008; Van Dessel P, DO ACTIONS INF UNPUB; Van Dessel P, 2018, ACTA PSYCHOL, V184, P137, DOI 10.1016/j.actpsy.2017.03.016; Van Dessel P, 2017, J EXP SOC PSYCHOL, V69, P23, DOI 10.1016/j.jesp.2016.10.004; Van Dessel P, 2016, PERS SOC PSYCHOL B, V42, P81, DOI 10.1177/0146167215615335; Van Dessel P, 2015, EXP PSYCHOL, V62, P161, DOI 10.1027/1618-3169/a000282; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Wilson-Barlow L, 2014, EAT BEHAV, V15, P490, DOI 10.1016/j.eatbeh.2014.06.004	48	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2018	13	7							e0201309	10.1371/journal.pone.0201309	http://dx.doi.org/10.1371/journal.pone.0201309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4DQ	30048511	Green Submitted, Green Published, gold			2022-12-27	WOS:000439952400073
J	Skewes, L; Fine, C; Haslam, N				Skewes, Lea; Fine, Cordelia; Haslam, Nick			Beyond Mars and Venus: The role of gender essentialism in support for gender inequality and backlash	PLOS ONE			English	Article							PSYCHOLOGICAL ESSENTIALISM; SYSTEM-JUSTIFICATION; WOMEN; STEREOTYPES; ATTITUDES; BELIEFS; METAANALYSIS; INVOLVEMENT; DIVERSITY; EQUALITY	It has been argued that gender essentialism impedes progress towards greater gender equality. Here we present a new gender essentialism scale (GES), and validate it in two large nationally representative samples from Denmark and Australia. In both samples the GES was highly reliable and predicted lack of support for sex-role egalitarianism and support for gender discrimination, as well as perceived fairness of gender-based treatment in the Australian sample, independently of two established predictors (i.e., social dominance orientation and conservative political orientation). In addition, gender essentialism assessed by the GES moderated some manifestations of the backlash effect: high essentialists were more likely to respond negatively towards a power-seeking female political candidate relative to a male candidate. Given the implications for possible workplace interventions, further work could usefully explore whether gender essentialism moderates other well-established forms of gender bias.	[Skewes, Lea] Aarhus Univ, Interacting Minds Ctr, Sch Culture & Soc, Aarhus, Denmark; [Fine, Cordelia] Univ Melbourne, Sch Hist & Philosoph Studies, Melbourne, Vic, Australia; [Haslam, Nick] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	Aarhus University; University of Melbourne; University of Melbourne	Fine, C (corresponding author), Univ Melbourne, Sch Hist & Philosoph Studies, Melbourne, Vic, Australia.	cfine@unimelb.edu.au	Haslam, Nick/D-9026-2011	Haslam, Nick/0000-0002-1913-2340; Skewes, Lea/0000-0001-6217-7870	Inge Lehmann Scholarship at The Royal Danish Academy of Science and Letters; Interacting Minds Centre at Aarhus University; Australian Research Council Future Fellowship [FT110100658]; Women's Leadership Institute Australia Research Fellowship; Women's Leadership Institute Australia; Inge Lehmann Scholarship the Royal Danish Academy of Science Letters	Inge Lehmann Scholarship at The Royal Danish Academy of Science and Letters; Interacting Minds Centre at Aarhus University; Australian Research Council Future Fellowship(Australian Research Council); Women's Leadership Institute Australia Research Fellowship; Women's Leadership Institute Australia; Inge Lehmann Scholarship the Royal Danish Academy of Science Letters	Lea Skewes was supported by an Inge Lehmann Scholarship at The Royal Danish Academy of Science and Letters and also received financial support from the Interacting Minds Centre at Aarhus University. Cordelia Fine was supported by an Australian Research Council Future Fellowship (FT110100658) and a Women's Leadership Institute Australia Research Fellowship.; Many thanks to Michelle Stratemeyer for her assistance with data analysis. The authors also thank Victoria Brescoll and Thomas Morton for generously sharing their experimental materials with us. The Sex-Role Egalitarianism Scale was translated by the first author under license from SIGMA Assessment Systems, Inc. Cordelia Fine thanks the Women's Leadership Institute Australia for their support and prior funding from the Australian Research Council (FT110100658). Lea Skewes is grateful for the support of an Inge Lehmann Scholarship awarded by the Royal Danish Academy of Science & Letters.	Bastian B, 2006, J EXP SOC PSYCHOL, V42, P228, DOI 10.1016/j.jesp.2005.03.003; BEERE CA, 1984, SEX ROLES, V10, P563; Beitel AH, 1998, J FAM PSYCHOL, V12, P268, DOI 10.1037/0893-3200.12.2.268; Brescoll VL, 2008, PSYCHOL SCI, V19, P268, DOI 10.1111/j.1467-9280.2008.02079.x; Brescoll VL, 2013, J PERS SOC PSYCHOL, V105, P891, DOI 10.1037/a0034701; EAGLY AH, 1992, PSYCHOL BULL, V111, P3, DOI 10.1037/0033-2909.111.1.3; Fine C., 2017, TESTOSTERONE REX MYT; Fine C., 2010, DELUSIONS GENDER OUR; Fullagar C.J., 2003, INT J CROSS CULTURAL, V3, P93, DOI [DOI 10.1177/1470595803003001112, 10.1177/1470595803003001112]; Gaunt R, 2006, SEX ROLES, V55, P523, DOI 10.1007/s11199-006-9105-0; Griffiths PE, 2002, MONIST, V85, P70, DOI 10.5840/monist20028518; Haslam A., 1997, PSYCHOL STEREOTYPING, P20; Haslam N, 2002, BRIT J SOC PSYCHOL, V41, P87, DOI 10.1348/014466602165072; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Heilman ME, 2007, J APPL PSYCHOL, V92, P81, DOI 10.1037/0021-9010.92.1.81; Heilman ME, 2012, RES ORGAN BEHAV, V32, P113, DOI 10.1016/j.riob.2012.11.003; Hoobler JM, 2018, J MANAGE, V44, P2473, DOI 10.1177/0149206316628643; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; Jahan S, 2016, HUMAN DEV REPORT 201; Joel D, 2015, P NATL ACAD SCI USA, V112, P15468, DOI 10.1073/pnas.1509654112; Joel D, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-27; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Kalev A, 2006, AM SOCIOL REV, V71, P589, DOI 10.1177/000312240607100404; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; KING LA, 1990, SEX ROLES, V23, P659, DOI 10.1007/BF00289254; Kinzler KD, 2010, EUR J SOC PSYCHOL, V40, P581, DOI 10.1002/ejsp.739; Koch AJ, 2015, J APPL PSYCHOL, V100, P128, DOI 10.1037/a0036734; Kray LJ, 2017, J PERS SOC PSYCHOL, V112, P98, DOI 10.1037/pspp0000124; LARSEN KS, 1988, SEX ROLES, V19, P1, DOI 10.1007/BF00292459; Litvin DR, 1997, ORGANIZATION, V4, P187, DOI 10.1177/135050849742003; Malik K., 2014, HUMAN DEV REPORT 201; Mansbridge J, 2005, POLIT GENDER, V1, P622, DOI 10.1017/S1743923X0521019X; Meyer M, 2016, SEX ROLES, V75, P409, DOI 10.1007/s11199-016-0646-6; Miller DI, 2015, J EDUC PSYCHOL, V107, P631, DOI 10.1037/edu0000005; Morton TA, 2009, J PERS SOC PSYCHOL, V96, P653, DOI 10.1037/a0012966; Okimoto TG, 2010, PERS SOC PSYCHOL B, V36, P923, DOI 10.1177/0146167210371949; Olson E, 2015, FORTUNE; Park B, 2015, J PERS SOC PSYCHOL, V109, P949, DOI 10.1037/pspa0000040; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Prentice DA, 2006, PSYCHOL SCI, V17, P129, DOI 10.1111/j.1467-9280.2006.01675.x; Prime J, 2008, INT J CROSS CULT MAN, V8, P171, DOI 10.1177/1470595808091789; Rangel U, 2011, J PERS SOC PSYCHOL, V100, P1056, DOI 10.1037/a0022401; Rhodes M, 2009, COGNITIVE PSYCHOL, V59, P244, DOI 10.1016/j.cogpsych.2009.05.001; Rothbart M., 1992, LANGUAGE INTERACTION, P11; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Rudman LA, 2008, RES ORGAN BEHAV, V28, P61, DOI 10.1016/j.riob.2008.04.003; Stoet G, 2018, PSYCHOL SCI, V29, P581, DOI 10.1177/0956797617741719; SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199; Tinsley CH, 2015, ORGAN BEHAV HUM DEC, V126, P37, DOI 10.1016/j.obhdp.2014.09.003; Williams MJ, 2016, PSYCHOL BULL, V142, P165, DOI 10.1037/bul0000039	50	45	45	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2018	13	7							e0200921	10.1371/journal.pone.0200921	http://dx.doi.org/10.1371/journal.pone.0200921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO1WA	30040839	Green Published, gold			2022-12-27	WOS:000439749200017
J	Javanmardi, A; Ibrahim, Z; Ghaedi, K; Khan, NB; Ghadim, HB				Javanmardi, Ahad; Ibrahim, Zainah; Ghaedi, Khaled; Khan, Niaz Bahadur; Ghadim, Hamed Benisi			Seismic isolation retrofitting solution for an existing steel cable-stayed bridge	PLOS ONE			English	Article							1988 SAGUENAY EARTHQUAKE; PASSIVE CONTROL; SYSTEMS; DAMAGE; VIBRATION	This paper investigated the seismic retrofitting of an existing cable-stayed bridge through the use of a seismic isolation system. The bridge is situated in a high seismic zone. During the Saguenay earthquake 1988, one of the anchorage plates of the bridge supports failed. Herein, several configurations of seismic isolation system were considered to identify an appropriate solution for the seismic retrofitting of the bridge in both the longitudinal and transverse directions. A three-dimensional model of the bridge was created, and its seismic behavior studied through nonlinear dynamic time-history analysis. The comparative performance study among the five retrofitting configurations showed that the partial seismic isolation of the bridge led to an enhancement of the seismic response of the bridge in one direction only. However, the overall seismic response of the cable-stayed bridge substantially improved in the longitudinal and transverse directions in cases where the isolation systems were utilized between the supports and the deck-tower connection of the bridge.	[Javanmardi, Ahad; Ibrahim, Zainah; Ghaedi, Khaled] Univ Malaya, Fac Engn, Civil Engn Dept, Kuala Lumpur, Malaysia; [Khan, Niaz Bahadur] Natl Univ Sci & Technol, Sch Mech & Mfg Engn, Islamabad, Pakistan; [Ghadim, Hamed Benisi] Fuzhou Univ, Fac Civil Engn, SIBERC, Fuzhou, Fujian, Peoples R China	Universiti Malaya; National University of Sciences & Technology - Pakistan; Fuzhou University	Javanmardi, A; Ibrahim, Z (corresponding author), Univ Malaya, Fac Engn, Civil Engn Dept, Kuala Lumpur, Malaysia.	ahadjavanmardi@gmail.com; zainah@um.edu.my	Ghaedi, Khaled/J-3643-2015; IBRAHIM, ZAINAH/R-5259-2019; IBRAHIM, ZAINAH/GQU-0237-2022; Khan, Niaz B/C-5539-2016; Javanmardi, Ahad/AAH-7594-2019; Khan, Niaz Bahadur/ACU-7263-2022; IBRAHIM, ZAINAH/C-1117-2010	Ghaedi, Khaled/0000-0002-3919-1479; IBRAHIM, ZAINAH/0000-0002-0748-9190; IBRAHIM, ZAINAH/0000-0002-0748-9190; Khan, Niaz B/0000-0003-4141-5600; Javanmardi, Ahad/0000-0003-0678-5227; Khan, Niaz Bahadur/0000-0003-4141-5600; IBRAHIM, ZAINAH/0000-0002-0748-9190	University Malaya Research Grant (UMRG) [RP004A/13AET]; University Malaya Postgraduate Research Fund (PPP) [PG242-2015B]; Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS) [FP028/2013A]	University Malaya Research Grant (UMRG); University Malaya Postgraduate Research Fund (PPP); Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS)	The authors gratefully acknowledge the support given by University Malaya Research Grant (UMRG - Project No. RP004A/13AET), University Malaya Postgraduate Research Fund (PPP - Project No. PG242-2015B) and Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS - Project No. FP028/2013A).	AASHTO, 2010, GUID SPEC SEISM ISOL; ALI HEM, 1995, SHOCK VIB, V2, P259, DOI 10.1155/1995/918721; ALI HEM, 1994, EARTHQUAKE ENG STRUC, V23, P877, DOI 10.1002/eqe.4290230805; ALI HM, 1995, COMPUT STRUCT, V54, P461, DOI 10.1016/0045-7949(94)00353-5; [Anonymous], 2017, 39 IABSE S ENG FUT I; [Anonymous], 2017, EARTHQUAKES TECTON H, DOI DOI 10.5772/65511; [Anonymous], NONLINEAR TEST PRECA; [Anonymous], 2012, LRFD BRIDG DES SPEC; Atmaca B, 2017, ADV COMPUT DES, V2, P43, DOI 10.12989/acd.2017.2.1.043; Atmaca B, 2012, STEEL COMPOS STRUCT, V12, P413; Bruno D, 2008, ENG STRUCT, V30, P1160, DOI 10.1016/j.engstruct.2007.07.001; Built SM, 1982, LEAD RUBBER DISSIPAT, DOI [10.1061/(ASCE)0733-9445(2003)129:(857), DOI 10.1061/(ASCE)0733-9445(2003)129:(857)]; Camara A, 2012, ENG STRUCT, V41, P444, DOI 10.1016/j.engstruct.2012.03.059; Casciati F, 2008, COMPUT STRUCT, V86, P1769, DOI 10.1016/j.compstruc.2008.01.012; Chang CM, 2006, J EARTHQ ENG, V10, P481, DOI 10.1142/S1363246906002839; Computers and Structures Inc, 2015, CI AN REF MAN; Cunha A, 2001, J BRIDGE ENG, V6, P54, DOI DOI 10.1061/(ASCE)1084-0702(2001)6:1(54); Dicleli M, 2003, ENG STRUCT, V25, P1139, DOI 10.1016/S0141-0296(03)00062-2; Dolce M, 2007, B EARTHQ ENG, V5, P491, DOI 10.1007/s10518-007-9044-3; Dyke SJ, 2003, J STRUCT ENG-ASCE, V129, P857, DOI 10.1061/(ASCE)0733-9445(2003)129:7(857); Felber AJ, 1992, CAN SOC CIV EN ANN C, P375; FILIATRAULT A, 1993, J STRUCT ENG-ASCE, V119, P1432, DOI 10.1061/(ASCE)0733-9445(1993)119:5(1432); FILIATRAULT A, 1993, J STRUCT ENG-ASCE, V119, P1450, DOI 10.1061/(ASCE)0733-9445(1993)119:5(1450); Ghaedi K, 2018, ADV CIV ENG, V2018, DOI 10.1155/2018/4517940; Ghaedi K, 2017, J VIBROENG, V19, P3564, DOI 10.21595/jve.2017.18900; He M, 2015, P I CIVIL ENG-STR B, V168, P890, DOI 10.1680/jstbu.14.00038; He WL, 2007, STRUCT CONTROL HLTH, V14, P1, DOI 10.1002/stc.81; Iemura H, 2002, J STRUCT CONTROL, V9, P189, DOI DOI 10.1002/STC.12; Javanmardi Ahad, 2015, Applied Mechanics and Materials, V735, P141, DOI 10.4028/www.scientific.net/AMM.735.141; Javanmardi A, 2017, ARCH CIV MECH ENG, V17, P419, DOI 10.1016/j.acme.2016.12.002; Karalar M, 2012, ENG STRUCT, V40, P276, DOI 10.1016/j.engstruct.2012.02.023; Li H, 2009, J EARTHQ TSUNAMI, V3, P227, DOI 10.1142/S1793431109000524; Martinez-Rodrigo MD, 2015, ENG STRUCT, V99, P232, DOI 10.1016/j.engstruct.2015.04.048; Mozos CM, 2010, ENG STRUCT, V32, P3288, DOI 10.1016/j.engstruct.2010.07.003; NAZMY AS, 1992, EARTHQUAKE ENG STRUC, V21, P1, DOI 10.1002/eqe.4290210101; Park K-S, 2014, SOIL DYN EARTHQ ENG, V66, P314; PARK YJ, 1986, EARTHQUAKE ENG STRUC, V14, P543, DOI 10.1002/eqe.4290140405; Ren W-X, 1999, J BRIDGE ENG, V4, P1404; Robinson W. H., 1977, B NZ NATL SOC EARTHQ, V10, P151, DOI 10.5459/bnzsee.10.3.151-153; Sharabash AM, 2009, ENG STRUCT, V31, P607, DOI 10.1016/j.engstruct.2008.11.007; Tuladhar R, 1999, CAN J CIVIL ENG, V26, P631; Wang PH, 1996, COMPUT STRUCT, V60, P243, DOI 10.1016/0045-7949(95)00382-7; Wesolowsky MJ, 2003, EARTHQ ENG STRUCT D, V32, P2107, DOI 10.1002/eqe.318; Xi Y, 2000, P I CIVIL ENG-STR B, V140, P227, DOI 10.1680/stbu.2000.140.3.227	44	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2018	13	7							e0200482	10.1371/journal.pone.0200482	http://dx.doi.org/10.1371/journal.pone.0200482			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO7MT	30059506	gold, Green Published, Green Submitted			2022-12-27	WOS:000440251600010
J	Boteon, YL; Wallace, L; Boteon, APCS; Mirza, DF; Mergental, H; Bhogal, RH; Afford, S				Boteon, Yuri L.; Wallace, Lorraine; Boteon, Amanda P. C. S.; Mirza, Darius F.; Mergental, Hynek; Bhogal, Ricky H.; Afford, Simon			An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; PEROXISOME PROLIFERATOR; MOLECULAR-MECHANISMS; ACTIVATED RECEPTORS; HEPATIC STEATOSIS; LIPID-METABOLISM; DRUG-METABOLISM; HEPG2 CELLS; CULTURE; INJURY	Introduction Pharmacological defatting of rat hepatocytes and hepatoma cell lines suggests that the same method could be used to ameliorate macrovesicular steatosis in moderate to severely fatty livers. However there is no data assessing the effects of those drugs on primary human liver cells. We aimed to determine the effectiveness of a pharmacological cocktail in reducing the in vitro lipid content of primary human hepatocytes (PHH). In addition we sought to determine the cytotoxicity of the cocktail towards non-parenchymal liver cells. Methods Steatosis was induced in PHH by supplementation with a combination of saturated and unsaturated free fatty acids. This was followed by addition of a defatting drug cocktail for up to 48 hours. The same experimental method was used with human intra-hepatic endothelial cells (HIEC) and human cholangiocytes. MTT assay was used to assess cell viability, triglyceride quantification and oil red 0 staining were used to determine intracellular lipids content whilst ketone bodies were measured in the supernatants following experimentation. Results Incubation of fat loaded PHH with the drugs over 48 hours reduced the intracellular lipid area by 54%, from 12.85% to 5.99% (p = 0.002) (percentage of total oil red O area), and intracellular triglyceride by 35%, from 28.24 to 18.30 nmol/million of cells (p<0.001). Total supernatant ketone bodies increased 1.4-fold over 48 hours in the defatted PHH compared with vehicle controls (p = 0.002). Moreover incubation with the drugs for 48 hours increased the viability of PHH by 11%, cholangiocytes by 25% whilst having no cytotoxic effects on HIEC. Conclusion These data demonstrate that pharmacological intervention can significantly decrease intracellular lipid content of PHH, increase fatty acids beta-oxidation whilst being non-toxic to PHH, HIEC or cholangiocytes.	[Boteon, Yuri L.; Boteon, Amanda P. C. S.; Mirza, Darius F.; Mergental, Hynek] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Boteon, Yuri L.; Wallace, Lorraine; Bhogal, Ricky H.; Afford, Simon] Univ Birmingham, Coll Med & Dent Sci, NIHR Birmingham Biomed Res Ctr, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Afford, S (corresponding author), Univ Birmingham, Coll Med & Dent Sci, NIHR Birmingham Biomed Res Ctr, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.	s.c.afford@bham.ac.uk	Mergental, Hynek/AAY-7122-2021; Mergental, Hynek/H-9485-2013; Boteon, Yuri/J-1940-2019	Mergental, Hynek/0000-0001-5480-9380; Mergental, Hynek/0000-0001-5480-9380; Boteon, Yuri/0000-0002-1709-9284	National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre; NIHR Birmingham Biomedical Research Centre based at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham	National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre; NIHR Birmingham Biomedical Research Centre based at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham	YLB, LW, and SA have received support from the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre based at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Chang TKH, 2009, AAPS J, V11, P590, DOI 10.1208/s12248-009-9135-y; Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; de Graaf EL, 2012, J GASTROEN HEPATOL, V27, P540, DOI 10.1111/j.1440-1746.2011.06844.x; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fuchs CD, 2014, TRENDS ENDOCRIN MET, V25, P576, DOI 10.1016/j.tem.2014.08.001; Gaddipati R, 2010, ANN HEPATOL, V9, P266, DOI 10.1016/S1665-2681(19)31635-7; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Gomez-Lechon MJ, 2004, CURR DRUG METAB, V5, P443, DOI 10.2174/1389200043335414; Gomez-Lechon MJ, 2014, EXPERT OPIN DRUG MET, V10, P1553, DOI 10.1517/17425255.2014.967680; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; LI SJ, 1989, J SURG RES, V46, P557, DOI 10.1016/0022-4804(89)90020-6; Lin G, 2010, ASIAN BIOMED, V4, P757, DOI 10.2478/abm-2010-0098; Liu Q, 2018, LIVER TRANSPLANT, V24, P233, DOI 10.1002/lt.24972; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Nagrath D, 2009, METAB ENG, V11, P274, DOI 10.1016/j.ymben.2009.05.005; Nativ NI, 2012, AM J TRANSPLANT, V12, P3176, DOI 10.1111/j.1600-6143.2012.04288.x; Nativ NI, 2014, LIVER TRANSPLANT, V20, P1000, DOI 10.1002/lt.23905; Nativ NI, 2013, J HEPATOL, V59, P1307, DOI 10.1016/j.jhep.2013.07.019; NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001; Nocito A, 2006, J HEPATOL, V45, P494, DOI 10.1016/j.jhep.2006.07.017; Oh KS, 2006, BIOCHEM BIOPH RES CO, V345, P1232, DOI 10.1016/j.bbrc.2006.04.182; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Perez-Daga JA, 2006, TRANSPLANT P, V38, P2468, DOI 10.1016/j.transproceed.2006.08.077; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Seifalian AM, 1998, LIVER TRANSPLANT SUR, V4, P71, DOI 10.1002/lt.500040110; Seifalian AM, 1999, TRANSPLANTATION, V68, P780, DOI 10.1097/00007890-199909270-00009; Sharma Shruti, 2009, Drug Discov Today Dis Mech, V6, pe31; Sison-Young RLC, 2015, TOXICOL SCI, V147, P412, DOI 10.1093/toxsci/kfv136; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014; Yarmush G, 2017, BIOMECH MODEL MECHAN, V16, P1095, DOI 10.1007/s10237-017-0882-x; Yarmush G, 2016, METABOLITES, V6, DOI 10.3390/metabo6010001	39	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201419	10.1371/journal.pone.0201419	http://dx.doi.org/10.1371/journal.pone.0201419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044872	Green Published, gold, Green Submitted			2022-12-27	WOS:000439942500103
J	Rhyasen, GW; Yao, Y; Zhang, JW; Dulak, A; Castriotta, L; Jacques, K; Zhao, W; Gharandaghi, F; Hattersley, MM; Lyne, PD; Clark, E; Zinda, M; Fawell, SE; Mills, GB; Che, HW				Rhyasen, Garrett W.; Yao, Yi; Zhang, Jingwen; Dulak, Austin; Castriotta, Lillian; Jacques, Kelly; Zhao, Wei; Gharandaghi, Farzin; Hattersley, Maureen M.; Lyne, Paul D.; Clark, Edwin; Zinda, Michael; Fawell, Stephen E.; Mills, Gordon B.; Che, Huawei			BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors	PLOS ONE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; DRUG-SENSITIVITY; REVEALS; MUTATIONS; CHROMATIN; RECURRENT; BINDING; SWI/SNF; NUMBER	BRD4 is a transcriptional co-activator functioning to recruit regulatory complexes to acety-lated chromatin. A subset of High-grade Serous Ovarian Cancer (HGSOC) patients are typified by focal, recurrent BRD4 gene amplifications. Despite previously described cancer dependencies, it is unclear whether BRD4 amplification events are oncogenic in HGSOC. We find that physiologically relevant levels of expression of BRD4 isoforms in non-transformed ovarian cells result in cellular transformation. Transcriptional profiling of BRD4-transformed ovarian cells, and BRD4-amplified HGSOC patient samples revealed shared expression patterns, including enriched MYC, and E2F1 gene signatures. Furthermore, we demonstrate that a novel BET inhibitor, AZD5153, is highly active in BRD4-amplified patient derived xenografts and uncover Neuregulin-1 as a novel BRD4 effector. Experiments involving Neuregulin-1 inhibition and exogenous addition, demonstrate Neuregulin-1 as necessary and sufficient for BRD4-mediated transformation. This study demonstrates the oncogenic potential of BRD4 amplification in cancer and establishes BRD4-amplified HGSOC as a potential patient population that could benefit from BET inhibitors.	[Rhyasen, Garrett W.; Yao, Yi; Zhang, Jingwen; Dulak, Austin; Castriotta, Lillian; Jacques, Kelly; Gharandaghi, Farzin; Hattersley, Maureen M.; Lyne, Paul D.; Clark, Edwin; Zinda, Michael; Fawell, Stephen E.; Che, Huawei] AstraZeneca, IMED Biotech Unit, Biosci, Oncol, Boston, MA USA; [Zhao, Wei; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	AstraZeneca; University of Texas System; UTMD Anderson Cancer Center	Che, HW (corresponding author), AstraZeneca, IMED Biotech Unit, Biosci, Oncol, Boston, MA USA.	raymond.chen@astrazeneca.com	Zhang, Jing/GWZ-7332-2022	Mills, Gordon/0000-0002-0144-9614	AstraZeneca Pharmaceuticals; NCI [P50CA083639]; NATIONAL CANCER INSTITUTE [P50CA083639] Funding Source: NIH RePORTER	AstraZeneca Pharmaceuticals(AstraZeneca); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is funded mainly by AstraZeneca Pharmaceuticals LP and also partially by grant P50CA083639 from NCI: https://www. cancer.gov/ (GBM). AstraZeneca provided support in the form of salaries for authors G.W.R., Y.Y., A. D., L.C, K.J., J.Z., F.G., M.H., P.L., E.C., M.Z., S.F., and H.C, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alsarraj J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080746; Baratta MG, 2015, P NATL ACAD SCI USA, V112, P232, DOI 10.1073/pnas.1422165112; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dhanasekaran SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6893; Duygu UaL, 2015, MOL CLIN ONCOLOGY, V3, P1291, DOI [10.3892/mco.2015.622, DOI 10.3892/MCO.2015.622]; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Goundiam O, 2015, INT J CANCER, V137, P1890, DOI 10.1002/ijc.29568; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Itzen F, 2014, NUCLEIC ACIDS RES, V42, P7577, DOI 10.1093/nar/gku449; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Rhyasen GW, 2016, MOL CANCER THER, V15, P2563, DOI 10.1158/1535-7163.MCT-16-0141; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart HJS, 2013, CANCER MED-US, V2, P826, DOI 10.1002/cam4.146; Sung CO, 2014, GYNECOL ONCOL, V132, P343, DOI 10.1016/j.ygyno.2013.11.036; Therapeutics T., DOSE ESCALATION COHO; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yu J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3248-y; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	39	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2018	13	7							e0200826	10.1371/journal.pone.0200826	http://dx.doi.org/10.1371/journal.pone.0200826			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8PM	30036377	Green Submitted, Green Published, gold			2022-12-27	WOS:000439429200018
J	Uchino, K; Tateishi, R; Nakagomi, R; Fujiwara, N; Minami, T; Sato, M; Enooku, K; Nakagawa, H; Asaoka, Y; Kondo, Y; Shibahara, J; Shiina, S; Koike, K				Uchino, Koji; Tateishi, Ryosuke; Nakagomi, Ryo; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Enooku, Kenichiro; Nakagawa, Hayato; Asaoka, Yoshinari; Kondo, Yuji; Shibahara, Junji; Shiina, Shuichiro; Koike, Kazuhiko			Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; IRON-OVERLOAD; CONTROLLED-TRIAL; RISK; MORTALITY; PHLEBOTOMY; MANAGEMENT; THERAPY; BIOPSY	Background & aims Hepatic iron accumulation can accelerate liver injury in patients with various chronic liver diseases and lead to hepatocarcinogenesis. We elucidated the impact of serum levels of ferritin on the prognosis of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA) in a large cohort. Methods We retrospectively analyzed 578 treatment-naive HCC patients who underwent RFA. We divided our cohort into four groups by the quartile points of serum ferritin level: G1 (<= 55 ng/mL, n = 148), G2 (56-130 ng/mL, n = 142), G3 (131-243 ng/mL, n = 144) and G4 (>= 244 ng/ mL, n = 144). We analyzed the recurrence and survival of patients using the Kaplan-Meier method. We also evaluated pathological iron deposition among patients with a solitary tumor smaller than 2 cm. Results The cumulative rates of overall recurrence and survival at 5 years were 81.6% and 66.3%, respectively. The serum levels of ferritin were correlated with pathological iron deposition. There were no significant differences in recurrence and survival rates according to serum levels of ferritin and pathological hepatic iron deposition. Conclusions Serum levels of ferritin do not affect the prognosis of HCC patients undergoing RFA.	[Uchino, Koji; Tateishi, Ryosuke; Nakagomi, Ryo; Fujiwara, Naoto; Minami, Tatsuya; Sato, Masaya; Enooku, Kenichiro; Nakagawa, Hayato; Asaoka, Yoshinari; Kondo, Yuji; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shibahara, Junji] Kyorin Univ, Dept Pathol, Schoole Med, Tokyo, Japan; [Shiina, Shuichiro] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; Kyorin University; Juntendo University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012; Fujiwara, Naoto/Y-5938-2019; Tateishi, Ryosuke/G-7758-2014; Asaoka, Yoshinari/ABC-5412-2021	Nakagawa, Hayato/0000-0002-6973-5094; Fujiwara, Naoto/0000-0002-4109-3421; Tateishi, Ryosuke/0000-0003-3021-2517; Asaoka, Yoshinari/0000-0002-2805-8226	AMED [JP17fk0210304, JP18fk0210040]; Miyakawa Memorial Research Foundation	AMED(Japan Agency for Medical Research and Development (AMED)); Miyakawa Memorial Research Foundation	This work was supported in part by AMED under Grant Number JP17fk0210304, JP18fk0210040, and Miyakawa Memorial Research Foundation.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chapoutot C, 2000, GUT, V46, P711, DOI 10.1136/gut.46.5.711; Deugnier Y, 2011, SEMIN LIVER DIS, V31, P260, DOI 10.1055/s-0031-1286057; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Facciorusso A, 2014, J GASTROEN HEPATOL, V29, P1905, DOI 10.1111/jgh.12618; FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Fujita N, 2009, CANCER EPIDEM BIOMAR, V18, P424, DOI 10.1158/1055-9965.EPI-08-0725; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Hagstrom H, 2016, LIVER INT, V36, P1688, DOI 10.1111/liv.13144; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Lambrecht RW, 2011, GASTROENTEROLOGY, V140, P1490, DOI 10.1053/j.gastro.2011.01.053; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Maiwall R, 2014, J HEPATOL, V61, P43, DOI 10.1016/j.jhep.2014.03.027; Manousou P, 2011, LIVER INT, V31, P730, DOI 10.1111/j.1478-3231.2011.02488.x; Metwally MA, 2004, AM J GASTROENTEROL, V99, P286, DOI 10.1111/j.1572-0241.2004.04049.x; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Scheuer PJ, 2000, LIVER BIOPSY INTERPR; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Sohda T, 1999, BIOCHEM GENET, V37, P63, DOI 10.1023/A:1018718101579; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Tanaka H, 2008, BRIT J CANCER, V98, P580, DOI 10.1038/sj.bjc.6604204; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; Uchino K, 2016, HEPATOL RES, V46, P259, DOI 10.1111/hepr.12517; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.23537; Weismuller TJ, 2011, HEPATOLOGY, V54, P2114, DOI 10.1002/hep.24635; Yano M, 2004, J GASTROENTEROL, V39, P570, DOI 10.1007/s00535-003-1344-z; Yano M, 2002, AM J GASTROENTEROL, V97, P133, DOI 10.1111/j.1572-0241.2002.05436.x; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646	45	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0200943	10.1371/journal.pone.0200943	http://dx.doi.org/10.1371/journal.pone.0200943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4AN	30044835	Green Published, Green Submitted, gold			2022-12-27	WOS:000439942500072
J	Choi, W; Jeon, ES; Chun, KY; Kim, YR; Park, KB; Kim, KB; Han, CS				Choi, Wook; Jeon, Eun-Seok; Chun, Kyoung-Yong; Kim, Young-Rok; Park, Kyeong-Beom; Kim, Ki-Bum; Han, Chang-Soo			A low-noise silicon nitride nanopore device on a polymer substrate	PLOS ONE			English	Article							SOLID-STATE NANOPORES; DNA TRANSLOCATION; SINGLE; MEMBRANE; IDENTIFICATION; MOLECULES; TRANSPORT; DISCRIMINATION; HOMOPOLYMERS; PASSIVATION	We report a novel low-noise nanopore device employing a polymer substrate. The Si substrate of a fabricated Si-substrate-based silicon nitride (Si3N4) membrane was replaced with a polymer substrate. As such, laser machining was used to make a micro-size hole through the polyimide (PI) substrate, and a thin Si3N4 membrane was then transferred onto the PI substrate. Finally, a nanopore was formed in the membrane using a transmission electron microscope for detection of biomolecules. Compared to the Si-substrate-based device, the dielectric noise was greatly reduced and the root-mean-square noise level was decreased from 146.7 to 5.4 pA. Using this device, the translocation of double-strand deoxyribonucleic acid (DNA) was detected with a high signal/noise (S/N) ratio. This type of device is anticipated to be available for future versatile sequencing technologies.	[Choi, Wook; Jeon, Eun-Seok; Chun, Kyoung-Yong; Han, Chang-Soo] Korea Univ, Coll Engn, Sch Mech Engn, Seoul, South Korea; [Kim, Young-Rok; Han, Chang-Soo] Kyung Hee Univ, Coll Life Sci, Inst Life Sci & Resources, Yongin, South Korea; [Kim, Young-Rok; Han, Chang-Soo] Kyung Hee Univ, Coll Life Sci, Dept Food Sci & Biotechnol, Yongin, South Korea; [Park, Kyeong-Beom; Kim, Ki-Bum] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea	Korea University; Kyung Hee University; Kyung Hee University; Seoul National University (SNU)	Han, CS (corresponding author), Korea Univ, Coll Engn, Sch Mech Engn, Seoul, South Korea.; Han, CS (corresponding author), Kyung Hee Univ, Coll Life Sci, Inst Life Sci & Resources, Yongin, South Korea.; Han, CS (corresponding author), Kyung Hee Univ, Coll Life Sci, Dept Food Sci & Biotechnol, Yongin, South Korea.	cshan@korea.ac.kr	Choi, Wook/M-9705-2013	Choi, Wook/0000-0002-3431-5137	Basic Science Research Program through the National Research Foundation of Korea - the Ministry of Science, ICT and Future Planning in Korea [NRF-2018R1A2A1A05023556]; ERC Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning in Korea [NRF-2016R1A5A1010148]	Basic Science Research Program through the National Research Foundation of Korea - the Ministry of Science, ICT and Future Planning in Korea; ERC Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning in Korea	This work was supported by Basic Science Research Program (Grant no. NRF-2018R1A2A1A05023556) and ERC Program (Grant no. NRF-2016R1A5A1010148) through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning in Korea.	Aberle AG, 1997, PROG PHOTOVOLTAICS, V5, P29, DOI 10.1002/(SICI)1099-159X(199701/02)5:1<29::AID-PIP149>3.0.CO;2-M; Apel PY, 2001, NUCL INSTRUM METH B, V184, P337, DOI 10.1016/S0168-583X(01)00722-4; Bafna JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157399; Boersma AJ, 2012, ANGEW CHEM INT EDIT, V51, P9606, DOI 10.1002/anie.201205687; Borukhov I, 1997, PHYS REV LETT, V79, P435, DOI 10.1103/PhysRevLett.79.435; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Dimitrov V, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065502; Feng JD, 2015, NAT NANOTECHNOL, V10, P1070, DOI [10.1038/nnano.2015.219, 10.1038/NNANO.2015.219]; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Ghosh M., 1996, POLYIMIDES FUNDAMENT, V1st; Goto Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31324; Healy K, 2007, NANOMEDICINE-UK, V2, P875, DOI 10.2217/17435889.2.6.875; Jeon TJ, 2008, LAB CHIP, V8, P1742, DOI 10.1039/b807932c; Kaps S, 2017, ACS OMEGA, V2, P2985, DOI 10.1021/acsomega.7b00041; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kim MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/20/205302; Kowalczyk SW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315101; Larkin J, 2013, ACS NANO, V7, P10121, DOI 10.1021/nn404326f; Lee MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07448; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Li W, 2013, ACS NANO, V7, P4129, DOI 10.1021/nn4004567; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Lim MC, 2015, J NANOSCI NANOTECHNO, V15, P5971, DOI 10.1166/jnn.2015.10500; Liu L, 2013, DEF TECHNOL, V9, P121, DOI 10.1016/j.dt.2013.10.004; Ma SD, 2016, POLYM ADVAN TECHNOL, V27, P414, DOI 10.1002/pat.3686; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Mara A, 2004, NANO LETT, V4, P497, DOI 10.1021/nl035141o; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Miles BN, 2013, CHEM SOC REV, V42, P15, DOI 10.1039/c2cs35286a; Mitsui T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036102; Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92; Park KB, 2016, NANOSCALE, V8, P5755, DOI 10.1039/c5nr09085g; Purnell RF, 2008, NANO LETT, V8, P3029, DOI 10.1021/nl802312f; Ramirez P, 2015, NANO ENERGY, V16, P375, DOI 10.1016/j.nanoen.2015.07.013; Reiner JE, 2012, CHEM REV, V112, P6431, DOI 10.1021/cr300381m; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Stava E, 2010, IEEE T NANOBIOSCI, V9, P307, DOI 10.1109/TNB.2010.2076830; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Steinbock LJ, 2013, ACS NANO, V7, P11255, DOI 10.1021/nn405029j; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; Tabard-Cossa V, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/30/305505; TSURU T, 1991, J CHEM ENG JPN, V24, P511, DOI 10.1252/jcej.24.511; van den Hout M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115304; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388; Wanunu M, 2007, NANO LETT, V7, P1580, DOI 10.1021/nl070462b; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wu MY, 2009, NANO LETT, V9, P479, DOI 10.1021/nl803613s; Xie P, 2012, NAT NANOTECHNOL, V7, P119, DOI [10.1038/nnano.2011.217, 10.1038/NNANO.2011.217]; Zhou Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03287	59	8	10	9	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2018	13	7							e0200831	10.1371/journal.pone.0200831	http://dx.doi.org/10.1371/journal.pone.0200831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN8GG	30028848	gold, Green Published, Green Submitted			2022-12-27	WOS:000439396900017
